data_2lc7_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lc7 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.453 ' HB3' ' HG2' ' A' ' 250' ' ' LYS 0.311 2.2 p-80 . . . . . 0 CA--C 1.505 -0.776 0 N-CA-C 116.043 1.868 . . . . 75.24 116.043 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 57.9 ttt180 -126.77 144.56 50.91 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 114.135 -1.393 . . . . 75.14 109.284 176.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.568 ' HG3' ' OG1' ' A' ' 248' ' ' THR . 0.1 OUTLIER -90.23 114.29 26.27 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 108.201 -1.037 . . . . 63.11 108.201 179.282 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 29.7 m -109.21 136.38 45.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-O 120.733 0.301 . . . . 74.43 111.215 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -99.08 121.71 41.35 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-O 121.516 0.674 . . . . 74.44 110.073 178.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.431 ' HB2' ' HB3' ' A' ' 245' ' ' LEU . 18.6 mt -104.24 137.06 42.71 Favored 'General case' 0 N--CA 1.403 -2.806 0 N-CA-C 106.637 -1.616 . . . . 70.52 106.637 177.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 14.2 tp . . . . . 0 C--N 1.288 -2.099 0 N-CA-C 114.264 1.209 . . . . 71.54 114.264 177.466 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 89.5 mt . . . . . 0 N--CA 1.467 0.421 0 N-CA-C 111.863 0.32 . . . . 75.35 111.863 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . 0.49 ' HA3' ' HA3' ' A' ' 204' ' ' GLY . . . 93.91 22.35 25.84 Favored Glycine 0 N--CA 1.429 -1.793 0 C-N-CA 120.115 -1.041 . . . . 61.14 114.169 173.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -160.18 154.1 22.97 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 117.74 0.77 . . . . 75.25 109.157 177.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -123.86 153.56 40.9 Favored 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 107.403 -1.332 . . . . 72.31 107.403 177.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 39.9 pt -113.73 166.62 7.39 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 CA-C-O 121.38 0.609 . . . . 72.53 111.021 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . 0.48 ' HG2' ' HB3' ' A' ' 198' ' ' SER . 16.2 ptt180 -147.12 154.75 41.49 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 115.286 -0.87 . . . . 62.45 109.833 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -110.32 142.79 41.47 Favored 'General case' 0 C--N 1.29 -1.998 0 O-C-N 123.901 0.75 . . . . 73.23 109.69 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -159.48 160.89 31.76 Favored Glycine 0 C--N 1.289 -2.072 0 N-CA-C 108.898 -1.681 . . . . 70.02 108.898 177.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' THR . . . . . 0.411 HG21 ' HG2' ' A' ' 191' ' ' LYS . 0.6 OUTLIER -90.82 123.6 34.49 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.169 -1.419 . . . . 74.41 107.169 178.844 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' SER . . . . . 0.5 ' O ' ' HA ' ' A' ' 191' ' ' LYS . 22.8 t . . . . . 0 C--N 1.283 -2.302 0 C-N-CA 123.311 0.644 . . . . 72.12 109.619 -175.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.5 ' HA ' ' O ' ' A' ' 181' ' ' SER . 34.0 ttmt . . . . . 0 N--CA 1.426 -1.631 0 N-CA-C 106.771 -1.566 . . . . 73.22 106.771 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.44 158.6 37.88 Favored Pre-proline 0 C--N 1.307 -1.27 0 CA-C-O 118.899 -0.572 . . . . 62.53 110.153 -169.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -67.42 130.42 22.36 Favored 'Trans proline' 0 C--O 1.25 1.099 0 CA-C-N 119.941 1.015 . . . . 71.13 111.645 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -142.88 151.11 22.88 Favored Glycine 0 N--CA 1.412 -2.956 0 CA-C-N 115.393 -0.822 . . . . 72.31 111.357 -177.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 2.7 mp -104.13 136.91 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.286 0 N-CA-C 109.535 -0.543 . . . . 63.22 109.535 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -127.21 164.75 20.99 Favored 'General case' 0 C--N 1.28 -2.434 0 N-CA-C 107.393 -1.336 . . . . 74.33 107.393 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 42.6 mm -76.46 131.43 34.89 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 N-CA-C 106.896 -1.52 . . . . 64.14 106.896 175.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' SER . . . . . 0.48 ' HB3' ' HG2' ' A' ' 177' ' ' ARG . 75.7 p -100.92 -41.1 6.96 Favored 'General case' 0 C--N 1.287 -2.142 0 C-N-CA 118.612 -1.235 . . . . 75.22 111.092 -177.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 31.6 tpt180 -148.32 141.32 24.87 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.302 -0.999 . . . . 73.3 108.302 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 2.6 tt -122.25 123.58 41.78 Favored 'General case' 0 N--CA 1.421 -1.882 0 N-CA-C 106.672 -1.603 . . . . 74.34 106.672 178.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 36.5 t -105.85 126.76 29.87 Favored Pre-proline 0 C--N 1.307 -1.273 0 C-N-CA 122.559 0.344 . . . . 55.51 111.33 -172.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . 0.475 ' HA ' ' HG3' ' A' ' 207' ' ' GLU . 45.0 Cg_endo -70.82 128.51 15.15 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 122.395 2.063 . . . . 73.4 110.954 176.164 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 114.38 -18.04 18.36 Favored Glycine 0 N--CA 1.439 -1.102 0 N-CA-C 110.47 -1.052 . . . . 63.11 110.47 -177.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . 0.49 ' HA3' ' HA3' ' A' ' 173' ' ' GLY . . . -96.04 171.42 28.47 Favored Glycine 0 N--CA 1.433 -1.525 0 N-CA-C 110.517 -1.033 . . . . 70.14 110.517 178.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -65.22 -29.79 70.62 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 117.267 0.534 . . . . 74.43 112.084 -174.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -62.75 -44.41 96.27 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.996 -0.547 . . . . 62.43 110.97 178.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.475 ' HG3' ' HA ' ' A' ' 202' ' ' PRO . 2.9 tm-20 -75.9 -33.75 59.94 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.375 -0.972 . . . . 73.24 108.375 179.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 50.4 m -56.83 -42.48 79.68 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 116.298 -0.41 . . . . 74.41 110.803 177.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 13.9 t -73.34 -40.91 64.06 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 119.095 -1.042 . . . . 73.32 108.442 174.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 56.18 29.61 56.48 Favored Glycine 0 C--N 1.347 1.193 0 CA-C-N 115.908 -0.587 . . . . 74.3 113.24 177.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 68.2 mt -103.39 -12.67 17.04 Favored 'General case' 0 C--N 1.308 -1.228 0 O-C-N 122.674 -0.31 . . . . 71.31 110.299 -178.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -113.68 158.07 21.36 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 115.484 -0.78 . . . . 64.51 109.552 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -130.46 165.59 22.32 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 123.047 0.539 . . . . 73.34 110.157 179.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 34.5 m -63.69 -30.07 48.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 113.599 0.963 . . . . 74.01 113.599 -179.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -76.77 -15.06 59.85 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 116.203 -0.453 . . . . 72.21 111.703 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -68.17 147.58 52.07 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-O 121.64 0.733 . . . . 50.51 112.649 -175.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -108.59 133.94 52.03 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.638 -1.164 . . . . 64.41 111.27 -177.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 39.8 t -83.62 133.96 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-O 121.811 0.815 . . . . 71.31 111.2 -175.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 46.8 mm -102.97 -56.47 5.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 CA-C-N 114.656 -1.156 . . . . 75.13 110.996 -178.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -152.37 165.19 35.77 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.986 -0.552 . . . . 72.41 109.934 -175.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . 0.507 ' HA ' ' O ' ' A' ' 246' ' ' ILE . 8.9 p -134.8 123.88 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 CA-C-N 115.92 -0.582 . . . . 65.45 110.052 177.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . 0.418 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 12.8 t-20 65.44 13.52 8.9 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 125.241 1.416 . . . . 75.42 110.706 177.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 107.0 -9.4 39.69 Favored Glycine 0 N--CA 1.442 -0.933 0 C-N-CA 120.84 -0.695 . . . . 74.3 112.079 -178.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 64.4 mt -105.06 124.27 59.69 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 N-CA-C 110.13 -0.322 . . . . 72.22 110.13 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -57.2 142.58 42.36 Favored 'General case' 0 C--N 1.31 -1.126 0 C-N-CA 124.483 1.113 . . . . 65.11 112.6 -178.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 30.6 m -118.91 -1.68 8.99 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 CA-C-N 115.525 -0.761 . . . . 73.23 109.8 175.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -76.92 99.04 5.09 Favored 'General case' 0 N--CA 1.428 -1.546 0 CA-C-N 115.356 -0.838 . . . . 74.23 109.719 -177.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 118.9 -14.0 11.41 Favored Glycine 0 N--CA 1.435 -1.39 0 C-N-CA 120.839 -0.696 . . . . 73.14 111.729 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -76.97 -179.93 5.81 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 120.987 0.422 . . . . 75.3 110.654 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 50.6 p -95.53 162.73 13.51 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 108.187 -1.042 . . . . 70.45 108.187 177.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -63.59 -33.26 75.22 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 109.067 -0.716 . . . . 75.22 109.067 -178.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -63.42 -49.7 72.7 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.516 -0.311 . . . . 61.44 110.293 176.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' GLN . . . . . 0.556 ' O ' ' HG2' ' A' ' 237' ' ' MET . 47.9 mt-30 -57.28 -41.72 80.32 Favored 'General case' 0 CA--C 1.509 -0.625 0 N-CA-C 112.447 0.536 . . . . 75.5 112.447 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 10.2 m -74.3 -34.57 37.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 C-N-CA 120.764 -0.375 . . . . 75.32 111.399 -177.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 26.0 m -71.14 -38.04 72.27 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 108.368 -0.975 . . . . 74.02 108.368 178.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -59.86 -35.6 75.14 Favored 'General case' 0 C--O 1.243 0.746 0 CA-C-N 115.385 -0.825 . . . . 74.51 110.144 177.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' MET . . . . . 0.556 ' HG2' ' O ' ' A' ' 233' ' ' GLN . 17.3 mmt -59.78 -52.43 65.49 Favored 'General case' 0 C--O 1.199 -1.576 0 N-CA-C 108.065 -1.087 . . . . 73.43 108.065 175.293 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 63.4 mtt -61.57 -36.96 82.13 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.754 -1.112 . . . . 74.33 112.422 -175.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 83.9 t -68.49 -36.8 76.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-O 121.396 0.617 . . . . 74.43 110.287 176.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -74.48 -36.4 63.29 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.905 0.859 . . . . 74.42 110.11 179.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -87.75 22.13 2.39 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 114.945 -1.025 . . . . 75.11 110.607 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 25.5 p -59.86 -28.2 67.31 Favored 'General case' 0 CA--C 1.554 1.13 0 N-CA-C 113.691 0.997 . . . . 52.45 113.691 -177.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 48.7 m -85.55 -9.28 57.59 Favored 'General case' 0 C--N 1.318 -0.789 0 O-C-N 121.672 -0.642 . . . . 73.33 112.038 177.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 14.8 p30 -164.56 78.24 0.35 Allowed 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.524 0.678 . . . . 71.02 111.376 -176.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . 0.431 ' HB3' ' HB2' ' A' ' 163' ' ' LEU . 1.2 tt -85.54 101.89 13.06 Favored 'General case' 0 N--CA 1.422 -1.844 0 C-N-CA 118.721 -1.192 . . . . 75.21 108.059 -174.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . 0.507 ' O ' ' HA ' ' A' ' 221' ' ' VAL . 68.7 mt -104.7 116.15 47.96 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.319 0 C-N-CA 119.713 -0.795 . . . . 61.51 108.963 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 23.2 mt -118.53 136.91 54.2 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.257 0 CA-C-O 121.627 0.727 . . . . 74.34 111.477 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.568 ' OG1' ' HG3' ' A' ' 160' ' ' ARG . 39.0 m -107.74 119.34 39.16 Favored 'General case' 0 N--CA 1.405 -2.713 0 CA-C-N 115.073 -0.967 . . . . 72.53 108.573 177.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 27.1 m -129.29 159.32 41.45 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 O-C-N 123.282 0.364 . . . . 64.44 110.296 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . 0.453 ' HG2' ' HB3' ' A' ' 158' ' ' HIS 0.346 35.7 mtmt -124.09 142.26 39.33 Favored Pre-proline 0 CA--C 1.475 -1.919 0 N-CA-C 104.435 -2.431 . . . . 75.41 104.435 175.538 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo . . . . . 0 C--N 1.286 -2.747 0 C-N-CA 120.871 1.047 . . . . 63.11 111.364 176.537 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.467 ' HB3' ' HG2' ' A' ' 250' ' ' LYS 0.374 2.3 p-80 . . . . . 0 N--CA 1.436 -1.159 0 N-CA-C 115.397 1.629 . . . . 70.23 115.397 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.53 ' O ' ' HA ' ' A' ' 248' ' ' THR . 3.7 ptp180 -125.25 144.96 50.21 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 113.575 -1.648 . . . . 75.53 108.944 -176.029 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.696 ' HB3' ' OG1' ' A' ' 248' ' ' THR . 37.0 ptt180 -117.27 119.25 34.58 Favored 'General case' 0 N--CA 1.426 -1.627 0 CA-C-O 121.901 0.858 . . . . 72.41 113.05 178.025 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.576 ' O ' ' HA ' ' A' ' 246' ' ' ILE . 26.6 m -102.78 135.02 42.12 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 CA-C-N 114.617 -1.174 . . . . 74.32 111.075 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.502 ' HG2' HG12 ' A' ' 246' ' ' ILE . 15.4 mtm180 -96.48 112.66 24.32 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 106.927 -1.508 . . . . 65.42 106.927 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 21.4 mt -99.34 134.23 42.5 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 109.52 -0.548 . . . . 75.44 109.52 -177.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.404 ' HB2' ' CD1' ' A' ' 172' ' ' LEU . 6.3 tt . . . . . 0 C--N 1.318 -0.774 0 O-C-N 124.344 1.027 . . . . 72.15 111.893 174.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.435 ' HG ' ' CD1' ' A' ' 245' ' ' LEU . 2.9 mm? . . . . . 0 N--CA 1.437 -1.083 0 CA-C-O 120.589 0.233 . . . . 75.25 111.021 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . 0.414 ' HA3' ' HA3' ' A' ' 204' ' ' GLY . . . 89.24 43.97 5.15 Favored Glycine 0 N--CA 1.436 -1.346 0 C-N-CA 120.592 -0.813 . . . . 75.21 113.983 174.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -161.94 154.76 20.2 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.627 -1.249 . . . . 74.34 107.627 174.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -123.95 157.88 33.3 Favored 'General case' 0 C--N 1.282 -2.353 0 N-CA-C 108.533 -0.914 . . . . 74.52 108.533 177.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.72 160.52 27.28 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 N-CA-C 109.571 -0.529 . . . . 72.44 109.571 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . 0.427 ' HG2' ' HB3' ' A' ' 198' ' ' SER . 10.1 ptp180 -132.21 154.64 49.38 Favored 'General case' 0 C--N 1.282 -2.355 0 CA-C-N 115.656 -0.702 . . . . 74.23 110.684 -178.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . 0.441 ' HB2' ' HG ' ' A' ' 231' ' ' LEU . 4.8 t70 -107.41 143.92 35.06 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 115.085 -0.961 . . . . 52.32 110.509 -179.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -164.92 179.79 39.35 Favored Glycine 0 N--CA 1.415 -2.715 0 N-CA-C 108.871 -1.692 . . . . 52.13 108.871 175.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' THR . . . . . 0.415 ' HB ' ' CG ' ' A' ' 191' ' ' LYS . 0.4 OUTLIER -89.99 122.34 32.91 Favored 'General case' 0 C--N 1.283 -2.301 0 CA-C-N 117.524 0.662 . . . . 74.0 111.024 175.667 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 47.3 t . . . . . 0 N--CA 1.414 -2.265 0 N-CA-C 107.87 -1.159 . . . . 64.31 107.87 177.817 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.415 ' CG ' ' HB ' ' A' ' 180' ' ' THR . 35.5 ttmt . . . . . 0 N--CA 1.422 -1.83 0 N-CA-C 107.785 -1.191 . . . . 72.4 107.785 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -151.09 164.98 18.39 Favored Pre-proline 0 C--N 1.293 -1.878 0 N-CA-C 108.256 -1.016 . . . . 72.5 108.256 -178.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -55.19 132.27 51.3 Favored 'Trans proline' 0 C--N 1.358 1.04 0 C-N-CA 121.637 1.558 . . . . 75.02 109.846 174.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -143.93 138.65 8.18 Favored Glycine 0 N--CA 1.409 -3.106 0 N-CA-C 111.38 -0.688 . . . . 71.13 111.38 -178.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 2.7 mp -103.63 134.52 44.59 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.94 0 CA-C-O 121.605 0.717 . . . . 72.14 110.883 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -124.27 166.17 16.36 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 106.149 -1.797 . . . . 71.23 106.149 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 47.8 mm -79.08 131.27 34.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 107.562 -1.273 . . . . 75.31 107.562 177.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' SER . . . . . 0.427 ' HB3' ' HG2' ' A' ' 177' ' ' ARG . 82.3 p -101.64 -31.64 10.72 Favored 'General case' 0 C--N 1.287 -2.111 0 C-N-CA 118.633 -1.227 . . . . 43.13 112.752 -175.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 29.6 tpt180 -166.76 146.15 5.54 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 120.781 -0.368 . . . . 74.02 110.344 -175.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 82.9 mt -102.54 146.38 28.22 Favored 'General case' 0 CA--C 1.489 -1.381 0 N-CA-C 108.932 -0.766 . . . . 70.43 108.932 172.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 47.8 t -107.52 115.89 58.64 Favored Pre-proline 0 C--N 1.282 -2.337 0 N-CA-C 105.3 -2.111 . . . . 73.42 105.3 172.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . 0.431 ' HA ' ' HG3' ' A' ' 207' ' ' GLU . 11.5 Cg_endo -55.03 128.67 31.53 Favored 'Trans proline' 0 C--O 1.248 0.98 0 C-N-CA 122.335 2.023 . . . . 75.25 111.129 -177.118 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 99.05 -11.4 62.17 Favored Glycine 0 N--CA 1.439 -1.158 0 C-N-CA 120.6 -0.809 . . . . 71.32 111.719 -177.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . 0.414 ' HA3' ' HA3' ' A' ' 173' ' ' GLY . . . -74.82 166.36 54.85 Favored Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 121.032 -0.604 . . . . 75.21 111.597 178.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . 0.428 HD21 ' HA ' ' A' ' 172' ' ' LEU . 3.0 mm? -66.09 -34.02 77.11 Favored 'General case' 0 C--N 1.312 -1.036 0 C-N-CA 122.996 0.518 . . . . 73.34 111.641 -176.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -67.75 -42.43 81.83 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.522 0.677 . . . . 72.4 110.051 178.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.431 ' HG3' ' HA ' ' A' ' 202' ' ' PRO . 6.0 tm-20 -75.39 -34.49 61.09 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 114.915 -1.039 . . . . 72.14 108.982 -178.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 35.9 t -58.54 -47.34 84.54 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 123.786 0.834 . . . . 73.21 110.795 177.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 10.2 t -75.6 -35.67 60.48 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 120.004 -0.678 . . . . 71.15 109.446 177.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 74.17 16.56 79.64 Favored Glycine 0 N--CA 1.442 -0.905 0 CA-C-N 115.984 -0.553 . . . . 40.33 112.672 177.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 54.9 mt -99.19 -0.55 41.29 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 120.933 0.397 . . . . 64.44 110.449 -178.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 80.6 mt -109.79 131.7 54.83 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 115.187 -0.915 . . . . 74.23 108.941 174.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -130.7 155.9 45.83 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 109.102 -0.703 . . . . 62.12 109.102 177.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 31.2 m -62.16 -29.28 46.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-O 122.078 0.942 . . . . 72.0 112.773 -177.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -77.99 -14.06 59.66 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 115.533 -0.758 . . . . 74.33 111.782 -178.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -76.71 150.68 36.28 Favored 'General case' 0 C--O 1.244 0.786 0 N-CA-C 113.02 0.748 . . . . 53.13 113.02 -173.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -108.81 132.34 54.09 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.016 -0.993 . . . . 72.22 109.766 -178.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . 0.431 ' HA ' HG13 ' A' ' 249' ' ' VAL . 39.7 t -83.33 138.33 19.48 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 CA-C-O 121.488 0.661 . . . . 71.32 111.509 -176.053 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 46.0 mm -105.22 -53.16 7.13 Favored 'Isoleucine or valine' 0 C--O 1.246 0.875 0 CA-C-N 115.171 -0.922 . . . . 75.32 111.099 -178.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.464 ' CG ' ' HG1' ' A' ' 248' ' ' THR . 10.5 pt-20 -153.92 165.85 34.81 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 116.049 -0.523 . . . . 74.43 109.82 -175.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' A' ' 246' ' ' ILE . 8.3 p -135.19 122.97 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.749 0 CA-C-N 115.647 -0.706 . . . . 74.34 109.148 176.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . 0.523 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 12.2 t-20 68.73 5.52 4.98 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 125.083 1.353 . . . . 73.22 111.198 178.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 113.63 -14.15 22.51 Favored Glycine 0 N--CA 1.439 -1.149 0 N-CA-C 110.882 -0.887 . . . . 75.32 110.882 -178.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 65.7 mt -96.34 123.75 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.521 0 N-CA-C 109.1 -0.704 . . . . 71.24 109.1 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -58.05 153.01 15.42 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 123.684 0.794 . . . . 73.45 112.002 -177.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 35.9 m -129.59 2.47 2.58 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 CA-C-N 115.411 -0.813 . . . . 71.23 110.248 174.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -71.84 98.56 2.02 Favored 'General case' 0 N--CA 1.432 -1.372 0 CA-C-N 115.634 -0.712 . . . . 71.1 110.693 -178.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 121.12 -17.57 9.11 Favored Glycine 0 CA--C 1.489 -1.551 0 N-CA-C 110.378 -1.089 . . . . 44.1 110.378 178.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -83.5 163.21 20.61 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.122 -0.539 . . . . 73.24 111.333 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' THR . . . . . 0.443 ' H ' ' NE2' ' A' ' 233' ' ' GLN . 37.2 p -97.19 172.32 7.89 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.756 -0.657 . . . . 75.35 110.667 -176.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . 0.441 ' HG ' ' HB2' ' A' ' 178' ' ' ASP . 78.0 mt -56.65 -40.32 75.25 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 111.837 0.31 . . . . 64.11 111.837 177.152 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -56.8 -42.7 79.96 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 121.279 0.561 . . . . 73.34 110.132 179.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' GLN . . . . . 0.443 ' NE2' ' H ' ' A' ' 230' ' ' THR . 49.0 mt-30 -72.94 -47.71 43.19 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.961 -1.018 . . . . 71.21 112.339 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.444 ' O ' ' HG3' ' A' ' 238' ' ' MET . 16.9 m -70.86 -34.47 56.18 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 112.092 0.404 . . . . 51.21 112.092 -176.056 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 50.3 m -69.57 -35.3 75.24 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 109.429 -0.582 . . . . 75.14 109.429 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -60.73 -38.93 86.78 Favored 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 108.863 -0.792 . . . . 73.3 108.863 177.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 15.9 mmt -59.46 -50.17 74.95 Favored 'General case' 0 C--O 1.199 -1.563 0 CA-C-N 115.332 -0.849 . . . . 74.15 108.725 177.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' MET . . . . . 0.444 ' HG3' ' O ' ' A' ' 234' ' ' VAL . 63.0 mtt -61.8 -37.31 83.91 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.895 0.878 . . . . 74.44 112.259 -176.313 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 97.3 t -65.13 -40.32 88.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 121.19 0.519 . . . . 53.14 109.942 176.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -72.97 -37.0 67.21 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.613 0.721 . . . . 74.44 110.297 178.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -86.87 21.11 2.35 Favored 'General case' 0 C--O 1.202 -1.431 0 CA-C-N 115.603 -0.726 . . . . 71.45 111.905 -178.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 69.8 m -65.21 -22.88 66.95 Favored 'General case' 0 C--N 1.312 -1.022 0 C-N-CA 120.41 -0.516 . . . . 71.53 111.548 177.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 23.1 m -70.47 -24.38 62.86 Favored 'General case' 0 CA--C 1.554 1.11 0 CA-C-N 116.363 -0.381 . . . . 74.22 111.032 176.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -174.3 97.3 0.1 Allowed 'General case' 0 C--O 1.246 0.913 0 C-N-CA 124.363 1.065 . . . . 51.2 109.205 177.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . 0.435 ' CD1' ' HG ' ' A' ' 172' ' ' LEU . 2.4 tt -88.16 103.03 15.38 Favored 'General case' 0 N--CA 1.414 -2.273 0 N-CA-C 109.211 -0.662 . . . . 72.3 109.211 -173.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . 0.576 ' HA ' ' O ' ' A' ' 161' ' ' VAL . 69.7 mt -100.87 116.7 44.88 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.179 0 N-CA-C 109.37 -0.604 . . . . 72.0 109.37 -179.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 27.0 mt -120.94 132.54 70.18 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 CA-C-O 121.541 0.686 . . . . 71.12 112.331 178.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.696 ' OG1' ' HB3' ' A' ' 160' ' ' ARG . 37.0 m -104.19 122.8 46.11 Favored 'General case' 0 N--CA 1.414 -2.244 0 CA-C-N 114.291 -1.322 . . . . 72.14 108.603 177.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . 0.431 HG13 ' HA ' ' A' ' 218' ' ' VAL . 34.7 m -130.79 164.09 34.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 110.035 -0.357 . . . . 71.34 110.035 177.204 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . 0.467 ' HG2' ' HB3' ' A' ' 158' ' ' HIS 0.296 38.6 mtmt -124.39 141.73 38.36 Favored Pre-proline 0 CA--C 1.48 -1.721 0 N-CA-C 104.788 -2.301 . . . . 74.54 104.788 173.919 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo . . . . . 0 N--CA 1.411 -3.351 0 C-N-CA 120.573 0.848 . . . . 74.23 111.257 176.992 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 4.7 m80 . . . . . 0 N--CA 1.443 -0.808 0 CA-C-O 121.658 0.742 . . . . 73.03 112.588 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.427 ' O ' ' HA ' ' A' ' 248' ' ' THR . 18.8 tpp180 -107.29 141.41 38.68 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 107.218 -1.401 . . . . 72.35 107.218 177.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -114.96 113.15 23.75 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 108.657 -0.868 . . . . 75.12 108.657 175.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 17.7 m -129.08 137.86 56.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-O 120.868 0.366 . . . . 75.3 111.986 179.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 42.9 ttp180 -116.81 112.5 21.21 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 108.904 -0.776 . . . . 71.35 108.904 173.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 13.5 mt -102.56 138.83 38.96 Favored 'General case' 0 C--N 1.281 -2.386 0 N-CA-C 107.319 -1.363 . . . . 75.14 107.319 -175.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.427 ' HB2' ' CD1' ' A' ' 172' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.446 -0.672 0 N-CA-C 108.263 -1.014 . . . . 74.31 108.263 174.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.427 ' CD1' ' HB2' ' A' ' 164' ' ' LEU . 3.3 mm? . . . . . 0 CA--C 1.506 -0.713 0 CA-C-O 121.201 0.524 . . . . 72.53 110.177 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . 0.436 ' HA3' ' HA3' ' A' ' 204' ' ' GLY . . . 90.53 25.15 26.48 Favored Glycine 0 N--CA 1.42 -2.368 0 CA-C-N 115.445 -0.798 . . . . 73.34 113.522 176.108 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -143.11 151.54 40.84 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 107.843 -1.169 . . . . 74.32 107.843 174.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -131.13 152.85 49.99 Favored 'General case' 0 CA--C 1.484 -1.588 0 CA-C-O 120.808 0.337 . . . . 74.11 110.227 178.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.425 ' HB ' ' CG2' ' A' ' 195' ' ' ILE . 0.2 OUTLIER -116.85 169.85 6.87 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.049 0 CA-C-N 115.66 -0.7 . . . . 63.53 112.219 -173.81 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . 0.579 ' CG ' ' HB2' ' A' ' 198' ' ' SER . 11.8 ptt180 -148.51 156.02 41.91 Favored 'General case' 0 C--N 1.287 -2.133 0 C-N-CA 125.478 1.511 . . . . 75.34 109.841 -175.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -110.89 144.61 39.67 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 123.466 0.479 . . . . 73.25 110.856 179.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -162.44 171.68 38.35 Favored Glycine 0 N--CA 1.427 -1.901 0 N-CA-C 108.876 -1.69 . . . . 43.42 108.876 175.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' THR . . . . . 0.455 ' HB ' ' CG ' ' A' ' 191' ' ' LYS . 0.6 OUTLIER -86.76 123.85 32.37 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 118.172 0.986 . . . . 74.23 111.658 175.966 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 34.7 t . . . . . 0 N--CA 1.404 -2.768 0 N-CA-C 107.927 -1.138 . . . . 74.55 107.927 177.411 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.455 ' CG ' ' HB ' ' A' ' 180' ' ' THR . 36.3 ttmt . . . . . 0 N--CA 1.44 -0.969 0 N-CA-C 109.071 -0.714 . . . . 74.3 109.071 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . 0.401 HE21 ' HB2' ' A' ' 227' ' ' ALA . 11.3 pt20 -144.21 164.33 29.71 Favored Pre-proline 0 C--N 1.297 -1.705 0 N-CA-C 107.503 -1.295 . . . . 75.33 107.503 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -65.17 132.86 33.17 Favored 'Trans proline' 0 C--O 1.247 0.934 0 C-N-CA 121.102 1.201 . . . . 74.23 109.776 174.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -137.94 141.62 12.36 Favored Glycine 0 N--CA 1.414 -2.787 0 N-CA-C 110.533 -1.027 . . . . 51.51 110.533 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.482 ' HB ' ' CG1' ' A' ' 218' ' ' VAL . 3.4 mp -103.74 136.04 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.402 0 N-CA-C 109.272 -0.64 . . . . 74.11 109.272 179.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -128.1 167.6 16.53 Favored 'General case' 0 C--N 1.282 -2.326 0 N-CA-C 107.73 -1.211 . . . . 73.12 107.73 -177.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 58.5 mt -83.6 131.71 33.19 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 N-CA-C 109.334 -0.617 . . . . 74.23 109.334 174.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' SER . . . . . 0.579 ' HB2' ' CG ' ' A' ' 177' ' ' ARG . 29.6 t -110.18 -27.91 8.9 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.557 -0.714 . . . . 70.32 112.691 -177.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -147.63 134.53 20.19 Favored 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 120.037 -0.665 . . . . 73.45 109.583 -176.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 1.4 tt -116.18 124.81 51.23 Favored 'General case' 0 N--CA 1.414 -2.239 0 N-CA-C 106.51 -1.663 . . . . 73.53 106.51 179.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 96.6 t -94.14 124.69 55.21 Favored Pre-proline 0 C--N 1.306 -1.284 0 N-CA-C 110.472 -0.196 . . . . 74.42 110.472 -178.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -60.59 126.29 19.5 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.459 2.106 . . . . 42.31 110.782 177.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 98.91 -6.66 60.31 Favored Glycine 0 N--CA 1.435 -1.405 0 C-N-CA 120.777 -0.725 . . . . 53.53 112.614 -178.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . 0.436 ' HA3' ' HA3' ' A' ' 173' ' ' GLY . . . -79.53 169.54 53.62 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.5 -0.857 . . . . 65.41 112.285 179.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -65.06 -34.63 78.87 Favored 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 122.723 0.409 . . . . 73.14 110.653 -178.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -60.3 -43.59 96.16 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.64 -0.709 . . . . 75.34 110.809 178.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -75.6 -35.89 60.44 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.257 -0.429 . . . . 75.23 110.324 179.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 37.9 t -56.61 -42.71 79.24 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.817 -0.629 . . . . 72.33 110.35 179.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 10.2 t -82.86 -35.73 26.02 Favored 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 120.454 -0.498 . . . . 72.33 109.912 176.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 75.18 5.74 77.43 Favored Glycine 0 C--O 1.217 -0.925 0 CA-C-N 116.202 -0.453 . . . . 65.13 112.986 177.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 67.0 mt -87.05 -11.79 49.26 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 120.813 0.339 . . . . 61.41 110.894 -177.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 4.3 mp -109.65 133.73 52.77 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 120.351 -0.54 . . . . 74.15 109.63 177.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -131.09 166.0 22.03 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 108.762 -0.829 . . . . 60.34 108.762 176.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 30.2 m -59.97 -28.06 40.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 113.324 0.861 . . . . 62.45 113.324 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 20.1 m-80 -71.95 -15.97 62.08 Favored 'General case' 0 C--N 1.312 -1.022 0 O-C-N 122.038 -0.414 . . . . 74.34 110.769 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.479 ' HA ' ' HA ' ' A' ' 251' ' ' PRO . 5.0 m-20 -71.18 132.35 44.87 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 114.426 1.269 . . . . 72.51 114.426 -174.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -105.19 131.12 53.06 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 126.328 1.851 . . . . 65.24 108.497 -179.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . 0.482 ' CG1' ' HB ' ' A' ' 195' ' ' ILE . 11.4 p -83.5 134.55 26.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-O 122.034 0.921 . . . . 75.51 112.58 -175.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 39.7 mm -99.49 -49.01 11.67 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 CA-C-N 114.303 -1.317 . . . . 63.32 110.645 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -160.12 160.51 33.08 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.192 -0.458 . . . . 75.03 110.775 -176.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' A' ' 246' ' ' ILE . 7.5 p -129.7 122.67 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.03 0 O-C-N 123.736 0.647 . . . . 71.55 109.675 175.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . 0.426 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 2.8 m-20 58.89 22.08 9.84 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 125.519 1.528 . . . . 73.22 113.651 -178.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 105.85 -13.87 45.57 Favored Glycine 0 N--CA 1.429 -1.83 0 C-N-CA 120.323 -0.941 . . . . 61.12 113.062 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 60.9 mt -97.9 123.85 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.046 0 C-N-CA 120.705 -0.398 . . . . 73.33 110.458 -179.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -51.64 133.7 30.52 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 124.711 1.257 . . . . 74.34 111.608 177.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . 0.411 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 29.7 m -115.74 11.47 7.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 CA-C-O 122.217 1.008 . . . . 73.2 108.338 172.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' ALA . . . . . 0.401 ' HB2' HE21 ' A' ' 192' ' ' GLN . . . -68.44 97.11 0.73 Allowed 'General case' 0 N--CA 1.422 -1.869 0 CA-C-N 113.468 -1.697 . . . . 72.43 111.142 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 95.56 10.3 56.92 Favored Glycine 0 C--N 1.307 -1.038 0 CA-C-N 115.609 -0.723 . . . . 64.4 112.88 174.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -82.94 178.31 8.22 Favored 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 120.506 -0.478 . . . . 73.34 109.83 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 41.1 p -87.82 157.64 18.95 Favored 'General case' 0 N--CA 1.421 -1.889 0 N-CA-C 107.135 -1.432 . . . . 61.53 107.135 174.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . 0.433 ' O ' HG21 ' A' ' 234' ' ' VAL . 1.3 tt -64.83 -32.72 74.55 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 108.1 -1.074 . . . . 74.43 108.1 -177.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -64.35 -38.99 92.98 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.411 -0.358 . . . . 75.21 110.487 177.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -60.34 -49.36 77.9 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 112.026 0.38 . . . . 73.43 112.026 175.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.433 HG21 ' O ' ' A' ' 231' ' ' LEU . 5.4 m -67.92 -32.76 57.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-O 121.242 0.544 . . . . 72.31 111.739 -176.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 88.2 m -74.18 -37.15 64.04 Favored 'General case' 0 CA--C 1.498 -1.044 0 CA-C-N 115.567 -0.742 . . . . 64.05 109.084 -176.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -60.39 -34.12 73.44 Favored 'General case' 0 CA--C 1.507 -0.682 0 CA-C-N 115.433 -0.803 . . . . 63.0 109.153 177.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 8.9 mtt -69.24 -44.88 71.09 Favored 'General case' 0 C--O 1.2 -1.527 0 N-CA-C 108.686 -0.857 . . . . 74.31 108.686 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' MET . . . . . 0.415 ' HG3' ' O ' ' A' ' 234' ' ' VAL . 64.7 mtt -60.12 -31.76 70.36 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.979 -0.555 . . . . 74.52 111.681 -178.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 91.0 t -74.12 -41.9 51.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-O 121.327 0.584 . . . . 74.23 110.004 176.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -70.51 -35.59 73.28 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.386 0.612 . . . . 75.01 111.106 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -84.71 21.95 1.43 Allowed 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 115.357 -0.838 . . . . 64.45 112.546 -178.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 67.9 m -59.41 -23.46 62.65 Favored 'General case' 0 C--O 1.207 -1.159 0 N-CA-C 113.08 0.771 . . . . 71.3 113.08 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 22.6 p -68.42 -33.93 75.09 Favored 'General case' 0 CA--C 1.552 1.033 0 O-C-N 121.76 -0.588 . . . . 53.04 111.861 177.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 -159.68 100.59 1.46 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.931 1.292 . . . . 54.31 108.264 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -86.55 103.1 14.74 Favored 'General case' 0 C--O 1.21 -1.012 0 N-CA-C 108.443 -0.947 . . . . 62.4 108.443 -178.123 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . 0.426 ' HB ' ' HA ' ' A' ' 222' ' ' ASN . 61.9 mt -103.78 116.32 47.34 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 N-CA-C 108.731 -0.84 . . . . 74.24 108.731 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 18.2 mt -121.99 134.54 64.97 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.155 0 CA-C-O 121.801 0.81 . . . . 72.23 112.318 178.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.427 ' HA ' ' O ' ' A' ' 159' ' ' ARG . 46.3 m -106.54 114.96 29.38 Favored 'General case' 0 N--CA 1.411 -2.413 0 N-CA-C 107.771 -1.196 . . . . 73.31 107.771 175.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . 0.446 ' HB ' ' HB3' ' A' ' 216' ' ' ASP . 18.1 m -123.27 161.42 25.13 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 CA-C-O 121.004 0.43 . . . . 75.44 110.354 177.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 16.0 ptmt -137.1 135.75 20.12 Favored Pre-proline 0 C--N 1.278 -2.54 0 N-CA-C 107.024 -1.473 . . . . 75.21 107.024 173.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . 0.479 ' HA ' ' HA ' ' A' ' 216' ' ' ASP . 38.8 Cg_exo . . . . . 0 N--CA 1.449 -1.136 0 C-N-CA 121.088 1.192 . . . . 73.31 111.249 178.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.214 -0.814 0 N-CA-C 109.105 -0.702 . . . . 72.01 109.105 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.574 ' O ' ' HA ' ' A' ' 248' ' ' THR . 24.5 tpt180 -119.69 128.88 54.22 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 120.202 -0.599 . . . . 70.14 110.342 176.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 32.1 ptt180 -115.85 114.24 24.46 Favored 'General case' 0 C--N 1.284 -2.243 0 CA-C-N 114.944 -1.025 . . . . 73.32 109.91 178.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 17.4 m -117.0 138.91 46.12 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 CA-C-N 115.459 -0.791 . . . . 73.41 111.097 -178.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.531 ' HD2' ' N ' ' A' ' 162' ' ' ARG . 1.3 mpt_? -107.76 111.99 24.44 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 106.589 -1.634 . . . . 74.22 106.589 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.459 ' HB2' ' HB3' ' A' ' 245' ' ' LEU . 29.1 mt -98.85 139.6 34.28 Favored 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 123.793 0.837 . . . . 74.43 111.72 -171.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.51 ' HB2' ' CD1' ' A' ' 172' ' ' LEU . 9.9 tp . . . . . 0 CA--C 1.515 -0.379 0 C-N-CA 125.75 1.62 . . . . 55.35 113.179 173.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.51 ' CD1' ' HB2' ' A' ' 164' ' ' LEU . 2.3 mm? . . . . . 0 N--CA 1.443 -0.797 0 CA-C-O 121.038 0.447 . . . . 74.32 110.036 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 84.08 49.57 4.69 Favored Glycine 0 N--CA 1.433 -1.516 0 CA-C-N 115.633 -0.712 . . . . 51.52 113.923 175.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -156.75 161.37 39.8 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 108.079 -1.082 . . . . 74.3 108.079 175.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -130.01 157.12 43.23 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 108.589 -0.893 . . . . 73.54 108.589 175.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.507 HD11 ' H ' ' A' ' 176' ' ' ILE . 0.2 OUTLIER -126.21 169.06 18.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 CA-C-O 121.595 0.712 . . . . 75.32 111.278 -179.04 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . 0.459 ' HG2' ' HB2' ' A' ' 198' ' ' SER . 16.9 ptt180 -157.79 155.44 29.8 Favored 'General case' 0 C--N 1.281 -2.385 0 CA-C-N 114.698 -1.137 . . . . 74.01 108.922 -175.184 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -112.77 158.26 20.32 Favored 'General case' 0 C--N 1.298 -1.664 0 C-N-CA 119.402 -0.919 . . . . 71.53 110.815 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -156.38 -179.23 31.23 Favored Glycine 0 C--N 1.29 -2.001 0 N-CA-C 107.726 -2.15 . . . . 54.51 107.726 176.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' THR . . . . . 0.405 ' CG2' ' HG2' ' A' ' 191' ' ' LYS . 0.2 OUTLIER -112.25 122.95 49.17 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 118.996 1.398 . . . . 75.42 108.178 179.63 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' SER . . . . . 0.435 ' O ' ' HA ' ' A' ' 191' ' ' LYS . 20.2 t . . . . . 0 C--N 1.289 -2.042 0 N-CA-C 108.547 -0.909 . . . . 44.23 108.547 -176.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.435 ' HA ' ' O ' ' A' ' 181' ' ' SER . 33.5 ttmt . . . . . 0 N--CA 1.426 -1.626 0 N-CA-C 106.821 -1.548 . . . . 71.22 106.821 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.33 151.82 34.53 Favored Pre-proline 0 C--N 1.299 -1.627 0 CA-C-O 118.956 -0.545 . . . . 74.34 109.645 -168.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -61.56 130.23 30.88 Favored 'Trans proline' 0 C--O 1.243 0.774 0 C-N-CA 121.339 1.359 . . . . 75.22 112.879 -176.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -135.86 142.42 13.71 Favored Glycine 0 N--CA 1.411 -2.984 0 N-CA-C 108.586 -1.805 . . . . 75.24 108.586 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.44 ' HB ' ' CG1' ' A' ' 218' ' ' VAL . 3.0 mp -104.17 138.06 30.37 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.526 0 C-N-CA 120.204 -0.598 . . . . 73.12 110.224 -178.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -122.98 166.68 14.68 Favored 'General case' 0 C--N 1.283 -2.314 0 N-CA-C 108.292 -1.003 . . . . 75.24 108.292 -177.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . 0.473 ' HB ' ' HA ' ' A' ' 214' ' ' VAL . 50.3 mm -78.49 131.21 34.96 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.265 0 N-CA-C 108.382 -0.97 . . . . 74.32 108.382 177.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' SER . . . . . 0.459 ' HB2' ' HG2' ' A' ' 177' ' ' ARG . 7.7 t -96.98 -32.43 12.02 Favored 'General case' 0 C--N 1.286 -2.178 0 O-C-N 121.703 -0.623 . . . . 72.31 112.408 -178.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -167.83 148.89 5.27 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.774 -0.194 . . . . 75.21 110.881 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 73.7 mt -102.84 146.05 28.86 Favored 'General case' 0 CA--C 1.495 -1.158 0 N-CA-C 108.599 -0.889 . . . . 74.02 108.599 170.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 59.5 t -109.14 114.3 58.1 Favored Pre-proline 0 C--N 1.28 -2.445 0 N-CA-C 106.606 -1.627 . . . . 72.33 106.606 171.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . 0.455 ' HA ' ' HG3' ' A' ' 207' ' ' GLU . 33.4 Cg_exo -59.16 128.93 29.41 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.309 2.006 . . . . 61.4 110.807 -179.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 102.17 -11.03 57.05 Favored Glycine 0 N--CA 1.442 -0.94 0 N-CA-C 110.806 -0.918 . . . . 75.23 110.806 -175.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -90.27 161.4 28.88 Favored Glycine 0 N--CA 1.439 -1.103 0 N-CA-C 110.33 -1.108 . . . . 61.12 110.33 177.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -57.24 -38.16 73.38 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 123.685 0.794 . . . . 73.23 111.946 -176.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -62.31 -44.52 96.32 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.315 0.579 . . . . 75.03 110.796 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.455 ' HG3' ' HA ' ' A' ' 202' ' ' PRO . 4.3 tm-20 -75.68 -35.8 60.25 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 115.72 -0.673 . . . . 71.42 110.063 179.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 50.9 m -60.13 -41.15 92.03 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 122.512 0.325 . . . . 62.35 111.021 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 9.3 t -76.94 -36.53 56.49 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 120.06 -0.656 . . . . 73.42 109.334 175.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 70.65 11.49 68.96 Favored Glycine 0 N--CA 1.444 -0.83 0 CA-C-N 115.81 -0.632 . . . . 73.22 112.99 176.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 57.0 mt -95.55 5.97 50.16 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 121.518 0.675 . . . . 73.21 109.71 -178.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 98.9 mt -113.71 131.01 56.33 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 114.485 -1.234 . . . . 71.52 108.227 172.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -132.53 157.84 43.67 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 108.738 -0.838 . . . . 71.51 108.738 176.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . 0.473 ' HA ' ' HB ' ' A' ' 197' ' ' ILE . 14.7 m -60.92 -30.94 48.47 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 N-CA-C 113.23 0.826 . . . . 74.01 113.23 -175.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -78.69 -14.12 59.46 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 112.914 0.709 . . . . 72.35 112.914 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -69.8 142.75 53.12 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.662 0.616 . . . . 74.41 112.662 -178.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -108.66 131.36 54.97 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.927 -1.033 . . . . 65.41 109.579 -176.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . 0.44 ' CG1' ' HB ' ' A' ' 195' ' ' ILE . 9.8 p -83.14 143.82 11.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-O 121.893 0.854 . . . . 73.4 112.172 -176.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 37.8 mm -108.14 -51.42 7.13 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 C-N-CA 124.719 1.208 . . . . 74.43 111.26 -178.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -155.27 160.26 40.66 Favored 'General case' 0 C--O 1.247 0.945 0 CA-C-N 116.441 -0.345 . . . . 74.33 110.877 -177.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' A' ' 246' ' ' ILE . 7.5 p -132.38 121.03 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 O-C-N 123.775 0.672 . . . . 71.13 110.397 174.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 67.48 12.1 8.72 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.52 1.528 . . . . 74.53 110.672 176.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 110.11 -10.6 31.57 Favored Glycine 0 N--CA 1.432 -1.578 0 CA-C-N 115.421 -0.808 . . . . 62.15 112.589 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 64.4 mt -96.9 126.2 49.69 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.165 0 N-CA-C 108.35 -0.982 . . . . 70.33 108.35 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -65.47 141.62 58.43 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 121.431 0.634 . . . . 73.31 110.482 -178.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . 0.504 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 27.2 m -117.54 -1.88 9.5 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 CA-C-N 115.66 -0.7 . . . . 61.1 110.721 178.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -79.66 96.39 6.19 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 115.775 -0.648 . . . . 73.12 109.826 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 124.58 -14.57 7.66 Favored Glycine 0 C--N 1.305 -1.146 0 N-CA-C 110.688 -0.965 . . . . 64.0 110.688 -178.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -83.55 171.8 12.99 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.299 -1.0 . . . . 73.3 108.299 177.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' THR . . . . . 0.475 ' O ' HG13 ' A' ' 234' ' ' VAL . 81.7 p -95.68 170.95 8.97 Favored 'General case' 0 N--CA 1.434 -1.248 0 N-CA-C 108.691 -0.855 . . . . 63.24 108.691 179.038 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -61.79 -37.19 83.43 Favored 'General case' 0 N--CA 1.424 -1.736 0 N-CA-C 110.145 -0.317 . . . . 65.3 110.145 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -63.71 -47.92 79.2 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.738 -0.467 . . . . 70.4 109.738 178.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -60.34 -43.48 96.4 Favored 'General case' 0 C--O 1.222 -0.35 0 N-CA-C 113.73 1.011 . . . . 75.11 113.73 178.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.504 ' CG1' ' HB ' ' A' ' 226' ' ' VAL . 12.7 m -73.22 -33.94 42.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-O 121.375 0.607 . . . . 75.44 112.072 -175.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 85.9 m -74.98 -35.59 62.05 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 115.418 -0.81 . . . . 74.44 109.49 -174.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -61.74 -33.11 73.46 Favored 'General case' 0 C--O 1.244 0.805 0 CA-C-N 115.75 -0.659 . . . . 73.12 109.538 177.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 13.6 mtt -68.09 -47.56 67.92 Favored 'General case' 0 C--O 1.209 -1.051 0 N-CA-C 107.835 -1.172 . . . . 75.45 107.835 179.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 64.7 mtt -59.01 -37.16 76.25 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.402 -0.817 . . . . 72.24 111.329 -178.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 92.2 t -69.46 -44.91 79.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 CA-C-N 116.308 -0.405 . . . . 71.11 110.782 177.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -69.72 -38.14 76.78 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.173 0.511 . . . . 75.53 110.96 -178.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -82.01 21.1 0.91 Allowed 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 115.525 -0.761 . . . . 74.25 112.45 -178.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 42.8 t -59.19 -28.32 66.52 Favored 'General case' 0 CA--C 1.559 1.324 0 CA-C-O 121.158 0.504 . . . . 72.21 111.04 178.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 20.2 m -67.29 -28.61 68.16 Favored 'General case' 0 CA--C 1.552 1.052 0 N-CA-C 111.896 0.332 . . . . 62.43 111.896 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -161.99 83.82 0.58 Allowed 'General case' 0 C--O 1.249 1.034 0 N-CA-C 107.079 -1.452 . . . . 64.31 107.079 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . 0.459 ' HB3' ' HB2' ' A' ' 163' ' ' LEU . 1.3 tt -85.95 103.42 14.64 Favored 'General case' 0 C--O 1.2 -1.548 0 C-N-CA 119.87 -0.732 . . . . 73.13 109.484 -173.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . 0.472 HG12 ' HG3' ' A' ' 162' ' ' ARG . 74.1 mt -105.25 116.71 49.59 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.22 0 N-CA-C 109.469 -0.567 . . . . 74.02 109.469 178.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 25.5 mt -120.05 134.33 63.91 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 CA-C-O 121.27 0.557 . . . . 74.25 111.674 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.574 ' HA ' ' O ' ' A' ' 159' ' ' ARG . 90.8 m -108.3 119.83 40.64 Favored 'General case' 0 N--CA 1.417 -2.114 0 CA-C-N 114.939 -1.028 . . . . 74.42 108.486 174.071 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 26.7 m -124.18 164.39 22.52 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.865 0 N-CA-C 108.43 -0.952 . . . . 60.02 108.43 174.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.66 136.58 13.01 Favored Pre-proline 0 C--N 1.264 -3.112 0 CA-C-N 115.449 -0.796 . . . . 74.44 109.916 173.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo . . . . . 0 N--CA 1.451 -0.995 0 C-N-CA 122.643 2.229 . . . . 72.33 110.962 179.076 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.437 -1.111 0 N-CA-C 108.892 -0.781 . . . . 73.41 108.892 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.445 ' O ' ' HA ' ' A' ' 248' ' ' THR . 23.5 tpp180 -112.07 132.93 54.54 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 108.72 -0.844 . . . . 74.23 108.72 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 82.7 mtt180 -109.49 115.48 30.01 Favored 'General case' 0 C--N 1.278 -2.529 0 CA-C-N 115.708 -0.678 . . . . 62.24 111.439 176.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.405 ' CG1' ' HB2' ' A' ' 211' ' ' LEU . 18.6 m -118.94 138.19 50.46 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.219 0 CA-C-N 114.778 -1.101 . . . . 74.31 109.971 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.51 ' HG3' HG12 ' A' ' 246' ' ' ILE . 4.8 mpt_? -110.12 112.14 23.94 Favored 'General case' 0 N--CA 1.415 -2.199 0 N-CA-C 107.769 -1.197 . . . . 75.22 107.769 177.179 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 9.6 mt -96.96 118.53 33.58 Favored 'General case' 0 N--CA 1.409 -2.502 0 N-CA-C 107.523 -1.288 . . . . 73.04 107.523 -176.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 12.9 tp . . . . . 0 C--N 1.299 -1.59 0 CA-C-O 122.38 1.086 . . . . 62.43 112.95 177.938 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 2.7 mm? . . . . . 0 C--O 1.239 0.541 0 CA-C-O 120.854 0.359 . . . . 73.32 111.373 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . 0.437 ' HA3' ' HA3' ' A' ' 204' ' ' GLY . . . 84.51 37.8 10.39 Favored Glycine 0 N--CA 1.433 -1.518 0 N-CA-C 114.575 0.59 . . . . 55.23 114.575 174.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -159.46 152.62 22.15 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 108.733 -0.84 . . . . 74.54 108.733 173.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -132.51 146.22 51.76 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 109.312 -0.625 . . . . 64.34 109.312 179.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.421 ' HB ' ' CG2' ' A' ' 195' ' ' ILE . 0.2 OUTLIER -111.04 170.34 3.54 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.634 0 CA-C-N 115.67 -0.695 . . . . 71.54 111.599 -175.397 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . 0.502 ' CG ' ' HB2' ' A' ' 198' ' ' SER . 25.5 ptt180 -147.42 155.57 42.07 Favored 'General case' 0 C--N 1.279 -2.49 0 C-N-CA 124.972 1.309 . . . . 75.43 109.242 -177.017 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -117.89 151.21 37.85 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-O 121.32 0.581 . . . . 74.32 111.163 -175.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -167.87 -162.13 19.07 Favored Glycine 0 N--CA 1.426 -2.022 0 N-CA-C 109.439 -1.464 . . . . 64.41 109.439 176.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.2 p -100.41 132.03 46.01 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 121.598 0.713 . . . . 61.24 112.322 176.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 33.6 t . . . . . 0 N--CA 1.409 -2.525 0 N-CA-C 107.483 -1.303 . . . . 63.11 107.483 173.874 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 33.9 ttmt . . . . . 0 N--CA 1.426 -1.651 0 N-CA-C 107.912 -1.144 . . . . 74.34 107.912 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -141.11 162.04 50.17 Favored Pre-proline 0 C--N 1.269 -2.922 0 N-CA-C 107.944 -1.132 . . . . 73.23 107.944 -177.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -57.88 131.57 44.62 Favored 'Trans proline' 0 N--CA 1.447 -1.25 0 C-N-CA 120.935 1.09 . . . . 73.42 109.476 175.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -135.82 138.1 9.66 Favored Glycine 0 CA--C 1.463 -3.218 0 N-CA-C 110.127 -1.189 . . . . 62.13 110.127 -177.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.543 HG12 HG21 ' A' ' 234' ' ' VAL . 3.3 mp -105.92 138.07 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.538 0 CA-C-O 121.301 0.572 . . . . 74.35 109.832 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -127.22 166.94 16.78 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 106.837 -1.542 . . . . 74.4 106.837 -178.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . 0.43 ' HB ' ' HA ' ' A' ' 214' ' ' VAL . 45.1 mt -85.0 131.69 33.47 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.335 0 CA-C-O 121.055 0.455 . . . . 64.5 109.846 178.093 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' SER . . . . . 0.502 ' HB2' ' CG ' ' A' ' 177' ' ' ARG . 14.1 t -101.2 -50.06 3.9 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 112.484 0.55 . . . . 52.34 112.484 -178.158 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 40.8 ttp-105 -139.44 132.79 30.04 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 109.573 -0.529 . . . . 72.2 109.573 -176.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 2.6 tt -117.75 130.38 56.28 Favored 'General case' 0 N--CA 1.42 -1.941 0 N-CA-C 107.038 -1.468 . . . . 64.44 107.038 -178.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 45.1 t -108.64 127.31 27.64 Favored Pre-proline 0 C--N 1.316 -0.886 0 N-CA-C 112.036 0.384 . . . . 73.22 112.036 -171.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . 0.48 ' HA ' ' HG3' ' A' ' 207' ' ' GLU . 34.4 Cg_endo -66.79 143.23 66.41 Favored 'Trans proline' 0 C--O 1.245 0.865 0 C-N-CA 122.432 2.088 . . . . 73.0 110.999 175.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 92.24 -9.9 75.36 Favored Glycine 0 N--CA 1.442 -0.959 0 N-CA-C 111.074 -0.811 . . . . 74.33 111.074 -177.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . 0.437 ' HA3' ' HA3' ' A' ' 173' ' ' GLY . . . -94.44 167.42 27.39 Favored Glycine 0 N--CA 1.435 -1.37 0 N-CA-C 110.472 -1.051 . . . . 61.41 110.472 178.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -66.72 -29.7 69.75 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 117.104 0.452 . . . . 72.02 111.675 -175.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -62.38 -46.28 89.33 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.636 0.731 . . . . 71.55 109.788 176.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.48 ' HG3' ' HA ' ' A' ' 202' ' ' PRO . 3.6 tm-20 -71.58 -32.62 68.27 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.513 -0.767 . . . . 75.13 110.667 179.15 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 44.7 m -55.78 -37.02 68.01 Favored 'General case' 0 CA--C 1.546 0.805 0 O-C-N 123.284 0.365 . . . . 75.22 110.967 178.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 8.9 t -87.49 -41.0 13.83 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 119.466 -0.894 . . . . 70.33 110.561 176.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 66.23 9.09 47.35 Favored Glycine 0 CA--C 1.531 1.051 0 N-CA-C 114.504 0.561 . . . . 71.44 114.504 177.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.405 ' HB2' ' CG1' ' A' ' 161' ' ' VAL . 69.1 mt -82.27 -18.03 43.85 Favored 'General case' 0 CA--C 1.503 -0.862 0 CA-C-O 121.119 0.485 . . . . 71.5 110.959 -178.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -108.99 149.02 29.84 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 108.884 -0.784 . . . . 64.24 108.884 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -129.97 166.11 20.76 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 109.502 -0.555 . . . . 74.25 109.502 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . 0.43 ' HA ' ' HB ' ' A' ' 197' ' ' ILE . 32.6 m -63.22 -29.79 48.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 N-CA-C 113.044 0.757 . . . . 73.15 113.044 -179.075 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -69.84 -15.31 63.08 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 122.019 -0.426 . . . . 74.43 111.669 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.464 ' HB3' ' HB ' ' A' ' 249' ' ' VAL . 8.4 m-20 -69.78 152.89 44.08 Favored 'General case' 0 C--O 1.247 0.971 0 N-CA-C 113.918 1.081 . . . . 71.51 113.918 -175.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -112.49 134.43 54.02 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 125.804 1.642 . . . . 74.5 108.324 -179.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . 0.41 ' HA ' HG13 ' A' ' 249' ' ' VAL . 9.9 p -86.32 146.19 6.75 Favored 'Isoleucine or valine' 0 C--O 1.245 0.847 0 CA-C-O 121.903 0.859 . . . . 73.1 112.321 -174.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 34.2 mm -113.0 -58.71 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 CA-C-N 114.536 -1.211 . . . . 75.13 111.285 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -150.35 158.89 44.65 Favored 'General case' 0 C--O 1.243 0.76 0 CA-C-N 116.8 -0.182 . . . . 72.21 110.523 -177.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 13.6 p -132.21 126.33 55.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 N-CA-C 109.079 -0.712 . . . . 73.43 109.079 177.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . 0.401 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 8.3 t-20 64.4 18.94 11.6 Favored 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 124.98 1.312 . . . . 53.32 110.108 176.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 102.8 -17.09 53.73 Favored Glycine 0 N--CA 1.436 -1.306 0 CA-C-N 115.858 -0.61 . . . . 70.23 112.322 -179.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 65.6 mt -98.97 127.02 52.03 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.09 0 CA-C-O 121.032 0.444 . . . . 73.43 109.977 -178.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -62.09 140.06 58.42 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-O 121.884 0.849 . . . . 75.23 112.833 -177.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . 0.419 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 16.3 m -118.13 3.56 7.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-N 114.986 -1.006 . . . . 74.51 110.272 176.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -79.15 101.95 8.21 Favored 'General case' 0 N--CA 1.422 -1.833 0 CA-C-N 115.176 -0.92 . . . . 73.2 109.544 178.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 118.31 -11.83 12.73 Favored Glycine 0 C--N 1.309 -0.927 0 C-N-CA 120.895 -0.669 . . . . 73.1 111.794 178.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -81.15 172.78 13.25 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 108.846 -0.798 . . . . 75.53 108.846 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' THR . . . . . 0.415 ' O ' HG13 ' A' ' 234' ' ' VAL . 72.5 p -88.77 168.2 12.67 Favored 'General case' 0 N--CA 1.433 -1.303 0 N-CA-C 108.198 -1.038 . . . . 65.32 108.198 178.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . 0.407 HD21 HG12 ' A' ' 176' ' ' ILE . 3.2 tm? -62.68 -36.3 82.45 Favored 'General case' 0 N--CA 1.426 -1.654 0 N-CA-C 109.249 -0.649 . . . . 62.44 109.249 179.006 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -67.3 -47.47 70.47 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.517 -0.473 . . . . 43.24 109.826 178.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -59.85 -38.41 82.02 Favored 'General case' 0 C--N 1.349 0.55 0 N-CA-C 113.27 0.841 . . . . 72.41 113.27 177.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.543 HG21 HG12 ' A' ' 195' ' ' ILE . 16.3 m -74.18 -36.15 42.83 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.458 0 C-N-CA 119.308 -0.957 . . . . 74.43 111.518 -179.139 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 39.5 m -68.61 -35.92 77.97 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 108.924 -0.769 . . . . 74.5 108.924 179.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -57.87 -41.12 81.78 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 115.716 -0.674 . . . . 43.14 109.908 175.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 13.6 mmt -58.77 -49.69 76.73 Favored 'General case' 0 C--O 1.204 -1.319 0 N-CA-C 108.242 -1.021 . . . . 70.32 108.242 177.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' MET . . . . . 0.43 ' HG3' ' O ' ' A' ' 234' ' ' VAL . 60.4 mtt -63.77 -35.6 81.14 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.904 -1.044 . . . . 75.51 112.8 -174.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 84.4 t -70.37 -38.11 73.03 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-O 121.092 0.472 . . . . 71.45 109.851 177.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -71.63 -36.66 70.81 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.507 0.67 . . . . 73.35 110.518 178.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -89.22 21.59 3.19 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 115.463 -0.79 . . . . 74.44 111.276 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 46.0 p -64.83 -23.16 67.15 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 113.479 0.918 . . . . 74.2 113.479 -178.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 67.0 m -79.09 -18.39 53.43 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 119.439 -0.905 . . . . 62.52 111.434 177.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -166.6 92.39 0.46 Allowed 'General case' 0 C--O 1.252 1.186 0 CA-C-O 121.813 0.816 . . . . 70.24 112.227 179.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 11.7 mt -85.29 102.94 13.79 Favored 'General case' 0 C--O 1.19 -2.067 0 CA-C-N 115.933 -0.576 . . . . 73.54 112.013 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . 0.51 HG12 ' HG3' ' A' ' 162' ' ' ARG . 88.7 mt -96.68 114.3 33.22 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.844 0 N-CA-C 106.078 -1.823 . . . . 71.15 106.078 172.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 83.5 mt -122.93 135.61 62.43 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 CA-C-O 121.505 0.669 . . . . 73.21 111.967 -176.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.445 ' HA ' ' O ' ' A' ' 159' ' ' ARG . 46.9 m -107.13 114.9 29.24 Favored 'General case' 0 N--CA 1.414 -2.258 0 CA-C-N 114.901 -1.045 . . . . 74.44 108.581 176.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . 0.464 ' HB ' ' HB3' ' A' ' 216' ' ' ASP . 31.3 m -124.96 151.9 30.92 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 N-CA-C 109.423 -0.584 . . . . 73.45 109.423 175.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 9.5 ptmt -127.54 141.67 41.66 Favored Pre-proline 0 C--N 1.269 -2.892 0 N-CA-C 107.635 -1.246 . . . . 74.33 107.635 178.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo . . . . . 0 CA--C 1.546 1.086 0 C-N-CA 121.913 1.742 . . . . 73.34 111.795 178.69 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.499 -1.013 0 N-CA-C 109.683 -0.488 . . . . 73.21 109.683 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 -137.78 129.35 28.19 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 108.134 -1.061 . . . . 71.2 108.134 174.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 35.6 ptt180 -112.66 119.64 38.81 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-O 121.659 0.742 . . . . 71.33 109.983 177.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.618 ' O ' ' HA ' ' A' ' 246' ' ' ILE . 27.5 m -114.21 139.15 41.5 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.3 0 CA-C-N 114.882 -1.053 . . . . 73.43 112.122 -175.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.466 ' HG2' HG12 ' A' ' 246' ' ' ILE . 44.8 mtm180 -99.15 112.29 24.47 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 106.891 -1.522 . . . . 72.14 106.891 178.097 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.485 ' HB2' ' HB3' ' A' ' 245' ' ' LEU . 22.1 mt -104.58 139.12 39.91 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 109.503 -0.554 . . . . 73.04 109.503 -177.245 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 25.4 tp . . . . . 0 C--N 1.304 -1.376 0 N-CA-C 113.455 0.909 . . . . 74.01 113.455 172.168 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.438 ' HG ' ' CD1' ' A' ' 245' ' ' LEU . 3.2 mm? . . . . . 0 CA--C 1.511 -0.521 0 N-CA-C 112.558 0.577 . . . . 71.02 112.558 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . 0.403 ' HA3' ' HA3' ' A' ' 204' ' ' GLY . . . 94.61 30.62 8.4 Favored Glycine 0 N--CA 1.428 -1.836 0 C-N-CA 119.534 -1.317 . . . . 75.2 112.897 178.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -154.98 154.66 32.89 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 107.654 -1.239 . . . . 74.31 107.654 175.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -126.5 157.45 38.68 Favored 'General case' 0 C--N 1.272 -2.788 0 N-CA-C 107.625 -1.25 . . . . 74.41 107.625 175.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.474 HD11 ' HE2' ' A' ' 238' ' ' MET . 30.8 pt -122.94 164.16 20.72 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.02 0 CA-C-O 121.605 0.717 . . . . 74.23 112.424 -178.134 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . 0.422 ' HG2' ' HB3' ' A' ' 198' ' ' SER . 4.0 ptp180 -139.39 154.73 47.87 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 114.238 -1.347 . . . . 75.2 108.18 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -121.44 143.11 49.42 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 108.917 -0.771 . . . . 73.14 108.917 176.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -156.26 -146.18 4.39 Favored Glycine 0 N--CA 1.415 -2.758 0 N-CA-C 109.425 -1.47 . . . . 73.1 109.425 178.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' THR . . . . . 0.503 ' HB ' ' CG ' ' A' ' 191' ' ' LYS . 1.3 p -108.74 127.32 53.9 Favored 'General case' 0 C--N 1.28 -2.45 0 N-CA-C 112.695 0.628 . . . . 62.11 112.695 179.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 28.7 t . . . . . 0 N--CA 1.413 -2.319 0 N-CA-C 106.951 -1.5 . . . . 73.15 106.951 175.045 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.503 ' CG ' ' HB ' ' A' ' 180' ' ' THR . 36.2 ttmt . . . . . 0 N--CA 1.417 -2.09 0 N-CA-C 108.305 -0.998 . . . . 64.45 108.305 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -140.92 164.1 38.28 Favored Pre-proline 0 C--N 1.287 -2.117 0 N-CA-C 108.946 -0.761 . . . . 60.51 108.946 -176.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -55.93 132.38 51.64 Favored 'Trans proline' 0 C--O 1.248 1.018 0 C-N-CA 121.642 1.561 . . . . 74.14 111.0 175.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -141.14 147.52 19.13 Favored Glycine 0 CA--C 1.471 -2.691 0 N-CA-C 110.7 -0.96 . . . . 73.25 110.7 -178.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 2.9 mp -104.24 142.17 18.3 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 CA-C-O 121.295 0.569 . . . . 73.33 110.132 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -137.07 164.42 28.45 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 107.244 -1.391 . . . . 75.21 107.244 -178.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . 0.456 ' HB ' ' HA ' ' A' ' 214' ' ' VAL . 48.6 mm -76.26 127.82 37.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 107.747 -1.205 . . . . 75.45 107.747 176.402 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' SER . . . . . 0.422 ' HB3' ' HG2' ' A' ' 177' ' ' ARG . 82.9 p -99.92 -38.88 8.43 Favored 'General case' 0 C--N 1.29 -1.994 0 C-N-CA 119.862 -0.735 . . . . 75.43 111.196 -175.045 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -150.43 139.4 20.98 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 108.809 -0.811 . . . . 74.01 108.809 -177.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 1.1 tt -111.59 132.45 54.55 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 107.395 -1.335 . . . . 64.4 107.395 -179.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 61.1 t -104.98 118.46 56.07 Favored Pre-proline 0 C--N 1.312 -1.054 0 CA-C-O 120.626 0.25 . . . . 63.35 111.453 -176.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . 0.474 ' HA ' ' HG2' ' A' ' 207' ' ' GLU . 37.8 Cg_exo -62.23 136.96 63.09 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 122.627 2.218 . . . . 72.44 110.866 176.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 96.55 -22.01 42.54 Favored Glycine 0 N--CA 1.439 -1.134 0 C-N-CA 121.12 -0.562 . . . . 75.04 112.253 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . 0.403 ' HA3' ' HA3' ' A' ' 173' ' ' GLY . . . -80.54 -176.18 49.98 Favored Glycine 0 N--CA 1.44 -1.067 0 C-N-CA 120.966 -0.635 . . . . 72.24 112.417 -179.047 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -67.87 -41.87 82.17 Favored 'General case' 0 N--CA 1.426 -1.668 0 C-N-CA 122.91 0.484 . . . . 73.41 110.754 -178.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -64.02 -34.2 77.48 Favored 'General case' 0 C--O 1.22 -0.481 0 N-CA-C 113.139 0.792 . . . . 63.34 113.139 -176.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.474 ' HG2' ' HA ' ' A' ' 202' ' ' PRO . 11.8 tp10 -75.61 -33.08 60.52 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-O 121.724 0.773 . . . . 71.44 108.971 179.221 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 19.3 t -65.86 -24.71 66.93 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.954 -1.021 . . . . 73.2 110.802 -178.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 2.4 m -69.18 -40.45 78.09 Favored 'General case' 0 N--CA 1.415 -2.212 0 CA-C-N 115.914 -0.585 . . . . 73.5 111.867 -171.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 70.02 24.21 76.63 Favored Glycine 0 C--O 1.225 -0.42 0 N-CA-C 111.012 -0.835 . . . . 75.4 111.012 -176.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 65.6 mt -140.72 -8.95 1.06 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 122.963 0.505 . . . . 71.12 111.053 -175.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 67.9 mt -109.48 131.22 55.27 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 115.888 -0.596 . . . . 71.44 110.583 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -134.15 166.23 23.24 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.727 -1.212 . . . . 74.11 107.727 175.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . 0.456 ' HA ' ' HB ' ' A' ' 197' ' ' ILE . 31.3 m -66.52 -30.8 50.96 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 N-CA-C 113.074 0.768 . . . . 71.21 113.074 -179.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 46.7 m-80 -75.15 -14.5 60.56 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 113.706 1.002 . . . . 72.34 113.706 -177.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.428 ' HB3' ' HB ' ' A' ' 249' ' ' VAL . 5.3 m-20 -63.74 131.59 48.37 Favored 'General case' 0 C--O 1.246 0.877 0 CA-C-O 121.172 0.51 . . . . 65.21 112.282 -179.034 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -97.55 140.85 31.36 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.462 -0.79 . . . . 75.52 109.48 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 5.2 p -81.86 145.56 8.55 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 CA-C-O 121.621 0.724 . . . . 73.3 112.229 -174.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 44.4 mm -115.96 -60.85 2.71 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 115.618 -0.719 . . . . 72.43 110.874 178.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -152.36 154.83 36.42 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 109.136 -0.69 . . . . 75.21 109.136 -176.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 44.2 t -128.94 122.91 57.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 108.466 -0.939 . . . . 44.14 108.466 179.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 65.7 20.35 11.52 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.137 1.375 . . . . 72.51 109.523 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 97.37 -15.2 62.58 Favored Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 115.243 -0.889 . . . . 73.53 111.975 -178.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 63.0 mt -92.67 123.77 44.88 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.747 0 N-CA-C 109.044 -0.724 . . . . 71.54 109.044 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -57.39 142.38 43.96 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.521 0.677 . . . . 74.41 112.139 -178.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . 0.509 ' HA ' ' CG ' ' A' ' 229' ' ' LYS . 15.6 m -120.93 10.46 6.21 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.845 0 CA-C-N 115.555 -0.748 . . . . 64.44 111.083 175.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -74.3 101.34 4.0 Favored 'General case' 0 N--CA 1.426 -1.657 0 CA-C-N 115.035 -0.984 . . . . 65.52 109.588 177.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 109.69 -1.57 30.53 Favored Glycine 0 CA--C 1.496 -1.121 0 C-N-CA 120.886 -0.673 . . . . 71.35 111.707 177.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . 0.509 ' CG ' ' HA ' ' A' ' 226' ' ' VAL . 71.9 mmtt -82.21 158.77 23.44 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.18 -0.674 . . . . 75.04 109.18 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 67.3 p -82.66 171.49 13.97 Favored 'General case' 0 N--CA 1.409 -2.512 0 C-N-CA 119.299 -0.96 . . . . 71.51 109.437 177.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -66.59 -35.48 80.3 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 108.578 -0.897 . . . . 73.33 108.578 -179.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -65.13 -41.22 95.02 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.581 -0.736 . . . . 73.14 109.698 178.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -61.34 -47.16 87.15 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.481 -0.781 . . . . 61.32 112.507 176.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 19.8 m -69.63 -33.74 58.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 C-N-CA 120.211 -0.596 . . . . 70.42 111.918 -177.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 90.4 m -64.86 -35.7 81.98 Favored 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 109.694 -0.484 . . . . 64.25 109.694 177.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -63.39 -35.84 81.76 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.279 -0.419 . . . . 74.52 110.125 176.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 16.8 mmt -58.08 -52.75 64.24 Favored 'General case' 0 C--O 1.201 -1.453 0 N-CA-C 107.814 -1.18 . . . . 71.3 107.814 174.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' MET . . . . . 0.474 ' HE2' HD11 ' A' ' 176' ' ' ILE . 66.6 mtt -58.21 -35.28 71.41 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.633 -1.167 . . . . 74.03 112.049 -175.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 94.5 t -71.96 -45.98 61.78 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-O 120.832 0.349 . . . . 72.24 110.615 177.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -68.01 -34.61 76.83 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.508 0.671 . . . . 74.31 111.076 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -89.76 21.84 3.36 Favored 'General case' 0 C--O 1.198 -1.633 0 CA-C-N 115.311 -0.859 . . . . 73.34 110.578 -179.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 25.2 t -60.63 -23.78 65.01 Favored 'General case' 0 CA--C 1.563 1.461 0 N-CA-C 112.149 0.426 . . . . 73.05 112.149 -178.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 6.9 p -81.07 -14.01 58.22 Favored 'General case' 0 CA--C 1.558 1.262 0 N-CA-C 112.641 0.608 . . . . 74.23 112.641 178.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -173.77 98.55 0.11 Allowed 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.908 1.283 . . . . 72.25 108.356 173.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . 0.485 ' HB3' ' HB2' ' A' ' 163' ' ' LEU . 1.2 tt -86.36 101.82 13.45 Favored 'General case' 0 N--CA 1.413 -2.305 0 N-CA-C 107.701 -1.222 . . . . 74.42 107.701 -176.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . 0.618 ' HA ' ' O ' ' A' ' 161' ' ' VAL . 73.5 mt -104.07 116.12 47.26 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 C-N-CA 120.163 -0.615 . . . . 74.04 109.812 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 91.7 mt -122.05 131.36 73.31 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.892 0 C-N-CA 120.151 -0.62 . . . . 74.5 110.085 176.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 56.3 m -96.77 114.95 26.63 Favored 'General case' 0 N--CA 1.412 -2.369 0 N-CA-C 107.545 -1.28 . . . . 71.44 107.545 174.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . 0.428 ' HB ' ' HB3' ' A' ' 216' ' ' ASP . 21.7 m -117.89 169.12 8.89 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.117 0 N-CA-C 109.098 -0.705 . . . . 71.02 109.098 176.069 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 15.5 ptmt -134.0 129.45 20.07 Favored Pre-proline 0 C--N 1.28 -2.456 0 CA-C-N 115.454 -0.793 . . . . 74.01 110.181 176.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo . . . . . 0 N--CA 1.44 -1.67 0 C-N-CA 121.738 1.626 . . . . 75.31 108.86 173.988 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 9.0 m80 . . . . . 0 N--CA 1.445 -0.72 0 N-CA-C 109.806 -0.442 . . . . 75.42 109.806 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.556 ' O ' ' HA ' ' A' ' 248' ' ' THR . 45.3 ttm180 -145.01 144.0 30.79 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 116.4 -0.364 . . . . 70.42 111.071 174.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.543 ' HA ' ' O ' ' A' ' 247' ' ' ILE . 0.0 OUTLIER -118.23 127.04 53.36 Favored 'General case' 0 C--N 1.32 -0.677 0 O-C-N 123.244 0.34 . . . . 74.11 110.42 175.445 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 11.9 m -122.25 139.05 50.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 CA-C-N 115.909 -0.587 . . . . 74.41 111.283 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 21.8 ttm180 -92.59 116.36 28.93 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 109.317 -0.623 . . . . 74.43 109.317 177.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 19.7 mt -107.87 138.73 43.6 Favored 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 107.144 -1.428 . . . . 72.3 107.144 -179.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.442 -0.864 0 CA-C-O 122.325 1.06 . . . . 74.14 108.322 173.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.423 ' HG ' ' CD1' ' A' ' 245' ' ' LEU . 2.8 mm? . . . . . 0 CA--C 1.492 -1.282 0 CA-C-O 120.894 0.378 . . . . 73.32 111.98 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . 0.486 ' HA3' ' HA3' ' A' ' 204' ' ' GLY . . . 97.95 17.1 31.1 Favored Glycine 0 N--CA 1.415 -2.746 0 C-N-CA 119.273 -1.441 . . . . 53.23 111.879 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -158.08 157.17 32.33 Favored 'General case' 0 N--CA 1.427 -1.605 0 N-CA-C 109.273 -0.64 . . . . 63.31 109.273 179.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -129.38 158.24 39.69 Favored 'General case' 0 C--N 1.283 -2.314 0 N-CA-C 107.995 -1.113 . . . . 74.34 107.995 172.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.423 ' HB ' ' CG2' ' A' ' 195' ' ' ILE . 0.1 OUTLIER -118.53 163.78 15.41 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.018 0 CA-C-O 121.744 0.783 . . . . 71.35 111.271 -178.68 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . 0.432 ' HG2' ' HB3' ' A' ' 198' ' ' SER . 15.6 ptt180 -142.35 154.77 44.94 Favored 'General case' 0 C--N 1.28 -2.424 0 CA-C-N 114.182 -1.372 . . . . 74.12 109.477 -177.137 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -110.67 138.21 47.35 Favored 'General case' 0 C--N 1.294 -1.848 0 CA-C-O 121.143 0.497 . . . . 73.25 110.551 179.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -145.06 176.46 24.09 Favored Glycine 0 C--N 1.28 -2.544 0 N-CA-C 106.858 -2.497 . . . . 74.35 106.858 175.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' THR . . . . . 0.554 ' CG2' ' HG2' ' A' ' 191' ' ' LYS . 0.2 OUTLIER -102.07 122.71 44.64 Favored 'General case' 0 C--N 1.273 -2.74 0 C-N-CA 117.312 -1.755 . . . . 72.43 107.103 177.965 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 33.3 t . . . . . 0 C--N 1.283 -2.293 0 N-CA-C 109.041 -0.725 . . . . 72.5 109.041 -176.577 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.554 ' HG2' ' CG2' ' A' ' 180' ' ' THR . 34.2 ttmt . . . . . 0 N--CA 1.43 -1.462 0 N-CA-C 108.295 -1.002 . . . . 73.43 108.295 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -147.88 165.17 19.26 Favored Pre-proline 0 C--N 1.306 -1.325 0 N-CA-C 109.127 -0.694 . . . . 55.31 109.127 -170.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -56.79 132.35 51.17 Favored 'Trans proline' 0 C--O 1.255 1.369 0 C-N-CA 121.378 1.386 . . . . 74.55 110.64 177.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -145.57 128.14 3.04 Favored Glycine 0 N--CA 1.419 -2.465 0 N-CA-C 110.504 -1.038 . . . . 73.35 110.504 -178.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.44 ' HB ' ' CG1' ' A' ' 218' ' ' VAL . 3.4 mp -103.92 136.24 37.97 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.415 0 CA-C-O 121.242 0.544 . . . . 73.42 110.422 -178.431 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -127.87 167.52 16.46 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 107.8 -1.185 . . . . 74.34 107.8 -177.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . 0.484 ' HB ' ' HA ' ' A' ' 214' ' ' VAL . 46.1 mm -75.4 131.19 35.4 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 N-CA-C 107.44 -1.319 . . . . 74.54 107.44 175.024 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' SER . . . . . 0.432 ' HB3' ' HG2' ' A' ' 177' ' ' ARG . 86.4 p -99.37 -33.32 10.75 Favored 'General case' 0 C--N 1.29 -1.986 0 O-C-N 121.53 -0.731 . . . . 74.2 111.356 -175.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 10.8 ttp180 -167.22 143.61 4.35 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.822 -0.626 . . . . 75.1 110.65 -175.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.438 HD13 ' O ' ' A' ' 212' ' ' LEU . 73.3 mt -101.87 146.7 27.45 Favored 'General case' 0 CA--C 1.494 -1.187 0 CA-C-N 116.168 -0.469 . . . . 74.41 109.796 174.052 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . 0.476 ' HB ' ' HA2' ' A' ' 173' ' ' GLY . 21.7 t -114.35 115.25 44.98 Favored Pre-proline 0 C--N 1.289 -2.058 0 N-CA-C 106.329 -1.73 . . . . 71.24 106.329 172.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . 0.458 ' HA ' ' HG2' ' A' ' 207' ' ' GLU . 31.3 Cg_exo -58.78 147.25 89.33 Favored 'Trans proline' 0 N--CA 1.444 -1.42 0 C-N-CA 121.95 1.766 . . . . 74.21 111.082 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 94.48 -23.24 33.07 Favored Glycine 0 C--N 1.305 -1.159 0 N-CA-C 110.794 -0.922 . . . . 54.14 110.794 -176.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . 0.486 ' HA3' ' HA3' ' A' ' 173' ' ' GLY . . . -83.48 163.53 40.87 Favored Glycine 0 N--CA 1.43 -1.701 0 N-CA-C 110.526 -1.029 . . . . 74.32 110.526 177.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . 0.412 ' H ' HD21 ' A' ' 205' ' ' LEU . 2.8 mm? -55.16 -42.62 73.36 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 123.842 0.857 . . . . 72.51 112.42 -175.047 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -59.17 -48.13 82.76 Favored 'General case' 0 C--O 1.244 0.764 0 N-CA-C 112.306 0.484 . . . . 74.12 112.306 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.458 ' HG2' ' HA ' ' A' ' 202' ' ' PRO . 8.3 tp10 -75.41 -33.4 60.95 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.958 -0.386 . . . . 75.41 109.958 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 35.5 t -57.66 -44.75 85.93 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 116.214 -0.448 . . . . 73.35 110.734 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' THR . . . . . 0.514 ' CG2' ' HG ' ' A' ' 211' ' ' LEU . 8.9 t -77.0 -31.87 56.77 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 119.679 -0.808 . . . . 73.02 109.537 176.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 70.13 19.9 76.04 Favored Glycine 0 N--CA 1.447 -0.61 0 CA-C-N 115.938 -0.574 . . . . 64.11 112.694 178.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.514 ' HG ' ' CG2' ' A' ' 209' ' ' THR . 1.4 pp -105.65 -0.52 25.53 Favored 'General case' 0 N--CA 1.432 -1.336 0 CA-C-O 121.072 0.463 . . . . 71.51 111.407 -178.498 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . 0.438 ' O ' HD13 ' A' ' 200' ' ' LEU . 60.7 mt -109.32 133.78 52.62 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.384 -0.826 . . . . 74.15 109.226 176.369 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -131.87 165.51 23.7 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.763 -0.828 . . . . 73.12 108.763 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . 0.484 ' HA ' ' HB ' ' A' ' 197' ' ' ILE . 33.4 m -64.28 -29.48 47.47 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 N-CA-C 113.914 1.079 . . . . 74.43 113.914 -177.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -74.44 -14.63 60.87 Favored 'General case' 0 C--N 1.308 -1.228 0 O-C-N 121.855 -0.528 . . . . 74.42 111.729 -178.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.4 ' HB3' ' HB ' ' A' ' 249' ' ' VAL . 54.3 m-20 -69.83 130.97 43.73 Favored 'General case' 0 C--O 1.245 0.867 0 CA-C-O 121.233 0.54 . . . . 53.3 112.237 -176.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -101.19 135.08 43.25 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.952 -1.022 . . . . 71.4 109.659 -178.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . 0.44 ' CG1' ' HB ' ' A' ' 195' ' ' ILE . 10.6 p -82.12 131.36 34.0 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.152 0 CA-C-O 121.749 0.785 . . . . 72.51 111.375 -176.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 36.8 mm -100.87 -52.71 8.34 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 CA-C-N 115.318 -0.855 . . . . 63.33 111.409 -179.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -154.68 152.8 30.37 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 116.449 -0.341 . . . . 65.3 110.146 -178.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 246' ' ' ILE . 10.7 p -125.27 125.51 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.644 0 N-CA-C 108.956 -0.757 . . . . 74.42 108.956 177.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 57.1 22.72 7.72 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.592 1.157 . . . . 54.21 112.945 -177.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 100.34 -11.46 59.97 Favored Glycine 0 C--N 1.309 -0.954 0 C-N-CA 120.912 -0.661 . . . . 75.22 112.348 179.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 64.2 mt -98.7 123.53 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.284 0 N-CA-C 109.361 -0.607 . . . . 72.15 109.361 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -60.52 140.24 57.4 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 121.796 0.808 . . . . 75.23 112.216 -177.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . 0.497 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 25.6 m -120.61 0.44 7.41 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 CA-C-N 115.083 -0.962 . . . . 64.1 109.561 175.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -78.35 98.26 5.91 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 115.323 -0.853 . . . . 72.01 109.649 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 120.32 -19.95 9.13 Favored Glycine 0 C--N 1.308 -0.975 0 N-CA-C 110.691 -0.964 . . . . 51.55 110.691 -178.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -72.49 164.78 25.85 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.61 -0.515 . . . . 75.2 109.61 177.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' THR . . . . . 0.456 ' O ' HG13 ' A' ' 234' ' ' VAL . 67.2 p -84.86 168.61 14.92 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 108.734 -0.839 . . . . 65.44 108.734 178.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 53.3 tp -63.43 -31.95 73.25 Favored 'General case' 0 N--CA 1.424 -1.745 0 N-CA-C 109.541 -0.54 . . . . 75.31 109.541 177.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -64.46 -50.94 65.51 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.472 -0.566 . . . . 75.3 109.472 176.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' GLN . . . . . 0.454 ' O ' ' HG2' ' A' ' 237' ' ' MET . 2.2 mp0 -58.49 -43.77 89.16 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 113.297 0.851 . . . . 74.13 113.297 177.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.497 ' CG1' ' HB ' ' A' ' 226' ' ' VAL . 7.2 m -72.06 -34.79 51.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 C-N-CA 119.796 -0.762 . . . . 74.22 111.811 -176.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' THR . . . . . 0.43 ' O ' HG21 ' A' ' 239' ' ' VAL . 42.8 m -69.6 -36.36 76.13 Favored 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 109.224 -0.658 . . . . 70.32 109.224 179.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -59.84 -37.74 80.11 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-N 116.11 -0.496 . . . . 75.41 110.049 176.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' MET . . . . . 0.454 ' HG2' ' O ' ' A' ' 233' ' ' GLN . 16.8 mmt -58.96 -52.13 67.1 Favored 'General case' 0 C--O 1.2 -1.523 0 N-CA-C 108.451 -0.944 . . . . 73.14 108.451 176.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' MET . . . . . 0.411 ' HG3' ' O ' ' A' ' 234' ' ' VAL . 58.1 mtt -62.82 -33.11 74.54 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.996 -1.002 . . . . 73.14 112.201 -175.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . 0.43 HG21 ' O ' ' A' ' 235' ' ' THR . 75.6 t -68.29 -41.31 83.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-O 121.328 0.585 . . . . 54.32 109.902 175.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -72.32 -38.84 68.58 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.438 -0.801 . . . . 73.33 110.664 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -84.03 21.47 1.34 Allowed 'General case' 0 C--O 1.198 -1.613 0 CA-C-N 115.399 -0.819 . . . . 73.31 111.742 -177.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 14.8 p -64.36 -22.54 66.99 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-O 121.121 0.486 . . . . 71.54 111.559 176.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 26.7 m -68.84 -27.13 65.56 Favored 'General case' 0 CA--C 1.557 1.24 0 CA-C-N 116.318 -0.401 . . . . 73.43 110.914 176.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -174.44 103.16 0.1 Allowed 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.794 1.237 . . . . 63.45 108.98 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . 0.423 ' CD1' ' HG ' ' A' ' 172' ' ' LEU . 1.0 OUTLIER -90.49 103.51 16.19 Favored 'General case' 0 C--O 1.201 -1.456 0 N-CA-C 109.634 -0.506 . . . . 73.12 109.634 -173.923 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . 0.489 ' O ' ' HA ' ' A' ' 221' ' ' VAL . 63.9 mt -105.02 115.42 46.87 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 O-C-N 121.445 -0.785 . . . . 71.44 109.255 178.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . 0.543 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 18.8 mt -119.31 133.43 66.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 113.375 0.88 . . . . 62.25 113.375 -179.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.556 ' HA ' ' O ' ' A' ' 159' ' ' ARG . 61.2 m -103.11 121.27 42.27 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 107.65 -1.241 . . . . 74.24 107.65 173.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . 0.4 ' HB ' ' HB3' ' A' ' 216' ' ' ASP . 17.1 m -122.81 163.83 20.97 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.061 0 CA-C-O 121.106 0.479 . . . . 75.44 110.523 175.376 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -134.29 128.9 19.55 Favored Pre-proline 0 N--CA 1.416 -2.156 0 CA-C-N 114.469 -1.241 . . . . 74.01 107.745 173.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo . . . . . 0 C--N 1.307 -1.618 0 C-N-CA 121.255 1.303 . . . . 74.3 112.386 178.266 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.484 ' ND1' ' HB3' ' A' ' 250' ' ' LYS . 0.6 OUTLIER . . . . . 0 C--O 1.244 0.775 0 N-CA-C 110.305 -0.258 . . . . 74.05 110.305 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.448 ' O ' ' HA ' ' A' ' 248' ' ' THR . 28.7 tpt180 -143.47 133.59 24.33 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 109.409 -0.589 . . . . 72.45 109.409 172.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 32.0 ptt180 -113.36 124.65 52.96 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 116.044 -0.525 . . . . 72.31 109.945 177.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.552 ' O ' ' HA ' ' A' ' 246' ' ' ILE . 17.4 m -127.0 139.25 52.45 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 CA-C-N 116.015 -0.539 . . . . 65.45 112.218 -176.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.503 ' HG2' HG12 ' A' ' 246' ' ' ILE . 95.6 mtt180 -87.95 112.57 22.71 Favored 'General case' 0 C--O 1.242 0.661 0 N-CA-C 108.264 -1.013 . . . . 73.41 108.264 176.192 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.482 ' HB2' ' HB3' ' A' ' 245' ' ' LEU . 33.5 mt -92.87 125.75 37.63 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 107.372 -1.344 . . . . 63.32 107.372 176.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.468 ' HB2' ' CD1' ' A' ' 172' ' ' LEU . 5.8 tt . . . . . 0 C--N 1.312 -1.038 0 O-C-N 124.664 1.227 . . . . 74.2 110.468 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.468 ' CD1' ' HB2' ' A' ' 164' ' ' LEU . 3.3 mm? . . . . . 0 C--O 1.235 0.336 0 N-CA-C 112.842 0.682 . . . . 72.31 112.842 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 96.17 47.43 2.42 Favored Glycine 0 N--CA 1.439 -1.131 0 C-N-CA 119.77 -1.205 . . . . 37.22 114.205 174.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -159.51 154.51 24.89 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.774 -0.824 . . . . 74.25 108.774 174.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -123.4 143.89 49.84 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 109.071 -0.714 . . . . 74.34 109.071 177.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -117.31 169.61 7.57 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.77 0 CA-C-N 115.379 -0.828 . . . . 75.23 109.608 -179.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . 0.51 ' CG ' ' HB2' ' A' ' 198' ' ' SER . 19.2 ptt180 -144.66 155.24 43.5 Favored 'General case' 0 C--N 1.269 -2.914 0 C-N-CA 124.057 0.943 . . . . 75.11 109.724 -175.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -115.15 145.75 42.06 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-O 121.235 0.54 . . . . 75.33 110.323 -178.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -157.62 171.46 34.79 Favored Glycine 0 N--CA 1.42 -2.372 0 N-CA-C 108.414 -1.874 . . . . 63.05 108.414 176.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -86.62 123.09 31.42 Favored 'General case' 0 C--N 1.294 -1.83 0 C-N-CA 118.174 -1.41 . . . . 75.0 107.425 178.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' SER . . . . . 0.5 ' O ' ' HA ' ' A' ' 191' ' ' LYS . 37.8 t . . . . . 0 C--N 1.273 -2.747 0 N-CA-C 108.476 -0.935 . . . . 73.02 108.476 -178.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.5 ' HA ' ' O ' ' A' ' 181' ' ' SER . 31.2 ttmt . . . . . 0 N--CA 1.424 -1.747 0 N-CA-C 107.275 -1.38 . . . . 75.24 107.275 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -152.02 165.4 17.54 Favored Pre-proline 0 C--N 1.287 -2.11 0 N-CA-C 108.068 -1.086 . . . . 73.41 108.068 -169.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -55.68 131.58 46.97 Favored 'Trans proline' 0 C--O 1.251 1.154 0 C-N-CA 120.942 1.095 . . . . 74.23 110.516 176.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -143.4 141.92 10.86 Favored Glycine 0 N--CA 1.413 -2.857 0 N-CA-C 109.319 -1.512 . . . . 53.22 109.319 -178.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 2.8 mp -109.38 133.73 53.66 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.435 0 CA-C-O 121.481 0.657 . . . . 74.13 111.608 -176.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -123.28 167.07 14.23 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.93 -1.137 . . . . 75.13 107.93 -177.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . 0.426 ' HB ' ' HA ' ' A' ' 214' ' ' VAL . 45.6 mm -79.58 131.97 33.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 108.947 -0.76 . . . . 72.41 108.947 177.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' SER . . . . . 0.51 ' HB2' ' CG ' ' A' ' 177' ' ' ARG . 14.4 t -106.55 -31.53 8.47 Favored 'General case' 0 C--N 1.295 -1.781 0 O-C-N 121.734 -0.604 . . . . 75.25 112.415 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -164.85 144.31 7.04 Favored 'General case' 0 C--N 1.313 -0.979 0 C-N-CA 120.986 -0.286 . . . . 74.33 110.643 -176.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 81.4 mt -107.74 134.48 50.64 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.849 -1.167 . . . . 74.44 107.849 172.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 60.2 t -92.93 114.89 63.91 Favored Pre-proline 0 C--N 1.29 -2.018 0 N-CA-C 105.744 -1.947 . . . . 65.25 105.744 172.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -61.06 137.19 70.13 Favored 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 121.8 1.667 . . . . 75.13 110.378 -177.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 98.77 -21.38 46.24 Favored Glycine 0 C--N 1.303 -1.271 0 C-N-CA 120.513 -0.851 . . . . 70.42 111.109 -177.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -76.06 175.32 52.48 Favored Glycine 0 N--CA 1.44 -1.064 0 C-N-CA 121.349 -0.453 . . . . 74.44 112.492 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -67.22 -30.79 70.81 Favored 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 123.743 0.817 . . . . 64.45 111.249 -177.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -68.68 -41.31 79.4 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.461 0.648 . . . . 75.4 109.783 178.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -68.17 -32.78 73.27 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.473 -0.785 . . . . 71.22 109.35 177.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 49.3 m -56.5 -40.96 75.84 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 116.058 -0.519 . . . . 73.24 111.581 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 7.2 t -84.87 -41.21 16.23 Favored 'General case' 0 N--CA 1.44 -0.941 0 C-N-CA 119.178 -1.009 . . . . 53.54 110.514 177.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 67.18 6.69 40.69 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 121.325 -0.464 . . . . 73.34 113.442 179.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 76.9 mt -84.07 -9.48 58.59 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-O 121.175 0.512 . . . . 62.12 111.089 -178.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -112.48 136.55 51.85 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-N 115.662 -0.699 . . . . 72.22 109.373 175.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -130.69 166.84 19.85 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.423 -0.954 . . . . 61.44 108.423 -178.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . 0.426 ' HA ' ' HB ' ' A' ' 197' ' ' ILE . 16.5 m -56.42 -30.38 30.79 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 N-CA-C 113.486 0.921 . . . . 73.22 113.486 -176.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 -79.38 -15.0 58.59 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 121.75 -0.594 . . . . 73.24 111.688 -179.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.468 ' HB3' ' HB ' ' A' ' 249' ' ' VAL . 1.5 m-20 -71.78 139.74 49.15 Favored 'General case' 0 C--O 1.248 0.974 0 CA-C-O 121.439 0.637 . . . . 62.14 111.92 -178.515 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 57.0 tt0 -101.46 138.54 38.33 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.973 -1.012 . . . . 53.42 111.266 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 35.4 t -83.54 124.44 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 CA-C-O 121.77 0.795 . . . . 75.25 110.133 -178.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 35.5 mm -93.64 -51.88 10.53 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 CA-C-N 115.044 -0.98 . . . . 74.44 111.121 -179.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -154.26 158.33 40.05 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 116.214 -0.448 . . . . 70.52 110.458 -177.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 12.5 p -127.69 120.26 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.663 0 CA-C-N 115.595 -0.73 . . . . 75.42 109.411 179.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . 0.469 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 12.0 t-20 68.28 4.23 4.08 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 126.329 1.851 . . . . 72.43 110.98 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 117.57 -15.45 12.83 Favored Glycine 0 N--CA 1.44 -1.078 0 N-CA-C 110.892 -0.883 . . . . 74.42 110.892 -177.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 65.4 mt -94.75 124.44 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 CA-C-O 121.132 0.492 . . . . 74.34 110.026 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -55.37 137.08 48.71 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 124.914 1.286 . . . . 74.44 112.425 -179.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 35.8 m -105.98 8.79 9.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 CA-C-O 121.801 0.81 . . . . 72.41 109.981 175.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -74.72 99.9 3.84 Favored 'General case' 0 N--CA 1.431 -1.398 0 CA-C-N 114.813 -1.085 . . . . 75.02 110.125 178.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 112.41 -8.63 26.49 Favored Glycine 0 CA--C 1.495 -1.171 0 N-CA-C 110.378 -1.089 . . . . 73.14 110.378 178.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -83.06 153.08 25.08 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 107.954 -1.128 . . . . 71.02 107.954 176.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 74.4 p -91.79 175.73 6.78 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 108.168 -1.049 . . . . 53.41 108.168 179.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . 0.47 ' HA ' HG21 ' A' ' 234' ' ' VAL . 2.8 tm? -65.06 -37.03 86.21 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 107.818 -1.178 . . . . 72.03 107.818 178.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -55.69 -51.82 65.96 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.016 -0.993 . . . . 45.43 109.395 177.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' GLN . . . . . 0.536 ' O ' ' HG3' ' A' ' 237' ' ' MET . 2.2 mp0 -66.84 -50.7 61.72 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 113.798 1.036 . . . . 65.44 113.798 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.544 ' O ' ' HG3' ' A' ' 238' ' ' MET . 26.7 m -58.89 -33.51 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 N-CA-C 112.588 0.588 . . . . 74.14 112.588 -174.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 91.3 m -72.77 -35.56 67.47 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 115.232 -0.895 . . . . 75.3 109.332 -175.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -69.02 -30.77 69.21 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.298 -0.864 . . . . 74.31 108.994 178.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' MET . . . . . 0.539 ' SD ' ' HA ' ' A' ' 234' ' ' VAL . 19.3 mtp -69.49 -47.25 64.49 Favored 'General case' 0 C--O 1.209 -1.067 0 N-CA-C 106.931 -1.507 . . . . 71.51 106.931 178.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' MET . . . . . 0.544 ' HG3' ' O ' ' A' ' 234' ' ' VAL . 65.3 mtt -59.55 -45.29 92.24 Favored 'General case' 0 C--O 1.22 -0.489 0 CA-C-N 115.42 -0.809 . . . . 72.41 112.186 -179.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 89.3 t -64.42 -38.26 82.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.161 0.505 . . . . 74.42 110.533 178.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -68.89 -36.13 77.7 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.383 0.611 . . . . 75.4 110.318 178.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -86.51 19.43 2.83 Favored 'General case' 0 C--O 1.199 -1.583 0 CA-C-N 115.472 -0.785 . . . . 61.34 111.906 179.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 30.4 p -61.26 -23.7 65.85 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 112.776 0.658 . . . . 74.14 112.776 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 25.4 p -74.8 -16.78 60.69 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 112.12 0.415 . . . . 72.14 112.12 178.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -175.29 88.24 0.04 OUTLIER 'General case' 0 C--O 1.257 1.451 0 N-CA-C 107.787 -1.19 . . . . 75.44 107.787 -179.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . 0.482 ' HB3' ' HB2' ' A' ' 163' ' ' LEU . 2.8 tt -92.15 102.11 14.63 Favored 'General case' 0 N--CA 1.416 -2.138 0 C-N-CA 118.923 -1.111 . . . . 72.11 109.268 -174.225 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . 0.552 ' HA ' ' O ' ' A' ' 161' ' ' VAL . 89.1 mt -97.81 116.4 40.3 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.98 0 C-N-CA 120.134 -0.627 . . . . 72.02 109.971 178.116 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 14.6 mt -117.99 134.63 60.99 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.84 0 CA-C-O 121.433 0.635 . . . . 73.11 111.403 176.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.448 ' HA ' ' O ' ' A' ' 159' ' ' ARG . 63.8 m -103.1 114.87 29.51 Favored 'General case' 0 N--CA 1.409 -2.5 0 CA-C-N 114.52 -1.218 . . . . 37.22 108.072 175.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . 0.468 ' HB ' ' HB3' ' A' ' 216' ' ' ASP . 17.4 m -118.89 159.91 19.11 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.165 0 CA-C-O 121.46 0.648 . . . . 74.52 110.754 177.12 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . 0.484 ' HB3' ' ND1' ' A' ' 158' ' ' HIS . 10.0 ptmt -127.69 128.84 23.86 Favored Pre-proline 0 C--N 1.272 -2.798 0 CA-C-N 114.291 -1.322 . . . . 74.33 109.161 177.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo . . . . . 0 N--CA 1.439 -1.683 0 C-N-CA 121.827 1.685 . . . . 64.3 110.5 178.809 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.499 -0.992 0 N-CA-C 109.815 -0.439 . . . . 75.03 109.815 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.545 ' O ' ' HA ' ' A' ' 248' ' ' THR . 2.1 tpm_? -140.18 140.36 35.9 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.619 -1.252 . . . . 74.41 107.619 177.101 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.573 ' HB3' ' OG1' ' A' ' 248' ' ' THR . 23.2 ptt180 -132.47 113.03 12.63 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 122.098 0.951 . . . . 75.41 113.067 178.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.624 ' O ' ' HA ' ' A' ' 246' ' ' ILE . 21.1 m -105.17 139.29 26.67 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 CA-C-N 113.929 -1.487 . . . . 70.42 113.014 -175.181 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.469 ' HG3' HG12 ' A' ' 246' ' ' ILE . 7.3 mpt_? -91.13 112.6 24.57 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 106.995 -1.483 . . . . 74.24 106.995 175.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.458 ' HB2' ' HB3' ' A' ' 245' ' ' LEU . 35.4 mt -100.23 135.49 41.58 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 108.49 -0.929 . . . . 64.41 108.49 179.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 8.1 tp . . . . . 0 N--CA 1.417 -2.102 0 C-N-CA 124.499 1.12 . . . . 55.11 110.567 175.759 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.444 ' HG ' ' CD1' ' A' ' 245' ' ' LEU . 3.3 mm? . . . . . 0 N--CA 1.445 -0.706 0 CA-C-O 120.916 0.388 . . . . 55.51 111.358 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . 0.411 ' HA3' ' HA3' ' A' ' 204' ' ' GLY . . . 93.28 35.49 6.26 Favored Glycine 0 N--CA 1.437 -1.247 0 C-N-CA 120.419 -0.896 . . . . 62.44 113.704 175.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -151.45 158.89 44.26 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.415 -0.958 . . . . 74.25 108.415 174.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -125.36 156.83 38.12 Favored 'General case' 0 C--N 1.284 -2.243 0 N-CA-C 108.761 -0.829 . . . . 72.45 108.761 175.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -124.96 166.64 20.24 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 CA-C-O 121.441 0.639 . . . . 61.21 110.421 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . 0.463 ' HG2' ' HB3' ' A' ' 198' ' ' SER . 14.7 ptt180 -144.78 154.76 43.04 Favored 'General case' 0 C--N 1.28 -2.438 0 CA-C-N 114.699 -1.137 . . . . 74.42 110.154 -176.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -112.98 145.39 40.9 Favored 'General case' 0 C--N 1.294 -1.822 0 C-N-CA 123.648 0.779 . . . . 73.44 110.094 -177.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -162.98 179.13 38.42 Favored Glycine 0 C--N 1.294 -1.797 0 N-CA-C 109.048 -1.621 . . . . 42.24 109.048 175.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 2.1 p -96.99 123.4 40.7 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-N 118.19 0.995 . . . . 75.12 111.154 174.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' SER . . . . . 0.526 ' O ' ' HA ' ' A' ' 191' ' ' LYS . 24.5 t . . . . . 0 C--N 1.291 -1.944 0 N-CA-C 107.684 -1.228 . . . . 71.22 107.684 177.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.526 ' HA ' ' O ' ' A' ' 181' ' ' SER . 43.8 mtmt . . . . . 0 CA--C 1.488 -1.423 0 CA-C-O 122.405 1.098 . . . . 72.01 112.402 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -132.08 163.47 49.93 Favored Pre-proline 0 C--N 1.259 -3.327 0 N-CA-C 105.184 -2.154 . . . . 65.05 105.184 176.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -66.48 131.07 25.22 Favored 'Trans proline' 0 N--CA 1.423 -2.666 0 N-CA-C 106.872 -2.011 . . . . 73.13 106.872 169.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -125.89 127.83 6.27 Favored Glycine 0 N--CA 1.397 -3.965 0 N-CA-C 109.499 -1.441 . . . . 73.11 109.499 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 3.4 mp -103.68 132.78 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.049 0 N-CA-C 109.084 -0.71 . . . . 75.0 109.084 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -125.6 167.38 15.16 Favored 'General case' 0 C--N 1.281 -2.405 0 N-CA-C 107.366 -1.346 . . . . 71.14 107.366 -176.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 47.5 mm -77.82 132.29 32.88 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 N-CA-C 107.021 -1.474 . . . . 73.11 107.021 175.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' SER . . . . . 0.463 ' HB3' ' HG2' ' A' ' 177' ' ' ARG . 83.4 p -100.47 -35.29 9.6 Favored 'General case' 0 C--N 1.28 -2.43 0 C-N-CA 118.806 -1.158 . . . . 74.21 111.053 -178.255 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 65.9 ttt180 -158.13 147.3 19.43 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.296 -0.411 . . . . 73.25 110.44 -176.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 71.0 mt -106.66 138.39 42.93 Favored 'General case' 0 CA--C 1.483 -1.609 0 N-CA-C 108.554 -0.906 . . . . 71.12 108.554 171.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 58.9 t -98.89 114.99 65.99 Favored Pre-proline 0 N--CA 1.415 -2.211 0 N-CA-C 106.377 -1.712 . . . . 75.32 106.377 172.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . 0.421 ' HA ' ' HG2' ' A' ' 207' ' ' GLU . 37.0 Cg_exo -58.73 126.8 22.28 Favored 'Trans proline' 0 N--CA 1.448 -1.149 0 C-N-CA 121.934 1.756 . . . . 75.23 110.65 -178.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 106.24 -16.3 42.1 Favored Glycine 0 N--CA 1.438 -1.2 0 C-N-CA 120.332 -0.937 . . . . 63.03 112.403 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . 0.411 ' HA3' ' HA3' ' A' ' 173' ' ' GLY . . . -81.01 -179.23 52.97 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.811 -0.709 . . . . 36.72 111.898 178.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -62.74 -42.85 99.87 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 123.1 0.56 . . . . 71.5 111.548 -177.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -60.96 -38.66 86.71 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.139 -0.482 . . . . 71.32 111.335 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.421 ' HG2' ' HA ' ' A' ' 202' ' ' PRO . 9.3 tp10 -75.51 -36.9 60.44 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.505 -0.554 . . . . 72.02 109.505 178.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 24.7 t -60.18 -45.98 91.25 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 115.915 -0.584 . . . . 54.13 110.444 -179.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 8.9 t -72.89 -40.33 65.65 Favored 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 120.311 -0.556 . . . . 74.5 110.037 176.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 73.16 9.32 76.49 Favored Glycine 0 N--CA 1.441 -0.998 0 CA-C-N 115.852 -0.613 . . . . 62.51 112.561 179.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 48.6 mt -97.25 1.97 50.28 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.542 0.687 . . . . 64.22 109.685 -179.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 87.6 mt -112.83 132.43 55.28 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 114.744 -1.116 . . . . 72.42 109.09 174.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -131.45 160.65 34.52 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 122.817 0.447 . . . . 74.22 109.889 176.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 32.8 m -62.22 -30.26 48.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 122.034 0.921 . . . . 74.41 112.922 -178.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -81.0 -14.07 58.28 Favored 'General case' 0 C--N 1.275 -2.641 0 CA-C-N 116.04 -0.527 . . . . 72.1 111.777 -175.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.46 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 72.0 m-20 -71.71 151.47 43.58 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 113.599 0.963 . . . . 74.52 113.599 -175.06 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -111.64 129.78 55.98 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.122 1.369 . . . . 72.44 109.955 -176.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 41.6 t -82.24 138.88 18.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 CA-C-O 121.488 0.661 . . . . 64.35 111.949 -175.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 47.4 mm -108.66 -51.76 6.82 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 C-N-CA 123.935 0.894 . . . . 71.2 111.631 -178.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -151.87 161.38 42.74 Favored 'General case' 0 C--O 1.244 0.808 0 CA-C-O 120.522 0.201 . . . . 70.34 110.663 -178.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . 0.41 ' CG1' ' HE1' ' A' ' 237' ' ' MET . 15.0 p -129.93 119.47 47.32 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.075 0 CA-C-O 121.449 0.642 . . . . 72.42 109.556 177.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . 0.501 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 13.7 t-20 70.23 0.02 2.99 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 125.859 1.663 . . . . 74.13 111.858 177.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 121.87 -13.8 9.15 Favored Glycine 0 N--CA 1.435 -1.369 0 N-CA-C 110.955 -0.858 . . . . 65.43 110.955 -177.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 66.6 mt -95.8 123.66 48.1 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 N-CA-C 108.725 -0.843 . . . . 71.44 108.725 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -55.76 147.65 18.32 Favored 'General case' 0 C--N 1.31 -1.138 0 O-C-N 123.912 0.758 . . . . 70.55 111.145 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . 0.468 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 33.5 m -120.5 -1.1 8.02 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 CA-C-O 121.472 0.653 . . . . 72.41 109.387 173.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -73.36 95.16 2.14 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-N 115.081 -0.963 . . . . 73.12 110.622 -178.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 127.43 -22.29 5.59 Favored Glycine 0 N--CA 1.429 -1.795 0 C-N-CA 120.432 -0.89 . . . . 71.11 110.939 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 55.9 mttm -83.78 164.93 19.25 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 109.996 -0.372 . . . . 74.34 109.996 177.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' THR . . . . . 0.405 ' O ' HG13 ' A' ' 234' ' ' VAL . 34.7 p -93.0 168.09 11.36 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 116.43 -0.35 . . . . 73.51 110.204 -177.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . 0.446 ' HA ' HG21 ' A' ' 234' ' ' VAL . 2.8 tm? -56.96 -41.94 79.24 Favored 'General case' 0 N--CA 1.44 -0.967 0 C-N-CA 123.083 0.553 . . . . 64.11 109.878 -178.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -56.43 -51.59 67.81 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.365 -0.379 . . . . 73.11 110.501 176.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -58.6 -49.75 76.32 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 115.229 -0.896 . . . . 72.22 112.362 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.468 ' CG1' ' HB ' ' A' ' 226' ' ' VAL . 15.1 m -69.45 -33.84 59.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 112.894 0.701 . . . . 74.22 112.894 -173.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' THR . . . . . 0.42 ' O ' HG21 ' A' ' 239' ' ' VAL . 84.4 m -73.42 -35.59 65.85 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 109.488 -0.56 . . . . 71.44 109.488 -174.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -63.39 -33.1 74.8 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.957 -0.757 . . . . 71.34 108.957 177.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' MET . . . . . 0.41 ' HE1' ' CG1' ' A' ' 221' ' ' VAL . 5.1 mtm -72.72 -38.98 67.29 Favored 'General case' 0 C--O 1.199 -1.555 0 CA-C-N 115.341 -0.845 . . . . 74.43 108.731 -179.124 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' MET . . . . . 0.444 ' HG3' ' O ' ' A' ' 234' ' ' VAL . 65.6 mtt -63.45 -37.96 89.3 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.285 -0.416 . . . . 75.22 110.815 179.113 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . 0.42 HG21 ' O ' ' A' ' 235' ' ' THR . 66.4 t -69.69 -41.0 79.97 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 CA-C-N 116.334 -0.393 . . . . 74.41 110.149 177.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -66.39 -34.19 77.4 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.768 0.794 . . . . 73.23 110.372 177.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -86.41 20.51 2.4 Favored 'General case' 0 C--O 1.2 -1.545 0 CA-C-N 115.267 -0.879 . . . . 75.32 112.506 178.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 67.4 m -64.88 -23.59 67.28 Favored 'General case' 0 C--O 1.212 -0.912 0 C-N-CA 120.172 -0.611 . . . . 74.01 112.545 178.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 12.4 p -65.3 -36.36 83.83 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 111.802 0.297 . . . . 75.31 111.802 176.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 46.2 m-80 -155.95 92.43 1.36 Allowed 'General case' 0 C--O 1.254 1.294 0 N-CA-C 107.301 -1.37 . . . . 72.14 107.301 177.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . 0.458 ' HB3' ' HB2' ' A' ' 163' ' ' LEU . 2.8 tt -88.6 103.18 15.67 Favored 'General case' 0 N--CA 1.423 -1.817 0 C-N-CA 119.381 -0.927 . . . . 75.14 109.641 -174.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . 0.624 ' HA ' ' O ' ' A' ' 161' ' ' VAL . 87.2 mt -102.58 116.59 46.55 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.992 0 C-N-CA 120.721 -0.392 . . . . 70.21 109.974 177.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . 0.431 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 25.5 mt -119.55 132.89 68.05 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.089 0 CA-C-O 121.146 0.498 . . . . 74.15 111.912 176.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.573 ' OG1' ' HB3' ' A' ' 160' ' ' ARG . 57.2 m -100.27 124.35 45.63 Favored 'General case' 0 N--CA 1.426 -1.648 0 N-CA-C 107.561 -1.274 . . . . 72.51 107.561 175.035 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 29.5 m -124.82 170.56 14.8 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 CA-C-O 121.579 0.704 . . . . 74.23 110.971 176.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . 0.312 44.0 mtpt -125.0 134.78 26.02 Favored Pre-proline 0 C--N 1.28 -2.417 0 N-CA-C 106.146 -1.798 . . . . 73.43 106.146 173.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . 0.46 ' HA ' ' OD1' ' A' ' 216' ' ' ASP . 5.6 Cg_exo . . . . . 0 N--CA 1.402 -3.871 0 CA-C-N 119.73 0.939 . . . . 74.23 110.346 173.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 23.6 m80 . . . . . 0 N--CA 1.432 -1.355 0 N-CA-C 112.161 0.43 . . . . 73.4 112.161 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.541 ' O ' ' HA ' ' A' ' 248' ' ' THR . 12.8 tpt180 -131.22 143.39 50.54 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.34 -1.356 . . . . 71.42 107.34 173.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 30.4 ttt85 -120.09 113.24 20.19 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 121.233 0.539 . . . . 75.31 109.911 -178.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.534 ' O ' ' HA ' ' A' ' 246' ' ' ILE . 25.2 m -119.24 139.14 47.62 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 N-CA-C 112.501 0.556 . . . . 65.34 112.501 -175.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.438 ' HG3' HG12 ' A' ' 246' ' ' ILE . 3.3 mpt_? -100.1 112.93 25.23 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 107.086 -1.449 . . . . 73.45 107.086 177.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 23.9 mt -95.69 130.59 42.54 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 109.412 -0.588 . . . . 74.0 109.412 -178.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 6.1 tt . . . . . 0 C--N 1.33 -0.248 0 CA-C-O 122.333 1.063 . . . . 74.14 110.757 176.327 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.433 ' HG ' ' CD1' ' A' ' 245' ' ' LEU . 2.6 mm? . . . . . 0 C--O 1.239 0.545 0 CA-C-O 121.032 0.444 . . . . 64.34 111.912 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . 0.455 ' HA3' ' HA3' ' A' ' 204' ' ' GLY . . . 91.56 38.92 5.73 Favored Glycine 0 N--CA 1.429 -1.823 0 C-N-CA 120.71 -0.757 . . . . 73.25 114.155 172.13 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -152.76 153.45 33.22 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 109.245 -0.65 . . . . 73.41 109.245 174.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -114.56 140.22 48.95 Favored 'General case' 0 C--N 1.282 -2.341 0 CA-C-N 115.674 -0.694 . . . . 71.13 109.282 178.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 29.1 pt -114.31 169.1 5.7 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.514 0 CA-C-N 115.446 -0.797 . . . . 75.32 109.885 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . 0.484 ' HG2' ' HB2' ' A' ' 198' ' ' SER . 3.1 ptp180 -153.75 154.64 34.42 Favored 'General case' 0 C--N 1.278 -2.52 0 CA-C-N 115.541 -0.754 . . . . 73.14 108.97 -179.273 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -101.47 154.99 18.34 Favored 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 108.659 -0.867 . . . . 74.41 108.659 178.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -165.23 -168.61 27.66 Favored Glycine 0 N--CA 1.412 -2.95 0 N-CA-C 109.274 -1.531 . . . . 65.13 109.274 177.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' THR . . . . . 0.57 ' HB ' ' CG ' ' A' ' 191' ' ' LYS . 1.3 p -100.48 123.64 44.96 Favored 'General case' 0 C--N 1.28 -2.426 0 CA-C-O 121.876 0.846 . . . . 63.34 112.716 178.259 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 27.6 t . . . . . 0 N--CA 1.416 -2.127 0 N-CA-C 106.466 -1.679 . . . . 42.25 106.466 176.637 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.57 ' CG ' ' HB ' ' A' ' 180' ' ' THR . 36.7 ttmt . . . . . 0 N--CA 1.409 -2.478 0 N-CA-C 107.731 -1.211 . . . . 73.13 107.731 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -141.23 164.46 35.39 Favored Pre-proline 0 C--N 1.284 -2.281 0 N-CA-C 108.712 -0.847 . . . . 72.24 108.712 -174.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -57.52 132.21 49.14 Favored 'Trans proline' 0 N--CA 1.448 -1.153 0 C-N-CA 121.504 1.47 . . . . 73.04 111.638 176.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -141.03 146.33 17.52 Favored Glycine 0 N--CA 1.408 -3.191 0 N-CA-C 108.244 -1.942 . . . . 72.25 108.244 177.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 2.6 mp -104.32 133.03 49.52 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.413 0 C-N-CA 120.165 -0.614 . . . . 64.04 111.189 -178.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -122.96 167.49 13.52 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 108.085 -1.08 . . . . 74.54 108.085 -176.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 41.3 mm -77.62 132.95 31.61 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 N-CA-C 108.527 -0.916 . . . . 73.24 108.527 177.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' SER . . . . . 0.484 ' HB2' ' HG2' ' A' ' 177' ' ' ARG . 11.1 t -104.14 -36.51 7.66 Favored 'General case' 0 C--N 1.275 -2.646 0 O-C-N 121.731 -0.605 . . . . 75.42 112.488 178.039 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 20.1 tpp180 -167.15 144.52 4.67 Favored 'General case' 0 C--O 1.213 -0.855 0 N-CA-C 110.136 -0.32 . . . . 71.25 110.136 -177.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 78.8 mt -101.89 145.43 29.23 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 108.514 -0.921 . . . . 73.33 108.514 171.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 61.9 t -105.19 114.0 63.98 Favored Pre-proline 0 N--CA 1.42 -1.971 0 N-CA-C 105.972 -1.862 . . . . 52.13 105.972 172.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . 0.438 ' HA ' ' HG3' ' A' ' 207' ' ' GLU . 27.7 Cg_exo -62.01 136.87 63.59 Favored 'Trans proline' 0 N--CA 1.446 -1.293 0 C-N-CA 121.802 1.668 . . . . 72.44 110.268 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 104.12 -26.34 23.32 Favored Glycine 0 C--N 1.298 -1.581 0 N-CA-C 110.087 -1.205 . . . . 75.21 110.087 -175.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . 0.455 ' HA3' ' HA3' ' A' ' 173' ' ' GLY . . . -79.72 162.74 47.34 Favored Glycine 0 N--CA 1.423 -2.198 0 N-CA-C 111.031 -0.828 . . . . 62.31 111.031 178.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -62.94 -29.57 70.89 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.372 0.669 . . . . 74.52 111.847 -173.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -63.6 -46.94 83.5 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.19 0.519 . . . . 74.05 110.289 177.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.438 ' HG3' ' HA ' ' A' ' 202' ' ' PRO . 3.9 tm-20 -71.51 -33.65 69.4 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.26 -0.427 . . . . 74.11 109.929 178.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 50.5 m -56.39 -39.25 72.68 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.186 -0.461 . . . . 74.24 111.159 177.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 13.0 t -83.91 -40.57 18.4 Favored 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 119.197 -1.001 . . . . 71.34 109.832 176.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 65.71 2.5 11.82 Favored Glycine 0 C--N 1.343 0.966 0 N-CA-C 114.183 0.433 . . . . 62.53 114.183 177.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 60.9 mt -78.88 -12.3 60.03 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-O 120.969 0.414 . . . . 75.25 110.708 -177.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -109.86 134.88 51.57 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.329 -0.989 . . . . 74.55 108.329 174.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -117.41 162.11 18.46 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 116.624 -0.262 . . . . 73.01 110.306 -178.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 35.6 m -56.64 -31.52 34.87 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.77 0 N-CA-C 114.471 1.286 . . . . 64.05 114.471 -176.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -82.72 -14.26 54.88 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 112.773 0.657 . . . . 72.42 112.773 -178.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.565 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 54.3 m-20 -69.01 156.13 39.15 Favored 'General case' 0 C--O 1.246 0.904 0 N-CA-C 113.266 0.839 . . . . 55.33 113.266 -173.123 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -107.4 137.07 46.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.933 -1.03 . . . . 63.1 110.246 -179.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 30.9 t -84.53 125.74 40.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 121.464 0.649 . . . . 73.41 109.975 -179.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 40.1 mm -90.23 -49.99 13.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 CA-C-N 115.167 -0.924 . . . . 75.42 110.607 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.405 ' CB ' ' HA ' ' A' ' 225' ' ' GLU . 9.3 pt-20 -154.59 160.93 41.78 Favored 'General case' 0 C--O 1.249 1.062 0 CA-C-N 116.313 -0.403 . . . . 72.12 110.438 -179.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . 0.415 ' CG1' ' HE1' ' A' ' 237' ' ' MET . 8.4 p -121.49 113.57 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.215 0 CA-C-O 122.109 0.957 . . . . 75.42 108.968 174.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . 0.443 ' OD1' HD11 ' A' ' 246' ' ' ILE . 60.0 t30 40.74 68.37 0.42 Allowed 'General case' 0 C--N 1.28 -2.421 0 C-N-CA 127.103 2.161 . . . . 73.4 114.497 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 84.35 -20.85 11.92 Favored Glycine 0 N--CA 1.443 -0.848 0 CA-C-N 114.93 -1.032 . . . . 73.35 113.738 178.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 54.6 mt -105.92 123.41 60.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 117.034 0.417 . . . . 72.43 110.011 -176.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . 0.405 ' HA ' ' CB ' ' A' ' 220' ' ' GLU . 11.8 pt-20 -66.03 144.14 56.92 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.352 0.596 . . . . 73.43 111.564 -178.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 33.9 m -115.19 -2.24 10.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-N 115.923 -0.58 . . . . 75.51 111.186 178.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -73.92 98.88 3.11 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.933 -0.576 . . . . 74.31 110.058 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 120.59 -17.07 9.59 Favored Glycine 0 CA--C 1.498 -0.988 0 N-CA-C 111.45 -0.66 . . . . 71.42 111.45 179.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -78.98 162.87 25.66 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 108.737 -0.838 . . . . 74.35 108.737 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' THR . . . . . 0.404 ' O ' HG13 ' A' ' 234' ' ' VAL . 68.2 p -87.34 170.63 11.24 Favored 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 107.599 -1.26 . . . . 62.42 107.599 177.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . 0.404 ' HA ' HG21 ' A' ' 234' ' ' VAL . 0.7 OUTLIER -68.08 -34.46 76.45 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 107.347 -1.353 . . . . 74.11 107.347 179.976 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -58.54 -47.41 84.3 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-N 115.734 -0.666 . . . . 62.23 110.075 176.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -64.6 -49.05 72.63 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 113.902 1.075 . . . . 73.21 113.902 178.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.404 HG13 ' O ' ' A' ' 230' ' ' THR . 17.0 m -61.6 -33.47 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 112.581 0.585 . . . . 73.22 112.581 -176.399 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' THR . . . . . 0.486 ' O ' HG21 ' A' ' 239' ' ' VAL . 58.3 m -70.03 -35.84 74.61 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 115.803 -0.635 . . . . 74.23 109.887 -175.011 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -64.93 -30.94 71.96 Favored 'General case' 0 CA--C 1.508 -0.65 0 N-CA-C 108.86 -0.793 . . . . 36.61 108.86 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' MET . . . . . 0.415 ' HE1' ' CG1' ' A' ' 221' ' ' VAL . 5.7 mtm -74.36 -37.54 63.46 Favored 'General case' 0 C--O 1.199 -1.567 0 N-CA-C 108.259 -1.015 . . . . 72.11 108.259 -179.257 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 65.5 mtt -69.57 -34.66 74.49 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.212 -0.449 . . . . 71.13 110.998 178.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . 0.486 HG21 ' O ' ' A' ' 235' ' ' THR . 99.0 t -67.04 -39.98 84.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.197 0.523 . . . . 71.52 110.222 176.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -68.29 -42.92 78.81 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.54 0.686 . . . . 75.24 109.325 176.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -79.69 18.13 0.81 Allowed 'General case' 0 C--O 1.192 -1.948 0 CA-C-N 115.025 -0.989 . . . . 73.21 112.237 178.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 70.3 m -68.26 -22.55 64.75 Favored 'General case' 0 N--CA 1.478 0.967 0 O-C-N 121.584 -0.698 . . . . 64.22 111.923 178.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 37.8 p -65.5 -22.48 66.73 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 116.275 -0.42 . . . . 73.15 110.727 176.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 178.05 101.12 0.02 OUTLIER 'General case' 0 CA--C 1.503 -0.834 0 C-N-CA 125.578 1.551 . . . . 74.22 107.63 176.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . 0.433 ' CD1' ' HG ' ' A' ' 172' ' ' LEU . 3.3 tt -90.01 106.52 18.53 Favored 'General case' 0 N--CA 1.414 -2.234 0 CA-C-N 115.515 -0.766 . . . . 63.21 110.203 -171.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . 0.534 ' HA ' ' O ' ' A' ' 161' ' ' VAL . 62.9 mt -95.32 127.92 46.92 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.068 0 N-CA-C 109.115 -0.698 . . . . 72.24 109.115 176.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 12.8 mt -132.16 142.54 42.53 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 CA-C-O 121.367 0.603 . . . . 73.11 112.26 176.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.541 ' HA ' ' O ' ' A' ' 159' ' ' ARG . 61.5 m -110.49 117.43 33.53 Favored 'General case' 0 N--CA 1.418 -2.058 0 N-CA-C 107.932 -1.136 . . . . 74.12 107.932 173.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 27.0 m -120.78 162.41 19.53 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 N-CA-C 109.322 -0.622 . . . . 62.43 109.322 175.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 15.8 ptmt -134.01 133.56 22.19 Favored Pre-proline 0 C--N 1.284 -2.24 0 CA-C-N 115.198 -0.91 . . . . 73.44 108.803 175.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . 0.565 ' HA ' ' OD1' ' A' ' 216' ' ' ASP . 61.1 Cg_exo . . . . . 0 N--CA 1.443 -1.488 0 C-N-CA 122.115 1.877 . . . . 71.33 110.527 173.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 9.5 m80 . . . . . 0 CA--C 1.499 -1.016 0 N-CA-C 110.638 -0.134 . . . . 74.13 110.638 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.53 ' O ' ' HA ' ' A' ' 248' ' ' THR . 18.3 tpt180 -139.34 133.12 30.72 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 110.303 -0.258 . . . . 75.21 110.303 178.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.468 ' HA ' ' O ' ' A' ' 247' ' ' ILE . 4.6 ptp180 -117.6 118.63 32.65 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-O 121.756 0.789 . . . . 73.33 110.519 175.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 16.2 m -111.4 139.43 35.53 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.086 0 CA-C-N 114.914 -1.039 . . . . 73.34 111.338 -178.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.528 ' HG3' HG12 ' A' ' 246' ' ' ILE . 7.6 mpt_? -92.66 111.5 23.12 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 107.568 -1.271 . . . . 74.42 107.568 176.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.467 ' HB2' ' HB2' ' A' ' 245' ' ' LEU . 21.2 mt -91.28 137.03 32.68 Favored 'General case' 0 N--CA 1.416 -2.151 0 N-CA-C 108.38 -0.97 . . . . 63.2 108.38 -179.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.562 ' HG ' ' CD1' ' A' ' 172' ' ' LEU 0.391 10.8 mt . . . . . 0 CA--C 1.476 -1.873 0 N-CA-C 115.305 1.595 . . . . 73.34 115.305 -175.054 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.562 ' CD1' ' HG ' ' A' ' 164' ' ' LEU . 2.6 mm? . . . . . 0 CA--C 1.502 -0.886 0 CA-C-O 121.081 0.467 . . . . 74.54 111.282 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 101.77 45.47 1.77 Allowed Glycine 0 N--CA 1.419 -2.448 0 CA-C-N 115.469 -0.787 . . . . 73.34 112.75 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -156.94 154.47 29.75 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.499 -0.926 . . . . 74.44 108.499 175.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -124.34 144.95 49.72 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 108.971 -0.751 . . . . 72.43 108.971 175.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -110.67 169.81 3.67 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.238 0 N-CA-C 108.935 -0.765 . . . . 72.04 108.935 177.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . 0.557 ' CG ' ' HB2' ' A' ' 198' ' ' SER . 16.4 ptt180 -149.43 154.49 38.95 Favored 'General case' 0 C--N 1.269 -2.921 0 CA-C-N 115.189 -0.914 . . . . 65.31 109.83 -178.069 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -111.98 138.2 48.95 Favored 'General case' 0 C--N 1.28 -2.434 0 N-CA-C 108.786 -0.82 . . . . 64.21 108.786 178.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -150.64 -175.4 22.6 Favored Glycine 0 C--N 1.285 -2.269 0 N-CA-C 108.469 -1.853 . . . . 52.42 108.469 178.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' THR . . . . . 0.587 ' CG2' ' HG2' ' A' ' 191' ' ' LYS . 0.2 OUTLIER -102.01 123.17 45.44 Favored 'General case' 0 N--CA 1.415 -2.181 0 C-N-CA 118.725 -1.19 . . . . 64.32 108.087 178.078 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' SER . . . . . 0.459 ' O ' ' HA ' ' A' ' 191' ' ' LYS . 37.5 t . . . . . 0 C--N 1.28 -2.423 0 N-CA-C 108.439 -0.949 . . . . 61.1 108.439 -178.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.587 ' HG2' ' CG2' ' A' ' 180' ' ' THR . 34.2 ttmt . . . . . 0 N--CA 1.418 -2.071 0 N-CA-C 107.395 -1.335 . . . . 75.01 107.395 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -151.54 161.22 30.24 Favored Pre-proline 0 C--N 1.298 -1.661 0 CA-C-N 115.861 -0.608 . . . . 73.2 109.588 -171.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -58.77 132.68 49.25 Favored 'Trans proline' 0 C--O 1.244 0.825 0 C-N-CA 121.472 1.448 . . . . 73.31 110.991 177.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -147.1 144.63 12.81 Favored Glycine 0 N--CA 1.419 -2.473 0 N-CA-C 109.987 -1.245 . . . . 72.42 109.987 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 3.0 mp -105.61 134.08 48.14 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 CA-C-O 121.338 0.589 . . . . 72.02 110.683 -178.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -128.25 168.5 15.4 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.191 -1.04 . . . . 65.14 108.191 -176.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . 0.444 ' HB ' ' HA ' ' A' ' 214' ' ' VAL . 43.3 mm -76.75 131.88 33.99 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 N-CA-C 108.131 -1.062 . . . . 72.43 108.131 176.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' SER . . . . . 0.557 ' HB2' ' CG ' ' A' ' 177' ' ' ARG . 13.0 t -103.96 -33.8 8.7 Favored 'General case' 0 C--N 1.284 -2.26 0 N-CA-C 113.181 0.808 . . . . 72.12 113.181 -178.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 15.0 ttp180 -168.17 142.77 3.49 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 116.621 -0.263 . . . . 74.25 111.025 -177.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 66.1 mt -103.71 137.06 42.28 Favored 'General case' 0 CA--C 1.486 -1.481 0 N-CA-C 108.162 -1.051 . . . . 71.43 108.162 172.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 66.6 t -93.44 114.5 63.07 Favored Pre-proline 0 C--N 1.288 -2.103 0 N-CA-C 105.733 -1.951 . . . . 71.24 105.733 174.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . 0.475 ' HA ' ' HG2' ' A' ' 207' ' ' GLU . 38.2 Cg_endo -70.37 126.23 12.69 Favored 'Trans proline' 0 N--CA 1.429 -2.308 0 C-N-CA 120.915 1.077 . . . . 72.44 110.201 -176.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 113.59 -12.98 23.02 Favored Glycine 0 C--N 1.302 -1.356 0 N-CA-C 109.787 -1.325 . . . . 64.42 109.787 -173.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -90.48 168.65 33.58 Favored Glycine 0 N--CA 1.436 -1.356 0 N-CA-C 110.15 -1.18 . . . . 73.03 110.15 176.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 66.0 mt -65.39 -29.56 70.28 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 117.41 0.605 . . . . 74.41 111.498 -177.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -61.93 -48.1 81.93 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.878 -0.601 . . . . 61.01 110.768 178.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.475 ' HG2' ' HA ' ' A' ' 202' ' ' PRO . 10.4 tp10 -73.04 -32.6 65.18 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.445 -0.576 . . . . 74.54 109.445 178.097 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 23.0 t -56.98 -40.33 76.33 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 115.91 -0.586 . . . . 63.14 110.45 178.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 14.9 t -79.29 -40.27 30.86 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 119.089 -1.044 . . . . 74.21 108.752 175.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 58.58 31.3 66.78 Favored Glycine 0 C--N 1.347 1.189 0 CA-C-N 115.888 -0.596 . . . . 71.14 113.139 178.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 1.8 pp -102.21 -19.33 15.11 Favored 'General case' 0 N--CA 1.424 -1.732 0 C-N-CA 120.297 -0.561 . . . . 61.3 110.692 -179.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -109.39 134.28 52.03 Favored 'General case' 0 N--CA 1.432 -1.362 0 N-CA-C 107.857 -1.164 . . . . 74.21 107.857 -179.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -129.8 165.92 20.98 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 116.474 -0.33 . . . . 61.51 110.566 -176.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . 0.444 ' HA ' ' HB ' ' A' ' 197' ' ' ILE . 17.4 m -53.92 -30.41 19.53 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 N-CA-C 114.195 1.183 . . . . 73.04 114.195 -176.012 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 -78.02 -15.36 59.0 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.823 -0.548 . . . . 75.32 112.24 -178.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.71 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 58.5 m-20 -79.34 155.92 28.24 Favored 'General case' 0 C--O 1.248 0.995 0 CA-C-O 121.079 0.466 . . . . 72.42 112.076 -174.08 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -109.58 139.43 44.6 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.333 -0.849 . . . . 61.11 111.872 -176.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 25.1 t -88.03 120.16 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 CA-C-O 121.349 0.595 . . . . 75.31 109.58 -179.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 38.8 mm -89.9 -53.97 8.36 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 CA-C-N 115.257 -0.883 . . . . 74.51 112.302 -176.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -155.27 151.98 28.7 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 116.742 -0.208 . . . . 62.35 111.534 -175.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 9.1 p -121.78 123.22 68.81 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 CA-C-O 121.293 0.568 . . . . 74.01 109.786 176.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . 0.467 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 9.0 t-20 66.69 7.58 5.28 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 125.487 1.515 . . . . 71.31 111.221 177.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 113.3 -7.17 24.88 Favored Glycine 0 N--CA 1.44 -1.036 0 CA-C-N 115.677 -0.692 . . . . 51.45 112.273 -177.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 66.3 mt -101.4 123.9 54.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 109.423 -0.584 . . . . 72.45 109.423 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -59.7 134.49 57.07 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-O 121.644 0.735 . . . . 75.54 111.932 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . 0.497 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 27.6 m -117.82 2.76 7.44 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 CA-C-N 115.158 -0.928 . . . . 74.44 110.047 177.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -83.57 98.77 9.76 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-N 115.332 -0.849 . . . . 74.33 109.38 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 120.35 -16.15 9.9 Favored Glycine 0 CA--C 1.489 -1.543 0 N-CA-C 111.283 -0.727 . . . . 74.54 111.283 -178.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -77.54 172.64 13.05 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 109.45 -0.574 . . . . 62.42 109.45 178.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 36.7 p -92.78 165.11 13.09 Favored 'General case' 0 N--CA 1.422 -1.841 0 N-CA-C 108.143 -1.058 . . . . 72.31 108.143 178.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 51.9 tp -61.16 -37.44 82.89 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 120.895 -0.322 . . . . 74.01 110.772 -177.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -57.76 -51.37 69.82 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 109.989 -0.375 . . . . 72.42 109.989 176.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -54.56 -48.55 71.93 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 115.676 -0.693 . . . . 72.4 112.508 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.497 ' CG1' ' HB ' ' A' ' 226' ' ' VAL . 7.1 m -75.27 -34.84 31.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 112.257 0.465 . . . . 64.02 112.257 -174.193 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 31.2 m -75.0 -35.6 61.99 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 108.905 -0.776 . . . . 63.31 108.905 -175.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -59.11 -33.49 70.91 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.119 -0.946 . . . . 71.24 109.415 176.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 5.8 mtt -73.56 -44.61 56.97 Favored 'General case' 0 C--O 1.2 -1.526 0 N-CA-C 107.91 -1.144 . . . . 73.22 107.91 178.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 238' ' ' MET . . . . . 0.421 ' HG3' ' O ' ' A' ' 234' ' ' VAL . 64.9 mtt -59.98 -41.65 92.46 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.36 -0.382 . . . . 73.53 111.943 -177.402 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 92.6 t -65.04 -38.71 83.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.227 0.536 . . . . 70.24 110.105 176.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -76.02 -19.9 58.27 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.355 0.598 . . . . 71.32 111.482 -179.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 -107.89 22.18 16.33 Favored 'General case' 0 C--O 1.205 -1.252 0 CA-C-N 115.94 -0.573 . . . . 62.03 110.471 177.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 22.8 t -63.44 -22.79 67.09 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.649 0.738 . . . . 75.04 109.141 177.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 16.1 p -69.56 -32.14 70.75 Favored 'General case' 0 N--CA 1.428 -1.569 0 CA-C-N 115.651 -0.704 . . . . 71.31 111.373 174.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -165.9 99.48 0.66 Allowed 'General case' 0 C--O 1.24 0.579 0 CA-C-O 121.749 0.785 . . . . 60.53 110.82 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . 0.467 ' HB2' ' HB2' ' A' ' 163' ' ' LEU . 10.3 mt -91.46 105.18 17.57 Favored 'General case' 0 C--O 1.195 -1.786 0 N-CA-C 113.085 0.772 . . . . 73.24 113.085 -178.264 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . 0.528 HG12 ' HG3' ' A' ' 162' ' ' ARG . 96.6 mt -95.51 114.12 31.44 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.432 0 N-CA-C 106.692 -1.596 . . . . 62.14 106.692 168.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . 0.468 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 76.9 mt -122.35 127.14 75.04 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.125 0 C-N-CA 120.436 -0.506 . . . . 72.3 111.153 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.53 ' HA ' ' O ' ' A' ' 159' ' ' ARG . 63.3 m -99.53 118.18 35.55 Favored 'General case' 0 N--CA 1.418 -2.05 0 CA-C-N 114.832 -1.076 . . . . 74.04 108.688 177.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 27.3 m -119.29 161.93 18.0 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 N-CA-C 108.974 -0.75 . . . . 70.43 108.974 174.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 17.4 ptmt -127.75 130.86 23.6 Favored Pre-proline 0 C--N 1.276 -2.616 0 CA-C-N 115.309 -0.86 . . . . 74.4 108.893 176.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . 0.71 ' HA ' ' OD1' ' A' ' 216' ' ' ASP . 29.0 Cg_endo . . . . . 0 N--CA 1.445 -1.341 0 C-N-CA 122.676 2.251 . . . . 75.01 112.394 177.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.539 ' HB3' ' HB3' ' A' ' 250' ' ' LYS . 4.4 p-80 . . . . . 0 CA--C 1.516 -0.333 0 N-CA-C 112.49 0.552 . . . . 70.41 112.49 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 36.6 ttm180 -125.58 143.7 50.9 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.581 -0.282 . . . . 75.14 110.407 -179.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 35.1 ptt180 -104.05 117.22 33.75 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.611 0.719 . . . . 72.44 111.783 179.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 30.3 m -114.93 139.93 38.64 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 CA-C-N 115.497 -0.774 . . . . 73.33 111.894 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 21.1 ttm180 -102.53 121.4 42.3 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 109.168 -0.679 . . . . 74.51 109.168 179.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 26.8 mt -103.08 139.68 38.29 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 123.347 0.659 . . . . 75.13 111.657 -174.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 6.0 tt . . . . . 0 CA--C 1.512 -0.503 0 C-N-CA 125.913 1.685 . . . . 74.03 112.216 171.247 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 2.3 mm? . . . . . 0 N--CA 1.471 0.598 0 N-CA-C 112.459 0.54 . . . . 74.01 112.459 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 103.69 36.12 3.34 Favored Glycine 0 N--CA 1.424 -2.121 0 C-N-CA 120.174 -1.012 . . . . 63.41 112.533 178.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -147.48 153.84 40.04 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 108.661 -0.866 . . . . 74.43 108.661 174.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -123.77 155.41 37.97 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 108.183 -1.043 . . . . 75.03 108.183 177.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.437 HD11 ' SD ' ' A' ' 238' ' ' MET . 27.3 pt -125.18 169.5 16.48 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 CA-C-O 120.909 0.385 . . . . 74.25 111.329 -176.119 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . 0.509 ' HG2' ' HB3' ' A' ' 198' ' ' SER . 1.1 ptp180 -148.91 154.15 39.02 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 123.332 0.653 . . . . 74.1 110.891 -179.157 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -103.38 138.84 39.58 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 109.065 -0.717 . . . . 62.04 109.065 176.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -154.38 -168.27 17.58 Favored Glycine 0 N--CA 1.416 -2.661 0 N-CA-C 109.197 -1.561 . . . . 73.31 109.197 177.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' THR . . . . . 0.502 ' HB ' ' CG ' ' A' ' 191' ' ' LYS . 1.0 OUTLIER -101.16 125.48 47.79 Favored 'General case' 0 C--N 1.276 -2.618 0 CA-C-O 121.14 0.495 . . . . 74.12 111.698 176.415 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 36.9 t . . . . . 0 N--CA 1.41 -2.463 0 N-CA-C 107.255 -1.387 . . . . 53.12 107.255 176.394 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.502 ' CG ' ' HB ' ' A' ' 180' ' ' THR . 35.4 ttmt . . . . . 0 N--CA 1.425 -1.71 0 N-CA-C 107.972 -1.121 . . . . 71.34 107.972 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -130.75 164.15 43.74 Favored Pre-proline 0 C--N 1.284 -2.261 0 CA-C-N 115.473 -0.785 . . . . 75.33 109.336 -172.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -61.69 132.31 39.63 Favored 'Trans proline' 0 N--CA 1.447 -1.221 0 C-N-CA 121.108 1.205 . . . . 54.2 109.135 172.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -139.82 138.77 9.4 Favored Glycine 0 N--CA 1.415 -2.725 0 N-CA-C 110.085 -1.206 . . . . 40.24 110.085 -178.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.426 ' HA ' ' O ' ' A' ' 177' ' ' ARG . 3.4 mp -103.8 128.26 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.127 0 CA-C-O 121.418 0.628 . . . . 72.3 110.929 -179.101 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -121.75 167.12 13.34 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 107.57 -1.27 . . . . 73.3 107.57 -177.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . 0.433 ' HB ' ' HA ' ' A' ' 214' ' ' VAL . 50.1 mm -77.58 130.32 36.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 107.515 -1.291 . . . . 75.24 107.515 175.286 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' SER . . . . . 0.509 ' HB3' ' HG2' ' A' ' 177' ' ' ARG . 81.4 p -103.49 -22.37 13.64 Favored 'General case' 0 C--N 1.291 -1.95 0 C-N-CA 119.624 -0.831 . . . . 74.34 111.538 -175.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 27.6 tpt180 -167.12 146.28 5.19 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.398 -0.593 . . . . 74.32 109.398 -176.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 69.7 mt -112.51 139.67 47.9 Favored 'General case' 0 CA--C 1.484 -1.571 0 N-CA-C 108.541 -0.911 . . . . 75.23 108.541 172.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 53.2 t -95.8 114.92 65.05 Favored Pre-proline 0 C--N 1.288 -2.07 0 N-CA-C 105.811 -1.922 . . . . 73.53 105.811 171.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . 0.511 ' HA ' ' HG3' ' A' ' 207' ' ' GLU . 19.3 Cg_endo -62.3 126.81 19.38 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 121.938 1.758 . . . . 73.22 110.644 -177.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 103.38 -14.32 54.55 Favored Glycine 0 C--N 1.297 -1.587 0 C-N-CA 120.157 -1.021 . . . . 74.32 111.266 -175.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -81.93 162.24 42.6 Favored Glycine 0 N--CA 1.435 -1.422 0 N-CA-C 110.221 -1.152 . . . . 61.14 110.221 176.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 32.1 mt -53.9 -38.34 64.72 Favored 'General case' 0 C--N 1.309 -1.158 0 C-N-CA 124.737 1.215 . . . . 73.35 112.777 -175.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -66.0 -43.73 86.86 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.538 0.685 . . . . 71.11 110.919 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.511 ' HG3' ' HA ' ' A' ' 202' ' ' PRO . 3.3 tm-20 -76.16 -35.93 58.96 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 115.255 -0.884 . . . . 64.11 109.619 -178.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 55.8 m -61.0 -41.46 96.57 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.474 -0.33 . . . . 53.33 111.572 178.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 9.2 t -73.27 -33.21 65.13 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 119.489 -0.884 . . . . 61.43 109.253 176.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 70.14 10.91 66.36 Favored Glycine 0 CA--C 1.5 -0.886 0 CA-C-N 115.75 -0.659 . . . . 40.11 112.842 176.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 52.0 mt -95.42 -5.97 41.93 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.989 -0.745 . . . . 74.24 108.989 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 95.6 mt -109.49 131.21 55.28 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 107.817 -1.179 . . . . 71.44 107.817 174.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -133.63 166.11 23.35 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.216 -1.031 . . . . 41.23 108.216 176.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . 0.433 ' HA ' ' HB ' ' A' ' 197' ' ' ILE . 34.6 m -62.86 -31.3 51.9 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 N-CA-C 113.466 0.913 . . . . 71.03 113.466 -178.585 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -72.37 -13.42 61.47 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.995 -0.441 . . . . 55.22 111.577 179.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.482 ' HB3' ' HB ' ' A' ' 249' ' ' VAL . 6.3 m-20 -73.78 131.09 41.19 Favored 'General case' 0 C--O 1.242 0.705 0 N-CA-C 113.516 0.932 . . . . 71.32 113.516 -176.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . 0.415 ' O ' ' HA ' ' A' ' 249' ' ' VAL . 35.7 tt0 -103.72 132.26 50.13 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 113.827 -1.533 . . . . 64.33 109.676 -179.122 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 22.9 t -79.97 130.19 36.4 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 CA-C-O 121.433 0.635 . . . . 74.44 110.732 -176.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . 0.415 HD11 ' HD3' ' A' ' 250' ' ' LYS . 38.8 mm -95.16 -50.3 11.85 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 C-N-CA 124.06 0.944 . . . . 65.22 110.122 178.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -154.41 154.22 32.88 Favored 'General case' 0 N--CA 1.433 -1.325 0 CA-C-N 115.446 -0.797 . . . . 72.11 110.695 -176.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . 0.502 ' C ' ' H ' ' A' ' 223' ' ' GLY . 7.5 p -124.18 121.2 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 N-CA-C 108.415 -0.958 . . . . 75.13 108.415 177.268 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . 0.558 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 24.6 t-20 75.55 -24.34 0.22 Allowed 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 126.406 1.882 . . . . 71.13 111.774 -176.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . 0.502 ' H ' ' C ' ' A' ' 221' ' ' VAL . . . 140.43 -11.33 2.99 Favored Glycine 0 C--N 1.278 -2.654 0 N-CA-C 109.932 -1.267 . . . . 75.02 109.932 -174.287 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 67.4 mt -92.1 123.85 44.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 108.936 -0.764 . . . . 71.22 108.936 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -57.62 143.43 41.35 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 123.992 0.917 . . . . 74.32 112.006 -179.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 34.7 m -117.57 1.0 8.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 CA-C-N 115.667 -0.697 . . . . 75.23 110.92 176.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -78.12 97.34 5.41 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.86 -0.609 . . . . 73.13 110.224 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 120.41 -14.57 10.06 Favored Glycine 0 C--N 1.316 -0.532 0 N-CA-C 110.826 -0.91 . . . . 74.22 110.826 -179.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -79.8 170.13 16.95 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 108.333 -0.988 . . . . 74.01 108.333 177.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 230' ' ' THR . . . . . 0.509 ' O ' HG13 ' A' ' 234' ' ' VAL . 73.1 p -93.55 164.11 13.3 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 108.445 -0.946 . . . . 72.22 108.445 177.54 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . 0.411 ' HA ' HG21 ' A' ' 234' ' ' VAL . 0.7 OUTLIER -63.07 -36.15 82.62 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 107.017 -1.475 . . . . 63.31 107.017 179.105 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -61.85 -45.82 92.14 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.286 -0.87 . . . . 74.45 109.945 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -61.94 -50.39 72.34 Favored 'General case' 0 C--N 1.344 0.341 0 N-CA-C 112.385 0.513 . . . . 74.31 112.385 175.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.509 HG13 ' O ' ' A' ' 230' ' ' THR . 12.2 m -62.08 -33.89 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 N-CA-C 112.749 0.648 . . . . 63.55 112.749 -173.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 61.9 m -68.9 -39.05 79.93 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 109.394 -0.595 . . . . 74.44 109.394 -175.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -68.53 -30.43 69.22 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-N 115.614 -0.721 . . . . 72.44 109.793 -178.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 3.5 mtm -73.21 -36.47 66.49 Favored 'General case' 0 C--O 1.196 -1.728 0 N-CA-C 107.894 -1.15 . . . . 73.42 107.894 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 238' ' ' MET . . . . . 0.486 ' HG3' ' O ' ' A' ' 234' ' ' VAL . 65.5 mtt -63.11 -39.78 95.69 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 120.844 0.354 . . . . 74.0 110.133 177.268 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 79.0 t -66.34 -41.06 88.27 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 CA-C-N 116.096 -0.502 . . . . 63.35 109.682 176.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -66.01 -22.34 66.45 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.131 -0.486 . . . . 74.32 111.991 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 54.4 m-80 -105.12 21.93 16.24 Favored 'General case' 0 C--O 1.202 -1.426 0 CA-C-N 116.542 -0.299 . . . . 65.41 110.815 178.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 46.5 t -56.36 -24.44 44.27 Favored 'General case' 0 C--O 1.213 -0.849 0 N-CA-C 113.68 0.992 . . . . 73.03 113.68 -179.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 29.1 m -78.59 -22.15 47.52 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 120.359 -0.537 . . . . 64.42 111.424 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -171.5 94.14 0.16 Allowed 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.726 1.211 . . . . 71.14 108.956 178.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 1.7 tt -90.77 109.24 20.44 Favored 'General case' 0 N--CA 1.419 -1.983 0 CA-C-N 114.618 -1.174 . . . . 62.02 110.071 -171.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . 0.558 ' HB ' ' HA ' ' A' ' 222' ' ' ASN . 61.3 mt -95.76 117.13 39.2 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 N-CA-C 108.963 -0.755 . . . . 75.43 108.963 176.528 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 9.3 mt -123.83 135.3 63.92 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.99 0 CA-C-O 121.819 0.818 . . . . 73.15 111.305 176.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 37.7 m -108.79 124.54 50.76 Favored 'General case' 0 N--CA 1.41 -2.441 0 CA-C-N 114.476 -1.238 . . . . 64.32 108.493 178.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . 0.482 ' HB ' ' HB3' ' A' ' 216' ' ' ASP . 29.1 m -134.75 152.99 34.09 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-O 121.754 0.788 . . . . 74.43 112.18 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . 0.539 ' HB3' ' HB3' ' A' ' 158' ' ' HIS . 1.1 ptmm? -128.79 132.6 24.46 Favored Pre-proline 0 C--N 1.293 -1.872 0 CA-C-N 113.938 -1.483 . . . . 73.35 109.203 172.517 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo . . . . . 0 N--CA 1.447 -1.25 0 C-N-CA 122.549 2.166 . . . . 73.44 110.713 176.297 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.405 ' ND1' ' HB3' ' A' ' 250' ' ' LYS . 0.3 OUTLIER . . . . . 0 CA--C 1.507 -0.703 0 N-CA-C 109.888 -0.412 . . . . 75.04 109.888 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.473 ' O ' ' HA ' ' A' ' 248' ' ' THR . 2.2 tpm_? -128.95 138.53 52.03 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 108.096 -1.076 . . . . 72.35 108.096 177.047 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 14.9 ptp180 -122.6 117.03 24.89 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-O 121.2 0.524 . . . . 71.23 110.222 178.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 27.7 m -122.66 140.49 46.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 CA-C-N 115.479 -0.782 . . . . 74.44 112.02 -175.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.508 ' HG2' HG12 ' A' ' 246' ' ' ILE . 67.0 mtm180 -92.95 111.29 22.86 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.824 -1.176 . . . . 72.11 107.824 177.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.452 ' HB2' ' HB3' ' A' ' 245' ' ' LEU . 31.8 mt -89.32 139.12 30.82 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 109.28 -0.637 . . . . 73.54 109.28 -178.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.403 HD13 ' O ' ' A' ' 242' ' ' SER . 6.1 tt . . . . . 0 C--N 1.312 -1.048 0 CA-C-O 123.037 1.399 . . . . 72.21 108.397 179.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 3.7 mm? . . . . . 0 CA--C 1.516 -0.364 0 N-CA-C 113.531 0.937 . . . . 74.25 113.531 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 91.77 36.42 6.44 Favored Glycine 0 N--CA 1.434 -1.48 0 C-N-CA 119.813 -1.184 . . . . 50.23 113.789 175.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . 0.425 ' HB3' ' CB ' ' A' ' 206' ' ' ALA . 18.9 p90 -156.61 153.33 28.43 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.755 -1.202 . . . . 63.34 107.755 173.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -128.7 150.29 50.32 Favored 'General case' 0 C--N 1.287 -2.129 0 N-CA-C 108.769 -0.826 . . . . 75.02 108.769 179.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -123.92 170.08 14.54 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.438 0 CA-C-O 121.372 0.606 . . . . 73.31 110.739 -176.222 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . 0.494 ' HG2' ' HB2' ' A' ' 198' ' ' SER . 2.7 ptp180 -147.46 154.39 40.74 Favored 'General case' 0 C--N 1.275 -2.638 0 CA-C-N 115.141 -0.936 . . . . 74.35 110.226 -177.456 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -104.7 138.3 41.22 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 109.509 -0.552 . . . . 74.31 109.509 179.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -155.54 136.77 5.25 Favored Glycine 0 C--N 1.284 -2.339 0 N-CA-C 109.823 -1.311 . . . . 74.14 109.823 177.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' THR . . . . . 0.442 ' CG2' ' HG2' ' A' ' 191' ' ' LYS . 0.2 OUTLIER -89.24 123.49 33.51 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 105.903 -1.888 . . . . 72.13 105.903 179.292 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 22.7 t . . . . . 0 C--N 1.269 -2.911 0 N-CA-C 109.112 -0.699 . . . . 73.12 109.112 -176.604 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.442 ' HG2' ' CG2' ' A' ' 180' ' ' THR . 34.2 ttmt . . . . . 0 N--CA 1.427 -1.606 0 N-CA-C 107.618 -1.252 . . . . 74.04 107.618 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 43.2 tp60 -140.98 134.54 14.77 Favored Pre-proline 0 C--N 1.287 -2.144 0 CA-C-N 115.78 -0.645 . . . . 70.32 109.816 -168.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -64.73 130.77 27.19 Favored 'Trans proline' 0 N--CA 1.447 -1.209 0 C-N-CA 121.726 1.617 . . . . 75.32 111.885 179.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -133.82 141.4 12.73 Favored Glycine 0 N--CA 1.403 -3.539 0 N-CA-C 109.285 -1.526 . . . . 63.22 109.285 174.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.528 ' HB ' ' CG1' ' A' ' 218' ' ' VAL . 3.8 mp -103.8 129.78 55.35 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.676 0 N-CA-C 108.351 -0.981 . . . . 73.43 108.351 175.129 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -123.59 161.15 25.56 Favored 'General case' 0 C--N 1.275 -2.644 0 N-CA-C 107.271 -1.381 . . . . 73.12 107.271 -174.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 57.6 mt -79.24 127.69 38.95 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.892 0 CA-C-O 121.588 0.709 . . . . 72.24 110.294 177.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' SER . . . . . 0.494 ' HB2' ' HG2' ' A' ' 177' ' ' ARG . 24.4 t -101.56 -18.67 15.82 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 112.891 0.701 . . . . 74.13 112.891 -177.246 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 75.3 ttt180 -166.55 139.5 3.83 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.327 -0.549 . . . . 74.22 111.239 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 88.3 mt -103.72 146.61 28.35 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.575 -0.898 . . . . 64.01 108.575 172.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 62.1 t -112.09 114.77 50.98 Favored Pre-proline 0 C--N 1.283 -2.298 0 N-CA-C 105.886 -1.894 . . . . 73.2 105.886 171.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . 0.408 ' HA ' ' HG2' ' A' ' 207' ' ' GLU . 31.1 Cg_endo -64.45 130.67 27.38 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 121.866 1.71 . . . . 71.14 110.6 -177.314 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 103.23 -17.65 50.94 Favored Glycine 0 N--CA 1.439 -1.137 0 N-CA-C 110.137 -1.185 . . . . 73.04 110.137 -175.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -83.74 171.76 49.48 Favored Glycine 0 N--CA 1.43 -1.751 0 N-CA-C 110.298 -1.121 . . . . 50.05 110.298 177.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -63.07 -33.24 75.02 Favored 'General case' 0 N--CA 1.432 -1.339 0 N-CA-C 113.272 0.842 . . . . 72.24 113.272 -174.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . 0.425 ' CB ' ' HB3' ' A' ' 174' ' ' PHE . . . -66.3 -48.13 71.35 Favored 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 120.847 -0.341 . . . . 75.33 111.22 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.408 ' HG2' ' HA ' ' A' ' 202' ' ' PRO . 8.2 tp10 -73.39 -33.1 64.84 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 109.34 -0.615 . . . . 64.23 109.34 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 30.8 t -56.4 -47.51 78.86 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-O 122.044 0.926 . . . . 73.22 109.038 176.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 84.1 m -70.09 -40.74 74.8 Favored 'General case' 0 N--CA 1.382 -3.86 0 CA-C-N 114.41 -1.268 . . . . 64.24 109.358 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 74.35 -7.28 18.56 Favored Glycine 0 CA--C 1.504 -0.621 0 CA-C-N 116.246 -0.434 . . . . 74.41 113.097 176.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 38.4 mt -87.46 -6.56 58.35 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 109.061 -0.718 . . . . 74.21 109.061 -178.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 9.4 mp -108.92 131.35 55.11 Favored 'General case' 0 N--CA 1.422 -1.834 0 CA-C-N 115.181 -0.918 . . . . 71.21 109.678 174.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -132.44 166.32 22.27 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 107.177 -1.416 . . . . 72.35 107.177 175.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 33.6 m -58.57 -30.32 41.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-O 121.828 0.823 . . . . 63.24 111.623 177.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -68.59 -15.04 63.4 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 115.367 -0.833 . . . . 74.41 112.271 -179.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.435 ' HB3' ' HB ' ' A' ' 249' ' ' VAL . 6.7 m-20 -75.07 141.49 43.82 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 113.623 0.971 . . . . 75.12 113.623 -176.46 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . 0.466 ' HB3' ' HG3' ' A' ' 250' ' ' LYS . 40.4 tt0 -113.45 128.11 56.34 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 125.455 1.502 . . . . 63.41 109.852 -176.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . 0.528 ' CG1' ' HB ' ' A' ' 195' ' ' ILE . 12.5 p -80.03 128.84 38.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 122.143 0.973 . . . . 54.44 111.808 -176.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 44.0 mm -99.14 -48.96 11.77 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 CA-C-N 114.398 -1.274 . . . . 73.14 110.121 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.426 ' CB ' ' HA ' ' A' ' 225' ' ' GLU . 10.8 pt-20 -157.94 160.16 37.28 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.842 -0.617 . . . . 54.54 110.198 -177.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 246' ' ' ILE . 8.8 p -131.0 120.61 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 O-C-N 123.758 0.661 . . . . 74.32 109.656 179.459 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . 0.455 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 10.7 m120 61.39 24.97 15.0 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.02 0.928 . . . . 74.42 112.946 176.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 97.23 -3.21 61.68 Favored Glycine 0 C--N 1.309 -0.953 0 CA-C-N 115.274 -0.876 . . . . 73.01 112.66 179.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 63.3 mt -111.22 123.51 67.16 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 N-CA-C 109.312 -0.625 . . . . 71.13 109.312 179.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . 0.426 ' HA ' ' CB ' ' A' ' 220' ' ' GLU . 12.5 pt-20 -62.73 153.71 31.81 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 121.551 0.691 . . . . 75.42 112.424 -178.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . 0.41 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 29.3 m -123.53 -3.51 6.99 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 CA-C-N 115.19 -0.914 . . . . 73.04 110.904 177.135 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -68.66 97.28 0.79 Allowed 'General case' 0 N--CA 1.443 -0.802 0 CA-C-O 121.416 0.627 . . . . 72.44 111.184 -177.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 127.78 -26.17 4.87 Favored Glycine 0 CA--C 1.49 -1.484 0 CA-C-N 115.488 -0.778 . . . . 74.35 111.571 177.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -73.65 170.98 14.1 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.231 0.539 . . . . 73.24 111.446 -178.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 47.6 p -88.53 163.89 15.68 Favored 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 108.674 -0.862 . . . . 73.21 108.674 -179.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -63.58 -36.97 85.56 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 107.712 -1.218 . . . . 71.43 107.712 -177.351 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -61.32 -40.9 95.92 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.561 -0.745 . . . . 75.44 110.824 177.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -66.02 -48.67 70.37 Favored 'General case' 0 C--O 1.218 -0.56 0 CA-C-N 116.307 -0.406 . . . . 71.22 111.691 177.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.424 ' O ' ' HG3' ' A' ' 238' ' ' MET . 13.7 m -66.8 -34.19 68.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 112.413 0.523 . . . . 63.13 112.413 -175.162 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 235' ' ' THR . . . . . 0.42 ' O ' HG21 ' A' ' 239' ' ' VAL . 32.9 m -72.01 -36.15 69.62 Favored 'General case' 0 CA--C 1.5 -0.976 0 N-CA-C 109.018 -0.734 . . . . 75.32 109.018 -177.062 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -60.46 -33.65 72.87 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 115.861 -0.609 . . . . 54.04 109.932 178.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 237' ' ' MET . . . . . 0.403 ' HE1' ' CG1' ' A' ' 221' ' ' VAL . 1.0 OUTLIER -72.08 -43.6 64.58 Favored 'General case' 0 C--O 1.206 -1.219 0 N-CA-C 108.052 -1.092 . . . . 73.42 108.052 -179.25 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 238' ' ' MET . . . . . 0.424 ' HG3' ' O ' ' A' ' 234' ' ' VAL . 64.4 mtt -62.83 -40.18 96.62 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.615 -0.72 . . . . 73.52 111.431 179.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . 0.42 HG21 ' O ' ' A' ' 235' ' ' THR . 97.6 t -66.92 -42.11 88.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.841 0.353 . . . . 73.23 110.463 178.256 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -65.42 -39.5 92.22 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.654 0.74 . . . . 63.23 110.078 178.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -83.57 20.98 1.28 Allowed 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 114.731 -1.122 . . . . 71.41 111.957 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 242' ' ' SER . . . . . 0.403 ' O ' HD13 ' A' ' 164' ' ' LEU . 22.9 t -62.35 -23.04 66.56 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 111.742 0.275 . . . . 61.32 111.742 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 16.5 m -63.33 -29.94 71.16 Favored 'General case' 0 CA--C 1.554 1.121 0 CA-C-O 120.893 0.377 . . . . 61.12 110.425 178.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -175.19 95.96 0.07 Allowed 'General case' 0 C--O 1.245 0.867 0 N-CA-C 106.856 -1.535 . . . . 75.41 106.856 179.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . 0.452 ' HB3' ' HB2' ' A' ' 163' ' ' LEU . 2.2 tt -85.97 108.0 18.01 Favored 'General case' 0 C--O 1.201 -1.453 0 CA-C-N 115.448 -0.796 . . . . 74.51 109.212 -171.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . 0.508 HG12 ' HG2' ' A' ' 162' ' ' ARG . 77.7 mt -101.12 116.76 45.29 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.105 0 O-C-N 121.777 -0.577 . . . . 73.23 109.736 -178.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . 0.506 ' CG2' HG13 ' A' ' 249' ' ' VAL . 15.8 mt -121.87 136.66 58.03 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.152 0 N-CA-C 113.172 0.804 . . . . 75.44 113.172 179.622 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.473 ' HA ' ' O ' ' A' ' 159' ' ' ARG . 63.3 m -103.56 114.83 29.39 Favored 'General case' 0 N--CA 1.413 -2.316 0 N-CA-C 107.633 -1.247 . . . . 63.11 107.633 172.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . 0.506 HG13 ' CG2' ' A' ' 247' ' ' ILE . 10.2 m -121.51 168.55 13.84 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.399 0 CA-C-O 121.809 0.814 . . . . 75.32 110.054 175.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . 0.466 ' HG3' ' HB3' ' A' ' 217' ' ' GLU . 8.1 ptmt -136.62 139.16 28.46 Favored Pre-proline 0 C--N 1.257 -3.448 0 CA-C-N 113.647 -1.615 . . . . 72.31 107.665 175.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo . . . . . 0 N--CA 1.443 -1.482 0 C-N-CA 121.202 1.268 . . . . 70.5 108.962 173.85 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 13.7 m80 . . . . . 0 CA--C 1.496 -1.106 0 CA-C-O 120.774 0.321 . . . . 73.42 111.191 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.468 ' O ' ' HA ' ' A' ' 248' ' ' THR . 8.3 ttm180 -131.64 141.82 49.71 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 107.681 -1.229 . . . . 71.21 107.681 179.34 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -128.75 112.55 14.31 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-O 121.175 0.512 . . . . 74.24 109.676 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 16.5 m -118.15 139.57 44.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-N 115.025 -0.989 . . . . 71.42 112.044 -177.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 17.4 ttm180 -100.29 112.48 24.81 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.107 -1.072 . . . . 70.11 108.107 177.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.401 ' HB2' ' HB3' ' A' ' 245' ' ' LEU . 20.8 mt -99.86 137.07 38.83 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 108.184 -1.043 . . . . 71.35 108.184 -176.071 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.416 ' O ' ' HA ' ' A' ' 244' ' ' ASN . 3.4 tt . . . . . 0 C--O 1.207 -1.141 0 N-CA-C 107.1 -1.444 . . . . 75.11 107.1 177.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.418 ' HA ' HD21 ' A' ' 205' ' ' LEU . 3.5 mm? . . . . . 0 CA--C 1.506 -0.744 0 N-CA-C 112.254 0.465 . . . . 73.14 112.254 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . 0.455 ' HA3' ' HA3' ' A' ' 204' ' ' GLY . . . 84.49 36.01 13.04 Favored Glycine 0 N--CA 1.427 -1.929 0 C-N-CA 120.389 -0.91 . . . . 74.12 112.948 177.204 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -150.0 154.24 37.87 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.338 -0.986 . . . . 73.13 108.338 174.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -121.32 143.65 49.07 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 108.966 -0.753 . . . . 73.34 108.966 175.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -114.38 166.23 8.47 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.467 0 CA-C-N 115.812 -0.631 . . . . 64.5 109.484 178.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . 0.562 ' HG2' ' HB2' ' A' ' 198' ' ' SER . 4.8 ptp180 -146.87 154.32 41.18 Favored 'General case' 0 C--N 1.277 -2.582 0 CA-C-N 115.072 -0.967 . . . . 74.23 110.589 -178.264 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -111.86 138.45 48.44 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 124.15 0.906 . . . . 75.44 111.145 -179.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -157.34 -164.35 13.62 Favored Glycine 0 C--N 1.29 -2.016 0 N-CA-C 108.424 -1.87 . . . . 73.0 108.424 175.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' THR . . . . . 0.447 ' CG2' ' HG2' ' A' ' 191' ' ' LYS . 0.4 OUTLIER -105.69 123.55 48.11 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-N 118.017 0.909 . . . . 73.24 111.827 175.546 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 41.0 t . . . . . 0 N--CA 1.414 -2.257 0 N-CA-C 107.326 -1.361 . . . . 54.04 107.326 176.303 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.447 ' HG2' ' CG2' ' A' ' 180' ' ' THR . 36.5 ttmt . . . . . 0 N--CA 1.426 -1.66 0 N-CA-C 108.155 -1.054 . . . . 75.42 108.155 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -136.53 165.56 34.35 Favored Pre-proline 0 C--N 1.279 -2.462 0 N-CA-C 108.228 -1.027 . . . . 62.52 108.228 -174.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' PRO . . . . . 0.409 ' HD2' ' HA2' ' A' ' 228' ' ' GLY . 53.8 Cg_exo -55.26 132.11 50.3 Favored 'Trans proline' 0 N--CA 1.445 -1.373 0 C-N-CA 121.126 1.218 . . . . 72.53 109.287 170.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -131.86 127.26 4.93 Favored Glycine 0 N--CA 1.403 -3.529 0 N-CA-C 109.278 -1.529 . . . . 64.54 109.278 -179.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.488 ' HB ' ' CG1' ' A' ' 218' ' ' VAL . 3.6 mp -104.37 132.06 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.814 0 CA-C-O 121.365 0.603 . . . . 75.42 109.51 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -127.61 167.4 16.43 Favored 'General case' 0 C--N 1.277 -2.553 0 N-CA-C 107.365 -1.346 . . . . 71.34 107.365 -175.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . 0.46 ' HB ' ' HA ' ' A' ' 214' ' ' VAL . 45.1 mm -79.17 130.1 36.62 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 N-CA-C 107.877 -1.157 . . . . 73.35 107.877 173.11 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' SER . . . . . 0.562 ' HB2' ' HG2' ' A' ' 177' ' ' ARG . 28.0 t -100.45 -34.07 10.09 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 111.946 0.35 . . . . 51.13 111.946 -178.44 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 15.4 ttp180 -160.64 141.23 11.58 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-O 120.748 0.309 . . . . 73.11 110.358 -178.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 1.1 tt -108.03 135.49 49.3 Favored 'General case' 0 N--CA 1.426 -1.67 0 N-CA-C 107.172 -1.418 . . . . 74.15 107.172 -177.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 59.7 t -106.0 121.3 46.13 Favored Pre-proline 0 C--N 1.311 -1.104 0 N-CA-C 110.129 -0.323 . . . . 75.51 110.129 179.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . 0.468 ' HA ' ' HG3' ' A' ' 207' ' ' GLU . 27.5 Cg_endo -62.6 135.54 53.47 Favored 'Trans proline' 0 C--O 1.247 0.956 0 C-N-CA 122.638 2.226 . . . . 73.2 111.466 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 96.95 -24.45 31.14 Favored Glycine 0 N--CA 1.439 -1.136 0 N-CA-C 111.641 -0.584 . . . . 73.41 111.641 -177.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . 0.455 ' HA3' ' HA3' ' A' ' 173' ' ' GLY . . . -72.71 173.97 46.49 Favored Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 121.306 -0.474 . . . . 73.33 112.042 -179.339 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . 0.418 HD21 ' HA ' ' A' ' 172' ' ' LEU . 3.6 mm? -63.11 -33.96 76.59 Favored 'General case' 0 N--CA 1.438 -1.069 0 C-N-CA 123.059 0.544 . . . . 71.23 111.75 -176.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -65.03 -43.26 92.98 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.067 0.46 . . . . 74.33 110.924 179.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.468 ' HG3' ' HA ' ' A' ' 202' ' ' PRO . 3.6 tm-20 -75.75 -40.1 56.02 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.033 -0.531 . . . . 70.53 109.998 178.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 33.3 t -57.97 -36.95 73.32 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.193 0.597 . . . . 63.13 110.959 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 11.7 t -81.38 -37.22 28.54 Favored 'General case' 0 N--CA 1.435 -1.188 0 C-N-CA 119.557 -0.857 . . . . 73.12 109.644 175.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 71.35 26.06 74.18 Favored Glycine 0 C--N 1.341 0.813 0 N-CA-C 112.14 -0.384 . . . . 52.33 112.14 178.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 43.0 mt -116.09 -4.24 12.0 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.577 0.703 . . . . 75.24 110.075 -177.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 60.1 mt -109.25 134.44 51.76 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 114.91 -1.041 . . . . 64.12 110.891 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -131.3 161.69 31.75 Favored 'General case' 0 N--CA 1.42 -1.967 0 N-CA-C 108.656 -0.868 . . . . 74.41 108.656 177.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . 0.46 ' HA ' ' HB ' ' A' ' 197' ' ' ILE . 33.8 m -62.2 -30.59 49.17 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 CA-C-O 121.377 0.608 . . . . 63.32 112.579 179.553 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -71.55 -14.26 62.04 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 116.123 -0.49 . . . . 75.44 112.143 -178.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.47 ' HB3' ' HB ' ' A' ' 249' ' ' VAL . 61.9 m-20 -74.19 139.15 44.24 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 112.754 0.65 . . . . 70.24 112.754 -176.183 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -110.01 137.52 47.67 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 124.975 1.31 . . . . 62.52 108.696 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . 0.488 ' CG1' ' HB ' ' A' ' 195' ' ' ILE . 12.1 p -83.82 138.41 19.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 122.103 0.954 . . . . 64.14 112.625 -175.545 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 44.1 mm -105.62 -44.75 8.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 114.731 -1.122 . . . . 75.02 111.058 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -161.12 154.98 22.31 Favored 'General case' 0 C--O 1.245 0.837 0 CA-C-N 116.511 -0.313 . . . . 65.42 110.75 -178.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 8.3 p -126.45 121.41 58.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 C-N-CA 123.786 0.834 . . . . 72.13 109.006 178.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . 0.468 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 18.7 t-20 65.09 15.52 10.04 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.322 1.049 . . . . 73.23 110.456 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 99.35 -8.12 60.32 Favored Glycine 0 N--CA 1.437 -1.261 0 C-N-CA 120.347 -0.93 . . . . 75.43 111.523 -177.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 64.0 mt -91.08 123.06 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.162 0 N-CA-C 108.787 -0.819 . . . . 73.12 108.787 179.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -55.45 131.19 45.34 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 124.24 0.962 . . . . 72.4 111.063 179.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 35.8 m -109.88 10.13 8.85 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 CA-C-O 121.876 0.846 . . . . 74.24 109.288 174.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -73.26 98.08 2.58 Favored 'General case' 0 N--CA 1.424 -1.737 0 CA-C-N 114.422 -1.263 . . . . 65.43 110.799 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . 0.409 ' HA2' ' HD2' ' A' ' 193' ' ' PRO . . . 101.23 5.29 52.86 Favored Glycine 0 N--CA 1.44 -1.092 0 C-N-CA 120.894 -0.67 . . . . 38.11 112.46 176.319 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -90.31 156.66 18.11 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 107.524 -1.287 . . . . 74.43 107.524 -178.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 230' ' ' THR . . . . . 0.638 ' OG1' ' HG2' ' A' ' 233' ' ' GLN . 81.5 p -79.97 166.52 21.51 Favored 'General case' 0 C--O 1.248 0.998 0 C-N-CA 118.905 -1.118 . . . . 72.21 110.067 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -61.02 -39.76 90.99 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 108.946 -0.761 . . . . 75.05 108.946 179.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -63.86 -31.01 72.05 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.078 -0.51 . . . . 73.11 110.626 177.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 233' ' ' GLN . . . . . 0.638 ' HG2' ' OG1' ' A' ' 230' ' ' THR . 13.3 mm-40 -74.14 -51.37 15.82 Favored 'General case' 0 C--O 1.216 -0.683 0 C-N-CA 119.478 -0.889 . . . . 74.13 110.211 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.482 ' O ' ' HG3' ' A' ' 238' ' ' MET . 21.2 m -65.99 -34.22 68.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 113.041 0.756 . . . . 71.32 113.041 -173.279 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 42.6 m -74.42 -35.49 63.4 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 109.056 -0.72 . . . . 74.32 109.056 -173.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -63.15 -34.25 77.21 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-N 115.376 -0.829 . . . . 73.5 108.835 177.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 10.3 mtm -72.88 -42.01 64.1 Favored 'General case' 0 C--O 1.201 -1.478 0 CA-C-N 115.117 -0.947 . . . . 74.02 108.546 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 238' ' ' MET . . . . . 0.482 ' HG3' ' O ' ' A' ' 234' ' ' VAL . 65.4 mtt -61.6 -40.16 93.8 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.486 -0.325 . . . . 74.52 111.568 178.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 96.0 t -68.76 -43.12 83.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.198 0.523 . . . . 75.12 111.004 178.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -68.68 -34.31 75.46 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.424 0.631 . . . . 71.02 110.555 179.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -88.81 15.44 8.35 Favored 'General case' 0 C--O 1.19 -2.053 0 CA-C-N 115.425 -0.807 . . . . 71.41 111.923 178.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 69.9 m -66.74 -23.26 66.07 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 114.363 1.246 . . . . 51.13 114.363 -178.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 20.5 m -63.94 -29.63 70.79 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 118.131 0.423 . . . . 74.44 110.735 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 244' ' ' ASN . . . . . 0.416 ' HA ' ' O ' ' A' ' 164' ' ' LEU . 42.6 m-80 -156.0 89.68 1.16 Allowed 'General case' 0 C--O 1.248 1.015 0 N-CA-C 106.381 -1.711 . . . . 71.21 106.381 173.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . 0.401 ' HB3' ' HB2' ' A' ' 163' ' ' LEU . 1.6 tt -85.28 103.55 14.33 Favored 'General case' 0 C--O 1.205 -1.274 0 CA-C-O 121.269 0.557 . . . . 74.21 109.846 -172.063 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . 0.468 ' HB ' ' HA ' ' A' ' 222' ' ' ASN . 75.5 mt -96.48 116.19 37.83 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.348 0 N-CA-C 109.373 -0.603 . . . . 73.5 109.373 179.053 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 9.8 mt -125.84 137.81 56.53 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 CA-C-O 121.551 0.691 . . . . 73.53 112.446 177.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 159' ' ' ARG . 49.9 m -107.43 121.87 45.47 Favored 'General case' 0 N--CA 1.423 -1.815 0 CA-C-N 114.717 -1.129 . . . . 73.11 107.985 174.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . 0.47 ' HB ' ' HB3' ' A' ' 216' ' ' ASP . 15.4 m -125.74 166.44 21.73 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 CA-C-O 121.126 0.489 . . . . 72.35 110.552 176.627 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 16.8 ptmt -138.64 134.01 17.07 Favored Pre-proline 0 C--N 1.285 -2.209 0 CA-C-N 114.471 -1.24 . . . . 74.44 107.763 174.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo . . . . . 0 N--CA 1.449 -1.112 0 C-N-CA 121.619 1.546 . . . . 74.21 111.166 178.924 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 1.9 m80 . . . . . 0 N--CA 1.428 -1.538 0 N-CA-C 109.738 -0.467 . . . . 62.1 109.738 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.437 ' CZ ' HG21 ' A' ' 161' ' ' VAL . 0.0 OUTLIER -127.63 142.0 51.47 Favored 'General case' 0 C--N 1.283 -2.288 0 N-CA-C 104.971 -2.233 . . . . 74.15 104.971 173.726 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -132.42 110.82 10.8 Favored 'General case' 0 C--N 1.285 -2.223 0 C-N-CA 117.718 -1.593 . . . . 75.21 111.065 -179.356 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.437 HG21 ' CZ ' ' A' ' 159' ' ' ARG . 30.3 m -113.56 140.31 34.51 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 CA-C-N 114.724 -1.125 . . . . 74.44 111.787 175.251 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 26.0 ttm180 -84.86 114.65 22.26 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 115.617 -0.72 . . . . 75.54 109.121 178.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.412 ' HB2' ' HB2' ' A' ' 245' ' ' LEU . 13.8 mt -87.47 127.27 35.23 Favored 'General case' 0 N--CA 1.421 -1.916 0 N-CA-C 107.078 -1.453 . . . . 73.31 107.078 -179.408 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.554 HD13 ' O ' ' A' ' 242' ' ' SER . 5.5 tt . . . . . 0 C--N 1.3 -1.563 0 CA-C-O 122.378 1.085 . . . . 75.41 110.416 178.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 3.7 mm? . . . . . 0 CA--C 1.509 -0.598 0 CA-C-O 120.791 0.329 . . . . 72.44 110.166 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . 0.46 ' HA3' ' HA3' ' A' ' 204' ' ' GLY . . . 90.24 51.44 2.76 Favored Glycine 0 N--CA 1.434 -1.45 0 CA-C-N 115.679 -0.691 . . . . 51.34 114.806 174.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -162.58 154.61 18.62 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 108.521 -0.918 . . . . 72.01 108.521 175.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -121.2 140.83 51.5 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 108.244 -1.021 . . . . 75.01 108.244 176.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.508 HD11 ' SD ' ' A' ' 238' ' ' MET . 28.6 pt -112.32 165.25 7.4 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.845 0 CA-C-O 121.04 0.448 . . . . 71.55 111.339 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . 0.474 ' CG ' ' HB2' ' A' ' 198' ' ' SER . 27.3 ptt180 -149.69 154.98 39.43 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 115.566 -0.743 . . . . 75.1 110.703 -175.372 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . 0.435 ' HB2' ' HB2' ' A' ' 231' ' ' LEU . 9.2 t70 -100.95 138.54 37.86 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 115.706 -0.679 . . . . 71.3 109.946 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -149.11 135.41 5.37 Favored Glycine 0 C--N 1.277 -2.743 0 N-CA-C 107.622 -2.191 . . . . 52.32 107.622 175.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' THR . . . . . 0.434 ' CG2' ' HG2' ' A' ' 191' ' ' LYS . 0.4 OUTLIER -86.53 122.63 30.73 Favored 'General case' 0 C--N 1.282 -2.361 0 C-N-CA 118.54 -1.264 . . . . 75.43 107.799 -175.962 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 10.9 t . . . . . 0 C--N 1.287 -2.146 0 C-N-CA 123.821 0.848 . . . . 63.11 109.01 -174.742 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.434 ' HG2' ' CG2' ' A' ' 180' ' ' THR . 32.5 ttmt . . . . . 0 N--CA 1.418 -2.029 0 N-CA-C 107.795 -1.187 . . . . 65.23 107.795 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.47 145.49 19.3 Favored Pre-proline 0 C--N 1.313 -1.005 0 CA-C-N 116.125 -0.489 . . . . 74.23 109.78 -171.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -56.82 130.84 42.02 Favored 'Trans proline' 0 C--O 1.242 0.708 0 C-N-CA 121.879 1.719 . . . . 54.24 113.784 -176.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -137.85 137.38 8.82 Favored Glycine 0 N--CA 1.414 -2.812 0 N-CA-C 109.03 -1.628 . . . . 73.01 109.03 177.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.504 HG12 HG21 ' A' ' 234' ' ' VAL . 3.1 mp -104.1 136.59 36.6 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.894 0 CA-C-O 121.355 0.598 . . . . 74.0 110.01 -179.211 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -126.76 165.94 18.34 Favored 'General case' 0 C--N 1.284 -2.25 0 N-CA-C 108.017 -1.105 . . . . 74.54 108.017 -177.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . 0.44 ' HB ' ' O ' ' A' ' 213' ' ' ALA . 49.1 mm -78.67 131.52 34.26 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 N-CA-C 108.464 -0.939 . . . . 70.42 108.464 174.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' SER . . . . . 0.474 ' HB2' ' CG ' ' A' ' 177' ' ' ARG . 11.2 t -101.92 -28.71 12.24 Favored 'General case' 0 C--N 1.284 -2.246 0 O-C-N 121.889 -0.507 . . . . 61.55 112.017 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 60.7 ttt180 -167.84 147.43 4.9 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 116.697 -0.229 . . . . 73.54 110.773 -176.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 85.7 mt -103.65 146.28 28.81 Favored 'General case' 0 CA--C 1.496 -1.134 0 N-CA-C 108.727 -0.842 . . . . 74.54 108.727 171.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 46.2 t -105.58 115.48 61.68 Favored Pre-proline 0 C--N 1.288 -2.07 0 N-CA-C 105.932 -1.877 . . . . 74.11 105.932 171.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . 0.453 ' HA ' ' HG3' ' A' ' 207' ' ' GLU . 16.7 Cg_endo -58.56 132.4 48.11 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 122.042 1.828 . . . . 70.04 111.218 -177.239 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 102.1 -18.98 50.7 Favored Glycine 0 N--CA 1.438 -1.196 0 N-CA-C 110.713 -0.955 . . . . 63.43 110.713 -175.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . 0.46 ' HA3' ' HA3' ' A' ' 173' ' ' GLY . . . -78.5 164.79 51.07 Favored Glycine 0 N--CA 1.434 -1.484 0 N-CA-C 111.018 -0.833 . . . . 45.01 111.018 178.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -61.24 -35.67 77.89 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 123.284 0.634 . . . . 75.51 111.434 -175.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -60.7 -47.41 86.41 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.629 -0.714 . . . . 73.15 110.732 179.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.453 ' HG3' ' HA ' ' A' ' 202' ' ' PRO . 3.2 tm-20 -75.46 -34.55 60.94 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.209 -0.905 . . . . 71.12 110.156 -179.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 48.7 m -56.96 -42.67 80.54 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 122.919 0.488 . . . . 72.2 111.837 179.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 14.9 t -87.1 -24.41 24.56 Favored 'General case' 0 N--CA 1.439 -1.0 0 C-N-CA 119.483 -0.887 . . . . 72.35 110.805 179.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 70.05 15.1 71.65 Favored Glycine 0 C--N 1.339 0.74 0 CA-C-O 121.498 0.499 . . . . 54.14 112.555 178.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 64.5 mt -102.03 13.14 35.57 Favored 'General case' 0 CA--C 1.495 -1.152 0 CA-C-O 121.592 0.71 . . . . 75.44 110.395 -177.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 30.2 mt -122.02 130.57 53.41 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 114.465 -1.243 . . . . 73.45 110.429 171.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . 0.44 ' O ' ' HB ' ' A' ' 197' ' ' ILE . . . -132.51 160.35 36.75 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 124.447 1.099 . . . . 52.35 108.344 176.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 17.5 m -61.38 -29.74 46.58 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 CA-C-O 121.653 0.74 . . . . 73.45 112.226 -179.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -75.53 -14.32 60.4 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 113.069 0.766 . . . . 74.24 113.069 -179.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -71.08 131.65 43.93 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 112.334 0.494 . . . . 71.51 112.334 -177.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -101.94 129.18 48.15 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.108 -0.951 . . . . 71.41 108.672 178.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . 0.412 ' CG1' ' HB ' ' A' ' 195' ' ' ILE . 10.2 p -79.44 137.2 22.16 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-O 121.597 0.713 . . . . 75.44 111.523 -176.029 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 45.6 mm -104.78 -48.34 9.54 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 CA-C-N 115.178 -0.919 . . . . 75.44 111.16 -178.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -153.23 151.99 30.69 Favored 'General case' 0 C--O 1.245 0.827 0 CA-C-N 116.675 -0.239 . . . . 64.31 111.355 -178.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . 0.519 ' C ' ' H ' ' A' ' 223' ' ' GLY . 14.2 p -124.09 129.64 74.09 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 N-CA-C 107.814 -1.18 . . . . 62.35 107.814 173.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . 0.56 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 23.1 t-20 75.01 -36.35 0.31 Allowed 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 126.462 1.905 . . . . 70.44 111.711 -176.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . 0.519 ' H ' ' C ' ' A' ' 221' ' ' VAL . . . 149.26 -6.08 0.79 Allowed Glycine 0 C--N 1.277 -2.717 0 N-CA-C 109.904 -1.278 . . . . 72.34 109.904 -174.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 71.9 mt -94.81 129.32 45.15 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.312 0 N-CA-C 108.223 -1.028 . . . . 72.51 108.223 179.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -62.02 138.17 58.34 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-O 121.531 0.682 . . . . 71.13 110.585 -179.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . 0.545 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 31.6 m -118.91 -2.62 9.52 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.22 0 CA-C-N 115.604 -0.726 . . . . 75.21 109.659 176.308 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -82.8 93.69 7.5 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 108.435 -0.95 . . . . 72.44 108.435 179.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 130.46 -17.59 5.29 Favored Glycine 0 N--CA 1.428 -1.853 0 N-CA-C 110.275 -1.13 . . . . 60.03 110.275 -176.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -85.43 167.81 15.17 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 107.423 -1.325 . . . . 74.41 107.423 174.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 40.6 p -94.74 171.72 8.61 Favored 'General case' 0 C--N 1.295 -1.765 0 C-N-CA 119.942 -0.703 . . . . 73.23 109.183 178.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . 0.435 ' HB2' ' HB2' ' A' ' 178' ' ' ASP . 49.9 tp -60.04 -39.25 85.28 Favored 'General case' 0 N--CA 1.432 -1.375 0 CA-C-O 120.677 0.275 . . . . 75.05 111.208 -176.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -58.54 -48.31 81.32 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 121.427 0.632 . . . . 62.22 109.999 177.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -61.96 -45.13 95.01 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.786 -1.097 . . . . 75.33 112.492 -179.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.545 ' CG1' ' HB ' ' A' ' 226' ' ' VAL . 6.7 m -73.96 -33.42 36.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-O 121.027 0.441 . . . . 72.21 112.013 -175.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 48.3 m -74.03 -36.7 64.45 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 108.713 -0.847 . . . . 74.44 108.713 -174.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -59.25 -34.64 72.47 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 115.326 -0.852 . . . . 72.2 109.131 177.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 5.7 mtt -73.34 -44.44 58.8 Favored 'General case' 0 C--O 1.2 -1.551 0 N-CA-C 108.954 -0.758 . . . . 74.54 108.954 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 238' ' ' MET . . . . . 0.508 ' SD ' HD11 ' A' ' 176' ' ' ILE . 65.7 mtt -59.95 -40.12 87.93 Favored 'General case' 0 C--O 1.214 -0.808 0 CA-C-O 120.543 0.211 . . . . 71.31 111.234 -178.257 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 93.9 t -65.75 -37.85 80.88 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 N-CA-C 109.736 -0.468 . . . . 74.21 109.736 177.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -76.74 -17.21 59.21 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.192 -0.458 . . . . 74.31 112.083 179.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -110.91 21.64 16.23 Favored 'General case' 0 C--O 1.205 -1.278 0 CA-C-N 116.45 -0.341 . . . . 73.14 110.463 176.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 242' ' ' SER . . . . . 0.554 ' O ' HD13 ' A' ' 164' ' ' LEU . 36.1 p -64.39 -22.78 67.07 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 112.966 0.728 . . . . 74.13 112.966 -178.219 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 18.1 m -79.22 -9.3 59.53 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 120.793 -0.363 . . . . 63.3 110.782 179.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -178.65 97.36 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.747 1.219 . . . . 72.04 110.894 175.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . 0.412 ' HB2' ' HB2' ' A' ' 163' ' ' LEU . 14.1 mt -87.92 111.83 21.88 Favored 'General case' 0 C--O 1.192 -1.932 0 N-CA-C 113.375 0.88 . . . . 75.44 113.375 -177.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . 0.56 ' HB ' ' HA ' ' A' ' 222' ' ' ASN . 66.1 mt -95.93 115.93 36.39 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.542 0 N-CA-C 106.173 -1.788 . . . . 71.42 106.173 170.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 67.5 mt -130.63 128.01 62.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 C-N-CA 119.649 -0.82 . . . . 73.35 112.547 -177.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 86.2 m -103.12 128.7 49.95 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 115.048 -0.978 . . . . 62.14 108.751 175.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 27.3 m -132.66 167.46 26.54 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 108.207 -1.034 . . . . 75.55 108.207 173.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.82 136.54 18.64 Favored Pre-proline 0 C--N 1.284 -2.267 0 CA-C-N 115.31 -0.859 . . . . 72.45 110.964 172.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo . . . . . 0 C--O 1.246 0.885 0 C-N-CA 123.535 2.823 . . . . 60.35 113.554 -177.826 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.421 ' CD2' ' HB3' ' A' ' 250' ' ' LYS . 49.9 m170 . . . . . 0 CA--C 1.486 -1.5 0 CA-C-O 121.164 0.507 . . . . 73.34 112.08 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.634 ' O ' ' HA ' ' A' ' 248' ' ' THR . 6.6 ptp180 -125.8 142.08 51.69 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 107.598 -1.26 . . . . 74.22 107.598 177.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 13.6 ptp180 -132.15 113.06 12.85 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 121.814 0.816 . . . . 75.44 111.277 177.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.662 ' O ' ' HA ' ' A' ' 246' ' ' ILE . 30.0 m -105.68 139.89 25.43 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 CA-C-N 114.554 -1.203 . . . . 62.14 112.402 -177.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.523 ' HG3' HG12 ' A' ' 246' ' ' ILE . 5.4 mpt_? -99.98 114.7 28.16 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 107.532 -1.284 . . . . 74.24 107.532 175.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.477 ' HB2' ' HB3' ' A' ' 245' ' ' LEU . 23.8 mt -114.41 139.91 49.11 Favored 'General case' 0 C--N 1.31 -1.137 0 C-N-CA 123.142 0.577 . . . . 75.13 111.368 -174.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.649 HD13 ' O ' ' A' ' 164' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.485 1.303 0 C-N-CA 123.877 0.871 . . . . 70.13 112.083 167.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.497 ' HG ' ' CD1' ' A' ' 245' ' ' LEU . 2.8 mm? . . . . . 0 CA--C 1.501 -0.919 0 N-CA-C 112.102 0.408 . . . . 74.22 112.102 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . 0.463 ' HA3' ' HA3' ' A' ' 204' ' ' GLY . . . 93.74 14.91 51.55 Favored Glycine 0 N--CA 1.424 -2.133 0 C-N-CA 120.346 -0.93 . . . . 50.1 112.292 177.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -139.45 152.54 47.11 Favored 'General case' 0 N--CA 1.426 -1.653 0 N-CA-C 106.056 -1.831 . . . . 74.42 106.056 173.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -127.76 149.31 50.3 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-O 120.858 0.361 . . . . 73.52 110.953 -178.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 37.8 pt -110.49 169.02 3.95 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 CA-C-N 115.552 -0.749 . . . . 73.32 110.374 -179.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . 0.561 ' CG ' ' HB2' ' A' ' 198' ' ' SER . 15.7 ptt180 -151.52 154.88 37.39 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 124.166 0.986 . . . . 74.41 109.351 -178.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -108.85 138.0 45.88 Favored 'General case' 0 C--N 1.293 -1.886 0 O-C-N 123.464 0.477 . . . . 74.21 109.86 -179.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -150.46 157.08 27.04 Favored Glycine 0 C--N 1.27 -3.088 0 N-CA-C 107.507 -2.237 . . . . 74.34 107.507 176.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' THR . . . . . 0.584 ' CG2' ' HG2' ' A' ' 191' ' ' LYS . 0.2 OUTLIER -86.65 121.58 29.37 Favored 'General case' 0 C--N 1.284 -2.252 0 C-N-CA 117.317 -1.753 . . . . 73.55 106.655 179.431 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' SER . . . . . 0.477 ' O ' ' HA ' ' A' ' 191' ' ' LYS . 31.2 t . . . . . 0 N--CA 1.414 -2.272 0 N-CA-C 108.758 -0.83 . . . . 65.14 108.758 -176.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.584 ' HG2' ' CG2' ' A' ' 180' ' ' THR . 37.2 ttmt . . . . . 0 N--CA 1.425 -1.68 0 N-CA-C 109.207 -0.664 . . . . 61.25 109.207 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -151.91 163.48 23.45 Favored Pre-proline 0 C--N 1.301 -1.538 0 N-CA-C 107.859 -1.163 . . . . 72.24 107.859 -176.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -58.96 132.23 46.26 Favored 'Trans proline' 0 C--O 1.255 1.332 0 C-N-CA 121.032 1.154 . . . . 72.12 110.689 176.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -141.99 135.56 6.78 Favored Glycine 0 N--CA 1.411 -2.968 0 N-CA-C 110.017 -1.233 . . . . 61.32 110.017 -178.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 3.2 mp -104.14 132.74 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.789 0 CA-C-O 121.457 0.646 . . . . 61.52 110.862 -178.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -124.76 167.75 14.15 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 107.543 -1.281 . . . . 75.13 107.543 -177.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 45.6 mt -85.69 131.96 33.1 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 N-CA-C 108.876 -0.787 . . . . 75.34 108.876 175.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' SER . . . . . 0.561 ' HB2' ' CG ' ' A' ' 177' ' ' ARG . 28.2 t -102.49 -30.71 10.83 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 113.727 1.01 . . . . 75.15 113.727 -177.101 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 13.4 ttp180 -165.16 144.47 6.7 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 120.013 -0.675 . . . . 74.44 112.185 -176.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.407 HD13 ' HG2' ' A' ' 207' ' ' GLU . 69.0 mt -106.51 141.01 38.5 Favored 'General case' 0 CA--C 1.494 -1.183 0 CA-C-N 115.169 -0.923 . . . . 72.4 109.575 173.411 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 47.5 t -109.71 114.81 56.41 Favored Pre-proline 0 C--N 1.285 -2.232 0 N-CA-C 105.748 -1.945 . . . . 64.33 105.748 171.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . 0.487 ' HA ' ' HG3' ' A' ' 207' ' ' GLU . 73.6 Cg_exo -53.31 126.15 20.72 Favored 'Trans proline' 0 C--O 1.244 0.804 0 C-N-CA 122.342 2.028 . . . . 72.04 110.838 179.409 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 110.69 -16.12 28.83 Favored Glycine 0 C--N 1.312 -0.767 0 C-N-CA 120.95 -0.643 . . . . 63.31 111.514 -175.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . 0.463 ' HA3' ' HA3' ' A' ' 173' ' ' GLY . . . -77.08 158.2 47.75 Favored Glycine 0 N--CA 1.441 -0.972 0 C-N-CA 121.147 -0.549 . . . . 71.31 111.924 178.503 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -53.84 -48.57 69.81 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 124.201 1.0 . . . . 55.43 112.263 -176.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -68.99 -32.24 71.65 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.776 -0.647 . . . . 74.33 111.33 -178.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.487 ' HG3' ' HA ' ' A' ' 202' ' ' PRO . 2.5 tm-20 -75.89 -44.41 40.6 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.658 -0.701 . . . . 65.44 109.282 -177.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 50.7 m -57.87 -33.38 68.63 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.338 0.496 . . . . 74.5 112.338 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 11.3 t -83.16 -17.44 42.9 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 119.945 -0.702 . . . . 73.1 110.989 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 64.65 17.08 62.03 Favored Glycine 0 C--N 1.334 0.436 0 CA-C-N 116.439 -0.346 . . . . 74.41 113.621 178.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 76.3 mt -95.69 -22.34 17.62 Favored 'General case' 0 C--O 1.199 -1.59 0 C-N-CA 120.224 -0.59 . . . . 73.42 110.776 -177.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 6.9 mp -107.22 134.1 50.81 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-O 121.366 0.603 . . . . 73.21 111.102 -178.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -131.27 165.39 23.5 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-N 114.23 -1.35 . . . . 75.11 109.88 -179.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 33.3 m -65.09 -29.39 47.2 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 N-CA-C 113.66 0.985 . . . . 65.24 113.66 -179.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -74.85 -14.14 60.64 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.7 -0.625 . . . . 74.42 111.252 -178.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.481 ' HB3' ' HB ' ' A' ' 249' ' ' VAL . 79.8 m-20 -66.69 142.97 57.24 Favored 'General case' 0 C--O 1.247 0.971 0 N-CA-C 112.984 0.735 . . . . 52.51 112.984 -176.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -109.21 133.13 53.42 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.635 -1.166 . . . . 74.34 108.802 177.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . 0.46 ' HA ' HG13 ' A' ' 249' ' ' VAL . 20.7 t -84.36 130.68 35.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.496 0.665 . . . . 73.25 111.289 -174.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 44.0 mm -99.44 -56.86 4.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-N 115.168 -0.923 . . . . 75.11 111.652 -177.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -155.02 151.2 28.16 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 116.108 -0.497 . . . . 70.23 110.503 -176.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . 0.487 ' HA ' ' O ' ' A' ' 246' ' ' ILE . 8.6 p -120.33 122.71 68.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 CA-C-N 115.648 -0.705 . . . . 64.54 109.24 177.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . 0.417 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 2.5 m-20 58.24 24.58 11.63 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.656 1.183 . . . . 53.33 112.474 -177.347 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 95.69 -7.23 67.97 Favored Glycine 0 N--CA 1.435 -1.418 0 CA-C-N 115.377 -0.829 . . . . 64.13 111.853 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 62.1 mt -97.31 122.63 49.07 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.509 0 N-CA-C 108.899 -0.778 . . . . 75.42 108.899 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -61.83 139.33 58.36 Favored 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 123.704 0.802 . . . . 72.43 112.674 -176.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . 0.468 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 34.3 m -117.11 3.21 7.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 CA-C-N 115.376 -0.829 . . . . 64.3 109.798 175.503 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -75.67 99.11 4.24 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 115.224 -0.898 . . . . 74.51 109.816 -179.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 113.26 -8.84 24.75 Favored Glycine 0 CA--C 1.5 -0.846 0 N-CA-C 110.983 -0.847 . . . . 52.52 110.983 179.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -83.14 158.27 22.45 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.781 -0.822 . . . . 74.14 108.781 178.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 230' ' ' THR . . . . . 0.442 ' O ' HG13 ' A' ' 234' ' ' VAL . 82.7 p -84.02 170.7 13.66 Favored 'General case' 0 N--CA 1.412 -2.35 0 C-N-CA 119.584 -0.846 . . . . 74.44 110.397 178.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . 0.4 ' HA ' HG21 ' A' ' 234' ' ' VAL . 3.0 tm? -61.85 -37.78 85.76 Favored 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 109.139 -0.689 . . . . 75.55 109.139 179.249 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -58.7 -52.29 66.34 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.198 0.523 . . . . 73.33 110.054 175.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 233' ' ' GLN . . . . . 0.497 ' O ' ' HG2' ' A' ' 237' ' ' MET . 39.6 mt-30 -54.78 -44.76 74.0 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.606 -1.179 . . . . 63.15 112.481 179.337 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.468 ' CG1' ' HB ' ' A' ' 226' ' ' VAL . 8.2 m -77.12 -34.47 21.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 112.438 0.533 . . . . 75.12 112.438 -176.563 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 235' ' ' THR . . . . . 0.44 ' O ' HG21 ' A' ' 239' ' ' VAL . 31.9 m -71.25 -35.81 71.55 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 109.522 -0.548 . . . . 65.25 109.522 -179.128 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -63.38 -31.14 72.21 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 109.722 -0.473 . . . . 72.34 109.722 176.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 237' ' ' MET . . . . . 0.497 ' HG2' ' O ' ' A' ' 233' ' ' GLN . 17.2 mmt -62.54 -52.55 63.0 Favored 'General case' 0 C--O 1.195 -1.767 0 N-CA-C 107.9 -1.148 . . . . 73.25 107.9 174.643 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 238' ' ' MET . . . . . 0.417 ' HG3' ' O ' ' A' ' 234' ' ' VAL . 59.5 mtt -63.93 -33.02 74.77 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.159 -0.928 . . . . 75.55 112.843 -173.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . 0.44 HG21 ' O ' ' A' ' 235' ' ' THR . 85.7 t -68.96 -44.12 81.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 N-CA-C 109.175 -0.676 . . . . 74.42 109.175 175.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -66.91 -36.3 81.95 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.85 -0.614 . . . . 74.52 110.594 178.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -87.29 22.13 2.22 Favored 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 124.364 1.066 . . . . 75.42 111.612 179.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 34.3 t -58.76 -42.29 88.54 Favored 'General case' 0 C--O 1.204 -1.334 0 CA-C-N 118.112 0.415 . . . . 72.24 112.064 -179.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 37.5 m -74.21 -16.98 60.95 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 112.405 0.52 . . . . 74.22 112.405 -178.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -153.18 85.12 1.21 Allowed 'General case' 0 CA--C 1.5 -0.949 0 N-CA-C 108.447 -0.946 . . . . 73.44 108.447 179.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . 0.497 ' CD1' ' HG ' ' A' ' 172' ' ' LEU . 2.0 tt -92.03 105.78 17.95 Favored 'General case' 0 N--CA 1.432 -1.343 0 C-N-CA 119.694 -0.803 . . . . 74.43 109.732 -177.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . 0.662 ' HA ' ' O ' ' A' ' 161' ' ' VAL . 93.2 mt -109.19 115.4 49.45 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 O-C-N 121.882 -0.511 . . . . 72.03 110.19 177.167 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 27.4 mt -119.26 133.27 66.64 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 N-CA-C 112.838 0.681 . . . . 75.14 112.838 177.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.634 ' HA ' ' O ' ' A' ' 159' ' ' ARG . 63.5 m -102.92 117.0 33.64 Favored 'General case' 0 N--CA 1.417 -2.095 0 CA-C-N 114.484 -1.235 . . . . 74.42 108.087 173.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . 0.481 ' HB ' ' HB3' ' A' ' 216' ' ' ASP . 18.9 m -122.54 165.57 18.35 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.064 0 CA-C-O 121.194 0.521 . . . . 72.54 110.198 175.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . 0.421 ' HB3' ' CD2' ' A' ' 158' ' ' HIS . 15.0 ptmt -129.46 128.53 23.15 Favored Pre-proline 0 C--N 1.277 -2.576 0 C-N-CA 125.137 1.375 . . . . 74.33 107.621 176.248 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo . . . . . 0 N--CA 1.441 -1.613 0 N-CA-C 109.598 -0.962 . . . . 74.12 109.598 176.214 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 4.0 m80 . . . . . 0 N--CA 1.432 -1.356 0 N-CA-C 108.622 -0.881 . . . . 73.13 108.622 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.484 ' O ' ' HA ' ' A' ' 248' ' ' THR . 36.7 ttm180 -133.12 142.84 48.9 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 109.329 -0.619 . . . . 72.33 109.329 173.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.406 ' HG3' ' OG1' ' A' ' 248' ' ' THR . 0.1 OUTLIER -106.69 117.12 33.2 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 109.072 -0.714 . . . . 73.53 109.072 -179.399 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.47 HG13 HD21 ' A' ' 211' ' ' LEU . 14.2 m -123.39 138.43 53.3 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.209 0 N-CA-C 112.18 0.437 . . . . 75.44 112.18 178.366 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.456 ' HG2' ' CG1' ' A' ' 246' ' ' ILE . 65.4 mtt180 -92.7 111.6 23.26 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 108.87 -0.789 . . . . 74.44 108.87 171.487 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.466 ' HB2' ' HB3' ' A' ' 245' ' ' LEU . 34.9 mt -93.33 139.3 30.81 Favored 'General case' 0 C--N 1.281 -2.388 0 N-CA-C 107.29 -1.374 . . . . 71.31 107.29 179.144 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.518 ' H ' ' HG ' ' A' ' 205' ' ' LEU . 2.3 tm? . . . . . 0 C--N 1.304 -1.395 0 N-CA-C 107.874 -1.158 . . . . 73.51 107.874 179.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 2.6 mm? . . . . . 0 CA--C 1.503 -0.864 0 CA-C-O 120.938 0.399 . . . . 60.12 110.776 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . 0.48 ' HA2' ' HB ' ' A' ' 201' ' ' VAL . . . 109.03 13.98 16.36 Favored Glycine 0 N--CA 1.421 -2.348 0 C-N-CA 119.677 -1.249 . . . . 64.02 114.213 174.281 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -162.66 153.79 17.5 Favored 'General case' 0 N--CA 1.435 -1.225 0 CA-C-N 118.155 0.978 . . . . 73.25 110.154 -177.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.462 ' CE1' HG21 ' A' ' 201' ' ' VAL . 71.0 m-85 -115.4 144.88 43.14 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 108.045 -1.095 . . . . 73.24 108.045 174.547 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.568 ' HB ' ' CG2' ' A' ' 195' ' ' ILE . 36.8 pt -110.47 168.96 3.98 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.393 0 CA-C-O 121.16 0.505 . . . . 73.3 110.538 179.575 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . 0.481 ' HG2' ' HB2' ' A' ' 198' ' ' SER . 5.1 ptp180 -154.07 153.88 32.67 Favored 'General case' 0 C--N 1.288 -2.084 0 C-N-CA 123.798 0.839 . . . . 74.42 109.091 178.159 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -100.16 141.52 32.88 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 109.156 -0.683 . . . . 74.3 109.156 177.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -153.9 -159.9 9.45 Favored Glycine 0 C--N 1.284 -2.325 0 N-CA-C 109.029 -1.629 . . . . 72.41 109.029 177.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -110.13 126.74 54.38 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 117.711 0.756 . . . . 71.41 112.462 177.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 26.5 t . . . . . 0 N--CA 1.413 -2.283 0 N-CA-C 107.79 -1.189 . . . . 75.53 107.79 177.143 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt . . . . . 0 N--CA 1.427 -1.612 0 N-CA-C 108.074 -1.084 . . . . 74.53 108.074 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -145.13 164.34 27.49 Favored Pre-proline 0 C--N 1.287 -2.146 0 N-CA-C 108.284 -1.006 . . . . 73.31 108.284 -177.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -60.84 131.71 38.79 Favored 'Trans proline' 0 N--CA 1.448 -1.159 0 N-CA-C 109.401 -1.038 . . . . 71.11 109.401 174.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -137.49 150.87 20.94 Favored Glycine 0 CA--C 1.474 -2.481 0 N-CA-C 109.393 -1.483 . . . . 44.51 109.393 -178.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.588 ' HB ' ' CG1' ' A' ' 218' ' ' VAL . 3.2 mp -108.22 138.22 35.96 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.291 0 C-N-CA 120.071 -0.652 . . . . 75.14 110.141 -179.172 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -131.44 163.7 27.36 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 107.185 -1.413 . . . . 72.24 107.185 -177.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 41.7 mt -81.97 128.52 38.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 CA-C-O 121.711 0.767 . . . . 73.3 110.447 175.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' SER . . . . . 0.481 ' HB2' ' HG2' ' A' ' 177' ' ' ARG . 27.8 t -100.47 -22.79 14.9 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 112.892 0.701 . . . . 70.13 112.892 -177.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 51.3 ttp180 -167.56 152.26 6.87 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 109.601 -0.518 . . . . 72.52 109.601 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 38.7 mt -100.96 146.34 27.52 Favored 'General case' 0 CA--C 1.48 -1.729 0 N-CA-C 108.85 -0.796 . . . . 73.54 108.85 173.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . 0.48 ' HB ' ' HA2' ' A' ' 173' ' ' GLY . 10.9 t -103.44 114.67 64.72 Favored Pre-proline 0 C--N 1.284 -2.252 0 N-CA-C 105.914 -1.884 . . . . 71.53 105.914 174.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . 0.427 ' HA ' ' HG2' ' A' ' 207' ' ' GLU . 23.9 Cg_exo -63.34 135.8 51.95 Favored 'Trans proline' 0 N--CA 1.447 -1.209 0 C-N-CA 121.888 1.725 . . . . 72.24 110.707 -178.085 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.427 ' H ' ' HG2' ' A' ' 207' ' ' GLU . . . 94.73 -12.6 68.47 Favored Glycine 0 C--N 1.312 -0.789 0 C-N-CA 120.891 -0.671 . . . . 75.24 112.152 -178.013 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . 0.43 ' HA3' ' CA ' ' A' ' 173' ' ' GLY . . . -80.05 172.95 54.93 Favored Glycine 0 N--CA 1.436 -1.328 0 C-N-CA 120.891 -0.671 . . . . 64.41 111.707 179.454 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . 0.518 ' HG ' ' H ' ' A' ' 164' ' ' LEU . 2.8 mm? -67.17 -41.91 85.18 Favored 'General case' 0 C--N 1.311 -1.089 0 C-N-CA 123.126 0.57 . . . . 73.23 111.761 -175.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -60.52 -39.18 86.89 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.102 0.477 . . . . 61.31 110.445 176.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.427 ' HG2' ' HA ' ' A' ' 202' ' ' PRO . 9.1 tp10 -67.85 -42.07 81.94 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.455 -0.793 . . . . 74.33 109.524 177.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 51.0 m -60.54 -45.12 95.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.4 -0.818 . . . . 72.13 112.032 -177.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 10.0 t -76.72 -30.12 56.5 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 109.362 -0.607 . . . . 65.0 109.362 178.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 66.04 16.55 64.42 Favored Glycine 0 C--N 1.34 0.754 0 CA-C-N 115.509 -0.769 . . . . 40.31 113.106 177.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.47 HD21 HG13 ' A' ' 161' ' ' VAL . 1.9 pp -99.74 -3.45 32.82 Favored 'General case' 0 N--CA 1.433 -1.28 0 C-N-CA 120.275 -0.57 . . . . 64.33 110.86 -177.426 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 5.4 mp -109.25 133.23 53.3 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 107.622 -1.251 . . . . 72.25 107.622 175.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -131.05 166.51 20.88 Favored 'General case' 0 C--N 1.279 -2.485 0 N-CA-C 108.599 -0.889 . . . . 64.44 108.599 178.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 35.5 m -57.38 -31.03 37.3 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 N-CA-C 112.726 0.639 . . . . 71.25 112.726 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 -73.22 -13.86 61.23 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 113.201 0.815 . . . . 71.12 113.201 -179.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -73.3 135.09 44.36 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.324 0.583 . . . . 73.43 112.405 -178.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -104.53 134.33 47.89 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.881 -1.054 . . . . 74.35 109.162 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . 0.588 ' CG1' ' HB ' ' A' ' 195' ' ' ILE . 13.1 p -84.08 134.97 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 CA-C-O 122.175 0.988 . . . . 72.55 111.395 -177.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 36.2 mm -99.27 -52.98 8.27 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.078 0 CA-C-N 114.332 -1.303 . . . . 73.01 111.025 -179.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -157.78 151.34 23.72 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 116.076 -0.511 . . . . 73.45 110.926 -175.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 246' ' ' ILE . 6.9 p -120.81 124.44 72.36 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 N-CA-C 108.959 -0.756 . . . . 74.14 108.959 176.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . 0.476 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 16.3 t-20 70.63 -3.8 1.83 Allowed 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 125.062 1.345 . . . . 70.34 111.164 -178.343 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 120.58 -17.91 9.42 Favored Glycine 0 C--N 1.301 -1.407 0 N-CA-C 111.019 -0.832 . . . . 54.4 111.019 -175.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 63.5 mt -88.52 123.77 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 N-CA-C 109.203 -0.666 . . . . 70.53 109.203 -179.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -61.54 147.84 44.1 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.585 0.707 . . . . 74.21 111.506 -178.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 26.1 m -117.8 -2.52 9.83 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 CA-C-N 115.408 -0.814 . . . . 71.21 112.239 179.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -82.16 104.34 12.42 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 109.169 -0.678 . . . . 51.32 109.169 177.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 122.58 -25.05 6.66 Favored Glycine 0 C--N 1.297 -1.597 0 N-CA-C 110.096 -1.202 . . . . 75.24 110.096 -179.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -74.0 166.7 22.92 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 107.711 -1.218 . . . . 75.21 107.711 176.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 230' ' ' THR . . . . . 0.437 ' O ' HG13 ' A' ' 234' ' ' VAL . 82.5 p -91.0 168.15 11.87 Favored 'General case' 0 C--O 1.249 1.06 0 N-CA-C 108.413 -0.958 . . . . 72.14 108.413 178.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 47.2 tp -66.07 -27.96 68.47 Favored 'General case' 0 N--CA 1.428 -1.566 0 C-N-CA 120.56 -0.456 . . . . 72.25 109.911 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -69.07 -47.71 64.6 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.725 -0.472 . . . . 71.24 109.725 176.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -58.92 -48.36 81.72 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 113.587 0.958 . . . . 74.24 113.587 177.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.437 HG13 ' O ' ' A' ' 230' ' ' THR . 13.3 m -65.14 -34.23 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-O 121.343 0.592 . . . . 64.21 111.598 -175.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 90.0 m -75.48 -35.65 60.78 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 115.52 -0.764 . . . . 61.4 109.394 -176.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -61.53 -34.03 74.84 Favored 'General case' 0 CA--C 1.508 -0.639 0 N-CA-C 108.8 -0.815 . . . . 71.43 108.8 177.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 237' ' ' MET . . . . . 0.404 ' HG3' ' HA ' ' A' ' 234' ' ' VAL . 9.9 mtt -67.66 -45.46 75.21 Favored 'General case' 0 C--O 1.211 -0.933 0 N-CA-C 108.113 -1.069 . . . . 75.14 108.113 178.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 65.9 mtt -59.25 -38.72 80.76 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.884 -0.598 . . . . 75.22 111.531 -178.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 60.6 t -69.76 -33.16 54.98 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-O 121.255 0.55 . . . . 73.01 110.217 178.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -75.28 -30.33 60.4 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.203 0.525 . . . . 73.02 111.404 179.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 -90.14 21.84 3.56 Favored 'General case' 0 C--O 1.2 -1.531 0 CA-C-N 115.895 -0.593 . . . . 72.21 112.519 -178.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 50.4 m -56.65 -22.97 38.3 Favored 'General case' 0 C--O 1.206 -1.22 0 N-CA-C 112.552 0.575 . . . . 72.11 112.552 177.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 18.4 m -64.16 -38.42 91.0 Favored 'General case' 0 CA--C 1.55 0.951 0 O-C-N 122.241 -0.287 . . . . 42.44 110.475 177.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -168.0 107.55 0.53 Allowed 'General case' 0 CA--C 1.491 -1.301 0 C-N-CA 126.876 2.071 . . . . 72.23 107.414 177.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . 0.466 ' HB3' ' HB2' ' A' ' 163' ' ' LEU . 0.2 OUTLIER -84.77 105.28 15.44 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 108.348 -0.982 . . . . 74.12 108.348 -174.667 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . 0.476 ' HB ' ' HA ' ' A' ' 222' ' ' ASN . 89.4 mt -94.08 115.31 32.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 109.003 -0.74 . . . . 64.03 109.003 179.079 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 13.3 mt -125.47 135.65 63.3 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.073 0 CA-C-O 121.467 0.651 . . . . 73.35 112.181 176.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.484 ' HA ' ' O ' ' A' ' 159' ' ' ARG . 70.1 m -107.55 115.52 30.3 Favored 'General case' 0 N--CA 1.414 -2.274 0 N-CA-C 107.636 -1.246 . . . . 65.22 107.636 173.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . 0.405 HG13 ' HA ' ' A' ' 218' ' ' VAL . 12.1 m -117.93 164.94 13.76 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.115 0 N-CA-C 109.491 -0.559 . . . . 75.24 109.491 174.298 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 17.4 ptmt -131.86 128.3 21.54 Favored Pre-proline 0 C--N 1.286 -2.16 0 CA-C-N 114.896 -1.047 . . . . 74.43 108.676 174.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo . . . . . 0 N--CA 1.442 -1.528 0 C-N-CA 121.559 1.506 . . . . 75.03 112.382 179.449 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.535 ' HB3' ' HB3' ' A' ' 250' ' ' LYS 0.407 6.0 p-80 . . . . . 0 CA--C 1.496 -1.107 0 N-CA-C 114.74 1.385 . . . . 72.24 114.74 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.564 ' O ' ' HA ' ' A' ' 248' ' ' THR . 11.3 ptt180 -110.34 143.84 39.97 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 113.562 -1.654 . . . . 72.54 110.812 -173.373 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -114.0 112.93 24.07 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 121.702 0.763 . . . . 74.15 110.887 178.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 28.4 m -114.3 139.7 38.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 CA-C-N 114.879 -1.055 . . . . 65.32 112.786 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 19.8 ttm180 -96.48 112.83 24.43 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.434 0.635 . . . . 74.12 109.781 177.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 19.8 mt -94.13 138.18 32.48 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-N 114.999 -1.0 . . . . 75.53 108.685 -178.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 15.4 tp . . . . . 0 C--N 1.312 -1.03 0 CA-C-O 122.121 0.962 . . . . 75.32 111.632 174.793 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.446 ' HG ' ' CD1' ' A' ' 245' ' ' LEU . 3.6 mm? . . . . . 0 CA--C 1.51 -0.595 0 N-CA-C 112.284 0.476 . . . . 74.51 112.284 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . 0.467 ' HA3' ' HA3' ' A' ' 204' ' ' GLY . . . 88.07 34.97 9.26 Favored Glycine 0 N--CA 1.426 -2.024 0 C-N-CA 120.595 -0.812 . . . . 50.45 113.271 177.008 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -154.73 154.02 32.2 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 107.487 -1.301 . . . . 62.42 107.487 174.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -125.45 148.94 48.64 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 108.939 -0.763 . . . . 74.4 108.939 176.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 35.6 pt -110.08 169.52 3.61 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 CA-C-O 121.32 0.581 . . . . 74.0 111.253 -176.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . 0.503 ' CG ' ' HB2' ' A' ' 198' ' ' SER . 15.7 ptt180 -149.21 154.79 39.64 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 115.112 -0.949 . . . . 72.42 109.312 -179.39 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -117.54 144.5 45.04 Favored 'General case' 0 C--N 1.287 -2.124 0 N-CA-C 109.014 -0.736 . . . . 64.23 109.014 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -161.95 179.96 36.98 Favored Glycine 0 N--CA 1.417 -2.63 0 N-CA-C 109.712 -1.355 . . . . 54.03 109.712 178.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' THR . . . . . 0.467 ' HB ' ' CG ' ' A' ' 191' ' ' LYS . 0.8 OUTLIER -86.46 123.92 32.22 Favored 'General case' 0 C--N 1.29 -1.997 0 CA-C-O 121.66 0.743 . . . . 73.45 112.193 177.298 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 37.4 t . . . . . 0 N--CA 1.403 -2.788 0 N-CA-C 107.356 -1.35 . . . . 74.42 107.356 177.225 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.467 ' CG ' ' HB ' ' A' ' 180' ' ' THR . 34.6 ttmt . . . . . 0 N--CA 1.432 -1.374 0 N-CA-C 108.964 -0.754 . . . . 72.24 108.964 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -145.71 164.71 24.34 Favored Pre-proline 0 C--N 1.292 -1.905 0 N-CA-C 107.893 -1.151 . . . . 74.02 107.893 -177.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -59.29 132.76 48.45 Favored 'Trans proline' 0 C--O 1.245 0.834 0 C-N-CA 121.533 1.488 . . . . 71.4 111.667 176.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -139.53 143.24 13.62 Favored Glycine 0 N--CA 1.419 -2.481 0 N-CA-C 109.778 -1.329 . . . . 63.12 109.778 178.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 3.2 mp -108.76 132.84 55.64 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 CA-C-O 121.117 0.484 . . . . 75.04 110.767 -179.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -125.31 167.72 14.51 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 107.946 -1.131 . . . . 75.22 107.946 -176.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . 0.456 ' HB ' ' HA ' ' A' ' 214' ' ' VAL . 46.5 mm -77.06 131.51 34.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 N-CA-C 108.189 -1.041 . . . . 75.43 108.189 174.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' SER . . . . . 0.503 ' HB2' ' CG ' ' A' ' 177' ' ' ARG . 12.7 t -104.48 -38.49 6.77 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 113.449 0.907 . . . . 52.31 113.449 -178.525 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 40.0 ttp180 -150.47 141.86 23.36 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 120.004 -0.678 . . . . 74.41 109.947 -177.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -108.45 133.79 52.13 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 107.562 -1.273 . . . . 65.22 107.562 -177.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 44.0 t -110.6 131.58 22.01 Favored Pre-proline 0 C--N 1.311 -1.073 0 C-N-CA 120.756 -0.378 . . . . 75.11 110.736 -177.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . 0.493 ' HA ' ' OE2' ' A' ' 207' ' ' GLU . 17.8 Cg_endo -60.78 135.21 58.47 Favored 'Trans proline' 0 C--O 1.247 0.939 0 C-N-CA 122.717 2.278 . . . . 73.32 111.682 176.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 86.37 0.78 86.46 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.812 -0.631 . . . . 72.32 112.63 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . 0.467 ' HA3' ' HA3' ' A' ' 173' ' ' GLY . . . -88.25 170.26 38.96 Favored Glycine 0 N--CA 1.439 -1.13 0 C-N-CA 120.577 -0.82 . . . . 74.22 112.526 -178.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -66.39 -34.25 77.54 Favored 'General case' 0 N--CA 1.438 -1.075 0 C-N-CA 123.088 0.555 . . . . 74.42 110.582 -179.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . 0.458 ' CB ' HD13 ' A' ' 212' ' ' LEU . . . -61.76 -41.55 97.83 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 115.613 -0.721 . . . . 62.41 110.49 176.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.493 ' OE2' ' HA ' ' A' ' 202' ' ' PRO . 41.2 tt0 -75.6 -33.52 60.56 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.946 -0.57 . . . . 75.33 110.234 178.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 44.3 t -56.34 -50.14 72.36 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 123.755 0.822 . . . . 65.55 111.042 -179.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 209' ' ' THR . . . . . 0.49 ' CG2' ' HG ' ' A' ' 211' ' ' LEU . 8.8 t -80.02 -25.98 39.99 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 119.648 -0.821 . . . . 75.33 109.59 176.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 65.6 22.84 70.13 Favored Glycine 0 N--CA 1.446 -0.689 0 CA-C-N 115.608 -0.724 . . . . 50.52 112.543 179.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.49 ' HG ' ' CG2' ' A' ' 209' ' ' THR . 1.1 pp -111.61 4.06 18.39 Favored 'General case' 0 N--CA 1.436 -1.174 0 C-N-CA 120.073 -0.651 . . . . 74.44 112.235 -177.33 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . 0.458 HD13 ' CB ' ' A' ' 206' ' ' ALA . 75.5 mt -108.39 133.13 53.0 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 108.65 -0.87 . . . . 75.21 108.65 177.577 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -131.86 165.23 24.3 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 107.613 -1.254 . . . . 74.45 107.613 177.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . 0.456 ' HA ' ' HB ' ' A' ' 197' ' ' ILE 0.259 18.7 m -65.53 -28.83 45.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 113.519 0.933 . . . . 75.34 113.519 -177.99 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -73.11 -15.14 61.49 Favored 'General case' 0 N--CA 1.484 1.247 0 O-C-N 121.906 -0.496 . . . . 42.43 111.636 178.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -66.43 131.95 47.21 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-O 121.337 0.589 . . . . 62.33 112.036 -179.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . 0.483 ' O ' ' HA ' ' A' ' 249' ' ' VAL . 38.6 tt0 -105.82 132.4 51.99 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.95 -1.023 . . . . 74.34 111.044 -178.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 35.4 t -81.66 127.37 39.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 C-N-CA 123.24 0.616 . . . . 74.1 110.643 -176.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 40.9 mm -98.84 -49.41 11.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 CA-C-N 115.341 -0.845 . . . . 71.35 110.806 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.428 ' CB ' ' HA ' ' A' ' 225' ' ' GLU . 12.7 pt-20 -152.55 158.41 42.46 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-O 120.529 0.204 . . . . 75.33 110.703 -179.255 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . 0.545 ' C ' ' H ' ' A' ' 223' ' ' GLY . 9.1 p -125.36 125.76 69.54 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 N-CA-C 109.088 -0.708 . . . . 73.21 109.088 178.406 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . 0.627 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 14.8 t-20 71.92 -31.8 0.23 Allowed 'General case' 0 N--CA 1.499 2.021 0 C-N-CA 126.421 1.888 . . . . 72.13 112.364 -178.281 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . 0.545 ' H ' ' C ' ' A' ' 221' ' ' VAL . . . 150.21 -4.6 0.62 Allowed Glycine 0 C--N 1.276 -2.797 0 CA-C-N 114.547 -1.206 . . . . 37.71 110.777 -175.163 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 68.6 mt -104.56 124.34 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.14 0 N-CA-C 109.364 -0.606 . . . . 71.2 109.364 179.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . 0.428 ' HA ' ' CB ' ' A' ' 220' ' ' GLU . 12.4 pt-20 -57.91 148.66 24.96 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 123.419 0.688 . . . . 71.33 112.801 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . 0.488 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 34.3 m -122.67 -2.54 7.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 CA-C-N 114.891 -1.049 . . . . 70.02 109.501 175.44 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -71.22 99.05 1.83 Allowed 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 115.547 -0.751 . . . . 73.1 110.441 -177.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 121.91 -23.2 7.44 Favored Glycine 0 N--CA 1.43 -1.742 0 N-CA-C 110.965 -0.854 . . . . 61.22 110.965 178.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 80.2 mttt -78.13 172.85 12.93 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 121.142 -0.223 . . . . 74.54 111.306 -179.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 230' ' ' THR . . . . . 0.446 ' O ' HG13 ' A' ' 234' ' ' VAL . 74.2 p -93.77 165.97 12.43 Favored 'General case' 0 N--CA 1.427 -1.612 0 C-N-CA 119.849 -0.74 . . . . 64.51 109.76 -175.424 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -60.96 -38.78 87.11 Favored 'General case' 0 N--CA 1.427 -1.614 0 CA-C-N 116.081 -0.508 . . . . 72.44 109.787 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -65.95 -40.16 91.09 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.458 -0.337 . . . . 62.2 110.664 179.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -64.31 -49.3 72.32 Favored 'General case' 0 C--O 1.223 -0.316 0 N-CA-C 112.667 0.618 . . . . 72.31 112.667 175.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.488 ' CG1' ' HB ' ' A' ' 226' ' ' VAL . 15.0 m -68.36 -34.05 63.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 112.729 0.64 . . . . 70.43 112.729 -173.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 75.1 m -71.0 -35.63 72.14 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 109.229 -0.656 . . . . 64.01 109.229 -176.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -62.63 -33.97 76.09 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.727 -0.669 . . . . 72.03 109.598 178.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 2.0 mtm -74.33 -34.91 63.58 Favored 'General case' 0 C--O 1.2 -1.55 0 N-CA-C 108.542 -0.91 . . . . 75.12 108.542 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 238' ' ' MET . . . . . 0.425 ' HG3' ' O ' ' A' ' 234' ' ' VAL . 65.3 mtt -68.66 -36.24 78.29 Favored 'General case' 0 C--N 1.314 -0.964 0 O-C-N 121.995 -0.441 . . . . 61.3 110.844 178.63 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 99.9 t -67.81 -39.57 82.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 CA-C-O 121.278 0.561 . . . . 64.41 109.665 176.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -69.59 -32.4 71.13 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.919 -0.582 . . . . 63.25 111.006 178.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 58.0 m-80 -96.24 21.04 9.45 Favored 'General case' 0 C--O 1.206 -1.187 0 CA-C-N 116.294 -0.412 . . . . 63.34 111.995 178.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 62.6 m -63.16 -23.1 67.28 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 120.537 -0.465 . . . . 75.41 111.895 178.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 19.2 m -66.03 -24.99 66.85 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 116.639 -0.255 . . . . 74.21 111.159 177.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -172.79 93.13 0.11 Allowed 'General case' 0 C--O 1.24 0.577 0 C-N-CA 124.602 1.161 . . . . 71.05 109.054 -178.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . 0.446 ' CD1' ' HG ' ' A' ' 172' ' ' LEU . 1.2 tt -88.66 105.05 17.42 Favored 'General case' 0 C--O 1.198 -1.643 0 CA-C-N 115.769 -0.65 . . . . 75.14 111.286 -169.301 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . 0.627 ' HB ' ' HA ' ' A' ' 222' ' ' ASN . 52.3 mt -96.95 122.61 48.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 108.506 -0.924 . . . . 72.3 108.506 176.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 14.9 mt -130.09 135.4 61.03 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.061 0 CA-C-O 121.441 0.639 . . . . 72.12 112.487 177.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.564 ' HA ' ' O ' ' A' ' 159' ' ' ARG . 87.6 m -99.99 122.67 43.25 Favored 'General case' 0 N--CA 1.423 -1.784 0 CA-C-N 114.906 -1.043 . . . . 75.14 108.417 174.507 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . 0.483 ' HA ' ' O ' ' A' ' 217' ' ' GLU . 23.5 m -132.61 151.83 35.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 CA-C-O 121.347 0.594 . . . . 63.51 111.06 177.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . 0.535 ' HB3' ' HB3' ' A' ' 158' ' ' HIS . 1.4 ptmm? -126.79 128.69 24.21 Favored Pre-proline 0 C--N 1.28 -2.437 0 CA-C-N 114.286 -1.325 . . . . 71.32 109.045 174.194 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo . . . . . 0 N--CA 1.44 -1.637 0 C-N-CA 122.221 1.947 . . . . 74.32 110.291 176.952 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 1.3 m80 . . . . . 0 CA--C 1.505 -0.776 0 CA-C-O 121.134 0.492 . . . . 72.41 111.755 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -132.84 135.12 45.45 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 107.739 -1.208 . . . . 73.0 107.739 175.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 12.9 ptp180 -124.58 113.32 17.91 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-O 121.792 0.806 . . . . 74.11 110.14 178.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 23.7 m -107.41 138.25 34.48 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.922 0 CA-C-N 114.996 -1.002 . . . . 71.31 112.614 -178.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.451 ' C ' ' HD3' ' A' ' 162' ' ' ARG . 0.1 OUTLIER -104.27 112.56 25.63 Favored 'General case' 0 N--CA 1.417 -2.076 0 N-CA-C 108.473 -0.936 . . . . 74.05 108.473 175.735 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.4 ' HB2' ' HB3' ' A' ' 245' ' ' LEU . 22.9 mt -101.01 139.89 36.07 Favored 'General case' 0 C--N 1.284 -2.239 0 CA-C-N 114.317 -1.31 . . . . 73.45 108.243 -175.451 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.426 -1.673 0 N-CA-C 106.097 -1.816 . . . . 73.42 106.097 173.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.504 ' HG ' ' CD1' ' A' ' 245' ' ' LEU . 3.1 mm? . . . . . 0 CA--C 1.509 -0.599 0 N-CA-C 112.336 0.495 . . . . 52.1 112.336 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . 0.411 ' HA3' ' HA3' ' A' ' 204' ' ' GLY . . . 90.88 34.23 7.84 Favored Glycine 0 N--CA 1.422 -2.247 0 C-N-CA 120.672 -0.775 . . . . 73.24 112.929 177.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 26.0 p90 -152.93 154.38 34.9 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 108.805 -0.813 . . . . 73.11 108.805 175.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -128.12 150.87 49.79 Favored 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 108.322 -0.992 . . . . 73.43 108.322 175.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.527 HD11 ' H ' ' A' ' 176' ' ' ILE . 0.2 OUTLIER -116.4 169.21 7.1 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.081 0 CA-C-O 121.474 0.654 . . . . 75.02 111.276 -177.584 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . 0.487 ' HG2' ' HB2' ' A' ' 198' ' ' SER . 4.3 ptp180 -147.98 155.2 41.26 Favored 'General case' 0 C--N 1.278 -2.524 0 C-N-CA 124.358 1.063 . . . . 62.24 109.884 -176.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -111.46 146.23 37.59 Favored 'General case' 0 C--N 1.294 -1.836 0 O-C-N 123.579 0.549 . . . . 73.24 110.135 179.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -159.61 -165.01 15.71 Favored Glycine 0 C--N 1.292 -1.914 0 N-CA-C 108.624 -1.791 . . . . 50.3 108.624 175.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' THR . . . . . 0.413 ' HB ' ' CG ' ' A' ' 191' ' ' LYS . 3.1 p -103.9 125.65 50.46 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 118.46 1.13 . . . . 64.2 112.627 175.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 67.8 m . . . . . 0 N--CA 1.403 -2.784 0 N-CA-C 107.484 -1.302 . . . . 74.41 107.484 173.586 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.413 ' CG ' ' HB ' ' A' ' 180' ' ' THR . 36.2 ttmt . . . . . 0 N--CA 1.413 -2.295 0 N-CA-C 106.851 -1.537 . . . . 75.54 106.851 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -126.02 160.13 58.49 Favored Pre-proline 0 C--N 1.268 -2.945 0 N-CA-C 107.603 -1.258 . . . . 73.24 107.603 -176.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -65.73 131.03 26.29 Favored 'Trans proline' 0 N--CA 1.416 -3.042 0 N-CA-C 107.861 -1.631 . . . . 73.12 107.861 168.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -122.47 138.76 12.14 Favored Glycine 0 N--CA 1.402 -3.621 0 N-CA-C 109.09 -1.604 . . . . 74.14 109.09 179.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.459 ' HB ' ' CG1' ' A' ' 218' ' ' VAL . 3.5 mp -104.05 132.16 51.18 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.626 0 C-N-CA 120.268 -0.573 . . . . 75.43 109.79 179.493 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -122.81 165.0 17.33 Favored 'General case' 0 C--N 1.284 -2.275 0 N-CA-C 108.188 -1.042 . . . . 75.14 108.188 -177.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . 0.435 ' HB ' ' HA ' ' A' ' 214' ' ' VAL . 46.8 mm -78.37 128.8 38.17 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 107.711 -1.218 . . . . 54.53 107.711 174.246 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' SER . . . . . 0.487 ' HB2' ' HG2' ' A' ' 177' ' ' ARG . 11.4 t -100.99 -28.21 12.86 Favored 'General case' 0 C--N 1.28 -2.45 0 O-C-N 121.488 -0.758 . . . . 60.2 113.013 -177.573 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 25.3 tpt180 -163.07 140.11 7.55 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 120.878 -0.329 . . . . 74.23 110.333 -175.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 61.4 mt -105.33 137.53 42.98 Favored 'General case' 0 CA--C 1.491 -1.29 0 N-CA-C 108.964 -0.754 . . . . 72.33 108.964 172.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 61.5 t -97.55 116.53 65.84 Favored Pre-proline 0 C--N 1.279 -2.463 0 N-CA-C 105.773 -1.936 . . . . 73.32 105.773 172.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . 0.578 ' HA ' ' OE1' ' A' ' 207' ' ' GLU . 21.1 Cg_endo -60.04 126.29 19.9 Favored 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 121.932 1.755 . . . . 72.21 111.707 -174.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 105.51 -9.08 44.64 Favored Glycine 0 C--N 1.307 -1.073 0 CA-C-N 115.421 -0.809 . . . . 53.22 111.104 -177.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . 0.411 ' HA3' ' HA3' ' A' ' 173' ' ' GLY . . . -74.77 167.55 54.82 Favored Glycine 0 N--CA 1.437 -1.248 0 C-N-CA 121.556 -0.354 . . . . 73.34 113.14 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -65.0 -29.16 70.07 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 124.281 1.032 . . . . 73.3 111.737 -177.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -59.81 -40.73 89.38 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.863 -0.608 . . . . 74.53 110.57 177.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.578 ' OE1' ' HA ' ' A' ' 202' ' ' PRO . 46.3 mt-10 -75.5 -31.42 60.16 Favored 'General case' 0 CA--C 1.507 -0.694 0 CA-C-N 116.2 -0.454 . . . . 70.43 110.885 175.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 24.8 m -55.73 -36.96 67.81 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.162 -0.472 . . . . 72.52 111.417 -177.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 9.7 t -84.72 -32.68 23.39 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 109.281 -0.637 . . . . 63.43 109.281 174.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 73.32 21.02 80.02 Favored Glycine 0 CA--C 1.497 -1.058 0 CA-C-N 115.876 -0.602 . . . . 40.24 112.061 177.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 38.4 mt -114.31 -0.32 13.9 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 109.655 -0.498 . . . . 71.23 109.655 -178.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 74.0 mt -109.03 130.93 55.49 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 120.113 -0.635 . . . . 75.34 110.684 176.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -133.82 166.23 23.14 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 114.605 -1.179 . . . . 75.4 108.04 176.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . 0.435 ' HA ' ' HB ' ' A' ' 197' ' ' ILE . 26.4 m -59.33 -29.37 41.79 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-O 121.934 0.873 . . . . 73.31 111.416 176.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -72.65 -15.79 61.71 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 115.377 -0.829 . . . . 41.35 112.617 -175.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -69.31 137.82 53.29 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 113.602 0.964 . . . . 63.45 113.602 -176.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -112.92 124.66 53.12 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.795 1.638 . . . . 75.22 108.87 -178.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . 0.459 ' CG1' ' HB ' ' A' ' 195' ' ' ILE . 8.2 p -80.1 146.47 7.63 Favored 'Isoleucine or valine' 0 C--O 1.251 1.168 0 N-CA-C 113.953 1.094 . . . . 74.02 113.953 -173.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . 0.455 HD11 ' CD ' ' A' ' 250' ' ' LYS . 44.4 mm -111.46 -53.13 5.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 113.988 -1.46 . . . . 75.15 110.435 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -158.07 156.28 30.76 Favored 'General case' 0 C--O 1.244 0.794 0 CA-C-N 116.324 -0.398 . . . . 74.32 110.245 -176.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' A' ' 246' ' ' ILE . 4.4 p -124.74 115.92 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.292 0 CA-C-O 121.586 0.707 . . . . 72.23 110.838 173.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . 0.436 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 21.4 t-20 58.95 34.61 23.71 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 126.124 1.77 . . . . 73.54 110.638 178.407 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 93.74 -4.83 72.73 Favored Glycine 0 C--N 1.301 -1.392 0 CA-C-N 115.165 -0.925 . . . . 71.33 113.172 177.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 58.1 mt -99.67 123.36 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.373 0 N-CA-C 108.628 -0.878 . . . . 73.15 108.628 179.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -62.93 134.99 57.06 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 121.403 0.621 . . . . 73.03 110.741 -179.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 27.6 m -115.57 10.97 7.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-O 122.202 1.001 . . . . 72.4 109.611 175.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -75.32 99.98 4.26 Favored 'General case' 0 N--CA 1.422 -1.83 0 CA-C-N 114.307 -1.315 . . . . 71.54 110.336 179.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 95.08 18.46 33.96 Favored Glycine 0 N--CA 1.438 -1.186 0 CA-C-N 115.489 -0.778 . . . . 71.25 112.919 175.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . 0.427 ' HB3' ' HG2' ' A' ' 233' ' ' GLN . 68.7 mmtt -95.63 172.2 8.2 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.963 0.382 . . . . 75.31 110.164 179.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 230' ' ' THR . . . . . 0.654 ' OG1' ' HB2' ' A' ' 233' ' ' GLN . 40.6 p -76.1 162.57 27.9 Favored 'General case' 0 N--CA 1.433 -1.296 0 C-N-CA 120.33 -0.548 . . . . 72.23 109.55 175.594 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -68.6 -39.18 81.01 Favored 'General case' 0 N--CA 1.429 -1.514 0 N-CA-C 108.982 -0.747 . . . . 71.5 108.982 -179.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -61.29 -39.39 90.28 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 116.302 -0.408 . . . . 72.21 110.338 176.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 233' ' ' GLN . . . . . 0.654 ' HB2' ' OG1' ' A' ' 230' ' ' THR . 3.5 tp-100 -58.16 -50.95 71.73 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 123.947 0.899 . . . . 73.01 109.796 -177.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.43 ' O ' ' HG3' ' A' ' 238' ' ' MET . 13.0 m -73.67 -34.2 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-N 115.265 -0.88 . . . . 75.34 111.536 -174.05 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 53.0 m -74.75 -36.52 62.6 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 115.42 -0.809 . . . . 73.2 109.251 -175.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -58.77 -34.72 71.76 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-N 115.39 -0.823 . . . . 74.13 109.602 175.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 10.1 mtt -69.79 -50.27 44.66 Favored 'General case' 0 C--O 1.208 -1.128 0 N-CA-C 108.002 -1.11 . . . . 70.21 108.002 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 238' ' ' MET . . . . . 0.43 ' HG3' ' O ' ' A' ' 234' ' ' VAL . 64.4 mtt -54.47 -40.01 68.03 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 123.426 0.69 . . . . 75.42 111.791 -177.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 80.3 t -69.09 -48.91 66.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.158 0.504 . . . . 71.33 110.915 178.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -65.78 -28.9 69.36 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.908 -0.587 . . . . 73.32 111.705 -178.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 -84.68 21.56 1.5 Allowed 'General case' 0 C--O 1.2 -1.549 0 N-CA-C 113.174 0.805 . . . . 74.44 113.174 -179.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 31.0 p -56.19 -23.76 37.34 Favored 'General case' 0 C--O 1.2 -1.54 0 N-CA-C 113.301 0.852 . . . . 75.34 113.301 177.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 19.4 m -71.28 -37.41 71.88 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 121.563 0.697 . . . . 63.33 110.214 177.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -158.19 92.22 1.15 Allowed 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 123.922 0.889 . . . . 73.43 110.091 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . 0.504 ' CD1' ' HG ' ' A' ' 172' ' ' LEU . 1.4 tt -88.64 103.75 16.22 Favored 'General case' 0 C--O 1.207 -1.145 0 N-CA-C 109.029 -0.73 . . . . 74.21 109.029 -175.472 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . 0.436 ' HB ' ' HA ' ' A' ' 222' ' ' ASN . 58.7 mt -106.1 115.73 48.39 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 109.053 -0.721 . . . . 74.53 109.053 179.144 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 32.1 mt -119.89 128.82 75.94 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 CA-C-O 121.472 0.653 . . . . 71.13 111.657 178.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 37.9 m -102.07 118.48 36.98 Favored 'General case' 0 N--CA 1.418 -2.066 0 CA-C-N 114.751 -1.113 . . . . 75.55 108.021 176.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 15.8 m -126.84 170.08 17.32 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.992 0 CA-C-O 121.793 0.806 . . . . 74.55 110.673 178.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . 0.455 ' CD ' HD11 ' A' ' 219' ' ' ILE 0.337 42.9 mtpt -125.72 152.4 72.21 Favored Pre-proline 0 C--N 1.271 -2.812 0 CA-C-N 113.492 -1.685 . . . . 74.31 106.67 174.897 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo . . . . . 0 N--CA 1.424 -2.566 0 N-CA-C 108.304 -1.46 . . . . 72.42 108.304 167.105 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.496 -1.098 0 N-CA-C 109.866 -0.42 . . . . 71.32 109.866 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.503 ' HA ' ' HE ' ' A' ' 159' ' ' ARG . 2.0 tpm_? -121.73 119.2 31.06 Favored 'General case' 0 N--CA 1.423 -1.799 0 N-CA-C 109.411 -0.588 . . . . 72.21 109.411 178.355 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 81.2 mtm180 -101.05 113.73 27.01 Favored 'General case' 0 C--N 1.281 -2.392 0 CA-C-N 115.123 -0.944 . . . . 71.44 109.507 179.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 23.6 m -119.67 139.23 47.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 CA-C-N 115.924 -0.58 . . . . 74.44 111.198 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -107.86 112.09 24.55 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.127 -1.064 . . . . 64.43 108.127 176.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.42 ' HB2' ' HB2' ' A' ' 245' ' ' LEU . 20.9 mt -103.03 139.87 38.02 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 108.323 -0.991 . . . . 64.3 108.323 -174.113 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.724 ' HG ' ' O ' ' A' ' 242' ' ' SER . 0.1 OUTLIER . . . . . 0 N--CA 1.443 -0.797 0 N-CA-C 105.911 -1.885 . . . . 64.33 105.911 -179.608 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.468 ' HG ' ' CD1' ' A' ' 245' ' ' LEU . 2.7 mm? . . . . . 0 N--CA 1.441 -0.89 0 N-CA-C 112.177 0.436 . . . . 71.54 112.177 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . 0.461 ' HA3' ' HA3' ' A' ' 204' ' ' GLY . . . 97.69 30.59 7.13 Favored Glycine 0 N--CA 1.44 -1.091 0 C-N-CA 120.258 -0.972 . . . . 75.4 112.968 177.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -147.55 155.8 42.21 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.239 -1.393 . . . . 74.2 107.239 174.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -131.45 143.57 50.53 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 108.078 -1.082 . . . . 72.12 108.078 177.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 30.2 pt -111.01 169.08 4.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 113.31 0.856 . . . . 75.02 113.31 -173.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . 0.455 ' HB3' ' HB2' ' A' ' 198' ' ' SER . 2.9 ptp180 -142.87 155.02 44.69 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 114.765 -1.107 . . . . 74.32 109.982 -178.254 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . 0.521 ' HB2' ' HB2' ' A' ' 231' ' ' LEU . 11.5 t70 -109.46 138.53 45.67 Favored 'General case' 0 C--N 1.29 -2.014 0 O-C-N 124.082 0.864 . . . . 73.41 109.138 179.047 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -151.46 -178.99 26.77 Favored Glycine 0 C--N 1.273 -2.967 0 N-CA-C 108.07 -2.012 . . . . 43.3 108.07 175.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' THR . . . . . 0.434 ' CG2' ' HG2' ' A' ' 191' ' ' LYS . 0.2 OUTLIER -109.59 122.36 47.27 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 106.581 -1.637 . . . . 71.51 106.581 177.128 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' SER . . . . . 0.497 ' O ' ' HA ' ' A' ' 191' ' ' LYS . 33.0 t . . . . . 0 C--N 1.287 -2.141 0 N-CA-C 109.062 -0.718 . . . . 73.1 109.062 -176.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.497 ' HA ' ' O ' ' A' ' 181' ' ' SER . 32.9 ttmt . . . . . 0 N--CA 1.425 -1.675 0 N-CA-C 107.735 -1.209 . . . . 75.42 107.735 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . 0.406 ' HB2' ' HD2' ' A' ' 193' ' ' PRO . 9.0 pt20 -151.59 164.53 19.95 Favored Pre-proline 0 C--N 1.305 -1.347 0 N-CA-C 108.152 -1.055 . . . . 74.11 108.152 -174.569 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' PRO . . . . . 0.406 ' HD2' ' HB2' ' A' ' 192' ' ' GLN . 9.5 Cg_endo -54.55 131.71 47.13 Favored 'Trans proline' 0 C--O 1.249 1.073 0 C-N-CA 121.431 1.421 . . . . 75.35 111.582 178.694 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -143.02 132.69 5.15 Favored Glycine 0 N--CA 1.411 -2.975 0 N-CA-C 109.716 -1.354 . . . . 61.0 109.716 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.515 HG12 HG21 ' A' ' 234' ' ' VAL . 3.5 mp -105.17 138.85 28.21 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.438 0 CA-C-O 121.112 0.482 . . . . 74.25 109.92 -179.599 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -132.34 167.66 19.48 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 107.285 -1.376 . . . . 73.34 107.285 -176.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 50.2 mm -75.54 131.69 34.52 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 N-CA-C 108.452 -0.944 . . . . 75.02 108.452 173.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' SER . . . . . 0.455 ' HB2' ' HB3' ' A' ' 177' ' ' ARG . 21.0 t -108.31 -25.24 11.12 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.792 -0.568 . . . . 72.5 111.926 178.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 68.7 ttt180 -154.05 142.35 20.53 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 109.266 -0.642 . . . . 65.41 109.266 179.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 50.5 tp -125.32 133.02 52.76 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 108.629 -0.878 . . . . 70.23 108.629 178.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 62.1 t -110.37 121.14 42.28 Favored Pre-proline 0 C--O 1.248 1.007 0 CA-C-N 116.766 -0.197 . . . . 72.3 110.766 -177.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . 0.485 ' HA ' ' HG2' ' A' ' 207' ' ' GLU . 28.7 Cg_exo -62.43 131.75 35.32 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 122.229 1.953 . . . . 71.34 110.065 175.341 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 106.17 -17.82 40.27 Favored Glycine 0 N--CA 1.434 -1.485 0 N-CA-C 110.2 -1.16 . . . . 52.3 110.2 -175.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . 0.461 ' HA3' ' HA3' ' A' ' 173' ' ' GLY . . . -83.87 161.24 38.01 Favored Glycine 0 N--CA 1.428 -1.894 0 N-CA-C 110.329 -1.108 . . . . 71.14 110.329 176.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . 0.418 ' O ' HG21 ' A' ' 209' ' ' THR . 3.1 mm? -58.9 -37.66 77.11 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 123.288 0.635 . . . . 74.31 111.599 -177.398 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -62.08 -47.28 85.35 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 116.071 -0.513 . . . . 73.43 112.112 -179.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.485 ' HG2' ' HA ' ' A' ' 202' ' ' PRO . 9.7 tp10 -75.28 -33.22 61.21 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.454 -0.573 . . . . 74.44 109.454 178.598 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 38.6 t -57.76 -48.17 80.41 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 116.059 -0.519 . . . . 72.33 110.208 177.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 209' ' ' THR . . . . . 0.418 HG21 ' O ' ' A' ' 205' ' ' LEU . 9.1 t -73.54 -40.42 63.99 Favored 'General case' 0 N--CA 1.437 -1.089 0 C-N-CA 120.098 -0.641 . . . . 63.23 110.201 176.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 83.35 -9.19 61.99 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.78 -0.724 . . . . 61.13 111.908 178.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 59.7 mt -77.75 -9.82 59.22 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.315 0.578 . . . . 75.2 110.013 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 79.6 mt -109.4 132.95 53.65 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 108.396 -0.964 . . . . 74.35 108.396 173.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -131.44 166.06 22.15 Favored 'General case' 0 N--CA 1.421 -1.914 0 N-CA-C 109.048 -0.723 . . . . 72.4 109.048 178.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 28.4 m -64.01 -30.29 49.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 115.193 1.553 . . . . 72.35 115.193 -175.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -82.26 -13.24 57.34 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 113.798 1.036 . . . . 73.34 113.798 -179.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -59.54 141.74 54.17 Favored 'General case' 0 C--O 1.245 0.833 0 N-CA-C 114.578 1.325 . . . . 73.11 114.578 -176.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -106.75 131.44 53.87 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 125.91 1.684 . . . . 73.02 109.008 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . 0.434 ' CG1' ' HB ' ' A' ' 195' ' ' ILE . 7.2 p -85.48 136.83 21.98 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-O 121.668 0.747 . . . . 74.34 112.554 -174.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 39.8 mm -103.37 -52.36 8.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.087 -0.961 . . . . 65.44 111.35 -179.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -155.83 154.62 31.6 Favored 'General case' 0 C--O 1.248 0.988 0 CA-C-N 116.465 -0.334 . . . . 75.14 111.219 -177.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . 0.441 HG13 ' CG1' ' A' ' 226' ' ' VAL . 10.5 p -129.57 121.01 51.96 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.197 0 CA-C-O 121.438 0.637 . . . . 73.42 110.67 176.6 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . 0.411 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 11.6 t-20 66.99 12.99 9.3 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 125.256 1.422 . . . . 74.31 111.599 175.312 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 112.69 -18.19 22.53 Favored Glycine 0 N--CA 1.437 -1.255 0 C-N-CA 120.729 -0.748 . . . . 45.34 111.726 -179.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 62.9 mt -92.55 124.87 45.15 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.501 0 N-CA-C 108.601 -0.889 . . . . 74.33 108.601 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -65.41 137.86 57.75 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-O 121.237 0.541 . . . . 74.52 110.372 179.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . 0.479 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 28.6 m -115.28 0.48 8.66 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 CA-C-O 121.595 0.712 . . . . 71.43 110.543 178.124 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -84.11 97.55 9.4 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-N 115.442 -0.799 . . . . 73.34 109.459 179.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 123.0 -17.9 8.02 Favored Glycine 0 C--N 1.313 -0.738 0 N-CA-C 110.704 -0.958 . . . . 54.22 110.704 -178.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -77.91 173.01 12.61 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 109.159 -0.682 . . . . 71.21 109.159 176.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 230' ' ' THR . . . . . 0.514 ' O ' HG13 ' A' ' 234' ' ' VAL . 74.7 p -94.21 163.73 13.33 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 108.312 -0.996 . . . . 70.03 108.312 178.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . 0.521 ' HB2' ' HB2' ' A' ' 178' ' ' ASP . 3.4 tm? -60.07 -38.67 83.57 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 109.778 -0.453 . . . . 74.35 109.778 178.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -62.52 -43.16 99.49 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.153 -0.476 . . . . 74.14 110.246 178.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -63.31 -48.59 77.42 Favored 'General case' 0 C--N 1.344 0.337 0 N-CA-C 113.113 0.783 . . . . 72.34 113.113 176.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.515 HG21 HG12 ' A' ' 195' ' ' ILE . 6.6 m -65.82 -33.59 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-O 121.272 0.558 . . . . 72.45 112.321 -174.607 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 60.2 m -74.08 -36.82 64.31 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.875 -0.787 . . . . 71.41 108.875 -175.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -61.09 -34.67 75.31 Favored 'General case' 0 CA--C 1.5 -0.948 0 CA-C-N 115.091 -0.959 . . . . 65.41 109.392 177.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 237' ' ' MET . . . . . 0.448 ' HG3' ' HA ' ' A' ' 234' ' ' VAL . 12.9 mtt -69.14 -46.91 66.46 Favored 'General case' 0 C--O 1.204 -1.321 0 N-CA-C 108.48 -0.933 . . . . 73.34 108.48 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 238' ' ' MET . . . . . 0.405 ' HG3' ' O ' ' A' ' 234' ' ' VAL . 62.1 mtt -61.33 -42.17 98.24 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.986 -0.552 . . . . 72.0 111.654 -176.69 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 87.5 t -64.2 -40.4 88.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 O-C-N 123.328 0.392 . . . . 75.35 110.458 178.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -69.6 -38.01 77.12 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.444 0.64 . . . . 73.41 110.365 178.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -85.6 21.4 1.83 Allowed 'General case' 0 C--O 1.202 -1.409 0 CA-C-N 115.522 -0.763 . . . . 73.12 112.076 -179.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 242' ' ' SER . . . . . 0.724 ' O ' ' HG ' ' A' ' 164' ' ' LEU . 29.4 p -64.75 -21.33 66.74 Favored 'General case' 0 C--O 1.208 -1.108 0 N-CA-C 109.619 -0.512 . . . . 71.33 109.619 172.517 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 47.4 t -62.76 -35.52 80.09 Favored 'General case' 0 CA--C 1.551 1.016 0 N-CA-C 108.85 -0.796 . . . . 72.32 108.85 173.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -177.14 106.87 0.06 Allowed 'General case' 0 C--O 1.246 0.902 0 C-N-CA 124.08 0.952 . . . . 64.01 111.277 177.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . 0.468 ' CD1' ' HG ' ' A' ' 172' ' ' LEU . 11.8 mt -86.67 129.52 34.84 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 115.364 -0.835 . . . . 74.23 111.025 179.481 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . 0.411 ' HB ' ' HA ' ' A' ' 222' ' ' ASN . 66.3 mt -118.62 113.72 42.66 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.618 0 N-CA-C 105.044 -2.206 . . . . 73.25 105.044 167.381 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 64.3 mt -122.22 135.52 62.05 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.257 0 CA-C-O 121.313 0.578 . . . . 73.01 111.699 -176.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.471 ' HA ' ' O ' ' A' ' 159' ' ' ARG . 58.3 m -112.14 118.29 34.94 Favored 'General case' 0 N--CA 1.416 -2.154 0 N-CA-C 108.251 -1.018 . . . . 75.33 108.251 175.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . 0.434 HG13 ' HA ' ' A' ' 218' ' ' VAL . 17.7 m -121.22 170.51 11.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 CA-C-O 121.436 0.636 . . . . 71.01 110.469 176.278 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . 0.336 43.0 mtpt -126.69 144.15 48.89 Favored Pre-proline 0 C--N 1.28 -2.435 0 CA-C-N 113.965 -1.471 . . . . 72.44 107.44 174.165 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo . . . . . 0 N--CA 1.424 -2.597 0 N-CA-C 108.035 -1.563 . . . . 71.44 108.035 167.632 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.238 0.493 0 N-CA-C 106.712 -1.588 . . . . 74.25 106.712 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 38.0 p -67.2 -32.92 74.31 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 116.553 2.057 . . . . 74.54 116.553 -172.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.453 ' HB3' ' HG2' ' A' ' 250' ' ' LYS 0.311 2.2 p-80 -96.87 140.17 31.82 Favored 'General case' 0 CA--C 1.505 -0.776 0 N-CA-C 116.043 1.868 . . . . 75.24 116.043 -173.394 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 57.9 ttt180 -126.77 144.56 50.91 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 114.135 -1.393 . . . . 75.14 109.284 176.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.568 ' HG3' ' OG1' ' A' ' 248' ' ' THR . 0.1 OUTLIER -90.23 114.29 26.27 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 108.201 -1.037 . . . . 63.11 108.201 179.282 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 29.7 m -109.21 136.38 45.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-O 120.733 0.301 . . . . 74.43 111.215 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -99.08 121.71 41.35 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-O 121.516 0.674 . . . . 74.44 110.073 178.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.431 ' HB2' ' HB3' ' A' ' 245' ' ' LEU . 18.6 mt -104.24 137.06 42.71 Favored 'General case' 0 N--CA 1.403 -2.806 0 N-CA-C 106.637 -1.616 . . . . 70.52 106.637 177.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 14.2 tp 69.67 99.82 0.06 Allowed 'General case' 0 C--N 1.288 -2.099 0 N-CA-C 114.264 1.209 . . . . 71.54 114.264 177.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 24.3 pttm -132.5 -0.7 3.55 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 114.386 -1.279 . . . . 70.31 108.184 169.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 22.5 t-80 -174.54 117.26 0.2 Allowed 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 114.402 -1.272 . . . . 64.33 108.801 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 123.66 60.91 0.19 Allowed Glycine 0 C--N 1.301 -1.384 0 C-N-CA 120.412 -0.899 . . . . 60.31 112.526 177.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 16.3 p -83.27 -4.18 58.18 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-O 121.195 0.521 . . . . 65.21 111.989 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -85.23 -38.8 18.51 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.971 -0.559 . . . . 61.1 109.845 178.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -80.76 153.91 73.12 Favored Pre-proline 0 N--CA 1.437 -1.09 0 CA-C-N 115.56 -0.746 . . . . 75.23 109.024 -179.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -68.91 153.36 72.8 Favored 'Trans proline' 0 C--O 1.247 0.949 0 C-N-CA 121.995 1.797 . . . . 61.4 110.688 174.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 89.5 mt -57.81 -31.85 67.0 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.452 -0.34 . . . . 75.35 111.863 179.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . 0.49 ' HA3' ' HA3' ' A' ' 204' ' ' GLY . . . 93.91 22.35 25.84 Favored Glycine 0 N--CA 1.429 -1.793 0 C-N-CA 120.115 -1.041 . . . . 61.14 114.169 173.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -160.18 154.1 22.97 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 117.74 0.77 . . . . 75.25 109.157 177.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -123.86 153.56 40.9 Favored 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 107.403 -1.332 . . . . 72.31 107.403 177.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 39.9 pt -113.73 166.62 7.39 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 CA-C-O 121.38 0.609 . . . . 72.53 111.021 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.48 ' HG2' ' HB3' ' A' ' 198' ' ' SER . 16.2 ptt180 -147.12 154.75 41.49 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 115.286 -0.87 . . . . 62.45 109.833 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -110.32 142.79 41.47 Favored 'General case' 0 C--N 1.29 -1.998 0 O-C-N 123.901 0.75 . . . . 73.23 109.69 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -159.48 160.89 31.76 Favored Glycine 0 C--N 1.289 -2.072 0 N-CA-C 108.898 -1.681 . . . . 70.02 108.898 177.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' THR . . . . . 0.411 HG21 ' HG2' ' A' ' 191' ' ' LYS . 0.6 OUTLIER -90.82 123.6 34.49 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.169 -1.419 . . . . 74.41 107.169 178.844 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' SER . . . . . 0.5 ' O ' ' HA ' ' A' ' 191' ' ' LYS . 22.8 t -103.1 126.3 50.21 Favored 'General case' 0 C--N 1.283 -2.302 0 C-N-CA 123.311 0.644 . . . . 72.12 109.619 -175.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.612 ' HA ' ' O ' ' A' ' 190' ' ' GLU . 7.3 p -104.72 122.45 57.78 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.214 0 C-N-CA 119.635 -0.826 . . . . 72.31 109.136 172.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 87.6 mtt180 -132.48 160.07 37.53 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 107.454 -1.313 . . . . 75.34 107.454 -176.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 90.6 t -89.56 118.98 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.796 0 N-CA-C 107.826 -1.176 . . . . 72.51 107.826 171.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 40.0 p -117.56 -174.88 2.71 Favored 'General case' 0 C--N 1.268 -2.971 0 CA-C-N 114.616 -1.175 . . . . 64.23 108.383 -177.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -64.64 -17.5 64.09 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.217 0.532 . . . . 64.24 109.612 175.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 18.4 m -92.08 -16.12 26.84 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-N 115.66 -0.7 . . . . 72.23 110.79 178.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 117.29 -154.27 16.81 Favored Glycine 0 CA--C 1.495 -1.219 0 N-CA-C 110.436 -1.065 . . . . 72.12 110.436 -178.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 5.0 mp -78.69 117.21 19.62 Favored 'General case' 0 CA--C 1.498 -1.04 0 N-CA-C 106.847 -1.538 . . . . 63.35 106.847 176.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . 0.612 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 9.2 tp10 -133.34 127.19 33.0 Favored 'General case' 0 C--N 1.288 -2.075 0 N-CA-C 109.052 -0.721 . . . . 62.02 109.052 -173.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.5 ' HA ' ' O ' ' A' ' 181' ' ' SER . 34.0 ttmt -100.23 129.14 46.21 Favored 'General case' 0 N--CA 1.426 -1.631 0 N-CA-C 106.771 -1.566 . . . . 73.22 106.771 178.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.44 158.6 37.88 Favored Pre-proline 0 C--N 1.307 -1.27 0 CA-C-O 118.899 -0.572 . . . . 62.53 110.153 -169.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -67.42 130.42 22.36 Favored 'Trans proline' 0 C--O 1.25 1.099 0 CA-C-N 119.941 1.015 . . . . 71.13 111.645 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -142.88 151.11 22.88 Favored Glycine 0 N--CA 1.412 -2.956 0 CA-C-N 115.393 -0.822 . . . . 72.31 111.357 -177.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 2.7 mp -104.13 136.91 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.286 0 N-CA-C 109.535 -0.543 . . . . 63.22 109.535 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -127.21 164.75 20.99 Favored 'General case' 0 C--N 1.28 -2.434 0 N-CA-C 107.393 -1.336 . . . . 74.33 107.393 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 42.6 mm -76.46 131.43 34.89 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 N-CA-C 106.896 -1.52 . . . . 64.14 106.896 175.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' SER . . . . . 0.48 ' HB3' ' HG2' ' A' ' 177' ' ' ARG . 75.7 p -100.92 -41.1 6.96 Favored 'General case' 0 C--N 1.287 -2.142 0 C-N-CA 118.612 -1.235 . . . . 75.22 111.092 -177.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 31.6 tpt180 -148.32 141.32 24.87 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.302 -0.999 . . . . 73.3 108.302 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 2.6 tt -122.25 123.58 41.78 Favored 'General case' 0 N--CA 1.421 -1.882 0 N-CA-C 106.672 -1.603 . . . . 74.34 106.672 178.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 36.5 t -105.85 126.76 29.87 Favored Pre-proline 0 C--N 1.307 -1.273 0 C-N-CA 122.559 0.344 . . . . 55.51 111.33 -172.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . 0.475 ' HA ' ' HG3' ' A' ' 207' ' ' GLU . 45.0 Cg_endo -70.82 128.51 15.15 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 122.395 2.063 . . . . 73.4 110.954 176.164 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 114.38 -18.04 18.36 Favored Glycine 0 N--CA 1.439 -1.102 0 N-CA-C 110.47 -1.052 . . . . 63.11 110.47 -177.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . 0.49 ' HA3' ' HA3' ' A' ' 173' ' ' GLY . . . -96.04 171.42 28.47 Favored Glycine 0 N--CA 1.433 -1.525 0 N-CA-C 110.517 -1.033 . . . . 70.14 110.517 178.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -65.22 -29.79 70.62 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 117.267 0.534 . . . . 74.43 112.084 -174.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -62.75 -44.41 96.27 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.996 -0.547 . . . . 62.43 110.97 178.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.475 ' HG3' ' HA ' ' A' ' 202' ' ' PRO . 2.9 tm-20 -75.9 -33.75 59.94 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.375 -0.972 . . . . 73.24 108.375 179.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 50.4 m -56.83 -42.48 79.68 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 116.298 -0.41 . . . . 74.41 110.803 177.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 13.9 t -73.34 -40.91 64.06 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 119.095 -1.042 . . . . 73.32 108.442 174.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 56.18 29.61 56.48 Favored Glycine 0 C--N 1.347 1.193 0 CA-C-N 115.908 -0.587 . . . . 74.3 113.24 177.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 68.2 mt -103.39 -12.67 17.04 Favored 'General case' 0 C--N 1.308 -1.228 0 O-C-N 122.674 -0.31 . . . . 71.31 110.299 -178.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -113.68 158.07 21.36 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 115.484 -0.78 . . . . 64.51 109.552 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -130.46 165.59 22.32 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 123.047 0.539 . . . . 73.34 110.157 179.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 34.5 m -63.69 -30.07 48.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 113.599 0.963 . . . . 74.01 113.599 -179.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -76.77 -15.06 59.85 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 116.203 -0.453 . . . . 72.21 111.703 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -68.17 147.58 52.07 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-O 121.64 0.733 . . . . 50.51 112.649 -175.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -108.59 133.94 52.03 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.638 -1.164 . . . . 64.41 111.27 -177.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 39.8 t -83.62 133.96 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-O 121.811 0.815 . . . . 71.31 111.2 -175.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 46.8 mm -102.97 -56.47 5.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 CA-C-N 114.656 -1.156 . . . . 75.13 110.996 -178.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -152.37 165.19 35.77 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.986 -0.552 . . . . 72.41 109.934 -175.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . 0.507 ' HA ' ' O ' ' A' ' 246' ' ' ILE . 8.9 p -134.8 123.88 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 CA-C-N 115.92 -0.582 . . . . 65.45 110.052 177.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . 0.418 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 12.8 t-20 65.44 13.52 8.9 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 125.241 1.416 . . . . 75.42 110.706 177.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 107.0 -9.4 39.69 Favored Glycine 0 N--CA 1.442 -0.933 0 C-N-CA 120.84 -0.695 . . . . 74.3 112.079 -178.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 64.4 mt -105.06 124.27 59.69 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 N-CA-C 110.13 -0.322 . . . . 72.22 110.13 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -57.2 142.58 42.36 Favored 'General case' 0 C--N 1.31 -1.126 0 C-N-CA 124.483 1.113 . . . . 65.11 112.6 -178.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 30.6 m -118.91 -1.68 8.99 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 CA-C-N 115.525 -0.761 . . . . 73.23 109.8 175.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -76.92 99.04 5.09 Favored 'General case' 0 N--CA 1.428 -1.546 0 CA-C-N 115.356 -0.838 . . . . 74.23 109.719 -177.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 118.9 -14.0 11.41 Favored Glycine 0 N--CA 1.435 -1.39 0 C-N-CA 120.839 -0.696 . . . . 73.14 111.729 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -76.97 -179.93 5.81 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 120.987 0.422 . . . . 75.3 110.654 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 50.6 p -95.53 162.73 13.51 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 108.187 -1.042 . . . . 70.45 108.187 177.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -63.59 -33.26 75.22 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 109.067 -0.716 . . . . 75.22 109.067 -178.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -63.42 -49.7 72.7 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.516 -0.311 . . . . 61.44 110.293 176.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' GLN . . . . . 0.556 ' O ' ' HG2' ' A' ' 237' ' ' MET . 47.9 mt-30 -57.28 -41.72 80.32 Favored 'General case' 0 CA--C 1.509 -0.625 0 N-CA-C 112.447 0.536 . . . . 75.5 112.447 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 10.2 m -74.3 -34.57 37.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 C-N-CA 120.764 -0.375 . . . . 75.32 111.399 -177.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 26.0 m -71.14 -38.04 72.27 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 108.368 -0.975 . . . . 74.02 108.368 178.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -59.86 -35.6 75.14 Favored 'General case' 0 C--O 1.243 0.746 0 CA-C-N 115.385 -0.825 . . . . 74.51 110.144 177.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' MET . . . . . 0.556 ' HG2' ' O ' ' A' ' 233' ' ' GLN . 17.3 mmt -59.78 -52.43 65.49 Favored 'General case' 0 C--O 1.199 -1.576 0 N-CA-C 108.065 -1.087 . . . . 73.43 108.065 175.293 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 63.4 mtt -61.57 -36.96 82.13 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.754 -1.112 . . . . 74.33 112.422 -175.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 83.9 t -68.49 -36.8 76.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-O 121.396 0.617 . . . . 74.43 110.287 176.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -74.48 -36.4 63.29 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.905 0.859 . . . . 74.42 110.11 179.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -87.75 22.13 2.39 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 114.945 -1.025 . . . . 75.11 110.607 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 25.5 p -59.86 -28.2 67.31 Favored 'General case' 0 CA--C 1.554 1.13 0 N-CA-C 113.691 0.997 . . . . 52.45 113.691 -177.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 48.7 m -85.55 -9.28 57.59 Favored 'General case' 0 C--N 1.318 -0.789 0 O-C-N 121.672 -0.642 . . . . 73.33 112.038 177.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 14.8 p30 -164.56 78.24 0.35 Allowed 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.524 0.678 . . . . 71.02 111.376 -176.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . 0.431 ' HB3' ' HB2' ' A' ' 163' ' ' LEU . 1.2 tt -85.54 101.89 13.06 Favored 'General case' 0 N--CA 1.422 -1.844 0 C-N-CA 118.721 -1.192 . . . . 75.21 108.059 -174.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . 0.507 ' O ' ' HA ' ' A' ' 221' ' ' VAL . 68.7 mt -104.7 116.15 47.96 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.319 0 C-N-CA 119.713 -0.795 . . . . 61.51 108.963 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 23.2 mt -118.53 136.91 54.2 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.257 0 CA-C-O 121.627 0.727 . . . . 74.34 111.477 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.568 ' OG1' ' HG3' ' A' ' 160' ' ' ARG . 39.0 m -107.74 119.34 39.16 Favored 'General case' 0 N--CA 1.405 -2.713 0 CA-C-N 115.073 -0.967 . . . . 72.53 108.573 177.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 27.1 m -129.29 159.32 41.45 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 O-C-N 123.282 0.364 . . . . 64.44 110.296 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . 0.453 ' HG2' ' HB3' ' A' ' 158' ' ' HIS 0.346 35.7 mtmt -124.09 142.26 39.33 Favored Pre-proline 0 CA--C 1.475 -1.919 0 N-CA-C 104.435 -2.431 . . . . 75.41 104.435 175.538 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -79.13 141.44 16.4 Favored 'Trans proline' 0 C--N 1.286 -2.747 0 C-N-CA 120.871 1.047 . . . . 63.11 111.364 176.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -66.82 -30.65 70.89 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.402 0.62 . . . . 53.53 110.341 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -92.06 20.46 5.84 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.202 -0.908 . . . . 72.35 109.024 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 14.7 mt-30 61.04 -178.48 0.11 Allowed 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 125.321 1.448 . . . . 71.34 112.767 -176.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 16.6 tpt180 . . . . . 0 C--N 1.31 -1.113 0 C-N-CA 119.585 -0.846 . . . . 74.42 110.513 -172.95 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 . . . . . 0 CA--C 1.509 -0.614 0 N-CA-C 109.249 -0.648 . . . . 71.4 109.249 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 47.1 p -65.61 -48.93 70.58 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 112.643 0.609 . . . . 72.55 112.643 -176.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.467 ' HB3' ' HG2' ' A' ' 250' ' ' LYS 0.374 2.3 p-80 -123.66 137.74 54.66 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 115.397 1.629 . . . . 70.23 115.397 177.353 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.53 ' O ' ' HA ' ' A' ' 248' ' ' THR . 3.7 ptp180 -125.25 144.96 50.21 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 113.575 -1.648 . . . . 75.53 108.944 -176.029 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.696 ' HB3' ' OG1' ' A' ' 248' ' ' THR . 37.0 ptt180 -117.27 119.25 34.58 Favored 'General case' 0 N--CA 1.426 -1.627 0 CA-C-O 121.901 0.858 . . . . 72.41 113.05 178.025 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.576 ' O ' ' HA ' ' A' ' 246' ' ' ILE . 26.6 m -102.78 135.02 42.12 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 CA-C-N 114.617 -1.174 . . . . 74.32 111.075 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.502 ' HG2' HG12 ' A' ' 246' ' ' ILE . 15.4 mtm180 -96.48 112.66 24.32 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 106.927 -1.508 . . . . 65.42 106.927 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 21.4 mt -99.34 134.23 42.5 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 109.52 -0.548 . . . . 75.44 109.52 -177.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.404 ' HB2' ' CD1' ' A' ' 172' ' ' LEU . 6.3 tt 77.38 101.86 0.07 Allowed 'General case' 0 C--N 1.318 -0.774 0 O-C-N 124.344 1.027 . . . . 72.15 111.893 174.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 57.7 pttt -129.61 6.86 5.22 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 114.504 -1.226 . . . . 74.12 108.047 173.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -144.3 97.66 3.08 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.712 -1.131 . . . . 75.25 110.323 -178.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 89.83 99.29 1.09 Allowed Glycine 0 C--O 1.21 -1.345 0 N-CA-C 111.352 -0.699 . . . . 64.33 111.352 176.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 17.2 t -94.56 -172.83 2.86 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 117.087 0.444 . . . . 73.23 109.804 -177.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 18.9 t70 72.91 -35.9 0.34 Allowed 'General case' 0 N--CA 1.497 1.918 0 C-N-CA 124.952 1.301 . . . . 74.13 112.437 -178.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 13.4 ptmm? -72.34 154.55 91.91 Favored Pre-proline 0 C--N 1.31 -1.149 0 C-N-CA 124.271 1.028 . . . . 72.22 111.789 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -57.7 154.06 39.33 Favored 'Trans proline' 0 C--O 1.258 1.494 0 C-N-CA 123.553 2.835 . . . . 63.33 112.55 178.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.435 ' HG ' ' CD1' ' A' ' 245' ' ' LEU . 2.9 mm? -91.03 -23.88 20.23 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.164 -0.926 . . . . 75.25 111.021 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . 0.414 ' HA3' ' HA3' ' A' ' 204' ' ' GLY . . . 89.24 43.97 5.15 Favored Glycine 0 N--CA 1.436 -1.346 0 C-N-CA 120.592 -0.813 . . . . 75.21 113.983 174.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -161.94 154.76 20.2 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.627 -1.249 . . . . 74.34 107.627 174.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -123.95 157.88 33.3 Favored 'General case' 0 C--N 1.282 -2.353 0 N-CA-C 108.533 -0.914 . . . . 74.52 108.533 177.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.72 160.52 27.28 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 N-CA-C 109.571 -0.529 . . . . 72.44 109.571 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.427 ' HG2' ' HB3' ' A' ' 198' ' ' SER . 10.1 ptp180 -132.21 154.64 49.38 Favored 'General case' 0 C--N 1.282 -2.355 0 CA-C-N 115.656 -0.702 . . . . 74.23 110.684 -178.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . 0.441 ' HB2' ' HG ' ' A' ' 231' ' ' LEU . 4.8 t70 -107.41 143.92 35.06 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 115.085 -0.961 . . . . 52.32 110.509 -179.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -164.92 179.79 39.35 Favored Glycine 0 N--CA 1.415 -2.715 0 N-CA-C 108.871 -1.692 . . . . 52.13 108.871 175.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' THR . . . . . 0.415 ' HB ' ' CG ' ' A' ' 191' ' ' LYS . 0.4 OUTLIER -89.99 122.34 32.91 Favored 'General case' 0 C--N 1.283 -2.301 0 CA-C-N 117.524 0.662 . . . . 74.0 111.024 175.667 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 47.3 t -99.5 113.18 25.4 Favored 'General case' 0 N--CA 1.414 -2.265 0 N-CA-C 107.87 -1.159 . . . . 64.31 107.87 177.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.656 ' HA ' ' O ' ' A' ' 190' ' ' GLU . 6.4 p -115.49 123.89 71.43 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.733 0 CA-C-O 121.404 0.621 . . . . 65.43 109.441 175.026 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -124.68 158.45 33.13 Favored 'General case' 0 C--N 1.279 -2.47 0 N-CA-C 107.539 -1.282 . . . . 73.54 107.539 -177.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 78.2 t -92.52 118.34 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.237 0 N-CA-C 106.895 -1.52 . . . . 73.13 106.895 169.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 67.2 p -111.11 -175.11 2.63 Favored 'General case' 0 C--N 1.272 -2.773 0 N-CA-C 107.938 -1.134 . . . . 72.34 107.938 -178.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -71.59 -12.68 61.48 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 121.279 0.561 . . . . 75.51 109.568 175.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 32.1 t -97.34 -13.89 21.61 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-N 115.693 -0.685 . . . . 73.23 110.663 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 126.85 -153.98 19.11 Favored Glycine 0 CA--C 1.495 -1.198 0 N-CA-C 110.787 -0.925 . . . . 74.14 110.787 177.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 5.2 mp -87.78 123.7 32.85 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 107.911 -1.144 . . . . 75.35 107.911 176.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . 0.656 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 45.1 mt-10 -131.28 119.26 21.52 Favored 'General case' 0 CA--C 1.454 -2.719 0 CA-C-O 121.115 0.484 . . . . 72.41 111.131 -177.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.415 ' CG ' ' HB ' ' A' ' 180' ' ' THR . 35.5 ttmt -103.21 131.69 50.04 Favored 'General case' 0 C--N 1.274 -2.688 0 CA-C-N 114.168 -1.378 . . . . 72.4 107.785 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -151.09 164.98 18.39 Favored Pre-proline 0 C--N 1.293 -1.878 0 N-CA-C 108.256 -1.016 . . . . 72.5 108.256 -178.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -55.19 132.27 51.3 Favored 'Trans proline' 0 C--N 1.358 1.04 0 C-N-CA 121.637 1.558 . . . . 75.02 109.846 174.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -143.93 138.65 8.18 Favored Glycine 0 N--CA 1.409 -3.106 0 N-CA-C 111.38 -0.688 . . . . 71.13 111.38 -178.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 2.7 mp -103.63 134.52 44.59 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.94 0 CA-C-O 121.605 0.717 . . . . 72.14 110.883 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -124.27 166.17 16.36 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 106.149 -1.797 . . . . 71.23 106.149 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 47.8 mm -79.08 131.27 34.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 107.562 -1.273 . . . . 75.31 107.562 177.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' SER . . . . . 0.427 ' HB3' ' HG2' ' A' ' 177' ' ' ARG . 82.3 p -101.64 -31.64 10.72 Favored 'General case' 0 C--N 1.287 -2.111 0 C-N-CA 118.633 -1.227 . . . . 43.13 112.752 -175.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 29.6 tpt180 -166.76 146.15 5.54 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 120.781 -0.368 . . . . 74.02 110.344 -175.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 82.9 mt -102.54 146.38 28.22 Favored 'General case' 0 CA--C 1.489 -1.381 0 N-CA-C 108.932 -0.766 . . . . 70.43 108.932 172.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 47.8 t -107.52 115.89 58.64 Favored Pre-proline 0 C--N 1.282 -2.337 0 N-CA-C 105.3 -2.111 . . . . 73.42 105.3 172.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . 0.431 ' HA ' ' HG3' ' A' ' 207' ' ' GLU . 11.5 Cg_endo -55.03 128.67 31.53 Favored 'Trans proline' 0 C--O 1.248 0.98 0 C-N-CA 122.335 2.023 . . . . 75.25 111.129 -177.118 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 99.05 -11.4 62.17 Favored Glycine 0 N--CA 1.439 -1.158 0 C-N-CA 120.6 -0.809 . . . . 71.32 111.719 -177.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . 0.414 ' HA3' ' HA3' ' A' ' 173' ' ' GLY . . . -74.82 166.36 54.85 Favored Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 121.032 -0.604 . . . . 75.21 111.597 178.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . 0.428 HD21 ' HA ' ' A' ' 172' ' ' LEU . 3.0 mm? -66.09 -34.02 77.11 Favored 'General case' 0 C--N 1.312 -1.036 0 C-N-CA 122.996 0.518 . . . . 73.34 111.641 -176.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -67.75 -42.43 81.83 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.522 0.677 . . . . 72.4 110.051 178.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.431 ' HG3' ' HA ' ' A' ' 202' ' ' PRO . 6.0 tm-20 -75.39 -34.49 61.09 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 114.915 -1.039 . . . . 72.14 108.982 -178.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 35.9 t -58.54 -47.34 84.54 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 123.786 0.834 . . . . 73.21 110.795 177.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 10.2 t -75.6 -35.67 60.48 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 120.004 -0.678 . . . . 71.15 109.446 177.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 74.17 16.56 79.64 Favored Glycine 0 N--CA 1.442 -0.905 0 CA-C-N 115.984 -0.553 . . . . 40.33 112.672 177.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 54.9 mt -99.19 -0.55 41.29 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 120.933 0.397 . . . . 64.44 110.449 -178.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 80.6 mt -109.79 131.7 54.83 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 115.187 -0.915 . . . . 74.23 108.941 174.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -130.7 155.9 45.83 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 109.102 -0.703 . . . . 62.12 109.102 177.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 31.2 m -62.16 -29.28 46.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-O 122.078 0.942 . . . . 72.0 112.773 -177.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -77.99 -14.06 59.66 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 115.533 -0.758 . . . . 74.33 111.782 -178.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -76.71 150.68 36.28 Favored 'General case' 0 C--O 1.244 0.786 0 N-CA-C 113.02 0.748 . . . . 53.13 113.02 -173.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -108.81 132.34 54.09 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.016 -0.993 . . . . 72.22 109.766 -178.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . 0.431 ' HA ' HG13 ' A' ' 249' ' ' VAL . 39.7 t -83.33 138.33 19.48 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 CA-C-O 121.488 0.661 . . . . 71.32 111.509 -176.053 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 46.0 mm -105.22 -53.16 7.13 Favored 'Isoleucine or valine' 0 C--O 1.246 0.875 0 CA-C-N 115.171 -0.922 . . . . 75.32 111.099 -178.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.464 ' CG ' ' HG1' ' A' ' 248' ' ' THR . 10.5 pt-20 -153.92 165.85 34.81 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 116.049 -0.523 . . . . 74.43 109.82 -175.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' A' ' 246' ' ' ILE . 8.3 p -135.19 122.97 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.749 0 CA-C-N 115.647 -0.706 . . . . 74.34 109.148 176.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . 0.523 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 12.2 t-20 68.73 5.52 4.98 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 125.083 1.353 . . . . 73.22 111.198 178.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 113.63 -14.15 22.51 Favored Glycine 0 N--CA 1.439 -1.149 0 N-CA-C 110.882 -0.887 . . . . 75.32 110.882 -178.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 65.7 mt -96.34 123.75 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.521 0 N-CA-C 109.1 -0.704 . . . . 71.24 109.1 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -58.05 153.01 15.42 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 123.684 0.794 . . . . 73.45 112.002 -177.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 35.9 m -129.59 2.47 2.58 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 CA-C-N 115.411 -0.813 . . . . 71.23 110.248 174.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -71.84 98.56 2.02 Favored 'General case' 0 N--CA 1.432 -1.372 0 CA-C-N 115.634 -0.712 . . . . 71.1 110.693 -178.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 121.12 -17.57 9.11 Favored Glycine 0 CA--C 1.489 -1.551 0 N-CA-C 110.378 -1.089 . . . . 44.1 110.378 178.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -83.5 163.21 20.61 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.122 -0.539 . . . . 73.24 111.333 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' THR . . . . . 0.443 ' H ' ' NE2' ' A' ' 233' ' ' GLN . 37.2 p -97.19 172.32 7.89 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.756 -0.657 . . . . 75.35 110.667 -176.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . 0.441 ' HG ' ' HB2' ' A' ' 178' ' ' ASP . 78.0 mt -56.65 -40.32 75.25 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 111.837 0.31 . . . . 64.11 111.837 177.152 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -56.8 -42.7 79.96 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 121.279 0.561 . . . . 73.34 110.132 179.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' GLN . . . . . 0.443 ' NE2' ' H ' ' A' ' 230' ' ' THR . 49.0 mt-30 -72.94 -47.71 43.19 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.961 -1.018 . . . . 71.21 112.339 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.444 ' O ' ' HG3' ' A' ' 238' ' ' MET . 16.9 m -70.86 -34.47 56.18 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 112.092 0.404 . . . . 51.21 112.092 -176.056 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 50.3 m -69.57 -35.3 75.24 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 109.429 -0.582 . . . . 75.14 109.429 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -60.73 -38.93 86.78 Favored 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 108.863 -0.792 . . . . 73.3 108.863 177.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 15.9 mmt -59.46 -50.17 74.95 Favored 'General case' 0 C--O 1.199 -1.563 0 CA-C-N 115.332 -0.849 . . . . 74.15 108.725 177.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' MET . . . . . 0.444 ' HG3' ' O ' ' A' ' 234' ' ' VAL . 63.0 mtt -61.8 -37.31 83.91 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.895 0.878 . . . . 74.44 112.259 -176.313 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 97.3 t -65.13 -40.32 88.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 121.19 0.519 . . . . 53.14 109.942 176.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -72.97 -37.0 67.21 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.613 0.721 . . . . 74.44 110.297 178.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -86.87 21.11 2.35 Favored 'General case' 0 C--O 1.202 -1.431 0 CA-C-N 115.603 -0.726 . . . . 71.45 111.905 -178.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 69.8 m -65.21 -22.88 66.95 Favored 'General case' 0 C--N 1.312 -1.022 0 C-N-CA 120.41 -0.516 . . . . 71.53 111.548 177.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 23.1 m -70.47 -24.38 62.86 Favored 'General case' 0 CA--C 1.554 1.11 0 CA-C-N 116.363 -0.381 . . . . 74.22 111.032 176.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -174.3 97.3 0.1 Allowed 'General case' 0 C--O 1.246 0.913 0 C-N-CA 124.363 1.065 . . . . 51.2 109.205 177.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . 0.435 ' CD1' ' HG ' ' A' ' 172' ' ' LEU . 2.4 tt -88.16 103.03 15.38 Favored 'General case' 0 N--CA 1.414 -2.273 0 N-CA-C 109.211 -0.662 . . . . 72.3 109.211 -173.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . 0.576 ' HA ' ' O ' ' A' ' 161' ' ' VAL . 69.7 mt -100.87 116.7 44.88 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.179 0 N-CA-C 109.37 -0.604 . . . . 72.0 109.37 -179.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 27.0 mt -120.94 132.54 70.18 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 CA-C-O 121.541 0.686 . . . . 71.12 112.331 178.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.696 ' OG1' ' HB3' ' A' ' 160' ' ' ARG . 37.0 m -104.19 122.8 46.11 Favored 'General case' 0 N--CA 1.414 -2.244 0 CA-C-N 114.291 -1.322 . . . . 72.14 108.603 177.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . 0.431 HG13 ' HA ' ' A' ' 218' ' ' VAL . 34.7 m -130.79 164.09 34.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 110.035 -0.357 . . . . 71.34 110.035 177.204 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . 0.467 ' HG2' ' HB3' ' A' ' 158' ' ' HIS 0.296 38.6 mtmt -124.39 141.73 38.36 Favored Pre-proline 0 CA--C 1.48 -1.721 0 N-CA-C 104.788 -2.301 . . . . 74.54 104.788 173.919 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -85.02 148.1 10.54 Favored 'Trans proline' 0 N--CA 1.411 -3.351 0 C-N-CA 120.573 0.848 . . . . 74.23 111.257 176.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -69.72 -30.97 68.71 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.974 0.893 . . . . 63.12 109.46 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -75.32 -27.58 59.32 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 114.635 -1.166 . . . . 63.43 110.468 178.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 62.11 108.93 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 114.553 1.316 . . . . 74.13 114.553 179.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 . . . . . 0 CA--C 1.499 -0.999 0 C-N-CA 125.069 1.348 . . . . 62.23 108.681 178.305 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.531 0.214 0 N-CA-C 106.472 -1.677 . . . . 74.12 106.472 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.432 HG21 ' H ' ' A' ' 255' ' ' ARG . 62.9 p -56.87 -35.14 68.57 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 113.921 1.082 . . . . 51.02 113.921 -171.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 4.7 m80 -80.54 130.32 35.06 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-O 121.658 0.742 . . . . 73.03 112.588 -174.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.427 ' O ' ' HA ' ' A' ' 248' ' ' THR . 18.8 tpp180 -107.29 141.41 38.68 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 107.218 -1.401 . . . . 72.35 107.218 177.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -114.96 113.15 23.75 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 108.657 -0.868 . . . . 75.12 108.657 175.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 17.7 m -129.08 137.86 56.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-O 120.868 0.366 . . . . 75.3 111.986 179.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 42.9 ttp180 -116.81 112.5 21.21 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 108.904 -0.776 . . . . 71.35 108.904 173.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 13.5 mt -102.56 138.83 38.96 Favored 'General case' 0 C--N 1.281 -2.386 0 N-CA-C 107.319 -1.363 . . . . 75.14 107.319 -175.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.501 HD13 ' H ' ' A' ' 168' ' ' SER . 0.7 OUTLIER 66.64 74.06 0.35 Allowed 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 108.263 -1.014 . . . . 74.31 108.263 174.542 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -98.4 -2.69 38.57 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.61 -0.723 . . . . 75.53 110.632 -176.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 32.3 m170 -95.64 -19.16 19.96 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 119.456 -0.898 . . . . 74.22 112.62 -177.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 71.34 68.88 1.51 Allowed Glycine 0 C--N 1.32 -0.335 0 C-N-CA 120.482 -0.866 . . . . 73.31 111.211 -177.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' SER . . . . . 0.501 ' H ' HD13 ' A' ' 164' ' ' LEU . 46.3 t -144.66 147.99 33.72 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 107.636 -1.246 . . . . 75.33 107.636 -178.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . 0.283 29.3 m-20 -84.8 69.59 10.73 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 122.607 1.194 . . . . 64.41 113.146 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.463 ' HB2' ' HZ1' ' A' ' 170' ' ' LYS . 0.0 OUTLIER -114.94 136.77 22.61 Favored Pre-proline 0 C--N 1.29 -2.009 0 CA-C-N 113.172 -1.831 . . . . 73.55 107.216 174.107 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -54.29 135.84 66.55 Favored 'Trans proline' 0 N--CA 1.479 0.672 0 C-N-CA 123.274 2.649 . . . . 64.31 113.38 -177.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.427 ' CD1' ' HB2' ' A' ' 164' ' ' LEU . 3.3 mm? -70.22 -39.77 74.91 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-O 121.201 0.524 . . . . 72.53 110.177 177.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . 0.436 ' HA3' ' HA3' ' A' ' 204' ' ' GLY . . . 90.53 25.15 26.48 Favored Glycine 0 N--CA 1.42 -2.368 0 CA-C-N 115.445 -0.798 . . . . 73.34 113.522 176.108 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -143.11 151.54 40.84 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 107.843 -1.169 . . . . 74.32 107.843 174.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -131.13 152.85 49.99 Favored 'General case' 0 CA--C 1.484 -1.588 0 CA-C-O 120.808 0.337 . . . . 74.11 110.227 178.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.425 ' HB ' ' CG2' ' A' ' 195' ' ' ILE . 0.2 OUTLIER -116.85 169.85 6.87 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.049 0 CA-C-N 115.66 -0.7 . . . . 63.53 112.219 -173.81 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.579 ' CG ' ' HB2' ' A' ' 198' ' ' SER . 11.8 ptt180 -148.51 156.02 41.91 Favored 'General case' 0 C--N 1.287 -2.133 0 C-N-CA 125.478 1.511 . . . . 75.34 109.841 -175.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -110.89 144.61 39.67 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 123.466 0.479 . . . . 73.25 110.856 179.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -162.44 171.68 38.35 Favored Glycine 0 N--CA 1.427 -1.901 0 N-CA-C 108.876 -1.69 . . . . 43.42 108.876 175.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' THR . . . . . 0.455 ' HB ' ' CG ' ' A' ' 191' ' ' LYS . 0.6 OUTLIER -86.76 123.85 32.37 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 118.172 0.986 . . . . 74.23 111.658 175.966 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 34.7 t -102.69 115.77 31.24 Favored 'General case' 0 N--CA 1.404 -2.768 0 N-CA-C 107.927 -1.138 . . . . 74.55 107.927 177.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.602 ' HA ' ' O ' ' A' ' 190' ' ' GLU . 3.7 p -112.69 126.3 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.75 0 N-CA-C 109.3 -0.63 . . . . 62.2 109.3 176.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -122.8 159.57 27.8 Favored 'General case' 0 C--N 1.29 -2.009 0 CA-C-N 115.307 -0.86 . . . . 73.4 108.748 -176.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 69.6 t -90.08 119.14 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.138 0 N-CA-C 107.313 -1.366 . . . . 73.43 107.313 171.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 46.2 p -116.83 -175.2 2.72 Favored 'General case' 0 C--N 1.266 -3.049 0 CA-C-N 114.359 -1.291 . . . . 75.21 107.936 -177.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -67.91 -14.64 63.13 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.284 0.564 . . . . 71.54 109.784 174.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 19.3 m -90.98 -18.05 25.3 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 115.557 -0.747 . . . . 74.43 110.373 178.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 116.58 -145.63 18.72 Favored Glycine 0 N--CA 1.436 -1.301 0 N-CA-C 109.211 -1.556 . . . . 75.11 109.211 -176.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 6.2 mp -80.81 118.7 22.55 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 117.953 0.877 . . . . 75.52 109.509 177.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . 0.602 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 38.9 tt0 -123.02 117.75 26.18 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.233 -1.025 . . . . 73.54 108.233 -175.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.455 ' CG ' ' HB ' ' A' ' 180' ' ' THR . 36.3 ttmt -105.51 133.31 50.47 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 109.071 -0.714 . . . . 74.3 109.071 -177.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . 0.401 HE21 ' HB2' ' A' ' 227' ' ' ALA . 11.3 pt20 -144.21 164.33 29.71 Favored Pre-proline 0 C--N 1.297 -1.705 0 N-CA-C 107.503 -1.295 . . . . 75.33 107.503 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -65.17 132.86 33.17 Favored 'Trans proline' 0 C--O 1.247 0.934 0 C-N-CA 121.102 1.201 . . . . 74.23 109.776 174.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -137.94 141.62 12.36 Favored Glycine 0 N--CA 1.414 -2.787 0 N-CA-C 110.533 -1.027 . . . . 51.51 110.533 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.482 ' HB ' ' CG1' ' A' ' 218' ' ' VAL . 3.4 mp -103.74 136.04 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.402 0 N-CA-C 109.272 -0.64 . . . . 74.11 109.272 179.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -128.1 167.6 16.53 Favored 'General case' 0 C--N 1.282 -2.326 0 N-CA-C 107.73 -1.211 . . . . 73.12 107.73 -177.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 58.5 mt -83.6 131.71 33.19 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 N-CA-C 109.334 -0.617 . . . . 74.23 109.334 174.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' SER . . . . . 0.579 ' HB2' ' CG ' ' A' ' 177' ' ' ARG . 29.6 t -110.18 -27.91 8.9 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.557 -0.714 . . . . 70.32 112.691 -177.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -147.63 134.53 20.19 Favored 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 120.037 -0.665 . . . . 73.45 109.583 -176.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 1.4 tt -116.18 124.81 51.23 Favored 'General case' 0 N--CA 1.414 -2.239 0 N-CA-C 106.51 -1.663 . . . . 73.53 106.51 179.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 96.6 t -94.14 124.69 55.21 Favored Pre-proline 0 C--N 1.306 -1.284 0 N-CA-C 110.472 -0.196 . . . . 74.42 110.472 -178.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -60.59 126.29 19.5 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.459 2.106 . . . . 42.31 110.782 177.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 98.91 -6.66 60.31 Favored Glycine 0 N--CA 1.435 -1.405 0 C-N-CA 120.777 -0.725 . . . . 53.53 112.614 -178.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . 0.436 ' HA3' ' HA3' ' A' ' 173' ' ' GLY . . . -79.53 169.54 53.62 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.5 -0.857 . . . . 65.41 112.285 179.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -65.06 -34.63 78.87 Favored 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 122.723 0.409 . . . . 73.14 110.653 -178.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -60.3 -43.59 96.16 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.64 -0.709 . . . . 75.34 110.809 178.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -75.6 -35.89 60.44 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.257 -0.429 . . . . 75.23 110.324 179.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 37.9 t -56.61 -42.71 79.24 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.817 -0.629 . . . . 72.33 110.35 179.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 10.2 t -82.86 -35.73 26.02 Favored 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 120.454 -0.498 . . . . 72.33 109.912 176.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 75.18 5.74 77.43 Favored Glycine 0 C--O 1.217 -0.925 0 CA-C-N 116.202 -0.453 . . . . 65.13 112.986 177.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 67.0 mt -87.05 -11.79 49.26 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 120.813 0.339 . . . . 61.41 110.894 -177.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 4.3 mp -109.65 133.73 52.77 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 120.351 -0.54 . . . . 74.15 109.63 177.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -131.09 166.0 22.03 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 108.762 -0.829 . . . . 60.34 108.762 176.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 30.2 m -59.97 -28.06 40.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 113.324 0.861 . . . . 62.45 113.324 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 20.1 m-80 -71.95 -15.97 62.08 Favored 'General case' 0 C--N 1.312 -1.022 0 O-C-N 122.038 -0.414 . . . . 74.34 110.769 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.479 ' HA ' ' HA ' ' A' ' 251' ' ' PRO . 5.0 m-20 -71.18 132.35 44.87 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 114.426 1.269 . . . . 72.51 114.426 -174.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -105.19 131.12 53.06 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 126.328 1.851 . . . . 65.24 108.497 -179.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . 0.482 ' CG1' ' HB ' ' A' ' 195' ' ' ILE . 11.4 p -83.5 134.55 26.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-O 122.034 0.921 . . . . 75.51 112.58 -175.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 39.7 mm -99.49 -49.01 11.67 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 CA-C-N 114.303 -1.317 . . . . 63.32 110.645 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -160.12 160.51 33.08 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.192 -0.458 . . . . 75.03 110.775 -176.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' A' ' 246' ' ' ILE . 7.5 p -129.7 122.67 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.03 0 O-C-N 123.736 0.647 . . . . 71.55 109.675 175.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . 0.426 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 2.8 m-20 58.89 22.08 9.84 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 125.519 1.528 . . . . 73.22 113.651 -178.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 105.85 -13.87 45.57 Favored Glycine 0 N--CA 1.429 -1.83 0 C-N-CA 120.323 -0.941 . . . . 61.12 113.062 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 60.9 mt -97.9 123.85 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.046 0 C-N-CA 120.705 -0.398 . . . . 73.33 110.458 -179.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -51.64 133.7 30.52 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 124.711 1.257 . . . . 74.34 111.608 177.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . 0.411 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 29.7 m -115.74 11.47 7.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 CA-C-O 122.217 1.008 . . . . 73.2 108.338 172.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . 0.401 ' HB2' HE21 ' A' ' 192' ' ' GLN . . . -68.44 97.11 0.73 Allowed 'General case' 0 N--CA 1.422 -1.869 0 CA-C-N 113.468 -1.697 . . . . 72.43 111.142 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 95.56 10.3 56.92 Favored Glycine 0 C--N 1.307 -1.038 0 CA-C-N 115.609 -0.723 . . . . 64.4 112.88 174.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -82.94 178.31 8.22 Favored 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 120.506 -0.478 . . . . 73.34 109.83 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 41.1 p -87.82 157.64 18.95 Favored 'General case' 0 N--CA 1.421 -1.889 0 N-CA-C 107.135 -1.432 . . . . 61.53 107.135 174.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . 0.433 ' O ' HG21 ' A' ' 234' ' ' VAL . 1.3 tt -64.83 -32.72 74.55 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 108.1 -1.074 . . . . 74.43 108.1 -177.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -64.35 -38.99 92.98 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.411 -0.358 . . . . 75.21 110.487 177.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -60.34 -49.36 77.9 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 112.026 0.38 . . . . 73.43 112.026 175.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.433 HG21 ' O ' ' A' ' 231' ' ' LEU . 5.4 m -67.92 -32.76 57.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-O 121.242 0.544 . . . . 72.31 111.739 -176.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 88.2 m -74.18 -37.15 64.04 Favored 'General case' 0 CA--C 1.498 -1.044 0 CA-C-N 115.567 -0.742 . . . . 64.05 109.084 -176.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -60.39 -34.12 73.44 Favored 'General case' 0 CA--C 1.507 -0.682 0 CA-C-N 115.433 -0.803 . . . . 63.0 109.153 177.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 8.9 mtt -69.24 -44.88 71.09 Favored 'General case' 0 C--O 1.2 -1.527 0 N-CA-C 108.686 -0.857 . . . . 74.31 108.686 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' MET . . . . . 0.415 ' HG3' ' O ' ' A' ' 234' ' ' VAL . 64.7 mtt -60.12 -31.76 70.36 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.979 -0.555 . . . . 74.52 111.681 -178.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 91.0 t -74.12 -41.9 51.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-O 121.327 0.584 . . . . 74.23 110.004 176.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -70.51 -35.59 73.28 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.386 0.612 . . . . 75.01 111.106 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -84.71 21.95 1.43 Allowed 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 115.357 -0.838 . . . . 64.45 112.546 -178.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 67.9 m -59.41 -23.46 62.65 Favored 'General case' 0 C--O 1.207 -1.159 0 N-CA-C 113.08 0.771 . . . . 71.3 113.08 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 22.6 p -68.42 -33.93 75.09 Favored 'General case' 0 CA--C 1.552 1.033 0 O-C-N 121.76 -0.588 . . . . 53.04 111.861 177.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 -159.68 100.59 1.46 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.931 1.292 . . . . 54.31 108.264 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -86.55 103.1 14.74 Favored 'General case' 0 C--O 1.21 -1.012 0 N-CA-C 108.443 -0.947 . . . . 62.4 108.443 -178.123 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . 0.426 ' HB ' ' HA ' ' A' ' 222' ' ' ASN . 61.9 mt -103.78 116.32 47.34 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 N-CA-C 108.731 -0.84 . . . . 74.24 108.731 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 18.2 mt -121.99 134.54 64.97 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.155 0 CA-C-O 121.801 0.81 . . . . 72.23 112.318 178.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.427 ' HA ' ' O ' ' A' ' 159' ' ' ARG . 46.3 m -106.54 114.96 29.38 Favored 'General case' 0 N--CA 1.411 -2.413 0 N-CA-C 107.771 -1.196 . . . . 73.31 107.771 175.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . 0.446 ' HB ' ' HB3' ' A' ' 216' ' ' ASP . 18.1 m -123.27 161.42 25.13 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 CA-C-O 121.004 0.43 . . . . 75.44 110.354 177.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 16.0 ptmt -137.1 135.75 20.12 Favored Pre-proline 0 C--N 1.278 -2.54 0 N-CA-C 107.024 -1.473 . . . . 75.21 107.024 173.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . 0.479 ' HA ' ' HA ' ' A' ' 216' ' ' ASP . 38.8 Cg_exo -61.1 136.87 67.84 Favored 'Trans proline' 0 N--CA 1.449 -1.136 0 C-N-CA 121.088 1.192 . . . . 73.31 111.249 178.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -54.83 -48.92 72.23 Favored 'General case' 0 CA--C 1.493 -1.236 0 N-CA-C 108.301 -1.0 . . . . 70.23 108.301 175.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -85.51 82.86 8.11 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 106.263 -1.754 . . . . 60.23 106.263 168.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -64.42 -178.14 0.35 Allowed 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 113.24 -1.8 . . . . 61.22 114.392 -171.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . 0.432 ' H ' HG21 ' A' ' 157' ' ' THR . 40.4 ttp180 . . . . . 0 N--CA 1.446 -0.634 0 CA-C-N 114.029 -1.441 . . . . 73.03 111.361 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 . . . . . 0 C--O 1.236 0.351 0 N-CA-C 108.905 -0.776 . . . . 74.2 108.905 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 35.2 p -87.89 -50.86 6.17 Favored 'General case' 0 N--CA 1.441 -0.925 0 C-N-CA 122.287 0.235 . . . . 63.31 111.149 -178.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -84.64 128.93 34.86 Favored 'General case' 0 C--O 1.214 -0.814 0 N-CA-C 109.105 -0.702 . . . . 72.01 109.105 174.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.574 ' O ' ' HA ' ' A' ' 248' ' ' THR . 24.5 tpt180 -119.69 128.88 54.22 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 120.202 -0.599 . . . . 70.14 110.342 176.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 32.1 ptt180 -115.85 114.24 24.46 Favored 'General case' 0 C--N 1.284 -2.243 0 CA-C-N 114.944 -1.025 . . . . 73.32 109.91 178.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 17.4 m -117.0 138.91 46.12 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 CA-C-N 115.459 -0.791 . . . . 73.41 111.097 -178.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.531 ' HD2' ' N ' ' A' ' 162' ' ' ARG . 1.3 mpt_? -107.76 111.99 24.44 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 106.589 -1.634 . . . . 74.22 106.589 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.459 ' HB2' ' HB3' ' A' ' 245' ' ' LEU . 29.1 mt -98.85 139.6 34.28 Favored 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 123.793 0.837 . . . . 74.43 111.72 -171.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.51 ' HB2' ' CD1' ' A' ' 172' ' ' LEU . 9.9 tp 90.75 20.71 0.03 OUTLIER 'General case' 0 CA--C 1.515 -0.379 0 C-N-CA 125.75 1.62 . . . . 55.35 113.179 173.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . 0.26 60.5 pttt -97.83 56.74 1.28 Allowed 'General case' 0 C--N 1.282 -2.346 0 C-N-CA 117.867 -1.533 . . . . 74.12 112.072 177.07 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 46.9 t-80 -153.94 20.72 0.51 Allowed 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 106.288 -1.745 . . . . 73.33 106.288 178.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 159.02 -152.28 23.32 Favored Glycine 0 N--CA 1.428 -1.848 0 N-CA-C 107.518 -2.233 . . . . 72.41 107.518 -175.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 31.9 t -168.66 161.83 11.52 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 117.894 0.847 . . . . 62.44 109.113 178.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 31.2 t70 70.09 -32.36 0.23 Allowed 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 125.516 1.526 . . . . 72.52 114.263 177.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.526 ' HB2' ' HZ3' ' A' ' 170' ' ' LYS . 0.0 OUTLIER -71.64 150.41 93.44 Favored Pre-proline 0 C--N 1.302 -1.474 0 N-CA-C 111.876 0.324 . . . . 72.02 111.876 -177.137 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -53.46 150.32 27.45 Favored 'Trans proline' 0 C--N 1.357 0.996 0 C-N-CA 123.872 3.048 . . . . 72.32 113.806 -179.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.51 ' CD1' ' HB2' ' A' ' 164' ' ' LEU . 2.3 mm? -84.85 -27.64 26.59 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.455 -0.793 . . . . 74.32 110.036 -178.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 84.08 49.57 4.69 Favored Glycine 0 N--CA 1.433 -1.516 0 CA-C-N 115.633 -0.712 . . . . 51.52 113.923 175.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -156.75 161.37 39.8 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 108.079 -1.082 . . . . 74.3 108.079 175.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -130.01 157.12 43.23 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 108.589 -0.893 . . . . 73.54 108.589 175.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.507 ' H ' HD11 ' A' ' 176' ' ' ILE . 0.2 OUTLIER -126.21 169.06 18.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 CA-C-O 121.595 0.712 . . . . 75.32 111.278 -179.04 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.459 ' HG2' ' HB2' ' A' ' 198' ' ' SER . 16.9 ptt180 -157.79 155.44 29.8 Favored 'General case' 0 C--N 1.281 -2.385 0 CA-C-N 114.698 -1.137 . . . . 74.01 108.922 -175.184 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -112.77 158.26 20.32 Favored 'General case' 0 C--N 1.298 -1.664 0 C-N-CA 119.402 -0.919 . . . . 71.53 110.815 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -156.38 -179.23 31.23 Favored Glycine 0 C--N 1.29 -2.001 0 N-CA-C 107.726 -2.15 . . . . 54.51 107.726 176.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' THR . . . . . 0.405 ' CG2' ' HG2' ' A' ' 191' ' ' LYS . 0.2 OUTLIER -112.25 122.95 49.17 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 118.996 1.398 . . . . 75.42 108.178 179.63 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' SER . . . . . 0.435 ' O ' ' HA ' ' A' ' 191' ' ' LYS . 20.2 t -100.98 130.01 46.91 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 108.547 -0.909 . . . . 44.23 108.547 -176.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.513 ' HA ' ' O ' ' A' ' 190' ' ' GLU . 7.2 p -106.64 119.25 55.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 C-N-CA 119.318 -0.953 . . . . 75.3 110.153 175.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -125.02 160.77 28.24 Favored 'General case' 0 CA--C 1.479 -1.756 0 CA-C-N 115.048 -0.978 . . . . 74.54 108.812 -175.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 84.3 t -90.19 118.68 35.93 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.048 0 N-CA-C 107.576 -1.268 . . . . 72.44 107.576 170.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 54.7 p -113.04 -174.49 2.46 Favored 'General case' 0 C--N 1.273 -2.748 0 CA-C-N 114.629 -1.169 . . . . 74.44 107.991 -179.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -62.86 -21.13 65.74 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.042 0.448 . . . . 73.32 110.128 176.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 25.0 m -90.26 -18.82 24.96 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-N 115.989 -0.55 . . . . 55.45 111.021 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 123.46 -147.14 16.61 Favored Glycine 0 CA--C 1.491 -1.411 0 N-CA-C 110.278 -1.129 . . . . 60.35 110.278 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 4.9 mp -81.82 118.16 22.68 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.454 -0.943 . . . . 63.53 108.454 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . 0.513 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 38.4 tt0 -131.57 121.65 24.76 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 109.528 -0.545 . . . . 73.32 109.528 -172.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 182' ' ' VAL . 33.5 ttmt -93.35 128.57 39.44 Favored 'General case' 0 N--CA 1.426 -1.626 0 N-CA-C 106.821 -1.548 . . . . 71.22 106.821 178.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.33 151.82 34.53 Favored Pre-proline 0 C--N 1.299 -1.627 0 CA-C-O 118.956 -0.545 . . . . 74.34 109.645 -168.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -61.56 130.23 30.88 Favored 'Trans proline' 0 C--O 1.243 0.774 0 C-N-CA 121.339 1.359 . . . . 75.22 112.879 -176.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -135.86 142.42 13.71 Favored Glycine 0 N--CA 1.411 -2.984 0 N-CA-C 108.586 -1.805 . . . . 75.24 108.586 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.44 ' HB ' ' CG1' ' A' ' 218' ' ' VAL . 3.0 mp -104.17 138.06 30.37 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.526 0 C-N-CA 120.204 -0.598 . . . . 73.12 110.224 -178.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -122.98 166.68 14.68 Favored 'General case' 0 C--N 1.283 -2.314 0 N-CA-C 108.292 -1.003 . . . . 75.24 108.292 -177.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . 0.473 ' HB ' ' HA ' ' A' ' 214' ' ' VAL . 50.3 mm -78.49 131.21 34.96 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.265 0 N-CA-C 108.382 -0.97 . . . . 74.32 108.382 177.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' SER . . . . . 0.459 ' HB2' ' HG2' ' A' ' 177' ' ' ARG . 7.7 t -96.98 -32.43 12.02 Favored 'General case' 0 C--N 1.286 -2.178 0 O-C-N 121.703 -0.623 . . . . 72.31 112.408 -178.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -167.83 148.89 5.27 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.774 -0.194 . . . . 75.21 110.881 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 73.7 mt -102.84 146.05 28.86 Favored 'General case' 0 CA--C 1.495 -1.158 0 N-CA-C 108.599 -0.889 . . . . 74.02 108.599 170.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 59.5 t -109.14 114.3 58.1 Favored Pre-proline 0 C--N 1.28 -2.445 0 N-CA-C 106.606 -1.627 . . . . 72.33 106.606 171.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . 0.455 ' HA ' ' HG3' ' A' ' 207' ' ' GLU . 33.4 Cg_exo -59.16 128.93 29.41 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.309 2.006 . . . . 61.4 110.807 -179.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 102.17 -11.03 57.05 Favored Glycine 0 N--CA 1.442 -0.94 0 N-CA-C 110.806 -0.918 . . . . 75.23 110.806 -175.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -90.27 161.4 28.88 Favored Glycine 0 N--CA 1.439 -1.103 0 N-CA-C 110.33 -1.108 . . . . 61.12 110.33 177.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -57.24 -38.16 73.38 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 123.685 0.794 . . . . 73.23 111.946 -176.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -62.31 -44.52 96.32 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.315 0.579 . . . . 75.03 110.796 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.455 ' HG3' ' HA ' ' A' ' 202' ' ' PRO . 4.3 tm-20 -75.68 -35.8 60.25 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 115.72 -0.673 . . . . 71.42 110.063 179.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 50.9 m -60.13 -41.15 92.03 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 122.512 0.325 . . . . 62.35 111.021 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 9.3 t -76.94 -36.53 56.49 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 120.06 -0.656 . . . . 73.42 109.334 175.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 70.65 11.49 68.96 Favored Glycine 0 N--CA 1.444 -0.83 0 CA-C-N 115.81 -0.632 . . . . 73.22 112.99 176.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 57.0 mt -95.55 5.97 50.16 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 121.518 0.675 . . . . 73.21 109.71 -178.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 98.9 mt -113.71 131.01 56.33 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 114.485 -1.234 . . . . 71.52 108.227 172.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -132.53 157.84 43.67 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 108.738 -0.838 . . . . 71.51 108.738 176.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . 0.473 ' HA ' ' HB ' ' A' ' 197' ' ' ILE . 14.7 m -60.92 -30.94 48.47 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 N-CA-C 113.23 0.826 . . . . 74.01 113.23 -175.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -78.69 -14.12 59.46 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 112.914 0.709 . . . . 72.35 112.914 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -69.8 142.75 53.12 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.662 0.616 . . . . 74.41 112.662 -178.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -108.66 131.36 54.97 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.927 -1.033 . . . . 65.41 109.579 -176.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . 0.44 ' CG1' ' HB ' ' A' ' 195' ' ' ILE . 9.8 p -83.14 143.82 11.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-O 121.893 0.854 . . . . 73.4 112.172 -176.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 37.8 mm -108.14 -51.42 7.13 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 C-N-CA 124.719 1.208 . . . . 74.43 111.26 -178.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -155.27 160.26 40.66 Favored 'General case' 0 C--O 1.247 0.945 0 CA-C-N 116.441 -0.345 . . . . 74.33 110.877 -177.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' A' ' 246' ' ' ILE . 7.5 p -132.38 121.03 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 O-C-N 123.775 0.672 . . . . 71.13 110.397 174.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 67.48 12.1 8.72 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.52 1.528 . . . . 74.53 110.672 176.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 110.11 -10.6 31.57 Favored Glycine 0 N--CA 1.432 -1.578 0 CA-C-N 115.421 -0.808 . . . . 62.15 112.589 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 64.4 mt -96.9 126.2 49.69 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.165 0 N-CA-C 108.35 -0.982 . . . . 70.33 108.35 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -65.47 141.62 58.43 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 121.431 0.634 . . . . 73.31 110.482 -178.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . 0.504 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 27.2 m -117.54 -1.88 9.5 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 CA-C-N 115.66 -0.7 . . . . 61.1 110.721 178.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -79.66 96.39 6.19 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 115.775 -0.648 . . . . 73.12 109.826 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 124.58 -14.57 7.66 Favored Glycine 0 C--N 1.305 -1.146 0 N-CA-C 110.688 -0.965 . . . . 64.0 110.688 -178.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -83.55 171.8 12.99 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.299 -1.0 . . . . 73.3 108.299 177.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' THR . . . . . 0.475 ' O ' HG13 ' A' ' 234' ' ' VAL . 81.7 p -95.68 170.95 8.97 Favored 'General case' 0 N--CA 1.434 -1.248 0 N-CA-C 108.691 -0.855 . . . . 63.24 108.691 179.038 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -61.79 -37.19 83.43 Favored 'General case' 0 N--CA 1.424 -1.736 0 N-CA-C 110.145 -0.317 . . . . 65.3 110.145 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -63.71 -47.92 79.2 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.738 -0.467 . . . . 70.4 109.738 178.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -60.34 -43.48 96.4 Favored 'General case' 0 C--O 1.222 -0.35 0 N-CA-C 113.73 1.011 . . . . 75.11 113.73 178.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.504 ' CG1' ' HB ' ' A' ' 226' ' ' VAL . 12.7 m -73.22 -33.94 42.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-O 121.375 0.607 . . . . 75.44 112.072 -175.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 85.9 m -74.98 -35.59 62.05 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 115.418 -0.81 . . . . 74.44 109.49 -174.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -61.74 -33.11 73.46 Favored 'General case' 0 C--O 1.244 0.805 0 CA-C-N 115.75 -0.659 . . . . 73.12 109.538 177.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 13.6 mtt -68.09 -47.56 67.92 Favored 'General case' 0 C--O 1.209 -1.051 0 N-CA-C 107.835 -1.172 . . . . 75.45 107.835 179.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 64.7 mtt -59.01 -37.16 76.25 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.402 -0.817 . . . . 72.24 111.329 -178.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 92.2 t -69.46 -44.91 79.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 CA-C-N 116.308 -0.405 . . . . 71.11 110.782 177.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -69.72 -38.14 76.78 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.173 0.511 . . . . 75.53 110.96 -178.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -82.01 21.1 0.91 Allowed 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 115.525 -0.761 . . . . 74.25 112.45 -178.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 42.8 t -59.19 -28.32 66.52 Favored 'General case' 0 CA--C 1.559 1.324 0 CA-C-O 121.158 0.504 . . . . 72.21 111.04 178.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 20.2 m -67.29 -28.61 68.16 Favored 'General case' 0 CA--C 1.552 1.052 0 N-CA-C 111.896 0.332 . . . . 62.43 111.896 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -161.99 83.82 0.58 Allowed 'General case' 0 C--O 1.249 1.034 0 N-CA-C 107.079 -1.452 . . . . 64.31 107.079 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . 0.459 ' HB3' ' HB2' ' A' ' 163' ' ' LEU . 1.3 tt -85.95 103.42 14.64 Favored 'General case' 0 C--O 1.2 -1.548 0 C-N-CA 119.87 -0.732 . . . . 73.13 109.484 -173.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . 0.472 HG12 ' HG3' ' A' ' 162' ' ' ARG . 74.1 mt -105.25 116.71 49.59 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.22 0 N-CA-C 109.469 -0.567 . . . . 74.02 109.469 178.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 25.5 mt -120.05 134.33 63.91 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 CA-C-O 121.27 0.557 . . . . 74.25 111.674 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.574 ' HA ' ' O ' ' A' ' 159' ' ' ARG . 90.8 m -108.3 119.83 40.64 Favored 'General case' 0 N--CA 1.417 -2.114 0 CA-C-N 114.939 -1.028 . . . . 74.42 108.486 174.071 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 26.7 m -124.18 164.39 22.52 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.865 0 N-CA-C 108.43 -0.952 . . . . 60.02 108.43 174.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.66 136.58 13.01 Favored Pre-proline 0 C--N 1.264 -3.112 0 CA-C-N 115.449 -0.796 . . . . 74.44 109.916 173.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -50.91 145.57 23.99 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 122.643 2.229 . . . . 72.33 110.962 179.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -48.22 -44.81 33.41 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 113.731 1.011 . . . . 64.32 113.731 -172.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -99.39 7.51 45.44 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 113.507 0.928 . . . . 65.33 113.507 -175.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -111.91 -170.88 1.74 Allowed 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.806 -0.442 . . . . 75.33 109.806 175.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 89.3 mtm180 . . . . . 0 CA--C 1.501 -0.907 0 CA-C-O 118.364 -0.827 . . . . 74.34 109.801 -176.974 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.469 0.502 0 N-CA-C 112.22 0.452 . . . . 73.44 112.22 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.47 ' HA ' ' OE1' ' A' ' 254' ' ' GLN . 34.9 p -73.54 -69.96 0.4 Allowed 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 121.341 0.591 . . . . 52.32 111.548 -176.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -90.07 129.93 36.31 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.892 -0.781 . . . . 73.41 108.892 173.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.445 ' O ' ' HA ' ' A' ' 248' ' ' THR . 23.5 tpp180 -112.07 132.93 54.54 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 108.72 -0.844 . . . . 74.23 108.72 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 82.7 mtt180 -109.49 115.48 30.01 Favored 'General case' 0 C--N 1.278 -2.529 0 CA-C-N 115.708 -0.678 . . . . 62.24 111.439 176.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.405 ' CG1' ' HB2' ' A' ' 211' ' ' LEU . 18.6 m -118.94 138.19 50.46 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.219 0 CA-C-N 114.778 -1.101 . . . . 74.31 109.971 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.51 ' HG3' HG12 ' A' ' 246' ' ' ILE . 4.8 mpt_? -110.12 112.14 23.94 Favored 'General case' 0 N--CA 1.415 -2.199 0 N-CA-C 107.769 -1.197 . . . . 75.22 107.769 177.179 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 9.6 mt -96.96 118.53 33.58 Favored 'General case' 0 N--CA 1.409 -2.502 0 N-CA-C 107.523 -1.288 . . . . 73.04 107.523 -176.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 12.9 tp 80.58 83.95 0.05 OUTLIER 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 122.38 1.086 . . . . 62.43 112.95 177.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -135.47 16.85 3.38 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 105.962 -1.866 . . . . 71.15 105.962 173.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 51.6 t-80 -96.36 -13.49 23.21 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 113.418 -1.719 . . . . 72.22 110.768 -174.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 76.46 67.11 1.73 Allowed Glycine 0 CA--C 1.492 -1.399 0 N-CA-C 109.598 -1.401 . . . . 53.33 109.598 -177.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 50.2 m -139.43 153.19 47.54 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-O 120.802 0.334 . . . . 65.42 110.356 -175.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -107.29 -9.93 15.93 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.955 -0.566 . . . . 63.32 110.908 -178.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.74 153.23 91.41 Favored Pre-proline 0 N--CA 1.44 -0.969 0 CA-C-N 116.619 -0.264 . . . . 73.24 110.696 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -46.25 150.18 2.2 Favored 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 124.368 3.379 . . . . 73.33 114.893 -178.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -67.93 -29.14 68.14 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.913 -1.039 . . . . 73.32 111.373 -177.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . 0.437 ' HA3' ' HA3' ' A' ' 204' ' ' GLY . . . 84.51 37.8 10.39 Favored Glycine 0 N--CA 1.433 -1.518 0 N-CA-C 114.575 0.59 . . . . 55.23 114.575 174.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -159.46 152.62 22.15 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 108.733 -0.84 . . . . 74.54 108.733 173.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -132.51 146.22 51.76 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 109.312 -0.625 . . . . 64.34 109.312 179.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.421 ' HB ' ' CG2' ' A' ' 195' ' ' ILE . 0.2 OUTLIER -111.04 170.34 3.54 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.634 0 CA-C-N 115.67 -0.695 . . . . 71.54 111.599 -175.397 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.502 ' CG ' ' HB2' ' A' ' 198' ' ' SER . 25.5 ptt180 -147.42 155.57 42.07 Favored 'General case' 0 C--N 1.279 -2.49 0 C-N-CA 124.972 1.309 . . . . 75.43 109.242 -177.017 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -117.89 151.21 37.85 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-O 121.32 0.581 . . . . 74.32 111.163 -175.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -167.87 -162.13 19.07 Favored Glycine 0 N--CA 1.426 -2.022 0 N-CA-C 109.439 -1.464 . . . . 64.41 109.439 176.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.2 p -100.41 132.03 46.01 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 121.598 0.713 . . . . 61.24 112.322 176.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 33.6 t -111.15 113.52 26.09 Favored 'General case' 0 N--CA 1.409 -2.525 0 N-CA-C 107.483 -1.303 . . . . 63.11 107.483 173.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.607 ' HA ' ' O ' ' A' ' 190' ' ' GLU . 5.2 p -109.75 119.11 58.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 N-CA-C 108.578 -0.897 . . . . 63.33 108.578 173.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 90.8 mtt180 -125.0 160.67 28.45 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-N 115.3 -0.863 . . . . 75.41 109.18 -174.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.501 ' HA ' ' O ' ' A' ' 188' ' ' GLY . 71.3 t -82.26 119.88 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.606 0 N-CA-C 108.257 -1.016 . . . . 73.41 108.257 170.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 36.2 p -132.15 -174.1 3.34 Favored 'General case' 0 C--N 1.271 -2.831 0 CA-C-N 113.869 -1.514 . . . . 75.14 109.126 -173.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -64.97 -18.74 65.53 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.221 0.534 . . . . 62.54 110.198 174.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 45.8 m -87.34 -13.18 44.27 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 116.193 -0.458 . . . . 70.11 110.144 176.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.501 ' O ' ' HA ' ' A' ' 184' ' ' VAL . . . 105.81 -123.22 7.42 Favored Glycine 0 CA--C 1.475 -2.462 0 N-CA-C 107.056 -2.417 . . . . 74.34 107.056 -175.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 6.3 mp -92.11 121.35 33.58 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 107.64 -1.244 . . . . 74.34 107.64 172.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . 0.607 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 40.4 tt0 -128.86 117.68 21.44 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 108.839 -0.8 . . . . 73.21 108.839 -174.139 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.425 ' HG3' ' HB ' ' A' ' 182' ' ' VAL . 33.9 ttmt -100.97 125.74 47.58 Favored 'General case' 0 N--CA 1.426 -1.651 0 N-CA-C 107.912 -1.144 . . . . 74.34 107.912 -178.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -141.11 162.04 50.17 Favored Pre-proline 0 C--N 1.269 -2.922 0 N-CA-C 107.944 -1.132 . . . . 73.23 107.944 -177.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -57.88 131.57 44.62 Favored 'Trans proline' 0 N--CA 1.447 -1.25 0 C-N-CA 120.935 1.09 . . . . 73.42 109.476 175.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -135.82 138.1 9.66 Favored Glycine 0 CA--C 1.463 -3.218 0 N-CA-C 110.127 -1.189 . . . . 62.13 110.127 -177.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.543 HG12 HG21 ' A' ' 234' ' ' VAL . 3.3 mp -105.92 138.07 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.538 0 CA-C-O 121.301 0.572 . . . . 74.35 109.832 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -127.22 166.94 16.78 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 106.837 -1.542 . . . . 74.4 106.837 -178.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . 0.43 ' HB ' ' HA ' ' A' ' 214' ' ' VAL . 45.1 mt -85.0 131.69 33.47 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.335 0 CA-C-O 121.055 0.455 . . . . 64.5 109.846 178.093 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' SER . . . . . 0.502 ' HB2' ' CG ' ' A' ' 177' ' ' ARG . 14.1 t -101.2 -50.06 3.9 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 112.484 0.55 . . . . 52.34 112.484 -178.158 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 40.8 ttp-105 -139.44 132.79 30.04 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 109.573 -0.529 . . . . 72.2 109.573 -176.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 2.6 tt -117.75 130.38 56.28 Favored 'General case' 0 N--CA 1.42 -1.941 0 N-CA-C 107.038 -1.468 . . . . 64.44 107.038 -178.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 45.1 t -108.64 127.31 27.64 Favored Pre-proline 0 C--N 1.316 -0.886 0 N-CA-C 112.036 0.384 . . . . 73.22 112.036 -171.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . 0.48 ' HA ' ' HG3' ' A' ' 207' ' ' GLU . 34.4 Cg_endo -66.79 143.23 66.41 Favored 'Trans proline' 0 C--O 1.245 0.865 0 C-N-CA 122.432 2.088 . . . . 73.0 110.999 175.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 92.24 -9.9 75.36 Favored Glycine 0 N--CA 1.442 -0.959 0 N-CA-C 111.074 -0.811 . . . . 74.33 111.074 -177.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . 0.437 ' HA3' ' HA3' ' A' ' 173' ' ' GLY . . . -94.44 167.42 27.39 Favored Glycine 0 N--CA 1.435 -1.37 0 N-CA-C 110.472 -1.051 . . . . 61.41 110.472 178.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -66.72 -29.7 69.75 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 117.104 0.452 . . . . 72.02 111.675 -175.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -62.38 -46.28 89.33 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.636 0.731 . . . . 71.55 109.788 176.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.48 ' HG3' ' HA ' ' A' ' 202' ' ' PRO . 3.6 tm-20 -71.58 -32.62 68.27 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.513 -0.767 . . . . 75.13 110.667 179.15 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 44.7 m -55.78 -37.02 68.01 Favored 'General case' 0 CA--C 1.546 0.805 0 O-C-N 123.284 0.365 . . . . 75.22 110.967 178.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 8.9 t -87.49 -41.0 13.83 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 119.466 -0.894 . . . . 70.33 110.561 176.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 66.23 9.09 47.35 Favored Glycine 0 CA--C 1.531 1.051 0 N-CA-C 114.504 0.561 . . . . 71.44 114.504 177.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.405 ' HB2' ' CG1' ' A' ' 161' ' ' VAL . 69.1 mt -82.27 -18.03 43.85 Favored 'General case' 0 CA--C 1.503 -0.862 0 CA-C-O 121.119 0.485 . . . . 71.5 110.959 -178.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -108.99 149.02 29.84 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 108.884 -0.784 . . . . 64.24 108.884 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -129.97 166.11 20.76 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 109.502 -0.555 . . . . 74.25 109.502 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . 0.43 ' HA ' ' HB ' ' A' ' 197' ' ' ILE . 32.6 m -63.22 -29.79 48.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 N-CA-C 113.044 0.757 . . . . 73.15 113.044 -179.075 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . 0.468 ' O ' ' HB2' ' A' ' 252' ' ' ALA . 10.0 p30 -69.84 -15.31 63.08 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 122.019 -0.426 . . . . 74.43 111.669 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.464 ' HB3' ' HB ' ' A' ' 249' ' ' VAL . 8.4 m-20 -69.78 152.89 44.08 Favored 'General case' 0 C--O 1.247 0.971 0 N-CA-C 113.918 1.081 . . . . 71.51 113.918 -175.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -112.49 134.43 54.02 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 125.804 1.642 . . . . 74.5 108.324 -179.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . 0.41 ' HA ' HG13 ' A' ' 249' ' ' VAL . 9.9 p -86.32 146.19 6.75 Favored 'Isoleucine or valine' 0 C--O 1.245 0.847 0 CA-C-O 121.903 0.859 . . . . 73.1 112.321 -174.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 34.2 mm -113.0 -58.71 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 CA-C-N 114.536 -1.211 . . . . 75.13 111.285 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -150.35 158.89 44.65 Favored 'General case' 0 C--O 1.243 0.76 0 CA-C-N 116.8 -0.182 . . . . 72.21 110.523 -177.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 13.6 p -132.21 126.33 55.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 N-CA-C 109.079 -0.712 . . . . 73.43 109.079 177.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . 0.401 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 8.3 t-20 64.4 18.94 11.6 Favored 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 124.98 1.312 . . . . 53.32 110.108 176.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 102.8 -17.09 53.73 Favored Glycine 0 N--CA 1.436 -1.306 0 CA-C-N 115.858 -0.61 . . . . 70.23 112.322 -179.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 65.6 mt -98.97 127.02 52.03 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.09 0 CA-C-O 121.032 0.444 . . . . 73.43 109.977 -178.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -62.09 140.06 58.42 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-O 121.884 0.849 . . . . 75.23 112.833 -177.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . 0.419 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 16.3 m -118.13 3.56 7.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-N 114.986 -1.006 . . . . 74.51 110.272 176.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -79.15 101.95 8.21 Favored 'General case' 0 N--CA 1.422 -1.833 0 CA-C-N 115.176 -0.92 . . . . 73.2 109.544 178.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 118.31 -11.83 12.73 Favored Glycine 0 C--N 1.309 -0.927 0 C-N-CA 120.895 -0.669 . . . . 73.1 111.794 178.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -81.15 172.78 13.25 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 108.846 -0.798 . . . . 75.53 108.846 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' THR . . . . . 0.415 ' O ' HG13 ' A' ' 234' ' ' VAL . 72.5 p -88.77 168.2 12.67 Favored 'General case' 0 N--CA 1.433 -1.303 0 N-CA-C 108.198 -1.038 . . . . 65.32 108.198 178.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . 0.407 HD21 HG12 ' A' ' 176' ' ' ILE . 3.2 tm? -62.68 -36.3 82.45 Favored 'General case' 0 N--CA 1.426 -1.654 0 N-CA-C 109.249 -0.649 . . . . 62.44 109.249 179.006 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -67.3 -47.47 70.47 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.517 -0.473 . . . . 43.24 109.826 178.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -59.85 -38.41 82.02 Favored 'General case' 0 C--N 1.349 0.55 0 N-CA-C 113.27 0.841 . . . . 72.41 113.27 177.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.543 HG21 HG12 ' A' ' 195' ' ' ILE . 16.3 m -74.18 -36.15 42.83 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.458 0 C-N-CA 119.308 -0.957 . . . . 74.43 111.518 -179.139 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 39.5 m -68.61 -35.92 77.97 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 108.924 -0.769 . . . . 74.5 108.924 179.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -57.87 -41.12 81.78 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 115.716 -0.674 . . . . 43.14 109.908 175.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 13.6 mmt -58.77 -49.69 76.73 Favored 'General case' 0 C--O 1.204 -1.319 0 N-CA-C 108.242 -1.021 . . . . 70.32 108.242 177.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' MET . . . . . 0.43 ' HG3' ' O ' ' A' ' 234' ' ' VAL . 60.4 mtt -63.77 -35.6 81.14 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.904 -1.044 . . . . 75.51 112.8 -174.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 84.4 t -70.37 -38.11 73.03 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-O 121.092 0.472 . . . . 71.45 109.851 177.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -71.63 -36.66 70.81 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.507 0.67 . . . . 73.35 110.518 178.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -89.22 21.59 3.19 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 115.463 -0.79 . . . . 74.44 111.276 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 46.0 p -64.83 -23.16 67.15 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 113.479 0.918 . . . . 74.2 113.479 -178.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 67.0 m -79.09 -18.39 53.43 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 119.439 -0.905 . . . . 62.52 111.434 177.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -166.6 92.39 0.46 Allowed 'General case' 0 C--O 1.252 1.186 0 CA-C-O 121.813 0.816 . . . . 70.24 112.227 179.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 11.7 mt -85.29 102.94 13.79 Favored 'General case' 0 C--O 1.19 -2.067 0 CA-C-N 115.933 -0.576 . . . . 73.54 112.013 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . 0.51 HG12 ' HG3' ' A' ' 162' ' ' ARG . 88.7 mt -96.68 114.3 33.22 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.844 0 N-CA-C 106.078 -1.823 . . . . 71.15 106.078 172.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 83.5 mt -122.93 135.61 62.43 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 CA-C-O 121.505 0.669 . . . . 73.21 111.967 -176.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.445 ' HA ' ' O ' ' A' ' 159' ' ' ARG . 46.9 m -107.13 114.9 29.24 Favored 'General case' 0 N--CA 1.414 -2.258 0 CA-C-N 114.901 -1.045 . . . . 74.44 108.581 176.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . 0.464 ' HB ' ' HB3' ' A' ' 216' ' ' ASP . 31.3 m -124.96 151.9 30.92 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 N-CA-C 109.423 -0.584 . . . . 73.45 109.423 175.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 9.5 ptmt -127.54 141.67 41.66 Favored Pre-proline 0 C--N 1.269 -2.892 0 N-CA-C 107.635 -1.246 . . . . 74.33 107.635 178.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . 0.442 ' HG2' ' NE2' ' A' ' 254' ' ' GLN . 63.8 Cg_exo -55.55 148.24 54.44 Favored 'Trans proline' 0 CA--C 1.546 1.086 0 C-N-CA 121.913 1.742 . . . . 73.34 111.795 178.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . 0.468 ' HB2' ' O ' ' A' ' 215' ' ' ASN . . . -44.07 -38.82 3.81 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 115.524 1.676 . . . . 75.43 115.524 -172.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -118.16 14.18 13.92 Favored 'General case' 0 C--N 1.282 -2.346 0 N-CA-C 112.148 0.425 . . . . 74.14 112.148 -174.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' GLN . . . . . 0.499 ' HG2' ' H ' ' A' ' 255' ' ' ARG . 7.5 tt0 -106.63 -172.01 2.0 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 107.971 -1.122 . . . . 70.3 107.971 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . 0.499 ' H ' ' HG2' ' A' ' 254' ' ' GLN . 73.3 ttt180 . . . . . 0 C--N 1.31 -1.132 0 N-CA-C 109.227 -0.657 . . . . 75.42 109.227 -178.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 . . . . . 0 CA--C 1.511 -0.555 0 N-CA-C 109.585 -0.524 . . . . 71.5 109.585 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 68.0 p -91.22 -36.93 13.64 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 121.698 0.761 . . . . 62.51 109.671 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -125.41 152.02 45.4 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 115.475 -0.784 . . . . 73.21 109.683 176.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 -137.78 129.35 28.19 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 108.134 -1.061 . . . . 71.2 108.134 174.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 35.6 ptt180 -112.66 119.64 38.81 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-O 121.659 0.742 . . . . 71.33 109.983 177.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.618 ' O ' ' HA ' ' A' ' 246' ' ' ILE . 27.5 m -114.21 139.15 41.5 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.3 0 CA-C-N 114.882 -1.053 . . . . 73.43 112.122 -175.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.466 ' HG2' HG12 ' A' ' 246' ' ' ILE . 44.8 mtm180 -99.15 112.29 24.47 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 106.891 -1.522 . . . . 72.14 106.891 178.097 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.485 ' HB2' ' HB3' ' A' ' 245' ' ' LEU . 22.1 mt -104.58 139.12 39.91 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 109.503 -0.554 . . . . 73.04 109.503 -177.245 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 25.4 tp 75.92 90.28 0.08 Allowed 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 113.455 0.909 . . . . 74.01 113.455 172.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 59.1 pttt -112.27 -12.1 13.64 Favored 'General case' 0 C--N 1.285 -2.207 0 CA-C-N 114.939 -1.028 . . . . 74.44 109.752 175.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 46.0 t-80 -144.53 113.57 6.87 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 108.155 -1.054 . . . . 74.01 108.155 179.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 159.4 -101.42 0.2 Allowed Glycine 0 N--CA 1.438 -1.193 0 C-N-CA 120.298 -0.953 . . . . 71.43 112.545 -178.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 35.1 t 64.75 35.61 8.65 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 122.143 0.973 . . . . 62.3 108.638 -176.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -158.03 -44.84 0.06 Allowed 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 114.309 -1.314 . . . . 64.33 109.153 -175.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 60.3 pttt -91.68 139.71 24.98 Favored Pre-proline 0 C--N 1.304 -1.406 0 CA-C-N 114.909 -1.041 . . . . 75.35 111.436 -177.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -57.08 152.42 44.55 Favored 'Trans proline' 0 C--O 1.249 1.028 0 C-N-CA 122.866 2.377 . . . . 75.14 111.592 177.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.438 ' HG ' ' CD1' ' A' ' 245' ' ' LEU . 3.2 mm? -69.24 -28.39 66.29 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.881 -0.6 . . . . 71.02 112.558 -176.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . 0.403 ' HA3' ' HA3' ' A' ' 204' ' ' GLY . . . 94.61 30.62 8.4 Favored Glycine 0 N--CA 1.428 -1.836 0 C-N-CA 119.534 -1.317 . . . . 75.2 112.897 178.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -154.98 154.66 32.89 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 107.654 -1.239 . . . . 74.31 107.654 175.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -126.5 157.45 38.68 Favored 'General case' 0 C--N 1.272 -2.788 0 N-CA-C 107.625 -1.25 . . . . 74.41 107.625 175.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.474 HD11 ' HE2' ' A' ' 238' ' ' MET . 30.8 pt -122.94 164.16 20.72 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.02 0 CA-C-O 121.605 0.717 . . . . 74.23 112.424 -178.134 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.422 ' HG2' ' HB3' ' A' ' 198' ' ' SER . 4.0 ptp180 -139.39 154.73 47.87 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 114.238 -1.347 . . . . 75.2 108.18 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -121.44 143.11 49.42 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 108.917 -0.771 . . . . 73.14 108.917 176.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -156.26 -146.18 4.39 Favored Glycine 0 N--CA 1.415 -2.758 0 N-CA-C 109.425 -1.47 . . . . 73.1 109.425 178.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' THR . . . . . 0.503 ' HB ' ' CG ' ' A' ' 191' ' ' LYS . 1.3 p -108.74 127.32 53.9 Favored 'General case' 0 C--N 1.28 -2.45 0 N-CA-C 112.695 0.628 . . . . 62.11 112.695 179.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 28.7 t -110.36 120.26 41.85 Favored 'General case' 0 N--CA 1.413 -2.319 0 N-CA-C 106.951 -1.5 . . . . 73.15 106.951 175.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.49 ' HA ' ' O ' ' A' ' 190' ' ' GLU . 7.7 p -117.61 119.05 60.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 109.09 -0.707 . . . . 64.41 109.09 176.082 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -128.06 160.28 32.45 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 115.753 -0.658 . . . . 74.14 109.327 -175.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 78.2 t -82.92 119.44 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.805 0 N-CA-C 107.345 -1.354 . . . . 74.52 107.345 171.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 49.0 p -119.0 -175.44 2.91 Favored 'General case' 0 C--N 1.261 -3.26 0 CA-C-N 114.684 -1.144 . . . . 74.23 108.239 -178.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -69.4 -9.56 54.09 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-O 121.382 0.611 . . . . 74.14 109.701 174.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 31.8 m -103.47 -3.58 25.19 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 115.639 -0.71 . . . . 74.45 110.654 177.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 105.68 -155.61 16.81 Favored Glycine 0 CA--C 1.498 -1.003 0 N-CA-C 110.271 -1.131 . . . . 52.41 110.271 179.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 5.6 mp -84.02 118.61 24.16 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 108.608 -0.886 . . . . 71.24 108.608 176.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . 0.49 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 42.6 tt0 -132.22 124.67 29.42 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.912 -0.773 . . . . 75.32 108.912 -176.079 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.503 ' CG ' ' HB ' ' A' ' 180' ' ' THR . 36.2 ttmt -96.41 125.59 41.01 Favored 'General case' 0 N--CA 1.417 -2.09 0 N-CA-C 108.305 -0.998 . . . . 64.45 108.305 -178.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -140.92 164.1 38.28 Favored Pre-proline 0 C--N 1.287 -2.117 0 N-CA-C 108.946 -0.761 . . . . 60.51 108.946 -176.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -55.93 132.38 51.64 Favored 'Trans proline' 0 C--O 1.248 1.018 0 C-N-CA 121.642 1.561 . . . . 74.14 111.0 175.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -141.14 147.52 19.13 Favored Glycine 0 CA--C 1.471 -2.691 0 N-CA-C 110.7 -0.96 . . . . 73.25 110.7 -178.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 2.9 mp -104.24 142.17 18.3 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 CA-C-O 121.295 0.569 . . . . 73.33 110.132 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -137.07 164.42 28.45 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 107.244 -1.391 . . . . 75.21 107.244 -178.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . 0.456 ' HB ' ' HA ' ' A' ' 214' ' ' VAL . 48.6 mm -76.26 127.82 37.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 107.747 -1.205 . . . . 75.45 107.747 176.402 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' SER . . . . . 0.422 ' HB3' ' HG2' ' A' ' 177' ' ' ARG . 82.9 p -99.92 -38.88 8.43 Favored 'General case' 0 C--N 1.29 -1.994 0 C-N-CA 119.862 -0.735 . . . . 75.43 111.196 -175.045 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -150.43 139.4 20.98 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 108.809 -0.811 . . . . 74.01 108.809 -177.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 1.1 tt -111.59 132.45 54.55 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 107.395 -1.335 . . . . 64.4 107.395 -179.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 61.1 t -104.98 118.46 56.07 Favored Pre-proline 0 C--N 1.312 -1.054 0 CA-C-O 120.626 0.25 . . . . 63.35 111.453 -176.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . 0.474 ' HA ' ' HG2' ' A' ' 207' ' ' GLU . 37.8 Cg_exo -62.23 136.96 63.09 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 122.627 2.218 . . . . 72.44 110.866 176.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 96.55 -22.01 42.54 Favored Glycine 0 N--CA 1.439 -1.134 0 C-N-CA 121.12 -0.562 . . . . 75.04 112.253 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . 0.403 ' HA3' ' HA3' ' A' ' 173' ' ' GLY . . . -80.54 -176.18 49.98 Favored Glycine 0 N--CA 1.44 -1.067 0 C-N-CA 120.966 -0.635 . . . . 72.24 112.417 -179.047 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -67.87 -41.87 82.17 Favored 'General case' 0 N--CA 1.426 -1.668 0 C-N-CA 122.91 0.484 . . . . 73.41 110.754 -178.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -64.02 -34.2 77.48 Favored 'General case' 0 C--O 1.22 -0.481 0 N-CA-C 113.139 0.792 . . . . 63.34 113.139 -176.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.474 ' HG2' ' HA ' ' A' ' 202' ' ' PRO . 11.8 tp10 -75.61 -33.08 60.52 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-O 121.724 0.773 . . . . 71.44 108.971 179.221 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 19.3 t -65.86 -24.71 66.93 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.954 -1.021 . . . . 73.2 110.802 -178.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 2.4 m -69.18 -40.45 78.09 Favored 'General case' 0 N--CA 1.415 -2.212 0 CA-C-N 115.914 -0.585 . . . . 73.5 111.867 -171.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 70.02 24.21 76.63 Favored Glycine 0 C--O 1.225 -0.42 0 N-CA-C 111.012 -0.835 . . . . 75.4 111.012 -176.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 65.6 mt -140.72 -8.95 1.06 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 122.963 0.505 . . . . 71.12 111.053 -175.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 67.9 mt -109.48 131.22 55.27 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 115.888 -0.596 . . . . 71.44 110.583 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -134.15 166.23 23.24 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.727 -1.212 . . . . 74.11 107.727 175.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . 0.456 ' HA ' ' HB ' ' A' ' 197' ' ' ILE . 31.3 m -66.52 -30.8 50.96 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 N-CA-C 113.074 0.768 . . . . 71.21 113.074 -179.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 46.7 m-80 -75.15 -14.5 60.56 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 113.706 1.002 . . . . 72.34 113.706 -177.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.428 ' HB3' ' HB ' ' A' ' 249' ' ' VAL . 5.3 m-20 -63.74 131.59 48.37 Favored 'General case' 0 C--O 1.246 0.877 0 CA-C-O 121.172 0.51 . . . . 65.21 112.282 -179.034 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -97.55 140.85 31.36 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.462 -0.79 . . . . 75.52 109.48 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 5.2 p -81.86 145.56 8.55 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 CA-C-O 121.621 0.724 . . . . 73.3 112.229 -174.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 44.4 mm -115.96 -60.85 2.71 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 115.618 -0.719 . . . . 72.43 110.874 178.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -152.36 154.83 36.42 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 109.136 -0.69 . . . . 75.21 109.136 -176.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 44.2 t -128.94 122.91 57.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 108.466 -0.939 . . . . 44.14 108.466 179.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 65.7 20.35 11.52 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.137 1.375 . . . . 72.51 109.523 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 97.37 -15.2 62.58 Favored Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 115.243 -0.889 . . . . 73.53 111.975 -178.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 63.0 mt -92.67 123.77 44.88 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.747 0 N-CA-C 109.044 -0.724 . . . . 71.54 109.044 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -57.39 142.38 43.96 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.521 0.677 . . . . 74.41 112.139 -178.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . 0.509 ' HA ' ' CG ' ' A' ' 229' ' ' LYS . 15.6 m -120.93 10.46 6.21 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.845 0 CA-C-N 115.555 -0.748 . . . . 64.44 111.083 175.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -74.3 101.34 4.0 Favored 'General case' 0 N--CA 1.426 -1.657 0 CA-C-N 115.035 -0.984 . . . . 65.52 109.588 177.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 109.69 -1.57 30.53 Favored Glycine 0 CA--C 1.496 -1.121 0 C-N-CA 120.886 -0.673 . . . . 71.35 111.707 177.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . 0.509 ' CG ' ' HA ' ' A' ' 226' ' ' VAL . 71.9 mmtt -82.21 158.77 23.44 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.18 -0.674 . . . . 75.04 109.18 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 67.3 p -82.66 171.49 13.97 Favored 'General case' 0 N--CA 1.409 -2.512 0 C-N-CA 119.299 -0.96 . . . . 71.51 109.437 177.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -66.59 -35.48 80.3 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 108.578 -0.897 . . . . 73.33 108.578 -179.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -65.13 -41.22 95.02 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.581 -0.736 . . . . 73.14 109.698 178.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -61.34 -47.16 87.15 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.481 -0.781 . . . . 61.32 112.507 176.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 19.8 m -69.63 -33.74 58.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 C-N-CA 120.211 -0.596 . . . . 70.42 111.918 -177.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 90.4 m -64.86 -35.7 81.98 Favored 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 109.694 -0.484 . . . . 64.25 109.694 177.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -63.39 -35.84 81.76 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.279 -0.419 . . . . 74.52 110.125 176.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 16.8 mmt -58.08 -52.75 64.24 Favored 'General case' 0 C--O 1.201 -1.453 0 N-CA-C 107.814 -1.18 . . . . 71.3 107.814 174.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' MET . . . . . 0.474 ' HE2' HD11 ' A' ' 176' ' ' ILE . 66.6 mtt -58.21 -35.28 71.41 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.633 -1.167 . . . . 74.03 112.049 -175.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 94.5 t -71.96 -45.98 61.78 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-O 120.832 0.349 . . . . 72.24 110.615 177.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -68.01 -34.61 76.83 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.508 0.671 . . . . 74.31 111.076 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -89.76 21.84 3.36 Favored 'General case' 0 C--O 1.198 -1.633 0 CA-C-N 115.311 -0.859 . . . . 73.34 110.578 -179.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 25.2 t -60.63 -23.78 65.01 Favored 'General case' 0 CA--C 1.563 1.461 0 N-CA-C 112.149 0.426 . . . . 73.05 112.149 -178.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 6.9 p -81.07 -14.01 58.22 Favored 'General case' 0 CA--C 1.558 1.262 0 N-CA-C 112.641 0.608 . . . . 74.23 112.641 178.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -173.77 98.55 0.11 Allowed 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.908 1.283 . . . . 72.25 108.356 173.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . 0.485 ' HB3' ' HB2' ' A' ' 163' ' ' LEU . 1.2 tt -86.36 101.82 13.45 Favored 'General case' 0 N--CA 1.413 -2.305 0 N-CA-C 107.701 -1.222 . . . . 74.42 107.701 -176.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . 0.618 ' HA ' ' O ' ' A' ' 161' ' ' VAL . 73.5 mt -104.07 116.12 47.26 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 C-N-CA 120.163 -0.615 . . . . 74.04 109.812 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 91.7 mt -122.05 131.36 73.31 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.892 0 C-N-CA 120.151 -0.62 . . . . 74.5 110.085 176.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 56.3 m -96.77 114.95 26.63 Favored 'General case' 0 N--CA 1.412 -2.369 0 N-CA-C 107.545 -1.28 . . . . 71.44 107.545 174.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . 0.428 ' HB ' ' HB3' ' A' ' 216' ' ' ASP . 21.7 m -117.89 169.12 8.89 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.117 0 N-CA-C 109.098 -0.705 . . . . 71.02 109.098 176.069 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 15.5 ptmt -134.0 129.45 20.07 Favored Pre-proline 0 C--N 1.28 -2.456 0 CA-C-N 115.454 -0.793 . . . . 74.01 110.181 176.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -68.41 148.44 73.49 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 C-N-CA 121.738 1.626 . . . . 75.31 108.86 173.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -56.09 -44.45 79.03 Favored 'General case' 0 CA--C 1.499 -1.003 0 CA-C-O 121.408 0.623 . . . . 74.31 110.518 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -97.19 83.63 3.36 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 108.206 -1.035 . . . . 74.43 108.206 177.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -67.32 114.16 5.8 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 114.721 -1.127 . . . . 71.35 112.816 179.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 82.9 mtp180 . . . . . 0 C--N 1.297 -1.691 0 N-CA-C 108.425 -0.954 . . . . 74.54 108.425 177.357 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.506 -0.719 0 N-CA-C 108.21 -1.033 . . . . 70.23 108.21 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 9.9 t -68.73 -18.4 64.23 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 112.14 0.422 . . . . 74.32 112.14 -179.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 9.0 m80 -124.66 127.99 48.16 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 109.806 -0.442 . . . . 75.42 109.806 170.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.556 ' O ' ' HA ' ' A' ' 248' ' ' THR . 45.3 ttm180 -145.01 144.0 30.79 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 116.4 -0.364 . . . . 70.42 111.071 174.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.543 ' HA ' ' O ' ' A' ' 247' ' ' ILE . 0.0 OUTLIER -118.23 127.04 53.36 Favored 'General case' 0 C--N 1.32 -0.677 0 O-C-N 123.244 0.34 . . . . 74.11 110.42 175.445 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 11.9 m -122.25 139.05 50.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 CA-C-N 115.909 -0.587 . . . . 74.41 111.283 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 21.8 ttm180 -92.59 116.36 28.93 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 109.317 -0.623 . . . . 74.43 109.317 177.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 19.7 mt -107.87 138.73 43.6 Favored 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 107.144 -1.428 . . . . 72.3 107.144 -179.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.459 HD13 ' H ' ' A' ' 168' ' ' SER . 1.0 OUTLIER 69.75 82.33 0.16 Allowed 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 122.325 1.06 . . . . 74.14 108.322 173.473 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -100.31 -0.15 38.97 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 114.811 -1.086 . . . . 73.15 110.022 -175.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -93.65 -11.94 30.5 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 114.246 1.202 . . . . 74.11 114.246 -177.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 65.89 75.65 0.4 Allowed Glycine 0 C--O 1.239 0.42 0 C-N-CA 120.167 -1.015 . . . . 64.33 111.425 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' SER . . . . . 0.459 ' H ' HD13 ' A' ' 164' ' ' LEU . 33.1 t -165.42 140.25 4.96 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 106.86 -1.533 . . . . 70.52 106.86 -176.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -81.01 74.33 8.02 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-O 122.256 1.027 . . . . 73.43 111.236 -178.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -99.27 153.29 37.86 Favored Pre-proline 0 C--N 1.277 -2.584 0 CA-C-N 113.887 -1.506 . . . . 74.44 108.711 173.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -63.08 131.32 32.06 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 121.922 1.748 . . . . 74.4 109.304 174.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.423 ' HG ' ' CD1' ' A' ' 245' ' ' LEU . 2.8 mm? -81.05 -18.67 45.9 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 116.099 -0.5 . . . . 73.32 111.98 -173.056 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . 0.486 ' HA3' ' HA3' ' A' ' 204' ' ' GLY . . . 97.95 17.1 31.1 Favored Glycine 0 N--CA 1.415 -2.746 0 C-N-CA 119.273 -1.441 . . . . 53.23 111.879 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -158.08 157.17 32.33 Favored 'General case' 0 N--CA 1.427 -1.605 0 N-CA-C 109.273 -0.64 . . . . 63.31 109.273 179.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -129.38 158.24 39.69 Favored 'General case' 0 C--N 1.283 -2.314 0 N-CA-C 107.995 -1.113 . . . . 74.34 107.995 172.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.423 ' HB ' ' CG2' ' A' ' 195' ' ' ILE . 0.1 OUTLIER -118.53 163.78 15.41 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.018 0 CA-C-O 121.744 0.783 . . . . 71.35 111.271 -178.68 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.432 ' HG2' ' HB3' ' A' ' 198' ' ' SER . 15.6 ptt180 -142.35 154.77 44.94 Favored 'General case' 0 C--N 1.28 -2.424 0 CA-C-N 114.182 -1.372 . . . . 74.12 109.477 -177.137 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -110.67 138.21 47.35 Favored 'General case' 0 C--N 1.294 -1.848 0 CA-C-O 121.143 0.497 . . . . 73.25 110.551 179.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -145.06 176.46 24.09 Favored Glycine 0 C--N 1.28 -2.544 0 N-CA-C 106.858 -2.497 . . . . 74.35 106.858 175.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' THR . . . . . 0.554 ' CG2' ' HG2' ' A' ' 191' ' ' LYS . 0.2 OUTLIER -102.07 122.71 44.64 Favored 'General case' 0 C--N 1.273 -2.74 0 C-N-CA 117.312 -1.755 . . . . 72.43 107.103 177.965 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 33.3 t -94.0 124.45 38.01 Favored 'General case' 0 C--N 1.283 -2.293 0 N-CA-C 109.041 -0.725 . . . . 72.5 109.041 -176.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.558 ' HA ' ' O ' ' A' ' 190' ' ' GLU . 4.0 p -112.8 121.85 65.85 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 CA-C-O 121.755 0.788 . . . . 65.24 110.137 175.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 86.6 mtt180 -126.88 158.38 36.88 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 107.801 -1.185 . . . . 73.21 107.801 -175.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.44 ' HA ' ' O ' ' A' ' 188' ' ' GLY . 99.8 t -88.08 118.71 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.785 0 C-N-CA 118.904 -1.118 . . . . 71.34 108.458 171.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 35.5 p -119.84 -173.21 2.49 Favored 'General case' 0 C--N 1.276 -2.597 0 CA-C-N 113.844 -1.525 . . . . 73.32 108.745 -175.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -60.46 -21.63 62.56 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.049 0.452 . . . . 71.24 110.554 174.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 28.5 m -88.09 -19.14 27.45 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 116.129 -0.487 . . . . 73.12 110.136 178.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.44 ' O ' ' HA ' ' A' ' 184' ' ' VAL . . . 112.09 -139.8 15.83 Favored Glycine 0 CA--C 1.482 -1.982 0 N-CA-C 108.836 -1.706 . . . . 75.44 108.836 -176.214 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 5.3 mp -78.42 119.11 21.27 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.019 -1.104 . . . . 71.34 108.019 177.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . 0.558 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 9.4 tp10 -131.61 123.24 27.48 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 108.611 -0.885 . . . . 72.53 108.611 -175.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.554 ' HG2' ' CG2' ' A' ' 180' ' ' THR . 34.2 ttmt -101.41 129.35 47.41 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.295 -1.002 . . . . 73.43 108.295 -176.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -147.88 165.17 19.26 Favored Pre-proline 0 C--N 1.306 -1.325 0 N-CA-C 109.127 -0.694 . . . . 55.31 109.127 -170.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -56.79 132.35 51.17 Favored 'Trans proline' 0 C--O 1.255 1.369 0 C-N-CA 121.378 1.386 . . . . 74.55 110.64 177.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -145.57 128.14 3.04 Favored Glycine 0 N--CA 1.419 -2.465 0 N-CA-C 110.504 -1.038 . . . . 73.35 110.504 -178.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.44 ' HB ' ' CG1' ' A' ' 218' ' ' VAL . 3.4 mp -103.92 136.24 37.97 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.415 0 CA-C-O 121.242 0.544 . . . . 73.42 110.422 -178.431 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -127.87 167.52 16.46 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 107.8 -1.185 . . . . 74.34 107.8 -177.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . 0.484 ' HB ' ' HA ' ' A' ' 214' ' ' VAL . 46.1 mm -75.4 131.19 35.4 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 N-CA-C 107.44 -1.319 . . . . 74.54 107.44 175.024 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' SER . . . . . 0.432 ' HB3' ' HG2' ' A' ' 177' ' ' ARG . 86.4 p -99.37 -33.32 10.75 Favored 'General case' 0 C--N 1.29 -1.986 0 O-C-N 121.53 -0.731 . . . . 74.2 111.356 -175.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 10.8 ttp180 -167.22 143.61 4.35 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.822 -0.626 . . . . 75.1 110.65 -175.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.438 HD13 ' O ' ' A' ' 212' ' ' LEU . 73.3 mt -101.87 146.7 27.45 Favored 'General case' 0 CA--C 1.494 -1.187 0 CA-C-N 116.168 -0.469 . . . . 74.41 109.796 174.052 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . 0.476 ' HB ' ' HA2' ' A' ' 173' ' ' GLY . 21.7 t -114.35 115.25 44.98 Favored Pre-proline 0 C--N 1.289 -2.058 0 N-CA-C 106.329 -1.73 . . . . 71.24 106.329 172.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . 0.458 ' HA ' ' HG2' ' A' ' 207' ' ' GLU . 31.3 Cg_exo -58.78 147.25 89.33 Favored 'Trans proline' 0 N--CA 1.444 -1.42 0 C-N-CA 121.95 1.766 . . . . 74.21 111.082 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 94.48 -23.24 33.07 Favored Glycine 0 C--N 1.305 -1.159 0 N-CA-C 110.794 -0.922 . . . . 54.14 110.794 -176.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . 0.486 ' HA3' ' HA3' ' A' ' 173' ' ' GLY . . . -83.48 163.53 40.87 Favored Glycine 0 N--CA 1.43 -1.701 0 N-CA-C 110.526 -1.029 . . . . 74.32 110.526 177.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . 0.412 ' H ' HD21 ' A' ' 205' ' ' LEU . 2.8 mm? -55.16 -42.62 73.36 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 123.842 0.857 . . . . 72.51 112.42 -175.047 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -59.17 -48.13 82.76 Favored 'General case' 0 C--O 1.244 0.764 0 N-CA-C 112.306 0.484 . . . . 74.12 112.306 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.458 ' HG2' ' HA ' ' A' ' 202' ' ' PRO . 8.3 tp10 -75.41 -33.4 60.95 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.958 -0.386 . . . . 75.41 109.958 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 35.5 t -57.66 -44.75 85.93 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 116.214 -0.448 . . . . 73.35 110.734 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' THR . . . . . 0.514 ' CG2' ' HG ' ' A' ' 211' ' ' LEU . 8.9 t -77.0 -31.87 56.77 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 119.679 -0.808 . . . . 73.02 109.537 176.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 70.13 19.9 76.04 Favored Glycine 0 N--CA 1.447 -0.61 0 CA-C-N 115.938 -0.574 . . . . 64.11 112.694 178.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.514 ' HG ' ' CG2' ' A' ' 209' ' ' THR . 1.4 pp -105.65 -0.52 25.53 Favored 'General case' 0 N--CA 1.432 -1.336 0 CA-C-O 121.072 0.463 . . . . 71.51 111.407 -178.498 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . 0.438 ' O ' HD13 ' A' ' 200' ' ' LEU . 60.7 mt -109.32 133.78 52.62 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.384 -0.826 . . . . 74.15 109.226 176.369 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -131.87 165.51 23.7 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.763 -0.828 . . . . 73.12 108.763 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . 0.484 ' HA ' ' HB ' ' A' ' 197' ' ' ILE . 33.4 m -64.28 -29.48 47.47 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 N-CA-C 113.914 1.079 . . . . 74.43 113.914 -177.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -74.44 -14.63 60.87 Favored 'General case' 0 C--N 1.308 -1.228 0 O-C-N 121.855 -0.528 . . . . 74.42 111.729 -178.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.4 ' HB3' ' HB ' ' A' ' 249' ' ' VAL . 54.3 m-20 -69.83 130.97 43.73 Favored 'General case' 0 C--O 1.245 0.867 0 CA-C-O 121.233 0.54 . . . . 53.3 112.237 -176.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -101.19 135.08 43.25 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.952 -1.022 . . . . 71.4 109.659 -178.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . 0.44 ' CG1' ' HB ' ' A' ' 195' ' ' ILE . 10.6 p -82.12 131.36 34.0 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.152 0 CA-C-O 121.749 0.785 . . . . 72.51 111.375 -176.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 36.8 mm -100.87 -52.71 8.34 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 CA-C-N 115.318 -0.855 . . . . 63.33 111.409 -179.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -154.68 152.8 30.37 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 116.449 -0.341 . . . . 65.3 110.146 -178.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 246' ' ' ILE . 10.7 p -125.27 125.51 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.644 0 N-CA-C 108.956 -0.757 . . . . 74.42 108.956 177.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 57.1 22.72 7.72 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.592 1.157 . . . . 54.21 112.945 -177.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 100.34 -11.46 59.97 Favored Glycine 0 C--N 1.309 -0.954 0 C-N-CA 120.912 -0.661 . . . . 75.22 112.348 179.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 64.2 mt -98.7 123.53 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.284 0 N-CA-C 109.361 -0.607 . . . . 72.15 109.361 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -60.52 140.24 57.4 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 121.796 0.808 . . . . 75.23 112.216 -177.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . 0.497 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 25.6 m -120.61 0.44 7.41 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 CA-C-N 115.083 -0.962 . . . . 64.1 109.561 175.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -78.35 98.26 5.91 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 115.323 -0.853 . . . . 72.01 109.649 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 120.32 -19.95 9.13 Favored Glycine 0 C--N 1.308 -0.975 0 N-CA-C 110.691 -0.964 . . . . 51.55 110.691 -178.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -72.49 164.78 25.85 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.61 -0.515 . . . . 75.2 109.61 177.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' THR . . . . . 0.456 ' O ' HG13 ' A' ' 234' ' ' VAL . 67.2 p -84.86 168.61 14.92 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 108.734 -0.839 . . . . 65.44 108.734 178.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 53.3 tp -63.43 -31.95 73.25 Favored 'General case' 0 N--CA 1.424 -1.745 0 N-CA-C 109.541 -0.54 . . . . 75.31 109.541 177.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -64.46 -50.94 65.51 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.472 -0.566 . . . . 75.3 109.472 176.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' GLN . . . . . 0.454 ' O ' ' HG2' ' A' ' 237' ' ' MET . 2.2 mp0 -58.49 -43.77 89.16 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 113.297 0.851 . . . . 74.13 113.297 177.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.497 ' CG1' ' HB ' ' A' ' 226' ' ' VAL . 7.2 m -72.06 -34.79 51.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 C-N-CA 119.796 -0.762 . . . . 74.22 111.811 -176.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' THR . . . . . 0.43 ' O ' HG21 ' A' ' 239' ' ' VAL . 42.8 m -69.6 -36.36 76.13 Favored 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 109.224 -0.658 . . . . 70.32 109.224 179.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -59.84 -37.74 80.11 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-N 116.11 -0.496 . . . . 75.41 110.049 176.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' MET . . . . . 0.454 ' HG2' ' O ' ' A' ' 233' ' ' GLN . 16.8 mmt -58.96 -52.13 67.1 Favored 'General case' 0 C--O 1.2 -1.523 0 N-CA-C 108.451 -0.944 . . . . 73.14 108.451 176.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' MET . . . . . 0.411 ' HG3' ' O ' ' A' ' 234' ' ' VAL . 58.1 mtt -62.82 -33.11 74.54 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.996 -1.002 . . . . 73.14 112.201 -175.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.43 HG21 ' O ' ' A' ' 235' ' ' THR . 75.6 t -68.29 -41.31 83.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-O 121.328 0.585 . . . . 54.32 109.902 175.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -72.32 -38.84 68.58 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.438 -0.801 . . . . 73.33 110.664 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -84.03 21.47 1.34 Allowed 'General case' 0 C--O 1.198 -1.613 0 CA-C-N 115.399 -0.819 . . . . 73.31 111.742 -177.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 14.8 p -64.36 -22.54 66.99 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-O 121.121 0.486 . . . . 71.54 111.559 176.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 26.7 m -68.84 -27.13 65.56 Favored 'General case' 0 CA--C 1.557 1.24 0 CA-C-N 116.318 -0.401 . . . . 73.43 110.914 176.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -174.44 103.16 0.1 Allowed 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.794 1.237 . . . . 63.45 108.98 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . 0.423 ' CD1' ' HG ' ' A' ' 172' ' ' LEU . 1.0 OUTLIER -90.49 103.51 16.19 Favored 'General case' 0 C--O 1.201 -1.456 0 N-CA-C 109.634 -0.506 . . . . 73.12 109.634 -173.923 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . 0.489 ' O ' ' HA ' ' A' ' 221' ' ' VAL . 63.9 mt -105.02 115.42 46.87 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 O-C-N 121.445 -0.785 . . . . 71.44 109.255 178.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . 0.543 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 18.8 mt -119.31 133.43 66.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 113.375 0.88 . . . . 62.25 113.375 -179.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.556 ' HA ' ' O ' ' A' ' 159' ' ' ARG . 61.2 m -103.11 121.27 42.27 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 107.65 -1.241 . . . . 74.24 107.65 173.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . 0.4 ' HB ' ' HB3' ' A' ' 216' ' ' ASP . 17.1 m -122.81 163.83 20.97 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.061 0 CA-C-O 121.106 0.479 . . . . 75.44 110.523 175.376 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -134.29 128.9 19.55 Favored Pre-proline 0 N--CA 1.416 -2.156 0 CA-C-N 114.469 -1.241 . . . . 74.01 107.745 173.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -61.4 133.59 46.97 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 121.255 1.303 . . . . 74.3 112.386 178.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -74.81 -14.62 60.71 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 109.268 -0.641 . . . . 62.23 109.268 176.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -96.55 6.43 48.75 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.303 -0.862 . . . . 72.42 109.302 174.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 43.37 96.29 0.01 OUTLIER 'General case' 0 C--N 1.354 0.79 0 C-N-CA 127.007 2.123 . . . . 65.44 114.222 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 . . . . . 0 C--O 1.255 1.389 0 C-N-CA 124.039 0.936 . . . . 62.14 110.325 -176.737 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.504 -0.803 0 N-CA-C 107.928 -1.138 . . . . 74.34 107.928 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.536 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 39.8 p -106.56 -34.19 7.44 Favored 'General case' 0 N--CA 1.418 -2.046 0 CA-C-N 114.78 -1.1 . . . . 73.51 108.111 173.044 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.484 ' ND1' ' HB3' ' A' ' 250' ' ' LYS . 0.6 OUTLIER -125.56 153.22 43.99 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 123.65 0.78 . . . . 74.05 110.305 174.029 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.448 ' O ' ' HA ' ' A' ' 248' ' ' THR . 28.7 tpt180 -143.47 133.59 24.33 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 109.409 -0.589 . . . . 72.45 109.409 172.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 32.0 ptt180 -113.36 124.65 52.96 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 116.044 -0.525 . . . . 72.31 109.945 177.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.552 ' O ' ' HA ' ' A' ' 246' ' ' ILE . 17.4 m -127.0 139.25 52.45 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 CA-C-N 116.015 -0.539 . . . . 65.45 112.218 -176.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.503 ' HG2' HG12 ' A' ' 246' ' ' ILE . 95.6 mtt180 -87.95 112.57 22.71 Favored 'General case' 0 C--O 1.242 0.661 0 N-CA-C 108.264 -1.013 . . . . 73.41 108.264 176.192 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.482 ' HB2' ' HB3' ' A' ' 245' ' ' LEU . 33.5 mt -92.87 125.75 37.63 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 107.372 -1.344 . . . . 63.32 107.372 176.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.468 ' HB2' ' CD1' ' A' ' 172' ' ' LEU . 5.8 tt 78.95 83.89 0.06 Allowed 'General case' 0 C--N 1.312 -1.038 0 O-C-N 124.664 1.227 . . . . 74.2 110.468 179.234 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -92.99 -25.77 17.83 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 106.853 -1.536 . . . . 74.22 106.853 173.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 52.3 t-80 -141.59 132.14 25.42 Favored 'General case' 0 N--CA 1.432 -1.346 0 CA-C-N 113.635 -1.62 . . . . 73.31 106.717 176.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 166.92 -114.39 0.58 Allowed Glycine 0 N--CA 1.43 -1.737 0 C-N-CA 120.012 -1.09 . . . . 65.44 112.132 -178.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 63.3 m 66.15 21.26 11.15 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.632 0.729 . . . . 73.41 111.282 -177.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -118.11 -49.43 2.5 Favored 'General case' 0 CA--C 1.495 -1.137 0 CA-C-N 115.162 -0.926 . . . . 71.43 109.03 177.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.494 ' HD3' ' H ' ' A' ' 170' ' ' LYS . 0.1 OUTLIER -120.66 153.95 56.9 Favored Pre-proline 0 N--CA 1.422 -1.869 0 CA-C-N 115.124 -0.944 . . . . 72.21 111.577 -173.027 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_exo -54.88 154.81 20.07 Favored 'Trans proline' 0 C--O 1.247 0.937 0 C-N-CA 124.099 3.199 . . . . 63.35 112.43 174.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.468 ' CD1' ' HB2' ' A' ' 164' ' ' LEU . 3.3 mm? -56.21 -40.31 73.83 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.842 0.682 . . . . 72.31 112.842 -178.082 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 96.17 47.43 2.42 Favored Glycine 0 N--CA 1.439 -1.131 0 C-N-CA 119.77 -1.205 . . . . 37.22 114.205 174.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -159.51 154.51 24.89 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.774 -0.824 . . . . 74.25 108.774 174.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -123.4 143.89 49.84 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 109.071 -0.714 . . . . 74.34 109.071 177.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -117.31 169.61 7.57 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.77 0 CA-C-N 115.379 -0.828 . . . . 75.23 109.608 -179.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.51 ' CG ' ' HB2' ' A' ' 198' ' ' SER . 19.2 ptt180 -144.66 155.24 43.5 Favored 'General case' 0 C--N 1.269 -2.914 0 C-N-CA 124.057 0.943 . . . . 75.11 109.724 -175.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -115.15 145.75 42.06 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-O 121.235 0.54 . . . . 75.33 110.323 -178.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -157.62 171.46 34.79 Favored Glycine 0 N--CA 1.42 -2.372 0 N-CA-C 108.414 -1.874 . . . . 63.05 108.414 176.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -86.62 123.09 31.42 Favored 'General case' 0 C--N 1.294 -1.83 0 C-N-CA 118.174 -1.41 . . . . 75.0 107.425 178.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' SER . . . . . 0.5 ' O ' ' HA ' ' A' ' 191' ' ' LYS . 37.8 t -105.51 129.68 53.74 Favored 'General case' 0 C--N 1.273 -2.747 0 N-CA-C 108.476 -0.935 . . . . 73.02 108.476 -178.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.601 ' HA ' ' O ' ' A' ' 190' ' ' GLU . 6.0 p -108.24 118.15 55.27 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.952 0 C-N-CA 119.377 -0.929 . . . . 72.22 109.048 172.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -125.0 161.52 26.53 Favored 'General case' 0 CA--C 1.475 -1.907 0 N-CA-C 108.185 -1.043 . . . . 64.31 108.185 -176.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 98.0 t -86.09 118.35 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.236 0 N-CA-C 107.094 -1.447 . . . . 73.2 107.094 171.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 76.1 p -109.17 -174.12 2.43 Favored 'General case' 0 C--N 1.259 -3.328 0 N-CA-C 107.562 -1.273 . . . . 75.34 107.562 -178.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -69.7 -10.03 56.7 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-O 120.836 0.35 . . . . 70.13 110.418 176.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 36.7 m -105.24 -14.94 15.2 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 111.746 0.276 . . . . 62.0 111.746 179.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 131.05 -146.14 17.55 Favored Glycine 0 C--O 1.21 -1.352 0 C-N-CA 120.233 -0.984 . . . . 71.24 110.649 178.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 5.2 mp -85.61 119.35 25.86 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.374 -0.973 . . . . 72.32 108.374 177.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . 0.601 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 53.3 mt-10 -131.23 125.71 33.59 Favored 'General case' 0 CA--C 1.455 -2.679 0 CA-C-O 121.002 0.43 . . . . 72.43 111.261 -178.007 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.5 ' HA ' ' O ' ' A' ' 181' ' ' SER . 31.2 ttmt -96.32 122.89 39.68 Favored 'General case' 0 C--N 1.276 -2.623 0 N-CA-C 107.275 -1.38 . . . . 75.24 107.275 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -152.02 165.4 17.54 Favored Pre-proline 0 C--N 1.287 -2.11 0 N-CA-C 108.068 -1.086 . . . . 73.41 108.068 -169.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -55.68 131.58 46.97 Favored 'Trans proline' 0 C--O 1.251 1.154 0 C-N-CA 120.942 1.095 . . . . 74.23 110.516 176.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -143.4 141.92 10.86 Favored Glycine 0 N--CA 1.413 -2.857 0 N-CA-C 109.319 -1.512 . . . . 53.22 109.319 -178.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 2.8 mp -109.38 133.73 53.66 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.435 0 CA-C-O 121.481 0.657 . . . . 74.13 111.608 -176.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -123.28 167.07 14.23 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.93 -1.137 . . . . 75.13 107.93 -177.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . 0.426 ' HB ' ' HA ' ' A' ' 214' ' ' VAL . 45.6 mm -79.58 131.97 33.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 108.947 -0.76 . . . . 72.41 108.947 177.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' SER . . . . . 0.51 ' HB2' ' CG ' ' A' ' 177' ' ' ARG . 14.4 t -106.55 -31.53 8.47 Favored 'General case' 0 C--N 1.295 -1.781 0 O-C-N 121.734 -0.604 . . . . 75.25 112.415 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -164.85 144.31 7.04 Favored 'General case' 0 C--N 1.313 -0.979 0 C-N-CA 120.986 -0.286 . . . . 74.33 110.643 -176.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 81.4 mt -107.74 134.48 50.64 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.849 -1.167 . . . . 74.44 107.849 172.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 60.2 t -92.93 114.89 63.91 Favored Pre-proline 0 C--N 1.29 -2.018 0 N-CA-C 105.744 -1.947 . . . . 65.25 105.744 172.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -61.06 137.19 70.13 Favored 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 121.8 1.667 . . . . 75.13 110.378 -177.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 98.77 -21.38 46.24 Favored Glycine 0 C--N 1.303 -1.271 0 C-N-CA 120.513 -0.851 . . . . 70.42 111.109 -177.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -76.06 175.32 52.48 Favored Glycine 0 N--CA 1.44 -1.064 0 C-N-CA 121.349 -0.453 . . . . 74.44 112.492 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -67.22 -30.79 70.81 Favored 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 123.743 0.817 . . . . 64.45 111.249 -177.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -68.68 -41.31 79.4 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.461 0.648 . . . . 75.4 109.783 178.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -68.17 -32.78 73.27 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.473 -0.785 . . . . 71.22 109.35 177.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 49.3 m -56.5 -40.96 75.84 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 116.058 -0.519 . . . . 73.24 111.581 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 7.2 t -84.87 -41.21 16.23 Favored 'General case' 0 N--CA 1.44 -0.941 0 C-N-CA 119.178 -1.009 . . . . 53.54 110.514 177.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 67.18 6.69 40.69 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 121.325 -0.464 . . . . 73.34 113.442 179.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 76.9 mt -84.07 -9.48 58.59 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-O 121.175 0.512 . . . . 62.12 111.089 -178.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -112.48 136.55 51.85 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-N 115.662 -0.699 . . . . 72.22 109.373 175.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -130.69 166.84 19.85 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.423 -0.954 . . . . 61.44 108.423 -178.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . 0.426 ' HA ' ' HB ' ' A' ' 197' ' ' ILE . 16.5 m -56.42 -30.38 30.79 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 N-CA-C 113.486 0.921 . . . . 73.22 113.486 -176.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 -79.38 -15.0 58.59 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 121.75 -0.594 . . . . 73.24 111.688 -179.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.468 ' HB3' ' HB ' ' A' ' 249' ' ' VAL . 1.5 m-20 -71.78 139.74 49.15 Favored 'General case' 0 C--O 1.248 0.974 0 CA-C-O 121.439 0.637 . . . . 62.14 111.92 -178.515 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 57.0 tt0 -101.46 138.54 38.33 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.973 -1.012 . . . . 53.42 111.266 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 35.4 t -83.54 124.44 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 CA-C-O 121.77 0.795 . . . . 75.25 110.133 -178.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 35.5 mm -93.64 -51.88 10.53 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 CA-C-N 115.044 -0.98 . . . . 74.44 111.121 -179.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -154.26 158.33 40.05 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 116.214 -0.448 . . . . 70.52 110.458 -177.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 12.5 p -127.69 120.26 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.663 0 CA-C-N 115.595 -0.73 . . . . 75.42 109.411 179.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . 0.469 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 12.0 t-20 68.28 4.23 4.08 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 126.329 1.851 . . . . 72.43 110.98 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 117.57 -15.45 12.83 Favored Glycine 0 N--CA 1.44 -1.078 0 N-CA-C 110.892 -0.883 . . . . 74.42 110.892 -177.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 65.4 mt -94.75 124.44 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 CA-C-O 121.132 0.492 . . . . 74.34 110.026 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -55.37 137.08 48.71 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 124.914 1.286 . . . . 74.44 112.425 -179.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 35.8 m -105.98 8.79 9.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 CA-C-O 121.801 0.81 . . . . 72.41 109.981 175.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -74.72 99.9 3.84 Favored 'General case' 0 N--CA 1.431 -1.398 0 CA-C-N 114.813 -1.085 . . . . 75.02 110.125 178.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 112.41 -8.63 26.49 Favored Glycine 0 CA--C 1.495 -1.171 0 N-CA-C 110.378 -1.089 . . . . 73.14 110.378 178.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -83.06 153.08 25.08 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 107.954 -1.128 . . . . 71.02 107.954 176.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 74.4 p -91.79 175.73 6.78 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 108.168 -1.049 . . . . 53.41 108.168 179.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . 0.47 ' HA ' HG21 ' A' ' 234' ' ' VAL . 2.8 tm? -65.06 -37.03 86.21 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 107.818 -1.178 . . . . 72.03 107.818 178.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -55.69 -51.82 65.96 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.016 -0.993 . . . . 45.43 109.395 177.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' GLN . . . . . 0.536 ' O ' ' HG3' ' A' ' 237' ' ' MET . 2.2 mp0 -66.84 -50.7 61.72 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 113.798 1.036 . . . . 65.44 113.798 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.544 ' O ' ' HG3' ' A' ' 238' ' ' MET . 26.7 m -58.89 -33.51 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 N-CA-C 112.588 0.588 . . . . 74.14 112.588 -174.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 91.3 m -72.77 -35.56 67.47 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 115.232 -0.895 . . . . 75.3 109.332 -175.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -69.02 -30.77 69.21 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.298 -0.864 . . . . 74.31 108.994 178.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' MET . . . . . 0.539 ' SD ' ' HA ' ' A' ' 234' ' ' VAL . 19.3 mtp -69.49 -47.25 64.49 Favored 'General case' 0 C--O 1.209 -1.067 0 N-CA-C 106.931 -1.507 . . . . 71.51 106.931 178.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' MET . . . . . 0.544 ' HG3' ' O ' ' A' ' 234' ' ' VAL . 65.3 mtt -59.55 -45.29 92.24 Favored 'General case' 0 C--O 1.22 -0.489 0 CA-C-N 115.42 -0.809 . . . . 72.41 112.186 -179.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 89.3 t -64.42 -38.26 82.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.161 0.505 . . . . 74.42 110.533 178.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -68.89 -36.13 77.7 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.383 0.611 . . . . 75.4 110.318 178.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -86.51 19.43 2.83 Favored 'General case' 0 C--O 1.199 -1.583 0 CA-C-N 115.472 -0.785 . . . . 61.34 111.906 179.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 30.4 p -61.26 -23.7 65.85 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 112.776 0.658 . . . . 74.14 112.776 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 25.4 p -74.8 -16.78 60.69 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 112.12 0.415 . . . . 72.14 112.12 178.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -175.29 88.24 0.04 OUTLIER 'General case' 0 C--O 1.257 1.451 0 N-CA-C 107.787 -1.19 . . . . 75.44 107.787 -179.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . 0.482 ' HB3' ' HB2' ' A' ' 163' ' ' LEU . 2.8 tt -92.15 102.11 14.63 Favored 'General case' 0 N--CA 1.416 -2.138 0 C-N-CA 118.923 -1.111 . . . . 72.11 109.268 -174.225 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . 0.552 ' HA ' ' O ' ' A' ' 161' ' ' VAL . 89.1 mt -97.81 116.4 40.3 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.98 0 C-N-CA 120.134 -0.627 . . . . 72.02 109.971 178.116 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 14.6 mt -117.99 134.63 60.99 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.84 0 CA-C-O 121.433 0.635 . . . . 73.11 111.403 176.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.448 ' HA ' ' O ' ' A' ' 159' ' ' ARG . 63.8 m -103.1 114.87 29.51 Favored 'General case' 0 N--CA 1.409 -2.5 0 CA-C-N 114.52 -1.218 . . . . 37.22 108.072 175.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . 0.468 ' HB ' ' HB3' ' A' ' 216' ' ' ASP . 17.4 m -118.89 159.91 19.11 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.165 0 CA-C-O 121.46 0.648 . . . . 74.52 110.754 177.12 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . 0.484 ' HB3' ' ND1' ' A' ' 158' ' ' HIS . 10.0 ptmt -127.69 128.84 23.86 Favored Pre-proline 0 C--N 1.272 -2.798 0 CA-C-N 114.291 -1.322 . . . . 74.33 109.161 177.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . 0.536 ' HD2' ' O ' ' A' ' 157' ' ' THR . 35.0 Cg_endo -66.61 148.56 83.5 Favored 'Trans proline' 0 N--CA 1.439 -1.683 0 C-N-CA 121.827 1.685 . . . . 64.3 110.5 178.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -62.43 -35.8 80.4 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 122.057 0.932 . . . . 42.31 109.147 177.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -97.98 73.36 2.25 Favored 'General case' 0 C--N 1.29 -1.986 0 CA-C-N 114.186 -1.37 . . . . 74.2 108.948 178.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' GLN . . . . . 0.422 ' HG3' ' O ' ' A' ' 251' ' ' PRO . 27.8 mt-30 -70.9 144.36 50.66 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 116.191 -0.459 . . . . 72.22 111.338 177.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.313 -0.992 0 CA-C-O 118.705 -0.664 . . . . 74.34 109.48 178.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 . . . . . 0 N--CA 1.452 -0.353 0 N-CA-C 108.375 -0.972 . . . . 74.34 108.375 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.488 ' O ' ' HA ' ' A' ' 250' ' ' LYS . 58.0 p -60.71 -35.87 77.4 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.059 0.544 . . . . 65.24 112.397 -176.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -125.19 129.78 50.8 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 109.815 -0.439 . . . . 75.03 109.815 173.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.545 ' O ' ' HA ' ' A' ' 248' ' ' THR . 2.1 tpm_? -140.18 140.36 35.9 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.619 -1.252 . . . . 74.41 107.619 177.101 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.573 ' HB3' ' OG1' ' A' ' 248' ' ' THR . 23.2 ptt180 -132.47 113.03 12.63 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 122.098 0.951 . . . . 75.41 113.067 178.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.624 ' O ' ' HA ' ' A' ' 246' ' ' ILE . 21.1 m -105.17 139.29 26.67 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 CA-C-N 113.929 -1.487 . . . . 70.42 113.014 -175.181 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.469 ' HG3' HG12 ' A' ' 246' ' ' ILE . 7.3 mpt_? -91.13 112.6 24.57 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 106.995 -1.483 . . . . 74.24 106.995 175.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.458 ' HB2' ' HB3' ' A' ' 245' ' ' LEU . 35.4 mt -100.23 135.49 41.58 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 108.49 -0.929 . . . . 64.41 108.49 179.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 8.1 tp 79.28 95.91 0.06 Allowed 'General case' 0 N--CA 1.417 -2.102 0 C-N-CA 124.499 1.12 . . . . 55.11 110.567 175.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 60.6 pttt -101.67 18.65 19.8 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 114.236 -1.347 . . . . 75.0 109.91 -179.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 61.4 m80 -125.1 176.14 6.9 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 114.406 -1.27 . . . . 75.13 110.176 176.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -120.64 80.42 0.33 Allowed Glycine 0 CA--C 1.484 -1.886 0 C-N-CA 120.614 -0.803 . . . . 36.72 111.198 -175.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 67.2 m -156.92 143.14 18.08 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.415 -0.957 . . . . 71.31 108.415 -178.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -79.85 73.45 6.6 Favored 'General case' 0 CA--C 1.494 -1.195 0 CA-C-O 122.166 0.984 . . . . 61.41 110.282 178.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -99.83 147.4 33.38 Favored Pre-proline 0 C--N 1.281 -2.38 0 CA-C-N 113.647 -1.615 . . . . 73.14 108.062 175.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -63.62 137.63 60.29 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 121.764 1.643 . . . . 70.15 109.452 174.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.444 ' HG ' ' CD1' ' A' ' 245' ' ' LEU . 3.3 mm? -75.19 -25.66 58.43 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 120.916 0.388 . . . . 55.51 111.358 -176.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . 0.411 ' HA3' ' HA3' ' A' ' 204' ' ' GLY . . . 93.28 35.49 6.26 Favored Glycine 0 N--CA 1.437 -1.247 0 C-N-CA 120.419 -0.896 . . . . 62.44 113.704 175.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -151.45 158.89 44.26 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.415 -0.958 . . . . 74.25 108.415 174.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -125.36 156.83 38.12 Favored 'General case' 0 C--N 1.284 -2.243 0 N-CA-C 108.761 -0.829 . . . . 72.45 108.761 175.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -124.96 166.64 20.24 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 CA-C-O 121.441 0.639 . . . . 61.21 110.421 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.463 ' HG2' ' HB3' ' A' ' 198' ' ' SER . 14.7 ptt180 -144.78 154.76 43.04 Favored 'General case' 0 C--N 1.28 -2.438 0 CA-C-N 114.699 -1.137 . . . . 74.42 110.154 -176.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -112.98 145.39 40.9 Favored 'General case' 0 C--N 1.294 -1.822 0 C-N-CA 123.648 0.779 . . . . 73.44 110.094 -177.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -162.98 179.13 38.42 Favored Glycine 0 C--N 1.294 -1.797 0 N-CA-C 109.048 -1.621 . . . . 42.24 109.048 175.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 2.1 p -96.99 123.4 40.7 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-N 118.19 0.995 . . . . 75.12 111.154 174.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' SER . . . . . 0.526 ' O ' ' HA ' ' A' ' 191' ' ' LYS . 24.5 t -108.88 123.65 49.41 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 107.684 -1.228 . . . . 71.22 107.684 177.309 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.593 ' HB ' ' HG3' ' A' ' 191' ' ' LYS . 7.8 p -103.1 124.27 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.334 0 N-CA-C 108.528 -0.916 . . . . 74.14 108.528 178.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . 0.445 ' O ' ' HA ' ' A' ' 189' ' ' LEU . 94.4 mtt180 -127.97 160.39 32.02 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 109.053 -0.721 . . . . 72.12 109.053 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 82.4 t -84.67 118.35 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.044 0 N-CA-C 107.349 -1.352 . . . . 75.32 107.349 173.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 76.5 p -111.4 -175.24 2.65 Favored 'General case' 0 C--N 1.265 -3.078 0 N-CA-C 107.592 -1.262 . . . . 75.45 107.592 -178.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -66.87 -16.98 64.66 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.064 0.459 . . . . 70.52 110.525 179.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 12.8 p -102.89 -18.05 15.24 Favored 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 113.479 0.918 . . . . 74.23 113.479 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 141.82 -163.75 26.88 Favored Glycine 0 CA--C 1.493 -1.294 0 C-N-CA 119.541 -1.314 . . . . 73.31 111.464 178.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.445 ' HA ' ' O ' ' A' ' 183' ' ' ARG . 5.2 mp -82.52 116.48 21.97 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 108.379 -0.971 . . . . 73.33 108.379 178.362 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . 0.509 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 45.5 mt-10 -134.48 135.21 42.29 Favored 'General case' 0 CA--C 1.488 -1.434 0 N-CA-C 114.548 1.314 . . . . 72.31 114.548 -176.349 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.593 ' HG3' ' HB ' ' A' ' 182' ' ' VAL . 43.8 mtmt -84.34 137.09 33.62 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 114.431 -1.259 . . . . 72.01 112.402 173.338 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -132.08 163.47 49.93 Favored Pre-proline 0 C--N 1.259 -3.327 0 N-CA-C 105.184 -2.154 . . . . 65.05 105.184 176.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -66.48 131.07 25.22 Favored 'Trans proline' 0 N--CA 1.423 -2.666 0 N-CA-C 106.872 -2.011 . . . . 73.13 106.872 169.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -125.89 127.83 6.27 Favored Glycine 0 N--CA 1.397 -3.965 0 N-CA-C 109.499 -1.441 . . . . 73.11 109.499 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 3.4 mp -103.68 132.78 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.049 0 N-CA-C 109.084 -0.71 . . . . 75.0 109.084 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -125.6 167.38 15.16 Favored 'General case' 0 C--N 1.281 -2.405 0 N-CA-C 107.366 -1.346 . . . . 71.14 107.366 -176.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 47.5 mm -77.82 132.29 32.88 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 N-CA-C 107.021 -1.474 . . . . 73.11 107.021 175.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' SER . . . . . 0.463 ' HB3' ' HG2' ' A' ' 177' ' ' ARG . 83.4 p -100.47 -35.29 9.6 Favored 'General case' 0 C--N 1.28 -2.43 0 C-N-CA 118.806 -1.158 . . . . 74.21 111.053 -178.255 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 65.9 ttt180 -158.13 147.3 19.43 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.296 -0.411 . . . . 73.25 110.44 -176.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 71.0 mt -106.66 138.39 42.93 Favored 'General case' 0 CA--C 1.483 -1.609 0 N-CA-C 108.554 -0.906 . . . . 71.12 108.554 171.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 58.9 t -98.89 114.99 65.99 Favored Pre-proline 0 N--CA 1.415 -2.211 0 N-CA-C 106.377 -1.712 . . . . 75.32 106.377 172.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . 0.421 ' HA ' ' HG2' ' A' ' 207' ' ' GLU . 37.0 Cg_exo -58.73 126.8 22.28 Favored 'Trans proline' 0 N--CA 1.448 -1.149 0 C-N-CA 121.934 1.756 . . . . 75.23 110.65 -178.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 106.24 -16.3 42.1 Favored Glycine 0 N--CA 1.438 -1.2 0 C-N-CA 120.332 -0.937 . . . . 63.03 112.403 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . 0.411 ' HA3' ' HA3' ' A' ' 173' ' ' GLY . . . -81.01 -179.23 52.97 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.811 -0.709 . . . . 36.72 111.898 178.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -62.74 -42.85 99.87 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 123.1 0.56 . . . . 71.5 111.548 -177.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -60.96 -38.66 86.71 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.139 -0.482 . . . . 71.32 111.335 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.421 ' HG2' ' HA ' ' A' ' 202' ' ' PRO . 9.3 tp10 -75.51 -36.9 60.44 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.505 -0.554 . . . . 72.02 109.505 178.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 24.7 t -60.18 -45.98 91.25 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 115.915 -0.584 . . . . 54.13 110.444 -179.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 8.9 t -72.89 -40.33 65.65 Favored 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 120.311 -0.556 . . . . 74.5 110.037 176.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 73.16 9.32 76.49 Favored Glycine 0 N--CA 1.441 -0.998 0 CA-C-N 115.852 -0.613 . . . . 62.51 112.561 179.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 48.6 mt -97.25 1.97 50.28 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.542 0.687 . . . . 64.22 109.685 -179.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 87.6 mt -112.83 132.43 55.28 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 114.744 -1.116 . . . . 72.42 109.09 174.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -131.45 160.65 34.52 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 122.817 0.447 . . . . 74.22 109.889 176.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 32.8 m -62.22 -30.26 48.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 122.034 0.921 . . . . 74.41 112.922 -178.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . 0.66 ' OD1' ' HB1' ' A' ' 252' ' ' ALA . 25.9 t-20 -81.0 -14.07 58.28 Favored 'General case' 0 C--N 1.275 -2.641 0 CA-C-N 116.04 -0.527 . . . . 72.1 111.777 -175.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.46 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 72.0 m-20 -71.71 151.47 43.58 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 113.599 0.963 . . . . 74.52 113.599 -175.06 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -111.64 129.78 55.98 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.122 1.369 . . . . 72.44 109.955 -176.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 41.6 t -82.24 138.88 18.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 CA-C-O 121.488 0.661 . . . . 64.35 111.949 -175.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 47.4 mm -108.66 -51.76 6.82 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 C-N-CA 123.935 0.894 . . . . 71.2 111.631 -178.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -151.87 161.38 42.74 Favored 'General case' 0 C--O 1.244 0.808 0 CA-C-O 120.522 0.201 . . . . 70.34 110.663 -178.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . 0.41 ' CG1' ' HE1' ' A' ' 237' ' ' MET . 15.0 p -129.93 119.47 47.32 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.075 0 CA-C-O 121.449 0.642 . . . . 72.42 109.556 177.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . 0.501 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 13.7 t-20 70.23 0.02 2.99 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 125.859 1.663 . . . . 74.13 111.858 177.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 121.87 -13.8 9.15 Favored Glycine 0 N--CA 1.435 -1.369 0 N-CA-C 110.955 -0.858 . . . . 65.43 110.955 -177.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 66.6 mt -95.8 123.66 48.1 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 N-CA-C 108.725 -0.843 . . . . 71.44 108.725 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -55.76 147.65 18.32 Favored 'General case' 0 C--N 1.31 -1.138 0 O-C-N 123.912 0.758 . . . . 70.55 111.145 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . 0.468 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 33.5 m -120.5 -1.1 8.02 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 CA-C-O 121.472 0.653 . . . . 72.41 109.387 173.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -73.36 95.16 2.14 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-N 115.081 -0.963 . . . . 73.12 110.622 -178.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 127.43 -22.29 5.59 Favored Glycine 0 N--CA 1.429 -1.795 0 C-N-CA 120.432 -0.89 . . . . 71.11 110.939 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 55.9 mttm -83.78 164.93 19.25 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 109.996 -0.372 . . . . 74.34 109.996 177.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' THR . . . . . 0.405 ' O ' HG13 ' A' ' 234' ' ' VAL . 34.7 p -93.0 168.09 11.36 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 116.43 -0.35 . . . . 73.51 110.204 -177.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . 0.446 ' HA ' HG21 ' A' ' 234' ' ' VAL . 2.8 tm? -56.96 -41.94 79.24 Favored 'General case' 0 N--CA 1.44 -0.967 0 C-N-CA 123.083 0.553 . . . . 64.11 109.878 -178.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -56.43 -51.59 67.81 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.365 -0.379 . . . . 73.11 110.501 176.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -58.6 -49.75 76.32 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 115.229 -0.896 . . . . 72.22 112.362 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.468 ' CG1' ' HB ' ' A' ' 226' ' ' VAL . 15.1 m -69.45 -33.84 59.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 112.894 0.701 . . . . 74.22 112.894 -173.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' THR . . . . . 0.42 ' O ' HG21 ' A' ' 239' ' ' VAL . 84.4 m -73.42 -35.59 65.85 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 109.488 -0.56 . . . . 71.44 109.488 -174.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -63.39 -33.1 74.8 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.957 -0.757 . . . . 71.34 108.957 177.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' MET . . . . . 0.41 ' HE1' ' CG1' ' A' ' 221' ' ' VAL . 5.1 mtm -72.72 -38.98 67.29 Favored 'General case' 0 C--O 1.199 -1.555 0 CA-C-N 115.341 -0.845 . . . . 74.43 108.731 -179.124 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' MET . . . . . 0.444 ' HG3' ' O ' ' A' ' 234' ' ' VAL . 65.6 mtt -63.45 -37.96 89.3 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.285 -0.416 . . . . 75.22 110.815 179.113 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.42 HG21 ' O ' ' A' ' 235' ' ' THR . 66.4 t -69.69 -41.0 79.97 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 CA-C-N 116.334 -0.393 . . . . 74.41 110.149 177.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -66.39 -34.19 77.4 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.768 0.794 . . . . 73.23 110.372 177.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -86.41 20.51 2.4 Favored 'General case' 0 C--O 1.2 -1.545 0 CA-C-N 115.267 -0.879 . . . . 75.32 112.506 178.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 67.4 m -64.88 -23.59 67.28 Favored 'General case' 0 C--O 1.212 -0.912 0 C-N-CA 120.172 -0.611 . . . . 74.01 112.545 178.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 12.4 p -65.3 -36.36 83.83 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 111.802 0.297 . . . . 75.31 111.802 176.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 46.2 m-80 -155.95 92.43 1.36 Allowed 'General case' 0 C--O 1.254 1.294 0 N-CA-C 107.301 -1.37 . . . . 72.14 107.301 177.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . 0.458 ' HB3' ' HB2' ' A' ' 163' ' ' LEU . 2.8 tt -88.6 103.18 15.67 Favored 'General case' 0 N--CA 1.423 -1.817 0 C-N-CA 119.381 -0.927 . . . . 75.14 109.641 -174.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . 0.624 ' HA ' ' O ' ' A' ' 161' ' ' VAL . 87.2 mt -102.58 116.59 46.55 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.992 0 C-N-CA 120.721 -0.392 . . . . 70.21 109.974 177.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . 0.431 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 25.5 mt -119.55 132.89 68.05 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.089 0 CA-C-O 121.146 0.498 . . . . 74.15 111.912 176.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.573 ' OG1' ' HB3' ' A' ' 160' ' ' ARG . 57.2 m -100.27 124.35 45.63 Favored 'General case' 0 N--CA 1.426 -1.648 0 N-CA-C 107.561 -1.274 . . . . 72.51 107.561 175.035 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 29.5 m -124.82 170.56 14.8 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 CA-C-O 121.579 0.704 . . . . 74.23 110.971 176.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . 0.488 ' HA ' ' O ' ' A' ' 157' ' ' THR 0.312 44.0 mtpt -125.0 134.78 26.02 Favored Pre-proline 0 C--N 1.28 -2.417 0 N-CA-C 106.146 -1.798 . . . . 73.43 106.146 173.971 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . 0.46 ' HA ' ' OD1' ' A' ' 216' ' ' ASP . 5.6 Cg_exo -79.17 132.0 10.11 Favored 'Trans proline' 0 N--CA 1.402 -3.871 0 CA-C-N 119.73 0.939 . . . . 74.23 110.346 173.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . 0.66 ' HB1' ' OD1' ' A' ' 215' ' ' ASN . . . -79.0 -2.5 40.49 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.994 0.902 . . . . 74.44 108.776 177.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 39.6 m-80 -90.16 -12.67 37.52 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 114.29 -1.323 . . . . 71.25 108.722 175.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 53.06 76.52 0.2 Allowed 'General case' 0 C--N 1.357 0.916 0 CA-C-O 122.171 0.986 . . . . 71.11 109.453 -171.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 . . . . . 0 C--N 1.294 -1.823 0 CA-C-N 113.818 -1.537 . . . . 71.41 108.526 -170.297 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.487 ' HB2' ' OXT' ' A' ' 255' ' ' ARG . 0.0 OUTLIER . . . . . 0 CA--C 1.514 -0.404 0 N-CA-C 108.896 -0.779 . . . . 74.32 108.896 . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 47.6 p 63.69 -68.8 0.08 Allowed 'General case' 0 C--O 1.216 -0.69 0 C-N-CA 125.887 1.675 . . . . 71.4 112.42 -175.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 23.6 m80 -81.84 129.65 34.82 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 112.161 0.43 . . . . 73.4 112.161 -175.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.541 ' O ' ' HA ' ' A' ' 248' ' ' THR . 12.8 tpt180 -131.22 143.39 50.54 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.34 -1.356 . . . . 71.42 107.34 173.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 30.4 ttt85 -120.09 113.24 20.19 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 121.233 0.539 . . . . 75.31 109.911 -178.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.534 ' O ' ' HA ' ' A' ' 246' ' ' ILE . 25.2 m -119.24 139.14 47.62 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 N-CA-C 112.501 0.556 . . . . 65.34 112.501 -175.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.438 ' HG3' HG12 ' A' ' 246' ' ' ILE . 3.3 mpt_? -100.1 112.93 25.23 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 107.086 -1.449 . . . . 73.45 107.086 177.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 23.9 mt -95.69 130.59 42.54 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 109.412 -0.588 . . . . 74.0 109.412 -178.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 6.1 tt 78.96 90.25 0.06 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 122.333 1.063 . . . . 74.14 110.757 176.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 57.0 pttt -101.32 -3.93 27.97 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-N 115.086 -0.961 . . . . 74.02 109.349 176.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 41.6 t-80 -161.09 120.32 2.57 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 114.169 -1.378 . . . . 73.42 107.952 175.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -179.45 -96.6 0.1 Allowed Glycine 0 N--CA 1.425 -2.095 0 C-N-CA 119.398 -1.382 . . . . 55.42 113.831 -179.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 66.7 m 67.55 7.03 5.32 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.563 0.745 . . . . 72.21 111.341 -174.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -148.65 15.92 0.99 Allowed 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 106.584 -1.636 . . . . 72.45 106.584 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -113.42 120.75 39.16 Favored Pre-proline 0 C--N 1.314 -0.948 0 CA-C-N 113.741 -1.572 . . . . 75.21 112.083 -172.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -70.13 141.2 43.14 Favored 'Trans proline' 0 N--CA 1.438 -1.789 0 N-CA-C 105.682 -2.468 . . . . 62.04 105.682 164.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.433 ' HG ' ' CD1' ' A' ' 245' ' ' LEU . 2.6 mm? -66.24 -27.09 67.69 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 120.235 -0.586 . . . . 64.34 111.912 -175.32 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . 0.455 ' HA3' ' HA3' ' A' ' 204' ' ' GLY . . . 91.56 38.92 5.73 Favored Glycine 0 N--CA 1.429 -1.823 0 C-N-CA 120.71 -0.757 . . . . 73.25 114.155 172.13 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -152.76 153.45 33.22 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 109.245 -0.65 . . . . 73.41 109.245 174.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -114.56 140.22 48.95 Favored 'General case' 0 C--N 1.282 -2.341 0 CA-C-N 115.674 -0.694 . . . . 71.13 109.282 178.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 29.1 pt -114.31 169.1 5.7 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.514 0 CA-C-N 115.446 -0.797 . . . . 75.32 109.885 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.484 ' HG2' ' HB2' ' A' ' 198' ' ' SER . 3.1 ptp180 -153.75 154.64 34.42 Favored 'General case' 0 C--N 1.278 -2.52 0 CA-C-N 115.541 -0.754 . . . . 73.14 108.97 -179.273 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -101.47 154.99 18.34 Favored 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 108.659 -0.867 . . . . 74.41 108.659 178.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -165.23 -168.61 27.66 Favored Glycine 0 N--CA 1.412 -2.95 0 N-CA-C 109.274 -1.531 . . . . 65.13 109.274 177.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' THR . . . . . 0.57 ' HB ' ' CG ' ' A' ' 191' ' ' LYS . 1.3 p -100.48 123.64 44.96 Favored 'General case' 0 C--N 1.28 -2.426 0 CA-C-O 121.876 0.846 . . . . 63.34 112.716 178.259 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 27.6 t -106.53 119.46 39.33 Favored 'General case' 0 N--CA 1.416 -2.127 0 N-CA-C 106.466 -1.679 . . . . 42.25 106.466 176.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.567 ' HA ' ' O ' ' A' ' 190' ' ' GLU . 6.7 p -119.74 120.81 64.47 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 CA-C-O 121.559 0.695 . . . . 72.24 110.154 177.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -126.8 161.14 28.89 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 115.22 -0.9 . . . . 71.31 108.791 -176.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.46 ' HA ' ' O ' ' A' ' 188' ' ' GLY . 69.7 t -87.3 118.81 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.044 0 N-CA-C 107.882 -1.155 . . . . 75.31 107.882 171.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 61.1 p -116.28 -174.62 2.59 Favored 'General case' 0 C--N 1.271 -2.829 0 CA-C-N 114.376 -1.284 . . . . 74.23 107.756 -178.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -68.18 -19.12 64.75 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.103 0.478 . . . . 70.33 110.108 177.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 46.2 m -88.64 -18.61 27.61 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 116.03 -0.532 . . . . 73.32 111.434 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.46 ' O ' ' HA ' ' A' ' 184' ' ' VAL . . . 126.97 -133.91 8.19 Favored Glycine 0 CA--C 1.486 -1.759 0 N-CA-C 110.0 -1.24 . . . . 73.03 110.0 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 5.7 mp -99.06 122.78 42.75 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.43 -0.952 . . . . 73.31 108.43 176.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . 0.567 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 52.3 mt-10 -129.18 119.44 24.08 Favored 'General case' 0 CA--C 1.448 -2.968 0 CA-C-O 121.321 0.582 . . . . 73.34 110.562 -177.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.57 ' CG ' ' HB ' ' A' ' 180' ' ' THR . 36.7 ttmt -99.62 121.48 41.27 Favored 'General case' 0 C--N 1.261 -3.263 0 CA-C-N 114.341 -1.299 . . . . 73.13 107.731 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -141.23 164.46 35.39 Favored Pre-proline 0 C--N 1.284 -2.281 0 N-CA-C 108.712 -0.847 . . . . 72.24 108.712 -174.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -57.52 132.21 49.14 Favored 'Trans proline' 0 N--CA 1.448 -1.153 0 C-N-CA 121.504 1.47 . . . . 73.04 111.638 176.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -141.03 146.33 17.52 Favored Glycine 0 N--CA 1.408 -3.191 0 N-CA-C 108.244 -1.942 . . . . 72.25 108.244 177.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 2.6 mp -104.32 133.03 49.52 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.413 0 C-N-CA 120.165 -0.614 . . . . 64.04 111.189 -178.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -122.96 167.49 13.52 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 108.085 -1.08 . . . . 74.54 108.085 -176.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 41.3 mm -77.62 132.95 31.61 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 N-CA-C 108.527 -0.916 . . . . 73.24 108.527 177.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' SER . . . . . 0.484 ' HB2' ' HG2' ' A' ' 177' ' ' ARG . 11.1 t -104.14 -36.51 7.66 Favored 'General case' 0 C--N 1.275 -2.646 0 O-C-N 121.731 -0.605 . . . . 75.42 112.488 178.039 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 20.1 tpp180 -167.15 144.52 4.67 Favored 'General case' 0 C--O 1.213 -0.855 0 N-CA-C 110.136 -0.32 . . . . 71.25 110.136 -177.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 78.8 mt -101.89 145.43 29.23 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 108.514 -0.921 . . . . 73.33 108.514 171.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 61.9 t -105.19 114.0 63.98 Favored Pre-proline 0 N--CA 1.42 -1.971 0 N-CA-C 105.972 -1.862 . . . . 52.13 105.972 172.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . 0.438 ' HA ' ' HG3' ' A' ' 207' ' ' GLU . 27.7 Cg_exo -62.01 136.87 63.59 Favored 'Trans proline' 0 N--CA 1.446 -1.293 0 C-N-CA 121.802 1.668 . . . . 72.44 110.268 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 104.12 -26.34 23.32 Favored Glycine 0 C--N 1.298 -1.581 0 N-CA-C 110.087 -1.205 . . . . 75.21 110.087 -175.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . 0.455 ' HA3' ' HA3' ' A' ' 173' ' ' GLY . . . -79.72 162.74 47.34 Favored Glycine 0 N--CA 1.423 -2.198 0 N-CA-C 111.031 -0.828 . . . . 62.31 111.031 178.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -62.94 -29.57 70.89 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.372 0.669 . . . . 74.52 111.847 -173.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -63.6 -46.94 83.5 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.19 0.519 . . . . 74.05 110.289 177.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.438 ' HG3' ' HA ' ' A' ' 202' ' ' PRO . 3.9 tm-20 -71.51 -33.65 69.4 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.26 -0.427 . . . . 74.11 109.929 178.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 50.5 m -56.39 -39.25 72.68 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.186 -0.461 . . . . 74.24 111.159 177.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 13.0 t -83.91 -40.57 18.4 Favored 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 119.197 -1.001 . . . . 71.34 109.832 176.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 65.71 2.5 11.82 Favored Glycine 0 C--N 1.343 0.966 0 N-CA-C 114.183 0.433 . . . . 62.53 114.183 177.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 60.9 mt -78.88 -12.3 60.03 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-O 120.969 0.414 . . . . 75.25 110.708 -177.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -109.86 134.88 51.57 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.329 -0.989 . . . . 74.55 108.329 174.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -117.41 162.11 18.46 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 116.624 -0.262 . . . . 73.01 110.306 -178.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 35.6 m -56.64 -31.52 34.87 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.77 0 N-CA-C 114.471 1.286 . . . . 64.05 114.471 -176.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -82.72 -14.26 54.88 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 112.773 0.657 . . . . 72.42 112.773 -178.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.565 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 54.3 m-20 -69.01 156.13 39.15 Favored 'General case' 0 C--O 1.246 0.904 0 N-CA-C 113.266 0.839 . . . . 55.33 113.266 -173.123 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -107.4 137.07 46.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.933 -1.03 . . . . 63.1 110.246 -179.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 30.9 t -84.53 125.74 40.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 121.464 0.649 . . . . 73.41 109.975 -179.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 40.1 mm -90.23 -49.99 13.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 CA-C-N 115.167 -0.924 . . . . 75.42 110.607 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.405 ' CB ' ' HA ' ' A' ' 225' ' ' GLU . 9.3 pt-20 -154.59 160.93 41.78 Favored 'General case' 0 C--O 1.249 1.062 0 CA-C-N 116.313 -0.403 . . . . 72.12 110.438 -179.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . 0.415 ' CG1' ' HE1' ' A' ' 237' ' ' MET . 8.4 p -121.49 113.57 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.215 0 CA-C-O 122.109 0.957 . . . . 75.42 108.968 174.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . 0.443 ' OD1' HD11 ' A' ' 246' ' ' ILE . 60.0 t30 40.74 68.37 0.42 Allowed 'General case' 0 C--N 1.28 -2.421 0 C-N-CA 127.103 2.161 . . . . 73.4 114.497 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 84.35 -20.85 11.92 Favored Glycine 0 N--CA 1.443 -0.848 0 CA-C-N 114.93 -1.032 . . . . 73.35 113.738 178.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 54.6 mt -105.92 123.41 60.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 117.034 0.417 . . . . 72.43 110.011 -176.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . 0.405 ' HA ' ' CB ' ' A' ' 220' ' ' GLU . 11.8 pt-20 -66.03 144.14 56.92 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.352 0.596 . . . . 73.43 111.564 -178.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 33.9 m -115.19 -2.24 10.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-N 115.923 -0.58 . . . . 75.51 111.186 178.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -73.92 98.88 3.11 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.933 -0.576 . . . . 74.31 110.058 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 120.59 -17.07 9.59 Favored Glycine 0 CA--C 1.498 -0.988 0 N-CA-C 111.45 -0.66 . . . . 71.42 111.45 179.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -78.98 162.87 25.66 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 108.737 -0.838 . . . . 74.35 108.737 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' THR . . . . . 0.404 ' O ' HG13 ' A' ' 234' ' ' VAL . 68.2 p -87.34 170.63 11.24 Favored 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 107.599 -1.26 . . . . 62.42 107.599 177.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . 0.404 ' HA ' HG21 ' A' ' 234' ' ' VAL . 0.7 OUTLIER -68.08 -34.46 76.45 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 107.347 -1.353 . . . . 74.11 107.347 179.976 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -58.54 -47.41 84.3 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-N 115.734 -0.666 . . . . 62.23 110.075 176.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -64.6 -49.05 72.63 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 113.902 1.075 . . . . 73.21 113.902 178.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.404 HG13 ' O ' ' A' ' 230' ' ' THR . 17.0 m -61.6 -33.47 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 112.581 0.585 . . . . 73.22 112.581 -176.399 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' THR . . . . . 0.486 ' O ' HG21 ' A' ' 239' ' ' VAL . 58.3 m -70.03 -35.84 74.61 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 115.803 -0.635 . . . . 74.23 109.887 -175.011 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -64.93 -30.94 71.96 Favored 'General case' 0 CA--C 1.508 -0.65 0 N-CA-C 108.86 -0.793 . . . . 36.61 108.86 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' MET . . . . . 0.415 ' HE1' ' CG1' ' A' ' 221' ' ' VAL . 5.7 mtm -74.36 -37.54 63.46 Favored 'General case' 0 C--O 1.199 -1.567 0 N-CA-C 108.259 -1.015 . . . . 72.11 108.259 -179.257 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 65.5 mtt -69.57 -34.66 74.49 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.212 -0.449 . . . . 71.13 110.998 178.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.486 HG21 ' O ' ' A' ' 235' ' ' THR . 99.0 t -67.04 -39.98 84.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.197 0.523 . . . . 71.52 110.222 176.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -68.29 -42.92 78.81 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.54 0.686 . . . . 75.24 109.325 176.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -79.69 18.13 0.81 Allowed 'General case' 0 C--O 1.192 -1.948 0 CA-C-N 115.025 -0.989 . . . . 73.21 112.237 178.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 70.3 m -68.26 -22.55 64.75 Favored 'General case' 0 N--CA 1.478 0.967 0 O-C-N 121.584 -0.698 . . . . 64.22 111.923 178.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 37.8 p -65.5 -22.48 66.73 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 116.275 -0.42 . . . . 73.15 110.727 176.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 178.05 101.12 0.02 OUTLIER 'General case' 0 CA--C 1.503 -0.834 0 C-N-CA 125.578 1.551 . . . . 74.22 107.63 176.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . 0.433 ' CD1' ' HG ' ' A' ' 172' ' ' LEU . 3.3 tt -90.01 106.52 18.53 Favored 'General case' 0 N--CA 1.414 -2.234 0 CA-C-N 115.515 -0.766 . . . . 63.21 110.203 -171.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . 0.534 ' HA ' ' O ' ' A' ' 161' ' ' VAL . 62.9 mt -95.32 127.92 46.92 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.068 0 N-CA-C 109.115 -0.698 . . . . 72.24 109.115 176.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 12.8 mt -132.16 142.54 42.53 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 CA-C-O 121.367 0.603 . . . . 73.11 112.26 176.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.541 ' HA ' ' O ' ' A' ' 159' ' ' ARG . 61.5 m -110.49 117.43 33.53 Favored 'General case' 0 N--CA 1.418 -2.058 0 N-CA-C 107.932 -1.136 . . . . 74.12 107.932 173.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 27.0 m -120.78 162.41 19.53 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 N-CA-C 109.322 -0.622 . . . . 62.43 109.322 175.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 15.8 ptmt -134.01 133.56 22.19 Favored Pre-proline 0 C--N 1.284 -2.24 0 CA-C-N 115.198 -0.91 . . . . 73.44 108.803 175.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . 0.565 ' HA ' ' OD1' ' A' ' 216' ' ' ASP . 61.1 Cg_exo -56.32 133.68 59.53 Favored 'Trans proline' 0 N--CA 1.443 -1.488 0 C-N-CA 122.115 1.877 . . . . 71.33 110.527 173.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -74.14 -7.31 52.14 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.834 0.826 . . . . 61.21 110.116 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -93.31 -4.9 50.86 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 114.508 -1.224 . . . . 55.1 109.196 178.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 58.37 90.8 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.533 0.733 . . . . 73.15 112.493 -176.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . 0.487 ' OXT' ' HB2' ' A' ' 156' ' ' GLU . 42.0 ttm180 . . . . . 0 C--N 1.301 -1.516 0 N-CA-C 108.76 -0.83 . . . . 65.44 108.76 179.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 . . . . . 0 N--CA 1.443 -0.803 0 N-CA-C 109.106 -0.701 . . . . 72.42 109.106 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.563 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 18.0 p -80.69 -27.3 37.06 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 121.259 0.552 . . . . 65.21 111.357 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 9.5 m80 -126.4 130.09 50.05 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 116.124 -0.489 . . . . 74.13 110.638 171.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.53 ' O ' ' HA ' ' A' ' 248' ' ' THR . 18.3 tpt180 -139.34 133.12 30.72 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 110.303 -0.258 . . . . 75.21 110.303 178.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.468 ' HA ' ' O ' ' A' ' 247' ' ' ILE . 4.6 ptp180 -117.6 118.63 32.65 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-O 121.756 0.789 . . . . 73.33 110.519 175.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 16.2 m -111.4 139.43 35.53 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.086 0 CA-C-N 114.914 -1.039 . . . . 73.34 111.338 -178.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.528 ' HG3' HG12 ' A' ' 246' ' ' ILE . 7.6 mpt_? -92.66 111.5 23.12 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 107.568 -1.271 . . . . 74.42 107.568 176.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.467 ' HB2' ' HB2' ' A' ' 245' ' ' LEU . 21.2 mt -91.28 137.03 32.68 Favored 'General case' 0 N--CA 1.416 -2.151 0 N-CA-C 108.38 -0.97 . . . . 63.2 108.38 -179.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.562 ' HG ' ' CD1' ' A' ' 172' ' ' LEU 0.391 10.8 mt 85.56 95.06 0.03 OUTLIER 'General case' 0 CA--C 1.476 -1.873 0 N-CA-C 115.305 1.595 . . . . 73.34 115.305 -175.054 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -139.08 14.65 2.64 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 113.508 -1.678 . . . . 71.22 108.211 177.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 24.5 t-80 -131.75 30.16 4.39 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 106.971 -1.492 . . . . 54.51 106.971 -179.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . 0.403 ' HA3' ' HD3' ' A' ' 170' ' ' LYS . . . 142.3 -167.19 26.19 Favored Glycine 0 N--CA 1.397 -3.93 0 N-CA-C 108.445 -1.862 . . . . 62.33 108.445 -179.285 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 30.0 p -154.82 143.5 20.7 Favored 'General case' 0 C--N 1.283 -2.299 0 CA-C-O 118.945 -0.55 . . . . 71.05 109.613 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 25.4 t70 77.69 0.78 2.87 Favored 'General case' 0 N--CA 1.506 2.343 0 C-N-CA 124.196 0.998 . . . . 75.43 111.022 -178.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.421 ' O ' HD13 ' A' ' 164' ' ' LEU . 57.2 mtpt -89.74 153.99 47.86 Favored Pre-proline 0 C--N 1.304 -1.413 0 C-N-CA 124.221 1.009 . . . . 74.53 110.593 -176.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -57.24 135.16 68.66 Favored 'Trans proline' 0 C--O 1.242 0.709 0 C-N-CA 122.927 2.418 . . . . 73.45 111.309 175.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.562 ' CD1' ' HG ' ' A' ' 164' ' ' LEU . 2.6 mm? -86.73 -34.97 19.49 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.081 0.467 . . . . 74.54 111.282 -175.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 101.77 45.47 1.77 Allowed Glycine 0 N--CA 1.419 -2.448 0 CA-C-N 115.469 -0.787 . . . . 73.34 112.75 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -156.94 154.47 29.75 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.499 -0.926 . . . . 74.44 108.499 175.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -124.34 144.95 49.72 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 108.971 -0.751 . . . . 72.43 108.971 175.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -110.67 169.81 3.67 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.238 0 N-CA-C 108.935 -0.765 . . . . 72.04 108.935 177.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.557 ' CG ' ' HB2' ' A' ' 198' ' ' SER . 16.4 ptt180 -149.43 154.49 38.95 Favored 'General case' 0 C--N 1.269 -2.921 0 CA-C-N 115.189 -0.914 . . . . 65.31 109.83 -178.069 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -111.98 138.2 48.95 Favored 'General case' 0 C--N 1.28 -2.434 0 N-CA-C 108.786 -0.82 . . . . 64.21 108.786 178.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -150.64 -175.4 22.6 Favored Glycine 0 C--N 1.285 -2.269 0 N-CA-C 108.469 -1.853 . . . . 52.42 108.469 178.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' THR . . . . . 0.587 ' CG2' ' HG2' ' A' ' 191' ' ' LYS . 0.2 OUTLIER -102.01 123.17 45.44 Favored 'General case' 0 N--CA 1.415 -2.181 0 C-N-CA 118.725 -1.19 . . . . 64.32 108.087 178.078 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' SER . . . . . 0.459 ' O ' ' HA ' ' A' ' 191' ' ' LYS . 37.5 t -96.82 125.95 41.63 Favored 'General case' 0 C--N 1.28 -2.423 0 N-CA-C 108.439 -0.949 . . . . 61.1 108.439 -178.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.669 ' HA ' ' O ' ' A' ' 190' ' ' GLU . 5.9 p -120.01 121.72 66.65 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.769 0 CA-C-O 121.461 0.648 . . . . 65.13 109.872 174.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -122.75 160.84 25.1 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 107.654 -1.239 . . . . 74.51 107.654 -178.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.514 ' HA ' ' O ' ' A' ' 188' ' ' GLY . 70.5 t -84.74 119.23 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.25 0 N-CA-C 107.489 -1.3 . . . . 63.52 107.489 169.155 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 42.4 p -115.03 -174.63 2.53 Favored 'General case' 0 C--N 1.264 -3.151 0 CA-C-N 114.565 -1.198 . . . . 74.41 108.073 -178.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -70.96 -9.8 58.57 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 120.979 0.419 . . . . 73.33 110.495 176.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 9.1 m -92.68 -19.34 21.94 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 109.043 -0.725 . . . . 65.32 109.043 178.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.514 ' O ' ' HA ' ' A' ' 184' ' ' VAL . . . 122.65 -120.23 4.22 Favored Glycine 0 C--O 1.197 -2.178 0 N-CA-C 107.981 -2.048 . . . . 54.33 107.981 -175.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 6.0 mp -101.24 128.29 47.44 Favored 'General case' 0 C--N 1.285 -2.224 0 CA-C-N 118.02 0.91 . . . . 75.33 109.591 175.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . 0.669 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 33.7 mt-10 -128.07 119.39 25.28 Favored 'General case' 0 CA--C 1.458 -2.562 0 CA-C-O 121.001 0.429 . . . . 72.23 110.974 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.587 ' HG2' ' CG2' ' A' ' 180' ' ' THR . 34.2 ttmt -104.14 126.37 51.2 Favored 'General case' 0 C--N 1.274 -2.695 0 CA-C-N 114.247 -1.342 . . . . 75.01 107.395 -179.525 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -151.54 161.22 30.24 Favored Pre-proline 0 C--N 1.298 -1.661 0 CA-C-N 115.861 -0.608 . . . . 73.2 109.588 -171.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -58.77 132.68 49.25 Favored 'Trans proline' 0 C--O 1.244 0.825 0 C-N-CA 121.472 1.448 . . . . 73.31 110.991 177.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -147.1 144.63 12.81 Favored Glycine 0 N--CA 1.419 -2.473 0 N-CA-C 109.987 -1.245 . . . . 72.42 109.987 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 3.0 mp -105.61 134.08 48.14 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 CA-C-O 121.338 0.589 . . . . 72.02 110.683 -178.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -128.25 168.5 15.4 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.191 -1.04 . . . . 65.14 108.191 -176.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . 0.444 ' HB ' ' HA ' ' A' ' 214' ' ' VAL . 43.3 mm -76.75 131.88 33.99 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 N-CA-C 108.131 -1.062 . . . . 72.43 108.131 176.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' SER . . . . . 0.557 ' HB2' ' CG ' ' A' ' 177' ' ' ARG . 13.0 t -103.96 -33.8 8.7 Favored 'General case' 0 C--N 1.284 -2.26 0 N-CA-C 113.181 0.808 . . . . 72.12 113.181 -178.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 15.0 ttp180 -168.17 142.77 3.49 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 116.621 -0.263 . . . . 74.25 111.025 -177.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 66.1 mt -103.71 137.06 42.28 Favored 'General case' 0 CA--C 1.486 -1.481 0 N-CA-C 108.162 -1.051 . . . . 71.43 108.162 172.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 66.6 t -93.44 114.5 63.07 Favored Pre-proline 0 C--N 1.288 -2.103 0 N-CA-C 105.733 -1.951 . . . . 71.24 105.733 174.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . 0.475 ' HA ' ' HG2' ' A' ' 207' ' ' GLU . 38.2 Cg_endo -70.37 126.23 12.69 Favored 'Trans proline' 0 N--CA 1.429 -2.308 0 C-N-CA 120.915 1.077 . . . . 72.44 110.201 -176.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 113.59 -12.98 23.02 Favored Glycine 0 C--N 1.302 -1.356 0 N-CA-C 109.787 -1.325 . . . . 64.42 109.787 -173.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -90.48 168.65 33.58 Favored Glycine 0 N--CA 1.436 -1.356 0 N-CA-C 110.15 -1.18 . . . . 73.03 110.15 176.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 66.0 mt -65.39 -29.56 70.28 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 117.41 0.605 . . . . 74.41 111.498 -177.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -61.93 -48.1 81.93 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.878 -0.601 . . . . 61.01 110.768 178.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.475 ' HG2' ' HA ' ' A' ' 202' ' ' PRO . 10.4 tp10 -73.04 -32.6 65.18 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.445 -0.576 . . . . 74.54 109.445 178.097 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 23.0 t -56.98 -40.33 76.33 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 115.91 -0.586 . . . . 63.14 110.45 178.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 14.9 t -79.29 -40.27 30.86 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 119.089 -1.044 . . . . 74.21 108.752 175.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 58.58 31.3 66.78 Favored Glycine 0 C--N 1.347 1.189 0 CA-C-N 115.888 -0.596 . . . . 71.14 113.139 178.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 1.8 pp -102.21 -19.33 15.11 Favored 'General case' 0 N--CA 1.424 -1.732 0 C-N-CA 120.297 -0.561 . . . . 61.3 110.692 -179.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -109.39 134.28 52.03 Favored 'General case' 0 N--CA 1.432 -1.362 0 N-CA-C 107.857 -1.164 . . . . 74.21 107.857 -179.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -129.8 165.92 20.98 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 116.474 -0.33 . . . . 61.51 110.566 -176.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . 0.444 ' HA ' ' HB ' ' A' ' 197' ' ' ILE . 17.4 m -53.92 -30.41 19.53 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 N-CA-C 114.195 1.183 . . . . 73.04 114.195 -176.012 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 -78.02 -15.36 59.0 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.823 -0.548 . . . . 75.32 112.24 -178.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.71 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 58.5 m-20 -79.34 155.92 28.24 Favored 'General case' 0 C--O 1.248 0.995 0 CA-C-O 121.079 0.466 . . . . 72.42 112.076 -174.08 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -109.58 139.43 44.6 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.333 -0.849 . . . . 61.11 111.872 -176.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 25.1 t -88.03 120.16 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 CA-C-O 121.349 0.595 . . . . 75.31 109.58 -179.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 38.8 mm -89.9 -53.97 8.36 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 CA-C-N 115.257 -0.883 . . . . 74.51 112.302 -176.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -155.27 151.98 28.7 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 116.742 -0.208 . . . . 62.35 111.534 -175.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 9.1 p -121.78 123.22 68.81 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 CA-C-O 121.293 0.568 . . . . 74.01 109.786 176.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . 0.467 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 9.0 t-20 66.69 7.58 5.28 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 125.487 1.515 . . . . 71.31 111.221 177.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 113.3 -7.17 24.88 Favored Glycine 0 N--CA 1.44 -1.036 0 CA-C-N 115.677 -0.692 . . . . 51.45 112.273 -177.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 66.3 mt -101.4 123.9 54.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 109.423 -0.584 . . . . 72.45 109.423 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -59.7 134.49 57.07 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-O 121.644 0.735 . . . . 75.54 111.932 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . 0.497 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 27.6 m -117.82 2.76 7.44 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 CA-C-N 115.158 -0.928 . . . . 74.44 110.047 177.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -83.57 98.77 9.76 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-N 115.332 -0.849 . . . . 74.33 109.38 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 120.35 -16.15 9.9 Favored Glycine 0 CA--C 1.489 -1.543 0 N-CA-C 111.283 -0.727 . . . . 74.54 111.283 -178.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -77.54 172.64 13.05 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 109.45 -0.574 . . . . 62.42 109.45 178.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 36.7 p -92.78 165.11 13.09 Favored 'General case' 0 N--CA 1.422 -1.841 0 N-CA-C 108.143 -1.058 . . . . 72.31 108.143 178.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 51.9 tp -61.16 -37.44 82.89 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 120.895 -0.322 . . . . 74.01 110.772 -177.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -57.76 -51.37 69.82 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 109.989 -0.375 . . . . 72.42 109.989 176.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -54.56 -48.55 71.93 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 115.676 -0.693 . . . . 72.4 112.508 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.497 ' CG1' ' HB ' ' A' ' 226' ' ' VAL . 7.1 m -75.27 -34.84 31.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 112.257 0.465 . . . . 64.02 112.257 -174.193 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 31.2 m -75.0 -35.6 61.99 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 108.905 -0.776 . . . . 63.31 108.905 -175.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -59.11 -33.49 70.91 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.119 -0.946 . . . . 71.24 109.415 176.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 5.8 mtt -73.56 -44.61 56.97 Favored 'General case' 0 C--O 1.2 -1.526 0 N-CA-C 107.91 -1.144 . . . . 73.22 107.91 178.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' MET . . . . . 0.421 ' HG3' ' O ' ' A' ' 234' ' ' VAL . 64.9 mtt -59.98 -41.65 92.46 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.36 -0.382 . . . . 73.53 111.943 -177.402 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 92.6 t -65.04 -38.71 83.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.227 0.536 . . . . 70.24 110.105 176.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -76.02 -19.9 58.27 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.355 0.598 . . . . 71.32 111.482 -179.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 -107.89 22.18 16.33 Favored 'General case' 0 C--O 1.205 -1.252 0 CA-C-N 115.94 -0.573 . . . . 62.03 110.471 177.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 22.8 t -63.44 -22.79 67.09 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.649 0.738 . . . . 75.04 109.141 177.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 16.1 p -69.56 -32.14 70.75 Favored 'General case' 0 N--CA 1.428 -1.569 0 CA-C-N 115.651 -0.704 . . . . 71.31 111.373 174.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -165.9 99.48 0.66 Allowed 'General case' 0 C--O 1.24 0.579 0 CA-C-O 121.749 0.785 . . . . 60.53 110.82 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . 0.467 ' HB2' ' HB2' ' A' ' 163' ' ' LEU . 10.3 mt -91.46 105.18 17.57 Favored 'General case' 0 C--O 1.195 -1.786 0 N-CA-C 113.085 0.772 . . . . 73.24 113.085 -178.264 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . 0.528 HG12 ' HG3' ' A' ' 162' ' ' ARG . 96.6 mt -95.51 114.12 31.44 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.432 0 N-CA-C 106.692 -1.596 . . . . 62.14 106.692 168.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . 0.468 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 76.9 mt -122.35 127.14 75.04 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.125 0 C-N-CA 120.436 -0.506 . . . . 72.3 111.153 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.53 ' HA ' ' O ' ' A' ' 159' ' ' ARG . 63.3 m -99.53 118.18 35.55 Favored 'General case' 0 N--CA 1.418 -2.05 0 CA-C-N 114.832 -1.076 . . . . 74.04 108.688 177.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 27.3 m -119.29 161.93 18.0 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 N-CA-C 108.974 -0.75 . . . . 70.43 108.974 174.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 17.4 ptmt -127.75 130.86 23.6 Favored Pre-proline 0 C--N 1.276 -2.616 0 CA-C-N 115.309 -0.86 . . . . 74.4 108.893 176.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . 0.71 ' HA ' ' OD1' ' A' ' 216' ' ' ASP . 29.0 Cg_endo -62.45 149.63 90.22 Favored 'Trans proline' 0 N--CA 1.445 -1.341 0 C-N-CA 122.676 2.251 . . . . 75.01 112.394 177.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -49.12 -38.13 23.96 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.267 -0.879 . . . . 75.12 111.369 178.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . 0.472 ' ND2' ' HG3' ' A' ' 254' ' ' GLN . 4.5 p-10 -136.15 -60.14 0.73 Allowed 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 115.798 -0.637 . . . . 60.33 111.151 174.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 254' ' ' GLN . . . . . 0.472 ' HG3' ' ND2' ' A' ' 253' ' ' ASN . 0.7 OUTLIER -153.83 161.15 42.29 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 117.565 0.166 . . . . 75.31 110.912 178.415 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 30.0 tpt180 . . . . . 0 C--O 1.245 0.828 0 N-CA-C 107.994 -1.113 . . . . 75.43 107.994 177.828 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 . . . . . 0 CA--C 1.517 -0.322 0 N-CA-C 109.463 -0.569 . . . . 72.13 109.463 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 57.9 p 38.28 -102.17 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 115.145 1.535 . . . . 64.13 115.145 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.539 ' HB3' ' HB3' ' A' ' 250' ' ' LYS . 4.4 p-80 -126.09 153.62 44.24 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.49 0.552 . . . . 70.41 112.49 179.381 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 36.6 ttm180 -125.58 143.7 50.9 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.581 -0.282 . . . . 75.14 110.407 -179.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 35.1 ptt180 -104.05 117.22 33.75 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.611 0.719 . . . . 72.44 111.783 179.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 30.3 m -114.93 139.93 38.64 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 CA-C-N 115.497 -0.774 . . . . 73.33 111.894 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 21.1 ttm180 -102.53 121.4 42.3 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 109.168 -0.679 . . . . 74.51 109.168 179.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 26.8 mt -103.08 139.68 38.29 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 123.347 0.659 . . . . 75.13 111.657 -174.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.498 HD13 ' HA ' ' A' ' 168' ' ' SER . 6.0 tt 84.81 91.62 0.03 OUTLIER 'General case' 0 CA--C 1.512 -0.503 0 C-N-CA 125.913 1.685 . . . . 74.03 112.216 171.247 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 60.8 pttt -102.23 -16.98 16.15 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.203 -0.908 . . . . 74.15 109.253 173.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 37.3 m80 -150.08 150.95 32.45 Favored 'General case' 0 CA--C 1.499 -1.011 0 CA-C-N 115.246 -0.888 . . . . 63.12 109.092 176.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 86.25 55.63 2.45 Favored Glycine 0 N--CA 1.437 -1.295 0 C-N-CA 120.735 -0.745 . . . . 64.2 112.913 176.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' SER . . . . . 0.498 ' HA ' HD13 ' A' ' 164' ' ' LEU . 33.9 t -79.37 2.69 20.7 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.322 0.582 . . . . 72.23 110.254 179.566 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -88.92 -19.71 25.45 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.586 -0.734 . . . . 70.32 111.238 178.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.407 ' HD2' ' O ' ' A' ' 170' ' ' LYS . 0.0 OUTLIER -118.74 153.67 52.45 Favored Pre-proline 0 N--CA 1.429 -1.514 0 N-CA-C 112.067 0.395 . . . . 74.01 112.067 -175.029 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -63.21 153.21 75.57 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 122.951 2.434 . . . . 72.12 111.304 176.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -58.39 -36.63 73.83 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 124.345 1.058 . . . . 74.01 112.459 -175.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 103.69 36.12 3.34 Favored Glycine 0 N--CA 1.424 -2.121 0 C-N-CA 120.174 -1.012 . . . . 63.41 112.533 178.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -147.48 153.84 40.04 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 108.661 -0.866 . . . . 74.43 108.661 174.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -123.77 155.41 37.97 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 108.183 -1.043 . . . . 75.03 108.183 177.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.437 HD11 ' SD ' ' A' ' 238' ' ' MET . 27.3 pt -125.18 169.5 16.48 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 CA-C-O 120.909 0.385 . . . . 74.25 111.329 -176.119 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.509 ' HG2' ' HB3' ' A' ' 198' ' ' SER . 1.1 ptp180 -148.91 154.15 39.02 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 123.332 0.653 . . . . 74.1 110.891 -179.157 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -103.38 138.84 39.58 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 109.065 -0.717 . . . . 62.04 109.065 176.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -154.38 -168.27 17.58 Favored Glycine 0 N--CA 1.416 -2.661 0 N-CA-C 109.197 -1.561 . . . . 73.31 109.197 177.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' THR . . . . . 0.502 ' HB ' ' CG ' ' A' ' 191' ' ' LYS . 1.0 OUTLIER -101.16 125.48 47.79 Favored 'General case' 0 C--N 1.276 -2.618 0 CA-C-O 121.14 0.495 . . . . 74.12 111.698 176.415 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 36.9 t -110.1 124.29 51.24 Favored 'General case' 0 N--CA 1.41 -2.463 0 N-CA-C 107.255 -1.387 . . . . 53.12 107.255 176.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.527 ' HA ' ' O ' ' A' ' 190' ' ' GLU . 5.2 p -120.39 127.97 75.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 CA-C-O 121.343 0.592 . . . . 73.52 110.176 177.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -126.09 159.47 32.74 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 115.291 -0.868 . . . . 72.03 109.153 -176.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.525 ' HA ' ' O ' ' A' ' 188' ' ' GLY . 71.1 t -89.77 118.29 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.193 0 N-CA-C 107.634 -1.247 . . . . 73.12 107.634 171.234 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 43.1 p -120.38 -174.9 2.89 Favored 'General case' 0 C--N 1.266 -3.024 0 CA-C-N 114.196 -1.366 . . . . 74.0 108.617 -177.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -62.67 -22.22 66.31 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-O 121.074 0.464 . . . . 64.44 109.838 175.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 16.6 m -86.4 -17.13 35.17 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-N 115.789 -0.641 . . . . 54.34 110.783 179.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.525 ' O ' ' HA ' ' A' ' 184' ' ' VAL . . . 115.77 -127.61 7.64 Favored Glycine 0 CA--C 1.482 -2.024 0 N-CA-C 108.606 -1.798 . . . . 75.15 108.606 -178.39 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 6.0 mp -98.49 123.43 42.64 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 108.775 -0.824 . . . . 63.22 108.775 176.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . 0.527 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 36.6 tt0 -129.21 119.05 23.38 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.38 -0.97 . . . . 61.43 108.38 -177.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.502 ' CG ' ' HB ' ' A' ' 180' ' ' THR . 35.4 ttmt -100.63 121.92 42.43 Favored 'General case' 0 N--CA 1.425 -1.71 0 N-CA-C 107.972 -1.121 . . . . 71.34 107.972 -178.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -130.75 164.15 43.74 Favored Pre-proline 0 C--N 1.284 -2.261 0 CA-C-N 115.473 -0.785 . . . . 75.33 109.336 -172.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -61.69 132.31 39.63 Favored 'Trans proline' 0 N--CA 1.447 -1.221 0 C-N-CA 121.108 1.205 . . . . 54.2 109.135 172.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -139.82 138.77 9.4 Favored Glycine 0 N--CA 1.415 -2.725 0 N-CA-C 110.085 -1.206 . . . . 40.24 110.085 -178.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.426 ' HA ' ' O ' ' A' ' 177' ' ' ARG . 3.4 mp -103.8 128.26 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.127 0 CA-C-O 121.418 0.628 . . . . 72.3 110.929 -179.101 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -121.75 167.12 13.34 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 107.57 -1.27 . . . . 73.3 107.57 -177.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . 0.433 ' HB ' ' HA ' ' A' ' 214' ' ' VAL . 50.1 mm -77.58 130.32 36.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 107.515 -1.291 . . . . 75.24 107.515 175.286 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' SER . . . . . 0.509 ' HB3' ' HG2' ' A' ' 177' ' ' ARG . 81.4 p -103.49 -22.37 13.64 Favored 'General case' 0 C--N 1.291 -1.95 0 C-N-CA 119.624 -0.831 . . . . 74.34 111.538 -175.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 27.6 tpt180 -167.12 146.28 5.19 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.398 -0.593 . . . . 74.32 109.398 -176.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 69.7 mt -112.51 139.67 47.9 Favored 'General case' 0 CA--C 1.484 -1.571 0 N-CA-C 108.541 -0.911 . . . . 75.23 108.541 172.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 53.2 t -95.8 114.92 65.05 Favored Pre-proline 0 C--N 1.288 -2.07 0 N-CA-C 105.811 -1.922 . . . . 73.53 105.811 171.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . 0.511 ' HA ' ' HG3' ' A' ' 207' ' ' GLU . 19.3 Cg_endo -62.3 126.81 19.38 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 121.938 1.758 . . . . 73.22 110.644 -177.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 103.38 -14.32 54.55 Favored Glycine 0 C--N 1.297 -1.587 0 C-N-CA 120.157 -1.021 . . . . 74.32 111.266 -175.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -81.93 162.24 42.6 Favored Glycine 0 N--CA 1.435 -1.422 0 N-CA-C 110.221 -1.152 . . . . 61.14 110.221 176.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 32.1 mt -53.9 -38.34 64.72 Favored 'General case' 0 C--N 1.309 -1.158 0 C-N-CA 124.737 1.215 . . . . 73.35 112.777 -175.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -66.0 -43.73 86.86 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.538 0.685 . . . . 71.11 110.919 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.511 ' HG3' ' HA ' ' A' ' 202' ' ' PRO . 3.3 tm-20 -76.16 -35.93 58.96 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 115.255 -0.884 . . . . 64.11 109.619 -178.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 55.8 m -61.0 -41.46 96.57 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.474 -0.33 . . . . 53.33 111.572 178.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 9.2 t -73.27 -33.21 65.13 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 119.489 -0.884 . . . . 61.43 109.253 176.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 70.14 10.91 66.36 Favored Glycine 0 CA--C 1.5 -0.886 0 CA-C-N 115.75 -0.659 . . . . 40.11 112.842 176.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 52.0 mt -95.42 -5.97 41.93 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.989 -0.745 . . . . 74.24 108.989 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 95.6 mt -109.49 131.21 55.28 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 107.817 -1.179 . . . . 71.44 107.817 174.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -133.63 166.11 23.35 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.216 -1.031 . . . . 41.23 108.216 176.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . 0.433 ' HA ' ' HB ' ' A' ' 197' ' ' ILE . 34.6 m -62.86 -31.3 51.9 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 N-CA-C 113.466 0.913 . . . . 71.03 113.466 -178.585 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -72.37 -13.42 61.47 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.995 -0.441 . . . . 55.22 111.577 179.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.482 ' HB3' ' HB ' ' A' ' 249' ' ' VAL . 6.3 m-20 -73.78 131.09 41.19 Favored 'General case' 0 C--O 1.242 0.705 0 N-CA-C 113.516 0.932 . . . . 71.32 113.516 -176.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . 0.415 ' O ' ' HA ' ' A' ' 249' ' ' VAL . 35.7 tt0 -103.72 132.26 50.13 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 113.827 -1.533 . . . . 64.33 109.676 -179.122 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 22.9 t -79.97 130.19 36.4 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 CA-C-O 121.433 0.635 . . . . 74.44 110.732 -176.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . 0.415 HD11 ' HD3' ' A' ' 250' ' ' LYS . 38.8 mm -95.16 -50.3 11.85 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 C-N-CA 124.06 0.944 . . . . 65.22 110.122 178.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -154.41 154.22 32.88 Favored 'General case' 0 N--CA 1.433 -1.325 0 CA-C-N 115.446 -0.797 . . . . 72.11 110.695 -176.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . 0.502 ' C ' ' H ' ' A' ' 223' ' ' GLY . 7.5 p -124.18 121.2 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 N-CA-C 108.415 -0.958 . . . . 75.13 108.415 177.268 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . 0.558 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 24.6 t-20 75.55 -24.34 0.22 Allowed 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 126.406 1.882 . . . . 71.13 111.774 -176.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . 0.502 ' H ' ' C ' ' A' ' 221' ' ' VAL . . . 140.43 -11.33 2.99 Favored Glycine 0 C--N 1.278 -2.654 0 N-CA-C 109.932 -1.267 . . . . 75.02 109.932 -174.287 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 67.4 mt -92.1 123.85 44.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 108.936 -0.764 . . . . 71.22 108.936 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -57.62 143.43 41.35 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 123.992 0.917 . . . . 74.32 112.006 -179.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 34.7 m -117.57 1.0 8.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 CA-C-N 115.667 -0.697 . . . . 75.23 110.92 176.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -78.12 97.34 5.41 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.86 -0.609 . . . . 73.13 110.224 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 120.41 -14.57 10.06 Favored Glycine 0 C--N 1.316 -0.532 0 N-CA-C 110.826 -0.91 . . . . 74.22 110.826 -179.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -79.8 170.13 16.95 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 108.333 -0.988 . . . . 74.01 108.333 177.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' THR . . . . . 0.509 ' O ' HG13 ' A' ' 234' ' ' VAL . 73.1 p -93.55 164.11 13.3 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 108.445 -0.946 . . . . 72.22 108.445 177.54 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . 0.411 ' HA ' HG21 ' A' ' 234' ' ' VAL . 0.7 OUTLIER -63.07 -36.15 82.62 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 107.017 -1.475 . . . . 63.31 107.017 179.105 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -61.85 -45.82 92.14 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.286 -0.87 . . . . 74.45 109.945 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -61.94 -50.39 72.34 Favored 'General case' 0 C--N 1.344 0.341 0 N-CA-C 112.385 0.513 . . . . 74.31 112.385 175.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.509 HG13 ' O ' ' A' ' 230' ' ' THR . 12.2 m -62.08 -33.89 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 N-CA-C 112.749 0.648 . . . . 63.55 112.749 -173.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 61.9 m -68.9 -39.05 79.93 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 109.394 -0.595 . . . . 74.44 109.394 -175.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -68.53 -30.43 69.22 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-N 115.614 -0.721 . . . . 72.44 109.793 -178.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 3.5 mtm -73.21 -36.47 66.49 Favored 'General case' 0 C--O 1.196 -1.728 0 N-CA-C 107.894 -1.15 . . . . 73.42 107.894 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' MET . . . . . 0.486 ' HG3' ' O ' ' A' ' 234' ' ' VAL . 65.5 mtt -63.11 -39.78 95.69 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 120.844 0.354 . . . . 74.0 110.133 177.268 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 79.0 t -66.34 -41.06 88.27 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 CA-C-N 116.096 -0.502 . . . . 63.35 109.682 176.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -66.01 -22.34 66.45 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.131 -0.486 . . . . 74.32 111.991 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 54.4 m-80 -105.12 21.93 16.24 Favored 'General case' 0 C--O 1.202 -1.426 0 CA-C-N 116.542 -0.299 . . . . 65.41 110.815 178.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 46.5 t -56.36 -24.44 44.27 Favored 'General case' 0 C--O 1.213 -0.849 0 N-CA-C 113.68 0.992 . . . . 73.03 113.68 -179.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 29.1 m -78.59 -22.15 47.52 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 120.359 -0.537 . . . . 64.42 111.424 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -171.5 94.14 0.16 Allowed 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.726 1.211 . . . . 71.14 108.956 178.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 1.7 tt -90.77 109.24 20.44 Favored 'General case' 0 N--CA 1.419 -1.983 0 CA-C-N 114.618 -1.174 . . . . 62.02 110.071 -171.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . 0.558 ' HB ' ' HA ' ' A' ' 222' ' ' ASN . 61.3 mt -95.76 117.13 39.2 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 N-CA-C 108.963 -0.755 . . . . 75.43 108.963 176.528 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 9.3 mt -123.83 135.3 63.92 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.99 0 CA-C-O 121.819 0.818 . . . . 73.15 111.305 176.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 37.7 m -108.79 124.54 50.76 Favored 'General case' 0 N--CA 1.41 -2.441 0 CA-C-N 114.476 -1.238 . . . . 64.32 108.493 178.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . 0.482 ' HB ' ' HB3' ' A' ' 216' ' ' ASP . 29.1 m -134.75 152.99 34.09 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-O 121.754 0.788 . . . . 74.43 112.18 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . 0.539 ' HB3' ' HB3' ' A' ' 158' ' ' HIS . 1.1 ptmm? -128.79 132.6 24.46 Favored Pre-proline 0 C--N 1.293 -1.872 0 CA-C-N 113.938 -1.483 . . . . 73.35 109.203 172.517 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -61.78 150.44 85.89 Favored 'Trans proline' 0 N--CA 1.447 -1.25 0 C-N-CA 122.549 2.166 . . . . 73.44 110.713 176.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -46.71 -49.02 20.12 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-O 121.345 0.593 . . . . 75.44 110.901 177.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -96.59 79.85 3.06 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 107.928 -1.138 . . . . 74.11 107.928 176.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 254' ' ' GLN . . . . . 0.451 ' HG2' ' HE2' ' A' ' 250' ' ' LYS . 4.8 pp0? -97.56 153.52 18.12 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 112.951 0.722 . . . . 74.4 112.951 -178.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 38.5 ttt180 . . . . . 0 N--CA 1.421 -1.909 0 N-CA-C 107.467 -1.308 . . . . 74.23 107.467 177.189 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 . . . . . 0 CA--C 1.508 -0.669 0 N-CA-C 109.147 -0.686 . . . . 55.1 109.147 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.528 ' HB ' ' OE1' ' A' ' 254' ' ' GLN . 41.7 p -92.77 -27.12 17.4 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-O 121.261 0.553 . . . . 73.13 110.131 176.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.405 ' ND1' ' HB3' ' A' ' 250' ' ' LYS . 0.3 OUTLIER -123.27 137.62 54.82 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 122.842 0.457 . . . . 75.04 109.888 174.288 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.473 ' O ' ' HA ' ' A' ' 248' ' ' THR . 2.2 tpm_? -128.95 138.53 52.03 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 108.096 -1.076 . . . . 72.35 108.096 177.047 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 14.9 ptp180 -122.6 117.03 24.89 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-O 121.2 0.524 . . . . 71.23 110.222 178.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 27.7 m -122.66 140.49 46.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 CA-C-N 115.479 -0.782 . . . . 74.44 112.02 -175.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.508 ' HG2' HG12 ' A' ' 246' ' ' ILE . 67.0 mtm180 -92.95 111.29 22.86 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.824 -1.176 . . . . 72.11 107.824 177.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.452 ' HB2' ' HB3' ' A' ' 245' ' ' LEU . 31.8 mt -89.32 139.12 30.82 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 109.28 -0.637 . . . . 73.54 109.28 -178.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.403 HD13 ' O ' ' A' ' 242' ' ' SER . 6.1 tt 71.63 83.09 0.14 Allowed 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 123.037 1.399 . . . . 72.21 108.397 179.337 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 49.0 pttt -100.34 2.14 42.21 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 113.027 -1.897 . . . . 62.33 109.839 -177.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 18.6 m170 -95.43 -171.11 2.31 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 114.403 -1.271 . . . . 73.13 109.118 173.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -123.15 76.84 0.36 Allowed Glycine 0 CA--C 1.484 -1.9 0 N-CA-C 108.06 -2.016 . . . . 53.13 108.06 176.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 40.1 m -141.8 143.47 33.45 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-N 115.487 -0.357 . . . . 63.31 110.676 -173.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -89.9 68.8 7.43 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 107.087 -1.449 . . . . 65.43 107.087 173.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 56.7 tttp -109.54 145.61 32.27 Favored Pre-proline 0 N--CA 1.401 -2.878 0 CA-C-N 112.968 -1.924 . . . . 73.02 111.283 -173.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -67.26 135.9 38.54 Favored 'Trans proline' 0 C--O 1.245 0.841 0 C-N-CA 122.455 2.103 . . . . 72.43 109.711 172.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -63.86 -35.11 79.55 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 113.531 0.937 . . . . 74.25 113.531 -175.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 91.77 36.42 6.44 Favored Glycine 0 N--CA 1.434 -1.48 0 C-N-CA 119.813 -1.184 . . . . 50.23 113.789 175.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . 0.425 ' HB3' ' CB ' ' A' ' 206' ' ' ALA . 18.9 p90 -156.61 153.33 28.43 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.755 -1.202 . . . . 63.34 107.755 173.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -128.7 150.29 50.32 Favored 'General case' 0 C--N 1.287 -2.129 0 N-CA-C 108.769 -0.826 . . . . 75.02 108.769 179.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -123.92 170.08 14.54 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.438 0 CA-C-O 121.372 0.606 . . . . 73.31 110.739 -176.222 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.494 ' HG2' ' HB2' ' A' ' 198' ' ' SER . 2.7 ptp180 -147.46 154.39 40.74 Favored 'General case' 0 C--N 1.275 -2.638 0 CA-C-N 115.141 -0.936 . . . . 74.35 110.226 -177.456 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -104.7 138.3 41.22 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 109.509 -0.552 . . . . 74.31 109.509 179.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -155.54 136.77 5.25 Favored Glycine 0 C--N 1.284 -2.339 0 N-CA-C 109.823 -1.311 . . . . 74.14 109.823 177.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' THR . . . . . 0.442 ' CG2' ' HG2' ' A' ' 191' ' ' LYS . 0.2 OUTLIER -89.24 123.49 33.51 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 105.903 -1.888 . . . . 72.13 105.903 179.292 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 22.7 t -109.64 126.54 53.76 Favored 'General case' 0 C--N 1.269 -2.911 0 N-CA-C 109.112 -0.699 . . . . 73.12 109.112 -176.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.569 ' HA ' ' O ' ' A' ' 190' ' ' GLU . 7.6 p -103.72 122.22 56.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 N-CA-C 108.973 -0.751 . . . . 70.43 108.973 177.089 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -129.58 160.56 32.88 Favored 'General case' 0 CA--C 1.468 -2.183 0 CA-C-N 115.381 -0.827 . . . . 71.4 109.654 -173.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.561 ' HA ' ' O ' ' A' ' 188' ' ' GLY . 98.1 t -82.28 118.61 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.428 0 N-CA-C 108.079 -1.082 . . . . 62.32 108.079 172.582 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 34.3 p -115.9 -174.44 2.53 Favored 'General case' 0 C--N 1.262 -3.219 0 CA-C-N 113.654 -1.612 . . . . 71.32 107.402 -178.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -66.2 -21.85 66.32 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 121.177 0.513 . . . . 73.43 109.807 176.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 30.5 p -88.85 -18.67 27.13 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-N 115.77 -0.65 . . . . 75.3 112.586 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.561 ' O ' ' HA ' ' A' ' 184' ' ' VAL . . . 125.06 -127.69 6.39 Favored Glycine 0 C--O 1.205 -1.679 0 N-CA-C 109.643 -1.383 . . . . 70.32 109.643 -178.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 7.0 mp -100.71 119.27 38.35 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 117.569 0.685 . . . . 74.15 109.365 176.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . 0.569 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 10.2 tp10 -131.72 126.79 35.4 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 108.646 -0.872 . . . . 74.51 108.646 -178.16 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.442 ' HG2' ' CG2' ' A' ' 180' ' ' THR . 34.2 ttmt -96.19 125.97 41.08 Favored 'General case' 0 N--CA 1.427 -1.606 0 N-CA-C 107.618 -1.252 . . . . 74.04 107.618 -178.121 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 43.2 tp60 -140.98 134.54 14.77 Favored Pre-proline 0 C--N 1.287 -2.144 0 CA-C-N 115.78 -0.645 . . . . 70.32 109.816 -168.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -64.73 130.77 27.19 Favored 'Trans proline' 0 N--CA 1.447 -1.209 0 C-N-CA 121.726 1.617 . . . . 75.32 111.885 179.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -133.82 141.4 12.73 Favored Glycine 0 N--CA 1.403 -3.539 0 N-CA-C 109.285 -1.526 . . . . 63.22 109.285 174.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.528 ' HB ' ' CG1' ' A' ' 218' ' ' VAL . 3.8 mp -103.8 129.78 55.35 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.676 0 N-CA-C 108.351 -0.981 . . . . 73.43 108.351 175.129 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -123.59 161.15 25.56 Favored 'General case' 0 C--N 1.275 -2.644 0 N-CA-C 107.271 -1.381 . . . . 73.12 107.271 -174.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 57.6 mt -79.24 127.69 38.95 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.892 0 CA-C-O 121.588 0.709 . . . . 72.24 110.294 177.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' SER . . . . . 0.494 ' HB2' ' HG2' ' A' ' 177' ' ' ARG . 24.4 t -101.56 -18.67 15.82 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 112.891 0.701 . . . . 74.13 112.891 -177.246 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 75.3 ttt180 -166.55 139.5 3.83 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.327 -0.549 . . . . 74.22 111.239 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 88.3 mt -103.72 146.61 28.35 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.575 -0.898 . . . . 64.01 108.575 172.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 62.1 t -112.09 114.77 50.98 Favored Pre-proline 0 C--N 1.283 -2.298 0 N-CA-C 105.886 -1.894 . . . . 73.2 105.886 171.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . 0.408 ' HA ' ' HG2' ' A' ' 207' ' ' GLU . 31.1 Cg_endo -64.45 130.67 27.38 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 121.866 1.71 . . . . 71.14 110.6 -177.314 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 103.23 -17.65 50.94 Favored Glycine 0 N--CA 1.439 -1.137 0 N-CA-C 110.137 -1.185 . . . . 73.04 110.137 -175.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -83.74 171.76 49.48 Favored Glycine 0 N--CA 1.43 -1.751 0 N-CA-C 110.298 -1.121 . . . . 50.05 110.298 177.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -63.07 -33.24 75.02 Favored 'General case' 0 N--CA 1.432 -1.339 0 N-CA-C 113.272 0.842 . . . . 72.24 113.272 -174.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . 0.425 ' CB ' ' HB3' ' A' ' 174' ' ' PHE . . . -66.3 -48.13 71.35 Favored 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 120.847 -0.341 . . . . 75.33 111.22 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.408 ' HG2' ' HA ' ' A' ' 202' ' ' PRO . 8.2 tp10 -73.39 -33.1 64.84 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 109.34 -0.615 . . . . 64.23 109.34 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 30.8 t -56.4 -47.51 78.86 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-O 122.044 0.926 . . . . 73.22 109.038 176.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 84.1 m -70.09 -40.74 74.8 Favored 'General case' 0 N--CA 1.382 -3.86 0 CA-C-N 114.41 -1.268 . . . . 64.24 109.358 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 74.35 -7.28 18.56 Favored Glycine 0 CA--C 1.504 -0.621 0 CA-C-N 116.246 -0.434 . . . . 74.41 113.097 176.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 38.4 mt -87.46 -6.56 58.35 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 109.061 -0.718 . . . . 74.21 109.061 -178.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 9.4 mp -108.92 131.35 55.11 Favored 'General case' 0 N--CA 1.422 -1.834 0 CA-C-N 115.181 -0.918 . . . . 71.21 109.678 174.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -132.44 166.32 22.27 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 107.177 -1.416 . . . . 72.35 107.177 175.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 33.6 m -58.57 -30.32 41.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-O 121.828 0.823 . . . . 63.24 111.623 177.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -68.59 -15.04 63.4 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 115.367 -0.833 . . . . 74.41 112.271 -179.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.435 ' HB3' ' HB ' ' A' ' 249' ' ' VAL . 6.7 m-20 -75.07 141.49 43.82 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 113.623 0.971 . . . . 75.12 113.623 -176.46 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . 0.466 ' HB3' ' HG3' ' A' ' 250' ' ' LYS . 40.4 tt0 -113.45 128.11 56.34 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 125.455 1.502 . . . . 63.41 109.852 -176.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . 0.528 ' CG1' ' HB ' ' A' ' 195' ' ' ILE . 12.5 p -80.03 128.84 38.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 122.143 0.973 . . . . 54.44 111.808 -176.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 44.0 mm -99.14 -48.96 11.77 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 CA-C-N 114.398 -1.274 . . . . 73.14 110.121 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.426 ' CB ' ' HA ' ' A' ' 225' ' ' GLU . 10.8 pt-20 -157.94 160.16 37.28 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.842 -0.617 . . . . 54.54 110.198 -177.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 246' ' ' ILE . 8.8 p -131.0 120.61 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 O-C-N 123.758 0.661 . . . . 74.32 109.656 179.459 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . 0.455 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 10.7 m120 61.39 24.97 15.0 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.02 0.928 . . . . 74.42 112.946 176.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 97.23 -3.21 61.68 Favored Glycine 0 C--N 1.309 -0.953 0 CA-C-N 115.274 -0.876 . . . . 73.01 112.66 179.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 63.3 mt -111.22 123.51 67.16 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 N-CA-C 109.312 -0.625 . . . . 71.13 109.312 179.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . 0.426 ' HA ' ' CB ' ' A' ' 220' ' ' GLU . 12.5 pt-20 -62.73 153.71 31.81 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 121.551 0.691 . . . . 75.42 112.424 -178.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . 0.41 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 29.3 m -123.53 -3.51 6.99 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 CA-C-N 115.19 -0.914 . . . . 73.04 110.904 177.135 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -68.66 97.28 0.79 Allowed 'General case' 0 N--CA 1.443 -0.802 0 CA-C-O 121.416 0.627 . . . . 72.44 111.184 -177.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 127.78 -26.17 4.87 Favored Glycine 0 CA--C 1.49 -1.484 0 CA-C-N 115.488 -0.778 . . . . 74.35 111.571 177.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -73.65 170.98 14.1 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.231 0.539 . . . . 73.24 111.446 -178.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 47.6 p -88.53 163.89 15.68 Favored 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 108.674 -0.862 . . . . 73.21 108.674 -179.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -63.58 -36.97 85.56 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 107.712 -1.218 . . . . 71.43 107.712 -177.351 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -61.32 -40.9 95.92 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.561 -0.745 . . . . 75.44 110.824 177.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -66.02 -48.67 70.37 Favored 'General case' 0 C--O 1.218 -0.56 0 CA-C-N 116.307 -0.406 . . . . 71.22 111.691 177.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.424 ' O ' ' HG3' ' A' ' 238' ' ' MET . 13.7 m -66.8 -34.19 68.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 112.413 0.523 . . . . 63.13 112.413 -175.162 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' THR . . . . . 0.42 ' O ' HG21 ' A' ' 239' ' ' VAL . 32.9 m -72.01 -36.15 69.62 Favored 'General case' 0 CA--C 1.5 -0.976 0 N-CA-C 109.018 -0.734 . . . . 75.32 109.018 -177.062 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -60.46 -33.65 72.87 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 115.861 -0.609 . . . . 54.04 109.932 178.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' MET . . . . . 0.403 ' HE1' ' CG1' ' A' ' 221' ' ' VAL . 1.0 OUTLIER -72.08 -43.6 64.58 Favored 'General case' 0 C--O 1.206 -1.219 0 N-CA-C 108.052 -1.092 . . . . 73.42 108.052 -179.25 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' MET . . . . . 0.424 ' HG3' ' O ' ' A' ' 234' ' ' VAL . 64.4 mtt -62.83 -40.18 96.62 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.615 -0.72 . . . . 73.52 111.431 179.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.42 HG21 ' O ' ' A' ' 235' ' ' THR . 97.6 t -66.92 -42.11 88.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.841 0.353 . . . . 73.23 110.463 178.256 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -65.42 -39.5 92.22 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.654 0.74 . . . . 63.23 110.078 178.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -83.57 20.98 1.28 Allowed 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 114.731 -1.122 . . . . 71.41 111.957 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 242' ' ' SER . . . . . 0.403 ' O ' HD13 ' A' ' 164' ' ' LEU . 22.9 t -62.35 -23.04 66.56 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 111.742 0.275 . . . . 61.32 111.742 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 16.5 m -63.33 -29.94 71.16 Favored 'General case' 0 CA--C 1.554 1.121 0 CA-C-O 120.893 0.377 . . . . 61.12 110.425 178.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -175.19 95.96 0.07 Allowed 'General case' 0 C--O 1.245 0.867 0 N-CA-C 106.856 -1.535 . . . . 75.41 106.856 179.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . 0.452 ' HB3' ' HB2' ' A' ' 163' ' ' LEU . 2.2 tt -85.97 108.0 18.01 Favored 'General case' 0 C--O 1.201 -1.453 0 CA-C-N 115.448 -0.796 . . . . 74.51 109.212 -171.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . 0.508 HG12 ' HG2' ' A' ' 162' ' ' ARG . 77.7 mt -101.12 116.76 45.29 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.105 0 O-C-N 121.777 -0.577 . . . . 73.23 109.736 -178.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . 0.506 ' CG2' HG13 ' A' ' 249' ' ' VAL . 15.8 mt -121.87 136.66 58.03 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.152 0 N-CA-C 113.172 0.804 . . . . 75.44 113.172 179.622 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.473 ' HA ' ' O ' ' A' ' 159' ' ' ARG . 63.3 m -103.56 114.83 29.39 Favored 'General case' 0 N--CA 1.413 -2.316 0 N-CA-C 107.633 -1.247 . . . . 63.11 107.633 172.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . 0.506 HG13 ' CG2' ' A' ' 247' ' ' ILE . 10.2 m -121.51 168.55 13.84 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.399 0 CA-C-O 121.809 0.814 . . . . 75.32 110.054 175.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . 0.466 ' HG3' ' HB3' ' A' ' 217' ' ' GLU . 8.1 ptmt -136.62 139.16 28.46 Favored Pre-proline 0 C--N 1.257 -3.448 0 CA-C-N 113.647 -1.615 . . . . 72.31 107.665 175.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -63.34 148.24 92.99 Favored 'Trans proline' 0 N--CA 1.443 -1.482 0 C-N-CA 121.202 1.268 . . . . 70.5 108.962 173.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -65.39 -33.93 77.11 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 108.078 -1.082 . . . . 74.02 108.078 175.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -93.41 77.98 4.43 Favored 'General case' 0 N--CA 1.415 -2.183 0 CA-C-N 113.774 -1.557 . . . . 64.4 108.506 175.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 254' ' ' GLN . . . . . 0.528 ' OE1' ' HB ' ' A' ' 157' ' ' THR . 42.3 mt-30 -77.42 128.7 34.69 Favored 'General case' 0 CA--C 1.497 -1.078 0 C-N-CA 119.983 -0.687 . . . . 75.41 110.53 178.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 38.1 mmt180 . . . . . 0 C--N 1.285 -2.225 0 N-CA-C 107.461 -1.311 . . . . 62.24 107.461 176.964 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.468 0.438 0 CA-C-O 121.153 0.502 . . . . 73.11 109.914 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 22.4 p -77.94 -47.6 18.25 Favored 'General case' 0 N--CA 1.424 -1.741 0 CA-C-N 116.126 -0.488 . . . . 61.12 111.422 178.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 13.7 m80 -81.99 130.19 35.0 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 120.464 -0.494 . . . . 73.42 111.191 176.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.468 ' O ' ' HA ' ' A' ' 248' ' ' THR . 8.3 ttm180 -131.64 141.82 49.71 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 107.681 -1.229 . . . . 71.21 107.681 179.34 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -128.75 112.55 14.31 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-O 121.175 0.512 . . . . 74.24 109.676 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 16.5 m -118.15 139.57 44.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-N 115.025 -0.989 . . . . 71.42 112.044 -177.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 17.4 ttm180 -100.29 112.48 24.81 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.107 -1.072 . . . . 70.11 108.107 177.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.401 ' HB2' ' HB3' ' A' ' 245' ' ' LEU . 20.8 mt -99.86 137.07 38.83 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 108.184 -1.043 . . . . 71.35 108.184 -176.071 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.416 ' O ' ' HA ' ' A' ' 244' ' ' ASN . 3.4 tt 62.2 70.92 0.55 Allowed 'General case' 0 C--O 1.207 -1.141 0 N-CA-C 107.1 -1.444 . . . . 75.11 107.1 177.157 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -100.11 0.1 40.03 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-N 115.558 -0.747 . . . . 74.4 111.096 -176.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 31.0 m170 -88.6 -25.12 22.62 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 120.446 -0.502 . . . . 75.21 111.565 179.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 84.53 41.54 7.78 Favored Glycine 0 C--O 1.226 -0.388 0 N-CA-C 110.483 -1.047 . . . . 73.0 110.483 -177.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 27.1 m -88.58 -12.9 41.37 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 112.533 0.568 . . . . 73.32 112.533 -177.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 30.0 t70 61.35 16.3 7.29 Favored 'General case' 0 N--CA 1.51 2.553 0 C-N-CA 124.357 1.063 . . . . 73.12 111.891 -179.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.478 ' HB2' ' HZ3' ' A' ' 170' ' ' LYS . 0.0 OUTLIER -76.47 154.27 83.85 Favored Pre-proline 0 C--N 1.302 -1.492 0 CA-C-N 115.615 -0.72 . . . . 64.42 110.414 -179.788 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -52.44 144.23 41.5 Favored 'Trans proline' 0 C--O 1.24 0.609 0 C-N-CA 122.697 2.265 . . . . 70.53 110.947 174.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.418 ' HA ' HD21 ' A' ' 205' ' ' LEU . 3.5 mm? -77.38 -32.64 55.05 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 112.254 0.465 . . . . 73.14 112.254 -176.416 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . 0.455 ' HA3' ' HA3' ' A' ' 204' ' ' GLY . . . 84.49 36.01 13.04 Favored Glycine 0 N--CA 1.427 -1.929 0 C-N-CA 120.389 -0.91 . . . . 74.12 112.948 177.204 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -150.0 154.24 37.87 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.338 -0.986 . . . . 73.13 108.338 174.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -121.32 143.65 49.07 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 108.966 -0.753 . . . . 73.34 108.966 175.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -114.38 166.23 8.47 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.467 0 CA-C-N 115.812 -0.631 . . . . 64.5 109.484 178.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.562 ' HG2' ' HB2' ' A' ' 198' ' ' SER . 4.8 ptp180 -146.87 154.32 41.18 Favored 'General case' 0 C--N 1.277 -2.582 0 CA-C-N 115.072 -0.967 . . . . 74.23 110.589 -178.264 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -111.86 138.45 48.44 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 124.15 0.906 . . . . 75.44 111.145 -179.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -157.34 -164.35 13.62 Favored Glycine 0 C--N 1.29 -2.016 0 N-CA-C 108.424 -1.87 . . . . 73.0 108.424 175.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' THR . . . . . 0.447 ' CG2' ' HG2' ' A' ' 191' ' ' LYS . 0.4 OUTLIER -105.69 123.55 48.11 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-N 118.017 0.909 . . . . 73.24 111.827 175.546 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 41.0 t -106.14 114.03 27.91 Favored 'General case' 0 N--CA 1.414 -2.257 0 N-CA-C 107.326 -1.361 . . . . 54.04 107.326 176.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.531 ' HA ' ' O ' ' A' ' 190' ' ' GLU . 6.7 p -106.08 119.79 56.0 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.779 0 N-CA-C 108.89 -0.782 . . . . 73.45 108.89 175.196 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . 0.418 ' O ' ' HA ' ' A' ' 189' ' ' LEU . 96.1 mtt180 -121.22 158.29 28.38 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-N 115.031 -0.986 . . . . 71.11 108.785 -175.411 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 74.3 t -87.89 119.42 35.34 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.203 0 N-CA-C 106.627 -1.62 . . . . 70.44 106.627 169.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 67.4 p -114.79 -175.21 2.64 Favored 'General case' 0 C--N 1.268 -2.958 0 CA-C-N 114.811 -1.086 . . . . 73.45 108.693 -176.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -60.71 -22.32 63.84 Favored 'General case' 0 C--N 1.314 -0.967 0 O-C-N 123.404 0.44 . . . . 55.04 110.416 175.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 20.0 m -99.52 -11.21 21.24 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 116.33 -0.395 . . . . 74.24 111.692 -179.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 121.06 -154.39 16.46 Favored Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 120.171 -1.014 . . . . 62.54 110.926 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.418 ' HA ' ' O ' ' A' ' 183' ' ' ARG . 4.9 mp -78.69 120.99 24.15 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 117.483 0.642 . . . . 74.13 109.41 -179.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . 0.531 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 38.8 tt0 -131.1 119.46 21.98 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 109.003 -0.74 . . . . 65.52 109.003 -177.326 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.447 ' HG2' ' CG2' ' A' ' 180' ' ' THR . 36.5 ttmt -96.18 121.69 38.22 Favored 'General case' 0 N--CA 1.426 -1.66 0 N-CA-C 108.155 -1.054 . . . . 75.42 108.155 -178.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -136.53 165.56 34.35 Favored Pre-proline 0 C--N 1.279 -2.462 0 N-CA-C 108.228 -1.027 . . . . 62.52 108.228 -174.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . 0.409 ' HD2' ' HA2' ' A' ' 228' ' ' GLY . 53.8 Cg_exo -55.26 132.11 50.3 Favored 'Trans proline' 0 N--CA 1.445 -1.373 0 C-N-CA 121.126 1.218 . . . . 72.53 109.287 170.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -131.86 127.26 4.93 Favored Glycine 0 N--CA 1.403 -3.529 0 N-CA-C 109.278 -1.529 . . . . 64.54 109.278 -179.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.488 ' HB ' ' CG1' ' A' ' 218' ' ' VAL . 3.6 mp -104.37 132.06 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.814 0 CA-C-O 121.365 0.603 . . . . 75.42 109.51 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -127.61 167.4 16.43 Favored 'General case' 0 C--N 1.277 -2.553 0 N-CA-C 107.365 -1.346 . . . . 71.34 107.365 -175.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . 0.46 ' HB ' ' HA ' ' A' ' 214' ' ' VAL . 45.1 mm -79.17 130.1 36.62 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 N-CA-C 107.877 -1.157 . . . . 73.35 107.877 173.11 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' SER . . . . . 0.562 ' HB2' ' HG2' ' A' ' 177' ' ' ARG . 28.0 t -100.45 -34.07 10.09 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 111.946 0.35 . . . . 51.13 111.946 -178.44 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 15.4 ttp180 -160.64 141.23 11.58 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-O 120.748 0.309 . . . . 73.11 110.358 -178.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 1.1 tt -108.03 135.49 49.3 Favored 'General case' 0 N--CA 1.426 -1.67 0 N-CA-C 107.172 -1.418 . . . . 74.15 107.172 -177.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 59.7 t -106.0 121.3 46.13 Favored Pre-proline 0 C--N 1.311 -1.104 0 N-CA-C 110.129 -0.323 . . . . 75.51 110.129 179.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . 0.468 ' HA ' ' HG3' ' A' ' 207' ' ' GLU . 27.5 Cg_endo -62.6 135.54 53.47 Favored 'Trans proline' 0 C--O 1.247 0.956 0 C-N-CA 122.638 2.226 . . . . 73.2 111.466 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 96.95 -24.45 31.14 Favored Glycine 0 N--CA 1.439 -1.136 0 N-CA-C 111.641 -0.584 . . . . 73.41 111.641 -177.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . 0.455 ' HA3' ' HA3' ' A' ' 173' ' ' GLY . . . -72.71 173.97 46.49 Favored Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 121.306 -0.474 . . . . 73.33 112.042 -179.339 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . 0.418 HD21 ' HA ' ' A' ' 172' ' ' LEU . 3.6 mm? -63.11 -33.96 76.59 Favored 'General case' 0 N--CA 1.438 -1.069 0 C-N-CA 123.059 0.544 . . . . 71.23 111.75 -176.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -65.03 -43.26 92.98 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.067 0.46 . . . . 74.33 110.924 179.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.468 ' HG3' ' HA ' ' A' ' 202' ' ' PRO . 3.6 tm-20 -75.75 -40.1 56.02 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.033 -0.531 . . . . 70.53 109.998 178.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 33.3 t -57.97 -36.95 73.32 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.193 0.597 . . . . 63.13 110.959 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 11.7 t -81.38 -37.22 28.54 Favored 'General case' 0 N--CA 1.435 -1.188 0 C-N-CA 119.557 -0.857 . . . . 73.12 109.644 175.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 71.35 26.06 74.18 Favored Glycine 0 C--N 1.341 0.813 0 N-CA-C 112.14 -0.384 . . . . 52.33 112.14 178.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 43.0 mt -116.09 -4.24 12.0 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.577 0.703 . . . . 75.24 110.075 -177.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 60.1 mt -109.25 134.44 51.76 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 114.91 -1.041 . . . . 64.12 110.891 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -131.3 161.69 31.75 Favored 'General case' 0 N--CA 1.42 -1.967 0 N-CA-C 108.656 -0.868 . . . . 74.41 108.656 177.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . 0.46 ' HA ' ' HB ' ' A' ' 197' ' ' ILE . 33.8 m -62.2 -30.59 49.17 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 CA-C-O 121.377 0.608 . . . . 63.32 112.579 179.553 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -71.55 -14.26 62.04 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 116.123 -0.49 . . . . 75.44 112.143 -178.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.47 ' HB3' ' HB ' ' A' ' 249' ' ' VAL . 61.9 m-20 -74.19 139.15 44.24 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 112.754 0.65 . . . . 70.24 112.754 -176.183 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -110.01 137.52 47.67 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 124.975 1.31 . . . . 62.52 108.696 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . 0.488 ' CG1' ' HB ' ' A' ' 195' ' ' ILE . 12.1 p -83.82 138.41 19.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 122.103 0.954 . . . . 64.14 112.625 -175.545 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 44.1 mm -105.62 -44.75 8.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 114.731 -1.122 . . . . 75.02 111.058 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -161.12 154.98 22.31 Favored 'General case' 0 C--O 1.245 0.837 0 CA-C-N 116.511 -0.313 . . . . 65.42 110.75 -178.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 8.3 p -126.45 121.41 58.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 C-N-CA 123.786 0.834 . . . . 72.13 109.006 178.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . 0.468 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 18.7 t-20 65.09 15.52 10.04 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.322 1.049 . . . . 73.23 110.456 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 99.35 -8.12 60.32 Favored Glycine 0 N--CA 1.437 -1.261 0 C-N-CA 120.347 -0.93 . . . . 75.43 111.523 -177.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 64.0 mt -91.08 123.06 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.162 0 N-CA-C 108.787 -0.819 . . . . 73.12 108.787 179.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -55.45 131.19 45.34 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 124.24 0.962 . . . . 72.4 111.063 179.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 35.8 m -109.88 10.13 8.85 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 CA-C-O 121.876 0.846 . . . . 74.24 109.288 174.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -73.26 98.08 2.58 Favored 'General case' 0 N--CA 1.424 -1.737 0 CA-C-N 114.422 -1.263 . . . . 65.43 110.799 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . 0.409 ' HA2' ' HD2' ' A' ' 193' ' ' PRO . . . 101.23 5.29 52.86 Favored Glycine 0 N--CA 1.44 -1.092 0 C-N-CA 120.894 -0.67 . . . . 38.11 112.46 176.319 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -90.31 156.66 18.11 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 107.524 -1.287 . . . . 74.43 107.524 -178.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' THR . . . . . 0.638 ' OG1' ' HG2' ' A' ' 233' ' ' GLN . 81.5 p -79.97 166.52 21.51 Favored 'General case' 0 C--O 1.248 0.998 0 C-N-CA 118.905 -1.118 . . . . 72.21 110.067 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -61.02 -39.76 90.99 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 108.946 -0.761 . . . . 75.05 108.946 179.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -63.86 -31.01 72.05 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.078 -0.51 . . . . 73.11 110.626 177.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' GLN . . . . . 0.638 ' HG2' ' OG1' ' A' ' 230' ' ' THR . 13.3 mm-40 -74.14 -51.37 15.82 Favored 'General case' 0 C--O 1.216 -0.683 0 C-N-CA 119.478 -0.889 . . . . 74.13 110.211 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.482 ' O ' ' HG3' ' A' ' 238' ' ' MET . 21.2 m -65.99 -34.22 68.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 113.041 0.756 . . . . 71.32 113.041 -173.279 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 42.6 m -74.42 -35.49 63.4 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 109.056 -0.72 . . . . 74.32 109.056 -173.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -63.15 -34.25 77.21 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-N 115.376 -0.829 . . . . 73.5 108.835 177.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 10.3 mtm -72.88 -42.01 64.1 Favored 'General case' 0 C--O 1.201 -1.478 0 CA-C-N 115.117 -0.947 . . . . 74.02 108.546 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' MET . . . . . 0.482 ' HG3' ' O ' ' A' ' 234' ' ' VAL . 65.4 mtt -61.6 -40.16 93.8 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.486 -0.325 . . . . 74.52 111.568 178.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 96.0 t -68.76 -43.12 83.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.198 0.523 . . . . 75.12 111.004 178.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -68.68 -34.31 75.46 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.424 0.631 . . . . 71.02 110.555 179.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -88.81 15.44 8.35 Favored 'General case' 0 C--O 1.19 -2.053 0 CA-C-N 115.425 -0.807 . . . . 71.41 111.923 178.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 69.9 m -66.74 -23.26 66.07 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 114.363 1.246 . . . . 51.13 114.363 -178.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 20.5 m -63.94 -29.63 70.79 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 118.131 0.423 . . . . 74.44 110.735 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 244' ' ' ASN . . . . . 0.416 ' HA ' ' O ' ' A' ' 164' ' ' LEU . 42.6 m-80 -156.0 89.68 1.16 Allowed 'General case' 0 C--O 1.248 1.015 0 N-CA-C 106.381 -1.711 . . . . 71.21 106.381 173.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . 0.401 ' HB3' ' HB2' ' A' ' 163' ' ' LEU . 1.6 tt -85.28 103.55 14.33 Favored 'General case' 0 C--O 1.205 -1.274 0 CA-C-O 121.269 0.557 . . . . 74.21 109.846 -172.063 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . 0.468 ' HB ' ' HA ' ' A' ' 222' ' ' ASN . 75.5 mt -96.48 116.19 37.83 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.348 0 N-CA-C 109.373 -0.603 . . . . 73.5 109.373 179.053 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 9.8 mt -125.84 137.81 56.53 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 CA-C-O 121.551 0.691 . . . . 73.53 112.446 177.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 159' ' ' ARG . 49.9 m -107.43 121.87 45.47 Favored 'General case' 0 N--CA 1.423 -1.815 0 CA-C-N 114.717 -1.129 . . . . 73.11 107.985 174.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . 0.47 ' HB ' ' HB3' ' A' ' 216' ' ' ASP . 15.4 m -125.74 166.44 21.73 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 CA-C-O 121.126 0.489 . . . . 72.35 110.552 176.627 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 16.8 ptmt -138.64 134.01 17.07 Favored Pre-proline 0 C--N 1.285 -2.209 0 CA-C-N 114.471 -1.24 . . . . 74.44 107.763 174.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -65.12 134.02 37.82 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 121.619 1.546 . . . . 74.21 111.166 178.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -63.41 -30.29 71.45 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.294 0.568 . . . . 74.42 111.326 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -93.52 -10.66 34.1 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.259 -0.882 . . . . 64.44 110.08 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 70.08 131.97 0.03 OUTLIER 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.634 1.174 . . . . 72.04 110.767 -172.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.419 -2.019 0 N-CA-C 106.025 -1.842 . . . . 71.22 106.025 -177.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 . . . . . 0 CA--C 1.512 -0.507 0 N-CA-C 110.136 -0.32 . . . . 73.54 110.136 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 70.7 p -74.1 -32.61 63.29 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 122.305 1.05 . . . . 75.4 108.196 178.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -82.23 130.26 35.05 Favored 'General case' 0 N--CA 1.428 -1.538 0 CA-C-N 113.864 -1.516 . . . . 62.1 109.738 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.437 ' CZ ' HG21 ' A' ' 161' ' ' VAL . 0.0 OUTLIER -127.63 142.0 51.47 Favored 'General case' 0 C--N 1.283 -2.288 0 N-CA-C 104.971 -2.233 . . . . 74.15 104.971 173.726 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -132.42 110.82 10.8 Favored 'General case' 0 C--N 1.285 -2.223 0 C-N-CA 117.718 -1.593 . . . . 75.21 111.065 -179.356 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.437 HG21 ' CZ ' ' A' ' 159' ' ' ARG . 30.3 m -113.56 140.31 34.51 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 CA-C-N 114.724 -1.125 . . . . 74.44 111.787 175.251 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 26.0 ttm180 -84.86 114.65 22.26 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 115.617 -0.72 . . . . 75.54 109.121 178.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.412 ' HB2' ' HB2' ' A' ' 245' ' ' LEU . 13.8 mt -87.47 127.27 35.23 Favored 'General case' 0 N--CA 1.421 -1.916 0 N-CA-C 107.078 -1.453 . . . . 73.31 107.078 -179.408 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.554 HD13 ' O ' ' A' ' 242' ' ' SER . 5.5 tt 73.66 90.68 0.09 Allowed 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 122.378 1.085 . . . . 75.41 110.416 178.3 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 60.3 pttt -116.79 0.12 12.45 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 107.481 -1.303 . . . . 74.32 107.481 172.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 45.4 m80 -150.64 146.13 26.3 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 114.141 -1.39 . . . . 74.0 107.781 177.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 81.59 43.41 8.46 Favored Glycine 0 C--N 1.315 -0.628 0 C-N-CA 120.873 -0.68 . . . . 72.43 113.231 177.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 35.2 t -76.73 87.26 3.36 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.363 -0.606 . . . . 73.52 109.363 179.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 19.5 t70 179.27 -41.75 0.01 OUTLIER 'General case' 0 CA--C 1.506 -0.741 0 CA-C-N 114.773 -1.103 . . . . 70.12 108.849 -176.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.59 154.4 37.95 Favored Pre-proline 0 N--CA 1.426 -1.638 0 CA-C-N 115.33 -0.85 . . . . 74.41 111.198 -176.559 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -49.29 153.07 4.92 Favored 'Trans proline' 0 C--O 1.25 1.095 0 C-N-CA 124.498 3.465 . . . . 74.32 115.177 -176.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -73.44 -39.68 64.81 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-N 114.791 -1.095 . . . . 72.44 110.166 177.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . 0.46 ' HA3' ' HA3' ' A' ' 204' ' ' GLY . . . 90.24 51.44 2.76 Favored Glycine 0 N--CA 1.434 -1.45 0 CA-C-N 115.679 -0.691 . . . . 51.34 114.806 174.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -162.58 154.61 18.62 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 108.521 -0.918 . . . . 72.01 108.521 175.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -121.2 140.83 51.5 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 108.244 -1.021 . . . . 75.01 108.244 176.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.508 HD11 ' SD ' ' A' ' 238' ' ' MET . 28.6 pt -112.32 165.25 7.4 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.845 0 CA-C-O 121.04 0.448 . . . . 71.55 111.339 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.474 ' CG ' ' HB2' ' A' ' 198' ' ' SER . 27.3 ptt180 -149.69 154.98 39.43 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 115.566 -0.743 . . . . 75.1 110.703 -175.372 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . 0.435 ' HB2' ' HB2' ' A' ' 231' ' ' LEU . 9.2 t70 -100.95 138.54 37.86 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 115.706 -0.679 . . . . 71.3 109.946 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -149.11 135.41 5.37 Favored Glycine 0 C--N 1.277 -2.743 0 N-CA-C 107.622 -2.191 . . . . 52.32 107.622 175.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' THR . . . . . 0.434 ' CG2' ' HG2' ' A' ' 191' ' ' LYS . 0.4 OUTLIER -86.53 122.63 30.73 Favored 'General case' 0 C--N 1.282 -2.361 0 C-N-CA 118.54 -1.264 . . . . 75.43 107.799 -175.962 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 10.9 t -95.93 121.29 37.52 Favored 'General case' 0 C--N 1.287 -2.146 0 C-N-CA 123.821 0.848 . . . . 63.11 109.01 -174.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.503 ' HA ' ' HA ' ' A' ' 191' ' ' LYS . 7.4 p -103.97 123.67 57.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-O 121.669 0.747 . . . . 72.31 110.269 178.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 42.1 mtt-85 -122.94 159.92 27.28 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 114.957 -1.02 . . . . 75.51 108.687 -174.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.474 ' HA ' ' O ' ' A' ' 188' ' ' GLY . 83.5 t -87.79 119.03 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.604 0 N-CA-C 108.54 -0.911 . . . . 72.41 108.54 174.455 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 46.4 p -114.42 -175.1 2.61 Favored 'General case' 0 C--N 1.265 -3.108 0 CA-C-N 114.125 -1.398 . . . . 62.02 108.703 -176.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -68.21 -13.5 62.29 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.054 0.454 . . . . 72.4 111.41 178.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 31.3 m -103.62 -12.84 16.79 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-O 120.784 0.326 . . . . 63.22 111.743 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.474 ' O ' ' HA ' ' A' ' 184' ' ' VAL . . . 131.13 -125.4 4.46 Favored Glycine 0 CA--C 1.48 -2.116 0 N-CA-C 110.028 -1.229 . . . . 73.52 110.028 178.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 6.8 mp -102.37 125.5 49.1 Favored 'General case' 0 C--N 1.286 -2.176 0 CA-C-N 117.395 0.597 . . . . 71.13 110.133 178.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . 0.49 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 38.3 mt-10 -130.75 119.99 23.13 Favored 'General case' 0 CA--C 1.466 -2.285 0 CA-C-O 121.419 0.628 . . . . 73.5 111.126 -179.416 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.503 ' HA ' ' HA ' ' A' ' 182' ' ' VAL . 32.5 ttmt -92.93 135.59 34.01 Favored 'General case' 0 C--N 1.278 -2.54 0 CA-C-N 114.144 -1.389 . . . . 65.23 107.795 -179.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.47 145.49 19.3 Favored Pre-proline 0 C--N 1.313 -1.005 0 CA-C-N 116.125 -0.489 . . . . 74.23 109.78 -171.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -56.82 130.84 42.02 Favored 'Trans proline' 0 C--O 1.242 0.708 0 C-N-CA 121.879 1.719 . . . . 54.24 113.784 -176.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -137.85 137.38 8.82 Favored Glycine 0 N--CA 1.414 -2.812 0 N-CA-C 109.03 -1.628 . . . . 73.01 109.03 177.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.504 HG12 HG21 ' A' ' 234' ' ' VAL . 3.1 mp -104.1 136.59 36.6 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.894 0 CA-C-O 121.355 0.598 . . . . 74.0 110.01 -179.211 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -126.76 165.94 18.34 Favored 'General case' 0 C--N 1.284 -2.25 0 N-CA-C 108.017 -1.105 . . . . 74.54 108.017 -177.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . 0.44 ' HB ' ' O ' ' A' ' 213' ' ' ALA . 49.1 mm -78.67 131.52 34.26 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 N-CA-C 108.464 -0.939 . . . . 70.42 108.464 174.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' SER . . . . . 0.474 ' HB2' ' CG ' ' A' ' 177' ' ' ARG . 11.2 t -101.92 -28.71 12.24 Favored 'General case' 0 C--N 1.284 -2.246 0 O-C-N 121.889 -0.507 . . . . 61.55 112.017 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 60.7 ttt180 -167.84 147.43 4.9 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 116.697 -0.229 . . . . 73.54 110.773 -176.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 85.7 mt -103.65 146.28 28.81 Favored 'General case' 0 CA--C 1.496 -1.134 0 N-CA-C 108.727 -0.842 . . . . 74.54 108.727 171.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 46.2 t -105.58 115.48 61.68 Favored Pre-proline 0 C--N 1.288 -2.07 0 N-CA-C 105.932 -1.877 . . . . 74.11 105.932 171.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . 0.453 ' HA ' ' HG3' ' A' ' 207' ' ' GLU . 16.7 Cg_endo -58.56 132.4 48.11 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 122.042 1.828 . . . . 70.04 111.218 -177.239 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 102.1 -18.98 50.7 Favored Glycine 0 N--CA 1.438 -1.196 0 N-CA-C 110.713 -0.955 . . . . 63.43 110.713 -175.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . 0.46 ' HA3' ' HA3' ' A' ' 173' ' ' GLY . . . -78.5 164.79 51.07 Favored Glycine 0 N--CA 1.434 -1.484 0 N-CA-C 111.018 -0.833 . . . . 45.01 111.018 178.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -61.24 -35.67 77.89 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 123.284 0.634 . . . . 75.51 111.434 -175.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -60.7 -47.41 86.41 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.629 -0.714 . . . . 73.15 110.732 179.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.453 ' HG3' ' HA ' ' A' ' 202' ' ' PRO . 3.2 tm-20 -75.46 -34.55 60.94 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.209 -0.905 . . . . 71.12 110.156 -179.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 48.7 m -56.96 -42.67 80.54 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 122.919 0.488 . . . . 72.2 111.837 179.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 14.9 t -87.1 -24.41 24.56 Favored 'General case' 0 N--CA 1.439 -1.0 0 C-N-CA 119.483 -0.887 . . . . 72.35 110.805 179.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 70.05 15.1 71.65 Favored Glycine 0 C--N 1.339 0.74 0 CA-C-O 121.498 0.499 . . . . 54.14 112.555 178.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 64.5 mt -102.03 13.14 35.57 Favored 'General case' 0 CA--C 1.495 -1.152 0 CA-C-O 121.592 0.71 . . . . 75.44 110.395 -177.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 30.2 mt -122.02 130.57 53.41 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 114.465 -1.243 . . . . 73.45 110.429 171.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . 0.44 ' O ' ' HB ' ' A' ' 197' ' ' ILE . . . -132.51 160.35 36.75 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 124.447 1.099 . . . . 52.35 108.344 176.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 17.5 m -61.38 -29.74 46.58 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 CA-C-O 121.653 0.74 . . . . 73.45 112.226 -179.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -75.53 -14.32 60.4 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 113.069 0.766 . . . . 74.24 113.069 -179.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -71.08 131.65 43.93 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 112.334 0.494 . . . . 71.51 112.334 -177.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -101.94 129.18 48.15 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.108 -0.951 . . . . 71.41 108.672 178.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . 0.412 ' CG1' ' HB ' ' A' ' 195' ' ' ILE . 10.2 p -79.44 137.2 22.16 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-O 121.597 0.713 . . . . 75.44 111.523 -176.029 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 45.6 mm -104.78 -48.34 9.54 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 CA-C-N 115.178 -0.919 . . . . 75.44 111.16 -178.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -153.23 151.99 30.69 Favored 'General case' 0 C--O 1.245 0.827 0 CA-C-N 116.675 -0.239 . . . . 64.31 111.355 -178.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . 0.519 ' C ' ' H ' ' A' ' 223' ' ' GLY . 14.2 p -124.09 129.64 74.09 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 N-CA-C 107.814 -1.18 . . . . 62.35 107.814 173.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . 0.56 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 23.1 t-20 75.01 -36.35 0.31 Allowed 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 126.462 1.905 . . . . 70.44 111.711 -176.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . 0.519 ' H ' ' C ' ' A' ' 221' ' ' VAL . . . 149.26 -6.08 0.79 Allowed Glycine 0 C--N 1.277 -2.717 0 N-CA-C 109.904 -1.278 . . . . 72.34 109.904 -174.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 71.9 mt -94.81 129.32 45.15 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.312 0 N-CA-C 108.223 -1.028 . . . . 72.51 108.223 179.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -62.02 138.17 58.34 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-O 121.531 0.682 . . . . 71.13 110.585 -179.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . 0.545 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 31.6 m -118.91 -2.62 9.52 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.22 0 CA-C-N 115.604 -0.726 . . . . 75.21 109.659 176.308 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -82.8 93.69 7.5 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 108.435 -0.95 . . . . 72.44 108.435 179.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 130.46 -17.59 5.29 Favored Glycine 0 N--CA 1.428 -1.853 0 N-CA-C 110.275 -1.13 . . . . 60.03 110.275 -176.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -85.43 167.81 15.17 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 107.423 -1.325 . . . . 74.41 107.423 174.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 40.6 p -94.74 171.72 8.61 Favored 'General case' 0 C--N 1.295 -1.765 0 C-N-CA 119.942 -0.703 . . . . 73.23 109.183 178.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . 0.435 ' HB2' ' HB2' ' A' ' 178' ' ' ASP . 49.9 tp -60.04 -39.25 85.28 Favored 'General case' 0 N--CA 1.432 -1.375 0 CA-C-O 120.677 0.275 . . . . 75.05 111.208 -176.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -58.54 -48.31 81.32 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 121.427 0.632 . . . . 62.22 109.999 177.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -61.96 -45.13 95.01 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.786 -1.097 . . . . 75.33 112.492 -179.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.545 ' CG1' ' HB ' ' A' ' 226' ' ' VAL . 6.7 m -73.96 -33.42 36.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-O 121.027 0.441 . . . . 72.21 112.013 -175.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 48.3 m -74.03 -36.7 64.45 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 108.713 -0.847 . . . . 74.44 108.713 -174.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -59.25 -34.64 72.47 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 115.326 -0.852 . . . . 72.2 109.131 177.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 5.7 mtt -73.34 -44.44 58.8 Favored 'General case' 0 C--O 1.2 -1.551 0 N-CA-C 108.954 -0.758 . . . . 74.54 108.954 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' MET . . . . . 0.508 ' SD ' HD11 ' A' ' 176' ' ' ILE . 65.7 mtt -59.95 -40.12 87.93 Favored 'General case' 0 C--O 1.214 -0.808 0 CA-C-O 120.543 0.211 . . . . 71.31 111.234 -178.257 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 93.9 t -65.75 -37.85 80.88 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 N-CA-C 109.736 -0.468 . . . . 74.21 109.736 177.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -76.74 -17.21 59.21 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.192 -0.458 . . . . 74.31 112.083 179.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -110.91 21.64 16.23 Favored 'General case' 0 C--O 1.205 -1.278 0 CA-C-N 116.45 -0.341 . . . . 73.14 110.463 176.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 242' ' ' SER . . . . . 0.554 ' O ' HD13 ' A' ' 164' ' ' LEU . 36.1 p -64.39 -22.78 67.07 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 112.966 0.728 . . . . 74.13 112.966 -178.219 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 18.1 m -79.22 -9.3 59.53 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 120.793 -0.363 . . . . 63.3 110.782 179.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -178.65 97.36 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.747 1.219 . . . . 72.04 110.894 175.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . 0.412 ' HB2' ' HB2' ' A' ' 163' ' ' LEU . 14.1 mt -87.92 111.83 21.88 Favored 'General case' 0 C--O 1.192 -1.932 0 N-CA-C 113.375 0.88 . . . . 75.44 113.375 -177.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . 0.56 ' HB ' ' HA ' ' A' ' 222' ' ' ASN . 66.1 mt -95.93 115.93 36.39 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.542 0 N-CA-C 106.173 -1.788 . . . . 71.42 106.173 170.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 67.5 mt -130.63 128.01 62.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 C-N-CA 119.649 -0.82 . . . . 73.35 112.547 -177.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 86.2 m -103.12 128.7 49.95 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 115.048 -0.978 . . . . 62.14 108.751 175.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 27.3 m -132.66 167.46 26.54 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 108.207 -1.034 . . . . 75.55 108.207 173.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.82 136.54 18.64 Favored Pre-proline 0 C--N 1.284 -2.267 0 CA-C-N 115.31 -0.859 . . . . 72.45 110.964 172.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -63.02 150.06 89.75 Favored 'Trans proline' 0 C--O 1.246 0.885 0 C-N-CA 123.535 2.823 . . . . 60.35 113.554 -177.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -59.96 -40.74 90.06 Favored 'General case' 0 CA--C 1.498 -1.055 0 CA-C-O 121.779 0.799 . . . . 62.52 108.966 175.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -85.82 78.81 9.45 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 107.22 -1.4 . . . . 74.31 107.22 173.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -84.29 179.26 7.5 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 115.26 -0.882 . . . . 74.25 111.762 -176.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? . . . . . 0 C--O 1.253 1.259 0 C-N-CA 125.713 1.605 . . . . 75.43 108.336 -178.321 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 . . . . . 0 N--CA 1.454 -0.266 0 CA-C-O 120.822 0.344 . . . . 72.32 110.814 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 7.2 p -153.64 -50.7 0.1 Allowed 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 124.694 1.198 . . . . 75.2 109.581 176.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.421 ' CD2' ' HB3' ' A' ' 250' ' ' LYS . 49.9 m170 -105.18 137.22 43.3 Favored 'General case' 0 CA--C 1.486 -1.5 0 CA-C-O 121.164 0.507 . . . . 73.34 112.08 175.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.634 ' O ' ' HA ' ' A' ' 248' ' ' THR . 6.6 ptp180 -125.8 142.08 51.69 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 107.598 -1.26 . . . . 74.22 107.598 177.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 13.6 ptp180 -132.15 113.06 12.85 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 121.814 0.816 . . . . 75.44 111.277 177.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.662 ' O ' ' HA ' ' A' ' 246' ' ' ILE . 30.0 m -105.68 139.89 25.43 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 CA-C-N 114.554 -1.203 . . . . 62.14 112.402 -177.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.523 ' HG3' HG12 ' A' ' 246' ' ' ILE . 5.4 mpt_? -99.98 114.7 28.16 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 107.532 -1.284 . . . . 74.24 107.532 175.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.477 ' HB2' ' HB3' ' A' ' 245' ' ' LEU . 23.8 mt -114.41 139.91 49.11 Favored 'General case' 0 C--N 1.31 -1.137 0 C-N-CA 123.142 0.577 . . . . 75.13 111.368 -174.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.649 HD13 ' O ' ' A' ' 164' ' ' LEU . 0.9 OUTLIER 76.04 20.3 1.71 Allowed 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.877 0.871 . . . . 70.13 112.083 167.935 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.444 ' HZ3' ' HB2' ' A' ' 165' ' ' LYS . 10.2 mtmp? -71.65 7.44 1.47 Allowed 'General case' 0 C--N 1.312 -1.025 0 O-C-N 121.03 -1.044 . . . . 74.41 113.775 -178.452 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 49.7 m80 -91.44 -6.59 52.51 Favored 'General case' 0 C--N 1.31 -1.119 0 O-C-N 121.963 -0.461 . . . . 75.21 111.091 177.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 80.93 87.55 0.61 Allowed Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.745 -0.74 . . . . 72.15 112.552 179.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 35.5 t -145.68 176.21 9.8 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.625 -0.879 . . . . 74.32 108.625 -179.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -123.87 -0.07 8.54 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.796 0.808 . . . . 72.43 109.456 -178.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -73.25 150.32 89.64 Favored Pre-proline 0 N--CA 1.437 -1.109 0 CA-C-N 115.603 -0.726 . . . . 74.15 111.83 -177.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_exo -53.26 144.1 50.08 Favored 'Trans proline' 0 C--O 1.243 0.755 0 C-N-CA 122.669 2.246 . . . . 72.32 110.469 173.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.497 ' HG ' ' CD1' ' A' ' 245' ' ' LEU . 2.8 mm? -70.08 -24.31 63.2 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 116.014 -0.539 . . . . 74.22 112.102 -175.205 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . 0.463 ' HA3' ' HA3' ' A' ' 204' ' ' GLY . . . 93.74 14.91 51.55 Favored Glycine 0 N--CA 1.424 -2.133 0 C-N-CA 120.346 -0.93 . . . . 50.1 112.292 177.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -139.45 152.54 47.11 Favored 'General case' 0 N--CA 1.426 -1.653 0 N-CA-C 106.056 -1.831 . . . . 74.42 106.056 173.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -127.76 149.31 50.3 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-O 120.858 0.361 . . . . 73.52 110.953 -178.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 37.8 pt -110.49 169.02 3.95 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 CA-C-N 115.552 -0.749 . . . . 73.32 110.374 -179.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.561 ' CG ' ' HB2' ' A' ' 198' ' ' SER . 15.7 ptt180 -151.52 154.88 37.39 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 124.166 0.986 . . . . 74.41 109.351 -178.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -108.85 138.0 45.88 Favored 'General case' 0 C--N 1.293 -1.886 0 O-C-N 123.464 0.477 . . . . 74.21 109.86 -179.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -150.46 157.08 27.04 Favored Glycine 0 C--N 1.27 -3.088 0 N-CA-C 107.507 -2.237 . . . . 74.34 107.507 176.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' THR . . . . . 0.584 ' CG2' ' HG2' ' A' ' 191' ' ' LYS . 0.2 OUTLIER -86.65 121.58 29.37 Favored 'General case' 0 C--N 1.284 -2.252 0 C-N-CA 117.317 -1.753 . . . . 73.55 106.655 179.431 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' SER . . . . . 0.477 ' O ' ' HA ' ' A' ' 191' ' ' LYS . 31.2 t -90.63 118.33 29.99 Favored 'General case' 0 N--CA 1.414 -2.272 0 N-CA-C 108.758 -0.83 . . . . 65.14 108.758 -176.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.676 ' HA ' ' O ' ' A' ' 190' ' ' GLU . 7.4 p -125.39 119.76 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 N-CA-C 109.316 -0.624 . . . . 73.4 109.316 174.554 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 78.0 mtt-85 -139.84 161.36 37.75 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 106.692 -1.595 . . . . 74.52 106.692 -178.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 99.2 t -76.91 117.91 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.168 0 N-CA-C 107.77 -1.196 . . . . 61.35 107.77 174.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 66.6 p -108.41 -174.17 2.45 Favored 'General case' 0 C--N 1.271 -2.818 0 N-CA-C 107.63 -1.248 . . . . 55.3 107.63 -179.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -60.72 -20.67 61.71 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 120.606 0.241 . . . . 75.23 110.685 174.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 31.4 t -98.82 -16.83 18.73 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 121.227 -0.189 . . . . 73.54 111.482 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 125.58 -145.84 15.9 Favored Glycine 0 C--O 1.201 -1.93 0 N-CA-C 110.135 -1.186 . . . . 75.42 110.135 -179.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 5.4 mp -83.2 119.36 24.45 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 118.145 0.972 . . . . 74.15 109.522 178.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . 0.676 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 52.7 mt-10 -130.51 122.9 28.47 Favored 'General case' 0 CA--C 1.461 -2.453 0 CA-C-O 121.001 0.429 . . . . 73.11 110.507 -178.621 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.584 ' HG2' ' CG2' ' A' ' 180' ' ' THR . 37.2 ttmt -108.43 126.23 52.65 Favored 'General case' 0 C--N 1.277 -2.55 0 CA-C-N 114.259 -1.337 . . . . 61.25 109.207 -176.458 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -151.91 163.48 23.45 Favored Pre-proline 0 C--N 1.301 -1.538 0 N-CA-C 107.859 -1.163 . . . . 72.24 107.859 -176.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -58.96 132.23 46.26 Favored 'Trans proline' 0 C--O 1.255 1.332 0 C-N-CA 121.032 1.154 . . . . 72.12 110.689 176.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -141.99 135.56 6.78 Favored Glycine 0 N--CA 1.411 -2.968 0 N-CA-C 110.017 -1.233 . . . . 61.32 110.017 -178.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 3.2 mp -104.14 132.74 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.789 0 CA-C-O 121.457 0.646 . . . . 61.52 110.862 -178.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -124.76 167.75 14.15 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 107.543 -1.281 . . . . 75.13 107.543 -177.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 45.6 mt -85.69 131.96 33.1 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 N-CA-C 108.876 -0.787 . . . . 75.34 108.876 175.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' SER . . . . . 0.561 ' HB2' ' CG ' ' A' ' 177' ' ' ARG . 28.2 t -102.49 -30.71 10.83 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 113.727 1.01 . . . . 75.15 113.727 -177.101 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 13.4 ttp180 -165.16 144.47 6.7 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 120.013 -0.675 . . . . 74.44 112.185 -176.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.407 HD13 ' HG2' ' A' ' 207' ' ' GLU . 69.0 mt -106.51 141.01 38.5 Favored 'General case' 0 CA--C 1.494 -1.183 0 CA-C-N 115.169 -0.923 . . . . 72.4 109.575 173.411 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 47.5 t -109.71 114.81 56.41 Favored Pre-proline 0 C--N 1.285 -2.232 0 N-CA-C 105.748 -1.945 . . . . 64.33 105.748 171.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . 0.487 ' HA ' ' HG3' ' A' ' 207' ' ' GLU . 73.6 Cg_exo -53.31 126.15 20.72 Favored 'Trans proline' 0 C--O 1.244 0.804 0 C-N-CA 122.342 2.028 . . . . 72.04 110.838 179.409 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 110.69 -16.12 28.83 Favored Glycine 0 C--N 1.312 -0.767 0 C-N-CA 120.95 -0.643 . . . . 63.31 111.514 -175.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . 0.463 ' HA3' ' HA3' ' A' ' 173' ' ' GLY . . . -77.08 158.2 47.75 Favored Glycine 0 N--CA 1.441 -0.972 0 C-N-CA 121.147 -0.549 . . . . 71.31 111.924 178.503 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -53.84 -48.57 69.81 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 124.201 1.0 . . . . 55.43 112.263 -176.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -68.99 -32.24 71.65 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.776 -0.647 . . . . 74.33 111.33 -178.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.487 ' HG3' ' HA ' ' A' ' 202' ' ' PRO . 2.5 tm-20 -75.89 -44.41 40.6 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.658 -0.701 . . . . 65.44 109.282 -177.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 50.7 m -57.87 -33.38 68.63 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.338 0.496 . . . . 74.5 112.338 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 11.3 t -83.16 -17.44 42.9 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 119.945 -0.702 . . . . 73.1 110.989 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 64.65 17.08 62.03 Favored Glycine 0 C--N 1.334 0.436 0 CA-C-N 116.439 -0.346 . . . . 74.41 113.621 178.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 76.3 mt -95.69 -22.34 17.62 Favored 'General case' 0 C--O 1.199 -1.59 0 C-N-CA 120.224 -0.59 . . . . 73.42 110.776 -177.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 6.9 mp -107.22 134.1 50.81 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-O 121.366 0.603 . . . . 73.21 111.102 -178.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -131.27 165.39 23.5 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-N 114.23 -1.35 . . . . 75.11 109.88 -179.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 33.3 m -65.09 -29.39 47.2 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 N-CA-C 113.66 0.985 . . . . 65.24 113.66 -179.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -74.85 -14.14 60.64 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.7 -0.625 . . . . 74.42 111.252 -178.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.481 ' HB3' ' HB ' ' A' ' 249' ' ' VAL . 79.8 m-20 -66.69 142.97 57.24 Favored 'General case' 0 C--O 1.247 0.971 0 N-CA-C 112.984 0.735 . . . . 52.51 112.984 -176.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -109.21 133.13 53.42 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.635 -1.166 . . . . 74.34 108.802 177.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . 0.46 ' HA ' HG13 ' A' ' 249' ' ' VAL . 20.7 t -84.36 130.68 35.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.496 0.665 . . . . 73.25 111.289 -174.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 44.0 mm -99.44 -56.86 4.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-N 115.168 -0.923 . . . . 75.11 111.652 -177.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -155.02 151.2 28.16 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 116.108 -0.497 . . . . 70.23 110.503 -176.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . 0.487 ' HA ' ' O ' ' A' ' 246' ' ' ILE . 8.6 p -120.33 122.71 68.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 CA-C-N 115.648 -0.705 . . . . 64.54 109.24 177.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . 0.417 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 2.5 m-20 58.24 24.58 11.63 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.656 1.183 . . . . 53.33 112.474 -177.347 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 95.69 -7.23 67.97 Favored Glycine 0 N--CA 1.435 -1.418 0 CA-C-N 115.377 -0.829 . . . . 64.13 111.853 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 62.1 mt -97.31 122.63 49.07 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.509 0 N-CA-C 108.899 -0.778 . . . . 75.42 108.899 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -61.83 139.33 58.36 Favored 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 123.704 0.802 . . . . 72.43 112.674 -176.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . 0.468 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 34.3 m -117.11 3.21 7.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 CA-C-N 115.376 -0.829 . . . . 64.3 109.798 175.503 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -75.67 99.11 4.24 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 115.224 -0.898 . . . . 74.51 109.816 -179.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 113.26 -8.84 24.75 Favored Glycine 0 CA--C 1.5 -0.846 0 N-CA-C 110.983 -0.847 . . . . 52.52 110.983 179.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -83.14 158.27 22.45 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.781 -0.822 . . . . 74.14 108.781 178.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' THR . . . . . 0.442 ' O ' HG13 ' A' ' 234' ' ' VAL . 82.7 p -84.02 170.7 13.66 Favored 'General case' 0 N--CA 1.412 -2.35 0 C-N-CA 119.584 -0.846 . . . . 74.44 110.397 178.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . 0.4 ' HA ' HG21 ' A' ' 234' ' ' VAL . 3.0 tm? -61.85 -37.78 85.76 Favored 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 109.139 -0.689 . . . . 75.55 109.139 179.249 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -58.7 -52.29 66.34 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.198 0.523 . . . . 73.33 110.054 175.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 233' ' ' GLN . . . . . 0.497 ' O ' ' HG2' ' A' ' 237' ' ' MET . 39.6 mt-30 -54.78 -44.76 74.0 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.606 -1.179 . . . . 63.15 112.481 179.337 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.468 ' CG1' ' HB ' ' A' ' 226' ' ' VAL . 8.2 m -77.12 -34.47 21.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 112.438 0.533 . . . . 75.12 112.438 -176.563 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 235' ' ' THR . . . . . 0.44 ' O ' HG21 ' A' ' 239' ' ' VAL . 31.9 m -71.25 -35.81 71.55 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 109.522 -0.548 . . . . 65.25 109.522 -179.128 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -63.38 -31.14 72.21 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 109.722 -0.473 . . . . 72.34 109.722 176.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 237' ' ' MET . . . . . 0.497 ' HG2' ' O ' ' A' ' 233' ' ' GLN . 17.2 mmt -62.54 -52.55 63.0 Favored 'General case' 0 C--O 1.195 -1.767 0 N-CA-C 107.9 -1.148 . . . . 73.25 107.9 174.643 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 238' ' ' MET . . . . . 0.417 ' HG3' ' O ' ' A' ' 234' ' ' VAL . 59.5 mtt -63.93 -33.02 74.77 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.159 -0.928 . . . . 75.55 112.843 -173.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.44 HG21 ' O ' ' A' ' 235' ' ' THR . 85.7 t -68.96 -44.12 81.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 N-CA-C 109.175 -0.676 . . . . 74.42 109.175 175.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -66.91 -36.3 81.95 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.85 -0.614 . . . . 74.52 110.594 178.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -87.29 22.13 2.22 Favored 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 124.364 1.066 . . . . 75.42 111.612 179.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 34.3 t -58.76 -42.29 88.54 Favored 'General case' 0 C--O 1.204 -1.334 0 CA-C-N 118.112 0.415 . . . . 72.24 112.064 -179.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 243' ' ' SER . . . . . 0.425 ' O ' ' HA ' ' A' ' 165' ' ' LYS . 37.5 m -74.21 -16.98 60.95 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 112.405 0.52 . . . . 74.22 112.405 -178.411 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -153.18 85.12 1.21 Allowed 'General case' 0 CA--C 1.5 -0.949 0 N-CA-C 108.447 -0.946 . . . . 73.44 108.447 179.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . 0.497 ' CD1' ' HG ' ' A' ' 172' ' ' LEU . 2.0 tt -92.03 105.78 17.95 Favored 'General case' 0 N--CA 1.432 -1.343 0 C-N-CA 119.694 -0.803 . . . . 74.43 109.732 -177.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . 0.662 ' HA ' ' O ' ' A' ' 161' ' ' VAL . 93.2 mt -109.19 115.4 49.45 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 O-C-N 121.882 -0.511 . . . . 72.03 110.19 177.167 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 27.4 mt -119.26 133.27 66.64 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 N-CA-C 112.838 0.681 . . . . 75.14 112.838 177.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.634 ' HA ' ' O ' ' A' ' 159' ' ' ARG . 63.5 m -102.92 117.0 33.64 Favored 'General case' 0 N--CA 1.417 -2.095 0 CA-C-N 114.484 -1.235 . . . . 74.42 108.087 173.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . 0.481 ' HB ' ' HB3' ' A' ' 216' ' ' ASP . 18.9 m -122.54 165.57 18.35 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.064 0 CA-C-O 121.194 0.521 . . . . 72.54 110.198 175.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . 0.421 ' HB3' ' CD2' ' A' ' 158' ' ' HIS . 15.0 ptmt -129.46 128.53 23.15 Favored Pre-proline 0 C--N 1.277 -2.576 0 C-N-CA 125.137 1.375 . . . . 74.33 107.621 176.248 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -67.86 133.03 28.1 Favored 'Trans proline' 0 N--CA 1.441 -1.613 0 N-CA-C 109.598 -0.962 . . . . 74.12 109.598 176.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -72.34 -24.28 61.27 Favored 'General case' 0 CA--C 1.499 -1.01 0 CA-C-O 121.524 0.678 . . . . 71.12 110.058 -178.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -93.3 1.12 57.12 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 114.782 -1.099 . . . . 72.44 109.661 178.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 63.34 166.42 0.13 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.846 0.858 . . . . 75.14 111.295 -175.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 61.3 ttt180 . . . . . 0 C--N 1.299 -1.595 0 N-CA-C 108.014 -1.106 . . . . 75.22 108.014 174.9 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.89 0 N-CA-C 111.632 0.234 . . . . 70.22 111.632 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 69.6 p -78.94 -28.77 43.77 Favored 'General case' 0 C--O 1.207 -1.162 0 CA-C-O 121.94 0.876 . . . . 75.11 108.904 177.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 4.0 m80 -120.59 136.32 54.84 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 114.363 -1.29 . . . . 73.13 108.622 177.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.484 ' O ' ' HA ' ' A' ' 248' ' ' THR . 36.7 ttm180 -133.12 142.84 48.9 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 109.329 -0.619 . . . . 72.33 109.329 173.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.406 ' HG3' ' OG1' ' A' ' 248' ' ' THR . 0.1 OUTLIER -106.69 117.12 33.2 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 109.072 -0.714 . . . . 73.53 109.072 -179.399 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.47 HG13 HD21 ' A' ' 211' ' ' LEU . 14.2 m -123.39 138.43 53.3 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.209 0 N-CA-C 112.18 0.437 . . . . 75.44 112.18 178.366 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.456 ' HG2' ' CG1' ' A' ' 246' ' ' ILE . 65.4 mtt180 -92.7 111.6 23.26 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 108.87 -0.789 . . . . 74.44 108.87 171.487 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.466 ' HB2' ' HB3' ' A' ' 245' ' ' LEU . 34.9 mt -93.33 139.3 30.81 Favored 'General case' 0 C--N 1.281 -2.388 0 N-CA-C 107.29 -1.374 . . . . 71.31 107.29 179.144 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.518 ' H ' ' HG ' ' A' ' 205' ' ' LEU . 2.3 tm? 76.0 80.18 0.1 Allowed 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 107.874 -1.158 . . . . 73.51 107.874 179.439 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -107.65 -22.37 12.53 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 114.315 -1.311 . . . . 74.51 110.424 179.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 21.4 t-80 -155.15 132.58 11.12 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.551 -0.907 . . . . 74.53 108.551 -178.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 134.57 -54.32 0.76 Allowed Glycine 0 N--CA 1.423 -2.205 0 N-CA-C 110.618 -0.993 . . . . 73.52 110.618 178.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 49.5 m 64.18 118.21 0.02 OUTLIER 'General case' 0 C--O 1.242 0.708 0 C-N-CA 124.402 1.081 . . . . 64.45 113.03 -179.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 73.32 8.66 5.21 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 114.612 1.338 . . . . 72.12 114.612 176.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.5 ' HZ3' ' HB3' ' A' ' 170' ' ' LYS . 0.1 OUTLIER -85.21 153.51 59.53 Favored Pre-proline 0 C--N 1.307 -1.259 0 N-CA-C 109.489 -0.56 . . . . 75.4 109.489 173.935 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -50.42 133.14 36.64 Favored 'Trans proline' 0 C--O 1.244 0.786 0 C-N-CA 123.259 2.639 . . . . 73.13 111.55 177.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -69.51 -27.27 65.04 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 115.522 -0.763 . . . . 60.12 110.776 -177.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . 0.48 ' HA2' ' HB ' ' A' ' 201' ' ' VAL . . . 109.03 13.98 16.36 Favored Glycine 0 N--CA 1.421 -2.348 0 C-N-CA 119.677 -1.249 . . . . 64.02 114.213 174.281 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -162.66 153.79 17.5 Favored 'General case' 0 N--CA 1.435 -1.225 0 CA-C-N 118.155 0.978 . . . . 73.25 110.154 -177.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.462 ' CE1' HG21 ' A' ' 201' ' ' VAL . 71.0 m-85 -115.4 144.88 43.14 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 108.045 -1.095 . . . . 73.24 108.045 174.547 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.568 ' HB ' ' CG2' ' A' ' 195' ' ' ILE . 36.8 pt -110.47 168.96 3.98 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.393 0 CA-C-O 121.16 0.505 . . . . 73.3 110.538 179.575 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.481 ' HG2' ' HB2' ' A' ' 198' ' ' SER . 5.1 ptp180 -154.07 153.88 32.67 Favored 'General case' 0 C--N 1.288 -2.084 0 C-N-CA 123.798 0.839 . . . . 74.42 109.091 178.159 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -100.16 141.52 32.88 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 109.156 -0.683 . . . . 74.3 109.156 177.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -153.9 -159.9 9.45 Favored Glycine 0 C--N 1.284 -2.325 0 N-CA-C 109.029 -1.629 . . . . 72.41 109.029 177.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -110.13 126.74 54.38 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 117.711 0.756 . . . . 71.41 112.462 177.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 26.5 t -110.63 116.95 32.24 Favored 'General case' 0 N--CA 1.413 -2.283 0 N-CA-C 107.79 -1.189 . . . . 75.53 107.79 177.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.549 ' HA ' ' O ' ' A' ' 190' ' ' GLU . 6.1 p -112.63 119.48 60.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 109.057 -0.72 . . . . 74.32 109.057 174.135 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 85.9 mtt180 -124.53 160.93 27.22 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 108.438 -0.949 . . . . 74.52 108.438 -175.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 72.9 t -90.49 118.39 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.141 0 N-CA-C 108.375 -0.972 . . . . 75.25 108.375 173.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 29.7 p -124.54 -174.15 2.95 Favored 'General case' 0 C--N 1.267 -3.005 0 CA-C-N 114.156 -1.384 . . . . 64.33 108.287 -177.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -64.45 -19.71 65.71 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.082 -0.71 . . . . 73.33 109.082 174.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 16.6 m -85.74 -10.11 56.08 Favored 'General case' 0 N--CA 1.435 -1.204 0 CA-C-N 115.214 -0.903 . . . . 61.55 110.249 178.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 100.53 -142.92 16.06 Favored Glycine 0 CA--C 1.482 -1.982 0 N-CA-C 109.021 -1.632 . . . . 39.34 109.021 -179.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 5.5 mp -83.1 120.15 25.4 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 107.97 -1.122 . . . . 72.21 107.97 175.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . 0.549 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 44.2 tt0 -131.49 119.15 21.16 Favored 'General case' 0 C--N 1.29 -1.978 0 N-CA-C 109.393 -0.595 . . . . 72.51 109.393 -176.623 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -97.69 132.0 43.73 Favored 'General case' 0 N--CA 1.427 -1.612 0 N-CA-C 108.074 -1.084 . . . . 74.53 108.074 -179.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -145.13 164.34 27.49 Favored Pre-proline 0 C--N 1.287 -2.146 0 N-CA-C 108.284 -1.006 . . . . 73.31 108.284 -177.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -60.84 131.71 38.79 Favored 'Trans proline' 0 N--CA 1.448 -1.159 0 N-CA-C 109.401 -1.038 . . . . 71.11 109.401 174.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -137.49 150.87 20.94 Favored Glycine 0 CA--C 1.474 -2.481 0 N-CA-C 109.393 -1.483 . . . . 44.51 109.393 -178.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.588 ' HB ' ' CG1' ' A' ' 218' ' ' VAL . 3.2 mp -108.22 138.22 35.96 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.291 0 C-N-CA 120.071 -0.652 . . . . 75.14 110.141 -179.172 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -131.44 163.7 27.36 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 107.185 -1.413 . . . . 72.24 107.185 -177.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 41.7 mt -81.97 128.52 38.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 CA-C-O 121.711 0.767 . . . . 73.3 110.447 175.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' SER . . . . . 0.481 ' HB2' ' HG2' ' A' ' 177' ' ' ARG . 27.8 t -100.47 -22.79 14.9 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 112.892 0.701 . . . . 70.13 112.892 -177.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 51.3 ttp180 -167.56 152.26 6.87 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 109.601 -0.518 . . . . 72.52 109.601 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 38.7 mt -100.96 146.34 27.52 Favored 'General case' 0 CA--C 1.48 -1.729 0 N-CA-C 108.85 -0.796 . . . . 73.54 108.85 173.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . 0.48 ' HB ' ' HA2' ' A' ' 173' ' ' GLY . 10.9 t -103.44 114.67 64.72 Favored Pre-proline 0 C--N 1.284 -2.252 0 N-CA-C 105.914 -1.884 . . . . 71.53 105.914 174.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . 0.427 ' HA ' ' HG2' ' A' ' 207' ' ' GLU . 23.9 Cg_exo -63.34 135.8 51.95 Favored 'Trans proline' 0 N--CA 1.447 -1.209 0 C-N-CA 121.888 1.725 . . . . 72.24 110.707 -178.085 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.427 ' H ' ' HG2' ' A' ' 207' ' ' GLU . . . 94.73 -12.6 68.47 Favored Glycine 0 C--N 1.312 -0.789 0 C-N-CA 120.891 -0.671 . . . . 75.24 112.152 -178.013 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . 0.43 ' HA3' ' CA ' ' A' ' 173' ' ' GLY . . . -80.05 172.95 54.93 Favored Glycine 0 N--CA 1.436 -1.328 0 C-N-CA 120.891 -0.671 . . . . 64.41 111.707 179.454 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . 0.518 ' HG ' ' H ' ' A' ' 164' ' ' LEU . 2.8 mm? -67.17 -41.91 85.18 Favored 'General case' 0 C--N 1.311 -1.089 0 C-N-CA 123.126 0.57 . . . . 73.23 111.761 -175.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -60.52 -39.18 86.89 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.102 0.477 . . . . 61.31 110.445 176.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.427 ' HG2' ' HA ' ' A' ' 202' ' ' PRO . 9.1 tp10 -67.85 -42.07 81.94 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.455 -0.793 . . . . 74.33 109.524 177.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 51.0 m -60.54 -45.12 95.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.4 -0.818 . . . . 72.13 112.032 -177.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 10.0 t -76.72 -30.12 56.5 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 109.362 -0.607 . . . . 65.0 109.362 178.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 66.04 16.55 64.42 Favored Glycine 0 C--N 1.34 0.754 0 CA-C-N 115.509 -0.769 . . . . 40.31 113.106 177.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.47 HD21 HG13 ' A' ' 161' ' ' VAL . 1.9 pp -99.74 -3.45 32.82 Favored 'General case' 0 N--CA 1.433 -1.28 0 C-N-CA 120.275 -0.57 . . . . 64.33 110.86 -177.426 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 5.4 mp -109.25 133.23 53.3 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 107.622 -1.251 . . . . 72.25 107.622 175.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -131.05 166.51 20.88 Favored 'General case' 0 C--N 1.279 -2.485 0 N-CA-C 108.599 -0.889 . . . . 64.44 108.599 178.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 35.5 m -57.38 -31.03 37.3 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 N-CA-C 112.726 0.639 . . . . 71.25 112.726 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 -73.22 -13.86 61.23 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 113.201 0.815 . . . . 71.12 113.201 -179.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -73.3 135.09 44.36 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.324 0.583 . . . . 73.43 112.405 -178.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -104.53 134.33 47.89 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.881 -1.054 . . . . 74.35 109.162 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . 0.588 ' CG1' ' HB ' ' A' ' 195' ' ' ILE . 13.1 p -84.08 134.97 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 CA-C-O 122.175 0.988 . . . . 72.55 111.395 -177.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 36.2 mm -99.27 -52.98 8.27 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.078 0 CA-C-N 114.332 -1.303 . . . . 73.01 111.025 -179.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -157.78 151.34 23.72 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 116.076 -0.511 . . . . 73.45 110.926 -175.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 246' ' ' ILE . 6.9 p -120.81 124.44 72.36 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 N-CA-C 108.959 -0.756 . . . . 74.14 108.959 176.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . 0.476 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 16.3 t-20 70.63 -3.8 1.83 Allowed 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 125.062 1.345 . . . . 70.34 111.164 -178.343 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 120.58 -17.91 9.42 Favored Glycine 0 C--N 1.301 -1.407 0 N-CA-C 111.019 -0.832 . . . . 54.4 111.019 -175.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 63.5 mt -88.52 123.77 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 N-CA-C 109.203 -0.666 . . . . 70.53 109.203 -179.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -61.54 147.84 44.1 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.585 0.707 . . . . 74.21 111.506 -178.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 26.1 m -117.8 -2.52 9.83 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 CA-C-N 115.408 -0.814 . . . . 71.21 112.239 179.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -82.16 104.34 12.42 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 109.169 -0.678 . . . . 51.32 109.169 177.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 122.58 -25.05 6.66 Favored Glycine 0 C--N 1.297 -1.597 0 N-CA-C 110.096 -1.202 . . . . 75.24 110.096 -179.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -74.0 166.7 22.92 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 107.711 -1.218 . . . . 75.21 107.711 176.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' THR . . . . . 0.437 ' O ' HG13 ' A' ' 234' ' ' VAL . 82.5 p -91.0 168.15 11.87 Favored 'General case' 0 C--O 1.249 1.06 0 N-CA-C 108.413 -0.958 . . . . 72.14 108.413 178.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 47.2 tp -66.07 -27.96 68.47 Favored 'General case' 0 N--CA 1.428 -1.566 0 C-N-CA 120.56 -0.456 . . . . 72.25 109.911 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -69.07 -47.71 64.6 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.725 -0.472 . . . . 71.24 109.725 176.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -58.92 -48.36 81.72 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 113.587 0.958 . . . . 74.24 113.587 177.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.437 HG13 ' O ' ' A' ' 230' ' ' THR . 13.3 m -65.14 -34.23 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-O 121.343 0.592 . . . . 64.21 111.598 -175.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 90.0 m -75.48 -35.65 60.78 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 115.52 -0.764 . . . . 61.4 109.394 -176.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -61.53 -34.03 74.84 Favored 'General case' 0 CA--C 1.508 -0.639 0 N-CA-C 108.8 -0.815 . . . . 71.43 108.8 177.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 237' ' ' MET . . . . . 0.404 ' HG3' ' HA ' ' A' ' 234' ' ' VAL . 9.9 mtt -67.66 -45.46 75.21 Favored 'General case' 0 C--O 1.211 -0.933 0 N-CA-C 108.113 -1.069 . . . . 75.14 108.113 178.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 65.9 mtt -59.25 -38.72 80.76 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.884 -0.598 . . . . 75.22 111.531 -178.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 60.6 t -69.76 -33.16 54.98 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-O 121.255 0.55 . . . . 73.01 110.217 178.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -75.28 -30.33 60.4 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.203 0.525 . . . . 73.02 111.404 179.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 -90.14 21.84 3.56 Favored 'General case' 0 C--O 1.2 -1.531 0 CA-C-N 115.895 -0.593 . . . . 72.21 112.519 -178.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 50.4 m -56.65 -22.97 38.3 Favored 'General case' 0 C--O 1.206 -1.22 0 N-CA-C 112.552 0.575 . . . . 72.11 112.552 177.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 18.4 m -64.16 -38.42 91.0 Favored 'General case' 0 CA--C 1.55 0.951 0 O-C-N 122.241 -0.287 . . . . 42.44 110.475 177.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -168.0 107.55 0.53 Allowed 'General case' 0 CA--C 1.491 -1.301 0 C-N-CA 126.876 2.071 . . . . 72.23 107.414 177.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . 0.466 ' HB3' ' HB2' ' A' ' 163' ' ' LEU . 0.2 OUTLIER -84.77 105.28 15.44 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 108.348 -0.982 . . . . 74.12 108.348 -174.667 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . 0.476 ' HB ' ' HA ' ' A' ' 222' ' ' ASN . 89.4 mt -94.08 115.31 32.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 109.003 -0.74 . . . . 64.03 109.003 179.079 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 13.3 mt -125.47 135.65 63.3 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.073 0 CA-C-O 121.467 0.651 . . . . 73.35 112.181 176.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.484 ' HA ' ' O ' ' A' ' 159' ' ' ARG . 70.1 m -107.55 115.52 30.3 Favored 'General case' 0 N--CA 1.414 -2.274 0 N-CA-C 107.636 -1.246 . . . . 65.22 107.636 173.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . 0.405 HG13 ' HA ' ' A' ' 218' ' ' VAL . 12.1 m -117.93 164.94 13.76 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.115 0 N-CA-C 109.491 -0.559 . . . . 75.24 109.491 174.298 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 17.4 ptmt -131.86 128.3 21.54 Favored Pre-proline 0 C--N 1.286 -2.16 0 CA-C-N 114.896 -1.047 . . . . 74.43 108.676 174.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -72.25 133.79 21.76 Favored 'Trans proline' 0 N--CA 1.442 -1.528 0 C-N-CA 121.559 1.506 . . . . 75.03 112.382 179.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -64.12 -19.93 65.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.032 -0.531 . . . . 73.54 111.355 179.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -81.85 -12.99 58.22 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.584 -0.735 . . . . 72.52 111.165 178.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 85.1 mm-40 67.73 172.23 0.27 Allowed 'General case' 0 C--O 1.24 0.59 0 CA-C-O 121.839 0.828 . . . . 72.45 112.822 -179.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? . . . . . 0 N--CA 1.418 -2.056 0 N-CA-C 105.29 -2.115 . . . . 71.3 105.29 178.339 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.239 0.527 0 N-CA-C 109.86 -0.422 . . . . 74.23 109.86 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 23.1 p -72.85 -45.56 57.68 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-O 120.68 0.276 . . . . 74.43 111.232 178.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.535 ' HB3' ' HB3' ' A' ' 250' ' ' LYS 0.407 6.0 p-80 -114.83 130.53 56.89 Favored 'General case' 0 CA--C 1.496 -1.107 0 N-CA-C 114.74 1.385 . . . . 72.24 114.74 174.064 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.564 ' O ' ' HA ' ' A' ' 248' ' ' THR . 11.3 ptt180 -110.34 143.84 39.97 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 113.562 -1.654 . . . . 72.54 110.812 -173.373 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -114.0 112.93 24.07 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 121.702 0.763 . . . . 74.15 110.887 178.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 28.4 m -114.3 139.7 38.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 CA-C-N 114.879 -1.055 . . . . 65.32 112.786 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 19.8 ttm180 -96.48 112.83 24.43 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.434 0.635 . . . . 74.12 109.781 177.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 19.8 mt -94.13 138.18 32.48 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-N 114.999 -1.0 . . . . 75.53 108.685 -178.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 15.4 tp 74.42 85.26 0.1 Allowed 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 122.121 0.962 . . . . 75.32 111.632 174.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -114.96 -8.42 12.5 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-N 114.708 -1.133 . . . . 64.31 110.888 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -107.5 77.9 1.17 Allowed 'General case' 0 C--N 1.307 -1.239 0 CA-C-O 121.034 0.445 . . . . 74.32 110.71 179.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . 0.456 ' O ' ' HB2' ' A' ' 168' ' ' SER . . . 84.48 -153.86 29.26 Favored Glycine 0 N--CA 1.402 -3.626 0 N-CA-C 108.157 -1.977 . . . . 71.35 108.157 177.279 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' SER . . . . . 0.456 ' HB2' ' O ' ' A' ' 167' ' ' GLY . 27.2 t -173.73 82.83 0.04 OUTLIER 'General case' 0 N--CA 1.404 -2.768 0 N-CA-C 108.749 -0.834 . . . . 73.51 108.749 178.291 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -138.52 -26.61 0.88 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.622 -1.172 . . . . 73.22 110.818 -178.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -96.63 153.67 38.7 Favored Pre-proline 0 N--CA 1.434 -1.253 0 CA-C-N 116.501 -0.318 . . . . 73.23 110.978 -178.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -63.37 153.96 71.23 Favored 'Trans proline' 0 C--O 1.245 0.855 0 C-N-CA 122.905 2.403 . . . . 72.11 110.576 173.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.446 ' HG ' ' CD1' ' A' ' 245' ' ' LEU . 3.6 mm? -68.49 -31.71 71.17 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 112.284 0.476 . . . . 74.51 112.284 -178.011 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . 0.467 ' HA3' ' HA3' ' A' ' 204' ' ' GLY . . . 88.07 34.97 9.26 Favored Glycine 0 N--CA 1.426 -2.024 0 C-N-CA 120.595 -0.812 . . . . 50.45 113.271 177.008 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -154.73 154.02 32.2 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 107.487 -1.301 . . . . 62.42 107.487 174.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -125.45 148.94 48.64 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 108.939 -0.763 . . . . 74.4 108.939 176.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 35.6 pt -110.08 169.52 3.61 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 CA-C-O 121.32 0.581 . . . . 74.0 111.253 -176.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.503 ' CG ' ' HB2' ' A' ' 198' ' ' SER . 15.7 ptt180 -149.21 154.79 39.64 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 115.112 -0.949 . . . . 72.42 109.312 -179.39 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -117.54 144.5 45.04 Favored 'General case' 0 C--N 1.287 -2.124 0 N-CA-C 109.014 -0.736 . . . . 64.23 109.014 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -161.95 179.96 36.98 Favored Glycine 0 N--CA 1.417 -2.63 0 N-CA-C 109.712 -1.355 . . . . 54.03 109.712 178.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' THR . . . . . 0.467 ' HB ' ' CG ' ' A' ' 191' ' ' LYS . 0.8 OUTLIER -86.46 123.92 32.22 Favored 'General case' 0 C--N 1.29 -1.997 0 CA-C-O 121.66 0.743 . . . . 73.45 112.193 177.298 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 37.4 t -104.56 113.62 27.31 Favored 'General case' 0 N--CA 1.403 -2.788 0 N-CA-C 107.356 -1.35 . . . . 74.42 107.356 177.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.632 ' HA ' ' O ' ' A' ' 190' ' ' GLU . 3.5 p -108.63 124.35 65.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 109.185 -0.672 . . . . 70.53 109.185 174.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -130.27 160.28 34.36 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-N 115.341 -0.845 . . . . 72.45 108.791 -172.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 56.6 t -84.98 119.69 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.38 0 CA-C-O 121.89 0.852 . . . . 73.21 108.781 172.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 40.9 p -128.45 -174.16 3.15 Favored 'General case' 0 C--N 1.276 -2.625 0 CA-C-N 114.001 -1.454 . . . . 75.35 108.342 -175.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -68.89 -15.53 63.52 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.421 0.629 . . . . 74.13 109.526 175.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 34.9 t -89.03 -9.0 52.94 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.389 -0.823 . . . . 75.3 109.027 177.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 98.07 -136.97 13.01 Favored Glycine 0 CA--C 1.483 -1.931 0 N-CA-C 108.523 -1.831 . . . . 63.21 108.523 -177.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 6.4 mp -80.54 118.81 22.46 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.282 -1.007 . . . . 70.14 108.282 173.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . 0.632 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 11.5 tp10 -129.88 123.3 30.47 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.532 -0.914 . . . . 73.43 108.532 -174.231 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.467 ' CG ' ' HB ' ' A' ' 180' ' ' THR . 34.6 ttmt -106.67 126.42 52.26 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.964 -0.754 . . . . 72.24 108.964 -177.217 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -145.71 164.71 24.34 Favored Pre-proline 0 C--N 1.292 -1.905 0 N-CA-C 107.893 -1.151 . . . . 74.02 107.893 -177.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -59.29 132.76 48.45 Favored 'Trans proline' 0 C--O 1.245 0.834 0 C-N-CA 121.533 1.488 . . . . 71.4 111.667 176.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -139.53 143.24 13.62 Favored Glycine 0 N--CA 1.419 -2.481 0 N-CA-C 109.778 -1.329 . . . . 63.12 109.778 178.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 3.2 mp -108.76 132.84 55.64 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 CA-C-O 121.117 0.484 . . . . 75.04 110.767 -179.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -125.31 167.72 14.51 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 107.946 -1.131 . . . . 75.22 107.946 -176.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . 0.456 ' HB ' ' HA ' ' A' ' 214' ' ' VAL . 46.5 mm -77.06 131.51 34.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 N-CA-C 108.189 -1.041 . . . . 75.43 108.189 174.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' SER . . . . . 0.503 ' HB2' ' CG ' ' A' ' 177' ' ' ARG . 12.7 t -104.48 -38.49 6.77 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 113.449 0.907 . . . . 52.31 113.449 -178.525 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 40.0 ttp180 -150.47 141.86 23.36 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 120.004 -0.678 . . . . 74.41 109.947 -177.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -108.45 133.79 52.13 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 107.562 -1.273 . . . . 65.22 107.562 -177.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 44.0 t -110.6 131.58 22.01 Favored Pre-proline 0 C--N 1.311 -1.073 0 C-N-CA 120.756 -0.378 . . . . 75.11 110.736 -177.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . 0.493 ' HA ' ' OE2' ' A' ' 207' ' ' GLU . 17.8 Cg_endo -60.78 135.21 58.47 Favored 'Trans proline' 0 C--O 1.247 0.939 0 C-N-CA 122.717 2.278 . . . . 73.32 111.682 176.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 86.37 0.78 86.46 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.812 -0.631 . . . . 72.32 112.63 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . 0.467 ' HA3' ' HA3' ' A' ' 173' ' ' GLY . . . -88.25 170.26 38.96 Favored Glycine 0 N--CA 1.439 -1.13 0 C-N-CA 120.577 -0.82 . . . . 74.22 112.526 -178.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -66.39 -34.25 77.54 Favored 'General case' 0 N--CA 1.438 -1.075 0 C-N-CA 123.088 0.555 . . . . 74.42 110.582 -179.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . 0.458 ' CB ' HD13 ' A' ' 212' ' ' LEU . . . -61.76 -41.55 97.83 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 115.613 -0.721 . . . . 62.41 110.49 176.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.493 ' OE2' ' HA ' ' A' ' 202' ' ' PRO . 41.2 tt0 -75.6 -33.52 60.56 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.946 -0.57 . . . . 75.33 110.234 178.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 44.3 t -56.34 -50.14 72.36 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 123.755 0.822 . . . . 65.55 111.042 -179.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' THR . . . . . 0.49 ' CG2' ' HG ' ' A' ' 211' ' ' LEU . 8.8 t -80.02 -25.98 39.99 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 119.648 -0.821 . . . . 75.33 109.59 176.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 65.6 22.84 70.13 Favored Glycine 0 N--CA 1.446 -0.689 0 CA-C-N 115.608 -0.724 . . . . 50.52 112.543 179.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.49 ' HG ' ' CG2' ' A' ' 209' ' ' THR . 1.1 pp -111.61 4.06 18.39 Favored 'General case' 0 N--CA 1.436 -1.174 0 C-N-CA 120.073 -0.651 . . . . 74.44 112.235 -177.33 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . 0.458 HD13 ' CB ' ' A' ' 206' ' ' ALA . 75.5 mt -108.39 133.13 53.0 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 108.65 -0.87 . . . . 75.21 108.65 177.577 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -131.86 165.23 24.3 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 107.613 -1.254 . . . . 74.45 107.613 177.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . 0.456 ' HA ' ' HB ' ' A' ' 197' ' ' ILE 0.259 18.7 m -65.53 -28.83 45.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 113.519 0.933 . . . . 75.34 113.519 -177.99 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -73.11 -15.14 61.49 Favored 'General case' 0 N--CA 1.484 1.247 0 O-C-N 121.906 -0.496 . . . . 42.43 111.636 178.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -66.43 131.95 47.21 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-O 121.337 0.589 . . . . 62.33 112.036 -179.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . 0.483 ' O ' ' HA ' ' A' ' 249' ' ' VAL . 38.6 tt0 -105.82 132.4 51.99 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.95 -1.023 . . . . 74.34 111.044 -178.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 35.4 t -81.66 127.37 39.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 C-N-CA 123.24 0.616 . . . . 74.1 110.643 -176.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 40.9 mm -98.84 -49.41 11.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 CA-C-N 115.341 -0.845 . . . . 71.35 110.806 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.428 ' CB ' ' HA ' ' A' ' 225' ' ' GLU . 12.7 pt-20 -152.55 158.41 42.46 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-O 120.529 0.204 . . . . 75.33 110.703 -179.255 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . 0.545 ' C ' ' H ' ' A' ' 223' ' ' GLY . 9.1 p -125.36 125.76 69.54 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 N-CA-C 109.088 -0.708 . . . . 73.21 109.088 178.406 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . 0.627 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 14.8 t-20 71.92 -31.8 0.23 Allowed 'General case' 0 N--CA 1.499 2.021 0 C-N-CA 126.421 1.888 . . . . 72.13 112.364 -178.281 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . 0.545 ' H ' ' C ' ' A' ' 221' ' ' VAL . . . 150.21 -4.6 0.62 Allowed Glycine 0 C--N 1.276 -2.797 0 CA-C-N 114.547 -1.206 . . . . 37.71 110.777 -175.163 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 68.6 mt -104.56 124.34 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.14 0 N-CA-C 109.364 -0.606 . . . . 71.2 109.364 179.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . 0.428 ' HA ' ' CB ' ' A' ' 220' ' ' GLU . 12.4 pt-20 -57.91 148.66 24.96 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 123.419 0.688 . . . . 71.33 112.801 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . 0.488 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 34.3 m -122.67 -2.54 7.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 CA-C-N 114.891 -1.049 . . . . 70.02 109.501 175.44 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -71.22 99.05 1.83 Allowed 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 115.547 -0.751 . . . . 73.1 110.441 -177.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 121.91 -23.2 7.44 Favored Glycine 0 N--CA 1.43 -1.742 0 N-CA-C 110.965 -0.854 . . . . 61.22 110.965 178.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 80.2 mttt -78.13 172.85 12.93 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 121.142 -0.223 . . . . 74.54 111.306 -179.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 230' ' ' THR . . . . . 0.446 ' O ' HG13 ' A' ' 234' ' ' VAL . 74.2 p -93.77 165.97 12.43 Favored 'General case' 0 N--CA 1.427 -1.612 0 C-N-CA 119.849 -0.74 . . . . 64.51 109.76 -175.424 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -60.96 -38.78 87.11 Favored 'General case' 0 N--CA 1.427 -1.614 0 CA-C-N 116.081 -0.508 . . . . 72.44 109.787 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -65.95 -40.16 91.09 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.458 -0.337 . . . . 62.2 110.664 179.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -64.31 -49.3 72.32 Favored 'General case' 0 C--O 1.223 -0.316 0 N-CA-C 112.667 0.618 . . . . 72.31 112.667 175.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.488 ' CG1' ' HB ' ' A' ' 226' ' ' VAL . 15.0 m -68.36 -34.05 63.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 112.729 0.64 . . . . 70.43 112.729 -173.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 75.1 m -71.0 -35.63 72.14 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 109.229 -0.656 . . . . 64.01 109.229 -176.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -62.63 -33.97 76.09 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.727 -0.669 . . . . 72.03 109.598 178.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 2.0 mtm -74.33 -34.91 63.58 Favored 'General case' 0 C--O 1.2 -1.55 0 N-CA-C 108.542 -0.91 . . . . 75.12 108.542 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 238' ' ' MET . . . . . 0.425 ' HG3' ' O ' ' A' ' 234' ' ' VAL . 65.3 mtt -68.66 -36.24 78.29 Favored 'General case' 0 C--N 1.314 -0.964 0 O-C-N 121.995 -0.441 . . . . 61.3 110.844 178.63 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 99.9 t -67.81 -39.57 82.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 CA-C-O 121.278 0.561 . . . . 64.41 109.665 176.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -69.59 -32.4 71.13 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.919 -0.582 . . . . 63.25 111.006 178.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 58.0 m-80 -96.24 21.04 9.45 Favored 'General case' 0 C--O 1.206 -1.187 0 CA-C-N 116.294 -0.412 . . . . 63.34 111.995 178.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 62.6 m -63.16 -23.1 67.28 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 120.537 -0.465 . . . . 75.41 111.895 178.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 19.2 m -66.03 -24.99 66.85 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 116.639 -0.255 . . . . 74.21 111.159 177.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -172.79 93.13 0.11 Allowed 'General case' 0 C--O 1.24 0.577 0 C-N-CA 124.602 1.161 . . . . 71.05 109.054 -178.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . 0.446 ' CD1' ' HG ' ' A' ' 172' ' ' LEU . 1.2 tt -88.66 105.05 17.42 Favored 'General case' 0 C--O 1.198 -1.643 0 CA-C-N 115.769 -0.65 . . . . 75.14 111.286 -169.301 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . 0.627 ' HB ' ' HA ' ' A' ' 222' ' ' ASN . 52.3 mt -96.95 122.61 48.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 108.506 -0.924 . . . . 72.3 108.506 176.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 14.9 mt -130.09 135.4 61.03 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.061 0 CA-C-O 121.441 0.639 . . . . 72.12 112.487 177.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.564 ' HA ' ' O ' ' A' ' 159' ' ' ARG . 87.6 m -99.99 122.67 43.25 Favored 'General case' 0 N--CA 1.423 -1.784 0 CA-C-N 114.906 -1.043 . . . . 75.14 108.417 174.507 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . 0.483 ' HA ' ' O ' ' A' ' 217' ' ' GLU . 23.5 m -132.61 151.83 35.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 CA-C-O 121.347 0.594 . . . . 63.51 111.06 177.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . 0.535 ' HB3' ' HB3' ' A' ' 158' ' ' HIS . 1.4 ptmm? -126.79 128.69 24.21 Favored Pre-proline 0 C--N 1.28 -2.437 0 CA-C-N 114.286 -1.325 . . . . 71.32 109.045 174.194 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -65.96 149.5 86.18 Favored 'Trans proline' 0 N--CA 1.44 -1.637 0 C-N-CA 122.221 1.947 . . . . 74.32 110.291 176.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -59.49 -35.05 73.37 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-O 121.775 0.797 . . . . 72.31 109.745 178.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -99.17 73.65 1.92 Allowed 'General case' 0 C--N 1.293 -1.848 0 CA-C-N 114.632 -1.167 . . . . 72.41 108.88 177.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -86.77 154.9 20.58 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 114.942 -1.026 . . . . 72.54 111.069 179.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 33.6 mmt180 . . . . . 0 C--N 1.311 -1.081 0 CA-C-O 118.537 -0.744 . . . . 64.32 109.308 -179.9 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 . . . . . 0 CA--C 1.503 -0.832 0 N-CA-C 109.34 -0.615 . . . . 73.43 109.34 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 35.0 p -89.9 -35.09 15.81 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-O 120.938 0.399 . . . . 74.22 111.419 178.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 1.3 m80 -124.37 130.72 52.99 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 121.134 0.492 . . . . 72.41 111.755 178.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -132.84 135.12 45.45 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 107.739 -1.208 . . . . 73.0 107.739 175.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 12.9 ptp180 -124.58 113.32 17.91 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-O 121.792 0.806 . . . . 74.11 110.14 178.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 23.7 m -107.41 138.25 34.48 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.922 0 CA-C-N 114.996 -1.002 . . . . 71.31 112.614 -178.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.63 ' CZ ' ' HA ' ' A' ' 165' ' ' LYS . 0.1 OUTLIER -104.27 112.56 25.63 Favored 'General case' 0 N--CA 1.417 -2.076 0 N-CA-C 108.473 -0.936 . . . . 74.05 108.473 175.735 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.4 ' HB2' ' HB3' ' A' ' 245' ' ' LEU . 22.9 mt -101.01 139.89 36.07 Favored 'General case' 0 C--N 1.284 -2.239 0 CA-C-N 114.317 -1.31 . . . . 73.45 108.243 -175.451 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 74.37 82.29 0.11 Allowed 'General case' 0 N--CA 1.426 -1.673 0 N-CA-C 106.097 -1.816 . . . . 73.42 106.097 173.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.63 ' HA ' ' CZ ' ' A' ' 162' ' ' ARG . 52.4 mtpt -93.64 4.33 54.11 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-N 113.961 -1.472 . . . . 74.44 113.076 -169.427 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 45.2 t-80 -127.85 -60.87 1.14 Allowed 'General case' 0 C--N 1.297 -1.698 0 C-N-CA 119.171 -1.012 . . . . 75.2 112.922 178.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 145.93 113.99 0.85 Allowed Glycine 0 C--N 1.298 -1.574 0 N-CA-C 109.881 -1.288 . . . . 71.01 109.881 -177.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' SER . . . . . 0.44 ' HB3' ' HG2' ' A' ' 170' ' ' LYS . 24.4 m -154.11 154.66 34.0 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 117.01 0.405 . . . . 75.42 110.445 -177.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -98.58 8.6 44.71 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.47 -0.786 . . . . 63.01 109.615 177.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.44 ' HG2' ' HB3' ' A' ' 168' ' ' SER . 22.5 pttm -83.37 150.5 60.53 Favored Pre-proline 0 N--CA 1.434 -1.275 0 CA-C-N 115.683 -0.69 . . . . 72.45 110.003 177.345 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -62.33 148.4 93.33 Favored 'Trans proline' 0 C--O 1.248 0.997 0 C-N-CA 122.624 2.216 . . . . 75.55 110.92 176.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.504 ' HG ' ' CD1' ' A' ' 245' ' ' LEU . 3.1 mm? -71.92 -22.2 61.51 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 115.749 -0.66 . . . . 52.1 112.336 -176.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . 0.411 ' HA3' ' HA3' ' A' ' 204' ' ' GLY . . . 90.88 34.23 7.84 Favored Glycine 0 N--CA 1.422 -2.247 0 C-N-CA 120.672 -0.775 . . . . 73.24 112.929 177.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 26.0 p90 -152.93 154.38 34.9 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 108.805 -0.813 . . . . 73.11 108.805 175.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -128.12 150.87 49.79 Favored 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 108.322 -0.992 . . . . 73.43 108.322 175.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.527 ' H ' HD11 ' A' ' 176' ' ' ILE . 0.2 OUTLIER -116.4 169.21 7.1 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.081 0 CA-C-O 121.474 0.654 . . . . 75.02 111.276 -177.584 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.487 ' HG2' ' HB2' ' A' ' 198' ' ' SER . 4.3 ptp180 -147.98 155.2 41.26 Favored 'General case' 0 C--N 1.278 -2.524 0 C-N-CA 124.358 1.063 . . . . 62.24 109.884 -176.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -111.46 146.23 37.59 Favored 'General case' 0 C--N 1.294 -1.836 0 O-C-N 123.579 0.549 . . . . 73.24 110.135 179.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -159.61 -165.01 15.71 Favored Glycine 0 C--N 1.292 -1.914 0 N-CA-C 108.624 -1.791 . . . . 50.3 108.624 175.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' THR . . . . . 0.413 ' HB ' ' CG ' ' A' ' 191' ' ' LYS . 3.1 p -103.9 125.65 50.46 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 118.46 1.13 . . . . 64.2 112.627 175.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 67.8 m -110.51 113.06 25.4 Favored 'General case' 0 N--CA 1.403 -2.784 0 N-CA-C 107.484 -1.302 . . . . 74.41 107.484 173.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.48 ' HA ' ' O ' ' A' ' 190' ' ' GLU . 6.7 p -105.08 119.94 54.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 C-N-CA 119.433 -0.907 . . . . 71.33 109.195 175.42 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 90.1 mtt180 -122.57 153.13 39.67 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 114.803 -1.09 . . . . 73.13 109.295 -173.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 74.5 t -83.58 119.39 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.845 0 N-CA-C 106.96 -1.496 . . . . 74.52 106.96 170.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 71.8 p -109.64 -175.0 2.63 Favored 'General case' 0 C--N 1.262 -3.198 0 CA-C-N 114.56 -1.2 . . . . 74.42 108.741 -176.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -70.09 -9.74 56.44 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 115.981 -0.554 . . . . 73.24 110.236 176.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 19.4 m -111.38 -4.31 14.94 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 116.094 -0.503 . . . . 74.32 111.167 179.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 119.91 -156.57 15.85 Favored Glycine 0 CA--C 1.498 -1.009 0 C-N-CA 120.026 -1.083 . . . . 52.33 110.816 178.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 5.1 mp -79.21 126.18 30.42 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 117.81 0.805 . . . . 74.34 109.695 179.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . 0.48 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 42.8 tt0 -132.96 119.4 20.06 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 109.071 -0.714 . . . . 72.31 109.071 -178.326 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.418 ' HG3' ' HB ' ' A' ' 182' ' ' VAL . 36.2 ttmt -92.51 121.69 34.21 Favored 'General case' 0 N--CA 1.413 -2.295 0 N-CA-C 106.851 -1.537 . . . . 75.54 106.851 176.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -126.02 160.13 58.49 Favored Pre-proline 0 C--N 1.268 -2.945 0 N-CA-C 107.603 -1.258 . . . . 73.24 107.603 -176.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -65.73 131.03 26.29 Favored 'Trans proline' 0 N--CA 1.416 -3.042 0 N-CA-C 107.861 -1.631 . . . . 73.12 107.861 168.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -122.47 138.76 12.14 Favored Glycine 0 N--CA 1.402 -3.621 0 N-CA-C 109.09 -1.604 . . . . 74.14 109.09 179.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.459 ' HB ' ' CG1' ' A' ' 218' ' ' VAL . 3.5 mp -104.05 132.16 51.18 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.626 0 C-N-CA 120.268 -0.573 . . . . 75.43 109.79 179.493 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -122.81 165.0 17.33 Favored 'General case' 0 C--N 1.284 -2.275 0 N-CA-C 108.188 -1.042 . . . . 75.14 108.188 -177.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . 0.435 ' HB ' ' HA ' ' A' ' 214' ' ' VAL . 46.8 mm -78.37 128.8 38.17 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 107.711 -1.218 . . . . 54.53 107.711 174.246 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' SER . . . . . 0.487 ' HB2' ' HG2' ' A' ' 177' ' ' ARG . 11.4 t -100.99 -28.21 12.86 Favored 'General case' 0 C--N 1.28 -2.45 0 O-C-N 121.488 -0.758 . . . . 60.2 113.013 -177.573 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 25.3 tpt180 -163.07 140.11 7.55 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 120.878 -0.329 . . . . 74.23 110.333 -175.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 61.4 mt -105.33 137.53 42.98 Favored 'General case' 0 CA--C 1.491 -1.29 0 N-CA-C 108.964 -0.754 . . . . 72.33 108.964 172.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 61.5 t -97.55 116.53 65.84 Favored Pre-proline 0 C--N 1.279 -2.463 0 N-CA-C 105.773 -1.936 . . . . 73.32 105.773 172.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . 0.578 ' HA ' ' OE1' ' A' ' 207' ' ' GLU . 21.1 Cg_endo -60.04 126.29 19.9 Favored 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 121.932 1.755 . . . . 72.21 111.707 -174.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 105.51 -9.08 44.64 Favored Glycine 0 C--N 1.307 -1.073 0 CA-C-N 115.421 -0.809 . . . . 53.22 111.104 -177.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . 0.411 ' HA3' ' HA3' ' A' ' 173' ' ' GLY . . . -74.77 167.55 54.82 Favored Glycine 0 N--CA 1.437 -1.248 0 C-N-CA 121.556 -0.354 . . . . 73.34 113.14 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -65.0 -29.16 70.07 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 124.281 1.032 . . . . 73.3 111.737 -177.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -59.81 -40.73 89.38 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.863 -0.608 . . . . 74.53 110.57 177.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.578 ' OE1' ' HA ' ' A' ' 202' ' ' PRO . 46.3 mt-10 -75.5 -31.42 60.16 Favored 'General case' 0 CA--C 1.507 -0.694 0 CA-C-N 116.2 -0.454 . . . . 70.43 110.885 175.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 24.8 m -55.73 -36.96 67.81 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.162 -0.472 . . . . 72.52 111.417 -177.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 9.7 t -84.72 -32.68 23.39 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 109.281 -0.637 . . . . 63.43 109.281 174.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 73.32 21.02 80.02 Favored Glycine 0 CA--C 1.497 -1.058 0 CA-C-N 115.876 -0.602 . . . . 40.24 112.061 177.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 38.4 mt -114.31 -0.32 13.9 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 109.655 -0.498 . . . . 71.23 109.655 -178.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 74.0 mt -109.03 130.93 55.49 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 120.113 -0.635 . . . . 75.34 110.684 176.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -133.82 166.23 23.14 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 114.605 -1.179 . . . . 75.4 108.04 176.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . 0.435 ' HA ' ' HB ' ' A' ' 197' ' ' ILE . 26.4 m -59.33 -29.37 41.79 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-O 121.934 0.873 . . . . 73.31 111.416 176.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -72.65 -15.79 61.71 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 115.377 -0.829 . . . . 41.35 112.617 -175.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -69.31 137.82 53.29 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 113.602 0.964 . . . . 63.45 113.602 -176.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -112.92 124.66 53.12 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.795 1.638 . . . . 75.22 108.87 -178.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . 0.459 ' CG1' ' HB ' ' A' ' 195' ' ' ILE . 8.2 p -80.1 146.47 7.63 Favored 'Isoleucine or valine' 0 C--O 1.251 1.168 0 N-CA-C 113.953 1.094 . . . . 74.02 113.953 -173.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . 0.455 HD11 ' CD ' ' A' ' 250' ' ' LYS . 44.4 mm -111.46 -53.13 5.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 113.988 -1.46 . . . . 75.15 110.435 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -158.07 156.28 30.76 Favored 'General case' 0 C--O 1.244 0.794 0 CA-C-N 116.324 -0.398 . . . . 74.32 110.245 -176.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' A' ' 246' ' ' ILE . 4.4 p -124.74 115.92 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.292 0 CA-C-O 121.586 0.707 . . . . 72.23 110.838 173.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . 0.436 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 21.4 t-20 58.95 34.61 23.71 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 126.124 1.77 . . . . 73.54 110.638 178.407 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 93.74 -4.83 72.73 Favored Glycine 0 C--N 1.301 -1.392 0 CA-C-N 115.165 -0.925 . . . . 71.33 113.172 177.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 58.1 mt -99.67 123.36 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.373 0 N-CA-C 108.628 -0.878 . . . . 73.15 108.628 179.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -62.93 134.99 57.06 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 121.403 0.621 . . . . 73.03 110.741 -179.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 27.6 m -115.57 10.97 7.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-O 122.202 1.001 . . . . 72.4 109.611 175.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -75.32 99.98 4.26 Favored 'General case' 0 N--CA 1.422 -1.83 0 CA-C-N 114.307 -1.315 . . . . 71.54 110.336 179.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 95.08 18.46 33.96 Favored Glycine 0 N--CA 1.438 -1.186 0 CA-C-N 115.489 -0.778 . . . . 71.25 112.919 175.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . 0.427 ' HB3' ' HG2' ' A' ' 233' ' ' GLN . 68.7 mmtt -95.63 172.2 8.2 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.963 0.382 . . . . 75.31 110.164 179.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 230' ' ' THR . . . . . 0.654 ' OG1' ' HB2' ' A' ' 233' ' ' GLN . 40.6 p -76.1 162.57 27.9 Favored 'General case' 0 N--CA 1.433 -1.296 0 C-N-CA 120.33 -0.548 . . . . 72.23 109.55 175.594 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -68.6 -39.18 81.01 Favored 'General case' 0 N--CA 1.429 -1.514 0 N-CA-C 108.982 -0.747 . . . . 71.5 108.982 -179.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -61.29 -39.39 90.28 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 116.302 -0.408 . . . . 72.21 110.338 176.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 233' ' ' GLN . . . . . 0.654 ' HB2' ' OG1' ' A' ' 230' ' ' THR . 3.5 tp-100 -58.16 -50.95 71.73 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 123.947 0.899 . . . . 73.01 109.796 -177.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.43 ' O ' ' HG3' ' A' ' 238' ' ' MET . 13.0 m -73.67 -34.2 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-N 115.265 -0.88 . . . . 75.34 111.536 -174.05 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 53.0 m -74.75 -36.52 62.6 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 115.42 -0.809 . . . . 73.2 109.251 -175.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -58.77 -34.72 71.76 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-N 115.39 -0.823 . . . . 74.13 109.602 175.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 10.1 mtt -69.79 -50.27 44.66 Favored 'General case' 0 C--O 1.208 -1.128 0 N-CA-C 108.002 -1.11 . . . . 70.21 108.002 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 238' ' ' MET . . . . . 0.43 ' HG3' ' O ' ' A' ' 234' ' ' VAL . 64.4 mtt -54.47 -40.01 68.03 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 123.426 0.69 . . . . 75.42 111.791 -177.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 80.3 t -69.09 -48.91 66.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.158 0.504 . . . . 71.33 110.915 178.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -65.78 -28.9 69.36 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.908 -0.587 . . . . 73.32 111.705 -178.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 -84.68 21.56 1.5 Allowed 'General case' 0 C--O 1.2 -1.549 0 N-CA-C 113.174 0.805 . . . . 74.44 113.174 -179.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 31.0 p -56.19 -23.76 37.34 Favored 'General case' 0 C--O 1.2 -1.54 0 N-CA-C 113.301 0.852 . . . . 75.34 113.301 177.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 19.4 m -71.28 -37.41 71.88 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 121.563 0.697 . . . . 63.33 110.214 177.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -158.19 92.22 1.15 Allowed 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 123.922 0.889 . . . . 73.43 110.091 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . 0.504 ' CD1' ' HG ' ' A' ' 172' ' ' LEU . 1.4 tt -88.64 103.75 16.22 Favored 'General case' 0 C--O 1.207 -1.145 0 N-CA-C 109.029 -0.73 . . . . 74.21 109.029 -175.472 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . 0.436 ' HB ' ' HA ' ' A' ' 222' ' ' ASN . 58.7 mt -106.1 115.73 48.39 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 109.053 -0.721 . . . . 74.53 109.053 179.144 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 32.1 mt -119.89 128.82 75.94 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 CA-C-O 121.472 0.653 . . . . 71.13 111.657 178.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 37.9 m -102.07 118.48 36.98 Favored 'General case' 0 N--CA 1.418 -2.066 0 CA-C-N 114.751 -1.113 . . . . 75.55 108.021 176.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 15.8 m -126.84 170.08 17.32 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.992 0 CA-C-O 121.793 0.806 . . . . 74.55 110.673 178.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . 0.455 ' CD ' HD11 ' A' ' 219' ' ' ILE 0.337 42.9 mtpt -125.72 152.4 72.21 Favored Pre-proline 0 C--N 1.271 -2.812 0 CA-C-N 113.492 -1.685 . . . . 74.31 106.67 174.897 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -80.19 143.9 16.17 Favored 'Trans proline' 0 N--CA 1.424 -2.566 0 N-CA-C 108.304 -1.46 . . . . 72.42 108.304 167.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -57.91 -38.77 76.47 Favored 'General case' 0 CA--C 1.49 -1.347 0 CA-C-O 121.895 0.855 . . . . 61.03 109.54 179.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -94.58 87.92 5.26 Favored 'General case' 0 C--N 1.284 -2.268 0 N-CA-C 107.198 -1.408 . . . . 73.22 107.198 172.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -49.06 101.32 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 114.316 -1.311 . . . . 53.15 110.711 178.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 27.9 ttm180 . . . . . 0 N--CA 1.437 -1.085 0 N-CA-C 108.851 -0.796 . . . . 74.14 108.851 -177.91 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.516 -0.328 0 N-CA-C 109.532 -0.544 . . . . 75.33 109.532 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 37.5 p -78.11 -30.23 49.35 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-O 121.268 0.556 . . . . 70.33 110.828 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -125.39 130.99 53.0 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.803 -0.635 . . . . 71.32 109.866 173.01 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.503 ' HA ' ' HE ' ' A' ' 159' ' ' ARG . 2.0 tpm_? -121.73 119.2 31.06 Favored 'General case' 0 N--CA 1.423 -1.799 0 N-CA-C 109.411 -0.588 . . . . 72.21 109.411 178.355 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 81.2 mtm180 -101.05 113.73 27.01 Favored 'General case' 0 C--N 1.281 -2.392 0 CA-C-N 115.123 -0.944 . . . . 71.44 109.507 179.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 23.6 m -119.67 139.23 47.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 CA-C-N 115.924 -0.58 . . . . 74.44 111.198 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -107.86 112.09 24.55 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.127 -1.064 . . . . 64.43 108.127 176.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.42 ' HB2' ' HB2' ' A' ' 245' ' ' LEU . 20.9 mt -103.03 139.87 38.02 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 108.323 -0.991 . . . . 64.3 108.323 -174.113 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.724 ' HG ' ' O ' ' A' ' 242' ' ' SER . 0.1 OUTLIER 72.76 77.96 0.15 Allowed 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 105.911 -1.885 . . . . 64.33 105.911 -179.608 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -98.82 -11.56 21.68 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 115.18 -0.918 . . . . 74.23 111.22 -174.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 44.5 m80 -148.43 104.97 3.55 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 116.024 -0.534 . . . . 71.14 110.431 177.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 126.3 -153.6 18.67 Favored Glycine 0 N--CA 1.422 -2.246 0 N-CA-C 110.232 -1.147 . . . . 65.31 110.232 177.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 32.1 t 179.91 173.35 0.95 Allowed 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 107.63 -1.248 . . . . 72.55 107.63 178.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 23.4 t70 73.88 -29.31 0.2 Allowed 'General case' 0 N--CA 1.504 2.238 0 N-CA-C 114.274 1.213 . . . . 65.53 114.274 174.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.4 ' HA ' ' HD3' ' A' ' 171' ' ' PRO . 28.0 mtpp -72.34 149.72 91.55 Favored Pre-proline 0 C--N 1.307 -1.271 0 C-N-CA 123.259 0.624 . . . . 75.12 112.621 -176.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 170' ' ' LYS . 21.7 Cg_exo -67.32 153.46 76.97 Favored 'Trans proline' 0 C--O 1.242 0.723 0 C-N-CA 122.813 2.342 . . . . 74.23 110.104 173.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.468 ' HG ' ' CD1' ' A' ' 245' ' ' LEU . 2.7 mm? -90.61 -27.54 19.02 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-N 116.132 -0.485 . . . . 71.54 112.177 -174.668 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . 0.461 ' HA3' ' HA3' ' A' ' 204' ' ' GLY . . . 97.69 30.59 7.13 Favored Glycine 0 N--CA 1.44 -1.091 0 C-N-CA 120.258 -0.972 . . . . 75.4 112.968 177.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -147.55 155.8 42.21 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.239 -1.393 . . . . 74.2 107.239 174.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -131.45 143.57 50.53 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 108.078 -1.082 . . . . 72.12 108.078 177.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 30.2 pt -111.01 169.08 4.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 113.31 0.856 . . . . 75.02 113.31 -173.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.455 ' HB3' ' HB2' ' A' ' 198' ' ' SER . 2.9 ptp180 -142.87 155.02 44.69 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 114.765 -1.107 . . . . 74.32 109.982 -178.254 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . 0.521 ' HB2' ' HB2' ' A' ' 231' ' ' LEU . 11.5 t70 -109.46 138.53 45.67 Favored 'General case' 0 C--N 1.29 -2.014 0 O-C-N 124.082 0.864 . . . . 73.41 109.138 179.047 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -151.46 -178.99 26.77 Favored Glycine 0 C--N 1.273 -2.967 0 N-CA-C 108.07 -2.012 . . . . 43.3 108.07 175.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' THR . . . . . 0.434 ' CG2' ' HG2' ' A' ' 191' ' ' LYS . 0.2 OUTLIER -109.59 122.36 47.27 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 106.581 -1.637 . . . . 71.51 106.581 177.128 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' SER . . . . . 0.497 ' O ' ' HA ' ' A' ' 191' ' ' LYS . 33.0 t -97.47 123.45 41.33 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 109.062 -0.718 . . . . 73.1 109.062 -176.202 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.571 ' HA ' ' O ' ' A' ' 190' ' ' GLU . 7.1 p -107.33 120.46 58.68 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 CA-C-O 121.415 0.626 . . . . 71.2 109.887 176.237 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -121.67 154.75 36.42 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-N 115.18 -0.918 . . . . 75.15 109.272 -177.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 78.2 t -84.3 119.09 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.901 0 N-CA-C 107.426 -1.324 . . . . 75.24 107.426 171.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 46.5 p -114.68 -176.5 2.91 Favored 'General case' 0 C--N 1.274 -2.712 0 CA-C-N 114.51 -1.223 . . . . 72.54 108.885 -177.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -59.69 -26.05 65.27 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.05 0.453 . . . . 54.12 110.429 177.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 21.3 m -91.9 -18.4 23.81 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 115.785 -0.643 . . . . 74.04 111.576 -179.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 127.48 -152.24 18.75 Favored Glycine 0 N--CA 1.442 -0.956 0 N-CA-C 110.269 -1.132 . . . . 50.23 110.269 -177.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 6.2 mp -78.1 122.98 26.32 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 117.88 0.84 . . . . 75.11 110.044 179.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . 0.571 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 9.3 tp10 -132.44 123.54 26.87 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.86 -0.609 . . . . 54.33 109.665 -178.343 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.497 ' HA ' ' O ' ' A' ' 181' ' ' SER . 32.9 ttmt -102.7 131.94 49.17 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 107.735 -1.209 . . . . 75.42 107.735 -178.362 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . 0.406 ' HB2' ' HD2' ' A' ' 193' ' ' PRO . 9.0 pt20 -151.59 164.53 19.95 Favored Pre-proline 0 C--N 1.305 -1.347 0 N-CA-C 108.152 -1.055 . . . . 74.11 108.152 -174.569 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . 0.406 ' HD2' ' HB2' ' A' ' 192' ' ' GLN . 9.5 Cg_endo -54.55 131.71 47.13 Favored 'Trans proline' 0 C--O 1.249 1.073 0 C-N-CA 121.431 1.421 . . . . 75.35 111.582 178.694 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -143.02 132.69 5.15 Favored Glycine 0 N--CA 1.411 -2.975 0 N-CA-C 109.716 -1.354 . . . . 61.0 109.716 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.515 HG12 HG21 ' A' ' 234' ' ' VAL . 3.5 mp -105.17 138.85 28.21 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.438 0 CA-C-O 121.112 0.482 . . . . 74.25 109.92 -179.599 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -132.34 167.66 19.48 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 107.285 -1.376 . . . . 73.34 107.285 -176.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 50.2 mm -75.54 131.69 34.52 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 N-CA-C 108.452 -0.944 . . . . 75.02 108.452 173.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' SER . . . . . 0.455 ' HB2' ' HB3' ' A' ' 177' ' ' ARG . 21.0 t -108.31 -25.24 11.12 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.792 -0.568 . . . . 72.5 111.926 178.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 68.7 ttt180 -154.05 142.35 20.53 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 109.266 -0.642 . . . . 65.41 109.266 179.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 50.5 tp -125.32 133.02 52.76 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 108.629 -0.878 . . . . 70.23 108.629 178.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 62.1 t -110.37 121.14 42.28 Favored Pre-proline 0 C--O 1.248 1.007 0 CA-C-N 116.766 -0.197 . . . . 72.3 110.766 -177.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . 0.485 ' HA ' ' HG2' ' A' ' 207' ' ' GLU . 28.7 Cg_exo -62.43 131.75 35.32 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 122.229 1.953 . . . . 71.34 110.065 175.341 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 106.17 -17.82 40.27 Favored Glycine 0 N--CA 1.434 -1.485 0 N-CA-C 110.2 -1.16 . . . . 52.3 110.2 -175.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . 0.461 ' HA3' ' HA3' ' A' ' 173' ' ' GLY . . . -83.87 161.24 38.01 Favored Glycine 0 N--CA 1.428 -1.894 0 N-CA-C 110.329 -1.108 . . . . 71.14 110.329 176.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . 0.418 ' O ' HG21 ' A' ' 209' ' ' THR . 3.1 mm? -58.9 -37.66 77.11 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 123.288 0.635 . . . . 74.31 111.599 -177.398 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -62.08 -47.28 85.35 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 116.071 -0.513 . . . . 73.43 112.112 -179.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.485 ' HG2' ' HA ' ' A' ' 202' ' ' PRO . 9.7 tp10 -75.28 -33.22 61.21 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.454 -0.573 . . . . 74.44 109.454 178.598 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 38.6 t -57.76 -48.17 80.41 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 116.059 -0.519 . . . . 72.33 110.208 177.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' THR . . . . . 0.418 HG21 ' O ' ' A' ' 205' ' ' LEU . 9.1 t -73.54 -40.42 63.99 Favored 'General case' 0 N--CA 1.437 -1.089 0 C-N-CA 120.098 -0.641 . . . . 63.23 110.201 176.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 83.35 -9.19 61.99 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.78 -0.724 . . . . 61.13 111.908 178.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 59.7 mt -77.75 -9.82 59.22 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.315 0.578 . . . . 75.2 110.013 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 79.6 mt -109.4 132.95 53.65 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 108.396 -0.964 . . . . 74.35 108.396 173.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -131.44 166.06 22.15 Favored 'General case' 0 N--CA 1.421 -1.914 0 N-CA-C 109.048 -0.723 . . . . 72.4 109.048 178.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 28.4 m -64.01 -30.29 49.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 115.193 1.553 . . . . 72.35 115.193 -175.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -82.26 -13.24 57.34 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 113.798 1.036 . . . . 73.34 113.798 -179.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -59.54 141.74 54.17 Favored 'General case' 0 C--O 1.245 0.833 0 N-CA-C 114.578 1.325 . . . . 73.11 114.578 -176.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -106.75 131.44 53.87 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 125.91 1.684 . . . . 73.02 109.008 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . 0.434 ' CG1' ' HB ' ' A' ' 195' ' ' ILE . 7.2 p -85.48 136.83 21.98 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-O 121.668 0.747 . . . . 74.34 112.554 -174.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 39.8 mm -103.37 -52.36 8.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.087 -0.961 . . . . 65.44 111.35 -179.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -155.83 154.62 31.6 Favored 'General case' 0 C--O 1.248 0.988 0 CA-C-N 116.465 -0.334 . . . . 75.14 111.219 -177.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . 0.441 HG13 ' CG1' ' A' ' 226' ' ' VAL . 10.5 p -129.57 121.01 51.96 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.197 0 CA-C-O 121.438 0.637 . . . . 73.42 110.67 176.6 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . 0.411 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 11.6 t-20 66.99 12.99 9.3 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 125.256 1.422 . . . . 74.31 111.599 175.312 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 112.69 -18.19 22.53 Favored Glycine 0 N--CA 1.437 -1.255 0 C-N-CA 120.729 -0.748 . . . . 45.34 111.726 -179.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 62.9 mt -92.55 124.87 45.15 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.501 0 N-CA-C 108.601 -0.889 . . . . 74.33 108.601 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -65.41 137.86 57.75 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-O 121.237 0.541 . . . . 74.52 110.372 179.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . 0.479 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 28.6 m -115.28 0.48 8.66 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 CA-C-O 121.595 0.712 . . . . 71.43 110.543 178.124 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -84.11 97.55 9.4 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-N 115.442 -0.799 . . . . 73.34 109.459 179.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 123.0 -17.9 8.02 Favored Glycine 0 C--N 1.313 -0.738 0 N-CA-C 110.704 -0.958 . . . . 54.22 110.704 -178.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -77.91 173.01 12.61 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 109.159 -0.682 . . . . 71.21 109.159 176.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 230' ' ' THR . . . . . 0.514 ' O ' HG13 ' A' ' 234' ' ' VAL . 74.7 p -94.21 163.73 13.33 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 108.312 -0.996 . . . . 70.03 108.312 178.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . 0.521 ' HB2' ' HB2' ' A' ' 178' ' ' ASP . 3.4 tm? -60.07 -38.67 83.57 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 109.778 -0.453 . . . . 74.35 109.778 178.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -62.52 -43.16 99.49 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.153 -0.476 . . . . 74.14 110.246 178.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -63.31 -48.59 77.42 Favored 'General case' 0 C--N 1.344 0.337 0 N-CA-C 113.113 0.783 . . . . 72.34 113.113 176.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.515 HG21 HG12 ' A' ' 195' ' ' ILE . 6.6 m -65.82 -33.59 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-O 121.272 0.558 . . . . 72.45 112.321 -174.607 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 60.2 m -74.08 -36.82 64.31 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.875 -0.787 . . . . 71.41 108.875 -175.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -61.09 -34.67 75.31 Favored 'General case' 0 CA--C 1.5 -0.948 0 CA-C-N 115.091 -0.959 . . . . 65.41 109.392 177.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 237' ' ' MET . . . . . 0.448 ' HG3' ' HA ' ' A' ' 234' ' ' VAL . 12.9 mtt -69.14 -46.91 66.46 Favored 'General case' 0 C--O 1.204 -1.321 0 N-CA-C 108.48 -0.933 . . . . 73.34 108.48 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 238' ' ' MET . . . . . 0.405 ' HG3' ' O ' ' A' ' 234' ' ' VAL . 62.1 mtt -61.33 -42.17 98.24 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.986 -0.552 . . . . 72.0 111.654 -176.69 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 87.5 t -64.2 -40.4 88.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 O-C-N 123.328 0.392 . . . . 75.35 110.458 178.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -69.6 -38.01 77.12 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.444 0.64 . . . . 73.41 110.365 178.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -85.6 21.4 1.83 Allowed 'General case' 0 C--O 1.202 -1.409 0 CA-C-N 115.522 -0.763 . . . . 73.12 112.076 -179.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 242' ' ' SER . . . . . 0.724 ' O ' ' HG ' ' A' ' 164' ' ' LEU . 29.4 p -64.75 -21.33 66.74 Favored 'General case' 0 C--O 1.208 -1.108 0 N-CA-C 109.619 -0.512 . . . . 71.33 109.619 172.517 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 47.4 t -62.76 -35.52 80.09 Favored 'General case' 0 CA--C 1.551 1.016 0 N-CA-C 108.85 -0.796 . . . . 72.32 108.85 173.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -177.14 106.87 0.06 Allowed 'General case' 0 C--O 1.246 0.902 0 C-N-CA 124.08 0.952 . . . . 64.01 111.277 177.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . 0.468 ' CD1' ' HG ' ' A' ' 172' ' ' LEU . 11.8 mt -86.67 129.52 34.84 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 115.364 -0.835 . . . . 74.23 111.025 179.481 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . 0.411 ' HB ' ' HA ' ' A' ' 222' ' ' ASN . 66.3 mt -118.62 113.72 42.66 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.618 0 N-CA-C 105.044 -2.206 . . . . 73.25 105.044 167.381 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 64.3 mt -122.22 135.52 62.05 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.257 0 CA-C-O 121.313 0.578 . . . . 73.01 111.699 -176.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.471 ' HA ' ' O ' ' A' ' 159' ' ' ARG . 58.3 m -112.14 118.29 34.94 Favored 'General case' 0 N--CA 1.416 -2.154 0 N-CA-C 108.251 -1.018 . . . . 75.33 108.251 175.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . 0.434 HG13 ' HA ' ' A' ' 218' ' ' VAL . 17.7 m -121.22 170.51 11.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 CA-C-O 121.436 0.636 . . . . 71.01 110.469 176.278 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . 0.336 43.0 mtpt -126.69 144.15 48.89 Favored Pre-proline 0 C--N 1.28 -2.435 0 CA-C-N 113.965 -1.471 . . . . 72.44 107.44 174.165 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -74.98 141.71 27.02 Favored 'Trans proline' 0 N--CA 1.424 -2.597 0 N-CA-C 108.035 -1.563 . . . . 71.44 108.035 167.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -53.08 -54.66 32.23 Favored 'General case' 0 CA--C 1.495 -1.135 0 CA-C-O 121.868 0.842 . . . . 61.42 108.99 178.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 37.7 t30 -91.09 81.61 5.59 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 106.375 -1.713 . . . . 71.32 106.375 172.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -74.3 151.98 39.73 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 115.192 -0.913 . . . . 64.44 113.039 -175.497 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? . . . . . 0 N--CA 1.416 -2.156 0 N-CA-C 105.329 -2.1 . . . . 73.31 105.329 176.012 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.574 ' HB3' ' HG2' ' A' ' 250' ' ' LYS 0.311 2.2 p-80 . . . . . 0 CA--C 1.505 -0.776 0 N-CA-C 116.043 1.868 . . . . 75.24 116.043 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 57.9 ttt180 -126.77 144.56 50.91 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 114.135 -1.393 . . . . 75.14 109.284 176.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.574 ' HG3' ' OG1' ' A' ' 248' ' ' THR . 0.1 OUTLIER -90.23 114.29 26.27 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 108.201 -1.037 . . . . 63.11 108.201 179.282 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.402 HG11 ' HB2' ' A' ' 211' ' ' LEU . 29.7 m -109.21 136.38 45.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-O 120.733 0.301 . . . . 74.43 111.215 179.149 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -99.08 121.71 41.35 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-O 121.516 0.674 . . . . 74.44 110.073 178.175 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.492 ' HB2' ' HB3' ' A' ' 245' ' ' LEU . 18.6 mt -104.24 137.06 42.71 Favored 'General case' 0 N--CA 1.403 -2.806 0 N-CA-C 106.637 -1.616 . . . . 70.14 106.637 177.456 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.46 HD23 ' O ' ' A' ' 242' ' ' SER . 14.2 tp . . . . . 0 C--N 1.288 -2.099 0 N-CA-C 114.264 1.209 . . . . 71.54 114.264 177.466 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 89.5 mt . . . . . 0 N--CA 1.467 0.421 0 N-CA-C 111.863 0.32 . . . . 75.35 111.863 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 173' ' ' GLY . . . . . 0.533 ' HA3' ' HA3' ' A' ' 204' ' ' GLY . . . 93.91 22.35 25.84 Favored Glycine 0 N--CA 1.429 -1.793 0 C-N-CA 120.115 -1.041 . . . . 61.14 114.169 173.68 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -160.18 154.1 22.97 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 117.74 0.77 . . . . 75.25 109.157 177.386 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -123.86 153.56 40.9 Favored 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 107.403 -1.332 . . . . 72.31 107.403 177.22 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 39.9 pt -113.73 166.62 7.39 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 CA-C-O 121.38 0.609 . . . . 72.53 111.021 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.468 ' HG2' ' HB3' ' A' ' 198' ' ' SER . 16.2 ptt180 -147.12 154.75 41.49 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 115.286 -0.87 . . . . 62.45 109.833 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -110.32 142.79 41.47 Favored 'General case' 0 C--N 1.29 -1.998 0 O-C-N 123.901 0.75 . . . . 63.12 109.69 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -159.48 160.89 31.76 Favored Glycine 0 C--N 1.289 -2.072 0 N-CA-C 108.898 -1.681 . . . . 70.02 108.898 177.011 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' THR . . . . . 0.521 HG22 ' HG2' ' A' ' 191' ' ' LYS . 0.6 OUTLIER -90.82 123.6 34.49 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.169 -1.419 . . . . 74.41 107.169 178.844 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 181' ' ' SER . . . . . 0.497 ' O ' ' HA ' ' A' ' 191' ' ' LYS . 22.8 t . . . . . 0 C--N 1.283 -2.302 0 C-N-CA 123.311 0.644 . . . . 72.12 109.619 -175.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.521 ' HG2' HG22 ' A' ' 180' ' ' THR . 34.0 ttmt . . . . . 0 N--CA 1.426 -1.631 0 N-CA-C 106.771 -1.566 . . . . 73.22 106.771 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.44 158.6 37.88 Favored Pre-proline 0 C--N 1.307 -1.27 0 CA-C-O 118.899 -0.572 . . . . 62.53 110.153 -169.525 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -67.42 130.42 22.36 Favored 'Trans proline' 0 C--O 1.25 1.099 0 CA-C-N 119.941 1.015 . . . . 53.22 111.645 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -142.88 151.11 22.88 Favored Glycine 0 N--CA 1.412 -2.956 0 CA-C-N 115.393 -0.822 . . . . 34.34 111.357 -177.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.582 HG12 HG21 ' A' ' 234' ' ' VAL . 2.7 mp -104.13 136.91 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.286 0 N-CA-C 109.535 -0.543 . . . . 63.22 109.535 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -127.21 164.75 20.99 Favored 'General case' 0 C--N 1.28 -2.434 0 N-CA-C 107.393 -1.336 . . . . 74.33 107.393 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 42.6 mm -76.46 131.43 34.89 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 N-CA-C 106.896 -1.52 . . . . 53.1 106.896 175.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 198' ' ' SER . . . . . 0.468 ' HB3' ' HG2' ' A' ' 177' ' ' ARG . 75.7 p -100.92 -41.1 6.96 Favored 'General case' 0 C--N 1.287 -2.142 0 C-N-CA 118.612 -1.235 . . . . 70.3 111.092 -177.419 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 31.6 tpt180 -148.32 141.32 24.87 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.302 -0.999 . . . . 64.41 108.302 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 2.6 tt -122.25 123.58 41.78 Favored 'General case' 0 N--CA 1.421 -1.882 0 N-CA-C 106.672 -1.603 . . . . 74.34 106.672 178.679 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 36.5 t -105.85 126.76 29.87 Favored Pre-proline 0 C--N 1.307 -1.273 0 C-N-CA 122.559 0.344 . . . . 55.51 111.33 -172.619 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 202' ' ' PRO . . . . . 0.513 ' HA ' ' HG3' ' A' ' 207' ' ' GLU . 45.0 Cg_endo -70.82 128.51 15.15 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 122.395 2.063 . . . . 73.4 110.954 176.164 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 114.38 -18.04 18.36 Favored Glycine 0 N--CA 1.439 -1.102 0 N-CA-C 110.47 -1.052 . . . . 63.11 110.47 -177.336 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 204' ' ' GLY . . . . . 0.533 ' HA3' ' HA3' ' A' ' 173' ' ' GLY . . . -96.04 171.42 28.47 Favored Glycine 0 N--CA 1.433 -1.525 0 N-CA-C 110.517 -1.033 . . . . 70.14 110.517 178.308 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.418 HD22 ' H ' ' A' ' 205' ' ' LEU . 2.7 mm? -65.22 -29.79 70.62 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 117.267 0.534 . . . . 74.43 112.084 -174.007 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -62.75 -44.41 96.27 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.996 -0.547 . . . . 62.43 110.97 178.284 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.513 ' HG3' ' HA ' ' A' ' 202' ' ' PRO . 2.9 tm-20 -75.9 -33.75 59.94 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.375 -0.972 . . . . 73.24 108.375 179.448 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 50.4 m -56.83 -42.48 79.68 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 116.298 -0.41 . . . . 73.32 110.803 177.173 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 13.9 t -73.34 -40.91 64.06 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 119.095 -1.042 . . . . 73.32 108.442 174.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 56.18 29.61 56.48 Favored Glycine 0 C--N 1.347 1.193 0 CA-C-N 115.908 -0.587 . . . . 72.23 113.24 177.146 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.402 ' HB2' HG11 ' A' ' 161' ' ' VAL . 68.2 mt -103.39 -12.67 17.04 Favored 'General case' 0 C--N 1.308 -1.228 0 O-C-N 122.674 -0.31 . . . . 71.31 110.299 -178.502 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.488 ' H ' HD23 ' A' ' 212' ' ' LEU . 2.0 pt? -113.68 158.07 21.36 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 115.484 -0.78 . . . . 43.31 109.552 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -130.46 165.59 22.32 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 123.047 0.539 . . . . 60.43 110.157 179.087 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 34.5 m -63.69 -30.07 48.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 113.599 0.963 . . . . 61.23 113.599 -179.118 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -76.77 -15.06 59.85 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 116.203 -0.453 . . . . 53.11 111.703 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -68.17 147.58 52.07 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-O 121.64 0.733 . . . . 50.51 112.649 -175.025 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -108.59 133.94 52.03 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.638 -1.164 . . . . 64.41 111.27 -177.256 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.487 ' HA ' HG12 ' A' ' 249' ' ' VAL . 39.8 t -83.62 133.96 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-O 121.811 0.815 . . . . 41.21 111.2 -175.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.438 HG13 ' ND1' ' A' ' 158' ' ' HIS . 46.8 mm -102.97 -56.47 5.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 CA-C-N 114.656 -1.156 . . . . 74.55 110.996 -178.314 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -152.37 165.19 35.77 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.986 -0.552 . . . . 61.32 109.934 -175.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.521 ' HA ' ' O ' ' A' ' 246' ' ' ILE . 8.9 p -134.8 123.88 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 CA-C-N 115.92 -0.582 . . . . 65.45 110.052 177.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 222' ' ' ASN . . . . . 0.426 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 12.8 t-20 65.44 13.52 8.9 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 125.241 1.416 . . . . 75.42 110.706 177.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 107.0 -9.4 39.69 Favored Glycine 0 N--CA 1.442 -0.933 0 C-N-CA 120.84 -0.695 . . . . 74.3 112.079 -178.332 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 64.4 mt -105.06 124.27 59.69 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 N-CA-C 110.13 -0.322 . . . . 72.22 110.13 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -57.2 142.58 42.36 Favored 'General case' 0 C--N 1.31 -1.126 0 C-N-CA 124.483 1.113 . . . . 65.11 112.6 -178.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 30.6 m -118.91 -1.68 8.99 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 CA-C-N 115.525 -0.761 . . . . 73.23 109.8 175.316 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -76.92 99.04 5.09 Favored 'General case' 0 N--CA 1.428 -1.546 0 CA-C-N 115.356 -0.838 . . . . 74.23 109.719 -177.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 118.9 -14.0 11.41 Favored Glycine 0 N--CA 1.435 -1.39 0 C-N-CA 120.839 -0.696 . . . . 63.53 111.729 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -76.97 -179.93 5.81 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 120.987 0.422 . . . . 75.3 110.654 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 230' ' ' THR . . . . . 0.444 ' O ' HG13 ' A' ' 234' ' ' VAL . 50.6 p -95.53 162.73 13.51 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 108.187 -1.042 . . . . 45.12 108.187 177.106 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -63.59 -33.26 75.22 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 109.067 -0.716 . . . . 75.22 109.067 -178.094 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -63.42 -49.7 72.7 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.516 -0.311 . . . . 61.44 110.293 176.28 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 233' ' ' GLN . . . . . 0.568 ' O ' ' HG2' ' A' ' 237' ' ' MET . 47.9 mt-30 -57.28 -41.72 80.32 Favored 'General case' 0 CA--C 1.509 -0.625 0 N-CA-C 112.447 0.536 . . . . 75.5 112.447 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.582 HG21 HG12 ' A' ' 195' ' ' ILE . 10.2 m -74.3 -34.57 37.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 C-N-CA 120.764 -0.375 . . . . 75.32 111.399 -177.139 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 235' ' ' THR . . . . . 0.407 ' O ' HG23 ' A' ' 239' ' ' VAL . 26.0 m -71.14 -38.04 72.27 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 108.368 -0.975 . . . . 74.02 108.368 178.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -59.86 -35.6 75.14 Favored 'General case' 0 C--O 1.243 0.746 0 CA-C-N 115.385 -0.825 . . . . 74.51 110.144 177.475 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 237' ' ' MET . . . . . 0.568 ' HG2' ' O ' ' A' ' 233' ' ' GLN . 17.3 mmt -59.78 -52.43 65.49 Favored 'General case' 0 C--O 1.199 -1.576 0 N-CA-C 108.065 -1.087 . . . . 73.43 108.065 175.293 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 63.4 mtt -61.57 -36.96 82.13 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.754 -1.112 . . . . 73.41 112.422 -175.093 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 235' ' ' THR . 83.9 t -68.49 -36.8 76.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-O 121.396 0.617 . . . . 74.43 110.287 176.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -74.48 -36.4 63.29 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.905 0.859 . . . . 72.54 110.11 179.199 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -87.75 22.13 2.39 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 114.945 -1.025 . . . . 75.11 110.607 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 242' ' ' SER . . . . . 0.46 ' O ' HD23 ' A' ' 164' ' ' LEU . 25.5 p -59.86 -28.2 67.31 Favored 'General case' 0 CA--C 1.554 1.13 0 N-CA-C 113.691 0.997 . . . . 52.45 113.691 -177.776 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 48.7 m -85.55 -9.28 57.59 Favored 'General case' 0 C--N 1.318 -0.789 0 O-C-N 121.672 -0.642 . . . . 73.33 112.038 177.684 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 14.8 p30 -164.56 78.24 0.35 Allowed 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.524 0.678 . . . . 71.02 111.376 -176.591 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.492 ' HB3' ' HB2' ' A' ' 163' ' ' LEU . 1.2 tt -85.54 101.89 13.06 Favored 'General case' 0 N--CA 1.422 -1.844 0 C-N-CA 118.721 -1.192 . . . . 75.21 108.059 -174.642 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.521 ' O ' ' HA ' ' A' ' 221' ' ' VAL . 68.7 mt -104.7 116.15 47.96 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.319 0 C-N-CA 119.713 -0.795 . . . . 53.13 108.963 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 247' ' ' ILE . . . . . 0.467 HG13 ' CD2' ' A' ' 245' ' ' LEU . 23.2 mt -118.53 136.91 54.2 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.257 0 CA-C-O 121.627 0.727 . . . . 60.24 111.477 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.574 ' OG1' ' HG3' ' A' ' 160' ' ' ARG . 39.0 m -107.74 119.34 39.16 Favored 'General case' 0 N--CA 1.405 -2.713 0 CA-C-N 115.073 -0.967 . . . . 61.34 108.573 177.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.487 HG12 ' HA ' ' A' ' 218' ' ' VAL . 27.1 m -129.29 159.32 41.45 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 O-C-N 123.282 0.364 . . . . 64.44 110.296 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 250' ' ' LYS . . . . . 0.574 ' HG2' ' HB3' ' A' ' 158' ' ' HIS 0.346 35.7 mtmt -124.09 142.26 39.33 Favored Pre-proline 0 CA--C 1.475 -1.919 0 N-CA-C 104.435 -2.431 . . . . 75.41 104.435 175.538 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo . . . . . 0 C--N 1.286 -2.747 0 C-N-CA 120.871 1.047 . . . . 63.11 111.364 176.537 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.575 ' HB3' ' HG2' ' A' ' 250' ' ' LYS 0.374 2.3 p-80 . . . . . 0 N--CA 1.436 -1.159 0 N-CA-C 115.397 1.629 . . . . 44.11 115.397 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.535 ' O ' ' HA ' ' A' ' 248' ' ' THR . 3.7 ptp180 -125.25 144.96 50.21 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 113.575 -1.648 . . . . 74.31 108.944 -176.029 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.705 ' HB3' ' OG1' ' A' ' 248' ' ' THR . 37.0 ptt180 -117.27 119.25 34.58 Favored 'General case' 0 N--CA 1.426 -1.627 0 CA-C-O 121.901 0.858 . . . . 72.41 113.05 178.025 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.582 ' O ' ' HA ' ' A' ' 246' ' ' ILE . 26.6 m -102.78 135.02 42.12 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 CA-C-N 114.617 -1.174 . . . . 74.32 111.075 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.523 ' HG2' HG12 ' A' ' 246' ' ' ILE . 15.4 mtm180 -96.48 112.66 24.32 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 106.927 -1.508 . . . . 65.42 106.927 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 21.4 mt -99.34 134.23 42.5 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 109.52 -0.548 . . . . 75.44 109.52 -177.043 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 6.3 tt . . . . . 0 C--N 1.318 -0.774 0 O-C-N 124.344 1.027 . . . . 72.15 111.893 174.207 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.47 ' HG ' ' CD1' ' A' ' 245' ' ' LEU . 2.9 mm? . . . . . 0 N--CA 1.437 -1.083 0 CA-C-O 120.589 0.233 . . . . 75.25 111.021 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' GLY . . . . . 0.454 ' HA3' ' HA3' ' A' ' 204' ' ' GLY . . . 89.24 43.97 5.15 Favored Glycine 0 N--CA 1.436 -1.346 0 C-N-CA 120.592 -0.813 . . . . 75.21 113.983 174.699 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -161.94 154.76 20.2 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.627 -1.249 . . . . 64.32 107.627 174.553 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -123.95 157.88 33.3 Favored 'General case' 0 C--N 1.282 -2.353 0 N-CA-C 108.533 -0.914 . . . . 74.52 108.533 177.534 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.582 HD13 ' H ' ' A' ' 176' ' ' ILE . 0.1 OUTLIER -123.72 160.52 27.28 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 N-CA-C 109.571 -0.529 . . . . 61.31 109.571 179.944 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.462 ' HB3' ' HB3' ' A' ' 198' ' ' SER . 10.1 ptp180 -132.21 154.64 49.38 Favored 'General case' 0 C--N 1.282 -2.355 0 CA-C-N 115.656 -0.702 . . . . 74.23 110.684 -178.529 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 178' ' ' ASP . . . . . 0.497 ' HB2' ' HG ' ' A' ' 231' ' ' LEU . 4.8 t70 -107.41 143.92 35.06 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 115.085 -0.961 . . . . 52.32 110.509 -179.412 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -164.92 179.79 39.35 Favored Glycine 0 N--CA 1.415 -2.715 0 N-CA-C 108.871 -1.692 . . . . 52.13 108.871 175.078 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' THR . . . . . 0.462 ' HB ' ' CG ' ' A' ' 191' ' ' LYS . 0.4 OUTLIER -89.99 122.34 32.91 Favored 'General case' 0 C--N 1.283 -2.301 0 CA-C-N 117.524 0.662 . . . . 71.42 111.024 175.667 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 47.3 t . . . . . 0 N--CA 1.414 -2.265 0 N-CA-C 107.87 -1.159 . . . . 55.42 107.87 177.817 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.462 ' CG ' ' HB ' ' A' ' 180' ' ' THR . 35.5 ttmt . . . . . 0 N--CA 1.422 -1.83 0 N-CA-C 107.785 -1.191 . . . . 72.4 107.785 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -151.09 164.98 18.39 Favored Pre-proline 0 C--N 1.293 -1.878 0 N-CA-C 108.256 -1.016 . . . . 72.5 108.256 -178.115 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -55.19 132.27 51.3 Favored 'Trans proline' 0 C--N 1.358 1.04 0 C-N-CA 121.637 1.558 . . . . 75.02 109.846 174.274 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -143.93 138.65 8.18 Favored Glycine 0 N--CA 1.409 -3.106 0 N-CA-C 111.38 -0.688 . . . . 71.13 111.38 -178.217 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.559 HG12 HG21 ' A' ' 234' ' ' VAL . 2.7 mp -103.63 134.52 44.59 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.94 0 CA-C-O 121.605 0.717 . . . . 72.14 110.883 179.452 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -124.27 166.17 16.36 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 106.149 -1.797 . . . . 71.23 106.149 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 47.8 mm -79.08 131.27 34.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 107.562 -1.273 . . . . 75.31 107.562 177.561 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 198' ' ' SER . . . . . 0.462 ' HB3' ' HB3' ' A' ' 177' ' ' ARG . 82.3 p -101.64 -31.64 10.72 Favored 'General case' 0 C--N 1.287 -2.111 0 C-N-CA 118.633 -1.227 . . . . 43.13 112.752 -175.298 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 29.6 tpt180 -166.76 146.15 5.54 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 120.781 -0.368 . . . . 70.1 110.344 -175.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 82.9 mt -102.54 146.38 28.22 Favored 'General case' 0 CA--C 1.489 -1.381 0 N-CA-C 108.932 -0.766 . . . . 70.43 108.932 172.409 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 47.8 t -107.52 115.89 58.64 Favored Pre-proline 0 C--N 1.282 -2.337 0 N-CA-C 105.3 -2.111 . . . . 73.42 105.3 172.187 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 202' ' ' PRO . . . . . 0.434 ' HA ' ' HG3' ' A' ' 207' ' ' GLU . 11.5 Cg_endo -55.03 128.67 31.53 Favored 'Trans proline' 0 C--O 1.248 0.98 0 C-N-CA 122.335 2.023 . . . . 75.25 111.129 -177.118 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 99.05 -11.4 62.17 Favored Glycine 0 N--CA 1.439 -1.158 0 C-N-CA 120.6 -0.809 . . . . 71.32 111.719 -177.386 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 204' ' ' GLY . . . . . 0.454 ' HA3' ' HA3' ' A' ' 173' ' ' GLY . . . -74.82 166.36 54.85 Favored Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 121.032 -0.604 . . . . 75.21 111.597 178.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.452 HD23 ' HA ' ' A' ' 172' ' ' LEU . 3.0 mm? -66.09 -34.02 77.11 Favored 'General case' 0 C--N 1.312 -1.036 0 C-N-CA 122.996 0.518 . . . . 73.32 111.641 -176.55 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 206' ' ' ALA . . . . . 0.562 ' CB ' HD12 ' A' ' 212' ' ' LEU . . . -67.75 -42.43 81.83 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.522 0.677 . . . . 72.4 110.051 178.444 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.434 ' HG3' ' HA ' ' A' ' 202' ' ' PRO . 6.0 tm-20 -75.39 -34.49 61.09 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 114.915 -1.039 . . . . 72.14 108.982 -178.469 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 35.9 t -58.54 -47.34 84.54 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 123.786 0.834 . . . . 73.21 110.795 177.303 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 209' ' ' THR . . . . . 0.474 HG23 ' H ' ' A' ' 211' ' ' LEU . 10.2 t -75.6 -35.67 60.48 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 120.004 -0.678 . . . . 53.51 109.446 177.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 74.17 16.56 79.64 Favored Glycine 0 N--CA 1.442 -0.905 0 CA-C-N 115.984 -0.553 . . . . 40.33 112.672 177.326 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.474 ' H ' HG23 ' A' ' 209' ' ' THR . 54.9 mt -99.19 -0.55 41.29 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 120.933 0.397 . . . . 64.44 110.449 -178.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.562 HD12 ' CB ' ' A' ' 206' ' ' ALA . 80.6 mt -109.79 131.7 54.83 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 115.187 -0.915 . . . . 72.23 108.941 174.277 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -130.7 155.9 45.83 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 109.102 -0.703 . . . . 62.12 109.102 177.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 31.2 m -62.16 -29.28 46.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-O 122.078 0.942 . . . . 70.42 112.773 -177.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -77.99 -14.06 59.66 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 115.533 -0.758 . . . . 74.33 111.782 -178.11 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -76.71 150.68 36.28 Favored 'General case' 0 C--O 1.244 0.786 0 N-CA-C 113.02 0.748 . . . . 53.13 113.02 -173.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -108.81 132.34 54.09 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.016 -0.993 . . . . 72.22 109.766 -178.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.54 ' HA ' HG12 ' A' ' 249' ' ' VAL . 39.7 t -83.33 138.33 19.48 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 CA-C-O 121.488 0.661 . . . . 70.54 111.509 -176.053 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 46.0 mm -105.22 -53.16 7.13 Favored 'Isoleucine or valine' 0 C--O 1.246 0.875 0 CA-C-N 115.171 -0.922 . . . . 74.24 111.099 -178.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.423 ' HB3' ' HA ' ' A' ' 225' ' ' GLU . 10.5 pt-20 -153.92 165.85 34.81 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 116.049 -0.523 . . . . 74.43 109.82 -175.611 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.487 ' HA ' ' O ' ' A' ' 246' ' ' ILE . 8.3 p -135.19 122.97 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.749 0 CA-C-N 115.647 -0.706 . . . . 74.34 109.148 176.639 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 222' ' ' ASN . . . . . 0.537 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 12.2 t-20 68.73 5.52 4.98 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 125.083 1.353 . . . . 70.23 111.198 178.623 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 113.63 -14.15 22.51 Favored Glycine 0 N--CA 1.439 -1.149 0 N-CA-C 110.882 -0.887 . . . . 75.32 110.882 -178.519 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 65.7 mt -96.34 123.75 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.521 0 N-CA-C 109.1 -0.704 . . . . 62.25 109.1 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 225' ' ' GLU . . . . . 0.423 ' HA ' ' HB3' ' A' ' 220' ' ' GLU . 12.4 pt-20 -58.05 153.01 15.42 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 123.684 0.794 . . . . 73.45 112.002 -177.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 226' ' ' VAL . . . . . 0.476 ' HB ' HG12 ' A' ' 234' ' ' VAL . 35.9 m -129.59 2.47 2.58 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 CA-C-N 115.411 -0.813 . . . . 52.04 110.248 174.829 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -71.84 98.56 2.02 Favored 'General case' 0 N--CA 1.432 -1.372 0 CA-C-N 115.634 -0.712 . . . . 71.1 110.693 -178.351 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 121.12 -17.57 9.11 Favored Glycine 0 CA--C 1.489 -1.551 0 N-CA-C 110.378 -1.089 . . . . 44.1 110.378 178.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -83.5 163.21 20.61 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.122 -0.539 . . . . 72.41 111.333 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 37.2 p -97.19 172.32 7.89 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.756 -0.657 . . . . 75.35 110.667 -176.588 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 231' ' ' LEU . . . . . 0.603 ' HA ' HG22 ' A' ' 234' ' ' VAL . 78.0 mt -56.65 -40.32 75.25 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 111.837 0.31 . . . . 64.11 111.837 177.152 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -56.8 -42.7 79.96 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 121.279 0.561 . . . . 73.34 110.132 179.022 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -72.94 -47.71 43.19 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.961 -1.018 . . . . 71.21 112.339 -179.49 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.603 HG22 ' HA ' ' A' ' 231' ' ' LEU . 16.9 m -70.86 -34.47 56.18 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 112.092 0.404 . . . . 51.21 112.092 -176.056 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 235' ' ' THR . . . . . 0.428 ' O ' HG23 ' A' ' 239' ' ' VAL . 50.3 m -69.57 -35.3 75.24 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 109.429 -0.582 . . . . 75.14 109.429 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -60.73 -38.93 86.78 Favored 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 108.863 -0.792 . . . . 73.3 108.863 177.262 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 15.9 mmt -59.46 -50.17 74.95 Favored 'General case' 0 C--O 1.199 -1.563 0 CA-C-N 115.332 -0.849 . . . . 74.15 108.725 177.216 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 238' ' ' MET . . . . . 0.444 ' HG3' ' O ' ' A' ' 234' ' ' VAL . 63.0 mtt -61.8 -37.31 83.91 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.895 0.878 . . . . 74.44 112.259 -176.313 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 235' ' ' THR . 97.3 t -65.13 -40.32 88.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 121.19 0.519 . . . . 52.23 109.942 176.324 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -72.97 -37.0 67.21 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.613 0.721 . . . . 62.25 110.297 178.558 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -86.87 21.11 2.35 Favored 'General case' 0 C--O 1.202 -1.431 0 CA-C-N 115.603 -0.726 . . . . 71.41 111.905 -178.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 69.8 m -65.21 -22.88 66.95 Favored 'General case' 0 C--N 1.312 -1.022 0 C-N-CA 120.41 -0.516 . . . . 71.53 111.548 177.402 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 23.1 m -70.47 -24.38 62.86 Favored 'General case' 0 CA--C 1.554 1.11 0 CA-C-N 116.363 -0.381 . . . . 74.22 111.032 176.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 -174.3 97.3 0.1 Allowed 'General case' 0 C--O 1.246 0.913 0 C-N-CA 124.363 1.065 . . . . 35.54 109.205 177.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.501 ' CD2' HG13 ' A' ' 247' ' ' ILE . 2.4 tt -88.16 103.03 15.38 Favored 'General case' 0 N--CA 1.414 -2.273 0 N-CA-C 109.211 -0.662 . . . . 71.24 109.211 -173.641 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.582 ' HA ' ' O ' ' A' ' 161' ' ' VAL . 69.7 mt -100.87 116.7 44.88 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.179 0 N-CA-C 109.37 -0.604 . . . . 72.0 109.37 -179.541 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 247' ' ' ILE . . . . . 0.501 HG13 ' CD2' ' A' ' 245' ' ' LEU . 27.0 mt -120.94 132.54 70.18 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 CA-C-O 121.541 0.686 . . . . 71.12 112.331 178.495 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.705 ' OG1' ' HB3' ' A' ' 160' ' ' ARG . 37.0 m -104.19 122.8 46.11 Favored 'General case' 0 N--CA 1.414 -2.244 0 CA-C-N 114.291 -1.322 . . . . 64.44 108.603 177.812 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.54 HG12 ' HA ' ' A' ' 218' ' ' VAL . 34.7 m -130.79 164.09 34.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 110.035 -0.357 . . . . 64.11 110.035 177.204 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 250' ' ' LYS . . . . . 0.575 ' HG2' ' HB3' ' A' ' 158' ' ' HIS 0.296 38.6 mtmt -124.39 141.73 38.36 Favored Pre-proline 0 CA--C 1.48 -1.721 0 N-CA-C 104.788 -2.301 . . . . 74.54 104.788 173.919 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo . . . . . 0 N--CA 1.411 -3.351 0 C-N-CA 120.573 0.848 . . . . 74.23 111.257 176.992 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.488 ' NE2' HG13 ' A' ' 219' ' ' ILE . 4.7 m80 . . . . . 0 N--CA 1.443 -0.808 0 CA-C-O 121.658 0.742 . . . . 71.51 112.588 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.434 ' O ' ' HA ' ' A' ' 248' ' ' THR . 18.8 tpp180 -107.29 141.41 38.68 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 107.218 -1.401 . . . . 72.35 107.218 177.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -114.96 113.15 23.75 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 108.657 -0.868 . . . . 73.55 108.657 175.517 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.507 HG21 HD11 ' A' ' 212' ' ' LEU . 17.7 m -129.08 137.86 56.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-O 120.868 0.366 . . . . 75.3 111.986 179.295 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 42.9 ttp180 -116.81 112.5 21.21 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 108.904 -0.776 . . . . 71.35 108.904 173.573 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 13.5 mt -102.56 138.83 38.96 Favored 'General case' 0 C--N 1.281 -2.386 0 N-CA-C 107.319 -1.363 . . . . 74.51 107.319 -175.365 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.585 HD12 ' O ' ' A' ' 242' ' ' SER . 0.7 OUTLIER . . . . . 0 N--CA 1.446 -0.672 0 N-CA-C 108.263 -1.014 . . . . 74.31 108.263 174.542 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.44 ' CD1' ' HB2' ' A' ' 164' ' ' LEU . 3.3 mm? . . . . . 0 CA--C 1.506 -0.713 0 CA-C-O 121.201 0.524 . . . . 72.53 110.177 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' GLY . . . . . 0.475 ' HA3' ' HA3' ' A' ' 204' ' ' GLY . . . 90.53 25.15 26.48 Favored Glycine 0 N--CA 1.42 -2.368 0 CA-C-N 115.445 -0.798 . . . . 73.34 113.522 176.108 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -143.11 151.54 40.84 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 107.843 -1.169 . . . . 74.32 107.843 174.099 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -131.13 152.85 49.99 Favored 'General case' 0 CA--C 1.484 -1.588 0 CA-C-O 120.808 0.337 . . . . 73.32 110.227 178.362 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.635 HD13 ' H ' ' A' ' 176' ' ' ILE . 0.2 OUTLIER -116.85 169.85 6.87 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.049 0 CA-C-N 115.66 -0.7 . . . . 52.31 112.219 -173.81 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.61 ' CG ' ' HB2' ' A' ' 198' ' ' SER . 11.8 ptt180 -148.51 156.02 41.91 Favored 'General case' 0 C--N 1.287 -2.133 0 C-N-CA 125.478 1.511 . . . . 75.34 109.841 -175.597 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -110.89 144.61 39.67 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 123.466 0.479 . . . . 73.25 110.856 179.129 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -162.44 171.68 38.35 Favored Glycine 0 N--CA 1.427 -1.901 0 N-CA-C 108.876 -1.69 . . . . 43.42 108.876 175.461 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' THR . . . . . 0.501 ' HB ' ' CG ' ' A' ' 191' ' ' LYS . 0.6 OUTLIER -86.76 123.85 32.37 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 118.172 0.986 . . . . 74.23 111.658 175.966 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 34.7 t . . . . . 0 N--CA 1.404 -2.768 0 N-CA-C 107.927 -1.138 . . . . 74.55 107.927 177.411 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.501 ' CG ' ' HB ' ' A' ' 180' ' ' THR . 36.3 ttmt . . . . . 0 N--CA 1.44 -0.969 0 N-CA-C 109.071 -0.714 . . . . 73.14 109.071 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -144.21 164.33 29.71 Favored Pre-proline 0 C--N 1.297 -1.705 0 N-CA-C 107.503 -1.295 . . . . 73.41 107.503 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -65.17 132.86 33.17 Favored 'Trans proline' 0 C--O 1.247 0.934 0 C-N-CA 121.102 1.201 . . . . 42.34 109.776 174.293 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -137.94 141.62 12.36 Favored Glycine 0 N--CA 1.414 -2.787 0 N-CA-C 110.533 -1.027 . . . . 51.51 110.533 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.511 ' O ' HG12 ' A' ' 218' ' ' VAL . 3.4 mp -103.74 136.04 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.402 0 N-CA-C 109.272 -0.64 . . . . 74.11 109.272 179.485 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -128.1 167.6 16.53 Favored 'General case' 0 C--N 1.282 -2.326 0 N-CA-C 107.73 -1.211 . . . . 70.52 107.73 -177.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 58.5 mt -83.6 131.71 33.19 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 N-CA-C 109.334 -0.617 . . . . 73.24 109.334 174.493 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 198' ' ' SER . . . . . 0.61 ' HB2' ' CG ' ' A' ' 177' ' ' ARG . 29.6 t -110.18 -27.91 8.9 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.557 -0.714 . . . . 70.32 112.691 -177.28 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -147.63 134.53 20.19 Favored 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 120.037 -0.665 . . . . 73.45 109.583 -176.594 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 1.4 tt -116.18 124.81 51.23 Favored 'General case' 0 N--CA 1.414 -2.239 0 N-CA-C 106.51 -1.663 . . . . 73.53 106.51 179.27 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 96.6 t -94.14 124.69 55.21 Favored Pre-proline 0 C--N 1.306 -1.284 0 N-CA-C 110.472 -0.196 . . . . 74.42 110.472 -178.067 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -60.59 126.29 19.5 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.459 2.106 . . . . 24.12 110.782 177.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 98.91 -6.66 60.31 Favored Glycine 0 N--CA 1.435 -1.405 0 C-N-CA 120.777 -0.725 . . . . 53.53 112.614 -178.245 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 204' ' ' GLY . . . . . 0.475 ' HA3' ' HA3' ' A' ' 173' ' ' GLY . . . -79.53 169.54 53.62 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.5 -0.857 . . . . 65.41 112.285 179.416 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -65.06 -34.63 78.87 Favored 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 122.723 0.409 . . . . 73.14 110.653 -178.52 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -60.3 -43.59 96.16 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.64 -0.709 . . . . 64.23 110.809 178.172 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -75.6 -35.89 60.44 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.257 -0.429 . . . . 75.23 110.324 179.064 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 37.9 t -56.61 -42.71 79.24 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.817 -0.629 . . . . 72.33 110.35 179.068 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 209' ' ' THR . . . . . 0.417 HG23 ' H ' ' A' ' 211' ' ' LEU . 10.2 t -82.86 -35.73 26.02 Favored 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 120.454 -0.498 . . . . 72.33 109.912 176.433 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 75.18 5.74 77.43 Favored Glycine 0 C--O 1.217 -0.925 0 CA-C-N 116.202 -0.453 . . . . 65.13 112.986 177.058 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.417 ' H ' HG23 ' A' ' 209' ' ' THR . 67.0 mt -87.05 -11.79 49.26 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 120.813 0.339 . . . . 55.23 110.894 -177.222 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.507 HD11 HG21 ' A' ' 161' ' ' VAL . 4.3 mp -109.65 133.73 52.77 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 120.351 -0.54 . . . . 74.15 109.63 177.752 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -131.09 166.0 22.03 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 108.762 -0.829 . . . . 53.12 108.762 176.056 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 30.2 m -59.97 -28.06 40.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 113.324 0.861 . . . . 62.45 113.324 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 20.1 m-80 -71.95 -15.97 62.08 Favored 'General case' 0 C--N 1.312 -1.022 0 O-C-N 122.038 -0.414 . . . . 74.34 110.769 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.5 ' HA ' ' HA ' ' A' ' 251' ' ' PRO . 5.0 m-20 -71.18 132.35 44.87 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 114.426 1.269 . . . . 72.51 114.426 -174.24 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -105.19 131.12 53.06 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 126.328 1.851 . . . . 65.24 108.497 -179.01 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.592 ' HA ' HG12 ' A' ' 249' ' ' VAL . 11.4 p -83.5 134.55 26.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-O 122.034 0.921 . . . . 75.51 112.58 -175.5 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.488 HG13 ' NE2' ' A' ' 158' ' ' HIS . 39.7 mm -99.49 -49.01 11.67 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 CA-C-N 114.303 -1.317 . . . . 61.51 110.645 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -160.12 160.51 33.08 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.192 -0.458 . . . . 75.03 110.775 -176.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' A' ' 246' ' ' ILE . 7.5 p -129.7 122.67 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.03 0 O-C-N 123.736 0.647 . . . . 71.55 109.675 175.473 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 222' ' ' ASN . . . . . 0.467 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 2.8 m-20 58.89 22.08 9.84 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 125.519 1.528 . . . . 73.22 113.651 -178.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 105.85 -13.87 45.57 Favored Glycine 0 N--CA 1.429 -1.83 0 C-N-CA 120.323 -0.941 . . . . 55.52 113.062 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 60.9 mt -97.9 123.85 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.046 0 C-N-CA 120.705 -0.398 . . . . 73.33 110.458 -179.271 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -51.64 133.7 30.52 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 124.711 1.257 . . . . 63.35 111.608 177.407 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 226' ' ' VAL . . . . . 0.406 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 29.7 m -115.74 11.47 7.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 CA-C-O 122.217 1.008 . . . . 73.2 108.338 172.599 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -68.44 97.11 0.73 Allowed 'General case' 0 N--CA 1.422 -1.869 0 CA-C-N 113.468 -1.697 . . . . 72.43 111.142 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 95.56 10.3 56.92 Favored Glycine 0 C--N 1.307 -1.038 0 CA-C-N 115.609 -0.723 . . . . 64.4 112.88 174.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -82.94 178.31 8.22 Favored 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 120.506 -0.478 . . . . 73.34 109.83 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 41.1 p -87.82 157.64 18.95 Favored 'General case' 0 N--CA 1.421 -1.889 0 N-CA-C 107.135 -1.432 . . . . 61.53 107.135 174.771 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 231' ' ' LEU . . . . . 0.429 ' O ' HG22 ' A' ' 234' ' ' VAL . 1.3 tt -64.83 -32.72 74.55 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 108.1 -1.074 . . . . 74.43 108.1 -177.372 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -64.35 -38.99 92.98 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.411 -0.358 . . . . 74.43 110.487 177.222 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -60.34 -49.36 77.9 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 112.026 0.38 . . . . 73.33 112.026 175.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.441 HG21 HG12 ' A' ' 195' ' ' ILE . 5.4 m -67.92 -32.76 57.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-O 121.242 0.544 . . . . 72.31 111.739 -176.342 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 235' ' ' THR . . . . . 0.407 ' O ' HG23 ' A' ' 239' ' ' VAL . 88.2 m -74.18 -37.15 64.04 Favored 'General case' 0 CA--C 1.498 -1.044 0 CA-C-N 115.567 -0.742 . . . . 64.05 109.084 -176.386 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -60.39 -34.12 73.44 Favored 'General case' 0 CA--C 1.507 -0.682 0 CA-C-N 115.433 -0.803 . . . . 55.12 109.153 177.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 8.9 mtt -69.24 -44.88 71.09 Favored 'General case' 0 C--O 1.2 -1.527 0 N-CA-C 108.686 -0.857 . . . . 74.31 108.686 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 238' ' ' MET . . . . . 0.421 ' HG3' ' O ' ' A' ' 234' ' ' VAL . 64.7 mtt -60.12 -31.76 70.36 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.979 -0.555 . . . . 62.24 111.681 -178.163 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 235' ' ' THR . 91.0 t -74.12 -41.9 51.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-O 121.327 0.584 . . . . 70.05 110.004 176.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -70.51 -35.59 73.28 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.386 0.612 . . . . 75.01 111.106 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -84.71 21.95 1.43 Allowed 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 115.357 -0.838 . . . . 62.3 112.546 -178.423 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 242' ' ' SER . . . . . 0.585 ' O ' HD12 ' A' ' 164' ' ' LEU . 67.9 m -59.41 -23.46 62.65 Favored 'General case' 0 C--O 1.207 -1.159 0 N-CA-C 113.08 0.771 . . . . 64.11 113.08 178.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 22.6 p -68.42 -33.93 75.09 Favored 'General case' 0 CA--C 1.552 1.033 0 O-C-N 121.76 -0.588 . . . . 53.04 111.861 177.439 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 -159.68 100.59 1.46 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.931 1.292 . . . . 54.31 108.264 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -86.55 103.1 14.74 Favored 'General case' 0 C--O 1.21 -1.012 0 N-CA-C 108.443 -0.947 . . . . 44.22 108.443 -178.123 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.467 ' HB ' ' HA ' ' A' ' 222' ' ' ASN . 61.9 mt -103.78 116.32 47.34 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 N-CA-C 108.731 -0.84 . . . . 74.24 108.731 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 247' ' ' ILE . . . . . 0.509 HG23 HG23 ' A' ' 218' ' ' VAL . 18.2 mt -121.99 134.54 64.97 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.155 0 CA-C-O 121.801 0.81 . . . . 72.23 112.318 178.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.434 ' HA ' ' O ' ' A' ' 159' ' ' ARG . 46.3 m -106.54 114.96 29.38 Favored 'General case' 0 N--CA 1.411 -2.413 0 N-CA-C 107.771 -1.196 . . . . 73.31 107.771 175.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.592 HG12 ' HA ' ' A' ' 218' ' ' VAL . 18.1 m -123.27 161.42 25.13 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 CA-C-O 121.004 0.43 . . . . 73.04 110.354 177.458 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 16.0 ptmt -137.1 135.75 20.12 Favored Pre-proline 0 C--N 1.278 -2.54 0 N-CA-C 107.024 -1.473 . . . . 75.21 107.024 173.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 251' ' ' PRO . . . . . 0.5 ' HA ' ' HA ' ' A' ' 216' ' ' ASP . 38.8 Cg_exo . . . . . 0 N--CA 1.449 -1.136 0 C-N-CA 121.088 1.192 . . . . 73.31 111.249 178.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.214 -0.814 0 N-CA-C 109.105 -0.702 . . . . 72.01 109.105 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.569 ' O ' ' HA ' ' A' ' 248' ' ' THR . 24.5 tpt180 -119.69 128.88 54.22 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 120.202 -0.599 . . . . 70.1 110.342 176.146 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 32.1 ptt180 -115.85 114.24 24.46 Favored 'General case' 0 C--N 1.284 -2.243 0 CA-C-N 114.944 -1.025 . . . . 73.32 109.91 178.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 17.4 m -117.0 138.91 46.12 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 CA-C-N 115.459 -0.791 . . . . 73.41 111.097 -178.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.538 ' HD2' ' N ' ' A' ' 162' ' ' ARG . 1.3 mpt_? -107.76 111.99 24.44 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 106.589 -1.634 . . . . 74.22 106.589 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.539 ' HB2' ' HB3' ' A' ' 245' ' ' LEU . 29.1 mt -98.85 139.6 34.28 Favored 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 123.793 0.837 . . . . 74.43 111.72 -171.631 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.554 HD23 ' O ' ' A' ' 242' ' ' SER . 9.9 tp . . . . . 0 CA--C 1.515 -0.379 0 C-N-CA 125.75 1.62 . . . . 55.34 113.179 173.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.52 ' CD1' ' HB2' ' A' ' 164' ' ' LEU . 2.3 mm? . . . . . 0 N--CA 1.443 -0.797 0 CA-C-O 121.038 0.447 . . . . 63.15 110.036 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' GLY . . . . . 0.418 ' HA3' ' HA3' ' A' ' 204' ' ' GLY . . . 84.08 49.57 4.69 Favored Glycine 0 N--CA 1.433 -1.516 0 CA-C-N 115.633 -0.712 . . . . 41.25 113.923 175.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -156.75 161.37 39.8 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 108.079 -1.082 . . . . 74.3 108.079 175.067 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -130.01 157.12 43.23 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 108.589 -0.893 . . . . 73.13 108.589 175.608 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.548 HD13 ' H ' ' A' ' 176' ' ' ILE . 0.2 OUTLIER -126.21 169.06 18.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 CA-C-O 121.595 0.712 . . . . 75.32 111.278 -179.04 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.472 ' HG2' ' HB2' ' A' ' 198' ' ' SER . 16.9 ptt180 -157.79 155.44 29.8 Favored 'General case' 0 C--N 1.281 -2.385 0 CA-C-N 114.698 -1.137 . . . . 74.01 108.922 -175.184 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -112.77 158.26 20.32 Favored 'General case' 0 C--N 1.298 -1.664 0 C-N-CA 119.402 -0.919 . . . . 71.53 110.815 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -156.38 -179.23 31.23 Favored Glycine 0 C--N 1.29 -2.001 0 N-CA-C 107.726 -2.15 . . . . 54.51 107.726 176.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' THR . . . . . 0.444 ' CG2' ' HG2' ' A' ' 191' ' ' LYS . 0.2 OUTLIER -112.25 122.95 49.17 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 118.996 1.398 . . . . 75.42 108.178 179.63 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 181' ' ' SER . . . . . 0.433 ' O ' ' HA ' ' A' ' 191' ' ' LYS . 20.2 t . . . . . 0 C--N 1.289 -2.042 0 N-CA-C 108.547 -0.909 . . . . 32.4 108.547 -176.357 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.444 ' HG2' ' CG2' ' A' ' 180' ' ' THR . 33.5 ttmt . . . . . 0 N--CA 1.426 -1.626 0 N-CA-C 106.821 -1.548 . . . . 63.41 106.821 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 5.4 pp0? -149.33 151.82 34.53 Favored Pre-proline 0 C--N 1.299 -1.627 0 CA-C-O 118.956 -0.545 . . . . 65.13 109.645 -168.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -61.56 130.23 30.88 Favored 'Trans proline' 0 C--O 1.243 0.774 0 C-N-CA 121.339 1.359 . . . . 74.22 112.879 -176.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -135.86 142.42 13.71 Favored Glycine 0 N--CA 1.411 -2.984 0 N-CA-C 108.586 -1.805 . . . . 60.22 108.586 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.582 HG12 HG21 ' A' ' 234' ' ' VAL . 3.0 mp -104.17 138.06 30.37 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.526 0 C-N-CA 120.204 -0.598 . . . . 73.12 110.224 -178.616 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -122.98 166.68 14.68 Favored 'General case' 0 C--N 1.283 -2.314 0 N-CA-C 108.292 -1.003 . . . . 75.24 108.292 -177.224 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 197' ' ' ILE . . . . . 0.49 ' HB ' ' HA ' ' A' ' 214' ' ' VAL . 50.3 mm -78.49 131.21 34.96 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.265 0 N-CA-C 108.382 -0.97 . . . . 74.32 108.382 177.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 198' ' ' SER . . . . . 0.472 ' HB2' ' HG2' ' A' ' 177' ' ' ARG . 7.7 t -96.98 -32.43 12.02 Favored 'General case' 0 C--N 1.286 -2.178 0 O-C-N 121.703 -0.623 . . . . 72.31 112.408 -178.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -167.83 148.89 5.27 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.774 -0.194 . . . . 71.14 110.881 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 73.7 mt -102.84 146.05 28.86 Favored 'General case' 0 CA--C 1.495 -1.158 0 N-CA-C 108.599 -0.889 . . . . 72.3 108.599 170.406 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 59.5 t -109.14 114.3 58.1 Favored Pre-proline 0 C--N 1.28 -2.445 0 N-CA-C 106.606 -1.627 . . . . 72.33 106.606 171.572 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 202' ' ' PRO . . . . . 0.435 ' HA ' ' HG3' ' A' ' 207' ' ' GLU . 33.4 Cg_exo -59.16 128.93 29.41 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.309 2.006 . . . . 61.4 110.807 -179.457 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 102.17 -11.03 57.05 Favored Glycine 0 N--CA 1.442 -0.94 0 N-CA-C 110.806 -0.918 . . . . 75.23 110.806 -175.542 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 204' ' ' GLY . . . . . 0.418 ' HA3' ' HA3' ' A' ' 173' ' ' GLY . . . -90.27 161.4 28.88 Favored Glycine 0 N--CA 1.439 -1.103 0 N-CA-C 110.33 -1.108 . . . . 61.12 110.33 177.09 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -57.24 -38.16 73.38 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 123.685 0.794 . . . . 71.31 111.946 -176.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 206' ' ' ALA . . . . . 0.485 ' CB ' HD12 ' A' ' 212' ' ' LEU . . . -62.31 -44.52 96.32 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.315 0.579 . . . . 75.03 110.796 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.435 ' HG3' ' HA ' ' A' ' 202' ' ' PRO . 4.3 tm-20 -75.68 -35.8 60.25 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 115.72 -0.673 . . . . 64.24 110.063 179.54 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 50.9 m -60.13 -41.15 92.03 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 122.512 0.325 . . . . 43.21 111.021 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 209' ' ' THR . . . . . 0.4 HG23 ' H ' ' A' ' 211' ' ' LEU . 9.3 t -76.94 -36.53 56.49 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 120.06 -0.656 . . . . 71.23 109.334 175.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 70.65 11.49 68.96 Favored Glycine 0 N--CA 1.444 -0.83 0 CA-C-N 115.81 -0.632 . . . . 73.22 112.99 176.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.4 ' H ' HG23 ' A' ' 209' ' ' THR . 57.0 mt -95.55 5.97 50.16 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 121.518 0.675 . . . . 71.3 109.71 -178.439 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.485 HD12 ' CB ' ' A' ' 206' ' ' ALA . 98.9 mt -113.71 131.01 56.33 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 114.485 -1.234 . . . . 71.52 108.227 172.794 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -132.53 157.84 43.67 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 108.738 -0.838 . . . . 71.51 108.738 176.048 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 214' ' ' VAL . . . . . 0.49 ' HA ' ' HB ' ' A' ' 197' ' ' ILE . 14.7 m -60.92 -30.94 48.47 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 N-CA-C 113.23 0.826 . . . . 73.34 113.23 -175.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -78.69 -14.12 59.46 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 112.914 0.709 . . . . 65.21 112.914 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -69.8 142.75 53.12 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.662 0.616 . . . . 74.41 112.662 -178.299 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -108.66 131.36 54.97 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.927 -1.033 . . . . 65.41 109.579 -176.115 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.552 HG12 ' O ' ' A' ' 195' ' ' ILE . 9.8 p -83.14 143.82 11.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-O 121.893 0.854 . . . . 73.4 112.172 -176.439 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.414 HD11 ' HD2' ' A' ' 250' ' ' LYS . 37.8 mm -108.14 -51.42 7.13 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 C-N-CA 124.719 1.208 . . . . 73.41 111.26 -178.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -155.27 160.26 40.66 Favored 'General case' 0 C--O 1.247 0.945 0 CA-C-N 116.441 -0.345 . . . . 74.33 110.877 -177.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.484 HG12 ' CG1' ' A' ' 226' ' ' VAL . 7.5 p -132.38 121.03 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 O-C-N 123.775 0.672 . . . . 71.13 110.397 174.273 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 67.48 12.1 8.72 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.52 1.528 . . . . 74.53 110.672 176.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 110.11 -10.6 31.57 Favored Glycine 0 N--CA 1.432 -1.578 0 CA-C-N 115.421 -0.808 . . . . 52.43 112.589 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 64.4 mt -96.9 126.2 49.69 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.165 0 N-CA-C 108.35 -0.982 . . . . 65.14 108.35 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -65.47 141.62 58.43 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 121.431 0.634 . . . . 73.31 110.482 -178.674 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 226' ' ' VAL . . . . . 0.511 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 27.2 m -117.54 -1.88 9.5 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 CA-C-N 115.66 -0.7 . . . . 54.14 110.721 178.698 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -79.66 96.39 6.19 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 115.775 -0.648 . . . . 73.12 109.826 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 124.58 -14.57 7.66 Favored Glycine 0 C--N 1.305 -1.146 0 N-CA-C 110.688 -0.965 . . . . 64.0 110.688 -178.239 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -83.55 171.8 12.99 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.299 -1.0 . . . . 65.23 108.299 177.31 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 230' ' ' THR . . . . . 0.474 ' O ' HG13 ' A' ' 234' ' ' VAL . 81.7 p -95.68 170.95 8.97 Favored 'General case' 0 N--CA 1.434 -1.248 0 N-CA-C 108.691 -0.855 . . . . 63.24 108.691 179.038 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 231' ' ' LEU . . . . . 0.493 HD21 HG12 ' A' ' 176' ' ' ILE . 3.3 tm? -61.79 -37.19 83.43 Favored 'General case' 0 N--CA 1.424 -1.736 0 N-CA-C 110.145 -0.317 . . . . 65.3 110.145 -179.264 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -63.71 -47.92 79.2 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.738 -0.467 . . . . 63.15 109.738 178.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -60.34 -43.48 96.4 Favored 'General case' 0 C--O 1.222 -0.35 0 N-CA-C 113.73 1.011 . . . . 75.11 113.73 178.454 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.582 HG21 HG12 ' A' ' 195' ' ' ILE . 12.7 m -73.22 -33.94 42.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-O 121.375 0.607 . . . . 75.44 112.072 -175.616 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 235' ' ' THR . . . . . 0.446 ' O ' HG23 ' A' ' 239' ' ' VAL . 85.9 m -74.98 -35.59 62.05 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 115.418 -0.81 . . . . 74.44 109.49 -174.723 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -61.74 -33.11 73.46 Favored 'General case' 0 C--O 1.244 0.805 0 CA-C-N 115.75 -0.659 . . . . 73.12 109.538 177.597 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 237' ' ' MET . . . . . 0.444 ' HB2' HG11 ' A' ' 221' ' ' VAL . 13.6 mtt -68.09 -47.56 67.92 Favored 'General case' 0 C--O 1.209 -1.051 0 N-CA-C 107.835 -1.172 . . . . 75.45 107.835 179.387 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 64.7 mtt -59.01 -37.16 76.25 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.402 -0.817 . . . . 72.24 111.329 -178.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 235' ' ' THR . 92.2 t -69.46 -44.91 79.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 CA-C-N 116.308 -0.405 . . . . 65.5 110.782 177.784 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -69.72 -38.14 76.78 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.173 0.511 . . . . 54.42 110.96 -178.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -82.01 21.1 0.91 Allowed 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 115.525 -0.761 . . . . 72.4 112.45 -178.483 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 242' ' ' SER . . . . . 0.554 ' O ' HD23 ' A' ' 164' ' ' LEU . 42.8 t -59.19 -28.32 66.52 Favored 'General case' 0 CA--C 1.559 1.324 0 CA-C-O 121.158 0.504 . . . . 72.21 111.04 178.836 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 20.2 m -67.29 -28.61 68.16 Favored 'General case' 0 CA--C 1.552 1.052 0 N-CA-C 111.896 0.332 . . . . 52.42 111.896 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -161.99 83.82 0.58 Allowed 'General case' 0 C--O 1.249 1.034 0 N-CA-C 107.079 -1.452 . . . . 64.24 107.079 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.539 ' HB3' ' HB2' ' A' ' 163' ' ' LEU . 1.3 tt -85.95 103.42 14.64 Favored 'General case' 0 C--O 1.2 -1.548 0 C-N-CA 119.87 -0.732 . . . . 73.13 109.484 -173.536 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.467 HG12 ' HG3' ' A' ' 162' ' ' ARG . 74.1 mt -105.25 116.71 49.59 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.22 0 N-CA-C 109.469 -0.567 . . . . 74.02 109.469 178.683 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 247' ' ' ILE . . . . . 0.5 HG13 ' CD2' ' A' ' 245' ' ' LEU . 25.5 mt -120.05 134.33 63.91 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 CA-C-O 121.27 0.557 . . . . 44.11 111.674 179.495 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.569 ' HA ' ' O ' ' A' ' 159' ' ' ARG . 90.8 m -108.3 119.83 40.64 Favored 'General case' 0 N--CA 1.417 -2.114 0 CA-C-N 114.939 -1.028 . . . . 74.42 108.486 174.071 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.457 HG12 ' HA ' ' A' ' 218' ' ' VAL . 26.7 m -124.18 164.39 22.52 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.865 0 N-CA-C 108.43 -0.952 . . . . 51.14 108.43 174.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 250' ' ' LYS . . . . . 0.414 ' HD2' HD11 ' A' ' 219' ' ' ILE . 0.0 OUTLIER -144.66 136.58 13.01 Favored Pre-proline 0 C--N 1.264 -3.112 0 CA-C-N 115.449 -0.796 . . . . 74.44 109.916 173.778 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo . . . . . 0 N--CA 1.451 -0.995 0 C-N-CA 122.643 2.229 . . . . 72.33 110.962 179.076 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.443 ' NE2' HG13 ' A' ' 219' ' ' ILE . 1.0 OUTLIER . . . . . 0 N--CA 1.437 -1.111 0 N-CA-C 108.892 -0.781 . . . . 73.41 108.892 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.455 ' O ' ' HA ' ' A' ' 248' ' ' THR . 23.5 tpp180 -112.07 132.93 54.54 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 108.72 -0.844 . . . . 74.23 108.72 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 82.7 mtt180 -109.49 115.48 30.01 Favored 'General case' 0 C--N 1.278 -2.529 0 CA-C-N 115.708 -0.678 . . . . 60.34 111.439 176.037 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.425 ' CG1' ' HB2' ' A' ' 211' ' ' LEU . 18.6 m -118.94 138.19 50.46 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.219 0 CA-C-N 114.778 -1.101 . . . . 74.31 109.971 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.548 ' HG3' HG12 ' A' ' 246' ' ' ILE . 4.8 mpt_? -110.12 112.14 23.94 Favored 'General case' 0 N--CA 1.415 -2.199 0 N-CA-C 107.769 -1.197 . . . . 75.22 107.769 177.179 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.46 ' HB2' ' HB2' ' A' ' 245' ' ' LEU . 9.6 mt -96.96 118.53 33.58 Favored 'General case' 0 N--CA 1.409 -2.502 0 N-CA-C 107.523 -1.288 . . . . 60.31 107.523 -176.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.609 HD23 ' O ' ' A' ' 242' ' ' SER . 12.9 tp . . . . . 0 C--N 1.299 -1.59 0 CA-C-O 122.38 1.086 . . . . 62.43 112.95 177.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.476 ' HA ' HD23 ' A' ' 205' ' ' LEU . 2.7 mm? . . . . . 0 C--O 1.239 0.541 0 CA-C-O 120.854 0.359 . . . . 73.2 111.373 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' GLY . . . . . 0.472 ' HA3' ' HA3' ' A' ' 204' ' ' GLY . . . 84.51 37.8 10.39 Favored Glycine 0 N--CA 1.433 -1.518 0 N-CA-C 114.575 0.59 . . . . 55.23 114.575 174.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -159.46 152.62 22.15 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 108.733 -0.84 . . . . 74.41 108.733 173.384 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -132.51 146.22 51.76 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 109.312 -0.625 . . . . 64.34 109.312 179.26 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.686 HD13 ' H ' ' A' ' 176' ' ' ILE . 0.2 OUTLIER -111.04 170.34 3.54 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.634 0 CA-C-N 115.67 -0.695 . . . . 71.54 111.599 -175.397 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.533 ' CG ' ' HB2' ' A' ' 198' ' ' SER . 25.5 ptt180 -147.42 155.57 42.07 Favored 'General case' 0 C--N 1.279 -2.49 0 C-N-CA 124.972 1.309 . . . . 75.43 109.242 -177.017 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -117.89 151.21 37.85 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-O 121.32 0.581 . . . . 71.14 111.163 -175.636 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -167.87 -162.13 19.07 Favored Glycine 0 N--CA 1.426 -2.022 0 N-CA-C 109.439 -1.464 . . . . 64.41 109.439 176.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' THR . . . . . 0.422 ' HB ' ' CG ' ' A' ' 191' ' ' LYS . 1.2 p -100.41 132.03 46.01 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 121.598 0.713 . . . . 61.24 112.322 176.042 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 33.6 t . . . . . 0 N--CA 1.409 -2.525 0 N-CA-C 107.483 -1.303 . . . . 63.11 107.483 173.874 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.422 ' CG ' ' HB ' ' A' ' 180' ' ' THR . 33.9 ttmt . . . . . 0 N--CA 1.426 -1.651 0 N-CA-C 107.912 -1.144 . . . . 74.34 107.912 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -141.11 162.04 50.17 Favored Pre-proline 0 C--N 1.269 -2.922 0 N-CA-C 107.944 -1.132 . . . . 73.23 107.944 -177.476 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -57.88 131.57 44.62 Favored 'Trans proline' 0 N--CA 1.447 -1.25 0 C-N-CA 120.935 1.09 . . . . 73.42 109.476 175.003 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -135.82 138.1 9.66 Favored Glycine 0 CA--C 1.463 -3.218 0 N-CA-C 110.127 -1.189 . . . . 62.13 110.127 -177.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.663 HG12 HG21 ' A' ' 234' ' ' VAL . 3.3 mp -105.92 138.07 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.538 0 CA-C-O 121.301 0.572 . . . . 71.11 109.832 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -127.22 166.94 16.78 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 106.837 -1.542 . . . . 63.55 106.837 -178.045 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 197' ' ' ILE . . . . . 0.473 ' HB ' ' HA ' ' A' ' 214' ' ' VAL . 45.1 mt -85.0 131.69 33.47 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.335 0 CA-C-O 121.055 0.455 . . . . 64.5 109.846 178.093 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 198' ' ' SER . . . . . 0.533 ' HB2' ' CG ' ' A' ' 177' ' ' ARG . 14.1 t -101.2 -50.06 3.9 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 112.484 0.55 . . . . 52.34 112.484 -178.158 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 40.8 ttp-105 -139.44 132.79 30.04 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 109.573 -0.529 . . . . 64.12 109.573 -176.709 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 2.6 tt -117.75 130.38 56.28 Favored 'General case' 0 N--CA 1.42 -1.941 0 N-CA-C 107.038 -1.468 . . . . 64.44 107.038 -178.533 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 45.1 t -108.64 127.31 27.64 Favored Pre-proline 0 C--N 1.316 -0.886 0 N-CA-C 112.036 0.384 . . . . 72.14 112.036 -171.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 202' ' ' PRO . . . . . 0.53 ' HA ' ' HG3' ' A' ' 207' ' ' GLU . 34.4 Cg_endo -66.79 143.23 66.41 Favored 'Trans proline' 0 C--O 1.245 0.865 0 C-N-CA 122.432 2.088 . . . . 44.23 110.999 175.196 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 92.24 -9.9 75.36 Favored Glycine 0 N--CA 1.442 -0.959 0 N-CA-C 111.074 -0.811 . . . . 74.33 111.074 -177.623 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 204' ' ' GLY . . . . . 0.472 ' HA3' ' HA3' ' A' ' 173' ' ' GLY . . . -94.44 167.42 27.39 Favored Glycine 0 N--CA 1.435 -1.37 0 N-CA-C 110.472 -1.051 . . . . 61.41 110.472 178.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.476 HD23 ' HA ' ' A' ' 172' ' ' LEU . 2.7 mm? -66.72 -29.7 69.75 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 117.104 0.452 . . . . 72.02 111.675 -175.465 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -62.38 -46.28 89.33 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.636 0.731 . . . . 62.02 109.788 176.663 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.53 ' HG3' ' HA ' ' A' ' 202' ' ' PRO . 3.6 tm-20 -71.58 -32.62 68.27 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.513 -0.767 . . . . 75.13 110.667 179.15 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 44.7 m -55.78 -37.02 68.01 Favored 'General case' 0 CA--C 1.546 0.805 0 O-C-N 123.284 0.365 . . . . 75.22 110.967 178.181 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 8.9 t -87.49 -41.0 13.83 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 119.466 -0.894 . . . . 62.53 110.561 176.384 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 66.23 9.09 47.35 Favored Glycine 0 CA--C 1.531 1.051 0 N-CA-C 114.504 0.561 . . . . 71.44 114.504 177.548 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.425 ' HB2' ' CG1' ' A' ' 161' ' ' VAL . 69.1 mt -82.27 -18.03 43.85 Favored 'General case' 0 CA--C 1.503 -0.862 0 CA-C-O 121.119 0.485 . . . . 64.1 110.959 -178.732 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.471 ' H ' HD23 ' A' ' 212' ' ' LEU . 1.8 pt? -108.99 149.02 29.84 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 108.884 -0.784 . . . . 64.24 108.884 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -129.97 166.11 20.76 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 109.502 -0.555 . . . . 74.25 109.502 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 214' ' ' VAL . . . . . 0.473 ' HA ' ' HB ' ' A' ' 197' ' ' ILE . 32.6 m -63.22 -29.79 48.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 N-CA-C 113.044 0.757 . . . . 73.15 113.044 -179.075 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -69.84 -15.31 63.08 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 122.019 -0.426 . . . . 72.44 111.669 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.505 ' HB3' ' HB ' ' A' ' 249' ' ' VAL . 8.4 m-20 -69.78 152.89 44.08 Favored 'General case' 0 C--O 1.247 0.971 0 N-CA-C 113.918 1.081 . . . . 71.51 113.918 -175.632 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -112.49 134.43 54.02 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 125.804 1.642 . . . . 74.5 108.324 -179.069 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.565 ' HA ' HG12 ' A' ' 249' ' ' VAL . 9.9 p -86.32 146.19 6.75 Favored 'Isoleucine or valine' 0 C--O 1.245 0.847 0 CA-C-O 121.903 0.859 . . . . 73.1 112.321 -174.651 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.443 HG13 ' NE2' ' A' ' 158' ' ' HIS . 34.2 mm -113.0 -58.71 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 CA-C-N 114.536 -1.211 . . . . 65.43 111.285 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -150.35 158.89 44.65 Favored 'General case' 0 C--O 1.243 0.76 0 CA-C-N 116.8 -0.182 . . . . 72.21 110.523 -177.152 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.462 HG12 HG13 ' A' ' 226' ' ' VAL . 13.6 p -132.21 126.33 55.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 N-CA-C 109.079 -0.712 . . . . 52.01 109.079 177.04 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 222' ' ' ASN . . . . . 0.403 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 8.3 t-20 64.4 18.94 11.6 Favored 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 124.98 1.312 . . . . 53.32 110.108 176.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 102.8 -17.09 53.73 Favored Glycine 0 N--CA 1.436 -1.306 0 CA-C-N 115.858 -0.61 . . . . 70.23 112.322 -179.246 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 65.6 mt -98.97 127.02 52.03 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.09 0 CA-C-O 121.032 0.444 . . . . 72.43 109.977 -178.231 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -62.09 140.06 58.42 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-O 121.884 0.849 . . . . 75.23 112.833 -177.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 226' ' ' VAL . . . . . 0.462 HG13 HG12 ' A' ' 221' ' ' VAL . 16.3 m -118.13 3.56 7.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-N 114.986 -1.006 . . . . 74.41 110.272 176.691 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -79.15 101.95 8.21 Favored 'General case' 0 N--CA 1.422 -1.833 0 CA-C-N 115.176 -0.92 . . . . 72.44 109.544 178.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 118.31 -11.83 12.73 Favored Glycine 0 C--N 1.309 -0.927 0 C-N-CA 120.895 -0.669 . . . . 71.32 111.794 178.637 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -81.15 172.78 13.25 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 108.846 -0.798 . . . . 75.53 108.846 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 230' ' ' THR . . . . . 0.412 ' O ' HG13 ' A' ' 234' ' ' VAL . 72.5 p -88.77 168.2 12.67 Favored 'General case' 0 N--CA 1.433 -1.303 0 N-CA-C 108.198 -1.038 . . . . 65.32 108.198 178.622 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 231' ' ' LEU . . . . . 0.48 HD21 HG12 ' A' ' 176' ' ' ILE . 3.2 tm? -62.68 -36.3 82.45 Favored 'General case' 0 N--CA 1.426 -1.654 0 N-CA-C 109.249 -0.649 . . . . 55.21 109.249 179.006 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -67.3 -47.47 70.47 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.517 -0.473 . . . . 35.11 109.826 178.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -59.85 -38.41 82.02 Favored 'General case' 0 C--N 1.349 0.55 0 N-CA-C 113.27 0.841 . . . . 72.41 113.27 177.312 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.663 HG21 HG12 ' A' ' 195' ' ' ILE . 16.3 m -74.18 -36.15 42.83 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.458 0 C-N-CA 119.308 -0.957 . . . . 74.43 111.518 -179.139 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 235' ' ' THR . . . . . 0.425 ' O ' HG23 ' A' ' 239' ' ' VAL . 39.5 m -68.61 -35.92 77.97 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 108.924 -0.769 . . . . 74.5 108.924 179.054 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -57.87 -41.12 81.78 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 115.716 -0.674 . . . . 33.3 109.908 175.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 13.6 mmt -58.77 -49.69 76.73 Favored 'General case' 0 C--O 1.204 -1.319 0 N-CA-C 108.242 -1.021 . . . . 62.14 108.242 177.073 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 238' ' ' MET . . . . . 0.502 ' HA ' HD21 ' A' ' 245' ' ' LEU . 60.4 mtt -63.77 -35.6 81.14 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.904 -1.044 . . . . 75.51 112.8 -174.388 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 235' ' ' THR . 84.4 t -70.37 -38.11 73.03 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-O 121.092 0.472 . . . . 71.45 109.851 177.076 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -71.63 -36.66 70.81 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.507 0.67 . . . . 72.53 110.518 178.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -89.22 21.59 3.19 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 115.463 -0.79 . . . . 74.44 111.276 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 242' ' ' SER . . . . . 0.609 ' O ' HD23 ' A' ' 164' ' ' LEU . 46.0 p -64.83 -23.16 67.15 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 113.479 0.918 . . . . 74.2 113.479 -178.245 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 67.0 m -79.09 -18.39 53.43 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 119.439 -0.905 . . . . 62.52 111.434 177.069 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -166.6 92.39 0.46 Allowed 'General case' 0 C--O 1.252 1.186 0 CA-C-O 121.813 0.816 . . . . 65.51 112.227 179.134 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.502 HD21 ' HA ' ' A' ' 238' ' ' MET . 11.7 mt -85.29 102.94 13.79 Favored 'General case' 0 C--O 1.19 -2.067 0 CA-C-N 115.933 -0.576 . . . . 73.54 112.013 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.548 HG12 ' HG3' ' A' ' 162' ' ' ARG . 88.7 mt -96.68 114.3 33.22 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.844 0 N-CA-C 106.078 -1.823 . . . . 51.03 106.078 172.475 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 83.5 mt -122.93 135.61 62.43 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 CA-C-O 121.505 0.669 . . . . 61.34 111.967 -176.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.455 ' HA ' ' O ' ' A' ' 159' ' ' ARG . 46.9 m -107.13 114.9 29.24 Favored 'General case' 0 N--CA 1.414 -2.258 0 CA-C-N 114.901 -1.045 . . . . 73.32 108.581 176.677 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.565 HG12 ' HA ' ' A' ' 218' ' ' VAL . 31.3 m -124.96 151.9 30.92 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 N-CA-C 109.423 -0.584 . . . . 73.45 109.423 175.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 250' ' ' LYS . . . . . 0.411 ' HD3' HD11 ' A' ' 219' ' ' ILE . 9.5 ptmt -127.54 141.67 41.66 Favored Pre-proline 0 C--N 1.269 -2.892 0 N-CA-C 107.635 -1.246 . . . . 74.11 107.635 178.8 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo . . . . . 0 CA--C 1.546 1.086 0 C-N-CA 121.913 1.742 . . . . 73.34 111.795 178.69 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.542 ' CD2' HG13 ' A' ' 219' ' ' ILE . 0.4 OUTLIER . . . . . 0 CA--C 1.499 -1.013 0 N-CA-C 109.683 -0.488 . . . . 73.21 109.683 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.421 ' HE ' HD13 ' A' ' 211' ' ' LEU . 15.2 tpt180 -137.78 129.35 28.19 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 108.134 -1.061 . . . . 71.2 108.134 174.198 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 35.6 ptt180 -112.66 119.64 38.81 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-O 121.659 0.742 . . . . 64.13 109.983 177.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.618 ' O ' ' HA ' ' A' ' 246' ' ' ILE . 27.5 m -114.21 139.15 41.5 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.3 0 CA-C-N 114.882 -1.053 . . . . 73.43 112.122 -175.575 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.487 ' HG2' HG12 ' A' ' 246' ' ' ILE . 44.8 mtm180 -99.15 112.29 24.47 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 106.891 -1.522 . . . . 72.14 106.891 178.097 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.565 ' HB2' ' HB3' ' A' ' 245' ' ' LEU . 22.1 mt -104.58 139.12 39.91 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 109.503 -0.554 . . . . 73.04 109.503 -177.245 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 25.4 tp . . . . . 0 C--N 1.304 -1.376 0 N-CA-C 113.455 0.909 . . . . 74.01 113.455 172.168 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.437 ' HG ' ' CD1' ' A' ' 245' ' ' LEU . 3.2 mm? . . . . . 0 CA--C 1.511 -0.521 0 N-CA-C 112.558 0.577 . . . . 71.02 112.558 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' GLY . . . . . 0.441 ' HA3' ' HA3' ' A' ' 204' ' ' GLY . . . 94.61 30.62 8.4 Favored Glycine 0 N--CA 1.428 -1.836 0 C-N-CA 119.534 -1.317 . . . . 75.2 112.897 178.472 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -154.98 154.66 32.89 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 107.654 -1.239 . . . . 74.31 107.654 175.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -126.5 157.45 38.68 Favored 'General case' 0 C--N 1.272 -2.788 0 N-CA-C 107.625 -1.25 . . . . 74.41 107.625 175.602 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 30.8 pt -122.94 164.16 20.72 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.02 0 CA-C-O 121.605 0.717 . . . . 63.35 112.424 -178.134 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.428 ' HG2' ' HB3' ' A' ' 198' ' ' SER . 4.0 ptp180 -139.39 154.73 47.87 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 114.238 -1.347 . . . . 75.12 108.18 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 178' ' ' ASP . . . . . 0.473 ' HB3' HD23 ' A' ' 231' ' ' LEU . 4.1 p-10 -121.44 143.11 49.42 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 108.917 -0.771 . . . . 73.14 108.917 176.839 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 179' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' A' ' 193' ' ' PRO . . . -156.26 -146.18 4.39 Favored Glycine 0 N--CA 1.415 -2.758 0 N-CA-C 109.425 -1.47 . . . . 73.1 109.425 178.812 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 180' ' ' THR . . . . . 0.555 ' HB ' ' CG ' ' A' ' 191' ' ' LYS . 1.3 p -108.74 127.32 53.9 Favored 'General case' 0 C--N 1.28 -2.45 0 N-CA-C 112.695 0.628 . . . . 53.12 112.695 179.252 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 28.7 t . . . . . 0 N--CA 1.413 -2.319 0 N-CA-C 106.951 -1.5 . . . . 61.35 106.951 175.045 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.555 ' CG ' ' HB ' ' A' ' 180' ' ' THR . 36.2 ttmt . . . . . 0 N--CA 1.417 -2.09 0 N-CA-C 108.305 -0.998 . . . . 64.45 108.305 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -140.92 164.1 38.28 Favored Pre-proline 0 C--N 1.287 -2.117 0 N-CA-C 108.946 -0.761 . . . . 60.51 108.946 -176.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 193' ' ' PRO . . . . . 0.427 ' HA ' ' O ' ' A' ' 179' ' ' GLY . 10.7 Cg_endo -55.93 132.38 51.64 Favored 'Trans proline' 0 C--O 1.248 1.018 0 C-N-CA 121.642 1.561 . . . . 74.02 111.0 175.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -141.14 147.52 19.13 Favored Glycine 0 CA--C 1.471 -2.691 0 N-CA-C 110.7 -0.96 . . . . 73.25 110.7 -178.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.759 HG12 HG21 ' A' ' 234' ' ' VAL . 2.9 mp -104.24 142.17 18.3 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 CA-C-O 121.295 0.569 . . . . 70.21 110.132 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -137.07 164.42 28.45 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 107.244 -1.391 . . . . 62.32 107.244 -178.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 197' ' ' ILE . . . . . 0.495 ' HB ' ' HA ' ' A' ' 214' ' ' VAL . 48.6 mm -76.26 127.82 37.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 107.747 -1.205 . . . . 75.45 107.747 176.402 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 198' ' ' SER . . . . . 0.428 ' HB3' ' HG2' ' A' ' 177' ' ' ARG . 82.9 p -99.92 -38.88 8.43 Favored 'General case' 0 C--N 1.29 -1.994 0 C-N-CA 119.862 -0.735 . . . . 75.43 111.196 -175.045 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -150.43 139.4 20.98 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 108.809 -0.811 . . . . 74.01 108.809 -177.524 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 1.1 tt -111.59 132.45 54.55 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 107.395 -1.335 . . . . 64.4 107.395 -179.135 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 61.1 t -104.98 118.46 56.07 Favored Pre-proline 0 C--N 1.312 -1.054 0 CA-C-O 120.626 0.25 . . . . 61.25 111.453 -176.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 202' ' ' PRO . . . . . 0.48 ' HA ' ' HG2' ' A' ' 207' ' ' GLU . 37.8 Cg_exo -62.23 136.96 63.09 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 122.627 2.218 . . . . 72.44 110.866 176.284 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 96.55 -22.01 42.54 Favored Glycine 0 N--CA 1.439 -1.134 0 C-N-CA 121.12 -0.562 . . . . 75.04 112.253 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 204' ' ' GLY . . . . . 0.441 ' HA3' ' HA3' ' A' ' 173' ' ' GLY . . . -80.54 -176.18 49.98 Favored Glycine 0 N--CA 1.44 -1.067 0 C-N-CA 120.966 -0.635 . . . . 72.24 112.417 -179.047 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 172' ' ' LEU . 3.2 mm? -67.87 -41.87 82.17 Favored 'General case' 0 N--CA 1.426 -1.668 0 C-N-CA 122.91 0.484 . . . . 71.33 110.754 -178.626 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -64.02 -34.2 77.48 Favored 'General case' 0 C--O 1.22 -0.481 0 N-CA-C 113.139 0.792 . . . . 31.41 113.139 -176.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.48 ' HG2' ' HA ' ' A' ' 202' ' ' PRO . 11.8 tp10 -75.61 -33.08 60.52 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-O 121.724 0.773 . . . . 71.44 108.971 179.221 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 19.3 t -65.86 -24.71 66.93 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.954 -1.021 . . . . 54.24 110.802 -178.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 2.4 m -69.18 -40.45 78.09 Favored 'General case' 0 N--CA 1.415 -2.212 0 CA-C-N 115.914 -0.585 . . . . 73.5 111.867 -171.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 70.02 24.21 76.63 Favored Glycine 0 C--O 1.225 -0.42 0 N-CA-C 111.012 -0.835 . . . . 75.4 111.012 -176.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.421 HD13 ' HE ' ' A' ' 159' ' ' ARG . 65.6 mt -140.72 -8.95 1.06 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 122.963 0.505 . . . . 65.52 111.053 -175.153 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 67.9 mt -109.48 131.22 55.27 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 115.888 -0.596 . . . . 71.44 110.583 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -134.15 166.23 23.24 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.727 -1.212 . . . . 74.11 107.727 175.329 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 214' ' ' VAL . . . . . 0.495 ' HA ' ' HB ' ' A' ' 197' ' ' ILE . 31.3 m -66.52 -30.8 50.96 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 N-CA-C 113.074 0.768 . . . . 71.21 113.074 -179.37 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 46.7 m-80 -75.15 -14.5 60.56 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 113.706 1.002 . . . . 72.34 113.706 -177.417 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.452 ' HB3' ' HB ' ' A' ' 249' ' ' VAL . 5.3 m-20 -63.74 131.59 48.37 Favored 'General case' 0 C--O 1.246 0.877 0 CA-C-O 121.172 0.51 . . . . 65.21 112.282 -179.034 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -97.55 140.85 31.36 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.462 -0.79 . . . . 75.52 109.48 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.518 HG11 ' HB ' ' A' ' 195' ' ' ILE . 5.2 p -81.86 145.56 8.55 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 CA-C-O 121.621 0.724 . . . . 70.2 112.229 -174.517 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.542 HG13 ' CD2' ' A' ' 158' ' ' HIS . 44.4 mm -115.96 -60.85 2.71 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 115.618 -0.719 . . . . 54.42 110.874 178.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -152.36 154.83 36.42 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 109.136 -0.69 . . . . 75.21 109.136 -176.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.521 HG22 HG12 ' A' ' 247' ' ' ILE . 44.2 t -128.94 122.91 57.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 108.466 -0.939 . . . . 44.14 108.466 179.123 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 65.7 20.35 11.52 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.137 1.375 . . . . 71.42 109.523 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 97.37 -15.2 62.58 Favored Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 115.243 -0.889 . . . . 13.34 111.975 -178.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 63.0 mt -92.67 123.77 44.88 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.747 0 N-CA-C 109.044 -0.724 . . . . 62.31 109.044 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -57.39 142.38 43.96 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.521 0.677 . . . . 74.41 112.139 -178.1 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 226' ' ' VAL . . . . . 0.499 ' HA ' ' CG ' ' A' ' 229' ' ' LYS . 15.6 m -120.93 10.46 6.21 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.845 0 CA-C-N 115.555 -0.748 . . . . 64.44 111.083 175.282 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -74.3 101.34 4.0 Favored 'General case' 0 N--CA 1.426 -1.657 0 CA-C-N 115.035 -0.984 . . . . 52.31 109.588 177.649 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 109.69 -1.57 30.53 Favored Glycine 0 CA--C 1.496 -1.121 0 C-N-CA 120.886 -0.673 . . . . 71.35 111.707 177.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 229' ' ' LYS . . . . . 0.499 ' CG ' ' HA ' ' A' ' 226' ' ' VAL . 71.9 mmtt -82.21 158.77 23.44 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.18 -0.674 . . . . 75.04 109.18 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 67.3 p -82.66 171.49 13.97 Favored 'General case' 0 N--CA 1.409 -2.512 0 C-N-CA 119.299 -0.96 . . . . 71.51 109.437 177.05 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 231' ' ' LEU . . . . . 0.473 HD23 ' HB3' ' A' ' 178' ' ' ASP . 2.1 tm? -66.59 -35.48 80.3 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 108.578 -0.897 . . . . 73.33 108.578 -179.262 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -65.13 -41.22 95.02 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.581 -0.736 . . . . 73.14 109.698 178.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -61.34 -47.16 87.15 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.481 -0.781 . . . . 55.21 112.507 176.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.759 HG21 HG12 ' A' ' 195' ' ' ILE . 19.8 m -69.63 -33.74 58.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 C-N-CA 120.211 -0.596 . . . . 70.1 111.918 -177.789 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 235' ' ' THR . . . . . 0.468 ' O ' HG23 ' A' ' 239' ' ' VAL . 90.4 m -64.86 -35.7 81.98 Favored 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 109.694 -0.484 . . . . 64.25 109.694 177.233 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -63.39 -35.84 81.76 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.279 -0.419 . . . . 74.52 110.125 176.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 16.8 mmt -58.08 -52.75 64.24 Favored 'General case' 0 C--O 1.201 -1.453 0 N-CA-C 107.814 -1.18 . . . . 71.3 107.814 174.144 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 66.6 mtt -58.21 -35.28 71.41 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.633 -1.167 . . . . 70.22 112.049 -175.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 235' ' ' THR . 94.5 t -71.96 -45.98 61.78 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-O 120.832 0.349 . . . . 72.24 110.615 177.135 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -68.01 -34.61 76.83 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.508 0.671 . . . . 74.31 111.076 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -89.76 21.84 3.36 Favored 'General case' 0 C--O 1.198 -1.633 0 CA-C-N 115.311 -0.859 . . . . 73.34 110.578 -179.372 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 25.2 t -60.63 -23.78 65.01 Favored 'General case' 0 CA--C 1.563 1.461 0 N-CA-C 112.149 0.426 . . . . 71.32 112.149 -178.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 6.9 p -81.07 -14.01 58.22 Favored 'General case' 0 CA--C 1.558 1.262 0 N-CA-C 112.641 0.608 . . . . 72.32 112.641 178.632 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -173.77 98.55 0.11 Allowed 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.908 1.283 . . . . 72.25 108.356 173.232 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.565 ' HB3' ' HB2' ' A' ' 163' ' ' LEU . 1.2 tt -86.36 101.82 13.45 Favored 'General case' 0 N--CA 1.413 -2.305 0 N-CA-C 107.701 -1.222 . . . . 53.44 107.701 -176.572 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.618 ' HA ' ' O ' ' A' ' 161' ' ' VAL . 73.5 mt -104.07 116.12 47.26 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 C-N-CA 120.163 -0.615 . . . . 63.14 109.812 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 247' ' ' ILE . . . . . 0.521 HG12 HG22 ' A' ' 221' ' ' VAL . 91.7 mt -122.05 131.36 73.31 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.892 0 C-N-CA 120.151 -0.62 . . . . 63.01 110.085 176.5 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 56.3 m -96.77 114.95 26.63 Favored 'General case' 0 N--CA 1.412 -2.369 0 N-CA-C 107.545 -1.28 . . . . 53.21 107.545 174.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.475 HG12 ' HA ' ' A' ' 218' ' ' VAL . 21.7 m -117.89 169.12 8.89 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.117 0 N-CA-C 109.098 -0.705 . . . . 70.34 109.098 176.069 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 15.5 ptmt -134.0 129.45 20.07 Favored Pre-proline 0 C--N 1.28 -2.456 0 CA-C-N 115.454 -0.793 . . . . 73.22 110.181 176.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo . . . . . 0 N--CA 1.44 -1.67 0 C-N-CA 121.738 1.626 . . . . 74.43 108.86 173.988 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.735 ' NE2' HG13 ' A' ' 219' ' ' ILE . 9.0 m80 . . . . . 0 N--CA 1.445 -0.72 0 N-CA-C 109.806 -0.442 . . . . 75.42 109.806 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.548 ' O ' ' HA ' ' A' ' 248' ' ' THR . 45.3 ttm180 -145.01 144.0 30.79 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 116.4 -0.364 . . . . 63.41 111.071 174.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.529 ' HA ' ' O ' ' A' ' 247' ' ' ILE . 0.0 OUTLIER -118.23 127.04 53.36 Favored 'General case' 0 C--N 1.32 -0.677 0 O-C-N 123.244 0.34 . . . . 71.42 110.42 175.445 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.512 HG11 HD21 ' A' ' 211' ' ' LEU . 11.9 m -122.25 139.05 50.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 CA-C-N 115.909 -0.587 . . . . 74.41 111.283 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 21.8 ttm180 -92.59 116.36 28.93 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 109.317 -0.623 . . . . 74.43 109.317 177.093 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.422 ' HB2' ' HB3' ' A' ' 245' ' ' LEU . 19.7 mt -107.87 138.73 43.6 Favored 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 107.144 -1.428 . . . . 72.3 107.144 -179.063 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.487 HD12 ' O ' ' A' ' 242' ' ' SER . 1.0 OUTLIER . . . . . 0 N--CA 1.442 -0.864 0 CA-C-O 122.325 1.06 . . . . 74.14 108.322 173.473 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.426 ' HG ' ' CD1' ' A' ' 245' ' ' LEU . 2.8 mm? . . . . . 0 CA--C 1.492 -1.282 0 CA-C-O 120.894 0.378 . . . . 63.5 111.98 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' GLY . . . . . 0.547 ' HA3' ' HA3' ' A' ' 204' ' ' GLY . . . 97.95 17.1 31.1 Favored Glycine 0 N--CA 1.415 -2.746 0 C-N-CA 119.273 -1.441 . . . . 53.23 111.879 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -158.08 157.17 32.33 Favored 'General case' 0 N--CA 1.427 -1.605 0 N-CA-C 109.273 -0.64 . . . . 51.3 109.273 179.07 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -129.38 158.24 39.69 Favored 'General case' 0 C--N 1.283 -2.314 0 N-CA-C 107.995 -1.113 . . . . 74.34 107.995 172.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.625 HD13 ' H ' ' A' ' 176' ' ' ILE . 0.1 OUTLIER -118.53 163.78 15.41 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.018 0 CA-C-O 121.744 0.783 . . . . 60.51 111.271 -178.68 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.439 ' HB3' ' HB3' ' A' ' 198' ' ' SER . 15.6 ptt180 -142.35 154.77 44.94 Favored 'General case' 0 C--N 1.28 -2.424 0 CA-C-N 114.182 -1.372 . . . . 74.12 109.477 -177.137 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -110.67 138.21 47.35 Favored 'General case' 0 C--N 1.294 -1.848 0 CA-C-O 121.143 0.497 . . . . 73.25 110.551 179.066 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -145.06 176.46 24.09 Favored Glycine 0 C--N 1.28 -2.544 0 N-CA-C 106.858 -2.497 . . . . 74.35 106.858 175.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' THR . . . . . 0.574 ' CG2' ' HG2' ' A' ' 191' ' ' LYS . 0.2 OUTLIER -102.07 122.71 44.64 Favored 'General case' 0 C--N 1.273 -2.74 0 C-N-CA 117.312 -1.755 . . . . 70.34 107.103 177.965 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 181' ' ' SER . . . . . 0.417 ' O ' ' HA ' ' A' ' 191' ' ' LYS . 33.3 t . . . . . 0 C--N 1.283 -2.293 0 N-CA-C 109.041 -0.725 . . . . 72.35 109.041 -176.577 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.574 ' HG2' ' CG2' ' A' ' 180' ' ' THR . 34.2 ttmt . . . . . 0 N--CA 1.43 -1.462 0 N-CA-C 108.295 -1.002 . . . . 73.43 108.295 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -147.88 165.17 19.26 Favored Pre-proline 0 C--N 1.306 -1.325 0 N-CA-C 109.127 -0.694 . . . . 53.12 109.127 -170.114 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -56.79 132.35 51.17 Favored 'Trans proline' 0 C--O 1.255 1.369 0 C-N-CA 121.378 1.386 . . . . 74.55 110.64 177.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -145.57 128.14 3.04 Favored Glycine 0 N--CA 1.419 -2.465 0 N-CA-C 110.504 -1.038 . . . . 73.35 110.504 -178.134 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.626 HG12 HG21 ' A' ' 234' ' ' VAL . 3.4 mp -103.92 136.24 37.97 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.415 0 CA-C-O 121.242 0.544 . . . . 73.42 110.422 -178.431 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -127.87 167.52 16.46 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 107.8 -1.185 . . . . 63.25 107.8 -177.478 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 197' ' ' ILE . . . . . 0.492 ' HB ' ' HA ' ' A' ' 214' ' ' VAL . 46.1 mm -75.4 131.19 35.4 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 N-CA-C 107.44 -1.319 . . . . 74.54 107.44 175.024 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 198' ' ' SER . . . . . 0.439 ' HB3' ' HB3' ' A' ' 177' ' ' ARG . 86.4 p -99.37 -33.32 10.75 Favored 'General case' 0 C--N 1.29 -1.986 0 O-C-N 121.53 -0.731 . . . . 54.11 111.356 -175.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 10.8 ttp180 -167.22 143.61 4.35 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.822 -0.626 . . . . 75.1 110.65 -175.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.442 HD11 ' O ' ' A' ' 212' ' ' LEU . 73.3 mt -101.87 146.7 27.45 Favored 'General case' 0 CA--C 1.494 -1.187 0 CA-C-N 116.168 -0.469 . . . . 74.41 109.796 174.052 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 201' ' ' VAL . . . . . 0.52 ' HB ' ' HA2' ' A' ' 173' ' ' GLY . 21.7 t -114.35 115.25 44.98 Favored Pre-proline 0 C--N 1.289 -2.058 0 N-CA-C 106.329 -1.73 . . . . 71.24 106.329 172.824 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 202' ' ' PRO . . . . . 0.449 ' HA ' ' HG2' ' A' ' 207' ' ' GLU . 31.3 Cg_exo -58.78 147.25 89.33 Favored 'Trans proline' 0 N--CA 1.444 -1.42 0 C-N-CA 121.95 1.766 . . . . 65.33 111.082 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 94.48 -23.24 33.07 Favored Glycine 0 C--N 1.305 -1.159 0 N-CA-C 110.794 -0.922 . . . . 54.14 110.794 -176.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 204' ' ' GLY . . . . . 0.547 ' HA3' ' HA3' ' A' ' 173' ' ' GLY . . . -83.48 163.53 40.87 Favored Glycine 0 N--CA 1.43 -1.701 0 N-CA-C 110.526 -1.029 . . . . 71.54 110.526 177.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.498 HD22 ' H ' ' A' ' 205' ' ' LEU . 2.8 mm? -55.16 -42.62 73.36 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 123.842 0.857 . . . . 72.51 112.42 -175.047 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -59.17 -48.13 82.76 Favored 'General case' 0 C--O 1.244 0.764 0 N-CA-C 112.306 0.484 . . . . 74.12 112.306 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.449 ' HG2' ' HA ' ' A' ' 202' ' ' PRO . 8.3 tp10 -75.41 -33.4 60.95 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.958 -0.386 . . . . 65.53 109.958 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 35.5 t -57.66 -44.75 85.93 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 116.214 -0.448 . . . . 73.35 110.734 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 209' ' ' THR . . . . . 0.629 HG23 ' H ' ' A' ' 211' ' ' LEU . 8.9 t -77.0 -31.87 56.77 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 119.679 -0.808 . . . . 73.02 109.537 176.712 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 70.13 19.9 76.04 Favored Glycine 0 N--CA 1.447 -0.61 0 CA-C-N 115.938 -0.574 . . . . 64.11 112.694 178.569 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.629 ' H ' HG23 ' A' ' 209' ' ' THR . 1.4 pp -105.65 -0.52 25.53 Favored 'General case' 0 N--CA 1.432 -1.336 0 CA-C-O 121.072 0.463 . . . . 71.51 111.407 -178.498 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.442 ' O ' HD11 ' A' ' 200' ' ' LEU . 60.7 mt -109.32 133.78 52.62 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.384 -0.826 . . . . 74.15 109.226 176.369 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -131.87 165.51 23.7 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.763 -0.828 . . . . 73.12 108.763 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 214' ' ' VAL . . . . . 0.492 ' HA ' ' HB ' ' A' ' 197' ' ' ILE . 33.4 m -64.28 -29.48 47.47 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 N-CA-C 113.914 1.079 . . . . 63.4 113.914 -177.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -74.44 -14.63 60.87 Favored 'General case' 0 C--N 1.308 -1.228 0 O-C-N 121.855 -0.528 . . . . 74.42 111.729 -178.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.414 ' HB3' ' HB ' ' A' ' 249' ' ' VAL . 54.3 m-20 -69.83 130.97 43.73 Favored 'General case' 0 C--O 1.245 0.867 0 CA-C-O 121.233 0.54 . . . . 53.3 112.237 -176.614 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -101.19 135.08 43.25 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.952 -1.022 . . . . 71.4 109.659 -178.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.534 HG23 HG23 ' A' ' 247' ' ' ILE . 10.6 p -82.12 131.36 34.0 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.152 0 CA-C-O 121.749 0.785 . . . . 51.14 111.375 -176.703 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.735 HG13 ' NE2' ' A' ' 158' ' ' HIS . 36.8 mm -100.87 -52.71 8.34 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 CA-C-N 115.318 -0.855 . . . . 63.33 111.409 -179.157 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -154.68 152.8 30.37 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 116.449 -0.341 . . . . 65.3 110.146 -178.288 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.507 ' HA ' ' O ' ' A' ' 246' ' ' ILE . 10.7 p -125.27 125.51 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.644 0 N-CA-C 108.956 -0.757 . . . . 74.42 108.956 177.805 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 222' ' ' ASN . . . . . 0.4 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 2.9 m-20 57.1 22.72 7.72 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.592 1.157 . . . . 53.02 112.945 -177.381 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 100.34 -11.46 59.97 Favored Glycine 0 C--N 1.309 -0.954 0 C-N-CA 120.912 -0.661 . . . . 75.22 112.348 179.535 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 64.2 mt -98.7 123.53 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.284 0 N-CA-C 109.361 -0.607 . . . . 64.12 109.361 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -60.52 140.24 57.4 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 121.796 0.808 . . . . 73.04 112.216 -177.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 226' ' ' VAL . . . . . 0.517 ' HB ' HG12 ' A' ' 234' ' ' VAL . 25.6 m -120.61 0.44 7.41 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 CA-C-N 115.083 -0.962 . . . . 55.15 109.561 175.656 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -78.35 98.26 5.91 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 115.323 -0.853 . . . . 72.01 109.649 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 120.32 -19.95 9.13 Favored Glycine 0 C--N 1.308 -0.975 0 N-CA-C 110.691 -0.964 . . . . 51.55 110.691 -178.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -72.49 164.78 25.85 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.61 -0.515 . . . . 73.13 109.61 177.172 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 230' ' ' THR . . . . . 0.464 ' O ' HG13 ' A' ' 234' ' ' VAL . 67.2 p -84.86 168.61 14.92 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 108.734 -0.839 . . . . 63.24 108.734 178.683 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 231' ' ' LEU . . . . . 0.404 ' HA ' HG22 ' A' ' 234' ' ' VAL . 53.3 tp -63.43 -31.95 73.25 Favored 'General case' 0 N--CA 1.424 -1.745 0 N-CA-C 109.541 -0.54 . . . . 75.31 109.541 177.602 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -64.46 -50.94 65.51 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.472 -0.566 . . . . 75.3 109.472 176.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 233' ' ' GLN . . . . . 0.464 ' O ' ' HG2' ' A' ' 237' ' ' MET . 1.1 mp0 -58.49 -43.77 89.16 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 113.297 0.851 . . . . 74.13 113.297 177.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.626 HG21 HG12 ' A' ' 195' ' ' ILE . 7.2 m -72.06 -34.79 51.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 C-N-CA 119.796 -0.762 . . . . 74.22 111.811 -176.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 235' ' ' THR . . . . . 0.442 ' O ' HG23 ' A' ' 239' ' ' VAL . 42.8 m -69.6 -36.36 76.13 Favored 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 109.224 -0.658 . . . . 70.32 109.224 179.447 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -59.84 -37.74 80.11 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-N 116.11 -0.496 . . . . 75.41 110.049 176.613 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 237' ' ' MET . . . . . 0.464 ' HG2' ' O ' ' A' ' 233' ' ' GLN . 16.8 mmt -58.96 -52.13 67.1 Favored 'General case' 0 C--O 1.2 -1.523 0 N-CA-C 108.451 -0.944 . . . . 73.14 108.451 176.504 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 238' ' ' MET . . . . . 0.412 ' HG3' ' O ' ' A' ' 234' ' ' VAL . 58.1 mtt -62.82 -33.11 74.54 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.996 -1.002 . . . . 72.45 112.201 -175.59 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 235' ' ' THR . 75.6 t -68.29 -41.31 83.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-O 121.328 0.585 . . . . 51.32 109.902 175.588 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -72.32 -38.84 68.58 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.438 -0.801 . . . . 73.33 110.664 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -84.03 21.47 1.34 Allowed 'General case' 0 C--O 1.198 -1.613 0 CA-C-N 115.399 -0.819 . . . . 73.31 111.742 -177.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 242' ' ' SER . . . . . 0.487 ' O ' HD12 ' A' ' 164' ' ' LEU . 14.8 p -64.36 -22.54 66.99 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-O 121.121 0.486 . . . . 62.1 111.559 176.519 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 26.7 m -68.84 -27.13 65.56 Favored 'General case' 0 CA--C 1.557 1.24 0 CA-C-N 116.318 -0.401 . . . . 73.43 110.914 176.231 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -174.44 103.16 0.1 Allowed 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.794 1.237 . . . . 63.45 108.98 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.491 ' CD2' HG13 ' A' ' 247' ' ' ILE . 1.0 OUTLIER -90.49 103.51 16.19 Favored 'General case' 0 C--O 1.201 -1.456 0 N-CA-C 109.634 -0.506 . . . . 73.12 109.634 -173.923 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.507 ' O ' ' HA ' ' A' ' 221' ' ' VAL . 63.9 mt -105.02 115.42 46.87 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 O-C-N 121.445 -0.785 . . . . 64.33 109.255 178.334 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 247' ' ' ILE . . . . . 0.534 HG23 HG23 ' A' ' 218' ' ' VAL . 18.8 mt -119.31 133.43 66.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 113.375 0.88 . . . . 54.31 113.375 -179.314 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.548 ' HA ' ' O ' ' A' ' 159' ' ' ARG . 61.2 m -103.11 121.27 42.27 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 107.65 -1.241 . . . . 74.24 107.65 173.337 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.498 HG12 ' HA ' ' A' ' 218' ' ' VAL . 17.1 m -122.81 163.83 20.97 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.061 0 CA-C-O 121.106 0.479 . . . . 75.44 110.523 175.376 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 250' ' ' LYS . . . . . 0.405 ' CD ' HD11 ' A' ' 219' ' ' ILE . 19.4 ptmt -134.29 128.9 19.55 Favored Pre-proline 0 N--CA 1.416 -2.156 0 CA-C-N 114.469 -1.241 . . . . 74.01 107.745 173.597 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo . . . . . 0 C--N 1.307 -1.618 0 C-N-CA 121.255 1.303 . . . . 74.3 112.386 178.266 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.499 ' ND1' ' HB3' ' A' ' 250' ' ' LYS . 0.6 OUTLIER . . . . . 0 C--O 1.244 0.775 0 N-CA-C 110.305 -0.258 . . . . 74.05 110.305 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.456 ' O ' ' HA ' ' A' ' 248' ' ' THR . 28.7 tpt180 -143.47 133.59 24.33 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 109.409 -0.589 . . . . 72.45 109.409 172.852 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 32.0 ptt180 -113.36 124.65 52.96 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 116.044 -0.525 . . . . 63.53 109.945 177.396 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.554 ' O ' ' HA ' ' A' ' 246' ' ' ILE . 17.4 m -127.0 139.25 52.45 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 CA-C-N 116.015 -0.539 . . . . 65.45 112.218 -176.575 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.608 ' HG2' HG12 ' A' ' 246' ' ' ILE . 95.6 mtt180 -87.95 112.57 22.71 Favored 'General case' 0 C--O 1.242 0.661 0 N-CA-C 108.264 -1.013 . . . . 62.24 108.264 176.192 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.539 ' HB2' ' HB3' ' A' ' 245' ' ' LEU . 33.5 mt -92.87 125.75 37.63 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 107.372 -1.344 . . . . 63.32 107.372 176.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.446 HD13 ' O ' ' A' ' 242' ' ' SER . 5.8 tt . . . . . 0 C--N 1.312 -1.038 0 O-C-N 124.664 1.227 . . . . 71.11 110.468 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.47 ' HG ' ' CD1' ' A' ' 245' ' ' LEU . 3.3 mm? . . . . . 0 C--O 1.235 0.336 0 N-CA-C 112.842 0.682 . . . . 62.35 112.842 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 96.17 47.43 2.42 Favored Glycine 0 N--CA 1.439 -1.131 0 C-N-CA 119.77 -1.205 . . . . 31.12 114.205 174.615 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -159.51 154.51 24.89 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.774 -0.824 . . . . 74.25 108.774 174.467 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -123.4 143.89 49.84 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 109.071 -0.714 . . . . 51.51 109.071 177.299 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.651 HD13 ' H ' ' A' ' 176' ' ' ILE . 0.2 OUTLIER -117.31 169.61 7.57 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.77 0 CA-C-N 115.379 -0.828 . . . . 75.23 109.608 -179.622 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.542 ' CG ' ' HB2' ' A' ' 198' ' ' SER . 19.2 ptt180 -144.66 155.24 43.5 Favored 'General case' 0 C--N 1.269 -2.914 0 C-N-CA 124.057 0.943 . . . . 75.11 109.724 -175.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -115.15 145.75 42.06 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-O 121.235 0.54 . . . . 75.33 110.323 -178.251 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -157.62 171.46 34.79 Favored Glycine 0 N--CA 1.42 -2.372 0 N-CA-C 108.414 -1.874 . . . . 33.01 108.414 176.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' THR . . . . . 0.411 ' CG2' ' HG2' ' A' ' 191' ' ' LYS . 0.3 OUTLIER -86.62 123.09 31.42 Favored 'General case' 0 C--N 1.294 -1.83 0 C-N-CA 118.174 -1.41 . . . . 60.23 107.425 178.503 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 181' ' ' SER . . . . . 0.497 ' O ' ' HA ' ' A' ' 191' ' ' LYS . 37.8 t . . . . . 0 C--N 1.273 -2.747 0 N-CA-C 108.476 -0.935 . . . . 65.21 108.476 -178.258 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.497 ' HA ' ' O ' ' A' ' 181' ' ' SER . 31.2 ttmt . . . . . 0 N--CA 1.424 -1.747 0 N-CA-C 107.275 -1.38 . . . . 74.52 107.275 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 192' ' ' GLN . . . . . 0.417 ' HB2' ' HD2' ' A' ' 193' ' ' PRO . 13.5 pt20 -152.02 165.4 17.54 Favored Pre-proline 0 C--N 1.287 -2.11 0 N-CA-C 108.068 -1.086 . . . . 73.41 108.068 -169.43 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 193' ' ' PRO . . . . . 0.417 ' HD2' ' HB2' ' A' ' 192' ' ' GLN . 9.8 Cg_endo -55.68 131.58 46.97 Favored 'Trans proline' 0 C--O 1.251 1.154 0 C-N-CA 120.942 1.095 . . . . 74.23 110.516 176.491 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -143.4 141.92 10.86 Favored Glycine 0 N--CA 1.413 -2.857 0 N-CA-C 109.319 -1.512 . . . . 32.01 109.319 -178.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.679 HG12 HG21 ' A' ' 234' ' ' VAL . 2.8 mp -109.38 133.73 53.66 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.435 0 CA-C-O 121.481 0.657 . . . . 74.13 111.608 -176.587 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -123.28 167.07 14.23 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.93 -1.137 . . . . 75.13 107.93 -177.184 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 197' ' ' ILE . . . . . 0.432 ' HB ' ' HA ' ' A' ' 214' ' ' VAL . 45.6 mm -79.58 131.97 33.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 108.947 -0.76 . . . . 72.41 108.947 177.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 198' ' ' SER . . . . . 0.542 ' HB2' ' CG ' ' A' ' 177' ' ' ARG . 14.4 t -106.55 -31.53 8.47 Favored 'General case' 0 C--N 1.295 -1.781 0 O-C-N 121.734 -0.604 . . . . 75.25 112.415 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -164.85 144.31 7.04 Favored 'General case' 0 C--N 1.313 -0.979 0 C-N-CA 120.986 -0.286 . . . . 72.04 110.643 -176.01 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 81.4 mt -107.74 134.48 50.64 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.849 -1.167 . . . . 74.44 107.849 172.354 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 60.2 t -92.93 114.89 63.91 Favored Pre-proline 0 C--N 1.29 -2.018 0 N-CA-C 105.744 -1.947 . . . . 65.25 105.744 172.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -61.06 137.19 70.13 Favored 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 121.8 1.667 . . . . 75.13 110.378 -177.419 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 98.77 -21.38 46.24 Favored Glycine 0 C--N 1.303 -1.271 0 C-N-CA 120.513 -0.851 . . . . 70.42 111.109 -177.195 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -76.06 175.32 52.48 Favored Glycine 0 N--CA 1.44 -1.064 0 C-N-CA 121.349 -0.453 . . . . 74.44 112.492 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -67.22 -30.79 70.81 Favored 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 123.743 0.817 . . . . 64.45 111.249 -177.209 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -68.68 -41.31 79.4 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.461 0.648 . . . . 75.4 109.783 178.052 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -68.17 -32.78 73.27 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.473 -0.785 . . . . 71.22 109.35 177.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 49.3 m -56.5 -40.96 75.84 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 116.058 -0.519 . . . . 73.24 111.581 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 7.2 t -84.87 -41.21 16.23 Favored 'General case' 0 N--CA 1.44 -0.941 0 C-N-CA 119.178 -1.009 . . . . 53.54 110.514 177.323 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 67.18 6.69 40.69 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 121.325 -0.464 . . . . 73.34 113.442 179.386 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 76.9 mt -84.07 -9.48 58.59 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-O 121.175 0.512 . . . . 62.12 111.089 -178.52 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.524 ' H ' HD23 ' A' ' 212' ' ' LEU . 2.2 pt? -112.48 136.55 51.85 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-N 115.662 -0.699 . . . . 72.22 109.373 175.709 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -130.69 166.84 19.85 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.423 -0.954 . . . . 60.32 108.423 -178.364 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 214' ' ' VAL . . . . . 0.432 ' HA ' ' HB ' ' A' ' 197' ' ' ILE . 16.5 m -56.42 -30.38 30.79 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 N-CA-C 113.486 0.921 . . . . 73.22 113.486 -176.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 -79.38 -15.0 58.59 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 121.75 -0.594 . . . . 73.24 111.688 -179.405 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.514 ' HB3' ' HB ' ' A' ' 249' ' ' VAL . 1.5 m-20 -71.78 139.74 49.15 Favored 'General case' 0 C--O 1.248 0.974 0 CA-C-O 121.439 0.637 . . . . 62.14 111.92 -178.515 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 57.0 tt0 -101.46 138.54 38.33 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.973 -1.012 . . . . 53.42 111.266 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.549 ' HA ' HG12 ' A' ' 249' ' ' VAL . 35.4 t -83.54 124.44 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 CA-C-O 121.77 0.795 . . . . 75.04 110.133 -178.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.438 HD11 ' CD ' ' A' ' 250' ' ' LYS . 35.5 mm -93.64 -51.88 10.53 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 CA-C-N 115.044 -0.98 . . . . 74.44 111.121 -179.376 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -154.26 158.33 40.05 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 116.214 -0.448 . . . . 55.12 110.458 -177.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 12.5 p -127.69 120.26 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.663 0 CA-C-N 115.595 -0.73 . . . . 75.42 109.411 179.275 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 222' ' ' ASN . . . . . 0.466 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 12.0 t-20 68.28 4.23 4.08 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 126.329 1.851 . . . . 71.14 110.98 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 117.57 -15.45 12.83 Favored Glycine 0 N--CA 1.44 -1.078 0 N-CA-C 110.892 -0.883 . . . . 74.42 110.892 -177.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 65.4 mt -94.75 124.44 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 CA-C-O 121.132 0.492 . . . . 74.34 110.026 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -55.37 137.08 48.71 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 124.914 1.286 . . . . 71.2 112.425 -179.363 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 226' ' ' VAL . . . . . 0.411 HG21 HG12 ' A' ' 218' ' ' VAL . 35.8 m -105.98 8.79 9.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 CA-C-O 121.801 0.81 . . . . 72.41 109.981 175.525 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -74.72 99.9 3.84 Favored 'General case' 0 N--CA 1.431 -1.398 0 CA-C-N 114.813 -1.085 . . . . 54.51 110.125 178.418 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 112.41 -8.63 26.49 Favored Glycine 0 CA--C 1.495 -1.171 0 N-CA-C 110.378 -1.089 . . . . 41.44 110.378 178.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -83.06 153.08 25.08 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 107.954 -1.128 . . . . 71.02 107.954 176.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 74.4 p -91.79 175.73 6.78 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 108.168 -1.049 . . . . 53.41 108.168 179.053 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 231' ' ' LEU . . . . . 0.461 ' HA ' HG22 ' A' ' 234' ' ' VAL . 2.8 tm? -65.06 -37.03 86.21 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 107.818 -1.178 . . . . 72.03 107.818 178.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -55.69 -51.82 65.96 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.016 -0.993 . . . . 45.43 109.395 177.201 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 233' ' ' GLN . . . . . 0.64 ' O ' ' HG3' ' A' ' 237' ' ' MET . 1.4 mp0 -66.84 -50.7 61.72 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 113.798 1.036 . . . . 64.53 113.798 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.679 HG21 HG12 ' A' ' 195' ' ' ILE . 26.7 m -58.89 -33.51 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 N-CA-C 112.588 0.588 . . . . 74.14 112.588 -174.642 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 235' ' ' THR . . . . . 0.421 ' O ' HG23 ' A' ' 239' ' ' VAL . 91.3 m -72.77 -35.56 67.47 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 115.232 -0.895 . . . . 75.3 109.332 -175.653 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -69.02 -30.77 69.21 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.298 -0.864 . . . . 72.43 108.994 178.317 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 237' ' ' MET . . . . . 0.64 ' HG3' ' O ' ' A' ' 233' ' ' GLN . 19.3 mtp -69.49 -47.25 64.49 Favored 'General case' 0 C--O 1.209 -1.067 0 N-CA-C 106.931 -1.507 . . . . 61.25 106.931 178.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 238' ' ' MET . . . . . 0.542 ' HG3' ' O ' ' A' ' 234' ' ' VAL . 65.3 mtt -59.55 -45.29 92.24 Favored 'General case' 0 C--O 1.22 -0.489 0 CA-C-N 115.42 -0.809 . . . . 72.41 112.186 -179.493 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 235' ' ' THR . 89.3 t -64.42 -38.26 82.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.161 0.505 . . . . 63.32 110.533 178.456 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -68.89 -36.13 77.7 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.383 0.611 . . . . 74.32 110.318 178.306 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -86.51 19.43 2.83 Favored 'General case' 0 C--O 1.199 -1.583 0 CA-C-N 115.472 -0.785 . . . . 61.34 111.906 179.133 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 242' ' ' SER . . . . . 0.446 ' O ' HD13 ' A' ' 164' ' ' LEU . 30.4 p -61.26 -23.7 65.85 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 112.776 0.658 . . . . 74.14 112.776 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 25.4 p -74.8 -16.78 60.69 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 112.12 0.415 . . . . 72.14 112.12 178.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -175.29 88.24 0.04 OUTLIER 'General case' 0 C--O 1.257 1.451 0 N-CA-C 107.787 -1.19 . . . . 75.44 107.787 -179.057 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.539 ' HB3' ' HB2' ' A' ' 163' ' ' LEU . 2.8 tt -92.15 102.11 14.63 Favored 'General case' 0 N--CA 1.416 -2.138 0 C-N-CA 118.923 -1.111 . . . . 64.34 109.268 -174.225 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.608 HG12 ' HG2' ' A' ' 162' ' ' ARG . 89.1 mt -97.81 116.4 40.3 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.98 0 C-N-CA 120.134 -0.627 . . . . 71.42 109.971 178.116 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 247' ' ' ILE . . . . . 0.492 HG13 ' CD2' ' A' ' 245' ' ' LEU . 14.6 mt -117.99 134.63 60.99 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.84 0 CA-C-O 121.433 0.635 . . . . 73.11 111.403 176.761 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.456 ' HA ' ' O ' ' A' ' 159' ' ' ARG . 63.8 m -103.1 114.87 29.51 Favored 'General case' 0 N--CA 1.409 -2.5 0 CA-C-N 114.52 -1.218 . . . . 23.42 108.072 175.536 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.549 HG12 ' HA ' ' A' ' 218' ' ' VAL . 17.4 m -118.89 159.91 19.11 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.165 0 CA-C-O 121.46 0.648 . . . . 41.24 110.754 177.12 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 250' ' ' LYS . . . . . 0.499 ' HB3' ' ND1' ' A' ' 158' ' ' HIS . 10.0 ptmt -127.69 128.84 23.86 Favored Pre-proline 0 C--N 1.272 -2.798 0 CA-C-N 114.291 -1.322 . . . . 74.33 109.161 177.861 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo . . . . . 0 N--CA 1.439 -1.683 0 C-N-CA 121.827 1.685 . . . . 63.1 110.5 178.809 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.499 -0.992 0 N-CA-C 109.815 -0.439 . . . . 75.03 109.815 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.543 ' O ' ' HA ' ' A' ' 248' ' ' THR . 2.1 tpm_? -140.18 140.36 35.9 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.619 -1.252 . . . . 74.41 107.619 177.101 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.583 ' HB3' ' OG1' ' A' ' 248' ' ' THR . 23.2 ptt180 -132.47 113.03 12.63 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 122.098 0.951 . . . . 75.41 113.067 178.578 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.63 ' O ' ' HA ' ' A' ' 246' ' ' ILE . 21.1 m -105.17 139.29 26.67 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 CA-C-N 113.929 -1.487 . . . . 45.21 113.014 -175.181 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.546 ' HG3' HG12 ' A' ' 246' ' ' ILE . 7.3 mpt_? -91.13 112.6 24.57 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 106.995 -1.483 . . . . 74.24 106.995 175.573 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.513 ' HB2' ' HB3' ' A' ' 245' ' ' LEU . 35.4 mt -100.23 135.49 41.58 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 108.49 -0.929 . . . . 62.11 108.49 179.505 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.466 HD23 ' O ' ' A' ' 242' ' ' SER . 8.1 tp . . . . . 0 N--CA 1.417 -2.102 0 C-N-CA 124.499 1.12 . . . . 54.21 110.567 175.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.472 ' HG ' ' CD1' ' A' ' 245' ' ' LEU . 3.3 mm? . . . . . 0 N--CA 1.445 -0.706 0 CA-C-O 120.916 0.388 . . . . 55.51 111.358 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' GLY . . . . . 0.439 ' HA3' ' HA3' ' A' ' 204' ' ' GLY . . . 93.28 35.49 6.26 Favored Glycine 0 N--CA 1.437 -1.247 0 C-N-CA 120.419 -0.896 . . . . 62.44 113.704 175.594 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -151.45 158.89 44.26 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.415 -0.958 . . . . 74.25 108.415 174.709 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -125.36 156.83 38.12 Favored 'General case' 0 C--N 1.284 -2.243 0 N-CA-C 108.761 -0.829 . . . . 72.45 108.761 175.588 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.59 HD13 ' H ' ' A' ' 176' ' ' ILE . 0.2 OUTLIER -124.96 166.64 20.24 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 CA-C-O 121.441 0.639 . . . . 61.21 110.421 -179.922 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.431 ' HG2' ' HB3' ' A' ' 198' ' ' SER . 14.7 ptt180 -144.78 154.76 43.04 Favored 'General case' 0 C--N 1.28 -2.438 0 CA-C-N 114.699 -1.137 . . . . 72.44 110.154 -176.506 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 178' ' ' ASP . . . . . 0.406 ' HB2' ' HB2' ' A' ' 231' ' ' LEU . 11.2 t70 -112.98 145.39 40.9 Favored 'General case' 0 C--N 1.294 -1.822 0 C-N-CA 123.648 0.779 . . . . 73.44 110.094 -177.714 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -162.98 179.13 38.42 Favored Glycine 0 C--N 1.294 -1.797 0 N-CA-C 109.048 -1.621 . . . . 42.24 109.048 175.431 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 2.1 p -96.99 123.4 40.7 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-N 118.19 0.995 . . . . 75.12 111.154 174.662 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' SER . . . . . 0.53 ' O ' ' HA ' ' A' ' 191' ' ' LYS . 24.5 t . . . . . 0 C--N 1.291 -1.944 0 N-CA-C 107.684 -1.228 . . . . 71.22 107.684 177.309 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.53 ' HA ' ' O ' ' A' ' 181' ' ' SER . 43.8 mtmt . . . . . 0 CA--C 1.488 -1.423 0 CA-C-O 122.405 1.098 . . . . 70.42 112.402 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -132.08 163.47 49.93 Favored Pre-proline 0 C--N 1.259 -3.327 0 N-CA-C 105.184 -2.154 . . . . 63.4 105.184 176.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -66.48 131.07 25.22 Favored 'Trans proline' 0 N--CA 1.423 -2.666 0 N-CA-C 106.872 -2.011 . . . . 73.13 106.872 169.528 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -125.89 127.83 6.27 Favored Glycine 0 N--CA 1.397 -3.965 0 N-CA-C 109.499 -1.441 . . . . 41.43 109.499 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.623 HG12 HG21 ' A' ' 234' ' ' VAL . 3.4 mp -103.68 132.78 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.049 0 N-CA-C 109.084 -0.71 . . . . 75.0 109.084 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -125.6 167.38 15.16 Favored 'General case' 0 C--N 1.281 -2.405 0 N-CA-C 107.366 -1.346 . . . . 71.14 107.366 -176.431 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 47.5 mm -77.82 132.29 32.88 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 N-CA-C 107.021 -1.474 . . . . 73.11 107.021 175.203 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 198' ' ' SER . . . . . 0.431 ' HB3' ' HG2' ' A' ' 177' ' ' ARG . 83.4 p -100.47 -35.29 9.6 Favored 'General case' 0 C--N 1.28 -2.43 0 C-N-CA 118.806 -1.158 . . . . 74.21 111.053 -178.255 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 65.9 ttt180 -158.13 147.3 19.43 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.296 -0.411 . . . . 73.25 110.44 -176.626 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 71.0 mt -106.66 138.39 42.93 Favored 'General case' 0 CA--C 1.483 -1.609 0 N-CA-C 108.554 -0.906 . . . . 71.1 108.554 171.65 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 58.9 t -98.89 114.99 65.99 Favored Pre-proline 0 N--CA 1.415 -2.211 0 N-CA-C 106.377 -1.712 . . . . 75.32 106.377 172.341 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 202' ' ' PRO . . . . . 0.527 ' HA ' ' HG2' ' A' ' 207' ' ' GLU . 37.0 Cg_exo -58.73 126.8 22.28 Favored 'Trans proline' 0 N--CA 1.448 -1.149 0 C-N-CA 121.934 1.756 . . . . 61.12 110.65 -178.267 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 106.24 -16.3 42.1 Favored Glycine 0 N--CA 1.438 -1.2 0 C-N-CA 120.332 -0.937 . . . . 63.03 112.403 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 204' ' ' GLY . . . . . 0.439 ' HA3' ' HA3' ' A' ' 173' ' ' GLY . . . -81.01 -179.23 52.97 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.811 -0.709 . . . . 15.21 111.898 178.597 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.453 HD23 ' HA ' ' A' ' 172' ' ' LEU . 3.4 mm? -62.74 -42.85 99.87 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 123.1 0.56 . . . . 71.5 111.548 -177.273 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -60.96 -38.66 86.71 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.139 -0.482 . . . . 71.32 111.335 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.527 ' HG2' ' HA ' ' A' ' 202' ' ' PRO . 9.3 tp10 -75.51 -36.9 60.44 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.505 -0.554 . . . . 72.02 109.505 178.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 24.7 t -60.18 -45.98 91.25 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 115.915 -0.584 . . . . 50.23 110.444 -179.211 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 209' ' ' THR . . . . . 0.46 HG23 ' H ' ' A' ' 211' ' ' LEU . 8.9 t -72.89 -40.33 65.65 Favored 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 120.311 -0.556 . . . . 72.44 110.037 176.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 73.16 9.32 76.49 Favored Glycine 0 N--CA 1.441 -0.998 0 CA-C-N 115.852 -0.613 . . . . 62.51 112.561 179.405 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.46 ' H ' HG23 ' A' ' 209' ' ' THR . 48.6 mt -97.25 1.97 50.28 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.542 0.687 . . . . 64.22 109.685 -179.004 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 87.6 mt -112.83 132.43 55.28 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 114.744 -1.116 . . . . 72.42 109.09 174.126 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -131.45 160.65 34.52 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 122.817 0.447 . . . . 71.2 109.889 176.456 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 32.8 m -62.22 -30.26 48.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 122.034 0.921 . . . . 74.33 112.922 -178.525 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -81.0 -14.07 58.28 Favored 'General case' 0 C--N 1.275 -2.641 0 CA-C-N 116.04 -0.527 . . . . 64.15 111.777 -175.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.475 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 72.0 m-20 -71.71 151.47 43.58 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 113.599 0.963 . . . . 74.52 113.599 -175.06 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -111.64 129.78 55.98 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.122 1.369 . . . . 72.44 109.955 -176.617 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.493 ' HA ' HG12 ' A' ' 249' ' ' VAL . 41.6 t -82.24 138.88 18.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 CA-C-O 121.488 0.661 . . . . 60.12 111.949 -175.391 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.481 HD11 ' CD ' ' A' ' 250' ' ' LYS . 47.4 mm -108.66 -51.76 6.82 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 C-N-CA 123.935 0.894 . . . . 71.2 111.631 -178.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.419 ' HB3' ' HA ' ' A' ' 225' ' ' GLU . 10.7 pt-20 -151.87 161.38 42.74 Favored 'General case' 0 C--O 1.244 0.808 0 CA-C-O 120.522 0.201 . . . . 60.41 110.663 -178.423 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.416 HG11 ' HB2' ' A' ' 237' ' ' MET . 15.0 p -129.93 119.47 47.32 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.075 0 CA-C-O 121.449 0.642 . . . . 72.42 109.556 177.574 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 222' ' ' ASN . . . . . 0.511 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 13.7 t-20 70.23 0.02 2.99 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 125.859 1.663 . . . . 74.13 111.858 177.776 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 121.87 -13.8 9.15 Favored Glycine 0 N--CA 1.435 -1.369 0 N-CA-C 110.955 -0.858 . . . . 65.43 110.955 -177.274 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 66.6 mt -95.8 123.66 48.1 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 N-CA-C 108.725 -0.843 . . . . 71.21 108.725 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 225' ' ' GLU . . . . . 0.419 ' HA ' ' HB3' ' A' ' 220' ' ' GLU . 13.0 pt-20 -55.76 147.65 18.32 Favored 'General case' 0 C--N 1.31 -1.138 0 O-C-N 123.912 0.758 . . . . 64.2 111.145 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 226' ' ' VAL . . . . . 0.472 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 33.5 m -120.5 -1.1 8.02 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 CA-C-O 121.472 0.653 . . . . 72.41 109.387 173.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -73.36 95.16 2.14 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-N 115.081 -0.963 . . . . 42.04 110.622 -178.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 127.43 -22.29 5.59 Favored Glycine 0 N--CA 1.429 -1.795 0 C-N-CA 120.432 -0.89 . . . . 44.22 110.939 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 55.9 mttm -83.78 164.93 19.25 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 109.996 -0.372 . . . . 53.22 109.996 177.603 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 230' ' ' THR . . . . . 0.41 ' O ' HG13 ' A' ' 234' ' ' VAL . 34.7 p -93.0 168.09 11.36 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 116.43 -0.35 . . . . 62.44 110.204 -177.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 231' ' ' LEU . . . . . 0.505 HD21 HG12 ' A' ' 176' ' ' ILE . 2.8 tm? -56.96 -41.94 79.24 Favored 'General case' 0 N--CA 1.44 -0.967 0 C-N-CA 123.083 0.553 . . . . 64.11 109.878 -178.68 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -56.43 -51.59 67.81 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.365 -0.379 . . . . 65.24 110.501 176.445 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -58.6 -49.75 76.32 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 115.229 -0.896 . . . . 72.22 112.362 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.623 HG21 HG12 ' A' ' 195' ' ' ILE . 15.1 m -69.45 -33.84 59.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 112.894 0.701 . . . . 74.22 112.894 -173.718 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 235' ' ' THR . . . . . 0.428 ' O ' HG23 ' A' ' 239' ' ' VAL . 84.4 m -73.42 -35.59 65.85 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 109.488 -0.56 . . . . 71.44 109.488 -174.081 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -63.39 -33.1 74.8 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.957 -0.757 . . . . 71.34 108.957 177.662 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 237' ' ' MET . . . . . 0.416 ' HB2' HG11 ' A' ' 221' ' ' VAL . 5.1 mtm -72.72 -38.98 67.29 Favored 'General case' 0 C--O 1.199 -1.555 0 CA-C-N 115.341 -0.845 . . . . 74.43 108.731 -179.124 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 238' ' ' MET . . . . . 0.449 ' HG3' ' O ' ' A' ' 234' ' ' VAL . 65.6 mtt -63.45 -37.96 89.3 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.285 -0.416 . . . . 75.22 110.815 179.113 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 235' ' ' THR . 66.4 t -69.69 -41.0 79.97 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 CA-C-N 116.334 -0.393 . . . . 63.13 110.149 177.318 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -66.39 -34.19 77.4 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.768 0.794 . . . . 55.22 110.372 177.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -86.41 20.51 2.4 Favored 'General case' 0 C--O 1.2 -1.545 0 CA-C-N 115.267 -0.879 . . . . 75.32 112.506 178.61 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 242' ' ' SER . . . . . 0.466 ' O ' HD23 ' A' ' 164' ' ' LEU . 67.4 m -64.88 -23.59 67.28 Favored 'General case' 0 C--O 1.212 -0.912 0 C-N-CA 120.172 -0.611 . . . . 74.01 112.545 178.427 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 12.4 p -65.3 -36.36 83.83 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 111.802 0.297 . . . . 75.31 111.802 176.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 46.2 m-80 -155.95 92.43 1.36 Allowed 'General case' 0 C--O 1.254 1.294 0 N-CA-C 107.301 -1.37 . . . . 72.14 107.301 177.102 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.513 ' HB3' ' HB2' ' A' ' 163' ' ' LEU . 2.8 tt -88.6 103.18 15.67 Favored 'General case' 0 N--CA 1.423 -1.817 0 C-N-CA 119.381 -0.927 . . . . 75.14 109.641 -174.833 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.63 ' HA ' ' O ' ' A' ' 161' ' ' VAL . 87.2 mt -102.58 116.59 46.55 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.992 0 C-N-CA 120.721 -0.392 . . . . 70.21 109.974 177.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 247' ' ' ILE . . . . . 0.486 HG13 ' CD2' ' A' ' 245' ' ' LEU . 25.5 mt -119.55 132.89 68.05 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.089 0 CA-C-O 121.146 0.498 . . . . 61.45 111.912 176.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.583 ' OG1' ' HB3' ' A' ' 160' ' ' ARG . 57.2 m -100.27 124.35 45.63 Favored 'General case' 0 N--CA 1.426 -1.648 0 N-CA-C 107.561 -1.274 . . . . 72.51 107.561 175.035 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.493 HG12 ' HA ' ' A' ' 218' ' ' VAL . 29.5 m -124.82 170.56 14.8 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 CA-C-O 121.579 0.704 . . . . 74.23 110.971 176.165 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 250' ' ' LYS . . . . . 0.481 ' CD ' HD11 ' A' ' 219' ' ' ILE 0.312 44.0 mtpt -125.0 134.78 26.02 Favored Pre-proline 0 C--N 1.28 -2.417 0 N-CA-C 106.146 -1.798 . . . . 73.43 106.146 173.971 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 251' ' ' PRO . . . . . 0.475 ' HA ' ' OD1' ' A' ' 216' ' ' ASP . 5.6 Cg_exo . . . . . 0 N--CA 1.402 -3.871 0 CA-C-N 119.73 0.939 . . . . 72.21 110.346 173.591 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.564 ' NE2' HG13 ' A' ' 219' ' ' ILE . 23.6 m80 . . . . . 0 N--CA 1.432 -1.355 0 N-CA-C 112.161 0.43 . . . . 73.4 112.161 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.548 ' O ' ' HA ' ' A' ' 248' ' ' THR . 12.8 tpt180 -131.22 143.39 50.54 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.34 -1.356 . . . . 71.42 107.34 173.696 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 30.4 ttt85 -120.09 113.24 20.19 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 121.233 0.539 . . . . 75.31 109.911 -178.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.535 ' O ' ' HA ' ' A' ' 246' ' ' ILE . 25.2 m -119.24 139.14 47.62 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 N-CA-C 112.501 0.556 . . . . 65.34 112.501 -175.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.451 ' HG3' HG12 ' A' ' 246' ' ' ILE . 3.3 mpt_? -100.1 112.93 25.23 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 107.086 -1.449 . . . . 73.45 107.086 177.45 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.412 ' HB2' ' HB3' ' A' ' 245' ' ' LEU . 23.9 mt -95.69 130.59 42.54 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 109.412 -0.588 . . . . 74.0 109.412 -178.317 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 6.1 tt . . . . . 0 C--N 1.33 -0.248 0 CA-C-O 122.333 1.063 . . . . 74.14 110.757 176.327 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.462 ' HG ' ' CD1' ' A' ' 245' ' ' LEU . 2.6 mm? . . . . . 0 C--O 1.239 0.545 0 CA-C-O 121.032 0.444 . . . . 61.31 111.912 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' GLY . . . . . 0.495 ' HA3' ' HA3' ' A' ' 204' ' ' GLY . . . 91.56 38.92 5.73 Favored Glycine 0 N--CA 1.429 -1.823 0 C-N-CA 120.71 -0.757 . . . . 73.25 114.155 172.13 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -152.76 153.45 33.22 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 109.245 -0.65 . . . . 73.41 109.245 174.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -114.56 140.22 48.95 Favored 'General case' 0 C--N 1.282 -2.341 0 CA-C-N 115.674 -0.694 . . . . 71.13 109.282 178.126 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.409 HD13 ' SD ' ' A' ' 238' ' ' MET . 29.1 pt -114.31 169.1 5.7 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.514 0 CA-C-N 115.446 -0.797 . . . . 73.43 109.885 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.501 ' HG2' ' HB2' ' A' ' 198' ' ' SER . 3.1 ptp180 -153.75 154.64 34.42 Favored 'General case' 0 C--N 1.278 -2.52 0 CA-C-N 115.541 -0.754 . . . . 73.14 108.97 -179.273 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 178' ' ' ASP . . . . . 0.401 ' OD1' HD12 ' A' ' 231' ' ' LEU . 6.9 p-10 -101.47 154.99 18.34 Favored 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 108.659 -0.867 . . . . 74.41 108.659 178.296 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -165.23 -168.61 27.66 Favored Glycine 0 N--CA 1.412 -2.95 0 N-CA-C 109.274 -1.531 . . . . 65.13 109.274 177.116 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' THR . . . . . 0.615 ' HB ' ' CG ' ' A' ' 191' ' ' LYS . 1.3 p -100.48 123.64 44.96 Favored 'General case' 0 C--N 1.28 -2.426 0 CA-C-O 121.876 0.846 . . . . 61.12 112.716 178.259 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 27.6 t . . . . . 0 N--CA 1.416 -2.127 0 N-CA-C 106.466 -1.679 . . . . 33.43 106.466 176.637 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.615 ' CG ' ' HB ' ' A' ' 180' ' ' THR . 36.7 ttmt . . . . . 0 N--CA 1.409 -2.478 0 N-CA-C 107.731 -1.211 . . . . 73.13 107.731 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 192' ' ' GLN . . . . . 0.42 ' HB2' ' HD2' ' A' ' 193' ' ' PRO . 13.4 pt20 -141.23 164.46 35.39 Favored Pre-proline 0 C--N 1.284 -2.281 0 N-CA-C 108.712 -0.847 . . . . 60.34 108.712 -174.765 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 193' ' ' PRO . . . . . 0.42 ' HD2' ' HB2' ' A' ' 192' ' ' GLN . 13.2 Cg_endo -57.52 132.21 49.14 Favored 'Trans proline' 0 N--CA 1.448 -1.153 0 C-N-CA 121.504 1.47 . . . . 73.04 111.638 176.562 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -141.03 146.33 17.52 Favored Glycine 0 N--CA 1.408 -3.191 0 N-CA-C 108.244 -1.942 . . . . 72.25 108.244 177.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.542 HG12 HG21 ' A' ' 234' ' ' VAL . 2.6 mp -104.32 133.03 49.52 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.413 0 C-N-CA 120.165 -0.614 . . . . 64.04 111.189 -178.405 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -122.96 167.49 13.52 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 108.085 -1.08 . . . . 74.53 108.085 -176.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 197' ' ' ILE . . . . . 0.403 ' CG2' ' HA ' ' A' ' 214' ' ' VAL . 41.3 mm -77.62 132.95 31.61 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 N-CA-C 108.527 -0.916 . . . . 73.24 108.527 177.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 198' ' ' SER . . . . . 0.501 ' HB2' ' HG2' ' A' ' 177' ' ' ARG . 11.1 t -104.14 -36.51 7.66 Favored 'General case' 0 C--N 1.275 -2.646 0 O-C-N 121.731 -0.605 . . . . 75.42 112.488 178.039 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 20.1 tpp180 -167.15 144.52 4.67 Favored 'General case' 0 C--O 1.213 -0.855 0 N-CA-C 110.136 -0.32 . . . . 71.25 110.136 -177.442 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 78.8 mt -101.89 145.43 29.23 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 108.514 -0.921 . . . . 73.33 108.514 171.471 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 61.9 t -105.19 114.0 63.98 Favored Pre-proline 0 N--CA 1.42 -1.971 0 N-CA-C 105.972 -1.862 . . . . 45.55 105.972 172.399 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 202' ' ' PRO . . . . . 0.47 ' HA ' ' HG3' ' A' ' 207' ' ' GLU . 27.7 Cg_exo -62.01 136.87 63.59 Favored 'Trans proline' 0 N--CA 1.446 -1.293 0 C-N-CA 121.802 1.668 . . . . 72.44 110.268 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 104.12 -26.34 23.32 Favored Glycine 0 C--N 1.298 -1.581 0 N-CA-C 110.087 -1.205 . . . . 75.21 110.087 -175.177 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 204' ' ' GLY . . . . . 0.495 ' HA3' ' HA3' ' A' ' 173' ' ' GLY . . . -79.72 162.74 47.34 Favored Glycine 0 N--CA 1.423 -2.198 0 N-CA-C 111.031 -0.828 . . . . 62.31 111.031 178.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.456 HD22 ' H ' ' A' ' 205' ' ' LEU . 2.6 mm? -62.94 -29.57 70.89 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.372 0.669 . . . . 74.52 111.847 -173.69 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -63.6 -46.94 83.5 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.19 0.519 . . . . 72.33 110.289 177.086 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.47 ' HG3' ' HA ' ' A' ' 202' ' ' PRO . 3.9 tm-20 -71.51 -33.65 69.4 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.26 -0.427 . . . . 55.23 109.929 178.799 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 50.5 m -56.39 -39.25 72.68 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.186 -0.461 . . . . 74.24 111.159 177.487 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 13.0 t -83.91 -40.57 18.4 Favored 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 119.197 -1.001 . . . . 65.0 109.832 176.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 65.71 2.5 11.82 Favored Glycine 0 C--N 1.343 0.966 0 N-CA-C 114.183 0.433 . . . . 62.53 114.183 177.139 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 60.9 mt -78.88 -12.3 60.03 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-O 120.969 0.414 . . . . 75.25 110.708 -177.413 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.535 ' H ' HD23 ' A' ' 212' ' ' LEU . 2.2 pt? -109.86 134.88 51.57 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.329 -0.989 . . . . 74.55 108.329 174.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -117.41 162.11 18.46 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 116.624 -0.262 . . . . 41.34 110.306 -178.541 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 214' ' ' VAL . . . . . 0.403 ' HA ' ' CG2' ' A' ' 197' ' ' ILE . 35.6 m -56.64 -31.52 34.87 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.77 0 N-CA-C 114.471 1.286 . . . . 64.05 114.471 -176.569 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -82.72 -14.26 54.88 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 112.773 0.657 . . . . 72.42 112.773 -178.2 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.53 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 54.3 m-20 -69.01 156.13 39.15 Favored 'General case' 0 C--O 1.246 0.904 0 N-CA-C 113.266 0.839 . . . . 55.33 113.266 -173.123 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -107.4 137.07 46.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.933 -1.03 . . . . 63.1 110.246 -179.225 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.599 ' HA ' HG12 ' A' ' 249' ' ' VAL . 30.9 t -84.53 125.74 40.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 121.464 0.649 . . . . 64.33 109.975 -179.32 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.564 HG13 ' NE2' ' A' ' 158' ' ' HIS . 40.1 mm -90.23 -49.99 13.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 CA-C-N 115.167 -0.924 . . . . 75.42 110.607 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.414 ' CB ' ' HA ' ' A' ' 225' ' ' GLU . 9.3 pt-20 -154.59 160.93 41.78 Favored 'General case' 0 C--O 1.249 1.062 0 CA-C-N 116.313 -0.403 . . . . 71.42 110.438 -179.592 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.484 HG22 HD22 ' A' ' 241' ' ' ASN . 8.4 p -121.49 113.57 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.215 0 CA-C-O 122.109 0.957 . . . . 75.42 108.968 174.606 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 222' ' ' ASN . . . . . 0.453 ' OD1' HD12 ' A' ' 246' ' ' ILE . 60.0 t30 40.74 68.37 0.42 Allowed 'General case' 0 C--N 1.28 -2.421 0 C-N-CA 127.103 2.161 . . . . 73.4 114.497 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 84.35 -20.85 11.92 Favored Glycine 0 N--CA 1.443 -0.848 0 CA-C-N 114.93 -1.032 . . . . 73.35 113.738 178.119 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 54.6 mt -105.92 123.41 60.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 117.034 0.417 . . . . 61.32 110.011 -176.189 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 225' ' ' GLU . . . . . 0.414 ' HA ' ' CB ' ' A' ' 220' ' ' GLU . 11.8 pt-20 -66.03 144.14 56.92 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.352 0.596 . . . . 55.34 111.564 -178.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 33.9 m -115.19 -2.24 10.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-N 115.923 -0.58 . . . . 75.51 111.186 178.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -73.92 98.88 3.11 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.933 -0.576 . . . . 74.31 110.058 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 120.59 -17.07 9.59 Favored Glycine 0 CA--C 1.498 -0.988 0 N-CA-C 111.45 -0.66 . . . . 71.42 111.45 179.111 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -78.98 162.87 25.66 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 108.737 -0.838 . . . . 64.45 108.737 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 230' ' ' THR . . . . . 0.409 ' O ' HG13 ' A' ' 234' ' ' VAL . 68.2 p -87.34 170.63 11.24 Favored 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 107.599 -1.26 . . . . 62.42 107.599 177.462 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 231' ' ' LEU . . . . . 0.401 HD12 ' OD1' ' A' ' 178' ' ' ASP . 0.7 OUTLIER -68.08 -34.46 76.45 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 107.347 -1.353 . . . . 74.11 107.347 179.976 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -58.54 -47.41 84.3 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-N 115.734 -0.666 . . . . 62.23 110.075 176.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -64.6 -49.05 72.63 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 113.902 1.075 . . . . 73.15 113.902 178.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.542 HG21 HG12 ' A' ' 195' ' ' ILE . 17.0 m -61.6 -33.47 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 112.581 0.585 . . . . 64.02 112.581 -176.399 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 235' ' ' THR . . . . . 0.49 ' O ' HG23 ' A' ' 239' ' ' VAL . 58.3 m -70.03 -35.84 74.61 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 115.803 -0.635 . . . . 74.23 109.887 -175.011 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -64.93 -30.94 71.96 Favored 'General case' 0 CA--C 1.508 -0.65 0 N-CA-C 108.86 -0.793 . . . . 35.51 108.86 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 237' ' ' MET . . . . . 0.437 ' HB2' HG11 ' A' ' 221' ' ' VAL . 5.7 mtm -74.36 -37.54 63.46 Favored 'General case' 0 C--O 1.199 -1.567 0 N-CA-C 108.259 -1.015 . . . . 72.11 108.259 -179.257 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 238' ' ' MET . . . . . 0.409 ' SD ' HD13 ' A' ' 176' ' ' ILE . 65.5 mtt -69.57 -34.66 74.49 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.212 -0.449 . . . . 64.31 110.998 178.169 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 235' ' ' THR . 99.0 t -67.04 -39.98 84.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.197 0.523 . . . . 71.52 110.222 176.686 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -68.29 -42.92 78.81 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.54 0.686 . . . . 75.24 109.325 176.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 241' ' ' ASN . . . . . 0.484 HD22 HG22 ' A' ' 221' ' ' VAL . 91.6 m-20 -79.69 18.13 0.81 Allowed 'General case' 0 C--O 1.192 -1.948 0 CA-C-N 115.025 -0.989 . . . . 73.21 112.237 178.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 70.3 m -68.26 -22.55 64.75 Favored 'General case' 0 N--CA 1.478 0.967 0 O-C-N 121.584 -0.698 . . . . 64.22 111.923 178.543 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 37.8 p -65.5 -22.48 66.73 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 116.275 -0.42 . . . . 73.15 110.727 176.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 178.05 101.12 0.02 OUTLIER 'General case' 0 CA--C 1.503 -0.834 0 C-N-CA 125.578 1.551 . . . . 74.22 107.63 176.239 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.546 ' CD2' HG13 ' A' ' 247' ' ' ILE . 3.3 tt -90.01 106.52 18.53 Favored 'General case' 0 N--CA 1.414 -2.234 0 CA-C-N 115.515 -0.766 . . . . 54.41 110.203 -171.594 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.535 ' HA ' ' O ' ' A' ' 161' ' ' VAL . 62.9 mt -95.32 127.92 46.92 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.068 0 N-CA-C 109.115 -0.698 . . . . 72.24 109.115 176.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 247' ' ' ILE . . . . . 0.546 HG13 ' CD2' ' A' ' 245' ' ' LEU . 12.8 mt -132.16 142.54 42.53 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 CA-C-O 121.367 0.603 . . . . 71.44 112.26 176.289 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.548 ' HA ' ' O ' ' A' ' 159' ' ' ARG . 61.5 m -110.49 117.43 33.53 Favored 'General case' 0 N--CA 1.418 -2.058 0 N-CA-C 107.932 -1.136 . . . . 74.12 107.932 173.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.599 HG12 ' HA ' ' A' ' 218' ' ' VAL . 27.0 m -120.78 162.41 19.53 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 N-CA-C 109.322 -0.622 . . . . 54.13 109.322 175.396 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 15.8 ptmt -134.01 133.56 22.19 Favored Pre-proline 0 C--N 1.284 -2.24 0 CA-C-N 115.198 -0.91 . . . . 71.33 108.803 175.189 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 251' ' ' PRO . . . . . 0.53 ' HA ' ' OD1' ' A' ' 216' ' ' ASP . 61.1 Cg_exo . . . . . 0 N--CA 1.443 -1.488 0 C-N-CA 122.115 1.877 . . . . 71.33 110.527 173.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.683 ' NE2' HG13 ' A' ' 219' ' ' ILE . 9.5 m80 . . . . . 0 CA--C 1.499 -1.016 0 N-CA-C 110.638 -0.134 . . . . 74.13 110.638 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.525 ' O ' ' HA ' ' A' ' 248' ' ' THR . 18.3 tpt180 -139.34 133.12 30.72 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 110.303 -0.258 . . . . 75.1 110.303 178.921 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.469 ' HB3' ' OG1' ' A' ' 248' ' ' THR . 4.6 ptp180 -117.6 118.63 32.65 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-O 121.756 0.789 . . . . 73.33 110.519 175.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.461 ' CG1' HD21 ' A' ' 211' ' ' LEU . 16.2 m -111.4 139.43 35.53 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.086 0 CA-C-N 114.914 -1.039 . . . . 73.34 111.338 -178.11 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.783 ' HG3' HG12 ' A' ' 246' ' ' ILE . 7.6 mpt_? -92.66 111.5 23.12 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 107.568 -1.271 . . . . 74.42 107.568 176.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.597 ' HB2' ' HB2' ' A' ' 245' ' ' LEU . 21.2 mt -91.28 137.03 32.68 Favored 'General case' 0 N--CA 1.416 -2.151 0 N-CA-C 108.38 -0.97 . . . . 60.34 108.38 -179.615 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.587 ' HG ' ' CD1' ' A' ' 172' ' ' LEU 0.391 10.8 mt . . . . . 0 CA--C 1.476 -1.873 0 N-CA-C 115.305 1.595 . . . . 73.24 115.305 -175.054 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.587 ' CD1' ' HG ' ' A' ' 164' ' ' LEU . 2.6 mm? . . . . . 0 CA--C 1.502 -0.886 0 CA-C-O 121.081 0.467 . . . . 64.32 111.282 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 101.77 45.47 1.77 Allowed Glycine 0 N--CA 1.419 -2.448 0 CA-C-N 115.469 -0.787 . . . . 73.34 112.75 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -156.94 154.47 29.75 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.499 -0.926 . . . . 73.13 108.499 175.61 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -124.34 144.95 49.72 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 108.971 -0.751 . . . . 72.43 108.971 175.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.61 HD13 ' H ' ' A' ' 176' ' ' ILE . 0.2 OUTLIER -110.67 169.81 3.67 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.238 0 N-CA-C 108.935 -0.765 . . . . 71.32 108.935 177.727 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.578 ' HB3' ' HB2' ' A' ' 198' ' ' SER . 16.4 ptt180 -149.43 154.49 38.95 Favored 'General case' 0 C--N 1.269 -2.921 0 CA-C-N 115.189 -0.914 . . . . 65.31 109.83 -178.069 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -111.98 138.2 48.95 Favored 'General case' 0 C--N 1.28 -2.434 0 N-CA-C 108.786 -0.82 . . . . 64.21 108.786 178.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -150.64 -175.4 22.6 Favored Glycine 0 C--N 1.285 -2.269 0 N-CA-C 108.469 -1.853 . . . . 52.42 108.469 178.31 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 180' ' ' THR . . . . . 0.603 ' CG2' ' HG2' ' A' ' 191' ' ' LYS . 0.2 OUTLIER -102.01 123.17 45.44 Favored 'General case' 0 N--CA 1.415 -2.181 0 C-N-CA 118.725 -1.19 . . . . 64.32 108.087 178.078 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 181' ' ' SER . . . . . 0.466 ' O ' ' HA ' ' A' ' 191' ' ' LYS . 37.5 t . . . . . 0 C--N 1.28 -2.423 0 N-CA-C 108.439 -0.949 . . . . 61.1 108.439 -178.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.603 ' HG2' ' CG2' ' A' ' 180' ' ' THR . 34.2 ttmt . . . . . 0 N--CA 1.418 -2.071 0 N-CA-C 107.395 -1.335 . . . . 75.01 107.395 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -151.54 161.22 30.24 Favored Pre-proline 0 C--N 1.298 -1.661 0 CA-C-N 115.861 -0.608 . . . . 73.2 109.588 -171.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -58.77 132.68 49.25 Favored 'Trans proline' 0 C--O 1.244 0.825 0 C-N-CA 121.472 1.448 . . . . 71.54 110.991 177.254 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -147.1 144.63 12.81 Favored Glycine 0 N--CA 1.419 -2.473 0 N-CA-C 109.987 -1.245 . . . . 72.42 109.987 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.573 HG12 HG21 ' A' ' 234' ' ' VAL . 3.0 mp -105.61 134.08 48.14 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 CA-C-O 121.338 0.589 . . . . 65.02 110.683 -178.759 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -128.25 168.5 15.4 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.191 -1.04 . . . . 65.14 108.191 -176.473 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 197' ' ' ILE . . . . . 0.476 ' HB ' ' HA ' ' A' ' 214' ' ' VAL . 43.3 mm -76.75 131.88 33.99 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 N-CA-C 108.131 -1.062 . . . . 72.43 108.131 176.684 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 198' ' ' SER . . . . . 0.578 ' HB2' ' HB3' ' A' ' 177' ' ' ARG . 13.0 t -103.96 -33.8 8.7 Favored 'General case' 0 C--N 1.284 -2.26 0 N-CA-C 113.181 0.808 . . . . 71.34 113.181 -178.734 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 15.0 ttp180 -168.17 142.77 3.49 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 116.621 -0.263 . . . . 73.32 111.025 -177.611 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 66.1 mt -103.71 137.06 42.28 Favored 'General case' 0 CA--C 1.486 -1.481 0 N-CA-C 108.162 -1.051 . . . . 71.43 108.162 172.702 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 66.6 t -93.44 114.5 63.07 Favored Pre-proline 0 C--N 1.288 -2.103 0 N-CA-C 105.733 -1.951 . . . . 71.24 105.733 174.107 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 202' ' ' PRO . . . . . 0.522 ' HA ' ' HG2' ' A' ' 207' ' ' GLU . 38.2 Cg_endo -70.37 126.23 12.69 Favored 'Trans proline' 0 N--CA 1.429 -2.308 0 C-N-CA 120.915 1.077 . . . . 72.44 110.201 -176.353 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 113.59 -12.98 23.02 Favored Glycine 0 C--N 1.302 -1.356 0 N-CA-C 109.787 -1.325 . . . . 64.42 109.787 -173.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -90.48 168.65 33.58 Favored Glycine 0 N--CA 1.436 -1.356 0 N-CA-C 110.15 -1.18 . . . . 73.03 110.15 176.193 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.542 HD12 ' H ' ' A' ' 164' ' ' LEU . 66.0 mt -65.39 -29.56 70.28 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 117.41 0.605 . . . . 63.41 111.498 -177.629 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -61.93 -48.1 81.93 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.878 -0.601 . . . . 52.23 110.768 178.137 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.522 ' HG2' ' HA ' ' A' ' 202' ' ' PRO . 10.4 tp10 -73.04 -32.6 65.18 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.445 -0.576 . . . . 73.45 109.445 178.097 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 23.0 t -56.98 -40.33 76.33 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 115.91 -0.586 . . . . 63.14 110.45 178.608 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 209' ' ' THR . . . . . 0.533 HG23 ' H ' ' A' ' 211' ' ' LEU . 14.9 t -79.29 -40.27 30.86 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 119.089 -1.044 . . . . 74.21 108.752 175.163 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 58.58 31.3 66.78 Favored Glycine 0 C--N 1.347 1.189 0 CA-C-N 115.888 -0.596 . . . . 71.14 113.139 178.043 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.533 ' H ' HG23 ' A' ' 209' ' ' THR . 1.8 pp -102.21 -19.33 15.11 Favored 'General case' 0 N--CA 1.424 -1.732 0 C-N-CA 120.297 -0.561 . . . . 61.3 110.692 -179.232 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.495 ' H ' HD23 ' A' ' 212' ' ' LEU . 2.1 pt? -109.39 134.28 52.03 Favored 'General case' 0 N--CA 1.432 -1.362 0 N-CA-C 107.857 -1.164 . . . . 73.14 107.857 -179.442 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -129.8 165.92 20.98 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 116.474 -0.33 . . . . 61.51 110.566 -176.651 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 214' ' ' VAL . . . . . 0.476 ' HA ' ' HB ' ' A' ' 197' ' ' ILE . 17.4 m -53.92 -30.41 19.53 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 N-CA-C 114.195 1.183 . . . . 71.11 114.195 -176.012 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 -78.02 -15.36 59.0 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.823 -0.548 . . . . 75.32 112.24 -178.376 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.708 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 58.5 m-20 -79.34 155.92 28.24 Favored 'General case' 0 C--O 1.248 0.995 0 CA-C-O 121.079 0.466 . . . . 72.42 112.076 -174.08 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -109.58 139.43 44.6 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.333 -0.849 . . . . 61.11 111.872 -176.192 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.565 ' HA ' HG12 ' A' ' 249' ' ' VAL . 25.1 t -88.03 120.16 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 CA-C-O 121.349 0.595 . . . . 75.31 109.58 -179.103 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.683 HG13 ' NE2' ' A' ' 158' ' ' HIS . 38.8 mm -89.9 -53.97 8.36 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 CA-C-N 115.257 -0.883 . . . . 74.51 112.302 -176.635 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -155.27 151.98 28.7 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 116.742 -0.208 . . . . 62.35 111.534 -175.513 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.431 HG12 ' CG1' ' A' ' 226' ' ' VAL . 9.1 p -121.78 123.22 68.81 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 CA-C-O 121.293 0.568 . . . . 64.35 109.786 176.057 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 222' ' ' ASN . . . . . 0.48 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 9.0 t-20 66.69 7.58 5.28 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 125.487 1.515 . . . . 71.1 111.221 177.706 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 113.3 -7.17 24.88 Favored Glycine 0 N--CA 1.44 -1.036 0 CA-C-N 115.677 -0.692 . . . . 51.45 112.273 -177.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 66.3 mt -101.4 123.9 54.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 109.423 -0.584 . . . . 62.24 109.423 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -59.7 134.49 57.07 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-O 121.644 0.735 . . . . 75.54 111.932 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 226' ' ' VAL . . . . . 0.494 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 27.6 m -117.82 2.76 7.44 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 CA-C-N 115.158 -0.928 . . . . 74.44 110.047 177.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -83.57 98.77 9.76 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-N 115.332 -0.849 . . . . 70.22 109.38 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 120.35 -16.15 9.9 Favored Glycine 0 CA--C 1.489 -1.543 0 N-CA-C 111.283 -0.727 . . . . 74.54 111.283 -178.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -77.54 172.64 13.05 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 109.45 -0.574 . . . . 62.32 109.45 178.728 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 36.7 p -92.78 165.11 13.09 Favored 'General case' 0 N--CA 1.422 -1.841 0 N-CA-C 108.143 -1.058 . . . . 71.23 108.143 178.046 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 51.9 tp -61.16 -37.44 82.89 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 120.895 -0.322 . . . . 74.01 110.772 -177.684 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -57.76 -51.37 69.82 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 109.989 -0.375 . . . . 72.42 109.989 176.259 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -54.56 -48.55 71.93 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 115.676 -0.693 . . . . 72.4 112.508 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.573 HG21 HG12 ' A' ' 195' ' ' ILE . 7.1 m -75.27 -34.84 31.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 112.257 0.465 . . . . 64.02 112.257 -174.193 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 31.2 m -75.0 -35.6 61.99 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 108.905 -0.776 . . . . 63.31 108.905 -175.147 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -59.11 -33.49 70.91 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.119 -0.946 . . . . 71.24 109.415 176.668 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 237' ' ' MET . . . . . 0.409 ' HG3' ' HA ' ' A' ' 234' ' ' VAL . 5.8 mtt -73.56 -44.61 56.97 Favored 'General case' 0 C--O 1.2 -1.526 0 N-CA-C 107.91 -1.144 . . . . 65.33 107.91 178.548 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 238' ' ' MET . . . . . 0.474 ' HA ' HD21 ' A' ' 245' ' ' LEU . 64.9 mtt -59.98 -41.65 92.46 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.36 -0.382 . . . . 72.23 111.943 -177.402 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 92.6 t -65.04 -38.71 83.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.227 0.536 . . . . 70.24 110.105 176.786 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -76.02 -19.9 58.27 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.355 0.598 . . . . 71.32 111.482 -179.327 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 -107.89 22.18 16.33 Favored 'General case' 0 C--O 1.205 -1.252 0 CA-C-N 115.94 -0.573 . . . . 52.31 110.471 177.489 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 22.8 t -63.44 -22.79 67.09 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.649 0.738 . . . . 75.04 109.141 177.503 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 16.1 p -69.56 -32.14 70.75 Favored 'General case' 0 N--CA 1.428 -1.569 0 CA-C-N 115.651 -0.704 . . . . 71.31 111.373 174.564 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -165.9 99.48 0.66 Allowed 'General case' 0 C--O 1.24 0.579 0 CA-C-O 121.749 0.785 . . . . 60.53 110.82 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.597 ' HB2' ' HB2' ' A' ' 163' ' ' LEU . 10.3 mt -91.46 105.18 17.57 Favored 'General case' 0 C--O 1.195 -1.786 0 N-CA-C 113.085 0.772 . . . . 73.24 113.085 -178.264 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.783 HG12 ' HG3' ' A' ' 162' ' ' ARG . 96.6 mt -95.51 114.12 31.44 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.432 0 N-CA-C 106.692 -1.596 . . . . 62.14 106.692 168.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 247' ' ' ILE . . . . . 0.464 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 76.9 mt -122.35 127.14 75.04 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.125 0 C-N-CA 120.436 -0.506 . . . . 53.44 111.153 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.525 ' HA ' ' O ' ' A' ' 159' ' ' ARG . 63.3 m -99.53 118.18 35.55 Favored 'General case' 0 N--CA 1.418 -2.05 0 CA-C-N 114.832 -1.076 . . . . 72.41 108.688 177.679 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.565 HG12 ' HA ' ' A' ' 218' ' ' VAL . 27.3 m -119.29 161.93 18.0 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 N-CA-C 108.974 -0.75 . . . . 70.43 108.974 174.214 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 17.4 ptmt -127.75 130.86 23.6 Favored Pre-proline 0 C--N 1.276 -2.616 0 CA-C-N 115.309 -0.86 . . . . 74.32 108.893 176.307 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 251' ' ' PRO . . . . . 0.708 ' HA ' ' OD1' ' A' ' 216' ' ' ASP . 29.0 Cg_endo . . . . . 0 N--CA 1.445 -1.341 0 C-N-CA 122.676 2.251 . . . . 75.01 112.394 177.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.734 ' HB3' ' HB3' ' A' ' 250' ' ' LYS . 4.4 p-80 . . . . . 0 CA--C 1.516 -0.333 0 N-CA-C 112.49 0.552 . . . . 70.41 112.49 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 36.6 ttm180 -125.58 143.7 50.9 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.581 -0.282 . . . . 75.14 110.407 -179.34 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 35.1 ptt180 -104.05 117.22 33.75 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.611 0.719 . . . . 72.44 111.783 179.04 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 30.3 m -114.93 139.93 38.64 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 CA-C-N 115.497 -0.774 . . . . 73.23 111.894 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 21.1 ttm180 -102.53 121.4 42.3 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 109.168 -0.679 . . . . 74.51 109.168 179.152 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.428 ' HB2' ' HB3' ' A' ' 245' ' ' LEU . 26.8 mt -103.08 139.68 38.29 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 123.347 0.659 . . . . 75.13 111.657 -174.431 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.565 HD13 ' O ' ' A' ' 242' ' ' SER . 6.0 tt . . . . . 0 CA--C 1.512 -0.503 0 C-N-CA 125.913 1.685 . . . . 73.41 112.216 171.247 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 2.3 mm? . . . . . 0 N--CA 1.471 0.598 0 N-CA-C 112.459 0.54 . . . . 74.01 112.459 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 103.69 36.12 3.34 Favored Glycine 0 N--CA 1.424 -2.121 0 C-N-CA 120.174 -1.012 . . . . 63.41 112.533 178.236 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -147.48 153.84 40.04 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 108.661 -0.866 . . . . 74.43 108.661 174.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -123.77 155.41 37.97 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 108.183 -1.043 . . . . 75.03 108.183 177.294 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.446 HD13 ' SD ' ' A' ' 238' ' ' MET . 27.3 pt -125.18 169.5 16.48 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 CA-C-O 120.909 0.385 . . . . 74.25 111.329 -176.119 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.513 ' HG2' ' HB3' ' A' ' 198' ' ' SER . 1.1 ptp180 -148.91 154.15 39.02 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 123.332 0.653 . . . . 74.1 110.891 -179.157 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -103.38 138.84 39.58 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 109.065 -0.717 . . . . 62.04 109.065 176.411 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -154.38 -168.27 17.58 Favored Glycine 0 N--CA 1.416 -2.661 0 N-CA-C 109.197 -1.561 . . . . 73.31 109.197 177.473 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 180' ' ' THR . . . . . 0.549 ' HB ' ' CG ' ' A' ' 191' ' ' LYS . 1.0 OUTLIER -101.16 125.48 47.79 Favored 'General case' 0 C--N 1.276 -2.618 0 CA-C-O 121.14 0.495 . . . . 73.12 111.698 176.415 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 36.9 t . . . . . 0 N--CA 1.41 -2.463 0 N-CA-C 107.255 -1.387 . . . . 53.12 107.255 176.394 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.549 ' CG ' ' HB ' ' A' ' 180' ' ' THR . 35.4 ttmt . . . . . 0 N--CA 1.425 -1.71 0 N-CA-C 107.972 -1.121 . . . . 71.34 107.972 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 27.4 pt20 -130.75 164.15 43.74 Favored Pre-proline 0 C--N 1.284 -2.261 0 CA-C-N 115.473 -0.785 . . . . 72.43 109.336 -172.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -61.69 132.31 39.63 Favored 'Trans proline' 0 N--CA 1.447 -1.221 0 C-N-CA 121.108 1.205 . . . . 54.2 109.135 172.011 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -139.82 138.77 9.4 Favored Glycine 0 N--CA 1.415 -2.725 0 N-CA-C 110.085 -1.206 . . . . 40.24 110.085 -178.714 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.548 HG12 HG21 ' A' ' 234' ' ' VAL . 3.4 mp -103.8 128.26 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.127 0 CA-C-O 121.418 0.628 . . . . 72.3 110.929 -179.101 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -121.75 167.12 13.34 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 107.57 -1.27 . . . . 73.3 107.57 -177.6 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 197' ' ' ILE . . . . . 0.432 ' HB ' ' HA ' ' A' ' 214' ' ' VAL . 50.1 mm -77.58 130.32 36.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 107.515 -1.291 . . . . 71.34 107.515 175.286 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 198' ' ' SER . . . . . 0.513 ' HB3' ' HG2' ' A' ' 177' ' ' ARG . 81.4 p -103.49 -22.37 13.64 Favored 'General case' 0 C--N 1.291 -1.95 0 C-N-CA 119.624 -0.831 . . . . 54.23 111.538 -175.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 27.6 tpt180 -167.12 146.28 5.19 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.398 -0.593 . . . . 74.32 109.398 -176.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 69.7 mt -112.51 139.67 47.9 Favored 'General case' 0 CA--C 1.484 -1.571 0 N-CA-C 108.541 -0.911 . . . . 75.23 108.541 172.728 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 53.2 t -95.8 114.92 65.05 Favored Pre-proline 0 C--N 1.288 -2.07 0 N-CA-C 105.811 -1.922 . . . . 72.35 105.811 171.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 202' ' ' PRO . . . . . 0.542 ' HA ' ' HG3' ' A' ' 207' ' ' GLU . 19.3 Cg_endo -62.3 126.81 19.38 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 121.938 1.758 . . . . 73.22 110.644 -177.748 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 103.38 -14.32 54.55 Favored Glycine 0 C--N 1.297 -1.587 0 C-N-CA 120.157 -1.021 . . . . 74.32 111.266 -175.541 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -81.93 162.24 42.6 Favored Glycine 0 N--CA 1.435 -1.422 0 N-CA-C 110.221 -1.152 . . . . 61.14 110.221 176.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.459 HD13 ' CA ' ' A' ' 164' ' ' LEU . 32.1 mt -53.9 -38.34 64.72 Favored 'General case' 0 C--N 1.309 -1.158 0 C-N-CA 124.737 1.215 . . . . 73.35 112.777 -175.095 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 206' ' ' ALA . . . . . 0.538 ' CB ' HD12 ' A' ' 212' ' ' LEU . . . -66.0 -43.73 86.86 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.538 0.685 . . . . 51.03 110.919 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.542 ' HG3' ' HA ' ' A' ' 202' ' ' PRO . 3.3 tm-20 -76.16 -35.93 58.96 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 115.255 -0.884 . . . . 64.11 109.619 -178.667 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 55.8 m -61.0 -41.46 96.57 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.474 -0.33 . . . . 53.33 111.572 178.329 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 209' ' ' THR . . . . . 0.457 HG23 ' H ' ' A' ' 211' ' ' LEU . 9.2 t -73.27 -33.21 65.13 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 119.489 -0.884 . . . . 61.43 109.253 176.257 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 70.14 10.91 66.36 Favored Glycine 0 CA--C 1.5 -0.886 0 CA-C-N 115.75 -0.659 . . . . 33.02 112.842 176.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.457 ' H ' HG23 ' A' ' 209' ' ' THR . 52.0 mt -95.42 -5.97 41.93 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.989 -0.745 . . . . 74.0 108.989 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.538 HD12 ' CB ' ' A' ' 206' ' ' ALA . 95.6 mt -109.49 131.21 55.28 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 107.817 -1.179 . . . . 60.04 107.817 174.313 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -133.63 166.11 23.35 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.216 -1.031 . . . . 41.23 108.216 176.294 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 214' ' ' VAL . . . . . 0.432 ' HA ' ' HB ' ' A' ' 197' ' ' ILE . 34.6 m -62.86 -31.3 51.9 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 N-CA-C 113.466 0.913 . . . . 71.03 113.466 -178.585 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 21.5 p-10 -72.37 -13.42 61.47 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.995 -0.441 . . . . 55.22 111.577 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.51 ' HB3' ' HB ' ' A' ' 249' ' ' VAL . 6.3 m-20 -73.78 131.09 41.19 Favored 'General case' 0 C--O 1.242 0.705 0 N-CA-C 113.516 0.932 . . . . 32.22 113.516 -176.55 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -103.72 132.26 50.13 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 113.827 -1.533 . . . . 61.32 109.676 -179.122 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.561 ' HA ' HG12 ' A' ' 249' ' ' VAL . 22.9 t -79.97 130.19 36.4 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 CA-C-O 121.433 0.635 . . . . 74.44 110.732 -176.771 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.452 HD11 ' HD3' ' A' ' 250' ' ' LYS . 38.8 mm -95.16 -50.3 11.85 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 C-N-CA 124.06 0.944 . . . . 65.22 110.122 178.85 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -154.41 154.22 32.88 Favored 'General case' 0 N--CA 1.433 -1.325 0 CA-C-N 115.446 -0.797 . . . . 72.11 110.695 -176.536 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.429 HG11 ' HB2' ' A' ' 237' ' ' MET . 7.5 p -124.18 121.2 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 N-CA-C 108.415 -0.958 . . . . 75.13 108.415 177.268 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 222' ' ' ASN . . . . . 0.563 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 8.6 t30 75.55 -24.34 0.22 Allowed 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 126.406 1.882 . . . . 71.13 111.774 -176.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 223' ' ' GLY . . . . . 0.427 ' H ' ' C ' ' A' ' 221' ' ' VAL . . . 140.43 -11.33 2.99 Favored Glycine 0 C--N 1.278 -2.654 0 N-CA-C 109.932 -1.267 . . . . 51.52 109.932 -174.287 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 67.4 mt -92.1 123.85 44.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 108.936 -0.764 . . . . 71.22 108.936 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -57.62 143.43 41.35 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 123.992 0.917 . . . . 74.32 112.006 -179.285 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 34.7 m -117.57 1.0 8.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 CA-C-N 115.667 -0.697 . . . . 75.23 110.92 176.275 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -78.12 97.34 5.41 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.86 -0.609 . . . . 73.13 110.224 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 120.41 -14.57 10.06 Favored Glycine 0 C--N 1.316 -0.532 0 N-CA-C 110.826 -0.91 . . . . 70.14 110.826 -179.153 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -79.8 170.13 16.95 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 108.333 -0.988 . . . . 72.33 108.333 177.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 230' ' ' THR . . . . . 0.517 ' O ' HG13 ' A' ' 234' ' ' VAL . 73.1 p -93.55 164.11 13.3 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 108.445 -0.946 . . . . 53.11 108.445 177.54 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 231' ' ' LEU . . . . . 0.445 ' HA ' HG22 ' A' ' 234' ' ' VAL . 0.7 OUTLIER -63.07 -36.15 82.62 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 107.017 -1.475 . . . . 61.02 107.017 179.105 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -61.85 -45.82 92.14 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.286 -0.87 . . . . 63.12 109.945 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -61.94 -50.39 72.34 Favored 'General case' 0 C--N 1.344 0.341 0 N-CA-C 112.385 0.513 . . . . 74.31 112.385 175.724 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.548 HG21 HG12 ' A' ' 195' ' ' ILE . 12.2 m -62.08 -33.89 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 N-CA-C 112.749 0.648 . . . . 63.55 112.749 -173.865 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 235' ' ' THR . . . . . 0.484 ' O ' HG23 ' A' ' 239' ' ' VAL . 61.9 m -68.9 -39.05 79.93 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 109.394 -0.595 . . . . 55.13 109.394 -175.182 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -68.53 -30.43 69.22 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-N 115.614 -0.721 . . . . 72.44 109.793 -178.038 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 237' ' ' MET . . . . . 0.429 ' HB2' HG11 ' A' ' 221' ' ' VAL . 3.5 mtm -73.21 -36.47 66.49 Favored 'General case' 0 C--O 1.196 -1.728 0 N-CA-C 107.894 -1.15 . . . . 73.42 107.894 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 238' ' ' MET . . . . . 0.484 ' HG3' ' O ' ' A' ' 234' ' ' VAL . 65.5 mtt -63.11 -39.78 95.69 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 120.844 0.354 . . . . 74.0 110.133 177.268 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 235' ' ' THR . 79.0 t -66.34 -41.06 88.27 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 CA-C-N 116.096 -0.502 . . . . 54.22 109.682 176.363 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -66.01 -22.34 66.45 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.131 -0.486 . . . . 44.02 111.991 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 54.4 m-80 -105.12 21.93 16.24 Favored 'General case' 0 C--O 1.202 -1.426 0 CA-C-N 116.542 -0.299 . . . . 65.41 110.815 178.501 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 242' ' ' SER . . . . . 0.565 ' O ' HD13 ' A' ' 164' ' ' LEU . 46.5 t -56.36 -24.44 44.27 Favored 'General case' 0 C--O 1.213 -0.849 0 N-CA-C 113.68 0.992 . . . . 71.12 113.68 -179.088 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 29.1 m -78.59 -22.15 47.52 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 120.359 -0.537 . . . . 64.42 111.424 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -171.5 94.14 0.16 Allowed 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.726 1.211 . . . . 71.14 108.956 178.509 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.527 ' CD2' HG13 ' A' ' 247' ' ' ILE . 1.7 tt -90.77 109.24 20.44 Favored 'General case' 0 N--CA 1.419 -1.983 0 CA-C-N 114.618 -1.174 . . . . 61.53 110.071 -171.056 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.563 ' HB ' ' HA ' ' A' ' 222' ' ' ASN . 61.3 mt -95.76 117.13 39.2 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 N-CA-C 108.963 -0.755 . . . . 62.02 108.963 176.528 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 247' ' ' ILE . . . . . 0.527 HG13 ' CD2' ' A' ' 245' ' ' LEU . 9.3 mt -123.83 135.3 63.92 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.99 0 CA-C-O 121.819 0.818 . . . . 73.15 111.305 176.522 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 37.7 m -108.79 124.54 50.76 Favored 'General case' 0 N--CA 1.41 -2.441 0 CA-C-N 114.476 -1.238 . . . . 61.34 108.493 178.306 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.561 HG12 ' HA ' ' A' ' 218' ' ' VAL . 29.1 m -134.75 152.99 34.09 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-O 121.754 0.788 . . . . 74.43 112.18 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 250' ' ' LYS . . . . . 0.734 ' HB3' ' HB3' ' A' ' 158' ' ' HIS . 1.1 ptmm? -128.79 132.6 24.46 Favored Pre-proline 0 C--N 1.293 -1.872 0 CA-C-N 113.938 -1.483 . . . . 73.35 109.203 172.517 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo . . . . . 0 N--CA 1.447 -1.25 0 C-N-CA 122.549 2.166 . . . . 73.44 110.713 176.297 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.419 ' ND1' ' HB3' ' A' ' 250' ' ' LYS . 0.3 OUTLIER . . . . . 0 CA--C 1.507 -0.703 0 N-CA-C 109.888 -0.412 . . . . 75.04 109.888 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.47 ' O ' ' HA ' ' A' ' 248' ' ' THR . 2.2 tpm_? -128.95 138.53 52.03 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 108.096 -1.076 . . . . 72.35 108.096 177.047 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.401 ' HA ' ' O ' ' A' ' 247' ' ' ILE . 14.9 ptp180 -122.6 117.03 24.89 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-O 121.2 0.524 . . . . 71.23 110.222 178.483 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.507 HG21 HD11 ' A' ' 212' ' ' LEU . 27.7 m -122.66 140.49 46.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 CA-C-N 115.479 -0.782 . . . . 62.34 112.02 -175.108 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.521 ' HG2' HG12 ' A' ' 246' ' ' ILE . 67.0 mtm180 -92.95 111.29 22.86 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.824 -1.176 . . . . 64.23 107.824 177.614 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.513 ' HB2' ' HB3' ' A' ' 245' ' ' LEU . 31.8 mt -89.32 139.12 30.82 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 109.28 -0.637 . . . . 73.54 109.28 -178.748 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.431 HD13 ' O ' ' A' ' 242' ' ' SER . 6.1 tt . . . . . 0 C--N 1.312 -1.048 0 CA-C-O 123.037 1.399 . . . . 72.21 108.397 179.337 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.435 ' HG ' HD12 ' A' ' 245' ' ' LEU . 3.7 mm? . . . . . 0 CA--C 1.516 -0.364 0 N-CA-C 113.531 0.937 . . . . 74.25 113.531 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 91.77 36.42 6.44 Favored Glycine 0 N--CA 1.434 -1.48 0 C-N-CA 119.813 -1.184 . . . . 50.23 113.789 175.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 174' ' ' PHE . . . . . 0.436 ' HB3' ' CB ' ' A' ' 206' ' ' ALA . 18.9 p90 -156.61 153.33 28.43 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.755 -1.202 . . . . 63.34 107.755 173.566 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -128.7 150.29 50.32 Favored 'General case' 0 C--N 1.287 -2.129 0 N-CA-C 108.769 -0.826 . . . . 75.02 108.769 179.497 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.602 HD13 ' H ' ' A' ' 176' ' ' ILE . 0.2 OUTLIER -123.92 170.08 14.54 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.438 0 CA-C-O 121.372 0.606 . . . . 53.12 110.739 -176.222 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.557 ' HG2' ' HB2' ' A' ' 198' ' ' SER . 2.7 ptp180 -147.46 154.39 40.74 Favored 'General case' 0 C--N 1.275 -2.638 0 CA-C-N 115.141 -0.936 . . . . 74.35 110.226 -177.456 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -104.7 138.3 41.22 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 109.509 -0.552 . . . . 74.31 109.509 179.148 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -155.54 136.77 5.25 Favored Glycine 0 C--N 1.284 -2.339 0 N-CA-C 109.823 -1.311 . . . . 74.14 109.823 177.406 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 180' ' ' THR . . . . . 0.474 ' CG2' ' HG2' ' A' ' 191' ' ' LYS . 0.2 OUTLIER -89.24 123.49 33.51 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 105.903 -1.888 . . . . 72.13 105.903 179.292 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 22.7 t . . . . . 0 C--N 1.269 -2.911 0 N-CA-C 109.112 -0.699 . . . . 73.12 109.112 -176.604 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.474 ' HG2' ' CG2' ' A' ' 180' ' ' THR . 34.2 ttmt . . . . . 0 N--CA 1.427 -1.606 0 N-CA-C 107.618 -1.252 . . . . 74.04 107.618 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 192' ' ' GLN . . . . . 0.421 ' HA ' ' HD3' ' A' ' 193' ' ' PRO . 5.1 tp-100 -140.98 134.54 14.77 Favored Pre-proline 0 C--N 1.287 -2.144 0 CA-C-N 115.78 -0.645 . . . . 70.32 109.816 -168.276 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 193' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 192' ' ' GLN . 24.7 Cg_exo -64.73 130.77 27.19 Favored 'Trans proline' 0 N--CA 1.447 -1.209 0 C-N-CA 121.726 1.617 . . . . 71.13 111.885 179.658 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -133.82 141.4 12.73 Favored Glycine 0 N--CA 1.403 -3.539 0 N-CA-C 109.285 -1.526 . . . . 63.22 109.285 174.171 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.547 ' O ' HG12 ' A' ' 218' ' ' VAL . 3.8 mp -103.8 129.78 55.35 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.676 0 N-CA-C 108.351 -0.981 . . . . 72.1 108.351 175.129 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -123.59 161.15 25.56 Favored 'General case' 0 C--N 1.275 -2.644 0 N-CA-C 107.271 -1.381 . . . . 73.12 107.271 -174.418 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 57.6 mt -79.24 127.69 38.95 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.892 0 CA-C-O 121.588 0.709 . . . . 72.24 110.294 177.712 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 198' ' ' SER . . . . . 0.557 ' HB2' ' HG2' ' A' ' 177' ' ' ARG . 24.4 t -101.56 -18.67 15.82 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 112.891 0.701 . . . . 63.44 112.891 -177.246 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 75.3 ttt180 -166.55 139.5 3.83 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.327 -0.549 . . . . 74.22 111.239 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 88.3 mt -103.72 146.61 28.35 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.575 -0.898 . . . . 63.54 108.575 172.446 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 62.1 t -112.09 114.77 50.98 Favored Pre-proline 0 C--N 1.283 -2.298 0 N-CA-C 105.886 -1.894 . . . . 73.2 105.886 171.31 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 202' ' ' PRO . . . . . 0.426 ' HA ' ' HG2' ' A' ' 207' ' ' GLU . 31.1 Cg_endo -64.45 130.67 27.38 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 121.866 1.71 . . . . 71.14 110.6 -177.314 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 103.23 -17.65 50.94 Favored Glycine 0 N--CA 1.439 -1.137 0 N-CA-C 110.137 -1.185 . . . . 73.04 110.137 -175.602 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -83.74 171.76 49.48 Favored Glycine 0 N--CA 1.43 -1.751 0 N-CA-C 110.298 -1.121 . . . . 44.11 110.298 177.526 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 172' ' ' LEU . 3.1 mm? -63.07 -33.24 75.02 Favored 'General case' 0 N--CA 1.432 -1.339 0 N-CA-C 113.272 0.842 . . . . 72.24 113.272 -174.047 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 206' ' ' ALA . . . . . 0.436 ' CB ' ' HB3' ' A' ' 174' ' ' PHE . . . -66.3 -48.13 71.35 Favored 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 120.847 -0.341 . . . . 75.33 111.22 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.426 ' HG2' ' HA ' ' A' ' 202' ' ' PRO . 8.2 tp10 -73.39 -33.1 64.84 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 109.34 -0.615 . . . . 64.23 109.34 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 30.8 t -56.4 -47.51 78.86 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-O 122.044 0.926 . . . . 73.22 109.038 176.749 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 84.1 m -70.09 -40.74 74.8 Favored 'General case' 0 N--CA 1.382 -3.86 0 CA-C-N 114.41 -1.268 . . . . 52.02 109.358 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 74.35 -7.28 18.56 Favored Glycine 0 CA--C 1.504 -0.621 0 CA-C-N 116.246 -0.434 . . . . 52.41 113.097 176.444 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.41 HD12 HG11 ' A' ' 161' ' ' VAL . 38.4 mt -87.46 -6.56 58.35 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 109.061 -0.718 . . . . 74.21 109.061 -178.28 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.507 HD11 HG21 ' A' ' 161' ' ' VAL . 9.4 mp -108.92 131.35 55.11 Favored 'General case' 0 N--CA 1.422 -1.834 0 CA-C-N 115.181 -0.918 . . . . 71.21 109.678 174.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -132.44 166.32 22.27 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 107.177 -1.416 . . . . 72.35 107.177 175.246 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 33.6 m -58.57 -30.32 41.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-O 121.828 0.823 . . . . 53.41 111.623 177.189 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -68.59 -15.04 63.4 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 115.367 -0.833 . . . . 54.13 112.271 -179.234 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.441 ' HB3' ' HB ' ' A' ' 249' ' ' VAL . 6.7 m-20 -75.07 141.49 43.82 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 113.623 0.971 . . . . 61.24 113.623 -176.46 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 217' ' ' GLU . . . . . 0.526 ' HB3' ' HG3' ' A' ' 250' ' ' LYS . 40.4 tt0 -113.45 128.11 56.34 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 125.455 1.502 . . . . 63.41 109.852 -176.789 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.547 HG12 ' O ' ' A' ' 195' ' ' ILE . 12.5 p -80.03 128.84 38.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 122.143 0.973 . . . . 54.22 111.808 -176.625 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 44.0 mm -99.14 -48.96 11.77 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 CA-C-N 114.398 -1.274 . . . . 73.14 110.121 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.474 ' HB3' ' HA ' ' A' ' 225' ' ' GLU . 10.8 pt-20 -157.94 160.16 37.28 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.842 -0.617 . . . . 54.54 110.198 -177.534 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' A' ' 246' ' ' ILE . 8.8 p -131.0 120.61 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 O-C-N 123.758 0.661 . . . . 74.32 109.656 179.459 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 222' ' ' ASN . . . . . 0.429 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 10.7 m120 61.39 24.97 15.0 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.02 0.928 . . . . 74.42 112.946 176.654 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 97.23 -3.21 61.68 Favored Glycine 0 C--N 1.309 -0.953 0 CA-C-N 115.274 -0.876 . . . . 73.01 112.66 179.498 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 63.3 mt -111.22 123.51 67.16 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 N-CA-C 109.312 -0.625 . . . . 63.23 109.312 179.136 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 225' ' ' GLU . . . . . 0.474 ' HA ' ' HB3' ' A' ' 220' ' ' GLU . 12.5 pt-20 -62.73 153.71 31.81 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 121.551 0.691 . . . . 75.42 112.424 -178.778 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 226' ' ' VAL . . . . . 0.429 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 29.3 m -123.53 -3.51 6.99 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 CA-C-N 115.19 -0.914 . . . . 61.34 110.904 177.135 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -68.66 97.28 0.79 Allowed 'General case' 0 N--CA 1.443 -0.802 0 CA-C-O 121.416 0.627 . . . . 72.44 111.184 -177.836 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 127.78 -26.17 4.87 Favored Glycine 0 CA--C 1.49 -1.484 0 CA-C-N 115.488 -0.778 . . . . 74.35 111.571 177.524 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -73.65 170.98 14.1 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.231 0.539 . . . . 70.0 111.446 -178.616 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 47.6 p -88.53 163.89 15.68 Favored 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 108.674 -0.862 . . . . 45.35 108.674 -179.501 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 231' ' ' LEU . . . . . 0.474 ' HA ' HG22 ' A' ' 234' ' ' VAL . 0.8 OUTLIER -63.58 -36.97 85.56 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 107.712 -1.218 . . . . 35.24 107.712 -177.351 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -61.32 -40.9 95.92 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.561 -0.745 . . . . 75.44 110.824 177.4 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -66.02 -48.67 70.37 Favored 'General case' 0 C--O 1.218 -0.56 0 CA-C-N 116.307 -0.406 . . . . 70.32 111.691 177.112 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.474 HG22 ' HA ' ' A' ' 231' ' ' LEU . 13.7 m -66.8 -34.19 68.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 112.413 0.523 . . . . 63.13 112.413 -175.162 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 235' ' ' THR . . . . . 0.429 ' O ' HG23 ' A' ' 239' ' ' VAL . 32.9 m -72.01 -36.15 69.62 Favored 'General case' 0 CA--C 1.5 -0.976 0 N-CA-C 109.018 -0.734 . . . . 75.32 109.018 -177.062 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -60.46 -33.65 72.87 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 115.861 -0.609 . . . . 54.04 109.932 178.694 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -72.08 -43.6 64.58 Favored 'General case' 0 C--O 1.206 -1.219 0 N-CA-C 108.052 -1.092 . . . . 73.42 108.052 -179.25 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 238' ' ' MET . . . . . 0.419 ' HG3' ' O ' ' A' ' 234' ' ' VAL . 64.4 mtt -62.83 -40.18 96.62 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.615 -0.72 . . . . 73.52 111.431 179.595 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 235' ' ' THR . 97.6 t -66.92 -42.11 88.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.841 0.353 . . . . 73.23 110.463 178.256 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -65.42 -39.5 92.22 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.654 0.74 . . . . 34.15 110.078 178.411 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -83.57 20.98 1.28 Allowed 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 114.731 -1.122 . . . . 71.41 111.957 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 242' ' ' SER . . . . . 0.431 ' O ' HD13 ' A' ' 164' ' ' LEU . 22.9 t -62.35 -23.04 66.56 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 111.742 0.275 . . . . 61.32 111.742 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 16.5 m -63.33 -29.94 71.16 Favored 'General case' 0 CA--C 1.554 1.121 0 CA-C-O 120.893 0.377 . . . . 61.12 110.425 178.535 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -175.19 95.96 0.07 Allowed 'General case' 0 C--O 1.245 0.867 0 N-CA-C 106.856 -1.535 . . . . 75.41 106.856 179.2 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.513 ' HB3' ' HB2' ' A' ' 163' ' ' LEU . 2.2 tt -85.97 108.0 18.01 Favored 'General case' 0 C--O 1.201 -1.453 0 CA-C-N 115.448 -0.796 . . . . 62.35 109.212 -171.747 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.521 HG12 ' HG2' ' A' ' 162' ' ' ARG . 77.7 mt -101.12 116.76 45.29 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.105 0 O-C-N 121.777 -0.577 . . . . 73.23 109.736 -178.808 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 247' ' ' ILE . . . . . 0.515 HG23 HG23 ' A' ' 218' ' ' VAL . 15.8 mt -121.87 136.66 58.03 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.152 0 N-CA-C 113.172 0.804 . . . . 75.44 113.172 179.622 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.47 ' HA ' ' O ' ' A' ' 159' ' ' ARG . 63.3 m -103.56 114.83 29.39 Favored 'General case' 0 N--CA 1.413 -2.316 0 N-CA-C 107.633 -1.247 . . . . 63.11 107.633 172.882 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.539 HG12 ' HA ' ' A' ' 218' ' ' VAL . 10.2 m -121.51 168.55 13.84 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.399 0 CA-C-O 121.809 0.814 . . . . 72.32 110.054 175.886 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 250' ' ' LYS . . . . . 0.526 ' HG3' ' HB3' ' A' ' 217' ' ' GLU . 8.1 ptmt -136.62 139.16 28.46 Favored Pre-proline 0 C--N 1.257 -3.448 0 CA-C-N 113.647 -1.615 . . . . 72.31 107.665 175.756 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo . . . . . 0 N--CA 1.443 -1.482 0 C-N-CA 121.202 1.268 . . . . 55.23 108.962 173.85 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.657 ' NE2' HG13 ' A' ' 219' ' ' ILE . 13.7 m80 . . . . . 0 CA--C 1.496 -1.106 0 CA-C-O 120.774 0.321 . . . . 73.42 111.191 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.471 ' O ' ' HA ' ' A' ' 248' ' ' THR . 8.3 ttm180 -131.64 141.82 49.71 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 107.681 -1.229 . . . . 63.22 107.681 179.34 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -128.75 112.55 14.31 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-O 121.175 0.512 . . . . 74.24 109.676 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 16.5 m -118.15 139.57 44.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-N 115.025 -0.989 . . . . 71.42 112.044 -177.012 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 17.4 ttm180 -100.29 112.48 24.81 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.107 -1.072 . . . . 70.11 108.107 177.123 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.478 ' HB2' ' HB3' ' A' ' 245' ' ' LEU . 20.8 mt -99.86 137.07 38.83 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 108.184 -1.043 . . . . 71.35 108.184 -176.071 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.42 ' O ' ' HA ' ' A' ' 244' ' ' ASN . 3.4 tt . . . . . 0 C--O 1.207 -1.141 0 N-CA-C 107.1 -1.444 . . . . 75.11 107.1 177.157 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.439 ' HA ' HD23 ' A' ' 205' ' ' LEU . 3.5 mm? . . . . . 0 CA--C 1.506 -0.744 0 N-CA-C 112.254 0.465 . . . . 73.14 112.254 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' GLY . . . . . 0.498 ' HA3' ' HA3' ' A' ' 204' ' ' GLY . . . 84.49 36.01 13.04 Favored Glycine 0 N--CA 1.427 -1.929 0 C-N-CA 120.389 -0.91 . . . . 54.32 112.948 177.204 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -150.0 154.24 37.87 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.338 -0.986 . . . . 72.12 108.338 174.104 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -121.32 143.65 49.07 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 108.966 -0.753 . . . . 73.34 108.966 175.456 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.621 HD13 ' H ' ' A' ' 176' ' ' ILE . 0.2 OUTLIER -114.38 166.23 8.47 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.467 0 CA-C-N 115.812 -0.631 . . . . 64.5 109.484 178.992 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.578 ' HG2' ' HB2' ' A' ' 198' ' ' SER . 4.8 ptp180 -146.87 154.32 41.18 Favored 'General case' 0 C--N 1.277 -2.582 0 CA-C-N 115.072 -0.967 . . . . 62.44 110.589 -178.264 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -111.86 138.45 48.44 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 124.15 0.906 . . . . 75.44 111.145 -179.003 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -157.34 -164.35 13.62 Favored Glycine 0 C--N 1.29 -2.016 0 N-CA-C 108.424 -1.87 . . . . 73.0 108.424 175.669 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 180' ' ' THR . . . . . 0.476 ' CG2' ' HG2' ' A' ' 191' ' ' LYS . 0.4 OUTLIER -105.69 123.55 48.11 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-N 118.017 0.909 . . . . 73.24 111.827 175.546 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 41.0 t . . . . . 0 N--CA 1.414 -2.257 0 N-CA-C 107.326 -1.361 . . . . 54.04 107.326 176.303 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.476 ' HG2' ' CG2' ' A' ' 180' ' ' THR . 36.5 ttmt . . . . . 0 N--CA 1.426 -1.66 0 N-CA-C 108.155 -1.054 . . . . 73.04 108.155 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -136.53 165.56 34.35 Favored Pre-proline 0 C--N 1.279 -2.462 0 N-CA-C 108.228 -1.027 . . . . 62.31 108.228 -174.447 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 193' ' ' PRO . . . . . 0.437 ' HD2' ' HA2' ' A' ' 228' ' ' GLY . 53.8 Cg_exo -55.26 132.11 50.3 Favored 'Trans proline' 0 N--CA 1.445 -1.373 0 C-N-CA 121.126 1.218 . . . . 72.53 109.287 170.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -131.86 127.26 4.93 Favored Glycine 0 N--CA 1.403 -3.529 0 N-CA-C 109.278 -1.529 . . . . 64.54 109.278 -179.309 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.566 HG12 HG21 ' A' ' 234' ' ' VAL . 3.6 mp -104.37 132.06 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.814 0 CA-C-O 121.365 0.603 . . . . 73.12 109.51 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -127.61 167.4 16.43 Favored 'General case' 0 C--N 1.277 -2.553 0 N-CA-C 107.365 -1.346 . . . . 71.34 107.365 -175.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 197' ' ' ILE . . . . . 0.495 ' HB ' ' HA ' ' A' ' 214' ' ' VAL . 45.1 mm -79.17 130.1 36.62 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 N-CA-C 107.877 -1.157 . . . . 62.44 107.877 173.11 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 198' ' ' SER . . . . . 0.578 ' HB2' ' HG2' ' A' ' 177' ' ' ARG . 28.0 t -100.45 -34.07 10.09 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 111.946 0.35 . . . . 51.13 111.946 -178.44 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 15.4 ttp180 -160.64 141.23 11.58 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-O 120.748 0.309 . . . . 73.11 110.358 -178.28 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 1.1 tt -108.03 135.49 49.3 Favored 'General case' 0 N--CA 1.426 -1.67 0 N-CA-C 107.172 -1.418 . . . . 65.01 107.172 -177.47 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 59.7 t -106.0 121.3 46.13 Favored Pre-proline 0 C--N 1.311 -1.104 0 N-CA-C 110.129 -0.323 . . . . 75.51 110.129 179.589 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 202' ' ' PRO . . . . . 0.505 ' HA ' ' HG3' ' A' ' 207' ' ' GLU . 27.5 Cg_endo -62.6 135.54 53.47 Favored 'Trans proline' 0 C--O 1.247 0.956 0 C-N-CA 122.638 2.226 . . . . 73.2 111.466 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 96.95 -24.45 31.14 Favored Glycine 0 N--CA 1.439 -1.136 0 N-CA-C 111.641 -0.584 . . . . 73.41 111.641 -177.037 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 204' ' ' GLY . . . . . 0.498 ' HA3' ' HA3' ' A' ' 173' ' ' GLY . . . -72.71 173.97 46.49 Favored Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 121.306 -0.474 . . . . 73.33 112.042 -179.339 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.439 HD23 ' HA ' ' A' ' 172' ' ' LEU . 3.6 mm? -63.11 -33.96 76.59 Favored 'General case' 0 N--CA 1.438 -1.069 0 C-N-CA 123.059 0.544 . . . . 71.23 111.75 -176.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -65.03 -43.26 92.98 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.067 0.46 . . . . 64.44 110.924 179.236 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.505 ' HG3' ' HA ' ' A' ' 202' ' ' PRO . 3.6 tm-20 -75.75 -40.1 56.02 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.033 -0.531 . . . . 61.44 109.998 178.656 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 33.3 t -57.97 -36.95 73.32 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.193 0.597 . . . . 63.13 110.959 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 209' ' ' THR . . . . . 0.544 HG23 ' H ' ' A' ' 211' ' ' LEU . 11.7 t -81.38 -37.22 28.54 Favored 'General case' 0 N--CA 1.435 -1.188 0 C-N-CA 119.557 -0.857 . . . . 73.12 109.644 175.522 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 71.35 26.06 74.18 Favored Glycine 0 C--N 1.341 0.813 0 N-CA-C 112.14 -0.384 . . . . 52.33 112.14 178.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.544 ' H ' HG23 ' A' ' 209' ' ' THR . 43.0 mt -116.09 -4.24 12.0 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.577 0.703 . . . . 75.24 110.075 -177.728 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 60.1 mt -109.25 134.44 51.76 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 114.91 -1.041 . . . . 63.31 110.891 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -131.3 161.69 31.75 Favored 'General case' 0 N--CA 1.42 -1.967 0 N-CA-C 108.656 -0.868 . . . . 74.41 108.656 177.36 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 214' ' ' VAL . . . . . 0.495 ' HA ' ' HB ' ' A' ' 197' ' ' ILE . 33.8 m -62.2 -30.59 49.17 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 CA-C-O 121.377 0.608 . . . . 63.32 112.579 179.553 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -71.55 -14.26 62.04 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 116.123 -0.49 . . . . 75.44 112.143 -178.245 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.49 ' HB3' ' HB ' ' A' ' 249' ' ' VAL . 61.9 m-20 -74.19 139.15 44.24 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 112.754 0.65 . . . . 70.24 112.754 -176.183 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -110.01 137.52 47.67 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 124.975 1.31 . . . . 62.52 108.696 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.52 HG12 ' O ' ' A' ' 195' ' ' ILE . 12.1 p -83.82 138.41 19.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 122.103 0.954 . . . . 64.14 112.625 -175.545 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.657 HG13 ' NE2' ' A' ' 158' ' ' HIS . 44.1 mm -105.62 -44.75 8.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 114.731 -1.122 . . . . 75.02 111.058 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -161.12 154.98 22.31 Favored 'General case' 0 C--O 1.245 0.837 0 CA-C-N 116.511 -0.313 . . . . 65.42 110.75 -178.608 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.414 HG11 ' HB2' ' A' ' 237' ' ' MET . 8.3 p -126.45 121.41 58.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 C-N-CA 123.786 0.834 . . . . 61.44 109.006 178.089 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 222' ' ' ASN . . . . . 0.473 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 18.7 t-20 65.09 15.52 10.04 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.322 1.049 . . . . 73.23 110.456 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 99.35 -8.12 60.32 Favored Glycine 0 N--CA 1.437 -1.261 0 C-N-CA 120.347 -0.93 . . . . 42.33 111.523 -177.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 64.0 mt -91.08 123.06 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.162 0 N-CA-C 108.787 -0.819 . . . . 73.12 108.787 179.668 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 225' ' ' GLU . . . . . 0.443 ' HG3' ' HE3' ' A' ' 229' ' ' LYS . 11.6 pt-20 -55.45 131.19 45.34 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 124.24 0.962 . . . . 62.31 111.063 179.421 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 35.8 m -109.88 10.13 8.85 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 CA-C-O 121.876 0.846 . . . . 73.32 109.288 174.748 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -73.26 98.08 2.58 Favored 'General case' 0 N--CA 1.424 -1.737 0 CA-C-N 114.422 -1.263 . . . . 64.35 110.799 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 228' ' ' GLY . . . . . 0.437 ' HA2' ' HD2' ' A' ' 193' ' ' PRO . . . 101.23 5.29 52.86 Favored Glycine 0 N--CA 1.44 -1.092 0 C-N-CA 120.894 -0.67 . . . . 34.44 112.46 176.319 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 229' ' ' LYS . . . . . 0.443 ' HE3' ' HG3' ' A' ' 225' ' ' GLU . 68.3 mmtt -90.31 156.66 18.11 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 107.524 -1.287 . . . . 74.43 107.524 -178.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 230' ' ' THR . . . . . 0.633 ' OG1' ' HG2' ' A' ' 233' ' ' GLN . 81.5 p -79.97 166.52 21.51 Favored 'General case' 0 C--O 1.248 0.998 0 C-N-CA 118.905 -1.118 . . . . 72.21 110.067 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 231' ' ' LEU . . . . . 0.436 ' HA ' HG22 ' A' ' 234' ' ' VAL . 3.3 tm? -61.02 -39.76 90.99 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 108.946 -0.761 . . . . 75.05 108.946 179.065 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -63.86 -31.01 72.05 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.078 -0.51 . . . . 73.11 110.626 177.145 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 233' ' ' GLN . . . . . 0.633 ' HG2' ' OG1' ' A' ' 230' ' ' THR . 13.3 mm-40 -74.14 -51.37 15.82 Favored 'General case' 0 C--O 1.216 -0.683 0 C-N-CA 119.478 -0.889 . . . . 65.21 110.211 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.566 HG21 HG12 ' A' ' 195' ' ' ILE . 21.2 m -65.99 -34.22 68.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 113.041 0.756 . . . . 71.32 113.041 -173.279 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 42.6 m -74.42 -35.49 63.4 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 109.056 -0.72 . . . . 74.32 109.056 -173.75 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -63.15 -34.25 77.21 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-N 115.376 -0.829 . . . . 73.5 108.835 177.781 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 237' ' ' MET . . . . . 0.493 ' HG3' ' O ' ' A' ' 233' ' ' GLN . 10.3 mtm -72.88 -42.01 64.1 Favored 'General case' 0 C--O 1.201 -1.478 0 CA-C-N 115.117 -0.947 . . . . 74.02 108.546 -179.485 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 238' ' ' MET . . . . . 0.483 ' HG3' ' O ' ' A' ' 234' ' ' VAL . 65.4 mtt -61.6 -40.16 93.8 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.486 -0.325 . . . . 74.52 111.568 178.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 96.0 t -68.76 -43.12 83.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.198 0.523 . . . . 75.12 111.004 178.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -68.68 -34.31 75.46 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.424 0.631 . . . . 62.32 110.555 179.172 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -88.81 15.44 8.35 Favored 'General case' 0 C--O 1.19 -2.053 0 CA-C-N 115.425 -0.807 . . . . 71.41 111.923 178.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 242' ' ' SER . . . . . 0.4 ' O ' HD13 ' A' ' 164' ' ' LEU . 69.9 m -66.74 -23.26 66.07 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 114.363 1.246 . . . . 51.13 114.363 -178.423 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 20.5 m -63.94 -29.63 70.79 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 118.131 0.423 . . . . 74.44 110.735 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 244' ' ' ASN . . . . . 0.42 ' HA ' ' O ' ' A' ' 164' ' ' LEU . 42.6 m-80 -156.0 89.68 1.16 Allowed 'General case' 0 C--O 1.248 1.015 0 N-CA-C 106.381 -1.711 . . . . 71.21 106.381 173.832 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.478 ' HB3' ' HB2' ' A' ' 163' ' ' LEU . 1.6 tt -85.28 103.55 14.33 Favored 'General case' 0 C--O 1.205 -1.274 0 CA-C-O 121.269 0.557 . . . . 74.21 109.846 -172.063 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.473 ' HB ' ' HA ' ' A' ' 222' ' ' ASN . 75.5 mt -96.48 116.19 37.83 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.348 0 N-CA-C 109.373 -0.603 . . . . 73.03 109.373 179.053 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 247' ' ' ILE . . . . . 0.51 HG23 HG23 ' A' ' 218' ' ' VAL . 9.8 mt -125.84 137.81 56.53 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 CA-C-O 121.551 0.691 . . . . 71.14 112.446 177.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.471 ' HA ' ' O ' ' A' ' 159' ' ' ARG . 49.9 m -107.43 121.87 45.47 Favored 'General case' 0 N--CA 1.423 -1.815 0 CA-C-N 114.717 -1.129 . . . . 73.11 107.985 174.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.503 HG12 ' HA ' ' A' ' 218' ' ' VAL . 15.4 m -125.74 166.44 21.73 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 CA-C-O 121.126 0.489 . . . . 71.31 110.552 176.627 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 16.8 ptmt -138.64 134.01 17.07 Favored Pre-proline 0 C--N 1.285 -2.209 0 CA-C-N 114.471 -1.24 . . . . 74.44 107.763 174.536 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 251' ' ' PRO . . . . . 0.411 ' HA ' ' HA ' ' A' ' 216' ' ' ASP . 23.8 Cg_exo . . . . . 0 N--CA 1.449 -1.112 0 C-N-CA 121.619 1.546 . . . . 74.21 111.166 178.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 1.9 m80 . . . . . 0 N--CA 1.428 -1.538 0 N-CA-C 109.738 -0.467 . . . . 62.1 109.738 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.447 ' CZ ' HG22 ' A' ' 161' ' ' VAL . 0.0 OUTLIER -127.63 142.0 51.47 Favored 'General case' 0 C--N 1.283 -2.288 0 N-CA-C 104.971 -2.233 . . . . 72.03 104.971 173.726 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -132.42 110.82 10.8 Favored 'General case' 0 C--N 1.285 -2.223 0 C-N-CA 117.718 -1.593 . . . . 75.21 111.065 -179.356 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.548 HG11 HD12 ' A' ' 211' ' ' LEU . 30.3 m -113.56 140.31 34.51 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 CA-C-N 114.724 -1.125 . . . . 43.24 111.787 175.251 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 26.0 ttm180 -84.86 114.65 22.26 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 115.617 -0.72 . . . . 75.54 109.121 178.457 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.544 ' HB2' ' HB2' ' A' ' 245' ' ' LEU . 13.8 mt -87.47 127.27 35.23 Favored 'General case' 0 N--CA 1.421 -1.916 0 N-CA-C 107.078 -1.453 . . . . 73.31 107.078 -179.408 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.58 HD13 ' O ' ' A' ' 242' ' ' SER . 5.5 tt . . . . . 0 C--N 1.3 -1.563 0 CA-C-O 122.378 1.085 . . . . 75.41 110.416 178.3 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 3.7 mm? . . . . . 0 CA--C 1.509 -0.598 0 CA-C-O 120.791 0.329 . . . . 72.44 110.166 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 173' ' ' GLY . . . . . 0.505 ' HA3' ' HA3' ' A' ' 204' ' ' GLY . . . 90.24 51.44 2.76 Favored Glycine 0 N--CA 1.434 -1.45 0 CA-C-N 115.679 -0.691 . . . . 51.34 114.806 174.859 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -162.58 154.61 18.62 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 108.521 -0.918 . . . . 64.1 108.521 175.233 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -121.2 140.83 51.5 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 108.244 -1.021 . . . . 75.01 108.244 176.785 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.513 HD13 ' SD ' ' A' ' 238' ' ' MET . 28.6 pt -112.32 165.25 7.4 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.845 0 CA-C-O 121.04 0.448 . . . . 71.55 111.339 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.511 ' CG ' ' HB2' ' A' ' 198' ' ' SER . 27.3 ptt180 -149.69 154.98 39.43 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 115.566 -0.743 . . . . 73.5 110.703 -175.372 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 178' ' ' ASP . . . . . 0.47 ' HB2' ' HB2' ' A' ' 231' ' ' LEU . 9.2 t70 -100.95 138.54 37.86 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 115.706 -0.679 . . . . 64.01 109.946 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -149.11 135.41 5.37 Favored Glycine 0 C--N 1.277 -2.743 0 N-CA-C 107.622 -2.191 . . . . 50.23 107.622 175.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 180' ' ' THR . . . . . 0.485 HG22 ' HG2' ' A' ' 191' ' ' LYS . 0.4 OUTLIER -86.53 122.63 30.73 Favored 'General case' 0 C--N 1.282 -2.361 0 C-N-CA 118.54 -1.264 . . . . 63.41 107.799 -175.962 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 10.9 t . . . . . 0 C--N 1.287 -2.146 0 C-N-CA 123.821 0.848 . . . . 63.11 109.01 -174.742 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.485 ' HG2' HG22 ' A' ' 180' ' ' THR . 32.5 ttmt . . . . . 0 N--CA 1.418 -2.029 0 N-CA-C 107.795 -1.187 . . . . 65.23 107.795 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.47 145.49 19.3 Favored Pre-proline 0 C--N 1.313 -1.005 0 CA-C-N 116.125 -0.489 . . . . 74.23 109.78 -171.666 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -56.82 130.84 42.02 Favored 'Trans proline' 0 C--O 1.242 0.708 0 C-N-CA 121.879 1.719 . . . . 43.34 113.784 -176.664 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -137.85 137.38 8.82 Favored Glycine 0 N--CA 1.414 -2.812 0 N-CA-C 109.03 -1.628 . . . . 73.01 109.03 177.534 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.634 HG12 HG21 ' A' ' 234' ' ' VAL . 3.1 mp -104.1 136.59 36.6 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.894 0 CA-C-O 121.355 0.598 . . . . 63.14 110.01 -179.211 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -126.76 165.94 18.34 Favored 'General case' 0 C--N 1.284 -2.25 0 N-CA-C 108.017 -1.105 . . . . 74.54 108.017 -177.22 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 197' ' ' ILE . . . . . 0.44 ' HB ' ' O ' ' A' ' 213' ' ' ALA . 49.1 mm -78.67 131.52 34.26 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 N-CA-C 108.464 -0.939 . . . . 70.42 108.464 174.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 198' ' ' SER . . . . . 0.511 ' HB2' ' CG ' ' A' ' 177' ' ' ARG . 11.2 t -101.92 -28.71 12.24 Favored 'General case' 0 C--N 1.284 -2.246 0 O-C-N 121.889 -0.507 . . . . 61.55 112.017 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 60.7 ttt180 -167.84 147.43 4.9 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 116.697 -0.229 . . . . 73.54 110.773 -176.363 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 85.7 mt -103.65 146.28 28.81 Favored 'General case' 0 CA--C 1.496 -1.134 0 N-CA-C 108.727 -0.842 . . . . 74.54 108.727 171.428 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 46.2 t -105.58 115.48 61.68 Favored Pre-proline 0 C--N 1.288 -2.07 0 N-CA-C 105.932 -1.877 . . . . 74.11 105.932 171.328 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 202' ' ' PRO . . . . . 0.466 ' HA ' ' HG3' ' A' ' 207' ' ' GLU . 16.7 Cg_endo -58.56 132.4 48.11 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 122.042 1.828 . . . . 70.04 111.218 -177.239 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 102.1 -18.98 50.7 Favored Glycine 0 N--CA 1.438 -1.196 0 N-CA-C 110.713 -0.955 . . . . 63.43 110.713 -175.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 204' ' ' GLY . . . . . 0.505 ' HA3' ' HA3' ' A' ' 173' ' ' GLY . . . -78.5 164.79 51.07 Favored Glycine 0 N--CA 1.434 -1.484 0 N-CA-C 111.018 -0.833 . . . . 45.01 111.018 178.531 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.4 HD22 ' H ' ' A' ' 205' ' ' LEU . 2.9 mm? -61.24 -35.67 77.89 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 123.284 0.634 . . . . 75.51 111.434 -175.485 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 206' ' ' ALA . . . . . 0.42 ' CB ' HD12 ' A' ' 212' ' ' LEU . . . -60.7 -47.41 86.41 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.629 -0.714 . . . . 65.12 110.732 179.647 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.466 ' HG3' ' HA ' ' A' ' 202' ' ' PRO . 3.2 tm-20 -75.46 -34.55 60.94 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.209 -0.905 . . . . 71.12 110.156 -179.668 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 48.7 m -56.96 -42.67 80.54 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 122.919 0.488 . . . . 72.2 111.837 179.546 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 209' ' ' THR . . . . . 0.588 HG23 ' H ' ' A' ' 211' ' ' LEU . 14.9 t -87.1 -24.41 24.56 Favored 'General case' 0 N--CA 1.439 -1.0 0 C-N-CA 119.483 -0.887 . . . . 72.35 110.805 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 70.05 15.1 71.65 Favored Glycine 0 C--N 1.339 0.74 0 CA-C-O 121.498 0.499 . . . . 54.14 112.555 178.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.588 ' H ' HG23 ' A' ' 209' ' ' THR . 64.5 mt -102.03 13.14 35.57 Favored 'General case' 0 CA--C 1.495 -1.152 0 CA-C-O 121.592 0.71 . . . . 75.44 110.395 -177.299 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.42 HD12 ' CB ' ' A' ' 206' ' ' ALA . 30.2 mt -122.02 130.57 53.41 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 114.465 -1.243 . . . . 55.04 110.429 171.293 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 213' ' ' ALA . . . . . 0.44 ' O ' ' HB ' ' A' ' 197' ' ' ILE . . . -132.51 160.35 36.75 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 124.447 1.099 . . . . 51.15 108.344 176.657 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 17.5 m -61.38 -29.74 46.58 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 CA-C-O 121.653 0.74 . . . . 73.45 112.226 -179.18 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -75.53 -14.32 60.4 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 113.069 0.766 . . . . 70.34 113.069 -179.711 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.402 ' HB3' ' HB ' ' A' ' 249' ' ' VAL . 63.3 m-20 -71.08 131.65 43.93 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 112.334 0.494 . . . . 71.51 112.334 -177.507 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -101.94 129.18 48.15 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.108 -0.951 . . . . 71.41 108.672 178.216 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.591 ' HA ' HG12 ' A' ' 249' ' ' VAL . 10.2 p -79.44 137.2 22.16 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-O 121.597 0.713 . . . . 75.44 111.523 -176.029 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.419 HD11 ' HD2' ' A' ' 250' ' ' LYS . 45.6 mm -104.78 -48.34 9.54 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 CA-C-N 115.178 -0.919 . . . . 75.44 111.16 -178.308 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.403 ' HA ' HG22 ' A' ' 226' ' ' VAL . 10.1 pt-20 -153.23 151.99 30.69 Favored 'General case' 0 C--O 1.245 0.827 0 CA-C-N 116.675 -0.239 . . . . 64.31 111.355 -178.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.516 HG12 ' CG1' ' A' ' 226' ' ' VAL . 14.2 p -124.09 129.64 74.09 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 N-CA-C 107.814 -1.18 . . . . 61.1 107.814 173.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 222' ' ' ASN . . . . . 0.548 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 23.1 t-20 75.01 -36.35 0.31 Allowed 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 126.462 1.905 . . . . 64.01 111.711 -176.65 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 223' ' ' GLY . . . . . 0.439 ' H ' ' C ' ' A' ' 221' ' ' VAL . . . 149.26 -6.08 0.79 Allowed Glycine 0 C--N 1.277 -2.717 0 N-CA-C 109.904 -1.278 . . . . 71.3 109.904 -174.892 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 71.9 mt -94.81 129.32 45.15 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.312 0 N-CA-C 108.223 -1.028 . . . . 72.51 108.223 179.523 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -62.02 138.17 58.34 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-O 121.531 0.682 . . . . 71.13 110.585 -179.227 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 226' ' ' VAL . . . . . 0.549 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 31.6 m -118.91 -2.62 9.52 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.22 0 CA-C-N 115.604 -0.726 . . . . 75.21 109.659 176.308 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -82.8 93.69 7.5 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 108.435 -0.95 . . . . 72.2 108.435 179.018 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 130.46 -17.59 5.29 Favored Glycine 0 N--CA 1.428 -1.853 0 N-CA-C 110.275 -1.13 . . . . 60.03 110.275 -176.275 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -85.43 167.81 15.17 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 107.423 -1.325 . . . . 74.41 107.423 174.737 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 230' ' ' THR . . . . . 0.461 ' O ' HG13 ' A' ' 234' ' ' VAL . 40.6 p -94.74 171.72 8.61 Favored 'General case' 0 C--N 1.295 -1.765 0 C-N-CA 119.942 -0.703 . . . . 73.23 109.183 178.574 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 231' ' ' LEU . . . . . 0.47 ' HB2' ' HB2' ' A' ' 178' ' ' ASP . 49.9 tp -60.04 -39.25 85.28 Favored 'General case' 0 N--CA 1.432 -1.375 0 CA-C-O 120.677 0.275 . . . . 75.05 111.208 -176.706 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -58.54 -48.31 81.32 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 121.427 0.632 . . . . 62.22 109.999 177.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -61.96 -45.13 95.01 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.786 -1.097 . . . . 75.33 112.492 -179.162 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.634 HG21 HG12 ' A' ' 195' ' ' ILE . 6.7 m -73.96 -33.42 36.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-O 121.027 0.441 . . . . 64.42 112.013 -175.789 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 235' ' ' THR . . . . . 0.444 ' O ' HG23 ' A' ' 239' ' ' VAL . 48.3 m -74.03 -36.7 64.45 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 108.713 -0.847 . . . . 71.33 108.713 -174.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -59.25 -34.64 72.47 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 115.326 -0.852 . . . . 71.45 109.131 177.502 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 237' ' ' MET . . . . . 0.506 ' HB2' HG11 ' A' ' 221' ' ' VAL . 5.7 mtt -73.34 -44.44 58.8 Favored 'General case' 0 C--O 1.2 -1.551 0 N-CA-C 108.954 -0.758 . . . . 61.32 108.954 -179.726 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 238' ' ' MET . . . . . 0.513 ' SD ' HD13 ' A' ' 176' ' ' ILE . 65.7 mtt -59.95 -40.12 87.93 Favored 'General case' 0 C--O 1.214 -0.808 0 CA-C-O 120.543 0.211 . . . . 63.45 111.234 -178.257 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 235' ' ' THR . 93.9 t -65.75 -37.85 80.88 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 N-CA-C 109.736 -0.468 . . . . 54.42 109.736 177.313 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -76.74 -17.21 59.21 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.192 -0.458 . . . . 61.24 112.083 179.31 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -110.91 21.64 16.23 Favored 'General case' 0 C--O 1.205 -1.278 0 CA-C-N 116.45 -0.341 . . . . 71.24 110.463 176.551 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 242' ' ' SER . . . . . 0.58 ' O ' HD13 ' A' ' 164' ' ' LEU . 36.1 p -64.39 -22.78 67.07 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 112.966 0.728 . . . . 74.13 112.966 -178.219 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 18.1 m -79.22 -9.3 59.53 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 120.793 -0.363 . . . . 55.02 110.782 179.313 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -178.65 97.36 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.747 1.219 . . . . 72.04 110.894 175.606 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.544 ' HB2' ' HB2' ' A' ' 163' ' ' LEU . 14.1 mt -87.92 111.83 21.88 Favored 'General case' 0 C--O 1.192 -1.932 0 N-CA-C 113.375 0.88 . . . . 75.44 113.375 -177.742 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.548 ' HB ' ' HA ' ' A' ' 222' ' ' ASN . 66.1 mt -95.93 115.93 36.39 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.542 0 N-CA-C 106.173 -1.788 . . . . 71.42 106.173 170.836 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 247' ' ' ILE . . . . . 0.404 HG23 HG23 ' A' ' 218' ' ' VAL . 67.5 mt -130.63 128.01 62.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 C-N-CA 119.649 -0.82 . . . . 64.14 112.547 -177.08 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 86.2 m -103.12 128.7 49.95 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 115.048 -0.978 . . . . 40.24 108.751 175.479 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.591 HG12 ' HA ' ' A' ' 218' ' ' VAL . 27.3 m -132.66 167.46 26.54 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 108.207 -1.034 . . . . 74.33 108.207 173.552 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 250' ' ' LYS . . . . . 0.419 ' HD2' HD11 ' A' ' 219' ' ' ILE . 0.0 OUTLIER -138.82 136.54 18.64 Favored Pre-proline 0 C--N 1.284 -2.267 0 CA-C-N 115.31 -0.859 . . . . 72.45 110.964 172.675 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo . . . . . 0 C--O 1.246 0.885 0 C-N-CA 123.535 2.823 . . . . 60.35 113.554 -177.826 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.48 ' NE2' HG13 ' A' ' 219' ' ' ILE . 49.9 m170 . . . . . 0 CA--C 1.486 -1.5 0 CA-C-O 121.164 0.507 . . . . 73.34 112.08 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.637 ' O ' ' HA ' ' A' ' 248' ' ' THR . 6.6 ptp180 -125.8 142.08 51.69 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 107.598 -1.26 . . . . 71.25 107.598 177.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.417 ' HA ' ' O ' ' A' ' 247' ' ' ILE . 13.6 ptp180 -132.15 113.06 12.85 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 121.814 0.816 . . . . 75.44 111.277 177.121 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.671 ' O ' ' HA ' ' A' ' 246' ' ' ILE . 30.0 m -105.68 139.89 25.43 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 CA-C-N 114.554 -1.203 . . . . 62.14 112.402 -177.635 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.68 ' HG3' HG12 ' A' ' 246' ' ' ILE . 5.4 mpt_? -99.98 114.7 28.16 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 107.532 -1.284 . . . . 65.51 107.532 175.819 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.579 ' HB2' ' HB3' ' A' ' 245' ' ' LEU . 23.8 mt -114.41 139.91 49.11 Favored 'General case' 0 C--N 1.31 -1.137 0 C-N-CA 123.142 0.577 . . . . 73.04 111.368 -174.851 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.635 HD12 ' O ' ' A' ' 242' ' ' SER . 0.9 OUTLIER . . . . . 0 N--CA 1.485 1.303 0 C-N-CA 123.877 0.871 . . . . 70.13 112.083 167.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.51 ' HG ' ' CD1' ' A' ' 245' ' ' LEU . 2.8 mm? . . . . . 0 CA--C 1.501 -0.919 0 N-CA-C 112.102 0.408 . . . . 65.3 112.102 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 173' ' ' GLY . . . . . 0.502 ' HA3' ' HA3' ' A' ' 204' ' ' GLY . . . 93.74 14.91 51.55 Favored Glycine 0 N--CA 1.424 -2.133 0 C-N-CA 120.346 -0.93 . . . . 50.1 112.292 177.849 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -139.45 152.54 47.11 Favored 'General case' 0 N--CA 1.426 -1.653 0 N-CA-C 106.056 -1.831 . . . . 74.42 106.056 173.072 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -127.76 149.31 50.3 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-O 120.858 0.361 . . . . 71.52 110.953 -178.188 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.413 HD13 ' SD ' ' A' ' 238' ' ' MET . 37.8 pt -110.49 169.02 3.95 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 CA-C-N 115.552 -0.749 . . . . 73.15 110.374 -179.021 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.578 ' CG ' ' HB2' ' A' ' 198' ' ' SER . 15.7 ptt180 -151.52 154.88 37.39 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 124.166 0.986 . . . . 63.41 109.351 -178.641 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -108.85 138.0 45.88 Favored 'General case' 0 C--N 1.293 -1.886 0 O-C-N 123.464 0.477 . . . . 74.21 109.86 -179.51 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -150.46 157.08 27.04 Favored Glycine 0 C--N 1.27 -3.088 0 N-CA-C 107.507 -2.237 . . . . 61.53 107.507 176.352 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 180' ' ' THR . . . . . 0.6 ' CG2' ' HG2' ' A' ' 191' ' ' LYS . 0.2 OUTLIER -86.65 121.58 29.37 Favored 'General case' 0 C--N 1.284 -2.252 0 C-N-CA 117.317 -1.753 . . . . 73.55 106.655 179.431 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 181' ' ' SER . . . . . 0.5 ' O ' ' HA ' ' A' ' 191' ' ' LYS . 31.2 t . . . . . 0 N--CA 1.414 -2.272 0 N-CA-C 108.758 -0.83 . . . . 54.42 108.758 -176.518 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.6 ' HG2' ' CG2' ' A' ' 180' ' ' THR . 37.2 ttmt . . . . . 0 N--CA 1.425 -1.68 0 N-CA-C 109.207 -0.664 . . . . 61.25 109.207 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -151.91 163.48 23.45 Favored Pre-proline 0 C--N 1.301 -1.538 0 N-CA-C 107.859 -1.163 . . . . 72.24 107.859 -176.6 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -58.96 132.23 46.26 Favored 'Trans proline' 0 C--O 1.255 1.332 0 C-N-CA 121.032 1.154 . . . . 72.12 110.689 176.768 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -141.99 135.56 6.78 Favored Glycine 0 N--CA 1.411 -2.968 0 N-CA-C 110.017 -1.233 . . . . 61.32 110.017 -178.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.649 HG12 HG21 ' A' ' 234' ' ' VAL . 3.2 mp -104.14 132.74 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.789 0 CA-C-O 121.457 0.646 . . . . 55.33 110.862 -178.731 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -124.76 167.75 14.15 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 107.543 -1.281 . . . . 63.42 107.543 -177.402 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 45.6 mt -85.69 131.96 33.1 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 N-CA-C 108.876 -0.787 . . . . 71.4 108.876 175.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 198' ' ' SER . . . . . 0.578 ' HB2' ' CG ' ' A' ' 177' ' ' ARG . 28.2 t -102.49 -30.71 10.83 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 113.727 1.01 . . . . 53.2 113.727 -177.101 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 13.4 ttp180 -165.16 144.47 6.7 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 120.013 -0.675 . . . . 70.24 112.185 -176.044 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 69.0 mt -106.51 141.01 38.5 Favored 'General case' 0 CA--C 1.494 -1.183 0 CA-C-N 115.169 -0.923 . . . . 72.4 109.575 173.411 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 47.5 t -109.71 114.81 56.41 Favored Pre-proline 0 C--N 1.285 -2.232 0 N-CA-C 105.748 -1.945 . . . . 64.33 105.748 171.36 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 202' ' ' PRO . . . . . 0.495 ' HA ' ' OE1' ' A' ' 207' ' ' GLU . 73.6 Cg_exo -53.31 126.15 20.72 Favored 'Trans proline' 0 C--O 1.244 0.804 0 C-N-CA 122.342 2.028 . . . . 53.05 110.838 179.409 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 110.69 -16.12 28.83 Favored Glycine 0 C--N 1.312 -0.767 0 C-N-CA 120.95 -0.643 . . . . 63.31 111.514 -175.838 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 204' ' ' GLY . . . . . 0.502 ' HA3' ' HA3' ' A' ' 173' ' ' GLY . . . -77.08 158.2 47.75 Favored Glycine 0 N--CA 1.441 -0.972 0 C-N-CA 121.147 -0.549 . . . . 71.31 111.924 178.503 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -53.84 -48.57 69.81 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 124.201 1.0 . . . . 55.43 112.263 -176.332 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -68.99 -32.24 71.65 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.776 -0.647 . . . . 74.33 111.33 -178.477 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.495 ' OE1' ' HA ' ' A' ' 202' ' ' PRO . 2.5 tm-20 -75.89 -44.41 40.6 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.658 -0.701 . . . . 65.23 109.282 -177.776 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 50.7 m -57.87 -33.38 68.63 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.338 0.496 . . . . 73.42 112.338 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 209' ' ' THR . . . . . 0.463 HG23 ' H ' ' A' ' 211' ' ' LEU . 11.3 t -83.16 -17.44 42.9 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 119.945 -0.702 . . . . 71.41 110.989 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 64.65 17.08 62.03 Favored Glycine 0 C--N 1.334 0.436 0 CA-C-N 116.439 -0.346 . . . . 74.41 113.621 178.334 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.463 ' H ' HG23 ' A' ' 209' ' ' THR . 76.3 mt -95.69 -22.34 17.62 Favored 'General case' 0 C--O 1.199 -1.59 0 C-N-CA 120.224 -0.59 . . . . 71.41 110.776 -177.271 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.513 HD11 HG21 ' A' ' 161' ' ' VAL . 6.9 mp -107.22 134.1 50.81 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-O 121.366 0.603 . . . . 54.4 111.102 -178.308 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -131.27 165.39 23.5 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-N 114.23 -1.35 . . . . 75.11 109.88 -179.284 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 33.3 m -65.09 -29.39 47.2 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 N-CA-C 113.66 0.985 . . . . 65.24 113.66 -179.209 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -74.85 -14.14 60.64 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.7 -0.625 . . . . 74.42 111.252 -178.233 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.502 ' HB3' ' HB ' ' A' ' 249' ' ' VAL . 79.8 m-20 -66.69 142.97 57.24 Favored 'General case' 0 C--O 1.247 0.971 0 N-CA-C 112.984 0.735 . . . . 52.51 112.984 -176.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 217' ' ' GLU . . . . . 0.419 ' HB3' ' HG3' ' A' ' 250' ' ' LYS . 41.1 tt0 -109.21 133.13 53.42 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.635 -1.166 . . . . 74.34 108.802 177.634 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.644 ' HA ' HG12 ' A' ' 249' ' ' VAL . 20.7 t -84.36 130.68 35.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.496 0.665 . . . . 73.03 111.289 -174.546 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.48 HG13 ' NE2' ' A' ' 158' ' ' HIS . 44.0 mm -99.44 -56.86 4.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-N 115.168 -0.923 . . . . 75.11 111.652 -177.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.409 ' HB3' ' HA ' ' A' ' 225' ' ' GLU . 10.9 pt-20 -155.02 151.2 28.16 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 116.108 -0.497 . . . . 70.23 110.503 -176.362 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.507 ' HA ' ' O ' ' A' ' 246' ' ' ILE . 8.6 p -120.33 122.71 68.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 CA-C-N 115.648 -0.705 . . . . 63.34 109.24 177.793 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 222' ' ' ASN . . . . . 0.438 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 2.5 m-20 58.24 24.58 11.63 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.656 1.183 . . . . 53.33 112.474 -177.347 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 95.69 -7.23 67.97 Favored Glycine 0 N--CA 1.435 -1.418 0 CA-C-N 115.377 -0.829 . . . . 64.13 111.853 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 62.1 mt -97.31 122.63 49.07 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.509 0 N-CA-C 108.899 -0.778 . . . . 75.42 108.899 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 225' ' ' GLU . . . . . 0.409 ' HA ' ' HB3' ' A' ' 220' ' ' GLU . 11.1 pt-20 -61.83 139.33 58.36 Favored 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 123.704 0.802 . . . . 72.23 112.674 -176.565 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 226' ' ' VAL . . . . . 0.465 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 34.3 m -117.11 3.21 7.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 CA-C-N 115.376 -0.829 . . . . 64.13 109.798 175.503 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -75.67 99.11 4.24 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 115.224 -0.898 . . . . 73.51 109.816 -179.723 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 113.26 -8.84 24.75 Favored Glycine 0 CA--C 1.5 -0.846 0 N-CA-C 110.983 -0.847 . . . . 52.32 110.983 179.316 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -83.14 158.27 22.45 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.781 -0.822 . . . . 70.43 108.781 178.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 230' ' ' THR . . . . . 0.444 ' O ' HG13 ' A' ' 234' ' ' VAL . 82.7 p -84.02 170.7 13.66 Favored 'General case' 0 N--CA 1.412 -2.35 0 C-N-CA 119.584 -0.846 . . . . 73.12 110.397 178.67 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -61.85 -37.78 85.76 Favored 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 109.139 -0.689 . . . . 75.55 109.139 179.249 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -58.7 -52.29 66.34 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.198 0.523 . . . . 73.33 110.054 175.187 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 233' ' ' GLN . . . . . 0.504 ' O ' ' HG2' ' A' ' 237' ' ' MET . 39.6 mt-30 -54.78 -44.76 74.0 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.606 -1.179 . . . . 63.15 112.481 179.337 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.649 HG21 HG12 ' A' ' 195' ' ' ILE . 8.2 m -77.12 -34.47 21.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 112.438 0.533 . . . . 55.31 112.438 -176.563 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 235' ' ' THR . . . . . 0.446 ' O ' HG23 ' A' ' 239' ' ' VAL . 31.9 m -71.25 -35.81 71.55 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 109.522 -0.548 . . . . 61.43 109.522 -179.128 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -63.38 -31.14 72.21 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 109.722 -0.473 . . . . 72.34 109.722 176.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 237' ' ' MET . . . . . 0.504 ' HG2' ' O ' ' A' ' 233' ' ' GLN . 17.2 mmt -62.54 -52.55 63.0 Favored 'General case' 0 C--O 1.195 -1.767 0 N-CA-C 107.9 -1.148 . . . . 73.25 107.9 174.643 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 238' ' ' MET . . . . . 0.419 ' HG3' ' O ' ' A' ' 234' ' ' VAL . 59.5 mtt -63.93 -33.02 74.77 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.159 -0.928 . . . . 52.42 112.843 -173.86 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 235' ' ' THR . 85.7 t -68.96 -44.12 81.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 N-CA-C 109.175 -0.676 . . . . 74.42 109.175 175.691 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -66.91 -36.3 81.95 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.85 -0.614 . . . . 74.52 110.594 178.621 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -87.29 22.13 2.22 Favored 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 124.364 1.066 . . . . 75.42 111.612 179.463 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 242' ' ' SER . . . . . 0.635 ' O ' HD12 ' A' ' 164' ' ' LEU . 34.3 t -58.76 -42.29 88.54 Favored 'General case' 0 C--O 1.204 -1.334 0 CA-C-N 118.112 0.415 . . . . 72.24 112.064 -179.683 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 37.5 m -74.21 -16.98 60.95 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 112.405 0.52 . . . . 50.51 112.405 -178.411 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -153.18 85.12 1.21 Allowed 'General case' 0 CA--C 1.5 -0.949 0 N-CA-C 108.447 -0.946 . . . . 73.44 108.447 179.348 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.579 ' HB3' ' HB2' ' A' ' 163' ' ' LEU . 2.0 tt -92.03 105.78 17.95 Favored 'General case' 0 N--CA 1.432 -1.343 0 C-N-CA 119.694 -0.803 . . . . 74.43 109.732 -177.7 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.68 HG12 ' HG3' ' A' ' 162' ' ' ARG . 93.2 mt -109.19 115.4 49.45 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 O-C-N 121.882 -0.511 . . . . 72.03 110.19 177.167 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 247' ' ' ILE . . . . . 0.483 HG13 ' CD2' ' A' ' 245' ' ' LEU . 27.4 mt -119.26 133.27 66.64 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 N-CA-C 112.838 0.681 . . . . 71.13 112.838 177.539 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.637 ' HA ' ' O ' ' A' ' 159' ' ' ARG . 63.5 m -102.92 117.0 33.64 Favored 'General case' 0 N--CA 1.417 -2.095 0 CA-C-N 114.484 -1.235 . . . . 74.42 108.087 173.904 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.644 HG12 ' HA ' ' A' ' 218' ' ' VAL . 18.9 m -122.54 165.57 18.35 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.064 0 CA-C-O 121.194 0.521 . . . . 72.54 110.198 175.897 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 250' ' ' LYS . . . . . 0.434 ' HB3' ' CD2' ' A' ' 158' ' ' HIS . 15.0 ptmt -129.46 128.53 23.15 Favored Pre-proline 0 C--N 1.277 -2.576 0 C-N-CA 125.137 1.375 . . . . 63.12 107.621 176.248 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo . . . . . 0 N--CA 1.441 -1.613 0 N-CA-C 109.598 -0.962 . . . . 74.12 109.598 176.214 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.615 ' NE2' HG13 ' A' ' 219' ' ' ILE . 4.0 m80 . . . . . 0 N--CA 1.432 -1.356 0 N-CA-C 108.622 -0.881 . . . . 73.13 108.622 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.502 HH11 HD22 ' A' ' 211' ' ' LEU . 36.7 ttm180 -133.12 142.84 48.9 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 109.329 -0.619 . . . . 72.33 109.329 173.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.414 ' HG3' ' OG1' ' A' ' 248' ' ' THR . 0.1 OUTLIER -106.69 117.12 33.2 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 109.072 -0.714 . . . . 71.24 109.072 -179.399 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.559 HG11 HD21 ' A' ' 211' ' ' LEU . 14.2 m -123.39 138.43 53.3 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.209 0 N-CA-C 112.18 0.437 . . . . 75.44 112.18 178.366 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.732 ' HG2' HG12 ' A' ' 246' ' ' ILE . 65.4 mtt180 -92.7 111.6 23.26 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 108.87 -0.789 . . . . 62.44 108.87 171.487 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.551 ' HB2' ' HB3' ' A' ' 245' ' ' LEU . 34.9 mt -93.33 139.3 30.81 Favored 'General case' 0 C--N 1.281 -2.388 0 N-CA-C 107.29 -1.374 . . . . 53.32 107.29 179.144 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.63 ' H ' ' HG ' ' A' ' 205' ' ' LEU . 2.3 tm? . . . . . 0 C--N 1.304 -1.395 0 N-CA-C 107.874 -1.158 . . . . 73.51 107.874 179.439 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 2.6 mm? . . . . . 0 CA--C 1.503 -0.864 0 CA-C-O 120.938 0.399 . . . . 60.12 110.776 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 173' ' ' GLY . . . . . 0.535 ' HA2' ' HB ' ' A' ' 201' ' ' VAL . . . 109.03 13.98 16.36 Favored Glycine 0 N--CA 1.421 -2.348 0 C-N-CA 119.677 -1.249 . . . . 64.02 114.213 174.281 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -162.66 153.79 17.5 Favored 'General case' 0 N--CA 1.435 -1.225 0 CA-C-N 118.155 0.978 . . . . 73.25 110.154 -177.049 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.482 ' CE1' HG22 ' A' ' 201' ' ' VAL . 71.0 m-85 -115.4 144.88 43.14 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 108.045 -1.095 . . . . 73.24 108.045 174.547 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.578 ' HB ' ' CG2' ' A' ' 195' ' ' ILE . 36.8 pt -110.47 168.96 3.98 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.393 0 CA-C-O 121.16 0.505 . . . . 70.14 110.538 179.575 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.567 ' HG2' ' HB2' ' A' ' 198' ' ' SER . 5.1 ptp180 -154.07 153.88 32.67 Favored 'General case' 0 C--N 1.288 -2.084 0 C-N-CA 123.798 0.839 . . . . 74.42 109.091 178.159 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -100.16 141.52 32.88 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 109.156 -0.683 . . . . 74.3 109.156 177.006 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -153.9 -159.9 9.45 Favored Glycine 0 C--N 1.284 -2.325 0 N-CA-C 109.029 -1.629 . . . . 72.41 109.029 177.766 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 180' ' ' THR . . . . . 0.404 ' HB ' ' CG ' ' A' ' 191' ' ' LYS . 0.7 OUTLIER -110.13 126.74 54.38 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 117.711 0.756 . . . . 71.41 112.462 177.809 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 26.5 t . . . . . 0 N--CA 1.413 -2.283 0 N-CA-C 107.79 -1.189 . . . . 75.53 107.79 177.143 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.404 ' CG ' ' HB ' ' A' ' 180' ' ' THR . 36.1 ttmt . . . . . 0 N--CA 1.427 -1.612 0 N-CA-C 108.074 -1.084 . . . . 74.53 108.074 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 27.9 pt20 -145.13 164.34 27.49 Favored Pre-proline 0 C--N 1.287 -2.146 0 N-CA-C 108.284 -1.006 . . . . 73.31 108.284 -177.598 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -60.84 131.71 38.79 Favored 'Trans proline' 0 N--CA 1.448 -1.159 0 N-CA-C 109.401 -1.038 . . . . 71.11 109.401 174.369 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -137.49 150.87 20.94 Favored Glycine 0 CA--C 1.474 -2.481 0 N-CA-C 109.393 -1.483 . . . . 44.51 109.393 -178.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.587 ' HB ' ' CG1' ' A' ' 218' ' ' VAL . 3.2 mp -108.22 138.22 35.96 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.291 0 C-N-CA 120.071 -0.652 . . . . 74.13 110.141 -179.172 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -131.44 163.7 27.36 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 107.185 -1.413 . . . . 72.24 107.185 -177.601 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 41.7 mt -81.97 128.52 38.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 CA-C-O 121.711 0.767 . . . . 64.44 110.447 175.519 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 198' ' ' SER . . . . . 0.567 ' HB2' ' HG2' ' A' ' 177' ' ' ARG . 27.8 t -100.47 -22.79 14.9 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 112.892 0.701 . . . . 61.14 112.892 -177.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 51.3 ttp180 -167.56 152.26 6.87 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 109.601 -0.518 . . . . 72.52 109.601 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 38.7 mt -100.96 146.34 27.52 Favored 'General case' 0 CA--C 1.48 -1.729 0 N-CA-C 108.85 -0.796 . . . . 73.54 108.85 173.823 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 201' ' ' VAL . . . . . 0.535 ' HB ' ' HA2' ' A' ' 173' ' ' GLY . 10.9 t -103.44 114.67 64.72 Favored Pre-proline 0 C--N 1.284 -2.252 0 N-CA-C 105.914 -1.884 . . . . 71.53 105.914 174.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 202' ' ' PRO . . . . . 0.543 ' HA ' ' HG2' ' A' ' 207' ' ' GLU . 23.9 Cg_exo -63.34 135.8 51.95 Favored 'Trans proline' 0 N--CA 1.447 -1.209 0 C-N-CA 121.888 1.725 . . . . 63.13 110.707 -178.085 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.426 ' H ' ' HG2' ' A' ' 207' ' ' GLU . . . 94.73 -12.6 68.47 Favored Glycine 0 C--N 1.312 -0.789 0 C-N-CA 120.891 -0.671 . . . . 75.24 112.152 -178.013 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 204' ' ' GLY . . . . . 0.438 ' HA3' ' CA ' ' A' ' 173' ' ' GLY . . . -80.05 172.95 54.93 Favored Glycine 0 N--CA 1.436 -1.328 0 C-N-CA 120.891 -0.671 . . . . 64.41 111.707 179.454 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.63 ' HG ' ' H ' ' A' ' 164' ' ' LEU . 2.8 mm? -67.17 -41.91 85.18 Favored 'General case' 0 C--N 1.311 -1.089 0 C-N-CA 123.126 0.57 . . . . 61.24 111.761 -175.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -60.52 -39.18 86.89 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.102 0.477 . . . . 61.31 110.445 176.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.543 ' HG2' ' HA ' ' A' ' 202' ' ' PRO . 9.1 tp10 -67.85 -42.07 81.94 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.455 -0.793 . . . . 74.33 109.524 177.55 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 51.0 m -60.54 -45.12 95.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.4 -0.818 . . . . 72.13 112.032 -177.841 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 209' ' ' THR . . . . . 0.61 HG23 ' H ' ' A' ' 211' ' ' LEU . 10.0 t -76.72 -30.12 56.5 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 109.362 -0.607 . . . . 65.0 109.362 178.025 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 66.04 16.55 64.42 Favored Glycine 0 C--N 1.34 0.754 0 CA-C-N 115.509 -0.769 . . . . 40.31 113.106 177.451 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.61 ' H ' HG23 ' A' ' 209' ' ' THR . 1.9 pp -99.74 -3.45 32.82 Favored 'General case' 0 N--CA 1.433 -1.28 0 C-N-CA 120.275 -0.57 . . . . 64.33 110.86 -177.426 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 5.4 mp -109.25 133.23 53.3 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 107.622 -1.251 . . . . 72.25 107.622 175.286 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -131.05 166.51 20.88 Favored 'General case' 0 C--N 1.279 -2.485 0 N-CA-C 108.599 -0.889 . . . . 63.53 108.599 178.368 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 35.5 m -57.38 -31.03 37.3 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 N-CA-C 112.726 0.639 . . . . 71.25 112.726 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 -73.22 -13.86 61.23 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 113.201 0.815 . . . . 64.25 113.201 -179.206 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -73.3 135.09 44.36 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.324 0.583 . . . . 73.43 112.405 -178.644 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -104.53 134.33 47.89 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.881 -1.054 . . . . 71.32 109.162 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.601 ' HA ' HG12 ' A' ' 249' ' ' VAL . 13.1 p -84.08 134.97 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 CA-C-O 122.175 0.988 . . . . 72.55 111.395 -177.696 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.615 HG13 ' NE2' ' A' ' 158' ' ' HIS . 36.2 mm -99.27 -52.98 8.27 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.078 0 CA-C-N 114.332 -1.303 . . . . 73.01 111.025 -179.147 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.414 ' HG2' ' HB ' ' A' ' 248' ' ' THR . 11.1 pt-20 -157.78 151.34 23.72 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 116.076 -0.511 . . . . 72.42 110.926 -175.487 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.425 HG12 ' CG1' ' A' ' 226' ' ' VAL . 6.9 p -120.81 124.44 72.36 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 N-CA-C 108.959 -0.756 . . . . 74.14 108.959 176.751 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 222' ' ' ASN . . . . . 0.494 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 16.3 t-20 70.63 -3.8 1.83 Allowed 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 125.062 1.345 . . . . 70.34 111.164 -178.343 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 120.58 -17.91 9.42 Favored Glycine 0 C--N 1.301 -1.407 0 N-CA-C 111.019 -0.832 . . . . 54.4 111.019 -175.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 63.5 mt -88.52 123.77 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 N-CA-C 109.203 -0.666 . . . . 70.53 109.203 -179.391 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 225' ' ' GLU . . . . . 0.403 ' HA ' ' HB3' ' A' ' 220' ' ' GLU . 13.1 pt-20 -61.54 147.84 44.1 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.585 0.707 . . . . 74.21 111.506 -178.597 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 226' ' ' VAL . . . . . 0.425 ' CG1' HG12 ' A' ' 221' ' ' VAL . 26.1 m -117.8 -2.52 9.83 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 CA-C-N 115.408 -0.814 . . . . 63.11 112.239 179.459 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -82.16 104.34 12.42 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 109.169 -0.678 . . . . 51.32 109.169 177.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 122.58 -25.05 6.66 Favored Glycine 0 C--N 1.297 -1.597 0 N-CA-C 110.096 -1.202 . . . . 75.24 110.096 -179.603 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -74.0 166.7 22.92 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 107.711 -1.218 . . . . 74.14 107.711 176.266 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 230' ' ' THR . . . . . 0.447 ' O ' HG13 ' A' ' 234' ' ' VAL . 82.5 p -91.0 168.15 11.87 Favored 'General case' 0 C--O 1.249 1.06 0 N-CA-C 108.413 -0.958 . . . . 52.15 108.413 178.741 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 47.2 tp -66.07 -27.96 68.47 Favored 'General case' 0 N--CA 1.428 -1.566 0 C-N-CA 120.56 -0.456 . . . . 72.25 109.911 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -69.07 -47.71 64.6 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.725 -0.472 . . . . 71.24 109.725 176.663 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -58.92 -48.36 81.72 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 113.587 0.958 . . . . 64.3 113.587 177.573 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.525 HG21 HG12 ' A' ' 195' ' ' ILE . 13.3 m -65.14 -34.23 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-O 121.343 0.592 . . . . 64.21 111.598 -175.797 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 235' ' ' THR . . . . . 0.471 ' O ' HG23 ' A' ' 239' ' ' VAL . 90.0 m -75.48 -35.65 60.78 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 115.52 -0.764 . . . . 54.23 109.394 -176.087 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -61.53 -34.03 74.84 Favored 'General case' 0 CA--C 1.508 -0.639 0 N-CA-C 108.8 -0.815 . . . . 71.43 108.8 177.762 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 9.9 mtt -67.66 -45.46 75.21 Favored 'General case' 0 C--O 1.211 -0.933 0 N-CA-C 108.113 -1.069 . . . . 75.14 108.113 178.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 65.9 mtt -59.25 -38.72 80.76 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.884 -0.598 . . . . 74.11 111.531 -178.662 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 235' ' ' THR . 60.6 t -69.76 -33.16 54.98 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-O 121.255 0.55 . . . . 73.01 110.217 178.371 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -75.28 -30.33 60.4 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.203 0.525 . . . . 53.4 111.404 179.222 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 -90.14 21.84 3.56 Favored 'General case' 0 C--O 1.2 -1.531 0 CA-C-N 115.895 -0.593 . . . . 72.21 112.519 -178.803 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 242' ' ' SER . . . . . 0.557 ' O ' HD12 ' A' ' 164' ' ' LEU . 50.4 m -56.65 -22.97 38.3 Favored 'General case' 0 C--O 1.206 -1.22 0 N-CA-C 112.552 0.575 . . . . 72.11 112.552 177.283 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 18.4 m -64.16 -38.42 91.0 Favored 'General case' 0 CA--C 1.55 0.951 0 O-C-N 122.241 -0.287 . . . . 40.0 110.475 177.255 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -168.0 107.55 0.53 Allowed 'General case' 0 CA--C 1.491 -1.301 0 C-N-CA 126.876 2.071 . . . . 72.23 107.414 177.371 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.551 ' HB3' ' HB2' ' A' ' 163' ' ' LEU . 0.2 OUTLIER -84.77 105.28 15.44 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 108.348 -0.982 . . . . 71.15 108.348 -174.667 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.732 HG12 ' HG2' ' A' ' 162' ' ' ARG . 89.4 mt -94.08 115.31 32.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 109.003 -0.74 . . . . 64.03 109.003 179.079 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 247' ' ' ILE . . . . . 0.53 HG23 HG23 ' A' ' 218' ' ' VAL . 13.3 mt -125.47 135.65 63.3 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.073 0 CA-C-O 121.467 0.651 . . . . 73.35 112.181 176.74 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.486 ' HA ' ' O ' ' A' ' 159' ' ' ARG . 70.1 m -107.55 115.52 30.3 Favored 'General case' 0 N--CA 1.414 -2.274 0 N-CA-C 107.636 -1.246 . . . . 65.22 107.636 173.809 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.601 HG12 ' HA ' ' A' ' 218' ' ' VAL . 12.1 m -117.93 164.94 13.76 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.115 0 N-CA-C 109.491 -0.559 . . . . 61.13 109.491 174.298 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 250' ' ' LYS . . . . . 0.427 ' CD ' HD11 ' A' ' 219' ' ' ILE . 17.4 ptmt -131.86 128.3 21.54 Favored Pre-proline 0 C--N 1.286 -2.16 0 CA-C-N 114.896 -1.047 . . . . 73.34 108.676 174.756 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo . . . . . 0 N--CA 1.442 -1.528 0 C-N-CA 121.559 1.506 . . . . 75.03 112.382 179.449 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.78 ' HB3' ' HB3' ' A' ' 250' ' ' LYS 0.407 6.0 p-80 . . . . . 0 CA--C 1.496 -1.107 0 N-CA-C 114.74 1.385 . . . . 72.24 114.74 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.559 ' O ' ' HA ' ' A' ' 248' ' ' THR . 11.3 ptt180 -110.34 143.84 39.97 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 113.562 -1.654 . . . . 72.54 110.812 -173.373 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -114.0 112.93 24.07 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 121.702 0.763 . . . . 73.33 110.887 178.671 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.576 HG11 HD21 ' A' ' 211' ' ' LEU . 28.4 m -114.3 139.7 38.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 CA-C-N 114.879 -1.055 . . . . 65.32 112.786 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.425 ' HA ' ' HA ' ' A' ' 246' ' ' ILE . 19.8 ttm180 -96.48 112.83 24.43 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.434 0.635 . . . . 74.12 109.781 177.413 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.41 ' HB2' ' HB3' ' A' ' 245' ' ' LEU . 19.8 mt -94.13 138.18 32.48 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-N 114.999 -1.0 . . . . 75.53 108.685 -178.318 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.416 HD23 ' O ' ' A' ' 242' ' ' SER . 15.4 tp . . . . . 0 C--N 1.312 -1.03 0 CA-C-O 122.121 0.962 . . . . 75.32 111.632 174.793 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.555 ' HG ' HD12 ' A' ' 245' ' ' LEU . 3.6 mm? . . . . . 0 CA--C 1.51 -0.595 0 N-CA-C 112.284 0.476 . . . . 74.51 112.284 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 173' ' ' GLY . . . . . 0.513 ' HA3' ' HA3' ' A' ' 204' ' ' GLY . . . 88.07 34.97 9.26 Favored Glycine 0 N--CA 1.426 -2.024 0 C-N-CA 120.595 -0.812 . . . . 50.45 113.271 177.008 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -154.73 154.02 32.2 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 107.487 -1.301 . . . . 55.0 107.487 174.273 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -125.45 148.94 48.64 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 108.939 -0.763 . . . . 74.4 108.939 176.468 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.541 HD13 ' SD ' ' A' ' 238' ' ' MET . 35.6 pt -110.08 169.52 3.61 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 CA-C-O 121.32 0.581 . . . . 54.02 111.253 -176.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.537 ' CG ' ' HB2' ' A' ' 198' ' ' SER . 15.7 ptt180 -149.21 154.79 39.64 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 115.112 -0.949 . . . . 72.42 109.312 -179.39 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -117.54 144.5 45.04 Favored 'General case' 0 C--N 1.287 -2.124 0 N-CA-C 109.014 -0.736 . . . . 64.23 109.014 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -161.95 179.96 36.98 Favored Glycine 0 N--CA 1.417 -2.63 0 N-CA-C 109.712 -1.355 . . . . 54.03 109.712 178.795 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 180' ' ' THR . . . . . 0.513 ' HB ' ' CG ' ' A' ' 191' ' ' LYS . 0.8 OUTLIER -86.46 123.92 32.22 Favored 'General case' 0 C--N 1.29 -1.997 0 CA-C-O 121.66 0.743 . . . . 61.33 112.193 177.298 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 37.4 t . . . . . 0 N--CA 1.403 -2.788 0 N-CA-C 107.356 -1.35 . . . . 74.42 107.356 177.225 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.513 ' CG ' ' HB ' ' A' ' 180' ' ' THR . 34.6 ttmt . . . . . 0 N--CA 1.432 -1.374 0 N-CA-C 108.964 -0.754 . . . . 71.42 108.964 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -145.71 164.71 24.34 Favored Pre-proline 0 C--N 1.292 -1.905 0 N-CA-C 107.893 -1.151 . . . . 74.02 107.893 -177.27 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -59.29 132.76 48.45 Favored 'Trans proline' 0 C--O 1.245 0.834 0 C-N-CA 121.533 1.488 . . . . 71.4 111.667 176.247 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -139.53 143.24 13.62 Favored Glycine 0 N--CA 1.419 -2.481 0 N-CA-C 109.778 -1.329 . . . . 63.12 109.778 178.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.623 HG12 HG21 ' A' ' 234' ' ' VAL . 3.2 mp -108.76 132.84 55.64 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 CA-C-O 121.117 0.484 . . . . 75.04 110.767 -179.2 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -125.31 167.72 14.51 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 107.946 -1.131 . . . . 75.22 107.946 -176.138 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 197' ' ' ILE . . . . . 0.467 ' HB ' ' HA ' ' A' ' 214' ' ' VAL . 46.5 mm -77.06 131.51 34.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 N-CA-C 108.189 -1.041 . . . . 75.43 108.189 174.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 198' ' ' SER . . . . . 0.537 ' HB2' ' CG ' ' A' ' 177' ' ' ARG . 12.7 t -104.48 -38.49 6.77 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 113.449 0.907 . . . . 52.31 113.449 -178.525 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 40.0 ttp180 -150.47 141.86 23.36 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 120.004 -0.678 . . . . 72.01 109.947 -177.322 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -108.45 133.79 52.13 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 107.562 -1.273 . . . . 64.41 107.562 -177.858 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 44.0 t -110.6 131.58 22.01 Favored Pre-proline 0 C--N 1.311 -1.073 0 C-N-CA 120.756 -0.378 . . . . 73.11 110.736 -177.458 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 202' ' ' PRO . . . . . 0.472 ' HA ' ' OE2' ' A' ' 207' ' ' GLU . 17.8 Cg_endo -60.78 135.21 58.47 Favored 'Trans proline' 0 C--O 1.247 0.939 0 C-N-CA 122.717 2.278 . . . . 55.54 111.682 176.621 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 86.37 0.78 86.46 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.812 -0.631 . . . . 72.32 112.63 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 204' ' ' GLY . . . . . 0.513 ' HA3' ' HA3' ' A' ' 173' ' ' GLY . . . -88.25 170.26 38.96 Favored Glycine 0 N--CA 1.439 -1.13 0 C-N-CA 120.577 -0.82 . . . . 74.22 112.526 -178.828 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 172' ' ' LEU . 3.6 mm? -66.39 -34.25 77.54 Favored 'General case' 0 N--CA 1.438 -1.075 0 C-N-CA 123.088 0.555 . . . . 74.42 110.582 -179.534 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 206' ' ' ALA . . . . . 0.469 ' CB ' HD12 ' A' ' 212' ' ' LEU . . . -61.76 -41.55 97.83 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 115.613 -0.721 . . . . 62.41 110.49 176.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.472 ' OE2' ' HA ' ' A' ' 202' ' ' PRO . 41.2 tt0 -75.6 -33.52 60.56 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.946 -0.57 . . . . 75.33 110.234 178.858 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 44.3 t -56.34 -50.14 72.36 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 123.755 0.822 . . . . 51.24 111.042 -179.306 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 209' ' ' THR . . . . . 0.617 HG23 ' H ' ' A' ' 211' ' ' LEU . 8.8 t -80.02 -25.98 39.99 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 119.648 -0.821 . . . . 75.33 109.59 176.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 65.6 22.84 70.13 Favored Glycine 0 N--CA 1.446 -0.689 0 CA-C-N 115.608 -0.724 . . . . 50.52 112.543 179.095 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.617 ' H ' HG23 ' A' ' 209' ' ' THR . 1.1 pp -111.61 4.06 18.39 Favored 'General case' 0 N--CA 1.436 -1.174 0 C-N-CA 120.073 -0.651 . . . . 61.22 112.235 -177.33 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.469 HD12 ' CB ' ' A' ' 206' ' ' ALA . 75.5 mt -108.39 133.13 53.0 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 108.65 -0.87 . . . . 72.33 108.65 177.577 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -131.86 165.23 24.3 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 107.613 -1.254 . . . . 63.03 107.613 177.61 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 214' ' ' VAL . . . . . 0.467 ' HA ' ' HB ' ' A' ' 197' ' ' ILE 0.259 18.7 m -65.53 -28.83 45.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 113.519 0.933 . . . . 71.3 113.519 -177.99 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -73.11 -15.14 61.49 Favored 'General case' 0 N--CA 1.484 1.247 0 O-C-N 121.906 -0.496 . . . . 41.32 111.636 178.611 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -66.43 131.95 47.21 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-O 121.337 0.589 . . . . 62.33 112.036 -179.595 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 217' ' ' GLU . . . . . 0.44 ' O ' ' HA ' ' A' ' 249' ' ' VAL . 38.6 tt0 -105.82 132.4 51.99 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.95 -1.023 . . . . 74.34 111.044 -178.707 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.525 HG13 HG23 ' A' ' 247' ' ' ILE . 35.4 t -81.66 127.37 39.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 C-N-CA 123.24 0.616 . . . . 74.1 110.643 -176.897 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 40.9 mm -98.84 -49.41 11.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 CA-C-N 115.341 -0.845 . . . . 71.35 110.806 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.457 ' CB ' ' HA ' ' A' ' 225' ' ' GLU . 12.7 pt-20 -152.55 158.41 42.46 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-O 120.529 0.204 . . . . 75.33 110.703 -179.255 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.47 ' C ' ' H ' ' A' ' 223' ' ' GLY . 9.1 p -125.36 125.76 69.54 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 N-CA-C 109.088 -0.708 . . . . 73.21 109.088 178.406 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 222' ' ' ASN . . . . . 0.687 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 5.7 t30 71.92 -31.8 0.23 Allowed 'General case' 0 N--CA 1.499 2.021 0 C-N-CA 126.421 1.888 . . . . 72.13 112.364 -178.281 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 223' ' ' GLY . . . . . 0.47 ' H ' ' C ' ' A' ' 221' ' ' VAL . . . 150.21 -4.6 0.62 Allowed Glycine 0 C--N 1.276 -2.797 0 CA-C-N 114.547 -1.206 . . . . 31.43 110.777 -175.163 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 68.6 mt -104.56 124.34 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.14 0 N-CA-C 109.364 -0.606 . . . . 64.04 109.364 179.144 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 225' ' ' GLU . . . . . 0.457 ' HA ' ' CB ' ' A' ' 220' ' ' GLU . 12.4 pt-20 -57.91 148.66 24.96 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 123.419 0.688 . . . . 71.33 112.801 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 226' ' ' VAL . . . . . 0.496 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 34.3 m -122.67 -2.54 7.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 CA-C-N 114.891 -1.049 . . . . 54.32 109.501 175.44 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -71.22 99.05 1.83 Allowed 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 115.547 -0.751 . . . . 61.12 110.441 -177.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 121.91 -23.2 7.44 Favored Glycine 0 N--CA 1.43 -1.742 0 N-CA-C 110.965 -0.854 . . . . 61.22 110.965 178.095 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 80.2 mttt -78.13 172.85 12.93 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 121.142 -0.223 . . . . 74.54 111.306 -179.169 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 230' ' ' THR . . . . . 0.456 ' O ' HG13 ' A' ' 234' ' ' VAL . 74.2 p -93.77 165.97 12.43 Favored 'General case' 0 N--CA 1.427 -1.612 0 C-N-CA 119.849 -0.74 . . . . 60.4 109.76 -175.424 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 231' ' ' LEU . . . . . 0.469 ' HA ' HG22 ' A' ' 234' ' ' VAL . 3.1 tm? -60.96 -38.78 87.11 Favored 'General case' 0 N--CA 1.427 -1.614 0 CA-C-N 116.081 -0.508 . . . . 72.44 109.787 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -65.95 -40.16 91.09 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.458 -0.337 . . . . 62.2 110.664 179.551 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -64.31 -49.3 72.32 Favored 'General case' 0 C--O 1.223 -0.316 0 N-CA-C 112.667 0.618 . . . . 72.31 112.667 175.653 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.623 HG21 HG12 ' A' ' 195' ' ' ILE . 15.0 m -68.36 -34.05 63.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 112.729 0.64 . . . . 70.43 112.729 -173.873 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 235' ' ' THR . . . . . 0.49 ' O ' HG23 ' A' ' 239' ' ' VAL . 75.1 m -71.0 -35.63 72.14 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 109.229 -0.656 . . . . 64.01 109.229 -176.31 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -62.63 -33.97 76.09 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.727 -0.669 . . . . 72.03 109.598 178.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 237' ' ' MET . . . . . 0.444 ' HB2' HG11 ' A' ' 221' ' ' VAL . 2.0 mtm -74.33 -34.91 63.58 Favored 'General case' 0 C--O 1.2 -1.55 0 N-CA-C 108.542 -0.91 . . . . 75.12 108.542 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 238' ' ' MET . . . . . 0.541 ' SD ' HD13 ' A' ' 176' ' ' ILE . 65.3 mtt -68.66 -36.24 78.29 Favored 'General case' 0 C--N 1.314 -0.964 0 O-C-N 121.995 -0.441 . . . . 53.45 110.844 178.63 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 235' ' ' THR . 99.9 t -67.81 -39.57 82.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 CA-C-O 121.278 0.561 . . . . 64.41 109.665 176.497 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -69.59 -32.4 71.13 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.919 -0.582 . . . . 63.25 111.006 178.567 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 58.0 m-80 -96.24 21.04 9.45 Favored 'General case' 0 C--O 1.206 -1.187 0 CA-C-N 116.294 -0.412 . . . . 63.34 111.995 178.904 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 242' ' ' SER . . . . . 0.416 ' O ' HD23 ' A' ' 164' ' ' LEU . 62.6 m -63.16 -23.1 67.28 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 120.537 -0.465 . . . . 75.41 111.895 178.281 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 19.2 m -66.03 -24.99 66.85 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 116.639 -0.255 . . . . 62.53 111.159 177.807 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -172.79 93.13 0.11 Allowed 'General case' 0 C--O 1.24 0.577 0 C-N-CA 124.602 1.161 . . . . 71.05 109.054 -178.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.555 HD12 ' HG ' ' A' ' 172' ' ' LEU . 1.2 tt -88.66 105.05 17.42 Favored 'General case' 0 C--O 1.198 -1.643 0 CA-C-N 115.769 -0.65 . . . . 74.33 111.286 -169.301 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.687 ' HB ' ' HA ' ' A' ' 222' ' ' ASN . 52.3 mt -96.95 122.61 48.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 108.506 -0.924 . . . . 62.0 108.506 176.722 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 247' ' ' ILE . . . . . 0.525 HG23 HG13 ' A' ' 218' ' ' VAL . 14.9 mt -130.09 135.4 61.03 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.061 0 CA-C-O 121.441 0.639 . . . . 72.12 112.487 177.606 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.559 ' HA ' ' O ' ' A' ' 159' ' ' ARG . 87.6 m -99.99 122.67 43.25 Favored 'General case' 0 N--CA 1.423 -1.784 0 CA-C-N 114.906 -1.043 . . . . 65.03 108.417 174.507 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.502 HG12 ' HA ' ' A' ' 218' ' ' VAL . 23.5 m -132.61 151.83 35.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 CA-C-O 121.347 0.594 . . . . 63.51 111.06 177.617 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 250' ' ' LYS . . . . . 0.78 ' HB3' ' HB3' ' A' ' 158' ' ' HIS . 1.4 ptmm? -126.79 128.69 24.21 Favored Pre-proline 0 C--N 1.28 -2.437 0 CA-C-N 114.286 -1.325 . . . . 64.24 109.045 174.194 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo . . . . . 0 N--CA 1.44 -1.637 0 C-N-CA 122.221 1.947 . . . . 74.32 110.291 176.952 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 1.3 m80 . . . . . 0 CA--C 1.505 -0.776 0 CA-C-O 121.134 0.492 . . . . 72.41 111.755 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -132.84 135.12 45.45 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 107.739 -1.208 . . . . 73.0 107.739 175.008 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 12.9 ptp180 -124.58 113.32 17.91 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-O 121.792 0.806 . . . . 72.2 110.14 178.261 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 23.7 m -107.41 138.25 34.48 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.922 0 CA-C-N 114.996 -1.002 . . . . 71.31 112.614 -178.242 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.486 ' HE ' ' HA ' ' A' ' 244' ' ' ASN . 0.1 OUTLIER -104.27 112.56 25.63 Favored 'General case' 0 N--CA 1.417 -2.076 0 N-CA-C 108.473 -0.936 . . . . 72.42 108.473 175.735 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.471 ' HB2' ' HB3' ' A' ' 245' ' ' LEU . 22.9 mt -101.01 139.89 36.07 Favored 'General case' 0 C--N 1.284 -2.239 0 CA-C-N 114.317 -1.31 . . . . 62.15 108.243 -175.451 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.554 HD12 ' O ' ' A' ' 242' ' ' SER . 0.6 OUTLIER . . . . . 0 N--CA 1.426 -1.673 0 N-CA-C 106.097 -1.816 . . . . 61.42 106.097 173.896 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.518 ' HG ' ' CD1' ' A' ' 245' ' ' LEU . 3.1 mm? . . . . . 0 CA--C 1.509 -0.599 0 N-CA-C 112.336 0.495 . . . . 51.23 112.336 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 173' ' ' GLY . . . . . 0.462 ' HA3' ' HA3' ' A' ' 204' ' ' GLY . . . 90.88 34.23 7.84 Favored Glycine 0 N--CA 1.422 -2.247 0 C-N-CA 120.672 -0.775 . . . . 73.24 112.929 177.735 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 26.0 p90 -152.93 154.38 34.9 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 108.805 -0.813 . . . . 73.11 108.805 175.312 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -128.12 150.87 49.79 Favored 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 108.322 -0.992 . . . . 73.43 108.322 175.354 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.646 HD13 ' H ' ' A' ' 176' ' ' ILE . 0.2 OUTLIER -116.4 169.21 7.1 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.081 0 CA-C-O 121.474 0.654 . . . . 73.2 111.276 -177.584 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.516 ' HG2' ' HB2' ' A' ' 198' ' ' SER . 4.3 ptp180 -147.98 155.2 41.26 Favored 'General case' 0 C--N 1.278 -2.524 0 C-N-CA 124.358 1.063 . . . . 62.24 109.884 -176.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -111.46 146.23 37.59 Favored 'General case' 0 C--N 1.294 -1.836 0 O-C-N 123.579 0.549 . . . . 52.1 110.135 179.368 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 179' ' ' GLY . . . . . 0.42 ' O ' ' HA ' ' A' ' 193' ' ' PRO . . . -159.61 -165.01 15.71 Favored Glycine 0 C--N 1.292 -1.914 0 N-CA-C 108.624 -1.791 . . . . 50.3 108.624 175.868 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 180' ' ' THR . . . . . 0.463 ' HB ' ' CG ' ' A' ' 191' ' ' LYS . 3.1 p -103.9 125.65 50.46 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 118.46 1.13 . . . . 55.25 112.627 175.927 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 67.8 m . . . . . 0 N--CA 1.403 -2.784 0 N-CA-C 107.484 -1.302 . . . . 61.24 107.484 173.586 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.463 ' CG ' ' HB ' ' A' ' 180' ' ' THR . 36.2 ttmt . . . . . 0 N--CA 1.413 -2.295 0 N-CA-C 106.851 -1.537 . . . . 75.54 106.851 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 192' ' ' GLN . . . . . 0.404 HE22 ' HA ' ' A' ' 227' ' ' ALA . 12.4 pt20 -126.02 160.13 58.49 Favored Pre-proline 0 C--N 1.268 -2.945 0 N-CA-C 107.603 -1.258 . . . . 73.24 107.603 -176.428 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 193' ' ' PRO . . . . . 0.42 ' HA ' ' O ' ' A' ' 179' ' ' GLY . 13.8 Cg_endo -65.73 131.03 26.29 Favored 'Trans proline' 0 N--CA 1.416 -3.042 0 N-CA-C 107.861 -1.631 . . . . 71.11 107.861 168.443 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -122.47 138.76 12.14 Favored Glycine 0 N--CA 1.402 -3.621 0 N-CA-C 109.09 -1.604 . . . . 74.14 109.09 179.333 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.531 HG12 HG21 ' A' ' 234' ' ' VAL . 3.5 mp -104.05 132.16 51.18 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.626 0 C-N-CA 120.268 -0.573 . . . . 75.43 109.79 179.493 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -122.81 165.0 17.33 Favored 'General case' 0 C--N 1.284 -2.275 0 N-CA-C 108.188 -1.042 . . . . 74.41 108.188 -177.108 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 197' ' ' ILE . . . . . 0.434 ' HB ' ' HA ' ' A' ' 214' ' ' VAL . 46.8 mm -78.37 128.8 38.17 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 107.711 -1.218 . . . . 54.53 107.711 174.246 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 198' ' ' SER . . . . . 0.516 ' HB2' ' HG2' ' A' ' 177' ' ' ARG . 11.4 t -100.99 -28.21 12.86 Favored 'General case' 0 C--N 1.28 -2.45 0 O-C-N 121.488 -0.758 . . . . 60.2 113.013 -177.573 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 25.3 tpt180 -163.07 140.11 7.55 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 120.878 -0.329 . . . . 74.23 110.333 -175.553 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 61.4 mt -105.33 137.53 42.98 Favored 'General case' 0 CA--C 1.491 -1.29 0 N-CA-C 108.964 -0.754 . . . . 72.33 108.964 172.396 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 201' ' ' VAL . . . . . 0.438 ' HB ' ' HA2' ' A' ' 173' ' ' GLY . 61.5 t -97.55 116.53 65.84 Favored Pre-proline 0 C--N 1.279 -2.463 0 N-CA-C 105.773 -1.936 . . . . 71.24 105.773 172.565 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 202' ' ' PRO . . . . . 0.639 ' HA ' ' OE1' ' A' ' 207' ' ' GLU . 21.1 Cg_endo -60.04 126.29 19.9 Favored 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 121.932 1.755 . . . . 63.14 111.707 -174.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 105.51 -9.08 44.64 Favored Glycine 0 C--N 1.307 -1.073 0 CA-C-N 115.421 -0.809 . . . . 53.22 111.104 -177.196 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 204' ' ' GLY . . . . . 0.462 ' HA3' ' HA3' ' A' ' 173' ' ' GLY . . . -74.77 167.55 54.82 Favored Glycine 0 N--CA 1.437 -1.248 0 C-N-CA 121.556 -0.354 . . . . 73.34 113.14 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -65.0 -29.16 70.07 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 124.281 1.032 . . . . 73.3 111.737 -177.73 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 206' ' ' ALA . . . . . 0.405 ' HA ' HD12 ' A' ' 212' ' ' LEU . . . -59.81 -40.73 89.38 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.863 -0.608 . . . . 73.1 110.57 177.286 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.639 ' OE1' ' HA ' ' A' ' 202' ' ' PRO . 46.3 mt-10 -75.5 -31.42 60.16 Favored 'General case' 0 CA--C 1.507 -0.694 0 CA-C-N 116.2 -0.454 . . . . 64.03 110.885 175.592 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 24.8 m -55.73 -36.96 67.81 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.162 -0.472 . . . . 72.52 111.417 -177.686 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 209' ' ' THR . . . . . 0.523 HG23 ' H ' ' A' ' 211' ' ' LEU . 9.7 t -84.72 -32.68 23.39 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 109.281 -0.637 . . . . 53.0 109.281 174.728 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 73.32 21.02 80.02 Favored Glycine 0 CA--C 1.497 -1.058 0 CA-C-N 115.876 -0.602 . . . . 40.24 112.061 177.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.523 ' H ' HG23 ' A' ' 209' ' ' THR . 38.4 mt -114.31 -0.32 13.9 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 109.655 -0.498 . . . . 71.23 109.655 -178.431 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' A' ' 206' ' ' ALA . 74.0 mt -109.03 130.93 55.49 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 120.113 -0.635 . . . . 75.34 110.684 176.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -133.82 166.23 23.14 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 114.605 -1.179 . . . . 75.4 108.04 176.038 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 214' ' ' VAL . . . . . 0.434 ' HA ' ' HB ' ' A' ' 197' ' ' ILE . 26.4 m -59.33 -29.37 41.79 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-O 121.934 0.873 . . . . 73.31 111.416 176.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -72.65 -15.79 61.71 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 115.377 -0.829 . . . . 41.35 112.617 -175.644 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -69.31 137.82 53.29 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 113.602 0.964 . . . . 63.45 113.602 -176.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -112.92 124.66 53.12 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.795 1.638 . . . . 75.22 108.87 -178.711 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.582 ' HA ' HG12 ' A' ' 249' ' ' VAL . 8.2 p -80.1 146.47 7.63 Favored 'Isoleucine or valine' 0 C--O 1.251 1.168 0 N-CA-C 113.953 1.094 . . . . 72.43 113.953 -173.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.478 HD11 ' CD ' ' A' ' 250' ' ' LYS . 44.4 mm -111.46 -53.13 5.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 113.988 -1.46 . . . . 70.01 110.435 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -158.07 156.28 30.76 Favored 'General case' 0 C--O 1.244 0.794 0 CA-C-N 116.324 -0.398 . . . . 74.32 110.245 -176.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.426 ' HA ' ' O ' ' A' ' 246' ' ' ILE . 4.4 p -124.74 115.92 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.292 0 CA-C-O 121.586 0.707 . . . . 72.23 110.838 173.854 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 222' ' ' ASN . . . . . 0.44 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 21.4 t-20 58.95 34.61 23.71 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 126.124 1.77 . . . . 73.54 110.638 178.407 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 93.74 -4.83 72.73 Favored Glycine 0 C--N 1.301 -1.392 0 CA-C-N 115.165 -0.925 . . . . 71.33 113.172 177.849 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 58.1 mt -99.67 123.36 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.373 0 N-CA-C 108.628 -0.878 . . . . 73.15 108.628 179.203 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 225' ' ' GLU . . . . . 0.458 ' HG3' ' HE3' ' A' ' 229' ' ' LYS . 12.1 pt-20 -62.93 134.99 57.06 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 121.403 0.621 . . . . 73.03 110.741 -179.374 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 27.6 m -115.57 10.97 7.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-O 122.202 1.001 . . . . 72.4 109.611 175.022 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 227' ' ' ALA . . . . . 0.404 ' HA ' HE22 ' A' ' 192' ' ' GLN . . . -75.32 99.98 4.26 Favored 'General case' 0 N--CA 1.422 -1.83 0 CA-C-N 114.307 -1.315 . . . . 71.54 110.336 179.128 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 95.08 18.46 33.96 Favored Glycine 0 N--CA 1.438 -1.186 0 CA-C-N 115.489 -0.778 . . . . 71.25 112.919 175.814 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 229' ' ' LYS . . . . . 0.467 ' HB3' ' HG2' ' A' ' 233' ' ' GLN . 68.7 mmtt -95.63 172.2 8.2 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.963 0.382 . . . . 64.42 110.164 179.75 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 230' ' ' THR . . . . . 0.666 ' OG1' ' HB2' ' A' ' 233' ' ' GLN . 40.6 p -76.1 162.57 27.9 Favored 'General case' 0 N--CA 1.433 -1.296 0 C-N-CA 120.33 -0.548 . . . . 72.23 109.55 175.594 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -68.6 -39.18 81.01 Favored 'General case' 0 N--CA 1.429 -1.514 0 N-CA-C 108.982 -0.747 . . . . 71.5 108.982 -179.161 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -61.29 -39.39 90.28 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 116.302 -0.408 . . . . 72.21 110.338 176.307 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 233' ' ' GLN . . . . . 0.666 ' HB2' ' OG1' ' A' ' 230' ' ' THR . 3.5 tp-100 -58.16 -50.95 71.73 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 123.947 0.899 . . . . 73.01 109.796 -177.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.531 HG21 HG12 ' A' ' 195' ' ' ILE . 13.0 m -73.67 -34.2 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-N 115.265 -0.88 . . . . 75.34 111.536 -174.05 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 235' ' ' THR . . . . . 0.495 ' O ' HG23 ' A' ' 239' ' ' VAL . 53.0 m -74.75 -36.52 62.6 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 115.42 -0.809 . . . . 62.42 109.251 -175.326 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -58.77 -34.72 71.76 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-N 115.39 -0.823 . . . . 74.13 109.602 175.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 237' ' ' MET . . . . . 0.41 ' HB2' HG11 ' A' ' 221' ' ' VAL . 10.1 mtt -69.79 -50.27 44.66 Favored 'General case' 0 C--O 1.208 -1.128 0 N-CA-C 108.002 -1.11 . . . . 70.21 108.002 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 238' ' ' MET . . . . . 0.429 ' HG3' ' O ' ' A' ' 234' ' ' VAL . 64.4 mtt -54.47 -40.01 68.03 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 123.426 0.69 . . . . 75.42 111.791 -177.834 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 235' ' ' THR . 80.3 t -69.09 -48.91 66.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.158 0.504 . . . . 65.42 110.915 178.05 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -65.78 -28.9 69.36 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.908 -0.587 . . . . 43.41 111.705 -178.012 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 -84.68 21.56 1.5 Allowed 'General case' 0 C--O 1.2 -1.549 0 N-CA-C 113.174 0.805 . . . . 73.43 113.174 -179.413 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 242' ' ' SER . . . . . 0.554 ' O ' HD12 ' A' ' 164' ' ' LEU . 31.0 p -56.19 -23.76 37.34 Favored 'General case' 0 C--O 1.2 -1.54 0 N-CA-C 113.301 0.852 . . . . 75.34 113.301 177.36 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 19.4 m -71.28 -37.41 71.88 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 121.563 0.697 . . . . 63.33 110.214 177.383 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 244' ' ' ASN . . . . . 0.486 ' HA ' ' HE ' ' A' ' 162' ' ' ARG . 5.1 p30 -158.19 92.22 1.15 Allowed 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 123.922 0.889 . . . . 73.43 110.091 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.518 ' CD1' ' HG ' ' A' ' 172' ' ' LEU . 1.4 tt -88.64 103.75 16.22 Favored 'General case' 0 C--O 1.207 -1.145 0 N-CA-C 109.029 -0.73 . . . . 74.21 109.029 -175.472 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.44 ' HB ' ' HA ' ' A' ' 222' ' ' ASN . 58.7 mt -106.1 115.73 48.39 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 109.053 -0.721 . . . . 61.05 109.053 179.144 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 247' ' ' ILE . . . . . 0.493 HG23 HG23 ' A' ' 218' ' ' VAL . 32.1 mt -119.89 128.82 75.94 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 CA-C-O 121.472 0.653 . . . . 71.13 111.657 178.613 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 37.9 m -102.07 118.48 36.98 Favored 'General case' 0 N--CA 1.418 -2.066 0 CA-C-N 114.751 -1.113 . . . . 75.55 108.021 176.318 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.582 HG12 ' HA ' ' A' ' 218' ' ' VAL . 15.8 m -126.84 170.08 17.32 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.992 0 CA-C-O 121.793 0.806 . . . . 64.42 110.673 178.642 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 250' ' ' LYS . . . . . 0.478 ' CD ' HD11 ' A' ' 219' ' ' ILE 0.337 42.9 mtpt -125.72 152.4 72.21 Favored Pre-proline 0 C--N 1.271 -2.812 0 CA-C-N 113.492 -1.685 . . . . 74.31 106.67 174.897 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo . . . . . 0 N--CA 1.424 -2.566 0 N-CA-C 108.304 -1.46 . . . . 72.12 108.304 167.105 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.496 -1.098 0 N-CA-C 109.866 -0.42 . . . . 71.32 109.866 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.579 ' HA ' ' HE ' ' A' ' 159' ' ' ARG . 2.0 tpm_? -121.73 119.2 31.06 Favored 'General case' 0 N--CA 1.423 -1.799 0 N-CA-C 109.411 -0.588 . . . . 71.31 109.411 178.355 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 81.2 mtm180 -101.05 113.73 27.01 Favored 'General case' 0 C--N 1.281 -2.392 0 CA-C-N 115.123 -0.944 . . . . 70.31 109.507 179.234 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 23.6 m -119.67 139.23 47.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 CA-C-N 115.924 -0.58 . . . . 74.44 111.198 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.408 ' HG3' HG12 ' A' ' 246' ' ' ILE . 14.9 ttm180 -107.86 112.09 24.55 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.127 -1.064 . . . . 64.14 108.127 176.533 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.619 ' HB2' ' HB2' ' A' ' 245' ' ' LEU . 20.9 mt -103.03 139.87 38.02 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 108.323 -0.991 . . . . 64.3 108.323 -174.113 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.736 ' HG ' ' O ' ' A' ' 242' ' ' SER . 0.1 OUTLIER . . . . . 0 N--CA 1.443 -0.797 0 N-CA-C 105.911 -1.885 . . . . 61.35 105.911 -179.608 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.551 ' HG ' HD12 ' A' ' 245' ' ' LEU . 2.7 mm? . . . . . 0 N--CA 1.441 -0.89 0 N-CA-C 112.177 0.436 . . . . 51.34 112.177 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 173' ' ' GLY . . . . . 0.529 ' HA3' ' HA3' ' A' ' 204' ' ' GLY . . . 97.69 30.59 7.13 Favored Glycine 0 N--CA 1.44 -1.091 0 C-N-CA 120.258 -0.972 . . . . 75.13 112.968 177.885 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -147.55 155.8 42.21 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.239 -1.393 . . . . 74.2 107.239 174.743 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.414 ' HB2' ' HB3' ' A' ' 199' ' ' ARG . 92.4 m-85 -131.45 143.57 50.53 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 108.078 -1.082 . . . . 72.12 108.078 177.368 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.429 HD13 ' SD ' ' A' ' 238' ' ' MET . 30.2 pt -111.01 169.08 4.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 113.31 0.856 . . . . 75.02 113.31 -173.849 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.593 ' HB3' ' HB2' ' A' ' 198' ' ' SER . 2.9 ptp180 -142.87 155.02 44.69 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 114.765 -1.107 . . . . 62.33 109.982 -178.254 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 178' ' ' ASP . . . . . 0.586 ' HB2' ' HB2' ' A' ' 231' ' ' LEU . 11.5 t70 -109.46 138.53 45.67 Favored 'General case' 0 C--N 1.29 -2.014 0 O-C-N 124.082 0.864 . . . . 73.41 109.138 179.047 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -151.46 -178.99 26.77 Favored Glycine 0 C--N 1.273 -2.967 0 N-CA-C 108.07 -2.012 . . . . 43.3 108.07 175.267 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 180' ' ' THR . . . . . 0.463 ' CG2' ' HG2' ' A' ' 191' ' ' LYS . 0.2 OUTLIER -109.59 122.36 47.27 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 106.581 -1.637 . . . . 71.51 106.581 177.128 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 181' ' ' SER . . . . . 0.508 ' O ' ' HA ' ' A' ' 191' ' ' LYS . 33.0 t . . . . . 0 C--N 1.287 -2.141 0 N-CA-C 109.062 -0.718 . . . . 64.24 109.062 -176.202 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.508 ' HA ' ' O ' ' A' ' 181' ' ' SER . 32.9 ttmt . . . . . 0 N--CA 1.425 -1.675 0 N-CA-C 107.735 -1.209 . . . . 73.35 107.735 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 192' ' ' GLN . . . . . 0.492 ' HB2' ' HD2' ' A' ' 193' ' ' PRO . 9.0 pt20 -151.59 164.53 19.95 Favored Pre-proline 0 C--N 1.305 -1.347 0 N-CA-C 108.152 -1.055 . . . . 64.52 108.152 -174.569 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 193' ' ' PRO . . . . . 0.492 ' HD2' ' HB2' ' A' ' 192' ' ' GLN . 9.5 Cg_endo -54.55 131.71 47.13 Favored 'Trans proline' 0 C--O 1.249 1.073 0 C-N-CA 121.431 1.421 . . . . 75.35 111.582 178.694 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -143.02 132.69 5.15 Favored Glycine 0 N--CA 1.411 -2.975 0 N-CA-C 109.716 -1.354 . . . . 61.0 109.716 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.626 HG12 HG21 ' A' ' 234' ' ' VAL . 3.5 mp -105.17 138.85 28.21 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.438 0 CA-C-O 121.112 0.482 . . . . 74.13 109.92 -179.599 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -132.34 167.66 19.48 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 107.285 -1.376 . . . . 73.34 107.285 -176.613 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 197' ' ' ILE . . . . . 0.401 ' CG2' ' HA ' ' A' ' 214' ' ' VAL . 50.2 mm -75.54 131.69 34.52 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 N-CA-C 108.452 -0.944 . . . . 75.02 108.452 173.738 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 198' ' ' SER . . . . . 0.593 ' HB2' ' HB3' ' A' ' 177' ' ' ARG . 21.0 t -108.31 -25.24 11.12 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.792 -0.568 . . . . 54.11 111.926 178.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 199' ' ' ARG . . . . . 0.414 ' HB3' ' HB2' ' A' ' 175' ' ' TYR . 68.7 ttt180 -154.05 142.35 20.53 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 109.266 -0.642 . . . . 62.43 109.266 179.326 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 50.5 tp -125.32 133.02 52.76 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 108.629 -0.878 . . . . 70.23 108.629 178.431 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 62.1 t -110.37 121.14 42.28 Favored Pre-proline 0 C--O 1.248 1.007 0 CA-C-N 116.766 -0.197 . . . . 61.51 110.766 -177.407 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 202' ' ' PRO . . . . . 0.525 ' HA ' ' HG2' ' A' ' 207' ' ' GLU . 28.7 Cg_exo -62.43 131.75 35.32 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 122.229 1.953 . . . . 71.34 110.065 175.341 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 106.17 -17.82 40.27 Favored Glycine 0 N--CA 1.434 -1.485 0 N-CA-C 110.2 -1.16 . . . . 52.3 110.2 -175.286 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 204' ' ' GLY . . . . . 0.529 ' HA3' ' HA3' ' A' ' 173' ' ' GLY . . . -83.87 161.24 38.01 Favored Glycine 0 N--CA 1.428 -1.894 0 N-CA-C 110.329 -1.108 . . . . 71.14 110.329 176.796 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.426 ' O ' HG22 ' A' ' 209' ' ' THR . 3.1 mm? -58.9 -37.66 77.11 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 123.288 0.635 . . . . 74.31 111.599 -177.398 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -62.08 -47.28 85.35 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 116.071 -0.513 . . . . 73.43 112.112 -179.62 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.525 ' HG2' ' HA ' ' A' ' 202' ' ' PRO . 9.7 tp10 -75.28 -33.22 61.21 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.454 -0.573 . . . . 74.44 109.454 178.598 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 38.6 t -57.76 -48.17 80.41 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 116.059 -0.519 . . . . 42.42 110.208 177.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 209' ' ' THR . . . . . 0.426 HG22 ' O ' ' A' ' 205' ' ' LEU . 9.1 t -73.54 -40.42 63.99 Favored 'General case' 0 N--CA 1.437 -1.089 0 C-N-CA 120.098 -0.641 . . . . 63.23 110.201 176.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 83.35 -9.19 61.99 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.78 -0.724 . . . . 61.13 111.908 178.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 59.7 mt -77.75 -9.82 59.22 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.315 0.578 . . . . 74.34 110.013 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.453 HD11 HD11 ' A' ' 163' ' ' LEU . 79.6 mt -109.4 132.95 53.65 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 108.396 -0.964 . . . . 74.35 108.396 173.021 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -131.44 166.06 22.15 Favored 'General case' 0 N--CA 1.421 -1.914 0 N-CA-C 109.048 -0.723 . . . . 72.4 109.048 178.839 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 214' ' ' VAL . . . . . 0.401 ' HA ' ' CG2' ' A' ' 197' ' ' ILE . 28.4 m -64.01 -30.29 49.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 115.193 1.553 . . . . 63.41 115.193 -175.251 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -82.26 -13.24 57.34 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 113.798 1.036 . . . . 63.51 113.798 -179.38 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -59.54 141.74 54.17 Favored 'General case' 0 C--O 1.245 0.833 0 N-CA-C 114.578 1.325 . . . . 73.11 114.578 -176.841 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -106.75 131.44 53.87 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 125.91 1.684 . . . . 73.02 109.008 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.576 ' HA ' HG12 ' A' ' 249' ' ' VAL . 7.2 p -85.48 136.83 21.98 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-O 121.668 0.747 . . . . 63.43 112.554 -174.677 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.518 HD11 ' CD ' ' A' ' 250' ' ' LYS . 39.8 mm -103.37 -52.36 8.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.087 -0.961 . . . . 65.44 111.35 -179.044 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.424 ' HB3' ' HA ' ' A' ' 225' ' ' GLU . 9.3 pt-20 -155.83 154.62 31.6 Favored 'General case' 0 C--O 1.248 0.988 0 CA-C-N 116.465 -0.334 . . . . 75.14 111.219 -177.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.497 HG12 ' CG1' ' A' ' 226' ' ' VAL . 10.5 p -129.57 121.01 51.96 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.197 0 CA-C-O 121.438 0.637 . . . . 73.42 110.67 176.6 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 222' ' ' ASN . . . . . 0.416 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 11.6 t-20 66.99 12.99 9.3 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 125.256 1.422 . . . . 74.31 111.599 175.312 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 112.69 -18.19 22.53 Favored Glycine 0 N--CA 1.437 -1.255 0 C-N-CA 120.729 -0.748 . . . . 45.34 111.726 -179.042 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 62.9 mt -92.55 124.87 45.15 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.501 0 N-CA-C 108.601 -0.889 . . . . 74.33 108.601 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 225' ' ' GLU . . . . . 0.424 ' HA ' ' HB3' ' A' ' 220' ' ' GLU . 12.6 pt-20 -65.41 137.86 57.75 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-O 121.237 0.541 . . . . 74.52 110.372 179.704 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 226' ' ' VAL . . . . . 0.497 ' CG1' HG12 ' A' ' 221' ' ' VAL . 28.6 m -115.28 0.48 8.66 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 CA-C-O 121.595 0.712 . . . . 71.43 110.543 178.124 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -84.11 97.55 9.4 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-N 115.442 -0.799 . . . . 73.34 109.459 179.316 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 123.0 -17.9 8.02 Favored Glycine 0 C--N 1.313 -0.738 0 N-CA-C 110.704 -0.958 . . . . 54.22 110.704 -178.046 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -77.91 173.01 12.61 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 109.159 -0.682 . . . . 61.41 109.159 176.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 230' ' ' THR . . . . . 0.519 ' O ' HG13 ' A' ' 234' ' ' VAL . 74.7 p -94.21 163.73 13.33 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 108.312 -0.996 . . . . 62.41 108.312 178.519 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 231' ' ' LEU . . . . . 0.586 ' HB2' ' HB2' ' A' ' 178' ' ' ASP . 3.4 tm? -60.07 -38.67 83.57 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 109.778 -0.453 . . . . 73.33 109.778 178.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -62.52 -43.16 99.49 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.153 -0.476 . . . . 74.14 110.246 178.721 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -63.31 -48.59 77.42 Favored 'General case' 0 C--N 1.344 0.337 0 N-CA-C 113.113 0.783 . . . . 72.34 113.113 176.266 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.626 HG21 HG12 ' A' ' 195' ' ' ILE . 6.6 m -65.82 -33.59 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-O 121.272 0.558 . . . . 72.45 112.321 -174.607 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 60.2 m -74.08 -36.82 64.31 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.875 -0.787 . . . . 60.45 108.875 -175.161 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -61.09 -34.67 75.31 Favored 'General case' 0 CA--C 1.5 -0.948 0 CA-C-N 115.091 -0.959 . . . . 65.41 109.392 177.896 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 237' ' ' MET . . . . . 0.431 ' HG3' ' HA ' ' A' ' 234' ' ' VAL . 12.9 mtt -69.14 -46.91 66.46 Favored 'General case' 0 C--O 1.204 -1.321 0 N-CA-C 108.48 -0.933 . . . . 72.53 108.48 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 238' ' ' MET . . . . . 0.454 ' HA ' HD21 ' A' ' 245' ' ' LEU . 62.1 mtt -61.33 -42.17 98.24 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.986 -0.552 . . . . 72.0 111.654 -176.69 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 87.5 t -64.2 -40.4 88.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 O-C-N 123.328 0.392 . . . . 74.43 110.458 178.132 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -69.6 -38.01 77.12 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.444 0.64 . . . . 71.43 110.365 178.629 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -85.6 21.4 1.83 Allowed 'General case' 0 C--O 1.202 -1.409 0 CA-C-N 115.522 -0.763 . . . . 51.42 112.076 -179.326 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 242' ' ' SER . . . . . 0.736 ' O ' ' HG ' ' A' ' 164' ' ' LEU . 29.4 p -64.75 -21.33 66.74 Favored 'General case' 0 C--O 1.208 -1.108 0 N-CA-C 109.619 -0.512 . . . . 71.33 109.619 172.517 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 47.4 t -62.76 -35.52 80.09 Favored 'General case' 0 CA--C 1.551 1.016 0 N-CA-C 108.85 -0.796 . . . . 43.51 108.85 173.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -177.14 106.87 0.06 Allowed 'General case' 0 C--O 1.246 0.902 0 C-N-CA 124.08 0.952 . . . . 64.01 111.277 177.534 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.619 ' HB2' ' HB2' ' A' ' 163' ' ' LEU . 11.8 mt -86.67 129.52 34.84 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 115.364 -0.835 . . . . 74.23 111.025 179.481 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.416 ' HB ' ' HA ' ' A' ' 222' ' ' ASN . 66.3 mt -118.62 113.72 42.66 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.618 0 N-CA-C 105.044 -2.206 . . . . 73.25 105.044 167.381 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 64.3 mt -122.22 135.52 62.05 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.257 0 CA-C-O 121.313 0.578 . . . . 72.13 111.699 -176.774 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.479 ' HA ' ' O ' ' A' ' 159' ' ' ARG . 58.3 m -112.14 118.29 34.94 Favored 'General case' 0 N--CA 1.416 -2.154 0 N-CA-C 108.251 -1.018 . . . . 75.33 108.251 175.796 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.576 HG12 ' HA ' ' A' ' 218' ' ' VAL . 17.7 m -121.22 170.51 11.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 CA-C-O 121.436 0.636 . . . . 65.32 110.469 176.278 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 250' ' ' LYS . . . . . 0.518 ' CD ' HD11 ' A' ' 219' ' ' ILE 0.336 43.0 mtpt -126.69 144.15 48.89 Favored Pre-proline 0 C--N 1.28 -2.435 0 CA-C-N 113.965 -1.471 . . . . 72.44 107.44 174.165 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo . . . . . 0 N--CA 1.424 -2.597 0 N-CA-C 108.035 -1.563 . . . . 71.44 108.035 167.632 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.238 0.493 0 N-CA-C 106.712 -1.588 . . . . 74.25 106.712 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 38.0 p -67.2 -32.92 74.31 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 116.553 2.057 . . . . 74.54 116.553 -172.027 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.574 ' HB3' ' HG2' ' A' ' 250' ' ' LYS 0.311 2.2 p-80 -96.87 140.17 31.82 Favored 'General case' 0 CA--C 1.505 -0.776 0 N-CA-C 116.043 1.868 . . . . 75.24 116.043 -173.394 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 57.9 ttt180 -126.77 144.56 50.91 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 114.135 -1.393 . . . . 75.14 109.284 176.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.574 ' HG3' ' OG1' ' A' ' 248' ' ' THR . 0.1 OUTLIER -90.23 114.29 26.27 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 108.201 -1.037 . . . . 63.11 108.201 179.282 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.402 HG11 ' HB2' ' A' ' 211' ' ' LEU . 29.7 m -109.21 136.38 45.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-O 120.733 0.301 . . . . 74.43 111.215 179.149 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -99.08 121.71 41.35 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-O 121.516 0.674 . . . . 74.44 110.073 178.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.492 ' HB2' ' HB3' ' A' ' 245' ' ' LEU . 18.6 mt -104.24 137.06 42.71 Favored 'General case' 0 N--CA 1.403 -2.806 0 N-CA-C 106.637 -1.616 . . . . 70.14 106.637 177.456 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.46 HD23 ' O ' ' A' ' 242' ' ' SER . 14.2 tp 69.67 99.82 0.06 Allowed 'General case' 0 C--N 1.288 -2.099 0 N-CA-C 114.264 1.209 . . . . 71.54 114.264 177.466 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 24.3 pttm -132.5 -0.7 3.55 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 114.386 -1.279 . . . . 70.31 108.184 169.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 22.5 t-80 -174.54 117.26 0.2 Allowed 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 114.402 -1.272 . . . . 64.33 108.801 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 123.66 60.91 0.19 Allowed Glycine 0 C--N 1.301 -1.384 0 C-N-CA 120.412 -0.899 . . . . 60.31 112.526 177.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 16.3 p -83.27 -4.18 58.18 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-O 121.195 0.521 . . . . 62.3 111.989 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -85.23 -38.8 18.51 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.971 -0.559 . . . . 55.21 109.845 178.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -80.76 153.91 73.12 Favored Pre-proline 0 N--CA 1.437 -1.09 0 CA-C-N 115.56 -0.746 . . . . 55.25 109.024 -179.306 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -68.91 153.36 72.8 Favored 'Trans proline' 0 C--O 1.247 0.949 0 C-N-CA 121.995 1.797 . . . . 61.34 110.688 174.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 89.5 mt -57.81 -31.85 67.0 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.452 -0.34 . . . . 75.35 111.863 179.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' GLY . . . . . 0.533 ' HA3' ' HA3' ' A' ' 204' ' ' GLY . . . 93.91 22.35 25.84 Favored Glycine 0 N--CA 1.429 -1.793 0 C-N-CA 120.115 -1.041 . . . . 61.14 114.169 173.68 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -160.18 154.1 22.97 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 117.74 0.77 . . . . 75.25 109.157 177.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -123.86 153.56 40.9 Favored 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 107.403 -1.332 . . . . 72.31 107.403 177.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 39.9 pt -113.73 166.62 7.39 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 CA-C-O 121.38 0.609 . . . . 72.53 111.021 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.468 ' HG2' ' HB3' ' A' ' 198' ' ' SER . 16.2 ptt180 -147.12 154.75 41.49 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 115.286 -0.87 . . . . 62.45 109.833 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -110.32 142.79 41.47 Favored 'General case' 0 C--N 1.29 -1.998 0 O-C-N 123.901 0.75 . . . . 63.12 109.69 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -159.48 160.89 31.76 Favored Glycine 0 C--N 1.289 -2.072 0 N-CA-C 108.898 -1.681 . . . . 70.02 108.898 177.011 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' THR . . . . . 0.521 HG22 ' HG2' ' A' ' 191' ' ' LYS . 0.6 OUTLIER -90.82 123.6 34.49 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.169 -1.419 . . . . 74.41 107.169 178.844 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 181' ' ' SER . . . . . 0.497 ' O ' ' HA ' ' A' ' 191' ' ' LYS . 22.8 t -103.1 126.3 50.21 Favored 'General case' 0 C--N 1.283 -2.302 0 C-N-CA 123.311 0.644 . . . . 72.12 109.619 -175.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.64 ' HA ' ' O ' ' A' ' 190' ' ' GLU . 7.3 p -104.72 122.45 57.78 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.214 0 C-N-CA 119.635 -0.826 . . . . 61.21 109.136 172.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 87.6 mtt180 -132.48 160.07 37.53 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 107.454 -1.313 . . . . 75.34 107.454 -176.096 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 90.6 t -89.56 118.98 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.796 0 N-CA-C 107.826 -1.176 . . . . 61.35 107.826 171.148 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 40.0 p -117.56 -174.88 2.71 Favored 'General case' 0 C--N 1.268 -2.971 0 CA-C-N 114.616 -1.175 . . . . 64.23 108.383 -177.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -64.64 -17.5 64.09 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.217 0.532 . . . . 63.44 109.612 175.16 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 18.4 m -92.08 -16.12 26.84 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-N 115.66 -0.7 . . . . 72.23 110.79 178.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 117.29 -154.27 16.81 Favored Glycine 0 CA--C 1.495 -1.219 0 N-CA-C 110.436 -1.065 . . . . 72.12 110.436 -178.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 5.0 mp -78.69 117.21 19.62 Favored 'General case' 0 CA--C 1.498 -1.04 0 N-CA-C 106.847 -1.538 . . . . 63.21 106.847 176.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' GLU . . . . . 0.64 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 9.2 tp10 -133.34 127.19 33.0 Favored 'General case' 0 C--N 1.288 -2.075 0 N-CA-C 109.052 -0.721 . . . . 54.2 109.052 -173.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.521 ' HG2' HG22 ' A' ' 180' ' ' THR . 34.0 ttmt -100.23 129.14 46.21 Favored 'General case' 0 N--CA 1.426 -1.631 0 N-CA-C 106.771 -1.566 . . . . 73.22 106.771 178.65 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.44 158.6 37.88 Favored Pre-proline 0 C--N 1.307 -1.27 0 CA-C-O 118.899 -0.572 . . . . 62.53 110.153 -169.525 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -67.42 130.42 22.36 Favored 'Trans proline' 0 C--O 1.25 1.099 0 CA-C-N 119.941 1.015 . . . . 53.22 111.645 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -142.88 151.11 22.88 Favored Glycine 0 N--CA 1.412 -2.956 0 CA-C-N 115.393 -0.822 . . . . 34.34 111.357 -177.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.582 HG12 HG21 ' A' ' 234' ' ' VAL . 2.7 mp -104.13 136.91 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.286 0 N-CA-C 109.535 -0.543 . . . . 63.22 109.535 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -127.21 164.75 20.99 Favored 'General case' 0 C--N 1.28 -2.434 0 N-CA-C 107.393 -1.336 . . . . 74.33 107.393 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 42.6 mm -76.46 131.43 34.89 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 N-CA-C 106.896 -1.52 . . . . 53.1 106.896 175.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' SER . . . . . 0.468 ' HB3' ' HG2' ' A' ' 177' ' ' ARG . 75.7 p -100.92 -41.1 6.96 Favored 'General case' 0 C--N 1.287 -2.142 0 C-N-CA 118.612 -1.235 . . . . 70.3 111.092 -177.419 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 31.6 tpt180 -148.32 141.32 24.87 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.302 -0.999 . . . . 64.41 108.302 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 2.6 tt -122.25 123.58 41.78 Favored 'General case' 0 N--CA 1.421 -1.882 0 N-CA-C 106.672 -1.603 . . . . 74.34 106.672 178.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 36.5 t -105.85 126.76 29.87 Favored Pre-proline 0 C--N 1.307 -1.273 0 C-N-CA 122.559 0.344 . . . . 55.51 111.33 -172.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.513 ' HA ' ' HG3' ' A' ' 207' ' ' GLU . 45.0 Cg_endo -70.82 128.51 15.15 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 122.395 2.063 . . . . 73.4 110.954 176.164 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 114.38 -18.04 18.36 Favored Glycine 0 N--CA 1.439 -1.102 0 N-CA-C 110.47 -1.052 . . . . 63.11 110.47 -177.336 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' GLY . . . . . 0.533 ' HA3' ' HA3' ' A' ' 173' ' ' GLY . . . -96.04 171.42 28.47 Favored Glycine 0 N--CA 1.433 -1.525 0 N-CA-C 110.517 -1.033 . . . . 70.14 110.517 178.308 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.418 HD22 ' H ' ' A' ' 205' ' ' LEU . 2.7 mm? -65.22 -29.79 70.62 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 117.267 0.534 . . . . 74.43 112.084 -174.007 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -62.75 -44.41 96.27 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.996 -0.547 . . . . 62.43 110.97 178.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.513 ' HG3' ' HA ' ' A' ' 202' ' ' PRO . 2.9 tm-20 -75.9 -33.75 59.94 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.375 -0.972 . . . . 73.24 108.375 179.448 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 50.4 m -56.83 -42.48 79.68 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 116.298 -0.41 . . . . 73.32 110.803 177.173 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 13.9 t -73.34 -40.91 64.06 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 119.095 -1.042 . . . . 73.32 108.442 174.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 56.18 29.61 56.48 Favored Glycine 0 C--N 1.347 1.193 0 CA-C-N 115.908 -0.587 . . . . 72.23 113.24 177.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.402 ' HB2' HG11 ' A' ' 161' ' ' VAL . 68.2 mt -103.39 -12.67 17.04 Favored 'General case' 0 C--N 1.308 -1.228 0 O-C-N 122.674 -0.31 . . . . 71.31 110.299 -178.502 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.488 ' H ' HD23 ' A' ' 212' ' ' LEU . 2.0 pt? -113.68 158.07 21.36 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 115.484 -0.78 . . . . 43.31 109.552 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -130.46 165.59 22.32 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 123.047 0.539 . . . . 60.43 110.157 179.087 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 34.5 m -63.69 -30.07 48.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 113.599 0.963 . . . . 61.23 113.599 -179.118 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -76.77 -15.06 59.85 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 116.203 -0.453 . . . . 53.11 111.703 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -68.17 147.58 52.07 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-O 121.64 0.733 . . . . 50.51 112.649 -175.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -108.59 133.94 52.03 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.638 -1.164 . . . . 64.41 111.27 -177.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.487 ' HA ' HG12 ' A' ' 249' ' ' VAL . 39.8 t -83.62 133.96 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-O 121.811 0.815 . . . . 41.21 111.2 -175.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.438 HG13 ' ND1' ' A' ' 158' ' ' HIS . 46.8 mm -102.97 -56.47 5.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 CA-C-N 114.656 -1.156 . . . . 74.55 110.996 -178.314 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -152.37 165.19 35.77 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.986 -0.552 . . . . 61.32 109.934 -175.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.521 ' HA ' ' O ' ' A' ' 246' ' ' ILE . 8.9 p -134.8 123.88 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 CA-C-N 115.92 -0.582 . . . . 65.45 110.052 177.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 222' ' ' ASN . . . . . 0.426 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 12.8 t-20 65.44 13.52 8.9 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 125.241 1.416 . . . . 75.42 110.706 177.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 107.0 -9.4 39.69 Favored Glycine 0 N--CA 1.442 -0.933 0 C-N-CA 120.84 -0.695 . . . . 74.3 112.079 -178.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 64.4 mt -105.06 124.27 59.69 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 N-CA-C 110.13 -0.322 . . . . 72.22 110.13 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -57.2 142.58 42.36 Favored 'General case' 0 C--N 1.31 -1.126 0 C-N-CA 124.483 1.113 . . . . 65.11 112.6 -178.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 30.6 m -118.91 -1.68 8.99 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 CA-C-N 115.525 -0.761 . . . . 73.23 109.8 175.316 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -76.92 99.04 5.09 Favored 'General case' 0 N--CA 1.428 -1.546 0 CA-C-N 115.356 -0.838 . . . . 74.23 109.719 -177.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 118.9 -14.0 11.41 Favored Glycine 0 N--CA 1.435 -1.39 0 C-N-CA 120.839 -0.696 . . . . 63.53 111.729 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -76.97 -179.93 5.81 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 120.987 0.422 . . . . 75.3 110.654 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' THR . . . . . 0.444 ' O ' HG13 ' A' ' 234' ' ' VAL . 50.6 p -95.53 162.73 13.51 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 108.187 -1.042 . . . . 45.12 108.187 177.106 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -63.59 -33.26 75.22 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 109.067 -0.716 . . . . 75.22 109.067 -178.094 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -63.42 -49.7 72.7 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.516 -0.311 . . . . 61.44 110.293 176.28 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 233' ' ' GLN . . . . . 0.568 ' O ' ' HG2' ' A' ' 237' ' ' MET . 47.9 mt-30 -57.28 -41.72 80.32 Favored 'General case' 0 CA--C 1.509 -0.625 0 N-CA-C 112.447 0.536 . . . . 75.5 112.447 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.582 HG21 HG12 ' A' ' 195' ' ' ILE . 10.2 m -74.3 -34.57 37.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 C-N-CA 120.764 -0.375 . . . . 75.32 111.399 -177.139 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 235' ' ' THR . . . . . 0.407 ' O ' HG23 ' A' ' 239' ' ' VAL . 26.0 m -71.14 -38.04 72.27 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 108.368 -0.975 . . . . 74.02 108.368 178.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -59.86 -35.6 75.14 Favored 'General case' 0 C--O 1.243 0.746 0 CA-C-N 115.385 -0.825 . . . . 74.51 110.144 177.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 237' ' ' MET . . . . . 0.568 ' HG2' ' O ' ' A' ' 233' ' ' GLN . 17.3 mmt -59.78 -52.43 65.49 Favored 'General case' 0 C--O 1.199 -1.576 0 N-CA-C 108.065 -1.087 . . . . 73.43 108.065 175.293 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 63.4 mtt -61.57 -36.96 82.13 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.754 -1.112 . . . . 73.41 112.422 -175.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 235' ' ' THR . 83.9 t -68.49 -36.8 76.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-O 121.396 0.617 . . . . 74.43 110.287 176.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -74.48 -36.4 63.29 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.905 0.859 . . . . 72.54 110.11 179.199 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -87.75 22.13 2.39 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 114.945 -1.025 . . . . 75.11 110.607 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 242' ' ' SER . . . . . 0.46 ' O ' HD23 ' A' ' 164' ' ' LEU . 25.5 p -59.86 -28.2 67.31 Favored 'General case' 0 CA--C 1.554 1.13 0 N-CA-C 113.691 0.997 . . . . 52.45 113.691 -177.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 48.7 m -85.55 -9.28 57.59 Favored 'General case' 0 C--N 1.318 -0.789 0 O-C-N 121.672 -0.642 . . . . 73.33 112.038 177.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 14.8 p30 -164.56 78.24 0.35 Allowed 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.524 0.678 . . . . 71.02 111.376 -176.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.492 ' HB3' ' HB2' ' A' ' 163' ' ' LEU . 1.2 tt -85.54 101.89 13.06 Favored 'General case' 0 N--CA 1.422 -1.844 0 C-N-CA 118.721 -1.192 . . . . 75.21 108.059 -174.642 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.521 ' O ' ' HA ' ' A' ' 221' ' ' VAL . 68.7 mt -104.7 116.15 47.96 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.319 0 C-N-CA 119.713 -0.795 . . . . 53.13 108.963 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 247' ' ' ILE . . . . . 0.467 HG13 ' CD2' ' A' ' 245' ' ' LEU . 23.2 mt -118.53 136.91 54.2 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.257 0 CA-C-O 121.627 0.727 . . . . 60.24 111.477 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.574 ' OG1' ' HG3' ' A' ' 160' ' ' ARG . 39.0 m -107.74 119.34 39.16 Favored 'General case' 0 N--CA 1.405 -2.713 0 CA-C-N 115.073 -0.967 . . . . 61.34 108.573 177.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.487 HG12 ' HA ' ' A' ' 218' ' ' VAL . 27.1 m -129.29 159.32 41.45 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 O-C-N 123.282 0.364 . . . . 64.44 110.296 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.574 ' HG2' ' HB3' ' A' ' 158' ' ' HIS 0.346 35.7 mtmt -124.09 142.26 39.33 Favored Pre-proline 0 CA--C 1.475 -1.919 0 N-CA-C 104.435 -2.431 . . . . 75.41 104.435 175.538 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -79.13 141.44 16.4 Favored 'Trans proline' 0 C--N 1.286 -2.747 0 C-N-CA 120.871 1.047 . . . . 63.11 111.364 176.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -66.82 -30.65 70.89 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.402 0.62 . . . . 53.53 110.341 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -92.06 20.46 5.84 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.202 -0.908 . . . . 72.35 109.024 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 14.7 mt-30 61.04 -178.48 0.11 Allowed 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 125.321 1.448 . . . . 71.34 112.767 -176.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 16.6 tpt180 . . . . . 0 C--N 1.31 -1.113 0 C-N-CA 119.585 -0.846 . . . . 72.1 110.513 -172.95 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 . . . . . 0 CA--C 1.509 -0.614 0 N-CA-C 109.249 -0.648 . . . . 71.4 109.249 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 47.1 p -65.61 -48.93 70.58 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 112.643 0.609 . . . . 72.55 112.643 -176.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.575 ' HB3' ' HG2' ' A' ' 250' ' ' LYS 0.374 2.3 p-80 -123.66 137.74 54.66 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 115.397 1.629 . . . . 44.11 115.397 177.353 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.535 ' O ' ' HA ' ' A' ' 248' ' ' THR . 3.7 ptp180 -125.25 144.96 50.21 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 113.575 -1.648 . . . . 74.31 108.944 -176.029 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.705 ' HB3' ' OG1' ' A' ' 248' ' ' THR . 37.0 ptt180 -117.27 119.25 34.58 Favored 'General case' 0 N--CA 1.426 -1.627 0 CA-C-O 121.901 0.858 . . . . 72.41 113.05 178.025 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.582 ' O ' ' HA ' ' A' ' 246' ' ' ILE . 26.6 m -102.78 135.02 42.12 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 CA-C-N 114.617 -1.174 . . . . 74.32 111.075 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.523 ' HG2' HG12 ' A' ' 246' ' ' ILE . 15.4 mtm180 -96.48 112.66 24.32 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 106.927 -1.508 . . . . 65.42 106.927 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 21.4 mt -99.34 134.23 42.5 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 109.52 -0.548 . . . . 75.44 109.52 -177.043 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.524 HD11 ' HA ' ' A' ' 168' ' ' SER . 6.3 tt 77.38 101.86 0.07 Allowed 'General case' 0 C--N 1.318 -0.774 0 O-C-N 124.344 1.027 . . . . 72.15 111.893 174.207 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 57.7 pttt -129.61 6.86 5.22 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 114.504 -1.226 . . . . 64.54 108.047 173.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -144.3 97.66 3.08 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.712 -1.131 . . . . 75.25 110.323 -178.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 89.83 99.29 1.09 Allowed Glycine 0 C--O 1.21 -1.345 0 N-CA-C 111.352 -0.699 . . . . 64.33 111.352 176.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' SER . . . . . 0.524 ' HA ' HD11 ' A' ' 164' ' ' LEU . 17.2 t -94.56 -172.83 2.86 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 117.087 0.444 . . . . 73.23 109.804 -177.178 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 18.9 t70 72.91 -35.9 0.34 Allowed 'General case' 0 N--CA 1.497 1.918 0 C-N-CA 124.952 1.301 . . . . 74.13 112.437 -178.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 13.4 ptmm? -72.34 154.55 91.91 Favored Pre-proline 0 C--N 1.31 -1.149 0 C-N-CA 124.271 1.028 . . . . 72.22 111.789 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -57.7 154.06 39.33 Favored 'Trans proline' 0 C--O 1.258 1.494 0 C-N-CA 123.553 2.835 . . . . 53.23 112.55 178.137 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.47 ' HG ' ' CD1' ' A' ' 245' ' ' LEU . 2.9 mm? -91.03 -23.88 20.23 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.164 -0.926 . . . . 75.25 111.021 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' GLY . . . . . 0.454 ' HA3' ' HA3' ' A' ' 204' ' ' GLY . . . 89.24 43.97 5.15 Favored Glycine 0 N--CA 1.436 -1.346 0 C-N-CA 120.592 -0.813 . . . . 75.21 113.983 174.699 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -161.94 154.76 20.2 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.627 -1.249 . . . . 64.32 107.627 174.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -123.95 157.88 33.3 Favored 'General case' 0 C--N 1.282 -2.353 0 N-CA-C 108.533 -0.914 . . . . 74.52 108.533 177.534 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.582 HD13 ' H ' ' A' ' 176' ' ' ILE . 0.1 OUTLIER -123.72 160.52 27.28 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 N-CA-C 109.571 -0.529 . . . . 61.31 109.571 179.944 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.462 ' HB3' ' HB3' ' A' ' 198' ' ' SER . 10.1 ptp180 -132.21 154.64 49.38 Favored 'General case' 0 C--N 1.282 -2.355 0 CA-C-N 115.656 -0.702 . . . . 74.23 110.684 -178.529 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' ASP . . . . . 0.497 ' HB2' ' HG ' ' A' ' 231' ' ' LEU . 4.8 t70 -107.41 143.92 35.06 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 115.085 -0.961 . . . . 52.32 110.509 -179.412 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -164.92 179.79 39.35 Favored Glycine 0 N--CA 1.415 -2.715 0 N-CA-C 108.871 -1.692 . . . . 52.13 108.871 175.078 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' THR . . . . . 0.462 ' HB ' ' CG ' ' A' ' 191' ' ' LYS . 0.4 OUTLIER -89.99 122.34 32.91 Favored 'General case' 0 C--N 1.283 -2.301 0 CA-C-N 117.524 0.662 . . . . 71.42 111.024 175.667 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 47.3 t -99.5 113.18 25.4 Favored 'General case' 0 N--CA 1.414 -2.265 0 N-CA-C 107.87 -1.159 . . . . 55.42 107.87 177.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.671 ' HA ' ' O ' ' A' ' 190' ' ' GLU . 6.4 p -115.49 123.89 71.43 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.733 0 CA-C-O 121.404 0.621 . . . . 55.12 109.441 175.026 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -124.68 158.45 33.13 Favored 'General case' 0 C--N 1.279 -2.47 0 N-CA-C 107.539 -1.282 . . . . 73.54 107.539 -177.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.41 HG22 ' HG ' ' A' ' 189' ' ' LEU . 78.2 t -92.52 118.34 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.237 0 N-CA-C 106.895 -1.52 . . . . 73.13 106.895 169.315 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 67.2 p -111.11 -175.11 2.63 Favored 'General case' 0 C--N 1.272 -2.773 0 N-CA-C 107.938 -1.134 . . . . 72.34 107.938 -178.188 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -71.59 -12.68 61.48 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 121.279 0.561 . . . . 53.04 109.568 175.039 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 32.1 t -97.34 -13.89 21.61 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-N 115.693 -0.685 . . . . 73.23 110.663 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 126.85 -153.98 19.11 Favored Glycine 0 CA--C 1.495 -1.198 0 N-CA-C 110.787 -0.925 . . . . 74.14 110.787 177.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.41 ' HG ' HG22 ' A' ' 184' ' ' VAL . 5.2 mp -87.78 123.7 32.85 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 107.911 -1.144 . . . . 53.33 107.911 176.262 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 190' ' ' GLU . . . . . 0.671 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 45.1 mt-10 -131.28 119.26 21.52 Favored 'General case' 0 CA--C 1.454 -2.719 0 CA-C-O 121.115 0.484 . . . . 72.41 111.131 -177.408 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.462 ' CG ' ' HB ' ' A' ' 180' ' ' THR . 35.5 ttmt -103.21 131.69 50.04 Favored 'General case' 0 C--N 1.274 -2.688 0 CA-C-N 114.168 -1.378 . . . . 72.4 107.785 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -151.09 164.98 18.39 Favored Pre-proline 0 C--N 1.293 -1.878 0 N-CA-C 108.256 -1.016 . . . . 72.5 108.256 -178.115 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -55.19 132.27 51.3 Favored 'Trans proline' 0 C--N 1.358 1.04 0 C-N-CA 121.637 1.558 . . . . 75.02 109.846 174.274 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -143.93 138.65 8.18 Favored Glycine 0 N--CA 1.409 -3.106 0 N-CA-C 111.38 -0.688 . . . . 71.13 111.38 -178.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.559 HG12 HG21 ' A' ' 234' ' ' VAL . 2.7 mp -103.63 134.52 44.59 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.94 0 CA-C-O 121.605 0.717 . . . . 72.14 110.883 179.452 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -124.27 166.17 16.36 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 106.149 -1.797 . . . . 71.23 106.149 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 47.8 mm -79.08 131.27 34.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 107.562 -1.273 . . . . 75.31 107.562 177.561 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' SER . . . . . 0.462 ' HB3' ' HB3' ' A' ' 177' ' ' ARG . 82.3 p -101.64 -31.64 10.72 Favored 'General case' 0 C--N 1.287 -2.111 0 C-N-CA 118.633 -1.227 . . . . 43.13 112.752 -175.298 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 29.6 tpt180 -166.76 146.15 5.54 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 120.781 -0.368 . . . . 70.1 110.344 -175.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 82.9 mt -102.54 146.38 28.22 Favored 'General case' 0 CA--C 1.489 -1.381 0 N-CA-C 108.932 -0.766 . . . . 70.43 108.932 172.409 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 47.8 t -107.52 115.89 58.64 Favored Pre-proline 0 C--N 1.282 -2.337 0 N-CA-C 105.3 -2.111 . . . . 73.42 105.3 172.187 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.434 ' HA ' ' HG3' ' A' ' 207' ' ' GLU . 11.5 Cg_endo -55.03 128.67 31.53 Favored 'Trans proline' 0 C--O 1.248 0.98 0 C-N-CA 122.335 2.023 . . . . 75.25 111.129 -177.118 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 99.05 -11.4 62.17 Favored Glycine 0 N--CA 1.439 -1.158 0 C-N-CA 120.6 -0.809 . . . . 71.32 111.719 -177.386 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' GLY . . . . . 0.454 ' HA3' ' HA3' ' A' ' 173' ' ' GLY . . . -74.82 166.36 54.85 Favored Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 121.032 -0.604 . . . . 75.21 111.597 178.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.452 HD23 ' HA ' ' A' ' 172' ' ' LEU . 3.0 mm? -66.09 -34.02 77.11 Favored 'General case' 0 C--N 1.312 -1.036 0 C-N-CA 122.996 0.518 . . . . 73.32 111.641 -176.55 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 206' ' ' ALA . . . . . 0.562 ' CB ' HD12 ' A' ' 212' ' ' LEU . . . -67.75 -42.43 81.83 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.522 0.677 . . . . 72.4 110.051 178.444 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.434 ' HG3' ' HA ' ' A' ' 202' ' ' PRO . 6.0 tm-20 -75.39 -34.49 61.09 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 114.915 -1.039 . . . . 72.14 108.982 -178.469 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 35.9 t -58.54 -47.34 84.54 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 123.786 0.834 . . . . 73.21 110.795 177.303 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' THR . . . . . 0.474 HG23 ' H ' ' A' ' 211' ' ' LEU . 10.2 t -75.6 -35.67 60.48 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 120.004 -0.678 . . . . 53.51 109.446 177.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 74.17 16.56 79.64 Favored Glycine 0 N--CA 1.442 -0.905 0 CA-C-N 115.984 -0.553 . . . . 40.33 112.672 177.326 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.474 ' H ' HG23 ' A' ' 209' ' ' THR . 54.9 mt -99.19 -0.55 41.29 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 120.933 0.397 . . . . 64.44 110.449 -178.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.562 HD12 ' CB ' ' A' ' 206' ' ' ALA . 80.6 mt -109.79 131.7 54.83 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 115.187 -0.915 . . . . 72.23 108.941 174.277 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -130.7 155.9 45.83 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 109.102 -0.703 . . . . 62.12 109.102 177.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 31.2 m -62.16 -29.28 46.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-O 122.078 0.942 . . . . 70.42 112.773 -177.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -77.99 -14.06 59.66 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 115.533 -0.758 . . . . 74.33 111.782 -178.11 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -76.71 150.68 36.28 Favored 'General case' 0 C--O 1.244 0.786 0 N-CA-C 113.02 0.748 . . . . 53.13 113.02 -173.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -108.81 132.34 54.09 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.016 -0.993 . . . . 72.22 109.766 -178.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.54 ' HA ' HG12 ' A' ' 249' ' ' VAL . 39.7 t -83.33 138.33 19.48 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 CA-C-O 121.488 0.661 . . . . 70.54 111.509 -176.053 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 46.0 mm -105.22 -53.16 7.13 Favored 'Isoleucine or valine' 0 C--O 1.246 0.875 0 CA-C-N 115.171 -0.922 . . . . 74.24 111.099 -178.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.423 ' HB3' ' HA ' ' A' ' 225' ' ' GLU . 10.5 pt-20 -153.92 165.85 34.81 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 116.049 -0.523 . . . . 74.43 109.82 -175.611 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.487 ' HA ' ' O ' ' A' ' 246' ' ' ILE . 8.3 p -135.19 122.97 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.749 0 CA-C-N 115.647 -0.706 . . . . 74.34 109.148 176.639 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 222' ' ' ASN . . . . . 0.537 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 12.2 t-20 68.73 5.52 4.98 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 125.083 1.353 . . . . 70.23 111.198 178.623 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 113.63 -14.15 22.51 Favored Glycine 0 N--CA 1.439 -1.149 0 N-CA-C 110.882 -0.887 . . . . 75.32 110.882 -178.519 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 65.7 mt -96.34 123.75 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.521 0 N-CA-C 109.1 -0.704 . . . . 62.25 109.1 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 225' ' ' GLU . . . . . 0.423 ' HA ' ' HB3' ' A' ' 220' ' ' GLU . 12.4 pt-20 -58.05 153.01 15.42 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 123.684 0.794 . . . . 73.45 112.002 -177.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 226' ' ' VAL . . . . . 0.476 ' HB ' HG12 ' A' ' 234' ' ' VAL . 35.9 m -129.59 2.47 2.58 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 CA-C-N 115.411 -0.813 . . . . 52.04 110.248 174.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -71.84 98.56 2.02 Favored 'General case' 0 N--CA 1.432 -1.372 0 CA-C-N 115.634 -0.712 . . . . 71.1 110.693 -178.351 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 121.12 -17.57 9.11 Favored Glycine 0 CA--C 1.489 -1.551 0 N-CA-C 110.378 -1.089 . . . . 44.1 110.378 178.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -83.5 163.21 20.61 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.122 -0.539 . . . . 72.41 111.333 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 37.2 p -97.19 172.32 7.89 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.756 -0.657 . . . . 75.35 110.667 -176.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.603 ' HA ' HG22 ' A' ' 234' ' ' VAL . 78.0 mt -56.65 -40.32 75.25 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 111.837 0.31 . . . . 64.11 111.837 177.152 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -56.8 -42.7 79.96 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 121.279 0.561 . . . . 73.34 110.132 179.022 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -72.94 -47.71 43.19 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.961 -1.018 . . . . 71.21 112.339 -179.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.603 HG22 ' HA ' ' A' ' 231' ' ' LEU . 16.9 m -70.86 -34.47 56.18 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 112.092 0.404 . . . . 51.21 112.092 -176.056 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 235' ' ' THR . . . . . 0.428 ' O ' HG23 ' A' ' 239' ' ' VAL . 50.3 m -69.57 -35.3 75.24 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 109.429 -0.582 . . . . 75.14 109.429 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -60.73 -38.93 86.78 Favored 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 108.863 -0.792 . . . . 73.3 108.863 177.262 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 15.9 mmt -59.46 -50.17 74.95 Favored 'General case' 0 C--O 1.199 -1.563 0 CA-C-N 115.332 -0.849 . . . . 74.15 108.725 177.216 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 238' ' ' MET . . . . . 0.444 ' HG3' ' O ' ' A' ' 234' ' ' VAL . 63.0 mtt -61.8 -37.31 83.91 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.895 0.878 . . . . 74.44 112.259 -176.313 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 235' ' ' THR . 97.3 t -65.13 -40.32 88.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 121.19 0.519 . . . . 52.23 109.942 176.324 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -72.97 -37.0 67.21 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.613 0.721 . . . . 62.25 110.297 178.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -86.87 21.11 2.35 Favored 'General case' 0 C--O 1.202 -1.431 0 CA-C-N 115.603 -0.726 . . . . 71.41 111.905 -178.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 69.8 m -65.21 -22.88 66.95 Favored 'General case' 0 C--N 1.312 -1.022 0 C-N-CA 120.41 -0.516 . . . . 71.53 111.548 177.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 23.1 m -70.47 -24.38 62.86 Favored 'General case' 0 CA--C 1.554 1.11 0 CA-C-N 116.363 -0.381 . . . . 74.22 111.032 176.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 -174.3 97.3 0.1 Allowed 'General case' 0 C--O 1.246 0.913 0 C-N-CA 124.363 1.065 . . . . 35.54 109.205 177.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.501 ' CD2' HG13 ' A' ' 247' ' ' ILE . 2.4 tt -88.16 103.03 15.38 Favored 'General case' 0 N--CA 1.414 -2.273 0 N-CA-C 109.211 -0.662 . . . . 71.24 109.211 -173.641 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.582 ' HA ' ' O ' ' A' ' 161' ' ' VAL . 69.7 mt -100.87 116.7 44.88 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.179 0 N-CA-C 109.37 -0.604 . . . . 72.0 109.37 -179.541 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 247' ' ' ILE . . . . . 0.501 HG13 ' CD2' ' A' ' 245' ' ' LEU . 27.0 mt -120.94 132.54 70.18 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 CA-C-O 121.541 0.686 . . . . 71.12 112.331 178.495 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.705 ' OG1' ' HB3' ' A' ' 160' ' ' ARG . 37.0 m -104.19 122.8 46.11 Favored 'General case' 0 N--CA 1.414 -2.244 0 CA-C-N 114.291 -1.322 . . . . 64.44 108.603 177.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.54 HG12 ' HA ' ' A' ' 218' ' ' VAL . 34.7 m -130.79 164.09 34.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 110.035 -0.357 . . . . 64.11 110.035 177.204 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.575 ' HG2' ' HB3' ' A' ' 158' ' ' HIS 0.296 38.6 mtmt -124.39 141.73 38.36 Favored Pre-proline 0 CA--C 1.48 -1.721 0 N-CA-C 104.788 -2.301 . . . . 74.54 104.788 173.919 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -85.02 148.1 10.54 Favored 'Trans proline' 0 N--CA 1.411 -3.351 0 C-N-CA 120.573 0.848 . . . . 74.23 111.257 176.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -69.72 -30.97 68.71 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.974 0.893 . . . . 43.25 109.46 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -75.32 -27.58 59.32 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 114.635 -1.166 . . . . 63.43 110.468 178.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 62.11 108.93 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 114.553 1.316 . . . . 74.13 114.553 179.019 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 . . . . . 0 CA--C 1.499 -0.999 0 C-N-CA 125.069 1.348 . . . . 55.1 108.681 178.305 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.531 0.214 0 N-CA-C 106.472 -1.677 . . . . 74.12 106.472 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.518 HG22 ' H ' ' A' ' 255' ' ' ARG . 62.9 p -56.87 -35.14 68.57 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 113.921 1.082 . . . . 51.02 113.921 -171.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.488 ' NE2' HG13 ' A' ' 219' ' ' ILE . 4.7 m80 -80.54 130.32 35.06 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-O 121.658 0.742 . . . . 71.51 112.588 -174.73 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.434 ' O ' ' HA ' ' A' ' 248' ' ' THR . 18.8 tpp180 -107.29 141.41 38.68 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 107.218 -1.401 . . . . 72.35 107.218 177.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -114.96 113.15 23.75 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 108.657 -0.868 . . . . 73.55 108.657 175.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.507 HG21 HD11 ' A' ' 212' ' ' LEU . 17.7 m -129.08 137.86 56.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-O 120.868 0.366 . . . . 75.3 111.986 179.295 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 42.9 ttp180 -116.81 112.5 21.21 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 108.904 -0.776 . . . . 71.35 108.904 173.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 13.5 mt -102.56 138.83 38.96 Favored 'General case' 0 C--N 1.281 -2.386 0 N-CA-C 107.319 -1.363 . . . . 74.51 107.319 -175.365 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.585 HD12 ' O ' ' A' ' 242' ' ' SER . 0.7 OUTLIER 66.64 74.06 0.35 Allowed 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 108.263 -1.014 . . . . 74.31 108.263 174.542 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -98.4 -2.69 38.57 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.61 -0.723 . . . . 70.1 110.632 -176.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 32.3 m170 -95.64 -19.16 19.96 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 119.456 -0.898 . . . . 73.51 112.62 -177.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 71.34 68.88 1.51 Allowed Glycine 0 C--N 1.32 -0.335 0 C-N-CA 120.482 -0.866 . . . . 55.43 111.211 -177.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' SER . . . . . 0.545 ' H ' HD11 ' A' ' 164' ' ' LEU . 46.3 t -144.66 147.99 33.72 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 107.636 -1.246 . . . . 75.33 107.636 -178.63 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . 0.283 29.3 m-20 -84.8 69.59 10.73 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 122.607 1.194 . . . . 64.41 113.146 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.94 136.77 22.61 Favored Pre-proline 0 C--N 1.29 -2.009 0 CA-C-N 113.172 -1.831 . . . . 73.55 107.216 174.107 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -54.29 135.84 66.55 Favored 'Trans proline' 0 N--CA 1.479 0.672 0 C-N-CA 123.274 2.649 . . . . 64.31 113.38 -177.042 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.44 ' CD1' ' HB2' ' A' ' 164' ' ' LEU . 3.3 mm? -70.22 -39.77 74.91 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-O 121.201 0.524 . . . . 72.53 110.177 177.726 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' GLY . . . . . 0.475 ' HA3' ' HA3' ' A' ' 204' ' ' GLY . . . 90.53 25.15 26.48 Favored Glycine 0 N--CA 1.42 -2.368 0 CA-C-N 115.445 -0.798 . . . . 73.34 113.522 176.108 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -143.11 151.54 40.84 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 107.843 -1.169 . . . . 74.32 107.843 174.099 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -131.13 152.85 49.99 Favored 'General case' 0 CA--C 1.484 -1.588 0 CA-C-O 120.808 0.337 . . . . 73.32 110.227 178.362 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.635 HD13 ' H ' ' A' ' 176' ' ' ILE . 0.2 OUTLIER -116.85 169.85 6.87 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.049 0 CA-C-N 115.66 -0.7 . . . . 52.31 112.219 -173.81 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.61 ' CG ' ' HB2' ' A' ' 198' ' ' SER . 11.8 ptt180 -148.51 156.02 41.91 Favored 'General case' 0 C--N 1.287 -2.133 0 C-N-CA 125.478 1.511 . . . . 75.34 109.841 -175.597 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -110.89 144.61 39.67 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 123.466 0.479 . . . . 73.25 110.856 179.129 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -162.44 171.68 38.35 Favored Glycine 0 N--CA 1.427 -1.901 0 N-CA-C 108.876 -1.69 . . . . 43.42 108.876 175.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' THR . . . . . 0.501 ' HB ' ' CG ' ' A' ' 191' ' ' LYS . 0.6 OUTLIER -86.76 123.85 32.37 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 118.172 0.986 . . . . 74.23 111.658 175.966 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 34.7 t -102.69 115.77 31.24 Favored 'General case' 0 N--CA 1.404 -2.768 0 N-CA-C 107.927 -1.138 . . . . 74.55 107.927 177.411 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.616 ' HA ' ' O ' ' A' ' 190' ' ' GLU . 3.7 p -112.69 126.3 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.75 0 N-CA-C 109.3 -0.63 . . . . 62.2 109.3 176.597 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -122.8 159.57 27.8 Favored 'General case' 0 C--N 1.29 -2.009 0 CA-C-N 115.307 -0.86 . . . . 73.4 108.748 -176.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 69.6 t -90.08 119.14 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.138 0 N-CA-C 107.313 -1.366 . . . . 73.43 107.313 171.232 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 46.2 p -116.83 -175.2 2.72 Favored 'General case' 0 C--N 1.266 -3.049 0 CA-C-N 114.359 -1.291 . . . . 71.2 107.936 -177.136 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -67.91 -14.64 63.13 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.284 0.564 . . . . 71.54 109.784 174.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 19.3 m -90.98 -18.05 25.3 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 115.557 -0.747 . . . . 74.43 110.373 178.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 116.58 -145.63 18.72 Favored Glycine 0 N--CA 1.436 -1.301 0 N-CA-C 109.211 -1.556 . . . . 75.11 109.211 -176.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 6.2 mp -80.81 118.7 22.55 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 117.953 0.877 . . . . 71.33 109.509 177.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' GLU . . . . . 0.616 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 38.9 tt0 -123.02 117.75 26.18 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.233 -1.025 . . . . 73.54 108.233 -175.448 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.501 ' CG ' ' HB ' ' A' ' 180' ' ' THR . 36.3 ttmt -105.51 133.31 50.47 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 109.071 -0.714 . . . . 73.14 109.071 -177.591 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -144.21 164.33 29.71 Favored Pre-proline 0 C--N 1.297 -1.705 0 N-CA-C 107.503 -1.295 . . . . 73.41 107.503 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -65.17 132.86 33.17 Favored 'Trans proline' 0 C--O 1.247 0.934 0 C-N-CA 121.102 1.201 . . . . 42.34 109.776 174.293 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -137.94 141.62 12.36 Favored Glycine 0 N--CA 1.414 -2.787 0 N-CA-C 110.533 -1.027 . . . . 51.51 110.533 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.511 ' O ' HG12 ' A' ' 218' ' ' VAL . 3.4 mp -103.74 136.04 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.402 0 N-CA-C 109.272 -0.64 . . . . 74.11 109.272 179.485 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -128.1 167.6 16.53 Favored 'General case' 0 C--N 1.282 -2.326 0 N-CA-C 107.73 -1.211 . . . . 70.52 107.73 -177.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 58.5 mt -83.6 131.71 33.19 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 N-CA-C 109.334 -0.617 . . . . 73.24 109.334 174.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' SER . . . . . 0.61 ' HB2' ' CG ' ' A' ' 177' ' ' ARG . 29.6 t -110.18 -27.91 8.9 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.557 -0.714 . . . . 70.32 112.691 -177.28 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -147.63 134.53 20.19 Favored 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 120.037 -0.665 . . . . 73.45 109.583 -176.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 1.4 tt -116.18 124.81 51.23 Favored 'General case' 0 N--CA 1.414 -2.239 0 N-CA-C 106.51 -1.663 . . . . 73.53 106.51 179.27 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 96.6 t -94.14 124.69 55.21 Favored Pre-proline 0 C--N 1.306 -1.284 0 N-CA-C 110.472 -0.196 . . . . 74.42 110.472 -178.067 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -60.59 126.29 19.5 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.459 2.106 . . . . 24.12 110.782 177.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 98.91 -6.66 60.31 Favored Glycine 0 N--CA 1.435 -1.405 0 C-N-CA 120.777 -0.725 . . . . 53.53 112.614 -178.245 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' GLY . . . . . 0.475 ' HA3' ' HA3' ' A' ' 173' ' ' GLY . . . -79.53 169.54 53.62 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.5 -0.857 . . . . 65.41 112.285 179.416 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -65.06 -34.63 78.87 Favored 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 122.723 0.409 . . . . 73.14 110.653 -178.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -60.3 -43.59 96.16 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.64 -0.709 . . . . 64.23 110.809 178.172 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -75.6 -35.89 60.44 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.257 -0.429 . . . . 75.23 110.324 179.064 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 37.9 t -56.61 -42.71 79.24 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.817 -0.629 . . . . 72.33 110.35 179.068 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' THR . . . . . 0.417 HG23 ' H ' ' A' ' 211' ' ' LEU . 10.2 t -82.86 -35.73 26.02 Favored 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 120.454 -0.498 . . . . 72.33 109.912 176.433 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 75.18 5.74 77.43 Favored Glycine 0 C--O 1.217 -0.925 0 CA-C-N 116.202 -0.453 . . . . 65.13 112.986 177.058 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.417 ' H ' HG23 ' A' ' 209' ' ' THR . 67.0 mt -87.05 -11.79 49.26 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 120.813 0.339 . . . . 55.23 110.894 -177.222 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.507 HD11 HG21 ' A' ' 161' ' ' VAL . 4.3 mp -109.65 133.73 52.77 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 120.351 -0.54 . . . . 74.15 109.63 177.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -131.09 166.0 22.03 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 108.762 -0.829 . . . . 53.12 108.762 176.056 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 30.2 m -59.97 -28.06 40.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 113.324 0.861 . . . . 62.45 113.324 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 20.1 m-80 -71.95 -15.97 62.08 Favored 'General case' 0 C--N 1.312 -1.022 0 O-C-N 122.038 -0.414 . . . . 74.34 110.769 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.5 ' HA ' ' HA ' ' A' ' 251' ' ' PRO . 5.0 m-20 -71.18 132.35 44.87 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 114.426 1.269 . . . . 72.51 114.426 -174.24 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -105.19 131.12 53.06 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 126.328 1.851 . . . . 65.24 108.497 -179.01 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.592 ' HA ' HG12 ' A' ' 249' ' ' VAL . 11.4 p -83.5 134.55 26.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-O 122.034 0.921 . . . . 75.51 112.58 -175.5 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.488 HG13 ' NE2' ' A' ' 158' ' ' HIS . 39.7 mm -99.49 -49.01 11.67 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 CA-C-N 114.303 -1.317 . . . . 61.51 110.645 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -160.12 160.51 33.08 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.192 -0.458 . . . . 75.03 110.775 -176.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' A' ' 246' ' ' ILE . 7.5 p -129.7 122.67 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.03 0 O-C-N 123.736 0.647 . . . . 71.55 109.675 175.473 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 222' ' ' ASN . . . . . 0.467 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 2.8 m-20 58.89 22.08 9.84 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 125.519 1.528 . . . . 73.22 113.651 -178.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 105.85 -13.87 45.57 Favored Glycine 0 N--CA 1.429 -1.83 0 C-N-CA 120.323 -0.941 . . . . 55.52 113.062 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 60.9 mt -97.9 123.85 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.046 0 C-N-CA 120.705 -0.398 . . . . 73.33 110.458 -179.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -51.64 133.7 30.52 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 124.711 1.257 . . . . 63.35 111.608 177.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 226' ' ' VAL . . . . . 0.406 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 29.7 m -115.74 11.47 7.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 CA-C-O 122.217 1.008 . . . . 73.2 108.338 172.599 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -68.44 97.11 0.73 Allowed 'General case' 0 N--CA 1.422 -1.869 0 CA-C-N 113.468 -1.697 . . . . 72.43 111.142 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 95.56 10.3 56.92 Favored Glycine 0 C--N 1.307 -1.038 0 CA-C-N 115.609 -0.723 . . . . 64.4 112.88 174.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -82.94 178.31 8.22 Favored 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 120.506 -0.478 . . . . 73.34 109.83 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 41.1 p -87.82 157.64 18.95 Favored 'General case' 0 N--CA 1.421 -1.889 0 N-CA-C 107.135 -1.432 . . . . 61.53 107.135 174.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.429 ' O ' HG22 ' A' ' 234' ' ' VAL . 1.3 tt -64.83 -32.72 74.55 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 108.1 -1.074 . . . . 74.43 108.1 -177.372 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -64.35 -38.99 92.98 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.411 -0.358 . . . . 74.43 110.487 177.222 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -60.34 -49.36 77.9 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 112.026 0.38 . . . . 73.33 112.026 175.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.441 HG21 HG12 ' A' ' 195' ' ' ILE . 5.4 m -67.92 -32.76 57.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-O 121.242 0.544 . . . . 72.31 111.739 -176.342 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 235' ' ' THR . . . . . 0.407 ' O ' HG23 ' A' ' 239' ' ' VAL . 88.2 m -74.18 -37.15 64.04 Favored 'General case' 0 CA--C 1.498 -1.044 0 CA-C-N 115.567 -0.742 . . . . 64.05 109.084 -176.386 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -60.39 -34.12 73.44 Favored 'General case' 0 CA--C 1.507 -0.682 0 CA-C-N 115.433 -0.803 . . . . 55.12 109.153 177.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 8.9 mtt -69.24 -44.88 71.09 Favored 'General case' 0 C--O 1.2 -1.527 0 N-CA-C 108.686 -0.857 . . . . 74.31 108.686 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 238' ' ' MET . . . . . 0.421 ' HG3' ' O ' ' A' ' 234' ' ' VAL . 64.7 mtt -60.12 -31.76 70.36 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.979 -0.555 . . . . 62.24 111.681 -178.163 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 235' ' ' THR . 91.0 t -74.12 -41.9 51.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-O 121.327 0.584 . . . . 70.05 110.004 176.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -70.51 -35.59 73.28 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.386 0.612 . . . . 75.01 111.106 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -84.71 21.95 1.43 Allowed 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 115.357 -0.838 . . . . 62.3 112.546 -178.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 242' ' ' SER . . . . . 0.585 ' O ' HD12 ' A' ' 164' ' ' LEU . 67.9 m -59.41 -23.46 62.65 Favored 'General case' 0 C--O 1.207 -1.159 0 N-CA-C 113.08 0.771 . . . . 64.11 113.08 178.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 22.6 p -68.42 -33.93 75.09 Favored 'General case' 0 CA--C 1.552 1.033 0 O-C-N 121.76 -0.588 . . . . 53.04 111.861 177.439 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 -159.68 100.59 1.46 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.931 1.292 . . . . 54.31 108.264 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -86.55 103.1 14.74 Favored 'General case' 0 C--O 1.21 -1.012 0 N-CA-C 108.443 -0.947 . . . . 44.22 108.443 -178.123 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.467 ' HB ' ' HA ' ' A' ' 222' ' ' ASN . 61.9 mt -103.78 116.32 47.34 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 N-CA-C 108.731 -0.84 . . . . 74.24 108.731 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 247' ' ' ILE . . . . . 0.509 HG23 HG23 ' A' ' 218' ' ' VAL . 18.2 mt -121.99 134.54 64.97 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.155 0 CA-C-O 121.801 0.81 . . . . 72.23 112.318 178.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.434 ' HA ' ' O ' ' A' ' 159' ' ' ARG . 46.3 m -106.54 114.96 29.38 Favored 'General case' 0 N--CA 1.411 -2.413 0 N-CA-C 107.771 -1.196 . . . . 73.31 107.771 175.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.592 HG12 ' HA ' ' A' ' 218' ' ' VAL . 18.1 m -123.27 161.42 25.13 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 CA-C-O 121.004 0.43 . . . . 73.04 110.354 177.458 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 16.0 ptmt -137.1 135.75 20.12 Favored Pre-proline 0 C--N 1.278 -2.54 0 N-CA-C 107.024 -1.473 . . . . 75.21 107.024 173.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 251' ' ' PRO . . . . . 0.5 ' HA ' ' HA ' ' A' ' 216' ' ' ASP . 38.8 Cg_exo -61.1 136.87 67.84 Favored 'Trans proline' 0 N--CA 1.449 -1.136 0 C-N-CA 121.088 1.192 . . . . 73.31 111.249 178.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -54.83 -48.92 72.23 Favored 'General case' 0 CA--C 1.493 -1.236 0 N-CA-C 108.301 -1.0 . . . . 70.23 108.301 175.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -85.51 82.86 8.11 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 106.263 -1.754 . . . . 60.23 106.263 168.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -64.42 -178.14 0.35 Allowed 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 113.24 -1.8 . . . . 61.22 114.392 -171.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 255' ' ' ARG . . . . . 0.518 ' H ' HG22 ' A' ' 157' ' ' THR . 40.4 ttp180 . . . . . 0 N--CA 1.446 -0.634 0 CA-C-N 114.029 -1.441 . . . . 73.03 111.361 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 . . . . . 0 C--O 1.236 0.351 0 N-CA-C 108.905 -0.776 . . . . 74.2 108.905 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 35.2 p -87.89 -50.86 6.17 Favored 'General case' 0 N--CA 1.441 -0.925 0 C-N-CA 122.287 0.235 . . . . 63.31 111.149 -178.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -84.64 128.93 34.86 Favored 'General case' 0 C--O 1.214 -0.814 0 N-CA-C 109.105 -0.702 . . . . 72.01 109.105 174.146 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.569 ' O ' ' HA ' ' A' ' 248' ' ' THR . 24.5 tpt180 -119.69 128.88 54.22 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 120.202 -0.599 . . . . 70.1 110.342 176.146 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 32.1 ptt180 -115.85 114.24 24.46 Favored 'General case' 0 C--N 1.284 -2.243 0 CA-C-N 114.944 -1.025 . . . . 73.32 109.91 178.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 17.4 m -117.0 138.91 46.12 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 CA-C-N 115.459 -0.791 . . . . 73.41 111.097 -178.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.538 ' HD2' ' N ' ' A' ' 162' ' ' ARG . 1.3 mpt_? -107.76 111.99 24.44 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 106.589 -1.634 . . . . 74.22 106.589 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.539 ' HB2' ' HB3' ' A' ' 245' ' ' LEU . 29.1 mt -98.85 139.6 34.28 Favored 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 123.793 0.837 . . . . 74.43 111.72 -171.631 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.554 HD23 ' O ' ' A' ' 242' ' ' SER . 9.9 tp 90.75 20.71 0.03 OUTLIER 'General case' 0 CA--C 1.515 -0.379 0 C-N-CA 125.75 1.62 . . . . 55.34 113.179 173.675 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . 0.26 60.5 pttt -97.83 56.74 1.28 Allowed 'General case' 0 C--N 1.282 -2.346 0 C-N-CA 117.867 -1.533 . . . . 71.41 112.072 177.07 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 46.9 t-80 -153.94 20.72 0.51 Allowed 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 106.288 -1.745 . . . . 73.33 106.288 178.32 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 159.02 -152.28 23.32 Favored Glycine 0 N--CA 1.428 -1.848 0 N-CA-C 107.518 -2.233 . . . . 72.41 107.518 -175.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 31.9 t -168.66 161.83 11.52 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 117.894 0.847 . . . . 62.44 109.113 178.116 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 31.2 t70 70.09 -32.36 0.23 Allowed 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 125.516 1.526 . . . . 72.52 114.263 177.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.64 150.41 93.44 Favored Pre-proline 0 C--N 1.302 -1.474 0 N-CA-C 111.876 0.324 . . . . 71.44 111.876 -177.137 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -53.46 150.32 27.45 Favored 'Trans proline' 0 C--N 1.357 0.996 0 C-N-CA 123.872 3.048 . . . . 72.32 113.806 -179.412 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.52 ' CD1' ' HB2' ' A' ' 164' ' ' LEU . 2.3 mm? -84.85 -27.64 26.59 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.455 -0.793 . . . . 63.15 110.036 -178.477 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' GLY . . . . . 0.418 ' HA3' ' HA3' ' A' ' 204' ' ' GLY . . . 84.08 49.57 4.69 Favored Glycine 0 N--CA 1.433 -1.516 0 CA-C-N 115.633 -0.712 . . . . 41.25 113.923 175.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -156.75 161.37 39.8 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 108.079 -1.082 . . . . 74.3 108.079 175.067 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -130.01 157.12 43.23 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 108.589 -0.893 . . . . 73.13 108.589 175.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.548 HD13 ' H ' ' A' ' 176' ' ' ILE . 0.2 OUTLIER -126.21 169.06 18.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 CA-C-O 121.595 0.712 . . . . 75.32 111.278 -179.04 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.472 ' HG2' ' HB2' ' A' ' 198' ' ' SER . 16.9 ptt180 -157.79 155.44 29.8 Favored 'General case' 0 C--N 1.281 -2.385 0 CA-C-N 114.698 -1.137 . . . . 74.01 108.922 -175.184 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -112.77 158.26 20.32 Favored 'General case' 0 C--N 1.298 -1.664 0 C-N-CA 119.402 -0.919 . . . . 71.53 110.815 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -156.38 -179.23 31.23 Favored Glycine 0 C--N 1.29 -2.001 0 N-CA-C 107.726 -2.15 . . . . 54.51 107.726 176.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' THR . . . . . 0.444 ' CG2' ' HG2' ' A' ' 191' ' ' LYS . 0.2 OUTLIER -112.25 122.95 49.17 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 118.996 1.398 . . . . 75.42 108.178 179.63 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 181' ' ' SER . . . . . 0.433 ' O ' ' HA ' ' A' ' 191' ' ' LYS . 20.2 t -100.98 130.01 46.91 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 108.547 -0.909 . . . . 32.4 108.547 -176.357 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.52 ' HA ' ' O ' ' A' ' 190' ' ' GLU . 7.2 p -106.64 119.25 55.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 C-N-CA 119.318 -0.953 . . . . 75.3 110.153 175.359 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -125.02 160.77 28.24 Favored 'General case' 0 CA--C 1.479 -1.756 0 CA-C-N 115.048 -0.978 . . . . 74.54 108.812 -175.199 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 84.3 t -90.19 118.68 35.93 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.048 0 N-CA-C 107.576 -1.268 . . . . 72.44 107.576 170.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 54.7 p -113.04 -174.49 2.46 Favored 'General case' 0 C--N 1.273 -2.748 0 CA-C-N 114.629 -1.169 . . . . 74.44 107.991 -179.094 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -62.86 -21.13 65.74 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.042 0.448 . . . . 73.32 110.128 176.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 25.0 m -90.26 -18.82 24.96 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-N 115.989 -0.55 . . . . 53.21 111.021 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 123.46 -147.14 16.61 Favored Glycine 0 CA--C 1.491 -1.411 0 N-CA-C 110.278 -1.129 . . . . 60.35 110.278 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 4.9 mp -81.82 118.16 22.68 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.454 -0.943 . . . . 61.12 108.454 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' GLU . . . . . 0.52 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 38.4 tt0 -131.57 121.65 24.76 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 109.528 -0.545 . . . . 65.21 109.528 -172.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.491 ' HA ' ' HA ' ' A' ' 182' ' ' VAL . 33.5 ttmt -93.35 128.57 39.44 Favored 'General case' 0 N--CA 1.426 -1.626 0 N-CA-C 106.821 -1.548 . . . . 63.41 106.821 178.579 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 5.4 pp0? -149.33 151.82 34.53 Favored Pre-proline 0 C--N 1.299 -1.627 0 CA-C-O 118.956 -0.545 . . . . 65.13 109.645 -168.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -61.56 130.23 30.88 Favored 'Trans proline' 0 C--O 1.243 0.774 0 C-N-CA 121.339 1.359 . . . . 74.22 112.879 -176.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -135.86 142.42 13.71 Favored Glycine 0 N--CA 1.411 -2.984 0 N-CA-C 108.586 -1.805 . . . . 60.22 108.586 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.582 HG12 HG21 ' A' ' 234' ' ' VAL . 3.0 mp -104.17 138.06 30.37 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.526 0 C-N-CA 120.204 -0.598 . . . . 73.12 110.224 -178.616 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -122.98 166.68 14.68 Favored 'General case' 0 C--N 1.283 -2.314 0 N-CA-C 108.292 -1.003 . . . . 75.24 108.292 -177.224 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' ILE . . . . . 0.49 ' HB ' ' HA ' ' A' ' 214' ' ' VAL . 50.3 mm -78.49 131.21 34.96 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.265 0 N-CA-C 108.382 -0.97 . . . . 74.32 108.382 177.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 198' ' ' SER . . . . . 0.472 ' HB2' ' HG2' ' A' ' 177' ' ' ARG . 7.7 t -96.98 -32.43 12.02 Favored 'General case' 0 C--N 1.286 -2.178 0 O-C-N 121.703 -0.623 . . . . 72.31 112.408 -178.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -167.83 148.89 5.27 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.774 -0.194 . . . . 71.14 110.881 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 73.7 mt -102.84 146.05 28.86 Favored 'General case' 0 CA--C 1.495 -1.158 0 N-CA-C 108.599 -0.889 . . . . 72.3 108.599 170.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 59.5 t -109.14 114.3 58.1 Favored Pre-proline 0 C--N 1.28 -2.445 0 N-CA-C 106.606 -1.627 . . . . 72.33 106.606 171.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.435 ' HA ' ' HG3' ' A' ' 207' ' ' GLU . 33.4 Cg_exo -59.16 128.93 29.41 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.309 2.006 . . . . 61.4 110.807 -179.457 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 102.17 -11.03 57.05 Favored Glycine 0 N--CA 1.442 -0.94 0 N-CA-C 110.806 -0.918 . . . . 75.23 110.806 -175.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' GLY . . . . . 0.418 ' HA3' ' HA3' ' A' ' 173' ' ' GLY . . . -90.27 161.4 28.88 Favored Glycine 0 N--CA 1.439 -1.103 0 N-CA-C 110.33 -1.108 . . . . 61.12 110.33 177.09 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -57.24 -38.16 73.38 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 123.685 0.794 . . . . 71.31 111.946 -176.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 206' ' ' ALA . . . . . 0.485 ' CB ' HD12 ' A' ' 212' ' ' LEU . . . -62.31 -44.52 96.32 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.315 0.579 . . . . 75.03 110.796 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.435 ' HG3' ' HA ' ' A' ' 202' ' ' PRO . 4.3 tm-20 -75.68 -35.8 60.25 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 115.72 -0.673 . . . . 64.24 110.063 179.54 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 50.9 m -60.13 -41.15 92.03 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 122.512 0.325 . . . . 43.21 111.021 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 209' ' ' THR . . . . . 0.4 HG23 ' H ' ' A' ' 211' ' ' LEU . 9.3 t -76.94 -36.53 56.49 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 120.06 -0.656 . . . . 71.23 109.334 175.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 70.65 11.49 68.96 Favored Glycine 0 N--CA 1.444 -0.83 0 CA-C-N 115.81 -0.632 . . . . 73.22 112.99 176.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.4 ' H ' HG23 ' A' ' 209' ' ' THR . 57.0 mt -95.55 5.97 50.16 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 121.518 0.675 . . . . 71.3 109.71 -178.439 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.485 HD12 ' CB ' ' A' ' 206' ' ' ALA . 98.9 mt -113.71 131.01 56.33 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 114.485 -1.234 . . . . 71.52 108.227 172.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -132.53 157.84 43.67 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 108.738 -0.838 . . . . 71.51 108.738 176.048 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 214' ' ' VAL . . . . . 0.49 ' HA ' ' HB ' ' A' ' 197' ' ' ILE . 14.7 m -60.92 -30.94 48.47 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 N-CA-C 113.23 0.826 . . . . 73.34 113.23 -175.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -78.69 -14.12 59.46 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 112.914 0.709 . . . . 65.21 112.914 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -69.8 142.75 53.12 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.662 0.616 . . . . 74.41 112.662 -178.299 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -108.66 131.36 54.97 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.927 -1.033 . . . . 65.41 109.579 -176.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.552 HG12 ' O ' ' A' ' 195' ' ' ILE . 9.8 p -83.14 143.82 11.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-O 121.893 0.854 . . . . 73.4 112.172 -176.439 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.414 HD11 ' HD2' ' A' ' 250' ' ' LYS . 37.8 mm -108.14 -51.42 7.13 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 C-N-CA 124.719 1.208 . . . . 73.41 111.26 -178.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -155.27 160.26 40.66 Favored 'General case' 0 C--O 1.247 0.945 0 CA-C-N 116.441 -0.345 . . . . 74.33 110.877 -177.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.484 HG12 ' CG1' ' A' ' 226' ' ' VAL . 7.5 p -132.38 121.03 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 O-C-N 123.775 0.672 . . . . 71.13 110.397 174.273 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 67.48 12.1 8.72 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.52 1.528 . . . . 74.53 110.672 176.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 110.11 -10.6 31.57 Favored Glycine 0 N--CA 1.432 -1.578 0 CA-C-N 115.421 -0.808 . . . . 52.43 112.589 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 64.4 mt -96.9 126.2 49.69 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.165 0 N-CA-C 108.35 -0.982 . . . . 65.14 108.35 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -65.47 141.62 58.43 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 121.431 0.634 . . . . 73.31 110.482 -178.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 226' ' ' VAL . . . . . 0.511 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 27.2 m -117.54 -1.88 9.5 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 CA-C-N 115.66 -0.7 . . . . 54.14 110.721 178.698 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -79.66 96.39 6.19 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 115.775 -0.648 . . . . 73.12 109.826 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 124.58 -14.57 7.66 Favored Glycine 0 C--N 1.305 -1.146 0 N-CA-C 110.688 -0.965 . . . . 64.0 110.688 -178.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -83.55 171.8 12.99 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.299 -1.0 . . . . 65.23 108.299 177.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 230' ' ' THR . . . . . 0.474 ' O ' HG13 ' A' ' 234' ' ' VAL . 81.7 p -95.68 170.95 8.97 Favored 'General case' 0 N--CA 1.434 -1.248 0 N-CA-C 108.691 -0.855 . . . . 63.24 108.691 179.038 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.493 HD21 HG12 ' A' ' 176' ' ' ILE . 3.3 tm? -61.79 -37.19 83.43 Favored 'General case' 0 N--CA 1.424 -1.736 0 N-CA-C 110.145 -0.317 . . . . 65.3 110.145 -179.264 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -63.71 -47.92 79.2 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.738 -0.467 . . . . 63.15 109.738 178.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -60.34 -43.48 96.4 Favored 'General case' 0 C--O 1.222 -0.35 0 N-CA-C 113.73 1.011 . . . . 75.11 113.73 178.454 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.582 HG21 HG12 ' A' ' 195' ' ' ILE . 12.7 m -73.22 -33.94 42.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-O 121.375 0.607 . . . . 75.44 112.072 -175.616 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 235' ' ' THR . . . . . 0.446 ' O ' HG23 ' A' ' 239' ' ' VAL . 85.9 m -74.98 -35.59 62.05 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 115.418 -0.81 . . . . 74.44 109.49 -174.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -61.74 -33.11 73.46 Favored 'General case' 0 C--O 1.244 0.805 0 CA-C-N 115.75 -0.659 . . . . 73.12 109.538 177.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 237' ' ' MET . . . . . 0.444 ' HB2' HG11 ' A' ' 221' ' ' VAL . 13.6 mtt -68.09 -47.56 67.92 Favored 'General case' 0 C--O 1.209 -1.051 0 N-CA-C 107.835 -1.172 . . . . 75.45 107.835 179.387 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 64.7 mtt -59.01 -37.16 76.25 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.402 -0.817 . . . . 72.24 111.329 -178.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 235' ' ' THR . 92.2 t -69.46 -44.91 79.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 CA-C-N 116.308 -0.405 . . . . 65.5 110.782 177.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -69.72 -38.14 76.78 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.173 0.511 . . . . 54.42 110.96 -178.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -82.01 21.1 0.91 Allowed 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 115.525 -0.761 . . . . 72.4 112.45 -178.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 242' ' ' SER . . . . . 0.554 ' O ' HD23 ' A' ' 164' ' ' LEU . 42.8 t -59.19 -28.32 66.52 Favored 'General case' 0 CA--C 1.559 1.324 0 CA-C-O 121.158 0.504 . . . . 72.21 111.04 178.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 20.2 m -67.29 -28.61 68.16 Favored 'General case' 0 CA--C 1.552 1.052 0 N-CA-C 111.896 0.332 . . . . 52.42 111.896 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -161.99 83.82 0.58 Allowed 'General case' 0 C--O 1.249 1.034 0 N-CA-C 107.079 -1.452 . . . . 64.24 107.079 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.539 ' HB3' ' HB2' ' A' ' 163' ' ' LEU . 1.3 tt -85.95 103.42 14.64 Favored 'General case' 0 C--O 1.2 -1.548 0 C-N-CA 119.87 -0.732 . . . . 73.13 109.484 -173.536 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.467 HG12 ' HG3' ' A' ' 162' ' ' ARG . 74.1 mt -105.25 116.71 49.59 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.22 0 N-CA-C 109.469 -0.567 . . . . 74.02 109.469 178.683 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 247' ' ' ILE . . . . . 0.5 HG13 ' CD2' ' A' ' 245' ' ' LEU . 25.5 mt -120.05 134.33 63.91 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 CA-C-O 121.27 0.557 . . . . 44.11 111.674 179.495 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.569 ' HA ' ' O ' ' A' ' 159' ' ' ARG . 90.8 m -108.3 119.83 40.64 Favored 'General case' 0 N--CA 1.417 -2.114 0 CA-C-N 114.939 -1.028 . . . . 74.42 108.486 174.071 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.457 HG12 ' HA ' ' A' ' 218' ' ' VAL . 26.7 m -124.18 164.39 22.52 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.865 0 N-CA-C 108.43 -0.952 . . . . 51.14 108.43 174.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.414 ' HD2' HD11 ' A' ' 219' ' ' ILE . 0.0 OUTLIER -144.66 136.58 13.01 Favored Pre-proline 0 C--N 1.264 -3.112 0 CA-C-N 115.449 -0.796 . . . . 74.44 109.916 173.778 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -50.91 145.57 23.99 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 122.643 2.229 . . . . 72.33 110.962 179.076 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -48.22 -44.81 33.41 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 113.731 1.011 . . . . 64.32 113.731 -172.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -99.39 7.51 45.44 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 113.507 0.928 . . . . 65.33 113.507 -175.113 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -111.91 -170.88 1.74 Allowed 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.806 -0.442 . . . . 75.33 109.806 175.125 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 89.3 mtm180 . . . . . 0 CA--C 1.501 -0.907 0 CA-C-O 118.364 -0.827 . . . . 73.41 109.801 -176.974 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.469 0.502 0 N-CA-C 112.22 0.452 . . . . 73.44 112.22 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.468 ' HA ' ' OE1' ' A' ' 254' ' ' GLN . 34.9 p -73.54 -69.96 0.4 Allowed 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 121.341 0.591 . . . . 51.42 111.548 -176.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.443 ' NE2' HG13 ' A' ' 219' ' ' ILE . 1.0 OUTLIER -90.07 129.93 36.31 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.892 -0.781 . . . . 73.41 108.892 173.415 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.455 ' O ' ' HA ' ' A' ' 248' ' ' THR . 23.5 tpp180 -112.07 132.93 54.54 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 108.72 -0.844 . . . . 74.23 108.72 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 82.7 mtt180 -109.49 115.48 30.01 Favored 'General case' 0 C--N 1.278 -2.529 0 CA-C-N 115.708 -0.678 . . . . 60.34 111.439 176.037 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.425 ' CG1' ' HB2' ' A' ' 211' ' ' LEU . 18.6 m -118.94 138.19 50.46 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.219 0 CA-C-N 114.778 -1.101 . . . . 74.31 109.971 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.548 ' HG3' HG12 ' A' ' 246' ' ' ILE . 4.8 mpt_? -110.12 112.14 23.94 Favored 'General case' 0 N--CA 1.415 -2.199 0 N-CA-C 107.769 -1.197 . . . . 75.22 107.769 177.179 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.46 ' HB2' ' HB2' ' A' ' 245' ' ' LEU . 9.6 mt -96.96 118.53 33.58 Favored 'General case' 0 N--CA 1.409 -2.502 0 N-CA-C 107.523 -1.288 . . . . 60.31 107.523 -176.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.609 HD23 ' O ' ' A' ' 242' ' ' SER . 12.9 tp 80.58 83.95 0.05 OUTLIER 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 122.38 1.086 . . . . 62.43 112.95 177.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -135.47 16.85 3.38 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 105.962 -1.866 . . . . 71.15 105.962 173.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 51.6 t-80 -96.36 -13.49 23.21 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 113.418 -1.719 . . . . 64.1 110.768 -174.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 76.46 67.11 1.73 Allowed Glycine 0 CA--C 1.492 -1.399 0 N-CA-C 109.598 -1.401 . . . . 52.24 109.598 -177.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 50.2 m -139.43 153.19 47.54 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-O 120.802 0.334 . . . . 65.42 110.356 -175.387 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -107.29 -9.93 15.93 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.955 -0.566 . . . . 53.24 110.908 -178.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.74 153.23 91.41 Favored Pre-proline 0 N--CA 1.44 -0.969 0 CA-C-N 116.619 -0.264 . . . . 61.12 110.696 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -46.25 150.18 2.2 Favored 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 124.368 3.379 . . . . 73.33 114.893 -178.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.476 ' HA ' HD23 ' A' ' 205' ' ' LEU . 2.7 mm? -67.93 -29.14 68.14 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.913 -1.039 . . . . 73.2 111.373 -177.277 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' GLY . . . . . 0.472 ' HA3' ' HA3' ' A' ' 204' ' ' GLY . . . 84.51 37.8 10.39 Favored Glycine 0 N--CA 1.433 -1.518 0 N-CA-C 114.575 0.59 . . . . 55.23 114.575 174.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -159.46 152.62 22.15 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 108.733 -0.84 . . . . 74.41 108.733 173.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -132.51 146.22 51.76 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 109.312 -0.625 . . . . 64.34 109.312 179.26 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.686 HD13 ' H ' ' A' ' 176' ' ' ILE . 0.2 OUTLIER -111.04 170.34 3.54 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.634 0 CA-C-N 115.67 -0.695 . . . . 71.54 111.599 -175.397 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.533 ' CG ' ' HB2' ' A' ' 198' ' ' SER . 25.5 ptt180 -147.42 155.57 42.07 Favored 'General case' 0 C--N 1.279 -2.49 0 C-N-CA 124.972 1.309 . . . . 75.43 109.242 -177.017 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -117.89 151.21 37.85 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-O 121.32 0.581 . . . . 71.14 111.163 -175.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -167.87 -162.13 19.07 Favored Glycine 0 N--CA 1.426 -2.022 0 N-CA-C 109.439 -1.464 . . . . 64.41 109.439 176.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' THR . . . . . 0.422 ' HB ' ' CG ' ' A' ' 191' ' ' LYS . 1.2 p -100.41 132.03 46.01 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 121.598 0.713 . . . . 61.24 112.322 176.042 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 33.6 t -111.15 113.52 26.09 Favored 'General case' 0 N--CA 1.409 -2.525 0 N-CA-C 107.483 -1.303 . . . . 63.11 107.483 173.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.621 ' HA ' ' O ' ' A' ' 190' ' ' GLU . 5.2 p -109.75 119.11 58.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 N-CA-C 108.578 -0.897 . . . . 63.33 108.578 173.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 90.8 mtt180 -125.0 160.67 28.45 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-N 115.3 -0.863 . . . . 75.41 109.18 -174.063 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.481 ' HA ' ' O ' ' A' ' 188' ' ' GLY . 71.3 t -82.26 119.88 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.606 0 N-CA-C 108.257 -1.016 . . . . 73.41 108.257 170.406 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 36.2 p -132.15 -174.1 3.34 Favored 'General case' 0 C--N 1.271 -2.831 0 CA-C-N 113.869 -1.514 . . . . 54.02 109.126 -173.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -64.97 -18.74 65.53 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.221 0.534 . . . . 54.53 110.198 174.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 45.8 m -87.34 -13.18 44.27 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 116.193 -0.458 . . . . 70.11 110.144 176.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.481 ' O ' ' HA ' ' A' ' 184' ' ' VAL . . . 105.81 -123.22 7.42 Favored Glycine 0 CA--C 1.475 -2.462 0 N-CA-C 107.056 -2.417 . . . . 74.34 107.056 -175.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 6.3 mp -92.11 121.35 33.58 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 107.64 -1.244 . . . . 61.1 107.64 172.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' GLU . . . . . 0.621 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 40.4 tt0 -128.86 117.68 21.44 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 108.839 -0.8 . . . . 73.21 108.839 -174.139 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.435 ' HG3' ' HB ' ' A' ' 182' ' ' VAL . 33.9 ttmt -100.97 125.74 47.58 Favored 'General case' 0 N--CA 1.426 -1.651 0 N-CA-C 107.912 -1.144 . . . . 74.34 107.912 -178.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -141.11 162.04 50.17 Favored Pre-proline 0 C--N 1.269 -2.922 0 N-CA-C 107.944 -1.132 . . . . 73.23 107.944 -177.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -57.88 131.57 44.62 Favored 'Trans proline' 0 N--CA 1.447 -1.25 0 C-N-CA 120.935 1.09 . . . . 73.42 109.476 175.003 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -135.82 138.1 9.66 Favored Glycine 0 CA--C 1.463 -3.218 0 N-CA-C 110.127 -1.189 . . . . 62.13 110.127 -177.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.663 HG12 HG21 ' A' ' 234' ' ' VAL . 3.3 mp -105.92 138.07 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.538 0 CA-C-O 121.301 0.572 . . . . 71.11 109.832 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -127.22 166.94 16.78 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 106.837 -1.542 . . . . 63.55 106.837 -178.045 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' ILE . . . . . 0.473 ' HB ' ' HA ' ' A' ' 214' ' ' VAL . 45.1 mt -85.0 131.69 33.47 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.335 0 CA-C-O 121.055 0.455 . . . . 64.5 109.846 178.093 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 198' ' ' SER . . . . . 0.533 ' HB2' ' CG ' ' A' ' 177' ' ' ARG . 14.1 t -101.2 -50.06 3.9 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 112.484 0.55 . . . . 52.34 112.484 -178.158 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 40.8 ttp-105 -139.44 132.79 30.04 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 109.573 -0.529 . . . . 64.12 109.573 -176.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 2.6 tt -117.75 130.38 56.28 Favored 'General case' 0 N--CA 1.42 -1.941 0 N-CA-C 107.038 -1.468 . . . . 64.44 107.038 -178.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 45.1 t -108.64 127.31 27.64 Favored Pre-proline 0 C--N 1.316 -0.886 0 N-CA-C 112.036 0.384 . . . . 72.14 112.036 -171.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.53 ' HA ' ' HG3' ' A' ' 207' ' ' GLU . 34.4 Cg_endo -66.79 143.23 66.41 Favored 'Trans proline' 0 C--O 1.245 0.865 0 C-N-CA 122.432 2.088 . . . . 44.23 110.999 175.196 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 92.24 -9.9 75.36 Favored Glycine 0 N--CA 1.442 -0.959 0 N-CA-C 111.074 -0.811 . . . . 74.33 111.074 -177.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' GLY . . . . . 0.472 ' HA3' ' HA3' ' A' ' 173' ' ' GLY . . . -94.44 167.42 27.39 Favored Glycine 0 N--CA 1.435 -1.37 0 N-CA-C 110.472 -1.051 . . . . 61.41 110.472 178.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.476 HD23 ' HA ' ' A' ' 172' ' ' LEU . 2.7 mm? -66.72 -29.7 69.75 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 117.104 0.452 . . . . 72.02 111.675 -175.465 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -62.38 -46.28 89.33 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.636 0.731 . . . . 62.02 109.788 176.663 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.53 ' HG3' ' HA ' ' A' ' 202' ' ' PRO . 3.6 tm-20 -71.58 -32.62 68.27 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.513 -0.767 . . . . 75.13 110.667 179.15 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 44.7 m -55.78 -37.02 68.01 Favored 'General case' 0 CA--C 1.546 0.805 0 O-C-N 123.284 0.365 . . . . 75.22 110.967 178.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 8.9 t -87.49 -41.0 13.83 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 119.466 -0.894 . . . . 62.53 110.561 176.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 66.23 9.09 47.35 Favored Glycine 0 CA--C 1.531 1.051 0 N-CA-C 114.504 0.561 . . . . 71.44 114.504 177.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.425 ' HB2' ' CG1' ' A' ' 161' ' ' VAL . 69.1 mt -82.27 -18.03 43.85 Favored 'General case' 0 CA--C 1.503 -0.862 0 CA-C-O 121.119 0.485 . . . . 64.1 110.959 -178.732 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.471 ' H ' HD23 ' A' ' 212' ' ' LEU . 1.8 pt? -108.99 149.02 29.84 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 108.884 -0.784 . . . . 64.24 108.884 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -129.97 166.11 20.76 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 109.502 -0.555 . . . . 74.25 109.502 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 214' ' ' VAL . . . . . 0.473 ' HA ' ' HB ' ' A' ' 197' ' ' ILE . 32.6 m -63.22 -29.79 48.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 N-CA-C 113.044 0.757 . . . . 73.15 113.044 -179.075 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 215' ' ' ASN . . . . . 0.465 ' O ' ' HB2' ' A' ' 252' ' ' ALA . 10.0 p30 -69.84 -15.31 63.08 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 122.019 -0.426 . . . . 72.44 111.669 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.505 ' HB3' ' HB ' ' A' ' 249' ' ' VAL . 8.4 m-20 -69.78 152.89 44.08 Favored 'General case' 0 C--O 1.247 0.971 0 N-CA-C 113.918 1.081 . . . . 71.51 113.918 -175.632 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -112.49 134.43 54.02 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 125.804 1.642 . . . . 74.5 108.324 -179.069 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.565 ' HA ' HG12 ' A' ' 249' ' ' VAL . 9.9 p -86.32 146.19 6.75 Favored 'Isoleucine or valine' 0 C--O 1.245 0.847 0 CA-C-O 121.903 0.859 . . . . 73.1 112.321 -174.651 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.443 HG13 ' NE2' ' A' ' 158' ' ' HIS . 34.2 mm -113.0 -58.71 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 CA-C-N 114.536 -1.211 . . . . 65.43 111.285 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -150.35 158.89 44.65 Favored 'General case' 0 C--O 1.243 0.76 0 CA-C-N 116.8 -0.182 . . . . 72.21 110.523 -177.152 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.462 HG12 HG13 ' A' ' 226' ' ' VAL . 13.6 p -132.21 126.33 55.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 N-CA-C 109.079 -0.712 . . . . 52.01 109.079 177.04 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 222' ' ' ASN . . . . . 0.403 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 8.3 t-20 64.4 18.94 11.6 Favored 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 124.98 1.312 . . . . 53.32 110.108 176.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 102.8 -17.09 53.73 Favored Glycine 0 N--CA 1.436 -1.306 0 CA-C-N 115.858 -0.61 . . . . 70.23 112.322 -179.246 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 65.6 mt -98.97 127.02 52.03 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.09 0 CA-C-O 121.032 0.444 . . . . 72.43 109.977 -178.231 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -62.09 140.06 58.42 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-O 121.884 0.849 . . . . 75.23 112.833 -177.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 226' ' ' VAL . . . . . 0.462 HG13 HG12 ' A' ' 221' ' ' VAL . 16.3 m -118.13 3.56 7.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-N 114.986 -1.006 . . . . 74.41 110.272 176.691 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -79.15 101.95 8.21 Favored 'General case' 0 N--CA 1.422 -1.833 0 CA-C-N 115.176 -0.92 . . . . 72.44 109.544 178.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 118.31 -11.83 12.73 Favored Glycine 0 C--N 1.309 -0.927 0 C-N-CA 120.895 -0.669 . . . . 71.32 111.794 178.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -81.15 172.78 13.25 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 108.846 -0.798 . . . . 75.53 108.846 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 230' ' ' THR . . . . . 0.412 ' O ' HG13 ' A' ' 234' ' ' VAL . 72.5 p -88.77 168.2 12.67 Favored 'General case' 0 N--CA 1.433 -1.303 0 N-CA-C 108.198 -1.038 . . . . 65.32 108.198 178.622 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.48 HD21 HG12 ' A' ' 176' ' ' ILE . 3.2 tm? -62.68 -36.3 82.45 Favored 'General case' 0 N--CA 1.426 -1.654 0 N-CA-C 109.249 -0.649 . . . . 55.21 109.249 179.006 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -67.3 -47.47 70.47 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.517 -0.473 . . . . 35.11 109.826 178.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -59.85 -38.41 82.02 Favored 'General case' 0 C--N 1.349 0.55 0 N-CA-C 113.27 0.841 . . . . 72.41 113.27 177.312 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.663 HG21 HG12 ' A' ' 195' ' ' ILE . 16.3 m -74.18 -36.15 42.83 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.458 0 C-N-CA 119.308 -0.957 . . . . 74.43 111.518 -179.139 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 235' ' ' THR . . . . . 0.425 ' O ' HG23 ' A' ' 239' ' ' VAL . 39.5 m -68.61 -35.92 77.97 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 108.924 -0.769 . . . . 74.5 108.924 179.054 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -57.87 -41.12 81.78 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 115.716 -0.674 . . . . 33.3 109.908 175.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 13.6 mmt -58.77 -49.69 76.73 Favored 'General case' 0 C--O 1.204 -1.319 0 N-CA-C 108.242 -1.021 . . . . 62.14 108.242 177.073 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 238' ' ' MET . . . . . 0.502 ' HA ' HD21 ' A' ' 245' ' ' LEU . 60.4 mtt -63.77 -35.6 81.14 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.904 -1.044 . . . . 75.51 112.8 -174.388 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 235' ' ' THR . 84.4 t -70.37 -38.11 73.03 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-O 121.092 0.472 . . . . 71.45 109.851 177.076 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -71.63 -36.66 70.81 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.507 0.67 . . . . 72.53 110.518 178.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -89.22 21.59 3.19 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 115.463 -0.79 . . . . 74.44 111.276 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 242' ' ' SER . . . . . 0.609 ' O ' HD23 ' A' ' 164' ' ' LEU . 46.0 p -64.83 -23.16 67.15 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 113.479 0.918 . . . . 74.2 113.479 -178.245 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 67.0 m -79.09 -18.39 53.43 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 119.439 -0.905 . . . . 62.52 111.434 177.069 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -166.6 92.39 0.46 Allowed 'General case' 0 C--O 1.252 1.186 0 CA-C-O 121.813 0.816 . . . . 65.51 112.227 179.134 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.502 HD21 ' HA ' ' A' ' 238' ' ' MET . 11.7 mt -85.29 102.94 13.79 Favored 'General case' 0 C--O 1.19 -2.067 0 CA-C-N 115.933 -0.576 . . . . 73.54 112.013 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.548 HG12 ' HG3' ' A' ' 162' ' ' ARG . 88.7 mt -96.68 114.3 33.22 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.844 0 N-CA-C 106.078 -1.823 . . . . 51.03 106.078 172.475 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 83.5 mt -122.93 135.61 62.43 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 CA-C-O 121.505 0.669 . . . . 61.34 111.967 -176.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.455 ' HA ' ' O ' ' A' ' 159' ' ' ARG . 46.9 m -107.13 114.9 29.24 Favored 'General case' 0 N--CA 1.414 -2.258 0 CA-C-N 114.901 -1.045 . . . . 73.32 108.581 176.677 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.565 HG12 ' HA ' ' A' ' 218' ' ' VAL . 31.3 m -124.96 151.9 30.92 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 N-CA-C 109.423 -0.584 . . . . 73.45 109.423 175.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.411 ' HD3' HD11 ' A' ' 219' ' ' ILE . 9.5 ptmt -127.54 141.67 41.66 Favored Pre-proline 0 C--N 1.269 -2.892 0 N-CA-C 107.635 -1.246 . . . . 74.11 107.635 178.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 251' ' ' PRO . . . . . 0.434 ' HG2' ' NE2' ' A' ' 254' ' ' GLN . 63.8 Cg_exo -55.55 148.24 54.44 Favored 'Trans proline' 0 CA--C 1.546 1.086 0 C-N-CA 121.913 1.742 . . . . 73.34 111.795 178.69 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 252' ' ' ALA . . . . . 0.465 ' HB2' ' O ' ' A' ' 215' ' ' ASN . . . -44.07 -38.82 3.81 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 115.524 1.676 . . . . 75.43 115.524 -172.715 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -118.16 14.18 13.92 Favored 'General case' 0 C--N 1.282 -2.346 0 N-CA-C 112.148 0.425 . . . . 74.14 112.148 -174.487 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 254' ' ' GLN . . . . . 0.527 ' HG2' ' H ' ' A' ' 255' ' ' ARG . 7.5 tt0 -106.63 -172.01 2.0 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 107.971 -1.122 . . . . 70.3 107.971 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 255' ' ' ARG . . . . . 0.527 ' H ' ' HG2' ' A' ' 254' ' ' GLN . 73.3 ttt180 . . . . . 0 C--N 1.31 -1.132 0 N-CA-C 109.227 -0.657 . . . . 75.42 109.227 -178.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 . . . . . 0 CA--C 1.511 -0.555 0 N-CA-C 109.585 -0.524 . . . . 71.5 109.585 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.405 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 68.0 p -91.22 -36.93 13.64 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 121.698 0.761 . . . . 62.51 109.671 -179.501 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.542 ' CD2' HG13 ' A' ' 219' ' ' ILE . 0.4 OUTLIER -125.41 152.02 45.4 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 115.475 -0.784 . . . . 73.21 109.683 176.81 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.421 ' HE ' HD13 ' A' ' 211' ' ' LEU . 15.2 tpt180 -137.78 129.35 28.19 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 108.134 -1.061 . . . . 71.2 108.134 174.198 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 35.6 ptt180 -112.66 119.64 38.81 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-O 121.659 0.742 . . . . 64.13 109.983 177.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.618 ' O ' ' HA ' ' A' ' 246' ' ' ILE . 27.5 m -114.21 139.15 41.5 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.3 0 CA-C-N 114.882 -1.053 . . . . 73.43 112.122 -175.575 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.487 ' HG2' HG12 ' A' ' 246' ' ' ILE . 44.8 mtm180 -99.15 112.29 24.47 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 106.891 -1.522 . . . . 72.14 106.891 178.097 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.565 ' HB2' ' HB3' ' A' ' 245' ' ' LEU . 22.1 mt -104.58 139.12 39.91 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 109.503 -0.554 . . . . 73.04 109.503 -177.245 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.404 HD11 ' HA3' ' A' ' 167' ' ' GLY . 25.4 tp 75.92 90.28 0.08 Allowed 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 113.455 0.909 . . . . 74.01 113.455 172.168 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 59.1 pttt -112.27 -12.1 13.64 Favored 'General case' 0 C--N 1.285 -2.207 0 CA-C-N 114.939 -1.028 . . . . 72.15 109.752 175.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 46.0 t-80 -144.53 113.57 6.87 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 108.155 -1.054 . . . . 74.01 108.155 179.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' GLY . . . . . 0.404 ' HA3' HD11 ' A' ' 164' ' ' LEU . . . 159.4 -101.42 0.2 Allowed Glycine 0 N--CA 1.438 -1.193 0 C-N-CA 120.298 -0.953 . . . . 71.43 112.545 -178.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 35.1 t 64.75 35.61 8.65 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 122.143 0.973 . . . . 62.3 108.638 -176.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -158.03 -44.84 0.06 Allowed 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 114.309 -1.314 . . . . 64.33 109.153 -175.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 60.3 pttt -91.68 139.71 24.98 Favored Pre-proline 0 C--N 1.304 -1.406 0 CA-C-N 114.909 -1.041 . . . . 75.35 111.436 -177.064 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -57.08 152.42 44.55 Favored 'Trans proline' 0 C--O 1.249 1.028 0 C-N-CA 122.866 2.377 . . . . 54.21 111.592 177.218 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.437 ' HG ' ' CD1' ' A' ' 245' ' ' LEU . 3.2 mm? -69.24 -28.39 66.29 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.881 -0.6 . . . . 71.02 112.558 -176.506 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' GLY . . . . . 0.441 ' HA3' ' HA3' ' A' ' 204' ' ' GLY . . . 94.61 30.62 8.4 Favored Glycine 0 N--CA 1.428 -1.836 0 C-N-CA 119.534 -1.317 . . . . 75.2 112.897 178.472 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -154.98 154.66 32.89 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 107.654 -1.239 . . . . 74.31 107.654 175.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -126.5 157.45 38.68 Favored 'General case' 0 C--N 1.272 -2.788 0 N-CA-C 107.625 -1.25 . . . . 74.41 107.625 175.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 30.8 pt -122.94 164.16 20.72 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.02 0 CA-C-O 121.605 0.717 . . . . 63.35 112.424 -178.134 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.428 ' HG2' ' HB3' ' A' ' 198' ' ' SER . 4.0 ptp180 -139.39 154.73 47.87 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 114.238 -1.347 . . . . 75.12 108.18 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' ASP . . . . . 0.473 ' HB3' HD23 ' A' ' 231' ' ' LEU . 4.1 p-10 -121.44 143.11 49.42 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 108.917 -0.771 . . . . 73.14 108.917 176.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' A' ' 193' ' ' PRO . . . -156.26 -146.18 4.39 Favored Glycine 0 N--CA 1.415 -2.758 0 N-CA-C 109.425 -1.47 . . . . 73.1 109.425 178.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' THR . . . . . 0.555 ' HB ' ' CG ' ' A' ' 191' ' ' LYS . 1.3 p -108.74 127.32 53.9 Favored 'General case' 0 C--N 1.28 -2.45 0 N-CA-C 112.695 0.628 . . . . 53.12 112.695 179.252 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 28.7 t -110.36 120.26 41.85 Favored 'General case' 0 N--CA 1.413 -2.319 0 N-CA-C 106.951 -1.5 . . . . 61.35 106.951 175.045 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.512 ' HA ' ' O ' ' A' ' 190' ' ' GLU . 7.7 p -117.61 119.05 60.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 109.09 -0.707 . . . . 62.13 109.09 176.082 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -128.06 160.28 32.45 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 115.753 -0.658 . . . . 74.14 109.327 -175.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 78.2 t -82.92 119.44 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.805 0 N-CA-C 107.345 -1.354 . . . . 74.52 107.345 171.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 49.0 p -119.0 -175.44 2.91 Favored 'General case' 0 C--N 1.261 -3.26 0 CA-C-N 114.684 -1.144 . . . . 72.23 108.239 -178.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -69.4 -9.56 54.09 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-O 121.382 0.611 . . . . 74.14 109.701 174.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 31.8 m -103.47 -3.58 25.19 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 115.639 -0.71 . . . . 74.45 110.654 177.112 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 105.68 -155.61 16.81 Favored Glycine 0 CA--C 1.498 -1.003 0 N-CA-C 110.271 -1.131 . . . . 52.41 110.271 179.315 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 5.6 mp -84.02 118.61 24.16 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 108.608 -0.886 . . . . 64.53 108.608 176.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' GLU . . . . . 0.512 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 42.6 tt0 -132.22 124.67 29.42 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.912 -0.773 . . . . 75.32 108.912 -176.079 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.555 ' CG ' ' HB ' ' A' ' 180' ' ' THR . 36.2 ttmt -96.41 125.59 41.01 Favored 'General case' 0 N--CA 1.417 -2.09 0 N-CA-C 108.305 -0.998 . . . . 64.45 108.305 -178.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -140.92 164.1 38.28 Favored Pre-proline 0 C--N 1.287 -2.117 0 N-CA-C 108.946 -0.761 . . . . 60.51 108.946 -176.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' PRO . . . . . 0.427 ' HA ' ' O ' ' A' ' 179' ' ' GLY . 10.7 Cg_endo -55.93 132.38 51.64 Favored 'Trans proline' 0 C--O 1.248 1.018 0 C-N-CA 121.642 1.561 . . . . 74.02 111.0 175.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -141.14 147.52 19.13 Favored Glycine 0 CA--C 1.471 -2.691 0 N-CA-C 110.7 -0.96 . . . . 73.25 110.7 -178.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.759 HG12 HG21 ' A' ' 234' ' ' VAL . 2.9 mp -104.24 142.17 18.3 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 CA-C-O 121.295 0.569 . . . . 70.21 110.132 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -137.07 164.42 28.45 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 107.244 -1.391 . . . . 62.32 107.244 -178.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' ILE . . . . . 0.495 ' HB ' ' HA ' ' A' ' 214' ' ' VAL . 48.6 mm -76.26 127.82 37.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 107.747 -1.205 . . . . 75.45 107.747 176.402 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 198' ' ' SER . . . . . 0.428 ' HB3' ' HG2' ' A' ' 177' ' ' ARG . 82.9 p -99.92 -38.88 8.43 Favored 'General case' 0 C--N 1.29 -1.994 0 C-N-CA 119.862 -0.735 . . . . 75.43 111.196 -175.045 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -150.43 139.4 20.98 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 108.809 -0.811 . . . . 74.01 108.809 -177.524 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 1.1 tt -111.59 132.45 54.55 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 107.395 -1.335 . . . . 64.4 107.395 -179.135 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 61.1 t -104.98 118.46 56.07 Favored Pre-proline 0 C--N 1.312 -1.054 0 CA-C-O 120.626 0.25 . . . . 61.25 111.453 -176.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.48 ' HA ' ' HG2' ' A' ' 207' ' ' GLU . 37.8 Cg_exo -62.23 136.96 63.09 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 122.627 2.218 . . . . 72.44 110.866 176.284 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 96.55 -22.01 42.54 Favored Glycine 0 N--CA 1.439 -1.134 0 C-N-CA 121.12 -0.562 . . . . 75.04 112.253 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' GLY . . . . . 0.441 ' HA3' ' HA3' ' A' ' 173' ' ' GLY . . . -80.54 -176.18 49.98 Favored Glycine 0 N--CA 1.44 -1.067 0 C-N-CA 120.966 -0.635 . . . . 72.24 112.417 -179.047 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 172' ' ' LEU . 3.2 mm? -67.87 -41.87 82.17 Favored 'General case' 0 N--CA 1.426 -1.668 0 C-N-CA 122.91 0.484 . . . . 71.33 110.754 -178.626 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -64.02 -34.2 77.48 Favored 'General case' 0 C--O 1.22 -0.481 0 N-CA-C 113.139 0.792 . . . . 31.41 113.139 -176.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.48 ' HG2' ' HA ' ' A' ' 202' ' ' PRO . 11.8 tp10 -75.61 -33.08 60.52 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-O 121.724 0.773 . . . . 71.44 108.971 179.221 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 19.3 t -65.86 -24.71 66.93 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.954 -1.021 . . . . 54.24 110.802 -178.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 2.4 m -69.18 -40.45 78.09 Favored 'General case' 0 N--CA 1.415 -2.212 0 CA-C-N 115.914 -0.585 . . . . 73.5 111.867 -171.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 70.02 24.21 76.63 Favored Glycine 0 C--O 1.225 -0.42 0 N-CA-C 111.012 -0.835 . . . . 75.4 111.012 -176.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.421 HD13 ' HE ' ' A' ' 159' ' ' ARG . 65.6 mt -140.72 -8.95 1.06 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 122.963 0.505 . . . . 65.52 111.053 -175.153 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 67.9 mt -109.48 131.22 55.27 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 115.888 -0.596 . . . . 71.44 110.583 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -134.15 166.23 23.24 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.727 -1.212 . . . . 74.11 107.727 175.329 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 214' ' ' VAL . . . . . 0.495 ' HA ' ' HB ' ' A' ' 197' ' ' ILE . 31.3 m -66.52 -30.8 50.96 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 N-CA-C 113.074 0.768 . . . . 71.21 113.074 -179.37 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 46.7 m-80 -75.15 -14.5 60.56 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 113.706 1.002 . . . . 72.34 113.706 -177.417 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.452 ' HB3' ' HB ' ' A' ' 249' ' ' VAL . 5.3 m-20 -63.74 131.59 48.37 Favored 'General case' 0 C--O 1.246 0.877 0 CA-C-O 121.172 0.51 . . . . 65.21 112.282 -179.034 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -97.55 140.85 31.36 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.462 -0.79 . . . . 75.52 109.48 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.518 HG11 ' HB ' ' A' ' 195' ' ' ILE . 5.2 p -81.86 145.56 8.55 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 CA-C-O 121.621 0.724 . . . . 70.2 112.229 -174.517 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.542 HG13 ' CD2' ' A' ' 158' ' ' HIS . 44.4 mm -115.96 -60.85 2.71 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 115.618 -0.719 . . . . 54.42 110.874 178.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -152.36 154.83 36.42 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 109.136 -0.69 . . . . 75.21 109.136 -176.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.521 HG22 HG12 ' A' ' 247' ' ' ILE . 44.2 t -128.94 122.91 57.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 108.466 -0.939 . . . . 44.14 108.466 179.123 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 65.7 20.35 11.52 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.137 1.375 . . . . 71.42 109.523 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 97.37 -15.2 62.58 Favored Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 115.243 -0.889 . . . . 13.34 111.975 -178.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 63.0 mt -92.67 123.77 44.88 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.747 0 N-CA-C 109.044 -0.724 . . . . 62.31 109.044 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -57.39 142.38 43.96 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.521 0.677 . . . . 74.41 112.139 -178.1 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 226' ' ' VAL . . . . . 0.499 ' HA ' ' CG ' ' A' ' 229' ' ' LYS . 15.6 m -120.93 10.46 6.21 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.845 0 CA-C-N 115.555 -0.748 . . . . 64.44 111.083 175.282 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -74.3 101.34 4.0 Favored 'General case' 0 N--CA 1.426 -1.657 0 CA-C-N 115.035 -0.984 . . . . 52.31 109.588 177.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 109.69 -1.57 30.53 Favored Glycine 0 CA--C 1.496 -1.121 0 C-N-CA 120.886 -0.673 . . . . 71.35 111.707 177.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.499 ' CG ' ' HA ' ' A' ' 226' ' ' VAL . 71.9 mmtt -82.21 158.77 23.44 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.18 -0.674 . . . . 75.04 109.18 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 67.3 p -82.66 171.49 13.97 Favored 'General case' 0 N--CA 1.409 -2.512 0 C-N-CA 119.299 -0.96 . . . . 71.51 109.437 177.05 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.473 HD23 ' HB3' ' A' ' 178' ' ' ASP . 2.1 tm? -66.59 -35.48 80.3 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 108.578 -0.897 . . . . 73.33 108.578 -179.262 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -65.13 -41.22 95.02 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.581 -0.736 . . . . 73.14 109.698 178.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -61.34 -47.16 87.15 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.481 -0.781 . . . . 55.21 112.507 176.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.759 HG21 HG12 ' A' ' 195' ' ' ILE . 19.8 m -69.63 -33.74 58.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 C-N-CA 120.211 -0.596 . . . . 70.1 111.918 -177.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 235' ' ' THR . . . . . 0.468 ' O ' HG23 ' A' ' 239' ' ' VAL . 90.4 m -64.86 -35.7 81.98 Favored 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 109.694 -0.484 . . . . 64.25 109.694 177.233 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -63.39 -35.84 81.76 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.279 -0.419 . . . . 74.52 110.125 176.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 16.8 mmt -58.08 -52.75 64.24 Favored 'General case' 0 C--O 1.201 -1.453 0 N-CA-C 107.814 -1.18 . . . . 71.3 107.814 174.144 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 66.6 mtt -58.21 -35.28 71.41 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.633 -1.167 . . . . 70.22 112.049 -175.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 235' ' ' THR . 94.5 t -71.96 -45.98 61.78 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-O 120.832 0.349 . . . . 72.24 110.615 177.135 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -68.01 -34.61 76.83 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.508 0.671 . . . . 74.31 111.076 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -89.76 21.84 3.36 Favored 'General case' 0 C--O 1.198 -1.633 0 CA-C-N 115.311 -0.859 . . . . 73.34 110.578 -179.372 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 25.2 t -60.63 -23.78 65.01 Favored 'General case' 0 CA--C 1.563 1.461 0 N-CA-C 112.149 0.426 . . . . 71.32 112.149 -178.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 6.9 p -81.07 -14.01 58.22 Favored 'General case' 0 CA--C 1.558 1.262 0 N-CA-C 112.641 0.608 . . . . 72.32 112.641 178.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -173.77 98.55 0.11 Allowed 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.908 1.283 . . . . 72.25 108.356 173.232 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.565 ' HB3' ' HB2' ' A' ' 163' ' ' LEU . 1.2 tt -86.36 101.82 13.45 Favored 'General case' 0 N--CA 1.413 -2.305 0 N-CA-C 107.701 -1.222 . . . . 53.44 107.701 -176.572 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.618 ' HA ' ' O ' ' A' ' 161' ' ' VAL . 73.5 mt -104.07 116.12 47.26 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 C-N-CA 120.163 -0.615 . . . . 63.14 109.812 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 247' ' ' ILE . . . . . 0.521 HG12 HG22 ' A' ' 221' ' ' VAL . 91.7 mt -122.05 131.36 73.31 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.892 0 C-N-CA 120.151 -0.62 . . . . 63.01 110.085 176.5 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 56.3 m -96.77 114.95 26.63 Favored 'General case' 0 N--CA 1.412 -2.369 0 N-CA-C 107.545 -1.28 . . . . 53.21 107.545 174.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.475 HG12 ' HA ' ' A' ' 218' ' ' VAL . 21.7 m -117.89 169.12 8.89 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.117 0 N-CA-C 109.098 -0.705 . . . . 70.34 109.098 176.069 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 15.5 ptmt -134.0 129.45 20.07 Favored Pre-proline 0 C--N 1.28 -2.456 0 CA-C-N 115.454 -0.793 . . . . 73.22 110.181 176.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 251' ' ' PRO . . . . . 0.405 ' HD2' ' O ' ' A' ' 157' ' ' THR . 33.6 Cg_endo -68.41 148.44 73.49 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 C-N-CA 121.738 1.626 . . . . 74.43 108.86 173.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -56.09 -44.45 79.03 Favored 'General case' 0 CA--C 1.499 -1.003 0 CA-C-O 121.408 0.623 . . . . 64.34 110.518 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -97.19 83.63 3.36 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 108.206 -1.035 . . . . 74.43 108.206 177.457 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -67.32 114.16 5.8 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 114.721 -1.127 . . . . 71.35 112.816 179.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 82.9 mtp180 . . . . . 0 C--N 1.297 -1.691 0 N-CA-C 108.425 -0.954 . . . . 74.54 108.425 177.357 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.506 -0.719 0 N-CA-C 108.21 -1.033 . . . . 70.23 108.21 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.42 ' O ' ' HA ' ' A' ' 250' ' ' LYS . 9.9 t -68.73 -18.4 64.23 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 112.14 0.422 . . . . 74.32 112.14 -179.174 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.735 ' NE2' HG13 ' A' ' 219' ' ' ILE . 9.0 m80 -124.66 127.99 48.16 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 109.806 -0.442 . . . . 75.42 109.806 170.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.548 ' O ' ' HA ' ' A' ' 248' ' ' THR . 45.3 ttm180 -145.01 144.0 30.79 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 116.4 -0.364 . . . . 63.41 111.071 174.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.529 ' HA ' ' O ' ' A' ' 247' ' ' ILE . 0.0 OUTLIER -118.23 127.04 53.36 Favored 'General case' 0 C--N 1.32 -0.677 0 O-C-N 123.244 0.34 . . . . 71.42 110.42 175.445 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.512 HG11 HD21 ' A' ' 211' ' ' LEU . 11.9 m -122.25 139.05 50.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 CA-C-N 115.909 -0.587 . . . . 74.41 111.283 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 21.8 ttm180 -92.59 116.36 28.93 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 109.317 -0.623 . . . . 74.43 109.317 177.093 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.422 ' HB2' ' HB3' ' A' ' 245' ' ' LEU . 19.7 mt -107.87 138.73 43.6 Favored 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 107.144 -1.428 . . . . 72.3 107.144 -179.063 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.558 HD11 ' H ' ' A' ' 168' ' ' SER . 1.0 OUTLIER 69.75 82.33 0.16 Allowed 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 122.325 1.06 . . . . 74.14 108.322 173.473 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -100.31 -0.15 38.97 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 114.811 -1.086 . . . . 65.42 110.022 -175.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -93.65 -11.94 30.5 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 114.246 1.202 . . . . 74.11 114.246 -177.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 65.89 75.65 0.4 Allowed Glycine 0 C--O 1.239 0.42 0 C-N-CA 120.167 -1.015 . . . . 51.03 111.425 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' SER . . . . . 0.558 ' H ' HD11 ' A' ' 164' ' ' LEU . 33.1 t -165.42 140.25 4.96 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 106.86 -1.533 . . . . 70.52 106.86 -176.247 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -81.01 74.33 8.02 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-O 122.256 1.027 . . . . 73.43 111.236 -178.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -99.27 153.29 37.86 Favored Pre-proline 0 C--N 1.277 -2.584 0 CA-C-N 113.887 -1.506 . . . . 52.13 108.711 173.308 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -63.08 131.32 32.06 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 121.922 1.748 . . . . 74.4 109.304 174.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.426 ' HG ' ' CD1' ' A' ' 245' ' ' LEU . 2.8 mm? -81.05 -18.67 45.9 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 116.099 -0.5 . . . . 63.5 111.98 -173.056 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' GLY . . . . . 0.547 ' HA3' ' HA3' ' A' ' 204' ' ' GLY . . . 97.95 17.1 31.1 Favored Glycine 0 N--CA 1.415 -2.746 0 C-N-CA 119.273 -1.441 . . . . 53.23 111.879 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -158.08 157.17 32.33 Favored 'General case' 0 N--CA 1.427 -1.605 0 N-CA-C 109.273 -0.64 . . . . 51.3 109.273 179.07 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -129.38 158.24 39.69 Favored 'General case' 0 C--N 1.283 -2.314 0 N-CA-C 107.995 -1.113 . . . . 74.34 107.995 172.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.625 HD13 ' H ' ' A' ' 176' ' ' ILE . 0.1 OUTLIER -118.53 163.78 15.41 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.018 0 CA-C-O 121.744 0.783 . . . . 60.51 111.271 -178.68 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.439 ' HB3' ' HB3' ' A' ' 198' ' ' SER . 15.6 ptt180 -142.35 154.77 44.94 Favored 'General case' 0 C--N 1.28 -2.424 0 CA-C-N 114.182 -1.372 . . . . 74.12 109.477 -177.137 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -110.67 138.21 47.35 Favored 'General case' 0 C--N 1.294 -1.848 0 CA-C-O 121.143 0.497 . . . . 73.25 110.551 179.066 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -145.06 176.46 24.09 Favored Glycine 0 C--N 1.28 -2.544 0 N-CA-C 106.858 -2.497 . . . . 74.35 106.858 175.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' THR . . . . . 0.574 ' CG2' ' HG2' ' A' ' 191' ' ' LYS . 0.2 OUTLIER -102.07 122.71 44.64 Favored 'General case' 0 C--N 1.273 -2.74 0 C-N-CA 117.312 -1.755 . . . . 70.34 107.103 177.965 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 181' ' ' SER . . . . . 0.417 ' O ' ' HA ' ' A' ' 191' ' ' LYS . 33.3 t -94.0 124.45 38.01 Favored 'General case' 0 C--N 1.283 -2.293 0 N-CA-C 109.041 -0.725 . . . . 72.35 109.041 -176.577 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.589 ' HA ' ' O ' ' A' ' 190' ' ' GLU . 4.0 p -112.8 121.85 65.85 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 CA-C-O 121.755 0.788 . . . . 65.24 110.137 175.652 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 86.6 mtt180 -126.88 158.38 36.88 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 107.801 -1.185 . . . . 73.21 107.801 -175.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' A' ' 188' ' ' GLY . 99.8 t -88.08 118.71 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.785 0 C-N-CA 118.904 -1.118 . . . . 62.12 108.458 171.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 35.5 p -119.84 -173.21 2.49 Favored 'General case' 0 C--N 1.276 -2.597 0 CA-C-N 113.844 -1.525 . . . . 54.03 108.745 -175.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -60.46 -21.63 62.56 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.049 0.452 . . . . 71.24 110.554 174.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 28.5 m -88.09 -19.14 27.45 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 116.129 -0.487 . . . . 54.11 110.136 178.182 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.418 ' O ' ' HA ' ' A' ' 184' ' ' VAL . . . 112.09 -139.8 15.83 Favored Glycine 0 CA--C 1.482 -1.982 0 N-CA-C 108.836 -1.706 . . . . 63.35 108.836 -176.214 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 5.3 mp -78.42 119.11 21.27 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.019 -1.104 . . . . 64.1 108.019 177.308 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' GLU . . . . . 0.589 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 9.4 tp10 -131.61 123.24 27.48 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 108.611 -0.885 . . . . 72.43 108.611 -175.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.574 ' HG2' ' CG2' ' A' ' 180' ' ' THR . 34.2 ttmt -101.41 129.35 47.41 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.295 -1.002 . . . . 73.43 108.295 -176.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -147.88 165.17 19.26 Favored Pre-proline 0 C--N 1.306 -1.325 0 N-CA-C 109.127 -0.694 . . . . 53.12 109.127 -170.114 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -56.79 132.35 51.17 Favored 'Trans proline' 0 C--O 1.255 1.369 0 C-N-CA 121.378 1.386 . . . . 74.55 110.64 177.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -145.57 128.14 3.04 Favored Glycine 0 N--CA 1.419 -2.465 0 N-CA-C 110.504 -1.038 . . . . 73.35 110.504 -178.134 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.626 HG12 HG21 ' A' ' 234' ' ' VAL . 3.4 mp -103.92 136.24 37.97 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.415 0 CA-C-O 121.242 0.544 . . . . 73.42 110.422 -178.431 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -127.87 167.52 16.46 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 107.8 -1.185 . . . . 63.25 107.8 -177.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' ILE . . . . . 0.492 ' HB ' ' HA ' ' A' ' 214' ' ' VAL . 46.1 mm -75.4 131.19 35.4 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 N-CA-C 107.44 -1.319 . . . . 74.54 107.44 175.024 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 198' ' ' SER . . . . . 0.439 ' HB3' ' HB3' ' A' ' 177' ' ' ARG . 86.4 p -99.37 -33.32 10.75 Favored 'General case' 0 C--N 1.29 -1.986 0 O-C-N 121.53 -0.731 . . . . 54.11 111.356 -175.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 10.8 ttp180 -167.22 143.61 4.35 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.822 -0.626 . . . . 75.1 110.65 -175.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.442 HD11 ' O ' ' A' ' 212' ' ' LEU . 73.3 mt -101.87 146.7 27.45 Favored 'General case' 0 CA--C 1.494 -1.187 0 CA-C-N 116.168 -0.469 . . . . 74.41 109.796 174.052 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 201' ' ' VAL . . . . . 0.52 ' HB ' ' HA2' ' A' ' 173' ' ' GLY . 21.7 t -114.35 115.25 44.98 Favored Pre-proline 0 C--N 1.289 -2.058 0 N-CA-C 106.329 -1.73 . . . . 71.24 106.329 172.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.449 ' HA ' ' HG2' ' A' ' 207' ' ' GLU . 31.3 Cg_exo -58.78 147.25 89.33 Favored 'Trans proline' 0 N--CA 1.444 -1.42 0 C-N-CA 121.95 1.766 . . . . 65.33 111.082 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 94.48 -23.24 33.07 Favored Glycine 0 C--N 1.305 -1.159 0 N-CA-C 110.794 -0.922 . . . . 54.14 110.794 -176.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 204' ' ' GLY . . . . . 0.547 ' HA3' ' HA3' ' A' ' 173' ' ' GLY . . . -83.48 163.53 40.87 Favored Glycine 0 N--CA 1.43 -1.701 0 N-CA-C 110.526 -1.029 . . . . 71.54 110.526 177.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.498 HD22 ' H ' ' A' ' 205' ' ' LEU . 2.8 mm? -55.16 -42.62 73.36 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 123.842 0.857 . . . . 72.51 112.42 -175.047 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -59.17 -48.13 82.76 Favored 'General case' 0 C--O 1.244 0.764 0 N-CA-C 112.306 0.484 . . . . 74.12 112.306 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.449 ' HG2' ' HA ' ' A' ' 202' ' ' PRO . 8.3 tp10 -75.41 -33.4 60.95 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.958 -0.386 . . . . 65.53 109.958 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 35.5 t -57.66 -44.75 85.93 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 116.214 -0.448 . . . . 73.35 110.734 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' THR . . . . . 0.629 HG23 ' H ' ' A' ' 211' ' ' LEU . 8.9 t -77.0 -31.87 56.77 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 119.679 -0.808 . . . . 73.02 109.537 176.712 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 70.13 19.9 76.04 Favored Glycine 0 N--CA 1.447 -0.61 0 CA-C-N 115.938 -0.574 . . . . 64.11 112.694 178.569 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.629 ' H ' HG23 ' A' ' 209' ' ' THR . 1.4 pp -105.65 -0.52 25.53 Favored 'General case' 0 N--CA 1.432 -1.336 0 CA-C-O 121.072 0.463 . . . . 71.51 111.407 -178.498 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.442 ' O ' HD11 ' A' ' 200' ' ' LEU . 60.7 mt -109.32 133.78 52.62 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.384 -0.826 . . . . 74.15 109.226 176.369 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -131.87 165.51 23.7 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.763 -0.828 . . . . 73.12 108.763 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 214' ' ' VAL . . . . . 0.492 ' HA ' ' HB ' ' A' ' 197' ' ' ILE . 33.4 m -64.28 -29.48 47.47 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 N-CA-C 113.914 1.079 . . . . 63.4 113.914 -177.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -74.44 -14.63 60.87 Favored 'General case' 0 C--N 1.308 -1.228 0 O-C-N 121.855 -0.528 . . . . 74.42 111.729 -178.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.414 ' HB3' ' HB ' ' A' ' 249' ' ' VAL . 54.3 m-20 -69.83 130.97 43.73 Favored 'General case' 0 C--O 1.245 0.867 0 CA-C-O 121.233 0.54 . . . . 53.3 112.237 -176.614 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -101.19 135.08 43.25 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.952 -1.022 . . . . 71.4 109.659 -178.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.534 HG23 HG23 ' A' ' 247' ' ' ILE . 10.6 p -82.12 131.36 34.0 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.152 0 CA-C-O 121.749 0.785 . . . . 51.14 111.375 -176.703 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.735 HG13 ' NE2' ' A' ' 158' ' ' HIS . 36.8 mm -100.87 -52.71 8.34 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 CA-C-N 115.318 -0.855 . . . . 63.33 111.409 -179.157 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -154.68 152.8 30.37 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 116.449 -0.341 . . . . 65.3 110.146 -178.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.507 ' HA ' ' O ' ' A' ' 246' ' ' ILE . 10.7 p -125.27 125.51 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.644 0 N-CA-C 108.956 -0.757 . . . . 74.42 108.956 177.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 222' ' ' ASN . . . . . 0.4 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 2.9 m-20 57.1 22.72 7.72 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.592 1.157 . . . . 53.02 112.945 -177.381 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 100.34 -11.46 59.97 Favored Glycine 0 C--N 1.309 -0.954 0 C-N-CA 120.912 -0.661 . . . . 75.22 112.348 179.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 64.2 mt -98.7 123.53 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.284 0 N-CA-C 109.361 -0.607 . . . . 64.12 109.361 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -60.52 140.24 57.4 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 121.796 0.808 . . . . 73.04 112.216 -177.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 226' ' ' VAL . . . . . 0.517 ' HB ' HG12 ' A' ' 234' ' ' VAL . 25.6 m -120.61 0.44 7.41 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 CA-C-N 115.083 -0.962 . . . . 55.15 109.561 175.656 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -78.35 98.26 5.91 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 115.323 -0.853 . . . . 72.01 109.649 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 120.32 -19.95 9.13 Favored Glycine 0 C--N 1.308 -0.975 0 N-CA-C 110.691 -0.964 . . . . 51.55 110.691 -178.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -72.49 164.78 25.85 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.61 -0.515 . . . . 73.13 109.61 177.172 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 230' ' ' THR . . . . . 0.464 ' O ' HG13 ' A' ' 234' ' ' VAL . 67.2 p -84.86 168.61 14.92 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 108.734 -0.839 . . . . 63.24 108.734 178.683 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.404 ' HA ' HG22 ' A' ' 234' ' ' VAL . 53.3 tp -63.43 -31.95 73.25 Favored 'General case' 0 N--CA 1.424 -1.745 0 N-CA-C 109.541 -0.54 . . . . 75.31 109.541 177.602 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -64.46 -50.94 65.51 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.472 -0.566 . . . . 75.3 109.472 176.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 233' ' ' GLN . . . . . 0.464 ' O ' ' HG2' ' A' ' 237' ' ' MET . 1.1 mp0 -58.49 -43.77 89.16 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 113.297 0.851 . . . . 74.13 113.297 177.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.626 HG21 HG12 ' A' ' 195' ' ' ILE . 7.2 m -72.06 -34.79 51.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 C-N-CA 119.796 -0.762 . . . . 74.22 111.811 -176.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 235' ' ' THR . . . . . 0.442 ' O ' HG23 ' A' ' 239' ' ' VAL . 42.8 m -69.6 -36.36 76.13 Favored 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 109.224 -0.658 . . . . 70.32 109.224 179.447 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -59.84 -37.74 80.11 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-N 116.11 -0.496 . . . . 75.41 110.049 176.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 237' ' ' MET . . . . . 0.464 ' HG2' ' O ' ' A' ' 233' ' ' GLN . 16.8 mmt -58.96 -52.13 67.1 Favored 'General case' 0 C--O 1.2 -1.523 0 N-CA-C 108.451 -0.944 . . . . 73.14 108.451 176.504 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 238' ' ' MET . . . . . 0.412 ' HG3' ' O ' ' A' ' 234' ' ' VAL . 58.1 mtt -62.82 -33.11 74.54 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.996 -1.002 . . . . 72.45 112.201 -175.59 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 235' ' ' THR . 75.6 t -68.29 -41.31 83.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-O 121.328 0.585 . . . . 51.32 109.902 175.588 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -72.32 -38.84 68.58 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.438 -0.801 . . . . 73.33 110.664 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -84.03 21.47 1.34 Allowed 'General case' 0 C--O 1.198 -1.613 0 CA-C-N 115.399 -0.819 . . . . 73.31 111.742 -177.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 242' ' ' SER . . . . . 0.487 ' O ' HD12 ' A' ' 164' ' ' LEU . 14.8 p -64.36 -22.54 66.99 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-O 121.121 0.486 . . . . 62.1 111.559 176.519 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 26.7 m -68.84 -27.13 65.56 Favored 'General case' 0 CA--C 1.557 1.24 0 CA-C-N 116.318 -0.401 . . . . 73.43 110.914 176.231 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -174.44 103.16 0.1 Allowed 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.794 1.237 . . . . 63.45 108.98 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.491 ' CD2' HG13 ' A' ' 247' ' ' ILE . 1.0 OUTLIER -90.49 103.51 16.19 Favored 'General case' 0 C--O 1.201 -1.456 0 N-CA-C 109.634 -0.506 . . . . 73.12 109.634 -173.923 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.507 ' O ' ' HA ' ' A' ' 221' ' ' VAL . 63.9 mt -105.02 115.42 46.87 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 O-C-N 121.445 -0.785 . . . . 64.33 109.255 178.334 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 247' ' ' ILE . . . . . 0.534 HG23 HG23 ' A' ' 218' ' ' VAL . 18.8 mt -119.31 133.43 66.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 113.375 0.88 . . . . 54.31 113.375 -179.314 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.548 ' HA ' ' O ' ' A' ' 159' ' ' ARG . 61.2 m -103.11 121.27 42.27 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 107.65 -1.241 . . . . 74.24 107.65 173.337 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.498 HG12 ' HA ' ' A' ' 218' ' ' VAL . 17.1 m -122.81 163.83 20.97 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.061 0 CA-C-O 121.106 0.479 . . . . 75.44 110.523 175.376 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.42 ' HA ' ' O ' ' A' ' 157' ' ' THR . 19.4 ptmt -134.29 128.9 19.55 Favored Pre-proline 0 N--CA 1.416 -2.156 0 CA-C-N 114.469 -1.241 . . . . 74.01 107.745 173.597 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -61.4 133.59 46.97 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 121.255 1.303 . . . . 74.3 112.386 178.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -74.81 -14.62 60.71 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 109.268 -0.641 . . . . 54.24 109.268 176.054 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -96.55 6.43 48.75 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.303 -0.862 . . . . 72.42 109.302 174.349 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 43.37 96.29 0.01 OUTLIER 'General case' 0 C--N 1.354 0.79 0 C-N-CA 127.007 2.123 . . . . 65.44 114.222 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 . . . . . 0 C--O 1.255 1.389 0 C-N-CA 124.039 0.936 . . . . 60.43 110.325 -176.737 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.504 -0.803 0 N-CA-C 107.928 -1.138 . . . . 74.34 107.928 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.56 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 39.8 p -106.56 -34.19 7.44 Favored 'General case' 0 N--CA 1.418 -2.046 0 CA-C-N 114.78 -1.1 . . . . 73.51 108.111 173.044 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.499 ' ND1' ' HB3' ' A' ' 250' ' ' LYS . 0.6 OUTLIER -125.56 153.22 43.99 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 123.65 0.78 . . . . 74.05 110.305 174.029 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.456 ' O ' ' HA ' ' A' ' 248' ' ' THR . 28.7 tpt180 -143.47 133.59 24.33 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 109.409 -0.589 . . . . 72.45 109.409 172.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 32.0 ptt180 -113.36 124.65 52.96 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 116.044 -0.525 . . . . 63.53 109.945 177.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.554 ' O ' ' HA ' ' A' ' 246' ' ' ILE . 17.4 m -127.0 139.25 52.45 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 CA-C-N 116.015 -0.539 . . . . 65.45 112.218 -176.575 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.608 ' HG2' HG12 ' A' ' 246' ' ' ILE . 95.6 mtt180 -87.95 112.57 22.71 Favored 'General case' 0 C--O 1.242 0.661 0 N-CA-C 108.264 -1.013 . . . . 62.24 108.264 176.192 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.539 ' HB2' ' HB3' ' A' ' 245' ' ' LEU . 33.5 mt -92.87 125.75 37.63 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 107.372 -1.344 . . . . 63.32 107.372 176.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.446 HD13 ' O ' ' A' ' 242' ' ' SER . 5.8 tt 78.95 83.89 0.06 Allowed 'General case' 0 C--N 1.312 -1.038 0 O-C-N 124.664 1.227 . . . . 71.11 110.468 179.234 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -92.99 -25.77 17.83 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 106.853 -1.536 . . . . 74.22 106.853 173.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 52.3 t-80 -141.59 132.14 25.42 Favored 'General case' 0 N--CA 1.432 -1.346 0 CA-C-N 113.635 -1.62 . . . . 73.31 106.717 176.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 166.92 -114.39 0.58 Allowed Glycine 0 N--CA 1.43 -1.737 0 C-N-CA 120.012 -1.09 . . . . 32.24 112.132 -178.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' SER . . . . . 0.424 ' H ' HD11 ' A' ' 164' ' ' LEU . 63.3 m 66.15 21.26 11.15 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.632 0.729 . . . . 73.41 111.282 -177.173 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -118.11 -49.43 2.5 Favored 'General case' 0 CA--C 1.495 -1.137 0 CA-C-N 115.162 -0.926 . . . . 71.1 109.03 177.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.574 ' HD3' ' H ' ' A' ' 170' ' ' LYS . 0.1 OUTLIER -120.66 153.95 56.9 Favored Pre-proline 0 N--CA 1.422 -1.869 0 CA-C-N 115.124 -0.944 . . . . 72.21 111.577 -173.027 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_exo -54.88 154.81 20.07 Favored 'Trans proline' 0 C--O 1.247 0.937 0 C-N-CA 124.099 3.199 . . . . 40.15 112.43 174.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.47 ' HG ' ' CD1' ' A' ' 245' ' ' LEU . 3.3 mm? -56.21 -40.31 73.83 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.842 0.682 . . . . 62.35 112.842 -178.082 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 96.17 47.43 2.42 Favored Glycine 0 N--CA 1.439 -1.131 0 C-N-CA 119.77 -1.205 . . . . 31.12 114.205 174.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -159.51 154.51 24.89 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.774 -0.824 . . . . 74.25 108.774 174.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -123.4 143.89 49.84 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 109.071 -0.714 . . . . 51.51 109.071 177.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.651 HD13 ' H ' ' A' ' 176' ' ' ILE . 0.2 OUTLIER -117.31 169.61 7.57 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.77 0 CA-C-N 115.379 -0.828 . . . . 75.23 109.608 -179.622 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.542 ' CG ' ' HB2' ' A' ' 198' ' ' SER . 19.2 ptt180 -144.66 155.24 43.5 Favored 'General case' 0 C--N 1.269 -2.914 0 C-N-CA 124.057 0.943 . . . . 75.11 109.724 -175.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -115.15 145.75 42.06 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-O 121.235 0.54 . . . . 75.33 110.323 -178.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -157.62 171.46 34.79 Favored Glycine 0 N--CA 1.42 -2.372 0 N-CA-C 108.414 -1.874 . . . . 33.01 108.414 176.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' THR . . . . . 0.411 ' CG2' ' HG2' ' A' ' 191' ' ' LYS . 0.3 OUTLIER -86.62 123.09 31.42 Favored 'General case' 0 C--N 1.294 -1.83 0 C-N-CA 118.174 -1.41 . . . . 60.23 107.425 178.503 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 181' ' ' SER . . . . . 0.497 ' O ' ' HA ' ' A' ' 191' ' ' LYS . 37.8 t -105.51 129.68 53.74 Favored 'General case' 0 C--N 1.273 -2.747 0 N-CA-C 108.476 -0.935 . . . . 65.21 108.476 -178.258 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.635 ' HA ' ' O ' ' A' ' 190' ' ' GLU . 6.0 p -108.24 118.15 55.27 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.952 0 C-N-CA 119.377 -0.929 . . . . 72.22 109.048 172.686 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -125.0 161.52 26.53 Favored 'General case' 0 CA--C 1.475 -1.907 0 N-CA-C 108.185 -1.043 . . . . 54.52 108.185 -176.152 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 98.0 t -86.09 118.35 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.236 0 N-CA-C 107.094 -1.447 . . . . 73.2 107.094 171.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 76.1 p -109.17 -174.12 2.43 Favored 'General case' 0 C--N 1.259 -3.328 0 N-CA-C 107.562 -1.273 . . . . 75.34 107.562 -178.12 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -69.7 -10.03 56.7 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-O 120.836 0.35 . . . . 70.13 110.418 176.338 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 36.7 m -105.24 -14.94 15.2 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 111.746 0.276 . . . . 54.51 111.746 179.381 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 131.05 -146.14 17.55 Favored Glycine 0 C--O 1.21 -1.352 0 C-N-CA 120.233 -0.984 . . . . 71.24 110.649 178.3 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 5.2 mp -85.61 119.35 25.86 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.374 -0.973 . . . . 72.24 108.374 177.057 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' GLU . . . . . 0.635 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 53.3 mt-10 -131.23 125.71 33.59 Favored 'General case' 0 CA--C 1.455 -2.679 0 CA-C-O 121.002 0.43 . . . . 72.43 111.261 -178.007 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.497 ' HA ' ' O ' ' A' ' 181' ' ' SER . 31.2 ttmt -96.32 122.89 39.68 Favored 'General case' 0 C--N 1.276 -2.623 0 N-CA-C 107.275 -1.38 . . . . 74.52 107.275 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 192' ' ' GLN . . . . . 0.417 ' HB2' ' HD2' ' A' ' 193' ' ' PRO . 13.5 pt20 -152.02 165.4 17.54 Favored Pre-proline 0 C--N 1.287 -2.11 0 N-CA-C 108.068 -1.086 . . . . 73.41 108.068 -169.43 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 193' ' ' PRO . . . . . 0.417 ' HD2' ' HB2' ' A' ' 192' ' ' GLN . 9.8 Cg_endo -55.68 131.58 46.97 Favored 'Trans proline' 0 C--O 1.251 1.154 0 C-N-CA 120.942 1.095 . . . . 74.23 110.516 176.491 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -143.4 141.92 10.86 Favored Glycine 0 N--CA 1.413 -2.857 0 N-CA-C 109.319 -1.512 . . . . 32.01 109.319 -178.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.679 HG12 HG21 ' A' ' 234' ' ' VAL . 2.8 mp -109.38 133.73 53.66 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.435 0 CA-C-O 121.481 0.657 . . . . 74.13 111.608 -176.587 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -123.28 167.07 14.23 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.93 -1.137 . . . . 75.13 107.93 -177.184 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' ILE . . . . . 0.432 ' HB ' ' HA ' ' A' ' 214' ' ' VAL . 45.6 mm -79.58 131.97 33.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 108.947 -0.76 . . . . 72.41 108.947 177.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 198' ' ' SER . . . . . 0.542 ' HB2' ' CG ' ' A' ' 177' ' ' ARG . 14.4 t -106.55 -31.53 8.47 Favored 'General case' 0 C--N 1.295 -1.781 0 O-C-N 121.734 -0.604 . . . . 75.25 112.415 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -164.85 144.31 7.04 Favored 'General case' 0 C--N 1.313 -0.979 0 C-N-CA 120.986 -0.286 . . . . 72.04 110.643 -176.01 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 81.4 mt -107.74 134.48 50.64 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.849 -1.167 . . . . 74.44 107.849 172.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 60.2 t -92.93 114.89 63.91 Favored Pre-proline 0 C--N 1.29 -2.018 0 N-CA-C 105.744 -1.947 . . . . 65.25 105.744 172.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -61.06 137.19 70.13 Favored 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 121.8 1.667 . . . . 75.13 110.378 -177.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 98.77 -21.38 46.24 Favored Glycine 0 C--N 1.303 -1.271 0 C-N-CA 120.513 -0.851 . . . . 70.42 111.109 -177.195 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -76.06 175.32 52.48 Favored Glycine 0 N--CA 1.44 -1.064 0 C-N-CA 121.349 -0.453 . . . . 74.44 112.492 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -67.22 -30.79 70.81 Favored 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 123.743 0.817 . . . . 64.45 111.249 -177.209 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -68.68 -41.31 79.4 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.461 0.648 . . . . 75.4 109.783 178.052 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -68.17 -32.78 73.27 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.473 -0.785 . . . . 71.22 109.35 177.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 49.3 m -56.5 -40.96 75.84 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 116.058 -0.519 . . . . 73.24 111.581 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 7.2 t -84.87 -41.21 16.23 Favored 'General case' 0 N--CA 1.44 -0.941 0 C-N-CA 119.178 -1.009 . . . . 53.54 110.514 177.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 67.18 6.69 40.69 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 121.325 -0.464 . . . . 73.34 113.442 179.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 76.9 mt -84.07 -9.48 58.59 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-O 121.175 0.512 . . . . 62.12 111.089 -178.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.524 ' H ' HD23 ' A' ' 212' ' ' LEU . 2.2 pt? -112.48 136.55 51.85 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-N 115.662 -0.699 . . . . 72.22 109.373 175.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -130.69 166.84 19.85 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.423 -0.954 . . . . 60.32 108.423 -178.364 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 214' ' ' VAL . . . . . 0.432 ' HA ' ' HB ' ' A' ' 197' ' ' ILE . 16.5 m -56.42 -30.38 30.79 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 N-CA-C 113.486 0.921 . . . . 73.22 113.486 -176.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 -79.38 -15.0 58.59 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 121.75 -0.594 . . . . 73.24 111.688 -179.405 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.514 ' HB3' ' HB ' ' A' ' 249' ' ' VAL . 1.5 m-20 -71.78 139.74 49.15 Favored 'General case' 0 C--O 1.248 0.974 0 CA-C-O 121.439 0.637 . . . . 62.14 111.92 -178.515 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 57.0 tt0 -101.46 138.54 38.33 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.973 -1.012 . . . . 53.42 111.266 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.549 ' HA ' HG12 ' A' ' 249' ' ' VAL . 35.4 t -83.54 124.44 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 CA-C-O 121.77 0.795 . . . . 75.04 110.133 -178.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.438 HD11 ' CD ' ' A' ' 250' ' ' LYS . 35.5 mm -93.64 -51.88 10.53 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 CA-C-N 115.044 -0.98 . . . . 74.44 111.121 -179.376 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -154.26 158.33 40.05 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 116.214 -0.448 . . . . 55.12 110.458 -177.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 12.5 p -127.69 120.26 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.663 0 CA-C-N 115.595 -0.73 . . . . 75.42 109.411 179.275 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 222' ' ' ASN . . . . . 0.466 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 12.0 t-20 68.28 4.23 4.08 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 126.329 1.851 . . . . 71.14 110.98 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 117.57 -15.45 12.83 Favored Glycine 0 N--CA 1.44 -1.078 0 N-CA-C 110.892 -0.883 . . . . 74.42 110.892 -177.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 65.4 mt -94.75 124.44 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 CA-C-O 121.132 0.492 . . . . 74.34 110.026 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -55.37 137.08 48.71 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 124.914 1.286 . . . . 71.2 112.425 -179.363 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 226' ' ' VAL . . . . . 0.411 HG21 HG12 ' A' ' 218' ' ' VAL . 35.8 m -105.98 8.79 9.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 CA-C-O 121.801 0.81 . . . . 72.41 109.981 175.525 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -74.72 99.9 3.84 Favored 'General case' 0 N--CA 1.431 -1.398 0 CA-C-N 114.813 -1.085 . . . . 54.51 110.125 178.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 112.41 -8.63 26.49 Favored Glycine 0 CA--C 1.495 -1.171 0 N-CA-C 110.378 -1.089 . . . . 41.44 110.378 178.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -83.06 153.08 25.08 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 107.954 -1.128 . . . . 71.02 107.954 176.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 74.4 p -91.79 175.73 6.78 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 108.168 -1.049 . . . . 53.41 108.168 179.053 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.461 ' HA ' HG22 ' A' ' 234' ' ' VAL . 2.8 tm? -65.06 -37.03 86.21 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 107.818 -1.178 . . . . 72.03 107.818 178.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -55.69 -51.82 65.96 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.016 -0.993 . . . . 45.43 109.395 177.201 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 233' ' ' GLN . . . . . 0.64 ' O ' ' HG3' ' A' ' 237' ' ' MET . 1.4 mp0 -66.84 -50.7 61.72 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 113.798 1.036 . . . . 64.53 113.798 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.679 HG21 HG12 ' A' ' 195' ' ' ILE . 26.7 m -58.89 -33.51 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 N-CA-C 112.588 0.588 . . . . 74.14 112.588 -174.642 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 235' ' ' THR . . . . . 0.421 ' O ' HG23 ' A' ' 239' ' ' VAL . 91.3 m -72.77 -35.56 67.47 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 115.232 -0.895 . . . . 75.3 109.332 -175.653 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -69.02 -30.77 69.21 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.298 -0.864 . . . . 72.43 108.994 178.317 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 237' ' ' MET . . . . . 0.64 ' HG3' ' O ' ' A' ' 233' ' ' GLN . 19.3 mtp -69.49 -47.25 64.49 Favored 'General case' 0 C--O 1.209 -1.067 0 N-CA-C 106.931 -1.507 . . . . 61.25 106.931 178.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 238' ' ' MET . . . . . 0.542 ' HG3' ' O ' ' A' ' 234' ' ' VAL . 65.3 mtt -59.55 -45.29 92.24 Favored 'General case' 0 C--O 1.22 -0.489 0 CA-C-N 115.42 -0.809 . . . . 72.41 112.186 -179.493 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 235' ' ' THR . 89.3 t -64.42 -38.26 82.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.161 0.505 . . . . 63.32 110.533 178.456 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -68.89 -36.13 77.7 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.383 0.611 . . . . 74.32 110.318 178.306 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -86.51 19.43 2.83 Favored 'General case' 0 C--O 1.199 -1.583 0 CA-C-N 115.472 -0.785 . . . . 61.34 111.906 179.133 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 242' ' ' SER . . . . . 0.446 ' O ' HD13 ' A' ' 164' ' ' LEU . 30.4 p -61.26 -23.7 65.85 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 112.776 0.658 . . . . 74.14 112.776 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 25.4 p -74.8 -16.78 60.69 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 112.12 0.415 . . . . 72.14 112.12 178.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -175.29 88.24 0.04 OUTLIER 'General case' 0 C--O 1.257 1.451 0 N-CA-C 107.787 -1.19 . . . . 75.44 107.787 -179.057 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.539 ' HB3' ' HB2' ' A' ' 163' ' ' LEU . 2.8 tt -92.15 102.11 14.63 Favored 'General case' 0 N--CA 1.416 -2.138 0 C-N-CA 118.923 -1.111 . . . . 64.34 109.268 -174.225 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.608 HG12 ' HG2' ' A' ' 162' ' ' ARG . 89.1 mt -97.81 116.4 40.3 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.98 0 C-N-CA 120.134 -0.627 . . . . 71.42 109.971 178.116 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 247' ' ' ILE . . . . . 0.492 HG13 ' CD2' ' A' ' 245' ' ' LEU . 14.6 mt -117.99 134.63 60.99 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.84 0 CA-C-O 121.433 0.635 . . . . 73.11 111.403 176.761 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.456 ' HA ' ' O ' ' A' ' 159' ' ' ARG . 63.8 m -103.1 114.87 29.51 Favored 'General case' 0 N--CA 1.409 -2.5 0 CA-C-N 114.52 -1.218 . . . . 23.42 108.072 175.536 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.549 HG12 ' HA ' ' A' ' 218' ' ' VAL . 17.4 m -118.89 159.91 19.11 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.165 0 CA-C-O 121.46 0.648 . . . . 41.24 110.754 177.12 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.499 ' HB3' ' ND1' ' A' ' 158' ' ' HIS . 10.0 ptmt -127.69 128.84 23.86 Favored Pre-proline 0 C--N 1.272 -2.798 0 CA-C-N 114.291 -1.322 . . . . 74.33 109.161 177.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 251' ' ' PRO . . . . . 0.56 ' HD2' ' O ' ' A' ' 157' ' ' THR . 35.0 Cg_endo -66.61 148.56 83.5 Favored 'Trans proline' 0 N--CA 1.439 -1.683 0 C-N-CA 121.827 1.685 . . . . 63.1 110.5 178.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -62.43 -35.8 80.4 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 122.057 0.932 . . . . 42.31 109.147 177.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -97.98 73.36 2.25 Favored 'General case' 0 C--N 1.29 -1.986 0 CA-C-N 114.186 -1.37 . . . . 74.2 108.948 178.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 254' ' ' GLN . . . . . 0.442 ' HG3' ' O ' ' A' ' 251' ' ' PRO . 27.8 mt-30 -70.9 144.36 50.66 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 116.191 -0.459 . . . . 72.22 111.338 177.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.313 -0.992 0 CA-C-O 118.705 -0.664 . . . . 74.34 109.48 178.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 . . . . . 0 N--CA 1.452 -0.353 0 N-CA-C 108.375 -0.972 . . . . 74.34 108.375 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.474 ' O ' ' HA ' ' A' ' 250' ' ' LYS . 58.0 p -60.71 -35.87 77.4 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.059 0.544 . . . . 53.02 112.397 -176.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -125.19 129.78 50.8 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 109.815 -0.439 . . . . 75.03 109.815 173.629 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.543 ' O ' ' HA ' ' A' ' 248' ' ' THR . 2.1 tpm_? -140.18 140.36 35.9 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.619 -1.252 . . . . 74.41 107.619 177.101 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.583 ' HB3' ' OG1' ' A' ' 248' ' ' THR . 23.2 ptt180 -132.47 113.03 12.63 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 122.098 0.951 . . . . 75.41 113.067 178.578 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.63 ' O ' ' HA ' ' A' ' 246' ' ' ILE . 21.1 m -105.17 139.29 26.67 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 CA-C-N 113.929 -1.487 . . . . 45.21 113.014 -175.181 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.546 ' HG3' HG12 ' A' ' 246' ' ' ILE . 7.3 mpt_? -91.13 112.6 24.57 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 106.995 -1.483 . . . . 74.24 106.995 175.573 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.513 ' HB2' ' HB3' ' A' ' 245' ' ' LEU . 35.4 mt -100.23 135.49 41.58 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 108.49 -0.929 . . . . 62.11 108.49 179.505 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.466 HD23 ' O ' ' A' ' 242' ' ' SER . 8.1 tp 79.28 95.91 0.06 Allowed 'General case' 0 N--CA 1.417 -2.102 0 C-N-CA 124.499 1.12 . . . . 54.21 110.567 175.759 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 60.6 pttt -101.67 18.65 19.8 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 114.236 -1.347 . . . . 75.0 109.91 -179.425 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 61.4 m80 -125.1 176.14 6.9 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 114.406 -1.27 . . . . 75.13 110.176 176.103 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -120.64 80.42 0.33 Allowed Glycine 0 CA--C 1.484 -1.886 0 C-N-CA 120.614 -0.803 . . . . 33.43 111.198 -175.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 67.2 m -156.92 143.14 18.08 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.415 -0.957 . . . . 71.31 108.415 -178.311 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -79.85 73.45 6.6 Favored 'General case' 0 CA--C 1.494 -1.195 0 CA-C-O 122.166 0.984 . . . . 60.12 110.282 178.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -99.83 147.4 33.38 Favored Pre-proline 0 C--N 1.281 -2.38 0 CA-C-N 113.647 -1.615 . . . . 73.03 108.062 175.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -63.62 137.63 60.29 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 121.764 1.643 . . . . 52.51 109.452 174.391 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.472 ' HG ' ' CD1' ' A' ' 245' ' ' LEU . 3.3 mm? -75.19 -25.66 58.43 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 120.916 0.388 . . . . 55.51 111.358 -176.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' GLY . . . . . 0.439 ' HA3' ' HA3' ' A' ' 204' ' ' GLY . . . 93.28 35.49 6.26 Favored Glycine 0 N--CA 1.437 -1.247 0 C-N-CA 120.419 -0.896 . . . . 62.44 113.704 175.594 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -151.45 158.89 44.26 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.415 -0.958 . . . . 74.25 108.415 174.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -125.36 156.83 38.12 Favored 'General case' 0 C--N 1.284 -2.243 0 N-CA-C 108.761 -0.829 . . . . 72.45 108.761 175.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.59 HD13 ' H ' ' A' ' 176' ' ' ILE . 0.2 OUTLIER -124.96 166.64 20.24 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 CA-C-O 121.441 0.639 . . . . 61.21 110.421 -179.922 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.431 ' HG2' ' HB3' ' A' ' 198' ' ' SER . 14.7 ptt180 -144.78 154.76 43.04 Favored 'General case' 0 C--N 1.28 -2.438 0 CA-C-N 114.699 -1.137 . . . . 72.44 110.154 -176.506 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' ASP . . . . . 0.406 ' HB2' ' HB2' ' A' ' 231' ' ' LEU . 11.2 t70 -112.98 145.39 40.9 Favored 'General case' 0 C--N 1.294 -1.822 0 C-N-CA 123.648 0.779 . . . . 73.44 110.094 -177.714 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -162.98 179.13 38.42 Favored Glycine 0 C--N 1.294 -1.797 0 N-CA-C 109.048 -1.621 . . . . 42.24 109.048 175.431 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 2.1 p -96.99 123.4 40.7 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-N 118.19 0.995 . . . . 75.12 111.154 174.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' SER . . . . . 0.53 ' O ' ' HA ' ' A' ' 191' ' ' LYS . 24.5 t -108.88 123.65 49.41 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 107.684 -1.228 . . . . 71.22 107.684 177.309 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.684 ' HB ' ' HG3' ' A' ' 191' ' ' LYS . 7.8 p -103.1 124.27 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.334 0 N-CA-C 108.528 -0.916 . . . . 64.42 108.528 178.653 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' ARG . . . . . 0.439 ' O ' ' HA ' ' A' ' 189' ' ' LEU . 94.4 mtt180 -127.97 160.39 32.02 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 109.053 -0.721 . . . . 72.12 109.053 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 82.4 t -84.67 118.35 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.044 0 N-CA-C 107.349 -1.352 . . . . 73.0 107.349 173.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 76.5 p -111.4 -175.24 2.65 Favored 'General case' 0 C--N 1.265 -3.078 0 N-CA-C 107.592 -1.262 . . . . 75.45 107.592 -178.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -66.87 -16.98 64.66 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.064 0.459 . . . . 63.34 110.525 179.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 12.8 p -102.89 -18.05 15.24 Favored 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 113.479 0.918 . . . . 62.12 113.479 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 141.82 -163.75 26.88 Favored Glycine 0 CA--C 1.493 -1.294 0 C-N-CA 119.541 -1.314 . . . . 70.32 111.464 178.258 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.439 ' HA ' ' O ' ' A' ' 183' ' ' ARG . 5.2 mp -82.52 116.48 21.97 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 108.379 -0.971 . . . . 73.04 108.379 178.362 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 190' ' ' GLU . . . . . 0.528 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 45.5 mt-10 -134.48 135.21 42.29 Favored 'General case' 0 CA--C 1.488 -1.434 0 N-CA-C 114.548 1.314 . . . . 72.31 114.548 -176.349 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.684 ' HG3' ' HB ' ' A' ' 182' ' ' VAL . 43.8 mtmt -84.34 137.09 33.62 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 114.431 -1.259 . . . . 70.42 112.402 173.338 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -132.08 163.47 49.93 Favored Pre-proline 0 C--N 1.259 -3.327 0 N-CA-C 105.184 -2.154 . . . . 63.4 105.184 176.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -66.48 131.07 25.22 Favored 'Trans proline' 0 N--CA 1.423 -2.666 0 N-CA-C 106.872 -2.011 . . . . 73.13 106.872 169.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -125.89 127.83 6.27 Favored Glycine 0 N--CA 1.397 -3.965 0 N-CA-C 109.499 -1.441 . . . . 41.43 109.499 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.623 HG12 HG21 ' A' ' 234' ' ' VAL . 3.4 mp -103.68 132.78 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.049 0 N-CA-C 109.084 -0.71 . . . . 75.0 109.084 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -125.6 167.38 15.16 Favored 'General case' 0 C--N 1.281 -2.405 0 N-CA-C 107.366 -1.346 . . . . 71.14 107.366 -176.431 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 47.5 mm -77.82 132.29 32.88 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 N-CA-C 107.021 -1.474 . . . . 73.11 107.021 175.203 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' SER . . . . . 0.431 ' HB3' ' HG2' ' A' ' 177' ' ' ARG . 83.4 p -100.47 -35.29 9.6 Favored 'General case' 0 C--N 1.28 -2.43 0 C-N-CA 118.806 -1.158 . . . . 74.21 111.053 -178.255 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 65.9 ttt180 -158.13 147.3 19.43 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.296 -0.411 . . . . 73.25 110.44 -176.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 71.0 mt -106.66 138.39 42.93 Favored 'General case' 0 CA--C 1.483 -1.609 0 N-CA-C 108.554 -0.906 . . . . 71.1 108.554 171.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 58.9 t -98.89 114.99 65.99 Favored Pre-proline 0 N--CA 1.415 -2.211 0 N-CA-C 106.377 -1.712 . . . . 75.32 106.377 172.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.527 ' HA ' ' HG2' ' A' ' 207' ' ' GLU . 37.0 Cg_exo -58.73 126.8 22.28 Favored 'Trans proline' 0 N--CA 1.448 -1.149 0 C-N-CA 121.934 1.756 . . . . 61.12 110.65 -178.267 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 106.24 -16.3 42.1 Favored Glycine 0 N--CA 1.438 -1.2 0 C-N-CA 120.332 -0.937 . . . . 63.03 112.403 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 204' ' ' GLY . . . . . 0.439 ' HA3' ' HA3' ' A' ' 173' ' ' GLY . . . -81.01 -179.23 52.97 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.811 -0.709 . . . . 15.21 111.898 178.597 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.453 HD23 ' HA ' ' A' ' 172' ' ' LEU . 3.4 mm? -62.74 -42.85 99.87 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 123.1 0.56 . . . . 71.5 111.548 -177.273 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -60.96 -38.66 86.71 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.139 -0.482 . . . . 71.32 111.335 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.527 ' HG2' ' HA ' ' A' ' 202' ' ' PRO . 9.3 tp10 -75.51 -36.9 60.44 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.505 -0.554 . . . . 72.02 109.505 178.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 24.7 t -60.18 -45.98 91.25 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 115.915 -0.584 . . . . 50.23 110.444 -179.211 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' THR . . . . . 0.46 HG23 ' H ' ' A' ' 211' ' ' LEU . 8.9 t -72.89 -40.33 65.65 Favored 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 120.311 -0.556 . . . . 72.44 110.037 176.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 73.16 9.32 76.49 Favored Glycine 0 N--CA 1.441 -0.998 0 CA-C-N 115.852 -0.613 . . . . 62.51 112.561 179.405 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.46 ' H ' HG23 ' A' ' 209' ' ' THR . 48.6 mt -97.25 1.97 50.28 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.542 0.687 . . . . 64.22 109.685 -179.004 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 87.6 mt -112.83 132.43 55.28 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 114.744 -1.116 . . . . 72.42 109.09 174.126 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -131.45 160.65 34.52 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 122.817 0.447 . . . . 71.2 109.889 176.456 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 32.8 m -62.22 -30.26 48.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 122.034 0.921 . . . . 74.33 112.922 -178.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 215' ' ' ASN . . . . . 0.659 ' OD1' ' HB3' ' A' ' 252' ' ' ALA . 25.9 t-20 -81.0 -14.07 58.28 Favored 'General case' 0 C--N 1.275 -2.641 0 CA-C-N 116.04 -0.527 . . . . 64.15 111.777 -175.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.475 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 72.0 m-20 -71.71 151.47 43.58 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 113.599 0.963 . . . . 74.52 113.599 -175.06 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -111.64 129.78 55.98 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.122 1.369 . . . . 72.44 109.955 -176.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.493 ' HA ' HG12 ' A' ' 249' ' ' VAL . 41.6 t -82.24 138.88 18.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 CA-C-O 121.488 0.661 . . . . 60.12 111.949 -175.391 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.481 HD11 ' CD ' ' A' ' 250' ' ' LYS . 47.4 mm -108.66 -51.76 6.82 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 C-N-CA 123.935 0.894 . . . . 71.2 111.631 -178.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.419 ' HB3' ' HA ' ' A' ' 225' ' ' GLU . 10.7 pt-20 -151.87 161.38 42.74 Favored 'General case' 0 C--O 1.244 0.808 0 CA-C-O 120.522 0.201 . . . . 60.41 110.663 -178.423 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.416 HG11 ' HB2' ' A' ' 237' ' ' MET . 15.0 p -129.93 119.47 47.32 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.075 0 CA-C-O 121.449 0.642 . . . . 72.42 109.556 177.574 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 222' ' ' ASN . . . . . 0.511 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 13.7 t-20 70.23 0.02 2.99 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 125.859 1.663 . . . . 74.13 111.858 177.776 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 121.87 -13.8 9.15 Favored Glycine 0 N--CA 1.435 -1.369 0 N-CA-C 110.955 -0.858 . . . . 65.43 110.955 -177.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 66.6 mt -95.8 123.66 48.1 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 N-CA-C 108.725 -0.843 . . . . 71.21 108.725 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 225' ' ' GLU . . . . . 0.419 ' HA ' ' HB3' ' A' ' 220' ' ' GLU . 13.0 pt-20 -55.76 147.65 18.32 Favored 'General case' 0 C--N 1.31 -1.138 0 O-C-N 123.912 0.758 . . . . 64.2 111.145 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 226' ' ' VAL . . . . . 0.472 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 33.5 m -120.5 -1.1 8.02 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 CA-C-O 121.472 0.653 . . . . 72.41 109.387 173.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -73.36 95.16 2.14 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-N 115.081 -0.963 . . . . 42.04 110.622 -178.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 127.43 -22.29 5.59 Favored Glycine 0 N--CA 1.429 -1.795 0 C-N-CA 120.432 -0.89 . . . . 44.22 110.939 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 55.9 mttm -83.78 164.93 19.25 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 109.996 -0.372 . . . . 53.22 109.996 177.603 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 230' ' ' THR . . . . . 0.41 ' O ' HG13 ' A' ' 234' ' ' VAL . 34.7 p -93.0 168.09 11.36 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 116.43 -0.35 . . . . 62.44 110.204 -177.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.505 HD21 HG12 ' A' ' 176' ' ' ILE . 2.8 tm? -56.96 -41.94 79.24 Favored 'General case' 0 N--CA 1.44 -0.967 0 C-N-CA 123.083 0.553 . . . . 64.11 109.878 -178.68 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -56.43 -51.59 67.81 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.365 -0.379 . . . . 65.24 110.501 176.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -58.6 -49.75 76.32 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 115.229 -0.896 . . . . 72.22 112.362 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.623 HG21 HG12 ' A' ' 195' ' ' ILE . 15.1 m -69.45 -33.84 59.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 112.894 0.701 . . . . 74.22 112.894 -173.718 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 235' ' ' THR . . . . . 0.428 ' O ' HG23 ' A' ' 239' ' ' VAL . 84.4 m -73.42 -35.59 65.85 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 109.488 -0.56 . . . . 71.44 109.488 -174.081 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -63.39 -33.1 74.8 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.957 -0.757 . . . . 71.34 108.957 177.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 237' ' ' MET . . . . . 0.416 ' HB2' HG11 ' A' ' 221' ' ' VAL . 5.1 mtm -72.72 -38.98 67.29 Favored 'General case' 0 C--O 1.199 -1.555 0 CA-C-N 115.341 -0.845 . . . . 74.43 108.731 -179.124 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 238' ' ' MET . . . . . 0.449 ' HG3' ' O ' ' A' ' 234' ' ' VAL . 65.6 mtt -63.45 -37.96 89.3 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.285 -0.416 . . . . 75.22 110.815 179.113 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 235' ' ' THR . 66.4 t -69.69 -41.0 79.97 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 CA-C-N 116.334 -0.393 . . . . 63.13 110.149 177.318 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -66.39 -34.19 77.4 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.768 0.794 . . . . 55.22 110.372 177.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -86.41 20.51 2.4 Favored 'General case' 0 C--O 1.2 -1.545 0 CA-C-N 115.267 -0.879 . . . . 75.32 112.506 178.61 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 242' ' ' SER . . . . . 0.466 ' O ' HD23 ' A' ' 164' ' ' LEU . 67.4 m -64.88 -23.59 67.28 Favored 'General case' 0 C--O 1.212 -0.912 0 C-N-CA 120.172 -0.611 . . . . 74.01 112.545 178.427 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 12.4 p -65.3 -36.36 83.83 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 111.802 0.297 . . . . 75.31 111.802 176.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 46.2 m-80 -155.95 92.43 1.36 Allowed 'General case' 0 C--O 1.254 1.294 0 N-CA-C 107.301 -1.37 . . . . 72.14 107.301 177.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.513 ' HB3' ' HB2' ' A' ' 163' ' ' LEU . 2.8 tt -88.6 103.18 15.67 Favored 'General case' 0 N--CA 1.423 -1.817 0 C-N-CA 119.381 -0.927 . . . . 75.14 109.641 -174.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.63 ' HA ' ' O ' ' A' ' 161' ' ' VAL . 87.2 mt -102.58 116.59 46.55 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.992 0 C-N-CA 120.721 -0.392 . . . . 70.21 109.974 177.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 247' ' ' ILE . . . . . 0.486 HG13 ' CD2' ' A' ' 245' ' ' LEU . 25.5 mt -119.55 132.89 68.05 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.089 0 CA-C-O 121.146 0.498 . . . . 61.45 111.912 176.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.583 ' OG1' ' HB3' ' A' ' 160' ' ' ARG . 57.2 m -100.27 124.35 45.63 Favored 'General case' 0 N--CA 1.426 -1.648 0 N-CA-C 107.561 -1.274 . . . . 72.51 107.561 175.035 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.493 HG12 ' HA ' ' A' ' 218' ' ' VAL . 29.5 m -124.82 170.56 14.8 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 CA-C-O 121.579 0.704 . . . . 74.23 110.971 176.165 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.481 ' CD ' HD11 ' A' ' 219' ' ' ILE 0.312 44.0 mtpt -125.0 134.78 26.02 Favored Pre-proline 0 C--N 1.28 -2.417 0 N-CA-C 106.146 -1.798 . . . . 73.43 106.146 173.971 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 251' ' ' PRO . . . . . 0.475 ' HA ' ' OD1' ' A' ' 216' ' ' ASP . 5.6 Cg_exo -79.17 132.0 10.11 Favored 'Trans proline' 0 N--CA 1.402 -3.871 0 CA-C-N 119.73 0.939 . . . . 72.21 110.346 173.591 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 252' ' ' ALA . . . . . 0.659 ' HB3' ' OD1' ' A' ' 215' ' ' ASN . . . -79.0 -2.5 40.49 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.994 0.902 . . . . 74.44 108.776 177.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -90.16 -12.67 37.52 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 114.29 -1.323 . . . . 71.25 108.722 175.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 53.06 76.52 0.2 Allowed 'General case' 0 C--N 1.357 0.916 0 CA-C-O 122.171 0.986 . . . . 70.54 109.453 -171.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 . . . . . 0 C--N 1.294 -1.823 0 CA-C-N 113.818 -1.537 . . . . 71.41 108.526 -170.297 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.489 ' HB2' ' OXT' ' A' ' 255' ' ' ARG . 0.0 OUTLIER . . . . . 0 CA--C 1.514 -0.404 0 N-CA-C 108.896 -0.779 . . . . 74.32 108.896 . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 47.6 p 63.69 -68.8 0.08 Allowed 'General case' 0 C--O 1.216 -0.69 0 C-N-CA 125.887 1.675 . . . . 71.4 112.42 -175.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.564 ' NE2' HG13 ' A' ' 219' ' ' ILE . 23.6 m80 -81.84 129.65 34.82 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 112.161 0.43 . . . . 73.4 112.161 -175.546 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.548 ' O ' ' HA ' ' A' ' 248' ' ' THR . 12.8 tpt180 -131.22 143.39 50.54 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.34 -1.356 . . . . 71.42 107.34 173.696 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 30.4 ttt85 -120.09 113.24 20.19 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 121.233 0.539 . . . . 75.31 109.911 -178.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.535 ' O ' ' HA ' ' A' ' 246' ' ' ILE . 25.2 m -119.24 139.14 47.62 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 N-CA-C 112.501 0.556 . . . . 65.34 112.501 -175.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.451 ' HG3' HG12 ' A' ' 246' ' ' ILE . 3.3 mpt_? -100.1 112.93 25.23 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 107.086 -1.449 . . . . 73.45 107.086 177.45 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.412 ' HB2' ' HB3' ' A' ' 245' ' ' LEU . 23.9 mt -95.69 130.59 42.54 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 109.412 -0.588 . . . . 74.0 109.412 -178.317 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.415 ' CD1' ' HB2' ' A' ' 170' ' ' LYS . 6.1 tt 78.96 90.25 0.06 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 122.333 1.063 . . . . 74.14 110.757 176.327 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 57.0 pttt -101.32 -3.93 27.97 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-N 115.086 -0.961 . . . . 74.02 109.349 176.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 41.6 t-80 -161.09 120.32 2.57 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 114.169 -1.378 . . . . 73.42 107.952 175.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -179.45 -96.6 0.1 Allowed Glycine 0 N--CA 1.425 -2.095 0 C-N-CA 119.398 -1.382 . . . . 55.42 113.831 -179.322 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 66.7 m 67.55 7.03 5.32 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.563 0.745 . . . . 64.4 111.341 -174.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -148.65 15.92 0.99 Allowed 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 106.584 -1.636 . . . . 71.53 106.584 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.415 ' HB2' ' CD1' ' A' ' 164' ' ' LEU . 72.4 mmtt -113.42 120.75 39.16 Favored Pre-proline 0 C--N 1.314 -0.948 0 CA-C-N 113.741 -1.572 . . . . 73.23 112.083 -172.626 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -70.13 141.2 43.14 Favored 'Trans proline' 0 N--CA 1.438 -1.789 0 N-CA-C 105.682 -2.468 . . . . 62.04 105.682 164.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.462 ' HG ' ' CD1' ' A' ' 245' ' ' LEU . 2.6 mm? -66.24 -27.09 67.69 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 120.235 -0.586 . . . . 61.31 111.912 -175.32 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' GLY . . . . . 0.495 ' HA3' ' HA3' ' A' ' 204' ' ' GLY . . . 91.56 38.92 5.73 Favored Glycine 0 N--CA 1.429 -1.823 0 C-N-CA 120.71 -0.757 . . . . 73.25 114.155 172.13 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -152.76 153.45 33.22 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 109.245 -0.65 . . . . 73.41 109.245 174.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -114.56 140.22 48.95 Favored 'General case' 0 C--N 1.282 -2.341 0 CA-C-N 115.674 -0.694 . . . . 71.13 109.282 178.126 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.409 HD13 ' SD ' ' A' ' 238' ' ' MET . 29.1 pt -114.31 169.1 5.7 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.514 0 CA-C-N 115.446 -0.797 . . . . 73.43 109.885 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.501 ' HG2' ' HB2' ' A' ' 198' ' ' SER . 3.1 ptp180 -153.75 154.64 34.42 Favored 'General case' 0 C--N 1.278 -2.52 0 CA-C-N 115.541 -0.754 . . . . 73.14 108.97 -179.273 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' ASP . . . . . 0.401 ' OD1' HD12 ' A' ' 231' ' ' LEU . 6.9 p-10 -101.47 154.99 18.34 Favored 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 108.659 -0.867 . . . . 74.41 108.659 178.296 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -165.23 -168.61 27.66 Favored Glycine 0 N--CA 1.412 -2.95 0 N-CA-C 109.274 -1.531 . . . . 65.13 109.274 177.116 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' THR . . . . . 0.615 ' HB ' ' CG ' ' A' ' 191' ' ' LYS . 1.3 p -100.48 123.64 44.96 Favored 'General case' 0 C--N 1.28 -2.426 0 CA-C-O 121.876 0.846 . . . . 61.12 112.716 178.259 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 27.6 t -106.53 119.46 39.33 Favored 'General case' 0 N--CA 1.416 -2.127 0 N-CA-C 106.466 -1.679 . . . . 33.43 106.466 176.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.595 ' HA ' ' O ' ' A' ' 190' ' ' GLU . 6.7 p -119.74 120.81 64.47 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 CA-C-O 121.559 0.695 . . . . 72.24 110.154 177.613 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -126.8 161.14 28.89 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 115.22 -0.9 . . . . 71.31 108.791 -176.358 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' A' ' 188' ' ' GLY . 69.7 t -87.3 118.81 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.044 0 N-CA-C 107.882 -1.155 . . . . 74.33 107.882 171.781 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 61.1 p -116.28 -174.62 2.59 Favored 'General case' 0 C--N 1.271 -2.829 0 CA-C-N 114.376 -1.284 . . . . 74.23 107.756 -178.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -68.18 -19.12 64.75 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.103 0.478 . . . . 70.33 110.108 177.11 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 46.2 m -88.64 -18.61 27.61 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 116.03 -0.532 . . . . 71.15 111.434 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.454 ' O ' ' HA ' ' A' ' 184' ' ' VAL . . . 126.97 -133.91 8.19 Favored Glycine 0 CA--C 1.486 -1.759 0 N-CA-C 110.0 -1.24 . . . . 73.03 110.0 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 5.7 mp -99.06 122.78 42.75 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.43 -0.952 . . . . 72.52 108.43 176.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' GLU . . . . . 0.595 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 52.3 mt-10 -129.18 119.44 24.08 Favored 'General case' 0 CA--C 1.448 -2.968 0 CA-C-O 121.321 0.582 . . . . 63.22 110.562 -177.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.615 ' CG ' ' HB ' ' A' ' 180' ' ' THR . 36.7 ttmt -99.62 121.48 41.27 Favored 'General case' 0 C--N 1.261 -3.263 0 CA-C-N 114.341 -1.299 . . . . 73.13 107.731 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 192' ' ' GLN . . . . . 0.42 ' HB2' ' HD2' ' A' ' 193' ' ' PRO . 13.4 pt20 -141.23 164.46 35.39 Favored Pre-proline 0 C--N 1.284 -2.281 0 N-CA-C 108.712 -0.847 . . . . 60.34 108.712 -174.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 193' ' ' PRO . . . . . 0.42 ' HD2' ' HB2' ' A' ' 192' ' ' GLN . 13.2 Cg_endo -57.52 132.21 49.14 Favored 'Trans proline' 0 N--CA 1.448 -1.153 0 C-N-CA 121.504 1.47 . . . . 73.04 111.638 176.562 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -141.03 146.33 17.52 Favored Glycine 0 N--CA 1.408 -3.191 0 N-CA-C 108.244 -1.942 . . . . 72.25 108.244 177.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.542 HG12 HG21 ' A' ' 234' ' ' VAL . 2.6 mp -104.32 133.03 49.52 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.413 0 C-N-CA 120.165 -0.614 . . . . 64.04 111.189 -178.405 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -122.96 167.49 13.52 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 108.085 -1.08 . . . . 74.53 108.085 -176.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' ILE . . . . . 0.403 ' CG2' ' HA ' ' A' ' 214' ' ' VAL . 41.3 mm -77.62 132.95 31.61 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 N-CA-C 108.527 -0.916 . . . . 73.24 108.527 177.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 198' ' ' SER . . . . . 0.501 ' HB2' ' HG2' ' A' ' 177' ' ' ARG . 11.1 t -104.14 -36.51 7.66 Favored 'General case' 0 C--N 1.275 -2.646 0 O-C-N 121.731 -0.605 . . . . 75.42 112.488 178.039 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 20.1 tpp180 -167.15 144.52 4.67 Favored 'General case' 0 C--O 1.213 -0.855 0 N-CA-C 110.136 -0.32 . . . . 71.25 110.136 -177.442 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 78.8 mt -101.89 145.43 29.23 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 108.514 -0.921 . . . . 73.33 108.514 171.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 61.9 t -105.19 114.0 63.98 Favored Pre-proline 0 N--CA 1.42 -1.971 0 N-CA-C 105.972 -1.862 . . . . 45.55 105.972 172.399 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.47 ' HA ' ' HG3' ' A' ' 207' ' ' GLU . 27.7 Cg_exo -62.01 136.87 63.59 Favored 'Trans proline' 0 N--CA 1.446 -1.293 0 C-N-CA 121.802 1.668 . . . . 72.44 110.268 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 104.12 -26.34 23.32 Favored Glycine 0 C--N 1.298 -1.581 0 N-CA-C 110.087 -1.205 . . . . 75.21 110.087 -175.177 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 204' ' ' GLY . . . . . 0.495 ' HA3' ' HA3' ' A' ' 173' ' ' GLY . . . -79.72 162.74 47.34 Favored Glycine 0 N--CA 1.423 -2.198 0 N-CA-C 111.031 -0.828 . . . . 62.31 111.031 178.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.456 HD22 ' H ' ' A' ' 205' ' ' LEU . 2.6 mm? -62.94 -29.57 70.89 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.372 0.669 . . . . 74.52 111.847 -173.69 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -63.6 -46.94 83.5 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.19 0.519 . . . . 72.33 110.289 177.086 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.47 ' HG3' ' HA ' ' A' ' 202' ' ' PRO . 3.9 tm-20 -71.51 -33.65 69.4 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.26 -0.427 . . . . 55.23 109.929 178.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 50.5 m -56.39 -39.25 72.68 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.186 -0.461 . . . . 74.24 111.159 177.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 13.0 t -83.91 -40.57 18.4 Favored 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 119.197 -1.001 . . . . 65.0 109.832 176.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 65.71 2.5 11.82 Favored Glycine 0 C--N 1.343 0.966 0 N-CA-C 114.183 0.433 . . . . 62.53 114.183 177.139 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 60.9 mt -78.88 -12.3 60.03 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-O 120.969 0.414 . . . . 75.25 110.708 -177.413 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.535 ' H ' HD23 ' A' ' 212' ' ' LEU . 2.2 pt? -109.86 134.88 51.57 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.329 -0.989 . . . . 74.55 108.329 174.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -117.41 162.11 18.46 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 116.624 -0.262 . . . . 41.34 110.306 -178.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 214' ' ' VAL . . . . . 0.403 ' HA ' ' CG2' ' A' ' 197' ' ' ILE . 35.6 m -56.64 -31.52 34.87 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.77 0 N-CA-C 114.471 1.286 . . . . 64.05 114.471 -176.569 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -82.72 -14.26 54.88 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 112.773 0.657 . . . . 72.42 112.773 -178.2 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.53 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 54.3 m-20 -69.01 156.13 39.15 Favored 'General case' 0 C--O 1.246 0.904 0 N-CA-C 113.266 0.839 . . . . 55.33 113.266 -173.123 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -107.4 137.07 46.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.933 -1.03 . . . . 63.1 110.246 -179.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.599 ' HA ' HG12 ' A' ' 249' ' ' VAL . 30.9 t -84.53 125.74 40.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 121.464 0.649 . . . . 64.33 109.975 -179.32 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.564 HG13 ' NE2' ' A' ' 158' ' ' HIS . 40.1 mm -90.23 -49.99 13.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 CA-C-N 115.167 -0.924 . . . . 75.42 110.607 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.414 ' CB ' ' HA ' ' A' ' 225' ' ' GLU . 9.3 pt-20 -154.59 160.93 41.78 Favored 'General case' 0 C--O 1.249 1.062 0 CA-C-N 116.313 -0.403 . . . . 71.42 110.438 -179.592 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.484 HG22 HD22 ' A' ' 241' ' ' ASN . 8.4 p -121.49 113.57 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.215 0 CA-C-O 122.109 0.957 . . . . 75.42 108.968 174.606 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 222' ' ' ASN . . . . . 0.453 ' OD1' HD12 ' A' ' 246' ' ' ILE . 60.0 t30 40.74 68.37 0.42 Allowed 'General case' 0 C--N 1.28 -2.421 0 C-N-CA 127.103 2.161 . . . . 73.4 114.497 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 84.35 -20.85 11.92 Favored Glycine 0 N--CA 1.443 -0.848 0 CA-C-N 114.93 -1.032 . . . . 73.35 113.738 178.119 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 54.6 mt -105.92 123.41 60.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 117.034 0.417 . . . . 61.32 110.011 -176.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 225' ' ' GLU . . . . . 0.414 ' HA ' ' CB ' ' A' ' 220' ' ' GLU . 11.8 pt-20 -66.03 144.14 56.92 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.352 0.596 . . . . 55.34 111.564 -178.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 33.9 m -115.19 -2.24 10.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-N 115.923 -0.58 . . . . 75.51 111.186 178.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -73.92 98.88 3.11 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.933 -0.576 . . . . 74.31 110.058 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 120.59 -17.07 9.59 Favored Glycine 0 CA--C 1.498 -0.988 0 N-CA-C 111.45 -0.66 . . . . 71.42 111.45 179.111 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -78.98 162.87 25.66 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 108.737 -0.838 . . . . 64.45 108.737 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 230' ' ' THR . . . . . 0.409 ' O ' HG13 ' A' ' 234' ' ' VAL . 68.2 p -87.34 170.63 11.24 Favored 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 107.599 -1.26 . . . . 62.42 107.599 177.462 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.401 HD12 ' OD1' ' A' ' 178' ' ' ASP . 0.7 OUTLIER -68.08 -34.46 76.45 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 107.347 -1.353 . . . . 74.11 107.347 179.976 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -58.54 -47.41 84.3 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-N 115.734 -0.666 . . . . 62.23 110.075 176.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -64.6 -49.05 72.63 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 113.902 1.075 . . . . 73.15 113.902 178.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.542 HG21 HG12 ' A' ' 195' ' ' ILE . 17.0 m -61.6 -33.47 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 112.581 0.585 . . . . 64.02 112.581 -176.399 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 235' ' ' THR . . . . . 0.49 ' O ' HG23 ' A' ' 239' ' ' VAL . 58.3 m -70.03 -35.84 74.61 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 115.803 -0.635 . . . . 74.23 109.887 -175.011 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -64.93 -30.94 71.96 Favored 'General case' 0 CA--C 1.508 -0.65 0 N-CA-C 108.86 -0.793 . . . . 35.51 108.86 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 237' ' ' MET . . . . . 0.437 ' HB2' HG11 ' A' ' 221' ' ' VAL . 5.7 mtm -74.36 -37.54 63.46 Favored 'General case' 0 C--O 1.199 -1.567 0 N-CA-C 108.259 -1.015 . . . . 72.11 108.259 -179.257 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 238' ' ' MET . . . . . 0.409 ' SD ' HD13 ' A' ' 176' ' ' ILE . 65.5 mtt -69.57 -34.66 74.49 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.212 -0.449 . . . . 64.31 110.998 178.169 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 235' ' ' THR . 99.0 t -67.04 -39.98 84.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.197 0.523 . . . . 71.52 110.222 176.686 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -68.29 -42.92 78.81 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.54 0.686 . . . . 75.24 109.325 176.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 241' ' ' ASN . . . . . 0.484 HD22 HG22 ' A' ' 221' ' ' VAL . 91.6 m-20 -79.69 18.13 0.81 Allowed 'General case' 0 C--O 1.192 -1.948 0 CA-C-N 115.025 -0.989 . . . . 73.21 112.237 178.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 70.3 m -68.26 -22.55 64.75 Favored 'General case' 0 N--CA 1.478 0.967 0 O-C-N 121.584 -0.698 . . . . 64.22 111.923 178.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 37.8 p -65.5 -22.48 66.73 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 116.275 -0.42 . . . . 73.15 110.727 176.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 178.05 101.12 0.02 OUTLIER 'General case' 0 CA--C 1.503 -0.834 0 C-N-CA 125.578 1.551 . . . . 74.22 107.63 176.239 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.546 ' CD2' HG13 ' A' ' 247' ' ' ILE . 3.3 tt -90.01 106.52 18.53 Favored 'General case' 0 N--CA 1.414 -2.234 0 CA-C-N 115.515 -0.766 . . . . 54.41 110.203 -171.594 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.535 ' HA ' ' O ' ' A' ' 161' ' ' VAL . 62.9 mt -95.32 127.92 46.92 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.068 0 N-CA-C 109.115 -0.698 . . . . 72.24 109.115 176.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 247' ' ' ILE . . . . . 0.546 HG13 ' CD2' ' A' ' 245' ' ' LEU . 12.8 mt -132.16 142.54 42.53 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 CA-C-O 121.367 0.603 . . . . 71.44 112.26 176.289 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.548 ' HA ' ' O ' ' A' ' 159' ' ' ARG . 61.5 m -110.49 117.43 33.53 Favored 'General case' 0 N--CA 1.418 -2.058 0 N-CA-C 107.932 -1.136 . . . . 74.12 107.932 173.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.599 HG12 ' HA ' ' A' ' 218' ' ' VAL . 27.0 m -120.78 162.41 19.53 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 N-CA-C 109.322 -0.622 . . . . 54.13 109.322 175.396 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 15.8 ptmt -134.01 133.56 22.19 Favored Pre-proline 0 C--N 1.284 -2.24 0 CA-C-N 115.198 -0.91 . . . . 71.33 108.803 175.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 251' ' ' PRO . . . . . 0.53 ' HA ' ' OD1' ' A' ' 216' ' ' ASP . 61.1 Cg_exo -56.32 133.68 59.53 Favored 'Trans proline' 0 N--CA 1.443 -1.488 0 C-N-CA 122.115 1.877 . . . . 71.33 110.527 173.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -74.14 -7.31 52.14 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.834 0.826 . . . . 61.21 110.116 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -93.31 -4.9 50.86 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 114.508 -1.224 . . . . 55.1 109.196 178.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 58.37 90.8 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.533 0.733 . . . . 73.15 112.493 -176.045 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 255' ' ' ARG . . . . . 0.489 ' OXT' ' HB2' ' A' ' 156' ' ' GLU . 42.0 ttm180 . . . . . 0 C--N 1.301 -1.516 0 N-CA-C 108.76 -0.83 . . . . 54.14 108.76 179.39 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 . . . . . 0 N--CA 1.443 -0.803 0 N-CA-C 109.106 -0.701 . . . . 72.42 109.106 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.579 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 18.0 p -80.69 -27.3 37.06 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 121.259 0.552 . . . . 65.21 111.357 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.683 ' NE2' HG13 ' A' ' 219' ' ' ILE . 9.5 m80 -126.4 130.09 50.05 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 116.124 -0.489 . . . . 74.13 110.638 171.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.525 ' O ' ' HA ' ' A' ' 248' ' ' THR . 18.3 tpt180 -139.34 133.12 30.72 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 110.303 -0.258 . . . . 75.1 110.303 178.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.469 ' HB3' ' OG1' ' A' ' 248' ' ' THR . 4.6 ptp180 -117.6 118.63 32.65 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-O 121.756 0.789 . . . . 73.33 110.519 175.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.461 ' CG1' HD21 ' A' ' 211' ' ' LEU . 16.2 m -111.4 139.43 35.53 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.086 0 CA-C-N 114.914 -1.039 . . . . 73.34 111.338 -178.11 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.783 ' HG3' HG12 ' A' ' 246' ' ' ILE . 7.6 mpt_? -92.66 111.5 23.12 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 107.568 -1.271 . . . . 74.42 107.568 176.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.597 ' HB2' ' HB2' ' A' ' 245' ' ' LEU . 21.2 mt -91.28 137.03 32.68 Favored 'General case' 0 N--CA 1.416 -2.151 0 N-CA-C 108.38 -0.97 . . . . 60.34 108.38 -179.615 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.587 ' HG ' ' CD1' ' A' ' 172' ' ' LEU 0.391 10.8 mt 85.56 95.06 0.03 OUTLIER 'General case' 0 CA--C 1.476 -1.873 0 N-CA-C 115.305 1.595 . . . . 73.24 115.305 -175.054 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -139.08 14.65 2.64 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 113.508 -1.678 . . . . 71.22 108.211 177.086 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 24.5 t-80 -131.75 30.16 4.39 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 106.971 -1.492 . . . . 51.42 106.971 -179.322 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' GLY . . . . . 0.454 ' HA3' ' HD3' ' A' ' 170' ' ' LYS . . . 142.3 -167.19 26.19 Favored Glycine 0 N--CA 1.397 -3.93 0 N-CA-C 108.445 -1.862 . . . . 62.33 108.445 -179.285 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' SER . . . . . 0.514 ' HA ' HD13 ' A' ' 164' ' ' LEU . 30.0 p -154.82 143.5 20.7 Favored 'General case' 0 C--N 1.283 -2.299 0 CA-C-O 118.945 -0.55 . . . . 62.13 109.613 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 25.4 t70 77.69 0.78 2.87 Favored 'General case' 0 N--CA 1.506 2.343 0 C-N-CA 124.196 0.998 . . . . 75.43 111.022 -178.627 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.454 ' HD3' ' HA3' ' A' ' 167' ' ' GLY . 57.2 mtpt -89.74 153.99 47.86 Favored Pre-proline 0 C--N 1.304 -1.413 0 C-N-CA 124.221 1.009 . . . . 73.42 110.593 -176.502 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -57.24 135.16 68.66 Favored 'Trans proline' 0 C--O 1.242 0.709 0 C-N-CA 122.927 2.418 . . . . 63.43 111.309 175.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.587 ' CD1' ' HG ' ' A' ' 164' ' ' LEU . 2.6 mm? -86.73 -34.97 19.49 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.081 0.467 . . . . 64.32 111.282 -175.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 101.77 45.47 1.77 Allowed Glycine 0 N--CA 1.419 -2.448 0 CA-C-N 115.469 -0.787 . . . . 73.34 112.75 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -156.94 154.47 29.75 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.499 -0.926 . . . . 73.13 108.499 175.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -124.34 144.95 49.72 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 108.971 -0.751 . . . . 72.43 108.971 175.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.61 HD13 ' H ' ' A' ' 176' ' ' ILE . 0.2 OUTLIER -110.67 169.81 3.67 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.238 0 N-CA-C 108.935 -0.765 . . . . 71.32 108.935 177.727 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.578 ' HB3' ' HB2' ' A' ' 198' ' ' SER . 16.4 ptt180 -149.43 154.49 38.95 Favored 'General case' 0 C--N 1.269 -2.921 0 CA-C-N 115.189 -0.914 . . . . 65.31 109.83 -178.069 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -111.98 138.2 48.95 Favored 'General case' 0 C--N 1.28 -2.434 0 N-CA-C 108.786 -0.82 . . . . 64.21 108.786 178.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -150.64 -175.4 22.6 Favored Glycine 0 C--N 1.285 -2.269 0 N-CA-C 108.469 -1.853 . . . . 52.42 108.469 178.31 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' THR . . . . . 0.603 ' CG2' ' HG2' ' A' ' 191' ' ' LYS . 0.2 OUTLIER -102.01 123.17 45.44 Favored 'General case' 0 N--CA 1.415 -2.181 0 C-N-CA 118.725 -1.19 . . . . 64.32 108.087 178.078 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 181' ' ' SER . . . . . 0.466 ' O ' ' HA ' ' A' ' 191' ' ' LYS . 37.5 t -96.82 125.95 41.63 Favored 'General case' 0 C--N 1.28 -2.423 0 N-CA-C 108.439 -0.949 . . . . 61.1 108.439 -178.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.709 ' HA ' ' O ' ' A' ' 190' ' ' GLU . 5.9 p -120.01 121.72 66.65 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.769 0 CA-C-O 121.461 0.648 . . . . 65.13 109.872 174.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -122.75 160.84 25.1 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 107.654 -1.239 . . . . 74.51 107.654 -178.312 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.497 ' HA ' ' O ' ' A' ' 188' ' ' GLY . 70.5 t -84.74 119.23 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.25 0 N-CA-C 107.489 -1.3 . . . . 63.52 107.489 169.155 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 42.4 p -115.03 -174.63 2.53 Favored 'General case' 0 C--N 1.264 -3.151 0 CA-C-N 114.565 -1.198 . . . . 74.41 108.073 -178.199 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -70.96 -9.8 58.57 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 120.979 0.419 . . . . 73.33 110.495 176.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 9.1 m -92.68 -19.34 21.94 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 109.043 -0.725 . . . . 65.13 109.043 178.047 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.497 ' O ' ' HA ' ' A' ' 184' ' ' VAL . . . 122.65 -120.23 4.22 Favored Glycine 0 C--O 1.197 -2.178 0 N-CA-C 107.981 -2.048 . . . . 54.33 107.981 -175.742 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 6.0 mp -101.24 128.29 47.44 Favored 'General case' 0 C--N 1.285 -2.224 0 CA-C-N 118.02 0.91 . . . . 73.01 109.591 175.374 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' GLU . . . . . 0.709 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 33.7 mt-10 -128.07 119.39 25.28 Favored 'General case' 0 CA--C 1.458 -2.562 0 CA-C-O 121.001 0.429 . . . . 72.02 110.974 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.603 ' HG2' ' CG2' ' A' ' 180' ' ' THR . 34.2 ttmt -104.14 126.37 51.2 Favored 'General case' 0 C--N 1.274 -2.695 0 CA-C-N 114.247 -1.342 . . . . 75.01 107.395 -179.525 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -151.54 161.22 30.24 Favored Pre-proline 0 C--N 1.298 -1.661 0 CA-C-N 115.861 -0.608 . . . . 73.2 109.588 -171.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -58.77 132.68 49.25 Favored 'Trans proline' 0 C--O 1.244 0.825 0 C-N-CA 121.472 1.448 . . . . 71.54 110.991 177.254 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -147.1 144.63 12.81 Favored Glycine 0 N--CA 1.419 -2.473 0 N-CA-C 109.987 -1.245 . . . . 72.42 109.987 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.573 HG12 HG21 ' A' ' 234' ' ' VAL . 3.0 mp -105.61 134.08 48.14 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 CA-C-O 121.338 0.589 . . . . 65.02 110.683 -178.759 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -128.25 168.5 15.4 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.191 -1.04 . . . . 65.14 108.191 -176.473 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 197' ' ' ILE . . . . . 0.476 ' HB ' ' HA ' ' A' ' 214' ' ' VAL . 43.3 mm -76.75 131.88 33.99 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 N-CA-C 108.131 -1.062 . . . . 72.43 108.131 176.684 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 198' ' ' SER . . . . . 0.578 ' HB2' ' HB3' ' A' ' 177' ' ' ARG . 13.0 t -103.96 -33.8 8.7 Favored 'General case' 0 C--N 1.284 -2.26 0 N-CA-C 113.181 0.808 . . . . 71.34 113.181 -178.734 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 15.0 ttp180 -168.17 142.77 3.49 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 116.621 -0.263 . . . . 73.32 111.025 -177.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 66.1 mt -103.71 137.06 42.28 Favored 'General case' 0 CA--C 1.486 -1.481 0 N-CA-C 108.162 -1.051 . . . . 71.43 108.162 172.702 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 66.6 t -93.44 114.5 63.07 Favored Pre-proline 0 C--N 1.288 -2.103 0 N-CA-C 105.733 -1.951 . . . . 71.24 105.733 174.107 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.522 ' HA ' ' HG2' ' A' ' 207' ' ' GLU . 38.2 Cg_endo -70.37 126.23 12.69 Favored 'Trans proline' 0 N--CA 1.429 -2.308 0 C-N-CA 120.915 1.077 . . . . 72.44 110.201 -176.353 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 113.59 -12.98 23.02 Favored Glycine 0 C--N 1.302 -1.356 0 N-CA-C 109.787 -1.325 . . . . 64.42 109.787 -173.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -90.48 168.65 33.58 Favored Glycine 0 N--CA 1.436 -1.356 0 N-CA-C 110.15 -1.18 . . . . 73.03 110.15 176.193 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.542 HD12 ' H ' ' A' ' 164' ' ' LEU . 66.0 mt -65.39 -29.56 70.28 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 117.41 0.605 . . . . 63.41 111.498 -177.629 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -61.93 -48.1 81.93 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.878 -0.601 . . . . 52.23 110.768 178.137 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.522 ' HG2' ' HA ' ' A' ' 202' ' ' PRO . 10.4 tp10 -73.04 -32.6 65.18 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.445 -0.576 . . . . 73.45 109.445 178.097 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 23.0 t -56.98 -40.33 76.33 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 115.91 -0.586 . . . . 63.14 110.45 178.608 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 209' ' ' THR . . . . . 0.533 HG23 ' H ' ' A' ' 211' ' ' LEU . 14.9 t -79.29 -40.27 30.86 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 119.089 -1.044 . . . . 74.21 108.752 175.163 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 58.58 31.3 66.78 Favored Glycine 0 C--N 1.347 1.189 0 CA-C-N 115.888 -0.596 . . . . 71.14 113.139 178.043 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.533 ' H ' HG23 ' A' ' 209' ' ' THR . 1.8 pp -102.21 -19.33 15.11 Favored 'General case' 0 N--CA 1.424 -1.732 0 C-N-CA 120.297 -0.561 . . . . 61.3 110.692 -179.232 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.495 ' H ' HD23 ' A' ' 212' ' ' LEU . 2.1 pt? -109.39 134.28 52.03 Favored 'General case' 0 N--CA 1.432 -1.362 0 N-CA-C 107.857 -1.164 . . . . 73.14 107.857 -179.442 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -129.8 165.92 20.98 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 116.474 -0.33 . . . . 61.51 110.566 -176.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 214' ' ' VAL . . . . . 0.476 ' HA ' ' HB ' ' A' ' 197' ' ' ILE . 17.4 m -53.92 -30.41 19.53 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 N-CA-C 114.195 1.183 . . . . 71.11 114.195 -176.012 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 -78.02 -15.36 59.0 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.823 -0.548 . . . . 75.32 112.24 -178.376 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.708 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 58.5 m-20 -79.34 155.92 28.24 Favored 'General case' 0 C--O 1.248 0.995 0 CA-C-O 121.079 0.466 . . . . 72.42 112.076 -174.08 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -109.58 139.43 44.6 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.333 -0.849 . . . . 61.11 111.872 -176.192 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.565 ' HA ' HG12 ' A' ' 249' ' ' VAL . 25.1 t -88.03 120.16 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 CA-C-O 121.349 0.595 . . . . 75.31 109.58 -179.103 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.683 HG13 ' NE2' ' A' ' 158' ' ' HIS . 38.8 mm -89.9 -53.97 8.36 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 CA-C-N 115.257 -0.883 . . . . 74.51 112.302 -176.635 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -155.27 151.98 28.7 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 116.742 -0.208 . . . . 62.35 111.534 -175.513 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.431 HG12 ' CG1' ' A' ' 226' ' ' VAL . 9.1 p -121.78 123.22 68.81 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 CA-C-O 121.293 0.568 . . . . 64.35 109.786 176.057 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 222' ' ' ASN . . . . . 0.48 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 9.0 t-20 66.69 7.58 5.28 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 125.487 1.515 . . . . 71.1 111.221 177.706 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 113.3 -7.17 24.88 Favored Glycine 0 N--CA 1.44 -1.036 0 CA-C-N 115.677 -0.692 . . . . 51.45 112.273 -177.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 66.3 mt -101.4 123.9 54.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 109.423 -0.584 . . . . 62.24 109.423 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -59.7 134.49 57.07 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-O 121.644 0.735 . . . . 75.54 111.932 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 226' ' ' VAL . . . . . 0.494 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 27.6 m -117.82 2.76 7.44 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 CA-C-N 115.158 -0.928 . . . . 74.44 110.047 177.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -83.57 98.77 9.76 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-N 115.332 -0.849 . . . . 70.22 109.38 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 120.35 -16.15 9.9 Favored Glycine 0 CA--C 1.489 -1.543 0 N-CA-C 111.283 -0.727 . . . . 74.54 111.283 -178.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -77.54 172.64 13.05 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 109.45 -0.574 . . . . 62.32 109.45 178.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 36.7 p -92.78 165.11 13.09 Favored 'General case' 0 N--CA 1.422 -1.841 0 N-CA-C 108.143 -1.058 . . . . 71.23 108.143 178.046 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 51.9 tp -61.16 -37.44 82.89 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 120.895 -0.322 . . . . 74.01 110.772 -177.684 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -57.76 -51.37 69.82 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 109.989 -0.375 . . . . 72.42 109.989 176.259 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -54.56 -48.55 71.93 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 115.676 -0.693 . . . . 72.4 112.508 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.573 HG21 HG12 ' A' ' 195' ' ' ILE . 7.1 m -75.27 -34.84 31.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 112.257 0.465 . . . . 64.02 112.257 -174.193 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 31.2 m -75.0 -35.6 61.99 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 108.905 -0.776 . . . . 63.31 108.905 -175.147 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -59.11 -33.49 70.91 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.119 -0.946 . . . . 71.24 109.415 176.668 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 237' ' ' MET . . . . . 0.409 ' HG3' ' HA ' ' A' ' 234' ' ' VAL . 5.8 mtt -73.56 -44.61 56.97 Favored 'General case' 0 C--O 1.2 -1.526 0 N-CA-C 107.91 -1.144 . . . . 65.33 107.91 178.548 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 238' ' ' MET . . . . . 0.474 ' HA ' HD21 ' A' ' 245' ' ' LEU . 64.9 mtt -59.98 -41.65 92.46 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.36 -0.382 . . . . 72.23 111.943 -177.402 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 92.6 t -65.04 -38.71 83.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.227 0.536 . . . . 70.24 110.105 176.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -76.02 -19.9 58.27 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.355 0.598 . . . . 71.32 111.482 -179.327 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 -107.89 22.18 16.33 Favored 'General case' 0 C--O 1.205 -1.252 0 CA-C-N 115.94 -0.573 . . . . 52.31 110.471 177.489 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 22.8 t -63.44 -22.79 67.09 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.649 0.738 . . . . 75.04 109.141 177.503 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 16.1 p -69.56 -32.14 70.75 Favored 'General case' 0 N--CA 1.428 -1.569 0 CA-C-N 115.651 -0.704 . . . . 71.31 111.373 174.564 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -165.9 99.48 0.66 Allowed 'General case' 0 C--O 1.24 0.579 0 CA-C-O 121.749 0.785 . . . . 60.53 110.82 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.597 ' HB2' ' HB2' ' A' ' 163' ' ' LEU . 10.3 mt -91.46 105.18 17.57 Favored 'General case' 0 C--O 1.195 -1.786 0 N-CA-C 113.085 0.772 . . . . 73.24 113.085 -178.264 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.783 HG12 ' HG3' ' A' ' 162' ' ' ARG . 96.6 mt -95.51 114.12 31.44 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.432 0 N-CA-C 106.692 -1.596 . . . . 62.14 106.692 168.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 247' ' ' ILE . . . . . 0.464 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 76.9 mt -122.35 127.14 75.04 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.125 0 C-N-CA 120.436 -0.506 . . . . 53.44 111.153 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.525 ' HA ' ' O ' ' A' ' 159' ' ' ARG . 63.3 m -99.53 118.18 35.55 Favored 'General case' 0 N--CA 1.418 -2.05 0 CA-C-N 114.832 -1.076 . . . . 72.41 108.688 177.679 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.565 HG12 ' HA ' ' A' ' 218' ' ' VAL . 27.3 m -119.29 161.93 18.0 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 N-CA-C 108.974 -0.75 . . . . 70.43 108.974 174.214 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 17.4 ptmt -127.75 130.86 23.6 Favored Pre-proline 0 C--N 1.276 -2.616 0 CA-C-N 115.309 -0.86 . . . . 74.32 108.893 176.307 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 251' ' ' PRO . . . . . 0.708 ' HA ' ' OD1' ' A' ' 216' ' ' ASP . 29.0 Cg_endo -62.45 149.63 90.22 Favored 'Trans proline' 0 N--CA 1.445 -1.341 0 C-N-CA 122.676 2.251 . . . . 75.01 112.394 177.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -49.12 -38.13 23.96 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.267 -0.879 . . . . 75.12 111.369 178.197 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -136.15 -60.14 0.73 Allowed 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 115.798 -0.637 . . . . 53.53 111.151 174.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -153.83 161.15 42.29 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 117.565 0.166 . . . . 70.11 110.912 178.415 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 30.0 tpt180 . . . . . 0 C--O 1.245 0.828 0 N-CA-C 107.994 -1.113 . . . . 75.43 107.994 177.828 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 . . . . . 0 CA--C 1.517 -0.322 0 N-CA-C 109.463 -0.569 . . . . 72.13 109.463 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 57.9 p 38.28 -102.17 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 115.145 1.535 . . . . 64.13 115.145 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.734 ' HB3' ' HB3' ' A' ' 250' ' ' LYS . 4.4 p-80 -126.09 153.62 44.24 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.49 0.552 . . . . 70.41 112.49 179.381 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 36.6 ttm180 -125.58 143.7 50.9 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.581 -0.282 . . . . 75.14 110.407 -179.34 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 35.1 ptt180 -104.05 117.22 33.75 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.611 0.719 . . . . 72.44 111.783 179.04 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 30.3 m -114.93 139.93 38.64 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 CA-C-N 115.497 -0.774 . . . . 73.23 111.894 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 21.1 ttm180 -102.53 121.4 42.3 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 109.168 -0.679 . . . . 74.51 109.168 179.152 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.428 ' HB2' ' HB3' ' A' ' 245' ' ' LEU . 26.8 mt -103.08 139.68 38.29 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 123.347 0.659 . . . . 75.13 111.657 -174.431 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.565 HD13 ' O ' ' A' ' 242' ' ' SER . 6.0 tt 84.81 91.62 0.03 OUTLIER 'General case' 0 CA--C 1.512 -0.503 0 C-N-CA 125.913 1.685 . . . . 73.41 112.216 171.247 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 60.8 pttt -102.23 -16.98 16.15 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.203 -0.908 . . . . 74.15 109.253 173.481 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 37.3 m80 -150.08 150.95 32.45 Favored 'General case' 0 CA--C 1.499 -1.011 0 CA-C-N 115.246 -0.888 . . . . 63.12 109.092 176.226 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 86.25 55.63 2.45 Favored Glycine 0 N--CA 1.437 -1.295 0 C-N-CA 120.735 -0.745 . . . . 64.2 112.913 176.317 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' SER . . . . . 0.557 ' HA ' HD11 ' A' ' 164' ' ' LEU . 33.9 t -79.37 2.69 20.7 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.322 0.582 . . . . 60.41 110.254 179.566 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -88.92 -19.71 25.45 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.586 -0.734 . . . . 70.13 111.238 178.22 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.402 ' HD2' ' O ' ' A' ' 170' ' ' LYS . 0.0 OUTLIER -118.74 153.67 52.45 Favored Pre-proline 0 N--CA 1.429 -1.514 0 N-CA-C 112.067 0.395 . . . . 43.01 112.067 -175.029 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -63.21 153.21 75.57 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 122.951 2.434 . . . . 71.01 111.304 176.003 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.431 HD22 ' H ' ' A' ' 172' ' ' LEU . 2.3 mm? -58.39 -36.63 73.83 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 124.345 1.058 . . . . 74.01 112.459 -175.181 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 103.69 36.12 3.34 Favored Glycine 0 N--CA 1.424 -2.121 0 C-N-CA 120.174 -1.012 . . . . 63.41 112.533 178.236 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -147.48 153.84 40.04 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 108.661 -0.866 . . . . 74.43 108.661 174.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -123.77 155.41 37.97 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 108.183 -1.043 . . . . 75.03 108.183 177.294 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.446 HD13 ' SD ' ' A' ' 238' ' ' MET . 27.3 pt -125.18 169.5 16.48 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 CA-C-O 120.909 0.385 . . . . 74.25 111.329 -176.119 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.513 ' HG2' ' HB3' ' A' ' 198' ' ' SER . 1.1 ptp180 -148.91 154.15 39.02 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 123.332 0.653 . . . . 74.1 110.891 -179.157 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -103.38 138.84 39.58 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 109.065 -0.717 . . . . 62.04 109.065 176.411 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -154.38 -168.27 17.58 Favored Glycine 0 N--CA 1.416 -2.661 0 N-CA-C 109.197 -1.561 . . . . 73.31 109.197 177.473 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' THR . . . . . 0.549 ' HB ' ' CG ' ' A' ' 191' ' ' LYS . 1.0 OUTLIER -101.16 125.48 47.79 Favored 'General case' 0 C--N 1.276 -2.618 0 CA-C-O 121.14 0.495 . . . . 73.12 111.698 176.415 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 36.9 t -110.1 124.29 51.24 Favored 'General case' 0 N--CA 1.41 -2.463 0 N-CA-C 107.255 -1.387 . . . . 53.12 107.255 176.394 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.552 ' HA ' ' O ' ' A' ' 190' ' ' GLU . 5.2 p -120.39 127.97 75.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 CA-C-O 121.343 0.592 . . . . 73.52 110.176 177.763 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -126.09 159.47 32.74 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 115.291 -0.868 . . . . 72.03 109.153 -176.686 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.506 ' HA ' ' O ' ' A' ' 188' ' ' GLY . 71.1 t -89.77 118.29 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.193 0 N-CA-C 107.634 -1.247 . . . . 73.12 107.634 171.234 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 43.1 p -120.38 -174.9 2.89 Favored 'General case' 0 C--N 1.266 -3.024 0 CA-C-N 114.196 -1.366 . . . . 45.41 108.617 -177.15 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -62.67 -22.22 66.31 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-O 121.074 0.464 . . . . 62.22 109.838 175.025 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 16.6 m -86.4 -17.13 35.17 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-N 115.789 -0.641 . . . . 54.34 110.783 179.494 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.506 ' O ' ' HA ' ' A' ' 184' ' ' VAL . . . 115.77 -127.61 7.64 Favored Glycine 0 CA--C 1.482 -2.024 0 N-CA-C 108.606 -1.798 . . . . 75.15 108.606 -178.39 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 6.0 mp -98.49 123.43 42.64 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 108.775 -0.824 . . . . 63.22 108.775 176.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' GLU . . . . . 0.552 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 36.6 tt0 -129.21 119.05 23.38 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.38 -0.97 . . . . 60.02 108.38 -177.729 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.549 ' CG ' ' HB ' ' A' ' 180' ' ' THR . 35.4 ttmt -100.63 121.92 42.43 Favored 'General case' 0 N--CA 1.425 -1.71 0 N-CA-C 107.972 -1.121 . . . . 71.34 107.972 -178.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 27.4 pt20 -130.75 164.15 43.74 Favored Pre-proline 0 C--N 1.284 -2.261 0 CA-C-N 115.473 -0.785 . . . . 72.43 109.336 -172.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -61.69 132.31 39.63 Favored 'Trans proline' 0 N--CA 1.447 -1.221 0 C-N-CA 121.108 1.205 . . . . 54.2 109.135 172.011 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -139.82 138.77 9.4 Favored Glycine 0 N--CA 1.415 -2.725 0 N-CA-C 110.085 -1.206 . . . . 40.24 110.085 -178.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.548 HG12 HG21 ' A' ' 234' ' ' VAL . 3.4 mp -103.8 128.26 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.127 0 CA-C-O 121.418 0.628 . . . . 72.3 110.929 -179.101 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -121.75 167.12 13.34 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 107.57 -1.27 . . . . 73.3 107.57 -177.6 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 197' ' ' ILE . . . . . 0.432 ' HB ' ' HA ' ' A' ' 214' ' ' VAL . 50.1 mm -77.58 130.32 36.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 107.515 -1.291 . . . . 71.34 107.515 175.286 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 198' ' ' SER . . . . . 0.513 ' HB3' ' HG2' ' A' ' 177' ' ' ARG . 81.4 p -103.49 -22.37 13.64 Favored 'General case' 0 C--N 1.291 -1.95 0 C-N-CA 119.624 -0.831 . . . . 54.23 111.538 -175.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 27.6 tpt180 -167.12 146.28 5.19 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.398 -0.593 . . . . 74.32 109.398 -176.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 69.7 mt -112.51 139.67 47.9 Favored 'General case' 0 CA--C 1.484 -1.571 0 N-CA-C 108.541 -0.911 . . . . 75.23 108.541 172.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 53.2 t -95.8 114.92 65.05 Favored Pre-proline 0 C--N 1.288 -2.07 0 N-CA-C 105.811 -1.922 . . . . 72.35 105.811 171.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.542 ' HA ' ' HG3' ' A' ' 207' ' ' GLU . 19.3 Cg_endo -62.3 126.81 19.38 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 121.938 1.758 . . . . 73.22 110.644 -177.748 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 103.38 -14.32 54.55 Favored Glycine 0 C--N 1.297 -1.587 0 C-N-CA 120.157 -1.021 . . . . 74.32 111.266 -175.541 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -81.93 162.24 42.6 Favored Glycine 0 N--CA 1.435 -1.422 0 N-CA-C 110.221 -1.152 . . . . 61.14 110.221 176.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.459 HD13 ' CA ' ' A' ' 164' ' ' LEU . 32.1 mt -53.9 -38.34 64.72 Favored 'General case' 0 C--N 1.309 -1.158 0 C-N-CA 124.737 1.215 . . . . 73.35 112.777 -175.095 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 206' ' ' ALA . . . . . 0.538 ' CB ' HD12 ' A' ' 212' ' ' LEU . . . -66.0 -43.73 86.86 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.538 0.685 . . . . 51.03 110.919 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.542 ' HG3' ' HA ' ' A' ' 202' ' ' PRO . 3.3 tm-20 -76.16 -35.93 58.96 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 115.255 -0.884 . . . . 64.11 109.619 -178.667 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 55.8 m -61.0 -41.46 96.57 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.474 -0.33 . . . . 53.33 111.572 178.329 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 209' ' ' THR . . . . . 0.457 HG23 ' H ' ' A' ' 211' ' ' LEU . 9.2 t -73.27 -33.21 65.13 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 119.489 -0.884 . . . . 61.43 109.253 176.257 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 70.14 10.91 66.36 Favored Glycine 0 CA--C 1.5 -0.886 0 CA-C-N 115.75 -0.659 . . . . 33.02 112.842 176.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.457 ' H ' HG23 ' A' ' 209' ' ' THR . 52.0 mt -95.42 -5.97 41.93 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.989 -0.745 . . . . 74.0 108.989 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.538 HD12 ' CB ' ' A' ' 206' ' ' ALA . 95.6 mt -109.49 131.21 55.28 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 107.817 -1.179 . . . . 60.04 107.817 174.313 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -133.63 166.11 23.35 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.216 -1.031 . . . . 41.23 108.216 176.294 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 214' ' ' VAL . . . . . 0.432 ' HA ' ' HB ' ' A' ' 197' ' ' ILE . 34.6 m -62.86 -31.3 51.9 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 N-CA-C 113.466 0.913 . . . . 71.03 113.466 -178.585 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 21.5 p-10 -72.37 -13.42 61.47 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.995 -0.441 . . . . 55.22 111.577 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.51 ' HB3' ' HB ' ' A' ' 249' ' ' VAL . 6.3 m-20 -73.78 131.09 41.19 Favored 'General case' 0 C--O 1.242 0.705 0 N-CA-C 113.516 0.932 . . . . 32.22 113.516 -176.55 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -103.72 132.26 50.13 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 113.827 -1.533 . . . . 61.32 109.676 -179.122 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.561 ' HA ' HG12 ' A' ' 249' ' ' VAL . 22.9 t -79.97 130.19 36.4 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 CA-C-O 121.433 0.635 . . . . 74.44 110.732 -176.771 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.452 HD11 ' HD3' ' A' ' 250' ' ' LYS . 38.8 mm -95.16 -50.3 11.85 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 C-N-CA 124.06 0.944 . . . . 65.22 110.122 178.85 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -154.41 154.22 32.88 Favored 'General case' 0 N--CA 1.433 -1.325 0 CA-C-N 115.446 -0.797 . . . . 72.11 110.695 -176.536 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.429 HG11 ' HB2' ' A' ' 237' ' ' MET . 7.5 p -124.18 121.2 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 N-CA-C 108.415 -0.958 . . . . 75.13 108.415 177.268 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 222' ' ' ASN . . . . . 0.563 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 8.6 t30 75.55 -24.34 0.22 Allowed 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 126.406 1.882 . . . . 71.13 111.774 -176.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 223' ' ' GLY . . . . . 0.427 ' H ' ' C ' ' A' ' 221' ' ' VAL . . . 140.43 -11.33 2.99 Favored Glycine 0 C--N 1.278 -2.654 0 N-CA-C 109.932 -1.267 . . . . 51.52 109.932 -174.287 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 67.4 mt -92.1 123.85 44.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 108.936 -0.764 . . . . 71.22 108.936 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -57.62 143.43 41.35 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 123.992 0.917 . . . . 74.32 112.006 -179.285 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 34.7 m -117.57 1.0 8.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 CA-C-N 115.667 -0.697 . . . . 75.23 110.92 176.275 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -78.12 97.34 5.41 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.86 -0.609 . . . . 73.13 110.224 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 120.41 -14.57 10.06 Favored Glycine 0 C--N 1.316 -0.532 0 N-CA-C 110.826 -0.91 . . . . 70.14 110.826 -179.153 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -79.8 170.13 16.95 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 108.333 -0.988 . . . . 72.33 108.333 177.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 230' ' ' THR . . . . . 0.517 ' O ' HG13 ' A' ' 234' ' ' VAL . 73.1 p -93.55 164.11 13.3 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 108.445 -0.946 . . . . 53.11 108.445 177.54 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.445 ' HA ' HG22 ' A' ' 234' ' ' VAL . 0.7 OUTLIER -63.07 -36.15 82.62 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 107.017 -1.475 . . . . 61.02 107.017 179.105 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -61.85 -45.82 92.14 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.286 -0.87 . . . . 63.12 109.945 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -61.94 -50.39 72.34 Favored 'General case' 0 C--N 1.344 0.341 0 N-CA-C 112.385 0.513 . . . . 74.31 112.385 175.724 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.548 HG21 HG12 ' A' ' 195' ' ' ILE . 12.2 m -62.08 -33.89 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 N-CA-C 112.749 0.648 . . . . 63.55 112.749 -173.865 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 235' ' ' THR . . . . . 0.484 ' O ' HG23 ' A' ' 239' ' ' VAL . 61.9 m -68.9 -39.05 79.93 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 109.394 -0.595 . . . . 55.13 109.394 -175.182 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -68.53 -30.43 69.22 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-N 115.614 -0.721 . . . . 72.44 109.793 -178.038 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 237' ' ' MET . . . . . 0.429 ' HB2' HG11 ' A' ' 221' ' ' VAL . 3.5 mtm -73.21 -36.47 66.49 Favored 'General case' 0 C--O 1.196 -1.728 0 N-CA-C 107.894 -1.15 . . . . 73.42 107.894 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 238' ' ' MET . . . . . 0.484 ' HG3' ' O ' ' A' ' 234' ' ' VAL . 65.5 mtt -63.11 -39.78 95.69 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 120.844 0.354 . . . . 74.0 110.133 177.268 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 235' ' ' THR . 79.0 t -66.34 -41.06 88.27 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 CA-C-N 116.096 -0.502 . . . . 54.22 109.682 176.363 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -66.01 -22.34 66.45 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.131 -0.486 . . . . 44.02 111.991 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 54.4 m-80 -105.12 21.93 16.24 Favored 'General case' 0 C--O 1.202 -1.426 0 CA-C-N 116.542 -0.299 . . . . 65.41 110.815 178.501 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 242' ' ' SER . . . . . 0.565 ' O ' HD13 ' A' ' 164' ' ' LEU . 46.5 t -56.36 -24.44 44.27 Favored 'General case' 0 C--O 1.213 -0.849 0 N-CA-C 113.68 0.992 . . . . 71.12 113.68 -179.088 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 29.1 m -78.59 -22.15 47.52 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 120.359 -0.537 . . . . 64.42 111.424 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -171.5 94.14 0.16 Allowed 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.726 1.211 . . . . 71.14 108.956 178.509 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.527 ' CD2' HG13 ' A' ' 247' ' ' ILE . 1.7 tt -90.77 109.24 20.44 Favored 'General case' 0 N--CA 1.419 -1.983 0 CA-C-N 114.618 -1.174 . . . . 61.53 110.071 -171.056 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.563 ' HB ' ' HA ' ' A' ' 222' ' ' ASN . 61.3 mt -95.76 117.13 39.2 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 N-CA-C 108.963 -0.755 . . . . 62.02 108.963 176.528 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 247' ' ' ILE . . . . . 0.527 HG13 ' CD2' ' A' ' 245' ' ' LEU . 9.3 mt -123.83 135.3 63.92 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.99 0 CA-C-O 121.819 0.818 . . . . 73.15 111.305 176.522 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 37.7 m -108.79 124.54 50.76 Favored 'General case' 0 N--CA 1.41 -2.441 0 CA-C-N 114.476 -1.238 . . . . 61.34 108.493 178.306 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.561 HG12 ' HA ' ' A' ' 218' ' ' VAL . 29.1 m -134.75 152.99 34.09 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-O 121.754 0.788 . . . . 74.43 112.18 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.734 ' HB3' ' HB3' ' A' ' 158' ' ' HIS . 1.1 ptmm? -128.79 132.6 24.46 Favored Pre-proline 0 C--N 1.293 -1.872 0 CA-C-N 113.938 -1.483 . . . . 73.35 109.203 172.517 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -61.78 150.44 85.89 Favored 'Trans proline' 0 N--CA 1.447 -1.25 0 C-N-CA 122.549 2.166 . . . . 73.44 110.713 176.297 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -46.71 -49.02 20.12 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-O 121.345 0.593 . . . . 64.23 110.901 177.146 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -96.59 79.85 3.06 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 107.928 -1.138 . . . . 64.24 107.928 176.231 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 254' ' ' GLN . . . . . 0.619 ' HG2' ' HE2' ' A' ' 250' ' ' LYS . 4.8 pp0? -97.56 153.52 18.12 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 112.951 0.722 . . . . 74.4 112.951 -178.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 38.5 ttt180 . . . . . 0 N--CA 1.421 -1.909 0 N-CA-C 107.467 -1.308 . . . . 72.13 107.467 177.189 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 . . . . . 0 CA--C 1.508 -0.669 0 N-CA-C 109.147 -0.686 . . . . 55.1 109.147 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.537 ' HB ' ' OE1' ' A' ' 254' ' ' GLN . 41.7 p -92.77 -27.12 17.4 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-O 121.261 0.553 . . . . 61.12 110.131 176.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.419 ' ND1' ' HB3' ' A' ' 250' ' ' LYS . 0.3 OUTLIER -123.27 137.62 54.82 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 122.842 0.457 . . . . 75.04 109.888 174.288 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.47 ' O ' ' HA ' ' A' ' 248' ' ' THR . 2.2 tpm_? -128.95 138.53 52.03 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 108.096 -1.076 . . . . 72.35 108.096 177.047 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.401 ' HA ' ' O ' ' A' ' 247' ' ' ILE . 14.9 ptp180 -122.6 117.03 24.89 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-O 121.2 0.524 . . . . 71.23 110.222 178.483 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.507 HG21 HD11 ' A' ' 212' ' ' LEU . 27.7 m -122.66 140.49 46.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 CA-C-N 115.479 -0.782 . . . . 62.34 112.02 -175.108 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.521 ' HG2' HG12 ' A' ' 246' ' ' ILE . 67.0 mtm180 -92.95 111.29 22.86 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.824 -1.176 . . . . 64.23 107.824 177.614 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.513 ' HB2' ' HB3' ' A' ' 245' ' ' LEU . 31.8 mt -89.32 139.12 30.82 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 109.28 -0.637 . . . . 73.54 109.28 -178.748 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.431 HD13 ' O ' ' A' ' 242' ' ' SER . 6.1 tt 71.63 83.09 0.14 Allowed 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 123.037 1.399 . . . . 72.21 108.397 179.337 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 49.0 pttt -100.34 2.14 42.21 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 113.027 -1.897 . . . . 62.33 109.839 -177.523 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 18.6 m170 -95.43 -171.11 2.31 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 114.403 -1.271 . . . . 73.13 109.118 173.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -123.15 76.84 0.36 Allowed Glycine 0 CA--C 1.484 -1.9 0 N-CA-C 108.06 -2.016 . . . . 53.13 108.06 176.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 40.1 m -141.8 143.47 33.45 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-N 115.487 -0.357 . . . . 61.1 110.676 -173.329 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -89.9 68.8 7.43 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 107.087 -1.449 . . . . 61.33 107.087 173.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 56.7 tttp -109.54 145.61 32.27 Favored Pre-proline 0 N--CA 1.401 -2.878 0 CA-C-N 112.968 -1.924 . . . . 73.02 111.283 -173.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -67.26 135.9 38.54 Favored 'Trans proline' 0 C--O 1.245 0.841 0 C-N-CA 122.455 2.103 . . . . 72.43 109.711 172.483 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.435 ' HG ' HD12 ' A' ' 245' ' ' LEU . 3.7 mm? -63.86 -35.11 79.55 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 113.531 0.937 . . . . 74.25 113.531 -175.032 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 91.77 36.42 6.44 Favored Glycine 0 N--CA 1.434 -1.48 0 C-N-CA 119.813 -1.184 . . . . 50.23 113.789 175.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.436 ' HB3' ' CB ' ' A' ' 206' ' ' ALA . 18.9 p90 -156.61 153.33 28.43 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.755 -1.202 . . . . 63.34 107.755 173.566 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -128.7 150.29 50.32 Favored 'General case' 0 C--N 1.287 -2.129 0 N-CA-C 108.769 -0.826 . . . . 75.02 108.769 179.497 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.602 HD13 ' H ' ' A' ' 176' ' ' ILE . 0.2 OUTLIER -123.92 170.08 14.54 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.438 0 CA-C-O 121.372 0.606 . . . . 53.12 110.739 -176.222 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.557 ' HG2' ' HB2' ' A' ' 198' ' ' SER . 2.7 ptp180 -147.46 154.39 40.74 Favored 'General case' 0 C--N 1.275 -2.638 0 CA-C-N 115.141 -0.936 . . . . 74.35 110.226 -177.456 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -104.7 138.3 41.22 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 109.509 -0.552 . . . . 74.31 109.509 179.148 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -155.54 136.77 5.25 Favored Glycine 0 C--N 1.284 -2.339 0 N-CA-C 109.823 -1.311 . . . . 74.14 109.823 177.406 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' THR . . . . . 0.474 ' CG2' ' HG2' ' A' ' 191' ' ' LYS . 0.2 OUTLIER -89.24 123.49 33.51 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 105.903 -1.888 . . . . 72.13 105.903 179.292 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 22.7 t -109.64 126.54 53.76 Favored 'General case' 0 C--N 1.269 -2.911 0 N-CA-C 109.112 -0.699 . . . . 73.12 109.112 -176.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.575 ' HA ' ' O ' ' A' ' 190' ' ' GLU . 7.6 p -103.72 122.22 56.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 N-CA-C 108.973 -0.751 . . . . 65.24 108.973 177.089 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -129.58 160.56 32.88 Favored 'General case' 0 CA--C 1.468 -2.183 0 CA-C-N 115.381 -0.827 . . . . 71.4 109.654 -173.115 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.552 ' HA ' ' O ' ' A' ' 188' ' ' GLY . 98.1 t -82.28 118.61 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.428 0 N-CA-C 108.079 -1.082 . . . . 52.22 108.079 172.582 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 34.3 p -115.9 -174.44 2.53 Favored 'General case' 0 C--N 1.262 -3.219 0 CA-C-N 113.654 -1.612 . . . . 71.32 107.402 -178.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -66.2 -21.85 66.32 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 121.177 0.513 . . . . 73.43 109.807 176.258 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 30.5 p -88.85 -18.67 27.13 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-N 115.77 -0.65 . . . . 71.04 112.586 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.552 ' O ' ' HA ' ' A' ' 184' ' ' VAL . . . 125.06 -127.69 6.39 Favored Glycine 0 C--O 1.205 -1.679 0 N-CA-C 109.643 -1.383 . . . . 70.32 109.643 -178.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 7.0 mp -100.71 119.27 38.35 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 117.569 0.685 . . . . 61.54 109.365 176.312 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' GLU . . . . . 0.575 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 10.2 tp10 -131.72 126.79 35.4 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 108.646 -0.872 . . . . 74.51 108.646 -178.16 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.474 ' HG2' ' CG2' ' A' ' 180' ' ' THR . 34.2 ttmt -96.19 125.97 41.08 Favored 'General case' 0 N--CA 1.427 -1.606 0 N-CA-C 107.618 -1.252 . . . . 74.04 107.618 -178.121 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 192' ' ' GLN . . . . . 0.421 ' HA ' ' HD3' ' A' ' 193' ' ' PRO . 5.1 tp-100 -140.98 134.54 14.77 Favored Pre-proline 0 C--N 1.287 -2.144 0 CA-C-N 115.78 -0.645 . . . . 70.32 109.816 -168.276 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 193' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 192' ' ' GLN . 24.7 Cg_exo -64.73 130.77 27.19 Favored 'Trans proline' 0 N--CA 1.447 -1.209 0 C-N-CA 121.726 1.617 . . . . 71.13 111.885 179.658 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -133.82 141.4 12.73 Favored Glycine 0 N--CA 1.403 -3.539 0 N-CA-C 109.285 -1.526 . . . . 63.22 109.285 174.171 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.547 ' O ' HG12 ' A' ' 218' ' ' VAL . 3.8 mp -103.8 129.78 55.35 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.676 0 N-CA-C 108.351 -0.981 . . . . 72.1 108.351 175.129 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -123.59 161.15 25.56 Favored 'General case' 0 C--N 1.275 -2.644 0 N-CA-C 107.271 -1.381 . . . . 73.12 107.271 -174.418 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 57.6 mt -79.24 127.69 38.95 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.892 0 CA-C-O 121.588 0.709 . . . . 72.24 110.294 177.712 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 198' ' ' SER . . . . . 0.557 ' HB2' ' HG2' ' A' ' 177' ' ' ARG . 24.4 t -101.56 -18.67 15.82 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 112.891 0.701 . . . . 63.44 112.891 -177.246 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 75.3 ttt180 -166.55 139.5 3.83 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.327 -0.549 . . . . 74.22 111.239 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 88.3 mt -103.72 146.61 28.35 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.575 -0.898 . . . . 63.54 108.575 172.446 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 62.1 t -112.09 114.77 50.98 Favored Pre-proline 0 C--N 1.283 -2.298 0 N-CA-C 105.886 -1.894 . . . . 73.2 105.886 171.31 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.426 ' HA ' ' HG2' ' A' ' 207' ' ' GLU . 31.1 Cg_endo -64.45 130.67 27.38 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 121.866 1.71 . . . . 71.14 110.6 -177.314 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 103.23 -17.65 50.94 Favored Glycine 0 N--CA 1.439 -1.137 0 N-CA-C 110.137 -1.185 . . . . 73.04 110.137 -175.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -83.74 171.76 49.48 Favored Glycine 0 N--CA 1.43 -1.751 0 N-CA-C 110.298 -1.121 . . . . 44.11 110.298 177.526 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 172' ' ' LEU . 3.1 mm? -63.07 -33.24 75.02 Favored 'General case' 0 N--CA 1.432 -1.339 0 N-CA-C 113.272 0.842 . . . . 72.24 113.272 -174.047 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 206' ' ' ALA . . . . . 0.436 ' CB ' ' HB3' ' A' ' 174' ' ' PHE . . . -66.3 -48.13 71.35 Favored 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 120.847 -0.341 . . . . 75.33 111.22 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.426 ' HG2' ' HA ' ' A' ' 202' ' ' PRO . 8.2 tp10 -73.39 -33.1 64.84 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 109.34 -0.615 . . . . 64.23 109.34 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 30.8 t -56.4 -47.51 78.86 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-O 122.044 0.926 . . . . 73.22 109.038 176.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 84.1 m -70.09 -40.74 74.8 Favored 'General case' 0 N--CA 1.382 -3.86 0 CA-C-N 114.41 -1.268 . . . . 52.02 109.358 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 74.35 -7.28 18.56 Favored Glycine 0 CA--C 1.504 -0.621 0 CA-C-N 116.246 -0.434 . . . . 52.41 113.097 176.444 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.41 HD12 HG11 ' A' ' 161' ' ' VAL . 38.4 mt -87.46 -6.56 58.35 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 109.061 -0.718 . . . . 74.21 109.061 -178.28 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.507 HD11 HG21 ' A' ' 161' ' ' VAL . 9.4 mp -108.92 131.35 55.11 Favored 'General case' 0 N--CA 1.422 -1.834 0 CA-C-N 115.181 -0.918 . . . . 71.21 109.678 174.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -132.44 166.32 22.27 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 107.177 -1.416 . . . . 72.35 107.177 175.246 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 33.6 m -58.57 -30.32 41.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-O 121.828 0.823 . . . . 53.41 111.623 177.189 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -68.59 -15.04 63.4 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 115.367 -0.833 . . . . 54.13 112.271 -179.234 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.441 ' HB3' ' HB ' ' A' ' 249' ' ' VAL . 6.7 m-20 -75.07 141.49 43.82 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 113.623 0.971 . . . . 61.24 113.623 -176.46 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 217' ' ' GLU . . . . . 0.526 ' HB3' ' HG3' ' A' ' 250' ' ' LYS . 40.4 tt0 -113.45 128.11 56.34 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 125.455 1.502 . . . . 63.41 109.852 -176.789 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.547 HG12 ' O ' ' A' ' 195' ' ' ILE . 12.5 p -80.03 128.84 38.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 122.143 0.973 . . . . 54.22 111.808 -176.625 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 44.0 mm -99.14 -48.96 11.77 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 CA-C-N 114.398 -1.274 . . . . 73.14 110.121 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.474 ' HB3' ' HA ' ' A' ' 225' ' ' GLU . 10.8 pt-20 -157.94 160.16 37.28 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.842 -0.617 . . . . 54.54 110.198 -177.534 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' A' ' 246' ' ' ILE . 8.8 p -131.0 120.61 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 O-C-N 123.758 0.661 . . . . 74.32 109.656 179.459 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 222' ' ' ASN . . . . . 0.429 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 10.7 m120 61.39 24.97 15.0 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.02 0.928 . . . . 74.42 112.946 176.654 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 97.23 -3.21 61.68 Favored Glycine 0 C--N 1.309 -0.953 0 CA-C-N 115.274 -0.876 . . . . 73.01 112.66 179.498 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 63.3 mt -111.22 123.51 67.16 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 N-CA-C 109.312 -0.625 . . . . 63.23 109.312 179.136 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 225' ' ' GLU . . . . . 0.474 ' HA ' ' HB3' ' A' ' 220' ' ' GLU . 12.5 pt-20 -62.73 153.71 31.81 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 121.551 0.691 . . . . 75.42 112.424 -178.778 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 226' ' ' VAL . . . . . 0.429 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 29.3 m -123.53 -3.51 6.99 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 CA-C-N 115.19 -0.914 . . . . 61.34 110.904 177.135 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -68.66 97.28 0.79 Allowed 'General case' 0 N--CA 1.443 -0.802 0 CA-C-O 121.416 0.627 . . . . 72.44 111.184 -177.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 127.78 -26.17 4.87 Favored Glycine 0 CA--C 1.49 -1.484 0 CA-C-N 115.488 -0.778 . . . . 74.35 111.571 177.524 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -73.65 170.98 14.1 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.231 0.539 . . . . 70.0 111.446 -178.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 47.6 p -88.53 163.89 15.68 Favored 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 108.674 -0.862 . . . . 45.35 108.674 -179.501 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.474 ' HA ' HG22 ' A' ' 234' ' ' VAL . 0.8 OUTLIER -63.58 -36.97 85.56 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 107.712 -1.218 . . . . 35.24 107.712 -177.351 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -61.32 -40.9 95.92 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.561 -0.745 . . . . 75.44 110.824 177.4 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -66.02 -48.67 70.37 Favored 'General case' 0 C--O 1.218 -0.56 0 CA-C-N 116.307 -0.406 . . . . 70.32 111.691 177.112 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.474 HG22 ' HA ' ' A' ' 231' ' ' LEU . 13.7 m -66.8 -34.19 68.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 112.413 0.523 . . . . 63.13 112.413 -175.162 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 235' ' ' THR . . . . . 0.429 ' O ' HG23 ' A' ' 239' ' ' VAL . 32.9 m -72.01 -36.15 69.62 Favored 'General case' 0 CA--C 1.5 -0.976 0 N-CA-C 109.018 -0.734 . . . . 75.32 109.018 -177.062 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -60.46 -33.65 72.87 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 115.861 -0.609 . . . . 54.04 109.932 178.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -72.08 -43.6 64.58 Favored 'General case' 0 C--O 1.206 -1.219 0 N-CA-C 108.052 -1.092 . . . . 73.42 108.052 -179.25 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 238' ' ' MET . . . . . 0.419 ' HG3' ' O ' ' A' ' 234' ' ' VAL . 64.4 mtt -62.83 -40.18 96.62 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.615 -0.72 . . . . 73.52 111.431 179.595 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 235' ' ' THR . 97.6 t -66.92 -42.11 88.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.841 0.353 . . . . 73.23 110.463 178.256 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -65.42 -39.5 92.22 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.654 0.74 . . . . 34.15 110.078 178.411 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -83.57 20.98 1.28 Allowed 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 114.731 -1.122 . . . . 71.41 111.957 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 242' ' ' SER . . . . . 0.431 ' O ' HD13 ' A' ' 164' ' ' LEU . 22.9 t -62.35 -23.04 66.56 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 111.742 0.275 . . . . 61.32 111.742 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 16.5 m -63.33 -29.94 71.16 Favored 'General case' 0 CA--C 1.554 1.121 0 CA-C-O 120.893 0.377 . . . . 61.12 110.425 178.535 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -175.19 95.96 0.07 Allowed 'General case' 0 C--O 1.245 0.867 0 N-CA-C 106.856 -1.535 . . . . 75.41 106.856 179.2 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.513 ' HB3' ' HB2' ' A' ' 163' ' ' LEU . 2.2 tt -85.97 108.0 18.01 Favored 'General case' 0 C--O 1.201 -1.453 0 CA-C-N 115.448 -0.796 . . . . 62.35 109.212 -171.747 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.521 HG12 ' HG2' ' A' ' 162' ' ' ARG . 77.7 mt -101.12 116.76 45.29 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.105 0 O-C-N 121.777 -0.577 . . . . 73.23 109.736 -178.808 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 247' ' ' ILE . . . . . 0.515 HG23 HG23 ' A' ' 218' ' ' VAL . 15.8 mt -121.87 136.66 58.03 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.152 0 N-CA-C 113.172 0.804 . . . . 75.44 113.172 179.622 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.47 ' HA ' ' O ' ' A' ' 159' ' ' ARG . 63.3 m -103.56 114.83 29.39 Favored 'General case' 0 N--CA 1.413 -2.316 0 N-CA-C 107.633 -1.247 . . . . 63.11 107.633 172.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.539 HG12 ' HA ' ' A' ' 218' ' ' VAL . 10.2 m -121.51 168.55 13.84 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.399 0 CA-C-O 121.809 0.814 . . . . 72.32 110.054 175.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.526 ' HG3' ' HB3' ' A' ' 217' ' ' GLU . 8.1 ptmt -136.62 139.16 28.46 Favored Pre-proline 0 C--N 1.257 -3.448 0 CA-C-N 113.647 -1.615 . . . . 72.31 107.665 175.756 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -63.34 148.24 92.99 Favored 'Trans proline' 0 N--CA 1.443 -1.482 0 C-N-CA 121.202 1.268 . . . . 55.23 108.962 173.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -65.39 -33.93 77.11 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 108.078 -1.082 . . . . 74.02 108.078 175.513 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -93.41 77.98 4.43 Favored 'General case' 0 N--CA 1.415 -2.183 0 CA-C-N 113.774 -1.557 . . . . 61.54 108.506 175.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 254' ' ' GLN . . . . . 0.537 ' OE1' ' HB ' ' A' ' 157' ' ' THR . 42.3 mt-30 -77.42 128.7 34.69 Favored 'General case' 0 CA--C 1.497 -1.078 0 C-N-CA 119.983 -0.687 . . . . 75.41 110.53 178.616 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 38.1 mmt180 . . . . . 0 C--N 1.285 -2.225 0 N-CA-C 107.461 -1.311 . . . . 62.1 107.461 176.964 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.468 0.438 0 CA-C-O 121.153 0.502 . . . . 73.11 109.914 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 22.4 p -77.94 -47.6 18.25 Favored 'General case' 0 N--CA 1.424 -1.741 0 CA-C-N 116.126 -0.488 . . . . 55.53 111.422 178.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.657 ' NE2' HG13 ' A' ' 219' ' ' ILE . 13.7 m80 -81.99 130.19 35.0 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 120.464 -0.494 . . . . 73.42 111.191 176.748 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.471 ' O ' ' HA ' ' A' ' 248' ' ' THR . 8.3 ttm180 -131.64 141.82 49.71 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 107.681 -1.229 . . . . 63.22 107.681 179.34 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -128.75 112.55 14.31 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-O 121.175 0.512 . . . . 74.24 109.676 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 16.5 m -118.15 139.57 44.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-N 115.025 -0.989 . . . . 71.42 112.044 -177.012 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 17.4 ttm180 -100.29 112.48 24.81 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.107 -1.072 . . . . 70.11 108.107 177.123 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.478 ' HB2' ' HB3' ' A' ' 245' ' ' LEU . 20.8 mt -99.86 137.07 38.83 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 108.184 -1.043 . . . . 71.35 108.184 -176.071 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.448 HD21 ' H ' ' A' ' 168' ' ' SER . 3.4 tt 62.2 70.92 0.55 Allowed 'General case' 0 C--O 1.207 -1.141 0 N-CA-C 107.1 -1.444 . . . . 75.11 107.1 177.157 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -100.11 0.1 40.03 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-N 115.558 -0.747 . . . . 73.12 111.096 -176.03 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 31.0 m170 -88.6 -25.12 22.62 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 120.446 -0.502 . . . . 75.21 111.565 179.133 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 84.53 41.54 7.78 Favored Glycine 0 C--O 1.226 -0.388 0 N-CA-C 110.483 -1.047 . . . . 73.0 110.483 -177.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' SER . . . . . 0.448 ' H ' HD21 ' A' ' 164' ' ' LEU . 27.1 m -88.58 -12.9 41.37 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 112.533 0.568 . . . . 54.11 112.533 -177.244 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 30.0 t70 61.35 16.3 7.29 Favored 'General case' 0 N--CA 1.51 2.553 0 C-N-CA 124.357 1.063 . . . . 63.33 111.891 -179.573 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.47 154.27 83.85 Favored Pre-proline 0 C--N 1.302 -1.492 0 CA-C-N 115.615 -0.72 . . . . 64.42 110.414 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -52.44 144.23 41.5 Favored 'Trans proline' 0 C--O 1.24 0.609 0 C-N-CA 122.697 2.265 . . . . 53.31 110.947 174.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.439 ' HA ' HD23 ' A' ' 205' ' ' LEU . 3.5 mm? -77.38 -32.64 55.05 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 112.254 0.465 . . . . 73.14 112.254 -176.416 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 173' ' ' GLY . . . . . 0.498 ' HA3' ' HA3' ' A' ' 204' ' ' GLY . . . 84.49 36.01 13.04 Favored Glycine 0 N--CA 1.427 -1.929 0 C-N-CA 120.389 -0.91 . . . . 54.32 112.948 177.204 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -150.0 154.24 37.87 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.338 -0.986 . . . . 72.12 108.338 174.104 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -121.32 143.65 49.07 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 108.966 -0.753 . . . . 73.34 108.966 175.456 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.621 HD13 ' H ' ' A' ' 176' ' ' ILE . 0.2 OUTLIER -114.38 166.23 8.47 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.467 0 CA-C-N 115.812 -0.631 . . . . 64.5 109.484 178.992 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.578 ' HG2' ' HB2' ' A' ' 198' ' ' SER . 4.8 ptp180 -146.87 154.32 41.18 Favored 'General case' 0 C--N 1.277 -2.582 0 CA-C-N 115.072 -0.967 . . . . 62.44 110.589 -178.264 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -111.86 138.45 48.44 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 124.15 0.906 . . . . 75.44 111.145 -179.003 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -157.34 -164.35 13.62 Favored Glycine 0 C--N 1.29 -2.016 0 N-CA-C 108.424 -1.87 . . . . 73.0 108.424 175.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' THR . . . . . 0.476 ' CG2' ' HG2' ' A' ' 191' ' ' LYS . 0.4 OUTLIER -105.69 123.55 48.11 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-N 118.017 0.909 . . . . 73.24 111.827 175.546 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 41.0 t -106.14 114.03 27.91 Favored 'General case' 0 N--CA 1.414 -2.257 0 N-CA-C 107.326 -1.361 . . . . 54.04 107.326 176.303 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.557 ' HA ' ' O ' ' A' ' 190' ' ' GLU . 6.7 p -106.08 119.79 56.0 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.779 0 N-CA-C 108.89 -0.782 . . . . 73.45 108.89 175.196 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 183' ' ' ARG . . . . . 0.401 ' O ' ' HA ' ' A' ' 189' ' ' LEU . 96.1 mtt180 -121.22 158.29 28.38 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-N 115.031 -0.986 . . . . 52.22 108.785 -175.411 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 74.3 t -87.89 119.42 35.34 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.203 0 N-CA-C 106.627 -1.62 . . . . 70.44 106.627 169.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 67.4 p -114.79 -175.21 2.64 Favored 'General case' 0 C--N 1.268 -2.958 0 CA-C-N 114.811 -1.086 . . . . 62.41 108.693 -176.612 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -60.71 -22.32 63.84 Favored 'General case' 0 C--N 1.314 -0.967 0 O-C-N 123.404 0.44 . . . . 51.35 110.416 175.308 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 20.0 m -99.52 -11.21 21.24 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 116.33 -0.395 . . . . 74.24 111.692 -179.475 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 121.06 -154.39 16.46 Favored Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 120.171 -1.014 . . . . 62.54 110.926 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.401 ' HA ' ' O ' ' A' ' 183' ' ' ARG . 4.9 mp -78.69 120.99 24.15 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 117.483 0.642 . . . . 73.31 109.41 -179.337 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 190' ' ' GLU . . . . . 0.557 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 38.8 tt0 -131.1 119.46 21.98 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 109.003 -0.74 . . . . 65.52 109.003 -177.326 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.476 ' HG2' ' CG2' ' A' ' 180' ' ' THR . 36.5 ttmt -96.18 121.69 38.22 Favored 'General case' 0 N--CA 1.426 -1.66 0 N-CA-C 108.155 -1.054 . . . . 73.04 108.155 -178.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -136.53 165.56 34.35 Favored Pre-proline 0 C--N 1.279 -2.462 0 N-CA-C 108.228 -1.027 . . . . 62.31 108.228 -174.447 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 193' ' ' PRO . . . . . 0.437 ' HD2' ' HA2' ' A' ' 228' ' ' GLY . 53.8 Cg_exo -55.26 132.11 50.3 Favored 'Trans proline' 0 N--CA 1.445 -1.373 0 C-N-CA 121.126 1.218 . . . . 72.53 109.287 170.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -131.86 127.26 4.93 Favored Glycine 0 N--CA 1.403 -3.529 0 N-CA-C 109.278 -1.529 . . . . 64.54 109.278 -179.309 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.566 HG12 HG21 ' A' ' 234' ' ' VAL . 3.6 mp -104.37 132.06 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.814 0 CA-C-O 121.365 0.603 . . . . 73.12 109.51 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -127.61 167.4 16.43 Favored 'General case' 0 C--N 1.277 -2.553 0 N-CA-C 107.365 -1.346 . . . . 71.34 107.365 -175.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 197' ' ' ILE . . . . . 0.495 ' HB ' ' HA ' ' A' ' 214' ' ' VAL . 45.1 mm -79.17 130.1 36.62 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 N-CA-C 107.877 -1.157 . . . . 62.44 107.877 173.11 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 198' ' ' SER . . . . . 0.578 ' HB2' ' HG2' ' A' ' 177' ' ' ARG . 28.0 t -100.45 -34.07 10.09 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 111.946 0.35 . . . . 51.13 111.946 -178.44 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 15.4 ttp180 -160.64 141.23 11.58 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-O 120.748 0.309 . . . . 73.11 110.358 -178.28 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 1.1 tt -108.03 135.49 49.3 Favored 'General case' 0 N--CA 1.426 -1.67 0 N-CA-C 107.172 -1.418 . . . . 65.01 107.172 -177.47 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 59.7 t -106.0 121.3 46.13 Favored Pre-proline 0 C--N 1.311 -1.104 0 N-CA-C 110.129 -0.323 . . . . 75.51 110.129 179.589 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.505 ' HA ' ' HG3' ' A' ' 207' ' ' GLU . 27.5 Cg_endo -62.6 135.54 53.47 Favored 'Trans proline' 0 C--O 1.247 0.956 0 C-N-CA 122.638 2.226 . . . . 73.2 111.466 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 96.95 -24.45 31.14 Favored Glycine 0 N--CA 1.439 -1.136 0 N-CA-C 111.641 -0.584 . . . . 73.41 111.641 -177.037 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 204' ' ' GLY . . . . . 0.498 ' HA3' ' HA3' ' A' ' 173' ' ' GLY . . . -72.71 173.97 46.49 Favored Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 121.306 -0.474 . . . . 73.33 112.042 -179.339 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.439 HD23 ' HA ' ' A' ' 172' ' ' LEU . 3.6 mm? -63.11 -33.96 76.59 Favored 'General case' 0 N--CA 1.438 -1.069 0 C-N-CA 123.059 0.544 . . . . 71.23 111.75 -176.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -65.03 -43.26 92.98 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.067 0.46 . . . . 64.44 110.924 179.236 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.505 ' HG3' ' HA ' ' A' ' 202' ' ' PRO . 3.6 tm-20 -75.75 -40.1 56.02 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.033 -0.531 . . . . 61.44 109.998 178.656 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 33.3 t -57.97 -36.95 73.32 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.193 0.597 . . . . 63.13 110.959 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 209' ' ' THR . . . . . 0.544 HG23 ' H ' ' A' ' 211' ' ' LEU . 11.7 t -81.38 -37.22 28.54 Favored 'General case' 0 N--CA 1.435 -1.188 0 C-N-CA 119.557 -0.857 . . . . 73.12 109.644 175.522 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 71.35 26.06 74.18 Favored Glycine 0 C--N 1.341 0.813 0 N-CA-C 112.14 -0.384 . . . . 52.33 112.14 178.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.544 ' H ' HG23 ' A' ' 209' ' ' THR . 43.0 mt -116.09 -4.24 12.0 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.577 0.703 . . . . 75.24 110.075 -177.728 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 60.1 mt -109.25 134.44 51.76 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 114.91 -1.041 . . . . 63.31 110.891 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -131.3 161.69 31.75 Favored 'General case' 0 N--CA 1.42 -1.967 0 N-CA-C 108.656 -0.868 . . . . 74.41 108.656 177.36 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 214' ' ' VAL . . . . . 0.495 ' HA ' ' HB ' ' A' ' 197' ' ' ILE . 33.8 m -62.2 -30.59 49.17 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 CA-C-O 121.377 0.608 . . . . 63.32 112.579 179.553 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -71.55 -14.26 62.04 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 116.123 -0.49 . . . . 75.44 112.143 -178.245 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.49 ' HB3' ' HB ' ' A' ' 249' ' ' VAL . 61.9 m-20 -74.19 139.15 44.24 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 112.754 0.65 . . . . 70.24 112.754 -176.183 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -110.01 137.52 47.67 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 124.975 1.31 . . . . 62.52 108.696 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.52 HG12 ' O ' ' A' ' 195' ' ' ILE . 12.1 p -83.82 138.41 19.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 122.103 0.954 . . . . 64.14 112.625 -175.545 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.657 HG13 ' NE2' ' A' ' 158' ' ' HIS . 44.1 mm -105.62 -44.75 8.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 114.731 -1.122 . . . . 75.02 111.058 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -161.12 154.98 22.31 Favored 'General case' 0 C--O 1.245 0.837 0 CA-C-N 116.511 -0.313 . . . . 65.42 110.75 -178.608 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.414 HG11 ' HB2' ' A' ' 237' ' ' MET . 8.3 p -126.45 121.41 58.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 C-N-CA 123.786 0.834 . . . . 61.44 109.006 178.089 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 222' ' ' ASN . . . . . 0.473 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 18.7 t-20 65.09 15.52 10.04 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.322 1.049 . . . . 73.23 110.456 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 99.35 -8.12 60.32 Favored Glycine 0 N--CA 1.437 -1.261 0 C-N-CA 120.347 -0.93 . . . . 42.33 111.523 -177.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 64.0 mt -91.08 123.06 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.162 0 N-CA-C 108.787 -0.819 . . . . 73.12 108.787 179.668 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 225' ' ' GLU . . . . . 0.443 ' HG3' ' HE3' ' A' ' 229' ' ' LYS . 11.6 pt-20 -55.45 131.19 45.34 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 124.24 0.962 . . . . 62.31 111.063 179.421 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 35.8 m -109.88 10.13 8.85 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 CA-C-O 121.876 0.846 . . . . 73.32 109.288 174.748 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -73.26 98.08 2.58 Favored 'General case' 0 N--CA 1.424 -1.737 0 CA-C-N 114.422 -1.263 . . . . 64.35 110.799 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 228' ' ' GLY . . . . . 0.437 ' HA2' ' HD2' ' A' ' 193' ' ' PRO . . . 101.23 5.29 52.86 Favored Glycine 0 N--CA 1.44 -1.092 0 C-N-CA 120.894 -0.67 . . . . 34.44 112.46 176.319 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.443 ' HE3' ' HG3' ' A' ' 225' ' ' GLU . 68.3 mmtt -90.31 156.66 18.11 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 107.524 -1.287 . . . . 74.43 107.524 -178.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 230' ' ' THR . . . . . 0.633 ' OG1' ' HG2' ' A' ' 233' ' ' GLN . 81.5 p -79.97 166.52 21.51 Favored 'General case' 0 C--O 1.248 0.998 0 C-N-CA 118.905 -1.118 . . . . 72.21 110.067 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.436 ' HA ' HG22 ' A' ' 234' ' ' VAL . 3.3 tm? -61.02 -39.76 90.99 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 108.946 -0.761 . . . . 75.05 108.946 179.065 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -63.86 -31.01 72.05 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.078 -0.51 . . . . 73.11 110.626 177.145 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 233' ' ' GLN . . . . . 0.633 ' HG2' ' OG1' ' A' ' 230' ' ' THR . 13.3 mm-40 -74.14 -51.37 15.82 Favored 'General case' 0 C--O 1.216 -0.683 0 C-N-CA 119.478 -0.889 . . . . 65.21 110.211 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.566 HG21 HG12 ' A' ' 195' ' ' ILE . 21.2 m -65.99 -34.22 68.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 113.041 0.756 . . . . 71.32 113.041 -173.279 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 42.6 m -74.42 -35.49 63.4 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 109.056 -0.72 . . . . 74.32 109.056 -173.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -63.15 -34.25 77.21 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-N 115.376 -0.829 . . . . 73.5 108.835 177.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 237' ' ' MET . . . . . 0.493 ' HG3' ' O ' ' A' ' 233' ' ' GLN . 10.3 mtm -72.88 -42.01 64.1 Favored 'General case' 0 C--O 1.201 -1.478 0 CA-C-N 115.117 -0.947 . . . . 74.02 108.546 -179.485 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 238' ' ' MET . . . . . 0.483 ' HG3' ' O ' ' A' ' 234' ' ' VAL . 65.4 mtt -61.6 -40.16 93.8 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.486 -0.325 . . . . 74.52 111.568 178.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 96.0 t -68.76 -43.12 83.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.198 0.523 . . . . 75.12 111.004 178.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -68.68 -34.31 75.46 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.424 0.631 . . . . 62.32 110.555 179.172 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -88.81 15.44 8.35 Favored 'General case' 0 C--O 1.19 -2.053 0 CA-C-N 115.425 -0.807 . . . . 71.41 111.923 178.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 242' ' ' SER . . . . . 0.4 ' O ' HD13 ' A' ' 164' ' ' LEU . 69.9 m -66.74 -23.26 66.07 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 114.363 1.246 . . . . 51.13 114.363 -178.423 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 20.5 m -63.94 -29.63 70.79 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 118.131 0.423 . . . . 74.44 110.735 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 244' ' ' ASN . . . . . 0.42 ' HA ' ' O ' ' A' ' 164' ' ' LEU . 42.6 m-80 -156.0 89.68 1.16 Allowed 'General case' 0 C--O 1.248 1.015 0 N-CA-C 106.381 -1.711 . . . . 71.21 106.381 173.832 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.478 ' HB3' ' HB2' ' A' ' 163' ' ' LEU . 1.6 tt -85.28 103.55 14.33 Favored 'General case' 0 C--O 1.205 -1.274 0 CA-C-O 121.269 0.557 . . . . 74.21 109.846 -172.063 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.473 ' HB ' ' HA ' ' A' ' 222' ' ' ASN . 75.5 mt -96.48 116.19 37.83 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.348 0 N-CA-C 109.373 -0.603 . . . . 73.03 109.373 179.053 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 247' ' ' ILE . . . . . 0.51 HG23 HG23 ' A' ' 218' ' ' VAL . 9.8 mt -125.84 137.81 56.53 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 CA-C-O 121.551 0.691 . . . . 71.14 112.446 177.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.471 ' HA ' ' O ' ' A' ' 159' ' ' ARG . 49.9 m -107.43 121.87 45.47 Favored 'General case' 0 N--CA 1.423 -1.815 0 CA-C-N 114.717 -1.129 . . . . 73.11 107.985 174.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.503 HG12 ' HA ' ' A' ' 218' ' ' VAL . 15.4 m -125.74 166.44 21.73 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 CA-C-O 121.126 0.489 . . . . 71.31 110.552 176.627 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 16.8 ptmt -138.64 134.01 17.07 Favored Pre-proline 0 C--N 1.285 -2.209 0 CA-C-N 114.471 -1.24 . . . . 74.44 107.763 174.536 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 251' ' ' PRO . . . . . 0.411 ' HA ' ' HA ' ' A' ' 216' ' ' ASP . 23.8 Cg_exo -65.12 134.02 37.82 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 121.619 1.546 . . . . 74.21 111.166 178.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -63.41 -30.29 71.45 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.294 0.568 . . . . 72.23 111.326 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -93.52 -10.66 34.1 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.259 -0.882 . . . . 54.32 110.08 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 70.08 131.97 0.03 OUTLIER 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.634 1.174 . . . . 72.04 110.767 -172.237 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.419 -2.019 0 N-CA-C 106.025 -1.842 . . . . 71.22 106.025 -177.406 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 . . . . . 0 CA--C 1.512 -0.507 0 N-CA-C 110.136 -0.32 . . . . 73.54 110.136 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.428 HG22 ' H ' ' A' ' 255' ' ' ARG . 70.7 p -74.1 -32.61 63.29 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 122.305 1.05 . . . . 75.4 108.196 178.255 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -82.23 130.26 35.05 Favored 'General case' 0 N--CA 1.428 -1.538 0 CA-C-N 113.864 -1.516 . . . . 62.1 109.738 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.447 ' CZ ' HG22 ' A' ' 161' ' ' VAL . 0.0 OUTLIER -127.63 142.0 51.47 Favored 'General case' 0 C--N 1.283 -2.288 0 N-CA-C 104.971 -2.233 . . . . 72.03 104.971 173.726 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -132.42 110.82 10.8 Favored 'General case' 0 C--N 1.285 -2.223 0 C-N-CA 117.718 -1.593 . . . . 75.21 111.065 -179.356 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.548 HG11 HD12 ' A' ' 211' ' ' LEU . 30.3 m -113.56 140.31 34.51 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 CA-C-N 114.724 -1.125 . . . . 43.24 111.787 175.251 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 26.0 ttm180 -84.86 114.65 22.26 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 115.617 -0.72 . . . . 75.54 109.121 178.457 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.544 ' HB2' ' HB2' ' A' ' 245' ' ' LEU . 13.8 mt -87.47 127.27 35.23 Favored 'General case' 0 N--CA 1.421 -1.916 0 N-CA-C 107.078 -1.453 . . . . 73.31 107.078 -179.408 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.58 HD13 ' O ' ' A' ' 242' ' ' SER . 5.5 tt 73.66 90.68 0.09 Allowed 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 122.378 1.085 . . . . 75.41 110.416 178.3 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 60.3 pttt -116.79 0.12 12.45 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 107.481 -1.303 . . . . 74.32 107.481 172.322 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 45.4 m80 -150.64 146.13 26.3 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 114.141 -1.39 . . . . 74.0 107.781 177.302 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 81.59 43.41 8.46 Favored Glycine 0 C--N 1.315 -0.628 0 C-N-CA 120.873 -0.68 . . . . 65.33 113.231 177.001 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 35.2 t -76.73 87.26 3.36 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.363 -0.606 . . . . 65.04 109.363 179.165 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 19.5 t70 179.27 -41.75 0.01 OUTLIER 'General case' 0 CA--C 1.506 -0.741 0 CA-C-N 114.773 -1.103 . . . . 70.12 108.849 -176.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.59 154.4 37.95 Favored Pre-proline 0 N--CA 1.426 -1.638 0 CA-C-N 115.33 -0.85 . . . . 74.41 111.198 -176.559 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -49.29 153.07 4.92 Favored 'Trans proline' 0 C--O 1.25 1.095 0 C-N-CA 124.498 3.465 . . . . 74.32 115.177 -176.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -73.44 -39.68 64.81 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-N 114.791 -1.095 . . . . 72.44 110.166 177.47 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' GLY . . . . . 0.505 ' HA3' ' HA3' ' A' ' 204' ' ' GLY . . . 90.24 51.44 2.76 Favored Glycine 0 N--CA 1.434 -1.45 0 CA-C-N 115.679 -0.691 . . . . 51.34 114.806 174.859 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -162.58 154.61 18.62 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 108.521 -0.918 . . . . 64.1 108.521 175.233 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -121.2 140.83 51.5 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 108.244 -1.021 . . . . 75.01 108.244 176.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.513 HD13 ' SD ' ' A' ' 238' ' ' MET . 28.6 pt -112.32 165.25 7.4 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.845 0 CA-C-O 121.04 0.448 . . . . 71.55 111.339 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.511 ' CG ' ' HB2' ' A' ' 198' ' ' SER . 27.3 ptt180 -149.69 154.98 39.43 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 115.566 -0.743 . . . . 73.5 110.703 -175.372 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 178' ' ' ASP . . . . . 0.47 ' HB2' ' HB2' ' A' ' 231' ' ' LEU . 9.2 t70 -100.95 138.54 37.86 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 115.706 -0.679 . . . . 64.01 109.946 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -149.11 135.41 5.37 Favored Glycine 0 C--N 1.277 -2.743 0 N-CA-C 107.622 -2.191 . . . . 50.23 107.622 175.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' THR . . . . . 0.485 HG22 ' HG2' ' A' ' 191' ' ' LYS . 0.4 OUTLIER -86.53 122.63 30.73 Favored 'General case' 0 C--N 1.282 -2.361 0 C-N-CA 118.54 -1.264 . . . . 63.41 107.799 -175.962 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 10.9 t -95.93 121.29 37.52 Favored 'General case' 0 C--N 1.287 -2.146 0 C-N-CA 123.821 0.848 . . . . 63.11 109.01 -174.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.568 ' HA ' ' HA ' ' A' ' 191' ' ' LYS . 7.4 p -103.97 123.67 57.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-O 121.669 0.747 . . . . 65.1 110.269 178.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 42.1 mtt-85 -122.94 159.92 27.28 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 114.957 -1.02 . . . . 75.51 108.687 -174.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.474 ' HA ' ' O ' ' A' ' 188' ' ' GLY . 83.5 t -87.79 119.03 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.604 0 N-CA-C 108.54 -0.911 . . . . 72.41 108.54 174.455 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 46.4 p -114.42 -175.1 2.61 Favored 'General case' 0 C--N 1.265 -3.108 0 CA-C-N 114.125 -1.398 . . . . 62.02 108.703 -176.641 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -68.21 -13.5 62.29 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.054 0.454 . . . . 61.21 111.41 178.487 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 31.3 m -103.62 -12.84 16.79 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-O 120.784 0.326 . . . . 63.22 111.743 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.474 ' O ' ' HA ' ' A' ' 184' ' ' VAL . . . 131.13 -125.4 4.46 Favored Glycine 0 CA--C 1.48 -2.116 0 N-CA-C 110.028 -1.229 . . . . 73.43 110.028 178.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 6.8 mp -102.37 125.5 49.1 Favored 'General case' 0 C--N 1.286 -2.176 0 CA-C-N 117.395 0.597 . . . . 63.1 110.133 178.171 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 190' ' ' GLU . . . . . 0.473 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 38.3 mt-10 -130.75 119.99 23.13 Favored 'General case' 0 CA--C 1.466 -2.285 0 CA-C-O 121.419 0.628 . . . . 73.5 111.126 -179.416 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.568 ' HA ' ' HA ' ' A' ' 182' ' ' VAL . 32.5 ttmt -92.93 135.59 34.01 Favored 'General case' 0 C--N 1.278 -2.54 0 CA-C-N 114.144 -1.389 . . . . 65.23 107.795 -179.588 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.47 145.49 19.3 Favored Pre-proline 0 C--N 1.313 -1.005 0 CA-C-N 116.125 -0.489 . . . . 74.23 109.78 -171.666 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -56.82 130.84 42.02 Favored 'Trans proline' 0 C--O 1.242 0.708 0 C-N-CA 121.879 1.719 . . . . 43.34 113.784 -176.664 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -137.85 137.38 8.82 Favored Glycine 0 N--CA 1.414 -2.812 0 N-CA-C 109.03 -1.628 . . . . 73.01 109.03 177.534 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.634 HG12 HG21 ' A' ' 234' ' ' VAL . 3.1 mp -104.1 136.59 36.6 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.894 0 CA-C-O 121.355 0.598 . . . . 63.14 110.01 -179.211 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -126.76 165.94 18.34 Favored 'General case' 0 C--N 1.284 -2.25 0 N-CA-C 108.017 -1.105 . . . . 74.54 108.017 -177.22 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 197' ' ' ILE . . . . . 0.44 ' HB ' ' O ' ' A' ' 213' ' ' ALA . 49.1 mm -78.67 131.52 34.26 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 N-CA-C 108.464 -0.939 . . . . 70.42 108.464 174.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 198' ' ' SER . . . . . 0.511 ' HB2' ' CG ' ' A' ' 177' ' ' ARG . 11.2 t -101.92 -28.71 12.24 Favored 'General case' 0 C--N 1.284 -2.246 0 O-C-N 121.889 -0.507 . . . . 61.55 112.017 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 60.7 ttt180 -167.84 147.43 4.9 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 116.697 -0.229 . . . . 73.54 110.773 -176.363 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 85.7 mt -103.65 146.28 28.81 Favored 'General case' 0 CA--C 1.496 -1.134 0 N-CA-C 108.727 -0.842 . . . . 74.54 108.727 171.428 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 46.2 t -105.58 115.48 61.68 Favored Pre-proline 0 C--N 1.288 -2.07 0 N-CA-C 105.932 -1.877 . . . . 74.11 105.932 171.328 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.466 ' HA ' ' HG3' ' A' ' 207' ' ' GLU . 16.7 Cg_endo -58.56 132.4 48.11 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 122.042 1.828 . . . . 70.04 111.218 -177.239 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 102.1 -18.98 50.7 Favored Glycine 0 N--CA 1.438 -1.196 0 N-CA-C 110.713 -0.955 . . . . 63.43 110.713 -175.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 204' ' ' GLY . . . . . 0.505 ' HA3' ' HA3' ' A' ' 173' ' ' GLY . . . -78.5 164.79 51.07 Favored Glycine 0 N--CA 1.434 -1.484 0 N-CA-C 111.018 -0.833 . . . . 45.01 111.018 178.531 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.4 HD22 ' H ' ' A' ' 205' ' ' LEU . 2.9 mm? -61.24 -35.67 77.89 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 123.284 0.634 . . . . 75.51 111.434 -175.485 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 206' ' ' ALA . . . . . 0.42 ' CB ' HD12 ' A' ' 212' ' ' LEU . . . -60.7 -47.41 86.41 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.629 -0.714 . . . . 65.12 110.732 179.647 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.466 ' HG3' ' HA ' ' A' ' 202' ' ' PRO . 3.2 tm-20 -75.46 -34.55 60.94 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.209 -0.905 . . . . 71.12 110.156 -179.668 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 48.7 m -56.96 -42.67 80.54 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 122.919 0.488 . . . . 72.2 111.837 179.546 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 209' ' ' THR . . . . . 0.588 HG23 ' H ' ' A' ' 211' ' ' LEU . 14.9 t -87.1 -24.41 24.56 Favored 'General case' 0 N--CA 1.439 -1.0 0 C-N-CA 119.483 -0.887 . . . . 72.35 110.805 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 70.05 15.1 71.65 Favored Glycine 0 C--N 1.339 0.74 0 CA-C-O 121.498 0.499 . . . . 54.14 112.555 178.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.588 ' H ' HG23 ' A' ' 209' ' ' THR . 64.5 mt -102.03 13.14 35.57 Favored 'General case' 0 CA--C 1.495 -1.152 0 CA-C-O 121.592 0.71 . . . . 75.44 110.395 -177.299 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.42 HD12 ' CB ' ' A' ' 206' ' ' ALA . 30.2 mt -122.02 130.57 53.41 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 114.465 -1.243 . . . . 55.04 110.429 171.293 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 213' ' ' ALA . . . . . 0.44 ' O ' ' HB ' ' A' ' 197' ' ' ILE . . . -132.51 160.35 36.75 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 124.447 1.099 . . . . 51.15 108.344 176.657 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 17.5 m -61.38 -29.74 46.58 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 CA-C-O 121.653 0.74 . . . . 73.45 112.226 -179.18 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -75.53 -14.32 60.4 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 113.069 0.766 . . . . 70.34 113.069 -179.711 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.402 ' HB3' ' HB ' ' A' ' 249' ' ' VAL . 63.3 m-20 -71.08 131.65 43.93 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 112.334 0.494 . . . . 71.51 112.334 -177.507 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -101.94 129.18 48.15 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.108 -0.951 . . . . 71.41 108.672 178.216 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.591 ' HA ' HG12 ' A' ' 249' ' ' VAL . 10.2 p -79.44 137.2 22.16 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-O 121.597 0.713 . . . . 75.44 111.523 -176.029 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.419 HD11 ' HD2' ' A' ' 250' ' ' LYS . 45.6 mm -104.78 -48.34 9.54 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 CA-C-N 115.178 -0.919 . . . . 75.44 111.16 -178.308 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.403 ' HA ' HG22 ' A' ' 226' ' ' VAL . 10.1 pt-20 -153.23 151.99 30.69 Favored 'General case' 0 C--O 1.245 0.827 0 CA-C-N 116.675 -0.239 . . . . 64.31 111.355 -178.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.516 HG12 ' CG1' ' A' ' 226' ' ' VAL . 14.2 p -124.09 129.64 74.09 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 N-CA-C 107.814 -1.18 . . . . 61.1 107.814 173.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 222' ' ' ASN . . . . . 0.548 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 23.1 t-20 75.01 -36.35 0.31 Allowed 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 126.462 1.905 . . . . 64.01 111.711 -176.65 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 223' ' ' GLY . . . . . 0.439 ' H ' ' C ' ' A' ' 221' ' ' VAL . . . 149.26 -6.08 0.79 Allowed Glycine 0 C--N 1.277 -2.717 0 N-CA-C 109.904 -1.278 . . . . 71.3 109.904 -174.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 71.9 mt -94.81 129.32 45.15 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.312 0 N-CA-C 108.223 -1.028 . . . . 72.51 108.223 179.523 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -62.02 138.17 58.34 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-O 121.531 0.682 . . . . 71.13 110.585 -179.227 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 226' ' ' VAL . . . . . 0.549 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 31.6 m -118.91 -2.62 9.52 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.22 0 CA-C-N 115.604 -0.726 . . . . 75.21 109.659 176.308 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -82.8 93.69 7.5 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 108.435 -0.95 . . . . 72.2 108.435 179.018 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 130.46 -17.59 5.29 Favored Glycine 0 N--CA 1.428 -1.853 0 N-CA-C 110.275 -1.13 . . . . 60.03 110.275 -176.275 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -85.43 167.81 15.17 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 107.423 -1.325 . . . . 74.41 107.423 174.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 230' ' ' THR . . . . . 0.461 ' O ' HG13 ' A' ' 234' ' ' VAL . 40.6 p -94.74 171.72 8.61 Favored 'General case' 0 C--N 1.295 -1.765 0 C-N-CA 119.942 -0.703 . . . . 73.23 109.183 178.574 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.47 ' HB2' ' HB2' ' A' ' 178' ' ' ASP . 49.9 tp -60.04 -39.25 85.28 Favored 'General case' 0 N--CA 1.432 -1.375 0 CA-C-O 120.677 0.275 . . . . 75.05 111.208 -176.706 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -58.54 -48.31 81.32 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 121.427 0.632 . . . . 62.22 109.999 177.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -61.96 -45.13 95.01 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.786 -1.097 . . . . 75.33 112.492 -179.162 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.634 HG21 HG12 ' A' ' 195' ' ' ILE . 6.7 m -73.96 -33.42 36.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-O 121.027 0.441 . . . . 64.42 112.013 -175.789 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 235' ' ' THR . . . . . 0.444 ' O ' HG23 ' A' ' 239' ' ' VAL . 48.3 m -74.03 -36.7 64.45 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 108.713 -0.847 . . . . 71.33 108.713 -174.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -59.25 -34.64 72.47 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 115.326 -0.852 . . . . 71.45 109.131 177.502 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 237' ' ' MET . . . . . 0.506 ' HB2' HG11 ' A' ' 221' ' ' VAL . 5.7 mtt -73.34 -44.44 58.8 Favored 'General case' 0 C--O 1.2 -1.551 0 N-CA-C 108.954 -0.758 . . . . 61.32 108.954 -179.726 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 238' ' ' MET . . . . . 0.513 ' SD ' HD13 ' A' ' 176' ' ' ILE . 65.7 mtt -59.95 -40.12 87.93 Favored 'General case' 0 C--O 1.214 -0.808 0 CA-C-O 120.543 0.211 . . . . 63.45 111.234 -178.257 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 235' ' ' THR . 93.9 t -65.75 -37.85 80.88 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 N-CA-C 109.736 -0.468 . . . . 54.42 109.736 177.313 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -76.74 -17.21 59.21 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.192 -0.458 . . . . 61.24 112.083 179.31 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -110.91 21.64 16.23 Favored 'General case' 0 C--O 1.205 -1.278 0 CA-C-N 116.45 -0.341 . . . . 71.24 110.463 176.551 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 242' ' ' SER . . . . . 0.58 ' O ' HD13 ' A' ' 164' ' ' LEU . 36.1 p -64.39 -22.78 67.07 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 112.966 0.728 . . . . 74.13 112.966 -178.219 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 18.1 m -79.22 -9.3 59.53 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 120.793 -0.363 . . . . 55.02 110.782 179.313 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -178.65 97.36 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.747 1.219 . . . . 72.04 110.894 175.606 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.544 ' HB2' ' HB2' ' A' ' 163' ' ' LEU . 14.1 mt -87.92 111.83 21.88 Favored 'General case' 0 C--O 1.192 -1.932 0 N-CA-C 113.375 0.88 . . . . 75.44 113.375 -177.742 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.548 ' HB ' ' HA ' ' A' ' 222' ' ' ASN . 66.1 mt -95.93 115.93 36.39 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.542 0 N-CA-C 106.173 -1.788 . . . . 71.42 106.173 170.836 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 247' ' ' ILE . . . . . 0.404 HG23 HG23 ' A' ' 218' ' ' VAL . 67.5 mt -130.63 128.01 62.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 C-N-CA 119.649 -0.82 . . . . 64.14 112.547 -177.08 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 86.2 m -103.12 128.7 49.95 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 115.048 -0.978 . . . . 40.24 108.751 175.479 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.591 HG12 ' HA ' ' A' ' 218' ' ' VAL . 27.3 m -132.66 167.46 26.54 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 108.207 -1.034 . . . . 74.33 108.207 173.552 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.419 ' HD2' HD11 ' A' ' 219' ' ' ILE . 0.0 OUTLIER -138.82 136.54 18.64 Favored Pre-proline 0 C--N 1.284 -2.267 0 CA-C-N 115.31 -0.859 . . . . 72.45 110.964 172.675 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -63.02 150.06 89.75 Favored 'Trans proline' 0 C--O 1.246 0.885 0 C-N-CA 123.535 2.823 . . . . 60.35 113.554 -177.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -59.96 -40.74 90.06 Favored 'General case' 0 CA--C 1.498 -1.055 0 CA-C-O 121.779 0.799 . . . . 61.42 108.966 175.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -85.82 78.81 9.45 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 107.22 -1.4 . . . . 74.31 107.22 173.197 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -84.29 179.26 7.5 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 115.26 -0.882 . . . . 74.25 111.762 -176.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 255' ' ' ARG . . . . . 0.428 ' H ' HG22 ' A' ' 157' ' ' THR . 1.1 tmt_? . . . . . 0 C--O 1.253 1.259 0 C-N-CA 125.713 1.605 . . . . 74.25 108.336 -178.321 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 . . . . . 0 N--CA 1.454 -0.266 0 CA-C-O 120.822 0.344 . . . . 72.32 110.814 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 7.2 p -153.64 -50.7 0.1 Allowed 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 124.694 1.198 . . . . 75.2 109.581 176.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.48 ' NE2' HG13 ' A' ' 219' ' ' ILE . 49.9 m170 -105.18 137.22 43.3 Favored 'General case' 0 CA--C 1.486 -1.5 0 CA-C-O 121.164 0.507 . . . . 73.34 112.08 175.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.637 ' O ' ' HA ' ' A' ' 248' ' ' THR . 6.6 ptp180 -125.8 142.08 51.69 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 107.598 -1.26 . . . . 71.25 107.598 177.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.417 ' HA ' ' O ' ' A' ' 247' ' ' ILE . 13.6 ptp180 -132.15 113.06 12.85 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 121.814 0.816 . . . . 75.44 111.277 177.121 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.671 ' O ' ' HA ' ' A' ' 246' ' ' ILE . 30.0 m -105.68 139.89 25.43 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 CA-C-N 114.554 -1.203 . . . . 62.14 112.402 -177.635 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.68 ' HG3' HG12 ' A' ' 246' ' ' ILE . 5.4 mpt_? -99.98 114.7 28.16 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 107.532 -1.284 . . . . 65.51 107.532 175.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.579 ' HB2' ' HB3' ' A' ' 245' ' ' LEU . 23.8 mt -114.41 139.91 49.11 Favored 'General case' 0 C--N 1.31 -1.137 0 C-N-CA 123.142 0.577 . . . . 73.04 111.368 -174.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.635 HD12 ' O ' ' A' ' 242' ' ' SER . 0.9 OUTLIER 76.04 20.3 1.71 Allowed 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.877 0.871 . . . . 70.13 112.083 167.935 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.434 ' HA ' ' O ' ' A' ' 243' ' ' SER . 10.2 mtmp? -71.65 7.44 1.47 Allowed 'General case' 0 C--N 1.312 -1.025 0 O-C-N 121.03 -1.044 . . . . 74.01 113.775 -178.452 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 49.7 m80 -91.44 -6.59 52.51 Favored 'General case' 0 C--N 1.31 -1.119 0 O-C-N 121.963 -0.461 . . . . 74.33 111.091 177.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 80.93 87.55 0.61 Allowed Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.745 -0.74 . . . . 72.15 112.552 179.007 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 35.5 t -145.68 176.21 9.8 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.625 -0.879 . . . . 54.32 108.625 -179.111 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -123.87 -0.07 8.54 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.796 0.808 . . . . 62.01 109.456 -178.323 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -73.25 150.32 89.64 Favored Pre-proline 0 N--CA 1.437 -1.109 0 CA-C-N 115.603 -0.726 . . . . 72.22 111.83 -177.025 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_exo -53.26 144.1 50.08 Favored 'Trans proline' 0 C--O 1.243 0.755 0 C-N-CA 122.669 2.246 . . . . 72.32 110.469 173.534 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.51 ' HG ' ' CD1' ' A' ' 245' ' ' LEU . 2.8 mm? -70.08 -24.31 63.2 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 116.014 -0.539 . . . . 65.3 112.102 -175.205 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 173' ' ' GLY . . . . . 0.502 ' HA3' ' HA3' ' A' ' 204' ' ' GLY . . . 93.74 14.91 51.55 Favored Glycine 0 N--CA 1.424 -2.133 0 C-N-CA 120.346 -0.93 . . . . 50.1 112.292 177.849 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -139.45 152.54 47.11 Favored 'General case' 0 N--CA 1.426 -1.653 0 N-CA-C 106.056 -1.831 . . . . 74.42 106.056 173.072 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -127.76 149.31 50.3 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-O 120.858 0.361 . . . . 71.52 110.953 -178.188 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.413 HD13 ' SD ' ' A' ' 238' ' ' MET . 37.8 pt -110.49 169.02 3.95 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 CA-C-N 115.552 -0.749 . . . . 73.15 110.374 -179.021 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.578 ' CG ' ' HB2' ' A' ' 198' ' ' SER . 15.7 ptt180 -151.52 154.88 37.39 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 124.166 0.986 . . . . 63.41 109.351 -178.641 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -108.85 138.0 45.88 Favored 'General case' 0 C--N 1.293 -1.886 0 O-C-N 123.464 0.477 . . . . 74.21 109.86 -179.51 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -150.46 157.08 27.04 Favored Glycine 0 C--N 1.27 -3.088 0 N-CA-C 107.507 -2.237 . . . . 61.53 107.507 176.352 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' THR . . . . . 0.6 ' CG2' ' HG2' ' A' ' 191' ' ' LYS . 0.2 OUTLIER -86.65 121.58 29.37 Favored 'General case' 0 C--N 1.284 -2.252 0 C-N-CA 117.317 -1.753 . . . . 73.55 106.655 179.431 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 181' ' ' SER . . . . . 0.5 ' O ' ' HA ' ' A' ' 191' ' ' LYS . 31.2 t -90.63 118.33 29.99 Favored 'General case' 0 N--CA 1.414 -2.272 0 N-CA-C 108.758 -0.83 . . . . 54.42 108.758 -176.518 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.693 ' HA ' ' O ' ' A' ' 190' ' ' GLU . 7.4 p -125.39 119.76 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 N-CA-C 109.316 -0.624 . . . . 73.4 109.316 174.554 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 78.0 mtt-85 -139.84 161.36 37.75 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 106.692 -1.595 . . . . 72.31 106.692 -178.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 99.2 t -76.91 117.91 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.168 0 N-CA-C 107.77 -1.196 . . . . 61.35 107.77 174.175 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 66.6 p -108.41 -174.17 2.45 Favored 'General case' 0 C--N 1.271 -2.818 0 N-CA-C 107.63 -1.248 . . . . 55.3 107.63 -179.112 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -60.72 -20.67 61.71 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 120.606 0.241 . . . . 75.23 110.685 174.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 31.4 t -98.82 -16.83 18.73 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 121.227 -0.189 . . . . 73.54 111.482 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 125.58 -145.84 15.9 Favored Glycine 0 C--O 1.201 -1.93 0 N-CA-C 110.135 -1.186 . . . . 75.42 110.135 -179.519 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 5.4 mp -83.2 119.36 24.45 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 118.145 0.972 . . . . 43.1 109.522 178.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 190' ' ' GLU . . . . . 0.693 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 52.7 mt-10 -130.51 122.9 28.47 Favored 'General case' 0 CA--C 1.461 -2.453 0 CA-C-O 121.001 0.429 . . . . 73.11 110.507 -178.621 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.6 ' HG2' ' CG2' ' A' ' 180' ' ' THR . 37.2 ttmt -108.43 126.23 52.65 Favored 'General case' 0 C--N 1.277 -2.55 0 CA-C-N 114.259 -1.337 . . . . 61.25 109.207 -176.458 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -151.91 163.48 23.45 Favored Pre-proline 0 C--N 1.301 -1.538 0 N-CA-C 107.859 -1.163 . . . . 72.24 107.859 -176.6 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -58.96 132.23 46.26 Favored 'Trans proline' 0 C--O 1.255 1.332 0 C-N-CA 121.032 1.154 . . . . 72.12 110.689 176.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -141.99 135.56 6.78 Favored Glycine 0 N--CA 1.411 -2.968 0 N-CA-C 110.017 -1.233 . . . . 61.32 110.017 -178.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.649 HG12 HG21 ' A' ' 234' ' ' VAL . 3.2 mp -104.14 132.74 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.789 0 CA-C-O 121.457 0.646 . . . . 55.33 110.862 -178.731 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -124.76 167.75 14.15 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 107.543 -1.281 . . . . 63.42 107.543 -177.402 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 45.6 mt -85.69 131.96 33.1 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 N-CA-C 108.876 -0.787 . . . . 71.4 108.876 175.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 198' ' ' SER . . . . . 0.578 ' HB2' ' CG ' ' A' ' 177' ' ' ARG . 28.2 t -102.49 -30.71 10.83 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 113.727 1.01 . . . . 53.2 113.727 -177.101 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 13.4 ttp180 -165.16 144.47 6.7 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 120.013 -0.675 . . . . 70.24 112.185 -176.044 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 69.0 mt -106.51 141.01 38.5 Favored 'General case' 0 CA--C 1.494 -1.183 0 CA-C-N 115.169 -0.923 . . . . 72.4 109.575 173.411 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 47.5 t -109.71 114.81 56.41 Favored Pre-proline 0 C--N 1.285 -2.232 0 N-CA-C 105.748 -1.945 . . . . 64.33 105.748 171.36 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.495 ' HA ' ' OE1' ' A' ' 207' ' ' GLU . 73.6 Cg_exo -53.31 126.15 20.72 Favored 'Trans proline' 0 C--O 1.244 0.804 0 C-N-CA 122.342 2.028 . . . . 53.05 110.838 179.409 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 110.69 -16.12 28.83 Favored Glycine 0 C--N 1.312 -0.767 0 C-N-CA 120.95 -0.643 . . . . 63.31 111.514 -175.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 204' ' ' GLY . . . . . 0.502 ' HA3' ' HA3' ' A' ' 173' ' ' GLY . . . -77.08 158.2 47.75 Favored Glycine 0 N--CA 1.441 -0.972 0 C-N-CA 121.147 -0.549 . . . . 71.31 111.924 178.503 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -53.84 -48.57 69.81 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 124.201 1.0 . . . . 55.43 112.263 -176.332 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -68.99 -32.24 71.65 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.776 -0.647 . . . . 74.33 111.33 -178.477 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.495 ' OE1' ' HA ' ' A' ' 202' ' ' PRO . 2.5 tm-20 -75.89 -44.41 40.6 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.658 -0.701 . . . . 65.23 109.282 -177.776 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 50.7 m -57.87 -33.38 68.63 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.338 0.496 . . . . 73.42 112.338 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 209' ' ' THR . . . . . 0.463 HG23 ' H ' ' A' ' 211' ' ' LEU . 11.3 t -83.16 -17.44 42.9 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 119.945 -0.702 . . . . 71.41 110.989 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 64.65 17.08 62.03 Favored Glycine 0 C--N 1.334 0.436 0 CA-C-N 116.439 -0.346 . . . . 74.41 113.621 178.334 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.463 ' H ' HG23 ' A' ' 209' ' ' THR . 76.3 mt -95.69 -22.34 17.62 Favored 'General case' 0 C--O 1.199 -1.59 0 C-N-CA 120.224 -0.59 . . . . 71.41 110.776 -177.271 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.513 HD11 HG21 ' A' ' 161' ' ' VAL . 6.9 mp -107.22 134.1 50.81 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-O 121.366 0.603 . . . . 54.4 111.102 -178.308 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -131.27 165.39 23.5 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-N 114.23 -1.35 . . . . 75.11 109.88 -179.284 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 33.3 m -65.09 -29.39 47.2 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 N-CA-C 113.66 0.985 . . . . 65.24 113.66 -179.209 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -74.85 -14.14 60.64 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.7 -0.625 . . . . 74.42 111.252 -178.233 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.502 ' HB3' ' HB ' ' A' ' 249' ' ' VAL . 79.8 m-20 -66.69 142.97 57.24 Favored 'General case' 0 C--O 1.247 0.971 0 N-CA-C 112.984 0.735 . . . . 52.51 112.984 -176.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 217' ' ' GLU . . . . . 0.419 ' HB3' ' HG3' ' A' ' 250' ' ' LYS . 41.1 tt0 -109.21 133.13 53.42 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.635 -1.166 . . . . 74.34 108.802 177.634 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.644 ' HA ' HG12 ' A' ' 249' ' ' VAL . 20.7 t -84.36 130.68 35.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.496 0.665 . . . . 73.03 111.289 -174.546 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.48 HG13 ' NE2' ' A' ' 158' ' ' HIS . 44.0 mm -99.44 -56.86 4.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-N 115.168 -0.923 . . . . 75.11 111.652 -177.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.409 ' HB3' ' HA ' ' A' ' 225' ' ' GLU . 10.9 pt-20 -155.02 151.2 28.16 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 116.108 -0.497 . . . . 70.23 110.503 -176.362 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.507 ' HA ' ' O ' ' A' ' 246' ' ' ILE . 8.6 p -120.33 122.71 68.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 CA-C-N 115.648 -0.705 . . . . 63.34 109.24 177.793 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 222' ' ' ASN . . . . . 0.438 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 2.5 m-20 58.24 24.58 11.63 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.656 1.183 . . . . 53.33 112.474 -177.347 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 95.69 -7.23 67.97 Favored Glycine 0 N--CA 1.435 -1.418 0 CA-C-N 115.377 -0.829 . . . . 64.13 111.853 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 62.1 mt -97.31 122.63 49.07 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.509 0 N-CA-C 108.899 -0.778 . . . . 75.42 108.899 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 225' ' ' GLU . . . . . 0.409 ' HA ' ' HB3' ' A' ' 220' ' ' GLU . 11.1 pt-20 -61.83 139.33 58.36 Favored 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 123.704 0.802 . . . . 72.23 112.674 -176.565 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 226' ' ' VAL . . . . . 0.465 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 34.3 m -117.11 3.21 7.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 CA-C-N 115.376 -0.829 . . . . 64.13 109.798 175.503 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -75.67 99.11 4.24 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 115.224 -0.898 . . . . 73.51 109.816 -179.723 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 113.26 -8.84 24.75 Favored Glycine 0 CA--C 1.5 -0.846 0 N-CA-C 110.983 -0.847 . . . . 52.32 110.983 179.316 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -83.14 158.27 22.45 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.781 -0.822 . . . . 70.43 108.781 178.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 230' ' ' THR . . . . . 0.444 ' O ' HG13 ' A' ' 234' ' ' VAL . 82.7 p -84.02 170.7 13.66 Favored 'General case' 0 N--CA 1.412 -2.35 0 C-N-CA 119.584 -0.846 . . . . 73.12 110.397 178.67 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -61.85 -37.78 85.76 Favored 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 109.139 -0.689 . . . . 75.55 109.139 179.249 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -58.7 -52.29 66.34 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.198 0.523 . . . . 73.33 110.054 175.187 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 233' ' ' GLN . . . . . 0.504 ' O ' ' HG2' ' A' ' 237' ' ' MET . 39.6 mt-30 -54.78 -44.76 74.0 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.606 -1.179 . . . . 63.15 112.481 179.337 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.649 HG21 HG12 ' A' ' 195' ' ' ILE . 8.2 m -77.12 -34.47 21.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 112.438 0.533 . . . . 55.31 112.438 -176.563 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 235' ' ' THR . . . . . 0.446 ' O ' HG23 ' A' ' 239' ' ' VAL . 31.9 m -71.25 -35.81 71.55 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 109.522 -0.548 . . . . 61.43 109.522 -179.128 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -63.38 -31.14 72.21 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 109.722 -0.473 . . . . 72.34 109.722 176.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 237' ' ' MET . . . . . 0.504 ' HG2' ' O ' ' A' ' 233' ' ' GLN . 17.2 mmt -62.54 -52.55 63.0 Favored 'General case' 0 C--O 1.195 -1.767 0 N-CA-C 107.9 -1.148 . . . . 73.25 107.9 174.643 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 238' ' ' MET . . . . . 0.419 ' HG3' ' O ' ' A' ' 234' ' ' VAL . 59.5 mtt -63.93 -33.02 74.77 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.159 -0.928 . . . . 52.42 112.843 -173.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 235' ' ' THR . 85.7 t -68.96 -44.12 81.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 N-CA-C 109.175 -0.676 . . . . 74.42 109.175 175.691 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -66.91 -36.3 81.95 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.85 -0.614 . . . . 74.52 110.594 178.621 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -87.29 22.13 2.22 Favored 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 124.364 1.066 . . . . 75.42 111.612 179.463 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 242' ' ' SER . . . . . 0.635 ' O ' HD12 ' A' ' 164' ' ' LEU . 34.3 t -58.76 -42.29 88.54 Favored 'General case' 0 C--O 1.204 -1.334 0 CA-C-N 118.112 0.415 . . . . 72.24 112.064 -179.683 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 243' ' ' SER . . . . . 0.434 ' O ' ' HA ' ' A' ' 165' ' ' LYS . 37.5 m -74.21 -16.98 60.95 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 112.405 0.52 . . . . 50.51 112.405 -178.411 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -153.18 85.12 1.21 Allowed 'General case' 0 CA--C 1.5 -0.949 0 N-CA-C 108.447 -0.946 . . . . 73.44 108.447 179.348 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.579 ' HB3' ' HB2' ' A' ' 163' ' ' LEU . 2.0 tt -92.03 105.78 17.95 Favored 'General case' 0 N--CA 1.432 -1.343 0 C-N-CA 119.694 -0.803 . . . . 74.43 109.732 -177.7 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.68 HG12 ' HG3' ' A' ' 162' ' ' ARG . 93.2 mt -109.19 115.4 49.45 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 O-C-N 121.882 -0.511 . . . . 72.03 110.19 177.167 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 247' ' ' ILE . . . . . 0.483 HG13 ' CD2' ' A' ' 245' ' ' LEU . 27.4 mt -119.26 133.27 66.64 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 N-CA-C 112.838 0.681 . . . . 71.13 112.838 177.539 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.637 ' HA ' ' O ' ' A' ' 159' ' ' ARG . 63.5 m -102.92 117.0 33.64 Favored 'General case' 0 N--CA 1.417 -2.095 0 CA-C-N 114.484 -1.235 . . . . 74.42 108.087 173.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.644 HG12 ' HA ' ' A' ' 218' ' ' VAL . 18.9 m -122.54 165.57 18.35 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.064 0 CA-C-O 121.194 0.521 . . . . 72.54 110.198 175.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.434 ' HB3' ' CD2' ' A' ' 158' ' ' HIS . 15.0 ptmt -129.46 128.53 23.15 Favored Pre-proline 0 C--N 1.277 -2.576 0 C-N-CA 125.137 1.375 . . . . 63.12 107.621 176.248 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -67.86 133.03 28.1 Favored 'Trans proline' 0 N--CA 1.441 -1.613 0 N-CA-C 109.598 -0.962 . . . . 74.12 109.598 176.214 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -72.34 -24.28 61.27 Favored 'General case' 0 CA--C 1.499 -1.01 0 CA-C-O 121.524 0.678 . . . . 71.12 110.058 -178.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -93.3 1.12 57.12 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 114.782 -1.099 . . . . 72.44 109.661 178.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 63.34 166.42 0.13 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.846 0.858 . . . . 73.43 111.295 -175.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 61.3 ttt180 . . . . . 0 C--N 1.299 -1.595 0 N-CA-C 108.014 -1.106 . . . . 75.22 108.014 174.9 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.89 0 N-CA-C 111.632 0.234 . . . . 70.22 111.632 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 69.6 p -78.94 -28.77 43.77 Favored 'General case' 0 C--O 1.207 -1.162 0 CA-C-O 121.94 0.876 . . . . 75.11 108.904 177.773 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.615 ' NE2' HG13 ' A' ' 219' ' ' ILE . 4.0 m80 -120.59 136.32 54.84 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 114.363 -1.29 . . . . 73.13 108.622 177.488 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.502 HH11 HD22 ' A' ' 211' ' ' LEU . 36.7 ttm180 -133.12 142.84 48.9 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 109.329 -0.619 . . . . 72.33 109.329 173.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.414 ' HG3' ' OG1' ' A' ' 248' ' ' THR . 0.1 OUTLIER -106.69 117.12 33.2 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 109.072 -0.714 . . . . 71.24 109.072 -179.399 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.559 HG11 HD21 ' A' ' 211' ' ' LEU . 14.2 m -123.39 138.43 53.3 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.209 0 N-CA-C 112.18 0.437 . . . . 75.44 112.18 178.366 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.732 ' HG2' HG12 ' A' ' 246' ' ' ILE . 65.4 mtt180 -92.7 111.6 23.26 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 108.87 -0.789 . . . . 62.44 108.87 171.487 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.551 ' HB2' ' HB3' ' A' ' 245' ' ' LEU . 34.9 mt -93.33 139.3 30.81 Favored 'General case' 0 C--N 1.281 -2.388 0 N-CA-C 107.29 -1.374 . . . . 53.32 107.29 179.144 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.63 ' H ' ' HG ' ' A' ' 205' ' ' LEU . 2.3 tm? 76.0 80.18 0.1 Allowed 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 107.874 -1.158 . . . . 73.51 107.874 179.439 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -107.65 -22.37 12.53 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 114.315 -1.311 . . . . 74.51 110.424 179.615 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 21.4 t-80 -155.15 132.58 11.12 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.551 -0.907 . . . . 74.53 108.551 -178.723 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' GLY . . . . . 0.464 ' HA3' ' HE2' ' A' ' 170' ' ' LYS . . . 134.57 -54.32 0.76 Allowed Glycine 0 N--CA 1.423 -2.205 0 N-CA-C 110.618 -0.993 . . . . 73.52 110.618 178.568 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 49.5 m 64.18 118.21 0.02 OUTLIER 'General case' 0 C--O 1.242 0.708 0 C-N-CA 124.402 1.081 . . . . 64.45 113.03 -179.047 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 73.32 8.66 5.21 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 114.612 1.338 . . . . 72.12 114.612 176.334 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.464 ' HE2' ' HA3' ' A' ' 167' ' ' GLY . 0.1 OUTLIER -85.21 153.51 59.53 Favored Pre-proline 0 C--N 1.307 -1.259 0 N-CA-C 109.489 -0.56 . . . . 72.01 109.489 173.935 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -50.42 133.14 36.64 Favored 'Trans proline' 0 C--O 1.244 0.786 0 C-N-CA 123.259 2.639 . . . . 71.42 111.55 177.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -69.51 -27.27 65.04 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 115.522 -0.763 . . . . 60.12 110.776 -177.176 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' GLY . . . . . 0.535 ' HA2' ' HB ' ' A' ' 201' ' ' VAL . . . 109.03 13.98 16.36 Favored Glycine 0 N--CA 1.421 -2.348 0 C-N-CA 119.677 -1.249 . . . . 64.02 114.213 174.281 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -162.66 153.79 17.5 Favored 'General case' 0 N--CA 1.435 -1.225 0 CA-C-N 118.155 0.978 . . . . 73.25 110.154 -177.049 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.482 ' CE1' HG22 ' A' ' 201' ' ' VAL . 71.0 m-85 -115.4 144.88 43.14 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 108.045 -1.095 . . . . 73.24 108.045 174.547 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.578 ' HB ' ' CG2' ' A' ' 195' ' ' ILE . 36.8 pt -110.47 168.96 3.98 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.393 0 CA-C-O 121.16 0.505 . . . . 70.14 110.538 179.575 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.567 ' HG2' ' HB2' ' A' ' 198' ' ' SER . 5.1 ptp180 -154.07 153.88 32.67 Favored 'General case' 0 C--N 1.288 -2.084 0 C-N-CA 123.798 0.839 . . . . 74.42 109.091 178.159 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -100.16 141.52 32.88 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 109.156 -0.683 . . . . 74.3 109.156 177.006 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -153.9 -159.9 9.45 Favored Glycine 0 C--N 1.284 -2.325 0 N-CA-C 109.029 -1.629 . . . . 72.41 109.029 177.766 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' THR . . . . . 0.404 ' HB ' ' CG ' ' A' ' 191' ' ' LYS . 0.7 OUTLIER -110.13 126.74 54.38 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 117.711 0.756 . . . . 71.41 112.462 177.809 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 26.5 t -110.63 116.95 32.24 Favored 'General case' 0 N--CA 1.413 -2.283 0 N-CA-C 107.79 -1.189 . . . . 75.53 107.79 177.143 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.568 ' HA ' ' O ' ' A' ' 190' ' ' GLU . 6.1 p -112.63 119.48 60.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 109.057 -0.72 . . . . 70.32 109.057 174.135 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 85.9 mtt180 -124.53 160.93 27.22 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 108.438 -0.949 . . . . 74.52 108.438 -175.018 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 72.9 t -90.49 118.39 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.141 0 N-CA-C 108.375 -0.972 . . . . 75.25 108.375 173.123 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 29.7 p -124.54 -174.15 2.95 Favored 'General case' 0 C--N 1.267 -3.005 0 CA-C-N 114.156 -1.384 . . . . 63.44 108.287 -177.473 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -64.45 -19.71 65.71 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.082 -0.71 . . . . 73.33 109.082 174.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 16.6 m -85.74 -10.11 56.08 Favored 'General case' 0 N--CA 1.435 -1.204 0 CA-C-N 115.214 -0.903 . . . . 60.53 110.249 178.18 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 100.53 -142.92 16.06 Favored Glycine 0 CA--C 1.482 -1.982 0 N-CA-C 109.021 -1.632 . . . . 32.32 109.021 -179.14 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 5.5 mp -83.1 120.15 25.4 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 107.97 -1.122 . . . . 72.21 107.97 175.243 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 190' ' ' GLU . . . . . 0.568 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 44.2 tt0 -131.49 119.15 21.16 Favored 'General case' 0 C--N 1.29 -1.978 0 N-CA-C 109.393 -0.595 . . . . 72.51 109.393 -176.623 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.404 ' CG ' ' HB ' ' A' ' 180' ' ' THR . 36.1 ttmt -97.69 132.0 43.73 Favored 'General case' 0 N--CA 1.427 -1.612 0 N-CA-C 108.074 -1.084 . . . . 74.53 108.074 -179.221 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 27.9 pt20 -145.13 164.34 27.49 Favored Pre-proline 0 C--N 1.287 -2.146 0 N-CA-C 108.284 -1.006 . . . . 73.31 108.284 -177.598 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -60.84 131.71 38.79 Favored 'Trans proline' 0 N--CA 1.448 -1.159 0 N-CA-C 109.401 -1.038 . . . . 71.11 109.401 174.369 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -137.49 150.87 20.94 Favored Glycine 0 CA--C 1.474 -2.481 0 N-CA-C 109.393 -1.483 . . . . 44.51 109.393 -178.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.587 ' HB ' ' CG1' ' A' ' 218' ' ' VAL . 3.2 mp -108.22 138.22 35.96 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.291 0 C-N-CA 120.071 -0.652 . . . . 74.13 110.141 -179.172 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -131.44 163.7 27.36 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 107.185 -1.413 . . . . 72.24 107.185 -177.601 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 41.7 mt -81.97 128.52 38.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 CA-C-O 121.711 0.767 . . . . 64.44 110.447 175.519 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 198' ' ' SER . . . . . 0.567 ' HB2' ' HG2' ' A' ' 177' ' ' ARG . 27.8 t -100.47 -22.79 14.9 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 112.892 0.701 . . . . 61.14 112.892 -177.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 51.3 ttp180 -167.56 152.26 6.87 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 109.601 -0.518 . . . . 72.52 109.601 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 38.7 mt -100.96 146.34 27.52 Favored 'General case' 0 CA--C 1.48 -1.729 0 N-CA-C 108.85 -0.796 . . . . 73.54 108.85 173.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 201' ' ' VAL . . . . . 0.535 ' HB ' ' HA2' ' A' ' 173' ' ' GLY . 10.9 t -103.44 114.67 64.72 Favored Pre-proline 0 C--N 1.284 -2.252 0 N-CA-C 105.914 -1.884 . . . . 71.53 105.914 174.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.543 ' HA ' ' HG2' ' A' ' 207' ' ' GLU . 23.9 Cg_exo -63.34 135.8 51.95 Favored 'Trans proline' 0 N--CA 1.447 -1.209 0 C-N-CA 121.888 1.725 . . . . 63.13 110.707 -178.085 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.426 ' H ' ' HG2' ' A' ' 207' ' ' GLU . . . 94.73 -12.6 68.47 Favored Glycine 0 C--N 1.312 -0.789 0 C-N-CA 120.891 -0.671 . . . . 75.24 112.152 -178.013 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 204' ' ' GLY . . . . . 0.438 ' HA3' ' CA ' ' A' ' 173' ' ' GLY . . . -80.05 172.95 54.93 Favored Glycine 0 N--CA 1.436 -1.328 0 C-N-CA 120.891 -0.671 . . . . 64.41 111.707 179.454 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.63 ' HG ' ' H ' ' A' ' 164' ' ' LEU . 2.8 mm? -67.17 -41.91 85.18 Favored 'General case' 0 C--N 1.311 -1.089 0 C-N-CA 123.126 0.57 . . . . 61.24 111.761 -175.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -60.52 -39.18 86.89 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.102 0.477 . . . . 61.31 110.445 176.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.543 ' HG2' ' HA ' ' A' ' 202' ' ' PRO . 9.1 tp10 -67.85 -42.07 81.94 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.455 -0.793 . . . . 74.33 109.524 177.55 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 51.0 m -60.54 -45.12 95.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.4 -0.818 . . . . 72.13 112.032 -177.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 209' ' ' THR . . . . . 0.61 HG23 ' H ' ' A' ' 211' ' ' LEU . 10.0 t -76.72 -30.12 56.5 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 109.362 -0.607 . . . . 65.0 109.362 178.025 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 66.04 16.55 64.42 Favored Glycine 0 C--N 1.34 0.754 0 CA-C-N 115.509 -0.769 . . . . 40.31 113.106 177.451 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.61 ' H ' HG23 ' A' ' 209' ' ' THR . 1.9 pp -99.74 -3.45 32.82 Favored 'General case' 0 N--CA 1.433 -1.28 0 C-N-CA 120.275 -0.57 . . . . 64.33 110.86 -177.426 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 5.4 mp -109.25 133.23 53.3 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 107.622 -1.251 . . . . 72.25 107.622 175.286 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -131.05 166.51 20.88 Favored 'General case' 0 C--N 1.279 -2.485 0 N-CA-C 108.599 -0.889 . . . . 63.53 108.599 178.368 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 35.5 m -57.38 -31.03 37.3 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 N-CA-C 112.726 0.639 . . . . 71.25 112.726 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 -73.22 -13.86 61.23 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 113.201 0.815 . . . . 64.25 113.201 -179.206 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -73.3 135.09 44.36 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.324 0.583 . . . . 73.43 112.405 -178.644 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -104.53 134.33 47.89 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.881 -1.054 . . . . 71.32 109.162 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.601 ' HA ' HG12 ' A' ' 249' ' ' VAL . 13.1 p -84.08 134.97 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 CA-C-O 122.175 0.988 . . . . 72.55 111.395 -177.696 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.615 HG13 ' NE2' ' A' ' 158' ' ' HIS . 36.2 mm -99.27 -52.98 8.27 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.078 0 CA-C-N 114.332 -1.303 . . . . 73.01 111.025 -179.147 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.414 ' HG2' ' HB ' ' A' ' 248' ' ' THR . 11.1 pt-20 -157.78 151.34 23.72 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 116.076 -0.511 . . . . 72.42 110.926 -175.487 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.425 HG12 ' CG1' ' A' ' 226' ' ' VAL . 6.9 p -120.81 124.44 72.36 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 N-CA-C 108.959 -0.756 . . . . 74.14 108.959 176.751 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 222' ' ' ASN . . . . . 0.494 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 16.3 t-20 70.63 -3.8 1.83 Allowed 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 125.062 1.345 . . . . 70.34 111.164 -178.343 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 120.58 -17.91 9.42 Favored Glycine 0 C--N 1.301 -1.407 0 N-CA-C 111.019 -0.832 . . . . 54.4 111.019 -175.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 63.5 mt -88.52 123.77 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 N-CA-C 109.203 -0.666 . . . . 70.53 109.203 -179.391 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 225' ' ' GLU . . . . . 0.403 ' HA ' ' HB3' ' A' ' 220' ' ' GLU . 13.1 pt-20 -61.54 147.84 44.1 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.585 0.707 . . . . 74.21 111.506 -178.597 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 226' ' ' VAL . . . . . 0.425 ' CG1' HG12 ' A' ' 221' ' ' VAL . 26.1 m -117.8 -2.52 9.83 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 CA-C-N 115.408 -0.814 . . . . 63.11 112.239 179.459 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -82.16 104.34 12.42 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 109.169 -0.678 . . . . 51.32 109.169 177.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 122.58 -25.05 6.66 Favored Glycine 0 C--N 1.297 -1.597 0 N-CA-C 110.096 -1.202 . . . . 75.24 110.096 -179.603 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -74.0 166.7 22.92 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 107.711 -1.218 . . . . 74.14 107.711 176.266 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 230' ' ' THR . . . . . 0.447 ' O ' HG13 ' A' ' 234' ' ' VAL . 82.5 p -91.0 168.15 11.87 Favored 'General case' 0 C--O 1.249 1.06 0 N-CA-C 108.413 -0.958 . . . . 52.15 108.413 178.741 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 47.2 tp -66.07 -27.96 68.47 Favored 'General case' 0 N--CA 1.428 -1.566 0 C-N-CA 120.56 -0.456 . . . . 72.25 109.911 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -69.07 -47.71 64.6 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.725 -0.472 . . . . 71.24 109.725 176.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -58.92 -48.36 81.72 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 113.587 0.958 . . . . 64.3 113.587 177.573 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.525 HG21 HG12 ' A' ' 195' ' ' ILE . 13.3 m -65.14 -34.23 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-O 121.343 0.592 . . . . 64.21 111.598 -175.797 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 235' ' ' THR . . . . . 0.471 ' O ' HG23 ' A' ' 239' ' ' VAL . 90.0 m -75.48 -35.65 60.78 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 115.52 -0.764 . . . . 54.23 109.394 -176.087 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -61.53 -34.03 74.84 Favored 'General case' 0 CA--C 1.508 -0.639 0 N-CA-C 108.8 -0.815 . . . . 71.43 108.8 177.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 9.9 mtt -67.66 -45.46 75.21 Favored 'General case' 0 C--O 1.211 -0.933 0 N-CA-C 108.113 -1.069 . . . . 75.14 108.113 178.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 65.9 mtt -59.25 -38.72 80.76 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.884 -0.598 . . . . 74.11 111.531 -178.662 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 235' ' ' THR . 60.6 t -69.76 -33.16 54.98 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-O 121.255 0.55 . . . . 73.01 110.217 178.371 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -75.28 -30.33 60.4 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.203 0.525 . . . . 53.4 111.404 179.222 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 -90.14 21.84 3.56 Favored 'General case' 0 C--O 1.2 -1.531 0 CA-C-N 115.895 -0.593 . . . . 72.21 112.519 -178.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 242' ' ' SER . . . . . 0.557 ' O ' HD12 ' A' ' 164' ' ' LEU . 50.4 m -56.65 -22.97 38.3 Favored 'General case' 0 C--O 1.206 -1.22 0 N-CA-C 112.552 0.575 . . . . 72.11 112.552 177.283 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 18.4 m -64.16 -38.42 91.0 Favored 'General case' 0 CA--C 1.55 0.951 0 O-C-N 122.241 -0.287 . . . . 40.0 110.475 177.255 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -168.0 107.55 0.53 Allowed 'General case' 0 CA--C 1.491 -1.301 0 C-N-CA 126.876 2.071 . . . . 72.23 107.414 177.371 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.551 ' HB3' ' HB2' ' A' ' 163' ' ' LEU . 0.2 OUTLIER -84.77 105.28 15.44 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 108.348 -0.982 . . . . 71.15 108.348 -174.667 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.732 HG12 ' HG2' ' A' ' 162' ' ' ARG . 89.4 mt -94.08 115.31 32.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 109.003 -0.74 . . . . 64.03 109.003 179.079 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 247' ' ' ILE . . . . . 0.53 HG23 HG23 ' A' ' 218' ' ' VAL . 13.3 mt -125.47 135.65 63.3 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.073 0 CA-C-O 121.467 0.651 . . . . 73.35 112.181 176.74 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.486 ' HA ' ' O ' ' A' ' 159' ' ' ARG . 70.1 m -107.55 115.52 30.3 Favored 'General case' 0 N--CA 1.414 -2.274 0 N-CA-C 107.636 -1.246 . . . . 65.22 107.636 173.809 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.601 HG12 ' HA ' ' A' ' 218' ' ' VAL . 12.1 m -117.93 164.94 13.76 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.115 0 N-CA-C 109.491 -0.559 . . . . 61.13 109.491 174.298 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.427 ' CD ' HD11 ' A' ' 219' ' ' ILE . 17.4 ptmt -131.86 128.3 21.54 Favored Pre-proline 0 C--N 1.286 -2.16 0 CA-C-N 114.896 -1.047 . . . . 73.34 108.676 174.756 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -72.25 133.79 21.76 Favored 'Trans proline' 0 N--CA 1.442 -1.528 0 C-N-CA 121.559 1.506 . . . . 75.03 112.382 179.449 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -64.12 -19.93 65.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.032 -0.531 . . . . 73.54 111.355 179.031 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -81.85 -12.99 58.22 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.584 -0.735 . . . . 72.52 111.165 178.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 85.1 mm-40 67.73 172.23 0.27 Allowed 'General case' 0 C--O 1.24 0.59 0 CA-C-O 121.839 0.828 . . . . 72.45 112.822 -179.328 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? . . . . . 0 N--CA 1.418 -2.056 0 N-CA-C 105.29 -2.115 . . . . 71.3 105.29 178.339 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.239 0.527 0 N-CA-C 109.86 -0.422 . . . . 74.23 109.86 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 23.1 p -72.85 -45.56 57.68 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-O 120.68 0.276 . . . . 74.43 111.232 178.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.78 ' HB3' ' HB3' ' A' ' 250' ' ' LYS 0.407 6.0 p-80 -114.83 130.53 56.89 Favored 'General case' 0 CA--C 1.496 -1.107 0 N-CA-C 114.74 1.385 . . . . 72.24 114.74 174.064 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.559 ' O ' ' HA ' ' A' ' 248' ' ' THR . 11.3 ptt180 -110.34 143.84 39.97 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 113.562 -1.654 . . . . 72.54 110.812 -173.373 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -114.0 112.93 24.07 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 121.702 0.763 . . . . 73.33 110.887 178.671 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.576 HG11 HD21 ' A' ' 211' ' ' LEU . 28.4 m -114.3 139.7 38.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 CA-C-N 114.879 -1.055 . . . . 65.32 112.786 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.425 ' HA ' ' HA ' ' A' ' 246' ' ' ILE . 19.8 ttm180 -96.48 112.83 24.43 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.434 0.635 . . . . 74.12 109.781 177.413 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.41 ' HB2' ' HB3' ' A' ' 245' ' ' LEU . 19.8 mt -94.13 138.18 32.48 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-N 114.999 -1.0 . . . . 75.53 108.685 -178.318 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.416 HD23 ' O ' ' A' ' 242' ' ' SER . 15.4 tp 74.42 85.26 0.1 Allowed 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 122.121 0.962 . . . . 75.32 111.632 174.793 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -114.96 -8.42 12.5 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-N 114.708 -1.133 . . . . 64.31 110.888 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -107.5 77.9 1.17 Allowed 'General case' 0 C--N 1.307 -1.239 0 CA-C-O 121.034 0.445 . . . . 74.32 110.71 179.541 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 84.48 -153.86 29.26 Favored Glycine 0 N--CA 1.402 -3.626 0 N-CA-C 108.157 -1.977 . . . . 71.35 108.157 177.279 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' SER . . . . . 0.408 ' HA ' HD21 ' A' ' 164' ' ' LEU . 27.2 t -173.73 82.83 0.04 OUTLIER 'General case' 0 N--CA 1.404 -2.768 0 N-CA-C 108.749 -0.834 . . . . 73.51 108.749 178.291 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -138.52 -26.61 0.88 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.622 -1.172 . . . . 73.22 110.818 -178.542 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.402 ' HB2' ' HE3' ' A' ' 170' ' ' LYS . 21.6 ptmt -96.63 153.67 38.7 Favored Pre-proline 0 N--CA 1.434 -1.253 0 CA-C-N 116.501 -0.318 . . . . 61.32 110.978 -178.061 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -63.37 153.96 71.23 Favored 'Trans proline' 0 C--O 1.245 0.855 0 C-N-CA 122.905 2.403 . . . . 55.04 110.576 173.459 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.555 ' HG ' HD12 ' A' ' 245' ' ' LEU . 3.6 mm? -68.49 -31.71 71.17 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 112.284 0.476 . . . . 74.51 112.284 -178.011 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 173' ' ' GLY . . . . . 0.513 ' HA3' ' HA3' ' A' ' 204' ' ' GLY . . . 88.07 34.97 9.26 Favored Glycine 0 N--CA 1.426 -2.024 0 C-N-CA 120.595 -0.812 . . . . 50.45 113.271 177.008 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -154.73 154.02 32.2 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 107.487 -1.301 . . . . 55.0 107.487 174.273 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -125.45 148.94 48.64 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 108.939 -0.763 . . . . 74.4 108.939 176.468 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.541 HD13 ' SD ' ' A' ' 238' ' ' MET . 35.6 pt -110.08 169.52 3.61 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 CA-C-O 121.32 0.581 . . . . 54.02 111.253 -176.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.537 ' CG ' ' HB2' ' A' ' 198' ' ' SER . 15.7 ptt180 -149.21 154.79 39.64 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 115.112 -0.949 . . . . 72.42 109.312 -179.39 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -117.54 144.5 45.04 Favored 'General case' 0 C--N 1.287 -2.124 0 N-CA-C 109.014 -0.736 . . . . 64.23 109.014 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -161.95 179.96 36.98 Favored Glycine 0 N--CA 1.417 -2.63 0 N-CA-C 109.712 -1.355 . . . . 54.03 109.712 178.795 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' THR . . . . . 0.513 ' HB ' ' CG ' ' A' ' 191' ' ' LYS . 0.8 OUTLIER -86.46 123.92 32.22 Favored 'General case' 0 C--N 1.29 -1.997 0 CA-C-O 121.66 0.743 . . . . 61.33 112.193 177.298 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 37.4 t -104.56 113.62 27.31 Favored 'General case' 0 N--CA 1.403 -2.788 0 N-CA-C 107.356 -1.35 . . . . 74.42 107.356 177.225 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.65 ' HA ' ' O ' ' A' ' 190' ' ' GLU . 3.5 p -108.63 124.35 65.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 109.185 -0.672 . . . . 70.53 109.185 174.757 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -130.27 160.28 34.36 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-N 115.341 -0.845 . . . . 72.45 108.791 -172.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 56.6 t -84.98 119.69 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.38 0 CA-C-O 121.89 0.852 . . . . 71.4 108.781 172.227 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 40.9 p -128.45 -174.16 3.15 Favored 'General case' 0 C--N 1.276 -2.625 0 CA-C-N 114.001 -1.454 . . . . 75.35 108.342 -175.071 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -68.89 -15.53 63.52 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.421 0.629 . . . . 41.03 109.526 175.026 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 34.9 t -89.03 -9.0 52.94 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.389 -0.823 . . . . 72.11 109.027 177.014 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 98.07 -136.97 13.01 Favored Glycine 0 CA--C 1.483 -1.931 0 N-CA-C 108.523 -1.831 . . . . 63.21 108.523 -177.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 6.4 mp -80.54 118.81 22.46 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.282 -1.007 . . . . 70.14 108.282 173.68 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 190' ' ' GLU . . . . . 0.65 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 11.5 tp10 -129.88 123.3 30.47 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.532 -0.914 . . . . 73.43 108.532 -174.231 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.513 ' CG ' ' HB ' ' A' ' 180' ' ' THR . 34.6 ttmt -106.67 126.42 52.26 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.964 -0.754 . . . . 71.42 108.964 -177.217 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -145.71 164.71 24.34 Favored Pre-proline 0 C--N 1.292 -1.905 0 N-CA-C 107.893 -1.151 . . . . 74.02 107.893 -177.27 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -59.29 132.76 48.45 Favored 'Trans proline' 0 C--O 1.245 0.834 0 C-N-CA 121.533 1.488 . . . . 71.4 111.667 176.247 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -139.53 143.24 13.62 Favored Glycine 0 N--CA 1.419 -2.481 0 N-CA-C 109.778 -1.329 . . . . 63.12 109.778 178.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.623 HG12 HG21 ' A' ' 234' ' ' VAL . 3.2 mp -108.76 132.84 55.64 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 CA-C-O 121.117 0.484 . . . . 75.04 110.767 -179.2 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -125.31 167.72 14.51 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 107.946 -1.131 . . . . 75.22 107.946 -176.138 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 197' ' ' ILE . . . . . 0.467 ' HB ' ' HA ' ' A' ' 214' ' ' VAL . 46.5 mm -77.06 131.51 34.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 N-CA-C 108.189 -1.041 . . . . 75.43 108.189 174.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 198' ' ' SER . . . . . 0.537 ' HB2' ' CG ' ' A' ' 177' ' ' ARG . 12.7 t -104.48 -38.49 6.77 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 113.449 0.907 . . . . 52.31 113.449 -178.525 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 40.0 ttp180 -150.47 141.86 23.36 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 120.004 -0.678 . . . . 72.01 109.947 -177.322 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -108.45 133.79 52.13 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 107.562 -1.273 . . . . 64.41 107.562 -177.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 44.0 t -110.6 131.58 22.01 Favored Pre-proline 0 C--N 1.311 -1.073 0 C-N-CA 120.756 -0.378 . . . . 73.11 110.736 -177.458 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.472 ' HA ' ' OE2' ' A' ' 207' ' ' GLU . 17.8 Cg_endo -60.78 135.21 58.47 Favored 'Trans proline' 0 C--O 1.247 0.939 0 C-N-CA 122.717 2.278 . . . . 55.54 111.682 176.621 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 86.37 0.78 86.46 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.812 -0.631 . . . . 72.32 112.63 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 204' ' ' GLY . . . . . 0.513 ' HA3' ' HA3' ' A' ' 173' ' ' GLY . . . -88.25 170.26 38.96 Favored Glycine 0 N--CA 1.439 -1.13 0 C-N-CA 120.577 -0.82 . . . . 74.22 112.526 -178.828 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 172' ' ' LEU . 3.6 mm? -66.39 -34.25 77.54 Favored 'General case' 0 N--CA 1.438 -1.075 0 C-N-CA 123.088 0.555 . . . . 74.42 110.582 -179.534 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 206' ' ' ALA . . . . . 0.469 ' CB ' HD12 ' A' ' 212' ' ' LEU . . . -61.76 -41.55 97.83 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 115.613 -0.721 . . . . 62.41 110.49 176.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.472 ' OE2' ' HA ' ' A' ' 202' ' ' PRO . 41.2 tt0 -75.6 -33.52 60.56 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.946 -0.57 . . . . 75.33 110.234 178.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 44.3 t -56.34 -50.14 72.36 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 123.755 0.822 . . . . 51.24 111.042 -179.306 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 209' ' ' THR . . . . . 0.617 HG23 ' H ' ' A' ' 211' ' ' LEU . 8.8 t -80.02 -25.98 39.99 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 119.648 -0.821 . . . . 75.33 109.59 176.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 65.6 22.84 70.13 Favored Glycine 0 N--CA 1.446 -0.689 0 CA-C-N 115.608 -0.724 . . . . 50.52 112.543 179.095 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.617 ' H ' HG23 ' A' ' 209' ' ' THR . 1.1 pp -111.61 4.06 18.39 Favored 'General case' 0 N--CA 1.436 -1.174 0 C-N-CA 120.073 -0.651 . . . . 61.22 112.235 -177.33 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.469 HD12 ' CB ' ' A' ' 206' ' ' ALA . 75.5 mt -108.39 133.13 53.0 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 108.65 -0.87 . . . . 72.33 108.65 177.577 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -131.86 165.23 24.3 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 107.613 -1.254 . . . . 63.03 107.613 177.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 214' ' ' VAL . . . . . 0.467 ' HA ' ' HB ' ' A' ' 197' ' ' ILE 0.259 18.7 m -65.53 -28.83 45.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 113.519 0.933 . . . . 71.3 113.519 -177.99 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -73.11 -15.14 61.49 Favored 'General case' 0 N--CA 1.484 1.247 0 O-C-N 121.906 -0.496 . . . . 41.32 111.636 178.611 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -66.43 131.95 47.21 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-O 121.337 0.589 . . . . 62.33 112.036 -179.595 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 217' ' ' GLU . . . . . 0.44 ' O ' ' HA ' ' A' ' 249' ' ' VAL . 38.6 tt0 -105.82 132.4 51.99 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.95 -1.023 . . . . 74.34 111.044 -178.707 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.525 HG13 HG23 ' A' ' 247' ' ' ILE . 35.4 t -81.66 127.37 39.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 C-N-CA 123.24 0.616 . . . . 74.1 110.643 -176.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 40.9 mm -98.84 -49.41 11.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 CA-C-N 115.341 -0.845 . . . . 71.35 110.806 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.457 ' CB ' ' HA ' ' A' ' 225' ' ' GLU . 12.7 pt-20 -152.55 158.41 42.46 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-O 120.529 0.204 . . . . 75.33 110.703 -179.255 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.47 ' C ' ' H ' ' A' ' 223' ' ' GLY . 9.1 p -125.36 125.76 69.54 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 N-CA-C 109.088 -0.708 . . . . 73.21 109.088 178.406 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 222' ' ' ASN . . . . . 0.687 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 5.7 t30 71.92 -31.8 0.23 Allowed 'General case' 0 N--CA 1.499 2.021 0 C-N-CA 126.421 1.888 . . . . 72.13 112.364 -178.281 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 223' ' ' GLY . . . . . 0.47 ' H ' ' C ' ' A' ' 221' ' ' VAL . . . 150.21 -4.6 0.62 Allowed Glycine 0 C--N 1.276 -2.797 0 CA-C-N 114.547 -1.206 . . . . 31.43 110.777 -175.163 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 68.6 mt -104.56 124.34 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.14 0 N-CA-C 109.364 -0.606 . . . . 64.04 109.364 179.144 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 225' ' ' GLU . . . . . 0.457 ' HA ' ' CB ' ' A' ' 220' ' ' GLU . 12.4 pt-20 -57.91 148.66 24.96 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 123.419 0.688 . . . . 71.33 112.801 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 226' ' ' VAL . . . . . 0.496 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 34.3 m -122.67 -2.54 7.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 CA-C-N 114.891 -1.049 . . . . 54.32 109.501 175.44 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -71.22 99.05 1.83 Allowed 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 115.547 -0.751 . . . . 61.12 110.441 -177.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 121.91 -23.2 7.44 Favored Glycine 0 N--CA 1.43 -1.742 0 N-CA-C 110.965 -0.854 . . . . 61.22 110.965 178.095 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 80.2 mttt -78.13 172.85 12.93 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 121.142 -0.223 . . . . 74.54 111.306 -179.169 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 230' ' ' THR . . . . . 0.456 ' O ' HG13 ' A' ' 234' ' ' VAL . 74.2 p -93.77 165.97 12.43 Favored 'General case' 0 N--CA 1.427 -1.612 0 C-N-CA 119.849 -0.74 . . . . 60.4 109.76 -175.424 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.469 ' HA ' HG22 ' A' ' 234' ' ' VAL . 3.1 tm? -60.96 -38.78 87.11 Favored 'General case' 0 N--CA 1.427 -1.614 0 CA-C-N 116.081 -0.508 . . . . 72.44 109.787 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -65.95 -40.16 91.09 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.458 -0.337 . . . . 62.2 110.664 179.551 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -64.31 -49.3 72.32 Favored 'General case' 0 C--O 1.223 -0.316 0 N-CA-C 112.667 0.618 . . . . 72.31 112.667 175.653 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.623 HG21 HG12 ' A' ' 195' ' ' ILE . 15.0 m -68.36 -34.05 63.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 112.729 0.64 . . . . 70.43 112.729 -173.873 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 235' ' ' THR . . . . . 0.49 ' O ' HG23 ' A' ' 239' ' ' VAL . 75.1 m -71.0 -35.63 72.14 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 109.229 -0.656 . . . . 64.01 109.229 -176.31 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -62.63 -33.97 76.09 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.727 -0.669 . . . . 72.03 109.598 178.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 237' ' ' MET . . . . . 0.444 ' HB2' HG11 ' A' ' 221' ' ' VAL . 2.0 mtm -74.33 -34.91 63.58 Favored 'General case' 0 C--O 1.2 -1.55 0 N-CA-C 108.542 -0.91 . . . . 75.12 108.542 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 238' ' ' MET . . . . . 0.541 ' SD ' HD13 ' A' ' 176' ' ' ILE . 65.3 mtt -68.66 -36.24 78.29 Favored 'General case' 0 C--N 1.314 -0.964 0 O-C-N 121.995 -0.441 . . . . 53.45 110.844 178.63 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 235' ' ' THR . 99.9 t -67.81 -39.57 82.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 CA-C-O 121.278 0.561 . . . . 64.41 109.665 176.497 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -69.59 -32.4 71.13 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.919 -0.582 . . . . 63.25 111.006 178.567 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 58.0 m-80 -96.24 21.04 9.45 Favored 'General case' 0 C--O 1.206 -1.187 0 CA-C-N 116.294 -0.412 . . . . 63.34 111.995 178.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 242' ' ' SER . . . . . 0.416 ' O ' HD23 ' A' ' 164' ' ' LEU . 62.6 m -63.16 -23.1 67.28 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 120.537 -0.465 . . . . 75.41 111.895 178.281 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 19.2 m -66.03 -24.99 66.85 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 116.639 -0.255 . . . . 62.53 111.159 177.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -172.79 93.13 0.11 Allowed 'General case' 0 C--O 1.24 0.577 0 C-N-CA 124.602 1.161 . . . . 71.05 109.054 -178.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.555 HD12 ' HG ' ' A' ' 172' ' ' LEU . 1.2 tt -88.66 105.05 17.42 Favored 'General case' 0 C--O 1.198 -1.643 0 CA-C-N 115.769 -0.65 . . . . 74.33 111.286 -169.301 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.687 ' HB ' ' HA ' ' A' ' 222' ' ' ASN . 52.3 mt -96.95 122.61 48.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 108.506 -0.924 . . . . 62.0 108.506 176.722 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 247' ' ' ILE . . . . . 0.525 HG23 HG13 ' A' ' 218' ' ' VAL . 14.9 mt -130.09 135.4 61.03 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.061 0 CA-C-O 121.441 0.639 . . . . 72.12 112.487 177.606 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.559 ' HA ' ' O ' ' A' ' 159' ' ' ARG . 87.6 m -99.99 122.67 43.25 Favored 'General case' 0 N--CA 1.423 -1.784 0 CA-C-N 114.906 -1.043 . . . . 65.03 108.417 174.507 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.502 HG12 ' HA ' ' A' ' 218' ' ' VAL . 23.5 m -132.61 151.83 35.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 CA-C-O 121.347 0.594 . . . . 63.51 111.06 177.617 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.78 ' HB3' ' HB3' ' A' ' 158' ' ' HIS . 1.4 ptmm? -126.79 128.69 24.21 Favored Pre-proline 0 C--N 1.28 -2.437 0 CA-C-N 114.286 -1.325 . . . . 64.24 109.045 174.194 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -65.96 149.5 86.18 Favored 'Trans proline' 0 N--CA 1.44 -1.637 0 C-N-CA 122.221 1.947 . . . . 74.32 110.291 176.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -59.49 -35.05 73.37 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-O 121.775 0.797 . . . . 71.4 109.745 178.79 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -99.17 73.65 1.92 Allowed 'General case' 0 C--N 1.293 -1.848 0 CA-C-N 114.632 -1.167 . . . . 72.41 108.88 177.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -86.77 154.9 20.58 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 114.942 -1.026 . . . . 40.34 111.069 179.502 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 33.6 mmt180 . . . . . 0 C--N 1.311 -1.081 0 CA-C-O 118.537 -0.744 . . . . 64.32 109.308 -179.9 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 . . . . . 0 CA--C 1.503 -0.832 0 N-CA-C 109.34 -0.615 . . . . 73.43 109.34 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 35.0 p -89.9 -35.09 15.81 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-O 120.938 0.399 . . . . 74.22 111.419 178.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 1.3 m80 -124.37 130.72 52.99 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 121.134 0.492 . . . . 72.41 111.755 178.007 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -132.84 135.12 45.45 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 107.739 -1.208 . . . . 73.0 107.739 175.008 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 12.9 ptp180 -124.58 113.32 17.91 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-O 121.792 0.806 . . . . 72.2 110.14 178.261 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 23.7 m -107.41 138.25 34.48 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.922 0 CA-C-N 114.996 -1.002 . . . . 71.31 112.614 -178.242 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.661 ' CZ ' ' HA ' ' A' ' 165' ' ' LYS . 0.1 OUTLIER -104.27 112.56 25.63 Favored 'General case' 0 N--CA 1.417 -2.076 0 N-CA-C 108.473 -0.936 . . . . 72.42 108.473 175.735 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.471 ' HB2' ' HB3' ' A' ' 245' ' ' LEU . 22.9 mt -101.01 139.89 36.07 Favored 'General case' 0 C--N 1.284 -2.239 0 CA-C-N 114.317 -1.31 . . . . 62.15 108.243 -175.451 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.554 HD12 ' O ' ' A' ' 242' ' ' SER . 0.6 OUTLIER 74.37 82.29 0.11 Allowed 'General case' 0 N--CA 1.426 -1.673 0 N-CA-C 106.097 -1.816 . . . . 61.42 106.097 173.896 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.661 ' HA ' ' CZ ' ' A' ' 162' ' ' ARG . 52.4 mtpt -93.64 4.33 54.11 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-N 113.961 -1.472 . . . . 73.54 113.076 -169.427 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 45.2 t-80 -127.85 -60.87 1.14 Allowed 'General case' 0 C--N 1.297 -1.698 0 C-N-CA 119.171 -1.012 . . . . 64.44 112.922 178.254 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 145.93 113.99 0.85 Allowed Glycine 0 C--N 1.298 -1.574 0 N-CA-C 109.881 -1.288 . . . . 55.2 109.881 -177.503 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' SER . . . . . 0.502 ' HB3' ' HG2' ' A' ' 170' ' ' LYS . 24.4 m -154.11 154.66 34.0 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 117.01 0.405 . . . . 64.35 110.445 -177.709 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -98.58 8.6 44.71 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.47 -0.786 . . . . 63.01 109.615 177.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.502 ' HG2' ' HB3' ' A' ' 168' ' ' SER . 22.5 pttm -83.37 150.5 60.53 Favored Pre-proline 0 N--CA 1.434 -1.275 0 CA-C-N 115.683 -0.69 . . . . 62.12 110.003 177.345 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -62.33 148.4 93.33 Favored 'Trans proline' 0 C--O 1.248 0.997 0 C-N-CA 122.624 2.216 . . . . 75.55 110.92 176.272 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.518 ' HG ' ' CD1' ' A' ' 245' ' ' LEU . 3.1 mm? -71.92 -22.2 61.51 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 115.749 -0.66 . . . . 51.23 112.336 -176.781 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 173' ' ' GLY . . . . . 0.462 ' HA3' ' HA3' ' A' ' 204' ' ' GLY . . . 90.88 34.23 7.84 Favored Glycine 0 N--CA 1.422 -2.247 0 C-N-CA 120.672 -0.775 . . . . 73.24 112.929 177.735 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 26.0 p90 -152.93 154.38 34.9 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 108.805 -0.813 . . . . 73.11 108.805 175.312 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -128.12 150.87 49.79 Favored 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 108.322 -0.992 . . . . 73.43 108.322 175.354 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.646 HD13 ' H ' ' A' ' 176' ' ' ILE . 0.2 OUTLIER -116.4 169.21 7.1 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.081 0 CA-C-O 121.474 0.654 . . . . 73.2 111.276 -177.584 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.516 ' HG2' ' HB2' ' A' ' 198' ' ' SER . 4.3 ptp180 -147.98 155.2 41.26 Favored 'General case' 0 C--N 1.278 -2.524 0 C-N-CA 124.358 1.063 . . . . 62.24 109.884 -176.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -111.46 146.23 37.59 Favored 'General case' 0 C--N 1.294 -1.836 0 O-C-N 123.579 0.549 . . . . 52.1 110.135 179.368 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.42 ' O ' ' HA ' ' A' ' 193' ' ' PRO . . . -159.61 -165.01 15.71 Favored Glycine 0 C--N 1.292 -1.914 0 N-CA-C 108.624 -1.791 . . . . 50.3 108.624 175.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 180' ' ' THR . . . . . 0.463 ' HB ' ' CG ' ' A' ' 191' ' ' LYS . 3.1 p -103.9 125.65 50.46 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 118.46 1.13 . . . . 55.25 112.627 175.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 67.8 m -110.51 113.06 25.4 Favored 'General case' 0 N--CA 1.403 -2.784 0 N-CA-C 107.484 -1.302 . . . . 61.24 107.484 173.586 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.502 ' HA ' ' O ' ' A' ' 190' ' ' GLU . 6.7 p -105.08 119.94 54.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 C-N-CA 119.433 -0.907 . . . . 71.33 109.195 175.42 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 90.1 mtt180 -122.57 153.13 39.67 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 114.803 -1.09 . . . . 73.13 109.295 -173.582 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 74.5 t -83.58 119.39 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.845 0 N-CA-C 106.96 -1.496 . . . . 74.52 106.96 170.529 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 71.8 p -109.64 -175.0 2.63 Favored 'General case' 0 C--N 1.262 -3.198 0 CA-C-N 114.56 -1.2 . . . . 74.42 108.741 -176.272 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -70.09 -9.74 56.44 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 115.981 -0.554 . . . . 73.24 110.236 176.238 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 19.4 m -111.38 -4.31 14.94 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 116.094 -0.503 . . . . 74.32 111.167 179.615 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 119.91 -156.57 15.85 Favored Glycine 0 CA--C 1.498 -1.009 0 C-N-CA 120.026 -1.083 . . . . 52.33 110.816 178.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 5.1 mp -79.21 126.18 30.42 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 117.81 0.805 . . . . 50.11 109.695 179.439 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 190' ' ' GLU . . . . . 0.502 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 42.8 tt0 -132.96 119.4 20.06 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 109.071 -0.714 . . . . 72.31 109.071 -178.326 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.463 ' CG ' ' HB ' ' A' ' 180' ' ' THR . 36.2 ttmt -92.51 121.69 34.21 Favored 'General case' 0 N--CA 1.413 -2.295 0 N-CA-C 106.851 -1.537 . . . . 75.54 106.851 176.829 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 192' ' ' GLN . . . . . 0.404 HE22 ' HA ' ' A' ' 227' ' ' ALA . 12.4 pt20 -126.02 160.13 58.49 Favored Pre-proline 0 C--N 1.268 -2.945 0 N-CA-C 107.603 -1.258 . . . . 73.24 107.603 -176.428 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 193' ' ' PRO . . . . . 0.42 ' HA ' ' O ' ' A' ' 179' ' ' GLY . 13.8 Cg_endo -65.73 131.03 26.29 Favored 'Trans proline' 0 N--CA 1.416 -3.042 0 N-CA-C 107.861 -1.631 . . . . 71.11 107.861 168.443 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -122.47 138.76 12.14 Favored Glycine 0 N--CA 1.402 -3.621 0 N-CA-C 109.09 -1.604 . . . . 74.14 109.09 179.333 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.531 HG12 HG21 ' A' ' 234' ' ' VAL . 3.5 mp -104.05 132.16 51.18 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.626 0 C-N-CA 120.268 -0.573 . . . . 75.43 109.79 179.493 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -122.81 165.0 17.33 Favored 'General case' 0 C--N 1.284 -2.275 0 N-CA-C 108.188 -1.042 . . . . 74.41 108.188 -177.108 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 197' ' ' ILE . . . . . 0.434 ' HB ' ' HA ' ' A' ' 214' ' ' VAL . 46.8 mm -78.37 128.8 38.17 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 107.711 -1.218 . . . . 54.53 107.711 174.246 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 198' ' ' SER . . . . . 0.516 ' HB2' ' HG2' ' A' ' 177' ' ' ARG . 11.4 t -100.99 -28.21 12.86 Favored 'General case' 0 C--N 1.28 -2.45 0 O-C-N 121.488 -0.758 . . . . 60.2 113.013 -177.573 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 25.3 tpt180 -163.07 140.11 7.55 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 120.878 -0.329 . . . . 74.23 110.333 -175.553 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 61.4 mt -105.33 137.53 42.98 Favored 'General case' 0 CA--C 1.491 -1.29 0 N-CA-C 108.964 -0.754 . . . . 72.33 108.964 172.396 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 201' ' ' VAL . . . . . 0.438 ' HB ' ' HA2' ' A' ' 173' ' ' GLY . 61.5 t -97.55 116.53 65.84 Favored Pre-proline 0 C--N 1.279 -2.463 0 N-CA-C 105.773 -1.936 . . . . 71.24 105.773 172.565 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.639 ' HA ' ' OE1' ' A' ' 207' ' ' GLU . 21.1 Cg_endo -60.04 126.29 19.9 Favored 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 121.932 1.755 . . . . 63.14 111.707 -174.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 105.51 -9.08 44.64 Favored Glycine 0 C--N 1.307 -1.073 0 CA-C-N 115.421 -0.809 . . . . 53.22 111.104 -177.196 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 204' ' ' GLY . . . . . 0.462 ' HA3' ' HA3' ' A' ' 173' ' ' GLY . . . -74.77 167.55 54.82 Favored Glycine 0 N--CA 1.437 -1.248 0 C-N-CA 121.556 -0.354 . . . . 73.34 113.14 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -65.0 -29.16 70.07 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 124.281 1.032 . . . . 73.3 111.737 -177.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 206' ' ' ALA . . . . . 0.405 ' HA ' HD12 ' A' ' 212' ' ' LEU . . . -59.81 -40.73 89.38 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.863 -0.608 . . . . 73.1 110.57 177.286 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.639 ' OE1' ' HA ' ' A' ' 202' ' ' PRO . 46.3 mt-10 -75.5 -31.42 60.16 Favored 'General case' 0 CA--C 1.507 -0.694 0 CA-C-N 116.2 -0.454 . . . . 64.03 110.885 175.592 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 24.8 m -55.73 -36.96 67.81 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.162 -0.472 . . . . 72.52 111.417 -177.686 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 209' ' ' THR . . . . . 0.523 HG23 ' H ' ' A' ' 211' ' ' LEU . 9.7 t -84.72 -32.68 23.39 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 109.281 -0.637 . . . . 53.0 109.281 174.728 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 73.32 21.02 80.02 Favored Glycine 0 CA--C 1.497 -1.058 0 CA-C-N 115.876 -0.602 . . . . 40.24 112.061 177.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.523 ' H ' HG23 ' A' ' 209' ' ' THR . 38.4 mt -114.31 -0.32 13.9 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 109.655 -0.498 . . . . 71.23 109.655 -178.431 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' A' ' 206' ' ' ALA . 74.0 mt -109.03 130.93 55.49 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 120.113 -0.635 . . . . 75.34 110.684 176.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -133.82 166.23 23.14 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 114.605 -1.179 . . . . 75.4 108.04 176.038 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 214' ' ' VAL . . . . . 0.434 ' HA ' ' HB ' ' A' ' 197' ' ' ILE . 26.4 m -59.33 -29.37 41.79 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-O 121.934 0.873 . . . . 73.31 111.416 176.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -72.65 -15.79 61.71 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 115.377 -0.829 . . . . 41.35 112.617 -175.644 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -69.31 137.82 53.29 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 113.602 0.964 . . . . 63.45 113.602 -176.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -112.92 124.66 53.12 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.795 1.638 . . . . 75.22 108.87 -178.711 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.582 ' HA ' HG12 ' A' ' 249' ' ' VAL . 8.2 p -80.1 146.47 7.63 Favored 'Isoleucine or valine' 0 C--O 1.251 1.168 0 N-CA-C 113.953 1.094 . . . . 72.43 113.953 -173.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.478 HD11 ' CD ' ' A' ' 250' ' ' LYS . 44.4 mm -111.46 -53.13 5.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 113.988 -1.46 . . . . 70.01 110.435 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -158.07 156.28 30.76 Favored 'General case' 0 C--O 1.244 0.794 0 CA-C-N 116.324 -0.398 . . . . 74.32 110.245 -176.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.426 ' HA ' ' O ' ' A' ' 246' ' ' ILE . 4.4 p -124.74 115.92 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.292 0 CA-C-O 121.586 0.707 . . . . 72.23 110.838 173.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 222' ' ' ASN . . . . . 0.44 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 21.4 t-20 58.95 34.61 23.71 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 126.124 1.77 . . . . 73.54 110.638 178.407 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 93.74 -4.83 72.73 Favored Glycine 0 C--N 1.301 -1.392 0 CA-C-N 115.165 -0.925 . . . . 71.33 113.172 177.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 58.1 mt -99.67 123.36 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.373 0 N-CA-C 108.628 -0.878 . . . . 73.15 108.628 179.203 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 225' ' ' GLU . . . . . 0.458 ' HG3' ' HE3' ' A' ' 229' ' ' LYS . 12.1 pt-20 -62.93 134.99 57.06 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 121.403 0.621 . . . . 73.03 110.741 -179.374 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 27.6 m -115.57 10.97 7.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-O 122.202 1.001 . . . . 72.4 109.611 175.022 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 227' ' ' ALA . . . . . 0.404 ' HA ' HE22 ' A' ' 192' ' ' GLN . . . -75.32 99.98 4.26 Favored 'General case' 0 N--CA 1.422 -1.83 0 CA-C-N 114.307 -1.315 . . . . 71.54 110.336 179.128 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 95.08 18.46 33.96 Favored Glycine 0 N--CA 1.438 -1.186 0 CA-C-N 115.489 -0.778 . . . . 71.25 112.919 175.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.467 ' HB3' ' HG2' ' A' ' 233' ' ' GLN . 68.7 mmtt -95.63 172.2 8.2 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.963 0.382 . . . . 64.42 110.164 179.75 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 230' ' ' THR . . . . . 0.666 ' OG1' ' HB2' ' A' ' 233' ' ' GLN . 40.6 p -76.1 162.57 27.9 Favored 'General case' 0 N--CA 1.433 -1.296 0 C-N-CA 120.33 -0.548 . . . . 72.23 109.55 175.594 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -68.6 -39.18 81.01 Favored 'General case' 0 N--CA 1.429 -1.514 0 N-CA-C 108.982 -0.747 . . . . 71.5 108.982 -179.161 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -61.29 -39.39 90.28 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 116.302 -0.408 . . . . 72.21 110.338 176.307 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 233' ' ' GLN . . . . . 0.666 ' HB2' ' OG1' ' A' ' 230' ' ' THR . 3.5 tp-100 -58.16 -50.95 71.73 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 123.947 0.899 . . . . 73.01 109.796 -177.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.531 HG21 HG12 ' A' ' 195' ' ' ILE . 13.0 m -73.67 -34.2 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-N 115.265 -0.88 . . . . 75.34 111.536 -174.05 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 235' ' ' THR . . . . . 0.495 ' O ' HG23 ' A' ' 239' ' ' VAL . 53.0 m -74.75 -36.52 62.6 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 115.42 -0.809 . . . . 62.42 109.251 -175.326 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -58.77 -34.72 71.76 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-N 115.39 -0.823 . . . . 74.13 109.602 175.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 237' ' ' MET . . . . . 0.41 ' HB2' HG11 ' A' ' 221' ' ' VAL . 10.1 mtt -69.79 -50.27 44.66 Favored 'General case' 0 C--O 1.208 -1.128 0 N-CA-C 108.002 -1.11 . . . . 70.21 108.002 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 238' ' ' MET . . . . . 0.429 ' HG3' ' O ' ' A' ' 234' ' ' VAL . 64.4 mtt -54.47 -40.01 68.03 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 123.426 0.69 . . . . 75.42 111.791 -177.834 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 235' ' ' THR . 80.3 t -69.09 -48.91 66.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.158 0.504 . . . . 65.42 110.915 178.05 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -65.78 -28.9 69.36 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.908 -0.587 . . . . 43.41 111.705 -178.012 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 -84.68 21.56 1.5 Allowed 'General case' 0 C--O 1.2 -1.549 0 N-CA-C 113.174 0.805 . . . . 73.43 113.174 -179.413 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 242' ' ' SER . . . . . 0.554 ' O ' HD12 ' A' ' 164' ' ' LEU . 31.0 p -56.19 -23.76 37.34 Favored 'General case' 0 C--O 1.2 -1.54 0 N-CA-C 113.301 0.852 . . . . 75.34 113.301 177.36 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 19.4 m -71.28 -37.41 71.88 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 121.563 0.697 . . . . 63.33 110.214 177.383 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 244' ' ' ASN . . . . . 0.486 ' HA ' ' HE ' ' A' ' 162' ' ' ARG . 5.1 p30 -158.19 92.22 1.15 Allowed 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 123.922 0.889 . . . . 73.43 110.091 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.518 ' CD1' ' HG ' ' A' ' 172' ' ' LEU . 1.4 tt -88.64 103.75 16.22 Favored 'General case' 0 C--O 1.207 -1.145 0 N-CA-C 109.029 -0.73 . . . . 74.21 109.029 -175.472 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.44 ' HB ' ' HA ' ' A' ' 222' ' ' ASN . 58.7 mt -106.1 115.73 48.39 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 109.053 -0.721 . . . . 61.05 109.053 179.144 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 247' ' ' ILE . . . . . 0.493 HG23 HG23 ' A' ' 218' ' ' VAL . 32.1 mt -119.89 128.82 75.94 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 CA-C-O 121.472 0.653 . . . . 71.13 111.657 178.613 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 37.9 m -102.07 118.48 36.98 Favored 'General case' 0 N--CA 1.418 -2.066 0 CA-C-N 114.751 -1.113 . . . . 75.55 108.021 176.318 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.582 HG12 ' HA ' ' A' ' 218' ' ' VAL . 15.8 m -126.84 170.08 17.32 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.992 0 CA-C-O 121.793 0.806 . . . . 64.42 110.673 178.642 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.478 ' CD ' HD11 ' A' ' 219' ' ' ILE 0.337 42.9 mtpt -125.72 152.4 72.21 Favored Pre-proline 0 C--N 1.271 -2.812 0 CA-C-N 113.492 -1.685 . . . . 74.31 106.67 174.897 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -80.19 143.9 16.17 Favored 'Trans proline' 0 N--CA 1.424 -2.566 0 N-CA-C 108.304 -1.46 . . . . 72.12 108.304 167.105 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -57.91 -38.77 76.47 Favored 'General case' 0 CA--C 1.49 -1.347 0 CA-C-O 121.895 0.855 . . . . 61.03 109.54 179.466 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -94.58 87.92 5.26 Favored 'General case' 0 C--N 1.284 -2.268 0 N-CA-C 107.198 -1.408 . . . . 62.35 107.198 172.606 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 254' ' ' GLN . . . . . 0.415 ' NE2' ' H ' ' A' ' 254' ' ' GLN . 1.7 mp0 -49.06 101.32 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 114.316 -1.311 . . . . 53.15 110.711 178.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 27.9 ttm180 . . . . . 0 N--CA 1.437 -1.085 0 N-CA-C 108.851 -0.796 . . . . 74.14 108.851 -177.91 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.516 -0.328 0 N-CA-C 109.532 -0.544 . . . . 75.33 109.532 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 37.5 p -78.11 -30.23 49.35 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-O 121.268 0.556 . . . . 70.33 110.828 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -125.39 130.99 53.0 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.803 -0.635 . . . . 71.32 109.866 173.01 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.579 ' HA ' ' HE ' ' A' ' 159' ' ' ARG . 2.0 tpm_? -121.73 119.2 31.06 Favored 'General case' 0 N--CA 1.423 -1.799 0 N-CA-C 109.411 -0.588 . . . . 71.31 109.411 178.355 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 81.2 mtm180 -101.05 113.73 27.01 Favored 'General case' 0 C--N 1.281 -2.392 0 CA-C-N 115.123 -0.944 . . . . 70.31 109.507 179.234 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 23.6 m -119.67 139.23 47.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 CA-C-N 115.924 -0.58 . . . . 74.44 111.198 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.408 ' HG3' HG12 ' A' ' 246' ' ' ILE . 14.9 ttm180 -107.86 112.09 24.55 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.127 -1.064 . . . . 64.14 108.127 176.533 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.619 ' HB2' ' HB2' ' A' ' 245' ' ' LEU . 20.9 mt -103.03 139.87 38.02 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 108.323 -0.991 . . . . 64.3 108.323 -174.113 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.736 ' HG ' ' O ' ' A' ' 242' ' ' SER . 0.1 OUTLIER 72.76 77.96 0.15 Allowed 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 105.911 -1.885 . . . . 61.35 105.911 -179.608 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -98.82 -11.56 21.68 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 115.18 -0.918 . . . . 71.12 111.22 -174.015 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 44.5 m80 -148.43 104.97 3.55 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 116.024 -0.534 . . . . 71.14 110.431 177.177 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 126.3 -153.6 18.67 Favored Glycine 0 N--CA 1.422 -2.246 0 N-CA-C 110.232 -1.147 . . . . 65.31 110.232 177.327 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 32.1 t 179.91 173.35 0.95 Allowed 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 107.63 -1.248 . . . . 72.55 107.63 178.499 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 23.4 t70 73.88 -29.31 0.2 Allowed 'General case' 0 N--CA 1.504 2.238 0 N-CA-C 114.274 1.213 . . . . 65.53 114.274 174.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.436 ' HA ' ' HD3' ' A' ' 171' ' ' PRO . 28.0 mtpp -72.34 149.72 91.55 Favored Pre-proline 0 C--N 1.307 -1.271 0 C-N-CA 123.259 0.624 . . . . 75.12 112.621 -176.851 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 171' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 170' ' ' LYS . 21.7 Cg_exo -67.32 153.46 76.97 Favored 'Trans proline' 0 C--O 1.242 0.723 0 C-N-CA 122.813 2.342 . . . . 63.24 110.104 173.593 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.551 ' HG ' HD12 ' A' ' 245' ' ' LEU . 2.7 mm? -90.61 -27.54 19.02 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-N 116.132 -0.485 . . . . 51.34 112.177 -174.668 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 173' ' ' GLY . . . . . 0.529 ' HA3' ' HA3' ' A' ' 204' ' ' GLY . . . 97.69 30.59 7.13 Favored Glycine 0 N--CA 1.44 -1.091 0 C-N-CA 120.258 -0.972 . . . . 75.13 112.968 177.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -147.55 155.8 42.21 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.239 -1.393 . . . . 74.2 107.239 174.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.414 ' HB2' ' HB3' ' A' ' 199' ' ' ARG . 92.4 m-85 -131.45 143.57 50.53 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 108.078 -1.082 . . . . 72.12 108.078 177.368 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.429 HD13 ' SD ' ' A' ' 238' ' ' MET . 30.2 pt -111.01 169.08 4.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 113.31 0.856 . . . . 75.02 113.31 -173.849 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.593 ' HB3' ' HB2' ' A' ' 198' ' ' SER . 2.9 ptp180 -142.87 155.02 44.69 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 114.765 -1.107 . . . . 62.33 109.982 -178.254 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 178' ' ' ASP . . . . . 0.586 ' HB2' ' HB2' ' A' ' 231' ' ' LEU . 11.5 t70 -109.46 138.53 45.67 Favored 'General case' 0 C--N 1.29 -2.014 0 O-C-N 124.082 0.864 . . . . 73.41 109.138 179.047 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -151.46 -178.99 26.77 Favored Glycine 0 C--N 1.273 -2.967 0 N-CA-C 108.07 -2.012 . . . . 43.3 108.07 175.267 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' THR . . . . . 0.463 ' CG2' ' HG2' ' A' ' 191' ' ' LYS . 0.2 OUTLIER -109.59 122.36 47.27 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 106.581 -1.637 . . . . 71.51 106.581 177.128 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 181' ' ' SER . . . . . 0.508 ' O ' ' HA ' ' A' ' 191' ' ' LYS . 33.0 t -97.47 123.45 41.33 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 109.062 -0.718 . . . . 64.24 109.062 -176.202 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.588 ' HA ' ' O ' ' A' ' 190' ' ' GLU . 7.1 p -107.33 120.46 58.68 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 CA-C-O 121.415 0.626 . . . . 71.2 109.887 176.237 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -121.67 154.75 36.42 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-N 115.18 -0.918 . . . . 73.11 109.272 -177.107 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 78.2 t -84.3 119.09 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.901 0 N-CA-C 107.426 -1.324 . . . . 75.24 107.426 171.124 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 46.5 p -114.68 -176.5 2.91 Favored 'General case' 0 C--N 1.274 -2.712 0 CA-C-N 114.51 -1.223 . . . . 71.45 108.885 -177.35 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -59.69 -26.05 65.27 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.05 0.453 . . . . 53.4 110.429 177.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 21.3 m -91.9 -18.4 23.81 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 115.785 -0.643 . . . . 63.34 111.576 -179.357 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 127.48 -152.24 18.75 Favored Glycine 0 N--CA 1.442 -0.956 0 N-CA-C 110.269 -1.132 . . . . 50.23 110.269 -177.844 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 6.2 mp -78.1 122.98 26.32 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 117.88 0.84 . . . . 72.22 110.044 179.383 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 190' ' ' GLU . . . . . 0.588 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 9.3 tp10 -132.44 123.54 26.87 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.86 -0.609 . . . . 54.33 109.665 -178.343 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.508 ' HA ' ' O ' ' A' ' 181' ' ' SER . 32.9 ttmt -102.7 131.94 49.17 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 107.735 -1.209 . . . . 73.35 107.735 -178.362 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 192' ' ' GLN . . . . . 0.492 ' HB2' ' HD2' ' A' ' 193' ' ' PRO . 9.0 pt20 -151.59 164.53 19.95 Favored Pre-proline 0 C--N 1.305 -1.347 0 N-CA-C 108.152 -1.055 . . . . 64.52 108.152 -174.569 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 193' ' ' PRO . . . . . 0.492 ' HD2' ' HB2' ' A' ' 192' ' ' GLN . 9.5 Cg_endo -54.55 131.71 47.13 Favored 'Trans proline' 0 C--O 1.249 1.073 0 C-N-CA 121.431 1.421 . . . . 75.35 111.582 178.694 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -143.02 132.69 5.15 Favored Glycine 0 N--CA 1.411 -2.975 0 N-CA-C 109.716 -1.354 . . . . 61.0 109.716 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.626 HG12 HG21 ' A' ' 234' ' ' VAL . 3.5 mp -105.17 138.85 28.21 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.438 0 CA-C-O 121.112 0.482 . . . . 74.13 109.92 -179.599 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -132.34 167.66 19.48 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 107.285 -1.376 . . . . 73.34 107.285 -176.613 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 197' ' ' ILE . . . . . 0.401 ' CG2' ' HA ' ' A' ' 214' ' ' VAL . 50.2 mm -75.54 131.69 34.52 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 N-CA-C 108.452 -0.944 . . . . 75.02 108.452 173.738 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 198' ' ' SER . . . . . 0.593 ' HB2' ' HB3' ' A' ' 177' ' ' ARG . 21.0 t -108.31 -25.24 11.12 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.792 -0.568 . . . . 54.11 111.926 178.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.414 ' HB3' ' HB2' ' A' ' 175' ' ' TYR . 68.7 ttt180 -154.05 142.35 20.53 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 109.266 -0.642 . . . . 62.43 109.266 179.326 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 50.5 tp -125.32 133.02 52.76 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 108.629 -0.878 . . . . 70.23 108.629 178.431 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 62.1 t -110.37 121.14 42.28 Favored Pre-proline 0 C--O 1.248 1.007 0 CA-C-N 116.766 -0.197 . . . . 61.51 110.766 -177.407 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.525 ' HA ' ' HG2' ' A' ' 207' ' ' GLU . 28.7 Cg_exo -62.43 131.75 35.32 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 122.229 1.953 . . . . 71.34 110.065 175.341 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 106.17 -17.82 40.27 Favored Glycine 0 N--CA 1.434 -1.485 0 N-CA-C 110.2 -1.16 . . . . 52.3 110.2 -175.286 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 204' ' ' GLY . . . . . 0.529 ' HA3' ' HA3' ' A' ' 173' ' ' GLY . . . -83.87 161.24 38.01 Favored Glycine 0 N--CA 1.428 -1.894 0 N-CA-C 110.329 -1.108 . . . . 71.14 110.329 176.796 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.426 ' O ' HG22 ' A' ' 209' ' ' THR . 3.1 mm? -58.9 -37.66 77.11 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 123.288 0.635 . . . . 74.31 111.599 -177.398 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -62.08 -47.28 85.35 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 116.071 -0.513 . . . . 73.43 112.112 -179.62 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.525 ' HG2' ' HA ' ' A' ' 202' ' ' PRO . 9.7 tp10 -75.28 -33.22 61.21 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.454 -0.573 . . . . 74.44 109.454 178.598 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 38.6 t -57.76 -48.17 80.41 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 116.059 -0.519 . . . . 42.42 110.208 177.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 209' ' ' THR . . . . . 0.426 HG22 ' O ' ' A' ' 205' ' ' LEU . 9.1 t -73.54 -40.42 63.99 Favored 'General case' 0 N--CA 1.437 -1.089 0 C-N-CA 120.098 -0.641 . . . . 63.23 110.201 176.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 83.35 -9.19 61.99 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.78 -0.724 . . . . 61.13 111.908 178.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 59.7 mt -77.75 -9.82 59.22 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.315 0.578 . . . . 74.34 110.013 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.453 HD11 HD11 ' A' ' 163' ' ' LEU . 79.6 mt -109.4 132.95 53.65 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 108.396 -0.964 . . . . 74.35 108.396 173.021 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -131.44 166.06 22.15 Favored 'General case' 0 N--CA 1.421 -1.914 0 N-CA-C 109.048 -0.723 . . . . 72.4 109.048 178.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 214' ' ' VAL . . . . . 0.401 ' HA ' ' CG2' ' A' ' 197' ' ' ILE . 28.4 m -64.01 -30.29 49.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 115.193 1.553 . . . . 63.41 115.193 -175.251 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -82.26 -13.24 57.34 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 113.798 1.036 . . . . 63.51 113.798 -179.38 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -59.54 141.74 54.17 Favored 'General case' 0 C--O 1.245 0.833 0 N-CA-C 114.578 1.325 . . . . 73.11 114.578 -176.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -106.75 131.44 53.87 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 125.91 1.684 . . . . 73.02 109.008 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.576 ' HA ' HG12 ' A' ' 249' ' ' VAL . 7.2 p -85.48 136.83 21.98 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-O 121.668 0.747 . . . . 63.43 112.554 -174.677 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.518 HD11 ' CD ' ' A' ' 250' ' ' LYS . 39.8 mm -103.37 -52.36 8.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.087 -0.961 . . . . 65.44 111.35 -179.044 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.424 ' HB3' ' HA ' ' A' ' 225' ' ' GLU . 9.3 pt-20 -155.83 154.62 31.6 Favored 'General case' 0 C--O 1.248 0.988 0 CA-C-N 116.465 -0.334 . . . . 75.14 111.219 -177.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.497 HG12 ' CG1' ' A' ' 226' ' ' VAL . 10.5 p -129.57 121.01 51.96 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.197 0 CA-C-O 121.438 0.637 . . . . 73.42 110.67 176.6 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 222' ' ' ASN . . . . . 0.416 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 11.6 t-20 66.99 12.99 9.3 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 125.256 1.422 . . . . 74.31 111.599 175.312 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 112.69 -18.19 22.53 Favored Glycine 0 N--CA 1.437 -1.255 0 C-N-CA 120.729 -0.748 . . . . 45.34 111.726 -179.042 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 62.9 mt -92.55 124.87 45.15 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.501 0 N-CA-C 108.601 -0.889 . . . . 74.33 108.601 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 225' ' ' GLU . . . . . 0.424 ' HA ' ' HB3' ' A' ' 220' ' ' GLU . 12.6 pt-20 -65.41 137.86 57.75 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-O 121.237 0.541 . . . . 74.52 110.372 179.704 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 226' ' ' VAL . . . . . 0.497 ' CG1' HG12 ' A' ' 221' ' ' VAL . 28.6 m -115.28 0.48 8.66 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 CA-C-O 121.595 0.712 . . . . 71.43 110.543 178.124 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -84.11 97.55 9.4 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-N 115.442 -0.799 . . . . 73.34 109.459 179.316 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 123.0 -17.9 8.02 Favored Glycine 0 C--N 1.313 -0.738 0 N-CA-C 110.704 -0.958 . . . . 54.22 110.704 -178.046 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -77.91 173.01 12.61 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 109.159 -0.682 . . . . 61.41 109.159 176.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 230' ' ' THR . . . . . 0.519 ' O ' HG13 ' A' ' 234' ' ' VAL . 74.7 p -94.21 163.73 13.33 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 108.312 -0.996 . . . . 62.41 108.312 178.519 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.586 ' HB2' ' HB2' ' A' ' 178' ' ' ASP . 3.4 tm? -60.07 -38.67 83.57 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 109.778 -0.453 . . . . 73.33 109.778 178.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -62.52 -43.16 99.49 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.153 -0.476 . . . . 74.14 110.246 178.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -63.31 -48.59 77.42 Favored 'General case' 0 C--N 1.344 0.337 0 N-CA-C 113.113 0.783 . . . . 72.34 113.113 176.266 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.626 HG21 HG12 ' A' ' 195' ' ' ILE . 6.6 m -65.82 -33.59 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-O 121.272 0.558 . . . . 72.45 112.321 -174.607 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 60.2 m -74.08 -36.82 64.31 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.875 -0.787 . . . . 60.45 108.875 -175.161 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -61.09 -34.67 75.31 Favored 'General case' 0 CA--C 1.5 -0.948 0 CA-C-N 115.091 -0.959 . . . . 65.41 109.392 177.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 237' ' ' MET . . . . . 0.431 ' HG3' ' HA ' ' A' ' 234' ' ' VAL . 12.9 mtt -69.14 -46.91 66.46 Favored 'General case' 0 C--O 1.204 -1.321 0 N-CA-C 108.48 -0.933 . . . . 72.53 108.48 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 238' ' ' MET . . . . . 0.454 ' HA ' HD21 ' A' ' 245' ' ' LEU . 62.1 mtt -61.33 -42.17 98.24 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.986 -0.552 . . . . 72.0 111.654 -176.69 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 87.5 t -64.2 -40.4 88.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 O-C-N 123.328 0.392 . . . . 74.43 110.458 178.132 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -69.6 -38.01 77.12 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.444 0.64 . . . . 71.43 110.365 178.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -85.6 21.4 1.83 Allowed 'General case' 0 C--O 1.202 -1.409 0 CA-C-N 115.522 -0.763 . . . . 51.42 112.076 -179.326 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 242' ' ' SER . . . . . 0.736 ' O ' ' HG ' ' A' ' 164' ' ' LEU . 29.4 p -64.75 -21.33 66.74 Favored 'General case' 0 C--O 1.208 -1.108 0 N-CA-C 109.619 -0.512 . . . . 71.33 109.619 172.517 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 47.4 t -62.76 -35.52 80.09 Favored 'General case' 0 CA--C 1.551 1.016 0 N-CA-C 108.85 -0.796 . . . . 43.51 108.85 173.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -177.14 106.87 0.06 Allowed 'General case' 0 C--O 1.246 0.902 0 C-N-CA 124.08 0.952 . . . . 64.01 111.277 177.534 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.619 ' HB2' ' HB2' ' A' ' 163' ' ' LEU . 11.8 mt -86.67 129.52 34.84 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 115.364 -0.835 . . . . 74.23 111.025 179.481 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.416 ' HB ' ' HA ' ' A' ' 222' ' ' ASN . 66.3 mt -118.62 113.72 42.66 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.618 0 N-CA-C 105.044 -2.206 . . . . 73.25 105.044 167.381 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 64.3 mt -122.22 135.52 62.05 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.257 0 CA-C-O 121.313 0.578 . . . . 72.13 111.699 -176.774 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.479 ' HA ' ' O ' ' A' ' 159' ' ' ARG . 58.3 m -112.14 118.29 34.94 Favored 'General case' 0 N--CA 1.416 -2.154 0 N-CA-C 108.251 -1.018 . . . . 75.33 108.251 175.796 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.576 HG12 ' HA ' ' A' ' 218' ' ' VAL . 17.7 m -121.22 170.51 11.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 CA-C-O 121.436 0.636 . . . . 65.32 110.469 176.278 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.518 ' CD ' HD11 ' A' ' 219' ' ' ILE 0.336 43.0 mtpt -126.69 144.15 48.89 Favored Pre-proline 0 C--N 1.28 -2.435 0 CA-C-N 113.965 -1.471 . . . . 72.44 107.44 174.165 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -74.98 141.71 27.02 Favored 'Trans proline' 0 N--CA 1.424 -2.597 0 N-CA-C 108.035 -1.563 . . . . 71.44 108.035 167.632 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -53.08 -54.66 32.23 Favored 'General case' 0 CA--C 1.495 -1.135 0 CA-C-O 121.868 0.842 . . . . 61.42 108.99 178.26 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 37.7 t30 -91.09 81.61 5.59 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 106.375 -1.713 . . . . 71.32 106.375 172.108 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -74.3 151.98 39.73 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 115.192 -0.913 . . . . 64.44 113.039 -175.497 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? . . . . . 0 N--CA 1.416 -2.156 0 N-CA-C 105.329 -2.1 . . . . 73.25 105.329 176.012 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.574 ' HB3' ' HG2' ' A' ' 250' ' ' LYS 0.311 2.2 p-80 . . . . . 0 CA--C 1.505 -0.776 0 N-CA-C 116.043 1.868 . . . . 75.239999999999995 116.043 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 57.9 ttt180 -126.77 144.56 50.91 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 114.135 -1.393 . . . . 75.140000000000001 109.284 176.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.574 ' HG3' ' OG1' ' A' ' 248' ' ' THR . 0.1 OUTLIER -90.23 114.29 26.27 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 108.201 -1.037 . . . . 63.109999999999999 108.201 179.282 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.402 HG11 ' HB2' ' A' ' 211' ' ' LEU . 29.7 m -109.21 136.38 45.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-O 120.733 0.301 . . . . 74.430000000000007 111.215 179.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -99.08 121.71 41.35 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-O 121.516 0.674 . . . . 74.439999999999998 110.073 178.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.492 ' HB2' ' HB3' ' A' ' 245' ' ' LEU . 18.6 mt -104.24 137.06 42.71 Favored 'General case' 0 N--CA 1.403 -2.806 0 N-CA-C 106.637 -1.616 . . . . 70.140000000000001 106.637 177.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.46 HD23 ' O ' ' A' ' 242' ' ' SER . 14.2 tp . . . . . 0 C--N 1.288 -2.099 0 N-CA-C 114.264 1.209 . . . . 71.540000000000006 114.264 177.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 89.5 mt . . . . . 0 N--CA 1.467 0.421 0 N-CA-C 111.863 0.32 . . . . 75.349999999999994 111.863 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . 0.533 ' HA3' ' HA3' ' A' ' 204' ' ' GLY . . . 93.91 22.35 25.84 Favored Glycine 0 N--CA 1.429 -1.793 0 C-N-CA 120.115 -1.041 . . . . 61.140000000000001 114.169 173.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -160.18 154.1 22.97 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 117.74 0.77 . . . . 75.25 109.157 177.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -123.86 153.56 40.9 Favored 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 107.403 -1.332 . . . . 72.310000000000002 107.403 177.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 39.9 pt -113.73 166.62 7.39 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 CA-C-O 121.38 0.609 . . . . 72.530000000000001 111.021 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.468 ' HG2' ' HB3' ' A' ' 198' ' ' SER . 16.2 ptt180 -147.12 154.75 41.49 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 115.286 -0.87 . . . . 62.450000000000003 109.833 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -110.32 142.79 41.47 Favored 'General case' 0 C--N 1.29 -1.998 0 O-C-N 123.901 0.75 . . . . 63.119999999999997 109.69 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -159.48 160.89 31.76 Favored Glycine 0 C--N 1.289 -2.072 0 N-CA-C 108.898 -1.681 . . . . 70.019999999999996 108.898 177.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . 0.521 HG22 ' HG2' ' A' ' 191' ' ' LYS . 0.6 OUTLIER -90.82 123.6 34.49 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.169 -1.419 . . . . 74.409999999999997 107.169 178.844 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . 0.497 ' O ' ' HA ' ' A' ' 191' ' ' LYS . 22.8 t . . . . . 0 C--N 1.283 -2.302 0 C-N-CA 123.311 0.644 . . . . 72.120000000000005 109.619 -175.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.521 ' HG2' HG22 ' A' ' 180' ' ' THR . 34.0 ttmt . . . . . 0 N--CA 1.426 -1.631 0 N-CA-C 106.771 -1.566 . . . . 73.219999999999999 106.771 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.44 158.6 37.88 Favored Pre-proline 0 C--N 1.307 -1.27 0 CA-C-O 118.899 -0.572 . . . . 62.530000000000001 110.153 -169.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -67.42 130.42 22.36 Favored 'Trans proline' 0 C--O 1.25 1.099 0 CA-C-N 119.941 1.015 . . . . 53.219999999999999 111.645 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -142.88 151.11 22.88 Favored Glycine 0 N--CA 1.412 -2.956 0 CA-C-N 115.393 -0.822 . . . . 34.340000000000003 111.357 -177.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.582 HG12 HG21 ' A' ' 234' ' ' VAL . 2.7 mp -104.13 136.91 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.286 0 N-CA-C 109.535 -0.543 . . . . 63.219999999999999 109.535 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -127.21 164.75 20.99 Favored 'General case' 0 C--N 1.28 -2.434 0 N-CA-C 107.393 -1.336 . . . . 74.329999999999998 107.393 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 42.6 mm -76.46 131.43 34.89 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 N-CA-C 106.896 -1.52 . . . . 53.100000000000001 106.896 175.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . 0.468 ' HB3' ' HG2' ' A' ' 177' ' ' ARG . 75.7 p -100.92 -41.1 6.96 Favored 'General case' 0 C--N 1.287 -2.142 0 C-N-CA 118.612 -1.235 . . . . 70.299999999999997 111.092 -177.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 31.6 tpt180 -148.32 141.32 24.87 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.302 -0.999 . . . . 64.409999999999997 108.302 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 2.6 tt -122.25 123.58 41.78 Favored 'General case' 0 N--CA 1.421 -1.882 0 N-CA-C 106.672 -1.603 . . . . 74.340000000000003 106.672 178.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 36.5 t -105.85 126.76 29.87 Favored Pre-proline 0 C--N 1.307 -1.273 0 C-N-CA 122.559 0.344 . . . . 55.509999999999998 111.33 -172.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . 0.513 ' HA ' ' HG3' ' A' ' 207' ' ' GLU . 45.0 Cg_endo -70.82 128.51 15.15 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 122.395 2.063 . . . . 73.400000000000006 110.954 176.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 114.38 -18.04 18.36 Favored Glycine 0 N--CA 1.439 -1.102 0 N-CA-C 110.47 -1.052 . . . . 63.109999999999999 110.47 -177.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . 0.533 ' HA3' ' HA3' ' A' ' 173' ' ' GLY . . . -96.04 171.42 28.47 Favored Glycine 0 N--CA 1.433 -1.525 0 N-CA-C 110.517 -1.033 . . . . 70.140000000000001 110.517 178.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.418 ' H ' HD22 ' A' ' 205' ' ' LEU . 2.7 mm? -65.22 -29.79 70.62 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 117.267 0.534 . . . . 74.430000000000007 112.084 -174.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -62.75 -44.41 96.27 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.996 -0.547 . . . . 62.43 110.97 178.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.513 ' HG3' ' HA ' ' A' ' 202' ' ' PRO . 2.9 tm-20 -75.9 -33.75 59.94 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.375 -0.972 . . . . 73.239999999999995 108.375 179.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 50.4 m -56.83 -42.48 79.68 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 116.298 -0.41 . . . . 73.319999999999993 110.803 177.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 13.9 t -73.34 -40.91 64.06 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 119.095 -1.042 . . . . 73.319999999999993 108.442 174.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 56.18 29.61 56.48 Favored Glycine 0 C--N 1.347 1.193 0 CA-C-N 115.908 -0.587 . . . . 72.230000000000004 113.24 177.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.402 ' HB2' HG11 ' A' ' 161' ' ' VAL . 68.2 mt -103.39 -12.67 17.04 Favored 'General case' 0 C--N 1.308 -1.228 0 O-C-N 122.674 -0.31 . . . . 71.310000000000002 110.299 -178.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.488 HD23 ' H ' ' A' ' 212' ' ' LEU . 2.0 pt? -113.68 158.07 21.36 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 115.484 -0.78 . . . . 43.310000000000002 109.552 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -130.46 165.59 22.32 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 123.047 0.539 . . . . 60.43 110.157 179.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 34.5 m -63.69 -30.07 48.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 113.599 0.963 . . . . 61.229999999999997 113.599 -179.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -76.77 -15.06 59.85 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 116.203 -0.453 . . . . 53.109999999999999 111.703 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -68.17 147.58 52.07 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-O 121.64 0.733 . . . . 50.509999999999998 112.649 -175.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -108.59 133.94 52.03 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.638 -1.164 . . . . 64.409999999999997 111.27 -177.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.487 ' HA ' HG12 ' A' ' 249' ' ' VAL . 39.8 t -83.62 133.96 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-O 121.811 0.815 . . . . 41.210000000000001 111.2 -175.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.438 HG13 ' ND1' ' A' ' 158' ' ' HIS . 46.8 mm -102.97 -56.47 5.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 CA-C-N 114.656 -1.156 . . . . 74.549999999999997 110.996 -178.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -152.37 165.19 35.77 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.986 -0.552 . . . . 61.32 109.934 -175.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.521 ' HA ' ' O ' ' A' ' 246' ' ' ILE . 8.9 p -134.8 123.88 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 CA-C-N 115.92 -0.582 . . . . 65.450000000000003 110.052 177.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . 0.426 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 12.8 t-20 65.44 13.52 8.9 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 125.241 1.416 . . . . 75.420000000000002 110.706 177.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 107.0 -9.4 39.69 Favored Glycine 0 N--CA 1.442 -0.933 0 C-N-CA 120.84 -0.695 . . . . 74.299999999999997 112.079 -178.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 64.4 mt -105.06 124.27 59.69 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 N-CA-C 110.13 -0.322 . . . . 72.219999999999999 110.13 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -57.2 142.58 42.36 Favored 'General case' 0 C--N 1.31 -1.126 0 C-N-CA 124.483 1.113 . . . . 65.109999999999999 112.6 -178.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 30.6 m -118.91 -1.68 8.99 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 CA-C-N 115.525 -0.761 . . . . 73.230000000000004 109.8 175.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -76.92 99.04 5.09 Favored 'General case' 0 N--CA 1.428 -1.546 0 CA-C-N 115.356 -0.838 . . . . 74.230000000000004 109.719 -177.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 118.9 -14.0 11.41 Favored Glycine 0 N--CA 1.435 -1.39 0 C-N-CA 120.839 -0.696 . . . . 63.530000000000001 111.729 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -76.97 -179.93 5.81 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 120.987 0.422 . . . . 75.299999999999997 110.654 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . 0.444 ' O ' HG13 ' A' ' 234' ' ' VAL . 50.6 p -95.53 162.73 13.51 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 108.187 -1.042 . . . . 45.119999999999997 108.187 177.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -63.59 -33.26 75.22 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 109.067 -0.716 . . . . 75.219999999999999 109.067 -178.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -63.42 -49.7 72.7 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.516 -0.311 . . . . 61.439999999999998 110.293 176.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' GLN . . . . . 0.568 ' O ' ' HG2' ' A' ' 237' ' ' MET . 47.9 mt-30 -57.28 -41.72 80.32 Favored 'General case' 0 CA--C 1.509 -0.625 0 N-CA-C 112.447 0.536 . . . . 75.5 112.447 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.582 HG21 HG12 ' A' ' 195' ' ' ILE . 10.2 m -74.3 -34.57 37.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 C-N-CA 120.764 -0.375 . . . . 75.319999999999993 111.399 -177.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . 0.407 ' O ' HG23 ' A' ' 239' ' ' VAL . 26.0 m -71.14 -38.04 72.27 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 108.368 -0.975 . . . . 74.019999999999996 108.368 178.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -59.86 -35.6 75.14 Favored 'General case' 0 C--O 1.243 0.746 0 CA-C-N 115.385 -0.825 . . . . 74.510000000000005 110.144 177.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' MET . . . . . 0.568 ' HG2' ' O ' ' A' ' 233' ' ' GLN . 17.3 mmt -59.78 -52.43 65.49 Favored 'General case' 0 C--O 1.199 -1.576 0 N-CA-C 108.065 -1.087 . . . . 73.430000000000007 108.065 175.293 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 63.4 mtt -61.57 -36.96 82.13 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.754 -1.112 . . . . 73.409999999999997 112.422 -175.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 235' ' ' THR . 83.9 t -68.49 -36.8 76.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-O 121.396 0.617 . . . . 74.430000000000007 110.287 176.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -74.48 -36.4 63.29 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.905 0.859 . . . . 72.540000000000006 110.11 179.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -87.75 22.13 2.39 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 114.945 -1.025 . . . . 75.109999999999999 110.607 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' SER . . . . . 0.46 ' O ' HD23 ' A' ' 164' ' ' LEU . 25.5 p -59.86 -28.2 67.31 Favored 'General case' 0 CA--C 1.554 1.13 0 N-CA-C 113.691 0.997 . . . . 52.450000000000003 113.691 -177.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 48.7 m -85.55 -9.28 57.59 Favored 'General case' 0 C--N 1.318 -0.789 0 O-C-N 121.672 -0.642 . . . . 73.329999999999998 112.038 177.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 14.8 p30 -164.56 78.24 0.35 Allowed 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.524 0.678 . . . . 71.019999999999996 111.376 -176.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.492 ' HB3' ' HB2' ' A' ' 163' ' ' LEU . 1.2 tt -85.54 101.89 13.06 Favored 'General case' 0 N--CA 1.422 -1.844 0 C-N-CA 118.721 -1.192 . . . . 75.209999999999994 108.059 -174.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.521 ' O ' ' HA ' ' A' ' 221' ' ' VAL . 68.7 mt -104.7 116.15 47.96 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.319 0 C-N-CA 119.713 -0.795 . . . . 53.130000000000003 108.963 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . 0.467 HG13 ' CD2' ' A' ' 245' ' ' LEU . 23.2 mt -118.53 136.91 54.2 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.257 0 CA-C-O 121.627 0.727 . . . . 60.240000000000002 111.477 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.574 ' OG1' ' HG3' ' A' ' 160' ' ' ARG . 39.0 m -107.74 119.34 39.16 Favored 'General case' 0 N--CA 1.405 -2.713 0 CA-C-N 115.073 -0.967 . . . . 61.340000000000003 108.573 177.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.487 HG12 ' HA ' ' A' ' 218' ' ' VAL . 27.1 m -129.29 159.32 41.45 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 O-C-N 123.282 0.364 . . . . 64.439999999999998 110.296 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . 0.574 ' HG2' ' HB3' ' A' ' 158' ' ' HIS 0.346 35.7 mtmt -124.09 142.26 39.33 Favored Pre-proline 0 CA--C 1.475 -1.919 0 N-CA-C 104.435 -2.431 . . . . 75.409999999999997 104.435 175.538 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo . . . . . 0 C--N 1.286 -2.747 0 C-N-CA 120.871 1.047 . . . . 63.109999999999999 111.364 176.537 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.575 ' HB3' ' HG2' ' A' ' 250' ' ' LYS 0.374 2.3 p-80 . . . . . 0 N--CA 1.436 -1.159 0 N-CA-C 115.397 1.629 . . . . 44.109999999999999 115.397 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.535 ' O ' ' HA ' ' A' ' 248' ' ' THR . 3.7 ptp180 -125.25 144.96 50.21 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 113.575 -1.648 . . . . 74.310000000000002 108.944 -176.029 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.705 ' HB3' ' OG1' ' A' ' 248' ' ' THR . 37.0 ptt180 -117.27 119.25 34.58 Favored 'General case' 0 N--CA 1.426 -1.627 0 CA-C-O 121.901 0.858 . . . . 72.409999999999997 113.05 178.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.582 ' O ' ' HA ' ' A' ' 246' ' ' ILE . 26.6 m -102.78 135.02 42.12 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 CA-C-N 114.617 -1.174 . . . . 74.319999999999993 111.075 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.523 ' HG2' HG12 ' A' ' 246' ' ' ILE . 15.4 mtm180 -96.48 112.66 24.32 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 106.927 -1.508 . . . . 65.420000000000002 106.927 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 21.4 mt -99.34 134.23 42.5 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 109.52 -0.548 . . . . 75.439999999999998 109.52 -177.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 6.3 tt . . . . . 0 C--N 1.318 -0.774 0 O-C-N 124.344 1.027 . . . . 72.150000000000006 111.893 174.207 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.47 ' HG ' ' CD1' ' A' ' 245' ' ' LEU . 2.9 mm? . . . . . 0 N--CA 1.437 -1.083 0 CA-C-O 120.589 0.233 . . . . 75.25 111.021 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . 0.454 ' HA3' ' HA3' ' A' ' 204' ' ' GLY . . . 89.24 43.97 5.15 Favored Glycine 0 N--CA 1.436 -1.346 0 C-N-CA 120.592 -0.813 . . . . 75.209999999999994 113.983 174.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -161.94 154.76 20.2 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.627 -1.249 . . . . 64.319999999999993 107.627 174.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -123.95 157.88 33.3 Favored 'General case' 0 C--N 1.282 -2.353 0 N-CA-C 108.533 -0.914 . . . . 74.519999999999996 108.533 177.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.582 ' H ' HD13 ' A' ' 176' ' ' ILE . 0.1 OUTLIER -123.72 160.52 27.28 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 N-CA-C 109.571 -0.529 . . . . 61.310000000000002 109.571 179.944 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.462 ' HB3' ' HB3' ' A' ' 198' ' ' SER . 10.1 ptp180 -132.21 154.64 49.38 Favored 'General case' 0 C--N 1.282 -2.355 0 CA-C-N 115.656 -0.702 . . . . 74.230000000000004 110.684 -178.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . 0.497 ' HB2' ' HG ' ' A' ' 231' ' ' LEU . 4.8 t70 -107.41 143.92 35.06 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 115.085 -0.961 . . . . 52.32 110.509 -179.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -164.92 179.79 39.35 Favored Glycine 0 N--CA 1.415 -2.715 0 N-CA-C 108.871 -1.692 . . . . 52.130000000000003 108.871 175.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . 0.462 ' HB ' ' CG ' ' A' ' 191' ' ' LYS . 0.4 OUTLIER -89.99 122.34 32.91 Favored 'General case' 0 C--N 1.283 -2.301 0 CA-C-N 117.524 0.662 . . . . 71.420000000000002 111.024 175.667 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 47.3 t . . . . . 0 N--CA 1.414 -2.265 0 N-CA-C 107.87 -1.159 . . . . 55.420000000000002 107.87 177.817 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.462 ' CG ' ' HB ' ' A' ' 180' ' ' THR . 35.5 ttmt . . . . . 0 N--CA 1.422 -1.83 0 N-CA-C 107.785 -1.191 . . . . 72.400000000000006 107.785 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -151.09 164.98 18.39 Favored Pre-proline 0 C--N 1.293 -1.878 0 N-CA-C 108.256 -1.016 . . . . 72.5 108.256 -178.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -55.19 132.27 51.3 Favored 'Trans proline' 0 C--N 1.358 1.04 0 C-N-CA 121.637 1.558 . . . . 75.019999999999996 109.846 174.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -143.93 138.65 8.18 Favored Glycine 0 N--CA 1.409 -3.106 0 N-CA-C 111.38 -0.688 . . . . 71.129999999999995 111.38 -178.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.559 HG12 HG21 ' A' ' 234' ' ' VAL . 2.7 mp -103.63 134.52 44.59 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.94 0 CA-C-O 121.605 0.717 . . . . 72.140000000000001 110.883 179.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -124.27 166.17 16.36 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 106.149 -1.797 . . . . 71.230000000000004 106.149 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 47.8 mm -79.08 131.27 34.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 107.562 -1.273 . . . . 75.310000000000002 107.562 177.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . 0.462 ' HB3' ' HB3' ' A' ' 177' ' ' ARG . 82.3 p -101.64 -31.64 10.72 Favored 'General case' 0 C--N 1.287 -2.111 0 C-N-CA 118.633 -1.227 . . . . 43.130000000000003 112.752 -175.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 29.6 tpt180 -166.76 146.15 5.54 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 120.781 -0.368 . . . . 70.099999999999994 110.344 -175.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 82.9 mt -102.54 146.38 28.22 Favored 'General case' 0 CA--C 1.489 -1.381 0 N-CA-C 108.932 -0.766 . . . . 70.430000000000007 108.932 172.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 47.8 t -107.52 115.89 58.64 Favored Pre-proline 0 C--N 1.282 -2.337 0 N-CA-C 105.3 -2.111 . . . . 73.420000000000002 105.3 172.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . 0.434 ' HA ' ' HG3' ' A' ' 207' ' ' GLU . 11.5 Cg_endo -55.03 128.67 31.53 Favored 'Trans proline' 0 C--O 1.248 0.98 0 C-N-CA 122.335 2.023 . . . . 75.25 111.129 -177.118 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 99.05 -11.4 62.17 Favored Glycine 0 N--CA 1.439 -1.158 0 C-N-CA 120.6 -0.809 . . . . 71.319999999999993 111.719 -177.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . 0.454 ' HA3' ' HA3' ' A' ' 173' ' ' GLY . . . -74.82 166.36 54.85 Favored Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 121.032 -0.604 . . . . 75.209999999999994 111.597 178.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.452 HD23 ' HA ' ' A' ' 172' ' ' LEU . 3.0 mm? -66.09 -34.02 77.11 Favored 'General case' 0 C--N 1.312 -1.036 0 C-N-CA 122.996 0.518 . . . . 73.319999999999993 111.641 -176.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . 0.562 ' CB ' HD12 ' A' ' 212' ' ' LEU . . . -67.75 -42.43 81.83 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.522 0.677 . . . . 72.400000000000006 110.051 178.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.434 ' HG3' ' HA ' ' A' ' 202' ' ' PRO . 6.0 tm-20 -75.39 -34.49 61.09 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 114.915 -1.039 . . . . 72.140000000000001 108.982 -178.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 35.9 t -58.54 -47.34 84.54 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 123.786 0.834 . . . . 73.209999999999994 110.795 177.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . 0.474 HG23 ' H ' ' A' ' 211' ' ' LEU . 10.2 t -75.6 -35.67 60.48 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 120.004 -0.678 . . . . 53.509999999999998 109.446 177.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 74.17 16.56 79.64 Favored Glycine 0 N--CA 1.442 -0.905 0 CA-C-N 115.984 -0.553 . . . . 40.329999999999998 112.672 177.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.474 ' H ' HG23 ' A' ' 209' ' ' THR . 54.9 mt -99.19 -0.55 41.29 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 120.933 0.397 . . . . 64.439999999999998 110.449 -178.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.562 HD12 ' CB ' ' A' ' 206' ' ' ALA . 80.6 mt -109.79 131.7 54.83 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 115.187 -0.915 . . . . 72.230000000000004 108.941 174.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -130.7 155.9 45.83 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 109.102 -0.703 . . . . 62.119999999999997 109.102 177.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 31.2 m -62.16 -29.28 46.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-O 122.078 0.942 . . . . 70.420000000000002 112.773 -177.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -77.99 -14.06 59.66 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 115.533 -0.758 . . . . 74.329999999999998 111.782 -178.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -76.71 150.68 36.28 Favored 'General case' 0 C--O 1.244 0.786 0 N-CA-C 113.02 0.748 . . . . 53.130000000000003 113.02 -173.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -108.81 132.34 54.09 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.016 -0.993 . . . . 72.219999999999999 109.766 -178.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.54 ' HA ' HG12 ' A' ' 249' ' ' VAL . 39.7 t -83.33 138.33 19.48 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 CA-C-O 121.488 0.661 . . . . 70.540000000000006 111.509 -176.053 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 46.0 mm -105.22 -53.16 7.13 Favored 'Isoleucine or valine' 0 C--O 1.246 0.875 0 CA-C-N 115.171 -0.922 . . . . 74.239999999999995 111.099 -178.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.423 ' HB3' ' HA ' ' A' ' 225' ' ' GLU . 10.5 pt-20 -153.92 165.85 34.81 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 116.049 -0.523 . . . . 74.430000000000007 109.82 -175.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.487 ' HA ' ' O ' ' A' ' 246' ' ' ILE . 8.3 p -135.19 122.97 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.749 0 CA-C-N 115.647 -0.706 . . . . 74.340000000000003 109.148 176.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . 0.537 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 12.2 t-20 68.73 5.52 4.98 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 125.083 1.353 . . . . 70.230000000000004 111.198 178.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 113.63 -14.15 22.51 Favored Glycine 0 N--CA 1.439 -1.149 0 N-CA-C 110.882 -0.887 . . . . 75.319999999999993 110.882 -178.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 65.7 mt -96.34 123.75 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.521 0 N-CA-C 109.1 -0.704 . . . . 62.25 109.1 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . 0.423 ' HA ' ' HB3' ' A' ' 220' ' ' GLU . 12.4 pt-20 -58.05 153.01 15.42 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 123.684 0.794 . . . . 73.450000000000003 112.002 -177.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . 0.476 ' HB ' HG12 ' A' ' 234' ' ' VAL . 35.9 m -129.59 2.47 2.58 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 CA-C-N 115.411 -0.813 . . . . 52.039999999999999 110.248 174.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -71.84 98.56 2.02 Favored 'General case' 0 N--CA 1.432 -1.372 0 CA-C-N 115.634 -0.712 . . . . 71.099999999999994 110.693 -178.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 121.12 -17.57 9.11 Favored Glycine 0 CA--C 1.489 -1.551 0 N-CA-C 110.378 -1.089 . . . . 44.100000000000001 110.378 178.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -83.5 163.21 20.61 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.122 -0.539 . . . . 72.409999999999997 111.333 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . 0.493 ' H ' ' NE2' ' A' ' 233' ' ' GLN . 37.2 p -97.19 172.32 7.89 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.756 -0.657 . . . . 75.349999999999994 110.667 -176.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . 0.603 ' HA ' HG22 ' A' ' 234' ' ' VAL . 78.0 mt -56.65 -40.32 75.25 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 111.837 0.31 . . . . 64.109999999999999 111.837 177.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -56.8 -42.7 79.96 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 121.279 0.561 . . . . 73.340000000000003 110.132 179.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' GLN . . . . . 0.493 ' NE2' ' H ' ' A' ' 230' ' ' THR . 49.0 mt-30 -72.94 -47.71 43.19 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.961 -1.018 . . . . 71.209999999999994 112.339 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.603 HG22 ' HA ' ' A' ' 231' ' ' LEU . 16.9 m -70.86 -34.47 56.18 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 112.092 0.404 . . . . 51.210000000000001 112.092 -176.056 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . 0.428 ' O ' HG23 ' A' ' 239' ' ' VAL . 50.3 m -69.57 -35.3 75.24 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 109.429 -0.582 . . . . 75.140000000000001 109.429 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -60.73 -38.93 86.78 Favored 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 108.863 -0.792 . . . . 73.299999999999997 108.863 177.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 15.9 mmt -59.46 -50.17 74.95 Favored 'General case' 0 C--O 1.199 -1.563 0 CA-C-N 115.332 -0.849 . . . . 74.150000000000006 108.725 177.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' MET . . . . . 0.444 ' HG3' ' O ' ' A' ' 234' ' ' VAL . 63.0 mtt -61.8 -37.31 83.91 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.895 0.878 . . . . 74.439999999999998 112.259 -176.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 235' ' ' THR . 97.3 t -65.13 -40.32 88.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 121.19 0.519 . . . . 52.229999999999997 109.942 176.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -72.97 -37.0 67.21 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.613 0.721 . . . . 62.25 110.297 178.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -86.87 21.11 2.35 Favored 'General case' 0 C--O 1.202 -1.431 0 CA-C-N 115.603 -0.726 . . . . 71.409999999999997 111.905 -178.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 69.8 m -65.21 -22.88 66.95 Favored 'General case' 0 C--N 1.312 -1.022 0 C-N-CA 120.41 -0.516 . . . . 71.530000000000001 111.548 177.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 23.1 m -70.47 -24.38 62.86 Favored 'General case' 0 CA--C 1.554 1.11 0 CA-C-N 116.363 -0.381 . . . . 74.219999999999999 111.032 176.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -174.3 97.3 0.1 Allowed 'General case' 0 C--O 1.246 0.913 0 C-N-CA 124.363 1.065 . . . . 35.539999999999999 109.205 177.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.501 ' CD2' HG13 ' A' ' 247' ' ' ILE . 2.4 tt -88.16 103.03 15.38 Favored 'General case' 0 N--CA 1.414 -2.273 0 N-CA-C 109.211 -0.662 . . . . 71.239999999999995 109.211 -173.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.582 ' HA ' ' O ' ' A' ' 161' ' ' VAL . 69.7 mt -100.87 116.7 44.88 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.179 0 N-CA-C 109.37 -0.604 . . . . 72.0 109.37 -179.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . 0.501 HG13 ' CD2' ' A' ' 245' ' ' LEU . 27.0 mt -120.94 132.54 70.18 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 CA-C-O 121.541 0.686 . . . . 71.120000000000005 112.331 178.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.705 ' OG1' ' HB3' ' A' ' 160' ' ' ARG . 37.0 m -104.19 122.8 46.11 Favored 'General case' 0 N--CA 1.414 -2.244 0 CA-C-N 114.291 -1.322 . . . . 64.439999999999998 108.603 177.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.54 HG12 ' HA ' ' A' ' 218' ' ' VAL . 34.7 m -130.79 164.09 34.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 110.035 -0.357 . . . . 64.109999999999999 110.035 177.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . 0.575 ' HG2' ' HB3' ' A' ' 158' ' ' HIS 0.296 38.6 mtmt -124.39 141.73 38.36 Favored Pre-proline 0 CA--C 1.48 -1.721 0 N-CA-C 104.788 -2.301 . . . . 74.540000000000006 104.788 173.919 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo . . . . . 0 N--CA 1.411 -3.351 0 C-N-CA 120.573 0.848 . . . . 74.230000000000004 111.257 176.992 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.488 ' NE2' HG13 ' A' ' 219' ' ' ILE . 4.7 m80 . . . . . 0 N--CA 1.443 -0.808 0 CA-C-O 121.658 0.742 . . . . 71.510000000000005 112.588 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.434 ' O ' ' HA ' ' A' ' 248' ' ' THR . 18.8 tpp180 -107.29 141.41 38.68 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 107.218 -1.401 . . . . 72.349999999999994 107.218 177.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -114.96 113.15 23.75 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 108.657 -0.868 . . . . 73.549999999999997 108.657 175.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.507 HG21 HD11 ' A' ' 212' ' ' LEU . 17.7 m -129.08 137.86 56.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-O 120.868 0.366 . . . . 75.299999999999997 111.986 179.295 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 42.9 ttp180 -116.81 112.5 21.21 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 108.904 -0.776 . . . . 71.349999999999994 108.904 173.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 13.5 mt -102.56 138.83 38.96 Favored 'General case' 0 C--N 1.281 -2.386 0 N-CA-C 107.319 -1.363 . . . . 74.510000000000005 107.319 -175.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.585 HD12 ' O ' ' A' ' 242' ' ' SER . 0.7 OUTLIER . . . . . 0 N--CA 1.446 -0.672 0 N-CA-C 108.263 -1.014 . . . . 74.310000000000002 108.263 174.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.44 ' CD1' ' HB2' ' A' ' 164' ' ' LEU . 3.3 mm? . . . . . 0 CA--C 1.506 -0.713 0 CA-C-O 121.201 0.524 . . . . 72.530000000000001 110.177 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . 0.475 ' HA3' ' HA3' ' A' ' 204' ' ' GLY . . . 90.53 25.15 26.48 Favored Glycine 0 N--CA 1.42 -2.368 0 CA-C-N 115.445 -0.798 . . . . 73.340000000000003 113.522 176.108 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -143.11 151.54 40.84 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 107.843 -1.169 . . . . 74.319999999999993 107.843 174.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -131.13 152.85 49.99 Favored 'General case' 0 CA--C 1.484 -1.588 0 CA-C-O 120.808 0.337 . . . . 73.319999999999993 110.227 178.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.635 ' H ' HD13 ' A' ' 176' ' ' ILE . 0.2 OUTLIER -116.85 169.85 6.87 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.049 0 CA-C-N 115.66 -0.7 . . . . 52.310000000000002 112.219 -173.81 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.61 ' CG ' ' HB2' ' A' ' 198' ' ' SER . 11.8 ptt180 -148.51 156.02 41.91 Favored 'General case' 0 C--N 1.287 -2.133 0 C-N-CA 125.478 1.511 . . . . 75.340000000000003 109.841 -175.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -110.89 144.61 39.67 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 123.466 0.479 . . . . 73.25 110.856 179.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -162.44 171.68 38.35 Favored Glycine 0 N--CA 1.427 -1.901 0 N-CA-C 108.876 -1.69 . . . . 43.420000000000002 108.876 175.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . 0.501 ' HB ' ' CG ' ' A' ' 191' ' ' LYS . 0.6 OUTLIER -86.76 123.85 32.37 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 118.172 0.986 . . . . 74.230000000000004 111.658 175.966 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 34.7 t . . . . . 0 N--CA 1.404 -2.768 0 N-CA-C 107.927 -1.138 . . . . 74.549999999999997 107.927 177.411 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.501 ' CG ' ' HB ' ' A' ' 180' ' ' THR . 36.3 ttmt . . . . . 0 N--CA 1.44 -0.969 0 N-CA-C 109.071 -0.714 . . . . 73.140000000000001 109.071 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . 0.456 HE22 ' HB1' ' A' ' 227' ' ' ALA . 11.3 pt20 -144.21 164.33 29.71 Favored Pre-proline 0 C--N 1.297 -1.705 0 N-CA-C 107.503 -1.295 . . . . 73.409999999999997 107.503 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -65.17 132.86 33.17 Favored 'Trans proline' 0 C--O 1.247 0.934 0 C-N-CA 121.102 1.201 . . . . 42.340000000000003 109.776 174.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -137.94 141.62 12.36 Favored Glycine 0 N--CA 1.414 -2.787 0 N-CA-C 110.533 -1.027 . . . . 51.509999999999998 110.533 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.511 ' O ' HG12 ' A' ' 218' ' ' VAL . 3.4 mp -103.74 136.04 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.402 0 N-CA-C 109.272 -0.64 . . . . 74.109999999999999 109.272 179.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -128.1 167.6 16.53 Favored 'General case' 0 C--N 1.282 -2.326 0 N-CA-C 107.73 -1.211 . . . . 70.519999999999996 107.73 -177.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 58.5 mt -83.6 131.71 33.19 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 N-CA-C 109.334 -0.617 . . . . 73.239999999999995 109.334 174.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . 0.61 ' HB2' ' CG ' ' A' ' 177' ' ' ARG . 29.6 t -110.18 -27.91 8.9 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.557 -0.714 . . . . 70.319999999999993 112.691 -177.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -147.63 134.53 20.19 Favored 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 120.037 -0.665 . . . . 73.450000000000003 109.583 -176.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 1.4 tt -116.18 124.81 51.23 Favored 'General case' 0 N--CA 1.414 -2.239 0 N-CA-C 106.51 -1.663 . . . . 73.530000000000001 106.51 179.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 96.6 t -94.14 124.69 55.21 Favored Pre-proline 0 C--N 1.306 -1.284 0 N-CA-C 110.472 -0.196 . . . . 74.420000000000002 110.472 -178.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -60.59 126.29 19.5 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.459 2.106 . . . . 24.120000000000001 110.782 177.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 98.91 -6.66 60.31 Favored Glycine 0 N--CA 1.435 -1.405 0 C-N-CA 120.777 -0.725 . . . . 53.530000000000001 112.614 -178.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . 0.475 ' HA3' ' HA3' ' A' ' 173' ' ' GLY . . . -79.53 169.54 53.62 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.5 -0.857 . . . . 65.409999999999997 112.285 179.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -65.06 -34.63 78.87 Favored 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 122.723 0.409 . . . . 73.140000000000001 110.653 -178.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -60.3 -43.59 96.16 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.64 -0.709 . . . . 64.230000000000004 110.809 178.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -75.6 -35.89 60.44 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.257 -0.429 . . . . 75.230000000000004 110.324 179.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 37.9 t -56.61 -42.71 79.24 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.817 -0.629 . . . . 72.329999999999998 110.35 179.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . 0.417 HG23 ' H ' ' A' ' 211' ' ' LEU . 10.2 t -82.86 -35.73 26.02 Favored 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 120.454 -0.498 . . . . 72.329999999999998 109.912 176.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 75.18 5.74 77.43 Favored Glycine 0 C--O 1.217 -0.925 0 CA-C-N 116.202 -0.453 . . . . 65.129999999999995 112.986 177.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.417 ' H ' HG23 ' A' ' 209' ' ' THR . 67.0 mt -87.05 -11.79 49.26 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 120.813 0.339 . . . . 55.229999999999997 110.894 -177.222 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.507 HD11 HG21 ' A' ' 161' ' ' VAL . 4.3 mp -109.65 133.73 52.77 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 120.351 -0.54 . . . . 74.150000000000006 109.63 177.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -131.09 166.0 22.03 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 108.762 -0.829 . . . . 53.119999999999997 108.762 176.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 30.2 m -59.97 -28.06 40.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 113.324 0.861 . . . . 62.450000000000003 113.324 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 20.1 m-80 -71.95 -15.97 62.08 Favored 'General case' 0 C--N 1.312 -1.022 0 O-C-N 122.038 -0.414 . . . . 74.340000000000003 110.769 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.5 ' HA ' ' HA ' ' A' ' 251' ' ' PRO . 5.0 m-20 -71.18 132.35 44.87 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 114.426 1.269 . . . . 72.510000000000005 114.426 -174.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -105.19 131.12 53.06 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 126.328 1.851 . . . . 65.239999999999995 108.497 -179.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.592 ' HA ' HG12 ' A' ' 249' ' ' VAL . 11.4 p -83.5 134.55 26.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-O 122.034 0.921 . . . . 75.510000000000005 112.58 -175.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.488 HG13 ' NE2' ' A' ' 158' ' ' HIS . 39.7 mm -99.49 -49.01 11.67 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 CA-C-N 114.303 -1.317 . . . . 61.509999999999998 110.645 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -160.12 160.51 33.08 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.192 -0.458 . . . . 75.030000000000001 110.775 -176.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' A' ' 246' ' ' ILE . 7.5 p -129.7 122.67 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.03 0 O-C-N 123.736 0.647 . . . . 71.549999999999997 109.675 175.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . 0.467 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 2.8 m-20 58.89 22.08 9.84 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 125.519 1.528 . . . . 73.219999999999999 113.651 -178.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 105.85 -13.87 45.57 Favored Glycine 0 N--CA 1.429 -1.83 0 C-N-CA 120.323 -0.941 . . . . 55.520000000000003 113.062 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 60.9 mt -97.9 123.85 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.046 0 C-N-CA 120.705 -0.398 . . . . 73.329999999999998 110.458 -179.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -51.64 133.7 30.52 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 124.711 1.257 . . . . 63.350000000000001 111.608 177.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . 0.406 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 29.7 m -115.74 11.47 7.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 CA-C-O 122.217 1.008 . . . . 73.200000000000003 108.338 172.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' ALA . . . . . 0.456 ' HB1' HE22 ' A' ' 192' ' ' GLN . . . -68.44 97.11 0.73 Allowed 'General case' 0 N--CA 1.422 -1.869 0 CA-C-N 113.468 -1.697 . . . . 72.430000000000007 111.142 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 95.56 10.3 56.92 Favored Glycine 0 C--N 1.307 -1.038 0 CA-C-N 115.609 -0.723 . . . . 64.400000000000006 112.88 174.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -82.94 178.31 8.22 Favored 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 120.506 -0.478 . . . . 73.340000000000003 109.83 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . 0.437 ' H ' ' NE2' ' A' ' 233' ' ' GLN . 41.1 p -87.82 157.64 18.95 Favored 'General case' 0 N--CA 1.421 -1.889 0 N-CA-C 107.135 -1.432 . . . . 61.530000000000001 107.135 174.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . 0.429 ' O ' HG22 ' A' ' 234' ' ' VAL . 1.3 tt -64.83 -32.72 74.55 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 108.1 -1.074 . . . . 74.430000000000007 108.1 -177.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -64.35 -38.99 92.98 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.411 -0.358 . . . . 74.430000000000007 110.487 177.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' GLN . . . . . 0.437 ' NE2' ' H ' ' A' ' 230' ' ' THR . 42.9 mt-30 -60.34 -49.36 77.9 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 112.026 0.38 . . . . 73.329999999999998 112.026 175.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.441 HG21 HG12 ' A' ' 195' ' ' ILE . 5.4 m -67.92 -32.76 57.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-O 121.242 0.544 . . . . 72.310000000000002 111.739 -176.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . 0.407 ' O ' HG23 ' A' ' 239' ' ' VAL . 88.2 m -74.18 -37.15 64.04 Favored 'General case' 0 CA--C 1.498 -1.044 0 CA-C-N 115.567 -0.742 . . . . 64.049999999999997 109.084 -176.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -60.39 -34.12 73.44 Favored 'General case' 0 CA--C 1.507 -0.682 0 CA-C-N 115.433 -0.803 . . . . 55.119999999999997 109.153 177.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 8.9 mtt -69.24 -44.88 71.09 Favored 'General case' 0 C--O 1.2 -1.527 0 N-CA-C 108.686 -0.857 . . . . 74.310000000000002 108.686 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' MET . . . . . 0.421 ' HG3' ' O ' ' A' ' 234' ' ' VAL . 64.7 mtt -60.12 -31.76 70.36 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.979 -0.555 . . . . 62.240000000000002 111.681 -178.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 235' ' ' THR . 91.0 t -74.12 -41.9 51.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-O 121.327 0.584 . . . . 70.049999999999997 110.004 176.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -70.51 -35.59 73.28 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.386 0.612 . . . . 75.010000000000005 111.106 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -84.71 21.95 1.43 Allowed 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 115.357 -0.838 . . . . 62.299999999999997 112.546 -178.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' SER . . . . . 0.585 ' O ' HD12 ' A' ' 164' ' ' LEU . 67.9 m -59.41 -23.46 62.65 Favored 'General case' 0 C--O 1.207 -1.159 0 N-CA-C 113.08 0.771 . . . . 64.109999999999999 113.08 178.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 22.6 p -68.42 -33.93 75.09 Favored 'General case' 0 CA--C 1.552 1.033 0 O-C-N 121.76 -0.588 . . . . 53.039999999999999 111.861 177.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 -159.68 100.59 1.46 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.931 1.292 . . . . 54.310000000000002 108.264 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -86.55 103.1 14.74 Favored 'General case' 0 C--O 1.21 -1.012 0 N-CA-C 108.443 -0.947 . . . . 44.219999999999999 108.443 -178.123 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.467 ' HB ' ' HA ' ' A' ' 222' ' ' ASN . 61.9 mt -103.78 116.32 47.34 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 N-CA-C 108.731 -0.84 . . . . 74.239999999999995 108.731 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . 0.509 HG23 HG23 ' A' ' 218' ' ' VAL . 18.2 mt -121.99 134.54 64.97 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.155 0 CA-C-O 121.801 0.81 . . . . 72.230000000000004 112.318 178.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.434 ' HA ' ' O ' ' A' ' 159' ' ' ARG . 46.3 m -106.54 114.96 29.38 Favored 'General case' 0 N--CA 1.411 -2.413 0 N-CA-C 107.771 -1.196 . . . . 73.310000000000002 107.771 175.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.592 HG12 ' HA ' ' A' ' 218' ' ' VAL . 18.1 m -123.27 161.42 25.13 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 CA-C-O 121.004 0.43 . . . . 73.040000000000006 110.354 177.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 16.0 ptmt -137.1 135.75 20.12 Favored Pre-proline 0 C--N 1.278 -2.54 0 N-CA-C 107.024 -1.473 . . . . 75.209999999999994 107.024 173.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . 0.5 ' HA ' ' HA ' ' A' ' 216' ' ' ASP . 38.8 Cg_exo . . . . . 0 N--CA 1.449 -1.136 0 C-N-CA 121.088 1.192 . . . . 73.310000000000002 111.249 178.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.214 -0.814 0 N-CA-C 109.105 -0.702 . . . . 72.010000000000005 109.105 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.569 ' O ' ' HA ' ' A' ' 248' ' ' THR . 24.5 tpt180 -119.69 128.88 54.22 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 120.202 -0.599 . . . . 70.099999999999994 110.342 176.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 32.1 ptt180 -115.85 114.24 24.46 Favored 'General case' 0 C--N 1.284 -2.243 0 CA-C-N 114.944 -1.025 . . . . 73.319999999999993 109.91 178.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 17.4 m -117.0 138.91 46.12 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 CA-C-N 115.459 -0.791 . . . . 73.409999999999997 111.097 -178.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.538 ' HD2' ' N ' ' A' ' 162' ' ' ARG . 1.3 mpt_? -107.76 111.99 24.44 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 106.589 -1.634 . . . . 74.219999999999999 106.589 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.539 ' HB2' ' HB3' ' A' ' 245' ' ' LEU . 29.1 mt -98.85 139.6 34.28 Favored 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 123.793 0.837 . . . . 74.430000000000007 111.72 -171.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.554 HD23 ' O ' ' A' ' 242' ' ' SER . 9.9 tp . . . . . 0 CA--C 1.515 -0.379 0 C-N-CA 125.75 1.62 . . . . 55.340000000000003 113.179 173.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.52 ' CD1' ' HB2' ' A' ' 164' ' ' LEU . 2.3 mm? . . . . . 0 N--CA 1.443 -0.797 0 CA-C-O 121.038 0.447 . . . . 63.149999999999999 110.036 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . 0.418 ' HA3' ' HA3' ' A' ' 204' ' ' GLY . . . 84.08 49.57 4.69 Favored Glycine 0 N--CA 1.433 -1.516 0 CA-C-N 115.633 -0.712 . . . . 41.25 113.923 175.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -156.75 161.37 39.8 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 108.079 -1.082 . . . . 74.299999999999997 108.079 175.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -130.01 157.12 43.23 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 108.589 -0.893 . . . . 73.129999999999995 108.589 175.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.548 ' H ' HD13 ' A' ' 176' ' ' ILE . 0.2 OUTLIER -126.21 169.06 18.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 CA-C-O 121.595 0.712 . . . . 75.319999999999993 111.278 -179.04 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.472 ' HG2' ' HB2' ' A' ' 198' ' ' SER . 16.9 ptt180 -157.79 155.44 29.8 Favored 'General case' 0 C--N 1.281 -2.385 0 CA-C-N 114.698 -1.137 . . . . 74.010000000000005 108.922 -175.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -112.77 158.26 20.32 Favored 'General case' 0 C--N 1.298 -1.664 0 C-N-CA 119.402 -0.919 . . . . 71.530000000000001 110.815 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -156.38 -179.23 31.23 Favored Glycine 0 C--N 1.29 -2.001 0 N-CA-C 107.726 -2.15 . . . . 54.509999999999998 107.726 176.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . 0.444 ' CG2' ' HG2' ' A' ' 191' ' ' LYS . 0.2 OUTLIER -112.25 122.95 49.17 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 118.996 1.398 . . . . 75.420000000000002 108.178 179.63 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . 0.433 ' O ' ' HA ' ' A' ' 191' ' ' LYS . 20.2 t . . . . . 0 C--N 1.289 -2.042 0 N-CA-C 108.547 -0.909 . . . . 32.399999999999999 108.547 -176.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.444 ' HG2' ' CG2' ' A' ' 180' ' ' THR . 33.5 ttmt . . . . . 0 N--CA 1.426 -1.626 0 N-CA-C 106.821 -1.548 . . . . 63.409999999999997 106.821 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.33 151.82 34.53 Favored Pre-proline 0 C--N 1.299 -1.627 0 CA-C-O 118.956 -0.545 . . . . 65.129999999999995 109.645 -168.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -61.56 130.23 30.88 Favored 'Trans proline' 0 C--O 1.243 0.774 0 C-N-CA 121.339 1.359 . . . . 74.219999999999999 112.879 -176.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -135.86 142.42 13.71 Favored Glycine 0 N--CA 1.411 -2.984 0 N-CA-C 108.586 -1.805 . . . . 60.219999999999999 108.586 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.582 HG12 HG21 ' A' ' 234' ' ' VAL . 3.0 mp -104.17 138.06 30.37 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.526 0 C-N-CA 120.204 -0.598 . . . . 73.120000000000005 110.224 -178.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -122.98 166.68 14.68 Favored 'General case' 0 C--N 1.283 -2.314 0 N-CA-C 108.292 -1.003 . . . . 75.239999999999995 108.292 -177.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . 0.49 ' HB ' ' HA ' ' A' ' 214' ' ' VAL . 50.3 mm -78.49 131.21 34.96 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.265 0 N-CA-C 108.382 -0.97 . . . . 74.319999999999993 108.382 177.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . 0.472 ' HB2' ' HG2' ' A' ' 177' ' ' ARG . 7.7 t -96.98 -32.43 12.02 Favored 'General case' 0 C--N 1.286 -2.178 0 O-C-N 121.703 -0.623 . . . . 72.310000000000002 112.408 -178.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -167.83 148.89 5.27 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.774 -0.194 . . . . 71.140000000000001 110.881 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 73.7 mt -102.84 146.05 28.86 Favored 'General case' 0 CA--C 1.495 -1.158 0 N-CA-C 108.599 -0.889 . . . . 72.299999999999997 108.599 170.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 59.5 t -109.14 114.3 58.1 Favored Pre-proline 0 C--N 1.28 -2.445 0 N-CA-C 106.606 -1.627 . . . . 72.329999999999998 106.606 171.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . 0.435 ' HA ' ' HG3' ' A' ' 207' ' ' GLU . 33.4 Cg_exo -59.16 128.93 29.41 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.309 2.006 . . . . 61.399999999999999 110.807 -179.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 102.17 -11.03 57.05 Favored Glycine 0 N--CA 1.442 -0.94 0 N-CA-C 110.806 -0.918 . . . . 75.230000000000004 110.806 -175.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . 0.418 ' HA3' ' HA3' ' A' ' 173' ' ' GLY . . . -90.27 161.4 28.88 Favored Glycine 0 N--CA 1.439 -1.103 0 N-CA-C 110.33 -1.108 . . . . 61.119999999999997 110.33 177.09 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -57.24 -38.16 73.38 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 123.685 0.794 . . . . 71.310000000000002 111.946 -176.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . 0.485 ' CB ' HD12 ' A' ' 212' ' ' LEU . . . -62.31 -44.52 96.32 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.315 0.579 . . . . 75.030000000000001 110.796 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.435 ' HG3' ' HA ' ' A' ' 202' ' ' PRO . 4.3 tm-20 -75.68 -35.8 60.25 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 115.72 -0.673 . . . . 64.239999999999995 110.063 179.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 50.9 m -60.13 -41.15 92.03 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 122.512 0.325 . . . . 43.210000000000001 111.021 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . 0.4 HG23 ' H ' ' A' ' 211' ' ' LEU . 9.3 t -76.94 -36.53 56.49 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 120.06 -0.656 . . . . 71.230000000000004 109.334 175.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 70.65 11.49 68.96 Favored Glycine 0 N--CA 1.444 -0.83 0 CA-C-N 115.81 -0.632 . . . . 73.219999999999999 112.99 176.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.4 ' H ' HG23 ' A' ' 209' ' ' THR . 57.0 mt -95.55 5.97 50.16 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 121.518 0.675 . . . . 71.299999999999997 109.71 -178.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.485 HD12 ' CB ' ' A' ' 206' ' ' ALA . 98.9 mt -113.71 131.01 56.33 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 114.485 -1.234 . . . . 71.519999999999996 108.227 172.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -132.53 157.84 43.67 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 108.738 -0.838 . . . . 71.510000000000005 108.738 176.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . 0.49 ' HA ' ' HB ' ' A' ' 197' ' ' ILE . 14.7 m -60.92 -30.94 48.47 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 N-CA-C 113.23 0.826 . . . . 73.340000000000003 113.23 -175.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -78.69 -14.12 59.46 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 112.914 0.709 . . . . 65.209999999999994 112.914 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -69.8 142.75 53.12 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.662 0.616 . . . . 74.409999999999997 112.662 -178.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -108.66 131.36 54.97 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.927 -1.033 . . . . 65.409999999999997 109.579 -176.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.552 HG12 ' O ' ' A' ' 195' ' ' ILE . 9.8 p -83.14 143.82 11.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-O 121.893 0.854 . . . . 73.400000000000006 112.172 -176.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.414 HD11 ' HD2' ' A' ' 250' ' ' LYS . 37.8 mm -108.14 -51.42 7.13 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 C-N-CA 124.719 1.208 . . . . 73.409999999999997 111.26 -178.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -155.27 160.26 40.66 Favored 'General case' 0 C--O 1.247 0.945 0 CA-C-N 116.441 -0.345 . . . . 74.329999999999998 110.877 -177.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.484 HG12 ' CG1' ' A' ' 226' ' ' VAL . 7.5 p -132.38 121.03 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 O-C-N 123.775 0.672 . . . . 71.129999999999995 110.397 174.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 67.48 12.1 8.72 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.52 1.528 . . . . 74.530000000000001 110.672 176.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 110.11 -10.6 31.57 Favored Glycine 0 N--CA 1.432 -1.578 0 CA-C-N 115.421 -0.808 . . . . 52.43 112.589 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 64.4 mt -96.9 126.2 49.69 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.165 0 N-CA-C 108.35 -0.982 . . . . 65.140000000000001 108.35 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -65.47 141.62 58.43 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 121.431 0.634 . . . . 73.310000000000002 110.482 -178.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . 0.511 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 27.2 m -117.54 -1.88 9.5 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 CA-C-N 115.66 -0.7 . . . . 54.140000000000001 110.721 178.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -79.66 96.39 6.19 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 115.775 -0.648 . . . . 73.120000000000005 109.826 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 124.58 -14.57 7.66 Favored Glycine 0 C--N 1.305 -1.146 0 N-CA-C 110.688 -0.965 . . . . 64.0 110.688 -178.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -83.55 171.8 12.99 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.299 -1.0 . . . . 65.230000000000004 108.299 177.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . 0.474 ' O ' HG13 ' A' ' 234' ' ' VAL . 81.7 p -95.68 170.95 8.97 Favored 'General case' 0 N--CA 1.434 -1.248 0 N-CA-C 108.691 -0.855 . . . . 63.240000000000002 108.691 179.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . 0.493 HD21 HG12 ' A' ' 176' ' ' ILE . 3.3 tm? -61.79 -37.19 83.43 Favored 'General case' 0 N--CA 1.424 -1.736 0 N-CA-C 110.145 -0.317 . . . . 65.299999999999997 110.145 -179.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -63.71 -47.92 79.2 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.738 -0.467 . . . . 63.149999999999999 109.738 178.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -60.34 -43.48 96.4 Favored 'General case' 0 C--O 1.222 -0.35 0 N-CA-C 113.73 1.011 . . . . 75.109999999999999 113.73 178.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.582 HG21 HG12 ' A' ' 195' ' ' ILE . 12.7 m -73.22 -33.94 42.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-O 121.375 0.607 . . . . 75.439999999999998 112.072 -175.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . 0.446 ' O ' HG23 ' A' ' 239' ' ' VAL . 85.9 m -74.98 -35.59 62.05 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 115.418 -0.81 . . . . 74.439999999999998 109.49 -174.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -61.74 -33.11 73.46 Favored 'General case' 0 C--O 1.244 0.805 0 CA-C-N 115.75 -0.659 . . . . 73.120000000000005 109.538 177.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' MET . . . . . 0.444 ' HB2' HG11 ' A' ' 221' ' ' VAL . 13.6 mtt -68.09 -47.56 67.92 Favored 'General case' 0 C--O 1.209 -1.051 0 N-CA-C 107.835 -1.172 . . . . 75.450000000000003 107.835 179.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 64.7 mtt -59.01 -37.16 76.25 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.402 -0.817 . . . . 72.239999999999995 111.329 -178.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 235' ' ' THR . 92.2 t -69.46 -44.91 79.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 CA-C-N 116.308 -0.405 . . . . 65.5 110.782 177.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -69.72 -38.14 76.78 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.173 0.511 . . . . 54.420000000000002 110.96 -178.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -82.01 21.1 0.91 Allowed 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 115.525 -0.761 . . . . 72.400000000000006 112.45 -178.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' SER . . . . . 0.554 ' O ' HD23 ' A' ' 164' ' ' LEU . 42.8 t -59.19 -28.32 66.52 Favored 'General case' 0 CA--C 1.559 1.324 0 CA-C-O 121.158 0.504 . . . . 72.209999999999994 111.04 178.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 20.2 m -67.29 -28.61 68.16 Favored 'General case' 0 CA--C 1.552 1.052 0 N-CA-C 111.896 0.332 . . . . 52.420000000000002 111.896 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -161.99 83.82 0.58 Allowed 'General case' 0 C--O 1.249 1.034 0 N-CA-C 107.079 -1.452 . . . . 64.239999999999995 107.079 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.539 ' HB3' ' HB2' ' A' ' 163' ' ' LEU . 1.3 tt -85.95 103.42 14.64 Favored 'General case' 0 C--O 1.2 -1.548 0 C-N-CA 119.87 -0.732 . . . . 73.129999999999995 109.484 -173.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.467 HG12 ' HG3' ' A' ' 162' ' ' ARG . 74.1 mt -105.25 116.71 49.59 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.22 0 N-CA-C 109.469 -0.567 . . . . 74.019999999999996 109.469 178.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . 0.5 HG13 ' CD2' ' A' ' 245' ' ' LEU . 25.5 mt -120.05 134.33 63.91 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 CA-C-O 121.27 0.557 . . . . 44.109999999999999 111.674 179.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.569 ' HA ' ' O ' ' A' ' 159' ' ' ARG . 90.8 m -108.3 119.83 40.64 Favored 'General case' 0 N--CA 1.417 -2.114 0 CA-C-N 114.939 -1.028 . . . . 74.420000000000002 108.486 174.071 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.457 HG12 ' HA ' ' A' ' 218' ' ' VAL . 26.7 m -124.18 164.39 22.52 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.865 0 N-CA-C 108.43 -0.952 . . . . 51.140000000000001 108.43 174.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . 0.414 ' HD2' HD11 ' A' ' 219' ' ' ILE . 0.0 OUTLIER -144.66 136.58 13.01 Favored Pre-proline 0 C--N 1.264 -3.112 0 CA-C-N 115.449 -0.796 . . . . 74.439999999999998 109.916 173.778 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo . . . . . 0 N--CA 1.451 -0.995 0 C-N-CA 122.643 2.229 . . . . 72.329999999999998 110.962 179.076 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.443 ' NE2' HG13 ' A' ' 219' ' ' ILE . 1.0 OUTLIER . . . . . 0 N--CA 1.437 -1.111 0 N-CA-C 108.892 -0.781 . . . . 73.409999999999997 108.892 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.455 ' O ' ' HA ' ' A' ' 248' ' ' THR . 23.5 tpp180 -112.07 132.93 54.54 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 108.72 -0.844 . . . . 74.230000000000004 108.72 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 82.7 mtt180 -109.49 115.48 30.01 Favored 'General case' 0 C--N 1.278 -2.529 0 CA-C-N 115.708 -0.678 . . . . 60.340000000000003 111.439 176.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.425 ' CG1' ' HB2' ' A' ' 211' ' ' LEU . 18.6 m -118.94 138.19 50.46 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.219 0 CA-C-N 114.778 -1.101 . . . . 74.310000000000002 109.971 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.548 ' HG3' HG12 ' A' ' 246' ' ' ILE . 4.8 mpt_? -110.12 112.14 23.94 Favored 'General case' 0 N--CA 1.415 -2.199 0 N-CA-C 107.769 -1.197 . . . . 75.219999999999999 107.769 177.179 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.46 ' HB2' ' HB2' ' A' ' 245' ' ' LEU . 9.6 mt -96.96 118.53 33.58 Favored 'General case' 0 N--CA 1.409 -2.502 0 N-CA-C 107.523 -1.288 . . . . 60.310000000000002 107.523 -176.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.609 HD23 ' O ' ' A' ' 242' ' ' SER . 12.9 tp . . . . . 0 C--N 1.299 -1.59 0 CA-C-O 122.38 1.086 . . . . 62.43 112.95 177.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.476 ' HA ' HD23 ' A' ' 205' ' ' LEU . 2.7 mm? . . . . . 0 C--O 1.239 0.541 0 CA-C-O 120.854 0.359 . . . . 73.200000000000003 111.373 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . 0.472 ' HA3' ' HA3' ' A' ' 204' ' ' GLY . . . 84.51 37.8 10.39 Favored Glycine 0 N--CA 1.433 -1.518 0 N-CA-C 114.575 0.59 . . . . 55.229999999999997 114.575 174.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -159.46 152.62 22.15 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 108.733 -0.84 . . . . 74.409999999999997 108.733 173.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -132.51 146.22 51.76 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 109.312 -0.625 . . . . 64.340000000000003 109.312 179.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.686 ' H ' HD13 ' A' ' 176' ' ' ILE . 0.2 OUTLIER -111.04 170.34 3.54 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.634 0 CA-C-N 115.67 -0.695 . . . . 71.540000000000006 111.599 -175.397 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.533 ' CG ' ' HB2' ' A' ' 198' ' ' SER . 25.5 ptt180 -147.42 155.57 42.07 Favored 'General case' 0 C--N 1.279 -2.49 0 C-N-CA 124.972 1.309 . . . . 75.430000000000007 109.242 -177.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -117.89 151.21 37.85 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-O 121.32 0.581 . . . . 71.140000000000001 111.163 -175.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -167.87 -162.13 19.07 Favored Glycine 0 N--CA 1.426 -2.022 0 N-CA-C 109.439 -1.464 . . . . 64.409999999999997 109.439 176.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . 0.422 ' HB ' ' CG ' ' A' ' 191' ' ' LYS . 1.2 p -100.41 132.03 46.01 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 121.598 0.713 . . . . 61.240000000000002 112.322 176.042 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 33.6 t . . . . . 0 N--CA 1.409 -2.525 0 N-CA-C 107.483 -1.303 . . . . 63.109999999999999 107.483 173.874 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.422 ' CG ' ' HB ' ' A' ' 180' ' ' THR . 33.9 ttmt . . . . . 0 N--CA 1.426 -1.651 0 N-CA-C 107.912 -1.144 . . . . 74.340000000000003 107.912 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -141.11 162.04 50.17 Favored Pre-proline 0 C--N 1.269 -2.922 0 N-CA-C 107.944 -1.132 . . . . 73.230000000000004 107.944 -177.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -57.88 131.57 44.62 Favored 'Trans proline' 0 N--CA 1.447 -1.25 0 C-N-CA 120.935 1.09 . . . . 73.420000000000002 109.476 175.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -135.82 138.1 9.66 Favored Glycine 0 CA--C 1.463 -3.218 0 N-CA-C 110.127 -1.189 . . . . 62.130000000000003 110.127 -177.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.663 HG12 HG21 ' A' ' 234' ' ' VAL . 3.3 mp -105.92 138.07 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.538 0 CA-C-O 121.301 0.572 . . . . 71.109999999999999 109.832 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -127.22 166.94 16.78 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 106.837 -1.542 . . . . 63.549999999999997 106.837 -178.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . 0.473 ' HB ' ' HA ' ' A' ' 214' ' ' VAL . 45.1 mt -85.0 131.69 33.47 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.335 0 CA-C-O 121.055 0.455 . . . . 64.5 109.846 178.093 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . 0.533 ' HB2' ' CG ' ' A' ' 177' ' ' ARG . 14.1 t -101.2 -50.06 3.9 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 112.484 0.55 . . . . 52.340000000000003 112.484 -178.158 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 40.8 ttp-105 -139.44 132.79 30.04 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 109.573 -0.529 . . . . 64.120000000000005 109.573 -176.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 2.6 tt -117.75 130.38 56.28 Favored 'General case' 0 N--CA 1.42 -1.941 0 N-CA-C 107.038 -1.468 . . . . 64.439999999999998 107.038 -178.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 45.1 t -108.64 127.31 27.64 Favored Pre-proline 0 C--N 1.316 -0.886 0 N-CA-C 112.036 0.384 . . . . 72.140000000000001 112.036 -171.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . 0.53 ' HA ' ' HG3' ' A' ' 207' ' ' GLU . 34.4 Cg_endo -66.79 143.23 66.41 Favored 'Trans proline' 0 C--O 1.245 0.865 0 C-N-CA 122.432 2.088 . . . . 44.229999999999997 110.999 175.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 92.24 -9.9 75.36 Favored Glycine 0 N--CA 1.442 -0.959 0 N-CA-C 111.074 -0.811 . . . . 74.329999999999998 111.074 -177.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . 0.472 ' HA3' ' HA3' ' A' ' 173' ' ' GLY . . . -94.44 167.42 27.39 Favored Glycine 0 N--CA 1.435 -1.37 0 N-CA-C 110.472 -1.051 . . . . 61.409999999999997 110.472 178.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.476 HD23 ' HA ' ' A' ' 172' ' ' LEU . 2.7 mm? -66.72 -29.7 69.75 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 117.104 0.452 . . . . 72.019999999999996 111.675 -175.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -62.38 -46.28 89.33 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.636 0.731 . . . . 62.020000000000003 109.788 176.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.53 ' HG3' ' HA ' ' A' ' 202' ' ' PRO . 3.6 tm-20 -71.58 -32.62 68.27 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.513 -0.767 . . . . 75.129999999999995 110.667 179.15 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 44.7 m -55.78 -37.02 68.01 Favored 'General case' 0 CA--C 1.546 0.805 0 O-C-N 123.284 0.365 . . . . 75.219999999999999 110.967 178.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 8.9 t -87.49 -41.0 13.83 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 119.466 -0.894 . . . . 62.530000000000001 110.561 176.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 66.23 9.09 47.35 Favored Glycine 0 CA--C 1.531 1.051 0 N-CA-C 114.504 0.561 . . . . 71.439999999999998 114.504 177.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.425 ' HB2' ' CG1' ' A' ' 161' ' ' VAL . 69.1 mt -82.27 -18.03 43.85 Favored 'General case' 0 CA--C 1.503 -0.862 0 CA-C-O 121.119 0.485 . . . . 64.099999999999994 110.959 -178.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.471 HD23 ' H ' ' A' ' 212' ' ' LEU . 1.8 pt? -108.99 149.02 29.84 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 108.884 -0.784 . . . . 64.239999999999995 108.884 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -129.97 166.11 20.76 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 109.502 -0.555 . . . . 74.25 109.502 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . 0.473 ' HA ' ' HB ' ' A' ' 197' ' ' ILE . 32.6 m -63.22 -29.79 48.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 N-CA-C 113.044 0.757 . . . . 73.150000000000006 113.044 -179.075 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -69.84 -15.31 63.08 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 122.019 -0.426 . . . . 72.439999999999998 111.669 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.505 ' HB3' ' HB ' ' A' ' 249' ' ' VAL . 8.4 m-20 -69.78 152.89 44.08 Favored 'General case' 0 C--O 1.247 0.971 0 N-CA-C 113.918 1.081 . . . . 71.510000000000005 113.918 -175.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -112.49 134.43 54.02 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 125.804 1.642 . . . . 74.5 108.324 -179.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.565 ' HA ' HG12 ' A' ' 249' ' ' VAL . 9.9 p -86.32 146.19 6.75 Favored 'Isoleucine or valine' 0 C--O 1.245 0.847 0 CA-C-O 121.903 0.859 . . . . 73.099999999999994 112.321 -174.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.443 HG13 ' NE2' ' A' ' 158' ' ' HIS . 34.2 mm -113.0 -58.71 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 CA-C-N 114.536 -1.211 . . . . 65.430000000000007 111.285 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -150.35 158.89 44.65 Favored 'General case' 0 C--O 1.243 0.76 0 CA-C-N 116.8 -0.182 . . . . 72.209999999999994 110.523 -177.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.462 HG12 HG13 ' A' ' 226' ' ' VAL . 13.6 p -132.21 126.33 55.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 N-CA-C 109.079 -0.712 . . . . 52.009999999999998 109.079 177.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . 0.403 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 8.3 t-20 64.4 18.94 11.6 Favored 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 124.98 1.312 . . . . 53.32 110.108 176.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 102.8 -17.09 53.73 Favored Glycine 0 N--CA 1.436 -1.306 0 CA-C-N 115.858 -0.61 . . . . 70.230000000000004 112.322 -179.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 65.6 mt -98.97 127.02 52.03 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.09 0 CA-C-O 121.032 0.444 . . . . 72.430000000000007 109.977 -178.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -62.09 140.06 58.42 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-O 121.884 0.849 . . . . 75.230000000000004 112.833 -177.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . 0.462 HG13 HG12 ' A' ' 221' ' ' VAL . 16.3 m -118.13 3.56 7.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-N 114.986 -1.006 . . . . 74.409999999999997 110.272 176.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -79.15 101.95 8.21 Favored 'General case' 0 N--CA 1.422 -1.833 0 CA-C-N 115.176 -0.92 . . . . 72.439999999999998 109.544 178.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 118.31 -11.83 12.73 Favored Glycine 0 C--N 1.309 -0.927 0 C-N-CA 120.895 -0.669 . . . . 71.319999999999993 111.794 178.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -81.15 172.78 13.25 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 108.846 -0.798 . . . . 75.530000000000001 108.846 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . 0.412 ' O ' HG13 ' A' ' 234' ' ' VAL . 72.5 p -88.77 168.2 12.67 Favored 'General case' 0 N--CA 1.433 -1.303 0 N-CA-C 108.198 -1.038 . . . . 65.319999999999993 108.198 178.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . 0.48 HD21 HG12 ' A' ' 176' ' ' ILE . 3.2 tm? -62.68 -36.3 82.45 Favored 'General case' 0 N--CA 1.426 -1.654 0 N-CA-C 109.249 -0.649 . . . . 55.210000000000001 109.249 179.006 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -67.3 -47.47 70.47 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.517 -0.473 . . . . 35.109999999999999 109.826 178.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -59.85 -38.41 82.02 Favored 'General case' 0 C--N 1.349 0.55 0 N-CA-C 113.27 0.841 . . . . 72.409999999999997 113.27 177.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.663 HG21 HG12 ' A' ' 195' ' ' ILE . 16.3 m -74.18 -36.15 42.83 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.458 0 C-N-CA 119.308 -0.957 . . . . 74.430000000000007 111.518 -179.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . 0.425 ' O ' HG23 ' A' ' 239' ' ' VAL . 39.5 m -68.61 -35.92 77.97 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 108.924 -0.769 . . . . 74.5 108.924 179.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -57.87 -41.12 81.78 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 115.716 -0.674 . . . . 33.299999999999997 109.908 175.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 13.6 mmt -58.77 -49.69 76.73 Favored 'General case' 0 C--O 1.204 -1.319 0 N-CA-C 108.242 -1.021 . . . . 62.140000000000001 108.242 177.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' MET . . . . . 0.502 ' HA ' HD21 ' A' ' 245' ' ' LEU . 60.4 mtt -63.77 -35.6 81.14 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.904 -1.044 . . . . 75.510000000000005 112.8 -174.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 235' ' ' THR . 84.4 t -70.37 -38.11 73.03 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-O 121.092 0.472 . . . . 71.450000000000003 109.851 177.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -71.63 -36.66 70.81 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.507 0.67 . . . . 72.530000000000001 110.518 178.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -89.22 21.59 3.19 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 115.463 -0.79 . . . . 74.439999999999998 111.276 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' SER . . . . . 0.609 ' O ' HD23 ' A' ' 164' ' ' LEU . 46.0 p -64.83 -23.16 67.15 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 113.479 0.918 . . . . 74.200000000000003 113.479 -178.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 67.0 m -79.09 -18.39 53.43 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 119.439 -0.905 . . . . 62.520000000000003 111.434 177.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -166.6 92.39 0.46 Allowed 'General case' 0 C--O 1.252 1.186 0 CA-C-O 121.813 0.816 . . . . 65.510000000000005 112.227 179.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.502 HD21 ' HA ' ' A' ' 238' ' ' MET . 11.7 mt -85.29 102.94 13.79 Favored 'General case' 0 C--O 1.19 -2.067 0 CA-C-N 115.933 -0.576 . . . . 73.540000000000006 112.013 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.548 HG12 ' HG3' ' A' ' 162' ' ' ARG . 88.7 mt -96.68 114.3 33.22 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.844 0 N-CA-C 106.078 -1.823 . . . . 51.030000000000001 106.078 172.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 83.5 mt -122.93 135.61 62.43 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 CA-C-O 121.505 0.669 . . . . 61.340000000000003 111.967 -176.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.455 ' HA ' ' O ' ' A' ' 159' ' ' ARG . 46.9 m -107.13 114.9 29.24 Favored 'General case' 0 N--CA 1.414 -2.258 0 CA-C-N 114.901 -1.045 . . . . 73.319999999999993 108.581 176.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.565 HG12 ' HA ' ' A' ' 218' ' ' VAL . 31.3 m -124.96 151.9 30.92 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 N-CA-C 109.423 -0.584 . . . . 73.450000000000003 109.423 175.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . 0.411 ' HD3' HD11 ' A' ' 219' ' ' ILE . 9.5 ptmt -127.54 141.67 41.66 Favored Pre-proline 0 C--N 1.269 -2.892 0 N-CA-C 107.635 -1.246 . . . . 74.109999999999999 107.635 178.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo . . . . . 0 CA--C 1.546 1.086 0 C-N-CA 121.913 1.742 . . . . 73.340000000000003 111.795 178.69 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.542 ' CD2' HG13 ' A' ' 219' ' ' ILE . 0.4 OUTLIER . . . . . 0 CA--C 1.499 -1.013 0 N-CA-C 109.683 -0.488 . . . . 73.209999999999994 109.683 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.421 ' HE ' HD13 ' A' ' 211' ' ' LEU . 15.2 tpt180 -137.78 129.35 28.19 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 108.134 -1.061 . . . . 71.200000000000003 108.134 174.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 35.6 ptt180 -112.66 119.64 38.81 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-O 121.659 0.742 . . . . 64.129999999999995 109.983 177.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.618 ' O ' ' HA ' ' A' ' 246' ' ' ILE . 27.5 m -114.21 139.15 41.5 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.3 0 CA-C-N 114.882 -1.053 . . . . 73.430000000000007 112.122 -175.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.487 ' HG2' HG12 ' A' ' 246' ' ' ILE . 44.8 mtm180 -99.15 112.29 24.47 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 106.891 -1.522 . . . . 72.140000000000001 106.891 178.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.565 ' HB2' ' HB3' ' A' ' 245' ' ' LEU . 22.1 mt -104.58 139.12 39.91 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 109.503 -0.554 . . . . 73.040000000000006 109.503 -177.245 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 25.4 tp . . . . . 0 C--N 1.304 -1.376 0 N-CA-C 113.455 0.909 . . . . 74.010000000000005 113.455 172.168 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.437 ' HG ' ' CD1' ' A' ' 245' ' ' LEU . 3.2 mm? . . . . . 0 CA--C 1.511 -0.521 0 N-CA-C 112.558 0.577 . . . . 71.019999999999996 112.558 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . 0.441 ' HA3' ' HA3' ' A' ' 204' ' ' GLY . . . 94.61 30.62 8.4 Favored Glycine 0 N--CA 1.428 -1.836 0 C-N-CA 119.534 -1.317 . . . . 75.200000000000003 112.897 178.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -154.98 154.66 32.89 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 107.654 -1.239 . . . . 74.310000000000002 107.654 175.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -126.5 157.45 38.68 Favored 'General case' 0 C--N 1.272 -2.788 0 N-CA-C 107.625 -1.25 . . . . 74.409999999999997 107.625 175.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 30.8 pt -122.94 164.16 20.72 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.02 0 CA-C-O 121.605 0.717 . . . . 63.350000000000001 112.424 -178.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.428 ' HG2' ' HB3' ' A' ' 198' ' ' SER . 4.0 ptp180 -139.39 154.73 47.87 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 114.238 -1.347 . . . . 75.120000000000005 108.18 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . 0.473 ' HB3' HD23 ' A' ' 231' ' ' LEU . 4.1 p-10 -121.44 143.11 49.42 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 108.917 -0.771 . . . . 73.140000000000001 108.917 176.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' A' ' 193' ' ' PRO . . . -156.26 -146.18 4.39 Favored Glycine 0 N--CA 1.415 -2.758 0 N-CA-C 109.425 -1.47 . . . . 73.099999999999994 109.425 178.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . 0.555 ' HB ' ' CG ' ' A' ' 191' ' ' LYS . 1.3 p -108.74 127.32 53.9 Favored 'General case' 0 C--N 1.28 -2.45 0 N-CA-C 112.695 0.628 . . . . 53.119999999999997 112.695 179.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 28.7 t . . . . . 0 N--CA 1.413 -2.319 0 N-CA-C 106.951 -1.5 . . . . 61.350000000000001 106.951 175.045 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.555 ' CG ' ' HB ' ' A' ' 180' ' ' THR . 36.2 ttmt . . . . . 0 N--CA 1.417 -2.09 0 N-CA-C 108.305 -0.998 . . . . 64.450000000000003 108.305 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -140.92 164.1 38.28 Favored Pre-proline 0 C--N 1.287 -2.117 0 N-CA-C 108.946 -0.761 . . . . 60.509999999999998 108.946 -176.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' PRO . . . . . 0.427 ' HA ' ' O ' ' A' ' 179' ' ' GLY . 10.7 Cg_endo -55.93 132.38 51.64 Favored 'Trans proline' 0 C--O 1.248 1.018 0 C-N-CA 121.642 1.561 . . . . 74.019999999999996 111.0 175.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -141.14 147.52 19.13 Favored Glycine 0 CA--C 1.471 -2.691 0 N-CA-C 110.7 -0.96 . . . . 73.25 110.7 -178.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.759 HG12 HG21 ' A' ' 234' ' ' VAL . 2.9 mp -104.24 142.17 18.3 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 CA-C-O 121.295 0.569 . . . . 70.209999999999994 110.132 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -137.07 164.42 28.45 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 107.244 -1.391 . . . . 62.32 107.244 -178.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . 0.495 ' HB ' ' HA ' ' A' ' 214' ' ' VAL . 48.6 mm -76.26 127.82 37.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 107.747 -1.205 . . . . 75.450000000000003 107.747 176.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . 0.428 ' HB3' ' HG2' ' A' ' 177' ' ' ARG . 82.9 p -99.92 -38.88 8.43 Favored 'General case' 0 C--N 1.29 -1.994 0 C-N-CA 119.862 -0.735 . . . . 75.430000000000007 111.196 -175.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -150.43 139.4 20.98 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 108.809 -0.811 . . . . 74.010000000000005 108.809 -177.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 1.1 tt -111.59 132.45 54.55 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 107.395 -1.335 . . . . 64.400000000000006 107.395 -179.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 61.1 t -104.98 118.46 56.07 Favored Pre-proline 0 C--N 1.312 -1.054 0 CA-C-O 120.626 0.25 . . . . 61.25 111.453 -176.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . 0.48 ' HA ' ' HG2' ' A' ' 207' ' ' GLU . 37.8 Cg_exo -62.23 136.96 63.09 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 122.627 2.218 . . . . 72.439999999999998 110.866 176.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 96.55 -22.01 42.54 Favored Glycine 0 N--CA 1.439 -1.134 0 C-N-CA 121.12 -0.562 . . . . 75.040000000000006 112.253 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . 0.441 ' HA3' ' HA3' ' A' ' 173' ' ' GLY . . . -80.54 -176.18 49.98 Favored Glycine 0 N--CA 1.44 -1.067 0 C-N-CA 120.966 -0.635 . . . . 72.239999999999995 112.417 -179.047 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 172' ' ' LEU . 3.2 mm? -67.87 -41.87 82.17 Favored 'General case' 0 N--CA 1.426 -1.668 0 C-N-CA 122.91 0.484 . . . . 71.329999999999998 110.754 -178.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -64.02 -34.2 77.48 Favored 'General case' 0 C--O 1.22 -0.481 0 N-CA-C 113.139 0.792 . . . . 31.41 113.139 -176.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.48 ' HG2' ' HA ' ' A' ' 202' ' ' PRO . 11.8 tp10 -75.61 -33.08 60.52 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-O 121.724 0.773 . . . . 71.439999999999998 108.971 179.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 19.3 t -65.86 -24.71 66.93 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.954 -1.021 . . . . 54.240000000000002 110.802 -178.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 2.4 m -69.18 -40.45 78.09 Favored 'General case' 0 N--CA 1.415 -2.212 0 CA-C-N 115.914 -0.585 . . . . 73.5 111.867 -171.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 70.02 24.21 76.63 Favored Glycine 0 C--O 1.225 -0.42 0 N-CA-C 111.012 -0.835 . . . . 75.400000000000006 111.012 -176.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.421 HD13 ' HE ' ' A' ' 159' ' ' ARG . 65.6 mt -140.72 -8.95 1.06 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 122.963 0.505 . . . . 65.519999999999996 111.053 -175.153 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 67.9 mt -109.48 131.22 55.27 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 115.888 -0.596 . . . . 71.439999999999998 110.583 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -134.15 166.23 23.24 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.727 -1.212 . . . . 74.109999999999999 107.727 175.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . 0.495 ' HA ' ' HB ' ' A' ' 197' ' ' ILE . 31.3 m -66.52 -30.8 50.96 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 N-CA-C 113.074 0.768 . . . . 71.209999999999994 113.074 -179.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 46.7 m-80 -75.15 -14.5 60.56 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 113.706 1.002 . . . . 72.340000000000003 113.706 -177.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.452 ' HB3' ' HB ' ' A' ' 249' ' ' VAL . 5.3 m-20 -63.74 131.59 48.37 Favored 'General case' 0 C--O 1.246 0.877 0 CA-C-O 121.172 0.51 . . . . 65.209999999999994 112.282 -179.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -97.55 140.85 31.36 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.462 -0.79 . . . . 75.519999999999996 109.48 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.518 HG11 ' HB ' ' A' ' 195' ' ' ILE . 5.2 p -81.86 145.56 8.55 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 CA-C-O 121.621 0.724 . . . . 70.200000000000003 112.229 -174.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.542 HG13 ' CD2' ' A' ' 158' ' ' HIS . 44.4 mm -115.96 -60.85 2.71 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 115.618 -0.719 . . . . 54.420000000000002 110.874 178.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -152.36 154.83 36.42 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 109.136 -0.69 . . . . 75.209999999999994 109.136 -176.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.521 HG22 HG12 ' A' ' 247' ' ' ILE . 44.2 t -128.94 122.91 57.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 108.466 -0.939 . . . . 44.140000000000001 108.466 179.123 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 65.7 20.35 11.52 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.137 1.375 . . . . 71.420000000000002 109.523 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 97.37 -15.2 62.58 Favored Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 115.243 -0.889 . . . . 13.34 111.975 -178.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 63.0 mt -92.67 123.77 44.88 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.747 0 N-CA-C 109.044 -0.724 . . . . 62.310000000000002 109.044 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -57.39 142.38 43.96 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.521 0.677 . . . . 74.409999999999997 112.139 -178.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . 0.499 ' HA ' ' CG ' ' A' ' 229' ' ' LYS . 15.6 m -120.93 10.46 6.21 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.845 0 CA-C-N 115.555 -0.748 . . . . 64.439999999999998 111.083 175.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -74.3 101.34 4.0 Favored 'General case' 0 N--CA 1.426 -1.657 0 CA-C-N 115.035 -0.984 . . . . 52.310000000000002 109.588 177.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 109.69 -1.57 30.53 Favored Glycine 0 CA--C 1.496 -1.121 0 C-N-CA 120.886 -0.673 . . . . 71.349999999999994 111.707 177.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . 0.499 ' CG ' ' HA ' ' A' ' 226' ' ' VAL . 71.9 mmtt -82.21 158.77 23.44 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.18 -0.674 . . . . 75.040000000000006 109.18 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 67.3 p -82.66 171.49 13.97 Favored 'General case' 0 N--CA 1.409 -2.512 0 C-N-CA 119.299 -0.96 . . . . 71.510000000000005 109.437 177.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . 0.473 HD23 ' HB3' ' A' ' 178' ' ' ASP . 2.1 tm? -66.59 -35.48 80.3 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 108.578 -0.897 . . . . 73.329999999999998 108.578 -179.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -65.13 -41.22 95.02 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.581 -0.736 . . . . 73.140000000000001 109.698 178.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -61.34 -47.16 87.15 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.481 -0.781 . . . . 55.210000000000001 112.507 176.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.759 HG21 HG12 ' A' ' 195' ' ' ILE . 19.8 m -69.63 -33.74 58.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 C-N-CA 120.211 -0.596 . . . . 70.099999999999994 111.918 -177.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . 0.468 ' O ' HG23 ' A' ' 239' ' ' VAL . 90.4 m -64.86 -35.7 81.98 Favored 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 109.694 -0.484 . . . . 64.25 109.694 177.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -63.39 -35.84 81.76 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.279 -0.419 . . . . 74.519999999999996 110.125 176.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 16.8 mmt -58.08 -52.75 64.24 Favored 'General case' 0 C--O 1.201 -1.453 0 N-CA-C 107.814 -1.18 . . . . 71.299999999999997 107.814 174.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 66.6 mtt -58.21 -35.28 71.41 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.633 -1.167 . . . . 70.219999999999999 112.049 -175.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 235' ' ' THR . 94.5 t -71.96 -45.98 61.78 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-O 120.832 0.349 . . . . 72.239999999999995 110.615 177.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -68.01 -34.61 76.83 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.508 0.671 . . . . 74.310000000000002 111.076 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -89.76 21.84 3.36 Favored 'General case' 0 C--O 1.198 -1.633 0 CA-C-N 115.311 -0.859 . . . . 73.340000000000003 110.578 -179.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 25.2 t -60.63 -23.78 65.01 Favored 'General case' 0 CA--C 1.563 1.461 0 N-CA-C 112.149 0.426 . . . . 71.319999999999993 112.149 -178.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 6.9 p -81.07 -14.01 58.22 Favored 'General case' 0 CA--C 1.558 1.262 0 N-CA-C 112.641 0.608 . . . . 72.319999999999993 112.641 178.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -173.77 98.55 0.11 Allowed 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.908 1.283 . . . . 72.25 108.356 173.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.565 ' HB3' ' HB2' ' A' ' 163' ' ' LEU . 1.2 tt -86.36 101.82 13.45 Favored 'General case' 0 N--CA 1.413 -2.305 0 N-CA-C 107.701 -1.222 . . . . 53.439999999999998 107.701 -176.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.618 ' HA ' ' O ' ' A' ' 161' ' ' VAL . 73.5 mt -104.07 116.12 47.26 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 C-N-CA 120.163 -0.615 . . . . 63.140000000000001 109.812 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . 0.521 HG12 HG22 ' A' ' 221' ' ' VAL . 91.7 mt -122.05 131.36 73.31 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.892 0 C-N-CA 120.151 -0.62 . . . . 63.009999999999998 110.085 176.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 56.3 m -96.77 114.95 26.63 Favored 'General case' 0 N--CA 1.412 -2.369 0 N-CA-C 107.545 -1.28 . . . . 53.210000000000001 107.545 174.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.475 HG12 ' HA ' ' A' ' 218' ' ' VAL . 21.7 m -117.89 169.12 8.89 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.117 0 N-CA-C 109.098 -0.705 . . . . 70.340000000000003 109.098 176.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 15.5 ptmt -134.0 129.45 20.07 Favored Pre-proline 0 C--N 1.28 -2.456 0 CA-C-N 115.454 -0.793 . . . . 73.219999999999999 110.181 176.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo . . . . . 0 N--CA 1.44 -1.67 0 C-N-CA 121.738 1.626 . . . . 74.430000000000007 108.86 173.988 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.735 ' NE2' HG13 ' A' ' 219' ' ' ILE . 9.0 m80 . . . . . 0 N--CA 1.445 -0.72 0 N-CA-C 109.806 -0.442 . . . . 75.420000000000002 109.806 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.548 ' O ' ' HA ' ' A' ' 248' ' ' THR . 45.3 ttm180 -145.01 144.0 30.79 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 116.4 -0.364 . . . . 63.409999999999997 111.071 174.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.529 ' HA ' ' O ' ' A' ' 247' ' ' ILE . 0.0 OUTLIER -118.23 127.04 53.36 Favored 'General case' 0 C--N 1.32 -0.677 0 O-C-N 123.244 0.34 . . . . 71.420000000000002 110.42 175.445 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.512 HG11 HD21 ' A' ' 211' ' ' LEU . 11.9 m -122.25 139.05 50.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 CA-C-N 115.909 -0.587 . . . . 74.409999999999997 111.283 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 21.8 ttm180 -92.59 116.36 28.93 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 109.317 -0.623 . . . . 74.430000000000007 109.317 177.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.422 ' HB2' ' HB3' ' A' ' 245' ' ' LEU . 19.7 mt -107.87 138.73 43.6 Favored 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 107.144 -1.428 . . . . 72.299999999999997 107.144 -179.063 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.487 HD12 ' O ' ' A' ' 242' ' ' SER . 1.0 OUTLIER . . . . . 0 N--CA 1.442 -0.864 0 CA-C-O 122.325 1.06 . . . . 74.140000000000001 108.322 173.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.426 ' HG ' ' CD1' ' A' ' 245' ' ' LEU . 2.8 mm? . . . . . 0 CA--C 1.492 -1.282 0 CA-C-O 120.894 0.378 . . . . 63.5 111.98 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . 0.547 ' HA3' ' HA3' ' A' ' 204' ' ' GLY . . . 97.95 17.1 31.1 Favored Glycine 0 N--CA 1.415 -2.746 0 C-N-CA 119.273 -1.441 . . . . 53.229999999999997 111.879 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -158.08 157.17 32.33 Favored 'General case' 0 N--CA 1.427 -1.605 0 N-CA-C 109.273 -0.64 . . . . 51.299999999999997 109.273 179.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -129.38 158.24 39.69 Favored 'General case' 0 C--N 1.283 -2.314 0 N-CA-C 107.995 -1.113 . . . . 74.340000000000003 107.995 172.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.625 ' H ' HD13 ' A' ' 176' ' ' ILE . 0.1 OUTLIER -118.53 163.78 15.41 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.018 0 CA-C-O 121.744 0.783 . . . . 60.509999999999998 111.271 -178.68 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.439 ' HB3' ' HB3' ' A' ' 198' ' ' SER . 15.6 ptt180 -142.35 154.77 44.94 Favored 'General case' 0 C--N 1.28 -2.424 0 CA-C-N 114.182 -1.372 . . . . 74.120000000000005 109.477 -177.137 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -110.67 138.21 47.35 Favored 'General case' 0 C--N 1.294 -1.848 0 CA-C-O 121.143 0.497 . . . . 73.25 110.551 179.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -145.06 176.46 24.09 Favored Glycine 0 C--N 1.28 -2.544 0 N-CA-C 106.858 -2.497 . . . . 74.349999999999994 106.858 175.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . 0.574 ' CG2' ' HG2' ' A' ' 191' ' ' LYS . 0.2 OUTLIER -102.07 122.71 44.64 Favored 'General case' 0 C--N 1.273 -2.74 0 C-N-CA 117.312 -1.755 . . . . 70.340000000000003 107.103 177.965 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . 0.417 ' O ' ' HA ' ' A' ' 191' ' ' LYS . 33.3 t . . . . . 0 C--N 1.283 -2.293 0 N-CA-C 109.041 -0.725 . . . . 72.349999999999994 109.041 -176.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.574 ' HG2' ' CG2' ' A' ' 180' ' ' THR . 34.2 ttmt . . . . . 0 N--CA 1.43 -1.462 0 N-CA-C 108.295 -1.002 . . . . 73.430000000000007 108.295 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -147.88 165.17 19.26 Favored Pre-proline 0 C--N 1.306 -1.325 0 N-CA-C 109.127 -0.694 . . . . 53.119999999999997 109.127 -170.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -56.79 132.35 51.17 Favored 'Trans proline' 0 C--O 1.255 1.369 0 C-N-CA 121.378 1.386 . . . . 74.549999999999997 110.64 177.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -145.57 128.14 3.04 Favored Glycine 0 N--CA 1.419 -2.465 0 N-CA-C 110.504 -1.038 . . . . 73.349999999999994 110.504 -178.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.626 HG12 HG21 ' A' ' 234' ' ' VAL . 3.4 mp -103.92 136.24 37.97 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.415 0 CA-C-O 121.242 0.544 . . . . 73.420000000000002 110.422 -178.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -127.87 167.52 16.46 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 107.8 -1.185 . . . . 63.25 107.8 -177.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . 0.492 ' HB ' ' HA ' ' A' ' 214' ' ' VAL . 46.1 mm -75.4 131.19 35.4 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 N-CA-C 107.44 -1.319 . . . . 74.540000000000006 107.44 175.024 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . 0.439 ' HB3' ' HB3' ' A' ' 177' ' ' ARG . 86.4 p -99.37 -33.32 10.75 Favored 'General case' 0 C--N 1.29 -1.986 0 O-C-N 121.53 -0.731 . . . . 54.109999999999999 111.356 -175.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 10.8 ttp180 -167.22 143.61 4.35 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.822 -0.626 . . . . 75.099999999999994 110.65 -175.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.442 HD11 ' O ' ' A' ' 212' ' ' LEU . 73.3 mt -101.87 146.7 27.45 Favored 'General case' 0 CA--C 1.494 -1.187 0 CA-C-N 116.168 -0.469 . . . . 74.409999999999997 109.796 174.052 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . 0.52 ' HB ' ' HA2' ' A' ' 173' ' ' GLY . 21.7 t -114.35 115.25 44.98 Favored Pre-proline 0 C--N 1.289 -2.058 0 N-CA-C 106.329 -1.73 . . . . 71.239999999999995 106.329 172.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . 0.449 ' HA ' ' HG2' ' A' ' 207' ' ' GLU . 31.3 Cg_exo -58.78 147.25 89.33 Favored 'Trans proline' 0 N--CA 1.444 -1.42 0 C-N-CA 121.95 1.766 . . . . 65.329999999999998 111.082 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 94.48 -23.24 33.07 Favored Glycine 0 C--N 1.305 -1.159 0 N-CA-C 110.794 -0.922 . . . . 54.140000000000001 110.794 -176.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . 0.547 ' HA3' ' HA3' ' A' ' 173' ' ' GLY . . . -83.48 163.53 40.87 Favored Glycine 0 N--CA 1.43 -1.701 0 N-CA-C 110.526 -1.029 . . . . 71.540000000000006 110.526 177.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.498 ' H ' HD22 ' A' ' 205' ' ' LEU . 2.8 mm? -55.16 -42.62 73.36 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 123.842 0.857 . . . . 72.510000000000005 112.42 -175.047 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -59.17 -48.13 82.76 Favored 'General case' 0 C--O 1.244 0.764 0 N-CA-C 112.306 0.484 . . . . 74.120000000000005 112.306 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.449 ' HG2' ' HA ' ' A' ' 202' ' ' PRO . 8.3 tp10 -75.41 -33.4 60.95 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.958 -0.386 . . . . 65.530000000000001 109.958 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 35.5 t -57.66 -44.75 85.93 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 116.214 -0.448 . . . . 73.349999999999994 110.734 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . 0.629 HG23 ' H ' ' A' ' 211' ' ' LEU . 8.9 t -77.0 -31.87 56.77 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 119.679 -0.808 . . . . 73.019999999999996 109.537 176.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 70.13 19.9 76.04 Favored Glycine 0 N--CA 1.447 -0.61 0 CA-C-N 115.938 -0.574 . . . . 64.109999999999999 112.694 178.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.629 ' H ' HG23 ' A' ' 209' ' ' THR . 1.4 pp -105.65 -0.52 25.53 Favored 'General case' 0 N--CA 1.432 -1.336 0 CA-C-O 121.072 0.463 . . . . 71.510000000000005 111.407 -178.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.442 ' O ' HD11 ' A' ' 200' ' ' LEU . 60.7 mt -109.32 133.78 52.62 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.384 -0.826 . . . . 74.150000000000006 109.226 176.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -131.87 165.51 23.7 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.763 -0.828 . . . . 73.120000000000005 108.763 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . 0.492 ' HA ' ' HB ' ' A' ' 197' ' ' ILE . 33.4 m -64.28 -29.48 47.47 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 N-CA-C 113.914 1.079 . . . . 63.399999999999999 113.914 -177.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -74.44 -14.63 60.87 Favored 'General case' 0 C--N 1.308 -1.228 0 O-C-N 121.855 -0.528 . . . . 74.420000000000002 111.729 -178.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.414 ' HB3' ' HB ' ' A' ' 249' ' ' VAL . 54.3 m-20 -69.83 130.97 43.73 Favored 'General case' 0 C--O 1.245 0.867 0 CA-C-O 121.233 0.54 . . . . 53.299999999999997 112.237 -176.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -101.19 135.08 43.25 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.952 -1.022 . . . . 71.400000000000006 109.659 -178.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.534 HG23 HG23 ' A' ' 247' ' ' ILE . 10.6 p -82.12 131.36 34.0 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.152 0 CA-C-O 121.749 0.785 . . . . 51.140000000000001 111.375 -176.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.735 HG13 ' NE2' ' A' ' 158' ' ' HIS . 36.8 mm -100.87 -52.71 8.34 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 CA-C-N 115.318 -0.855 . . . . 63.329999999999998 111.409 -179.157 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -154.68 152.8 30.37 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 116.449 -0.341 . . . . 65.299999999999997 110.146 -178.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.507 ' HA ' ' O ' ' A' ' 246' ' ' ILE . 10.7 p -125.27 125.51 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.644 0 N-CA-C 108.956 -0.757 . . . . 74.420000000000002 108.956 177.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . 0.4 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 2.9 m-20 57.1 22.72 7.72 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.592 1.157 . . . . 53.020000000000003 112.945 -177.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 100.34 -11.46 59.97 Favored Glycine 0 C--N 1.309 -0.954 0 C-N-CA 120.912 -0.661 . . . . 75.219999999999999 112.348 179.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 64.2 mt -98.7 123.53 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.284 0 N-CA-C 109.361 -0.607 . . . . 64.120000000000005 109.361 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -60.52 140.24 57.4 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 121.796 0.808 . . . . 73.040000000000006 112.216 -177.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . 0.517 ' HB ' HG12 ' A' ' 234' ' ' VAL . 25.6 m -120.61 0.44 7.41 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 CA-C-N 115.083 -0.962 . . . . 55.149999999999999 109.561 175.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -78.35 98.26 5.91 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 115.323 -0.853 . . . . 72.010000000000005 109.649 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 120.32 -19.95 9.13 Favored Glycine 0 C--N 1.308 -0.975 0 N-CA-C 110.691 -0.964 . . . . 51.549999999999997 110.691 -178.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -72.49 164.78 25.85 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.61 -0.515 . . . . 73.129999999999995 109.61 177.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . 0.464 ' O ' HG13 ' A' ' 234' ' ' VAL . 67.2 p -84.86 168.61 14.92 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 108.734 -0.839 . . . . 63.240000000000002 108.734 178.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . 0.404 ' HA ' HG22 ' A' ' 234' ' ' VAL . 53.3 tp -63.43 -31.95 73.25 Favored 'General case' 0 N--CA 1.424 -1.745 0 N-CA-C 109.541 -0.54 . . . . 75.310000000000002 109.541 177.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -64.46 -50.94 65.51 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.472 -0.566 . . . . 75.299999999999997 109.472 176.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' GLN . . . . . 0.464 ' O ' ' HG2' ' A' ' 237' ' ' MET . 2.2 mp0 -58.49 -43.77 89.16 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 113.297 0.851 . . . . 74.129999999999995 113.297 177.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.626 HG21 HG12 ' A' ' 195' ' ' ILE . 7.2 m -72.06 -34.79 51.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 C-N-CA 119.796 -0.762 . . . . 74.219999999999999 111.811 -176.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . 0.442 ' O ' HG23 ' A' ' 239' ' ' VAL . 42.8 m -69.6 -36.36 76.13 Favored 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 109.224 -0.658 . . . . 70.319999999999993 109.224 179.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -59.84 -37.74 80.11 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-N 116.11 -0.496 . . . . 75.409999999999997 110.049 176.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' MET . . . . . 0.464 ' HG2' ' O ' ' A' ' 233' ' ' GLN . 16.8 mmt -58.96 -52.13 67.1 Favored 'General case' 0 C--O 1.2 -1.523 0 N-CA-C 108.451 -0.944 . . . . 73.140000000000001 108.451 176.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' MET . . . . . 0.412 ' HG3' ' O ' ' A' ' 234' ' ' VAL . 58.1 mtt -62.82 -33.11 74.54 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.996 -1.002 . . . . 72.450000000000003 112.201 -175.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 235' ' ' THR . 75.6 t -68.29 -41.31 83.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-O 121.328 0.585 . . . . 51.32 109.902 175.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -72.32 -38.84 68.58 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.438 -0.801 . . . . 73.329999999999998 110.664 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -84.03 21.47 1.34 Allowed 'General case' 0 C--O 1.198 -1.613 0 CA-C-N 115.399 -0.819 . . . . 73.310000000000002 111.742 -177.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' SER . . . . . 0.487 ' O ' HD12 ' A' ' 164' ' ' LEU . 14.8 p -64.36 -22.54 66.99 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-O 121.121 0.486 . . . . 62.100000000000001 111.559 176.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 26.7 m -68.84 -27.13 65.56 Favored 'General case' 0 CA--C 1.557 1.24 0 CA-C-N 116.318 -0.401 . . . . 73.430000000000007 110.914 176.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -174.44 103.16 0.1 Allowed 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.794 1.237 . . . . 63.450000000000003 108.98 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.491 ' CD2' HG13 ' A' ' 247' ' ' ILE . 1.0 OUTLIER -90.49 103.51 16.19 Favored 'General case' 0 C--O 1.201 -1.456 0 N-CA-C 109.634 -0.506 . . . . 73.120000000000005 109.634 -173.923 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.507 ' O ' ' HA ' ' A' ' 221' ' ' VAL . 63.9 mt -105.02 115.42 46.87 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 O-C-N 121.445 -0.785 . . . . 64.329999999999998 109.255 178.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . 0.534 HG23 HG23 ' A' ' 218' ' ' VAL . 18.8 mt -119.31 133.43 66.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 113.375 0.88 . . . . 54.310000000000002 113.375 -179.314 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.548 ' HA ' ' O ' ' A' ' 159' ' ' ARG . 61.2 m -103.11 121.27 42.27 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 107.65 -1.241 . . . . 74.239999999999995 107.65 173.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.498 HG12 ' HA ' ' A' ' 218' ' ' VAL . 17.1 m -122.81 163.83 20.97 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.061 0 CA-C-O 121.106 0.479 . . . . 75.439999999999998 110.523 175.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . 0.405 ' CD ' HD11 ' A' ' 219' ' ' ILE . 19.4 ptmt -134.29 128.9 19.55 Favored Pre-proline 0 N--CA 1.416 -2.156 0 CA-C-N 114.469 -1.241 . . . . 74.010000000000005 107.745 173.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo . . . . . 0 C--N 1.307 -1.618 0 C-N-CA 121.255 1.303 . . . . 74.299999999999997 112.386 178.266 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.499 ' ND1' ' HB3' ' A' ' 250' ' ' LYS . 0.6 OUTLIER . . . . . 0 C--O 1.244 0.775 0 N-CA-C 110.305 -0.258 . . . . 74.049999999999997 110.305 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.456 ' O ' ' HA ' ' A' ' 248' ' ' THR . 28.7 tpt180 -143.47 133.59 24.33 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 109.409 -0.589 . . . . 72.450000000000003 109.409 172.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 32.0 ptt180 -113.36 124.65 52.96 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 116.044 -0.525 . . . . 63.530000000000001 109.945 177.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.554 ' O ' ' HA ' ' A' ' 246' ' ' ILE . 17.4 m -127.0 139.25 52.45 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 CA-C-N 116.015 -0.539 . . . . 65.450000000000003 112.218 -176.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.608 ' HG2' HG12 ' A' ' 246' ' ' ILE . 95.6 mtt180 -87.95 112.57 22.71 Favored 'General case' 0 C--O 1.242 0.661 0 N-CA-C 108.264 -1.013 . . . . 62.240000000000002 108.264 176.192 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.539 ' HB2' ' HB3' ' A' ' 245' ' ' LEU . 33.5 mt -92.87 125.75 37.63 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 107.372 -1.344 . . . . 63.32 107.372 176.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.446 HD13 ' O ' ' A' ' 242' ' ' SER . 5.8 tt . . . . . 0 C--N 1.312 -1.038 0 O-C-N 124.664 1.227 . . . . 71.109999999999999 110.468 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.47 ' HG ' ' CD1' ' A' ' 245' ' ' LEU . 3.3 mm? . . . . . 0 C--O 1.235 0.336 0 N-CA-C 112.842 0.682 . . . . 62.350000000000001 112.842 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 96.17 47.43 2.42 Favored Glycine 0 N--CA 1.439 -1.131 0 C-N-CA 119.77 -1.205 . . . . 31.120000000000001 114.205 174.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -159.51 154.51 24.89 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.774 -0.824 . . . . 74.25 108.774 174.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -123.4 143.89 49.84 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 109.071 -0.714 . . . . 51.509999999999998 109.071 177.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.651 ' H ' HD13 ' A' ' 176' ' ' ILE . 0.2 OUTLIER -117.31 169.61 7.57 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.77 0 CA-C-N 115.379 -0.828 . . . . 75.230000000000004 109.608 -179.622 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.542 ' CG ' ' HB2' ' A' ' 198' ' ' SER . 19.2 ptt180 -144.66 155.24 43.5 Favored 'General case' 0 C--N 1.269 -2.914 0 C-N-CA 124.057 0.943 . . . . 75.109999999999999 109.724 -175.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -115.15 145.75 42.06 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-O 121.235 0.54 . . . . 75.329999999999998 110.323 -178.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -157.62 171.46 34.79 Favored Glycine 0 N--CA 1.42 -2.372 0 N-CA-C 108.414 -1.874 . . . . 33.009999999999998 108.414 176.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . 0.411 ' CG2' ' HG2' ' A' ' 191' ' ' LYS . 0.3 OUTLIER -86.62 123.09 31.42 Favored 'General case' 0 C--N 1.294 -1.83 0 C-N-CA 118.174 -1.41 . . . . 60.229999999999997 107.425 178.503 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . 0.497 ' O ' ' HA ' ' A' ' 191' ' ' LYS . 37.8 t . . . . . 0 C--N 1.273 -2.747 0 N-CA-C 108.476 -0.935 . . . . 65.209999999999994 108.476 -178.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.497 ' HA ' ' O ' ' A' ' 181' ' ' SER . 31.2 ttmt . . . . . 0 N--CA 1.424 -1.747 0 N-CA-C 107.275 -1.38 . . . . 74.519999999999996 107.275 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . 0.417 ' HB2' ' HD2' ' A' ' 193' ' ' PRO . 13.5 pt20 -152.02 165.4 17.54 Favored Pre-proline 0 C--N 1.287 -2.11 0 N-CA-C 108.068 -1.086 . . . . 73.409999999999997 108.068 -169.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' PRO . . . . . 0.417 ' HD2' ' HB2' ' A' ' 192' ' ' GLN . 9.8 Cg_endo -55.68 131.58 46.97 Favored 'Trans proline' 0 C--O 1.251 1.154 0 C-N-CA 120.942 1.095 . . . . 74.230000000000004 110.516 176.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -143.4 141.92 10.86 Favored Glycine 0 N--CA 1.413 -2.857 0 N-CA-C 109.319 -1.512 . . . . 32.009999999999998 109.319 -178.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.679 HG12 HG21 ' A' ' 234' ' ' VAL . 2.8 mp -109.38 133.73 53.66 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.435 0 CA-C-O 121.481 0.657 . . . . 74.129999999999995 111.608 -176.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -123.28 167.07 14.23 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.93 -1.137 . . . . 75.129999999999995 107.93 -177.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . 0.432 ' HB ' ' HA ' ' A' ' 214' ' ' VAL . 45.6 mm -79.58 131.97 33.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 108.947 -0.76 . . . . 72.409999999999997 108.947 177.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . 0.542 ' HB2' ' CG ' ' A' ' 177' ' ' ARG . 14.4 t -106.55 -31.53 8.47 Favored 'General case' 0 C--N 1.295 -1.781 0 O-C-N 121.734 -0.604 . . . . 75.25 112.415 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -164.85 144.31 7.04 Favored 'General case' 0 C--N 1.313 -0.979 0 C-N-CA 120.986 -0.286 . . . . 72.040000000000006 110.643 -176.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 81.4 mt -107.74 134.48 50.64 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.849 -1.167 . . . . 74.439999999999998 107.849 172.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 60.2 t -92.93 114.89 63.91 Favored Pre-proline 0 C--N 1.29 -2.018 0 N-CA-C 105.744 -1.947 . . . . 65.25 105.744 172.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -61.06 137.19 70.13 Favored 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 121.8 1.667 . . . . 75.129999999999995 110.378 -177.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 98.77 -21.38 46.24 Favored Glycine 0 C--N 1.303 -1.271 0 C-N-CA 120.513 -0.851 . . . . 70.420000000000002 111.109 -177.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -76.06 175.32 52.48 Favored Glycine 0 N--CA 1.44 -1.064 0 C-N-CA 121.349 -0.453 . . . . 74.439999999999998 112.492 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -67.22 -30.79 70.81 Favored 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 123.743 0.817 . . . . 64.450000000000003 111.249 -177.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -68.68 -41.31 79.4 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.461 0.648 . . . . 75.400000000000006 109.783 178.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -68.17 -32.78 73.27 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.473 -0.785 . . . . 71.219999999999999 109.35 177.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 49.3 m -56.5 -40.96 75.84 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 116.058 -0.519 . . . . 73.239999999999995 111.581 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 7.2 t -84.87 -41.21 16.23 Favored 'General case' 0 N--CA 1.44 -0.941 0 C-N-CA 119.178 -1.009 . . . . 53.539999999999999 110.514 177.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 67.18 6.69 40.69 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 121.325 -0.464 . . . . 73.340000000000003 113.442 179.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 76.9 mt -84.07 -9.48 58.59 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-O 121.175 0.512 . . . . 62.119999999999997 111.089 -178.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.524 HD23 ' H ' ' A' ' 212' ' ' LEU . 2.2 pt? -112.48 136.55 51.85 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-N 115.662 -0.699 . . . . 72.219999999999999 109.373 175.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -130.69 166.84 19.85 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.423 -0.954 . . . . 60.32 108.423 -178.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . 0.432 ' HA ' ' HB ' ' A' ' 197' ' ' ILE . 16.5 m -56.42 -30.38 30.79 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 N-CA-C 113.486 0.921 . . . . 73.219999999999999 113.486 -176.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 -79.38 -15.0 58.59 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 121.75 -0.594 . . . . 73.239999999999995 111.688 -179.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.514 ' HB3' ' HB ' ' A' ' 249' ' ' VAL . 1.5 m-20 -71.78 139.74 49.15 Favored 'General case' 0 C--O 1.248 0.974 0 CA-C-O 121.439 0.637 . . . . 62.140000000000001 111.92 -178.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 57.0 tt0 -101.46 138.54 38.33 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.973 -1.012 . . . . 53.420000000000002 111.266 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.549 ' HA ' HG12 ' A' ' 249' ' ' VAL . 35.4 t -83.54 124.44 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 CA-C-O 121.77 0.795 . . . . 75.040000000000006 110.133 -178.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.438 HD11 ' CD ' ' A' ' 250' ' ' LYS . 35.5 mm -93.64 -51.88 10.53 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 CA-C-N 115.044 -0.98 . . . . 74.439999999999998 111.121 -179.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -154.26 158.33 40.05 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 116.214 -0.448 . . . . 55.119999999999997 110.458 -177.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.44 HG22 HD22 ' A' ' 241' ' ' ASN . 12.5 p -127.69 120.26 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.663 0 CA-C-N 115.595 -0.73 . . . . 75.420000000000002 109.411 179.275 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . 0.466 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 12.0 t-20 68.28 4.23 4.08 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 126.329 1.851 . . . . 71.140000000000001 110.98 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 117.57 -15.45 12.83 Favored Glycine 0 N--CA 1.44 -1.078 0 N-CA-C 110.892 -0.883 . . . . 74.420000000000002 110.892 -177.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 65.4 mt -94.75 124.44 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 CA-C-O 121.132 0.492 . . . . 74.340000000000003 110.026 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -55.37 137.08 48.71 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 124.914 1.286 . . . . 71.200000000000003 112.425 -179.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . 0.411 HG21 HG12 ' A' ' 218' ' ' VAL . 35.8 m -105.98 8.79 9.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 CA-C-O 121.801 0.81 . . . . 72.409999999999997 109.981 175.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -74.72 99.9 3.84 Favored 'General case' 0 N--CA 1.431 -1.398 0 CA-C-N 114.813 -1.085 . . . . 54.509999999999998 110.125 178.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 112.41 -8.63 26.49 Favored Glycine 0 CA--C 1.495 -1.171 0 N-CA-C 110.378 -1.089 . . . . 41.439999999999998 110.378 178.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -83.06 153.08 25.08 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 107.954 -1.128 . . . . 71.019999999999996 107.954 176.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 74.4 p -91.79 175.73 6.78 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 108.168 -1.049 . . . . 53.409999999999997 108.168 179.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . 0.461 ' HA ' HG22 ' A' ' 234' ' ' VAL . 2.8 tm? -65.06 -37.03 86.21 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 107.818 -1.178 . . . . 72.030000000000001 107.818 178.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -55.69 -51.82 65.96 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.016 -0.993 . . . . 45.43 109.395 177.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' GLN . . . . . 0.64 ' O ' ' HG3' ' A' ' 237' ' ' MET . 2.2 mp0 -66.84 -50.7 61.72 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 113.798 1.036 . . . . 64.530000000000001 113.798 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.679 HG21 HG12 ' A' ' 195' ' ' ILE . 26.7 m -58.89 -33.51 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 N-CA-C 112.588 0.588 . . . . 74.140000000000001 112.588 -174.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . 0.421 ' O ' HG23 ' A' ' 239' ' ' VAL . 91.3 m -72.77 -35.56 67.47 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 115.232 -0.895 . . . . 75.299999999999997 109.332 -175.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -69.02 -30.77 69.21 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.298 -0.864 . . . . 72.430000000000007 108.994 178.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' MET . . . . . 0.64 ' HG3' ' O ' ' A' ' 233' ' ' GLN . 19.3 mtp -69.49 -47.25 64.49 Favored 'General case' 0 C--O 1.209 -1.067 0 N-CA-C 106.931 -1.507 . . . . 61.25 106.931 178.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' MET . . . . . 0.542 ' HG3' ' O ' ' A' ' 234' ' ' VAL . 65.3 mtt -59.55 -45.29 92.24 Favored 'General case' 0 C--O 1.22 -0.489 0 CA-C-N 115.42 -0.809 . . . . 72.409999999999997 112.186 -179.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 235' ' ' THR . 89.3 t -64.42 -38.26 82.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.161 0.505 . . . . 63.32 110.533 178.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -68.89 -36.13 77.7 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.383 0.611 . . . . 74.319999999999993 110.318 178.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . 0.44 HD22 HG22 ' A' ' 221' ' ' VAL . 89.9 m-20 -86.51 19.43 2.83 Favored 'General case' 0 C--O 1.199 -1.583 0 CA-C-N 115.472 -0.785 . . . . 61.340000000000003 111.906 179.133 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' SER . . . . . 0.446 ' O ' HD13 ' A' ' 164' ' ' LEU . 30.4 p -61.26 -23.7 65.85 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 112.776 0.658 . . . . 74.140000000000001 112.776 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 25.4 p -74.8 -16.78 60.69 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 112.12 0.415 . . . . 72.140000000000001 112.12 178.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -175.29 88.24 0.04 OUTLIER 'General case' 0 C--O 1.257 1.451 0 N-CA-C 107.787 -1.19 . . . . 75.439999999999998 107.787 -179.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.539 ' HB3' ' HB2' ' A' ' 163' ' ' LEU . 2.8 tt -92.15 102.11 14.63 Favored 'General case' 0 N--CA 1.416 -2.138 0 C-N-CA 118.923 -1.111 . . . . 64.340000000000003 109.268 -174.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.608 HG12 ' HG2' ' A' ' 162' ' ' ARG . 89.1 mt -97.81 116.4 40.3 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.98 0 C-N-CA 120.134 -0.627 . . . . 71.420000000000002 109.971 178.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . 0.492 HG13 ' CD2' ' A' ' 245' ' ' LEU . 14.6 mt -117.99 134.63 60.99 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.84 0 CA-C-O 121.433 0.635 . . . . 73.109999999999999 111.403 176.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.456 ' HA ' ' O ' ' A' ' 159' ' ' ARG . 63.8 m -103.1 114.87 29.51 Favored 'General case' 0 N--CA 1.409 -2.5 0 CA-C-N 114.52 -1.218 . . . . 23.420000000000002 108.072 175.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.549 HG12 ' HA ' ' A' ' 218' ' ' VAL . 17.4 m -118.89 159.91 19.11 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.165 0 CA-C-O 121.46 0.648 . . . . 41.240000000000002 110.754 177.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . 0.499 ' HB3' ' ND1' ' A' ' 158' ' ' HIS . 10.0 ptmt -127.69 128.84 23.86 Favored Pre-proline 0 C--N 1.272 -2.798 0 CA-C-N 114.291 -1.322 . . . . 74.329999999999998 109.161 177.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo . . . . . 0 N--CA 1.439 -1.683 0 C-N-CA 121.827 1.685 . . . . 63.100000000000001 110.5 178.809 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.499 -0.992 0 N-CA-C 109.815 -0.439 . . . . 75.030000000000001 109.815 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.543 ' O ' ' HA ' ' A' ' 248' ' ' THR . 2.1 tpm_? -140.18 140.36 35.9 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.619 -1.252 . . . . 74.409999999999997 107.619 177.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.583 ' HB3' ' OG1' ' A' ' 248' ' ' THR . 23.2 ptt180 -132.47 113.03 12.63 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 122.098 0.951 . . . . 75.409999999999997 113.067 178.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.63 ' O ' ' HA ' ' A' ' 246' ' ' ILE . 21.1 m -105.17 139.29 26.67 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 CA-C-N 113.929 -1.487 . . . . 45.210000000000001 113.014 -175.181 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.546 ' HG3' HG12 ' A' ' 246' ' ' ILE . 7.3 mpt_? -91.13 112.6 24.57 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 106.995 -1.483 . . . . 74.239999999999995 106.995 175.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.513 ' HB2' ' HB3' ' A' ' 245' ' ' LEU . 35.4 mt -100.23 135.49 41.58 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 108.49 -0.929 . . . . 62.109999999999999 108.49 179.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.466 HD23 ' O ' ' A' ' 242' ' ' SER . 8.1 tp . . . . . 0 N--CA 1.417 -2.102 0 C-N-CA 124.499 1.12 . . . . 54.210000000000001 110.567 175.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.472 ' HG ' ' CD1' ' A' ' 245' ' ' LEU . 3.3 mm? . . . . . 0 N--CA 1.445 -0.706 0 CA-C-O 120.916 0.388 . . . . 55.509999999999998 111.358 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . 0.439 ' HA3' ' HA3' ' A' ' 204' ' ' GLY . . . 93.28 35.49 6.26 Favored Glycine 0 N--CA 1.437 -1.247 0 C-N-CA 120.419 -0.896 . . . . 62.439999999999998 113.704 175.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -151.45 158.89 44.26 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.415 -0.958 . . . . 74.25 108.415 174.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -125.36 156.83 38.12 Favored 'General case' 0 C--N 1.284 -2.243 0 N-CA-C 108.761 -0.829 . . . . 72.450000000000003 108.761 175.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.59 ' H ' HD13 ' A' ' 176' ' ' ILE . 0.2 OUTLIER -124.96 166.64 20.24 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 CA-C-O 121.441 0.639 . . . . 61.210000000000001 110.421 -179.922 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.431 ' HG2' ' HB3' ' A' ' 198' ' ' SER . 14.7 ptt180 -144.78 154.76 43.04 Favored 'General case' 0 C--N 1.28 -2.438 0 CA-C-N 114.699 -1.137 . . . . 72.439999999999998 110.154 -176.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . 0.406 ' HB2' ' HB2' ' A' ' 231' ' ' LEU . 11.2 t70 -112.98 145.39 40.9 Favored 'General case' 0 C--N 1.294 -1.822 0 C-N-CA 123.648 0.779 . . . . 73.439999999999998 110.094 -177.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -162.98 179.13 38.42 Favored Glycine 0 C--N 1.294 -1.797 0 N-CA-C 109.048 -1.621 . . . . 42.240000000000002 109.048 175.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 2.1 p -96.99 123.4 40.7 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-N 118.19 0.995 . . . . 75.120000000000005 111.154 174.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . 0.53 ' O ' ' HA ' ' A' ' 191' ' ' LYS . 24.5 t . . . . . 0 C--N 1.291 -1.944 0 N-CA-C 107.684 -1.228 . . . . 71.219999999999999 107.684 177.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.53 ' HA ' ' O ' ' A' ' 181' ' ' SER . 43.8 mtmt . . . . . 0 CA--C 1.488 -1.423 0 CA-C-O 122.405 1.098 . . . . 70.420000000000002 112.402 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -132.08 163.47 49.93 Favored Pre-proline 0 C--N 1.259 -3.327 0 N-CA-C 105.184 -2.154 . . . . 63.399999999999999 105.184 176.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -66.48 131.07 25.22 Favored 'Trans proline' 0 N--CA 1.423 -2.666 0 N-CA-C 106.872 -2.011 . . . . 73.129999999999995 106.872 169.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -125.89 127.83 6.27 Favored Glycine 0 N--CA 1.397 -3.965 0 N-CA-C 109.499 -1.441 . . . . 41.43 109.499 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.623 HG12 HG21 ' A' ' 234' ' ' VAL . 3.4 mp -103.68 132.78 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.049 0 N-CA-C 109.084 -0.71 . . . . 75.0 109.084 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -125.6 167.38 15.16 Favored 'General case' 0 C--N 1.281 -2.405 0 N-CA-C 107.366 -1.346 . . . . 71.140000000000001 107.366 -176.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 47.5 mm -77.82 132.29 32.88 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 N-CA-C 107.021 -1.474 . . . . 73.109999999999999 107.021 175.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . 0.431 ' HB3' ' HG2' ' A' ' 177' ' ' ARG . 83.4 p -100.47 -35.29 9.6 Favored 'General case' 0 C--N 1.28 -2.43 0 C-N-CA 118.806 -1.158 . . . . 74.209999999999994 111.053 -178.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 65.9 ttt180 -158.13 147.3 19.43 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.296 -0.411 . . . . 73.25 110.44 -176.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 71.0 mt -106.66 138.39 42.93 Favored 'General case' 0 CA--C 1.483 -1.609 0 N-CA-C 108.554 -0.906 . . . . 71.099999999999994 108.554 171.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 58.9 t -98.89 114.99 65.99 Favored Pre-proline 0 N--CA 1.415 -2.211 0 N-CA-C 106.377 -1.712 . . . . 75.319999999999993 106.377 172.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . 0.527 ' HA ' ' HG2' ' A' ' 207' ' ' GLU . 37.0 Cg_exo -58.73 126.8 22.28 Favored 'Trans proline' 0 N--CA 1.448 -1.149 0 C-N-CA 121.934 1.756 . . . . 61.119999999999997 110.65 -178.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 106.24 -16.3 42.1 Favored Glycine 0 N--CA 1.438 -1.2 0 C-N-CA 120.332 -0.937 . . . . 63.030000000000001 112.403 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . 0.439 ' HA3' ' HA3' ' A' ' 173' ' ' GLY . . . -81.01 -179.23 52.97 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.811 -0.709 . . . . 15.210000000000001 111.898 178.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.453 HD23 ' HA ' ' A' ' 172' ' ' LEU . 3.4 mm? -62.74 -42.85 99.87 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 123.1 0.56 . . . . 71.5 111.548 -177.273 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -60.96 -38.66 86.71 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.139 -0.482 . . . . 71.319999999999993 111.335 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.527 ' HG2' ' HA ' ' A' ' 202' ' ' PRO . 9.3 tp10 -75.51 -36.9 60.44 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.505 -0.554 . . . . 72.019999999999996 109.505 178.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 24.7 t -60.18 -45.98 91.25 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 115.915 -0.584 . . . . 50.229999999999997 110.444 -179.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . 0.46 HG23 ' H ' ' A' ' 211' ' ' LEU . 8.9 t -72.89 -40.33 65.65 Favored 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 120.311 -0.556 . . . . 72.439999999999998 110.037 176.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 73.16 9.32 76.49 Favored Glycine 0 N--CA 1.441 -0.998 0 CA-C-N 115.852 -0.613 . . . . 62.509999999999998 112.561 179.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.46 ' H ' HG23 ' A' ' 209' ' ' THR . 48.6 mt -97.25 1.97 50.28 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.542 0.687 . . . . 64.219999999999999 109.685 -179.004 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 87.6 mt -112.83 132.43 55.28 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 114.744 -1.116 . . . . 72.420000000000002 109.09 174.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -131.45 160.65 34.52 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 122.817 0.447 . . . . 71.200000000000003 109.889 176.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 32.8 m -62.22 -30.26 48.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 122.034 0.921 . . . . 74.329999999999998 112.922 -178.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -81.0 -14.07 58.28 Favored 'General case' 0 C--N 1.275 -2.641 0 CA-C-N 116.04 -0.527 . . . . 64.150000000000006 111.777 -175.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.475 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 72.0 m-20 -71.71 151.47 43.58 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 113.599 0.963 . . . . 74.519999999999996 113.599 -175.06 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -111.64 129.78 55.98 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.122 1.369 . . . . 72.439999999999998 109.955 -176.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.493 ' HA ' HG12 ' A' ' 249' ' ' VAL . 41.6 t -82.24 138.88 18.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 CA-C-O 121.488 0.661 . . . . 60.119999999999997 111.949 -175.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.481 HD11 ' CD ' ' A' ' 250' ' ' LYS . 47.4 mm -108.66 -51.76 6.82 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 C-N-CA 123.935 0.894 . . . . 71.200000000000003 111.631 -178.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.419 ' HB3' ' HA ' ' A' ' 225' ' ' GLU . 10.7 pt-20 -151.87 161.38 42.74 Favored 'General case' 0 C--O 1.244 0.808 0 CA-C-O 120.522 0.201 . . . . 60.409999999999997 110.663 -178.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.445 HG22 HD22 ' A' ' 241' ' ' ASN . 15.0 p -129.93 119.47 47.32 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.075 0 CA-C-O 121.449 0.642 . . . . 72.420000000000002 109.556 177.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . 0.511 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 13.7 t-20 70.23 0.02 2.99 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 125.859 1.663 . . . . 74.129999999999995 111.858 177.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 121.87 -13.8 9.15 Favored Glycine 0 N--CA 1.435 -1.369 0 N-CA-C 110.955 -0.858 . . . . 65.430000000000007 110.955 -177.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 66.6 mt -95.8 123.66 48.1 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 N-CA-C 108.725 -0.843 . . . . 71.209999999999994 108.725 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . 0.419 ' HA ' ' HB3' ' A' ' 220' ' ' GLU . 13.0 pt-20 -55.76 147.65 18.32 Favored 'General case' 0 C--N 1.31 -1.138 0 O-C-N 123.912 0.758 . . . . 64.200000000000003 111.145 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . 0.472 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 33.5 m -120.5 -1.1 8.02 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 CA-C-O 121.472 0.653 . . . . 72.409999999999997 109.387 173.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -73.36 95.16 2.14 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-N 115.081 -0.963 . . . . 42.039999999999999 110.622 -178.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 127.43 -22.29 5.59 Favored Glycine 0 N--CA 1.429 -1.795 0 C-N-CA 120.432 -0.89 . . . . 44.219999999999999 110.939 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 55.9 mttm -83.78 164.93 19.25 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 109.996 -0.372 . . . . 53.219999999999999 109.996 177.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . 0.44 ' H ' ' NE2' ' A' ' 233' ' ' GLN . 34.7 p -93.0 168.09 11.36 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 116.43 -0.35 . . . . 62.439999999999998 110.204 -177.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . 0.505 HD21 HG12 ' A' ' 176' ' ' ILE . 2.8 tm? -56.96 -41.94 79.24 Favored 'General case' 0 N--CA 1.44 -0.967 0 C-N-CA 123.083 0.553 . . . . 64.109999999999999 109.878 -178.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -56.43 -51.59 67.81 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.365 -0.379 . . . . 65.239999999999995 110.501 176.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' GLN . . . . . 0.44 ' NE2' ' H ' ' A' ' 230' ' ' THR . 48.9 mt-30 -58.6 -49.75 76.32 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 115.229 -0.896 . . . . 72.219999999999999 112.362 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.623 HG21 HG12 ' A' ' 195' ' ' ILE . 15.1 m -69.45 -33.84 59.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 112.894 0.701 . . . . 74.219999999999999 112.894 -173.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . 0.428 ' O ' HG23 ' A' ' 239' ' ' VAL . 84.4 m -73.42 -35.59 65.85 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 109.488 -0.56 . . . . 71.439999999999998 109.488 -174.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -63.39 -33.1 74.8 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.957 -0.757 . . . . 71.340000000000003 108.957 177.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' MET . . . . . 0.416 ' HB2' HG11 ' A' ' 221' ' ' VAL . 5.1 mtm -72.72 -38.98 67.29 Favored 'General case' 0 C--O 1.199 -1.555 0 CA-C-N 115.341 -0.845 . . . . 74.430000000000007 108.731 -179.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' MET . . . . . 0.449 ' HG3' ' O ' ' A' ' 234' ' ' VAL . 65.6 mtt -63.45 -37.96 89.3 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.285 -0.416 . . . . 75.219999999999999 110.815 179.113 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 235' ' ' THR . 66.4 t -69.69 -41.0 79.97 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 CA-C-N 116.334 -0.393 . . . . 63.130000000000003 110.149 177.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -66.39 -34.19 77.4 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.768 0.794 . . . . 55.219999999999999 110.372 177.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . 0.445 HD22 HG22 ' A' ' 221' ' ' VAL . 91.5 m-20 -86.41 20.51 2.4 Favored 'General case' 0 C--O 1.2 -1.545 0 CA-C-N 115.267 -0.879 . . . . 75.319999999999993 112.506 178.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' SER . . . . . 0.466 ' O ' HD23 ' A' ' 164' ' ' LEU . 67.4 m -64.88 -23.59 67.28 Favored 'General case' 0 C--O 1.212 -0.912 0 C-N-CA 120.172 -0.611 . . . . 74.010000000000005 112.545 178.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 12.4 p -65.3 -36.36 83.83 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 111.802 0.297 . . . . 75.310000000000002 111.802 176.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 46.2 m-80 -155.95 92.43 1.36 Allowed 'General case' 0 C--O 1.254 1.294 0 N-CA-C 107.301 -1.37 . . . . 72.140000000000001 107.301 177.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.513 ' HB3' ' HB2' ' A' ' 163' ' ' LEU . 2.8 tt -88.6 103.18 15.67 Favored 'General case' 0 N--CA 1.423 -1.817 0 C-N-CA 119.381 -0.927 . . . . 75.140000000000001 109.641 -174.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.63 ' HA ' ' O ' ' A' ' 161' ' ' VAL . 87.2 mt -102.58 116.59 46.55 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.992 0 C-N-CA 120.721 -0.392 . . . . 70.209999999999994 109.974 177.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . 0.486 HG13 ' CD2' ' A' ' 245' ' ' LEU . 25.5 mt -119.55 132.89 68.05 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.089 0 CA-C-O 121.146 0.498 . . . . 61.450000000000003 111.912 176.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.583 ' OG1' ' HB3' ' A' ' 160' ' ' ARG . 57.2 m -100.27 124.35 45.63 Favored 'General case' 0 N--CA 1.426 -1.648 0 N-CA-C 107.561 -1.274 . . . . 72.510000000000005 107.561 175.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.493 HG12 ' HA ' ' A' ' 218' ' ' VAL . 29.5 m -124.82 170.56 14.8 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 CA-C-O 121.579 0.704 . . . . 74.230000000000004 110.971 176.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . 0.481 ' CD ' HD11 ' A' ' 219' ' ' ILE 0.312 44.0 mtpt -125.0 134.78 26.02 Favored Pre-proline 0 C--N 1.28 -2.417 0 N-CA-C 106.146 -1.798 . . . . 73.430000000000007 106.146 173.971 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . 0.475 ' HA ' ' OD1' ' A' ' 216' ' ' ASP . 5.6 Cg_exo . . . . . 0 N--CA 1.402 -3.871 0 CA-C-N 119.73 0.939 . . . . 72.209999999999994 110.346 173.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.564 ' NE2' HG13 ' A' ' 219' ' ' ILE . 23.6 m80 . . . . . 0 N--CA 1.432 -1.355 0 N-CA-C 112.161 0.43 . . . . 73.400000000000006 112.161 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.548 ' O ' ' HA ' ' A' ' 248' ' ' THR . 12.8 tpt180 -131.22 143.39 50.54 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.34 -1.356 . . . . 71.420000000000002 107.34 173.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 30.4 ttt85 -120.09 113.24 20.19 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 121.233 0.539 . . . . 75.310000000000002 109.911 -178.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.535 ' O ' ' HA ' ' A' ' 246' ' ' ILE . 25.2 m -119.24 139.14 47.62 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 N-CA-C 112.501 0.556 . . . . 65.340000000000003 112.501 -175.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.451 ' HG3' HG12 ' A' ' 246' ' ' ILE . 3.3 mpt_? -100.1 112.93 25.23 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 107.086 -1.449 . . . . 73.450000000000003 107.086 177.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.412 ' HB2' ' HB3' ' A' ' 245' ' ' LEU . 23.9 mt -95.69 130.59 42.54 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 109.412 -0.588 . . . . 74.0 109.412 -178.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 6.1 tt . . . . . 0 C--N 1.33 -0.248 0 CA-C-O 122.333 1.063 . . . . 74.140000000000001 110.757 176.327 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.462 ' HG ' ' CD1' ' A' ' 245' ' ' LEU . 2.6 mm? . . . . . 0 C--O 1.239 0.545 0 CA-C-O 121.032 0.444 . . . . 61.310000000000002 111.912 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . 0.495 ' HA3' ' HA3' ' A' ' 204' ' ' GLY . . . 91.56 38.92 5.73 Favored Glycine 0 N--CA 1.429 -1.823 0 C-N-CA 120.71 -0.757 . . . . 73.25 114.155 172.13 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -152.76 153.45 33.22 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 109.245 -0.65 . . . . 73.409999999999997 109.245 174.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -114.56 140.22 48.95 Favored 'General case' 0 C--N 1.282 -2.341 0 CA-C-N 115.674 -0.694 . . . . 71.129999999999995 109.282 178.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.409 HD13 ' SD ' ' A' ' 238' ' ' MET . 29.1 pt -114.31 169.1 5.7 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.514 0 CA-C-N 115.446 -0.797 . . . . 73.430000000000007 109.885 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.501 ' HG2' ' HB2' ' A' ' 198' ' ' SER . 3.1 ptp180 -153.75 154.64 34.42 Favored 'General case' 0 C--N 1.278 -2.52 0 CA-C-N 115.541 -0.754 . . . . 73.140000000000001 108.97 -179.273 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . 0.401 ' OD1' HD12 ' A' ' 231' ' ' LEU . 6.9 p-10 -101.47 154.99 18.34 Favored 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 108.659 -0.867 . . . . 74.409999999999997 108.659 178.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -165.23 -168.61 27.66 Favored Glycine 0 N--CA 1.412 -2.95 0 N-CA-C 109.274 -1.531 . . . . 65.129999999999995 109.274 177.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . 0.615 ' HB ' ' CG ' ' A' ' 191' ' ' LYS . 1.3 p -100.48 123.64 44.96 Favored 'General case' 0 C--N 1.28 -2.426 0 CA-C-O 121.876 0.846 . . . . 61.119999999999997 112.716 178.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 27.6 t . . . . . 0 N--CA 1.416 -2.127 0 N-CA-C 106.466 -1.679 . . . . 33.43 106.466 176.637 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.615 ' CG ' ' HB ' ' A' ' 180' ' ' THR . 36.7 ttmt . . . . . 0 N--CA 1.409 -2.478 0 N-CA-C 107.731 -1.211 . . . . 73.129999999999995 107.731 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . 0.42 ' HB2' ' HD2' ' A' ' 193' ' ' PRO . 13.4 pt20 -141.23 164.46 35.39 Favored Pre-proline 0 C--N 1.284 -2.281 0 N-CA-C 108.712 -0.847 . . . . 60.340000000000003 108.712 -174.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' PRO . . . . . 0.42 ' HD2' ' HB2' ' A' ' 192' ' ' GLN . 13.2 Cg_endo -57.52 132.21 49.14 Favored 'Trans proline' 0 N--CA 1.448 -1.153 0 C-N-CA 121.504 1.47 . . . . 73.040000000000006 111.638 176.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -141.03 146.33 17.52 Favored Glycine 0 N--CA 1.408 -3.191 0 N-CA-C 108.244 -1.942 . . . . 72.25 108.244 177.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.542 HG12 HG21 ' A' ' 234' ' ' VAL . 2.6 mp -104.32 133.03 49.52 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.413 0 C-N-CA 120.165 -0.614 . . . . 64.040000000000006 111.189 -178.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -122.96 167.49 13.52 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 108.085 -1.08 . . . . 74.530000000000001 108.085 -176.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . 0.403 ' CG2' ' HA ' ' A' ' 214' ' ' VAL . 41.3 mm -77.62 132.95 31.61 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 N-CA-C 108.527 -0.916 . . . . 73.239999999999995 108.527 177.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . 0.501 ' HB2' ' HG2' ' A' ' 177' ' ' ARG . 11.1 t -104.14 -36.51 7.66 Favored 'General case' 0 C--N 1.275 -2.646 0 O-C-N 121.731 -0.605 . . . . 75.420000000000002 112.488 178.039 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 20.1 tpp180 -167.15 144.52 4.67 Favored 'General case' 0 C--O 1.213 -0.855 0 N-CA-C 110.136 -0.32 . . . . 71.25 110.136 -177.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 78.8 mt -101.89 145.43 29.23 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 108.514 -0.921 . . . . 73.329999999999998 108.514 171.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 61.9 t -105.19 114.0 63.98 Favored Pre-proline 0 N--CA 1.42 -1.971 0 N-CA-C 105.972 -1.862 . . . . 45.549999999999997 105.972 172.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . 0.47 ' HA ' ' HG3' ' A' ' 207' ' ' GLU . 27.7 Cg_exo -62.01 136.87 63.59 Favored 'Trans proline' 0 N--CA 1.446 -1.293 0 C-N-CA 121.802 1.668 . . . . 72.439999999999998 110.268 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 104.12 -26.34 23.32 Favored Glycine 0 C--N 1.298 -1.581 0 N-CA-C 110.087 -1.205 . . . . 75.209999999999994 110.087 -175.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . 0.495 ' HA3' ' HA3' ' A' ' 173' ' ' GLY . . . -79.72 162.74 47.34 Favored Glycine 0 N--CA 1.423 -2.198 0 N-CA-C 111.031 -0.828 . . . . 62.310000000000002 111.031 178.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.456 ' H ' HD22 ' A' ' 205' ' ' LEU . 2.6 mm? -62.94 -29.57 70.89 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.372 0.669 . . . . 74.519999999999996 111.847 -173.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -63.6 -46.94 83.5 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.19 0.519 . . . . 72.329999999999998 110.289 177.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.47 ' HG3' ' HA ' ' A' ' 202' ' ' PRO . 3.9 tm-20 -71.51 -33.65 69.4 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.26 -0.427 . . . . 55.229999999999997 109.929 178.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 50.5 m -56.39 -39.25 72.68 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.186 -0.461 . . . . 74.239999999999995 111.159 177.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 13.0 t -83.91 -40.57 18.4 Favored 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 119.197 -1.001 . . . . 65.0 109.832 176.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 65.71 2.5 11.82 Favored Glycine 0 C--N 1.343 0.966 0 N-CA-C 114.183 0.433 . . . . 62.530000000000001 114.183 177.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 60.9 mt -78.88 -12.3 60.03 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-O 120.969 0.414 . . . . 75.25 110.708 -177.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.535 HD23 ' H ' ' A' ' 212' ' ' LEU . 2.2 pt? -109.86 134.88 51.57 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.329 -0.989 . . . . 74.549999999999997 108.329 174.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -117.41 162.11 18.46 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 116.624 -0.262 . . . . 41.340000000000003 110.306 -178.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . 0.403 ' HA ' ' CG2' ' A' ' 197' ' ' ILE . 35.6 m -56.64 -31.52 34.87 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.77 0 N-CA-C 114.471 1.286 . . . . 64.049999999999997 114.471 -176.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -82.72 -14.26 54.88 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 112.773 0.657 . . . . 72.420000000000002 112.773 -178.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.53 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 54.3 m-20 -69.01 156.13 39.15 Favored 'General case' 0 C--O 1.246 0.904 0 N-CA-C 113.266 0.839 . . . . 55.329999999999998 113.266 -173.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -107.4 137.07 46.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.933 -1.03 . . . . 63.100000000000001 110.246 -179.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.599 ' HA ' HG12 ' A' ' 249' ' ' VAL . 30.9 t -84.53 125.74 40.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 121.464 0.649 . . . . 64.329999999999998 109.975 -179.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.564 HG13 ' NE2' ' A' ' 158' ' ' HIS . 40.1 mm -90.23 -49.99 13.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 CA-C-N 115.167 -0.924 . . . . 75.420000000000002 110.607 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.414 ' CB ' ' HA ' ' A' ' 225' ' ' GLU . 9.3 pt-20 -154.59 160.93 41.78 Favored 'General case' 0 C--O 1.249 1.062 0 CA-C-N 116.313 -0.403 . . . . 71.420000000000002 110.438 -179.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.484 HG22 HD22 ' A' ' 241' ' ' ASN . 8.4 p -121.49 113.57 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.215 0 CA-C-O 122.109 0.957 . . . . 75.420000000000002 108.968 174.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . 0.453 ' OD1' HD12 ' A' ' 246' ' ' ILE . 60.0 t30 40.74 68.37 0.42 Allowed 'General case' 0 C--N 1.28 -2.421 0 C-N-CA 127.103 2.161 . . . . 73.400000000000006 114.497 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 84.35 -20.85 11.92 Favored Glycine 0 N--CA 1.443 -0.848 0 CA-C-N 114.93 -1.032 . . . . 73.349999999999994 113.738 178.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 54.6 mt -105.92 123.41 60.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 117.034 0.417 . . . . 61.32 110.011 -176.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . 0.414 ' HA ' ' CB ' ' A' ' 220' ' ' GLU . 11.8 pt-20 -66.03 144.14 56.92 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.352 0.596 . . . . 55.340000000000003 111.564 -178.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 33.9 m -115.19 -2.24 10.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-N 115.923 -0.58 . . . . 75.510000000000005 111.186 178.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -73.92 98.88 3.11 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.933 -0.576 . . . . 74.310000000000002 110.058 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 120.59 -17.07 9.59 Favored Glycine 0 CA--C 1.498 -0.988 0 N-CA-C 111.45 -0.66 . . . . 71.420000000000002 111.45 179.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -78.98 162.87 25.66 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 108.737 -0.838 . . . . 64.450000000000003 108.737 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . 0.409 ' O ' HG13 ' A' ' 234' ' ' VAL . 68.2 p -87.34 170.63 11.24 Favored 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 107.599 -1.26 . . . . 62.420000000000002 107.599 177.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . 0.401 HD12 ' OD1' ' A' ' 178' ' ' ASP . 0.7 OUTLIER -68.08 -34.46 76.45 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 107.347 -1.353 . . . . 74.109999999999999 107.347 179.976 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -58.54 -47.41 84.3 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-N 115.734 -0.666 . . . . 62.229999999999997 110.075 176.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -64.6 -49.05 72.63 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 113.902 1.075 . . . . 73.150000000000006 113.902 178.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.542 HG21 HG12 ' A' ' 195' ' ' ILE . 17.0 m -61.6 -33.47 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 112.581 0.585 . . . . 64.019999999999996 112.581 -176.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . 0.49 ' O ' HG23 ' A' ' 239' ' ' VAL . 58.3 m -70.03 -35.84 74.61 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 115.803 -0.635 . . . . 74.230000000000004 109.887 -175.011 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -64.93 -30.94 71.96 Favored 'General case' 0 CA--C 1.508 -0.65 0 N-CA-C 108.86 -0.793 . . . . 35.509999999999998 108.86 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' MET . . . . . 0.437 ' HB2' HG11 ' A' ' 221' ' ' VAL . 5.7 mtm -74.36 -37.54 63.46 Favored 'General case' 0 C--O 1.199 -1.567 0 N-CA-C 108.259 -1.015 . . . . 72.109999999999999 108.259 -179.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' MET . . . . . 0.409 ' SD ' HD13 ' A' ' 176' ' ' ILE . 65.5 mtt -69.57 -34.66 74.49 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.212 -0.449 . . . . 64.310000000000002 110.998 178.169 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 235' ' ' THR . 99.0 t -67.04 -39.98 84.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.197 0.523 . . . . 71.519999999999996 110.222 176.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -68.29 -42.92 78.81 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.54 0.686 . . . . 75.239999999999995 109.325 176.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . 0.484 HD22 HG22 ' A' ' 221' ' ' VAL . 91.6 m-20 -79.69 18.13 0.81 Allowed 'General case' 0 C--O 1.192 -1.948 0 CA-C-N 115.025 -0.989 . . . . 73.209999999999994 112.237 178.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 70.3 m -68.26 -22.55 64.75 Favored 'General case' 0 N--CA 1.478 0.967 0 O-C-N 121.584 -0.698 . . . . 64.219999999999999 111.923 178.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 37.8 p -65.5 -22.48 66.73 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 116.275 -0.42 . . . . 73.150000000000006 110.727 176.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 178.05 101.12 0.02 OUTLIER 'General case' 0 CA--C 1.503 -0.834 0 C-N-CA 125.578 1.551 . . . . 74.219999999999999 107.63 176.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.546 ' CD2' HG13 ' A' ' 247' ' ' ILE . 3.3 tt -90.01 106.52 18.53 Favored 'General case' 0 N--CA 1.414 -2.234 0 CA-C-N 115.515 -0.766 . . . . 54.409999999999997 110.203 -171.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.535 ' HA ' ' O ' ' A' ' 161' ' ' VAL . 62.9 mt -95.32 127.92 46.92 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.068 0 N-CA-C 109.115 -0.698 . . . . 72.239999999999995 109.115 176.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . 0.546 HG13 ' CD2' ' A' ' 245' ' ' LEU . 12.8 mt -132.16 142.54 42.53 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 CA-C-O 121.367 0.603 . . . . 71.439999999999998 112.26 176.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.548 ' HA ' ' O ' ' A' ' 159' ' ' ARG . 61.5 m -110.49 117.43 33.53 Favored 'General case' 0 N--CA 1.418 -2.058 0 N-CA-C 107.932 -1.136 . . . . 74.120000000000005 107.932 173.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.599 HG12 ' HA ' ' A' ' 218' ' ' VAL . 27.0 m -120.78 162.41 19.53 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 N-CA-C 109.322 -0.622 . . . . 54.130000000000003 109.322 175.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 15.8 ptmt -134.01 133.56 22.19 Favored Pre-proline 0 C--N 1.284 -2.24 0 CA-C-N 115.198 -0.91 . . . . 71.329999999999998 108.803 175.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . 0.53 ' HA ' ' OD1' ' A' ' 216' ' ' ASP . 61.1 Cg_exo . . . . . 0 N--CA 1.443 -1.488 0 C-N-CA 122.115 1.877 . . . . 71.329999999999998 110.527 173.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.683 ' NE2' HG13 ' A' ' 219' ' ' ILE . 9.5 m80 . . . . . 0 CA--C 1.499 -1.016 0 N-CA-C 110.638 -0.134 . . . . 74.129999999999995 110.638 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.525 ' O ' ' HA ' ' A' ' 248' ' ' THR . 18.3 tpt180 -139.34 133.12 30.72 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 110.303 -0.258 . . . . 75.099999999999994 110.303 178.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.469 ' HB3' ' OG1' ' A' ' 248' ' ' THR . 4.6 ptp180 -117.6 118.63 32.65 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-O 121.756 0.789 . . . . 73.329999999999998 110.519 175.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.461 ' CG1' HD21 ' A' ' 211' ' ' LEU . 16.2 m -111.4 139.43 35.53 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.086 0 CA-C-N 114.914 -1.039 . . . . 73.340000000000003 111.338 -178.11 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.783 ' HG3' HG12 ' A' ' 246' ' ' ILE . 7.6 mpt_? -92.66 111.5 23.12 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 107.568 -1.271 . . . . 74.420000000000002 107.568 176.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.597 ' HB2' ' HB2' ' A' ' 245' ' ' LEU . 21.2 mt -91.28 137.03 32.68 Favored 'General case' 0 N--CA 1.416 -2.151 0 N-CA-C 108.38 -0.97 . . . . 60.340000000000003 108.38 -179.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.587 ' HG ' ' CD1' ' A' ' 172' ' ' LEU 0.391 10.8 mt . . . . . 0 CA--C 1.476 -1.873 0 N-CA-C 115.305 1.595 . . . . 73.239999999999995 115.305 -175.054 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.587 ' CD1' ' HG ' ' A' ' 164' ' ' LEU . 2.6 mm? . . . . . 0 CA--C 1.502 -0.886 0 CA-C-O 121.081 0.467 . . . . 64.319999999999993 111.282 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 101.77 45.47 1.77 Allowed Glycine 0 N--CA 1.419 -2.448 0 CA-C-N 115.469 -0.787 . . . . 73.340000000000003 112.75 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -156.94 154.47 29.75 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.499 -0.926 . . . . 73.129999999999995 108.499 175.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -124.34 144.95 49.72 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 108.971 -0.751 . . . . 72.430000000000007 108.971 175.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.61 ' H ' HD13 ' A' ' 176' ' ' ILE . 0.2 OUTLIER -110.67 169.81 3.67 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.238 0 N-CA-C 108.935 -0.765 . . . . 71.319999999999993 108.935 177.727 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.578 ' HB3' ' HB2' ' A' ' 198' ' ' SER . 16.4 ptt180 -149.43 154.49 38.95 Favored 'General case' 0 C--N 1.269 -2.921 0 CA-C-N 115.189 -0.914 . . . . 65.310000000000002 109.83 -178.069 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -111.98 138.2 48.95 Favored 'General case' 0 C--N 1.28 -2.434 0 N-CA-C 108.786 -0.82 . . . . 64.209999999999994 108.786 178.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -150.64 -175.4 22.6 Favored Glycine 0 C--N 1.285 -2.269 0 N-CA-C 108.469 -1.853 . . . . 52.420000000000002 108.469 178.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . 0.603 ' CG2' ' HG2' ' A' ' 191' ' ' LYS . 0.2 OUTLIER -102.01 123.17 45.44 Favored 'General case' 0 N--CA 1.415 -2.181 0 C-N-CA 118.725 -1.19 . . . . 64.319999999999993 108.087 178.078 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . 0.466 ' O ' ' HA ' ' A' ' 191' ' ' LYS . 37.5 t . . . . . 0 C--N 1.28 -2.423 0 N-CA-C 108.439 -0.949 . . . . 61.100000000000001 108.439 -178.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.603 ' HG2' ' CG2' ' A' ' 180' ' ' THR . 34.2 ttmt . . . . . 0 N--CA 1.418 -2.071 0 N-CA-C 107.395 -1.335 . . . . 75.010000000000005 107.395 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . 0.416 HE21 ' HA2' ' A' ' 228' ' ' GLY . 17.1 pt20 -151.54 161.22 30.24 Favored Pre-proline 0 C--N 1.298 -1.661 0 CA-C-N 115.861 -0.608 . . . . 73.200000000000003 109.588 -171.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -58.77 132.68 49.25 Favored 'Trans proline' 0 C--O 1.244 0.825 0 C-N-CA 121.472 1.448 . . . . 71.540000000000006 110.991 177.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -147.1 144.63 12.81 Favored Glycine 0 N--CA 1.419 -2.473 0 N-CA-C 109.987 -1.245 . . . . 72.420000000000002 109.987 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.573 HG12 HG21 ' A' ' 234' ' ' VAL . 3.0 mp -105.61 134.08 48.14 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 CA-C-O 121.338 0.589 . . . . 65.019999999999996 110.683 -178.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -128.25 168.5 15.4 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.191 -1.04 . . . . 65.140000000000001 108.191 -176.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . 0.476 ' HB ' ' HA ' ' A' ' 214' ' ' VAL . 43.3 mm -76.75 131.88 33.99 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 N-CA-C 108.131 -1.062 . . . . 72.430000000000007 108.131 176.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . 0.578 ' HB2' ' HB3' ' A' ' 177' ' ' ARG . 13.0 t -103.96 -33.8 8.7 Favored 'General case' 0 C--N 1.284 -2.26 0 N-CA-C 113.181 0.808 . . . . 71.340000000000003 113.181 -178.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 15.0 ttp180 -168.17 142.77 3.49 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 116.621 -0.263 . . . . 73.319999999999993 111.025 -177.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 66.1 mt -103.71 137.06 42.28 Favored 'General case' 0 CA--C 1.486 -1.481 0 N-CA-C 108.162 -1.051 . . . . 71.430000000000007 108.162 172.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 66.6 t -93.44 114.5 63.07 Favored Pre-proline 0 C--N 1.288 -2.103 0 N-CA-C 105.733 -1.951 . . . . 71.239999999999995 105.733 174.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . 0.522 ' HA ' ' HG2' ' A' ' 207' ' ' GLU . 38.2 Cg_endo -70.37 126.23 12.69 Favored 'Trans proline' 0 N--CA 1.429 -2.308 0 C-N-CA 120.915 1.077 . . . . 72.439999999999998 110.201 -176.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 113.59 -12.98 23.02 Favored Glycine 0 C--N 1.302 -1.356 0 N-CA-C 109.787 -1.325 . . . . 64.420000000000002 109.787 -173.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -90.48 168.65 33.58 Favored Glycine 0 N--CA 1.436 -1.356 0 N-CA-C 110.15 -1.18 . . . . 73.030000000000001 110.15 176.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.542 HD12 ' H ' ' A' ' 164' ' ' LEU . 66.0 mt -65.39 -29.56 70.28 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 117.41 0.605 . . . . 63.409999999999997 111.498 -177.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -61.93 -48.1 81.93 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.878 -0.601 . . . . 52.229999999999997 110.768 178.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.522 ' HG2' ' HA ' ' A' ' 202' ' ' PRO . 10.4 tp10 -73.04 -32.6 65.18 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.445 -0.576 . . . . 73.450000000000003 109.445 178.097 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 23.0 t -56.98 -40.33 76.33 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 115.91 -0.586 . . . . 63.140000000000001 110.45 178.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . 0.533 HG23 ' H ' ' A' ' 211' ' ' LEU . 14.9 t -79.29 -40.27 30.86 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 119.089 -1.044 . . . . 74.209999999999994 108.752 175.163 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 58.58 31.3 66.78 Favored Glycine 0 C--N 1.347 1.189 0 CA-C-N 115.888 -0.596 . . . . 71.140000000000001 113.139 178.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.533 ' H ' HG23 ' A' ' 209' ' ' THR . 1.8 pp -102.21 -19.33 15.11 Favored 'General case' 0 N--CA 1.424 -1.732 0 C-N-CA 120.297 -0.561 . . . . 61.299999999999997 110.692 -179.232 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.495 HD23 ' H ' ' A' ' 212' ' ' LEU . 2.1 pt? -109.39 134.28 52.03 Favored 'General case' 0 N--CA 1.432 -1.362 0 N-CA-C 107.857 -1.164 . . . . 73.140000000000001 107.857 -179.442 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -129.8 165.92 20.98 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 116.474 -0.33 . . . . 61.509999999999998 110.566 -176.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . 0.476 ' HA ' ' HB ' ' A' ' 197' ' ' ILE . 17.4 m -53.92 -30.41 19.53 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 N-CA-C 114.195 1.183 . . . . 71.109999999999999 114.195 -176.012 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 -78.02 -15.36 59.0 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.823 -0.548 . . . . 75.319999999999993 112.24 -178.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.708 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 58.5 m-20 -79.34 155.92 28.24 Favored 'General case' 0 C--O 1.248 0.995 0 CA-C-O 121.079 0.466 . . . . 72.420000000000002 112.076 -174.08 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -109.58 139.43 44.6 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.333 -0.849 . . . . 61.109999999999999 111.872 -176.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.565 ' HA ' HG12 ' A' ' 249' ' ' VAL . 25.1 t -88.03 120.16 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 CA-C-O 121.349 0.595 . . . . 75.310000000000002 109.58 -179.103 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.683 HG13 ' NE2' ' A' ' 158' ' ' HIS . 38.8 mm -89.9 -53.97 8.36 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 CA-C-N 115.257 -0.883 . . . . 74.510000000000005 112.302 -176.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -155.27 151.98 28.7 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 116.742 -0.208 . . . . 62.350000000000001 111.534 -175.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.431 HG12 ' CG1' ' A' ' 226' ' ' VAL . 9.1 p -121.78 123.22 68.81 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 CA-C-O 121.293 0.568 . . . . 64.349999999999994 109.786 176.057 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . 0.48 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 9.0 t-20 66.69 7.58 5.28 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 125.487 1.515 . . . . 71.099999999999994 111.221 177.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 113.3 -7.17 24.88 Favored Glycine 0 N--CA 1.44 -1.036 0 CA-C-N 115.677 -0.692 . . . . 51.450000000000003 112.273 -177.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 66.3 mt -101.4 123.9 54.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 109.423 -0.584 . . . . 62.240000000000002 109.423 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -59.7 134.49 57.07 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-O 121.644 0.735 . . . . 75.540000000000006 111.932 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . 0.494 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 27.6 m -117.82 2.76 7.44 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 CA-C-N 115.158 -0.928 . . . . 74.439999999999998 110.047 177.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -83.57 98.77 9.76 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-N 115.332 -0.849 . . . . 70.219999999999999 109.38 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . 0.416 ' HA2' HE21 ' A' ' 192' ' ' GLN . . . 120.35 -16.15 9.9 Favored Glycine 0 CA--C 1.489 -1.543 0 N-CA-C 111.283 -0.727 . . . . 74.540000000000006 111.283 -178.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -77.54 172.64 13.05 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 109.45 -0.574 . . . . 62.32 109.45 178.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . 0.421 ' H ' ' NE2' ' A' ' 233' ' ' GLN . 36.7 p -92.78 165.11 13.09 Favored 'General case' 0 N--CA 1.422 -1.841 0 N-CA-C 108.143 -1.058 . . . . 71.230000000000004 108.143 178.046 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 51.9 tp -61.16 -37.44 82.89 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 120.895 -0.322 . . . . 74.010000000000005 110.772 -177.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -57.76 -51.37 69.82 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 109.989 -0.375 . . . . 72.420000000000002 109.989 176.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 233' ' ' GLN . . . . . 0.421 ' NE2' ' H ' ' A' ' 230' ' ' THR . 48.7 mt-30 -54.56 -48.55 71.93 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 115.676 -0.693 . . . . 72.400000000000006 112.508 179.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.573 HG21 HG12 ' A' ' 195' ' ' ILE . 7.1 m -75.27 -34.84 31.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 112.257 0.465 . . . . 64.019999999999996 112.257 -174.193 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 31.2 m -75.0 -35.6 61.99 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 108.905 -0.776 . . . . 63.310000000000002 108.905 -175.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -59.11 -33.49 70.91 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.119 -0.946 . . . . 71.239999999999995 109.415 176.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 237' ' ' MET . . . . . 0.409 ' HG3' ' HA ' ' A' ' 234' ' ' VAL . 5.8 mtt -73.56 -44.61 56.97 Favored 'General case' 0 C--O 1.2 -1.526 0 N-CA-C 107.91 -1.144 . . . . 65.329999999999998 107.91 178.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 238' ' ' MET . . . . . 0.474 ' HA ' HD21 ' A' ' 245' ' ' LEU . 64.9 mtt -59.98 -41.65 92.46 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.36 -0.382 . . . . 72.230000000000004 111.943 -177.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 92.6 t -65.04 -38.71 83.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.227 0.536 . . . . 70.239999999999995 110.105 176.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -76.02 -19.9 58.27 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.355 0.598 . . . . 71.319999999999993 111.482 -179.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 -107.89 22.18 16.33 Favored 'General case' 0 C--O 1.205 -1.252 0 CA-C-N 115.94 -0.573 . . . . 52.310000000000002 110.471 177.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 22.8 t -63.44 -22.79 67.09 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.649 0.738 . . . . 75.040000000000006 109.141 177.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 16.1 p -69.56 -32.14 70.75 Favored 'General case' 0 N--CA 1.428 -1.569 0 CA-C-N 115.651 -0.704 . . . . 71.310000000000002 111.373 174.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -165.9 99.48 0.66 Allowed 'General case' 0 C--O 1.24 0.579 0 CA-C-O 121.749 0.785 . . . . 60.530000000000001 110.82 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.597 ' HB2' ' HB2' ' A' ' 163' ' ' LEU . 10.3 mt -91.46 105.18 17.57 Favored 'General case' 0 C--O 1.195 -1.786 0 N-CA-C 113.085 0.772 . . . . 73.239999999999995 113.085 -178.264 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.783 HG12 ' HG3' ' A' ' 162' ' ' ARG . 96.6 mt -95.51 114.12 31.44 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.432 0 N-CA-C 106.692 -1.596 . . . . 62.140000000000001 106.692 168.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . 0.464 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 76.9 mt -122.35 127.14 75.04 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.125 0 C-N-CA 120.436 -0.506 . . . . 53.439999999999998 111.153 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.525 ' HA ' ' O ' ' A' ' 159' ' ' ARG . 63.3 m -99.53 118.18 35.55 Favored 'General case' 0 N--CA 1.418 -2.05 0 CA-C-N 114.832 -1.076 . . . . 72.409999999999997 108.688 177.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.565 HG12 ' HA ' ' A' ' 218' ' ' VAL . 27.3 m -119.29 161.93 18.0 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 N-CA-C 108.974 -0.75 . . . . 70.430000000000007 108.974 174.214 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 17.4 ptmt -127.75 130.86 23.6 Favored Pre-proline 0 C--N 1.276 -2.616 0 CA-C-N 115.309 -0.86 . . . . 74.319999999999993 108.893 176.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . 0.708 ' HA ' ' OD1' ' A' ' 216' ' ' ASP . 29.0 Cg_endo . . . . . 0 N--CA 1.445 -1.341 0 C-N-CA 122.676 2.251 . . . . 75.010000000000005 112.394 177.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.734 ' HB3' ' HB3' ' A' ' 250' ' ' LYS . 4.4 p-80 . . . . . 0 CA--C 1.516 -0.333 0 N-CA-C 112.49 0.552 . . . . 70.409999999999997 112.49 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 36.6 ttm180 -125.58 143.7 50.9 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.581 -0.282 . . . . 75.140000000000001 110.407 -179.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 35.1 ptt180 -104.05 117.22 33.75 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.611 0.719 . . . . 72.439999999999998 111.783 179.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 30.3 m -114.93 139.93 38.64 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 CA-C-N 115.497 -0.774 . . . . 73.230000000000004 111.894 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 21.1 ttm180 -102.53 121.4 42.3 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 109.168 -0.679 . . . . 74.510000000000005 109.168 179.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.428 ' HB2' ' HB3' ' A' ' 245' ' ' LEU . 26.8 mt -103.08 139.68 38.29 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 123.347 0.659 . . . . 75.129999999999995 111.657 -174.431 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.565 HD13 ' O ' ' A' ' 242' ' ' SER . 6.0 tt . . . . . 0 CA--C 1.512 -0.503 0 C-N-CA 125.913 1.685 . . . . 73.409999999999997 112.216 171.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 2.3 mm? . . . . . 0 N--CA 1.471 0.598 0 N-CA-C 112.459 0.54 . . . . 74.010000000000005 112.459 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 103.69 36.12 3.34 Favored Glycine 0 N--CA 1.424 -2.121 0 C-N-CA 120.174 -1.012 . . . . 63.409999999999997 112.533 178.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -147.48 153.84 40.04 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 108.661 -0.866 . . . . 74.430000000000007 108.661 174.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -123.77 155.41 37.97 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 108.183 -1.043 . . . . 75.030000000000001 108.183 177.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.446 HD13 ' SD ' ' A' ' 238' ' ' MET . 27.3 pt -125.18 169.5 16.48 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 CA-C-O 120.909 0.385 . . . . 74.25 111.329 -176.119 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.513 ' HG2' ' HB3' ' A' ' 198' ' ' SER . 1.1 ptp180 -148.91 154.15 39.02 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 123.332 0.653 . . . . 74.099999999999994 110.891 -179.157 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -103.38 138.84 39.58 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 109.065 -0.717 . . . . 62.039999999999999 109.065 176.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -154.38 -168.27 17.58 Favored Glycine 0 N--CA 1.416 -2.661 0 N-CA-C 109.197 -1.561 . . . . 73.310000000000002 109.197 177.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . 0.549 ' HB ' ' CG ' ' A' ' 191' ' ' LYS . 1.0 OUTLIER -101.16 125.48 47.79 Favored 'General case' 0 C--N 1.276 -2.618 0 CA-C-O 121.14 0.495 . . . . 73.120000000000005 111.698 176.415 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 36.9 t . . . . . 0 N--CA 1.41 -2.463 0 N-CA-C 107.255 -1.387 . . . . 53.119999999999997 107.255 176.394 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.549 ' CG ' ' HB ' ' A' ' 180' ' ' THR . 35.4 ttmt . . . . . 0 N--CA 1.425 -1.71 0 N-CA-C 107.972 -1.121 . . . . 71.340000000000003 107.972 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -130.75 164.15 43.74 Favored Pre-proline 0 C--N 1.284 -2.261 0 CA-C-N 115.473 -0.785 . . . . 72.430000000000007 109.336 -172.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -61.69 132.31 39.63 Favored 'Trans proline' 0 N--CA 1.447 -1.221 0 C-N-CA 121.108 1.205 . . . . 54.200000000000003 109.135 172.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -139.82 138.77 9.4 Favored Glycine 0 N--CA 1.415 -2.725 0 N-CA-C 110.085 -1.206 . . . . 40.240000000000002 110.085 -178.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.548 HG12 HG21 ' A' ' 234' ' ' VAL . 3.4 mp -103.8 128.26 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.127 0 CA-C-O 121.418 0.628 . . . . 72.299999999999997 110.929 -179.101 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -121.75 167.12 13.34 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 107.57 -1.27 . . . . 73.299999999999997 107.57 -177.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . 0.432 ' HB ' ' HA ' ' A' ' 214' ' ' VAL . 50.1 mm -77.58 130.32 36.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 107.515 -1.291 . . . . 71.340000000000003 107.515 175.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . 0.513 ' HB3' ' HG2' ' A' ' 177' ' ' ARG . 81.4 p -103.49 -22.37 13.64 Favored 'General case' 0 C--N 1.291 -1.95 0 C-N-CA 119.624 -0.831 . . . . 54.229999999999997 111.538 -175.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 27.6 tpt180 -167.12 146.28 5.19 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.398 -0.593 . . . . 74.319999999999993 109.398 -176.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 69.7 mt -112.51 139.67 47.9 Favored 'General case' 0 CA--C 1.484 -1.571 0 N-CA-C 108.541 -0.911 . . . . 75.230000000000004 108.541 172.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 53.2 t -95.8 114.92 65.05 Favored Pre-proline 0 C--N 1.288 -2.07 0 N-CA-C 105.811 -1.922 . . . . 72.349999999999994 105.811 171.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . 0.542 ' HA ' ' HG3' ' A' ' 207' ' ' GLU . 19.3 Cg_endo -62.3 126.81 19.38 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 121.938 1.758 . . . . 73.219999999999999 110.644 -177.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 103.38 -14.32 54.55 Favored Glycine 0 C--N 1.297 -1.587 0 C-N-CA 120.157 -1.021 . . . . 74.319999999999993 111.266 -175.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -81.93 162.24 42.6 Favored Glycine 0 N--CA 1.435 -1.422 0 N-CA-C 110.221 -1.152 . . . . 61.140000000000001 110.221 176.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.459 HD13 ' CA ' ' A' ' 164' ' ' LEU . 32.1 mt -53.9 -38.34 64.72 Favored 'General case' 0 C--N 1.309 -1.158 0 C-N-CA 124.737 1.215 . . . . 73.349999999999994 112.777 -175.095 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . 0.538 ' CB ' HD12 ' A' ' 212' ' ' LEU . . . -66.0 -43.73 86.86 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.538 0.685 . . . . 51.030000000000001 110.919 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.542 ' HG3' ' HA ' ' A' ' 202' ' ' PRO . 3.3 tm-20 -76.16 -35.93 58.96 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 115.255 -0.884 . . . . 64.109999999999999 109.619 -178.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 55.8 m -61.0 -41.46 96.57 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.474 -0.33 . . . . 53.329999999999998 111.572 178.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . 0.457 HG23 ' H ' ' A' ' 211' ' ' LEU . 9.2 t -73.27 -33.21 65.13 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 119.489 -0.884 . . . . 61.43 109.253 176.257 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 70.14 10.91 66.36 Favored Glycine 0 CA--C 1.5 -0.886 0 CA-C-N 115.75 -0.659 . . . . 33.020000000000003 112.842 176.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.457 ' H ' HG23 ' A' ' 209' ' ' THR . 52.0 mt -95.42 -5.97 41.93 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.989 -0.745 . . . . 74.0 108.989 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.538 HD12 ' CB ' ' A' ' 206' ' ' ALA . 95.6 mt -109.49 131.21 55.28 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 107.817 -1.179 . . . . 60.039999999999999 107.817 174.313 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -133.63 166.11 23.35 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.216 -1.031 . . . . 41.229999999999997 108.216 176.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . 0.432 ' HA ' ' HB ' ' A' ' 197' ' ' ILE . 34.6 m -62.86 -31.3 51.9 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 N-CA-C 113.466 0.913 . . . . 71.030000000000001 113.466 -178.585 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -72.37 -13.42 61.47 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.995 -0.441 . . . . 55.219999999999999 111.577 179.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.51 ' HB3' ' HB ' ' A' ' 249' ' ' VAL . 6.3 m-20 -73.78 131.09 41.19 Favored 'General case' 0 C--O 1.242 0.705 0 N-CA-C 113.516 0.932 . . . . 32.219999999999999 113.516 -176.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -103.72 132.26 50.13 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 113.827 -1.533 . . . . 61.32 109.676 -179.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.561 ' HA ' HG12 ' A' ' 249' ' ' VAL . 22.9 t -79.97 130.19 36.4 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 CA-C-O 121.433 0.635 . . . . 74.439999999999998 110.732 -176.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.452 HD11 ' HD3' ' A' ' 250' ' ' LYS . 38.8 mm -95.16 -50.3 11.85 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 C-N-CA 124.06 0.944 . . . . 65.219999999999999 110.122 178.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -154.41 154.22 32.88 Favored 'General case' 0 N--CA 1.433 -1.325 0 CA-C-N 115.446 -0.797 . . . . 72.109999999999999 110.695 -176.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.429 HG11 ' HB2' ' A' ' 237' ' ' MET . 7.5 p -124.18 121.2 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 N-CA-C 108.415 -0.958 . . . . 75.129999999999995 108.415 177.268 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . 0.563 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 24.6 t-20 75.55 -24.34 0.22 Allowed 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 126.406 1.882 . . . . 71.129999999999995 111.774 -176.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . 0.427 ' H ' ' C ' ' A' ' 221' ' ' VAL . . . 140.43 -11.33 2.99 Favored Glycine 0 C--N 1.278 -2.654 0 N-CA-C 109.932 -1.267 . . . . 51.520000000000003 109.932 -174.287 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 67.4 mt -92.1 123.85 44.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 108.936 -0.764 . . . . 71.219999999999999 108.936 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -57.62 143.43 41.35 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 123.992 0.917 . . . . 74.319999999999993 112.006 -179.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 34.7 m -117.57 1.0 8.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 CA-C-N 115.667 -0.697 . . . . 75.230000000000004 110.92 176.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -78.12 97.34 5.41 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.86 -0.609 . . . . 73.129999999999995 110.224 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 120.41 -14.57 10.06 Favored Glycine 0 C--N 1.316 -0.532 0 N-CA-C 110.826 -0.91 . . . . 70.140000000000001 110.826 -179.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -79.8 170.13 16.95 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 108.333 -0.988 . . . . 72.329999999999998 108.333 177.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . 0.517 ' O ' HG13 ' A' ' 234' ' ' VAL . 73.1 p -93.55 164.11 13.3 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 108.445 -0.946 . . . . 53.109999999999999 108.445 177.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . 0.445 ' HA ' HG22 ' A' ' 234' ' ' VAL . 0.7 OUTLIER -63.07 -36.15 82.62 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 107.017 -1.475 . . . . 61.020000000000003 107.017 179.105 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -61.85 -45.82 92.14 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.286 -0.87 . . . . 63.119999999999997 109.945 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -61.94 -50.39 72.34 Favored 'General case' 0 C--N 1.344 0.341 0 N-CA-C 112.385 0.513 . . . . 74.310000000000002 112.385 175.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.548 HG21 HG12 ' A' ' 195' ' ' ILE . 12.2 m -62.08 -33.89 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 N-CA-C 112.749 0.648 . . . . 63.549999999999997 112.749 -173.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . 0.484 ' O ' HG23 ' A' ' 239' ' ' VAL . 61.9 m -68.9 -39.05 79.93 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 109.394 -0.595 . . . . 55.130000000000003 109.394 -175.182 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -68.53 -30.43 69.22 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-N 115.614 -0.721 . . . . 72.439999999999998 109.793 -178.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 237' ' ' MET . . . . . 0.429 ' HB2' HG11 ' A' ' 221' ' ' VAL . 3.5 mtm -73.21 -36.47 66.49 Favored 'General case' 0 C--O 1.196 -1.728 0 N-CA-C 107.894 -1.15 . . . . 73.420000000000002 107.894 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 238' ' ' MET . . . . . 0.484 ' HG3' ' O ' ' A' ' 234' ' ' VAL . 65.5 mtt -63.11 -39.78 95.69 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 120.844 0.354 . . . . 74.0 110.133 177.268 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 235' ' ' THR . 79.0 t -66.34 -41.06 88.27 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 CA-C-N 116.096 -0.502 . . . . 54.219999999999999 109.682 176.363 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -66.01 -22.34 66.45 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.131 -0.486 . . . . 44.020000000000003 111.991 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 54.4 m-80 -105.12 21.93 16.24 Favored 'General case' 0 C--O 1.202 -1.426 0 CA-C-N 116.542 -0.299 . . . . 65.409999999999997 110.815 178.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 242' ' ' SER . . . . . 0.565 ' O ' HD13 ' A' ' 164' ' ' LEU . 46.5 t -56.36 -24.44 44.27 Favored 'General case' 0 C--O 1.213 -0.849 0 N-CA-C 113.68 0.992 . . . . 71.120000000000005 113.68 -179.088 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 29.1 m -78.59 -22.15 47.52 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 120.359 -0.537 . . . . 64.420000000000002 111.424 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -171.5 94.14 0.16 Allowed 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.726 1.211 . . . . 71.140000000000001 108.956 178.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.527 ' CD2' HG13 ' A' ' 247' ' ' ILE . 1.7 tt -90.77 109.24 20.44 Favored 'General case' 0 N--CA 1.419 -1.983 0 CA-C-N 114.618 -1.174 . . . . 61.530000000000001 110.071 -171.056 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.563 ' HB ' ' HA ' ' A' ' 222' ' ' ASN . 61.3 mt -95.76 117.13 39.2 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 N-CA-C 108.963 -0.755 . . . . 62.020000000000003 108.963 176.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . 0.527 HG13 ' CD2' ' A' ' 245' ' ' LEU . 9.3 mt -123.83 135.3 63.92 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.99 0 CA-C-O 121.819 0.818 . . . . 73.150000000000006 111.305 176.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 37.7 m -108.79 124.54 50.76 Favored 'General case' 0 N--CA 1.41 -2.441 0 CA-C-N 114.476 -1.238 . . . . 61.340000000000003 108.493 178.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.561 HG12 ' HA ' ' A' ' 218' ' ' VAL . 29.1 m -134.75 152.99 34.09 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-O 121.754 0.788 . . . . 74.430000000000007 112.18 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . 0.734 ' HB3' ' HB3' ' A' ' 158' ' ' HIS . 1.1 ptmm? -128.79 132.6 24.46 Favored Pre-proline 0 C--N 1.293 -1.872 0 CA-C-N 113.938 -1.483 . . . . 73.349999999999994 109.203 172.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo . . . . . 0 N--CA 1.447 -1.25 0 C-N-CA 122.549 2.166 . . . . 73.439999999999998 110.713 176.297 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.419 ' ND1' ' HB3' ' A' ' 250' ' ' LYS . 0.3 OUTLIER . . . . . 0 CA--C 1.507 -0.703 0 N-CA-C 109.888 -0.412 . . . . 75.040000000000006 109.888 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.47 ' O ' ' HA ' ' A' ' 248' ' ' THR . 2.2 tpm_? -128.95 138.53 52.03 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 108.096 -1.076 . . . . 72.349999999999994 108.096 177.047 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.401 ' HA ' ' O ' ' A' ' 247' ' ' ILE . 14.9 ptp180 -122.6 117.03 24.89 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-O 121.2 0.524 . . . . 71.230000000000004 110.222 178.483 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.507 HG21 HD11 ' A' ' 212' ' ' LEU . 27.7 m -122.66 140.49 46.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 CA-C-N 115.479 -0.782 . . . . 62.340000000000003 112.02 -175.108 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.521 ' HG2' HG12 ' A' ' 246' ' ' ILE . 67.0 mtm180 -92.95 111.29 22.86 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.824 -1.176 . . . . 64.230000000000004 107.824 177.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.513 ' HB2' ' HB3' ' A' ' 245' ' ' LEU . 31.8 mt -89.32 139.12 30.82 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 109.28 -0.637 . . . . 73.540000000000006 109.28 -178.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.431 HD13 ' O ' ' A' ' 242' ' ' SER . 6.1 tt . . . . . 0 C--N 1.312 -1.048 0 CA-C-O 123.037 1.399 . . . . 72.209999999999994 108.397 179.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.435 ' HG ' HD12 ' A' ' 245' ' ' LEU . 3.7 mm? . . . . . 0 CA--C 1.516 -0.364 0 N-CA-C 113.531 0.937 . . . . 74.25 113.531 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 91.77 36.42 6.44 Favored Glycine 0 N--CA 1.434 -1.48 0 C-N-CA 119.813 -1.184 . . . . 50.229999999999997 113.789 175.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . 0.436 ' HB3' ' CB ' ' A' ' 206' ' ' ALA . 18.9 p90 -156.61 153.33 28.43 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.755 -1.202 . . . . 63.340000000000003 107.755 173.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -128.7 150.29 50.32 Favored 'General case' 0 C--N 1.287 -2.129 0 N-CA-C 108.769 -0.826 . . . . 75.019999999999996 108.769 179.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.602 ' H ' HD13 ' A' ' 176' ' ' ILE . 0.2 OUTLIER -123.92 170.08 14.54 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.438 0 CA-C-O 121.372 0.606 . . . . 53.119999999999997 110.739 -176.222 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.557 ' HG2' ' HB2' ' A' ' 198' ' ' SER . 2.7 ptp180 -147.46 154.39 40.74 Favored 'General case' 0 C--N 1.275 -2.638 0 CA-C-N 115.141 -0.936 . . . . 74.349999999999994 110.226 -177.456 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -104.7 138.3 41.22 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 109.509 -0.552 . . . . 74.310000000000002 109.509 179.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -155.54 136.77 5.25 Favored Glycine 0 C--N 1.284 -2.339 0 N-CA-C 109.823 -1.311 . . . . 74.140000000000001 109.823 177.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . 0.474 ' CG2' ' HG2' ' A' ' 191' ' ' LYS . 0.2 OUTLIER -89.24 123.49 33.51 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 105.903 -1.888 . . . . 72.129999999999995 105.903 179.292 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 22.7 t . . . . . 0 C--N 1.269 -2.911 0 N-CA-C 109.112 -0.699 . . . . 73.120000000000005 109.112 -176.604 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.474 ' HG2' ' CG2' ' A' ' 180' ' ' THR . 34.2 ttmt . . . . . 0 N--CA 1.427 -1.606 0 N-CA-C 107.618 -1.252 . . . . 74.040000000000006 107.618 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . 0.421 ' HA ' ' HD3' ' A' ' 193' ' ' PRO . 43.2 tp60 -140.98 134.54 14.77 Favored Pre-proline 0 C--N 1.287 -2.144 0 CA-C-N 115.78 -0.645 . . . . 70.319999999999993 109.816 -168.276 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 192' ' ' GLN . 24.7 Cg_exo -64.73 130.77 27.19 Favored 'Trans proline' 0 N--CA 1.447 -1.209 0 C-N-CA 121.726 1.617 . . . . 71.129999999999995 111.885 179.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -133.82 141.4 12.73 Favored Glycine 0 N--CA 1.403 -3.539 0 N-CA-C 109.285 -1.526 . . . . 63.219999999999999 109.285 174.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.547 ' O ' HG12 ' A' ' 218' ' ' VAL . 3.8 mp -103.8 129.78 55.35 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.676 0 N-CA-C 108.351 -0.981 . . . . 72.099999999999994 108.351 175.129 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -123.59 161.15 25.56 Favored 'General case' 0 C--N 1.275 -2.644 0 N-CA-C 107.271 -1.381 . . . . 73.120000000000005 107.271 -174.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 57.6 mt -79.24 127.69 38.95 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.892 0 CA-C-O 121.588 0.709 . . . . 72.239999999999995 110.294 177.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . 0.557 ' HB2' ' HG2' ' A' ' 177' ' ' ARG . 24.4 t -101.56 -18.67 15.82 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 112.891 0.701 . . . . 63.439999999999998 112.891 -177.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 75.3 ttt180 -166.55 139.5 3.83 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.327 -0.549 . . . . 74.219999999999999 111.239 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 88.3 mt -103.72 146.61 28.35 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.575 -0.898 . . . . 63.539999999999999 108.575 172.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 62.1 t -112.09 114.77 50.98 Favored Pre-proline 0 C--N 1.283 -2.298 0 N-CA-C 105.886 -1.894 . . . . 73.200000000000003 105.886 171.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . 0.426 ' HA ' ' HG2' ' A' ' 207' ' ' GLU . 31.1 Cg_endo -64.45 130.67 27.38 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 121.866 1.71 . . . . 71.140000000000001 110.6 -177.314 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 103.23 -17.65 50.94 Favored Glycine 0 N--CA 1.439 -1.137 0 N-CA-C 110.137 -1.185 . . . . 73.040000000000006 110.137 -175.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -83.74 171.76 49.48 Favored Glycine 0 N--CA 1.43 -1.751 0 N-CA-C 110.298 -1.121 . . . . 44.109999999999999 110.298 177.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 172' ' ' LEU . 3.1 mm? -63.07 -33.24 75.02 Favored 'General case' 0 N--CA 1.432 -1.339 0 N-CA-C 113.272 0.842 . . . . 72.239999999999995 113.272 -174.047 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . 0.436 ' CB ' ' HB3' ' A' ' 174' ' ' PHE . . . -66.3 -48.13 71.35 Favored 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 120.847 -0.341 . . . . 75.329999999999998 111.22 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.426 ' HG2' ' HA ' ' A' ' 202' ' ' PRO . 8.2 tp10 -73.39 -33.1 64.84 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 109.34 -0.615 . . . . 64.230000000000004 109.34 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 30.8 t -56.4 -47.51 78.86 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-O 122.044 0.926 . . . . 73.219999999999999 109.038 176.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 84.1 m -70.09 -40.74 74.8 Favored 'General case' 0 N--CA 1.382 -3.86 0 CA-C-N 114.41 -1.268 . . . . 52.020000000000003 109.358 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 74.35 -7.28 18.56 Favored Glycine 0 CA--C 1.504 -0.621 0 CA-C-N 116.246 -0.434 . . . . 52.409999999999997 113.097 176.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.41 HD12 HG11 ' A' ' 161' ' ' VAL . 38.4 mt -87.46 -6.56 58.35 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 109.061 -0.718 . . . . 74.209999999999994 109.061 -178.28 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.507 HD11 HG21 ' A' ' 161' ' ' VAL . 9.4 mp -108.92 131.35 55.11 Favored 'General case' 0 N--CA 1.422 -1.834 0 CA-C-N 115.181 -0.918 . . . . 71.209999999999994 109.678 174.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -132.44 166.32 22.27 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 107.177 -1.416 . . . . 72.349999999999994 107.177 175.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 33.6 m -58.57 -30.32 41.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-O 121.828 0.823 . . . . 53.409999999999997 111.623 177.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -68.59 -15.04 63.4 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 115.367 -0.833 . . . . 54.130000000000003 112.271 -179.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.441 ' HB3' ' HB ' ' A' ' 249' ' ' VAL . 6.7 m-20 -75.07 141.49 43.82 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 113.623 0.971 . . . . 61.240000000000002 113.623 -176.46 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . 0.526 ' HB3' ' HG3' ' A' ' 250' ' ' LYS . 40.4 tt0 -113.45 128.11 56.34 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 125.455 1.502 . . . . 63.409999999999997 109.852 -176.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.547 HG12 ' O ' ' A' ' 195' ' ' ILE . 12.5 p -80.03 128.84 38.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 122.143 0.973 . . . . 54.219999999999999 111.808 -176.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 44.0 mm -99.14 -48.96 11.77 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 CA-C-N 114.398 -1.274 . . . . 73.140000000000001 110.121 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.474 ' HB3' ' HA ' ' A' ' 225' ' ' GLU . 10.8 pt-20 -157.94 160.16 37.28 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.842 -0.617 . . . . 54.539999999999999 110.198 -177.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' A' ' 246' ' ' ILE . 8.8 p -131.0 120.61 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 O-C-N 123.758 0.661 . . . . 74.319999999999993 109.656 179.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . 0.429 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 10.7 m120 61.39 24.97 15.0 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.02 0.928 . . . . 74.420000000000002 112.946 176.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 97.23 -3.21 61.68 Favored Glycine 0 C--N 1.309 -0.953 0 CA-C-N 115.274 -0.876 . . . . 73.010000000000005 112.66 179.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 63.3 mt -111.22 123.51 67.16 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 N-CA-C 109.312 -0.625 . . . . 63.229999999999997 109.312 179.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . 0.474 ' HA ' ' HB3' ' A' ' 220' ' ' GLU . 12.5 pt-20 -62.73 153.71 31.81 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 121.551 0.691 . . . . 75.420000000000002 112.424 -178.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . 0.429 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 29.3 m -123.53 -3.51 6.99 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 CA-C-N 115.19 -0.914 . . . . 61.340000000000003 110.904 177.135 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -68.66 97.28 0.79 Allowed 'General case' 0 N--CA 1.443 -0.802 0 CA-C-O 121.416 0.627 . . . . 72.439999999999998 111.184 -177.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 127.78 -26.17 4.87 Favored Glycine 0 CA--C 1.49 -1.484 0 CA-C-N 115.488 -0.778 . . . . 74.349999999999994 111.571 177.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -73.65 170.98 14.1 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.231 0.539 . . . . 70.0 111.446 -178.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 47.6 p -88.53 163.89 15.68 Favored 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 108.674 -0.862 . . . . 45.350000000000001 108.674 -179.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . 0.474 ' HA ' HG22 ' A' ' 234' ' ' VAL . 0.8 OUTLIER -63.58 -36.97 85.56 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 107.712 -1.218 . . . . 35.240000000000002 107.712 -177.351 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -61.32 -40.9 95.92 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.561 -0.745 . . . . 75.439999999999998 110.824 177.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -66.02 -48.67 70.37 Favored 'General case' 0 C--O 1.218 -0.56 0 CA-C-N 116.307 -0.406 . . . . 70.319999999999993 111.691 177.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.474 HG22 ' HA ' ' A' ' 231' ' ' LEU . 13.7 m -66.8 -34.19 68.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 112.413 0.523 . . . . 63.130000000000003 112.413 -175.162 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . 0.429 ' O ' HG23 ' A' ' 239' ' ' VAL . 32.9 m -72.01 -36.15 69.62 Favored 'General case' 0 CA--C 1.5 -0.976 0 N-CA-C 109.018 -0.734 . . . . 75.319999999999993 109.018 -177.062 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -60.46 -33.65 72.87 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 115.861 -0.609 . . . . 54.039999999999999 109.932 178.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -72.08 -43.6 64.58 Favored 'General case' 0 C--O 1.206 -1.219 0 N-CA-C 108.052 -1.092 . . . . 73.420000000000002 108.052 -179.25 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 238' ' ' MET . . . . . 0.419 ' HG3' ' O ' ' A' ' 234' ' ' VAL . 64.4 mtt -62.83 -40.18 96.62 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.615 -0.72 . . . . 73.519999999999996 111.431 179.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 235' ' ' THR . 97.6 t -66.92 -42.11 88.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.841 0.353 . . . . 73.230000000000004 110.463 178.256 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -65.42 -39.5 92.22 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.654 0.74 . . . . 34.149999999999999 110.078 178.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -83.57 20.98 1.28 Allowed 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 114.731 -1.122 . . . . 71.409999999999997 111.957 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 242' ' ' SER . . . . . 0.431 ' O ' HD13 ' A' ' 164' ' ' LEU . 22.9 t -62.35 -23.04 66.56 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 111.742 0.275 . . . . 61.32 111.742 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 16.5 m -63.33 -29.94 71.16 Favored 'General case' 0 CA--C 1.554 1.121 0 CA-C-O 120.893 0.377 . . . . 61.119999999999997 110.425 178.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 244' ' ' ASN . . . . . 0.422 HD21 ' HB3' ' A' ' 162' ' ' ARG . 3.3 t-20 -175.19 95.96 0.07 Allowed 'General case' 0 C--O 1.245 0.867 0 N-CA-C 106.856 -1.535 . . . . 75.409999999999997 106.856 179.2 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.513 ' HB3' ' HB2' ' A' ' 163' ' ' LEU . 2.2 tt -85.97 108.0 18.01 Favored 'General case' 0 C--O 1.201 -1.453 0 CA-C-N 115.448 -0.796 . . . . 62.350000000000001 109.212 -171.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.521 HG12 ' HG2' ' A' ' 162' ' ' ARG . 77.7 mt -101.12 116.76 45.29 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.105 0 O-C-N 121.777 -0.577 . . . . 73.230000000000004 109.736 -178.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . 0.515 HG23 HG23 ' A' ' 218' ' ' VAL . 15.8 mt -121.87 136.66 58.03 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.152 0 N-CA-C 113.172 0.804 . . . . 75.439999999999998 113.172 179.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.47 ' HA ' ' O ' ' A' ' 159' ' ' ARG . 63.3 m -103.56 114.83 29.39 Favored 'General case' 0 N--CA 1.413 -2.316 0 N-CA-C 107.633 -1.247 . . . . 63.109999999999999 107.633 172.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.539 HG12 ' HA ' ' A' ' 218' ' ' VAL . 10.2 m -121.51 168.55 13.84 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.399 0 CA-C-O 121.809 0.814 . . . . 72.319999999999993 110.054 175.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . 0.526 ' HG3' ' HB3' ' A' ' 217' ' ' GLU . 8.1 ptmt -136.62 139.16 28.46 Favored Pre-proline 0 C--N 1.257 -3.448 0 CA-C-N 113.647 -1.615 . . . . 72.310000000000002 107.665 175.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo . . . . . 0 N--CA 1.443 -1.482 0 C-N-CA 121.202 1.268 . . . . 55.229999999999997 108.962 173.85 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.657 ' NE2' HG13 ' A' ' 219' ' ' ILE . 13.7 m80 . . . . . 0 CA--C 1.496 -1.106 0 CA-C-O 120.774 0.321 . . . . 73.420000000000002 111.191 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.471 ' O ' ' HA ' ' A' ' 248' ' ' THR . 8.3 ttm180 -131.64 141.82 49.71 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 107.681 -1.229 . . . . 63.219999999999999 107.681 179.34 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -128.75 112.55 14.31 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-O 121.175 0.512 . . . . 74.239999999999995 109.676 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 16.5 m -118.15 139.57 44.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-N 115.025 -0.989 . . . . 71.420000000000002 112.044 -177.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 17.4 ttm180 -100.29 112.48 24.81 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.107 -1.072 . . . . 70.109999999999999 108.107 177.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.478 ' HB2' ' HB3' ' A' ' 245' ' ' LEU . 20.8 mt -99.86 137.07 38.83 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 108.184 -1.043 . . . . 71.349999999999994 108.184 -176.071 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.42 ' O ' ' HA ' ' A' ' 244' ' ' ASN . 3.4 tt . . . . . 0 C--O 1.207 -1.141 0 N-CA-C 107.1 -1.444 . . . . 75.109999999999999 107.1 177.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.439 ' HA ' HD23 ' A' ' 205' ' ' LEU . 3.5 mm? . . . . . 0 CA--C 1.506 -0.744 0 N-CA-C 112.254 0.465 . . . . 73.140000000000001 112.254 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . 0.498 ' HA3' ' HA3' ' A' ' 204' ' ' GLY . . . 84.49 36.01 13.04 Favored Glycine 0 N--CA 1.427 -1.929 0 C-N-CA 120.389 -0.91 . . . . 54.32 112.948 177.204 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -150.0 154.24 37.87 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.338 -0.986 . . . . 72.120000000000005 108.338 174.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -121.32 143.65 49.07 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 108.966 -0.753 . . . . 73.340000000000003 108.966 175.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.621 ' H ' HD13 ' A' ' 176' ' ' ILE . 0.2 OUTLIER -114.38 166.23 8.47 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.467 0 CA-C-N 115.812 -0.631 . . . . 64.5 109.484 178.992 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.578 ' HG2' ' HB2' ' A' ' 198' ' ' SER . 4.8 ptp180 -146.87 154.32 41.18 Favored 'General case' 0 C--N 1.277 -2.582 0 CA-C-N 115.072 -0.967 . . . . 62.439999999999998 110.589 -178.264 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -111.86 138.45 48.44 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 124.15 0.906 . . . . 75.439999999999998 111.145 -179.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -157.34 -164.35 13.62 Favored Glycine 0 C--N 1.29 -2.016 0 N-CA-C 108.424 -1.87 . . . . 73.0 108.424 175.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . 0.476 ' CG2' ' HG2' ' A' ' 191' ' ' LYS . 0.4 OUTLIER -105.69 123.55 48.11 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-N 118.017 0.909 . . . . 73.239999999999995 111.827 175.546 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 41.0 t . . . . . 0 N--CA 1.414 -2.257 0 N-CA-C 107.326 -1.361 . . . . 54.039999999999999 107.326 176.303 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.476 ' HG2' ' CG2' ' A' ' 180' ' ' THR . 36.5 ttmt . . . . . 0 N--CA 1.426 -1.66 0 N-CA-C 108.155 -1.054 . . . . 73.040000000000006 108.155 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -136.53 165.56 34.35 Favored Pre-proline 0 C--N 1.279 -2.462 0 N-CA-C 108.228 -1.027 . . . . 62.310000000000002 108.228 -174.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' PRO . . . . . 0.437 ' HD2' ' HA2' ' A' ' 228' ' ' GLY . 53.8 Cg_exo -55.26 132.11 50.3 Favored 'Trans proline' 0 N--CA 1.445 -1.373 0 C-N-CA 121.126 1.218 . . . . 72.530000000000001 109.287 170.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -131.86 127.26 4.93 Favored Glycine 0 N--CA 1.403 -3.529 0 N-CA-C 109.278 -1.529 . . . . 64.540000000000006 109.278 -179.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.566 HG12 HG21 ' A' ' 234' ' ' VAL . 3.6 mp -104.37 132.06 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.814 0 CA-C-O 121.365 0.603 . . . . 73.120000000000005 109.51 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -127.61 167.4 16.43 Favored 'General case' 0 C--N 1.277 -2.553 0 N-CA-C 107.365 -1.346 . . . . 71.340000000000003 107.365 -175.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . 0.495 ' HB ' ' HA ' ' A' ' 214' ' ' VAL . 45.1 mm -79.17 130.1 36.62 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 N-CA-C 107.877 -1.157 . . . . 62.439999999999998 107.877 173.11 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . 0.578 ' HB2' ' HG2' ' A' ' 177' ' ' ARG . 28.0 t -100.45 -34.07 10.09 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 111.946 0.35 . . . . 51.130000000000003 111.946 -178.44 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 15.4 ttp180 -160.64 141.23 11.58 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-O 120.748 0.309 . . . . 73.109999999999999 110.358 -178.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 1.1 tt -108.03 135.49 49.3 Favored 'General case' 0 N--CA 1.426 -1.67 0 N-CA-C 107.172 -1.418 . . . . 65.010000000000005 107.172 -177.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 59.7 t -106.0 121.3 46.13 Favored Pre-proline 0 C--N 1.311 -1.104 0 N-CA-C 110.129 -0.323 . . . . 75.510000000000005 110.129 179.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . 0.505 ' HA ' ' HG3' ' A' ' 207' ' ' GLU . 27.5 Cg_endo -62.6 135.54 53.47 Favored 'Trans proline' 0 C--O 1.247 0.956 0 C-N-CA 122.638 2.226 . . . . 73.200000000000003 111.466 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 96.95 -24.45 31.14 Favored Glycine 0 N--CA 1.439 -1.136 0 N-CA-C 111.641 -0.584 . . . . 73.409999999999997 111.641 -177.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . 0.498 ' HA3' ' HA3' ' A' ' 173' ' ' GLY . . . -72.71 173.97 46.49 Favored Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 121.306 -0.474 . . . . 73.329999999999998 112.042 -179.339 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.439 HD23 ' HA ' ' A' ' 172' ' ' LEU . 3.6 mm? -63.11 -33.96 76.59 Favored 'General case' 0 N--CA 1.438 -1.069 0 C-N-CA 123.059 0.544 . . . . 71.230000000000004 111.75 -176.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -65.03 -43.26 92.98 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.067 0.46 . . . . 64.439999999999998 110.924 179.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.505 ' HG3' ' HA ' ' A' ' 202' ' ' PRO . 3.6 tm-20 -75.75 -40.1 56.02 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.033 -0.531 . . . . 61.439999999999998 109.998 178.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 33.3 t -57.97 -36.95 73.32 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.193 0.597 . . . . 63.130000000000003 110.959 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . 0.544 HG23 ' H ' ' A' ' 211' ' ' LEU . 11.7 t -81.38 -37.22 28.54 Favored 'General case' 0 N--CA 1.435 -1.188 0 C-N-CA 119.557 -0.857 . . . . 73.120000000000005 109.644 175.522 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 71.35 26.06 74.18 Favored Glycine 0 C--N 1.341 0.813 0 N-CA-C 112.14 -0.384 . . . . 52.329999999999998 112.14 178.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.544 ' H ' HG23 ' A' ' 209' ' ' THR . 43.0 mt -116.09 -4.24 12.0 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.577 0.703 . . . . 75.239999999999995 110.075 -177.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 60.1 mt -109.25 134.44 51.76 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 114.91 -1.041 . . . . 63.310000000000002 110.891 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -131.3 161.69 31.75 Favored 'General case' 0 N--CA 1.42 -1.967 0 N-CA-C 108.656 -0.868 . . . . 74.409999999999997 108.656 177.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . 0.495 ' HA ' ' HB ' ' A' ' 197' ' ' ILE . 33.8 m -62.2 -30.59 49.17 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 CA-C-O 121.377 0.608 . . . . 63.32 112.579 179.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -71.55 -14.26 62.04 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 116.123 -0.49 . . . . 75.439999999999998 112.143 -178.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.49 ' HB3' ' HB ' ' A' ' 249' ' ' VAL . 61.9 m-20 -74.19 139.15 44.24 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 112.754 0.65 . . . . 70.239999999999995 112.754 -176.183 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -110.01 137.52 47.67 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 124.975 1.31 . . . . 62.520000000000003 108.696 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.52 HG12 ' O ' ' A' ' 195' ' ' ILE . 12.1 p -83.82 138.41 19.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 122.103 0.954 . . . . 64.140000000000001 112.625 -175.545 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.657 HG13 ' NE2' ' A' ' 158' ' ' HIS . 44.1 mm -105.62 -44.75 8.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 114.731 -1.122 . . . . 75.019999999999996 111.058 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -161.12 154.98 22.31 Favored 'General case' 0 C--O 1.245 0.837 0 CA-C-N 116.511 -0.313 . . . . 65.420000000000002 110.75 -178.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.414 HG11 ' HB2' ' A' ' 237' ' ' MET . 8.3 p -126.45 121.41 58.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 C-N-CA 123.786 0.834 . . . . 61.439999999999998 109.006 178.089 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . 0.473 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 18.7 t-20 65.09 15.52 10.04 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.322 1.049 . . . . 73.230000000000004 110.456 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 99.35 -8.12 60.32 Favored Glycine 0 N--CA 1.437 -1.261 0 C-N-CA 120.347 -0.93 . . . . 42.329999999999998 111.523 -177.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 64.0 mt -91.08 123.06 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.162 0 N-CA-C 108.787 -0.819 . . . . 73.120000000000005 108.787 179.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . 0.443 ' HG3' ' HE3' ' A' ' 229' ' ' LYS . 11.6 pt-20 -55.45 131.19 45.34 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 124.24 0.962 . . . . 62.310000000000002 111.063 179.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 35.8 m -109.88 10.13 8.85 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 CA-C-O 121.876 0.846 . . . . 73.319999999999993 109.288 174.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -73.26 98.08 2.58 Favored 'General case' 0 N--CA 1.424 -1.737 0 CA-C-N 114.422 -1.263 . . . . 64.349999999999994 110.799 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . 0.437 ' HA2' ' HD2' ' A' ' 193' ' ' PRO . . . 101.23 5.29 52.86 Favored Glycine 0 N--CA 1.44 -1.092 0 C-N-CA 120.894 -0.67 . . . . 34.439999999999998 112.46 176.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . 0.443 ' HE3' ' HG3' ' A' ' 225' ' ' GLU . 68.3 mmtt -90.31 156.66 18.11 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 107.524 -1.287 . . . . 74.430000000000007 107.524 -178.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . 0.633 ' OG1' ' HG2' ' A' ' 233' ' ' GLN . 81.5 p -79.97 166.52 21.51 Favored 'General case' 0 C--O 1.248 0.998 0 C-N-CA 118.905 -1.118 . . . . 72.209999999999994 110.067 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . 0.436 ' HA ' HG22 ' A' ' 234' ' ' VAL . 3.3 tm? -61.02 -39.76 90.99 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 108.946 -0.761 . . . . 75.049999999999997 108.946 179.065 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -63.86 -31.01 72.05 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.078 -0.51 . . . . 73.109999999999999 110.626 177.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 233' ' ' GLN . . . . . 0.633 ' HG2' ' OG1' ' A' ' 230' ' ' THR . 13.3 mm-40 -74.14 -51.37 15.82 Favored 'General case' 0 C--O 1.216 -0.683 0 C-N-CA 119.478 -0.889 . . . . 65.209999999999994 110.211 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.566 HG21 HG12 ' A' ' 195' ' ' ILE . 21.2 m -65.99 -34.22 68.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 113.041 0.756 . . . . 71.319999999999993 113.041 -173.279 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 42.6 m -74.42 -35.49 63.4 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 109.056 -0.72 . . . . 74.319999999999993 109.056 -173.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -63.15 -34.25 77.21 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-N 115.376 -0.829 . . . . 73.5 108.835 177.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 237' ' ' MET . . . . . 0.493 ' HG3' ' O ' ' A' ' 233' ' ' GLN . 10.3 mtm -72.88 -42.01 64.1 Favored 'General case' 0 C--O 1.201 -1.478 0 CA-C-N 115.117 -0.947 . . . . 74.019999999999996 108.546 -179.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 238' ' ' MET . . . . . 0.483 ' HG3' ' O ' ' A' ' 234' ' ' VAL . 65.4 mtt -61.6 -40.16 93.8 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.486 -0.325 . . . . 74.519999999999996 111.568 178.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 96.0 t -68.76 -43.12 83.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.198 0.523 . . . . 75.120000000000005 111.004 178.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -68.68 -34.31 75.46 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.424 0.631 . . . . 62.32 110.555 179.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -88.81 15.44 8.35 Favored 'General case' 0 C--O 1.19 -2.053 0 CA-C-N 115.425 -0.807 . . . . 71.409999999999997 111.923 178.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 242' ' ' SER . . . . . 0.4 ' O ' HD13 ' A' ' 164' ' ' LEU . 69.9 m -66.74 -23.26 66.07 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 114.363 1.246 . . . . 51.130000000000003 114.363 -178.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 20.5 m -63.94 -29.63 70.79 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 118.131 0.423 . . . . 74.439999999999998 110.735 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 244' ' ' ASN . . . . . 0.42 ' HA ' ' O ' ' A' ' 164' ' ' LEU . 42.6 m-80 -156.0 89.68 1.16 Allowed 'General case' 0 C--O 1.248 1.015 0 N-CA-C 106.381 -1.711 . . . . 71.209999999999994 106.381 173.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.478 ' HB3' ' HB2' ' A' ' 163' ' ' LEU . 1.6 tt -85.28 103.55 14.33 Favored 'General case' 0 C--O 1.205 -1.274 0 CA-C-O 121.269 0.557 . . . . 74.209999999999994 109.846 -172.063 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.473 ' HB ' ' HA ' ' A' ' 222' ' ' ASN . 75.5 mt -96.48 116.19 37.83 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.348 0 N-CA-C 109.373 -0.603 . . . . 73.030000000000001 109.373 179.053 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . 0.51 HG23 HG23 ' A' ' 218' ' ' VAL . 9.8 mt -125.84 137.81 56.53 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 CA-C-O 121.551 0.691 . . . . 71.140000000000001 112.446 177.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.471 ' HA ' ' O ' ' A' ' 159' ' ' ARG . 49.9 m -107.43 121.87 45.47 Favored 'General case' 0 N--CA 1.423 -1.815 0 CA-C-N 114.717 -1.129 . . . . 73.109999999999999 107.985 174.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.503 HG12 ' HA ' ' A' ' 218' ' ' VAL . 15.4 m -125.74 166.44 21.73 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 CA-C-O 121.126 0.489 . . . . 71.310000000000002 110.552 176.627 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 16.8 ptmt -138.64 134.01 17.07 Favored Pre-proline 0 C--N 1.285 -2.209 0 CA-C-N 114.471 -1.24 . . . . 74.439999999999998 107.763 174.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . 0.411 ' HA ' ' HA ' ' A' ' 216' ' ' ASP . 23.8 Cg_exo . . . . . 0 N--CA 1.449 -1.112 0 C-N-CA 121.619 1.546 . . . . 74.209999999999994 111.166 178.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 1.9 m80 . . . . . 0 N--CA 1.428 -1.538 0 N-CA-C 109.738 -0.467 . . . . 62.100000000000001 109.738 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.447 ' CZ ' HG22 ' A' ' 161' ' ' VAL . 0.0 OUTLIER -127.63 142.0 51.47 Favored 'General case' 0 C--N 1.283 -2.288 0 N-CA-C 104.971 -2.233 . . . . 72.030000000000001 104.971 173.726 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -132.42 110.82 10.8 Favored 'General case' 0 C--N 1.285 -2.223 0 C-N-CA 117.718 -1.593 . . . . 75.209999999999994 111.065 -179.356 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.548 HG11 HD12 ' A' ' 211' ' ' LEU . 30.3 m -113.56 140.31 34.51 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 CA-C-N 114.724 -1.125 . . . . 43.240000000000002 111.787 175.251 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 26.0 ttm180 -84.86 114.65 22.26 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 115.617 -0.72 . . . . 75.540000000000006 109.121 178.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.544 ' HB2' ' HB2' ' A' ' 245' ' ' LEU . 13.8 mt -87.47 127.27 35.23 Favored 'General case' 0 N--CA 1.421 -1.916 0 N-CA-C 107.078 -1.453 . . . . 73.310000000000002 107.078 -179.408 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.58 HD13 ' O ' ' A' ' 242' ' ' SER . 5.5 tt . . . . . 0 C--N 1.3 -1.563 0 CA-C-O 122.378 1.085 . . . . 75.409999999999997 110.416 178.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 3.7 mm? . . . . . 0 CA--C 1.509 -0.598 0 CA-C-O 120.791 0.329 . . . . 72.439999999999998 110.166 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . 0.505 ' HA3' ' HA3' ' A' ' 204' ' ' GLY . . . 90.24 51.44 2.76 Favored Glycine 0 N--CA 1.434 -1.45 0 CA-C-N 115.679 -0.691 . . . . 51.340000000000003 114.806 174.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -162.58 154.61 18.62 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 108.521 -0.918 . . . . 64.099999999999994 108.521 175.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -121.2 140.83 51.5 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 108.244 -1.021 . . . . 75.010000000000005 108.244 176.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.513 HD13 ' SD ' ' A' ' 238' ' ' MET . 28.6 pt -112.32 165.25 7.4 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.845 0 CA-C-O 121.04 0.448 . . . . 71.549999999999997 111.339 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.511 ' CG ' ' HB2' ' A' ' 198' ' ' SER . 27.3 ptt180 -149.69 154.98 39.43 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 115.566 -0.743 . . . . 73.5 110.703 -175.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . 0.47 ' HB2' ' HB2' ' A' ' 231' ' ' LEU . 9.2 t70 -100.95 138.54 37.86 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 115.706 -0.679 . . . . 64.010000000000005 109.946 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -149.11 135.41 5.37 Favored Glycine 0 C--N 1.277 -2.743 0 N-CA-C 107.622 -2.191 . . . . 50.229999999999997 107.622 175.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . 0.485 HG22 ' HG2' ' A' ' 191' ' ' LYS . 0.4 OUTLIER -86.53 122.63 30.73 Favored 'General case' 0 C--N 1.282 -2.361 0 C-N-CA 118.54 -1.264 . . . . 63.409999999999997 107.799 -175.962 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 10.9 t . . . . . 0 C--N 1.287 -2.146 0 C-N-CA 123.821 0.848 . . . . 63.109999999999999 109.01 -174.742 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.485 ' HG2' HG22 ' A' ' 180' ' ' THR . 32.5 ttmt . . . . . 0 N--CA 1.418 -2.029 0 N-CA-C 107.795 -1.187 . . . . 65.230000000000004 107.795 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.47 145.49 19.3 Favored Pre-proline 0 C--N 1.313 -1.005 0 CA-C-N 116.125 -0.489 . . . . 74.230000000000004 109.78 -171.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -56.82 130.84 42.02 Favored 'Trans proline' 0 C--O 1.242 0.708 0 C-N-CA 121.879 1.719 . . . . 43.340000000000003 113.784 -176.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -137.85 137.38 8.82 Favored Glycine 0 N--CA 1.414 -2.812 0 N-CA-C 109.03 -1.628 . . . . 73.010000000000005 109.03 177.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.634 HG12 HG21 ' A' ' 234' ' ' VAL . 3.1 mp -104.1 136.59 36.6 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.894 0 CA-C-O 121.355 0.598 . . . . 63.140000000000001 110.01 -179.211 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -126.76 165.94 18.34 Favored 'General case' 0 C--N 1.284 -2.25 0 N-CA-C 108.017 -1.105 . . . . 74.540000000000006 108.017 -177.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . 0.44 ' HB ' ' O ' ' A' ' 213' ' ' ALA . 49.1 mm -78.67 131.52 34.26 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 N-CA-C 108.464 -0.939 . . . . 70.420000000000002 108.464 174.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . 0.511 ' HB2' ' CG ' ' A' ' 177' ' ' ARG . 11.2 t -101.92 -28.71 12.24 Favored 'General case' 0 C--N 1.284 -2.246 0 O-C-N 121.889 -0.507 . . . . 61.549999999999997 112.017 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 60.7 ttt180 -167.84 147.43 4.9 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 116.697 -0.229 . . . . 73.540000000000006 110.773 -176.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 85.7 mt -103.65 146.28 28.81 Favored 'General case' 0 CA--C 1.496 -1.134 0 N-CA-C 108.727 -0.842 . . . . 74.540000000000006 108.727 171.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 46.2 t -105.58 115.48 61.68 Favored Pre-proline 0 C--N 1.288 -2.07 0 N-CA-C 105.932 -1.877 . . . . 74.109999999999999 105.932 171.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . 0.466 ' HA ' ' HG3' ' A' ' 207' ' ' GLU . 16.7 Cg_endo -58.56 132.4 48.11 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 122.042 1.828 . . . . 70.040000000000006 111.218 -177.239 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 102.1 -18.98 50.7 Favored Glycine 0 N--CA 1.438 -1.196 0 N-CA-C 110.713 -0.955 . . . . 63.43 110.713 -175.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . 0.505 ' HA3' ' HA3' ' A' ' 173' ' ' GLY . . . -78.5 164.79 51.07 Favored Glycine 0 N--CA 1.434 -1.484 0 N-CA-C 111.018 -0.833 . . . . 45.009999999999998 111.018 178.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.4 HD22 ' H ' ' A' ' 205' ' ' LEU . 2.9 mm? -61.24 -35.67 77.89 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 123.284 0.634 . . . . 75.510000000000005 111.434 -175.485 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . 0.42 ' CB ' HD12 ' A' ' 212' ' ' LEU . . . -60.7 -47.41 86.41 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.629 -0.714 . . . . 65.120000000000005 110.732 179.647 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.466 ' HG3' ' HA ' ' A' ' 202' ' ' PRO . 3.2 tm-20 -75.46 -34.55 60.94 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.209 -0.905 . . . . 71.120000000000005 110.156 -179.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 48.7 m -56.96 -42.67 80.54 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 122.919 0.488 . . . . 72.200000000000003 111.837 179.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . 0.588 HG23 ' H ' ' A' ' 211' ' ' LEU . 14.9 t -87.1 -24.41 24.56 Favored 'General case' 0 N--CA 1.439 -1.0 0 C-N-CA 119.483 -0.887 . . . . 72.349999999999994 110.805 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 70.05 15.1 71.65 Favored Glycine 0 C--N 1.339 0.74 0 CA-C-O 121.498 0.499 . . . . 54.140000000000001 112.555 178.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.588 ' H ' HG23 ' A' ' 209' ' ' THR . 64.5 mt -102.03 13.14 35.57 Favored 'General case' 0 CA--C 1.495 -1.152 0 CA-C-O 121.592 0.71 . . . . 75.439999999999998 110.395 -177.299 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.42 HD12 ' CB ' ' A' ' 206' ' ' ALA . 30.2 mt -122.02 130.57 53.41 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 114.465 -1.243 . . . . 55.039999999999999 110.429 171.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . 0.44 ' O ' ' HB ' ' A' ' 197' ' ' ILE . . . -132.51 160.35 36.75 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 124.447 1.099 . . . . 51.149999999999999 108.344 176.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 17.5 m -61.38 -29.74 46.58 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 CA-C-O 121.653 0.74 . . . . 73.450000000000003 112.226 -179.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -75.53 -14.32 60.4 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 113.069 0.766 . . . . 70.340000000000003 113.069 -179.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.402 ' HB3' ' HB ' ' A' ' 249' ' ' VAL . 63.3 m-20 -71.08 131.65 43.93 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 112.334 0.494 . . . . 71.510000000000005 112.334 -177.507 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -101.94 129.18 48.15 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.108 -0.951 . . . . 71.409999999999997 108.672 178.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.591 ' HA ' HG12 ' A' ' 249' ' ' VAL . 10.2 p -79.44 137.2 22.16 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-O 121.597 0.713 . . . . 75.439999999999998 111.523 -176.029 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.419 HD11 ' HD2' ' A' ' 250' ' ' LYS . 45.6 mm -104.78 -48.34 9.54 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 CA-C-N 115.178 -0.919 . . . . 75.439999999999998 111.16 -178.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.403 ' HA ' HG22 ' A' ' 226' ' ' VAL . 10.1 pt-20 -153.23 151.99 30.69 Favored 'General case' 0 C--O 1.245 0.827 0 CA-C-N 116.675 -0.239 . . . . 64.310000000000002 111.355 -178.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.516 HG12 ' CG1' ' A' ' 226' ' ' VAL . 14.2 p -124.09 129.64 74.09 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 N-CA-C 107.814 -1.18 . . . . 61.100000000000001 107.814 173.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . 0.548 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 23.1 t-20 75.01 -36.35 0.31 Allowed 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 126.462 1.905 . . . . 64.010000000000005 111.711 -176.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . 0.439 ' H ' ' C ' ' A' ' 221' ' ' VAL . . . 149.26 -6.08 0.79 Allowed Glycine 0 C--N 1.277 -2.717 0 N-CA-C 109.904 -1.278 . . . . 71.299999999999997 109.904 -174.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 71.9 mt -94.81 129.32 45.15 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.312 0 N-CA-C 108.223 -1.028 . . . . 72.510000000000005 108.223 179.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -62.02 138.17 58.34 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-O 121.531 0.682 . . . . 71.129999999999995 110.585 -179.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . 0.549 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 31.6 m -118.91 -2.62 9.52 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.22 0 CA-C-N 115.604 -0.726 . . . . 75.209999999999994 109.659 176.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -82.8 93.69 7.5 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 108.435 -0.95 . . . . 72.200000000000003 108.435 179.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 130.46 -17.59 5.29 Favored Glycine 0 N--CA 1.428 -1.853 0 N-CA-C 110.275 -1.13 . . . . 60.030000000000001 110.275 -176.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -85.43 167.81 15.17 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 107.423 -1.325 . . . . 74.409999999999997 107.423 174.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . 0.461 ' O ' HG13 ' A' ' 234' ' ' VAL . 40.6 p -94.74 171.72 8.61 Favored 'General case' 0 C--N 1.295 -1.765 0 C-N-CA 119.942 -0.703 . . . . 73.230000000000004 109.183 178.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . 0.47 ' HB2' ' HB2' ' A' ' 178' ' ' ASP . 49.9 tp -60.04 -39.25 85.28 Favored 'General case' 0 N--CA 1.432 -1.375 0 CA-C-O 120.677 0.275 . . . . 75.049999999999997 111.208 -176.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -58.54 -48.31 81.32 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 121.427 0.632 . . . . 62.219999999999999 109.999 177.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -61.96 -45.13 95.01 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.786 -1.097 . . . . 75.329999999999998 112.492 -179.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.634 HG21 HG12 ' A' ' 195' ' ' ILE . 6.7 m -73.96 -33.42 36.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-O 121.027 0.441 . . . . 64.420000000000002 112.013 -175.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . 0.444 ' O ' HG23 ' A' ' 239' ' ' VAL . 48.3 m -74.03 -36.7 64.45 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 108.713 -0.847 . . . . 71.329999999999998 108.713 -174.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -59.25 -34.64 72.47 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 115.326 -0.852 . . . . 71.450000000000003 109.131 177.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 237' ' ' MET . . . . . 0.506 ' HB2' HG11 ' A' ' 221' ' ' VAL . 5.7 mtt -73.34 -44.44 58.8 Favored 'General case' 0 C--O 1.2 -1.551 0 N-CA-C 108.954 -0.758 . . . . 61.32 108.954 -179.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 238' ' ' MET . . . . . 0.513 ' SD ' HD13 ' A' ' 176' ' ' ILE . 65.7 mtt -59.95 -40.12 87.93 Favored 'General case' 0 C--O 1.214 -0.808 0 CA-C-O 120.543 0.211 . . . . 63.450000000000003 111.234 -178.257 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 235' ' ' THR . 93.9 t -65.75 -37.85 80.88 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 N-CA-C 109.736 -0.468 . . . . 54.420000000000002 109.736 177.313 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -76.74 -17.21 59.21 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.192 -0.458 . . . . 61.240000000000002 112.083 179.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -110.91 21.64 16.23 Favored 'General case' 0 C--O 1.205 -1.278 0 CA-C-N 116.45 -0.341 . . . . 71.239999999999995 110.463 176.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 242' ' ' SER . . . . . 0.58 ' O ' HD13 ' A' ' 164' ' ' LEU . 36.1 p -64.39 -22.78 67.07 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 112.966 0.728 . . . . 74.129999999999995 112.966 -178.219 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 18.1 m -79.22 -9.3 59.53 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 120.793 -0.363 . . . . 55.020000000000003 110.782 179.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -178.65 97.36 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.747 1.219 . . . . 72.040000000000006 110.894 175.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.544 ' HB2' ' HB2' ' A' ' 163' ' ' LEU . 14.1 mt -87.92 111.83 21.88 Favored 'General case' 0 C--O 1.192 -1.932 0 N-CA-C 113.375 0.88 . . . . 75.439999999999998 113.375 -177.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.548 ' HB ' ' HA ' ' A' ' 222' ' ' ASN . 66.1 mt -95.93 115.93 36.39 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.542 0 N-CA-C 106.173 -1.788 . . . . 71.420000000000002 106.173 170.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . 0.404 HG23 HG23 ' A' ' 218' ' ' VAL . 67.5 mt -130.63 128.01 62.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 C-N-CA 119.649 -0.82 . . . . 64.140000000000001 112.547 -177.08 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 86.2 m -103.12 128.7 49.95 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 115.048 -0.978 . . . . 40.240000000000002 108.751 175.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.591 HG12 ' HA ' ' A' ' 218' ' ' VAL . 27.3 m -132.66 167.46 26.54 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 108.207 -1.034 . . . . 74.329999999999998 108.207 173.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . 0.419 ' HD2' HD11 ' A' ' 219' ' ' ILE . 0.0 OUTLIER -138.82 136.54 18.64 Favored Pre-proline 0 C--N 1.284 -2.267 0 CA-C-N 115.31 -0.859 . . . . 72.450000000000003 110.964 172.675 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo . . . . . 0 C--O 1.246 0.885 0 C-N-CA 123.535 2.823 . . . . 60.350000000000001 113.554 -177.826 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.48 ' NE2' HG13 ' A' ' 219' ' ' ILE . 49.9 m170 . . . . . 0 CA--C 1.486 -1.5 0 CA-C-O 121.164 0.507 . . . . 73.340000000000003 112.08 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.637 ' O ' ' HA ' ' A' ' 248' ' ' THR . 6.6 ptp180 -125.8 142.08 51.69 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 107.598 -1.26 . . . . 71.25 107.598 177.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.417 ' HA ' ' O ' ' A' ' 247' ' ' ILE . 13.6 ptp180 -132.15 113.06 12.85 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 121.814 0.816 . . . . 75.439999999999998 111.277 177.121 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.671 ' O ' ' HA ' ' A' ' 246' ' ' ILE . 30.0 m -105.68 139.89 25.43 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 CA-C-N 114.554 -1.203 . . . . 62.140000000000001 112.402 -177.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.68 ' HG3' HG12 ' A' ' 246' ' ' ILE . 5.4 mpt_? -99.98 114.7 28.16 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 107.532 -1.284 . . . . 65.510000000000005 107.532 175.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.579 ' HB2' ' HB3' ' A' ' 245' ' ' LEU . 23.8 mt -114.41 139.91 49.11 Favored 'General case' 0 C--N 1.31 -1.137 0 C-N-CA 123.142 0.577 . . . . 73.040000000000006 111.368 -174.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.635 HD12 ' O ' ' A' ' 242' ' ' SER . 0.9 OUTLIER . . . . . 0 N--CA 1.485 1.303 0 C-N-CA 123.877 0.871 . . . . 70.129999999999995 112.083 167.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.51 ' HG ' ' CD1' ' A' ' 245' ' ' LEU . 2.8 mm? . . . . . 0 CA--C 1.501 -0.919 0 N-CA-C 112.102 0.408 . . . . 65.299999999999997 112.102 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . 0.502 ' HA3' ' HA3' ' A' ' 204' ' ' GLY . . . 93.74 14.91 51.55 Favored Glycine 0 N--CA 1.424 -2.133 0 C-N-CA 120.346 -0.93 . . . . 50.100000000000001 112.292 177.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -139.45 152.54 47.11 Favored 'General case' 0 N--CA 1.426 -1.653 0 N-CA-C 106.056 -1.831 . . . . 74.420000000000002 106.056 173.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -127.76 149.31 50.3 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-O 120.858 0.361 . . . . 71.519999999999996 110.953 -178.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.413 HD13 ' SD ' ' A' ' 238' ' ' MET . 37.8 pt -110.49 169.02 3.95 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 CA-C-N 115.552 -0.749 . . . . 73.150000000000006 110.374 -179.021 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.578 ' CG ' ' HB2' ' A' ' 198' ' ' SER . 15.7 ptt180 -151.52 154.88 37.39 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 124.166 0.986 . . . . 63.409999999999997 109.351 -178.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -108.85 138.0 45.88 Favored 'General case' 0 C--N 1.293 -1.886 0 O-C-N 123.464 0.477 . . . . 74.209999999999994 109.86 -179.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -150.46 157.08 27.04 Favored Glycine 0 C--N 1.27 -3.088 0 N-CA-C 107.507 -2.237 . . . . 61.530000000000001 107.507 176.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . 0.6 ' CG2' ' HG2' ' A' ' 191' ' ' LYS . 0.2 OUTLIER -86.65 121.58 29.37 Favored 'General case' 0 C--N 1.284 -2.252 0 C-N-CA 117.317 -1.753 . . . . 73.549999999999997 106.655 179.431 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . 0.5 ' O ' ' HA ' ' A' ' 191' ' ' LYS . 31.2 t . . . . . 0 N--CA 1.414 -2.272 0 N-CA-C 108.758 -0.83 . . . . 54.420000000000002 108.758 -176.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.6 ' HG2' ' CG2' ' A' ' 180' ' ' THR . 37.2 ttmt . . . . . 0 N--CA 1.425 -1.68 0 N-CA-C 109.207 -0.664 . . . . 61.25 109.207 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -151.91 163.48 23.45 Favored Pre-proline 0 C--N 1.301 -1.538 0 N-CA-C 107.859 -1.163 . . . . 72.239999999999995 107.859 -176.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -58.96 132.23 46.26 Favored 'Trans proline' 0 C--O 1.255 1.332 0 C-N-CA 121.032 1.154 . . . . 72.120000000000005 110.689 176.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -141.99 135.56 6.78 Favored Glycine 0 N--CA 1.411 -2.968 0 N-CA-C 110.017 -1.233 . . . . 61.32 110.017 -178.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.649 HG12 HG21 ' A' ' 234' ' ' VAL . 3.2 mp -104.14 132.74 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.789 0 CA-C-O 121.457 0.646 . . . . 55.329999999999998 110.862 -178.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -124.76 167.75 14.15 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 107.543 -1.281 . . . . 63.420000000000002 107.543 -177.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 45.6 mt -85.69 131.96 33.1 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 N-CA-C 108.876 -0.787 . . . . 71.400000000000006 108.876 175.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . 0.578 ' HB2' ' CG ' ' A' ' 177' ' ' ARG . 28.2 t -102.49 -30.71 10.83 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 113.727 1.01 . . . . 53.200000000000003 113.727 -177.101 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 13.4 ttp180 -165.16 144.47 6.7 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 120.013 -0.675 . . . . 70.239999999999995 112.185 -176.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 69.0 mt -106.51 141.01 38.5 Favored 'General case' 0 CA--C 1.494 -1.183 0 CA-C-N 115.169 -0.923 . . . . 72.400000000000006 109.575 173.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 47.5 t -109.71 114.81 56.41 Favored Pre-proline 0 C--N 1.285 -2.232 0 N-CA-C 105.748 -1.945 . . . . 64.329999999999998 105.748 171.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . 0.495 ' HA ' ' OE1' ' A' ' 207' ' ' GLU . 73.6 Cg_exo -53.31 126.15 20.72 Favored 'Trans proline' 0 C--O 1.244 0.804 0 C-N-CA 122.342 2.028 . . . . 53.049999999999997 110.838 179.409 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 110.69 -16.12 28.83 Favored Glycine 0 C--N 1.312 -0.767 0 C-N-CA 120.95 -0.643 . . . . 63.310000000000002 111.514 -175.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . 0.502 ' HA3' ' HA3' ' A' ' 173' ' ' GLY . . . -77.08 158.2 47.75 Favored Glycine 0 N--CA 1.441 -0.972 0 C-N-CA 121.147 -0.549 . . . . 71.310000000000002 111.924 178.503 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -53.84 -48.57 69.81 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 124.201 1.0 . . . . 55.43 112.263 -176.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -68.99 -32.24 71.65 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.776 -0.647 . . . . 74.329999999999998 111.33 -178.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.495 ' OE1' ' HA ' ' A' ' 202' ' ' PRO . 2.5 tm-20 -75.89 -44.41 40.6 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.658 -0.701 . . . . 65.230000000000004 109.282 -177.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 50.7 m -57.87 -33.38 68.63 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.338 0.496 . . . . 73.420000000000002 112.338 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . 0.463 HG23 ' H ' ' A' ' 211' ' ' LEU . 11.3 t -83.16 -17.44 42.9 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 119.945 -0.702 . . . . 71.409999999999997 110.989 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 64.65 17.08 62.03 Favored Glycine 0 C--N 1.334 0.436 0 CA-C-N 116.439 -0.346 . . . . 74.409999999999997 113.621 178.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.463 ' H ' HG23 ' A' ' 209' ' ' THR . 76.3 mt -95.69 -22.34 17.62 Favored 'General case' 0 C--O 1.199 -1.59 0 C-N-CA 120.224 -0.59 . . . . 71.409999999999997 110.776 -177.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.513 HD11 HG21 ' A' ' 161' ' ' VAL . 6.9 mp -107.22 134.1 50.81 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-O 121.366 0.603 . . . . 54.399999999999999 111.102 -178.308 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -131.27 165.39 23.5 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-N 114.23 -1.35 . . . . 75.109999999999999 109.88 -179.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 33.3 m -65.09 -29.39 47.2 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 N-CA-C 113.66 0.985 . . . . 65.239999999999995 113.66 -179.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -74.85 -14.14 60.64 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.7 -0.625 . . . . 74.420000000000002 111.252 -178.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.502 ' HB3' ' HB ' ' A' ' 249' ' ' VAL . 79.8 m-20 -66.69 142.97 57.24 Favored 'General case' 0 C--O 1.247 0.971 0 N-CA-C 112.984 0.735 . . . . 52.509999999999998 112.984 -176.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . 0.419 ' HB3' ' HG3' ' A' ' 250' ' ' LYS . 41.1 tt0 -109.21 133.13 53.42 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.635 -1.166 . . . . 74.340000000000003 108.802 177.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.644 ' HA ' HG12 ' A' ' 249' ' ' VAL . 20.7 t -84.36 130.68 35.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.496 0.665 . . . . 73.030000000000001 111.289 -174.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.48 HG13 ' NE2' ' A' ' 158' ' ' HIS . 44.0 mm -99.44 -56.86 4.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-N 115.168 -0.923 . . . . 75.109999999999999 111.652 -177.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.409 ' HB3' ' HA ' ' A' ' 225' ' ' GLU . 10.9 pt-20 -155.02 151.2 28.16 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 116.108 -0.497 . . . . 70.230000000000004 110.503 -176.362 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.507 ' HA ' ' O ' ' A' ' 246' ' ' ILE . 8.6 p -120.33 122.71 68.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 CA-C-N 115.648 -0.705 . . . . 63.340000000000003 109.24 177.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . 0.438 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 2.5 m-20 58.24 24.58 11.63 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.656 1.183 . . . . 53.329999999999998 112.474 -177.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 95.69 -7.23 67.97 Favored Glycine 0 N--CA 1.435 -1.418 0 CA-C-N 115.377 -0.829 . . . . 64.129999999999995 111.853 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 62.1 mt -97.31 122.63 49.07 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.509 0 N-CA-C 108.899 -0.778 . . . . 75.420000000000002 108.899 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . 0.409 ' HA ' ' HB3' ' A' ' 220' ' ' GLU . 11.1 pt-20 -61.83 139.33 58.36 Favored 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 123.704 0.802 . . . . 72.230000000000004 112.674 -176.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . 0.465 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 34.3 m -117.11 3.21 7.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 CA-C-N 115.376 -0.829 . . . . 64.129999999999995 109.798 175.503 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -75.67 99.11 4.24 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 115.224 -0.898 . . . . 73.510000000000005 109.816 -179.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 113.26 -8.84 24.75 Favored Glycine 0 CA--C 1.5 -0.846 0 N-CA-C 110.983 -0.847 . . . . 52.32 110.983 179.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -83.14 158.27 22.45 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.781 -0.822 . . . . 70.430000000000007 108.781 178.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . 0.444 ' O ' HG13 ' A' ' 234' ' ' VAL . 82.7 p -84.02 170.7 13.66 Favored 'General case' 0 N--CA 1.412 -2.35 0 C-N-CA 119.584 -0.846 . . . . 73.120000000000005 110.397 178.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -61.85 -37.78 85.76 Favored 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 109.139 -0.689 . . . . 75.549999999999997 109.139 179.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -58.7 -52.29 66.34 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.198 0.523 . . . . 73.329999999999998 110.054 175.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 233' ' ' GLN . . . . . 0.504 ' O ' ' HG2' ' A' ' 237' ' ' MET . 39.6 mt-30 -54.78 -44.76 74.0 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.606 -1.179 . . . . 63.149999999999999 112.481 179.337 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.649 HG21 HG12 ' A' ' 195' ' ' ILE . 8.2 m -77.12 -34.47 21.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 112.438 0.533 . . . . 55.310000000000002 112.438 -176.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . 0.446 ' O ' HG23 ' A' ' 239' ' ' VAL . 31.9 m -71.25 -35.81 71.55 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 109.522 -0.548 . . . . 61.43 109.522 -179.128 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -63.38 -31.14 72.21 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 109.722 -0.473 . . . . 72.340000000000003 109.722 176.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 237' ' ' MET . . . . . 0.504 ' HG2' ' O ' ' A' ' 233' ' ' GLN . 17.2 mmt -62.54 -52.55 63.0 Favored 'General case' 0 C--O 1.195 -1.767 0 N-CA-C 107.9 -1.148 . . . . 73.25 107.9 174.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 238' ' ' MET . . . . . 0.419 ' HG3' ' O ' ' A' ' 234' ' ' VAL . 59.5 mtt -63.93 -33.02 74.77 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.159 -0.928 . . . . 52.420000000000002 112.843 -173.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 235' ' ' THR . 85.7 t -68.96 -44.12 81.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 N-CA-C 109.175 -0.676 . . . . 74.420000000000002 109.175 175.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -66.91 -36.3 81.95 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.85 -0.614 . . . . 74.519999999999996 110.594 178.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -87.29 22.13 2.22 Favored 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 124.364 1.066 . . . . 75.420000000000002 111.612 179.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 242' ' ' SER . . . . . 0.635 ' O ' HD12 ' A' ' 164' ' ' LEU . 34.3 t -58.76 -42.29 88.54 Favored 'General case' 0 C--O 1.204 -1.334 0 CA-C-N 118.112 0.415 . . . . 72.239999999999995 112.064 -179.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 37.5 m -74.21 -16.98 60.95 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 112.405 0.52 . . . . 50.509999999999998 112.405 -178.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -153.18 85.12 1.21 Allowed 'General case' 0 CA--C 1.5 -0.949 0 N-CA-C 108.447 -0.946 . . . . 73.439999999999998 108.447 179.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.579 ' HB3' ' HB2' ' A' ' 163' ' ' LEU . 2.0 tt -92.03 105.78 17.95 Favored 'General case' 0 N--CA 1.432 -1.343 0 C-N-CA 119.694 -0.803 . . . . 74.430000000000007 109.732 -177.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.68 HG12 ' HG3' ' A' ' 162' ' ' ARG . 93.2 mt -109.19 115.4 49.45 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 O-C-N 121.882 -0.511 . . . . 72.030000000000001 110.19 177.167 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . 0.483 HG13 ' CD2' ' A' ' 245' ' ' LEU . 27.4 mt -119.26 133.27 66.64 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 N-CA-C 112.838 0.681 . . . . 71.129999999999995 112.838 177.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.637 ' HA ' ' O ' ' A' ' 159' ' ' ARG . 63.5 m -102.92 117.0 33.64 Favored 'General case' 0 N--CA 1.417 -2.095 0 CA-C-N 114.484 -1.235 . . . . 74.420000000000002 108.087 173.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.644 HG12 ' HA ' ' A' ' 218' ' ' VAL . 18.9 m -122.54 165.57 18.35 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.064 0 CA-C-O 121.194 0.521 . . . . 72.540000000000006 110.198 175.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . 0.434 ' HB3' ' CD2' ' A' ' 158' ' ' HIS . 15.0 ptmt -129.46 128.53 23.15 Favored Pre-proline 0 C--N 1.277 -2.576 0 C-N-CA 125.137 1.375 . . . . 63.119999999999997 107.621 176.248 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo . . . . . 0 N--CA 1.441 -1.613 0 N-CA-C 109.598 -0.962 . . . . 74.120000000000005 109.598 176.214 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.615 ' NE2' HG13 ' A' ' 219' ' ' ILE . 4.0 m80 . . . . . 0 N--CA 1.432 -1.356 0 N-CA-C 108.622 -0.881 . . . . 73.129999999999995 108.622 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.502 HH11 HD22 ' A' ' 211' ' ' LEU . 36.7 ttm180 -133.12 142.84 48.9 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 109.329 -0.619 . . . . 72.329999999999998 109.329 173.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.414 ' HG3' ' OG1' ' A' ' 248' ' ' THR . 0.1 OUTLIER -106.69 117.12 33.2 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 109.072 -0.714 . . . . 71.239999999999995 109.072 -179.399 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.559 HG11 HD21 ' A' ' 211' ' ' LEU . 14.2 m -123.39 138.43 53.3 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.209 0 N-CA-C 112.18 0.437 . . . . 75.439999999999998 112.18 178.366 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.732 ' HG2' HG12 ' A' ' 246' ' ' ILE . 65.4 mtt180 -92.7 111.6 23.26 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 108.87 -0.789 . . . . 62.439999999999998 108.87 171.487 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.551 ' HB2' ' HB3' ' A' ' 245' ' ' LEU . 34.9 mt -93.33 139.3 30.81 Favored 'General case' 0 C--N 1.281 -2.388 0 N-CA-C 107.29 -1.374 . . . . 53.32 107.29 179.144 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.63 ' H ' ' HG ' ' A' ' 205' ' ' LEU . 2.3 tm? . . . . . 0 C--N 1.304 -1.395 0 N-CA-C 107.874 -1.158 . . . . 73.510000000000005 107.874 179.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 2.6 mm? . . . . . 0 CA--C 1.503 -0.864 0 CA-C-O 120.938 0.399 . . . . 60.119999999999997 110.776 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . 0.535 ' HA2' ' HB ' ' A' ' 201' ' ' VAL . . . 109.03 13.98 16.36 Favored Glycine 0 N--CA 1.421 -2.348 0 C-N-CA 119.677 -1.249 . . . . 64.019999999999996 114.213 174.281 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -162.66 153.79 17.5 Favored 'General case' 0 N--CA 1.435 -1.225 0 CA-C-N 118.155 0.978 . . . . 73.25 110.154 -177.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.482 ' CE1' HG22 ' A' ' 201' ' ' VAL . 71.0 m-85 -115.4 144.88 43.14 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 108.045 -1.095 . . . . 73.239999999999995 108.045 174.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.578 ' HB ' ' CG2' ' A' ' 195' ' ' ILE . 36.8 pt -110.47 168.96 3.98 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.393 0 CA-C-O 121.16 0.505 . . . . 70.140000000000001 110.538 179.575 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.567 ' HG2' ' HB2' ' A' ' 198' ' ' SER . 5.1 ptp180 -154.07 153.88 32.67 Favored 'General case' 0 C--N 1.288 -2.084 0 C-N-CA 123.798 0.839 . . . . 74.420000000000002 109.091 178.159 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -100.16 141.52 32.88 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 109.156 -0.683 . . . . 74.299999999999997 109.156 177.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -153.9 -159.9 9.45 Favored Glycine 0 C--N 1.284 -2.325 0 N-CA-C 109.029 -1.629 . . . . 72.409999999999997 109.029 177.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . 0.404 ' HB ' ' CG ' ' A' ' 191' ' ' LYS . 0.7 OUTLIER -110.13 126.74 54.38 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 117.711 0.756 . . . . 71.409999999999997 112.462 177.809 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 26.5 t . . . . . 0 N--CA 1.413 -2.283 0 N-CA-C 107.79 -1.189 . . . . 75.530000000000001 107.79 177.143 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.404 ' CG ' ' HB ' ' A' ' 180' ' ' THR . 36.1 ttmt . . . . . 0 N--CA 1.427 -1.612 0 N-CA-C 108.074 -1.084 . . . . 74.530000000000001 108.074 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -145.13 164.34 27.49 Favored Pre-proline 0 C--N 1.287 -2.146 0 N-CA-C 108.284 -1.006 . . . . 73.310000000000002 108.284 -177.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -60.84 131.71 38.79 Favored 'Trans proline' 0 N--CA 1.448 -1.159 0 N-CA-C 109.401 -1.038 . . . . 71.109999999999999 109.401 174.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -137.49 150.87 20.94 Favored Glycine 0 CA--C 1.474 -2.481 0 N-CA-C 109.393 -1.483 . . . . 44.509999999999998 109.393 -178.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.587 ' HB ' ' CG1' ' A' ' 218' ' ' VAL . 3.2 mp -108.22 138.22 35.96 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.291 0 C-N-CA 120.071 -0.652 . . . . 74.129999999999995 110.141 -179.172 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -131.44 163.7 27.36 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 107.185 -1.413 . . . . 72.239999999999995 107.185 -177.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 41.7 mt -81.97 128.52 38.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 CA-C-O 121.711 0.767 . . . . 64.439999999999998 110.447 175.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . 0.567 ' HB2' ' HG2' ' A' ' 177' ' ' ARG . 27.8 t -100.47 -22.79 14.9 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 112.892 0.701 . . . . 61.140000000000001 112.892 -177.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 51.3 ttp180 -167.56 152.26 6.87 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 109.601 -0.518 . . . . 72.519999999999996 109.601 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 38.7 mt -100.96 146.34 27.52 Favored 'General case' 0 CA--C 1.48 -1.729 0 N-CA-C 108.85 -0.796 . . . . 73.540000000000006 108.85 173.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . 0.535 ' HB ' ' HA2' ' A' ' 173' ' ' GLY . 10.9 t -103.44 114.67 64.72 Favored Pre-proline 0 C--N 1.284 -2.252 0 N-CA-C 105.914 -1.884 . . . . 71.530000000000001 105.914 174.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . 0.543 ' HA ' ' HG2' ' A' ' 207' ' ' GLU . 23.9 Cg_exo -63.34 135.8 51.95 Favored 'Trans proline' 0 N--CA 1.447 -1.209 0 C-N-CA 121.888 1.725 . . . . 63.130000000000003 110.707 -178.085 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.426 ' H ' ' HG2' ' A' ' 207' ' ' GLU . . . 94.73 -12.6 68.47 Favored Glycine 0 C--N 1.312 -0.789 0 C-N-CA 120.891 -0.671 . . . . 75.239999999999995 112.152 -178.013 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . 0.438 ' HA3' ' CA ' ' A' ' 173' ' ' GLY . . . -80.05 172.95 54.93 Favored Glycine 0 N--CA 1.436 -1.328 0 C-N-CA 120.891 -0.671 . . . . 64.409999999999997 111.707 179.454 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.63 ' HG ' ' H ' ' A' ' 164' ' ' LEU . 2.8 mm? -67.17 -41.91 85.18 Favored 'General case' 0 C--N 1.311 -1.089 0 C-N-CA 123.126 0.57 . . . . 61.240000000000002 111.761 -175.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -60.52 -39.18 86.89 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.102 0.477 . . . . 61.310000000000002 110.445 176.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.543 ' HG2' ' HA ' ' A' ' 202' ' ' PRO . 9.1 tp10 -67.85 -42.07 81.94 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.455 -0.793 . . . . 74.329999999999998 109.524 177.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 51.0 m -60.54 -45.12 95.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.4 -0.818 . . . . 72.129999999999995 112.032 -177.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . 0.61 HG23 ' H ' ' A' ' 211' ' ' LEU . 10.0 t -76.72 -30.12 56.5 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 109.362 -0.607 . . . . 65.0 109.362 178.025 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 66.04 16.55 64.42 Favored Glycine 0 C--N 1.34 0.754 0 CA-C-N 115.509 -0.769 . . . . 40.310000000000002 113.106 177.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.61 ' H ' HG23 ' A' ' 209' ' ' THR . 1.9 pp -99.74 -3.45 32.82 Favored 'General case' 0 N--CA 1.433 -1.28 0 C-N-CA 120.275 -0.57 . . . . 64.329999999999998 110.86 -177.426 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 5.4 mp -109.25 133.23 53.3 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 107.622 -1.251 . . . . 72.25 107.622 175.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -131.05 166.51 20.88 Favored 'General case' 0 C--N 1.279 -2.485 0 N-CA-C 108.599 -0.889 . . . . 63.530000000000001 108.599 178.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 35.5 m -57.38 -31.03 37.3 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 N-CA-C 112.726 0.639 . . . . 71.25 112.726 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 -73.22 -13.86 61.23 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 113.201 0.815 . . . . 64.25 113.201 -179.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -73.3 135.09 44.36 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.324 0.583 . . . . 73.430000000000007 112.405 -178.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -104.53 134.33 47.89 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.881 -1.054 . . . . 71.319999999999993 109.162 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.601 ' HA ' HG12 ' A' ' 249' ' ' VAL . 13.1 p -84.08 134.97 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 CA-C-O 122.175 0.988 . . . . 72.549999999999997 111.395 -177.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.615 HG13 ' NE2' ' A' ' 158' ' ' HIS . 36.2 mm -99.27 -52.98 8.27 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.078 0 CA-C-N 114.332 -1.303 . . . . 73.010000000000005 111.025 -179.147 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.414 ' HG2' ' HB ' ' A' ' 248' ' ' THR . 11.1 pt-20 -157.78 151.34 23.72 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 116.076 -0.511 . . . . 72.420000000000002 110.926 -175.487 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.425 HG12 ' CG1' ' A' ' 226' ' ' VAL . 6.9 p -120.81 124.44 72.36 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 N-CA-C 108.959 -0.756 . . . . 74.140000000000001 108.959 176.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . 0.494 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 16.3 t-20 70.63 -3.8 1.83 Allowed 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 125.062 1.345 . . . . 70.340000000000003 111.164 -178.343 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 120.58 -17.91 9.42 Favored Glycine 0 C--N 1.301 -1.407 0 N-CA-C 111.019 -0.832 . . . . 54.399999999999999 111.019 -175.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 63.5 mt -88.52 123.77 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 N-CA-C 109.203 -0.666 . . . . 70.530000000000001 109.203 -179.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . 0.403 ' HA ' ' HB3' ' A' ' 220' ' ' GLU . 13.1 pt-20 -61.54 147.84 44.1 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.585 0.707 . . . . 74.209999999999994 111.506 -178.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . 0.425 ' CG1' HG12 ' A' ' 221' ' ' VAL . 26.1 m -117.8 -2.52 9.83 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 CA-C-N 115.408 -0.814 . . . . 63.109999999999999 112.239 179.459 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -82.16 104.34 12.42 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 109.169 -0.678 . . . . 51.32 109.169 177.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 122.58 -25.05 6.66 Favored Glycine 0 C--N 1.297 -1.597 0 N-CA-C 110.096 -1.202 . . . . 75.239999999999995 110.096 -179.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -74.0 166.7 22.92 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 107.711 -1.218 . . . . 74.140000000000001 107.711 176.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . 0.447 ' O ' HG13 ' A' ' 234' ' ' VAL . 82.5 p -91.0 168.15 11.87 Favored 'General case' 0 C--O 1.249 1.06 0 N-CA-C 108.413 -0.958 . . . . 52.149999999999999 108.413 178.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 47.2 tp -66.07 -27.96 68.47 Favored 'General case' 0 N--CA 1.428 -1.566 0 C-N-CA 120.56 -0.456 . . . . 72.25 109.911 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -69.07 -47.71 64.6 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.725 -0.472 . . . . 71.239999999999995 109.725 176.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -58.92 -48.36 81.72 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 113.587 0.958 . . . . 64.299999999999997 113.587 177.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.525 HG21 HG12 ' A' ' 195' ' ' ILE . 13.3 m -65.14 -34.23 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-O 121.343 0.592 . . . . 64.209999999999994 111.598 -175.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . 0.471 ' O ' HG23 ' A' ' 239' ' ' VAL . 90.0 m -75.48 -35.65 60.78 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 115.52 -0.764 . . . . 54.229999999999997 109.394 -176.087 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -61.53 -34.03 74.84 Favored 'General case' 0 CA--C 1.508 -0.639 0 N-CA-C 108.8 -0.815 . . . . 71.430000000000007 108.8 177.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 9.9 mtt -67.66 -45.46 75.21 Favored 'General case' 0 C--O 1.211 -0.933 0 N-CA-C 108.113 -1.069 . . . . 75.140000000000001 108.113 178.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 65.9 mtt -59.25 -38.72 80.76 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.884 -0.598 . . . . 74.109999999999999 111.531 -178.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 235' ' ' THR . 60.6 t -69.76 -33.16 54.98 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-O 121.255 0.55 . . . . 73.010000000000005 110.217 178.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -75.28 -30.33 60.4 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.203 0.525 . . . . 53.399999999999999 111.404 179.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 -90.14 21.84 3.56 Favored 'General case' 0 C--O 1.2 -1.531 0 CA-C-N 115.895 -0.593 . . . . 72.209999999999994 112.519 -178.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 242' ' ' SER . . . . . 0.557 ' O ' HD12 ' A' ' 164' ' ' LEU . 50.4 m -56.65 -22.97 38.3 Favored 'General case' 0 C--O 1.206 -1.22 0 N-CA-C 112.552 0.575 . . . . 72.109999999999999 112.552 177.283 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 18.4 m -64.16 -38.42 91.0 Favored 'General case' 0 CA--C 1.55 0.951 0 O-C-N 122.241 -0.287 . . . . 40.0 110.475 177.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -168.0 107.55 0.53 Allowed 'General case' 0 CA--C 1.491 -1.301 0 C-N-CA 126.876 2.071 . . . . 72.230000000000004 107.414 177.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.551 ' HB3' ' HB2' ' A' ' 163' ' ' LEU . 0.2 OUTLIER -84.77 105.28 15.44 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 108.348 -0.982 . . . . 71.150000000000006 108.348 -174.667 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.732 HG12 ' HG2' ' A' ' 162' ' ' ARG . 89.4 mt -94.08 115.31 32.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 109.003 -0.74 . . . . 64.030000000000001 109.003 179.079 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . 0.53 HG23 HG23 ' A' ' 218' ' ' VAL . 13.3 mt -125.47 135.65 63.3 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.073 0 CA-C-O 121.467 0.651 . . . . 73.349999999999994 112.181 176.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.486 ' HA ' ' O ' ' A' ' 159' ' ' ARG . 70.1 m -107.55 115.52 30.3 Favored 'General case' 0 N--CA 1.414 -2.274 0 N-CA-C 107.636 -1.246 . . . . 65.219999999999999 107.636 173.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.601 HG12 ' HA ' ' A' ' 218' ' ' VAL . 12.1 m -117.93 164.94 13.76 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.115 0 N-CA-C 109.491 -0.559 . . . . 61.130000000000003 109.491 174.298 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . 0.427 ' CD ' HD11 ' A' ' 219' ' ' ILE . 17.4 ptmt -131.86 128.3 21.54 Favored Pre-proline 0 C--N 1.286 -2.16 0 CA-C-N 114.896 -1.047 . . . . 73.340000000000003 108.676 174.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo . . . . . 0 N--CA 1.442 -1.528 0 C-N-CA 121.559 1.506 . . . . 75.030000000000001 112.382 179.449 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.78 ' HB3' ' HB3' ' A' ' 250' ' ' LYS 0.407 6.0 p-80 . . . . . 0 CA--C 1.496 -1.107 0 N-CA-C 114.74 1.385 . . . . 72.239999999999995 114.74 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.559 ' O ' ' HA ' ' A' ' 248' ' ' THR . 11.3 ptt180 -110.34 143.84 39.97 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 113.562 -1.654 . . . . 72.540000000000006 110.812 -173.373 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -114.0 112.93 24.07 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 121.702 0.763 . . . . 73.329999999999998 110.887 178.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.576 HG11 HD21 ' A' ' 211' ' ' LEU . 28.4 m -114.3 139.7 38.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 CA-C-N 114.879 -1.055 . . . . 65.319999999999993 112.786 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.425 ' HA ' ' HA ' ' A' ' 246' ' ' ILE . 19.8 ttm180 -96.48 112.83 24.43 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.434 0.635 . . . . 74.120000000000005 109.781 177.413 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.41 ' HB2' ' HB3' ' A' ' 245' ' ' LEU . 19.8 mt -94.13 138.18 32.48 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-N 114.999 -1.0 . . . . 75.530000000000001 108.685 -178.318 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.416 HD23 ' O ' ' A' ' 242' ' ' SER . 15.4 tp . . . . . 0 C--N 1.312 -1.03 0 CA-C-O 122.121 0.962 . . . . 75.319999999999993 111.632 174.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.555 ' HG ' HD12 ' A' ' 245' ' ' LEU . 3.6 mm? . . . . . 0 CA--C 1.51 -0.595 0 N-CA-C 112.284 0.476 . . . . 74.510000000000005 112.284 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . 0.513 ' HA3' ' HA3' ' A' ' 204' ' ' GLY . . . 88.07 34.97 9.26 Favored Glycine 0 N--CA 1.426 -2.024 0 C-N-CA 120.595 -0.812 . . . . 50.450000000000003 113.271 177.008 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -154.73 154.02 32.2 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 107.487 -1.301 . . . . 55.0 107.487 174.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -125.45 148.94 48.64 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 108.939 -0.763 . . . . 74.400000000000006 108.939 176.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.541 HD13 ' SD ' ' A' ' 238' ' ' MET . 35.6 pt -110.08 169.52 3.61 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 CA-C-O 121.32 0.581 . . . . 54.020000000000003 111.253 -176.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.537 ' CG ' ' HB2' ' A' ' 198' ' ' SER . 15.7 ptt180 -149.21 154.79 39.64 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 115.112 -0.949 . . . . 72.420000000000002 109.312 -179.39 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -117.54 144.5 45.04 Favored 'General case' 0 C--N 1.287 -2.124 0 N-CA-C 109.014 -0.736 . . . . 64.230000000000004 109.014 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -161.95 179.96 36.98 Favored Glycine 0 N--CA 1.417 -2.63 0 N-CA-C 109.712 -1.355 . . . . 54.030000000000001 109.712 178.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . 0.513 ' HB ' ' CG ' ' A' ' 191' ' ' LYS . 0.8 OUTLIER -86.46 123.92 32.22 Favored 'General case' 0 C--N 1.29 -1.997 0 CA-C-O 121.66 0.743 . . . . 61.329999999999998 112.193 177.298 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 37.4 t . . . . . 0 N--CA 1.403 -2.788 0 N-CA-C 107.356 -1.35 . . . . 74.420000000000002 107.356 177.225 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.513 ' CG ' ' HB ' ' A' ' 180' ' ' THR . 34.6 ttmt . . . . . 0 N--CA 1.432 -1.374 0 N-CA-C 108.964 -0.754 . . . . 71.420000000000002 108.964 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -145.71 164.71 24.34 Favored Pre-proline 0 C--N 1.292 -1.905 0 N-CA-C 107.893 -1.151 . . . . 74.019999999999996 107.893 -177.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -59.29 132.76 48.45 Favored 'Trans proline' 0 C--O 1.245 0.834 0 C-N-CA 121.533 1.488 . . . . 71.400000000000006 111.667 176.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -139.53 143.24 13.62 Favored Glycine 0 N--CA 1.419 -2.481 0 N-CA-C 109.778 -1.329 . . . . 63.119999999999997 109.778 178.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.623 HG12 HG21 ' A' ' 234' ' ' VAL . 3.2 mp -108.76 132.84 55.64 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 CA-C-O 121.117 0.484 . . . . 75.040000000000006 110.767 -179.2 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -125.31 167.72 14.51 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 107.946 -1.131 . . . . 75.219999999999999 107.946 -176.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . 0.467 ' HB ' ' HA ' ' A' ' 214' ' ' VAL . 46.5 mm -77.06 131.51 34.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 N-CA-C 108.189 -1.041 . . . . 75.430000000000007 108.189 174.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . 0.537 ' HB2' ' CG ' ' A' ' 177' ' ' ARG . 12.7 t -104.48 -38.49 6.77 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 113.449 0.907 . . . . 52.310000000000002 113.449 -178.525 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 40.0 ttp180 -150.47 141.86 23.36 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 120.004 -0.678 . . . . 72.010000000000005 109.947 -177.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -108.45 133.79 52.13 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 107.562 -1.273 . . . . 64.409999999999997 107.562 -177.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 44.0 t -110.6 131.58 22.01 Favored Pre-proline 0 C--N 1.311 -1.073 0 C-N-CA 120.756 -0.378 . . . . 73.109999999999999 110.736 -177.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . 0.472 ' HA ' ' OE2' ' A' ' 207' ' ' GLU . 17.8 Cg_endo -60.78 135.21 58.47 Favored 'Trans proline' 0 C--O 1.247 0.939 0 C-N-CA 122.717 2.278 . . . . 55.539999999999999 111.682 176.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 86.37 0.78 86.46 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.812 -0.631 . . . . 72.319999999999993 112.63 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . 0.513 ' HA3' ' HA3' ' A' ' 173' ' ' GLY . . . -88.25 170.26 38.96 Favored Glycine 0 N--CA 1.439 -1.13 0 C-N-CA 120.577 -0.82 . . . . 74.219999999999999 112.526 -178.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 172' ' ' LEU . 3.6 mm? -66.39 -34.25 77.54 Favored 'General case' 0 N--CA 1.438 -1.075 0 C-N-CA 123.088 0.555 . . . . 74.420000000000002 110.582 -179.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . 0.469 ' CB ' HD12 ' A' ' 212' ' ' LEU . . . -61.76 -41.55 97.83 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 115.613 -0.721 . . . . 62.409999999999997 110.49 176.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.472 ' OE2' ' HA ' ' A' ' 202' ' ' PRO . 41.2 tt0 -75.6 -33.52 60.56 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.946 -0.57 . . . . 75.329999999999998 110.234 178.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 44.3 t -56.34 -50.14 72.36 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 123.755 0.822 . . . . 51.240000000000002 111.042 -179.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . 0.617 HG23 ' H ' ' A' ' 211' ' ' LEU . 8.8 t -80.02 -25.98 39.99 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 119.648 -0.821 . . . . 75.329999999999998 109.59 176.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 65.6 22.84 70.13 Favored Glycine 0 N--CA 1.446 -0.689 0 CA-C-N 115.608 -0.724 . . . . 50.520000000000003 112.543 179.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.617 ' H ' HG23 ' A' ' 209' ' ' THR . 1.1 pp -111.61 4.06 18.39 Favored 'General case' 0 N--CA 1.436 -1.174 0 C-N-CA 120.073 -0.651 . . . . 61.219999999999999 112.235 -177.33 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.469 HD12 ' CB ' ' A' ' 206' ' ' ALA . 75.5 mt -108.39 133.13 53.0 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 108.65 -0.87 . . . . 72.329999999999998 108.65 177.577 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -131.86 165.23 24.3 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 107.613 -1.254 . . . . 63.030000000000001 107.613 177.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . 0.467 ' HA ' ' HB ' ' A' ' 197' ' ' ILE 0.259 18.7 m -65.53 -28.83 45.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 113.519 0.933 . . . . 71.299999999999997 113.519 -177.99 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -73.11 -15.14 61.49 Favored 'General case' 0 N--CA 1.484 1.247 0 O-C-N 121.906 -0.496 . . . . 41.32 111.636 178.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -66.43 131.95 47.21 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-O 121.337 0.589 . . . . 62.329999999999998 112.036 -179.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . 0.44 ' O ' ' HA ' ' A' ' 249' ' ' VAL . 38.6 tt0 -105.82 132.4 51.99 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.95 -1.023 . . . . 74.340000000000003 111.044 -178.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.525 HG13 HG23 ' A' ' 247' ' ' ILE . 35.4 t -81.66 127.37 39.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 C-N-CA 123.24 0.616 . . . . 74.099999999999994 110.643 -176.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 40.9 mm -98.84 -49.41 11.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 CA-C-N 115.341 -0.845 . . . . 71.349999999999994 110.806 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.457 ' CB ' ' HA ' ' A' ' 225' ' ' GLU . 12.7 pt-20 -152.55 158.41 42.46 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-O 120.529 0.204 . . . . 75.329999999999998 110.703 -179.255 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.47 ' C ' ' H ' ' A' ' 223' ' ' GLY . 9.1 p -125.36 125.76 69.54 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 N-CA-C 109.088 -0.708 . . . . 73.209999999999994 109.088 178.406 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . 0.687 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 14.8 t-20 71.92 -31.8 0.23 Allowed 'General case' 0 N--CA 1.499 2.021 0 C-N-CA 126.421 1.888 . . . . 72.129999999999995 112.364 -178.281 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . 0.47 ' H ' ' C ' ' A' ' 221' ' ' VAL . . . 150.21 -4.6 0.62 Allowed Glycine 0 C--N 1.276 -2.797 0 CA-C-N 114.547 -1.206 . . . . 31.43 110.777 -175.163 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 68.6 mt -104.56 124.34 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.14 0 N-CA-C 109.364 -0.606 . . . . 64.040000000000006 109.364 179.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . 0.457 ' HA ' ' CB ' ' A' ' 220' ' ' GLU . 12.4 pt-20 -57.91 148.66 24.96 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 123.419 0.688 . . . . 71.329999999999998 112.801 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . 0.496 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 34.3 m -122.67 -2.54 7.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 CA-C-N 114.891 -1.049 . . . . 54.32 109.501 175.44 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -71.22 99.05 1.83 Allowed 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 115.547 -0.751 . . . . 61.119999999999997 110.441 -177.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 121.91 -23.2 7.44 Favored Glycine 0 N--CA 1.43 -1.742 0 N-CA-C 110.965 -0.854 . . . . 61.219999999999999 110.965 178.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 80.2 mttt -78.13 172.85 12.93 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 121.142 -0.223 . . . . 74.540000000000006 111.306 -179.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . 0.456 ' O ' HG13 ' A' ' 234' ' ' VAL . 74.2 p -93.77 165.97 12.43 Favored 'General case' 0 N--CA 1.427 -1.612 0 C-N-CA 119.849 -0.74 . . . . 60.399999999999999 109.76 -175.424 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . 0.469 ' HA ' HG22 ' A' ' 234' ' ' VAL . 3.1 tm? -60.96 -38.78 87.11 Favored 'General case' 0 N--CA 1.427 -1.614 0 CA-C-N 116.081 -0.508 . . . . 72.439999999999998 109.787 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -65.95 -40.16 91.09 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.458 -0.337 . . . . 62.200000000000003 110.664 179.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -64.31 -49.3 72.32 Favored 'General case' 0 C--O 1.223 -0.316 0 N-CA-C 112.667 0.618 . . . . 72.310000000000002 112.667 175.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.623 HG21 HG12 ' A' ' 195' ' ' ILE . 15.0 m -68.36 -34.05 63.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 112.729 0.64 . . . . 70.430000000000007 112.729 -173.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . 0.49 ' O ' HG23 ' A' ' 239' ' ' VAL . 75.1 m -71.0 -35.63 72.14 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 109.229 -0.656 . . . . 64.010000000000005 109.229 -176.31 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -62.63 -33.97 76.09 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.727 -0.669 . . . . 72.030000000000001 109.598 178.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 237' ' ' MET . . . . . 0.444 ' HB2' HG11 ' A' ' 221' ' ' VAL . 2.0 mtm -74.33 -34.91 63.58 Favored 'General case' 0 C--O 1.2 -1.55 0 N-CA-C 108.542 -0.91 . . . . 75.120000000000005 108.542 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 238' ' ' MET . . . . . 0.541 ' SD ' HD13 ' A' ' 176' ' ' ILE . 65.3 mtt -68.66 -36.24 78.29 Favored 'General case' 0 C--N 1.314 -0.964 0 O-C-N 121.995 -0.441 . . . . 53.450000000000003 110.844 178.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 235' ' ' THR . 99.9 t -67.81 -39.57 82.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 CA-C-O 121.278 0.561 . . . . 64.409999999999997 109.665 176.497 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -69.59 -32.4 71.13 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.919 -0.582 . . . . 63.25 111.006 178.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 58.0 m-80 -96.24 21.04 9.45 Favored 'General case' 0 C--O 1.206 -1.187 0 CA-C-N 116.294 -0.412 . . . . 63.340000000000003 111.995 178.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 242' ' ' SER . . . . . 0.416 ' O ' HD23 ' A' ' 164' ' ' LEU . 62.6 m -63.16 -23.1 67.28 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 120.537 -0.465 . . . . 75.409999999999997 111.895 178.281 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 19.2 m -66.03 -24.99 66.85 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 116.639 -0.255 . . . . 62.530000000000001 111.159 177.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -172.79 93.13 0.11 Allowed 'General case' 0 C--O 1.24 0.577 0 C-N-CA 124.602 1.161 . . . . 71.049999999999997 109.054 -178.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.555 HD12 ' HG ' ' A' ' 172' ' ' LEU . 1.2 tt -88.66 105.05 17.42 Favored 'General case' 0 C--O 1.198 -1.643 0 CA-C-N 115.769 -0.65 . . . . 74.329999999999998 111.286 -169.301 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.687 ' HB ' ' HA ' ' A' ' 222' ' ' ASN . 52.3 mt -96.95 122.61 48.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 108.506 -0.924 . . . . 62.0 108.506 176.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . 0.525 HG23 HG13 ' A' ' 218' ' ' VAL . 14.9 mt -130.09 135.4 61.03 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.061 0 CA-C-O 121.441 0.639 . . . . 72.120000000000005 112.487 177.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.559 ' HA ' ' O ' ' A' ' 159' ' ' ARG . 87.6 m -99.99 122.67 43.25 Favored 'General case' 0 N--CA 1.423 -1.784 0 CA-C-N 114.906 -1.043 . . . . 65.030000000000001 108.417 174.507 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.502 HG12 ' HA ' ' A' ' 218' ' ' VAL . 23.5 m -132.61 151.83 35.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 CA-C-O 121.347 0.594 . . . . 63.509999999999998 111.06 177.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . 0.78 ' HB3' ' HB3' ' A' ' 158' ' ' HIS . 1.4 ptmm? -126.79 128.69 24.21 Favored Pre-proline 0 C--N 1.28 -2.437 0 CA-C-N 114.286 -1.325 . . . . 64.239999999999995 109.045 174.194 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo . . . . . 0 N--CA 1.44 -1.637 0 C-N-CA 122.221 1.947 . . . . 74.319999999999993 110.291 176.952 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 1.3 m80 . . . . . 0 CA--C 1.505 -0.776 0 CA-C-O 121.134 0.492 . . . . 72.409999999999997 111.755 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -132.84 135.12 45.45 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 107.739 -1.208 . . . . 73.0 107.739 175.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 12.9 ptp180 -124.58 113.32 17.91 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-O 121.792 0.806 . . . . 72.200000000000003 110.14 178.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 23.7 m -107.41 138.25 34.48 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.922 0 CA-C-N 114.996 -1.002 . . . . 71.310000000000002 112.614 -178.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.486 ' HE ' ' HA ' ' A' ' 244' ' ' ASN . 0.1 OUTLIER -104.27 112.56 25.63 Favored 'General case' 0 N--CA 1.417 -2.076 0 N-CA-C 108.473 -0.936 . . . . 72.420000000000002 108.473 175.735 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.471 ' HB2' ' HB3' ' A' ' 245' ' ' LEU . 22.9 mt -101.01 139.89 36.07 Favored 'General case' 0 C--N 1.284 -2.239 0 CA-C-N 114.317 -1.31 . . . . 62.149999999999999 108.243 -175.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.554 HD12 ' O ' ' A' ' 242' ' ' SER . 0.6 OUTLIER . . . . . 0 N--CA 1.426 -1.673 0 N-CA-C 106.097 -1.816 . . . . 61.420000000000002 106.097 173.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.518 ' HG ' ' CD1' ' A' ' 245' ' ' LEU . 3.1 mm? . . . . . 0 CA--C 1.509 -0.599 0 N-CA-C 112.336 0.495 . . . . 51.229999999999997 112.336 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . 0.462 ' HA3' ' HA3' ' A' ' 204' ' ' GLY . . . 90.88 34.23 7.84 Favored Glycine 0 N--CA 1.422 -2.247 0 C-N-CA 120.672 -0.775 . . . . 73.239999999999995 112.929 177.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 26.0 p90 -152.93 154.38 34.9 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 108.805 -0.813 . . . . 73.109999999999999 108.805 175.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -128.12 150.87 49.79 Favored 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 108.322 -0.992 . . . . 73.430000000000007 108.322 175.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.646 ' H ' HD13 ' A' ' 176' ' ' ILE . 0.2 OUTLIER -116.4 169.21 7.1 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.081 0 CA-C-O 121.474 0.654 . . . . 73.200000000000003 111.276 -177.584 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.516 ' HG2' ' HB2' ' A' ' 198' ' ' SER . 4.3 ptp180 -147.98 155.2 41.26 Favored 'General case' 0 C--N 1.278 -2.524 0 C-N-CA 124.358 1.063 . . . . 62.240000000000002 109.884 -176.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -111.46 146.23 37.59 Favored 'General case' 0 C--N 1.294 -1.836 0 O-C-N 123.579 0.549 . . . . 52.100000000000001 110.135 179.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . 0.42 ' O ' ' HA ' ' A' ' 193' ' ' PRO . . . -159.61 -165.01 15.71 Favored Glycine 0 C--N 1.292 -1.914 0 N-CA-C 108.624 -1.791 . . . . 50.299999999999997 108.624 175.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . 0.463 ' HB ' ' CG ' ' A' ' 191' ' ' LYS . 3.1 p -103.9 125.65 50.46 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 118.46 1.13 . . . . 55.25 112.627 175.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 67.8 m . . . . . 0 N--CA 1.403 -2.784 0 N-CA-C 107.484 -1.302 . . . . 61.240000000000002 107.484 173.586 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.463 ' CG ' ' HB ' ' A' ' 180' ' ' THR . 36.2 ttmt . . . . . 0 N--CA 1.413 -2.295 0 N-CA-C 106.851 -1.537 . . . . 75.540000000000006 106.851 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . 0.404 HE22 ' HA ' ' A' ' 227' ' ' ALA . 12.4 pt20 -126.02 160.13 58.49 Favored Pre-proline 0 C--N 1.268 -2.945 0 N-CA-C 107.603 -1.258 . . . . 73.239999999999995 107.603 -176.428 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' PRO . . . . . 0.42 ' HA ' ' O ' ' A' ' 179' ' ' GLY . 13.8 Cg_endo -65.73 131.03 26.29 Favored 'Trans proline' 0 N--CA 1.416 -3.042 0 N-CA-C 107.861 -1.631 . . . . 71.109999999999999 107.861 168.443 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -122.47 138.76 12.14 Favored Glycine 0 N--CA 1.402 -3.621 0 N-CA-C 109.09 -1.604 . . . . 74.140000000000001 109.09 179.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.531 HG12 HG21 ' A' ' 234' ' ' VAL . 3.5 mp -104.05 132.16 51.18 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.626 0 C-N-CA 120.268 -0.573 . . . . 75.430000000000007 109.79 179.493 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -122.81 165.0 17.33 Favored 'General case' 0 C--N 1.284 -2.275 0 N-CA-C 108.188 -1.042 . . . . 74.409999999999997 108.188 -177.108 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . 0.434 ' HB ' ' HA ' ' A' ' 214' ' ' VAL . 46.8 mm -78.37 128.8 38.17 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 107.711 -1.218 . . . . 54.530000000000001 107.711 174.246 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . 0.516 ' HB2' ' HG2' ' A' ' 177' ' ' ARG . 11.4 t -100.99 -28.21 12.86 Favored 'General case' 0 C--N 1.28 -2.45 0 O-C-N 121.488 -0.758 . . . . 60.200000000000003 113.013 -177.573 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 25.3 tpt180 -163.07 140.11 7.55 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 120.878 -0.329 . . . . 74.230000000000004 110.333 -175.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 61.4 mt -105.33 137.53 42.98 Favored 'General case' 0 CA--C 1.491 -1.29 0 N-CA-C 108.964 -0.754 . . . . 72.329999999999998 108.964 172.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . 0.438 ' HB ' ' HA2' ' A' ' 173' ' ' GLY . 61.5 t -97.55 116.53 65.84 Favored Pre-proline 0 C--N 1.279 -2.463 0 N-CA-C 105.773 -1.936 . . . . 71.239999999999995 105.773 172.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . 0.639 ' HA ' ' OE1' ' A' ' 207' ' ' GLU . 21.1 Cg_endo -60.04 126.29 19.9 Favored 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 121.932 1.755 . . . . 63.140000000000001 111.707 -174.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 105.51 -9.08 44.64 Favored Glycine 0 C--N 1.307 -1.073 0 CA-C-N 115.421 -0.809 . . . . 53.219999999999999 111.104 -177.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . 0.462 ' HA3' ' HA3' ' A' ' 173' ' ' GLY . . . -74.77 167.55 54.82 Favored Glycine 0 N--CA 1.437 -1.248 0 C-N-CA 121.556 -0.354 . . . . 73.340000000000003 113.14 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -65.0 -29.16 70.07 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 124.281 1.032 . . . . 73.299999999999997 111.737 -177.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . 0.405 ' HA ' HD12 ' A' ' 212' ' ' LEU . . . -59.81 -40.73 89.38 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.863 -0.608 . . . . 73.099999999999994 110.57 177.286 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.639 ' OE1' ' HA ' ' A' ' 202' ' ' PRO . 46.3 mt-10 -75.5 -31.42 60.16 Favored 'General case' 0 CA--C 1.507 -0.694 0 CA-C-N 116.2 -0.454 . . . . 64.030000000000001 110.885 175.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 24.8 m -55.73 -36.96 67.81 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.162 -0.472 . . . . 72.519999999999996 111.417 -177.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . 0.523 HG23 ' H ' ' A' ' 211' ' ' LEU . 9.7 t -84.72 -32.68 23.39 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 109.281 -0.637 . . . . 53.0 109.281 174.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 73.32 21.02 80.02 Favored Glycine 0 CA--C 1.497 -1.058 0 CA-C-N 115.876 -0.602 . . . . 40.240000000000002 112.061 177.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.523 ' H ' HG23 ' A' ' 209' ' ' THR . 38.4 mt -114.31 -0.32 13.9 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 109.655 -0.498 . . . . 71.230000000000004 109.655 -178.431 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' A' ' 206' ' ' ALA . 74.0 mt -109.03 130.93 55.49 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 120.113 -0.635 . . . . 75.340000000000003 110.684 176.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -133.82 166.23 23.14 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 114.605 -1.179 . . . . 75.400000000000006 108.04 176.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . 0.434 ' HA ' ' HB ' ' A' ' 197' ' ' ILE . 26.4 m -59.33 -29.37 41.79 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-O 121.934 0.873 . . . . 73.310000000000002 111.416 176.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -72.65 -15.79 61.71 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 115.377 -0.829 . . . . 41.350000000000001 112.617 -175.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -69.31 137.82 53.29 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 113.602 0.964 . . . . 63.450000000000003 113.602 -176.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -112.92 124.66 53.12 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.795 1.638 . . . . 75.219999999999999 108.87 -178.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.582 ' HA ' HG12 ' A' ' 249' ' ' VAL . 8.2 p -80.1 146.47 7.63 Favored 'Isoleucine or valine' 0 C--O 1.251 1.168 0 N-CA-C 113.953 1.094 . . . . 72.430000000000007 113.953 -173.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.478 HD11 ' CD ' ' A' ' 250' ' ' LYS . 44.4 mm -111.46 -53.13 5.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 113.988 -1.46 . . . . 70.010000000000005 110.435 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -158.07 156.28 30.76 Favored 'General case' 0 C--O 1.244 0.794 0 CA-C-N 116.324 -0.398 . . . . 74.319999999999993 110.245 -176.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.426 ' HA ' ' O ' ' A' ' 246' ' ' ILE . 4.4 p -124.74 115.92 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.292 0 CA-C-O 121.586 0.707 . . . . 72.230000000000004 110.838 173.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . 0.44 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 21.4 t-20 58.95 34.61 23.71 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 126.124 1.77 . . . . 73.540000000000006 110.638 178.407 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 93.74 -4.83 72.73 Favored Glycine 0 C--N 1.301 -1.392 0 CA-C-N 115.165 -0.925 . . . . 71.329999999999998 113.172 177.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 58.1 mt -99.67 123.36 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.373 0 N-CA-C 108.628 -0.878 . . . . 73.150000000000006 108.628 179.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . 0.458 ' HG3' ' HE3' ' A' ' 229' ' ' LYS . 12.1 pt-20 -62.93 134.99 57.06 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 121.403 0.621 . . . . 73.030000000000001 110.741 -179.374 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 27.6 m -115.57 10.97 7.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-O 122.202 1.001 . . . . 72.400000000000006 109.611 175.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 227' ' ' ALA . . . . . 0.404 ' HA ' HE22 ' A' ' 192' ' ' GLN . . . -75.32 99.98 4.26 Favored 'General case' 0 N--CA 1.422 -1.83 0 CA-C-N 114.307 -1.315 . . . . 71.540000000000006 110.336 179.128 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 95.08 18.46 33.96 Favored Glycine 0 N--CA 1.438 -1.186 0 CA-C-N 115.489 -0.778 . . . . 71.25 112.919 175.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . 0.467 ' HB3' ' HG2' ' A' ' 233' ' ' GLN . 68.7 mmtt -95.63 172.2 8.2 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.963 0.382 . . . . 64.420000000000002 110.164 179.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . 0.666 ' OG1' ' HB2' ' A' ' 233' ' ' GLN . 40.6 p -76.1 162.57 27.9 Favored 'General case' 0 N--CA 1.433 -1.296 0 C-N-CA 120.33 -0.548 . . . . 72.230000000000004 109.55 175.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -68.6 -39.18 81.01 Favored 'General case' 0 N--CA 1.429 -1.514 0 N-CA-C 108.982 -0.747 . . . . 71.5 108.982 -179.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -61.29 -39.39 90.28 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 116.302 -0.408 . . . . 72.209999999999994 110.338 176.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 233' ' ' GLN . . . . . 0.666 ' HB2' ' OG1' ' A' ' 230' ' ' THR . 3.5 tp-100 -58.16 -50.95 71.73 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 123.947 0.899 . . . . 73.010000000000005 109.796 -177.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.531 HG21 HG12 ' A' ' 195' ' ' ILE . 13.0 m -73.67 -34.2 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-N 115.265 -0.88 . . . . 75.340000000000003 111.536 -174.05 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . 0.495 ' O ' HG23 ' A' ' 239' ' ' VAL . 53.0 m -74.75 -36.52 62.6 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 115.42 -0.809 . . . . 62.420000000000002 109.251 -175.326 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -58.77 -34.72 71.76 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-N 115.39 -0.823 . . . . 74.129999999999995 109.602 175.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 237' ' ' MET . . . . . 0.41 ' HB2' HG11 ' A' ' 221' ' ' VAL . 10.1 mtt -69.79 -50.27 44.66 Favored 'General case' 0 C--O 1.208 -1.128 0 N-CA-C 108.002 -1.11 . . . . 70.209999999999994 108.002 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 238' ' ' MET . . . . . 0.429 ' HG3' ' O ' ' A' ' 234' ' ' VAL . 64.4 mtt -54.47 -40.01 68.03 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 123.426 0.69 . . . . 75.420000000000002 111.791 -177.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 235' ' ' THR . 80.3 t -69.09 -48.91 66.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.158 0.504 . . . . 65.420000000000002 110.915 178.05 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -65.78 -28.9 69.36 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.908 -0.587 . . . . 43.409999999999997 111.705 -178.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 -84.68 21.56 1.5 Allowed 'General case' 0 C--O 1.2 -1.549 0 N-CA-C 113.174 0.805 . . . . 73.430000000000007 113.174 -179.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 242' ' ' SER . . . . . 0.554 ' O ' HD12 ' A' ' 164' ' ' LEU . 31.0 p -56.19 -23.76 37.34 Favored 'General case' 0 C--O 1.2 -1.54 0 N-CA-C 113.301 0.852 . . . . 75.340000000000003 113.301 177.36 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 19.4 m -71.28 -37.41 71.88 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 121.563 0.697 . . . . 63.329999999999998 110.214 177.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 244' ' ' ASN . . . . . 0.486 ' HA ' ' HE ' ' A' ' 162' ' ' ARG . 5.1 p30 -158.19 92.22 1.15 Allowed 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 123.922 0.889 . . . . 73.430000000000007 110.091 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.518 ' CD1' ' HG ' ' A' ' 172' ' ' LEU . 1.4 tt -88.64 103.75 16.22 Favored 'General case' 0 C--O 1.207 -1.145 0 N-CA-C 109.029 -0.73 . . . . 74.209999999999994 109.029 -175.472 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.44 ' HB ' ' HA ' ' A' ' 222' ' ' ASN . 58.7 mt -106.1 115.73 48.39 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 109.053 -0.721 . . . . 61.049999999999997 109.053 179.144 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . 0.493 HG23 HG23 ' A' ' 218' ' ' VAL . 32.1 mt -119.89 128.82 75.94 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 CA-C-O 121.472 0.653 . . . . 71.129999999999995 111.657 178.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 37.9 m -102.07 118.48 36.98 Favored 'General case' 0 N--CA 1.418 -2.066 0 CA-C-N 114.751 -1.113 . . . . 75.549999999999997 108.021 176.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.582 HG12 ' HA ' ' A' ' 218' ' ' VAL . 15.8 m -126.84 170.08 17.32 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.992 0 CA-C-O 121.793 0.806 . . . . 64.420000000000002 110.673 178.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . 0.478 ' CD ' HD11 ' A' ' 219' ' ' ILE 0.337 42.9 mtpt -125.72 152.4 72.21 Favored Pre-proline 0 C--N 1.271 -2.812 0 CA-C-N 113.492 -1.685 . . . . 74.310000000000002 106.67 174.897 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo . . . . . 0 N--CA 1.424 -2.566 0 N-CA-C 108.304 -1.46 . . . . 72.120000000000005 108.304 167.105 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.496 -1.098 0 N-CA-C 109.866 -0.42 . . . . 71.319999999999993 109.866 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.579 ' HA ' ' HE ' ' A' ' 159' ' ' ARG . 2.0 tpm_? -121.73 119.2 31.06 Favored 'General case' 0 N--CA 1.423 -1.799 0 N-CA-C 109.411 -0.588 . . . . 71.310000000000002 109.411 178.355 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 81.2 mtm180 -101.05 113.73 27.01 Favored 'General case' 0 C--N 1.281 -2.392 0 CA-C-N 115.123 -0.944 . . . . 70.310000000000002 109.507 179.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 23.6 m -119.67 139.23 47.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 CA-C-N 115.924 -0.58 . . . . 74.439999999999998 111.198 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.408 ' HG3' HG12 ' A' ' 246' ' ' ILE . 14.9 ttm180 -107.86 112.09 24.55 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.127 -1.064 . . . . 64.140000000000001 108.127 176.533 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.619 ' HB2' ' HB2' ' A' ' 245' ' ' LEU . 20.9 mt -103.03 139.87 38.02 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 108.323 -0.991 . . . . 64.299999999999997 108.323 -174.113 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.736 ' HG ' ' O ' ' A' ' 242' ' ' SER . 0.1 OUTLIER . . . . . 0 N--CA 1.443 -0.797 0 N-CA-C 105.911 -1.885 . . . . 61.350000000000001 105.911 -179.608 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.551 ' HG ' HD12 ' A' ' 245' ' ' LEU . 2.7 mm? . . . . . 0 N--CA 1.441 -0.89 0 N-CA-C 112.177 0.436 . . . . 51.340000000000003 112.177 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . 0.529 ' HA3' ' HA3' ' A' ' 204' ' ' GLY . . . 97.69 30.59 7.13 Favored Glycine 0 N--CA 1.44 -1.091 0 C-N-CA 120.258 -0.972 . . . . 75.129999999999995 112.968 177.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -147.55 155.8 42.21 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.239 -1.393 . . . . 74.200000000000003 107.239 174.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.414 ' HB2' ' HB3' ' A' ' 199' ' ' ARG . 92.4 m-85 -131.45 143.57 50.53 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 108.078 -1.082 . . . . 72.120000000000005 108.078 177.368 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.429 HD13 ' SD ' ' A' ' 238' ' ' MET . 30.2 pt -111.01 169.08 4.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 113.31 0.856 . . . . 75.019999999999996 113.31 -173.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.593 ' HB3' ' HB2' ' A' ' 198' ' ' SER . 2.9 ptp180 -142.87 155.02 44.69 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 114.765 -1.107 . . . . 62.329999999999998 109.982 -178.254 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . 0.586 ' HB2' ' HB2' ' A' ' 231' ' ' LEU . 11.5 t70 -109.46 138.53 45.67 Favored 'General case' 0 C--N 1.29 -2.014 0 O-C-N 124.082 0.864 . . . . 73.409999999999997 109.138 179.047 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -151.46 -178.99 26.77 Favored Glycine 0 C--N 1.273 -2.967 0 N-CA-C 108.07 -2.012 . . . . 43.299999999999997 108.07 175.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . 0.463 ' CG2' ' HG2' ' A' ' 191' ' ' LYS . 0.2 OUTLIER -109.59 122.36 47.27 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 106.581 -1.637 . . . . 71.510000000000005 106.581 177.128 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . 0.508 ' O ' ' HA ' ' A' ' 191' ' ' LYS . 33.0 t . . . . . 0 C--N 1.287 -2.141 0 N-CA-C 109.062 -0.718 . . . . 64.239999999999995 109.062 -176.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.508 ' HA ' ' O ' ' A' ' 181' ' ' SER . 32.9 ttmt . . . . . 0 N--CA 1.425 -1.675 0 N-CA-C 107.735 -1.209 . . . . 73.349999999999994 107.735 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . 0.492 ' HB2' ' HD2' ' A' ' 193' ' ' PRO . 9.0 pt20 -151.59 164.53 19.95 Favored Pre-proline 0 C--N 1.305 -1.347 0 N-CA-C 108.152 -1.055 . . . . 64.519999999999996 108.152 -174.569 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' PRO . . . . . 0.492 ' HD2' ' HB2' ' A' ' 192' ' ' GLN . 9.5 Cg_endo -54.55 131.71 47.13 Favored 'Trans proline' 0 C--O 1.249 1.073 0 C-N-CA 121.431 1.421 . . . . 75.349999999999994 111.582 178.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -143.02 132.69 5.15 Favored Glycine 0 N--CA 1.411 -2.975 0 N-CA-C 109.716 -1.354 . . . . 61.0 109.716 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.626 HG12 HG21 ' A' ' 234' ' ' VAL . 3.5 mp -105.17 138.85 28.21 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.438 0 CA-C-O 121.112 0.482 . . . . 74.129999999999995 109.92 -179.599 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -132.34 167.66 19.48 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 107.285 -1.376 . . . . 73.340000000000003 107.285 -176.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . 0.401 ' CG2' ' HA ' ' A' ' 214' ' ' VAL . 50.2 mm -75.54 131.69 34.52 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 N-CA-C 108.452 -0.944 . . . . 75.019999999999996 108.452 173.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . 0.593 ' HB2' ' HB3' ' A' ' 177' ' ' ARG . 21.0 t -108.31 -25.24 11.12 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.792 -0.568 . . . . 54.109999999999999 111.926 178.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . 0.414 ' HB3' ' HB2' ' A' ' 175' ' ' TYR . 68.7 ttt180 -154.05 142.35 20.53 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 109.266 -0.642 . . . . 62.43 109.266 179.326 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 50.5 tp -125.32 133.02 52.76 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 108.629 -0.878 . . . . 70.230000000000004 108.629 178.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 62.1 t -110.37 121.14 42.28 Favored Pre-proline 0 C--O 1.248 1.007 0 CA-C-N 116.766 -0.197 . . . . 61.509999999999998 110.766 -177.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . 0.525 ' HA ' ' HG2' ' A' ' 207' ' ' GLU . 28.7 Cg_exo -62.43 131.75 35.32 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 122.229 1.953 . . . . 71.340000000000003 110.065 175.341 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 106.17 -17.82 40.27 Favored Glycine 0 N--CA 1.434 -1.485 0 N-CA-C 110.2 -1.16 . . . . 52.299999999999997 110.2 -175.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . 0.529 ' HA3' ' HA3' ' A' ' 173' ' ' GLY . . . -83.87 161.24 38.01 Favored Glycine 0 N--CA 1.428 -1.894 0 N-CA-C 110.329 -1.108 . . . . 71.140000000000001 110.329 176.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.426 ' O ' HG22 ' A' ' 209' ' ' THR . 3.1 mm? -58.9 -37.66 77.11 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 123.288 0.635 . . . . 74.310000000000002 111.599 -177.398 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -62.08 -47.28 85.35 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 116.071 -0.513 . . . . 73.430000000000007 112.112 -179.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.525 ' HG2' ' HA ' ' A' ' 202' ' ' PRO . 9.7 tp10 -75.28 -33.22 61.21 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.454 -0.573 . . . . 74.439999999999998 109.454 178.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 38.6 t -57.76 -48.17 80.41 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 116.059 -0.519 . . . . 42.420000000000002 110.208 177.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . 0.426 HG22 ' O ' ' A' ' 205' ' ' LEU . 9.1 t -73.54 -40.42 63.99 Favored 'General case' 0 N--CA 1.437 -1.089 0 C-N-CA 120.098 -0.641 . . . . 63.229999999999997 110.201 176.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 83.35 -9.19 61.99 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.78 -0.724 . . . . 61.130000000000003 111.908 178.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 59.7 mt -77.75 -9.82 59.22 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.315 0.578 . . . . 74.340000000000003 110.013 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.453 HD11 HD11 ' A' ' 163' ' ' LEU . 79.6 mt -109.4 132.95 53.65 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 108.396 -0.964 . . . . 74.349999999999994 108.396 173.021 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -131.44 166.06 22.15 Favored 'General case' 0 N--CA 1.421 -1.914 0 N-CA-C 109.048 -0.723 . . . . 72.400000000000006 109.048 178.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . 0.401 ' HA ' ' CG2' ' A' ' 197' ' ' ILE . 28.4 m -64.01 -30.29 49.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 115.193 1.553 . . . . 63.409999999999997 115.193 -175.251 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -82.26 -13.24 57.34 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 113.798 1.036 . . . . 63.509999999999998 113.798 -179.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -59.54 141.74 54.17 Favored 'General case' 0 C--O 1.245 0.833 0 N-CA-C 114.578 1.325 . . . . 73.109999999999999 114.578 -176.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -106.75 131.44 53.87 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 125.91 1.684 . . . . 73.019999999999996 109.008 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.576 ' HA ' HG12 ' A' ' 249' ' ' VAL . 7.2 p -85.48 136.83 21.98 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-O 121.668 0.747 . . . . 63.43 112.554 -174.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.518 HD11 ' CD ' ' A' ' 250' ' ' LYS . 39.8 mm -103.37 -52.36 8.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.087 -0.961 . . . . 65.439999999999998 111.35 -179.044 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.424 ' HB3' ' HA ' ' A' ' 225' ' ' GLU . 9.3 pt-20 -155.83 154.62 31.6 Favored 'General case' 0 C--O 1.248 0.988 0 CA-C-N 116.465 -0.334 . . . . 75.140000000000001 111.219 -177.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.497 HG12 ' CG1' ' A' ' 226' ' ' VAL . 10.5 p -129.57 121.01 51.96 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.197 0 CA-C-O 121.438 0.637 . . . . 73.420000000000002 110.67 176.6 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . 0.416 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 11.6 t-20 66.99 12.99 9.3 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 125.256 1.422 . . . . 74.310000000000002 111.599 175.312 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 112.69 -18.19 22.53 Favored Glycine 0 N--CA 1.437 -1.255 0 C-N-CA 120.729 -0.748 . . . . 45.340000000000003 111.726 -179.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 62.9 mt -92.55 124.87 45.15 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.501 0 N-CA-C 108.601 -0.889 . . . . 74.329999999999998 108.601 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . 0.424 ' HA ' ' HB3' ' A' ' 220' ' ' GLU . 12.6 pt-20 -65.41 137.86 57.75 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-O 121.237 0.541 . . . . 74.519999999999996 110.372 179.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . 0.497 ' CG1' HG12 ' A' ' 221' ' ' VAL . 28.6 m -115.28 0.48 8.66 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 CA-C-O 121.595 0.712 . . . . 71.430000000000007 110.543 178.124 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -84.11 97.55 9.4 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-N 115.442 -0.799 . . . . 73.340000000000003 109.459 179.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 123.0 -17.9 8.02 Favored Glycine 0 C--N 1.313 -0.738 0 N-CA-C 110.704 -0.958 . . . . 54.219999999999999 110.704 -178.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -77.91 173.01 12.61 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 109.159 -0.682 . . . . 61.409999999999997 109.159 176.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . 0.519 ' O ' HG13 ' A' ' 234' ' ' VAL . 74.7 p -94.21 163.73 13.33 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 108.312 -0.996 . . . . 62.409999999999997 108.312 178.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . 0.586 ' HB2' ' HB2' ' A' ' 178' ' ' ASP . 3.4 tm? -60.07 -38.67 83.57 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 109.778 -0.453 . . . . 73.329999999999998 109.778 178.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -62.52 -43.16 99.49 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.153 -0.476 . . . . 74.140000000000001 110.246 178.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -63.31 -48.59 77.42 Favored 'General case' 0 C--N 1.344 0.337 0 N-CA-C 113.113 0.783 . . . . 72.340000000000003 113.113 176.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.626 HG21 HG12 ' A' ' 195' ' ' ILE . 6.6 m -65.82 -33.59 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-O 121.272 0.558 . . . . 72.450000000000003 112.321 -174.607 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 60.2 m -74.08 -36.82 64.31 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.875 -0.787 . . . . 60.450000000000003 108.875 -175.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -61.09 -34.67 75.31 Favored 'General case' 0 CA--C 1.5 -0.948 0 CA-C-N 115.091 -0.959 . . . . 65.409999999999997 109.392 177.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 237' ' ' MET . . . . . 0.431 ' HG3' ' HA ' ' A' ' 234' ' ' VAL . 12.9 mtt -69.14 -46.91 66.46 Favored 'General case' 0 C--O 1.204 -1.321 0 N-CA-C 108.48 -0.933 . . . . 72.530000000000001 108.48 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 238' ' ' MET . . . . . 0.454 ' HA ' HD21 ' A' ' 245' ' ' LEU . 62.1 mtt -61.33 -42.17 98.24 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.986 -0.552 . . . . 72.0 111.654 -176.69 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 87.5 t -64.2 -40.4 88.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 O-C-N 123.328 0.392 . . . . 74.430000000000007 110.458 178.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -69.6 -38.01 77.12 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.444 0.64 . . . . 71.430000000000007 110.365 178.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -85.6 21.4 1.83 Allowed 'General case' 0 C--O 1.202 -1.409 0 CA-C-N 115.522 -0.763 . . . . 51.420000000000002 112.076 -179.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 242' ' ' SER . . . . . 0.736 ' O ' ' HG ' ' A' ' 164' ' ' LEU . 29.4 p -64.75 -21.33 66.74 Favored 'General case' 0 C--O 1.208 -1.108 0 N-CA-C 109.619 -0.512 . . . . 71.329999999999998 109.619 172.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 47.4 t -62.76 -35.52 80.09 Favored 'General case' 0 CA--C 1.551 1.016 0 N-CA-C 108.85 -0.796 . . . . 43.509999999999998 108.85 173.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -177.14 106.87 0.06 Allowed 'General case' 0 C--O 1.246 0.902 0 C-N-CA 124.08 0.952 . . . . 64.010000000000005 111.277 177.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.619 ' HB2' ' HB2' ' A' ' 163' ' ' LEU . 11.8 mt -86.67 129.52 34.84 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 115.364 -0.835 . . . . 74.230000000000004 111.025 179.481 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.416 ' HB ' ' HA ' ' A' ' 222' ' ' ASN . 66.3 mt -118.62 113.72 42.66 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.618 0 N-CA-C 105.044 -2.206 . . . . 73.25 105.044 167.381 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 64.3 mt -122.22 135.52 62.05 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.257 0 CA-C-O 121.313 0.578 . . . . 72.129999999999995 111.699 -176.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.479 ' HA ' ' O ' ' A' ' 159' ' ' ARG . 58.3 m -112.14 118.29 34.94 Favored 'General case' 0 N--CA 1.416 -2.154 0 N-CA-C 108.251 -1.018 . . . . 75.329999999999998 108.251 175.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.576 HG12 ' HA ' ' A' ' 218' ' ' VAL . 17.7 m -121.22 170.51 11.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 CA-C-O 121.436 0.636 . . . . 65.319999999999993 110.469 176.278 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . 0.518 ' CD ' HD11 ' A' ' 219' ' ' ILE 0.336 43.0 mtpt -126.69 144.15 48.89 Favored Pre-proline 0 C--N 1.28 -2.435 0 CA-C-N 113.965 -1.471 . . . . 72.439999999999998 107.44 174.165 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo . . . . . 0 N--CA 1.424 -2.597 0 N-CA-C 108.035 -1.563 . . . . 71.439999999999998 108.035 167.632 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.238 0.493 0 N-CA-C 106.712 -1.588 . . . . 74.25 106.712 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 38.0 p -67.2 -32.92 74.31 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 116.553 2.057 . . . . 74.540000000000006 116.553 -172.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.574 ' HB3' ' HG2' ' A' ' 250' ' ' LYS 0.311 2.2 p-80 -96.87 140.17 31.82 Favored 'General case' 0 CA--C 1.505 -0.776 0 N-CA-C 116.043 1.868 . . . . 75.239999999999995 116.043 -173.394 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 57.9 ttt180 -126.77 144.56 50.91 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 114.135 -1.393 . . . . 75.140000000000001 109.284 176.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.574 ' HG3' ' OG1' ' A' ' 248' ' ' THR . 0.1 OUTLIER -90.23 114.29 26.27 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 108.201 -1.037 . . . . 63.109999999999999 108.201 179.282 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.402 HG11 ' HB2' ' A' ' 211' ' ' LEU . 29.7 m -109.21 136.38 45.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-O 120.733 0.301 . . . . 74.430000000000007 111.215 179.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -99.08 121.71 41.35 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-O 121.516 0.674 . . . . 74.439999999999998 110.073 178.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.492 ' HB2' ' HB3' ' A' ' 245' ' ' LEU . 18.6 mt -104.24 137.06 42.71 Favored 'General case' 0 N--CA 1.403 -2.806 0 N-CA-C 106.637 -1.616 . . . . 70.140000000000001 106.637 177.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.46 HD23 ' O ' ' A' ' 242' ' ' SER . 14.2 tp 69.67 99.82 0.06 Allowed 'General case' 0 C--N 1.288 -2.099 0 N-CA-C 114.264 1.209 . . . . 71.540000000000006 114.264 177.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 24.3 pttm -132.5 -0.7 3.55 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 114.386 -1.279 . . . . 70.310000000000002 108.184 169.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 22.5 t-80 -174.54 117.26 0.2 Allowed 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 114.402 -1.272 . . . . 64.329999999999998 108.801 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 123.66 60.91 0.19 Allowed Glycine 0 C--N 1.301 -1.384 0 C-N-CA 120.412 -0.899 . . . . 60.310000000000002 112.526 177.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 16.3 p -83.27 -4.18 58.18 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-O 121.195 0.521 . . . . 62.299999999999997 111.989 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -85.23 -38.8 18.51 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.971 -0.559 . . . . 55.210000000000001 109.845 178.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -80.76 153.91 73.12 Favored Pre-proline 0 N--CA 1.437 -1.09 0 CA-C-N 115.56 -0.746 . . . . 55.25 109.024 -179.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -68.91 153.36 72.8 Favored 'Trans proline' 0 C--O 1.247 0.949 0 C-N-CA 121.995 1.797 . . . . 61.340000000000003 110.688 174.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 89.5 mt -57.81 -31.85 67.0 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.452 -0.34 . . . . 75.349999999999994 111.863 179.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . 0.533 ' HA3' ' HA3' ' A' ' 204' ' ' GLY . . . 93.91 22.35 25.84 Favored Glycine 0 N--CA 1.429 -1.793 0 C-N-CA 120.115 -1.041 . . . . 61.140000000000001 114.169 173.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -160.18 154.1 22.97 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 117.74 0.77 . . . . 75.25 109.157 177.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -123.86 153.56 40.9 Favored 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 107.403 -1.332 . . . . 72.310000000000002 107.403 177.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 39.9 pt -113.73 166.62 7.39 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 CA-C-O 121.38 0.609 . . . . 72.530000000000001 111.021 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.468 ' HG2' ' HB3' ' A' ' 198' ' ' SER . 16.2 ptt180 -147.12 154.75 41.49 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 115.286 -0.87 . . . . 62.450000000000003 109.833 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -110.32 142.79 41.47 Favored 'General case' 0 C--N 1.29 -1.998 0 O-C-N 123.901 0.75 . . . . 63.119999999999997 109.69 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -159.48 160.89 31.76 Favored Glycine 0 C--N 1.289 -2.072 0 N-CA-C 108.898 -1.681 . . . . 70.019999999999996 108.898 177.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . 0.521 HG22 ' HG2' ' A' ' 191' ' ' LYS . 0.6 OUTLIER -90.82 123.6 34.49 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.169 -1.419 . . . . 74.409999999999997 107.169 178.844 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . 0.497 ' O ' ' HA ' ' A' ' 191' ' ' LYS . 22.8 t -103.1 126.3 50.21 Favored 'General case' 0 C--N 1.283 -2.302 0 C-N-CA 123.311 0.644 . . . . 72.120000000000005 109.619 -175.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.64 ' HA ' ' O ' ' A' ' 190' ' ' GLU . 7.3 p -104.72 122.45 57.78 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.214 0 C-N-CA 119.635 -0.826 . . . . 61.210000000000001 109.136 172.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 87.6 mtt180 -132.48 160.07 37.53 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 107.454 -1.313 . . . . 75.340000000000003 107.454 -176.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 90.6 t -89.56 118.98 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.796 0 N-CA-C 107.826 -1.176 . . . . 61.350000000000001 107.826 171.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 40.0 p -117.56 -174.88 2.71 Favored 'General case' 0 C--N 1.268 -2.971 0 CA-C-N 114.616 -1.175 . . . . 64.230000000000004 108.383 -177.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -64.64 -17.5 64.09 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.217 0.532 . . . . 63.439999999999998 109.612 175.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 18.4 m -92.08 -16.12 26.84 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-N 115.66 -0.7 . . . . 72.230000000000004 110.79 178.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 117.29 -154.27 16.81 Favored Glycine 0 CA--C 1.495 -1.219 0 N-CA-C 110.436 -1.065 . . . . 72.120000000000005 110.436 -178.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 5.0 mp -78.69 117.21 19.62 Favored 'General case' 0 CA--C 1.498 -1.04 0 N-CA-C 106.847 -1.538 . . . . 63.210000000000001 106.847 176.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . 0.64 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 9.2 tp10 -133.34 127.19 33.0 Favored 'General case' 0 C--N 1.288 -2.075 0 N-CA-C 109.052 -0.721 . . . . 54.200000000000003 109.052 -173.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.521 ' HG2' HG22 ' A' ' 180' ' ' THR . 34.0 ttmt -100.23 129.14 46.21 Favored 'General case' 0 N--CA 1.426 -1.631 0 N-CA-C 106.771 -1.566 . . . . 73.219999999999999 106.771 178.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.44 158.6 37.88 Favored Pre-proline 0 C--N 1.307 -1.27 0 CA-C-O 118.899 -0.572 . . . . 62.530000000000001 110.153 -169.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -67.42 130.42 22.36 Favored 'Trans proline' 0 C--O 1.25 1.099 0 CA-C-N 119.941 1.015 . . . . 53.219999999999999 111.645 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -142.88 151.11 22.88 Favored Glycine 0 N--CA 1.412 -2.956 0 CA-C-N 115.393 -0.822 . . . . 34.340000000000003 111.357 -177.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.582 HG12 HG21 ' A' ' 234' ' ' VAL . 2.7 mp -104.13 136.91 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.286 0 N-CA-C 109.535 -0.543 . . . . 63.219999999999999 109.535 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -127.21 164.75 20.99 Favored 'General case' 0 C--N 1.28 -2.434 0 N-CA-C 107.393 -1.336 . . . . 74.329999999999998 107.393 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 42.6 mm -76.46 131.43 34.89 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 N-CA-C 106.896 -1.52 . . . . 53.100000000000001 106.896 175.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . 0.468 ' HB3' ' HG2' ' A' ' 177' ' ' ARG . 75.7 p -100.92 -41.1 6.96 Favored 'General case' 0 C--N 1.287 -2.142 0 C-N-CA 118.612 -1.235 . . . . 70.299999999999997 111.092 -177.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 31.6 tpt180 -148.32 141.32 24.87 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.302 -0.999 . . . . 64.409999999999997 108.302 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 2.6 tt -122.25 123.58 41.78 Favored 'General case' 0 N--CA 1.421 -1.882 0 N-CA-C 106.672 -1.603 . . . . 74.340000000000003 106.672 178.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 36.5 t -105.85 126.76 29.87 Favored Pre-proline 0 C--N 1.307 -1.273 0 C-N-CA 122.559 0.344 . . . . 55.509999999999998 111.33 -172.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.513 ' HA ' ' HG3' ' A' ' 207' ' ' GLU . 45.0 Cg_endo -70.82 128.51 15.15 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 122.395 2.063 . . . . 73.400000000000006 110.954 176.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 114.38 -18.04 18.36 Favored Glycine 0 N--CA 1.439 -1.102 0 N-CA-C 110.47 -1.052 . . . . 63.109999999999999 110.47 -177.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . 0.533 ' HA3' ' HA3' ' A' ' 173' ' ' GLY . . . -96.04 171.42 28.47 Favored Glycine 0 N--CA 1.433 -1.525 0 N-CA-C 110.517 -1.033 . . . . 70.140000000000001 110.517 178.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.418 ' H ' HD22 ' A' ' 205' ' ' LEU . 2.7 mm? -65.22 -29.79 70.62 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 117.267 0.534 . . . . 74.430000000000007 112.084 -174.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -62.75 -44.41 96.27 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.996 -0.547 . . . . 62.43 110.97 178.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.513 ' HG3' ' HA ' ' A' ' 202' ' ' PRO . 2.9 tm-20 -75.9 -33.75 59.94 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.375 -0.972 . . . . 73.239999999999995 108.375 179.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 50.4 m -56.83 -42.48 79.68 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 116.298 -0.41 . . . . 73.319999999999993 110.803 177.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 13.9 t -73.34 -40.91 64.06 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 119.095 -1.042 . . . . 73.319999999999993 108.442 174.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 56.18 29.61 56.48 Favored Glycine 0 C--N 1.347 1.193 0 CA-C-N 115.908 -0.587 . . . . 72.230000000000004 113.24 177.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.402 ' HB2' HG11 ' A' ' 161' ' ' VAL . 68.2 mt -103.39 -12.67 17.04 Favored 'General case' 0 C--N 1.308 -1.228 0 O-C-N 122.674 -0.31 . . . . 71.310000000000002 110.299 -178.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.488 HD23 ' H ' ' A' ' 212' ' ' LEU . 2.0 pt? -113.68 158.07 21.36 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 115.484 -0.78 . . . . 43.310000000000002 109.552 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -130.46 165.59 22.32 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 123.047 0.539 . . . . 60.43 110.157 179.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 34.5 m -63.69 -30.07 48.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 113.599 0.963 . . . . 61.229999999999997 113.599 -179.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -76.77 -15.06 59.85 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 116.203 -0.453 . . . . 53.109999999999999 111.703 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -68.17 147.58 52.07 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-O 121.64 0.733 . . . . 50.509999999999998 112.649 -175.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -108.59 133.94 52.03 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.638 -1.164 . . . . 64.409999999999997 111.27 -177.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.487 ' HA ' HG12 ' A' ' 249' ' ' VAL . 39.8 t -83.62 133.96 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-O 121.811 0.815 . . . . 41.210000000000001 111.2 -175.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.438 HG13 ' ND1' ' A' ' 158' ' ' HIS . 46.8 mm -102.97 -56.47 5.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 CA-C-N 114.656 -1.156 . . . . 74.549999999999997 110.996 -178.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -152.37 165.19 35.77 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.986 -0.552 . . . . 61.32 109.934 -175.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.521 ' HA ' ' O ' ' A' ' 246' ' ' ILE . 8.9 p -134.8 123.88 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 CA-C-N 115.92 -0.582 . . . . 65.450000000000003 110.052 177.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . 0.426 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 12.8 t-20 65.44 13.52 8.9 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 125.241 1.416 . . . . 75.420000000000002 110.706 177.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 107.0 -9.4 39.69 Favored Glycine 0 N--CA 1.442 -0.933 0 C-N-CA 120.84 -0.695 . . . . 74.299999999999997 112.079 -178.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 64.4 mt -105.06 124.27 59.69 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 N-CA-C 110.13 -0.322 . . . . 72.219999999999999 110.13 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -57.2 142.58 42.36 Favored 'General case' 0 C--N 1.31 -1.126 0 C-N-CA 124.483 1.113 . . . . 65.109999999999999 112.6 -178.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 30.6 m -118.91 -1.68 8.99 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 CA-C-N 115.525 -0.761 . . . . 73.230000000000004 109.8 175.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -76.92 99.04 5.09 Favored 'General case' 0 N--CA 1.428 -1.546 0 CA-C-N 115.356 -0.838 . . . . 74.230000000000004 109.719 -177.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 118.9 -14.0 11.41 Favored Glycine 0 N--CA 1.435 -1.39 0 C-N-CA 120.839 -0.696 . . . . 63.530000000000001 111.729 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -76.97 -179.93 5.81 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 120.987 0.422 . . . . 75.299999999999997 110.654 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . 0.444 ' O ' HG13 ' A' ' 234' ' ' VAL . 50.6 p -95.53 162.73 13.51 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 108.187 -1.042 . . . . 45.119999999999997 108.187 177.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -63.59 -33.26 75.22 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 109.067 -0.716 . . . . 75.219999999999999 109.067 -178.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -63.42 -49.7 72.7 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.516 -0.311 . . . . 61.439999999999998 110.293 176.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' GLN . . . . . 0.568 ' O ' ' HG2' ' A' ' 237' ' ' MET . 47.9 mt-30 -57.28 -41.72 80.32 Favored 'General case' 0 CA--C 1.509 -0.625 0 N-CA-C 112.447 0.536 . . . . 75.5 112.447 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.582 HG21 HG12 ' A' ' 195' ' ' ILE . 10.2 m -74.3 -34.57 37.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 C-N-CA 120.764 -0.375 . . . . 75.319999999999993 111.399 -177.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . 0.407 ' O ' HG23 ' A' ' 239' ' ' VAL . 26.0 m -71.14 -38.04 72.27 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 108.368 -0.975 . . . . 74.019999999999996 108.368 178.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -59.86 -35.6 75.14 Favored 'General case' 0 C--O 1.243 0.746 0 CA-C-N 115.385 -0.825 . . . . 74.510000000000005 110.144 177.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' MET . . . . . 0.568 ' HG2' ' O ' ' A' ' 233' ' ' GLN . 17.3 mmt -59.78 -52.43 65.49 Favored 'General case' 0 C--O 1.199 -1.576 0 N-CA-C 108.065 -1.087 . . . . 73.430000000000007 108.065 175.293 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 63.4 mtt -61.57 -36.96 82.13 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.754 -1.112 . . . . 73.409999999999997 112.422 -175.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 235' ' ' THR . 83.9 t -68.49 -36.8 76.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-O 121.396 0.617 . . . . 74.430000000000007 110.287 176.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -74.48 -36.4 63.29 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.905 0.859 . . . . 72.540000000000006 110.11 179.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -87.75 22.13 2.39 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 114.945 -1.025 . . . . 75.109999999999999 110.607 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . 0.46 ' O ' HD23 ' A' ' 164' ' ' LEU . 25.5 p -59.86 -28.2 67.31 Favored 'General case' 0 CA--C 1.554 1.13 0 N-CA-C 113.691 0.997 . . . . 52.450000000000003 113.691 -177.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 48.7 m -85.55 -9.28 57.59 Favored 'General case' 0 C--N 1.318 -0.789 0 O-C-N 121.672 -0.642 . . . . 73.329999999999998 112.038 177.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 14.8 p30 -164.56 78.24 0.35 Allowed 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.524 0.678 . . . . 71.019999999999996 111.376 -176.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.492 ' HB3' ' HB2' ' A' ' 163' ' ' LEU . 1.2 tt -85.54 101.89 13.06 Favored 'General case' 0 N--CA 1.422 -1.844 0 C-N-CA 118.721 -1.192 . . . . 75.209999999999994 108.059 -174.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.521 ' O ' ' HA ' ' A' ' 221' ' ' VAL . 68.7 mt -104.7 116.15 47.96 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.319 0 C-N-CA 119.713 -0.795 . . . . 53.130000000000003 108.963 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . 0.467 HG13 ' CD2' ' A' ' 245' ' ' LEU . 23.2 mt -118.53 136.91 54.2 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.257 0 CA-C-O 121.627 0.727 . . . . 60.240000000000002 111.477 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.574 ' OG1' ' HG3' ' A' ' 160' ' ' ARG . 39.0 m -107.74 119.34 39.16 Favored 'General case' 0 N--CA 1.405 -2.713 0 CA-C-N 115.073 -0.967 . . . . 61.340000000000003 108.573 177.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.487 HG12 ' HA ' ' A' ' 218' ' ' VAL . 27.1 m -129.29 159.32 41.45 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 O-C-N 123.282 0.364 . . . . 64.439999999999998 110.296 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.574 ' HG2' ' HB3' ' A' ' 158' ' ' HIS 0.346 35.7 mtmt -124.09 142.26 39.33 Favored Pre-proline 0 CA--C 1.475 -1.919 0 N-CA-C 104.435 -2.431 . . . . 75.409999999999997 104.435 175.538 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -79.13 141.44 16.4 Favored 'Trans proline' 0 C--N 1.286 -2.747 0 C-N-CA 120.871 1.047 . . . . 63.109999999999999 111.364 176.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -66.82 -30.65 70.89 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.402 0.62 . . . . 53.530000000000001 110.341 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -92.06 20.46 5.84 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.202 -0.908 . . . . 72.349999999999994 109.024 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 14.7 mt-30 61.04 -178.48 0.11 Allowed 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 125.321 1.448 . . . . 71.340000000000003 112.767 -176.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 16.6 tpt180 . . . . . 0 C--N 1.31 -1.113 0 C-N-CA 119.585 -0.846 . . . . 72.099999999999994 110.513 -172.95 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 . . . . . 0 CA--C 1.509 -0.614 0 N-CA-C 109.249 -0.648 . . . . 71.400000000000006 109.249 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 47.1 p -65.61 -48.93 70.58 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 112.643 0.609 . . . . 72.549999999999997 112.643 -176.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.575 ' HB3' ' HG2' ' A' ' 250' ' ' LYS 0.374 2.3 p-80 -123.66 137.74 54.66 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 115.397 1.629 . . . . 44.109999999999999 115.397 177.353 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.535 ' O ' ' HA ' ' A' ' 248' ' ' THR . 3.7 ptp180 -125.25 144.96 50.21 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 113.575 -1.648 . . . . 74.310000000000002 108.944 -176.029 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.705 ' HB3' ' OG1' ' A' ' 248' ' ' THR . 37.0 ptt180 -117.27 119.25 34.58 Favored 'General case' 0 N--CA 1.426 -1.627 0 CA-C-O 121.901 0.858 . . . . 72.409999999999997 113.05 178.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.582 ' O ' ' HA ' ' A' ' 246' ' ' ILE . 26.6 m -102.78 135.02 42.12 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 CA-C-N 114.617 -1.174 . . . . 74.319999999999993 111.075 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.523 ' HG2' HG12 ' A' ' 246' ' ' ILE . 15.4 mtm180 -96.48 112.66 24.32 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 106.927 -1.508 . . . . 65.420000000000002 106.927 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 21.4 mt -99.34 134.23 42.5 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 109.52 -0.548 . . . . 75.439999999999998 109.52 -177.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.524 HD11 ' HA ' ' A' ' 168' ' ' SER . 6.3 tt 77.38 101.86 0.07 Allowed 'General case' 0 C--N 1.318 -0.774 0 O-C-N 124.344 1.027 . . . . 72.150000000000006 111.893 174.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 57.7 pttt -129.61 6.86 5.22 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 114.504 -1.226 . . . . 64.540000000000006 108.047 173.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -144.3 97.66 3.08 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.712 -1.131 . . . . 75.25 110.323 -178.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 89.83 99.29 1.09 Allowed Glycine 0 C--O 1.21 -1.345 0 N-CA-C 111.352 -0.699 . . . . 64.329999999999998 111.352 176.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . 0.524 ' HA ' HD11 ' A' ' 164' ' ' LEU . 17.2 t -94.56 -172.83 2.86 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 117.087 0.444 . . . . 73.230000000000004 109.804 -177.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 18.9 t70 72.91 -35.9 0.34 Allowed 'General case' 0 N--CA 1.497 1.918 0 C-N-CA 124.952 1.301 . . . . 74.129999999999995 112.437 -178.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 13.4 ptmm? -72.34 154.55 91.91 Favored Pre-proline 0 C--N 1.31 -1.149 0 C-N-CA 124.271 1.028 . . . . 72.219999999999999 111.789 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -57.7 154.06 39.33 Favored 'Trans proline' 0 C--O 1.258 1.494 0 C-N-CA 123.553 2.835 . . . . 53.229999999999997 112.55 178.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.47 ' HG ' ' CD1' ' A' ' 245' ' ' LEU . 2.9 mm? -91.03 -23.88 20.23 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.164 -0.926 . . . . 75.25 111.021 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . 0.454 ' HA3' ' HA3' ' A' ' 204' ' ' GLY . . . 89.24 43.97 5.15 Favored Glycine 0 N--CA 1.436 -1.346 0 C-N-CA 120.592 -0.813 . . . . 75.209999999999994 113.983 174.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -161.94 154.76 20.2 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.627 -1.249 . . . . 64.319999999999993 107.627 174.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -123.95 157.88 33.3 Favored 'General case' 0 C--N 1.282 -2.353 0 N-CA-C 108.533 -0.914 . . . . 74.519999999999996 108.533 177.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.582 ' H ' HD13 ' A' ' 176' ' ' ILE . 0.1 OUTLIER -123.72 160.52 27.28 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 N-CA-C 109.571 -0.529 . . . . 61.310000000000002 109.571 179.944 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.462 ' HB3' ' HB3' ' A' ' 198' ' ' SER . 10.1 ptp180 -132.21 154.64 49.38 Favored 'General case' 0 C--N 1.282 -2.355 0 CA-C-N 115.656 -0.702 . . . . 74.230000000000004 110.684 -178.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . 0.497 ' HB2' ' HG ' ' A' ' 231' ' ' LEU . 4.8 t70 -107.41 143.92 35.06 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 115.085 -0.961 . . . . 52.32 110.509 -179.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -164.92 179.79 39.35 Favored Glycine 0 N--CA 1.415 -2.715 0 N-CA-C 108.871 -1.692 . . . . 52.130000000000003 108.871 175.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . 0.462 ' HB ' ' CG ' ' A' ' 191' ' ' LYS . 0.4 OUTLIER -89.99 122.34 32.91 Favored 'General case' 0 C--N 1.283 -2.301 0 CA-C-N 117.524 0.662 . . . . 71.420000000000002 111.024 175.667 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 47.3 t -99.5 113.18 25.4 Favored 'General case' 0 N--CA 1.414 -2.265 0 N-CA-C 107.87 -1.159 . . . . 55.420000000000002 107.87 177.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.671 ' HA ' ' O ' ' A' ' 190' ' ' GLU . 6.4 p -115.49 123.89 71.43 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.733 0 CA-C-O 121.404 0.621 . . . . 55.119999999999997 109.441 175.026 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -124.68 158.45 33.13 Favored 'General case' 0 C--N 1.279 -2.47 0 N-CA-C 107.539 -1.282 . . . . 73.540000000000006 107.539 -177.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.41 HG22 ' HG ' ' A' ' 189' ' ' LEU . 78.2 t -92.52 118.34 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.237 0 N-CA-C 106.895 -1.52 . . . . 73.129999999999995 106.895 169.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 67.2 p -111.11 -175.11 2.63 Favored 'General case' 0 C--N 1.272 -2.773 0 N-CA-C 107.938 -1.134 . . . . 72.340000000000003 107.938 -178.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -71.59 -12.68 61.48 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 121.279 0.561 . . . . 53.039999999999999 109.568 175.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 32.1 t -97.34 -13.89 21.61 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-N 115.693 -0.685 . . . . 73.230000000000004 110.663 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 126.85 -153.98 19.11 Favored Glycine 0 CA--C 1.495 -1.198 0 N-CA-C 110.787 -0.925 . . . . 74.140000000000001 110.787 177.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.41 ' HG ' HG22 ' A' ' 184' ' ' VAL . 5.2 mp -87.78 123.7 32.85 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 107.911 -1.144 . . . . 53.329999999999998 107.911 176.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . 0.671 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 45.1 mt-10 -131.28 119.26 21.52 Favored 'General case' 0 CA--C 1.454 -2.719 0 CA-C-O 121.115 0.484 . . . . 72.409999999999997 111.131 -177.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.462 ' CG ' ' HB ' ' A' ' 180' ' ' THR . 35.5 ttmt -103.21 131.69 50.04 Favored 'General case' 0 C--N 1.274 -2.688 0 CA-C-N 114.168 -1.378 . . . . 72.400000000000006 107.785 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -151.09 164.98 18.39 Favored Pre-proline 0 C--N 1.293 -1.878 0 N-CA-C 108.256 -1.016 . . . . 72.5 108.256 -178.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -55.19 132.27 51.3 Favored 'Trans proline' 0 C--N 1.358 1.04 0 C-N-CA 121.637 1.558 . . . . 75.019999999999996 109.846 174.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -143.93 138.65 8.18 Favored Glycine 0 N--CA 1.409 -3.106 0 N-CA-C 111.38 -0.688 . . . . 71.129999999999995 111.38 -178.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.559 HG12 HG21 ' A' ' 234' ' ' VAL . 2.7 mp -103.63 134.52 44.59 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.94 0 CA-C-O 121.605 0.717 . . . . 72.140000000000001 110.883 179.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -124.27 166.17 16.36 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 106.149 -1.797 . . . . 71.230000000000004 106.149 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 47.8 mm -79.08 131.27 34.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 107.562 -1.273 . . . . 75.310000000000002 107.562 177.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . 0.462 ' HB3' ' HB3' ' A' ' 177' ' ' ARG . 82.3 p -101.64 -31.64 10.72 Favored 'General case' 0 C--N 1.287 -2.111 0 C-N-CA 118.633 -1.227 . . . . 43.130000000000003 112.752 -175.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 29.6 tpt180 -166.76 146.15 5.54 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 120.781 -0.368 . . . . 70.099999999999994 110.344 -175.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 82.9 mt -102.54 146.38 28.22 Favored 'General case' 0 CA--C 1.489 -1.381 0 N-CA-C 108.932 -0.766 . . . . 70.430000000000007 108.932 172.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 47.8 t -107.52 115.89 58.64 Favored Pre-proline 0 C--N 1.282 -2.337 0 N-CA-C 105.3 -2.111 . . . . 73.420000000000002 105.3 172.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.434 ' HA ' ' HG3' ' A' ' 207' ' ' GLU . 11.5 Cg_endo -55.03 128.67 31.53 Favored 'Trans proline' 0 C--O 1.248 0.98 0 C-N-CA 122.335 2.023 . . . . 75.25 111.129 -177.118 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 99.05 -11.4 62.17 Favored Glycine 0 N--CA 1.439 -1.158 0 C-N-CA 120.6 -0.809 . . . . 71.319999999999993 111.719 -177.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . 0.454 ' HA3' ' HA3' ' A' ' 173' ' ' GLY . . . -74.82 166.36 54.85 Favored Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 121.032 -0.604 . . . . 75.209999999999994 111.597 178.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.452 HD23 ' HA ' ' A' ' 172' ' ' LEU . 3.0 mm? -66.09 -34.02 77.11 Favored 'General case' 0 C--N 1.312 -1.036 0 C-N-CA 122.996 0.518 . . . . 73.319999999999993 111.641 -176.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . 0.562 ' CB ' HD12 ' A' ' 212' ' ' LEU . . . -67.75 -42.43 81.83 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.522 0.677 . . . . 72.400000000000006 110.051 178.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.434 ' HG3' ' HA ' ' A' ' 202' ' ' PRO . 6.0 tm-20 -75.39 -34.49 61.09 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 114.915 -1.039 . . . . 72.140000000000001 108.982 -178.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 35.9 t -58.54 -47.34 84.54 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 123.786 0.834 . . . . 73.209999999999994 110.795 177.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . 0.474 HG23 ' H ' ' A' ' 211' ' ' LEU . 10.2 t -75.6 -35.67 60.48 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 120.004 -0.678 . . . . 53.509999999999998 109.446 177.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 74.17 16.56 79.64 Favored Glycine 0 N--CA 1.442 -0.905 0 CA-C-N 115.984 -0.553 . . . . 40.329999999999998 112.672 177.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.474 ' H ' HG23 ' A' ' 209' ' ' THR . 54.9 mt -99.19 -0.55 41.29 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 120.933 0.397 . . . . 64.439999999999998 110.449 -178.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.562 HD12 ' CB ' ' A' ' 206' ' ' ALA . 80.6 mt -109.79 131.7 54.83 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 115.187 -0.915 . . . . 72.230000000000004 108.941 174.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -130.7 155.9 45.83 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 109.102 -0.703 . . . . 62.119999999999997 109.102 177.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 31.2 m -62.16 -29.28 46.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-O 122.078 0.942 . . . . 70.420000000000002 112.773 -177.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -77.99 -14.06 59.66 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 115.533 -0.758 . . . . 74.329999999999998 111.782 -178.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -76.71 150.68 36.28 Favored 'General case' 0 C--O 1.244 0.786 0 N-CA-C 113.02 0.748 . . . . 53.130000000000003 113.02 -173.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -108.81 132.34 54.09 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.016 -0.993 . . . . 72.219999999999999 109.766 -178.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.54 ' HA ' HG12 ' A' ' 249' ' ' VAL . 39.7 t -83.33 138.33 19.48 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 CA-C-O 121.488 0.661 . . . . 70.540000000000006 111.509 -176.053 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 46.0 mm -105.22 -53.16 7.13 Favored 'Isoleucine or valine' 0 C--O 1.246 0.875 0 CA-C-N 115.171 -0.922 . . . . 74.239999999999995 111.099 -178.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.423 ' HB3' ' HA ' ' A' ' 225' ' ' GLU . 10.5 pt-20 -153.92 165.85 34.81 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 116.049 -0.523 . . . . 74.430000000000007 109.82 -175.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.487 ' HA ' ' O ' ' A' ' 246' ' ' ILE . 8.3 p -135.19 122.97 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.749 0 CA-C-N 115.647 -0.706 . . . . 74.340000000000003 109.148 176.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . 0.537 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 12.2 t-20 68.73 5.52 4.98 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 125.083 1.353 . . . . 70.230000000000004 111.198 178.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 113.63 -14.15 22.51 Favored Glycine 0 N--CA 1.439 -1.149 0 N-CA-C 110.882 -0.887 . . . . 75.319999999999993 110.882 -178.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 65.7 mt -96.34 123.75 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.521 0 N-CA-C 109.1 -0.704 . . . . 62.25 109.1 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . 0.423 ' HA ' ' HB3' ' A' ' 220' ' ' GLU . 12.4 pt-20 -58.05 153.01 15.42 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 123.684 0.794 . . . . 73.450000000000003 112.002 -177.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . 0.476 ' HB ' HG12 ' A' ' 234' ' ' VAL . 35.9 m -129.59 2.47 2.58 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 CA-C-N 115.411 -0.813 . . . . 52.039999999999999 110.248 174.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -71.84 98.56 2.02 Favored 'General case' 0 N--CA 1.432 -1.372 0 CA-C-N 115.634 -0.712 . . . . 71.099999999999994 110.693 -178.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 121.12 -17.57 9.11 Favored Glycine 0 CA--C 1.489 -1.551 0 N-CA-C 110.378 -1.089 . . . . 44.100000000000001 110.378 178.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -83.5 163.21 20.61 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.122 -0.539 . . . . 72.409999999999997 111.333 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . 0.493 ' H ' ' NE2' ' A' ' 233' ' ' GLN . 37.2 p -97.19 172.32 7.89 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.756 -0.657 . . . . 75.349999999999994 110.667 -176.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.603 ' HA ' HG22 ' A' ' 234' ' ' VAL . 78.0 mt -56.65 -40.32 75.25 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 111.837 0.31 . . . . 64.109999999999999 111.837 177.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -56.8 -42.7 79.96 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 121.279 0.561 . . . . 73.340000000000003 110.132 179.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' GLN . . . . . 0.493 ' NE2' ' H ' ' A' ' 230' ' ' THR . 49.0 mt-30 -72.94 -47.71 43.19 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.961 -1.018 . . . . 71.209999999999994 112.339 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.603 HG22 ' HA ' ' A' ' 231' ' ' LEU . 16.9 m -70.86 -34.47 56.18 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 112.092 0.404 . . . . 51.210000000000001 112.092 -176.056 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . 0.428 ' O ' HG23 ' A' ' 239' ' ' VAL . 50.3 m -69.57 -35.3 75.24 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 109.429 -0.582 . . . . 75.140000000000001 109.429 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -60.73 -38.93 86.78 Favored 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 108.863 -0.792 . . . . 73.299999999999997 108.863 177.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 15.9 mmt -59.46 -50.17 74.95 Favored 'General case' 0 C--O 1.199 -1.563 0 CA-C-N 115.332 -0.849 . . . . 74.150000000000006 108.725 177.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' MET . . . . . 0.444 ' HG3' ' O ' ' A' ' 234' ' ' VAL . 63.0 mtt -61.8 -37.31 83.91 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.895 0.878 . . . . 74.439999999999998 112.259 -176.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 235' ' ' THR . 97.3 t -65.13 -40.32 88.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 121.19 0.519 . . . . 52.229999999999997 109.942 176.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -72.97 -37.0 67.21 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.613 0.721 . . . . 62.25 110.297 178.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -86.87 21.11 2.35 Favored 'General case' 0 C--O 1.202 -1.431 0 CA-C-N 115.603 -0.726 . . . . 71.409999999999997 111.905 -178.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 69.8 m -65.21 -22.88 66.95 Favored 'General case' 0 C--N 1.312 -1.022 0 C-N-CA 120.41 -0.516 . . . . 71.530000000000001 111.548 177.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 23.1 m -70.47 -24.38 62.86 Favored 'General case' 0 CA--C 1.554 1.11 0 CA-C-N 116.363 -0.381 . . . . 74.219999999999999 111.032 176.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -174.3 97.3 0.1 Allowed 'General case' 0 C--O 1.246 0.913 0 C-N-CA 124.363 1.065 . . . . 35.539999999999999 109.205 177.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.501 ' CD2' HG13 ' A' ' 247' ' ' ILE . 2.4 tt -88.16 103.03 15.38 Favored 'General case' 0 N--CA 1.414 -2.273 0 N-CA-C 109.211 -0.662 . . . . 71.239999999999995 109.211 -173.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.582 ' HA ' ' O ' ' A' ' 161' ' ' VAL . 69.7 mt -100.87 116.7 44.88 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.179 0 N-CA-C 109.37 -0.604 . . . . 72.0 109.37 -179.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . 0.501 HG13 ' CD2' ' A' ' 245' ' ' LEU . 27.0 mt -120.94 132.54 70.18 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 CA-C-O 121.541 0.686 . . . . 71.120000000000005 112.331 178.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.705 ' OG1' ' HB3' ' A' ' 160' ' ' ARG . 37.0 m -104.19 122.8 46.11 Favored 'General case' 0 N--CA 1.414 -2.244 0 CA-C-N 114.291 -1.322 . . . . 64.439999999999998 108.603 177.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.54 HG12 ' HA ' ' A' ' 218' ' ' VAL . 34.7 m -130.79 164.09 34.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 110.035 -0.357 . . . . 64.109999999999999 110.035 177.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.575 ' HG2' ' HB3' ' A' ' 158' ' ' HIS 0.296 38.6 mtmt -124.39 141.73 38.36 Favored Pre-proline 0 CA--C 1.48 -1.721 0 N-CA-C 104.788 -2.301 . . . . 74.540000000000006 104.788 173.919 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -85.02 148.1 10.54 Favored 'Trans proline' 0 N--CA 1.411 -3.351 0 C-N-CA 120.573 0.848 . . . . 74.230000000000004 111.257 176.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -69.72 -30.97 68.71 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.974 0.893 . . . . 43.25 109.46 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -75.32 -27.58 59.32 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 114.635 -1.166 . . . . 63.43 110.468 178.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 62.11 108.93 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 114.553 1.316 . . . . 74.129999999999995 114.553 179.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 . . . . . 0 CA--C 1.499 -0.999 0 C-N-CA 125.069 1.348 . . . . 55.100000000000001 108.681 178.305 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.531 0.214 0 N-CA-C 106.472 -1.677 . . . . 74.120000000000005 106.472 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.518 HG22 ' H ' ' A' ' 255' ' ' ARG . 62.9 p -56.87 -35.14 68.57 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 113.921 1.082 . . . . 51.020000000000003 113.921 -171.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.488 ' NE2' HG13 ' A' ' 219' ' ' ILE . 4.7 m80 -80.54 130.32 35.06 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-O 121.658 0.742 . . . . 71.510000000000005 112.588 -174.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.434 ' O ' ' HA ' ' A' ' 248' ' ' THR . 18.8 tpp180 -107.29 141.41 38.68 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 107.218 -1.401 . . . . 72.349999999999994 107.218 177.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -114.96 113.15 23.75 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 108.657 -0.868 . . . . 73.549999999999997 108.657 175.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.507 HG21 HD11 ' A' ' 212' ' ' LEU . 17.7 m -129.08 137.86 56.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-O 120.868 0.366 . . . . 75.299999999999997 111.986 179.295 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 42.9 ttp180 -116.81 112.5 21.21 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 108.904 -0.776 . . . . 71.349999999999994 108.904 173.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 13.5 mt -102.56 138.83 38.96 Favored 'General case' 0 C--N 1.281 -2.386 0 N-CA-C 107.319 -1.363 . . . . 74.510000000000005 107.319 -175.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.585 HD12 ' O ' ' A' ' 242' ' ' SER . 0.7 OUTLIER 66.64 74.06 0.35 Allowed 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 108.263 -1.014 . . . . 74.310000000000002 108.263 174.542 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -98.4 -2.69 38.57 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.61 -0.723 . . . . 70.099999999999994 110.632 -176.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 32.3 m170 -95.64 -19.16 19.96 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 119.456 -0.898 . . . . 73.510000000000005 112.62 -177.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 71.34 68.88 1.51 Allowed Glycine 0 C--N 1.32 -0.335 0 C-N-CA 120.482 -0.866 . . . . 55.43 111.211 -177.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . 0.545 ' H ' HD11 ' A' ' 164' ' ' LEU . 46.3 t -144.66 147.99 33.72 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 107.636 -1.246 . . . . 75.329999999999998 107.636 -178.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . 0.283 29.3 m-20 -84.8 69.59 10.73 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 122.607 1.194 . . . . 64.409999999999997 113.146 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.94 136.77 22.61 Favored Pre-proline 0 C--N 1.29 -2.009 0 CA-C-N 113.172 -1.831 . . . . 73.549999999999997 107.216 174.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -54.29 135.84 66.55 Favored 'Trans proline' 0 N--CA 1.479 0.672 0 C-N-CA 123.274 2.649 . . . . 64.310000000000002 113.38 -177.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.44 ' CD1' ' HB2' ' A' ' 164' ' ' LEU . 3.3 mm? -70.22 -39.77 74.91 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-O 121.201 0.524 . . . . 72.530000000000001 110.177 177.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . 0.475 ' HA3' ' HA3' ' A' ' 204' ' ' GLY . . . 90.53 25.15 26.48 Favored Glycine 0 N--CA 1.42 -2.368 0 CA-C-N 115.445 -0.798 . . . . 73.340000000000003 113.522 176.108 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -143.11 151.54 40.84 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 107.843 -1.169 . . . . 74.319999999999993 107.843 174.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -131.13 152.85 49.99 Favored 'General case' 0 CA--C 1.484 -1.588 0 CA-C-O 120.808 0.337 . . . . 73.319999999999993 110.227 178.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.635 ' H ' HD13 ' A' ' 176' ' ' ILE . 0.2 OUTLIER -116.85 169.85 6.87 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.049 0 CA-C-N 115.66 -0.7 . . . . 52.310000000000002 112.219 -173.81 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.61 ' CG ' ' HB2' ' A' ' 198' ' ' SER . 11.8 ptt180 -148.51 156.02 41.91 Favored 'General case' 0 C--N 1.287 -2.133 0 C-N-CA 125.478 1.511 . . . . 75.340000000000003 109.841 -175.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -110.89 144.61 39.67 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 123.466 0.479 . . . . 73.25 110.856 179.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -162.44 171.68 38.35 Favored Glycine 0 N--CA 1.427 -1.901 0 N-CA-C 108.876 -1.69 . . . . 43.420000000000002 108.876 175.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . 0.501 ' HB ' ' CG ' ' A' ' 191' ' ' LYS . 0.6 OUTLIER -86.76 123.85 32.37 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 118.172 0.986 . . . . 74.230000000000004 111.658 175.966 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 34.7 t -102.69 115.77 31.24 Favored 'General case' 0 N--CA 1.404 -2.768 0 N-CA-C 107.927 -1.138 . . . . 74.549999999999997 107.927 177.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.616 ' HA ' ' O ' ' A' ' 190' ' ' GLU . 3.7 p -112.69 126.3 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.75 0 N-CA-C 109.3 -0.63 . . . . 62.200000000000003 109.3 176.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -122.8 159.57 27.8 Favored 'General case' 0 C--N 1.29 -2.009 0 CA-C-N 115.307 -0.86 . . . . 73.400000000000006 108.748 -176.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 69.6 t -90.08 119.14 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.138 0 N-CA-C 107.313 -1.366 . . . . 73.430000000000007 107.313 171.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 46.2 p -116.83 -175.2 2.72 Favored 'General case' 0 C--N 1.266 -3.049 0 CA-C-N 114.359 -1.291 . . . . 71.200000000000003 107.936 -177.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -67.91 -14.64 63.13 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.284 0.564 . . . . 71.540000000000006 109.784 174.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 19.3 m -90.98 -18.05 25.3 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 115.557 -0.747 . . . . 74.430000000000007 110.373 178.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 116.58 -145.63 18.72 Favored Glycine 0 N--CA 1.436 -1.301 0 N-CA-C 109.211 -1.556 . . . . 75.109999999999999 109.211 -176.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 6.2 mp -80.81 118.7 22.55 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 117.953 0.877 . . . . 71.329999999999998 109.509 177.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . 0.616 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 38.9 tt0 -123.02 117.75 26.18 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.233 -1.025 . . . . 73.540000000000006 108.233 -175.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.501 ' CG ' ' HB ' ' A' ' 180' ' ' THR . 36.3 ttmt -105.51 133.31 50.47 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 109.071 -0.714 . . . . 73.140000000000001 109.071 -177.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . 0.456 HE22 ' HB1' ' A' ' 227' ' ' ALA . 11.3 pt20 -144.21 164.33 29.71 Favored Pre-proline 0 C--N 1.297 -1.705 0 N-CA-C 107.503 -1.295 . . . . 73.409999999999997 107.503 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -65.17 132.86 33.17 Favored 'Trans proline' 0 C--O 1.247 0.934 0 C-N-CA 121.102 1.201 . . . . 42.340000000000003 109.776 174.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -137.94 141.62 12.36 Favored Glycine 0 N--CA 1.414 -2.787 0 N-CA-C 110.533 -1.027 . . . . 51.509999999999998 110.533 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.511 ' O ' HG12 ' A' ' 218' ' ' VAL . 3.4 mp -103.74 136.04 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.402 0 N-CA-C 109.272 -0.64 . . . . 74.109999999999999 109.272 179.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -128.1 167.6 16.53 Favored 'General case' 0 C--N 1.282 -2.326 0 N-CA-C 107.73 -1.211 . . . . 70.519999999999996 107.73 -177.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 58.5 mt -83.6 131.71 33.19 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 N-CA-C 109.334 -0.617 . . . . 73.239999999999995 109.334 174.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . 0.61 ' HB2' ' CG ' ' A' ' 177' ' ' ARG . 29.6 t -110.18 -27.91 8.9 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.557 -0.714 . . . . 70.319999999999993 112.691 -177.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -147.63 134.53 20.19 Favored 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 120.037 -0.665 . . . . 73.450000000000003 109.583 -176.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 1.4 tt -116.18 124.81 51.23 Favored 'General case' 0 N--CA 1.414 -2.239 0 N-CA-C 106.51 -1.663 . . . . 73.530000000000001 106.51 179.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 96.6 t -94.14 124.69 55.21 Favored Pre-proline 0 C--N 1.306 -1.284 0 N-CA-C 110.472 -0.196 . . . . 74.420000000000002 110.472 -178.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -60.59 126.29 19.5 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.459 2.106 . . . . 24.120000000000001 110.782 177.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 98.91 -6.66 60.31 Favored Glycine 0 N--CA 1.435 -1.405 0 C-N-CA 120.777 -0.725 . . . . 53.530000000000001 112.614 -178.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . 0.475 ' HA3' ' HA3' ' A' ' 173' ' ' GLY . . . -79.53 169.54 53.62 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.5 -0.857 . . . . 65.409999999999997 112.285 179.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -65.06 -34.63 78.87 Favored 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 122.723 0.409 . . . . 73.140000000000001 110.653 -178.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -60.3 -43.59 96.16 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.64 -0.709 . . . . 64.230000000000004 110.809 178.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -75.6 -35.89 60.44 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.257 -0.429 . . . . 75.230000000000004 110.324 179.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 37.9 t -56.61 -42.71 79.24 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.817 -0.629 . . . . 72.329999999999998 110.35 179.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . 0.417 HG23 ' H ' ' A' ' 211' ' ' LEU . 10.2 t -82.86 -35.73 26.02 Favored 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 120.454 -0.498 . . . . 72.329999999999998 109.912 176.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 75.18 5.74 77.43 Favored Glycine 0 C--O 1.217 -0.925 0 CA-C-N 116.202 -0.453 . . . . 65.129999999999995 112.986 177.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.417 ' H ' HG23 ' A' ' 209' ' ' THR . 67.0 mt -87.05 -11.79 49.26 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 120.813 0.339 . . . . 55.229999999999997 110.894 -177.222 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.507 HD11 HG21 ' A' ' 161' ' ' VAL . 4.3 mp -109.65 133.73 52.77 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 120.351 -0.54 . . . . 74.150000000000006 109.63 177.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -131.09 166.0 22.03 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 108.762 -0.829 . . . . 53.119999999999997 108.762 176.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 30.2 m -59.97 -28.06 40.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 113.324 0.861 . . . . 62.450000000000003 113.324 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 20.1 m-80 -71.95 -15.97 62.08 Favored 'General case' 0 C--N 1.312 -1.022 0 O-C-N 122.038 -0.414 . . . . 74.340000000000003 110.769 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.5 ' HA ' ' HA ' ' A' ' 251' ' ' PRO . 5.0 m-20 -71.18 132.35 44.87 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 114.426 1.269 . . . . 72.510000000000005 114.426 -174.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -105.19 131.12 53.06 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 126.328 1.851 . . . . 65.239999999999995 108.497 -179.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.592 ' HA ' HG12 ' A' ' 249' ' ' VAL . 11.4 p -83.5 134.55 26.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-O 122.034 0.921 . . . . 75.510000000000005 112.58 -175.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.488 HG13 ' NE2' ' A' ' 158' ' ' HIS . 39.7 mm -99.49 -49.01 11.67 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 CA-C-N 114.303 -1.317 . . . . 61.509999999999998 110.645 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -160.12 160.51 33.08 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.192 -0.458 . . . . 75.030000000000001 110.775 -176.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' A' ' 246' ' ' ILE . 7.5 p -129.7 122.67 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.03 0 O-C-N 123.736 0.647 . . . . 71.549999999999997 109.675 175.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . 0.467 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 2.8 m-20 58.89 22.08 9.84 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 125.519 1.528 . . . . 73.219999999999999 113.651 -178.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 105.85 -13.87 45.57 Favored Glycine 0 N--CA 1.429 -1.83 0 C-N-CA 120.323 -0.941 . . . . 55.520000000000003 113.062 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 60.9 mt -97.9 123.85 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.046 0 C-N-CA 120.705 -0.398 . . . . 73.329999999999998 110.458 -179.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -51.64 133.7 30.52 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 124.711 1.257 . . . . 63.350000000000001 111.608 177.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . 0.406 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 29.7 m -115.74 11.47 7.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 CA-C-O 122.217 1.008 . . . . 73.200000000000003 108.338 172.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . 0.456 ' HB1' HE22 ' A' ' 192' ' ' GLN . . . -68.44 97.11 0.73 Allowed 'General case' 0 N--CA 1.422 -1.869 0 CA-C-N 113.468 -1.697 . . . . 72.430000000000007 111.142 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 95.56 10.3 56.92 Favored Glycine 0 C--N 1.307 -1.038 0 CA-C-N 115.609 -0.723 . . . . 64.400000000000006 112.88 174.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -82.94 178.31 8.22 Favored 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 120.506 -0.478 . . . . 73.340000000000003 109.83 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . 0.437 ' H ' ' NE2' ' A' ' 233' ' ' GLN . 41.1 p -87.82 157.64 18.95 Favored 'General case' 0 N--CA 1.421 -1.889 0 N-CA-C 107.135 -1.432 . . . . 61.530000000000001 107.135 174.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.429 ' O ' HG22 ' A' ' 234' ' ' VAL . 1.3 tt -64.83 -32.72 74.55 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 108.1 -1.074 . . . . 74.430000000000007 108.1 -177.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -64.35 -38.99 92.98 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.411 -0.358 . . . . 74.430000000000007 110.487 177.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' GLN . . . . . 0.437 ' NE2' ' H ' ' A' ' 230' ' ' THR . 42.9 mt-30 -60.34 -49.36 77.9 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 112.026 0.38 . . . . 73.329999999999998 112.026 175.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.441 HG21 HG12 ' A' ' 195' ' ' ILE . 5.4 m -67.92 -32.76 57.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-O 121.242 0.544 . . . . 72.310000000000002 111.739 -176.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . 0.407 ' O ' HG23 ' A' ' 239' ' ' VAL . 88.2 m -74.18 -37.15 64.04 Favored 'General case' 0 CA--C 1.498 -1.044 0 CA-C-N 115.567 -0.742 . . . . 64.049999999999997 109.084 -176.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -60.39 -34.12 73.44 Favored 'General case' 0 CA--C 1.507 -0.682 0 CA-C-N 115.433 -0.803 . . . . 55.119999999999997 109.153 177.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 8.9 mtt -69.24 -44.88 71.09 Favored 'General case' 0 C--O 1.2 -1.527 0 N-CA-C 108.686 -0.857 . . . . 74.310000000000002 108.686 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' MET . . . . . 0.421 ' HG3' ' O ' ' A' ' 234' ' ' VAL . 64.7 mtt -60.12 -31.76 70.36 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.979 -0.555 . . . . 62.240000000000002 111.681 -178.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 235' ' ' THR . 91.0 t -74.12 -41.9 51.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-O 121.327 0.584 . . . . 70.049999999999997 110.004 176.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -70.51 -35.59 73.28 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.386 0.612 . . . . 75.010000000000005 111.106 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -84.71 21.95 1.43 Allowed 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 115.357 -0.838 . . . . 62.299999999999997 112.546 -178.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . 0.585 ' O ' HD12 ' A' ' 164' ' ' LEU . 67.9 m -59.41 -23.46 62.65 Favored 'General case' 0 C--O 1.207 -1.159 0 N-CA-C 113.08 0.771 . . . . 64.109999999999999 113.08 178.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 22.6 p -68.42 -33.93 75.09 Favored 'General case' 0 CA--C 1.552 1.033 0 O-C-N 121.76 -0.588 . . . . 53.039999999999999 111.861 177.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 -159.68 100.59 1.46 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.931 1.292 . . . . 54.310000000000002 108.264 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -86.55 103.1 14.74 Favored 'General case' 0 C--O 1.21 -1.012 0 N-CA-C 108.443 -0.947 . . . . 44.219999999999999 108.443 -178.123 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.467 ' HB ' ' HA ' ' A' ' 222' ' ' ASN . 61.9 mt -103.78 116.32 47.34 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 N-CA-C 108.731 -0.84 . . . . 74.239999999999995 108.731 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . 0.509 HG23 HG23 ' A' ' 218' ' ' VAL . 18.2 mt -121.99 134.54 64.97 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.155 0 CA-C-O 121.801 0.81 . . . . 72.230000000000004 112.318 178.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.434 ' HA ' ' O ' ' A' ' 159' ' ' ARG . 46.3 m -106.54 114.96 29.38 Favored 'General case' 0 N--CA 1.411 -2.413 0 N-CA-C 107.771 -1.196 . . . . 73.310000000000002 107.771 175.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.592 HG12 ' HA ' ' A' ' 218' ' ' VAL . 18.1 m -123.27 161.42 25.13 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 CA-C-O 121.004 0.43 . . . . 73.040000000000006 110.354 177.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 16.0 ptmt -137.1 135.75 20.12 Favored Pre-proline 0 C--N 1.278 -2.54 0 N-CA-C 107.024 -1.473 . . . . 75.209999999999994 107.024 173.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . 0.5 ' HA ' ' HA ' ' A' ' 216' ' ' ASP . 38.8 Cg_exo -61.1 136.87 67.84 Favored 'Trans proline' 0 N--CA 1.449 -1.136 0 C-N-CA 121.088 1.192 . . . . 73.310000000000002 111.249 178.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -54.83 -48.92 72.23 Favored 'General case' 0 CA--C 1.493 -1.236 0 N-CA-C 108.301 -1.0 . . . . 70.230000000000004 108.301 175.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -85.51 82.86 8.11 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 106.263 -1.754 . . . . 60.229999999999997 106.263 168.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -64.42 -178.14 0.35 Allowed 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 113.24 -1.8 . . . . 61.219999999999999 114.392 -171.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . 0.518 ' H ' HG22 ' A' ' 157' ' ' THR . 40.4 ttp180 . . . . . 0 N--CA 1.446 -0.634 0 CA-C-N 114.029 -1.441 . . . . 73.030000000000001 111.361 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 . . . . . 0 C--O 1.236 0.351 0 N-CA-C 108.905 -0.776 . . . . 74.200000000000003 108.905 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 35.2 p -87.89 -50.86 6.17 Favored 'General case' 0 N--CA 1.441 -0.925 0 C-N-CA 122.287 0.235 . . . . 63.310000000000002 111.149 -178.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -84.64 128.93 34.86 Favored 'General case' 0 C--O 1.214 -0.814 0 N-CA-C 109.105 -0.702 . . . . 72.010000000000005 109.105 174.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.569 ' O ' ' HA ' ' A' ' 248' ' ' THR . 24.5 tpt180 -119.69 128.88 54.22 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 120.202 -0.599 . . . . 70.099999999999994 110.342 176.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 32.1 ptt180 -115.85 114.24 24.46 Favored 'General case' 0 C--N 1.284 -2.243 0 CA-C-N 114.944 -1.025 . . . . 73.319999999999993 109.91 178.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 17.4 m -117.0 138.91 46.12 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 CA-C-N 115.459 -0.791 . . . . 73.409999999999997 111.097 -178.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.538 ' HD2' ' N ' ' A' ' 162' ' ' ARG . 1.3 mpt_? -107.76 111.99 24.44 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 106.589 -1.634 . . . . 74.219999999999999 106.589 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.539 ' HB2' ' HB3' ' A' ' 245' ' ' LEU . 29.1 mt -98.85 139.6 34.28 Favored 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 123.793 0.837 . . . . 74.430000000000007 111.72 -171.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.554 HD23 ' O ' ' A' ' 242' ' ' SER . 9.9 tp 90.75 20.71 0.03 OUTLIER 'General case' 0 CA--C 1.515 -0.379 0 C-N-CA 125.75 1.62 . . . . 55.340000000000003 113.179 173.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . 0.26 60.5 pttt -97.83 56.74 1.28 Allowed 'General case' 0 C--N 1.282 -2.346 0 C-N-CA 117.867 -1.533 . . . . 71.409999999999997 112.072 177.07 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 46.9 t-80 -153.94 20.72 0.51 Allowed 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 106.288 -1.745 . . . . 73.329999999999998 106.288 178.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 159.02 -152.28 23.32 Favored Glycine 0 N--CA 1.428 -1.848 0 N-CA-C 107.518 -2.233 . . . . 72.409999999999997 107.518 -175.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 31.9 t -168.66 161.83 11.52 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 117.894 0.847 . . . . 62.439999999999998 109.113 178.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 31.2 t70 70.09 -32.36 0.23 Allowed 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 125.516 1.526 . . . . 72.519999999999996 114.263 177.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.64 150.41 93.44 Favored Pre-proline 0 C--N 1.302 -1.474 0 N-CA-C 111.876 0.324 . . . . 71.439999999999998 111.876 -177.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -53.46 150.32 27.45 Favored 'Trans proline' 0 C--N 1.357 0.996 0 C-N-CA 123.872 3.048 . . . . 72.319999999999993 113.806 -179.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.52 ' CD1' ' HB2' ' A' ' 164' ' ' LEU . 2.3 mm? -84.85 -27.64 26.59 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.455 -0.793 . . . . 63.149999999999999 110.036 -178.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . 0.418 ' HA3' ' HA3' ' A' ' 204' ' ' GLY . . . 84.08 49.57 4.69 Favored Glycine 0 N--CA 1.433 -1.516 0 CA-C-N 115.633 -0.712 . . . . 41.25 113.923 175.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -156.75 161.37 39.8 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 108.079 -1.082 . . . . 74.299999999999997 108.079 175.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -130.01 157.12 43.23 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 108.589 -0.893 . . . . 73.129999999999995 108.589 175.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.548 ' H ' HD13 ' A' ' 176' ' ' ILE . 0.2 OUTLIER -126.21 169.06 18.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 CA-C-O 121.595 0.712 . . . . 75.319999999999993 111.278 -179.04 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.472 ' HG2' ' HB2' ' A' ' 198' ' ' SER . 16.9 ptt180 -157.79 155.44 29.8 Favored 'General case' 0 C--N 1.281 -2.385 0 CA-C-N 114.698 -1.137 . . . . 74.010000000000005 108.922 -175.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -112.77 158.26 20.32 Favored 'General case' 0 C--N 1.298 -1.664 0 C-N-CA 119.402 -0.919 . . . . 71.530000000000001 110.815 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -156.38 -179.23 31.23 Favored Glycine 0 C--N 1.29 -2.001 0 N-CA-C 107.726 -2.15 . . . . 54.509999999999998 107.726 176.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . 0.444 ' CG2' ' HG2' ' A' ' 191' ' ' LYS . 0.2 OUTLIER -112.25 122.95 49.17 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 118.996 1.398 . . . . 75.420000000000002 108.178 179.63 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . 0.433 ' O ' ' HA ' ' A' ' 191' ' ' LYS . 20.2 t -100.98 130.01 46.91 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 108.547 -0.909 . . . . 32.399999999999999 108.547 -176.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.52 ' HA ' ' O ' ' A' ' 190' ' ' GLU . 7.2 p -106.64 119.25 55.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 C-N-CA 119.318 -0.953 . . . . 75.299999999999997 110.153 175.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -125.02 160.77 28.24 Favored 'General case' 0 CA--C 1.479 -1.756 0 CA-C-N 115.048 -0.978 . . . . 74.540000000000006 108.812 -175.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 84.3 t -90.19 118.68 35.93 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.048 0 N-CA-C 107.576 -1.268 . . . . 72.439999999999998 107.576 170.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 54.7 p -113.04 -174.49 2.46 Favored 'General case' 0 C--N 1.273 -2.748 0 CA-C-N 114.629 -1.169 . . . . 74.439999999999998 107.991 -179.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -62.86 -21.13 65.74 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.042 0.448 . . . . 73.319999999999993 110.128 176.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 25.0 m -90.26 -18.82 24.96 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-N 115.989 -0.55 . . . . 53.210000000000001 111.021 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 123.46 -147.14 16.61 Favored Glycine 0 CA--C 1.491 -1.411 0 N-CA-C 110.278 -1.129 . . . . 60.350000000000001 110.278 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 4.9 mp -81.82 118.16 22.68 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.454 -0.943 . . . . 61.119999999999997 108.454 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . 0.52 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 38.4 tt0 -131.57 121.65 24.76 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 109.528 -0.545 . . . . 65.209999999999994 109.528 -172.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.491 ' HA ' ' HA ' ' A' ' 182' ' ' VAL . 33.5 ttmt -93.35 128.57 39.44 Favored 'General case' 0 N--CA 1.426 -1.626 0 N-CA-C 106.821 -1.548 . . . . 63.409999999999997 106.821 178.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.33 151.82 34.53 Favored Pre-proline 0 C--N 1.299 -1.627 0 CA-C-O 118.956 -0.545 . . . . 65.129999999999995 109.645 -168.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -61.56 130.23 30.88 Favored 'Trans proline' 0 C--O 1.243 0.774 0 C-N-CA 121.339 1.359 . . . . 74.219999999999999 112.879 -176.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -135.86 142.42 13.71 Favored Glycine 0 N--CA 1.411 -2.984 0 N-CA-C 108.586 -1.805 . . . . 60.219999999999999 108.586 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.582 HG12 HG21 ' A' ' 234' ' ' VAL . 3.0 mp -104.17 138.06 30.37 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.526 0 C-N-CA 120.204 -0.598 . . . . 73.120000000000005 110.224 -178.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -122.98 166.68 14.68 Favored 'General case' 0 C--N 1.283 -2.314 0 N-CA-C 108.292 -1.003 . . . . 75.239999999999995 108.292 -177.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . 0.49 ' HB ' ' HA ' ' A' ' 214' ' ' VAL . 50.3 mm -78.49 131.21 34.96 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.265 0 N-CA-C 108.382 -0.97 . . . . 74.319999999999993 108.382 177.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . 0.472 ' HB2' ' HG2' ' A' ' 177' ' ' ARG . 7.7 t -96.98 -32.43 12.02 Favored 'General case' 0 C--N 1.286 -2.178 0 O-C-N 121.703 -0.623 . . . . 72.310000000000002 112.408 -178.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -167.83 148.89 5.27 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.774 -0.194 . . . . 71.140000000000001 110.881 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 73.7 mt -102.84 146.05 28.86 Favored 'General case' 0 CA--C 1.495 -1.158 0 N-CA-C 108.599 -0.889 . . . . 72.299999999999997 108.599 170.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 59.5 t -109.14 114.3 58.1 Favored Pre-proline 0 C--N 1.28 -2.445 0 N-CA-C 106.606 -1.627 . . . . 72.329999999999998 106.606 171.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.435 ' HA ' ' HG3' ' A' ' 207' ' ' GLU . 33.4 Cg_exo -59.16 128.93 29.41 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.309 2.006 . . . . 61.399999999999999 110.807 -179.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 102.17 -11.03 57.05 Favored Glycine 0 N--CA 1.442 -0.94 0 N-CA-C 110.806 -0.918 . . . . 75.230000000000004 110.806 -175.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . 0.418 ' HA3' ' HA3' ' A' ' 173' ' ' GLY . . . -90.27 161.4 28.88 Favored Glycine 0 N--CA 1.439 -1.103 0 N-CA-C 110.33 -1.108 . . . . 61.119999999999997 110.33 177.09 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -57.24 -38.16 73.38 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 123.685 0.794 . . . . 71.310000000000002 111.946 -176.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . 0.485 ' CB ' HD12 ' A' ' 212' ' ' LEU . . . -62.31 -44.52 96.32 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.315 0.579 . . . . 75.030000000000001 110.796 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.435 ' HG3' ' HA ' ' A' ' 202' ' ' PRO . 4.3 tm-20 -75.68 -35.8 60.25 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 115.72 -0.673 . . . . 64.239999999999995 110.063 179.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 50.9 m -60.13 -41.15 92.03 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 122.512 0.325 . . . . 43.210000000000001 111.021 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . 0.4 HG23 ' H ' ' A' ' 211' ' ' LEU . 9.3 t -76.94 -36.53 56.49 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 120.06 -0.656 . . . . 71.230000000000004 109.334 175.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 70.65 11.49 68.96 Favored Glycine 0 N--CA 1.444 -0.83 0 CA-C-N 115.81 -0.632 . . . . 73.219999999999999 112.99 176.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.4 ' H ' HG23 ' A' ' 209' ' ' THR . 57.0 mt -95.55 5.97 50.16 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 121.518 0.675 . . . . 71.299999999999997 109.71 -178.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.485 HD12 ' CB ' ' A' ' 206' ' ' ALA . 98.9 mt -113.71 131.01 56.33 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 114.485 -1.234 . . . . 71.519999999999996 108.227 172.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -132.53 157.84 43.67 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 108.738 -0.838 . . . . 71.510000000000005 108.738 176.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . 0.49 ' HA ' ' HB ' ' A' ' 197' ' ' ILE . 14.7 m -60.92 -30.94 48.47 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 N-CA-C 113.23 0.826 . . . . 73.340000000000003 113.23 -175.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -78.69 -14.12 59.46 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 112.914 0.709 . . . . 65.209999999999994 112.914 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -69.8 142.75 53.12 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.662 0.616 . . . . 74.409999999999997 112.662 -178.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -108.66 131.36 54.97 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.927 -1.033 . . . . 65.409999999999997 109.579 -176.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.552 HG12 ' O ' ' A' ' 195' ' ' ILE . 9.8 p -83.14 143.82 11.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-O 121.893 0.854 . . . . 73.400000000000006 112.172 -176.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.414 HD11 ' HD2' ' A' ' 250' ' ' LYS . 37.8 mm -108.14 -51.42 7.13 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 C-N-CA 124.719 1.208 . . . . 73.409999999999997 111.26 -178.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -155.27 160.26 40.66 Favored 'General case' 0 C--O 1.247 0.945 0 CA-C-N 116.441 -0.345 . . . . 74.329999999999998 110.877 -177.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.484 HG12 ' CG1' ' A' ' 226' ' ' VAL . 7.5 p -132.38 121.03 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 O-C-N 123.775 0.672 . . . . 71.129999999999995 110.397 174.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 67.48 12.1 8.72 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.52 1.528 . . . . 74.530000000000001 110.672 176.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 110.11 -10.6 31.57 Favored Glycine 0 N--CA 1.432 -1.578 0 CA-C-N 115.421 -0.808 . . . . 52.43 112.589 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 64.4 mt -96.9 126.2 49.69 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.165 0 N-CA-C 108.35 -0.982 . . . . 65.140000000000001 108.35 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -65.47 141.62 58.43 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 121.431 0.634 . . . . 73.310000000000002 110.482 -178.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . 0.511 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 27.2 m -117.54 -1.88 9.5 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 CA-C-N 115.66 -0.7 . . . . 54.140000000000001 110.721 178.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -79.66 96.39 6.19 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 115.775 -0.648 . . . . 73.120000000000005 109.826 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 124.58 -14.57 7.66 Favored Glycine 0 C--N 1.305 -1.146 0 N-CA-C 110.688 -0.965 . . . . 64.0 110.688 -178.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -83.55 171.8 12.99 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.299 -1.0 . . . . 65.230000000000004 108.299 177.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . 0.474 ' O ' HG13 ' A' ' 234' ' ' VAL . 81.7 p -95.68 170.95 8.97 Favored 'General case' 0 N--CA 1.434 -1.248 0 N-CA-C 108.691 -0.855 . . . . 63.240000000000002 108.691 179.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.493 HD21 HG12 ' A' ' 176' ' ' ILE . 3.3 tm? -61.79 -37.19 83.43 Favored 'General case' 0 N--CA 1.424 -1.736 0 N-CA-C 110.145 -0.317 . . . . 65.299999999999997 110.145 -179.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -63.71 -47.92 79.2 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.738 -0.467 . . . . 63.149999999999999 109.738 178.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -60.34 -43.48 96.4 Favored 'General case' 0 C--O 1.222 -0.35 0 N-CA-C 113.73 1.011 . . . . 75.109999999999999 113.73 178.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.582 HG21 HG12 ' A' ' 195' ' ' ILE . 12.7 m -73.22 -33.94 42.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-O 121.375 0.607 . . . . 75.439999999999998 112.072 -175.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . 0.446 ' O ' HG23 ' A' ' 239' ' ' VAL . 85.9 m -74.98 -35.59 62.05 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 115.418 -0.81 . . . . 74.439999999999998 109.49 -174.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -61.74 -33.11 73.46 Favored 'General case' 0 C--O 1.244 0.805 0 CA-C-N 115.75 -0.659 . . . . 73.120000000000005 109.538 177.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' MET . . . . . 0.444 ' HB2' HG11 ' A' ' 221' ' ' VAL . 13.6 mtt -68.09 -47.56 67.92 Favored 'General case' 0 C--O 1.209 -1.051 0 N-CA-C 107.835 -1.172 . . . . 75.450000000000003 107.835 179.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 64.7 mtt -59.01 -37.16 76.25 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.402 -0.817 . . . . 72.239999999999995 111.329 -178.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 235' ' ' THR . 92.2 t -69.46 -44.91 79.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 CA-C-N 116.308 -0.405 . . . . 65.5 110.782 177.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -69.72 -38.14 76.78 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.173 0.511 . . . . 54.420000000000002 110.96 -178.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -82.01 21.1 0.91 Allowed 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 115.525 -0.761 . . . . 72.400000000000006 112.45 -178.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . 0.554 ' O ' HD23 ' A' ' 164' ' ' LEU . 42.8 t -59.19 -28.32 66.52 Favored 'General case' 0 CA--C 1.559 1.324 0 CA-C-O 121.158 0.504 . . . . 72.209999999999994 111.04 178.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 20.2 m -67.29 -28.61 68.16 Favored 'General case' 0 CA--C 1.552 1.052 0 N-CA-C 111.896 0.332 . . . . 52.420000000000002 111.896 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -161.99 83.82 0.58 Allowed 'General case' 0 C--O 1.249 1.034 0 N-CA-C 107.079 -1.452 . . . . 64.239999999999995 107.079 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.539 ' HB3' ' HB2' ' A' ' 163' ' ' LEU . 1.3 tt -85.95 103.42 14.64 Favored 'General case' 0 C--O 1.2 -1.548 0 C-N-CA 119.87 -0.732 . . . . 73.129999999999995 109.484 -173.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.467 HG12 ' HG3' ' A' ' 162' ' ' ARG . 74.1 mt -105.25 116.71 49.59 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.22 0 N-CA-C 109.469 -0.567 . . . . 74.019999999999996 109.469 178.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . 0.5 HG13 ' CD2' ' A' ' 245' ' ' LEU . 25.5 mt -120.05 134.33 63.91 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 CA-C-O 121.27 0.557 . . . . 44.109999999999999 111.674 179.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.569 ' HA ' ' O ' ' A' ' 159' ' ' ARG . 90.8 m -108.3 119.83 40.64 Favored 'General case' 0 N--CA 1.417 -2.114 0 CA-C-N 114.939 -1.028 . . . . 74.420000000000002 108.486 174.071 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.457 HG12 ' HA ' ' A' ' 218' ' ' VAL . 26.7 m -124.18 164.39 22.52 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.865 0 N-CA-C 108.43 -0.952 . . . . 51.140000000000001 108.43 174.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.414 ' HD2' HD11 ' A' ' 219' ' ' ILE . 0.0 OUTLIER -144.66 136.58 13.01 Favored Pre-proline 0 C--N 1.264 -3.112 0 CA-C-N 115.449 -0.796 . . . . 74.439999999999998 109.916 173.778 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -50.91 145.57 23.99 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 122.643 2.229 . . . . 72.329999999999998 110.962 179.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -48.22 -44.81 33.41 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 113.731 1.011 . . . . 64.319999999999993 113.731 -172.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -99.39 7.51 45.44 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 113.507 0.928 . . . . 65.329999999999998 113.507 -175.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -111.91 -170.88 1.74 Allowed 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.806 -0.442 . . . . 75.329999999999998 109.806 175.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 89.3 mtm180 . . . . . 0 CA--C 1.501 -0.907 0 CA-C-O 118.364 -0.827 . . . . 73.409999999999997 109.801 -176.974 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.469 0.502 0 N-CA-C 112.22 0.452 . . . . 73.439999999999998 112.22 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.468 ' HA ' ' OE1' ' A' ' 254' ' ' GLN . 34.9 p -73.54 -69.96 0.4 Allowed 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 121.341 0.591 . . . . 51.420000000000002 111.548 -176.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.443 ' NE2' HG13 ' A' ' 219' ' ' ILE . 1.0 OUTLIER -90.07 129.93 36.31 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.892 -0.781 . . . . 73.409999999999997 108.892 173.415 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.455 ' O ' ' HA ' ' A' ' 248' ' ' THR . 23.5 tpp180 -112.07 132.93 54.54 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 108.72 -0.844 . . . . 74.230000000000004 108.72 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 82.7 mtt180 -109.49 115.48 30.01 Favored 'General case' 0 C--N 1.278 -2.529 0 CA-C-N 115.708 -0.678 . . . . 60.340000000000003 111.439 176.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.425 ' CG1' ' HB2' ' A' ' 211' ' ' LEU . 18.6 m -118.94 138.19 50.46 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.219 0 CA-C-N 114.778 -1.101 . . . . 74.310000000000002 109.971 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.548 ' HG3' HG12 ' A' ' 246' ' ' ILE . 4.8 mpt_? -110.12 112.14 23.94 Favored 'General case' 0 N--CA 1.415 -2.199 0 N-CA-C 107.769 -1.197 . . . . 75.219999999999999 107.769 177.179 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.46 ' HB2' ' HB2' ' A' ' 245' ' ' LEU . 9.6 mt -96.96 118.53 33.58 Favored 'General case' 0 N--CA 1.409 -2.502 0 N-CA-C 107.523 -1.288 . . . . 60.310000000000002 107.523 -176.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.609 HD23 ' O ' ' A' ' 242' ' ' SER . 12.9 tp 80.58 83.95 0.05 OUTLIER 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 122.38 1.086 . . . . 62.43 112.95 177.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -135.47 16.85 3.38 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 105.962 -1.866 . . . . 71.150000000000006 105.962 173.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 51.6 t-80 -96.36 -13.49 23.21 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 113.418 -1.719 . . . . 64.099999999999994 110.768 -174.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 76.46 67.11 1.73 Allowed Glycine 0 CA--C 1.492 -1.399 0 N-CA-C 109.598 -1.401 . . . . 52.240000000000002 109.598 -177.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 50.2 m -139.43 153.19 47.54 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-O 120.802 0.334 . . . . 65.420000000000002 110.356 -175.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -107.29 -9.93 15.93 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.955 -0.566 . . . . 53.240000000000002 110.908 -178.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.74 153.23 91.41 Favored Pre-proline 0 N--CA 1.44 -0.969 0 CA-C-N 116.619 -0.264 . . . . 61.119999999999997 110.696 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -46.25 150.18 2.2 Favored 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 124.368 3.379 . . . . 73.329999999999998 114.893 -178.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.476 ' HA ' HD23 ' A' ' 205' ' ' LEU . 2.7 mm? -67.93 -29.14 68.14 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.913 -1.039 . . . . 73.200000000000003 111.373 -177.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . 0.472 ' HA3' ' HA3' ' A' ' 204' ' ' GLY . . . 84.51 37.8 10.39 Favored Glycine 0 N--CA 1.433 -1.518 0 N-CA-C 114.575 0.59 . . . . 55.229999999999997 114.575 174.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -159.46 152.62 22.15 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 108.733 -0.84 . . . . 74.409999999999997 108.733 173.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -132.51 146.22 51.76 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 109.312 -0.625 . . . . 64.340000000000003 109.312 179.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.686 ' H ' HD13 ' A' ' 176' ' ' ILE . 0.2 OUTLIER -111.04 170.34 3.54 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.634 0 CA-C-N 115.67 -0.695 . . . . 71.540000000000006 111.599 -175.397 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.533 ' CG ' ' HB2' ' A' ' 198' ' ' SER . 25.5 ptt180 -147.42 155.57 42.07 Favored 'General case' 0 C--N 1.279 -2.49 0 C-N-CA 124.972 1.309 . . . . 75.430000000000007 109.242 -177.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -117.89 151.21 37.85 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-O 121.32 0.581 . . . . 71.140000000000001 111.163 -175.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -167.87 -162.13 19.07 Favored Glycine 0 N--CA 1.426 -2.022 0 N-CA-C 109.439 -1.464 . . . . 64.409999999999997 109.439 176.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . 0.422 ' HB ' ' CG ' ' A' ' 191' ' ' LYS . 1.2 p -100.41 132.03 46.01 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 121.598 0.713 . . . . 61.240000000000002 112.322 176.042 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 33.6 t -111.15 113.52 26.09 Favored 'General case' 0 N--CA 1.409 -2.525 0 N-CA-C 107.483 -1.303 . . . . 63.109999999999999 107.483 173.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.621 ' HA ' ' O ' ' A' ' 190' ' ' GLU . 5.2 p -109.75 119.11 58.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 N-CA-C 108.578 -0.897 . . . . 63.329999999999998 108.578 173.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 90.8 mtt180 -125.0 160.67 28.45 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-N 115.3 -0.863 . . . . 75.409999999999997 109.18 -174.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.481 ' HA ' ' O ' ' A' ' 188' ' ' GLY . 71.3 t -82.26 119.88 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.606 0 N-CA-C 108.257 -1.016 . . . . 73.409999999999997 108.257 170.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 36.2 p -132.15 -174.1 3.34 Favored 'General case' 0 C--N 1.271 -2.831 0 CA-C-N 113.869 -1.514 . . . . 54.020000000000003 109.126 -173.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -64.97 -18.74 65.53 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.221 0.534 . . . . 54.530000000000001 110.198 174.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 45.8 m -87.34 -13.18 44.27 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 116.193 -0.458 . . . . 70.109999999999999 110.144 176.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.481 ' O ' ' HA ' ' A' ' 184' ' ' VAL . . . 105.81 -123.22 7.42 Favored Glycine 0 CA--C 1.475 -2.462 0 N-CA-C 107.056 -2.417 . . . . 74.340000000000003 107.056 -175.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 6.3 mp -92.11 121.35 33.58 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 107.64 -1.244 . . . . 61.100000000000001 107.64 172.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . 0.621 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 40.4 tt0 -128.86 117.68 21.44 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 108.839 -0.8 . . . . 73.209999999999994 108.839 -174.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.435 ' HG3' ' HB ' ' A' ' 182' ' ' VAL . 33.9 ttmt -100.97 125.74 47.58 Favored 'General case' 0 N--CA 1.426 -1.651 0 N-CA-C 107.912 -1.144 . . . . 74.340000000000003 107.912 -178.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -141.11 162.04 50.17 Favored Pre-proline 0 C--N 1.269 -2.922 0 N-CA-C 107.944 -1.132 . . . . 73.230000000000004 107.944 -177.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -57.88 131.57 44.62 Favored 'Trans proline' 0 N--CA 1.447 -1.25 0 C-N-CA 120.935 1.09 . . . . 73.420000000000002 109.476 175.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -135.82 138.1 9.66 Favored Glycine 0 CA--C 1.463 -3.218 0 N-CA-C 110.127 -1.189 . . . . 62.130000000000003 110.127 -177.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.663 HG12 HG21 ' A' ' 234' ' ' VAL . 3.3 mp -105.92 138.07 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.538 0 CA-C-O 121.301 0.572 . . . . 71.109999999999999 109.832 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -127.22 166.94 16.78 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 106.837 -1.542 . . . . 63.549999999999997 106.837 -178.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . 0.473 ' HB ' ' HA ' ' A' ' 214' ' ' VAL . 45.1 mt -85.0 131.69 33.47 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.335 0 CA-C-O 121.055 0.455 . . . . 64.5 109.846 178.093 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . 0.533 ' HB2' ' CG ' ' A' ' 177' ' ' ARG . 14.1 t -101.2 -50.06 3.9 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 112.484 0.55 . . . . 52.340000000000003 112.484 -178.158 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 40.8 ttp-105 -139.44 132.79 30.04 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 109.573 -0.529 . . . . 64.120000000000005 109.573 -176.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 2.6 tt -117.75 130.38 56.28 Favored 'General case' 0 N--CA 1.42 -1.941 0 N-CA-C 107.038 -1.468 . . . . 64.439999999999998 107.038 -178.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 45.1 t -108.64 127.31 27.64 Favored Pre-proline 0 C--N 1.316 -0.886 0 N-CA-C 112.036 0.384 . . . . 72.140000000000001 112.036 -171.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.53 ' HA ' ' HG3' ' A' ' 207' ' ' GLU . 34.4 Cg_endo -66.79 143.23 66.41 Favored 'Trans proline' 0 C--O 1.245 0.865 0 C-N-CA 122.432 2.088 . . . . 44.229999999999997 110.999 175.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 92.24 -9.9 75.36 Favored Glycine 0 N--CA 1.442 -0.959 0 N-CA-C 111.074 -0.811 . . . . 74.329999999999998 111.074 -177.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . 0.472 ' HA3' ' HA3' ' A' ' 173' ' ' GLY . . . -94.44 167.42 27.39 Favored Glycine 0 N--CA 1.435 -1.37 0 N-CA-C 110.472 -1.051 . . . . 61.409999999999997 110.472 178.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.476 HD23 ' HA ' ' A' ' 172' ' ' LEU . 2.7 mm? -66.72 -29.7 69.75 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 117.104 0.452 . . . . 72.019999999999996 111.675 -175.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -62.38 -46.28 89.33 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.636 0.731 . . . . 62.020000000000003 109.788 176.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.53 ' HG3' ' HA ' ' A' ' 202' ' ' PRO . 3.6 tm-20 -71.58 -32.62 68.27 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.513 -0.767 . . . . 75.129999999999995 110.667 179.15 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 44.7 m -55.78 -37.02 68.01 Favored 'General case' 0 CA--C 1.546 0.805 0 O-C-N 123.284 0.365 . . . . 75.219999999999999 110.967 178.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 8.9 t -87.49 -41.0 13.83 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 119.466 -0.894 . . . . 62.530000000000001 110.561 176.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 66.23 9.09 47.35 Favored Glycine 0 CA--C 1.531 1.051 0 N-CA-C 114.504 0.561 . . . . 71.439999999999998 114.504 177.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.425 ' HB2' ' CG1' ' A' ' 161' ' ' VAL . 69.1 mt -82.27 -18.03 43.85 Favored 'General case' 0 CA--C 1.503 -0.862 0 CA-C-O 121.119 0.485 . . . . 64.099999999999994 110.959 -178.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.471 HD23 ' H ' ' A' ' 212' ' ' LEU . 1.8 pt? -108.99 149.02 29.84 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 108.884 -0.784 . . . . 64.239999999999995 108.884 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -129.97 166.11 20.76 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 109.502 -0.555 . . . . 74.25 109.502 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . 0.473 ' HA ' ' HB ' ' A' ' 197' ' ' ILE . 32.6 m -63.22 -29.79 48.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 N-CA-C 113.044 0.757 . . . . 73.150000000000006 113.044 -179.075 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . 0.465 ' O ' ' HB2' ' A' ' 252' ' ' ALA . 10.0 p30 -69.84 -15.31 63.08 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 122.019 -0.426 . . . . 72.439999999999998 111.669 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.505 ' HB3' ' HB ' ' A' ' 249' ' ' VAL . 8.4 m-20 -69.78 152.89 44.08 Favored 'General case' 0 C--O 1.247 0.971 0 N-CA-C 113.918 1.081 . . . . 71.510000000000005 113.918 -175.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -112.49 134.43 54.02 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 125.804 1.642 . . . . 74.5 108.324 -179.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.565 ' HA ' HG12 ' A' ' 249' ' ' VAL . 9.9 p -86.32 146.19 6.75 Favored 'Isoleucine or valine' 0 C--O 1.245 0.847 0 CA-C-O 121.903 0.859 . . . . 73.099999999999994 112.321 -174.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.443 HG13 ' NE2' ' A' ' 158' ' ' HIS . 34.2 mm -113.0 -58.71 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 CA-C-N 114.536 -1.211 . . . . 65.430000000000007 111.285 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -150.35 158.89 44.65 Favored 'General case' 0 C--O 1.243 0.76 0 CA-C-N 116.8 -0.182 . . . . 72.209999999999994 110.523 -177.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.462 HG12 HG13 ' A' ' 226' ' ' VAL . 13.6 p -132.21 126.33 55.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 N-CA-C 109.079 -0.712 . . . . 52.009999999999998 109.079 177.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . 0.403 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 8.3 t-20 64.4 18.94 11.6 Favored 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 124.98 1.312 . . . . 53.32 110.108 176.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 102.8 -17.09 53.73 Favored Glycine 0 N--CA 1.436 -1.306 0 CA-C-N 115.858 -0.61 . . . . 70.230000000000004 112.322 -179.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 65.6 mt -98.97 127.02 52.03 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.09 0 CA-C-O 121.032 0.444 . . . . 72.430000000000007 109.977 -178.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -62.09 140.06 58.42 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-O 121.884 0.849 . . . . 75.230000000000004 112.833 -177.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . 0.462 HG13 HG12 ' A' ' 221' ' ' VAL . 16.3 m -118.13 3.56 7.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-N 114.986 -1.006 . . . . 74.409999999999997 110.272 176.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -79.15 101.95 8.21 Favored 'General case' 0 N--CA 1.422 -1.833 0 CA-C-N 115.176 -0.92 . . . . 72.439999999999998 109.544 178.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 118.31 -11.83 12.73 Favored Glycine 0 C--N 1.309 -0.927 0 C-N-CA 120.895 -0.669 . . . . 71.319999999999993 111.794 178.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -81.15 172.78 13.25 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 108.846 -0.798 . . . . 75.530000000000001 108.846 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . 0.412 ' O ' HG13 ' A' ' 234' ' ' VAL . 72.5 p -88.77 168.2 12.67 Favored 'General case' 0 N--CA 1.433 -1.303 0 N-CA-C 108.198 -1.038 . . . . 65.319999999999993 108.198 178.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.48 HD21 HG12 ' A' ' 176' ' ' ILE . 3.2 tm? -62.68 -36.3 82.45 Favored 'General case' 0 N--CA 1.426 -1.654 0 N-CA-C 109.249 -0.649 . . . . 55.210000000000001 109.249 179.006 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -67.3 -47.47 70.47 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.517 -0.473 . . . . 35.109999999999999 109.826 178.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -59.85 -38.41 82.02 Favored 'General case' 0 C--N 1.349 0.55 0 N-CA-C 113.27 0.841 . . . . 72.409999999999997 113.27 177.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.663 HG21 HG12 ' A' ' 195' ' ' ILE . 16.3 m -74.18 -36.15 42.83 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.458 0 C-N-CA 119.308 -0.957 . . . . 74.430000000000007 111.518 -179.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . 0.425 ' O ' HG23 ' A' ' 239' ' ' VAL . 39.5 m -68.61 -35.92 77.97 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 108.924 -0.769 . . . . 74.5 108.924 179.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -57.87 -41.12 81.78 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 115.716 -0.674 . . . . 33.299999999999997 109.908 175.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 13.6 mmt -58.77 -49.69 76.73 Favored 'General case' 0 C--O 1.204 -1.319 0 N-CA-C 108.242 -1.021 . . . . 62.140000000000001 108.242 177.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' MET . . . . . 0.502 ' HA ' HD21 ' A' ' 245' ' ' LEU . 60.4 mtt -63.77 -35.6 81.14 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.904 -1.044 . . . . 75.510000000000005 112.8 -174.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 235' ' ' THR . 84.4 t -70.37 -38.11 73.03 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-O 121.092 0.472 . . . . 71.450000000000003 109.851 177.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -71.63 -36.66 70.81 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.507 0.67 . . . . 72.530000000000001 110.518 178.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -89.22 21.59 3.19 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 115.463 -0.79 . . . . 74.439999999999998 111.276 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . 0.609 ' O ' HD23 ' A' ' 164' ' ' LEU . 46.0 p -64.83 -23.16 67.15 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 113.479 0.918 . . . . 74.200000000000003 113.479 -178.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 67.0 m -79.09 -18.39 53.43 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 119.439 -0.905 . . . . 62.520000000000003 111.434 177.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -166.6 92.39 0.46 Allowed 'General case' 0 C--O 1.252 1.186 0 CA-C-O 121.813 0.816 . . . . 65.510000000000005 112.227 179.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.502 HD21 ' HA ' ' A' ' 238' ' ' MET . 11.7 mt -85.29 102.94 13.79 Favored 'General case' 0 C--O 1.19 -2.067 0 CA-C-N 115.933 -0.576 . . . . 73.540000000000006 112.013 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.548 HG12 ' HG3' ' A' ' 162' ' ' ARG . 88.7 mt -96.68 114.3 33.22 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.844 0 N-CA-C 106.078 -1.823 . . . . 51.030000000000001 106.078 172.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 83.5 mt -122.93 135.61 62.43 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 CA-C-O 121.505 0.669 . . . . 61.340000000000003 111.967 -176.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.455 ' HA ' ' O ' ' A' ' 159' ' ' ARG . 46.9 m -107.13 114.9 29.24 Favored 'General case' 0 N--CA 1.414 -2.258 0 CA-C-N 114.901 -1.045 . . . . 73.319999999999993 108.581 176.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.565 HG12 ' HA ' ' A' ' 218' ' ' VAL . 31.3 m -124.96 151.9 30.92 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 N-CA-C 109.423 -0.584 . . . . 73.450000000000003 109.423 175.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.411 ' HD3' HD11 ' A' ' 219' ' ' ILE . 9.5 ptmt -127.54 141.67 41.66 Favored Pre-proline 0 C--N 1.269 -2.892 0 N-CA-C 107.635 -1.246 . . . . 74.109999999999999 107.635 178.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . 0.434 ' HG2' ' NE2' ' A' ' 254' ' ' GLN . 63.8 Cg_exo -55.55 148.24 54.44 Favored 'Trans proline' 0 CA--C 1.546 1.086 0 C-N-CA 121.913 1.742 . . . . 73.340000000000003 111.795 178.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . 0.465 ' HB2' ' O ' ' A' ' 215' ' ' ASN . . . -44.07 -38.82 3.81 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 115.524 1.676 . . . . 75.430000000000007 115.524 -172.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -118.16 14.18 13.92 Favored 'General case' 0 C--N 1.282 -2.346 0 N-CA-C 112.148 0.425 . . . . 74.140000000000001 112.148 -174.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' GLN . . . . . 0.527 ' HG2' ' H ' ' A' ' 255' ' ' ARG . 7.5 tt0 -106.63 -172.01 2.0 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 107.971 -1.122 . . . . 70.299999999999997 107.971 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . 0.527 ' H ' ' HG2' ' A' ' 254' ' ' GLN . 73.3 ttt180 . . . . . 0 C--N 1.31 -1.132 0 N-CA-C 109.227 -0.657 . . . . 75.420000000000002 109.227 -178.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 . . . . . 0 CA--C 1.511 -0.555 0 N-CA-C 109.585 -0.524 . . . . 71.5 109.585 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.405 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 68.0 p -91.22 -36.93 13.64 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 121.698 0.761 . . . . 62.509999999999998 109.671 -179.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.542 ' CD2' HG13 ' A' ' 219' ' ' ILE . 0.4 OUTLIER -125.41 152.02 45.4 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 115.475 -0.784 . . . . 73.209999999999994 109.683 176.81 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.421 ' HE ' HD13 ' A' ' 211' ' ' LEU . 15.2 tpt180 -137.78 129.35 28.19 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 108.134 -1.061 . . . . 71.200000000000003 108.134 174.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 35.6 ptt180 -112.66 119.64 38.81 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-O 121.659 0.742 . . . . 64.129999999999995 109.983 177.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.618 ' O ' ' HA ' ' A' ' 246' ' ' ILE . 27.5 m -114.21 139.15 41.5 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.3 0 CA-C-N 114.882 -1.053 . . . . 73.430000000000007 112.122 -175.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.487 ' HG2' HG12 ' A' ' 246' ' ' ILE . 44.8 mtm180 -99.15 112.29 24.47 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 106.891 -1.522 . . . . 72.140000000000001 106.891 178.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.565 ' HB2' ' HB3' ' A' ' 245' ' ' LEU . 22.1 mt -104.58 139.12 39.91 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 109.503 -0.554 . . . . 73.040000000000006 109.503 -177.245 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.404 HD11 ' HA3' ' A' ' 167' ' ' GLY . 25.4 tp 75.92 90.28 0.08 Allowed 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 113.455 0.909 . . . . 74.010000000000005 113.455 172.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 59.1 pttt -112.27 -12.1 13.64 Favored 'General case' 0 C--N 1.285 -2.207 0 CA-C-N 114.939 -1.028 . . . . 72.150000000000006 109.752 175.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 46.0 t-80 -144.53 113.57 6.87 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 108.155 -1.054 . . . . 74.010000000000005 108.155 179.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . 0.404 ' HA3' HD11 ' A' ' 164' ' ' LEU . . . 159.4 -101.42 0.2 Allowed Glycine 0 N--CA 1.438 -1.193 0 C-N-CA 120.298 -0.953 . . . . 71.430000000000007 112.545 -178.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 35.1 t 64.75 35.61 8.65 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 122.143 0.973 . . . . 62.299999999999997 108.638 -176.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -158.03 -44.84 0.06 Allowed 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 114.309 -1.314 . . . . 64.329999999999998 109.153 -175.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 60.3 pttt -91.68 139.71 24.98 Favored Pre-proline 0 C--N 1.304 -1.406 0 CA-C-N 114.909 -1.041 . . . . 75.349999999999994 111.436 -177.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -57.08 152.42 44.55 Favored 'Trans proline' 0 C--O 1.249 1.028 0 C-N-CA 122.866 2.377 . . . . 54.210000000000001 111.592 177.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.437 ' HG ' ' CD1' ' A' ' 245' ' ' LEU . 3.2 mm? -69.24 -28.39 66.29 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.881 -0.6 . . . . 71.019999999999996 112.558 -176.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . 0.441 ' HA3' ' HA3' ' A' ' 204' ' ' GLY . . . 94.61 30.62 8.4 Favored Glycine 0 N--CA 1.428 -1.836 0 C-N-CA 119.534 -1.317 . . . . 75.200000000000003 112.897 178.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -154.98 154.66 32.89 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 107.654 -1.239 . . . . 74.310000000000002 107.654 175.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -126.5 157.45 38.68 Favored 'General case' 0 C--N 1.272 -2.788 0 N-CA-C 107.625 -1.25 . . . . 74.409999999999997 107.625 175.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 30.8 pt -122.94 164.16 20.72 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.02 0 CA-C-O 121.605 0.717 . . . . 63.350000000000001 112.424 -178.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.428 ' HG2' ' HB3' ' A' ' 198' ' ' SER . 4.0 ptp180 -139.39 154.73 47.87 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 114.238 -1.347 . . . . 75.120000000000005 108.18 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . 0.473 ' HB3' HD23 ' A' ' 231' ' ' LEU . 4.1 p-10 -121.44 143.11 49.42 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 108.917 -0.771 . . . . 73.140000000000001 108.917 176.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' A' ' 193' ' ' PRO . . . -156.26 -146.18 4.39 Favored Glycine 0 N--CA 1.415 -2.758 0 N-CA-C 109.425 -1.47 . . . . 73.099999999999994 109.425 178.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . 0.555 ' HB ' ' CG ' ' A' ' 191' ' ' LYS . 1.3 p -108.74 127.32 53.9 Favored 'General case' 0 C--N 1.28 -2.45 0 N-CA-C 112.695 0.628 . . . . 53.119999999999997 112.695 179.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 28.7 t -110.36 120.26 41.85 Favored 'General case' 0 N--CA 1.413 -2.319 0 N-CA-C 106.951 -1.5 . . . . 61.350000000000001 106.951 175.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.512 ' HA ' ' O ' ' A' ' 190' ' ' GLU . 7.7 p -117.61 119.05 60.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 109.09 -0.707 . . . . 62.130000000000003 109.09 176.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -128.06 160.28 32.45 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 115.753 -0.658 . . . . 74.140000000000001 109.327 -175.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 78.2 t -82.92 119.44 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.805 0 N-CA-C 107.345 -1.354 . . . . 74.519999999999996 107.345 171.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 49.0 p -119.0 -175.44 2.91 Favored 'General case' 0 C--N 1.261 -3.26 0 CA-C-N 114.684 -1.144 . . . . 72.230000000000004 108.239 -178.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -69.4 -9.56 54.09 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-O 121.382 0.611 . . . . 74.140000000000001 109.701 174.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 31.8 m -103.47 -3.58 25.19 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 115.639 -0.71 . . . . 74.450000000000003 110.654 177.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 105.68 -155.61 16.81 Favored Glycine 0 CA--C 1.498 -1.003 0 N-CA-C 110.271 -1.131 . . . . 52.409999999999997 110.271 179.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 5.6 mp -84.02 118.61 24.16 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 108.608 -0.886 . . . . 64.530000000000001 108.608 176.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . 0.512 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 42.6 tt0 -132.22 124.67 29.42 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.912 -0.773 . . . . 75.319999999999993 108.912 -176.079 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.555 ' CG ' ' HB ' ' A' ' 180' ' ' THR . 36.2 ttmt -96.41 125.59 41.01 Favored 'General case' 0 N--CA 1.417 -2.09 0 N-CA-C 108.305 -0.998 . . . . 64.450000000000003 108.305 -178.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -140.92 164.1 38.28 Favored Pre-proline 0 C--N 1.287 -2.117 0 N-CA-C 108.946 -0.761 . . . . 60.509999999999998 108.946 -176.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . 0.427 ' HA ' ' O ' ' A' ' 179' ' ' GLY . 10.7 Cg_endo -55.93 132.38 51.64 Favored 'Trans proline' 0 C--O 1.248 1.018 0 C-N-CA 121.642 1.561 . . . . 74.019999999999996 111.0 175.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -141.14 147.52 19.13 Favored Glycine 0 CA--C 1.471 -2.691 0 N-CA-C 110.7 -0.96 . . . . 73.25 110.7 -178.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.759 HG12 HG21 ' A' ' 234' ' ' VAL . 2.9 mp -104.24 142.17 18.3 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 CA-C-O 121.295 0.569 . . . . 70.209999999999994 110.132 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -137.07 164.42 28.45 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 107.244 -1.391 . . . . 62.32 107.244 -178.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . 0.495 ' HB ' ' HA ' ' A' ' 214' ' ' VAL . 48.6 mm -76.26 127.82 37.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 107.747 -1.205 . . . . 75.450000000000003 107.747 176.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . 0.428 ' HB3' ' HG2' ' A' ' 177' ' ' ARG . 82.9 p -99.92 -38.88 8.43 Favored 'General case' 0 C--N 1.29 -1.994 0 C-N-CA 119.862 -0.735 . . . . 75.430000000000007 111.196 -175.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -150.43 139.4 20.98 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 108.809 -0.811 . . . . 74.010000000000005 108.809 -177.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 1.1 tt -111.59 132.45 54.55 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 107.395 -1.335 . . . . 64.400000000000006 107.395 -179.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 61.1 t -104.98 118.46 56.07 Favored Pre-proline 0 C--N 1.312 -1.054 0 CA-C-O 120.626 0.25 . . . . 61.25 111.453 -176.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.48 ' HA ' ' HG2' ' A' ' 207' ' ' GLU . 37.8 Cg_exo -62.23 136.96 63.09 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 122.627 2.218 . . . . 72.439999999999998 110.866 176.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 96.55 -22.01 42.54 Favored Glycine 0 N--CA 1.439 -1.134 0 C-N-CA 121.12 -0.562 . . . . 75.040000000000006 112.253 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . 0.441 ' HA3' ' HA3' ' A' ' 173' ' ' GLY . . . -80.54 -176.18 49.98 Favored Glycine 0 N--CA 1.44 -1.067 0 C-N-CA 120.966 -0.635 . . . . 72.239999999999995 112.417 -179.047 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 172' ' ' LEU . 3.2 mm? -67.87 -41.87 82.17 Favored 'General case' 0 N--CA 1.426 -1.668 0 C-N-CA 122.91 0.484 . . . . 71.329999999999998 110.754 -178.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -64.02 -34.2 77.48 Favored 'General case' 0 C--O 1.22 -0.481 0 N-CA-C 113.139 0.792 . . . . 31.41 113.139 -176.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.48 ' HG2' ' HA ' ' A' ' 202' ' ' PRO . 11.8 tp10 -75.61 -33.08 60.52 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-O 121.724 0.773 . . . . 71.439999999999998 108.971 179.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 19.3 t -65.86 -24.71 66.93 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.954 -1.021 . . . . 54.240000000000002 110.802 -178.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 2.4 m -69.18 -40.45 78.09 Favored 'General case' 0 N--CA 1.415 -2.212 0 CA-C-N 115.914 -0.585 . . . . 73.5 111.867 -171.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 70.02 24.21 76.63 Favored Glycine 0 C--O 1.225 -0.42 0 N-CA-C 111.012 -0.835 . . . . 75.400000000000006 111.012 -176.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.421 HD13 ' HE ' ' A' ' 159' ' ' ARG . 65.6 mt -140.72 -8.95 1.06 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 122.963 0.505 . . . . 65.519999999999996 111.053 -175.153 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 67.9 mt -109.48 131.22 55.27 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 115.888 -0.596 . . . . 71.439999999999998 110.583 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -134.15 166.23 23.24 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.727 -1.212 . . . . 74.109999999999999 107.727 175.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . 0.495 ' HA ' ' HB ' ' A' ' 197' ' ' ILE . 31.3 m -66.52 -30.8 50.96 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 N-CA-C 113.074 0.768 . . . . 71.209999999999994 113.074 -179.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 46.7 m-80 -75.15 -14.5 60.56 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 113.706 1.002 . . . . 72.340000000000003 113.706 -177.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.452 ' HB3' ' HB ' ' A' ' 249' ' ' VAL . 5.3 m-20 -63.74 131.59 48.37 Favored 'General case' 0 C--O 1.246 0.877 0 CA-C-O 121.172 0.51 . . . . 65.209999999999994 112.282 -179.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -97.55 140.85 31.36 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.462 -0.79 . . . . 75.519999999999996 109.48 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.518 HG11 ' HB ' ' A' ' 195' ' ' ILE . 5.2 p -81.86 145.56 8.55 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 CA-C-O 121.621 0.724 . . . . 70.200000000000003 112.229 -174.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.542 HG13 ' CD2' ' A' ' 158' ' ' HIS . 44.4 mm -115.96 -60.85 2.71 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 115.618 -0.719 . . . . 54.420000000000002 110.874 178.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -152.36 154.83 36.42 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 109.136 -0.69 . . . . 75.209999999999994 109.136 -176.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.521 HG22 HG12 ' A' ' 247' ' ' ILE . 44.2 t -128.94 122.91 57.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 108.466 -0.939 . . . . 44.140000000000001 108.466 179.123 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 65.7 20.35 11.52 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.137 1.375 . . . . 71.420000000000002 109.523 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 97.37 -15.2 62.58 Favored Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 115.243 -0.889 . . . . 13.34 111.975 -178.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 63.0 mt -92.67 123.77 44.88 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.747 0 N-CA-C 109.044 -0.724 . . . . 62.310000000000002 109.044 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -57.39 142.38 43.96 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.521 0.677 . . . . 74.409999999999997 112.139 -178.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . 0.499 ' HA ' ' CG ' ' A' ' 229' ' ' LYS . 15.6 m -120.93 10.46 6.21 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.845 0 CA-C-N 115.555 -0.748 . . . . 64.439999999999998 111.083 175.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -74.3 101.34 4.0 Favored 'General case' 0 N--CA 1.426 -1.657 0 CA-C-N 115.035 -0.984 . . . . 52.310000000000002 109.588 177.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 109.69 -1.57 30.53 Favored Glycine 0 CA--C 1.496 -1.121 0 C-N-CA 120.886 -0.673 . . . . 71.349999999999994 111.707 177.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.499 ' CG ' ' HA ' ' A' ' 226' ' ' VAL . 71.9 mmtt -82.21 158.77 23.44 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.18 -0.674 . . . . 75.040000000000006 109.18 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 67.3 p -82.66 171.49 13.97 Favored 'General case' 0 N--CA 1.409 -2.512 0 C-N-CA 119.299 -0.96 . . . . 71.510000000000005 109.437 177.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.473 HD23 ' HB3' ' A' ' 178' ' ' ASP . 2.1 tm? -66.59 -35.48 80.3 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 108.578 -0.897 . . . . 73.329999999999998 108.578 -179.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -65.13 -41.22 95.02 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.581 -0.736 . . . . 73.140000000000001 109.698 178.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -61.34 -47.16 87.15 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.481 -0.781 . . . . 55.210000000000001 112.507 176.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.759 HG21 HG12 ' A' ' 195' ' ' ILE . 19.8 m -69.63 -33.74 58.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 C-N-CA 120.211 -0.596 . . . . 70.099999999999994 111.918 -177.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . 0.468 ' O ' HG23 ' A' ' 239' ' ' VAL . 90.4 m -64.86 -35.7 81.98 Favored 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 109.694 -0.484 . . . . 64.25 109.694 177.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -63.39 -35.84 81.76 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.279 -0.419 . . . . 74.519999999999996 110.125 176.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 16.8 mmt -58.08 -52.75 64.24 Favored 'General case' 0 C--O 1.201 -1.453 0 N-CA-C 107.814 -1.18 . . . . 71.299999999999997 107.814 174.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 66.6 mtt -58.21 -35.28 71.41 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.633 -1.167 . . . . 70.219999999999999 112.049 -175.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 235' ' ' THR . 94.5 t -71.96 -45.98 61.78 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-O 120.832 0.349 . . . . 72.239999999999995 110.615 177.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -68.01 -34.61 76.83 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.508 0.671 . . . . 74.310000000000002 111.076 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -89.76 21.84 3.36 Favored 'General case' 0 C--O 1.198 -1.633 0 CA-C-N 115.311 -0.859 . . . . 73.340000000000003 110.578 -179.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 25.2 t -60.63 -23.78 65.01 Favored 'General case' 0 CA--C 1.563 1.461 0 N-CA-C 112.149 0.426 . . . . 71.319999999999993 112.149 -178.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 6.9 p -81.07 -14.01 58.22 Favored 'General case' 0 CA--C 1.558 1.262 0 N-CA-C 112.641 0.608 . . . . 72.319999999999993 112.641 178.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -173.77 98.55 0.11 Allowed 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.908 1.283 . . . . 72.25 108.356 173.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.565 ' HB3' ' HB2' ' A' ' 163' ' ' LEU . 1.2 tt -86.36 101.82 13.45 Favored 'General case' 0 N--CA 1.413 -2.305 0 N-CA-C 107.701 -1.222 . . . . 53.439999999999998 107.701 -176.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.618 ' HA ' ' O ' ' A' ' 161' ' ' VAL . 73.5 mt -104.07 116.12 47.26 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 C-N-CA 120.163 -0.615 . . . . 63.140000000000001 109.812 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . 0.521 HG12 HG22 ' A' ' 221' ' ' VAL . 91.7 mt -122.05 131.36 73.31 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.892 0 C-N-CA 120.151 -0.62 . . . . 63.009999999999998 110.085 176.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 56.3 m -96.77 114.95 26.63 Favored 'General case' 0 N--CA 1.412 -2.369 0 N-CA-C 107.545 -1.28 . . . . 53.210000000000001 107.545 174.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.475 HG12 ' HA ' ' A' ' 218' ' ' VAL . 21.7 m -117.89 169.12 8.89 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.117 0 N-CA-C 109.098 -0.705 . . . . 70.340000000000003 109.098 176.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 15.5 ptmt -134.0 129.45 20.07 Favored Pre-proline 0 C--N 1.28 -2.456 0 CA-C-N 115.454 -0.793 . . . . 73.219999999999999 110.181 176.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . 0.405 ' HD2' ' O ' ' A' ' 157' ' ' THR . 33.6 Cg_endo -68.41 148.44 73.49 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 C-N-CA 121.738 1.626 . . . . 74.430000000000007 108.86 173.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -56.09 -44.45 79.03 Favored 'General case' 0 CA--C 1.499 -1.003 0 CA-C-O 121.408 0.623 . . . . 64.340000000000003 110.518 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -97.19 83.63 3.36 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 108.206 -1.035 . . . . 74.430000000000007 108.206 177.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -67.32 114.16 5.8 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 114.721 -1.127 . . . . 71.349999999999994 112.816 179.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 82.9 mtp180 . . . . . 0 C--N 1.297 -1.691 0 N-CA-C 108.425 -0.954 . . . . 74.540000000000006 108.425 177.357 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.506 -0.719 0 N-CA-C 108.21 -1.033 . . . . 70.230000000000004 108.21 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.42 ' O ' ' HA ' ' A' ' 250' ' ' LYS . 9.9 t -68.73 -18.4 64.23 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 112.14 0.422 . . . . 74.319999999999993 112.14 -179.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.735 ' NE2' HG13 ' A' ' 219' ' ' ILE . 9.0 m80 -124.66 127.99 48.16 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 109.806 -0.442 . . . . 75.420000000000002 109.806 170.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.548 ' O ' ' HA ' ' A' ' 248' ' ' THR . 45.3 ttm180 -145.01 144.0 30.79 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 116.4 -0.364 . . . . 63.409999999999997 111.071 174.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.529 ' HA ' ' O ' ' A' ' 247' ' ' ILE . 0.0 OUTLIER -118.23 127.04 53.36 Favored 'General case' 0 C--N 1.32 -0.677 0 O-C-N 123.244 0.34 . . . . 71.420000000000002 110.42 175.445 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.512 HG11 HD21 ' A' ' 211' ' ' LEU . 11.9 m -122.25 139.05 50.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 CA-C-N 115.909 -0.587 . . . . 74.409999999999997 111.283 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 21.8 ttm180 -92.59 116.36 28.93 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 109.317 -0.623 . . . . 74.430000000000007 109.317 177.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.422 ' HB2' ' HB3' ' A' ' 245' ' ' LEU . 19.7 mt -107.87 138.73 43.6 Favored 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 107.144 -1.428 . . . . 72.299999999999997 107.144 -179.063 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.558 HD11 ' H ' ' A' ' 168' ' ' SER . 1.0 OUTLIER 69.75 82.33 0.16 Allowed 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 122.325 1.06 . . . . 74.140000000000001 108.322 173.473 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -100.31 -0.15 38.97 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 114.811 -1.086 . . . . 65.420000000000002 110.022 -175.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -93.65 -11.94 30.5 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 114.246 1.202 . . . . 74.109999999999999 114.246 -177.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 65.89 75.65 0.4 Allowed Glycine 0 C--O 1.239 0.42 0 C-N-CA 120.167 -1.015 . . . . 51.030000000000001 111.425 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . 0.558 ' H ' HD11 ' A' ' 164' ' ' LEU . 33.1 t -165.42 140.25 4.96 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 106.86 -1.533 . . . . 70.519999999999996 106.86 -176.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -81.01 74.33 8.02 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-O 122.256 1.027 . . . . 73.430000000000007 111.236 -178.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -99.27 153.29 37.86 Favored Pre-proline 0 C--N 1.277 -2.584 0 CA-C-N 113.887 -1.506 . . . . 52.130000000000003 108.711 173.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -63.08 131.32 32.06 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 121.922 1.748 . . . . 74.400000000000006 109.304 174.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.426 ' HG ' ' CD1' ' A' ' 245' ' ' LEU . 2.8 mm? -81.05 -18.67 45.9 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 116.099 -0.5 . . . . 63.5 111.98 -173.056 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . 0.547 ' HA3' ' HA3' ' A' ' 204' ' ' GLY . . . 97.95 17.1 31.1 Favored Glycine 0 N--CA 1.415 -2.746 0 C-N-CA 119.273 -1.441 . . . . 53.229999999999997 111.879 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -158.08 157.17 32.33 Favored 'General case' 0 N--CA 1.427 -1.605 0 N-CA-C 109.273 -0.64 . . . . 51.299999999999997 109.273 179.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -129.38 158.24 39.69 Favored 'General case' 0 C--N 1.283 -2.314 0 N-CA-C 107.995 -1.113 . . . . 74.340000000000003 107.995 172.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.625 ' H ' HD13 ' A' ' 176' ' ' ILE . 0.1 OUTLIER -118.53 163.78 15.41 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.018 0 CA-C-O 121.744 0.783 . . . . 60.509999999999998 111.271 -178.68 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.439 ' HB3' ' HB3' ' A' ' 198' ' ' SER . 15.6 ptt180 -142.35 154.77 44.94 Favored 'General case' 0 C--N 1.28 -2.424 0 CA-C-N 114.182 -1.372 . . . . 74.120000000000005 109.477 -177.137 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -110.67 138.21 47.35 Favored 'General case' 0 C--N 1.294 -1.848 0 CA-C-O 121.143 0.497 . . . . 73.25 110.551 179.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -145.06 176.46 24.09 Favored Glycine 0 C--N 1.28 -2.544 0 N-CA-C 106.858 -2.497 . . . . 74.349999999999994 106.858 175.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . 0.574 ' CG2' ' HG2' ' A' ' 191' ' ' LYS . 0.2 OUTLIER -102.07 122.71 44.64 Favored 'General case' 0 C--N 1.273 -2.74 0 C-N-CA 117.312 -1.755 . . . . 70.340000000000003 107.103 177.965 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . 0.417 ' O ' ' HA ' ' A' ' 191' ' ' LYS . 33.3 t -94.0 124.45 38.01 Favored 'General case' 0 C--N 1.283 -2.293 0 N-CA-C 109.041 -0.725 . . . . 72.349999999999994 109.041 -176.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.589 ' HA ' ' O ' ' A' ' 190' ' ' GLU . 4.0 p -112.8 121.85 65.85 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 CA-C-O 121.755 0.788 . . . . 65.239999999999995 110.137 175.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 86.6 mtt180 -126.88 158.38 36.88 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 107.801 -1.185 . . . . 73.209999999999994 107.801 -175.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' A' ' 188' ' ' GLY . 99.8 t -88.08 118.71 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.785 0 C-N-CA 118.904 -1.118 . . . . 62.119999999999997 108.458 171.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 35.5 p -119.84 -173.21 2.49 Favored 'General case' 0 C--N 1.276 -2.597 0 CA-C-N 113.844 -1.525 . . . . 54.030000000000001 108.745 -175.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -60.46 -21.63 62.56 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.049 0.452 . . . . 71.239999999999995 110.554 174.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 28.5 m -88.09 -19.14 27.45 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 116.129 -0.487 . . . . 54.109999999999999 110.136 178.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.418 ' O ' ' HA ' ' A' ' 184' ' ' VAL . . . 112.09 -139.8 15.83 Favored Glycine 0 CA--C 1.482 -1.982 0 N-CA-C 108.836 -1.706 . . . . 63.350000000000001 108.836 -176.214 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 5.3 mp -78.42 119.11 21.27 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.019 -1.104 . . . . 64.099999999999994 108.019 177.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . 0.589 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 9.4 tp10 -131.61 123.24 27.48 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 108.611 -0.885 . . . . 72.430000000000007 108.611 -175.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.574 ' HG2' ' CG2' ' A' ' 180' ' ' THR . 34.2 ttmt -101.41 129.35 47.41 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.295 -1.002 . . . . 73.430000000000007 108.295 -176.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -147.88 165.17 19.26 Favored Pre-proline 0 C--N 1.306 -1.325 0 N-CA-C 109.127 -0.694 . . . . 53.119999999999997 109.127 -170.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -56.79 132.35 51.17 Favored 'Trans proline' 0 C--O 1.255 1.369 0 C-N-CA 121.378 1.386 . . . . 74.549999999999997 110.64 177.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -145.57 128.14 3.04 Favored Glycine 0 N--CA 1.419 -2.465 0 N-CA-C 110.504 -1.038 . . . . 73.349999999999994 110.504 -178.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.626 HG12 HG21 ' A' ' 234' ' ' VAL . 3.4 mp -103.92 136.24 37.97 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.415 0 CA-C-O 121.242 0.544 . . . . 73.420000000000002 110.422 -178.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -127.87 167.52 16.46 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 107.8 -1.185 . . . . 63.25 107.8 -177.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . 0.492 ' HB ' ' HA ' ' A' ' 214' ' ' VAL . 46.1 mm -75.4 131.19 35.4 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 N-CA-C 107.44 -1.319 . . . . 74.540000000000006 107.44 175.024 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . 0.439 ' HB3' ' HB3' ' A' ' 177' ' ' ARG . 86.4 p -99.37 -33.32 10.75 Favored 'General case' 0 C--N 1.29 -1.986 0 O-C-N 121.53 -0.731 . . . . 54.109999999999999 111.356 -175.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 10.8 ttp180 -167.22 143.61 4.35 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.822 -0.626 . . . . 75.099999999999994 110.65 -175.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.442 HD11 ' O ' ' A' ' 212' ' ' LEU . 73.3 mt -101.87 146.7 27.45 Favored 'General case' 0 CA--C 1.494 -1.187 0 CA-C-N 116.168 -0.469 . . . . 74.409999999999997 109.796 174.052 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . 0.52 ' HB ' ' HA2' ' A' ' 173' ' ' GLY . 21.7 t -114.35 115.25 44.98 Favored Pre-proline 0 C--N 1.289 -2.058 0 N-CA-C 106.329 -1.73 . . . . 71.239999999999995 106.329 172.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.449 ' HA ' ' HG2' ' A' ' 207' ' ' GLU . 31.3 Cg_exo -58.78 147.25 89.33 Favored 'Trans proline' 0 N--CA 1.444 -1.42 0 C-N-CA 121.95 1.766 . . . . 65.329999999999998 111.082 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 94.48 -23.24 33.07 Favored Glycine 0 C--N 1.305 -1.159 0 N-CA-C 110.794 -0.922 . . . . 54.140000000000001 110.794 -176.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . 0.547 ' HA3' ' HA3' ' A' ' 173' ' ' GLY . . . -83.48 163.53 40.87 Favored Glycine 0 N--CA 1.43 -1.701 0 N-CA-C 110.526 -1.029 . . . . 71.540000000000006 110.526 177.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.498 ' H ' HD22 ' A' ' 205' ' ' LEU . 2.8 mm? -55.16 -42.62 73.36 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 123.842 0.857 . . . . 72.510000000000005 112.42 -175.047 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -59.17 -48.13 82.76 Favored 'General case' 0 C--O 1.244 0.764 0 N-CA-C 112.306 0.484 . . . . 74.120000000000005 112.306 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.449 ' HG2' ' HA ' ' A' ' 202' ' ' PRO . 8.3 tp10 -75.41 -33.4 60.95 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.958 -0.386 . . . . 65.530000000000001 109.958 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 35.5 t -57.66 -44.75 85.93 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 116.214 -0.448 . . . . 73.349999999999994 110.734 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . 0.629 HG23 ' H ' ' A' ' 211' ' ' LEU . 8.9 t -77.0 -31.87 56.77 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 119.679 -0.808 . . . . 73.019999999999996 109.537 176.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 70.13 19.9 76.04 Favored Glycine 0 N--CA 1.447 -0.61 0 CA-C-N 115.938 -0.574 . . . . 64.109999999999999 112.694 178.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.629 ' H ' HG23 ' A' ' 209' ' ' THR . 1.4 pp -105.65 -0.52 25.53 Favored 'General case' 0 N--CA 1.432 -1.336 0 CA-C-O 121.072 0.463 . . . . 71.510000000000005 111.407 -178.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.442 ' O ' HD11 ' A' ' 200' ' ' LEU . 60.7 mt -109.32 133.78 52.62 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.384 -0.826 . . . . 74.150000000000006 109.226 176.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -131.87 165.51 23.7 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.763 -0.828 . . . . 73.120000000000005 108.763 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . 0.492 ' HA ' ' HB ' ' A' ' 197' ' ' ILE . 33.4 m -64.28 -29.48 47.47 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 N-CA-C 113.914 1.079 . . . . 63.399999999999999 113.914 -177.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -74.44 -14.63 60.87 Favored 'General case' 0 C--N 1.308 -1.228 0 O-C-N 121.855 -0.528 . . . . 74.420000000000002 111.729 -178.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.414 ' HB3' ' HB ' ' A' ' 249' ' ' VAL . 54.3 m-20 -69.83 130.97 43.73 Favored 'General case' 0 C--O 1.245 0.867 0 CA-C-O 121.233 0.54 . . . . 53.299999999999997 112.237 -176.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -101.19 135.08 43.25 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.952 -1.022 . . . . 71.400000000000006 109.659 -178.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.534 HG23 HG23 ' A' ' 247' ' ' ILE . 10.6 p -82.12 131.36 34.0 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.152 0 CA-C-O 121.749 0.785 . . . . 51.140000000000001 111.375 -176.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.735 HG13 ' NE2' ' A' ' 158' ' ' HIS . 36.8 mm -100.87 -52.71 8.34 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 CA-C-N 115.318 -0.855 . . . . 63.329999999999998 111.409 -179.157 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -154.68 152.8 30.37 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 116.449 -0.341 . . . . 65.299999999999997 110.146 -178.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.507 ' HA ' ' O ' ' A' ' 246' ' ' ILE . 10.7 p -125.27 125.51 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.644 0 N-CA-C 108.956 -0.757 . . . . 74.420000000000002 108.956 177.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . 0.4 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 2.9 m-20 57.1 22.72 7.72 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.592 1.157 . . . . 53.020000000000003 112.945 -177.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 100.34 -11.46 59.97 Favored Glycine 0 C--N 1.309 -0.954 0 C-N-CA 120.912 -0.661 . . . . 75.219999999999999 112.348 179.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 64.2 mt -98.7 123.53 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.284 0 N-CA-C 109.361 -0.607 . . . . 64.120000000000005 109.361 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -60.52 140.24 57.4 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 121.796 0.808 . . . . 73.040000000000006 112.216 -177.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . 0.517 ' HB ' HG12 ' A' ' 234' ' ' VAL . 25.6 m -120.61 0.44 7.41 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 CA-C-N 115.083 -0.962 . . . . 55.149999999999999 109.561 175.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -78.35 98.26 5.91 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 115.323 -0.853 . . . . 72.010000000000005 109.649 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 120.32 -19.95 9.13 Favored Glycine 0 C--N 1.308 -0.975 0 N-CA-C 110.691 -0.964 . . . . 51.549999999999997 110.691 -178.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -72.49 164.78 25.85 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.61 -0.515 . . . . 73.129999999999995 109.61 177.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . 0.464 ' O ' HG13 ' A' ' 234' ' ' VAL . 67.2 p -84.86 168.61 14.92 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 108.734 -0.839 . . . . 63.240000000000002 108.734 178.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.404 ' HA ' HG22 ' A' ' 234' ' ' VAL . 53.3 tp -63.43 -31.95 73.25 Favored 'General case' 0 N--CA 1.424 -1.745 0 N-CA-C 109.541 -0.54 . . . . 75.310000000000002 109.541 177.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -64.46 -50.94 65.51 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.472 -0.566 . . . . 75.299999999999997 109.472 176.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' GLN . . . . . 0.464 ' O ' ' HG2' ' A' ' 237' ' ' MET . 2.2 mp0 -58.49 -43.77 89.16 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 113.297 0.851 . . . . 74.129999999999995 113.297 177.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.626 HG21 HG12 ' A' ' 195' ' ' ILE . 7.2 m -72.06 -34.79 51.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 C-N-CA 119.796 -0.762 . . . . 74.219999999999999 111.811 -176.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . 0.442 ' O ' HG23 ' A' ' 239' ' ' VAL . 42.8 m -69.6 -36.36 76.13 Favored 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 109.224 -0.658 . . . . 70.319999999999993 109.224 179.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -59.84 -37.74 80.11 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-N 116.11 -0.496 . . . . 75.409999999999997 110.049 176.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' MET . . . . . 0.464 ' HG2' ' O ' ' A' ' 233' ' ' GLN . 16.8 mmt -58.96 -52.13 67.1 Favored 'General case' 0 C--O 1.2 -1.523 0 N-CA-C 108.451 -0.944 . . . . 73.140000000000001 108.451 176.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' MET . . . . . 0.412 ' HG3' ' O ' ' A' ' 234' ' ' VAL . 58.1 mtt -62.82 -33.11 74.54 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.996 -1.002 . . . . 72.450000000000003 112.201 -175.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 235' ' ' THR . 75.6 t -68.29 -41.31 83.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-O 121.328 0.585 . . . . 51.32 109.902 175.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -72.32 -38.84 68.58 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.438 -0.801 . . . . 73.329999999999998 110.664 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -84.03 21.47 1.34 Allowed 'General case' 0 C--O 1.198 -1.613 0 CA-C-N 115.399 -0.819 . . . . 73.310000000000002 111.742 -177.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . 0.487 ' O ' HD12 ' A' ' 164' ' ' LEU . 14.8 p -64.36 -22.54 66.99 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-O 121.121 0.486 . . . . 62.100000000000001 111.559 176.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 26.7 m -68.84 -27.13 65.56 Favored 'General case' 0 CA--C 1.557 1.24 0 CA-C-N 116.318 -0.401 . . . . 73.430000000000007 110.914 176.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -174.44 103.16 0.1 Allowed 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.794 1.237 . . . . 63.450000000000003 108.98 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.491 ' CD2' HG13 ' A' ' 247' ' ' ILE . 1.0 OUTLIER -90.49 103.51 16.19 Favored 'General case' 0 C--O 1.201 -1.456 0 N-CA-C 109.634 -0.506 . . . . 73.120000000000005 109.634 -173.923 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.507 ' O ' ' HA ' ' A' ' 221' ' ' VAL . 63.9 mt -105.02 115.42 46.87 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 O-C-N 121.445 -0.785 . . . . 64.329999999999998 109.255 178.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . 0.534 HG23 HG23 ' A' ' 218' ' ' VAL . 18.8 mt -119.31 133.43 66.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 113.375 0.88 . . . . 54.310000000000002 113.375 -179.314 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.548 ' HA ' ' O ' ' A' ' 159' ' ' ARG . 61.2 m -103.11 121.27 42.27 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 107.65 -1.241 . . . . 74.239999999999995 107.65 173.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.498 HG12 ' HA ' ' A' ' 218' ' ' VAL . 17.1 m -122.81 163.83 20.97 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.061 0 CA-C-O 121.106 0.479 . . . . 75.439999999999998 110.523 175.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.42 ' HA ' ' O ' ' A' ' 157' ' ' THR . 19.4 ptmt -134.29 128.9 19.55 Favored Pre-proline 0 N--CA 1.416 -2.156 0 CA-C-N 114.469 -1.241 . . . . 74.010000000000005 107.745 173.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -61.4 133.59 46.97 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 121.255 1.303 . . . . 74.299999999999997 112.386 178.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -74.81 -14.62 60.71 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 109.268 -0.641 . . . . 54.240000000000002 109.268 176.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -96.55 6.43 48.75 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.303 -0.862 . . . . 72.420000000000002 109.302 174.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 43.37 96.29 0.01 OUTLIER 'General case' 0 C--N 1.354 0.79 0 C-N-CA 127.007 2.123 . . . . 65.439999999999998 114.222 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 . . . . . 0 C--O 1.255 1.389 0 C-N-CA 124.039 0.936 . . . . 60.43 110.325 -176.737 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.504 -0.803 0 N-CA-C 107.928 -1.138 . . . . 74.340000000000003 107.928 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.56 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 39.8 p -106.56 -34.19 7.44 Favored 'General case' 0 N--CA 1.418 -2.046 0 CA-C-N 114.78 -1.1 . . . . 73.510000000000005 108.111 173.044 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.499 ' ND1' ' HB3' ' A' ' 250' ' ' LYS . 0.6 OUTLIER -125.56 153.22 43.99 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 123.65 0.78 . . . . 74.049999999999997 110.305 174.029 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.456 ' O ' ' HA ' ' A' ' 248' ' ' THR . 28.7 tpt180 -143.47 133.59 24.33 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 109.409 -0.589 . . . . 72.450000000000003 109.409 172.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 32.0 ptt180 -113.36 124.65 52.96 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 116.044 -0.525 . . . . 63.530000000000001 109.945 177.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.554 ' O ' ' HA ' ' A' ' 246' ' ' ILE . 17.4 m -127.0 139.25 52.45 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 CA-C-N 116.015 -0.539 . . . . 65.450000000000003 112.218 -176.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.608 ' HG2' HG12 ' A' ' 246' ' ' ILE . 95.6 mtt180 -87.95 112.57 22.71 Favored 'General case' 0 C--O 1.242 0.661 0 N-CA-C 108.264 -1.013 . . . . 62.240000000000002 108.264 176.192 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.539 ' HB2' ' HB3' ' A' ' 245' ' ' LEU . 33.5 mt -92.87 125.75 37.63 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 107.372 -1.344 . . . . 63.32 107.372 176.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.446 HD13 ' O ' ' A' ' 242' ' ' SER . 5.8 tt 78.95 83.89 0.06 Allowed 'General case' 0 C--N 1.312 -1.038 0 O-C-N 124.664 1.227 . . . . 71.109999999999999 110.468 179.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -92.99 -25.77 17.83 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 106.853 -1.536 . . . . 74.219999999999999 106.853 173.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 52.3 t-80 -141.59 132.14 25.42 Favored 'General case' 0 N--CA 1.432 -1.346 0 CA-C-N 113.635 -1.62 . . . . 73.310000000000002 106.717 176.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 166.92 -114.39 0.58 Allowed Glycine 0 N--CA 1.43 -1.737 0 C-N-CA 120.012 -1.09 . . . . 32.240000000000002 112.132 -178.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . 0.424 ' H ' HD11 ' A' ' 164' ' ' LEU . 63.3 m 66.15 21.26 11.15 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.632 0.729 . . . . 73.409999999999997 111.282 -177.173 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -118.11 -49.43 2.5 Favored 'General case' 0 CA--C 1.495 -1.137 0 CA-C-N 115.162 -0.926 . . . . 71.099999999999994 109.03 177.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.574 ' HD3' ' H ' ' A' ' 170' ' ' LYS . 0.1 OUTLIER -120.66 153.95 56.9 Favored Pre-proline 0 N--CA 1.422 -1.869 0 CA-C-N 115.124 -0.944 . . . . 72.209999999999994 111.577 -173.027 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_exo -54.88 154.81 20.07 Favored 'Trans proline' 0 C--O 1.247 0.937 0 C-N-CA 124.099 3.199 . . . . 40.149999999999999 112.43 174.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.47 ' HG ' ' CD1' ' A' ' 245' ' ' LEU . 3.3 mm? -56.21 -40.31 73.83 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.842 0.682 . . . . 62.350000000000001 112.842 -178.082 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 96.17 47.43 2.42 Favored Glycine 0 N--CA 1.439 -1.131 0 C-N-CA 119.77 -1.205 . . . . 31.120000000000001 114.205 174.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -159.51 154.51 24.89 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.774 -0.824 . . . . 74.25 108.774 174.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -123.4 143.89 49.84 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 109.071 -0.714 . . . . 51.509999999999998 109.071 177.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.651 ' H ' HD13 ' A' ' 176' ' ' ILE . 0.2 OUTLIER -117.31 169.61 7.57 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.77 0 CA-C-N 115.379 -0.828 . . . . 75.230000000000004 109.608 -179.622 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.542 ' CG ' ' HB2' ' A' ' 198' ' ' SER . 19.2 ptt180 -144.66 155.24 43.5 Favored 'General case' 0 C--N 1.269 -2.914 0 C-N-CA 124.057 0.943 . . . . 75.109999999999999 109.724 -175.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -115.15 145.75 42.06 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-O 121.235 0.54 . . . . 75.329999999999998 110.323 -178.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -157.62 171.46 34.79 Favored Glycine 0 N--CA 1.42 -2.372 0 N-CA-C 108.414 -1.874 . . . . 33.009999999999998 108.414 176.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . 0.411 ' CG2' ' HG2' ' A' ' 191' ' ' LYS . 0.3 OUTLIER -86.62 123.09 31.42 Favored 'General case' 0 C--N 1.294 -1.83 0 C-N-CA 118.174 -1.41 . . . . 60.229999999999997 107.425 178.503 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . 0.497 ' O ' ' HA ' ' A' ' 191' ' ' LYS . 37.8 t -105.51 129.68 53.74 Favored 'General case' 0 C--N 1.273 -2.747 0 N-CA-C 108.476 -0.935 . . . . 65.209999999999994 108.476 -178.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.635 ' HA ' ' O ' ' A' ' 190' ' ' GLU . 6.0 p -108.24 118.15 55.27 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.952 0 C-N-CA 119.377 -0.929 . . . . 72.219999999999999 109.048 172.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -125.0 161.52 26.53 Favored 'General case' 0 CA--C 1.475 -1.907 0 N-CA-C 108.185 -1.043 . . . . 54.520000000000003 108.185 -176.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 98.0 t -86.09 118.35 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.236 0 N-CA-C 107.094 -1.447 . . . . 73.200000000000003 107.094 171.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 76.1 p -109.17 -174.12 2.43 Favored 'General case' 0 C--N 1.259 -3.328 0 N-CA-C 107.562 -1.273 . . . . 75.340000000000003 107.562 -178.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -69.7 -10.03 56.7 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-O 120.836 0.35 . . . . 70.129999999999995 110.418 176.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 36.7 m -105.24 -14.94 15.2 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 111.746 0.276 . . . . 54.509999999999998 111.746 179.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 131.05 -146.14 17.55 Favored Glycine 0 C--O 1.21 -1.352 0 C-N-CA 120.233 -0.984 . . . . 71.239999999999995 110.649 178.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 5.2 mp -85.61 119.35 25.86 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.374 -0.973 . . . . 72.239999999999995 108.374 177.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . 0.635 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 53.3 mt-10 -131.23 125.71 33.59 Favored 'General case' 0 CA--C 1.455 -2.679 0 CA-C-O 121.002 0.43 . . . . 72.430000000000007 111.261 -178.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.497 ' HA ' ' O ' ' A' ' 181' ' ' SER . 31.2 ttmt -96.32 122.89 39.68 Favored 'General case' 0 C--N 1.276 -2.623 0 N-CA-C 107.275 -1.38 . . . . 74.519999999999996 107.275 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . 0.417 ' HB2' ' HD2' ' A' ' 193' ' ' PRO . 13.5 pt20 -152.02 165.4 17.54 Favored Pre-proline 0 C--N 1.287 -2.11 0 N-CA-C 108.068 -1.086 . . . . 73.409999999999997 108.068 -169.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . 0.417 ' HD2' ' HB2' ' A' ' 192' ' ' GLN . 9.8 Cg_endo -55.68 131.58 46.97 Favored 'Trans proline' 0 C--O 1.251 1.154 0 C-N-CA 120.942 1.095 . . . . 74.230000000000004 110.516 176.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -143.4 141.92 10.86 Favored Glycine 0 N--CA 1.413 -2.857 0 N-CA-C 109.319 -1.512 . . . . 32.009999999999998 109.319 -178.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.679 HG12 HG21 ' A' ' 234' ' ' VAL . 2.8 mp -109.38 133.73 53.66 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.435 0 CA-C-O 121.481 0.657 . . . . 74.129999999999995 111.608 -176.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -123.28 167.07 14.23 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.93 -1.137 . . . . 75.129999999999995 107.93 -177.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . 0.432 ' HB ' ' HA ' ' A' ' 214' ' ' VAL . 45.6 mm -79.58 131.97 33.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 108.947 -0.76 . . . . 72.409999999999997 108.947 177.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . 0.542 ' HB2' ' CG ' ' A' ' 177' ' ' ARG . 14.4 t -106.55 -31.53 8.47 Favored 'General case' 0 C--N 1.295 -1.781 0 O-C-N 121.734 -0.604 . . . . 75.25 112.415 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -164.85 144.31 7.04 Favored 'General case' 0 C--N 1.313 -0.979 0 C-N-CA 120.986 -0.286 . . . . 72.040000000000006 110.643 -176.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 81.4 mt -107.74 134.48 50.64 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.849 -1.167 . . . . 74.439999999999998 107.849 172.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 60.2 t -92.93 114.89 63.91 Favored Pre-proline 0 C--N 1.29 -2.018 0 N-CA-C 105.744 -1.947 . . . . 65.25 105.744 172.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -61.06 137.19 70.13 Favored 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 121.8 1.667 . . . . 75.129999999999995 110.378 -177.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 98.77 -21.38 46.24 Favored Glycine 0 C--N 1.303 -1.271 0 C-N-CA 120.513 -0.851 . . . . 70.420000000000002 111.109 -177.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -76.06 175.32 52.48 Favored Glycine 0 N--CA 1.44 -1.064 0 C-N-CA 121.349 -0.453 . . . . 74.439999999999998 112.492 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -67.22 -30.79 70.81 Favored 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 123.743 0.817 . . . . 64.450000000000003 111.249 -177.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -68.68 -41.31 79.4 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.461 0.648 . . . . 75.400000000000006 109.783 178.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -68.17 -32.78 73.27 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.473 -0.785 . . . . 71.219999999999999 109.35 177.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 49.3 m -56.5 -40.96 75.84 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 116.058 -0.519 . . . . 73.239999999999995 111.581 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 7.2 t -84.87 -41.21 16.23 Favored 'General case' 0 N--CA 1.44 -0.941 0 C-N-CA 119.178 -1.009 . . . . 53.539999999999999 110.514 177.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 67.18 6.69 40.69 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 121.325 -0.464 . . . . 73.340000000000003 113.442 179.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 76.9 mt -84.07 -9.48 58.59 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-O 121.175 0.512 . . . . 62.119999999999997 111.089 -178.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.524 HD23 ' H ' ' A' ' 212' ' ' LEU . 2.2 pt? -112.48 136.55 51.85 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-N 115.662 -0.699 . . . . 72.219999999999999 109.373 175.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -130.69 166.84 19.85 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.423 -0.954 . . . . 60.32 108.423 -178.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . 0.432 ' HA ' ' HB ' ' A' ' 197' ' ' ILE . 16.5 m -56.42 -30.38 30.79 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 N-CA-C 113.486 0.921 . . . . 73.219999999999999 113.486 -176.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 -79.38 -15.0 58.59 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 121.75 -0.594 . . . . 73.239999999999995 111.688 -179.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.514 ' HB3' ' HB ' ' A' ' 249' ' ' VAL . 1.5 m-20 -71.78 139.74 49.15 Favored 'General case' 0 C--O 1.248 0.974 0 CA-C-O 121.439 0.637 . . . . 62.140000000000001 111.92 -178.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 57.0 tt0 -101.46 138.54 38.33 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.973 -1.012 . . . . 53.420000000000002 111.266 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.549 ' HA ' HG12 ' A' ' 249' ' ' VAL . 35.4 t -83.54 124.44 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 CA-C-O 121.77 0.795 . . . . 75.040000000000006 110.133 -178.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.438 HD11 ' CD ' ' A' ' 250' ' ' LYS . 35.5 mm -93.64 -51.88 10.53 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 CA-C-N 115.044 -0.98 . . . . 74.439999999999998 111.121 -179.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -154.26 158.33 40.05 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 116.214 -0.448 . . . . 55.119999999999997 110.458 -177.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.44 HG22 HD22 ' A' ' 241' ' ' ASN . 12.5 p -127.69 120.26 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.663 0 CA-C-N 115.595 -0.73 . . . . 75.420000000000002 109.411 179.275 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . 0.466 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 12.0 t-20 68.28 4.23 4.08 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 126.329 1.851 . . . . 71.140000000000001 110.98 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 117.57 -15.45 12.83 Favored Glycine 0 N--CA 1.44 -1.078 0 N-CA-C 110.892 -0.883 . . . . 74.420000000000002 110.892 -177.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 65.4 mt -94.75 124.44 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 CA-C-O 121.132 0.492 . . . . 74.340000000000003 110.026 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -55.37 137.08 48.71 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 124.914 1.286 . . . . 71.200000000000003 112.425 -179.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . 0.411 HG21 HG12 ' A' ' 218' ' ' VAL . 35.8 m -105.98 8.79 9.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 CA-C-O 121.801 0.81 . . . . 72.409999999999997 109.981 175.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -74.72 99.9 3.84 Favored 'General case' 0 N--CA 1.431 -1.398 0 CA-C-N 114.813 -1.085 . . . . 54.509999999999998 110.125 178.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 112.41 -8.63 26.49 Favored Glycine 0 CA--C 1.495 -1.171 0 N-CA-C 110.378 -1.089 . . . . 41.439999999999998 110.378 178.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -83.06 153.08 25.08 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 107.954 -1.128 . . . . 71.019999999999996 107.954 176.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 74.4 p -91.79 175.73 6.78 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 108.168 -1.049 . . . . 53.409999999999997 108.168 179.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.461 ' HA ' HG22 ' A' ' 234' ' ' VAL . 2.8 tm? -65.06 -37.03 86.21 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 107.818 -1.178 . . . . 72.030000000000001 107.818 178.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -55.69 -51.82 65.96 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.016 -0.993 . . . . 45.43 109.395 177.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' GLN . . . . . 0.64 ' O ' ' HG3' ' A' ' 237' ' ' MET . 2.2 mp0 -66.84 -50.7 61.72 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 113.798 1.036 . . . . 64.530000000000001 113.798 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.679 HG21 HG12 ' A' ' 195' ' ' ILE . 26.7 m -58.89 -33.51 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 N-CA-C 112.588 0.588 . . . . 74.140000000000001 112.588 -174.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . 0.421 ' O ' HG23 ' A' ' 239' ' ' VAL . 91.3 m -72.77 -35.56 67.47 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 115.232 -0.895 . . . . 75.299999999999997 109.332 -175.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -69.02 -30.77 69.21 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.298 -0.864 . . . . 72.430000000000007 108.994 178.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' MET . . . . . 0.64 ' HG3' ' O ' ' A' ' 233' ' ' GLN . 19.3 mtp -69.49 -47.25 64.49 Favored 'General case' 0 C--O 1.209 -1.067 0 N-CA-C 106.931 -1.507 . . . . 61.25 106.931 178.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' MET . . . . . 0.542 ' HG3' ' O ' ' A' ' 234' ' ' VAL . 65.3 mtt -59.55 -45.29 92.24 Favored 'General case' 0 C--O 1.22 -0.489 0 CA-C-N 115.42 -0.809 . . . . 72.409999999999997 112.186 -179.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 235' ' ' THR . 89.3 t -64.42 -38.26 82.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.161 0.505 . . . . 63.32 110.533 178.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -68.89 -36.13 77.7 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.383 0.611 . . . . 74.319999999999993 110.318 178.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . 0.44 HD22 HG22 ' A' ' 221' ' ' VAL . 89.9 m-20 -86.51 19.43 2.83 Favored 'General case' 0 C--O 1.199 -1.583 0 CA-C-N 115.472 -0.785 . . . . 61.340000000000003 111.906 179.133 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . 0.446 ' O ' HD13 ' A' ' 164' ' ' LEU . 30.4 p -61.26 -23.7 65.85 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 112.776 0.658 . . . . 74.140000000000001 112.776 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 25.4 p -74.8 -16.78 60.69 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 112.12 0.415 . . . . 72.140000000000001 112.12 178.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -175.29 88.24 0.04 OUTLIER 'General case' 0 C--O 1.257 1.451 0 N-CA-C 107.787 -1.19 . . . . 75.439999999999998 107.787 -179.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.539 ' HB3' ' HB2' ' A' ' 163' ' ' LEU . 2.8 tt -92.15 102.11 14.63 Favored 'General case' 0 N--CA 1.416 -2.138 0 C-N-CA 118.923 -1.111 . . . . 64.340000000000003 109.268 -174.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.608 HG12 ' HG2' ' A' ' 162' ' ' ARG . 89.1 mt -97.81 116.4 40.3 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.98 0 C-N-CA 120.134 -0.627 . . . . 71.420000000000002 109.971 178.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . 0.492 HG13 ' CD2' ' A' ' 245' ' ' LEU . 14.6 mt -117.99 134.63 60.99 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.84 0 CA-C-O 121.433 0.635 . . . . 73.109999999999999 111.403 176.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.456 ' HA ' ' O ' ' A' ' 159' ' ' ARG . 63.8 m -103.1 114.87 29.51 Favored 'General case' 0 N--CA 1.409 -2.5 0 CA-C-N 114.52 -1.218 . . . . 23.420000000000002 108.072 175.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.549 HG12 ' HA ' ' A' ' 218' ' ' VAL . 17.4 m -118.89 159.91 19.11 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.165 0 CA-C-O 121.46 0.648 . . . . 41.240000000000002 110.754 177.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.499 ' HB3' ' ND1' ' A' ' 158' ' ' HIS . 10.0 ptmt -127.69 128.84 23.86 Favored Pre-proline 0 C--N 1.272 -2.798 0 CA-C-N 114.291 -1.322 . . . . 74.329999999999998 109.161 177.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . 0.56 ' HD2' ' O ' ' A' ' 157' ' ' THR . 35.0 Cg_endo -66.61 148.56 83.5 Favored 'Trans proline' 0 N--CA 1.439 -1.683 0 C-N-CA 121.827 1.685 . . . . 63.100000000000001 110.5 178.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -62.43 -35.8 80.4 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 122.057 0.932 . . . . 42.310000000000002 109.147 177.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -97.98 73.36 2.25 Favored 'General case' 0 C--N 1.29 -1.986 0 CA-C-N 114.186 -1.37 . . . . 74.200000000000003 108.948 178.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' GLN . . . . . 0.442 ' HG3' ' O ' ' A' ' 251' ' ' PRO . 27.8 mt-30 -70.9 144.36 50.66 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 116.191 -0.459 . . . . 72.219999999999999 111.338 177.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.313 -0.992 0 CA-C-O 118.705 -0.664 . . . . 74.340000000000003 109.48 178.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 . . . . . 0 N--CA 1.452 -0.353 0 N-CA-C 108.375 -0.972 . . . . 74.340000000000003 108.375 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.474 ' O ' ' HA ' ' A' ' 250' ' ' LYS . 58.0 p -60.71 -35.87 77.4 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.059 0.544 . . . . 53.020000000000003 112.397 -176.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -125.19 129.78 50.8 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 109.815 -0.439 . . . . 75.030000000000001 109.815 173.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.543 ' O ' ' HA ' ' A' ' 248' ' ' THR . 2.1 tpm_? -140.18 140.36 35.9 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.619 -1.252 . . . . 74.409999999999997 107.619 177.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.583 ' HB3' ' OG1' ' A' ' 248' ' ' THR . 23.2 ptt180 -132.47 113.03 12.63 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 122.098 0.951 . . . . 75.409999999999997 113.067 178.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.63 ' O ' ' HA ' ' A' ' 246' ' ' ILE . 21.1 m -105.17 139.29 26.67 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 CA-C-N 113.929 -1.487 . . . . 45.210000000000001 113.014 -175.181 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.546 ' HG3' HG12 ' A' ' 246' ' ' ILE . 7.3 mpt_? -91.13 112.6 24.57 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 106.995 -1.483 . . . . 74.239999999999995 106.995 175.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.513 ' HB2' ' HB3' ' A' ' 245' ' ' LEU . 35.4 mt -100.23 135.49 41.58 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 108.49 -0.929 . . . . 62.109999999999999 108.49 179.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.466 HD23 ' O ' ' A' ' 242' ' ' SER . 8.1 tp 79.28 95.91 0.06 Allowed 'General case' 0 N--CA 1.417 -2.102 0 C-N-CA 124.499 1.12 . . . . 54.210000000000001 110.567 175.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 60.6 pttt -101.67 18.65 19.8 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 114.236 -1.347 . . . . 75.0 109.91 -179.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 61.4 m80 -125.1 176.14 6.9 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 114.406 -1.27 . . . . 75.129999999999995 110.176 176.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -120.64 80.42 0.33 Allowed Glycine 0 CA--C 1.484 -1.886 0 C-N-CA 120.614 -0.803 . . . . 33.43 111.198 -175.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 67.2 m -156.92 143.14 18.08 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.415 -0.957 . . . . 71.310000000000002 108.415 -178.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -79.85 73.45 6.6 Favored 'General case' 0 CA--C 1.494 -1.195 0 CA-C-O 122.166 0.984 . . . . 60.119999999999997 110.282 178.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -99.83 147.4 33.38 Favored Pre-proline 0 C--N 1.281 -2.38 0 CA-C-N 113.647 -1.615 . . . . 73.030000000000001 108.062 175.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -63.62 137.63 60.29 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 121.764 1.643 . . . . 52.509999999999998 109.452 174.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.472 ' HG ' ' CD1' ' A' ' 245' ' ' LEU . 3.3 mm? -75.19 -25.66 58.43 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 120.916 0.388 . . . . 55.509999999999998 111.358 -176.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . 0.439 ' HA3' ' HA3' ' A' ' 204' ' ' GLY . . . 93.28 35.49 6.26 Favored Glycine 0 N--CA 1.437 -1.247 0 C-N-CA 120.419 -0.896 . . . . 62.439999999999998 113.704 175.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -151.45 158.89 44.26 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.415 -0.958 . . . . 74.25 108.415 174.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -125.36 156.83 38.12 Favored 'General case' 0 C--N 1.284 -2.243 0 N-CA-C 108.761 -0.829 . . . . 72.450000000000003 108.761 175.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.59 ' H ' HD13 ' A' ' 176' ' ' ILE . 0.2 OUTLIER -124.96 166.64 20.24 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 CA-C-O 121.441 0.639 . . . . 61.210000000000001 110.421 -179.922 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.431 ' HG2' ' HB3' ' A' ' 198' ' ' SER . 14.7 ptt180 -144.78 154.76 43.04 Favored 'General case' 0 C--N 1.28 -2.438 0 CA-C-N 114.699 -1.137 . . . . 72.439999999999998 110.154 -176.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . 0.406 ' HB2' ' HB2' ' A' ' 231' ' ' LEU . 11.2 t70 -112.98 145.39 40.9 Favored 'General case' 0 C--N 1.294 -1.822 0 C-N-CA 123.648 0.779 . . . . 73.439999999999998 110.094 -177.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -162.98 179.13 38.42 Favored Glycine 0 C--N 1.294 -1.797 0 N-CA-C 109.048 -1.621 . . . . 42.240000000000002 109.048 175.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 2.1 p -96.99 123.4 40.7 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-N 118.19 0.995 . . . . 75.120000000000005 111.154 174.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . 0.53 ' O ' ' HA ' ' A' ' 191' ' ' LYS . 24.5 t -108.88 123.65 49.41 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 107.684 -1.228 . . . . 71.219999999999999 107.684 177.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.684 ' HB ' ' HG3' ' A' ' 191' ' ' LYS . 7.8 p -103.1 124.27 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.334 0 N-CA-C 108.528 -0.916 . . . . 64.420000000000002 108.528 178.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . 0.439 ' O ' ' HA ' ' A' ' 189' ' ' LEU . 94.4 mtt180 -127.97 160.39 32.02 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 109.053 -0.721 . . . . 72.120000000000005 109.053 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 82.4 t -84.67 118.35 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.044 0 N-CA-C 107.349 -1.352 . . . . 73.0 107.349 173.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 76.5 p -111.4 -175.24 2.65 Favored 'General case' 0 C--N 1.265 -3.078 0 N-CA-C 107.592 -1.262 . . . . 75.450000000000003 107.592 -178.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -66.87 -16.98 64.66 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.064 0.459 . . . . 63.340000000000003 110.525 179.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 12.8 p -102.89 -18.05 15.24 Favored 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 113.479 0.918 . . . . 62.119999999999997 113.479 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 141.82 -163.75 26.88 Favored Glycine 0 CA--C 1.493 -1.294 0 C-N-CA 119.541 -1.314 . . . . 70.319999999999993 111.464 178.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.439 ' HA ' ' O ' ' A' ' 183' ' ' ARG . 5.2 mp -82.52 116.48 21.97 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 108.379 -0.971 . . . . 73.040000000000006 108.379 178.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . 0.528 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 45.5 mt-10 -134.48 135.21 42.29 Favored 'General case' 0 CA--C 1.488 -1.434 0 N-CA-C 114.548 1.314 . . . . 72.310000000000002 114.548 -176.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.684 ' HG3' ' HB ' ' A' ' 182' ' ' VAL . 43.8 mtmt -84.34 137.09 33.62 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 114.431 -1.259 . . . . 70.420000000000002 112.402 173.338 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -132.08 163.47 49.93 Favored Pre-proline 0 C--N 1.259 -3.327 0 N-CA-C 105.184 -2.154 . . . . 63.399999999999999 105.184 176.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -66.48 131.07 25.22 Favored 'Trans proline' 0 N--CA 1.423 -2.666 0 N-CA-C 106.872 -2.011 . . . . 73.129999999999995 106.872 169.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -125.89 127.83 6.27 Favored Glycine 0 N--CA 1.397 -3.965 0 N-CA-C 109.499 -1.441 . . . . 41.43 109.499 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.623 HG12 HG21 ' A' ' 234' ' ' VAL . 3.4 mp -103.68 132.78 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.049 0 N-CA-C 109.084 -0.71 . . . . 75.0 109.084 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -125.6 167.38 15.16 Favored 'General case' 0 C--N 1.281 -2.405 0 N-CA-C 107.366 -1.346 . . . . 71.140000000000001 107.366 -176.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 47.5 mm -77.82 132.29 32.88 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 N-CA-C 107.021 -1.474 . . . . 73.109999999999999 107.021 175.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . 0.431 ' HB3' ' HG2' ' A' ' 177' ' ' ARG . 83.4 p -100.47 -35.29 9.6 Favored 'General case' 0 C--N 1.28 -2.43 0 C-N-CA 118.806 -1.158 . . . . 74.209999999999994 111.053 -178.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 65.9 ttt180 -158.13 147.3 19.43 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.296 -0.411 . . . . 73.25 110.44 -176.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 71.0 mt -106.66 138.39 42.93 Favored 'General case' 0 CA--C 1.483 -1.609 0 N-CA-C 108.554 -0.906 . . . . 71.099999999999994 108.554 171.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 58.9 t -98.89 114.99 65.99 Favored Pre-proline 0 N--CA 1.415 -2.211 0 N-CA-C 106.377 -1.712 . . . . 75.319999999999993 106.377 172.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.527 ' HA ' ' HG2' ' A' ' 207' ' ' GLU . 37.0 Cg_exo -58.73 126.8 22.28 Favored 'Trans proline' 0 N--CA 1.448 -1.149 0 C-N-CA 121.934 1.756 . . . . 61.119999999999997 110.65 -178.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 106.24 -16.3 42.1 Favored Glycine 0 N--CA 1.438 -1.2 0 C-N-CA 120.332 -0.937 . . . . 63.030000000000001 112.403 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . 0.439 ' HA3' ' HA3' ' A' ' 173' ' ' GLY . . . -81.01 -179.23 52.97 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.811 -0.709 . . . . 15.210000000000001 111.898 178.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.453 HD23 ' HA ' ' A' ' 172' ' ' LEU . 3.4 mm? -62.74 -42.85 99.87 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 123.1 0.56 . . . . 71.5 111.548 -177.273 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -60.96 -38.66 86.71 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.139 -0.482 . . . . 71.319999999999993 111.335 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.527 ' HG2' ' HA ' ' A' ' 202' ' ' PRO . 9.3 tp10 -75.51 -36.9 60.44 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.505 -0.554 . . . . 72.019999999999996 109.505 178.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 24.7 t -60.18 -45.98 91.25 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 115.915 -0.584 . . . . 50.229999999999997 110.444 -179.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . 0.46 HG23 ' H ' ' A' ' 211' ' ' LEU . 8.9 t -72.89 -40.33 65.65 Favored 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 120.311 -0.556 . . . . 72.439999999999998 110.037 176.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 73.16 9.32 76.49 Favored Glycine 0 N--CA 1.441 -0.998 0 CA-C-N 115.852 -0.613 . . . . 62.509999999999998 112.561 179.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.46 ' H ' HG23 ' A' ' 209' ' ' THR . 48.6 mt -97.25 1.97 50.28 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.542 0.687 . . . . 64.219999999999999 109.685 -179.004 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 87.6 mt -112.83 132.43 55.28 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 114.744 -1.116 . . . . 72.420000000000002 109.09 174.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -131.45 160.65 34.52 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 122.817 0.447 . . . . 71.200000000000003 109.889 176.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 32.8 m -62.22 -30.26 48.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 122.034 0.921 . . . . 74.329999999999998 112.922 -178.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . 0.659 ' OD1' ' HB3' ' A' ' 252' ' ' ALA . 25.9 t-20 -81.0 -14.07 58.28 Favored 'General case' 0 C--N 1.275 -2.641 0 CA-C-N 116.04 -0.527 . . . . 64.150000000000006 111.777 -175.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.475 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 72.0 m-20 -71.71 151.47 43.58 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 113.599 0.963 . . . . 74.519999999999996 113.599 -175.06 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -111.64 129.78 55.98 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.122 1.369 . . . . 72.439999999999998 109.955 -176.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.493 ' HA ' HG12 ' A' ' 249' ' ' VAL . 41.6 t -82.24 138.88 18.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 CA-C-O 121.488 0.661 . . . . 60.119999999999997 111.949 -175.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.481 HD11 ' CD ' ' A' ' 250' ' ' LYS . 47.4 mm -108.66 -51.76 6.82 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 C-N-CA 123.935 0.894 . . . . 71.200000000000003 111.631 -178.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.419 ' HB3' ' HA ' ' A' ' 225' ' ' GLU . 10.7 pt-20 -151.87 161.38 42.74 Favored 'General case' 0 C--O 1.244 0.808 0 CA-C-O 120.522 0.201 . . . . 60.409999999999997 110.663 -178.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.445 HG22 HD22 ' A' ' 241' ' ' ASN . 15.0 p -129.93 119.47 47.32 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.075 0 CA-C-O 121.449 0.642 . . . . 72.420000000000002 109.556 177.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . 0.511 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 13.7 t-20 70.23 0.02 2.99 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 125.859 1.663 . . . . 74.129999999999995 111.858 177.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 121.87 -13.8 9.15 Favored Glycine 0 N--CA 1.435 -1.369 0 N-CA-C 110.955 -0.858 . . . . 65.430000000000007 110.955 -177.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 66.6 mt -95.8 123.66 48.1 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 N-CA-C 108.725 -0.843 . . . . 71.209999999999994 108.725 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . 0.419 ' HA ' ' HB3' ' A' ' 220' ' ' GLU . 13.0 pt-20 -55.76 147.65 18.32 Favored 'General case' 0 C--N 1.31 -1.138 0 O-C-N 123.912 0.758 . . . . 64.200000000000003 111.145 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . 0.472 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 33.5 m -120.5 -1.1 8.02 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 CA-C-O 121.472 0.653 . . . . 72.409999999999997 109.387 173.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -73.36 95.16 2.14 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-N 115.081 -0.963 . . . . 42.039999999999999 110.622 -178.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 127.43 -22.29 5.59 Favored Glycine 0 N--CA 1.429 -1.795 0 C-N-CA 120.432 -0.89 . . . . 44.219999999999999 110.939 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 55.9 mttm -83.78 164.93 19.25 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 109.996 -0.372 . . . . 53.219999999999999 109.996 177.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . 0.44 ' H ' ' NE2' ' A' ' 233' ' ' GLN . 34.7 p -93.0 168.09 11.36 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 116.43 -0.35 . . . . 62.439999999999998 110.204 -177.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.505 HD21 HG12 ' A' ' 176' ' ' ILE . 2.8 tm? -56.96 -41.94 79.24 Favored 'General case' 0 N--CA 1.44 -0.967 0 C-N-CA 123.083 0.553 . . . . 64.109999999999999 109.878 -178.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -56.43 -51.59 67.81 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.365 -0.379 . . . . 65.239999999999995 110.501 176.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' GLN . . . . . 0.44 ' NE2' ' H ' ' A' ' 230' ' ' THR . 48.9 mt-30 -58.6 -49.75 76.32 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 115.229 -0.896 . . . . 72.219999999999999 112.362 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.623 HG21 HG12 ' A' ' 195' ' ' ILE . 15.1 m -69.45 -33.84 59.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 112.894 0.701 . . . . 74.219999999999999 112.894 -173.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . 0.428 ' O ' HG23 ' A' ' 239' ' ' VAL . 84.4 m -73.42 -35.59 65.85 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 109.488 -0.56 . . . . 71.439999999999998 109.488 -174.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -63.39 -33.1 74.8 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.957 -0.757 . . . . 71.340000000000003 108.957 177.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' MET . . . . . 0.416 ' HB2' HG11 ' A' ' 221' ' ' VAL . 5.1 mtm -72.72 -38.98 67.29 Favored 'General case' 0 C--O 1.199 -1.555 0 CA-C-N 115.341 -0.845 . . . . 74.430000000000007 108.731 -179.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' MET . . . . . 0.449 ' HG3' ' O ' ' A' ' 234' ' ' VAL . 65.6 mtt -63.45 -37.96 89.3 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.285 -0.416 . . . . 75.219999999999999 110.815 179.113 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 235' ' ' THR . 66.4 t -69.69 -41.0 79.97 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 CA-C-N 116.334 -0.393 . . . . 63.130000000000003 110.149 177.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -66.39 -34.19 77.4 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.768 0.794 . . . . 55.219999999999999 110.372 177.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . 0.445 HD22 HG22 ' A' ' 221' ' ' VAL . 91.5 m-20 -86.41 20.51 2.4 Favored 'General case' 0 C--O 1.2 -1.545 0 CA-C-N 115.267 -0.879 . . . . 75.319999999999993 112.506 178.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . 0.466 ' O ' HD23 ' A' ' 164' ' ' LEU . 67.4 m -64.88 -23.59 67.28 Favored 'General case' 0 C--O 1.212 -0.912 0 C-N-CA 120.172 -0.611 . . . . 74.010000000000005 112.545 178.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 12.4 p -65.3 -36.36 83.83 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 111.802 0.297 . . . . 75.310000000000002 111.802 176.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 46.2 m-80 -155.95 92.43 1.36 Allowed 'General case' 0 C--O 1.254 1.294 0 N-CA-C 107.301 -1.37 . . . . 72.140000000000001 107.301 177.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.513 ' HB3' ' HB2' ' A' ' 163' ' ' LEU . 2.8 tt -88.6 103.18 15.67 Favored 'General case' 0 N--CA 1.423 -1.817 0 C-N-CA 119.381 -0.927 . . . . 75.140000000000001 109.641 -174.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.63 ' HA ' ' O ' ' A' ' 161' ' ' VAL . 87.2 mt -102.58 116.59 46.55 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.992 0 C-N-CA 120.721 -0.392 . . . . 70.209999999999994 109.974 177.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . 0.486 HG13 ' CD2' ' A' ' 245' ' ' LEU . 25.5 mt -119.55 132.89 68.05 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.089 0 CA-C-O 121.146 0.498 . . . . 61.450000000000003 111.912 176.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.583 ' OG1' ' HB3' ' A' ' 160' ' ' ARG . 57.2 m -100.27 124.35 45.63 Favored 'General case' 0 N--CA 1.426 -1.648 0 N-CA-C 107.561 -1.274 . . . . 72.510000000000005 107.561 175.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.493 HG12 ' HA ' ' A' ' 218' ' ' VAL . 29.5 m -124.82 170.56 14.8 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 CA-C-O 121.579 0.704 . . . . 74.230000000000004 110.971 176.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.481 ' CD ' HD11 ' A' ' 219' ' ' ILE 0.312 44.0 mtpt -125.0 134.78 26.02 Favored Pre-proline 0 C--N 1.28 -2.417 0 N-CA-C 106.146 -1.798 . . . . 73.430000000000007 106.146 173.971 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . 0.475 ' HA ' ' OD1' ' A' ' 216' ' ' ASP . 5.6 Cg_exo -79.17 132.0 10.11 Favored 'Trans proline' 0 N--CA 1.402 -3.871 0 CA-C-N 119.73 0.939 . . . . 72.209999999999994 110.346 173.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . 0.659 ' HB3' ' OD1' ' A' ' 215' ' ' ASN . . . -79.0 -2.5 40.49 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.994 0.902 . . . . 74.439999999999998 108.776 177.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 39.6 m-80 -90.16 -12.67 37.52 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 114.29 -1.323 . . . . 71.25 108.722 175.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 53.06 76.52 0.2 Allowed 'General case' 0 C--N 1.357 0.916 0 CA-C-O 122.171 0.986 . . . . 70.540000000000006 109.453 -171.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 . . . . . 0 C--N 1.294 -1.823 0 CA-C-N 113.818 -1.537 . . . . 71.409999999999997 108.526 -170.297 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.489 ' HB2' ' OXT' ' A' ' 255' ' ' ARG . 0.0 OUTLIER . . . . . 0 CA--C 1.514 -0.404 0 N-CA-C 108.896 -0.779 . . . . 74.319999999999993 108.896 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 47.6 p 63.69 -68.8 0.08 Allowed 'General case' 0 C--O 1.216 -0.69 0 C-N-CA 125.887 1.675 . . . . 71.400000000000006 112.42 -175.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.564 ' NE2' HG13 ' A' ' 219' ' ' ILE . 23.6 m80 -81.84 129.65 34.82 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 112.161 0.43 . . . . 73.400000000000006 112.161 -175.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.548 ' O ' ' HA ' ' A' ' 248' ' ' THR . 12.8 tpt180 -131.22 143.39 50.54 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.34 -1.356 . . . . 71.420000000000002 107.34 173.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 30.4 ttt85 -120.09 113.24 20.19 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 121.233 0.539 . . . . 75.310000000000002 109.911 -178.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.535 ' O ' ' HA ' ' A' ' 246' ' ' ILE . 25.2 m -119.24 139.14 47.62 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 N-CA-C 112.501 0.556 . . . . 65.340000000000003 112.501 -175.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.451 ' HG3' HG12 ' A' ' 246' ' ' ILE . 3.3 mpt_? -100.1 112.93 25.23 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 107.086 -1.449 . . . . 73.450000000000003 107.086 177.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.412 ' HB2' ' HB3' ' A' ' 245' ' ' LEU . 23.9 mt -95.69 130.59 42.54 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 109.412 -0.588 . . . . 74.0 109.412 -178.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.415 ' CD1' ' HB2' ' A' ' 170' ' ' LYS . 6.1 tt 78.96 90.25 0.06 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 122.333 1.063 . . . . 74.140000000000001 110.757 176.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 57.0 pttt -101.32 -3.93 27.97 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-N 115.086 -0.961 . . . . 74.019999999999996 109.349 176.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 41.6 t-80 -161.09 120.32 2.57 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 114.169 -1.378 . . . . 73.420000000000002 107.952 175.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -179.45 -96.6 0.1 Allowed Glycine 0 N--CA 1.425 -2.095 0 C-N-CA 119.398 -1.382 . . . . 55.420000000000002 113.831 -179.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 66.7 m 67.55 7.03 5.32 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.563 0.745 . . . . 64.400000000000006 111.341 -174.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -148.65 15.92 0.99 Allowed 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 106.584 -1.636 . . . . 71.530000000000001 106.584 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.415 ' HB2' ' CD1' ' A' ' 164' ' ' LEU . 72.4 mmtt -113.42 120.75 39.16 Favored Pre-proline 0 C--N 1.314 -0.948 0 CA-C-N 113.741 -1.572 . . . . 73.230000000000004 112.083 -172.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -70.13 141.2 43.14 Favored 'Trans proline' 0 N--CA 1.438 -1.789 0 N-CA-C 105.682 -2.468 . . . . 62.039999999999999 105.682 164.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.462 ' HG ' ' CD1' ' A' ' 245' ' ' LEU . 2.6 mm? -66.24 -27.09 67.69 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 120.235 -0.586 . . . . 61.310000000000002 111.912 -175.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . 0.495 ' HA3' ' HA3' ' A' ' 204' ' ' GLY . . . 91.56 38.92 5.73 Favored Glycine 0 N--CA 1.429 -1.823 0 C-N-CA 120.71 -0.757 . . . . 73.25 114.155 172.13 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -152.76 153.45 33.22 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 109.245 -0.65 . . . . 73.409999999999997 109.245 174.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -114.56 140.22 48.95 Favored 'General case' 0 C--N 1.282 -2.341 0 CA-C-N 115.674 -0.694 . . . . 71.129999999999995 109.282 178.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.409 HD13 ' SD ' ' A' ' 238' ' ' MET . 29.1 pt -114.31 169.1 5.7 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.514 0 CA-C-N 115.446 -0.797 . . . . 73.430000000000007 109.885 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.501 ' HG2' ' HB2' ' A' ' 198' ' ' SER . 3.1 ptp180 -153.75 154.64 34.42 Favored 'General case' 0 C--N 1.278 -2.52 0 CA-C-N 115.541 -0.754 . . . . 73.140000000000001 108.97 -179.273 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . 0.401 ' OD1' HD12 ' A' ' 231' ' ' LEU . 6.9 p-10 -101.47 154.99 18.34 Favored 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 108.659 -0.867 . . . . 74.409999999999997 108.659 178.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -165.23 -168.61 27.66 Favored Glycine 0 N--CA 1.412 -2.95 0 N-CA-C 109.274 -1.531 . . . . 65.129999999999995 109.274 177.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . 0.615 ' HB ' ' CG ' ' A' ' 191' ' ' LYS . 1.3 p -100.48 123.64 44.96 Favored 'General case' 0 C--N 1.28 -2.426 0 CA-C-O 121.876 0.846 . . . . 61.119999999999997 112.716 178.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 27.6 t -106.53 119.46 39.33 Favored 'General case' 0 N--CA 1.416 -2.127 0 N-CA-C 106.466 -1.679 . . . . 33.43 106.466 176.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.595 ' HA ' ' O ' ' A' ' 190' ' ' GLU . 6.7 p -119.74 120.81 64.47 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 CA-C-O 121.559 0.695 . . . . 72.239999999999995 110.154 177.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -126.8 161.14 28.89 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 115.22 -0.9 . . . . 71.310000000000002 108.791 -176.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' A' ' 188' ' ' GLY . 69.7 t -87.3 118.81 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.044 0 N-CA-C 107.882 -1.155 . . . . 74.329999999999998 107.882 171.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 61.1 p -116.28 -174.62 2.59 Favored 'General case' 0 C--N 1.271 -2.829 0 CA-C-N 114.376 -1.284 . . . . 74.230000000000004 107.756 -178.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -68.18 -19.12 64.75 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.103 0.478 . . . . 70.329999999999998 110.108 177.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 46.2 m -88.64 -18.61 27.61 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 116.03 -0.532 . . . . 71.150000000000006 111.434 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.454 ' O ' ' HA ' ' A' ' 184' ' ' VAL . . . 126.97 -133.91 8.19 Favored Glycine 0 CA--C 1.486 -1.759 0 N-CA-C 110.0 -1.24 . . . . 73.030000000000001 110.0 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 5.7 mp -99.06 122.78 42.75 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.43 -0.952 . . . . 72.519999999999996 108.43 176.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . 0.595 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 52.3 mt-10 -129.18 119.44 24.08 Favored 'General case' 0 CA--C 1.448 -2.968 0 CA-C-O 121.321 0.582 . . . . 63.219999999999999 110.562 -177.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.615 ' CG ' ' HB ' ' A' ' 180' ' ' THR . 36.7 ttmt -99.62 121.48 41.27 Favored 'General case' 0 C--N 1.261 -3.263 0 CA-C-N 114.341 -1.299 . . . . 73.129999999999995 107.731 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . 0.42 ' HB2' ' HD2' ' A' ' 193' ' ' PRO . 13.4 pt20 -141.23 164.46 35.39 Favored Pre-proline 0 C--N 1.284 -2.281 0 N-CA-C 108.712 -0.847 . . . . 60.340000000000003 108.712 -174.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . 0.42 ' HD2' ' HB2' ' A' ' 192' ' ' GLN . 13.2 Cg_endo -57.52 132.21 49.14 Favored 'Trans proline' 0 N--CA 1.448 -1.153 0 C-N-CA 121.504 1.47 . . . . 73.040000000000006 111.638 176.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -141.03 146.33 17.52 Favored Glycine 0 N--CA 1.408 -3.191 0 N-CA-C 108.244 -1.942 . . . . 72.25 108.244 177.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.542 HG12 HG21 ' A' ' 234' ' ' VAL . 2.6 mp -104.32 133.03 49.52 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.413 0 C-N-CA 120.165 -0.614 . . . . 64.040000000000006 111.189 -178.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -122.96 167.49 13.52 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 108.085 -1.08 . . . . 74.530000000000001 108.085 -176.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . 0.403 ' CG2' ' HA ' ' A' ' 214' ' ' VAL . 41.3 mm -77.62 132.95 31.61 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 N-CA-C 108.527 -0.916 . . . . 73.239999999999995 108.527 177.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . 0.501 ' HB2' ' HG2' ' A' ' 177' ' ' ARG . 11.1 t -104.14 -36.51 7.66 Favored 'General case' 0 C--N 1.275 -2.646 0 O-C-N 121.731 -0.605 . . . . 75.420000000000002 112.488 178.039 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 20.1 tpp180 -167.15 144.52 4.67 Favored 'General case' 0 C--O 1.213 -0.855 0 N-CA-C 110.136 -0.32 . . . . 71.25 110.136 -177.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 78.8 mt -101.89 145.43 29.23 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 108.514 -0.921 . . . . 73.329999999999998 108.514 171.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 61.9 t -105.19 114.0 63.98 Favored Pre-proline 0 N--CA 1.42 -1.971 0 N-CA-C 105.972 -1.862 . . . . 45.549999999999997 105.972 172.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.47 ' HA ' ' HG3' ' A' ' 207' ' ' GLU . 27.7 Cg_exo -62.01 136.87 63.59 Favored 'Trans proline' 0 N--CA 1.446 -1.293 0 C-N-CA 121.802 1.668 . . . . 72.439999999999998 110.268 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 104.12 -26.34 23.32 Favored Glycine 0 C--N 1.298 -1.581 0 N-CA-C 110.087 -1.205 . . . . 75.209999999999994 110.087 -175.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . 0.495 ' HA3' ' HA3' ' A' ' 173' ' ' GLY . . . -79.72 162.74 47.34 Favored Glycine 0 N--CA 1.423 -2.198 0 N-CA-C 111.031 -0.828 . . . . 62.310000000000002 111.031 178.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.456 ' H ' HD22 ' A' ' 205' ' ' LEU . 2.6 mm? -62.94 -29.57 70.89 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.372 0.669 . . . . 74.519999999999996 111.847 -173.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -63.6 -46.94 83.5 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.19 0.519 . . . . 72.329999999999998 110.289 177.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.47 ' HG3' ' HA ' ' A' ' 202' ' ' PRO . 3.9 tm-20 -71.51 -33.65 69.4 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.26 -0.427 . . . . 55.229999999999997 109.929 178.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 50.5 m -56.39 -39.25 72.68 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.186 -0.461 . . . . 74.239999999999995 111.159 177.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 13.0 t -83.91 -40.57 18.4 Favored 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 119.197 -1.001 . . . . 65.0 109.832 176.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 65.71 2.5 11.82 Favored Glycine 0 C--N 1.343 0.966 0 N-CA-C 114.183 0.433 . . . . 62.530000000000001 114.183 177.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 60.9 mt -78.88 -12.3 60.03 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-O 120.969 0.414 . . . . 75.25 110.708 -177.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.535 HD23 ' H ' ' A' ' 212' ' ' LEU . 2.2 pt? -109.86 134.88 51.57 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.329 -0.989 . . . . 74.549999999999997 108.329 174.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -117.41 162.11 18.46 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 116.624 -0.262 . . . . 41.340000000000003 110.306 -178.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . 0.403 ' HA ' ' CG2' ' A' ' 197' ' ' ILE . 35.6 m -56.64 -31.52 34.87 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.77 0 N-CA-C 114.471 1.286 . . . . 64.049999999999997 114.471 -176.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -82.72 -14.26 54.88 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 112.773 0.657 . . . . 72.420000000000002 112.773 -178.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.53 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 54.3 m-20 -69.01 156.13 39.15 Favored 'General case' 0 C--O 1.246 0.904 0 N-CA-C 113.266 0.839 . . . . 55.329999999999998 113.266 -173.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -107.4 137.07 46.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.933 -1.03 . . . . 63.100000000000001 110.246 -179.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.599 ' HA ' HG12 ' A' ' 249' ' ' VAL . 30.9 t -84.53 125.74 40.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 121.464 0.649 . . . . 64.329999999999998 109.975 -179.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.564 HG13 ' NE2' ' A' ' 158' ' ' HIS . 40.1 mm -90.23 -49.99 13.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 CA-C-N 115.167 -0.924 . . . . 75.420000000000002 110.607 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.414 ' CB ' ' HA ' ' A' ' 225' ' ' GLU . 9.3 pt-20 -154.59 160.93 41.78 Favored 'General case' 0 C--O 1.249 1.062 0 CA-C-N 116.313 -0.403 . . . . 71.420000000000002 110.438 -179.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.484 HG22 HD22 ' A' ' 241' ' ' ASN . 8.4 p -121.49 113.57 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.215 0 CA-C-O 122.109 0.957 . . . . 75.420000000000002 108.968 174.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . 0.453 ' OD1' HD12 ' A' ' 246' ' ' ILE . 60.0 t30 40.74 68.37 0.42 Allowed 'General case' 0 C--N 1.28 -2.421 0 C-N-CA 127.103 2.161 . . . . 73.400000000000006 114.497 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 84.35 -20.85 11.92 Favored Glycine 0 N--CA 1.443 -0.848 0 CA-C-N 114.93 -1.032 . . . . 73.349999999999994 113.738 178.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 54.6 mt -105.92 123.41 60.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 117.034 0.417 . . . . 61.32 110.011 -176.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . 0.414 ' HA ' ' CB ' ' A' ' 220' ' ' GLU . 11.8 pt-20 -66.03 144.14 56.92 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.352 0.596 . . . . 55.340000000000003 111.564 -178.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 33.9 m -115.19 -2.24 10.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-N 115.923 -0.58 . . . . 75.510000000000005 111.186 178.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -73.92 98.88 3.11 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.933 -0.576 . . . . 74.310000000000002 110.058 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 120.59 -17.07 9.59 Favored Glycine 0 CA--C 1.498 -0.988 0 N-CA-C 111.45 -0.66 . . . . 71.420000000000002 111.45 179.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -78.98 162.87 25.66 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 108.737 -0.838 . . . . 64.450000000000003 108.737 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . 0.409 ' O ' HG13 ' A' ' 234' ' ' VAL . 68.2 p -87.34 170.63 11.24 Favored 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 107.599 -1.26 . . . . 62.420000000000002 107.599 177.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.401 HD12 ' OD1' ' A' ' 178' ' ' ASP . 0.7 OUTLIER -68.08 -34.46 76.45 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 107.347 -1.353 . . . . 74.109999999999999 107.347 179.976 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -58.54 -47.41 84.3 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-N 115.734 -0.666 . . . . 62.229999999999997 110.075 176.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -64.6 -49.05 72.63 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 113.902 1.075 . . . . 73.150000000000006 113.902 178.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.542 HG21 HG12 ' A' ' 195' ' ' ILE . 17.0 m -61.6 -33.47 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 112.581 0.585 . . . . 64.019999999999996 112.581 -176.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . 0.49 ' O ' HG23 ' A' ' 239' ' ' VAL . 58.3 m -70.03 -35.84 74.61 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 115.803 -0.635 . . . . 74.230000000000004 109.887 -175.011 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -64.93 -30.94 71.96 Favored 'General case' 0 CA--C 1.508 -0.65 0 N-CA-C 108.86 -0.793 . . . . 35.509999999999998 108.86 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' MET . . . . . 0.437 ' HB2' HG11 ' A' ' 221' ' ' VAL . 5.7 mtm -74.36 -37.54 63.46 Favored 'General case' 0 C--O 1.199 -1.567 0 N-CA-C 108.259 -1.015 . . . . 72.109999999999999 108.259 -179.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' MET . . . . . 0.409 ' SD ' HD13 ' A' ' 176' ' ' ILE . 65.5 mtt -69.57 -34.66 74.49 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.212 -0.449 . . . . 64.310000000000002 110.998 178.169 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 235' ' ' THR . 99.0 t -67.04 -39.98 84.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.197 0.523 . . . . 71.519999999999996 110.222 176.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -68.29 -42.92 78.81 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.54 0.686 . . . . 75.239999999999995 109.325 176.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . 0.484 HD22 HG22 ' A' ' 221' ' ' VAL . 91.6 m-20 -79.69 18.13 0.81 Allowed 'General case' 0 C--O 1.192 -1.948 0 CA-C-N 115.025 -0.989 . . . . 73.209999999999994 112.237 178.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 70.3 m -68.26 -22.55 64.75 Favored 'General case' 0 N--CA 1.478 0.967 0 O-C-N 121.584 -0.698 . . . . 64.219999999999999 111.923 178.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 37.8 p -65.5 -22.48 66.73 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 116.275 -0.42 . . . . 73.150000000000006 110.727 176.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 178.05 101.12 0.02 OUTLIER 'General case' 0 CA--C 1.503 -0.834 0 C-N-CA 125.578 1.551 . . . . 74.219999999999999 107.63 176.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.546 ' CD2' HG13 ' A' ' 247' ' ' ILE . 3.3 tt -90.01 106.52 18.53 Favored 'General case' 0 N--CA 1.414 -2.234 0 CA-C-N 115.515 -0.766 . . . . 54.409999999999997 110.203 -171.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.535 ' HA ' ' O ' ' A' ' 161' ' ' VAL . 62.9 mt -95.32 127.92 46.92 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.068 0 N-CA-C 109.115 -0.698 . . . . 72.239999999999995 109.115 176.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . 0.546 HG13 ' CD2' ' A' ' 245' ' ' LEU . 12.8 mt -132.16 142.54 42.53 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 CA-C-O 121.367 0.603 . . . . 71.439999999999998 112.26 176.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.548 ' HA ' ' O ' ' A' ' 159' ' ' ARG . 61.5 m -110.49 117.43 33.53 Favored 'General case' 0 N--CA 1.418 -2.058 0 N-CA-C 107.932 -1.136 . . . . 74.120000000000005 107.932 173.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.599 HG12 ' HA ' ' A' ' 218' ' ' VAL . 27.0 m -120.78 162.41 19.53 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 N-CA-C 109.322 -0.622 . . . . 54.130000000000003 109.322 175.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 15.8 ptmt -134.01 133.56 22.19 Favored Pre-proline 0 C--N 1.284 -2.24 0 CA-C-N 115.198 -0.91 . . . . 71.329999999999998 108.803 175.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . 0.53 ' HA ' ' OD1' ' A' ' 216' ' ' ASP . 61.1 Cg_exo -56.32 133.68 59.53 Favored 'Trans proline' 0 N--CA 1.443 -1.488 0 C-N-CA 122.115 1.877 . . . . 71.329999999999998 110.527 173.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -74.14 -7.31 52.14 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.834 0.826 . . . . 61.210000000000001 110.116 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -93.31 -4.9 50.86 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 114.508 -1.224 . . . . 55.100000000000001 109.196 178.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 58.37 90.8 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.533 0.733 . . . . 73.150000000000006 112.493 -176.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . 0.489 ' OXT' ' HB2' ' A' ' 156' ' ' GLU . 42.0 ttm180 . . . . . 0 C--N 1.301 -1.516 0 N-CA-C 108.76 -0.83 . . . . 54.140000000000001 108.76 179.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 . . . . . 0 N--CA 1.443 -0.803 0 N-CA-C 109.106 -0.701 . . . . 72.420000000000002 109.106 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.579 ' O ' ' HD2' ' A' ' 251' ' ' PRO . 18.0 p -80.69 -27.3 37.06 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 121.259 0.552 . . . . 65.209999999999994 111.357 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.683 ' NE2' HG13 ' A' ' 219' ' ' ILE . 9.5 m80 -126.4 130.09 50.05 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 116.124 -0.489 . . . . 74.129999999999995 110.638 171.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.525 ' O ' ' HA ' ' A' ' 248' ' ' THR . 18.3 tpt180 -139.34 133.12 30.72 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 110.303 -0.258 . . . . 75.099999999999994 110.303 178.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.469 ' HB3' ' OG1' ' A' ' 248' ' ' THR . 4.6 ptp180 -117.6 118.63 32.65 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-O 121.756 0.789 . . . . 73.329999999999998 110.519 175.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.461 ' CG1' HD21 ' A' ' 211' ' ' LEU . 16.2 m -111.4 139.43 35.53 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.086 0 CA-C-N 114.914 -1.039 . . . . 73.340000000000003 111.338 -178.11 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.783 ' HG3' HG12 ' A' ' 246' ' ' ILE . 7.6 mpt_? -92.66 111.5 23.12 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 107.568 -1.271 . . . . 74.420000000000002 107.568 176.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.597 ' HB2' ' HB2' ' A' ' 245' ' ' LEU . 21.2 mt -91.28 137.03 32.68 Favored 'General case' 0 N--CA 1.416 -2.151 0 N-CA-C 108.38 -0.97 . . . . 60.340000000000003 108.38 -179.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.587 ' HG ' ' CD1' ' A' ' 172' ' ' LEU 0.391 10.8 mt 85.56 95.06 0.03 OUTLIER 'General case' 0 CA--C 1.476 -1.873 0 N-CA-C 115.305 1.595 . . . . 73.239999999999995 115.305 -175.054 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -139.08 14.65 2.64 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 113.508 -1.678 . . . . 71.219999999999999 108.211 177.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 24.5 t-80 -131.75 30.16 4.39 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 106.971 -1.492 . . . . 51.420000000000002 106.971 -179.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . 0.454 ' HA3' ' HD3' ' A' ' 170' ' ' LYS . . . 142.3 -167.19 26.19 Favored Glycine 0 N--CA 1.397 -3.93 0 N-CA-C 108.445 -1.862 . . . . 62.329999999999998 108.445 -179.285 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . 0.514 ' HA ' HD13 ' A' ' 164' ' ' LEU . 30.0 p -154.82 143.5 20.7 Favored 'General case' 0 C--N 1.283 -2.299 0 CA-C-O 118.945 -0.55 . . . . 62.130000000000003 109.613 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 25.4 t70 77.69 0.78 2.87 Favored 'General case' 0 N--CA 1.506 2.343 0 C-N-CA 124.196 0.998 . . . . 75.430000000000007 111.022 -178.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.454 ' HD3' ' HA3' ' A' ' 167' ' ' GLY . 57.2 mtpt -89.74 153.99 47.86 Favored Pre-proline 0 C--N 1.304 -1.413 0 C-N-CA 124.221 1.009 . . . . 73.420000000000002 110.593 -176.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -57.24 135.16 68.66 Favored 'Trans proline' 0 C--O 1.242 0.709 0 C-N-CA 122.927 2.418 . . . . 63.43 111.309 175.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.587 ' CD1' ' HG ' ' A' ' 164' ' ' LEU . 2.6 mm? -86.73 -34.97 19.49 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.081 0.467 . . . . 64.319999999999993 111.282 -175.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 101.77 45.47 1.77 Allowed Glycine 0 N--CA 1.419 -2.448 0 CA-C-N 115.469 -0.787 . . . . 73.340000000000003 112.75 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -156.94 154.47 29.75 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.499 -0.926 . . . . 73.129999999999995 108.499 175.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -124.34 144.95 49.72 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 108.971 -0.751 . . . . 72.430000000000007 108.971 175.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.61 ' H ' HD13 ' A' ' 176' ' ' ILE . 0.2 OUTLIER -110.67 169.81 3.67 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.238 0 N-CA-C 108.935 -0.765 . . . . 71.319999999999993 108.935 177.727 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.578 ' HB3' ' HB2' ' A' ' 198' ' ' SER . 16.4 ptt180 -149.43 154.49 38.95 Favored 'General case' 0 C--N 1.269 -2.921 0 CA-C-N 115.189 -0.914 . . . . 65.310000000000002 109.83 -178.069 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -111.98 138.2 48.95 Favored 'General case' 0 C--N 1.28 -2.434 0 N-CA-C 108.786 -0.82 . . . . 64.209999999999994 108.786 178.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -150.64 -175.4 22.6 Favored Glycine 0 C--N 1.285 -2.269 0 N-CA-C 108.469 -1.853 . . . . 52.420000000000002 108.469 178.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . 0.603 ' CG2' ' HG2' ' A' ' 191' ' ' LYS . 0.2 OUTLIER -102.01 123.17 45.44 Favored 'General case' 0 N--CA 1.415 -2.181 0 C-N-CA 118.725 -1.19 . . . . 64.319999999999993 108.087 178.078 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . 0.466 ' O ' ' HA ' ' A' ' 191' ' ' LYS . 37.5 t -96.82 125.95 41.63 Favored 'General case' 0 C--N 1.28 -2.423 0 N-CA-C 108.439 -0.949 . . . . 61.100000000000001 108.439 -178.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.709 ' HA ' ' O ' ' A' ' 190' ' ' GLU . 5.9 p -120.01 121.72 66.65 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.769 0 CA-C-O 121.461 0.648 . . . . 65.129999999999995 109.872 174.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -122.75 160.84 25.1 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 107.654 -1.239 . . . . 74.510000000000005 107.654 -178.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.497 ' HA ' ' O ' ' A' ' 188' ' ' GLY . 70.5 t -84.74 119.23 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.25 0 N-CA-C 107.489 -1.3 . . . . 63.520000000000003 107.489 169.155 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 42.4 p -115.03 -174.63 2.53 Favored 'General case' 0 C--N 1.264 -3.151 0 CA-C-N 114.565 -1.198 . . . . 74.409999999999997 108.073 -178.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -70.96 -9.8 58.57 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 120.979 0.419 . . . . 73.329999999999998 110.495 176.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 9.1 m -92.68 -19.34 21.94 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 109.043 -0.725 . . . . 65.129999999999995 109.043 178.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.497 ' O ' ' HA ' ' A' ' 184' ' ' VAL . . . 122.65 -120.23 4.22 Favored Glycine 0 C--O 1.197 -2.178 0 N-CA-C 107.981 -2.048 . . . . 54.329999999999998 107.981 -175.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 6.0 mp -101.24 128.29 47.44 Favored 'General case' 0 C--N 1.285 -2.224 0 CA-C-N 118.02 0.91 . . . . 73.010000000000005 109.591 175.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . 0.709 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 33.7 mt-10 -128.07 119.39 25.28 Favored 'General case' 0 CA--C 1.458 -2.562 0 CA-C-O 121.001 0.429 . . . . 72.019999999999996 110.974 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.603 ' HG2' ' CG2' ' A' ' 180' ' ' THR . 34.2 ttmt -104.14 126.37 51.2 Favored 'General case' 0 C--N 1.274 -2.695 0 CA-C-N 114.247 -1.342 . . . . 75.010000000000005 107.395 -179.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . 0.416 HE21 ' HA2' ' A' ' 228' ' ' GLY . 17.1 pt20 -151.54 161.22 30.24 Favored Pre-proline 0 C--N 1.298 -1.661 0 CA-C-N 115.861 -0.608 . . . . 73.200000000000003 109.588 -171.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -58.77 132.68 49.25 Favored 'Trans proline' 0 C--O 1.244 0.825 0 C-N-CA 121.472 1.448 . . . . 71.540000000000006 110.991 177.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -147.1 144.63 12.81 Favored Glycine 0 N--CA 1.419 -2.473 0 N-CA-C 109.987 -1.245 . . . . 72.420000000000002 109.987 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.573 HG12 HG21 ' A' ' 234' ' ' VAL . 3.0 mp -105.61 134.08 48.14 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 CA-C-O 121.338 0.589 . . . . 65.019999999999996 110.683 -178.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -128.25 168.5 15.4 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.191 -1.04 . . . . 65.140000000000001 108.191 -176.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . 0.476 ' HB ' ' HA ' ' A' ' 214' ' ' VAL . 43.3 mm -76.75 131.88 33.99 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 N-CA-C 108.131 -1.062 . . . . 72.430000000000007 108.131 176.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . 0.578 ' HB2' ' HB3' ' A' ' 177' ' ' ARG . 13.0 t -103.96 -33.8 8.7 Favored 'General case' 0 C--N 1.284 -2.26 0 N-CA-C 113.181 0.808 . . . . 71.340000000000003 113.181 -178.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 15.0 ttp180 -168.17 142.77 3.49 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 116.621 -0.263 . . . . 73.319999999999993 111.025 -177.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 66.1 mt -103.71 137.06 42.28 Favored 'General case' 0 CA--C 1.486 -1.481 0 N-CA-C 108.162 -1.051 . . . . 71.430000000000007 108.162 172.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 66.6 t -93.44 114.5 63.07 Favored Pre-proline 0 C--N 1.288 -2.103 0 N-CA-C 105.733 -1.951 . . . . 71.239999999999995 105.733 174.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.522 ' HA ' ' HG2' ' A' ' 207' ' ' GLU . 38.2 Cg_endo -70.37 126.23 12.69 Favored 'Trans proline' 0 N--CA 1.429 -2.308 0 C-N-CA 120.915 1.077 . . . . 72.439999999999998 110.201 -176.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 113.59 -12.98 23.02 Favored Glycine 0 C--N 1.302 -1.356 0 N-CA-C 109.787 -1.325 . . . . 64.420000000000002 109.787 -173.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -90.48 168.65 33.58 Favored Glycine 0 N--CA 1.436 -1.356 0 N-CA-C 110.15 -1.18 . . . . 73.030000000000001 110.15 176.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.542 HD12 ' H ' ' A' ' 164' ' ' LEU . 66.0 mt -65.39 -29.56 70.28 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 117.41 0.605 . . . . 63.409999999999997 111.498 -177.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -61.93 -48.1 81.93 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.878 -0.601 . . . . 52.229999999999997 110.768 178.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.522 ' HG2' ' HA ' ' A' ' 202' ' ' PRO . 10.4 tp10 -73.04 -32.6 65.18 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.445 -0.576 . . . . 73.450000000000003 109.445 178.097 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 23.0 t -56.98 -40.33 76.33 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 115.91 -0.586 . . . . 63.140000000000001 110.45 178.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . 0.533 HG23 ' H ' ' A' ' 211' ' ' LEU . 14.9 t -79.29 -40.27 30.86 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 119.089 -1.044 . . . . 74.209999999999994 108.752 175.163 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 58.58 31.3 66.78 Favored Glycine 0 C--N 1.347 1.189 0 CA-C-N 115.888 -0.596 . . . . 71.140000000000001 113.139 178.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.533 ' H ' HG23 ' A' ' 209' ' ' THR . 1.8 pp -102.21 -19.33 15.11 Favored 'General case' 0 N--CA 1.424 -1.732 0 C-N-CA 120.297 -0.561 . . . . 61.299999999999997 110.692 -179.232 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.495 HD23 ' H ' ' A' ' 212' ' ' LEU . 2.1 pt? -109.39 134.28 52.03 Favored 'General case' 0 N--CA 1.432 -1.362 0 N-CA-C 107.857 -1.164 . . . . 73.140000000000001 107.857 -179.442 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -129.8 165.92 20.98 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 116.474 -0.33 . . . . 61.509999999999998 110.566 -176.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . 0.476 ' HA ' ' HB ' ' A' ' 197' ' ' ILE . 17.4 m -53.92 -30.41 19.53 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 N-CA-C 114.195 1.183 . . . . 71.109999999999999 114.195 -176.012 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 -78.02 -15.36 59.0 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.823 -0.548 . . . . 75.319999999999993 112.24 -178.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.708 ' OD1' ' HA ' ' A' ' 251' ' ' PRO . 58.5 m-20 -79.34 155.92 28.24 Favored 'General case' 0 C--O 1.248 0.995 0 CA-C-O 121.079 0.466 . . . . 72.420000000000002 112.076 -174.08 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -109.58 139.43 44.6 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.333 -0.849 . . . . 61.109999999999999 111.872 -176.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.565 ' HA ' HG12 ' A' ' 249' ' ' VAL . 25.1 t -88.03 120.16 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 CA-C-O 121.349 0.595 . . . . 75.310000000000002 109.58 -179.103 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.683 HG13 ' NE2' ' A' ' 158' ' ' HIS . 38.8 mm -89.9 -53.97 8.36 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 CA-C-N 115.257 -0.883 . . . . 74.510000000000005 112.302 -176.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -155.27 151.98 28.7 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 116.742 -0.208 . . . . 62.350000000000001 111.534 -175.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.431 HG12 ' CG1' ' A' ' 226' ' ' VAL . 9.1 p -121.78 123.22 68.81 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 CA-C-O 121.293 0.568 . . . . 64.349999999999994 109.786 176.057 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . 0.48 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 9.0 t-20 66.69 7.58 5.28 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 125.487 1.515 . . . . 71.099999999999994 111.221 177.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 113.3 -7.17 24.88 Favored Glycine 0 N--CA 1.44 -1.036 0 CA-C-N 115.677 -0.692 . . . . 51.450000000000003 112.273 -177.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 66.3 mt -101.4 123.9 54.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 109.423 -0.584 . . . . 62.240000000000002 109.423 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -59.7 134.49 57.07 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-O 121.644 0.735 . . . . 75.540000000000006 111.932 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . 0.494 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 27.6 m -117.82 2.76 7.44 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 CA-C-N 115.158 -0.928 . . . . 74.439999999999998 110.047 177.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -83.57 98.77 9.76 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-N 115.332 -0.849 . . . . 70.219999999999999 109.38 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . 0.416 ' HA2' HE21 ' A' ' 192' ' ' GLN . . . 120.35 -16.15 9.9 Favored Glycine 0 CA--C 1.489 -1.543 0 N-CA-C 111.283 -0.727 . . . . 74.540000000000006 111.283 -178.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -77.54 172.64 13.05 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 109.45 -0.574 . . . . 62.32 109.45 178.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . 0.421 ' H ' ' NE2' ' A' ' 233' ' ' GLN . 36.7 p -92.78 165.11 13.09 Favored 'General case' 0 N--CA 1.422 -1.841 0 N-CA-C 108.143 -1.058 . . . . 71.230000000000004 108.143 178.046 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 51.9 tp -61.16 -37.44 82.89 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 120.895 -0.322 . . . . 74.010000000000005 110.772 -177.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -57.76 -51.37 69.82 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 109.989 -0.375 . . . . 72.420000000000002 109.989 176.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' GLN . . . . . 0.421 ' NE2' ' H ' ' A' ' 230' ' ' THR . 48.7 mt-30 -54.56 -48.55 71.93 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 115.676 -0.693 . . . . 72.400000000000006 112.508 179.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.573 HG21 HG12 ' A' ' 195' ' ' ILE . 7.1 m -75.27 -34.84 31.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 112.257 0.465 . . . . 64.019999999999996 112.257 -174.193 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 31.2 m -75.0 -35.6 61.99 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 108.905 -0.776 . . . . 63.310000000000002 108.905 -175.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -59.11 -33.49 70.91 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.119 -0.946 . . . . 71.239999999999995 109.415 176.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' MET . . . . . 0.409 ' HG3' ' HA ' ' A' ' 234' ' ' VAL . 5.8 mtt -73.56 -44.61 56.97 Favored 'General case' 0 C--O 1.2 -1.526 0 N-CA-C 107.91 -1.144 . . . . 65.329999999999998 107.91 178.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' MET . . . . . 0.474 ' HA ' HD21 ' A' ' 245' ' ' LEU . 64.9 mtt -59.98 -41.65 92.46 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.36 -0.382 . . . . 72.230000000000004 111.943 -177.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 92.6 t -65.04 -38.71 83.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.227 0.536 . . . . 70.239999999999995 110.105 176.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -76.02 -19.9 58.27 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.355 0.598 . . . . 71.319999999999993 111.482 -179.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 -107.89 22.18 16.33 Favored 'General case' 0 C--O 1.205 -1.252 0 CA-C-N 115.94 -0.573 . . . . 52.310000000000002 110.471 177.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 22.8 t -63.44 -22.79 67.09 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.649 0.738 . . . . 75.040000000000006 109.141 177.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 16.1 p -69.56 -32.14 70.75 Favored 'General case' 0 N--CA 1.428 -1.569 0 CA-C-N 115.651 -0.704 . . . . 71.310000000000002 111.373 174.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -165.9 99.48 0.66 Allowed 'General case' 0 C--O 1.24 0.579 0 CA-C-O 121.749 0.785 . . . . 60.530000000000001 110.82 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.597 ' HB2' ' HB2' ' A' ' 163' ' ' LEU . 10.3 mt -91.46 105.18 17.57 Favored 'General case' 0 C--O 1.195 -1.786 0 N-CA-C 113.085 0.772 . . . . 73.239999999999995 113.085 -178.264 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.783 HG12 ' HG3' ' A' ' 162' ' ' ARG . 96.6 mt -95.51 114.12 31.44 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.432 0 N-CA-C 106.692 -1.596 . . . . 62.140000000000001 106.692 168.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . 0.464 ' O ' ' HA ' ' A' ' 160' ' ' ARG . 76.9 mt -122.35 127.14 75.04 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.125 0 C-N-CA 120.436 -0.506 . . . . 53.439999999999998 111.153 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.525 ' HA ' ' O ' ' A' ' 159' ' ' ARG . 63.3 m -99.53 118.18 35.55 Favored 'General case' 0 N--CA 1.418 -2.05 0 CA-C-N 114.832 -1.076 . . . . 72.409999999999997 108.688 177.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.565 HG12 ' HA ' ' A' ' 218' ' ' VAL . 27.3 m -119.29 161.93 18.0 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 N-CA-C 108.974 -0.75 . . . . 70.430000000000007 108.974 174.214 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 17.4 ptmt -127.75 130.86 23.6 Favored Pre-proline 0 C--N 1.276 -2.616 0 CA-C-N 115.309 -0.86 . . . . 74.319999999999993 108.893 176.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . 0.708 ' HA ' ' OD1' ' A' ' 216' ' ' ASP . 29.0 Cg_endo -62.45 149.63 90.22 Favored 'Trans proline' 0 N--CA 1.445 -1.341 0 C-N-CA 122.676 2.251 . . . . 75.010000000000005 112.394 177.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -49.12 -38.13 23.96 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.267 -0.879 . . . . 75.120000000000005 111.369 178.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . 0.481 ' ND2' ' HG3' ' A' ' 254' ' ' GLN . 4.5 p-10 -136.15 -60.14 0.73 Allowed 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 115.798 -0.637 . . . . 53.530000000000001 111.151 174.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 254' ' ' GLN . . . . . 0.481 ' HG3' ' ND2' ' A' ' 253' ' ' ASN . 0.7 OUTLIER -153.83 161.15 42.29 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 117.565 0.166 . . . . 70.109999999999999 110.912 178.415 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 30.0 tpt180 . . . . . 0 C--O 1.245 0.828 0 N-CA-C 107.994 -1.113 . . . . 75.430000000000007 107.994 177.828 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 . . . . . 0 CA--C 1.517 -0.322 0 N-CA-C 109.463 -0.569 . . . . 72.129999999999995 109.463 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 57.9 p 38.28 -102.17 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 115.145 1.535 . . . . 64.129999999999995 115.145 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.734 ' HB3' ' HB3' ' A' ' 250' ' ' LYS . 4.4 p-80 -126.09 153.62 44.24 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.49 0.552 . . . . 70.409999999999997 112.49 179.381 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 36.6 ttm180 -125.58 143.7 50.9 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.581 -0.282 . . . . 75.140000000000001 110.407 -179.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 35.1 ptt180 -104.05 117.22 33.75 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.611 0.719 . . . . 72.439999999999998 111.783 179.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 30.3 m -114.93 139.93 38.64 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 CA-C-N 115.497 -0.774 . . . . 73.230000000000004 111.894 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 21.1 ttm180 -102.53 121.4 42.3 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 109.168 -0.679 . . . . 74.510000000000005 109.168 179.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.428 ' HB2' ' HB3' ' A' ' 245' ' ' LEU . 26.8 mt -103.08 139.68 38.29 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 123.347 0.659 . . . . 75.129999999999995 111.657 -174.431 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.565 HD13 ' O ' ' A' ' 242' ' ' SER . 6.0 tt 84.81 91.62 0.03 OUTLIER 'General case' 0 CA--C 1.512 -0.503 0 C-N-CA 125.913 1.685 . . . . 73.409999999999997 112.216 171.247 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 60.8 pttt -102.23 -16.98 16.15 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.203 -0.908 . . . . 74.150000000000006 109.253 173.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 37.3 m80 -150.08 150.95 32.45 Favored 'General case' 0 CA--C 1.499 -1.011 0 CA-C-N 115.246 -0.888 . . . . 63.119999999999997 109.092 176.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 86.25 55.63 2.45 Favored Glycine 0 N--CA 1.437 -1.295 0 C-N-CA 120.735 -0.745 . . . . 64.200000000000003 112.913 176.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . 0.557 ' HA ' HD11 ' A' ' 164' ' ' LEU . 33.9 t -79.37 2.69 20.7 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.322 0.582 . . . . 60.409999999999997 110.254 179.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -88.92 -19.71 25.45 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.586 -0.734 . . . . 70.129999999999995 111.238 178.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.402 ' HD2' ' O ' ' A' ' 170' ' ' LYS . 0.0 OUTLIER -118.74 153.67 52.45 Favored Pre-proline 0 N--CA 1.429 -1.514 0 N-CA-C 112.067 0.395 . . . . 43.009999999999998 112.067 -175.029 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -63.21 153.21 75.57 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 122.951 2.434 . . . . 71.010000000000005 111.304 176.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.431 ' H ' HD22 ' A' ' 172' ' ' LEU . 2.3 mm? -58.39 -36.63 73.83 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 124.345 1.058 . . . . 74.010000000000005 112.459 -175.181 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 103.69 36.12 3.34 Favored Glycine 0 N--CA 1.424 -2.121 0 C-N-CA 120.174 -1.012 . . . . 63.409999999999997 112.533 178.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -147.48 153.84 40.04 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 108.661 -0.866 . . . . 74.430000000000007 108.661 174.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -123.77 155.41 37.97 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 108.183 -1.043 . . . . 75.030000000000001 108.183 177.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.446 HD13 ' SD ' ' A' ' 238' ' ' MET . 27.3 pt -125.18 169.5 16.48 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 CA-C-O 120.909 0.385 . . . . 74.25 111.329 -176.119 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.513 ' HG2' ' HB3' ' A' ' 198' ' ' SER . 1.1 ptp180 -148.91 154.15 39.02 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 123.332 0.653 . . . . 74.099999999999994 110.891 -179.157 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -103.38 138.84 39.58 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 109.065 -0.717 . . . . 62.039999999999999 109.065 176.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -154.38 -168.27 17.58 Favored Glycine 0 N--CA 1.416 -2.661 0 N-CA-C 109.197 -1.561 . . . . 73.310000000000002 109.197 177.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . 0.549 ' HB ' ' CG ' ' A' ' 191' ' ' LYS . 1.0 OUTLIER -101.16 125.48 47.79 Favored 'General case' 0 C--N 1.276 -2.618 0 CA-C-O 121.14 0.495 . . . . 73.120000000000005 111.698 176.415 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 36.9 t -110.1 124.29 51.24 Favored 'General case' 0 N--CA 1.41 -2.463 0 N-CA-C 107.255 -1.387 . . . . 53.119999999999997 107.255 176.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.552 ' HA ' ' O ' ' A' ' 190' ' ' GLU . 5.2 p -120.39 127.97 75.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 CA-C-O 121.343 0.592 . . . . 73.519999999999996 110.176 177.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -126.09 159.47 32.74 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 115.291 -0.868 . . . . 72.030000000000001 109.153 -176.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.506 ' HA ' ' O ' ' A' ' 188' ' ' GLY . 71.1 t -89.77 118.29 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.193 0 N-CA-C 107.634 -1.247 . . . . 73.120000000000005 107.634 171.234 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 43.1 p -120.38 -174.9 2.89 Favored 'General case' 0 C--N 1.266 -3.024 0 CA-C-N 114.196 -1.366 . . . . 45.409999999999997 108.617 -177.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -62.67 -22.22 66.31 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-O 121.074 0.464 . . . . 62.219999999999999 109.838 175.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 16.6 m -86.4 -17.13 35.17 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-N 115.789 -0.641 . . . . 54.340000000000003 110.783 179.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.506 ' O ' ' HA ' ' A' ' 184' ' ' VAL . . . 115.77 -127.61 7.64 Favored Glycine 0 CA--C 1.482 -2.024 0 N-CA-C 108.606 -1.798 . . . . 75.150000000000006 108.606 -178.39 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 6.0 mp -98.49 123.43 42.64 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 108.775 -0.824 . . . . 63.219999999999999 108.775 176.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . 0.552 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 36.6 tt0 -129.21 119.05 23.38 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.38 -0.97 . . . . 60.020000000000003 108.38 -177.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.549 ' CG ' ' HB ' ' A' ' 180' ' ' THR . 35.4 ttmt -100.63 121.92 42.43 Favored 'General case' 0 N--CA 1.425 -1.71 0 N-CA-C 107.972 -1.121 . . . . 71.340000000000003 107.972 -178.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -130.75 164.15 43.74 Favored Pre-proline 0 C--N 1.284 -2.261 0 CA-C-N 115.473 -0.785 . . . . 72.430000000000007 109.336 -172.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -61.69 132.31 39.63 Favored 'Trans proline' 0 N--CA 1.447 -1.221 0 C-N-CA 121.108 1.205 . . . . 54.200000000000003 109.135 172.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -139.82 138.77 9.4 Favored Glycine 0 N--CA 1.415 -2.725 0 N-CA-C 110.085 -1.206 . . . . 40.240000000000002 110.085 -178.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.548 HG12 HG21 ' A' ' 234' ' ' VAL . 3.4 mp -103.8 128.26 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.127 0 CA-C-O 121.418 0.628 . . . . 72.299999999999997 110.929 -179.101 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -121.75 167.12 13.34 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 107.57 -1.27 . . . . 73.299999999999997 107.57 -177.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . 0.432 ' HB ' ' HA ' ' A' ' 214' ' ' VAL . 50.1 mm -77.58 130.32 36.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 107.515 -1.291 . . . . 71.340000000000003 107.515 175.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . 0.513 ' HB3' ' HG2' ' A' ' 177' ' ' ARG . 81.4 p -103.49 -22.37 13.64 Favored 'General case' 0 C--N 1.291 -1.95 0 C-N-CA 119.624 -0.831 . . . . 54.229999999999997 111.538 -175.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 27.6 tpt180 -167.12 146.28 5.19 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.398 -0.593 . . . . 74.319999999999993 109.398 -176.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 69.7 mt -112.51 139.67 47.9 Favored 'General case' 0 CA--C 1.484 -1.571 0 N-CA-C 108.541 -0.911 . . . . 75.230000000000004 108.541 172.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 53.2 t -95.8 114.92 65.05 Favored Pre-proline 0 C--N 1.288 -2.07 0 N-CA-C 105.811 -1.922 . . . . 72.349999999999994 105.811 171.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.542 ' HA ' ' HG3' ' A' ' 207' ' ' GLU . 19.3 Cg_endo -62.3 126.81 19.38 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 121.938 1.758 . . . . 73.219999999999999 110.644 -177.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 103.38 -14.32 54.55 Favored Glycine 0 C--N 1.297 -1.587 0 C-N-CA 120.157 -1.021 . . . . 74.319999999999993 111.266 -175.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -81.93 162.24 42.6 Favored Glycine 0 N--CA 1.435 -1.422 0 N-CA-C 110.221 -1.152 . . . . 61.140000000000001 110.221 176.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.459 HD13 ' CA ' ' A' ' 164' ' ' LEU . 32.1 mt -53.9 -38.34 64.72 Favored 'General case' 0 C--N 1.309 -1.158 0 C-N-CA 124.737 1.215 . . . . 73.349999999999994 112.777 -175.095 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . 0.538 ' CB ' HD12 ' A' ' 212' ' ' LEU . . . -66.0 -43.73 86.86 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.538 0.685 . . . . 51.030000000000001 110.919 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.542 ' HG3' ' HA ' ' A' ' 202' ' ' PRO . 3.3 tm-20 -76.16 -35.93 58.96 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 115.255 -0.884 . . . . 64.109999999999999 109.619 -178.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 55.8 m -61.0 -41.46 96.57 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.474 -0.33 . . . . 53.329999999999998 111.572 178.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . 0.457 HG23 ' H ' ' A' ' 211' ' ' LEU . 9.2 t -73.27 -33.21 65.13 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 119.489 -0.884 . . . . 61.43 109.253 176.257 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 70.14 10.91 66.36 Favored Glycine 0 CA--C 1.5 -0.886 0 CA-C-N 115.75 -0.659 . . . . 33.020000000000003 112.842 176.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.457 ' H ' HG23 ' A' ' 209' ' ' THR . 52.0 mt -95.42 -5.97 41.93 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.989 -0.745 . . . . 74.0 108.989 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.538 HD12 ' CB ' ' A' ' 206' ' ' ALA . 95.6 mt -109.49 131.21 55.28 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 107.817 -1.179 . . . . 60.039999999999999 107.817 174.313 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -133.63 166.11 23.35 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.216 -1.031 . . . . 41.229999999999997 108.216 176.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . 0.432 ' HA ' ' HB ' ' A' ' 197' ' ' ILE . 34.6 m -62.86 -31.3 51.9 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 N-CA-C 113.466 0.913 . . . . 71.030000000000001 113.466 -178.585 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -72.37 -13.42 61.47 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.995 -0.441 . . . . 55.219999999999999 111.577 179.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.51 ' HB3' ' HB ' ' A' ' 249' ' ' VAL . 6.3 m-20 -73.78 131.09 41.19 Favored 'General case' 0 C--O 1.242 0.705 0 N-CA-C 113.516 0.932 . . . . 32.219999999999999 113.516 -176.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -103.72 132.26 50.13 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 113.827 -1.533 . . . . 61.32 109.676 -179.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.561 ' HA ' HG12 ' A' ' 249' ' ' VAL . 22.9 t -79.97 130.19 36.4 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 CA-C-O 121.433 0.635 . . . . 74.439999999999998 110.732 -176.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.452 HD11 ' HD3' ' A' ' 250' ' ' LYS . 38.8 mm -95.16 -50.3 11.85 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 C-N-CA 124.06 0.944 . . . . 65.219999999999999 110.122 178.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -154.41 154.22 32.88 Favored 'General case' 0 N--CA 1.433 -1.325 0 CA-C-N 115.446 -0.797 . . . . 72.109999999999999 110.695 -176.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.429 HG11 ' HB2' ' A' ' 237' ' ' MET . 7.5 p -124.18 121.2 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 N-CA-C 108.415 -0.958 . . . . 75.129999999999995 108.415 177.268 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . 0.563 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 24.6 t-20 75.55 -24.34 0.22 Allowed 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 126.406 1.882 . . . . 71.129999999999995 111.774 -176.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . 0.427 ' H ' ' C ' ' A' ' 221' ' ' VAL . . . 140.43 -11.33 2.99 Favored Glycine 0 C--N 1.278 -2.654 0 N-CA-C 109.932 -1.267 . . . . 51.520000000000003 109.932 -174.287 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 67.4 mt -92.1 123.85 44.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 108.936 -0.764 . . . . 71.219999999999999 108.936 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -57.62 143.43 41.35 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 123.992 0.917 . . . . 74.319999999999993 112.006 -179.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 34.7 m -117.57 1.0 8.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 CA-C-N 115.667 -0.697 . . . . 75.230000000000004 110.92 176.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -78.12 97.34 5.41 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.86 -0.609 . . . . 73.129999999999995 110.224 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 120.41 -14.57 10.06 Favored Glycine 0 C--N 1.316 -0.532 0 N-CA-C 110.826 -0.91 . . . . 70.140000000000001 110.826 -179.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -79.8 170.13 16.95 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 108.333 -0.988 . . . . 72.329999999999998 108.333 177.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . 0.517 ' O ' HG13 ' A' ' 234' ' ' VAL . 73.1 p -93.55 164.11 13.3 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 108.445 -0.946 . . . . 53.109999999999999 108.445 177.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.445 ' HA ' HG22 ' A' ' 234' ' ' VAL . 0.7 OUTLIER -63.07 -36.15 82.62 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 107.017 -1.475 . . . . 61.020000000000003 107.017 179.105 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -61.85 -45.82 92.14 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.286 -0.87 . . . . 63.119999999999997 109.945 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -61.94 -50.39 72.34 Favored 'General case' 0 C--N 1.344 0.341 0 N-CA-C 112.385 0.513 . . . . 74.310000000000002 112.385 175.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.548 HG21 HG12 ' A' ' 195' ' ' ILE . 12.2 m -62.08 -33.89 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 N-CA-C 112.749 0.648 . . . . 63.549999999999997 112.749 -173.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . 0.484 ' O ' HG23 ' A' ' 239' ' ' VAL . 61.9 m -68.9 -39.05 79.93 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 109.394 -0.595 . . . . 55.130000000000003 109.394 -175.182 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -68.53 -30.43 69.22 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-N 115.614 -0.721 . . . . 72.439999999999998 109.793 -178.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' MET . . . . . 0.429 ' HB2' HG11 ' A' ' 221' ' ' VAL . 3.5 mtm -73.21 -36.47 66.49 Favored 'General case' 0 C--O 1.196 -1.728 0 N-CA-C 107.894 -1.15 . . . . 73.420000000000002 107.894 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' MET . . . . . 0.484 ' HG3' ' O ' ' A' ' 234' ' ' VAL . 65.5 mtt -63.11 -39.78 95.69 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 120.844 0.354 . . . . 74.0 110.133 177.268 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 235' ' ' THR . 79.0 t -66.34 -41.06 88.27 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 CA-C-N 116.096 -0.502 . . . . 54.219999999999999 109.682 176.363 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -66.01 -22.34 66.45 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.131 -0.486 . . . . 44.020000000000003 111.991 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 54.4 m-80 -105.12 21.93 16.24 Favored 'General case' 0 C--O 1.202 -1.426 0 CA-C-N 116.542 -0.299 . . . . 65.409999999999997 110.815 178.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . 0.565 ' O ' HD13 ' A' ' 164' ' ' LEU . 46.5 t -56.36 -24.44 44.27 Favored 'General case' 0 C--O 1.213 -0.849 0 N-CA-C 113.68 0.992 . . . . 71.120000000000005 113.68 -179.088 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 29.1 m -78.59 -22.15 47.52 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 120.359 -0.537 . . . . 64.420000000000002 111.424 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -171.5 94.14 0.16 Allowed 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.726 1.211 . . . . 71.140000000000001 108.956 178.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.527 ' CD2' HG13 ' A' ' 247' ' ' ILE . 1.7 tt -90.77 109.24 20.44 Favored 'General case' 0 N--CA 1.419 -1.983 0 CA-C-N 114.618 -1.174 . . . . 61.530000000000001 110.071 -171.056 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.563 ' HB ' ' HA ' ' A' ' 222' ' ' ASN . 61.3 mt -95.76 117.13 39.2 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 N-CA-C 108.963 -0.755 . . . . 62.020000000000003 108.963 176.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . 0.527 HG13 ' CD2' ' A' ' 245' ' ' LEU . 9.3 mt -123.83 135.3 63.92 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.99 0 CA-C-O 121.819 0.818 . . . . 73.150000000000006 111.305 176.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 37.7 m -108.79 124.54 50.76 Favored 'General case' 0 N--CA 1.41 -2.441 0 CA-C-N 114.476 -1.238 . . . . 61.340000000000003 108.493 178.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.561 HG12 ' HA ' ' A' ' 218' ' ' VAL . 29.1 m -134.75 152.99 34.09 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-O 121.754 0.788 . . . . 74.430000000000007 112.18 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.734 ' HB3' ' HB3' ' A' ' 158' ' ' HIS . 1.1 ptmm? -128.79 132.6 24.46 Favored Pre-proline 0 C--N 1.293 -1.872 0 CA-C-N 113.938 -1.483 . . . . 73.349999999999994 109.203 172.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -61.78 150.44 85.89 Favored 'Trans proline' 0 N--CA 1.447 -1.25 0 C-N-CA 122.549 2.166 . . . . 73.439999999999998 110.713 176.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -46.71 -49.02 20.12 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-O 121.345 0.593 . . . . 64.230000000000004 110.901 177.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -96.59 79.85 3.06 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 107.928 -1.138 . . . . 64.239999999999995 107.928 176.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 254' ' ' GLN . . . . . 0.619 ' HG2' ' HE2' ' A' ' 250' ' ' LYS . 4.8 pp0? -97.56 153.52 18.12 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 112.951 0.722 . . . . 74.400000000000006 112.951 -178.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 38.5 ttt180 . . . . . 0 N--CA 1.421 -1.909 0 N-CA-C 107.467 -1.308 . . . . 72.129999999999995 107.467 177.189 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 . . . . . 0 CA--C 1.508 -0.669 0 N-CA-C 109.147 -0.686 . . . . 55.100000000000001 109.147 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.537 ' HB ' ' OE1' ' A' ' 254' ' ' GLN . 41.7 p -92.77 -27.12 17.4 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-O 121.261 0.553 . . . . 61.119999999999997 110.131 176.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.419 ' ND1' ' HB3' ' A' ' 250' ' ' LYS . 0.3 OUTLIER -123.27 137.62 54.82 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 122.842 0.457 . . . . 75.040000000000006 109.888 174.288 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.47 ' O ' ' HA ' ' A' ' 248' ' ' THR . 2.2 tpm_? -128.95 138.53 52.03 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 108.096 -1.076 . . . . 72.349999999999994 108.096 177.047 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.401 ' HA ' ' O ' ' A' ' 247' ' ' ILE . 14.9 ptp180 -122.6 117.03 24.89 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-O 121.2 0.524 . . . . 71.230000000000004 110.222 178.483 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.507 HG21 HD11 ' A' ' 212' ' ' LEU . 27.7 m -122.66 140.49 46.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 CA-C-N 115.479 -0.782 . . . . 62.340000000000003 112.02 -175.108 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.521 ' HG2' HG12 ' A' ' 246' ' ' ILE . 67.0 mtm180 -92.95 111.29 22.86 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.824 -1.176 . . . . 64.230000000000004 107.824 177.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.513 ' HB2' ' HB3' ' A' ' 245' ' ' LEU . 31.8 mt -89.32 139.12 30.82 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 109.28 -0.637 . . . . 73.540000000000006 109.28 -178.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.431 HD13 ' O ' ' A' ' 242' ' ' SER . 6.1 tt 71.63 83.09 0.14 Allowed 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 123.037 1.399 . . . . 72.209999999999994 108.397 179.337 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 49.0 pttt -100.34 2.14 42.21 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 113.027 -1.897 . . . . 62.329999999999998 109.839 -177.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 18.6 m170 -95.43 -171.11 2.31 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 114.403 -1.271 . . . . 73.129999999999995 109.118 173.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -123.15 76.84 0.36 Allowed Glycine 0 CA--C 1.484 -1.9 0 N-CA-C 108.06 -2.016 . . . . 53.130000000000003 108.06 176.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 40.1 m -141.8 143.47 33.45 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-N 115.487 -0.357 . . . . 61.100000000000001 110.676 -173.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -89.9 68.8 7.43 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 107.087 -1.449 . . . . 61.329999999999998 107.087 173.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 56.7 tttp -109.54 145.61 32.27 Favored Pre-proline 0 N--CA 1.401 -2.878 0 CA-C-N 112.968 -1.924 . . . . 73.019999999999996 111.283 -173.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -67.26 135.9 38.54 Favored 'Trans proline' 0 C--O 1.245 0.841 0 C-N-CA 122.455 2.103 . . . . 72.430000000000007 109.711 172.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.435 ' HG ' HD12 ' A' ' 245' ' ' LEU . 3.7 mm? -63.86 -35.11 79.55 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 113.531 0.937 . . . . 74.25 113.531 -175.032 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 91.77 36.42 6.44 Favored Glycine 0 N--CA 1.434 -1.48 0 C-N-CA 119.813 -1.184 . . . . 50.229999999999997 113.789 175.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.436 ' HB3' ' CB ' ' A' ' 206' ' ' ALA . 18.9 p90 -156.61 153.33 28.43 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.755 -1.202 . . . . 63.340000000000003 107.755 173.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -128.7 150.29 50.32 Favored 'General case' 0 C--N 1.287 -2.129 0 N-CA-C 108.769 -0.826 . . . . 75.019999999999996 108.769 179.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.602 ' H ' HD13 ' A' ' 176' ' ' ILE . 0.2 OUTLIER -123.92 170.08 14.54 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.438 0 CA-C-O 121.372 0.606 . . . . 53.119999999999997 110.739 -176.222 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.557 ' HG2' ' HB2' ' A' ' 198' ' ' SER . 2.7 ptp180 -147.46 154.39 40.74 Favored 'General case' 0 C--N 1.275 -2.638 0 CA-C-N 115.141 -0.936 . . . . 74.349999999999994 110.226 -177.456 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -104.7 138.3 41.22 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 109.509 -0.552 . . . . 74.310000000000002 109.509 179.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -155.54 136.77 5.25 Favored Glycine 0 C--N 1.284 -2.339 0 N-CA-C 109.823 -1.311 . . . . 74.140000000000001 109.823 177.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . 0.474 ' CG2' ' HG2' ' A' ' 191' ' ' LYS . 0.2 OUTLIER -89.24 123.49 33.51 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 105.903 -1.888 . . . . 72.129999999999995 105.903 179.292 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 22.7 t -109.64 126.54 53.76 Favored 'General case' 0 C--N 1.269 -2.911 0 N-CA-C 109.112 -0.699 . . . . 73.120000000000005 109.112 -176.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.575 ' HA ' ' O ' ' A' ' 190' ' ' GLU . 7.6 p -103.72 122.22 56.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 N-CA-C 108.973 -0.751 . . . . 65.239999999999995 108.973 177.089 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -129.58 160.56 32.88 Favored 'General case' 0 CA--C 1.468 -2.183 0 CA-C-N 115.381 -0.827 . . . . 71.400000000000006 109.654 -173.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.552 ' HA ' ' O ' ' A' ' 188' ' ' GLY . 98.1 t -82.28 118.61 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.428 0 N-CA-C 108.079 -1.082 . . . . 52.219999999999999 108.079 172.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 34.3 p -115.9 -174.44 2.53 Favored 'General case' 0 C--N 1.262 -3.219 0 CA-C-N 113.654 -1.612 . . . . 71.319999999999993 107.402 -178.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -66.2 -21.85 66.32 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 121.177 0.513 . . . . 73.430000000000007 109.807 176.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 30.5 p -88.85 -18.67 27.13 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-N 115.77 -0.65 . . . . 71.040000000000006 112.586 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.552 ' O ' ' HA ' ' A' ' 184' ' ' VAL . . . 125.06 -127.69 6.39 Favored Glycine 0 C--O 1.205 -1.679 0 N-CA-C 109.643 -1.383 . . . . 70.319999999999993 109.643 -178.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 7.0 mp -100.71 119.27 38.35 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 117.569 0.685 . . . . 61.539999999999999 109.365 176.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . 0.575 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 10.2 tp10 -131.72 126.79 35.4 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 108.646 -0.872 . . . . 74.510000000000005 108.646 -178.16 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.474 ' HG2' ' CG2' ' A' ' 180' ' ' THR . 34.2 ttmt -96.19 125.97 41.08 Favored 'General case' 0 N--CA 1.427 -1.606 0 N-CA-C 107.618 -1.252 . . . . 74.040000000000006 107.618 -178.121 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . 0.421 ' HA ' ' HD3' ' A' ' 193' ' ' PRO . 43.2 tp60 -140.98 134.54 14.77 Favored Pre-proline 0 C--N 1.287 -2.144 0 CA-C-N 115.78 -0.645 . . . . 70.319999999999993 109.816 -168.276 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 192' ' ' GLN . 24.7 Cg_exo -64.73 130.77 27.19 Favored 'Trans proline' 0 N--CA 1.447 -1.209 0 C-N-CA 121.726 1.617 . . . . 71.129999999999995 111.885 179.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -133.82 141.4 12.73 Favored Glycine 0 N--CA 1.403 -3.539 0 N-CA-C 109.285 -1.526 . . . . 63.219999999999999 109.285 174.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.547 ' O ' HG12 ' A' ' 218' ' ' VAL . 3.8 mp -103.8 129.78 55.35 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.676 0 N-CA-C 108.351 -0.981 . . . . 72.099999999999994 108.351 175.129 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -123.59 161.15 25.56 Favored 'General case' 0 C--N 1.275 -2.644 0 N-CA-C 107.271 -1.381 . . . . 73.120000000000005 107.271 -174.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 57.6 mt -79.24 127.69 38.95 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.892 0 CA-C-O 121.588 0.709 . . . . 72.239999999999995 110.294 177.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . 0.557 ' HB2' ' HG2' ' A' ' 177' ' ' ARG . 24.4 t -101.56 -18.67 15.82 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 112.891 0.701 . . . . 63.439999999999998 112.891 -177.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 75.3 ttt180 -166.55 139.5 3.83 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.327 -0.549 . . . . 74.219999999999999 111.239 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 88.3 mt -103.72 146.61 28.35 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.575 -0.898 . . . . 63.539999999999999 108.575 172.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 62.1 t -112.09 114.77 50.98 Favored Pre-proline 0 C--N 1.283 -2.298 0 N-CA-C 105.886 -1.894 . . . . 73.200000000000003 105.886 171.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.426 ' HA ' ' HG2' ' A' ' 207' ' ' GLU . 31.1 Cg_endo -64.45 130.67 27.38 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 121.866 1.71 . . . . 71.140000000000001 110.6 -177.314 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 103.23 -17.65 50.94 Favored Glycine 0 N--CA 1.439 -1.137 0 N-CA-C 110.137 -1.185 . . . . 73.040000000000006 110.137 -175.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -83.74 171.76 49.48 Favored Glycine 0 N--CA 1.43 -1.751 0 N-CA-C 110.298 -1.121 . . . . 44.109999999999999 110.298 177.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 172' ' ' LEU . 3.1 mm? -63.07 -33.24 75.02 Favored 'General case' 0 N--CA 1.432 -1.339 0 N-CA-C 113.272 0.842 . . . . 72.239999999999995 113.272 -174.047 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . 0.436 ' CB ' ' HB3' ' A' ' 174' ' ' PHE . . . -66.3 -48.13 71.35 Favored 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 120.847 -0.341 . . . . 75.329999999999998 111.22 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.426 ' HG2' ' HA ' ' A' ' 202' ' ' PRO . 8.2 tp10 -73.39 -33.1 64.84 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 109.34 -0.615 . . . . 64.230000000000004 109.34 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 30.8 t -56.4 -47.51 78.86 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-O 122.044 0.926 . . . . 73.219999999999999 109.038 176.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 84.1 m -70.09 -40.74 74.8 Favored 'General case' 0 N--CA 1.382 -3.86 0 CA-C-N 114.41 -1.268 . . . . 52.020000000000003 109.358 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 74.35 -7.28 18.56 Favored Glycine 0 CA--C 1.504 -0.621 0 CA-C-N 116.246 -0.434 . . . . 52.409999999999997 113.097 176.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.41 HD12 HG11 ' A' ' 161' ' ' VAL . 38.4 mt -87.46 -6.56 58.35 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 109.061 -0.718 . . . . 74.209999999999994 109.061 -178.28 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.507 HD11 HG21 ' A' ' 161' ' ' VAL . 9.4 mp -108.92 131.35 55.11 Favored 'General case' 0 N--CA 1.422 -1.834 0 CA-C-N 115.181 -0.918 . . . . 71.209999999999994 109.678 174.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -132.44 166.32 22.27 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 107.177 -1.416 . . . . 72.349999999999994 107.177 175.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 33.6 m -58.57 -30.32 41.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-O 121.828 0.823 . . . . 53.409999999999997 111.623 177.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -68.59 -15.04 63.4 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 115.367 -0.833 . . . . 54.130000000000003 112.271 -179.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.441 ' HB3' ' HB ' ' A' ' 249' ' ' VAL . 6.7 m-20 -75.07 141.49 43.82 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 113.623 0.971 . . . . 61.240000000000002 113.623 -176.46 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . 0.526 ' HB3' ' HG3' ' A' ' 250' ' ' LYS . 40.4 tt0 -113.45 128.11 56.34 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 125.455 1.502 . . . . 63.409999999999997 109.852 -176.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.547 HG12 ' O ' ' A' ' 195' ' ' ILE . 12.5 p -80.03 128.84 38.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 122.143 0.973 . . . . 54.219999999999999 111.808 -176.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 44.0 mm -99.14 -48.96 11.77 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 CA-C-N 114.398 -1.274 . . . . 73.140000000000001 110.121 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.474 ' HB3' ' HA ' ' A' ' 225' ' ' GLU . 10.8 pt-20 -157.94 160.16 37.28 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.842 -0.617 . . . . 54.539999999999999 110.198 -177.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' A' ' 246' ' ' ILE . 8.8 p -131.0 120.61 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 O-C-N 123.758 0.661 . . . . 74.319999999999993 109.656 179.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . 0.429 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 10.7 m120 61.39 24.97 15.0 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.02 0.928 . . . . 74.420000000000002 112.946 176.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 97.23 -3.21 61.68 Favored Glycine 0 C--N 1.309 -0.953 0 CA-C-N 115.274 -0.876 . . . . 73.010000000000005 112.66 179.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 63.3 mt -111.22 123.51 67.16 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 N-CA-C 109.312 -0.625 . . . . 63.229999999999997 109.312 179.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . 0.474 ' HA ' ' HB3' ' A' ' 220' ' ' GLU . 12.5 pt-20 -62.73 153.71 31.81 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 121.551 0.691 . . . . 75.420000000000002 112.424 -178.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . 0.429 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 29.3 m -123.53 -3.51 6.99 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 CA-C-N 115.19 -0.914 . . . . 61.340000000000003 110.904 177.135 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -68.66 97.28 0.79 Allowed 'General case' 0 N--CA 1.443 -0.802 0 CA-C-O 121.416 0.627 . . . . 72.439999999999998 111.184 -177.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 127.78 -26.17 4.87 Favored Glycine 0 CA--C 1.49 -1.484 0 CA-C-N 115.488 -0.778 . . . . 74.349999999999994 111.571 177.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -73.65 170.98 14.1 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.231 0.539 . . . . 70.0 111.446 -178.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 47.6 p -88.53 163.89 15.68 Favored 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 108.674 -0.862 . . . . 45.350000000000001 108.674 -179.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.474 ' HA ' HG22 ' A' ' 234' ' ' VAL . 0.8 OUTLIER -63.58 -36.97 85.56 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 107.712 -1.218 . . . . 35.240000000000002 107.712 -177.351 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -61.32 -40.9 95.92 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.561 -0.745 . . . . 75.439999999999998 110.824 177.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -66.02 -48.67 70.37 Favored 'General case' 0 C--O 1.218 -0.56 0 CA-C-N 116.307 -0.406 . . . . 70.319999999999993 111.691 177.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.474 HG22 ' HA ' ' A' ' 231' ' ' LEU . 13.7 m -66.8 -34.19 68.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 112.413 0.523 . . . . 63.130000000000003 112.413 -175.162 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . 0.429 ' O ' HG23 ' A' ' 239' ' ' VAL . 32.9 m -72.01 -36.15 69.62 Favored 'General case' 0 CA--C 1.5 -0.976 0 N-CA-C 109.018 -0.734 . . . . 75.319999999999993 109.018 -177.062 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -60.46 -33.65 72.87 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 115.861 -0.609 . . . . 54.039999999999999 109.932 178.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -72.08 -43.6 64.58 Favored 'General case' 0 C--O 1.206 -1.219 0 N-CA-C 108.052 -1.092 . . . . 73.420000000000002 108.052 -179.25 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' MET . . . . . 0.419 ' HG3' ' O ' ' A' ' 234' ' ' VAL . 64.4 mtt -62.83 -40.18 96.62 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.615 -0.72 . . . . 73.519999999999996 111.431 179.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 235' ' ' THR . 97.6 t -66.92 -42.11 88.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.841 0.353 . . . . 73.230000000000004 110.463 178.256 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -65.42 -39.5 92.22 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.654 0.74 . . . . 34.149999999999999 110.078 178.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -83.57 20.98 1.28 Allowed 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 114.731 -1.122 . . . . 71.409999999999997 111.957 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . 0.431 ' O ' HD13 ' A' ' 164' ' ' LEU . 22.9 t -62.35 -23.04 66.56 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 111.742 0.275 . . . . 61.32 111.742 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 16.5 m -63.33 -29.94 71.16 Favored 'General case' 0 CA--C 1.554 1.121 0 CA-C-O 120.893 0.377 . . . . 61.119999999999997 110.425 178.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 244' ' ' ASN . . . . . 0.422 HD21 ' HB3' ' A' ' 162' ' ' ARG . 3.3 t-20 -175.19 95.96 0.07 Allowed 'General case' 0 C--O 1.245 0.867 0 N-CA-C 106.856 -1.535 . . . . 75.409999999999997 106.856 179.2 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.513 ' HB3' ' HB2' ' A' ' 163' ' ' LEU . 2.2 tt -85.97 108.0 18.01 Favored 'General case' 0 C--O 1.201 -1.453 0 CA-C-N 115.448 -0.796 . . . . 62.350000000000001 109.212 -171.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.521 HG12 ' HG2' ' A' ' 162' ' ' ARG . 77.7 mt -101.12 116.76 45.29 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.105 0 O-C-N 121.777 -0.577 . . . . 73.230000000000004 109.736 -178.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . 0.515 HG23 HG23 ' A' ' 218' ' ' VAL . 15.8 mt -121.87 136.66 58.03 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.152 0 N-CA-C 113.172 0.804 . . . . 75.439999999999998 113.172 179.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.47 ' HA ' ' O ' ' A' ' 159' ' ' ARG . 63.3 m -103.56 114.83 29.39 Favored 'General case' 0 N--CA 1.413 -2.316 0 N-CA-C 107.633 -1.247 . . . . 63.109999999999999 107.633 172.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.539 HG12 ' HA ' ' A' ' 218' ' ' VAL . 10.2 m -121.51 168.55 13.84 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.399 0 CA-C-O 121.809 0.814 . . . . 72.319999999999993 110.054 175.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.526 ' HG3' ' HB3' ' A' ' 217' ' ' GLU . 8.1 ptmt -136.62 139.16 28.46 Favored Pre-proline 0 C--N 1.257 -3.448 0 CA-C-N 113.647 -1.615 . . . . 72.310000000000002 107.665 175.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -63.34 148.24 92.99 Favored 'Trans proline' 0 N--CA 1.443 -1.482 0 C-N-CA 121.202 1.268 . . . . 55.229999999999997 108.962 173.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -65.39 -33.93 77.11 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 108.078 -1.082 . . . . 74.019999999999996 108.078 175.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -93.41 77.98 4.43 Favored 'General case' 0 N--CA 1.415 -2.183 0 CA-C-N 113.774 -1.557 . . . . 61.539999999999999 108.506 175.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 254' ' ' GLN . . . . . 0.537 ' OE1' ' HB ' ' A' ' 157' ' ' THR . 42.3 mt-30 -77.42 128.7 34.69 Favored 'General case' 0 CA--C 1.497 -1.078 0 C-N-CA 119.983 -0.687 . . . . 75.409999999999997 110.53 178.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 38.1 mmt180 . . . . . 0 C--N 1.285 -2.225 0 N-CA-C 107.461 -1.311 . . . . 62.100000000000001 107.461 176.964 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.468 0.438 0 CA-C-O 121.153 0.502 . . . . 73.109999999999999 109.914 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 22.4 p -77.94 -47.6 18.25 Favored 'General case' 0 N--CA 1.424 -1.741 0 CA-C-N 116.126 -0.488 . . . . 55.530000000000001 111.422 178.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.657 ' NE2' HG13 ' A' ' 219' ' ' ILE . 13.7 m80 -81.99 130.19 35.0 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 120.464 -0.494 . . . . 73.420000000000002 111.191 176.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.471 ' O ' ' HA ' ' A' ' 248' ' ' THR . 8.3 ttm180 -131.64 141.82 49.71 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 107.681 -1.229 . . . . 63.219999999999999 107.681 179.34 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -128.75 112.55 14.31 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-O 121.175 0.512 . . . . 74.239999999999995 109.676 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 16.5 m -118.15 139.57 44.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-N 115.025 -0.989 . . . . 71.420000000000002 112.044 -177.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 17.4 ttm180 -100.29 112.48 24.81 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.107 -1.072 . . . . 70.109999999999999 108.107 177.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.478 ' HB2' ' HB3' ' A' ' 245' ' ' LEU . 20.8 mt -99.86 137.07 38.83 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 108.184 -1.043 . . . . 71.349999999999994 108.184 -176.071 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.448 HD21 ' H ' ' A' ' 168' ' ' SER . 3.4 tt 62.2 70.92 0.55 Allowed 'General case' 0 C--O 1.207 -1.141 0 N-CA-C 107.1 -1.444 . . . . 75.109999999999999 107.1 177.157 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -100.11 0.1 40.03 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-N 115.558 -0.747 . . . . 73.120000000000005 111.096 -176.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 31.0 m170 -88.6 -25.12 22.62 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 120.446 -0.502 . . . . 75.209999999999994 111.565 179.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 84.53 41.54 7.78 Favored Glycine 0 C--O 1.226 -0.388 0 N-CA-C 110.483 -1.047 . . . . 73.0 110.483 -177.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . 0.448 ' H ' HD21 ' A' ' 164' ' ' LEU . 27.1 m -88.58 -12.9 41.37 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 112.533 0.568 . . . . 54.109999999999999 112.533 -177.244 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 30.0 t70 61.35 16.3 7.29 Favored 'General case' 0 N--CA 1.51 2.553 0 C-N-CA 124.357 1.063 . . . . 63.329999999999998 111.891 -179.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.47 154.27 83.85 Favored Pre-proline 0 C--N 1.302 -1.492 0 CA-C-N 115.615 -0.72 . . . . 64.420000000000002 110.414 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -52.44 144.23 41.5 Favored 'Trans proline' 0 C--O 1.24 0.609 0 C-N-CA 122.697 2.265 . . . . 53.310000000000002 110.947 174.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.439 ' HA ' HD23 ' A' ' 205' ' ' LEU . 3.5 mm? -77.38 -32.64 55.05 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 112.254 0.465 . . . . 73.140000000000001 112.254 -176.416 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . 0.498 ' HA3' ' HA3' ' A' ' 204' ' ' GLY . . . 84.49 36.01 13.04 Favored Glycine 0 N--CA 1.427 -1.929 0 C-N-CA 120.389 -0.91 . . . . 54.32 112.948 177.204 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -150.0 154.24 37.87 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.338 -0.986 . . . . 72.120000000000005 108.338 174.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -121.32 143.65 49.07 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 108.966 -0.753 . . . . 73.340000000000003 108.966 175.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.621 ' H ' HD13 ' A' ' 176' ' ' ILE . 0.2 OUTLIER -114.38 166.23 8.47 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.467 0 CA-C-N 115.812 -0.631 . . . . 64.5 109.484 178.992 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.578 ' HG2' ' HB2' ' A' ' 198' ' ' SER . 4.8 ptp180 -146.87 154.32 41.18 Favored 'General case' 0 C--N 1.277 -2.582 0 CA-C-N 115.072 -0.967 . . . . 62.439999999999998 110.589 -178.264 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -111.86 138.45 48.44 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 124.15 0.906 . . . . 75.439999999999998 111.145 -179.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -157.34 -164.35 13.62 Favored Glycine 0 C--N 1.29 -2.016 0 N-CA-C 108.424 -1.87 . . . . 73.0 108.424 175.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . 0.476 ' CG2' ' HG2' ' A' ' 191' ' ' LYS . 0.4 OUTLIER -105.69 123.55 48.11 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-N 118.017 0.909 . . . . 73.239999999999995 111.827 175.546 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 41.0 t -106.14 114.03 27.91 Favored 'General case' 0 N--CA 1.414 -2.257 0 N-CA-C 107.326 -1.361 . . . . 54.039999999999999 107.326 176.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.557 ' HA ' ' O ' ' A' ' 190' ' ' GLU . 6.7 p -106.08 119.79 56.0 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.779 0 N-CA-C 108.89 -0.782 . . . . 73.450000000000003 108.89 175.196 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . 0.401 ' O ' ' HA ' ' A' ' 189' ' ' LEU . 96.1 mtt180 -121.22 158.29 28.38 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-N 115.031 -0.986 . . . . 52.219999999999999 108.785 -175.411 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 74.3 t -87.89 119.42 35.34 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.203 0 N-CA-C 106.627 -1.62 . . . . 70.439999999999998 106.627 169.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 67.4 p -114.79 -175.21 2.64 Favored 'General case' 0 C--N 1.268 -2.958 0 CA-C-N 114.811 -1.086 . . . . 62.409999999999997 108.693 -176.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -60.71 -22.32 63.84 Favored 'General case' 0 C--N 1.314 -0.967 0 O-C-N 123.404 0.44 . . . . 51.350000000000001 110.416 175.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 20.0 m -99.52 -11.21 21.24 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 116.33 -0.395 . . . . 74.239999999999995 111.692 -179.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 121.06 -154.39 16.46 Favored Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 120.171 -1.014 . . . . 62.539999999999999 110.926 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.401 ' HA ' ' O ' ' A' ' 183' ' ' ARG . 4.9 mp -78.69 120.99 24.15 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 117.483 0.642 . . . . 73.310000000000002 109.41 -179.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . 0.557 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 38.8 tt0 -131.1 119.46 21.98 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 109.003 -0.74 . . . . 65.519999999999996 109.003 -177.326 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.476 ' HG2' ' CG2' ' A' ' 180' ' ' THR . 36.5 ttmt -96.18 121.69 38.22 Favored 'General case' 0 N--CA 1.426 -1.66 0 N-CA-C 108.155 -1.054 . . . . 73.040000000000006 108.155 -178.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -136.53 165.56 34.35 Favored Pre-proline 0 C--N 1.279 -2.462 0 N-CA-C 108.228 -1.027 . . . . 62.310000000000002 108.228 -174.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . 0.437 ' HD2' ' HA2' ' A' ' 228' ' ' GLY . 53.8 Cg_exo -55.26 132.11 50.3 Favored 'Trans proline' 0 N--CA 1.445 -1.373 0 C-N-CA 121.126 1.218 . . . . 72.530000000000001 109.287 170.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -131.86 127.26 4.93 Favored Glycine 0 N--CA 1.403 -3.529 0 N-CA-C 109.278 -1.529 . . . . 64.540000000000006 109.278 -179.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.566 HG12 HG21 ' A' ' 234' ' ' VAL . 3.6 mp -104.37 132.06 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.814 0 CA-C-O 121.365 0.603 . . . . 73.120000000000005 109.51 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -127.61 167.4 16.43 Favored 'General case' 0 C--N 1.277 -2.553 0 N-CA-C 107.365 -1.346 . . . . 71.340000000000003 107.365 -175.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . 0.495 ' HB ' ' HA ' ' A' ' 214' ' ' VAL . 45.1 mm -79.17 130.1 36.62 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 N-CA-C 107.877 -1.157 . . . . 62.439999999999998 107.877 173.11 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . 0.578 ' HB2' ' HG2' ' A' ' 177' ' ' ARG . 28.0 t -100.45 -34.07 10.09 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 111.946 0.35 . . . . 51.130000000000003 111.946 -178.44 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 15.4 ttp180 -160.64 141.23 11.58 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-O 120.748 0.309 . . . . 73.109999999999999 110.358 -178.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 1.1 tt -108.03 135.49 49.3 Favored 'General case' 0 N--CA 1.426 -1.67 0 N-CA-C 107.172 -1.418 . . . . 65.010000000000005 107.172 -177.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 59.7 t -106.0 121.3 46.13 Favored Pre-proline 0 C--N 1.311 -1.104 0 N-CA-C 110.129 -0.323 . . . . 75.510000000000005 110.129 179.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.505 ' HA ' ' HG3' ' A' ' 207' ' ' GLU . 27.5 Cg_endo -62.6 135.54 53.47 Favored 'Trans proline' 0 C--O 1.247 0.956 0 C-N-CA 122.638 2.226 . . . . 73.200000000000003 111.466 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 96.95 -24.45 31.14 Favored Glycine 0 N--CA 1.439 -1.136 0 N-CA-C 111.641 -0.584 . . . . 73.409999999999997 111.641 -177.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . 0.498 ' HA3' ' HA3' ' A' ' 173' ' ' GLY . . . -72.71 173.97 46.49 Favored Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 121.306 -0.474 . . . . 73.329999999999998 112.042 -179.339 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.439 HD23 ' HA ' ' A' ' 172' ' ' LEU . 3.6 mm? -63.11 -33.96 76.59 Favored 'General case' 0 N--CA 1.438 -1.069 0 C-N-CA 123.059 0.544 . . . . 71.230000000000004 111.75 -176.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -65.03 -43.26 92.98 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.067 0.46 . . . . 64.439999999999998 110.924 179.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.505 ' HG3' ' HA ' ' A' ' 202' ' ' PRO . 3.6 tm-20 -75.75 -40.1 56.02 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.033 -0.531 . . . . 61.439999999999998 109.998 178.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 33.3 t -57.97 -36.95 73.32 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.193 0.597 . . . . 63.130000000000003 110.959 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . 0.544 HG23 ' H ' ' A' ' 211' ' ' LEU . 11.7 t -81.38 -37.22 28.54 Favored 'General case' 0 N--CA 1.435 -1.188 0 C-N-CA 119.557 -0.857 . . . . 73.120000000000005 109.644 175.522 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 71.35 26.06 74.18 Favored Glycine 0 C--N 1.341 0.813 0 N-CA-C 112.14 -0.384 . . . . 52.329999999999998 112.14 178.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.544 ' H ' HG23 ' A' ' 209' ' ' THR . 43.0 mt -116.09 -4.24 12.0 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.577 0.703 . . . . 75.239999999999995 110.075 -177.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 60.1 mt -109.25 134.44 51.76 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 114.91 -1.041 . . . . 63.310000000000002 110.891 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -131.3 161.69 31.75 Favored 'General case' 0 N--CA 1.42 -1.967 0 N-CA-C 108.656 -0.868 . . . . 74.409999999999997 108.656 177.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . 0.495 ' HA ' ' HB ' ' A' ' 197' ' ' ILE . 33.8 m -62.2 -30.59 49.17 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 CA-C-O 121.377 0.608 . . . . 63.32 112.579 179.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -71.55 -14.26 62.04 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 116.123 -0.49 . . . . 75.439999999999998 112.143 -178.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.49 ' HB3' ' HB ' ' A' ' 249' ' ' VAL . 61.9 m-20 -74.19 139.15 44.24 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 112.754 0.65 . . . . 70.239999999999995 112.754 -176.183 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -110.01 137.52 47.67 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 124.975 1.31 . . . . 62.520000000000003 108.696 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.52 HG12 ' O ' ' A' ' 195' ' ' ILE . 12.1 p -83.82 138.41 19.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 122.103 0.954 . . . . 64.140000000000001 112.625 -175.545 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.657 HG13 ' NE2' ' A' ' 158' ' ' HIS . 44.1 mm -105.62 -44.75 8.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 114.731 -1.122 . . . . 75.019999999999996 111.058 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -161.12 154.98 22.31 Favored 'General case' 0 C--O 1.245 0.837 0 CA-C-N 116.511 -0.313 . . . . 65.420000000000002 110.75 -178.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.414 HG11 ' HB2' ' A' ' 237' ' ' MET . 8.3 p -126.45 121.41 58.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 C-N-CA 123.786 0.834 . . . . 61.439999999999998 109.006 178.089 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . 0.473 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 18.7 t-20 65.09 15.52 10.04 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.322 1.049 . . . . 73.230000000000004 110.456 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 99.35 -8.12 60.32 Favored Glycine 0 N--CA 1.437 -1.261 0 C-N-CA 120.347 -0.93 . . . . 42.329999999999998 111.523 -177.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 64.0 mt -91.08 123.06 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.162 0 N-CA-C 108.787 -0.819 . . . . 73.120000000000005 108.787 179.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . 0.443 ' HG3' ' HE3' ' A' ' 229' ' ' LYS . 11.6 pt-20 -55.45 131.19 45.34 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 124.24 0.962 . . . . 62.310000000000002 111.063 179.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 35.8 m -109.88 10.13 8.85 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 CA-C-O 121.876 0.846 . . . . 73.319999999999993 109.288 174.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -73.26 98.08 2.58 Favored 'General case' 0 N--CA 1.424 -1.737 0 CA-C-N 114.422 -1.263 . . . . 64.349999999999994 110.799 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . 0.437 ' HA2' ' HD2' ' A' ' 193' ' ' PRO . . . 101.23 5.29 52.86 Favored Glycine 0 N--CA 1.44 -1.092 0 C-N-CA 120.894 -0.67 . . . . 34.439999999999998 112.46 176.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.443 ' HE3' ' HG3' ' A' ' 225' ' ' GLU . 68.3 mmtt -90.31 156.66 18.11 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 107.524 -1.287 . . . . 74.430000000000007 107.524 -178.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . 0.633 ' OG1' ' HG2' ' A' ' 233' ' ' GLN . 81.5 p -79.97 166.52 21.51 Favored 'General case' 0 C--O 1.248 0.998 0 C-N-CA 118.905 -1.118 . . . . 72.209999999999994 110.067 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.436 ' HA ' HG22 ' A' ' 234' ' ' VAL . 3.3 tm? -61.02 -39.76 90.99 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 108.946 -0.761 . . . . 75.049999999999997 108.946 179.065 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -63.86 -31.01 72.05 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.078 -0.51 . . . . 73.109999999999999 110.626 177.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' GLN . . . . . 0.633 ' HG2' ' OG1' ' A' ' 230' ' ' THR . 13.3 mm-40 -74.14 -51.37 15.82 Favored 'General case' 0 C--O 1.216 -0.683 0 C-N-CA 119.478 -0.889 . . . . 65.209999999999994 110.211 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.566 HG21 HG12 ' A' ' 195' ' ' ILE . 21.2 m -65.99 -34.22 68.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 113.041 0.756 . . . . 71.319999999999993 113.041 -173.279 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 42.6 m -74.42 -35.49 63.4 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 109.056 -0.72 . . . . 74.319999999999993 109.056 -173.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -63.15 -34.25 77.21 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-N 115.376 -0.829 . . . . 73.5 108.835 177.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' MET . . . . . 0.493 ' HG3' ' O ' ' A' ' 233' ' ' GLN . 10.3 mtm -72.88 -42.01 64.1 Favored 'General case' 0 C--O 1.201 -1.478 0 CA-C-N 115.117 -0.947 . . . . 74.019999999999996 108.546 -179.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' MET . . . . . 0.483 ' HG3' ' O ' ' A' ' 234' ' ' VAL . 65.4 mtt -61.6 -40.16 93.8 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.486 -0.325 . . . . 74.519999999999996 111.568 178.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 96.0 t -68.76 -43.12 83.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.198 0.523 . . . . 75.120000000000005 111.004 178.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -68.68 -34.31 75.46 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.424 0.631 . . . . 62.32 110.555 179.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -88.81 15.44 8.35 Favored 'General case' 0 C--O 1.19 -2.053 0 CA-C-N 115.425 -0.807 . . . . 71.409999999999997 111.923 178.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . 0.4 ' O ' HD13 ' A' ' 164' ' ' LEU . 69.9 m -66.74 -23.26 66.07 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 114.363 1.246 . . . . 51.130000000000003 114.363 -178.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 20.5 m -63.94 -29.63 70.79 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 118.131 0.423 . . . . 74.439999999999998 110.735 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 244' ' ' ASN . . . . . 0.42 ' HA ' ' O ' ' A' ' 164' ' ' LEU . 42.6 m-80 -156.0 89.68 1.16 Allowed 'General case' 0 C--O 1.248 1.015 0 N-CA-C 106.381 -1.711 . . . . 71.209999999999994 106.381 173.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.478 ' HB3' ' HB2' ' A' ' 163' ' ' LEU . 1.6 tt -85.28 103.55 14.33 Favored 'General case' 0 C--O 1.205 -1.274 0 CA-C-O 121.269 0.557 . . . . 74.209999999999994 109.846 -172.063 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.473 ' HB ' ' HA ' ' A' ' 222' ' ' ASN . 75.5 mt -96.48 116.19 37.83 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.348 0 N-CA-C 109.373 -0.603 . . . . 73.030000000000001 109.373 179.053 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . 0.51 HG23 HG23 ' A' ' 218' ' ' VAL . 9.8 mt -125.84 137.81 56.53 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 CA-C-O 121.551 0.691 . . . . 71.140000000000001 112.446 177.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.471 ' HA ' ' O ' ' A' ' 159' ' ' ARG . 49.9 m -107.43 121.87 45.47 Favored 'General case' 0 N--CA 1.423 -1.815 0 CA-C-N 114.717 -1.129 . . . . 73.109999999999999 107.985 174.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.503 HG12 ' HA ' ' A' ' 218' ' ' VAL . 15.4 m -125.74 166.44 21.73 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 CA-C-O 121.126 0.489 . . . . 71.310000000000002 110.552 176.627 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 16.8 ptmt -138.64 134.01 17.07 Favored Pre-proline 0 C--N 1.285 -2.209 0 CA-C-N 114.471 -1.24 . . . . 74.439999999999998 107.763 174.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . 0.411 ' HA ' ' HA ' ' A' ' 216' ' ' ASP . 23.8 Cg_exo -65.12 134.02 37.82 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 121.619 1.546 . . . . 74.209999999999994 111.166 178.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -63.41 -30.29 71.45 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.294 0.568 . . . . 72.230000000000004 111.326 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -93.52 -10.66 34.1 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.259 -0.882 . . . . 54.32 110.08 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 70.08 131.97 0.03 OUTLIER 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.634 1.174 . . . . 72.040000000000006 110.767 -172.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.419 -2.019 0 N-CA-C 106.025 -1.842 . . . . 71.219999999999999 106.025 -177.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 . . . . . 0 CA--C 1.512 -0.507 0 N-CA-C 110.136 -0.32 . . . . 73.540000000000006 110.136 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.428 HG22 ' H ' ' A' ' 255' ' ' ARG . 70.7 p -74.1 -32.61 63.29 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 122.305 1.05 . . . . 75.400000000000006 108.196 178.255 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -82.23 130.26 35.05 Favored 'General case' 0 N--CA 1.428 -1.538 0 CA-C-N 113.864 -1.516 . . . . 62.100000000000001 109.738 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.447 ' CZ ' HG22 ' A' ' 161' ' ' VAL . 0.0 OUTLIER -127.63 142.0 51.47 Favored 'General case' 0 C--N 1.283 -2.288 0 N-CA-C 104.971 -2.233 . . . . 72.030000000000001 104.971 173.726 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -132.42 110.82 10.8 Favored 'General case' 0 C--N 1.285 -2.223 0 C-N-CA 117.718 -1.593 . . . . 75.209999999999994 111.065 -179.356 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.548 HG11 HD12 ' A' ' 211' ' ' LEU . 30.3 m -113.56 140.31 34.51 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 CA-C-N 114.724 -1.125 . . . . 43.240000000000002 111.787 175.251 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 26.0 ttm180 -84.86 114.65 22.26 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 115.617 -0.72 . . . . 75.540000000000006 109.121 178.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.544 ' HB2' ' HB2' ' A' ' 245' ' ' LEU . 13.8 mt -87.47 127.27 35.23 Favored 'General case' 0 N--CA 1.421 -1.916 0 N-CA-C 107.078 -1.453 . . . . 73.310000000000002 107.078 -179.408 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.58 HD13 ' O ' ' A' ' 242' ' ' SER . 5.5 tt 73.66 90.68 0.09 Allowed 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 122.378 1.085 . . . . 75.409999999999997 110.416 178.3 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 60.3 pttt -116.79 0.12 12.45 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 107.481 -1.303 . . . . 74.319999999999993 107.481 172.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 45.4 m80 -150.64 146.13 26.3 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 114.141 -1.39 . . . . 74.0 107.781 177.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 81.59 43.41 8.46 Favored Glycine 0 C--N 1.315 -0.628 0 C-N-CA 120.873 -0.68 . . . . 65.329999999999998 113.231 177.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 35.2 t -76.73 87.26 3.36 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.363 -0.606 . . . . 65.040000000000006 109.363 179.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 19.5 t70 179.27 -41.75 0.01 OUTLIER 'General case' 0 CA--C 1.506 -0.741 0 CA-C-N 114.773 -1.103 . . . . 70.120000000000005 108.849 -176.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.59 154.4 37.95 Favored Pre-proline 0 N--CA 1.426 -1.638 0 CA-C-N 115.33 -0.85 . . . . 74.409999999999997 111.198 -176.559 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -49.29 153.07 4.92 Favored 'Trans proline' 0 C--O 1.25 1.095 0 C-N-CA 124.498 3.465 . . . . 74.319999999999993 115.177 -176.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -73.44 -39.68 64.81 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-N 114.791 -1.095 . . . . 72.439999999999998 110.166 177.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . 0.505 ' HA3' ' HA3' ' A' ' 204' ' ' GLY . . . 90.24 51.44 2.76 Favored Glycine 0 N--CA 1.434 -1.45 0 CA-C-N 115.679 -0.691 . . . . 51.340000000000003 114.806 174.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -162.58 154.61 18.62 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 108.521 -0.918 . . . . 64.099999999999994 108.521 175.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -121.2 140.83 51.5 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 108.244 -1.021 . . . . 75.010000000000005 108.244 176.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.513 HD13 ' SD ' ' A' ' 238' ' ' MET . 28.6 pt -112.32 165.25 7.4 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.845 0 CA-C-O 121.04 0.448 . . . . 71.549999999999997 111.339 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.511 ' CG ' ' HB2' ' A' ' 198' ' ' SER . 27.3 ptt180 -149.69 154.98 39.43 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 115.566 -0.743 . . . . 73.5 110.703 -175.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . 0.47 ' HB2' ' HB2' ' A' ' 231' ' ' LEU . 9.2 t70 -100.95 138.54 37.86 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 115.706 -0.679 . . . . 64.010000000000005 109.946 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -149.11 135.41 5.37 Favored Glycine 0 C--N 1.277 -2.743 0 N-CA-C 107.622 -2.191 . . . . 50.229999999999997 107.622 175.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . 0.485 HG22 ' HG2' ' A' ' 191' ' ' LYS . 0.4 OUTLIER -86.53 122.63 30.73 Favored 'General case' 0 C--N 1.282 -2.361 0 C-N-CA 118.54 -1.264 . . . . 63.409999999999997 107.799 -175.962 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 10.9 t -95.93 121.29 37.52 Favored 'General case' 0 C--N 1.287 -2.146 0 C-N-CA 123.821 0.848 . . . . 63.109999999999999 109.01 -174.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.568 ' HA ' ' HA ' ' A' ' 191' ' ' LYS . 7.4 p -103.97 123.67 57.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-O 121.669 0.747 . . . . 65.099999999999994 110.269 178.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 42.1 mtt-85 -122.94 159.92 27.28 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 114.957 -1.02 . . . . 75.510000000000005 108.687 -174.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.474 ' HA ' ' O ' ' A' ' 188' ' ' GLY . 83.5 t -87.79 119.03 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.604 0 N-CA-C 108.54 -0.911 . . . . 72.409999999999997 108.54 174.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 46.4 p -114.42 -175.1 2.61 Favored 'General case' 0 C--N 1.265 -3.108 0 CA-C-N 114.125 -1.398 . . . . 62.020000000000003 108.703 -176.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -68.21 -13.5 62.29 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.054 0.454 . . . . 61.210000000000001 111.41 178.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 31.3 m -103.62 -12.84 16.79 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-O 120.784 0.326 . . . . 63.219999999999999 111.743 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.474 ' O ' ' HA ' ' A' ' 184' ' ' VAL . . . 131.13 -125.4 4.46 Favored Glycine 0 CA--C 1.48 -2.116 0 N-CA-C 110.028 -1.229 . . . . 73.430000000000007 110.028 178.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 6.8 mp -102.37 125.5 49.1 Favored 'General case' 0 C--N 1.286 -2.176 0 CA-C-N 117.395 0.597 . . . . 63.100000000000001 110.133 178.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . 0.473 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 38.3 mt-10 -130.75 119.99 23.13 Favored 'General case' 0 CA--C 1.466 -2.285 0 CA-C-O 121.419 0.628 . . . . 73.5 111.126 -179.416 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.568 ' HA ' ' HA ' ' A' ' 182' ' ' VAL . 32.5 ttmt -92.93 135.59 34.01 Favored 'General case' 0 C--N 1.278 -2.54 0 CA-C-N 114.144 -1.389 . . . . 65.230000000000004 107.795 -179.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.47 145.49 19.3 Favored Pre-proline 0 C--N 1.313 -1.005 0 CA-C-N 116.125 -0.489 . . . . 74.230000000000004 109.78 -171.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -56.82 130.84 42.02 Favored 'Trans proline' 0 C--O 1.242 0.708 0 C-N-CA 121.879 1.719 . . . . 43.340000000000003 113.784 -176.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -137.85 137.38 8.82 Favored Glycine 0 N--CA 1.414 -2.812 0 N-CA-C 109.03 -1.628 . . . . 73.010000000000005 109.03 177.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.634 HG12 HG21 ' A' ' 234' ' ' VAL . 3.1 mp -104.1 136.59 36.6 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.894 0 CA-C-O 121.355 0.598 . . . . 63.140000000000001 110.01 -179.211 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -126.76 165.94 18.34 Favored 'General case' 0 C--N 1.284 -2.25 0 N-CA-C 108.017 -1.105 . . . . 74.540000000000006 108.017 -177.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . 0.44 ' HB ' ' O ' ' A' ' 213' ' ' ALA . 49.1 mm -78.67 131.52 34.26 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 N-CA-C 108.464 -0.939 . . . . 70.420000000000002 108.464 174.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . 0.511 ' HB2' ' CG ' ' A' ' 177' ' ' ARG . 11.2 t -101.92 -28.71 12.24 Favored 'General case' 0 C--N 1.284 -2.246 0 O-C-N 121.889 -0.507 . . . . 61.549999999999997 112.017 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 60.7 ttt180 -167.84 147.43 4.9 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 116.697 -0.229 . . . . 73.540000000000006 110.773 -176.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 85.7 mt -103.65 146.28 28.81 Favored 'General case' 0 CA--C 1.496 -1.134 0 N-CA-C 108.727 -0.842 . . . . 74.540000000000006 108.727 171.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 46.2 t -105.58 115.48 61.68 Favored Pre-proline 0 C--N 1.288 -2.07 0 N-CA-C 105.932 -1.877 . . . . 74.109999999999999 105.932 171.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.466 ' HA ' ' HG3' ' A' ' 207' ' ' GLU . 16.7 Cg_endo -58.56 132.4 48.11 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 122.042 1.828 . . . . 70.040000000000006 111.218 -177.239 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 102.1 -18.98 50.7 Favored Glycine 0 N--CA 1.438 -1.196 0 N-CA-C 110.713 -0.955 . . . . 63.43 110.713 -175.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . 0.505 ' HA3' ' HA3' ' A' ' 173' ' ' GLY . . . -78.5 164.79 51.07 Favored Glycine 0 N--CA 1.434 -1.484 0 N-CA-C 111.018 -0.833 . . . . 45.009999999999998 111.018 178.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.4 HD22 ' H ' ' A' ' 205' ' ' LEU . 2.9 mm? -61.24 -35.67 77.89 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 123.284 0.634 . . . . 75.510000000000005 111.434 -175.485 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . 0.42 ' CB ' HD12 ' A' ' 212' ' ' LEU . . . -60.7 -47.41 86.41 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.629 -0.714 . . . . 65.120000000000005 110.732 179.647 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.466 ' HG3' ' HA ' ' A' ' 202' ' ' PRO . 3.2 tm-20 -75.46 -34.55 60.94 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.209 -0.905 . . . . 71.120000000000005 110.156 -179.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 48.7 m -56.96 -42.67 80.54 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 122.919 0.488 . . . . 72.200000000000003 111.837 179.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . 0.588 HG23 ' H ' ' A' ' 211' ' ' LEU . 14.9 t -87.1 -24.41 24.56 Favored 'General case' 0 N--CA 1.439 -1.0 0 C-N-CA 119.483 -0.887 . . . . 72.349999999999994 110.805 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 70.05 15.1 71.65 Favored Glycine 0 C--N 1.339 0.74 0 CA-C-O 121.498 0.499 . . . . 54.140000000000001 112.555 178.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.588 ' H ' HG23 ' A' ' 209' ' ' THR . 64.5 mt -102.03 13.14 35.57 Favored 'General case' 0 CA--C 1.495 -1.152 0 CA-C-O 121.592 0.71 . . . . 75.439999999999998 110.395 -177.299 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.42 HD12 ' CB ' ' A' ' 206' ' ' ALA . 30.2 mt -122.02 130.57 53.41 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 114.465 -1.243 . . . . 55.039999999999999 110.429 171.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . 0.44 ' O ' ' HB ' ' A' ' 197' ' ' ILE . . . -132.51 160.35 36.75 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 124.447 1.099 . . . . 51.149999999999999 108.344 176.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 17.5 m -61.38 -29.74 46.58 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 CA-C-O 121.653 0.74 . . . . 73.450000000000003 112.226 -179.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -75.53 -14.32 60.4 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 113.069 0.766 . . . . 70.340000000000003 113.069 -179.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.402 ' HB3' ' HB ' ' A' ' 249' ' ' VAL . 63.3 m-20 -71.08 131.65 43.93 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 112.334 0.494 . . . . 71.510000000000005 112.334 -177.507 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -101.94 129.18 48.15 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.108 -0.951 . . . . 71.409999999999997 108.672 178.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.591 ' HA ' HG12 ' A' ' 249' ' ' VAL . 10.2 p -79.44 137.2 22.16 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-O 121.597 0.713 . . . . 75.439999999999998 111.523 -176.029 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.419 HD11 ' HD2' ' A' ' 250' ' ' LYS . 45.6 mm -104.78 -48.34 9.54 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 CA-C-N 115.178 -0.919 . . . . 75.439999999999998 111.16 -178.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.403 ' HA ' HG22 ' A' ' 226' ' ' VAL . 10.1 pt-20 -153.23 151.99 30.69 Favored 'General case' 0 C--O 1.245 0.827 0 CA-C-N 116.675 -0.239 . . . . 64.310000000000002 111.355 -178.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.516 HG12 ' CG1' ' A' ' 226' ' ' VAL . 14.2 p -124.09 129.64 74.09 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 N-CA-C 107.814 -1.18 . . . . 61.100000000000001 107.814 173.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . 0.548 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 23.1 t-20 75.01 -36.35 0.31 Allowed 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 126.462 1.905 . . . . 64.010000000000005 111.711 -176.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . 0.439 ' H ' ' C ' ' A' ' 221' ' ' VAL . . . 149.26 -6.08 0.79 Allowed Glycine 0 C--N 1.277 -2.717 0 N-CA-C 109.904 -1.278 . . . . 71.299999999999997 109.904 -174.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 71.9 mt -94.81 129.32 45.15 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.312 0 N-CA-C 108.223 -1.028 . . . . 72.510000000000005 108.223 179.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -62.02 138.17 58.34 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-O 121.531 0.682 . . . . 71.129999999999995 110.585 -179.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . 0.549 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 31.6 m -118.91 -2.62 9.52 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.22 0 CA-C-N 115.604 -0.726 . . . . 75.209999999999994 109.659 176.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -82.8 93.69 7.5 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 108.435 -0.95 . . . . 72.200000000000003 108.435 179.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 130.46 -17.59 5.29 Favored Glycine 0 N--CA 1.428 -1.853 0 N-CA-C 110.275 -1.13 . . . . 60.030000000000001 110.275 -176.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -85.43 167.81 15.17 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 107.423 -1.325 . . . . 74.409999999999997 107.423 174.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . 0.461 ' O ' HG13 ' A' ' 234' ' ' VAL . 40.6 p -94.74 171.72 8.61 Favored 'General case' 0 C--N 1.295 -1.765 0 C-N-CA 119.942 -0.703 . . . . 73.230000000000004 109.183 178.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.47 ' HB2' ' HB2' ' A' ' 178' ' ' ASP . 49.9 tp -60.04 -39.25 85.28 Favored 'General case' 0 N--CA 1.432 -1.375 0 CA-C-O 120.677 0.275 . . . . 75.049999999999997 111.208 -176.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -58.54 -48.31 81.32 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 121.427 0.632 . . . . 62.219999999999999 109.999 177.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -61.96 -45.13 95.01 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.786 -1.097 . . . . 75.329999999999998 112.492 -179.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.634 HG21 HG12 ' A' ' 195' ' ' ILE . 6.7 m -73.96 -33.42 36.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-O 121.027 0.441 . . . . 64.420000000000002 112.013 -175.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . 0.444 ' O ' HG23 ' A' ' 239' ' ' VAL . 48.3 m -74.03 -36.7 64.45 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 108.713 -0.847 . . . . 71.329999999999998 108.713 -174.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -59.25 -34.64 72.47 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 115.326 -0.852 . . . . 71.450000000000003 109.131 177.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' MET . . . . . 0.506 ' HB2' HG11 ' A' ' 221' ' ' VAL . 5.7 mtt -73.34 -44.44 58.8 Favored 'General case' 0 C--O 1.2 -1.551 0 N-CA-C 108.954 -0.758 . . . . 61.32 108.954 -179.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' MET . . . . . 0.513 ' SD ' HD13 ' A' ' 176' ' ' ILE . 65.7 mtt -59.95 -40.12 87.93 Favored 'General case' 0 C--O 1.214 -0.808 0 CA-C-O 120.543 0.211 . . . . 63.450000000000003 111.234 -178.257 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 235' ' ' THR . 93.9 t -65.75 -37.85 80.88 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 N-CA-C 109.736 -0.468 . . . . 54.420000000000002 109.736 177.313 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -76.74 -17.21 59.21 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.192 -0.458 . . . . 61.240000000000002 112.083 179.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -110.91 21.64 16.23 Favored 'General case' 0 C--O 1.205 -1.278 0 CA-C-N 116.45 -0.341 . . . . 71.239999999999995 110.463 176.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . 0.58 ' O ' HD13 ' A' ' 164' ' ' LEU . 36.1 p -64.39 -22.78 67.07 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 112.966 0.728 . . . . 74.129999999999995 112.966 -178.219 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 18.1 m -79.22 -9.3 59.53 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 120.793 -0.363 . . . . 55.020000000000003 110.782 179.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -178.65 97.36 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.747 1.219 . . . . 72.040000000000006 110.894 175.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.544 ' HB2' ' HB2' ' A' ' 163' ' ' LEU . 14.1 mt -87.92 111.83 21.88 Favored 'General case' 0 C--O 1.192 -1.932 0 N-CA-C 113.375 0.88 . . . . 75.439999999999998 113.375 -177.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.548 ' HB ' ' HA ' ' A' ' 222' ' ' ASN . 66.1 mt -95.93 115.93 36.39 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.542 0 N-CA-C 106.173 -1.788 . . . . 71.420000000000002 106.173 170.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . 0.404 HG23 HG23 ' A' ' 218' ' ' VAL . 67.5 mt -130.63 128.01 62.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 C-N-CA 119.649 -0.82 . . . . 64.140000000000001 112.547 -177.08 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 86.2 m -103.12 128.7 49.95 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 115.048 -0.978 . . . . 40.240000000000002 108.751 175.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.591 HG12 ' HA ' ' A' ' 218' ' ' VAL . 27.3 m -132.66 167.46 26.54 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 108.207 -1.034 . . . . 74.329999999999998 108.207 173.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.419 ' HD2' HD11 ' A' ' 219' ' ' ILE . 0.0 OUTLIER -138.82 136.54 18.64 Favored Pre-proline 0 C--N 1.284 -2.267 0 CA-C-N 115.31 -0.859 . . . . 72.450000000000003 110.964 172.675 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -63.02 150.06 89.75 Favored 'Trans proline' 0 C--O 1.246 0.885 0 C-N-CA 123.535 2.823 . . . . 60.350000000000001 113.554 -177.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -59.96 -40.74 90.06 Favored 'General case' 0 CA--C 1.498 -1.055 0 CA-C-O 121.779 0.799 . . . . 61.420000000000002 108.966 175.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -85.82 78.81 9.45 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 107.22 -1.4 . . . . 74.310000000000002 107.22 173.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -84.29 179.26 7.5 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 115.26 -0.882 . . . . 74.25 111.762 -176.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . 0.428 ' H ' HG22 ' A' ' 157' ' ' THR . 1.1 tmt_? . . . . . 0 C--O 1.253 1.259 0 C-N-CA 125.713 1.605 . . . . 74.25 108.336 -178.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 . . . . . 0 N--CA 1.454 -0.266 0 CA-C-O 120.822 0.344 . . . . 72.319999999999993 110.814 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 7.2 p -153.64 -50.7 0.1 Allowed 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 124.694 1.198 . . . . 75.200000000000003 109.581 176.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.48 ' NE2' HG13 ' A' ' 219' ' ' ILE . 49.9 m170 -105.18 137.22 43.3 Favored 'General case' 0 CA--C 1.486 -1.5 0 CA-C-O 121.164 0.507 . . . . 73.340000000000003 112.08 175.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.637 ' O ' ' HA ' ' A' ' 248' ' ' THR . 6.6 ptp180 -125.8 142.08 51.69 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 107.598 -1.26 . . . . 71.25 107.598 177.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.417 ' HA ' ' O ' ' A' ' 247' ' ' ILE . 13.6 ptp180 -132.15 113.06 12.85 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 121.814 0.816 . . . . 75.439999999999998 111.277 177.121 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.671 ' O ' ' HA ' ' A' ' 246' ' ' ILE . 30.0 m -105.68 139.89 25.43 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 CA-C-N 114.554 -1.203 . . . . 62.140000000000001 112.402 -177.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.68 ' HG3' HG12 ' A' ' 246' ' ' ILE . 5.4 mpt_? -99.98 114.7 28.16 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 107.532 -1.284 . . . . 65.510000000000005 107.532 175.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.579 ' HB2' ' HB3' ' A' ' 245' ' ' LEU . 23.8 mt -114.41 139.91 49.11 Favored 'General case' 0 C--N 1.31 -1.137 0 C-N-CA 123.142 0.577 . . . . 73.040000000000006 111.368 -174.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.635 HD12 ' O ' ' A' ' 242' ' ' SER . 0.9 OUTLIER 76.04 20.3 1.71 Allowed 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.877 0.871 . . . . 70.129999999999995 112.083 167.935 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.434 ' HA ' ' O ' ' A' ' 243' ' ' SER . 10.2 mtmp? -71.65 7.44 1.47 Allowed 'General case' 0 C--N 1.312 -1.025 0 O-C-N 121.03 -1.044 . . . . 74.010000000000005 113.775 -178.452 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 49.7 m80 -91.44 -6.59 52.51 Favored 'General case' 0 C--N 1.31 -1.119 0 O-C-N 121.963 -0.461 . . . . 74.329999999999998 111.091 177.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 80.93 87.55 0.61 Allowed Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.745 -0.74 . . . . 72.150000000000006 112.552 179.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 35.5 t -145.68 176.21 9.8 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.625 -0.879 . . . . 54.32 108.625 -179.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -123.87 -0.07 8.54 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.796 0.808 . . . . 62.009999999999998 109.456 -178.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -73.25 150.32 89.64 Favored Pre-proline 0 N--CA 1.437 -1.109 0 CA-C-N 115.603 -0.726 . . . . 72.219999999999999 111.83 -177.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_exo -53.26 144.1 50.08 Favored 'Trans proline' 0 C--O 1.243 0.755 0 C-N-CA 122.669 2.246 . . . . 72.319999999999993 110.469 173.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.51 ' HG ' ' CD1' ' A' ' 245' ' ' LEU . 2.8 mm? -70.08 -24.31 63.2 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 116.014 -0.539 . . . . 65.299999999999997 112.102 -175.205 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . 0.502 ' HA3' ' HA3' ' A' ' 204' ' ' GLY . . . 93.74 14.91 51.55 Favored Glycine 0 N--CA 1.424 -2.133 0 C-N-CA 120.346 -0.93 . . . . 50.100000000000001 112.292 177.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -139.45 152.54 47.11 Favored 'General case' 0 N--CA 1.426 -1.653 0 N-CA-C 106.056 -1.831 . . . . 74.420000000000002 106.056 173.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -127.76 149.31 50.3 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-O 120.858 0.361 . . . . 71.519999999999996 110.953 -178.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.413 HD13 ' SD ' ' A' ' 238' ' ' MET . 37.8 pt -110.49 169.02 3.95 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 CA-C-N 115.552 -0.749 . . . . 73.150000000000006 110.374 -179.021 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.578 ' CG ' ' HB2' ' A' ' 198' ' ' SER . 15.7 ptt180 -151.52 154.88 37.39 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 124.166 0.986 . . . . 63.409999999999997 109.351 -178.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -108.85 138.0 45.88 Favored 'General case' 0 C--N 1.293 -1.886 0 O-C-N 123.464 0.477 . . . . 74.209999999999994 109.86 -179.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -150.46 157.08 27.04 Favored Glycine 0 C--N 1.27 -3.088 0 N-CA-C 107.507 -2.237 . . . . 61.530000000000001 107.507 176.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . 0.6 ' CG2' ' HG2' ' A' ' 191' ' ' LYS . 0.2 OUTLIER -86.65 121.58 29.37 Favored 'General case' 0 C--N 1.284 -2.252 0 C-N-CA 117.317 -1.753 . . . . 73.549999999999997 106.655 179.431 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . 0.5 ' O ' ' HA ' ' A' ' 191' ' ' LYS . 31.2 t -90.63 118.33 29.99 Favored 'General case' 0 N--CA 1.414 -2.272 0 N-CA-C 108.758 -0.83 . . . . 54.420000000000002 108.758 -176.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.693 ' HA ' ' O ' ' A' ' 190' ' ' GLU . 7.4 p -125.39 119.76 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 N-CA-C 109.316 -0.624 . . . . 73.400000000000006 109.316 174.554 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 78.0 mtt-85 -139.84 161.36 37.75 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 106.692 -1.595 . . . . 72.310000000000002 106.692 -178.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 99.2 t -76.91 117.91 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.168 0 N-CA-C 107.77 -1.196 . . . . 61.350000000000001 107.77 174.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 66.6 p -108.41 -174.17 2.45 Favored 'General case' 0 C--N 1.271 -2.818 0 N-CA-C 107.63 -1.248 . . . . 55.299999999999997 107.63 -179.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -60.72 -20.67 61.71 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 120.606 0.241 . . . . 75.230000000000004 110.685 174.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 31.4 t -98.82 -16.83 18.73 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 121.227 -0.189 . . . . 73.540000000000006 111.482 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 125.58 -145.84 15.9 Favored Glycine 0 C--O 1.201 -1.93 0 N-CA-C 110.135 -1.186 . . . . 75.420000000000002 110.135 -179.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 5.4 mp -83.2 119.36 24.45 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 118.145 0.972 . . . . 43.100000000000001 109.522 178.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . 0.693 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 52.7 mt-10 -130.51 122.9 28.47 Favored 'General case' 0 CA--C 1.461 -2.453 0 CA-C-O 121.001 0.429 . . . . 73.109999999999999 110.507 -178.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.6 ' HG2' ' CG2' ' A' ' 180' ' ' THR . 37.2 ttmt -108.43 126.23 52.65 Favored 'General case' 0 C--N 1.277 -2.55 0 CA-C-N 114.259 -1.337 . . . . 61.25 109.207 -176.458 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -151.91 163.48 23.45 Favored Pre-proline 0 C--N 1.301 -1.538 0 N-CA-C 107.859 -1.163 . . . . 72.239999999999995 107.859 -176.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -58.96 132.23 46.26 Favored 'Trans proline' 0 C--O 1.255 1.332 0 C-N-CA 121.032 1.154 . . . . 72.120000000000005 110.689 176.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -141.99 135.56 6.78 Favored Glycine 0 N--CA 1.411 -2.968 0 N-CA-C 110.017 -1.233 . . . . 61.32 110.017 -178.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.649 HG12 HG21 ' A' ' 234' ' ' VAL . 3.2 mp -104.14 132.74 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.789 0 CA-C-O 121.457 0.646 . . . . 55.329999999999998 110.862 -178.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -124.76 167.75 14.15 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 107.543 -1.281 . . . . 63.420000000000002 107.543 -177.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 45.6 mt -85.69 131.96 33.1 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 N-CA-C 108.876 -0.787 . . . . 71.400000000000006 108.876 175.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . 0.578 ' HB2' ' CG ' ' A' ' 177' ' ' ARG . 28.2 t -102.49 -30.71 10.83 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 113.727 1.01 . . . . 53.200000000000003 113.727 -177.101 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 13.4 ttp180 -165.16 144.47 6.7 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 120.013 -0.675 . . . . 70.239999999999995 112.185 -176.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 69.0 mt -106.51 141.01 38.5 Favored 'General case' 0 CA--C 1.494 -1.183 0 CA-C-N 115.169 -0.923 . . . . 72.400000000000006 109.575 173.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 47.5 t -109.71 114.81 56.41 Favored Pre-proline 0 C--N 1.285 -2.232 0 N-CA-C 105.748 -1.945 . . . . 64.329999999999998 105.748 171.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.495 ' HA ' ' OE1' ' A' ' 207' ' ' GLU . 73.6 Cg_exo -53.31 126.15 20.72 Favored 'Trans proline' 0 C--O 1.244 0.804 0 C-N-CA 122.342 2.028 . . . . 53.049999999999997 110.838 179.409 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 110.69 -16.12 28.83 Favored Glycine 0 C--N 1.312 -0.767 0 C-N-CA 120.95 -0.643 . . . . 63.310000000000002 111.514 -175.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . 0.502 ' HA3' ' HA3' ' A' ' 173' ' ' GLY . . . -77.08 158.2 47.75 Favored Glycine 0 N--CA 1.441 -0.972 0 C-N-CA 121.147 -0.549 . . . . 71.310000000000002 111.924 178.503 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -53.84 -48.57 69.81 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 124.201 1.0 . . . . 55.43 112.263 -176.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -68.99 -32.24 71.65 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.776 -0.647 . . . . 74.329999999999998 111.33 -178.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.495 ' OE1' ' HA ' ' A' ' 202' ' ' PRO . 2.5 tm-20 -75.89 -44.41 40.6 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.658 -0.701 . . . . 65.230000000000004 109.282 -177.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 50.7 m -57.87 -33.38 68.63 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.338 0.496 . . . . 73.420000000000002 112.338 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . 0.463 HG23 ' H ' ' A' ' 211' ' ' LEU . 11.3 t -83.16 -17.44 42.9 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 119.945 -0.702 . . . . 71.409999999999997 110.989 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 64.65 17.08 62.03 Favored Glycine 0 C--N 1.334 0.436 0 CA-C-N 116.439 -0.346 . . . . 74.409999999999997 113.621 178.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.463 ' H ' HG23 ' A' ' 209' ' ' THR . 76.3 mt -95.69 -22.34 17.62 Favored 'General case' 0 C--O 1.199 -1.59 0 C-N-CA 120.224 -0.59 . . . . 71.409999999999997 110.776 -177.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.513 HD11 HG21 ' A' ' 161' ' ' VAL . 6.9 mp -107.22 134.1 50.81 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-O 121.366 0.603 . . . . 54.399999999999999 111.102 -178.308 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -131.27 165.39 23.5 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-N 114.23 -1.35 . . . . 75.109999999999999 109.88 -179.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 33.3 m -65.09 -29.39 47.2 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 N-CA-C 113.66 0.985 . . . . 65.239999999999995 113.66 -179.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -74.85 -14.14 60.64 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.7 -0.625 . . . . 74.420000000000002 111.252 -178.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.502 ' HB3' ' HB ' ' A' ' 249' ' ' VAL . 79.8 m-20 -66.69 142.97 57.24 Favored 'General case' 0 C--O 1.247 0.971 0 N-CA-C 112.984 0.735 . . . . 52.509999999999998 112.984 -176.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . 0.419 ' HB3' ' HG3' ' A' ' 250' ' ' LYS . 41.1 tt0 -109.21 133.13 53.42 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.635 -1.166 . . . . 74.340000000000003 108.802 177.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.644 ' HA ' HG12 ' A' ' 249' ' ' VAL . 20.7 t -84.36 130.68 35.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.496 0.665 . . . . 73.030000000000001 111.289 -174.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.48 HG13 ' NE2' ' A' ' 158' ' ' HIS . 44.0 mm -99.44 -56.86 4.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-N 115.168 -0.923 . . . . 75.109999999999999 111.652 -177.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.409 ' HB3' ' HA ' ' A' ' 225' ' ' GLU . 10.9 pt-20 -155.02 151.2 28.16 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 116.108 -0.497 . . . . 70.230000000000004 110.503 -176.362 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.507 ' HA ' ' O ' ' A' ' 246' ' ' ILE . 8.6 p -120.33 122.71 68.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 CA-C-N 115.648 -0.705 . . . . 63.340000000000003 109.24 177.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . 0.438 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 2.5 m-20 58.24 24.58 11.63 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.656 1.183 . . . . 53.329999999999998 112.474 -177.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 95.69 -7.23 67.97 Favored Glycine 0 N--CA 1.435 -1.418 0 CA-C-N 115.377 -0.829 . . . . 64.129999999999995 111.853 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 62.1 mt -97.31 122.63 49.07 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.509 0 N-CA-C 108.899 -0.778 . . . . 75.420000000000002 108.899 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . 0.409 ' HA ' ' HB3' ' A' ' 220' ' ' GLU . 11.1 pt-20 -61.83 139.33 58.36 Favored 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 123.704 0.802 . . . . 72.230000000000004 112.674 -176.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . 0.465 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 34.3 m -117.11 3.21 7.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 CA-C-N 115.376 -0.829 . . . . 64.129999999999995 109.798 175.503 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -75.67 99.11 4.24 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 115.224 -0.898 . . . . 73.510000000000005 109.816 -179.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 113.26 -8.84 24.75 Favored Glycine 0 CA--C 1.5 -0.846 0 N-CA-C 110.983 -0.847 . . . . 52.32 110.983 179.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -83.14 158.27 22.45 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.781 -0.822 . . . . 70.430000000000007 108.781 178.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . 0.444 ' O ' HG13 ' A' ' 234' ' ' VAL . 82.7 p -84.02 170.7 13.66 Favored 'General case' 0 N--CA 1.412 -2.35 0 C-N-CA 119.584 -0.846 . . . . 73.120000000000005 110.397 178.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -61.85 -37.78 85.76 Favored 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 109.139 -0.689 . . . . 75.549999999999997 109.139 179.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -58.7 -52.29 66.34 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.198 0.523 . . . . 73.329999999999998 110.054 175.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 233' ' ' GLN . . . . . 0.504 ' O ' ' HG2' ' A' ' 237' ' ' MET . 39.6 mt-30 -54.78 -44.76 74.0 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.606 -1.179 . . . . 63.149999999999999 112.481 179.337 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.649 HG21 HG12 ' A' ' 195' ' ' ILE . 8.2 m -77.12 -34.47 21.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 112.438 0.533 . . . . 55.310000000000002 112.438 -176.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . 0.446 ' O ' HG23 ' A' ' 239' ' ' VAL . 31.9 m -71.25 -35.81 71.55 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 109.522 -0.548 . . . . 61.43 109.522 -179.128 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -63.38 -31.14 72.21 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 109.722 -0.473 . . . . 72.340000000000003 109.722 176.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 237' ' ' MET . . . . . 0.504 ' HG2' ' O ' ' A' ' 233' ' ' GLN . 17.2 mmt -62.54 -52.55 63.0 Favored 'General case' 0 C--O 1.195 -1.767 0 N-CA-C 107.9 -1.148 . . . . 73.25 107.9 174.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 238' ' ' MET . . . . . 0.419 ' HG3' ' O ' ' A' ' 234' ' ' VAL . 59.5 mtt -63.93 -33.02 74.77 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.159 -0.928 . . . . 52.420000000000002 112.843 -173.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 235' ' ' THR . 85.7 t -68.96 -44.12 81.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 N-CA-C 109.175 -0.676 . . . . 74.420000000000002 109.175 175.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -66.91 -36.3 81.95 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.85 -0.614 . . . . 74.519999999999996 110.594 178.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -87.29 22.13 2.22 Favored 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 124.364 1.066 . . . . 75.420000000000002 111.612 179.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . 0.635 ' O ' HD12 ' A' ' 164' ' ' LEU . 34.3 t -58.76 -42.29 88.54 Favored 'General case' 0 C--O 1.204 -1.334 0 CA-C-N 118.112 0.415 . . . . 72.239999999999995 112.064 -179.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . 0.434 ' O ' ' HA ' ' A' ' 165' ' ' LYS . 37.5 m -74.21 -16.98 60.95 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 112.405 0.52 . . . . 50.509999999999998 112.405 -178.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -153.18 85.12 1.21 Allowed 'General case' 0 CA--C 1.5 -0.949 0 N-CA-C 108.447 -0.946 . . . . 73.439999999999998 108.447 179.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.579 ' HB3' ' HB2' ' A' ' 163' ' ' LEU . 2.0 tt -92.03 105.78 17.95 Favored 'General case' 0 N--CA 1.432 -1.343 0 C-N-CA 119.694 -0.803 . . . . 74.430000000000007 109.732 -177.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.68 HG12 ' HG3' ' A' ' 162' ' ' ARG . 93.2 mt -109.19 115.4 49.45 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 O-C-N 121.882 -0.511 . . . . 72.030000000000001 110.19 177.167 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . 0.483 HG13 ' CD2' ' A' ' 245' ' ' LEU . 27.4 mt -119.26 133.27 66.64 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 N-CA-C 112.838 0.681 . . . . 71.129999999999995 112.838 177.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.637 ' HA ' ' O ' ' A' ' 159' ' ' ARG . 63.5 m -102.92 117.0 33.64 Favored 'General case' 0 N--CA 1.417 -2.095 0 CA-C-N 114.484 -1.235 . . . . 74.420000000000002 108.087 173.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.644 HG12 ' HA ' ' A' ' 218' ' ' VAL . 18.9 m -122.54 165.57 18.35 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.064 0 CA-C-O 121.194 0.521 . . . . 72.540000000000006 110.198 175.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.434 ' HB3' ' CD2' ' A' ' 158' ' ' HIS . 15.0 ptmt -129.46 128.53 23.15 Favored Pre-proline 0 C--N 1.277 -2.576 0 C-N-CA 125.137 1.375 . . . . 63.119999999999997 107.621 176.248 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -67.86 133.03 28.1 Favored 'Trans proline' 0 N--CA 1.441 -1.613 0 N-CA-C 109.598 -0.962 . . . . 74.120000000000005 109.598 176.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -72.34 -24.28 61.27 Favored 'General case' 0 CA--C 1.499 -1.01 0 CA-C-O 121.524 0.678 . . . . 71.120000000000005 110.058 -178.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . 0.471 ' N ' HD22 ' A' ' 253' ' ' ASN . 0.7 OUTLIER -93.3 1.12 57.12 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 114.782 -1.099 . . . . 72.439999999999998 109.661 178.822 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 63.34 166.42 0.13 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.846 0.858 . . . . 73.430000000000007 111.295 -175.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 61.3 ttt180 . . . . . 0 C--N 1.299 -1.595 0 N-CA-C 108.014 -1.106 . . . . 75.219999999999999 108.014 174.9 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.89 0 N-CA-C 111.632 0.234 . . . . 70.219999999999999 111.632 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 69.6 p -78.94 -28.77 43.77 Favored 'General case' 0 C--O 1.207 -1.162 0 CA-C-O 121.94 0.876 . . . . 75.109999999999999 108.904 177.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.615 ' NE2' HG13 ' A' ' 219' ' ' ILE . 4.0 m80 -120.59 136.32 54.84 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 114.363 -1.29 . . . . 73.129999999999995 108.622 177.488 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.502 HH11 HD22 ' A' ' 211' ' ' LEU . 36.7 ttm180 -133.12 142.84 48.9 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 109.329 -0.619 . . . . 72.329999999999998 109.329 173.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.414 ' HG3' ' OG1' ' A' ' 248' ' ' THR . 0.1 OUTLIER -106.69 117.12 33.2 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 109.072 -0.714 . . . . 71.239999999999995 109.072 -179.399 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.559 HG11 HD21 ' A' ' 211' ' ' LEU . 14.2 m -123.39 138.43 53.3 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.209 0 N-CA-C 112.18 0.437 . . . . 75.439999999999998 112.18 178.366 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.732 ' HG2' HG12 ' A' ' 246' ' ' ILE . 65.4 mtt180 -92.7 111.6 23.26 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 108.87 -0.789 . . . . 62.439999999999998 108.87 171.487 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.551 ' HB2' ' HB3' ' A' ' 245' ' ' LEU . 34.9 mt -93.33 139.3 30.81 Favored 'General case' 0 C--N 1.281 -2.388 0 N-CA-C 107.29 -1.374 . . . . 53.32 107.29 179.144 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.63 ' H ' ' HG ' ' A' ' 205' ' ' LEU . 2.3 tm? 76.0 80.18 0.1 Allowed 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 107.874 -1.158 . . . . 73.510000000000005 107.874 179.439 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -107.65 -22.37 12.53 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 114.315 -1.311 . . . . 74.510000000000005 110.424 179.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 21.4 t-80 -155.15 132.58 11.12 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.551 -0.907 . . . . 74.530000000000001 108.551 -178.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . 0.464 ' HA3' ' HE2' ' A' ' 170' ' ' LYS . . . 134.57 -54.32 0.76 Allowed Glycine 0 N--CA 1.423 -2.205 0 N-CA-C 110.618 -0.993 . . . . 73.519999999999996 110.618 178.568 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 49.5 m 64.18 118.21 0.02 OUTLIER 'General case' 0 C--O 1.242 0.708 0 C-N-CA 124.402 1.081 . . . . 64.450000000000003 113.03 -179.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 73.32 8.66 5.21 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 114.612 1.338 . . . . 72.120000000000005 114.612 176.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.464 ' HE2' ' HA3' ' A' ' 167' ' ' GLY . 0.1 OUTLIER -85.21 153.51 59.53 Favored Pre-proline 0 C--N 1.307 -1.259 0 N-CA-C 109.489 -0.56 . . . . 72.010000000000005 109.489 173.935 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -50.42 133.14 36.64 Favored 'Trans proline' 0 C--O 1.244 0.786 0 C-N-CA 123.259 2.639 . . . . 71.420000000000002 111.55 177.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -69.51 -27.27 65.04 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 115.522 -0.763 . . . . 60.119999999999997 110.776 -177.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . 0.535 ' HA2' ' HB ' ' A' ' 201' ' ' VAL . . . 109.03 13.98 16.36 Favored Glycine 0 N--CA 1.421 -2.348 0 C-N-CA 119.677 -1.249 . . . . 64.019999999999996 114.213 174.281 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -162.66 153.79 17.5 Favored 'General case' 0 N--CA 1.435 -1.225 0 CA-C-N 118.155 0.978 . . . . 73.25 110.154 -177.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.482 ' CE1' HG22 ' A' ' 201' ' ' VAL . 71.0 m-85 -115.4 144.88 43.14 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 108.045 -1.095 . . . . 73.239999999999995 108.045 174.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.578 ' HB ' ' CG2' ' A' ' 195' ' ' ILE . 36.8 pt -110.47 168.96 3.98 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.393 0 CA-C-O 121.16 0.505 . . . . 70.140000000000001 110.538 179.575 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.567 ' HG2' ' HB2' ' A' ' 198' ' ' SER . 5.1 ptp180 -154.07 153.88 32.67 Favored 'General case' 0 C--N 1.288 -2.084 0 C-N-CA 123.798 0.839 . . . . 74.420000000000002 109.091 178.159 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -100.16 141.52 32.88 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 109.156 -0.683 . . . . 74.299999999999997 109.156 177.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -153.9 -159.9 9.45 Favored Glycine 0 C--N 1.284 -2.325 0 N-CA-C 109.029 -1.629 . . . . 72.409999999999997 109.029 177.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . 0.404 ' HB ' ' CG ' ' A' ' 191' ' ' LYS . 0.7 OUTLIER -110.13 126.74 54.38 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 117.711 0.756 . . . . 71.409999999999997 112.462 177.809 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 26.5 t -110.63 116.95 32.24 Favored 'General case' 0 N--CA 1.413 -2.283 0 N-CA-C 107.79 -1.189 . . . . 75.530000000000001 107.79 177.143 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.568 ' HA ' ' O ' ' A' ' 190' ' ' GLU . 6.1 p -112.63 119.48 60.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 109.057 -0.72 . . . . 70.319999999999993 109.057 174.135 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 85.9 mtt180 -124.53 160.93 27.22 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 108.438 -0.949 . . . . 74.519999999999996 108.438 -175.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 72.9 t -90.49 118.39 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.141 0 N-CA-C 108.375 -0.972 . . . . 75.25 108.375 173.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 29.7 p -124.54 -174.15 2.95 Favored 'General case' 0 C--N 1.267 -3.005 0 CA-C-N 114.156 -1.384 . . . . 63.439999999999998 108.287 -177.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -64.45 -19.71 65.71 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.082 -0.71 . . . . 73.329999999999998 109.082 174.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 16.6 m -85.74 -10.11 56.08 Favored 'General case' 0 N--CA 1.435 -1.204 0 CA-C-N 115.214 -0.903 . . . . 60.530000000000001 110.249 178.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 100.53 -142.92 16.06 Favored Glycine 0 CA--C 1.482 -1.982 0 N-CA-C 109.021 -1.632 . . . . 32.32 109.021 -179.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 5.5 mp -83.1 120.15 25.4 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 107.97 -1.122 . . . . 72.209999999999994 107.97 175.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . 0.568 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 44.2 tt0 -131.49 119.15 21.16 Favored 'General case' 0 C--N 1.29 -1.978 0 N-CA-C 109.393 -0.595 . . . . 72.510000000000005 109.393 -176.623 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.404 ' CG ' ' HB ' ' A' ' 180' ' ' THR . 36.1 ttmt -97.69 132.0 43.73 Favored 'General case' 0 N--CA 1.427 -1.612 0 N-CA-C 108.074 -1.084 . . . . 74.530000000000001 108.074 -179.221 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -145.13 164.34 27.49 Favored Pre-proline 0 C--N 1.287 -2.146 0 N-CA-C 108.284 -1.006 . . . . 73.310000000000002 108.284 -177.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -60.84 131.71 38.79 Favored 'Trans proline' 0 N--CA 1.448 -1.159 0 N-CA-C 109.401 -1.038 . . . . 71.109999999999999 109.401 174.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -137.49 150.87 20.94 Favored Glycine 0 CA--C 1.474 -2.481 0 N-CA-C 109.393 -1.483 . . . . 44.509999999999998 109.393 -178.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.587 ' HB ' ' CG1' ' A' ' 218' ' ' VAL . 3.2 mp -108.22 138.22 35.96 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.291 0 C-N-CA 120.071 -0.652 . . . . 74.129999999999995 110.141 -179.172 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -131.44 163.7 27.36 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 107.185 -1.413 . . . . 72.239999999999995 107.185 -177.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 41.7 mt -81.97 128.52 38.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 CA-C-O 121.711 0.767 . . . . 64.439999999999998 110.447 175.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . 0.567 ' HB2' ' HG2' ' A' ' 177' ' ' ARG . 27.8 t -100.47 -22.79 14.9 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 112.892 0.701 . . . . 61.140000000000001 112.892 -177.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 51.3 ttp180 -167.56 152.26 6.87 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 109.601 -0.518 . . . . 72.519999999999996 109.601 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 38.7 mt -100.96 146.34 27.52 Favored 'General case' 0 CA--C 1.48 -1.729 0 N-CA-C 108.85 -0.796 . . . . 73.540000000000006 108.85 173.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . 0.535 ' HB ' ' HA2' ' A' ' 173' ' ' GLY . 10.9 t -103.44 114.67 64.72 Favored Pre-proline 0 C--N 1.284 -2.252 0 N-CA-C 105.914 -1.884 . . . . 71.530000000000001 105.914 174.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.543 ' HA ' ' HG2' ' A' ' 207' ' ' GLU . 23.9 Cg_exo -63.34 135.8 51.95 Favored 'Trans proline' 0 N--CA 1.447 -1.209 0 C-N-CA 121.888 1.725 . . . . 63.130000000000003 110.707 -178.085 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.426 ' H ' ' HG2' ' A' ' 207' ' ' GLU . . . 94.73 -12.6 68.47 Favored Glycine 0 C--N 1.312 -0.789 0 C-N-CA 120.891 -0.671 . . . . 75.239999999999995 112.152 -178.013 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . 0.438 ' HA3' ' CA ' ' A' ' 173' ' ' GLY . . . -80.05 172.95 54.93 Favored Glycine 0 N--CA 1.436 -1.328 0 C-N-CA 120.891 -0.671 . . . . 64.409999999999997 111.707 179.454 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.63 ' HG ' ' H ' ' A' ' 164' ' ' LEU . 2.8 mm? -67.17 -41.91 85.18 Favored 'General case' 0 C--N 1.311 -1.089 0 C-N-CA 123.126 0.57 . . . . 61.240000000000002 111.761 -175.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -60.52 -39.18 86.89 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.102 0.477 . . . . 61.310000000000002 110.445 176.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.543 ' HG2' ' HA ' ' A' ' 202' ' ' PRO . 9.1 tp10 -67.85 -42.07 81.94 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.455 -0.793 . . . . 74.329999999999998 109.524 177.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 51.0 m -60.54 -45.12 95.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.4 -0.818 . . . . 72.129999999999995 112.032 -177.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . 0.61 HG23 ' H ' ' A' ' 211' ' ' LEU . 10.0 t -76.72 -30.12 56.5 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 109.362 -0.607 . . . . 65.0 109.362 178.025 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 66.04 16.55 64.42 Favored Glycine 0 C--N 1.34 0.754 0 CA-C-N 115.509 -0.769 . . . . 40.310000000000002 113.106 177.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.61 ' H ' HG23 ' A' ' 209' ' ' THR . 1.9 pp -99.74 -3.45 32.82 Favored 'General case' 0 N--CA 1.433 -1.28 0 C-N-CA 120.275 -0.57 . . . . 64.329999999999998 110.86 -177.426 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 5.4 mp -109.25 133.23 53.3 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 107.622 -1.251 . . . . 72.25 107.622 175.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -131.05 166.51 20.88 Favored 'General case' 0 C--N 1.279 -2.485 0 N-CA-C 108.599 -0.889 . . . . 63.530000000000001 108.599 178.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 35.5 m -57.38 -31.03 37.3 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 N-CA-C 112.726 0.639 . . . . 71.25 112.726 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 -73.22 -13.86 61.23 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 113.201 0.815 . . . . 64.25 113.201 -179.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -73.3 135.09 44.36 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.324 0.583 . . . . 73.430000000000007 112.405 -178.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -104.53 134.33 47.89 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.881 -1.054 . . . . 71.319999999999993 109.162 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.601 ' HA ' HG12 ' A' ' 249' ' ' VAL . 13.1 p -84.08 134.97 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 CA-C-O 122.175 0.988 . . . . 72.549999999999997 111.395 -177.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.615 HG13 ' NE2' ' A' ' 158' ' ' HIS . 36.2 mm -99.27 -52.98 8.27 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.078 0 CA-C-N 114.332 -1.303 . . . . 73.010000000000005 111.025 -179.147 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.414 ' HG2' ' HB ' ' A' ' 248' ' ' THR . 11.1 pt-20 -157.78 151.34 23.72 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 116.076 -0.511 . . . . 72.420000000000002 110.926 -175.487 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.425 HG12 ' CG1' ' A' ' 226' ' ' VAL . 6.9 p -120.81 124.44 72.36 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 N-CA-C 108.959 -0.756 . . . . 74.140000000000001 108.959 176.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . 0.494 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 16.3 t-20 70.63 -3.8 1.83 Allowed 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 125.062 1.345 . . . . 70.340000000000003 111.164 -178.343 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 120.58 -17.91 9.42 Favored Glycine 0 C--N 1.301 -1.407 0 N-CA-C 111.019 -0.832 . . . . 54.399999999999999 111.019 -175.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 63.5 mt -88.52 123.77 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 N-CA-C 109.203 -0.666 . . . . 70.530000000000001 109.203 -179.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . 0.403 ' HA ' ' HB3' ' A' ' 220' ' ' GLU . 13.1 pt-20 -61.54 147.84 44.1 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.585 0.707 . . . . 74.209999999999994 111.506 -178.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . 0.425 ' CG1' HG12 ' A' ' 221' ' ' VAL . 26.1 m -117.8 -2.52 9.83 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 CA-C-N 115.408 -0.814 . . . . 63.109999999999999 112.239 179.459 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -82.16 104.34 12.42 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 109.169 -0.678 . . . . 51.32 109.169 177.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 122.58 -25.05 6.66 Favored Glycine 0 C--N 1.297 -1.597 0 N-CA-C 110.096 -1.202 . . . . 75.239999999999995 110.096 -179.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -74.0 166.7 22.92 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 107.711 -1.218 . . . . 74.140000000000001 107.711 176.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . 0.447 ' O ' HG13 ' A' ' 234' ' ' VAL . 82.5 p -91.0 168.15 11.87 Favored 'General case' 0 C--O 1.249 1.06 0 N-CA-C 108.413 -0.958 . . . . 52.149999999999999 108.413 178.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 47.2 tp -66.07 -27.96 68.47 Favored 'General case' 0 N--CA 1.428 -1.566 0 C-N-CA 120.56 -0.456 . . . . 72.25 109.911 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -69.07 -47.71 64.6 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.725 -0.472 . . . . 71.239999999999995 109.725 176.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -58.92 -48.36 81.72 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 113.587 0.958 . . . . 64.299999999999997 113.587 177.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.525 HG21 HG12 ' A' ' 195' ' ' ILE . 13.3 m -65.14 -34.23 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-O 121.343 0.592 . . . . 64.209999999999994 111.598 -175.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . 0.471 ' O ' HG23 ' A' ' 239' ' ' VAL . 90.0 m -75.48 -35.65 60.78 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 115.52 -0.764 . . . . 54.229999999999997 109.394 -176.087 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -61.53 -34.03 74.84 Favored 'General case' 0 CA--C 1.508 -0.639 0 N-CA-C 108.8 -0.815 . . . . 71.430000000000007 108.8 177.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 237' ' ' MET . . . . . . . . . . . . . 9.9 mtt -67.66 -45.46 75.21 Favored 'General case' 0 C--O 1.211 -0.933 0 N-CA-C 108.113 -1.069 . . . . 75.140000000000001 108.113 178.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 65.9 mtt -59.25 -38.72 80.76 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.884 -0.598 . . . . 74.109999999999999 111.531 -178.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 235' ' ' THR . 60.6 t -69.76 -33.16 54.98 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-O 121.255 0.55 . . . . 73.010000000000005 110.217 178.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -75.28 -30.33 60.4 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.203 0.525 . . . . 53.399999999999999 111.404 179.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 -90.14 21.84 3.56 Favored 'General case' 0 C--O 1.2 -1.531 0 CA-C-N 115.895 -0.593 . . . . 72.209999999999994 112.519 -178.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . 0.557 ' O ' HD12 ' A' ' 164' ' ' LEU . 50.4 m -56.65 -22.97 38.3 Favored 'General case' 0 C--O 1.206 -1.22 0 N-CA-C 112.552 0.575 . . . . 72.109999999999999 112.552 177.283 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 18.4 m -64.16 -38.42 91.0 Favored 'General case' 0 CA--C 1.55 0.951 0 O-C-N 122.241 -0.287 . . . . 40.0 110.475 177.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -168.0 107.55 0.53 Allowed 'General case' 0 CA--C 1.491 -1.301 0 C-N-CA 126.876 2.071 . . . . 72.230000000000004 107.414 177.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.551 ' HB3' ' HB2' ' A' ' 163' ' ' LEU . 0.2 OUTLIER -84.77 105.28 15.44 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 108.348 -0.982 . . . . 71.150000000000006 108.348 -174.667 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.732 HG12 ' HG2' ' A' ' 162' ' ' ARG . 89.4 mt -94.08 115.31 32.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 109.003 -0.74 . . . . 64.030000000000001 109.003 179.079 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . 0.53 HG23 HG23 ' A' ' 218' ' ' VAL . 13.3 mt -125.47 135.65 63.3 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.073 0 CA-C-O 121.467 0.651 . . . . 73.349999999999994 112.181 176.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.486 ' HA ' ' O ' ' A' ' 159' ' ' ARG . 70.1 m -107.55 115.52 30.3 Favored 'General case' 0 N--CA 1.414 -2.274 0 N-CA-C 107.636 -1.246 . . . . 65.219999999999999 107.636 173.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.601 HG12 ' HA ' ' A' ' 218' ' ' VAL . 12.1 m -117.93 164.94 13.76 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.115 0 N-CA-C 109.491 -0.559 . . . . 61.130000000000003 109.491 174.298 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.427 ' CD ' HD11 ' A' ' 219' ' ' ILE . 17.4 ptmt -131.86 128.3 21.54 Favored Pre-proline 0 C--N 1.286 -2.16 0 CA-C-N 114.896 -1.047 . . . . 73.340000000000003 108.676 174.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -72.25 133.79 21.76 Favored 'Trans proline' 0 N--CA 1.442 -1.528 0 C-N-CA 121.559 1.506 . . . . 75.030000000000001 112.382 179.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -64.12 -19.93 65.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.032 -0.531 . . . . 73.540000000000006 111.355 179.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -81.85 -12.99 58.22 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.584 -0.735 . . . . 72.519999999999996 111.165 178.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 85.1 mm-40 67.73 172.23 0.27 Allowed 'General case' 0 C--O 1.24 0.59 0 CA-C-O 121.839 0.828 . . . . 72.450000000000003 112.822 -179.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? . . . . . 0 N--CA 1.418 -2.056 0 N-CA-C 105.29 -2.115 . . . . 71.299999999999997 105.29 178.339 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.239 0.527 0 N-CA-C 109.86 -0.422 . . . . 74.230000000000004 109.86 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 23.1 p -72.85 -45.56 57.68 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-O 120.68 0.276 . . . . 74.430000000000007 111.232 178.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.78 ' HB3' ' HB3' ' A' ' 250' ' ' LYS 0.407 6.0 p-80 -114.83 130.53 56.89 Favored 'General case' 0 CA--C 1.496 -1.107 0 N-CA-C 114.74 1.385 . . . . 72.239999999999995 114.74 174.064 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.559 ' O ' ' HA ' ' A' ' 248' ' ' THR . 11.3 ptt180 -110.34 143.84 39.97 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 113.562 -1.654 . . . . 72.540000000000006 110.812 -173.373 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -114.0 112.93 24.07 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 121.702 0.763 . . . . 73.329999999999998 110.887 178.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.576 HG11 HD21 ' A' ' 211' ' ' LEU . 28.4 m -114.3 139.7 38.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 CA-C-N 114.879 -1.055 . . . . 65.319999999999993 112.786 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.425 ' HA ' ' HA ' ' A' ' 246' ' ' ILE . 19.8 ttm180 -96.48 112.83 24.43 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.434 0.635 . . . . 74.120000000000005 109.781 177.413 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.41 ' HB2' ' HB3' ' A' ' 245' ' ' LEU . 19.8 mt -94.13 138.18 32.48 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-N 114.999 -1.0 . . . . 75.530000000000001 108.685 -178.318 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.416 HD23 ' O ' ' A' ' 242' ' ' SER . 15.4 tp 74.42 85.26 0.1 Allowed 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 122.121 0.962 . . . . 75.319999999999993 111.632 174.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -114.96 -8.42 12.5 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-N 114.708 -1.133 . . . . 64.310000000000002 110.888 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -107.5 77.9 1.17 Allowed 'General case' 0 C--N 1.307 -1.239 0 CA-C-O 121.034 0.445 . . . . 74.319999999999993 110.71 179.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 84.48 -153.86 29.26 Favored Glycine 0 N--CA 1.402 -3.626 0 N-CA-C 108.157 -1.977 . . . . 71.349999999999994 108.157 177.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . 0.408 ' HA ' HD21 ' A' ' 164' ' ' LEU . 27.2 t -173.73 82.83 0.04 OUTLIER 'General case' 0 N--CA 1.404 -2.768 0 N-CA-C 108.749 -0.834 . . . . 73.510000000000005 108.749 178.291 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -138.52 -26.61 0.88 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.622 -1.172 . . . . 73.219999999999999 110.818 -178.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.402 ' HB2' ' HE3' ' A' ' 170' ' ' LYS . 21.6 ptmt -96.63 153.67 38.7 Favored Pre-proline 0 N--CA 1.434 -1.253 0 CA-C-N 116.501 -0.318 . . . . 61.32 110.978 -178.061 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -63.37 153.96 71.23 Favored 'Trans proline' 0 C--O 1.245 0.855 0 C-N-CA 122.905 2.403 . . . . 55.039999999999999 110.576 173.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.555 ' HG ' HD12 ' A' ' 245' ' ' LEU . 3.6 mm? -68.49 -31.71 71.17 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 112.284 0.476 . . . . 74.510000000000005 112.284 -178.011 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . 0.513 ' HA3' ' HA3' ' A' ' 204' ' ' GLY . . . 88.07 34.97 9.26 Favored Glycine 0 N--CA 1.426 -2.024 0 C-N-CA 120.595 -0.812 . . . . 50.450000000000003 113.271 177.008 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -154.73 154.02 32.2 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 107.487 -1.301 . . . . 55.0 107.487 174.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -125.45 148.94 48.64 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 108.939 -0.763 . . . . 74.400000000000006 108.939 176.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.541 HD13 ' SD ' ' A' ' 238' ' ' MET . 35.6 pt -110.08 169.52 3.61 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 CA-C-O 121.32 0.581 . . . . 54.020000000000003 111.253 -176.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.537 ' CG ' ' HB2' ' A' ' 198' ' ' SER . 15.7 ptt180 -149.21 154.79 39.64 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 115.112 -0.949 . . . . 72.420000000000002 109.312 -179.39 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -117.54 144.5 45.04 Favored 'General case' 0 C--N 1.287 -2.124 0 N-CA-C 109.014 -0.736 . . . . 64.230000000000004 109.014 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -161.95 179.96 36.98 Favored Glycine 0 N--CA 1.417 -2.63 0 N-CA-C 109.712 -1.355 . . . . 54.030000000000001 109.712 178.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . 0.513 ' HB ' ' CG ' ' A' ' 191' ' ' LYS . 0.8 OUTLIER -86.46 123.92 32.22 Favored 'General case' 0 C--N 1.29 -1.997 0 CA-C-O 121.66 0.743 . . . . 61.329999999999998 112.193 177.298 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 37.4 t -104.56 113.62 27.31 Favored 'General case' 0 N--CA 1.403 -2.788 0 N-CA-C 107.356 -1.35 . . . . 74.420000000000002 107.356 177.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.65 ' HA ' ' O ' ' A' ' 190' ' ' GLU . 3.5 p -108.63 124.35 65.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 109.185 -0.672 . . . . 70.530000000000001 109.185 174.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -130.27 160.28 34.36 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-N 115.341 -0.845 . . . . 72.450000000000003 108.791 -172.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 56.6 t -84.98 119.69 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.38 0 CA-C-O 121.89 0.852 . . . . 71.400000000000006 108.781 172.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 40.9 p -128.45 -174.16 3.15 Favored 'General case' 0 C--N 1.276 -2.625 0 CA-C-N 114.001 -1.454 . . . . 75.349999999999994 108.342 -175.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -68.89 -15.53 63.52 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.421 0.629 . . . . 41.030000000000001 109.526 175.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 34.9 t -89.03 -9.0 52.94 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.389 -0.823 . . . . 72.109999999999999 109.027 177.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 98.07 -136.97 13.01 Favored Glycine 0 CA--C 1.483 -1.931 0 N-CA-C 108.523 -1.831 . . . . 63.210000000000001 108.523 -177.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 6.4 mp -80.54 118.81 22.46 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.282 -1.007 . . . . 70.140000000000001 108.282 173.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . 0.65 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 11.5 tp10 -129.88 123.3 30.47 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.532 -0.914 . . . . 73.430000000000007 108.532 -174.231 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.513 ' CG ' ' HB ' ' A' ' 180' ' ' THR . 34.6 ttmt -106.67 126.42 52.26 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.964 -0.754 . . . . 71.420000000000002 108.964 -177.217 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -145.71 164.71 24.34 Favored Pre-proline 0 C--N 1.292 -1.905 0 N-CA-C 107.893 -1.151 . . . . 74.019999999999996 107.893 -177.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -59.29 132.76 48.45 Favored 'Trans proline' 0 C--O 1.245 0.834 0 C-N-CA 121.533 1.488 . . . . 71.400000000000006 111.667 176.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -139.53 143.24 13.62 Favored Glycine 0 N--CA 1.419 -2.481 0 N-CA-C 109.778 -1.329 . . . . 63.119999999999997 109.778 178.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.623 HG12 HG21 ' A' ' 234' ' ' VAL . 3.2 mp -108.76 132.84 55.64 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 CA-C-O 121.117 0.484 . . . . 75.040000000000006 110.767 -179.2 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -125.31 167.72 14.51 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 107.946 -1.131 . . . . 75.219999999999999 107.946 -176.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . 0.467 ' HB ' ' HA ' ' A' ' 214' ' ' VAL . 46.5 mm -77.06 131.51 34.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 N-CA-C 108.189 -1.041 . . . . 75.430000000000007 108.189 174.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . 0.537 ' HB2' ' CG ' ' A' ' 177' ' ' ARG . 12.7 t -104.48 -38.49 6.77 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 113.449 0.907 . . . . 52.310000000000002 113.449 -178.525 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 40.0 ttp180 -150.47 141.86 23.36 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 120.004 -0.678 . . . . 72.010000000000005 109.947 -177.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -108.45 133.79 52.13 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 107.562 -1.273 . . . . 64.409999999999997 107.562 -177.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 44.0 t -110.6 131.58 22.01 Favored Pre-proline 0 C--N 1.311 -1.073 0 C-N-CA 120.756 -0.378 . . . . 73.109999999999999 110.736 -177.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.472 ' HA ' ' OE2' ' A' ' 207' ' ' GLU . 17.8 Cg_endo -60.78 135.21 58.47 Favored 'Trans proline' 0 C--O 1.247 0.939 0 C-N-CA 122.717 2.278 . . . . 55.539999999999999 111.682 176.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 86.37 0.78 86.46 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.812 -0.631 . . . . 72.319999999999993 112.63 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . 0.513 ' HA3' ' HA3' ' A' ' 173' ' ' GLY . . . -88.25 170.26 38.96 Favored Glycine 0 N--CA 1.439 -1.13 0 C-N-CA 120.577 -0.82 . . . . 74.219999999999999 112.526 -178.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 172' ' ' LEU . 3.6 mm? -66.39 -34.25 77.54 Favored 'General case' 0 N--CA 1.438 -1.075 0 C-N-CA 123.088 0.555 . . . . 74.420000000000002 110.582 -179.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . 0.469 ' CB ' HD12 ' A' ' 212' ' ' LEU . . . -61.76 -41.55 97.83 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 115.613 -0.721 . . . . 62.409999999999997 110.49 176.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.472 ' OE2' ' HA ' ' A' ' 202' ' ' PRO . 41.2 tt0 -75.6 -33.52 60.56 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.946 -0.57 . . . . 75.329999999999998 110.234 178.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 44.3 t -56.34 -50.14 72.36 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 123.755 0.822 . . . . 51.240000000000002 111.042 -179.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . 0.617 HG23 ' H ' ' A' ' 211' ' ' LEU . 8.8 t -80.02 -25.98 39.99 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 119.648 -0.821 . . . . 75.329999999999998 109.59 176.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 65.6 22.84 70.13 Favored Glycine 0 N--CA 1.446 -0.689 0 CA-C-N 115.608 -0.724 . . . . 50.520000000000003 112.543 179.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.617 ' H ' HG23 ' A' ' 209' ' ' THR . 1.1 pp -111.61 4.06 18.39 Favored 'General case' 0 N--CA 1.436 -1.174 0 C-N-CA 120.073 -0.651 . . . . 61.219999999999999 112.235 -177.33 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.469 HD12 ' CB ' ' A' ' 206' ' ' ALA . 75.5 mt -108.39 133.13 53.0 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 108.65 -0.87 . . . . 72.329999999999998 108.65 177.577 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -131.86 165.23 24.3 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 107.613 -1.254 . . . . 63.030000000000001 107.613 177.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . 0.467 ' HA ' ' HB ' ' A' ' 197' ' ' ILE 0.259 18.7 m -65.53 -28.83 45.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 113.519 0.933 . . . . 71.299999999999997 113.519 -177.99 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -73.11 -15.14 61.49 Favored 'General case' 0 N--CA 1.484 1.247 0 O-C-N 121.906 -0.496 . . . . 41.32 111.636 178.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -66.43 131.95 47.21 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-O 121.337 0.589 . . . . 62.329999999999998 112.036 -179.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . 0.44 ' O ' ' HA ' ' A' ' 249' ' ' VAL . 38.6 tt0 -105.82 132.4 51.99 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.95 -1.023 . . . . 74.340000000000003 111.044 -178.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.525 HG13 HG23 ' A' ' 247' ' ' ILE . 35.4 t -81.66 127.37 39.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 C-N-CA 123.24 0.616 . . . . 74.099999999999994 110.643 -176.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 40.9 mm -98.84 -49.41 11.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 CA-C-N 115.341 -0.845 . . . . 71.349999999999994 110.806 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.457 ' CB ' ' HA ' ' A' ' 225' ' ' GLU . 12.7 pt-20 -152.55 158.41 42.46 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-O 120.529 0.204 . . . . 75.329999999999998 110.703 -179.255 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.47 ' C ' ' H ' ' A' ' 223' ' ' GLY . 9.1 p -125.36 125.76 69.54 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 N-CA-C 109.088 -0.708 . . . . 73.209999999999994 109.088 178.406 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . 0.687 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 14.8 t-20 71.92 -31.8 0.23 Allowed 'General case' 0 N--CA 1.499 2.021 0 C-N-CA 126.421 1.888 . . . . 72.129999999999995 112.364 -178.281 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . 0.47 ' H ' ' C ' ' A' ' 221' ' ' VAL . . . 150.21 -4.6 0.62 Allowed Glycine 0 C--N 1.276 -2.797 0 CA-C-N 114.547 -1.206 . . . . 31.43 110.777 -175.163 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 68.6 mt -104.56 124.34 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.14 0 N-CA-C 109.364 -0.606 . . . . 64.040000000000006 109.364 179.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . 0.457 ' HA ' ' CB ' ' A' ' 220' ' ' GLU . 12.4 pt-20 -57.91 148.66 24.96 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 123.419 0.688 . . . . 71.329999999999998 112.801 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . 0.496 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 34.3 m -122.67 -2.54 7.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 CA-C-N 114.891 -1.049 . . . . 54.32 109.501 175.44 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -71.22 99.05 1.83 Allowed 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 115.547 -0.751 . . . . 61.119999999999997 110.441 -177.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 121.91 -23.2 7.44 Favored Glycine 0 N--CA 1.43 -1.742 0 N-CA-C 110.965 -0.854 . . . . 61.219999999999999 110.965 178.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 80.2 mttt -78.13 172.85 12.93 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 121.142 -0.223 . . . . 74.540000000000006 111.306 -179.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . 0.456 ' O ' HG13 ' A' ' 234' ' ' VAL . 74.2 p -93.77 165.97 12.43 Favored 'General case' 0 N--CA 1.427 -1.612 0 C-N-CA 119.849 -0.74 . . . . 60.399999999999999 109.76 -175.424 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.469 ' HA ' HG22 ' A' ' 234' ' ' VAL . 3.1 tm? -60.96 -38.78 87.11 Favored 'General case' 0 N--CA 1.427 -1.614 0 CA-C-N 116.081 -0.508 . . . . 72.439999999999998 109.787 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -65.95 -40.16 91.09 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.458 -0.337 . . . . 62.200000000000003 110.664 179.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -64.31 -49.3 72.32 Favored 'General case' 0 C--O 1.223 -0.316 0 N-CA-C 112.667 0.618 . . . . 72.310000000000002 112.667 175.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.623 HG21 HG12 ' A' ' 195' ' ' ILE . 15.0 m -68.36 -34.05 63.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 112.729 0.64 . . . . 70.430000000000007 112.729 -173.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . 0.49 ' O ' HG23 ' A' ' 239' ' ' VAL . 75.1 m -71.0 -35.63 72.14 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 109.229 -0.656 . . . . 64.010000000000005 109.229 -176.31 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -62.63 -33.97 76.09 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.727 -0.669 . . . . 72.030000000000001 109.598 178.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 237' ' ' MET . . . . . 0.444 ' HB2' HG11 ' A' ' 221' ' ' VAL . 2.0 mtm -74.33 -34.91 63.58 Favored 'General case' 0 C--O 1.2 -1.55 0 N-CA-C 108.542 -0.91 . . . . 75.120000000000005 108.542 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 238' ' ' MET . . . . . 0.541 ' SD ' HD13 ' A' ' 176' ' ' ILE . 65.3 mtt -68.66 -36.24 78.29 Favored 'General case' 0 C--N 1.314 -0.964 0 O-C-N 121.995 -0.441 . . . . 53.450000000000003 110.844 178.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 235' ' ' THR . 99.9 t -67.81 -39.57 82.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 CA-C-O 121.278 0.561 . . . . 64.409999999999997 109.665 176.497 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -69.59 -32.4 71.13 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.919 -0.582 . . . . 63.25 111.006 178.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 58.0 m-80 -96.24 21.04 9.45 Favored 'General case' 0 C--O 1.206 -1.187 0 CA-C-N 116.294 -0.412 . . . . 63.340000000000003 111.995 178.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . 0.416 ' O ' HD23 ' A' ' 164' ' ' LEU . 62.6 m -63.16 -23.1 67.28 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 120.537 -0.465 . . . . 75.409999999999997 111.895 178.281 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 19.2 m -66.03 -24.99 66.85 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 116.639 -0.255 . . . . 62.530000000000001 111.159 177.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -172.79 93.13 0.11 Allowed 'General case' 0 C--O 1.24 0.577 0 C-N-CA 124.602 1.161 . . . . 71.049999999999997 109.054 -178.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.555 HD12 ' HG ' ' A' ' 172' ' ' LEU . 1.2 tt -88.66 105.05 17.42 Favored 'General case' 0 C--O 1.198 -1.643 0 CA-C-N 115.769 -0.65 . . . . 74.329999999999998 111.286 -169.301 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.687 ' HB ' ' HA ' ' A' ' 222' ' ' ASN . 52.3 mt -96.95 122.61 48.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 108.506 -0.924 . . . . 62.0 108.506 176.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . 0.525 HG23 HG13 ' A' ' 218' ' ' VAL . 14.9 mt -130.09 135.4 61.03 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.061 0 CA-C-O 121.441 0.639 . . . . 72.120000000000005 112.487 177.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.559 ' HA ' ' O ' ' A' ' 159' ' ' ARG . 87.6 m -99.99 122.67 43.25 Favored 'General case' 0 N--CA 1.423 -1.784 0 CA-C-N 114.906 -1.043 . . . . 65.030000000000001 108.417 174.507 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.502 HG12 ' HA ' ' A' ' 218' ' ' VAL . 23.5 m -132.61 151.83 35.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 CA-C-O 121.347 0.594 . . . . 63.509999999999998 111.06 177.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.78 ' HB3' ' HB3' ' A' ' 158' ' ' HIS . 1.4 ptmm? -126.79 128.69 24.21 Favored Pre-proline 0 C--N 1.28 -2.437 0 CA-C-N 114.286 -1.325 . . . . 64.239999999999995 109.045 174.194 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -65.96 149.5 86.18 Favored 'Trans proline' 0 N--CA 1.44 -1.637 0 C-N-CA 122.221 1.947 . . . . 74.319999999999993 110.291 176.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -59.49 -35.05 73.37 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-O 121.775 0.797 . . . . 71.400000000000006 109.745 178.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -99.17 73.65 1.92 Allowed 'General case' 0 C--N 1.293 -1.848 0 CA-C-N 114.632 -1.167 . . . . 72.409999999999997 108.88 177.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -86.77 154.9 20.58 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 114.942 -1.026 . . . . 40.340000000000003 111.069 179.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 33.6 mmt180 . . . . . 0 C--N 1.311 -1.081 0 CA-C-O 118.537 -0.744 . . . . 64.319999999999993 109.308 -179.9 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 . . . . . 0 CA--C 1.503 -0.832 0 N-CA-C 109.34 -0.615 . . . . 73.430000000000007 109.34 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 35.0 p -89.9 -35.09 15.81 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-O 120.938 0.399 . . . . 74.219999999999999 111.419 178.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 1.3 m80 -124.37 130.72 52.99 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 121.134 0.492 . . . . 72.409999999999997 111.755 178.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -132.84 135.12 45.45 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 107.739 -1.208 . . . . 73.0 107.739 175.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 12.9 ptp180 -124.58 113.32 17.91 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-O 121.792 0.806 . . . . 72.200000000000003 110.14 178.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 23.7 m -107.41 138.25 34.48 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.922 0 CA-C-N 114.996 -1.002 . . . . 71.310000000000002 112.614 -178.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.661 ' CZ ' ' HA ' ' A' ' 165' ' ' LYS . 0.1 OUTLIER -104.27 112.56 25.63 Favored 'General case' 0 N--CA 1.417 -2.076 0 N-CA-C 108.473 -0.936 . . . . 72.420000000000002 108.473 175.735 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.471 ' HB2' ' HB3' ' A' ' 245' ' ' LEU . 22.9 mt -101.01 139.89 36.07 Favored 'General case' 0 C--N 1.284 -2.239 0 CA-C-N 114.317 -1.31 . . . . 62.149999999999999 108.243 -175.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.554 HD12 ' O ' ' A' ' 242' ' ' SER . 0.6 OUTLIER 74.37 82.29 0.11 Allowed 'General case' 0 N--CA 1.426 -1.673 0 N-CA-C 106.097 -1.816 . . . . 61.420000000000002 106.097 173.896 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.661 ' HA ' ' CZ ' ' A' ' 162' ' ' ARG . 52.4 mtpt -93.64 4.33 54.11 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-N 113.961 -1.472 . . . . 73.540000000000006 113.076 -169.427 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 45.2 t-80 -127.85 -60.87 1.14 Allowed 'General case' 0 C--N 1.297 -1.698 0 C-N-CA 119.171 -1.012 . . . . 64.439999999999998 112.922 178.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 145.93 113.99 0.85 Allowed Glycine 0 C--N 1.298 -1.574 0 N-CA-C 109.881 -1.288 . . . . 55.200000000000003 109.881 -177.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . 0.502 ' HB3' ' HG2' ' A' ' 170' ' ' LYS . 24.4 m -154.11 154.66 34.0 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 117.01 0.405 . . . . 64.349999999999994 110.445 -177.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -98.58 8.6 44.71 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.47 -0.786 . . . . 63.009999999999998 109.615 177.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.502 ' HG2' ' HB3' ' A' ' 168' ' ' SER . 22.5 pttm -83.37 150.5 60.53 Favored Pre-proline 0 N--CA 1.434 -1.275 0 CA-C-N 115.683 -0.69 . . . . 62.119999999999997 110.003 177.345 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -62.33 148.4 93.33 Favored 'Trans proline' 0 C--O 1.248 0.997 0 C-N-CA 122.624 2.216 . . . . 75.549999999999997 110.92 176.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.518 ' HG ' ' CD1' ' A' ' 245' ' ' LEU . 3.1 mm? -71.92 -22.2 61.51 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 115.749 -0.66 . . . . 51.229999999999997 112.336 -176.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . 0.462 ' HA3' ' HA3' ' A' ' 204' ' ' GLY . . . 90.88 34.23 7.84 Favored Glycine 0 N--CA 1.422 -2.247 0 C-N-CA 120.672 -0.775 . . . . 73.239999999999995 112.929 177.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 26.0 p90 -152.93 154.38 34.9 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 108.805 -0.813 . . . . 73.109999999999999 108.805 175.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -128.12 150.87 49.79 Favored 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 108.322 -0.992 . . . . 73.430000000000007 108.322 175.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.646 ' H ' HD13 ' A' ' 176' ' ' ILE . 0.2 OUTLIER -116.4 169.21 7.1 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.081 0 CA-C-O 121.474 0.654 . . . . 73.200000000000003 111.276 -177.584 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.516 ' HG2' ' HB2' ' A' ' 198' ' ' SER . 4.3 ptp180 -147.98 155.2 41.26 Favored 'General case' 0 C--N 1.278 -2.524 0 C-N-CA 124.358 1.063 . . . . 62.240000000000002 109.884 -176.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -111.46 146.23 37.59 Favored 'General case' 0 C--N 1.294 -1.836 0 O-C-N 123.579 0.549 . . . . 52.100000000000001 110.135 179.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.42 ' O ' ' HA ' ' A' ' 193' ' ' PRO . . . -159.61 -165.01 15.71 Favored Glycine 0 C--N 1.292 -1.914 0 N-CA-C 108.624 -1.791 . . . . 50.299999999999997 108.624 175.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . 0.463 ' HB ' ' CG ' ' A' ' 191' ' ' LYS . 3.1 p -103.9 125.65 50.46 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 118.46 1.13 . . . . 55.25 112.627 175.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 67.8 m -110.51 113.06 25.4 Favored 'General case' 0 N--CA 1.403 -2.784 0 N-CA-C 107.484 -1.302 . . . . 61.240000000000002 107.484 173.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.502 ' HA ' ' O ' ' A' ' 190' ' ' GLU . 6.7 p -105.08 119.94 54.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 C-N-CA 119.433 -0.907 . . . . 71.329999999999998 109.195 175.42 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 90.1 mtt180 -122.57 153.13 39.67 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 114.803 -1.09 . . . . 73.129999999999995 109.295 -173.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 74.5 t -83.58 119.39 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.845 0 N-CA-C 106.96 -1.496 . . . . 74.519999999999996 106.96 170.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 71.8 p -109.64 -175.0 2.63 Favored 'General case' 0 C--N 1.262 -3.198 0 CA-C-N 114.56 -1.2 . . . . 74.420000000000002 108.741 -176.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -70.09 -9.74 56.44 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 115.981 -0.554 . . . . 73.239999999999995 110.236 176.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 19.4 m -111.38 -4.31 14.94 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 116.094 -0.503 . . . . 74.319999999999993 111.167 179.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 119.91 -156.57 15.85 Favored Glycine 0 CA--C 1.498 -1.009 0 C-N-CA 120.026 -1.083 . . . . 52.329999999999998 110.816 178.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 5.1 mp -79.21 126.18 30.42 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 117.81 0.805 . . . . 50.109999999999999 109.695 179.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . 0.502 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 42.8 tt0 -132.96 119.4 20.06 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 109.071 -0.714 . . . . 72.310000000000002 109.071 -178.326 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.463 ' CG ' ' HB ' ' A' ' 180' ' ' THR . 36.2 ttmt -92.51 121.69 34.21 Favored 'General case' 0 N--CA 1.413 -2.295 0 N-CA-C 106.851 -1.537 . . . . 75.540000000000006 106.851 176.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . 0.404 HE22 ' HA ' ' A' ' 227' ' ' ALA . 12.4 pt20 -126.02 160.13 58.49 Favored Pre-proline 0 C--N 1.268 -2.945 0 N-CA-C 107.603 -1.258 . . . . 73.239999999999995 107.603 -176.428 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . 0.42 ' HA ' ' O ' ' A' ' 179' ' ' GLY . 13.8 Cg_endo -65.73 131.03 26.29 Favored 'Trans proline' 0 N--CA 1.416 -3.042 0 N-CA-C 107.861 -1.631 . . . . 71.109999999999999 107.861 168.443 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -122.47 138.76 12.14 Favored Glycine 0 N--CA 1.402 -3.621 0 N-CA-C 109.09 -1.604 . . . . 74.140000000000001 109.09 179.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.531 HG12 HG21 ' A' ' 234' ' ' VAL . 3.5 mp -104.05 132.16 51.18 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.626 0 C-N-CA 120.268 -0.573 . . . . 75.430000000000007 109.79 179.493 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -122.81 165.0 17.33 Favored 'General case' 0 C--N 1.284 -2.275 0 N-CA-C 108.188 -1.042 . . . . 74.409999999999997 108.188 -177.108 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . 0.434 ' HB ' ' HA ' ' A' ' 214' ' ' VAL . 46.8 mm -78.37 128.8 38.17 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 107.711 -1.218 . . . . 54.530000000000001 107.711 174.246 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . 0.516 ' HB2' ' HG2' ' A' ' 177' ' ' ARG . 11.4 t -100.99 -28.21 12.86 Favored 'General case' 0 C--N 1.28 -2.45 0 O-C-N 121.488 -0.758 . . . . 60.200000000000003 113.013 -177.573 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 25.3 tpt180 -163.07 140.11 7.55 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 120.878 -0.329 . . . . 74.230000000000004 110.333 -175.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 61.4 mt -105.33 137.53 42.98 Favored 'General case' 0 CA--C 1.491 -1.29 0 N-CA-C 108.964 -0.754 . . . . 72.329999999999998 108.964 172.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . 0.438 ' HB ' ' HA2' ' A' ' 173' ' ' GLY . 61.5 t -97.55 116.53 65.84 Favored Pre-proline 0 C--N 1.279 -2.463 0 N-CA-C 105.773 -1.936 . . . . 71.239999999999995 105.773 172.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.639 ' HA ' ' OE1' ' A' ' 207' ' ' GLU . 21.1 Cg_endo -60.04 126.29 19.9 Favored 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 121.932 1.755 . . . . 63.140000000000001 111.707 -174.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 105.51 -9.08 44.64 Favored Glycine 0 C--N 1.307 -1.073 0 CA-C-N 115.421 -0.809 . . . . 53.219999999999999 111.104 -177.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . 0.462 ' HA3' ' HA3' ' A' ' 173' ' ' GLY . . . -74.77 167.55 54.82 Favored Glycine 0 N--CA 1.437 -1.248 0 C-N-CA 121.556 -0.354 . . . . 73.340000000000003 113.14 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -65.0 -29.16 70.07 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 124.281 1.032 . . . . 73.299999999999997 111.737 -177.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . 0.405 ' HA ' HD12 ' A' ' 212' ' ' LEU . . . -59.81 -40.73 89.38 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.863 -0.608 . . . . 73.099999999999994 110.57 177.286 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.639 ' OE1' ' HA ' ' A' ' 202' ' ' PRO . 46.3 mt-10 -75.5 -31.42 60.16 Favored 'General case' 0 CA--C 1.507 -0.694 0 CA-C-N 116.2 -0.454 . . . . 64.030000000000001 110.885 175.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 24.8 m -55.73 -36.96 67.81 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.162 -0.472 . . . . 72.519999999999996 111.417 -177.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . 0.523 HG23 ' H ' ' A' ' 211' ' ' LEU . 9.7 t -84.72 -32.68 23.39 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 109.281 -0.637 . . . . 53.0 109.281 174.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 73.32 21.02 80.02 Favored Glycine 0 CA--C 1.497 -1.058 0 CA-C-N 115.876 -0.602 . . . . 40.240000000000002 112.061 177.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.523 ' H ' HG23 ' A' ' 209' ' ' THR . 38.4 mt -114.31 -0.32 13.9 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 109.655 -0.498 . . . . 71.230000000000004 109.655 -178.431 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' A' ' 206' ' ' ALA . 74.0 mt -109.03 130.93 55.49 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 120.113 -0.635 . . . . 75.340000000000003 110.684 176.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -133.82 166.23 23.14 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 114.605 -1.179 . . . . 75.400000000000006 108.04 176.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . 0.434 ' HA ' ' HB ' ' A' ' 197' ' ' ILE . 26.4 m -59.33 -29.37 41.79 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-O 121.934 0.873 . . . . 73.310000000000002 111.416 176.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -72.65 -15.79 61.71 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 115.377 -0.829 . . . . 41.350000000000001 112.617 -175.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -69.31 137.82 53.29 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 113.602 0.964 . . . . 63.450000000000003 113.602 -176.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -112.92 124.66 53.12 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.795 1.638 . . . . 75.219999999999999 108.87 -178.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.582 ' HA ' HG12 ' A' ' 249' ' ' VAL . 8.2 p -80.1 146.47 7.63 Favored 'Isoleucine or valine' 0 C--O 1.251 1.168 0 N-CA-C 113.953 1.094 . . . . 72.430000000000007 113.953 -173.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.478 HD11 ' CD ' ' A' ' 250' ' ' LYS . 44.4 mm -111.46 -53.13 5.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 113.988 -1.46 . . . . 70.010000000000005 110.435 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -158.07 156.28 30.76 Favored 'General case' 0 C--O 1.244 0.794 0 CA-C-N 116.324 -0.398 . . . . 74.319999999999993 110.245 -176.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.426 ' HA ' ' O ' ' A' ' 246' ' ' ILE . 4.4 p -124.74 115.92 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.292 0 CA-C-O 121.586 0.707 . . . . 72.230000000000004 110.838 173.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . 0.44 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 21.4 t-20 58.95 34.61 23.71 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 126.124 1.77 . . . . 73.540000000000006 110.638 178.407 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 93.74 -4.83 72.73 Favored Glycine 0 C--N 1.301 -1.392 0 CA-C-N 115.165 -0.925 . . . . 71.329999999999998 113.172 177.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 58.1 mt -99.67 123.36 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.373 0 N-CA-C 108.628 -0.878 . . . . 73.150000000000006 108.628 179.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . 0.458 ' HG3' ' HE3' ' A' ' 229' ' ' LYS . 12.1 pt-20 -62.93 134.99 57.06 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 121.403 0.621 . . . . 73.030000000000001 110.741 -179.374 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 27.6 m -115.57 10.97 7.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-O 122.202 1.001 . . . . 72.400000000000006 109.611 175.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . 0.404 ' HA ' HE22 ' A' ' 192' ' ' GLN . . . -75.32 99.98 4.26 Favored 'General case' 0 N--CA 1.422 -1.83 0 CA-C-N 114.307 -1.315 . . . . 71.540000000000006 110.336 179.128 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 95.08 18.46 33.96 Favored Glycine 0 N--CA 1.438 -1.186 0 CA-C-N 115.489 -0.778 . . . . 71.25 112.919 175.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.467 ' HB3' ' HG2' ' A' ' 233' ' ' GLN . 68.7 mmtt -95.63 172.2 8.2 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.963 0.382 . . . . 64.420000000000002 110.164 179.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . 0.666 ' OG1' ' HB2' ' A' ' 233' ' ' GLN . 40.6 p -76.1 162.57 27.9 Favored 'General case' 0 N--CA 1.433 -1.296 0 C-N-CA 120.33 -0.548 . . . . 72.230000000000004 109.55 175.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -68.6 -39.18 81.01 Favored 'General case' 0 N--CA 1.429 -1.514 0 N-CA-C 108.982 -0.747 . . . . 71.5 108.982 -179.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -61.29 -39.39 90.28 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 116.302 -0.408 . . . . 72.209999999999994 110.338 176.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 233' ' ' GLN . . . . . 0.666 ' HB2' ' OG1' ' A' ' 230' ' ' THR . 3.5 tp-100 -58.16 -50.95 71.73 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 123.947 0.899 . . . . 73.010000000000005 109.796 -177.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.531 HG21 HG12 ' A' ' 195' ' ' ILE . 13.0 m -73.67 -34.2 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-N 115.265 -0.88 . . . . 75.340000000000003 111.536 -174.05 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . 0.495 ' O ' HG23 ' A' ' 239' ' ' VAL . 53.0 m -74.75 -36.52 62.6 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 115.42 -0.809 . . . . 62.420000000000002 109.251 -175.326 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -58.77 -34.72 71.76 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-N 115.39 -0.823 . . . . 74.129999999999995 109.602 175.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 237' ' ' MET . . . . . 0.41 ' HB2' HG11 ' A' ' 221' ' ' VAL . 10.1 mtt -69.79 -50.27 44.66 Favored 'General case' 0 C--O 1.208 -1.128 0 N-CA-C 108.002 -1.11 . . . . 70.209999999999994 108.002 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 238' ' ' MET . . . . . 0.429 ' HG3' ' O ' ' A' ' 234' ' ' VAL . 64.4 mtt -54.47 -40.01 68.03 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 123.426 0.69 . . . . 75.420000000000002 111.791 -177.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 235' ' ' THR . 80.3 t -69.09 -48.91 66.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.158 0.504 . . . . 65.420000000000002 110.915 178.05 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -65.78 -28.9 69.36 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.908 -0.587 . . . . 43.409999999999997 111.705 -178.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 -84.68 21.56 1.5 Allowed 'General case' 0 C--O 1.2 -1.549 0 N-CA-C 113.174 0.805 . . . . 73.430000000000007 113.174 -179.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . 0.554 ' O ' HD12 ' A' ' 164' ' ' LEU . 31.0 p -56.19 -23.76 37.34 Favored 'General case' 0 C--O 1.2 -1.54 0 N-CA-C 113.301 0.852 . . . . 75.340000000000003 113.301 177.36 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 19.4 m -71.28 -37.41 71.88 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 121.563 0.697 . . . . 63.329999999999998 110.214 177.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 244' ' ' ASN . . . . . 0.486 ' HA ' ' HE ' ' A' ' 162' ' ' ARG . 5.1 p30 -158.19 92.22 1.15 Allowed 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 123.922 0.889 . . . . 73.430000000000007 110.091 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.518 ' CD1' ' HG ' ' A' ' 172' ' ' LEU . 1.4 tt -88.64 103.75 16.22 Favored 'General case' 0 C--O 1.207 -1.145 0 N-CA-C 109.029 -0.73 . . . . 74.209999999999994 109.029 -175.472 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.44 ' HB ' ' HA ' ' A' ' 222' ' ' ASN . 58.7 mt -106.1 115.73 48.39 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 109.053 -0.721 . . . . 61.049999999999997 109.053 179.144 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . 0.493 HG23 HG23 ' A' ' 218' ' ' VAL . 32.1 mt -119.89 128.82 75.94 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 CA-C-O 121.472 0.653 . . . . 71.129999999999995 111.657 178.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 37.9 m -102.07 118.48 36.98 Favored 'General case' 0 N--CA 1.418 -2.066 0 CA-C-N 114.751 -1.113 . . . . 75.549999999999997 108.021 176.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.582 HG12 ' HA ' ' A' ' 218' ' ' VAL . 15.8 m -126.84 170.08 17.32 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.992 0 CA-C-O 121.793 0.806 . . . . 64.420000000000002 110.673 178.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.478 ' CD ' HD11 ' A' ' 219' ' ' ILE 0.337 42.9 mtpt -125.72 152.4 72.21 Favored Pre-proline 0 C--N 1.271 -2.812 0 CA-C-N 113.492 -1.685 . . . . 74.310000000000002 106.67 174.897 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -80.19 143.9 16.17 Favored 'Trans proline' 0 N--CA 1.424 -2.566 0 N-CA-C 108.304 -1.46 . . . . 72.120000000000005 108.304 167.105 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -57.91 -38.77 76.47 Favored 'General case' 0 CA--C 1.49 -1.347 0 CA-C-O 121.895 0.855 . . . . 61.030000000000001 109.54 179.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -94.58 87.92 5.26 Favored 'General case' 0 C--N 1.284 -2.268 0 N-CA-C 107.198 -1.408 . . . . 62.350000000000001 107.198 172.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 254' ' ' GLN . . . . . 0.415 ' NE2' ' H ' ' A' ' 254' ' ' GLN . 1.7 mp0 -49.06 101.32 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 114.316 -1.311 . . . . 53.149999999999999 110.711 178.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 27.9 ttm180 . . . . . 0 N--CA 1.437 -1.085 0 N-CA-C 108.851 -0.796 . . . . 74.140000000000001 108.851 -177.91 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.516 -0.328 0 N-CA-C 109.532 -0.544 . . . . 75.329999999999998 109.532 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 37.5 p -78.11 -30.23 49.35 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-O 121.268 0.556 . . . . 70.329999999999998 110.828 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -125.39 130.99 53.0 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.803 -0.635 . . . . 71.319999999999993 109.866 173.01 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.579 ' HA ' ' HE ' ' A' ' 159' ' ' ARG . 2.0 tpm_? -121.73 119.2 31.06 Favored 'General case' 0 N--CA 1.423 -1.799 0 N-CA-C 109.411 -0.588 . . . . 71.310000000000002 109.411 178.355 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 81.2 mtm180 -101.05 113.73 27.01 Favored 'General case' 0 C--N 1.281 -2.392 0 CA-C-N 115.123 -0.944 . . . . 70.310000000000002 109.507 179.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 23.6 m -119.67 139.23 47.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 CA-C-N 115.924 -0.58 . . . . 74.439999999999998 111.198 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.408 ' HG3' HG12 ' A' ' 246' ' ' ILE . 14.9 ttm180 -107.86 112.09 24.55 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.127 -1.064 . . . . 64.140000000000001 108.127 176.533 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.619 ' HB2' ' HB2' ' A' ' 245' ' ' LEU . 20.9 mt -103.03 139.87 38.02 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 108.323 -0.991 . . . . 64.299999999999997 108.323 -174.113 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.736 ' HG ' ' O ' ' A' ' 242' ' ' SER . 0.1 OUTLIER 72.76 77.96 0.15 Allowed 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 105.911 -1.885 . . . . 61.350000000000001 105.911 -179.608 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -98.82 -11.56 21.68 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 115.18 -0.918 . . . . 71.120000000000005 111.22 -174.015 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 44.5 m80 -148.43 104.97 3.55 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 116.024 -0.534 . . . . 71.140000000000001 110.431 177.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 126.3 -153.6 18.67 Favored Glycine 0 N--CA 1.422 -2.246 0 N-CA-C 110.232 -1.147 . . . . 65.310000000000002 110.232 177.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 32.1 t 179.91 173.35 0.95 Allowed 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 107.63 -1.248 . . . . 72.549999999999997 107.63 178.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 23.4 t70 73.88 -29.31 0.2 Allowed 'General case' 0 N--CA 1.504 2.238 0 N-CA-C 114.274 1.213 . . . . 65.530000000000001 114.274 174.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.436 ' HA ' ' HD3' ' A' ' 171' ' ' PRO . 28.0 mtpp -72.34 149.72 91.55 Favored Pre-proline 0 C--N 1.307 -1.271 0 C-N-CA 123.259 0.624 . . . . 75.120000000000005 112.621 -176.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 170' ' ' LYS . 21.7 Cg_exo -67.32 153.46 76.97 Favored 'Trans proline' 0 C--O 1.242 0.723 0 C-N-CA 122.813 2.342 . . . . 63.240000000000002 110.104 173.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.551 ' HG ' HD12 ' A' ' 245' ' ' LEU . 2.7 mm? -90.61 -27.54 19.02 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-N 116.132 -0.485 . . . . 51.340000000000003 112.177 -174.668 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . 0.529 ' HA3' ' HA3' ' A' ' 204' ' ' GLY . . . 97.69 30.59 7.13 Favored Glycine 0 N--CA 1.44 -1.091 0 C-N-CA 120.258 -0.972 . . . . 75.129999999999995 112.968 177.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -147.55 155.8 42.21 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.239 -1.393 . . . . 74.200000000000003 107.239 174.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.414 ' HB2' ' HB3' ' A' ' 199' ' ' ARG . 92.4 m-85 -131.45 143.57 50.53 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 108.078 -1.082 . . . . 72.120000000000005 108.078 177.368 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.429 HD13 ' SD ' ' A' ' 238' ' ' MET . 30.2 pt -111.01 169.08 4.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 113.31 0.856 . . . . 75.019999999999996 113.31 -173.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.593 ' HB3' ' HB2' ' A' ' 198' ' ' SER . 2.9 ptp180 -142.87 155.02 44.69 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 114.765 -1.107 . . . . 62.329999999999998 109.982 -178.254 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . 0.586 ' HB2' ' HB2' ' A' ' 231' ' ' LEU . 11.5 t70 -109.46 138.53 45.67 Favored 'General case' 0 C--N 1.29 -2.014 0 O-C-N 124.082 0.864 . . . . 73.409999999999997 109.138 179.047 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -151.46 -178.99 26.77 Favored Glycine 0 C--N 1.273 -2.967 0 N-CA-C 108.07 -2.012 . . . . 43.299999999999997 108.07 175.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . 0.463 ' CG2' ' HG2' ' A' ' 191' ' ' LYS . 0.2 OUTLIER -109.59 122.36 47.27 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 106.581 -1.637 . . . . 71.510000000000005 106.581 177.128 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . 0.508 ' O ' ' HA ' ' A' ' 191' ' ' LYS . 33.0 t -97.47 123.45 41.33 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 109.062 -0.718 . . . . 64.239999999999995 109.062 -176.202 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.588 ' HA ' ' O ' ' A' ' 190' ' ' GLU . 7.1 p -107.33 120.46 58.68 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 CA-C-O 121.415 0.626 . . . . 71.200000000000003 109.887 176.237 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -121.67 154.75 36.42 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-N 115.18 -0.918 . . . . 73.109999999999999 109.272 -177.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 78.2 t -84.3 119.09 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.901 0 N-CA-C 107.426 -1.324 . . . . 75.239999999999995 107.426 171.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 46.5 p -114.68 -176.5 2.91 Favored 'General case' 0 C--N 1.274 -2.712 0 CA-C-N 114.51 -1.223 . . . . 71.450000000000003 108.885 -177.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -59.69 -26.05 65.27 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.05 0.453 . . . . 53.399999999999999 110.429 177.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 21.3 m -91.9 -18.4 23.81 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 115.785 -0.643 . . . . 63.340000000000003 111.576 -179.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 127.48 -152.24 18.75 Favored Glycine 0 N--CA 1.442 -0.956 0 N-CA-C 110.269 -1.132 . . . . 50.229999999999997 110.269 -177.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 6.2 mp -78.1 122.98 26.32 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 117.88 0.84 . . . . 72.219999999999999 110.044 179.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . 0.588 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 9.3 tp10 -132.44 123.54 26.87 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.86 -0.609 . . . . 54.329999999999998 109.665 -178.343 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.508 ' HA ' ' O ' ' A' ' 181' ' ' SER . 32.9 ttmt -102.7 131.94 49.17 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 107.735 -1.209 . . . . 73.349999999999994 107.735 -178.362 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . 0.492 ' HB2' ' HD2' ' A' ' 193' ' ' PRO . 9.0 pt20 -151.59 164.53 19.95 Favored Pre-proline 0 C--N 1.305 -1.347 0 N-CA-C 108.152 -1.055 . . . . 64.519999999999996 108.152 -174.569 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . 0.492 ' HD2' ' HB2' ' A' ' 192' ' ' GLN . 9.5 Cg_endo -54.55 131.71 47.13 Favored 'Trans proline' 0 C--O 1.249 1.073 0 C-N-CA 121.431 1.421 . . . . 75.349999999999994 111.582 178.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -143.02 132.69 5.15 Favored Glycine 0 N--CA 1.411 -2.975 0 N-CA-C 109.716 -1.354 . . . . 61.0 109.716 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.626 HG12 HG21 ' A' ' 234' ' ' VAL . 3.5 mp -105.17 138.85 28.21 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.438 0 CA-C-O 121.112 0.482 . . . . 74.129999999999995 109.92 -179.599 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -132.34 167.66 19.48 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 107.285 -1.376 . . . . 73.340000000000003 107.285 -176.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . 0.401 ' CG2' ' HA ' ' A' ' 214' ' ' VAL . 50.2 mm -75.54 131.69 34.52 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 N-CA-C 108.452 -0.944 . . . . 75.019999999999996 108.452 173.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . 0.593 ' HB2' ' HB3' ' A' ' 177' ' ' ARG . 21.0 t -108.31 -25.24 11.12 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.792 -0.568 . . . . 54.109999999999999 111.926 178.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.414 ' HB3' ' HB2' ' A' ' 175' ' ' TYR . 68.7 ttt180 -154.05 142.35 20.53 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 109.266 -0.642 . . . . 62.43 109.266 179.326 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 50.5 tp -125.32 133.02 52.76 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 108.629 -0.878 . . . . 70.230000000000004 108.629 178.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 62.1 t -110.37 121.14 42.28 Favored Pre-proline 0 C--O 1.248 1.007 0 CA-C-N 116.766 -0.197 . . . . 61.509999999999998 110.766 -177.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.525 ' HA ' ' HG2' ' A' ' 207' ' ' GLU . 28.7 Cg_exo -62.43 131.75 35.32 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 122.229 1.953 . . . . 71.340000000000003 110.065 175.341 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 106.17 -17.82 40.27 Favored Glycine 0 N--CA 1.434 -1.485 0 N-CA-C 110.2 -1.16 . . . . 52.299999999999997 110.2 -175.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . 0.529 ' HA3' ' HA3' ' A' ' 173' ' ' GLY . . . -83.87 161.24 38.01 Favored Glycine 0 N--CA 1.428 -1.894 0 N-CA-C 110.329 -1.108 . . . . 71.140000000000001 110.329 176.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.426 ' O ' HG22 ' A' ' 209' ' ' THR . 3.1 mm? -58.9 -37.66 77.11 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 123.288 0.635 . . . . 74.310000000000002 111.599 -177.398 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -62.08 -47.28 85.35 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 116.071 -0.513 . . . . 73.430000000000007 112.112 -179.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.525 ' HG2' ' HA ' ' A' ' 202' ' ' PRO . 9.7 tp10 -75.28 -33.22 61.21 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.454 -0.573 . . . . 74.439999999999998 109.454 178.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 38.6 t -57.76 -48.17 80.41 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 116.059 -0.519 . . . . 42.420000000000002 110.208 177.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . 0.426 HG22 ' O ' ' A' ' 205' ' ' LEU . 9.1 t -73.54 -40.42 63.99 Favored 'General case' 0 N--CA 1.437 -1.089 0 C-N-CA 120.098 -0.641 . . . . 63.229999999999997 110.201 176.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 83.35 -9.19 61.99 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.78 -0.724 . . . . 61.130000000000003 111.908 178.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 59.7 mt -77.75 -9.82 59.22 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.315 0.578 . . . . 74.340000000000003 110.013 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.453 HD11 HD11 ' A' ' 163' ' ' LEU . 79.6 mt -109.4 132.95 53.65 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 108.396 -0.964 . . . . 74.349999999999994 108.396 173.021 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -131.44 166.06 22.15 Favored 'General case' 0 N--CA 1.421 -1.914 0 N-CA-C 109.048 -0.723 . . . . 72.400000000000006 109.048 178.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . 0.401 ' HA ' ' CG2' ' A' ' 197' ' ' ILE . 28.4 m -64.01 -30.29 49.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 115.193 1.553 . . . . 63.409999999999997 115.193 -175.251 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -82.26 -13.24 57.34 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 113.798 1.036 . . . . 63.509999999999998 113.798 -179.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -59.54 141.74 54.17 Favored 'General case' 0 C--O 1.245 0.833 0 N-CA-C 114.578 1.325 . . . . 73.109999999999999 114.578 -176.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -106.75 131.44 53.87 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 125.91 1.684 . . . . 73.019999999999996 109.008 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.576 ' HA ' HG12 ' A' ' 249' ' ' VAL . 7.2 p -85.48 136.83 21.98 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-O 121.668 0.747 . . . . 63.43 112.554 -174.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.518 HD11 ' CD ' ' A' ' 250' ' ' LYS . 39.8 mm -103.37 -52.36 8.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.087 -0.961 . . . . 65.439999999999998 111.35 -179.044 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.424 ' HB3' ' HA ' ' A' ' 225' ' ' GLU . 9.3 pt-20 -155.83 154.62 31.6 Favored 'General case' 0 C--O 1.248 0.988 0 CA-C-N 116.465 -0.334 . . . . 75.140000000000001 111.219 -177.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.497 HG12 ' CG1' ' A' ' 226' ' ' VAL . 10.5 p -129.57 121.01 51.96 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.197 0 CA-C-O 121.438 0.637 . . . . 73.420000000000002 110.67 176.6 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . 0.416 ' HA ' ' HB ' ' A' ' 246' ' ' ILE . 11.6 t-20 66.99 12.99 9.3 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 125.256 1.422 . . . . 74.310000000000002 111.599 175.312 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 112.69 -18.19 22.53 Favored Glycine 0 N--CA 1.437 -1.255 0 C-N-CA 120.729 -0.748 . . . . 45.340000000000003 111.726 -179.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 62.9 mt -92.55 124.87 45.15 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.501 0 N-CA-C 108.601 -0.889 . . . . 74.329999999999998 108.601 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . 0.424 ' HA ' ' HB3' ' A' ' 220' ' ' GLU . 12.6 pt-20 -65.41 137.86 57.75 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-O 121.237 0.541 . . . . 74.519999999999996 110.372 179.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . 0.497 ' CG1' HG12 ' A' ' 221' ' ' VAL . 28.6 m -115.28 0.48 8.66 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 CA-C-O 121.595 0.712 . . . . 71.430000000000007 110.543 178.124 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -84.11 97.55 9.4 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-N 115.442 -0.799 . . . . 73.340000000000003 109.459 179.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 123.0 -17.9 8.02 Favored Glycine 0 C--N 1.313 -0.738 0 N-CA-C 110.704 -0.958 . . . . 54.219999999999999 110.704 -178.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -77.91 173.01 12.61 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 109.159 -0.682 . . . . 61.409999999999997 109.159 176.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . 0.519 ' O ' HG13 ' A' ' 234' ' ' VAL . 74.7 p -94.21 163.73 13.33 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 108.312 -0.996 . . . . 62.409999999999997 108.312 178.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.586 ' HB2' ' HB2' ' A' ' 178' ' ' ASP . 3.4 tm? -60.07 -38.67 83.57 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 109.778 -0.453 . . . . 73.329999999999998 109.778 178.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -62.52 -43.16 99.49 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.153 -0.476 . . . . 74.140000000000001 110.246 178.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -63.31 -48.59 77.42 Favored 'General case' 0 C--N 1.344 0.337 0 N-CA-C 113.113 0.783 . . . . 72.340000000000003 113.113 176.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.626 HG21 HG12 ' A' ' 195' ' ' ILE . 6.6 m -65.82 -33.59 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-O 121.272 0.558 . . . . 72.450000000000003 112.321 -174.607 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 60.2 m -74.08 -36.82 64.31 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.875 -0.787 . . . . 60.450000000000003 108.875 -175.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -61.09 -34.67 75.31 Favored 'General case' 0 CA--C 1.5 -0.948 0 CA-C-N 115.091 -0.959 . . . . 65.409999999999997 109.392 177.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 237' ' ' MET . . . . . 0.431 ' HG3' ' HA ' ' A' ' 234' ' ' VAL . 12.9 mtt -69.14 -46.91 66.46 Favored 'General case' 0 C--O 1.204 -1.321 0 N-CA-C 108.48 -0.933 . . . . 72.530000000000001 108.48 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 238' ' ' MET . . . . . 0.454 ' HA ' HD21 ' A' ' 245' ' ' LEU . 62.1 mtt -61.33 -42.17 98.24 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.986 -0.552 . . . . 72.0 111.654 -176.69 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 87.5 t -64.2 -40.4 88.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 O-C-N 123.328 0.392 . . . . 74.430000000000007 110.458 178.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -69.6 -38.01 77.12 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.444 0.64 . . . . 71.430000000000007 110.365 178.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -85.6 21.4 1.83 Allowed 'General case' 0 C--O 1.202 -1.409 0 CA-C-N 115.522 -0.763 . . . . 51.420000000000002 112.076 -179.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . 0.736 ' O ' ' HG ' ' A' ' 164' ' ' LEU . 29.4 p -64.75 -21.33 66.74 Favored 'General case' 0 C--O 1.208 -1.108 0 N-CA-C 109.619 -0.512 . . . . 71.329999999999998 109.619 172.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 47.4 t -62.76 -35.52 80.09 Favored 'General case' 0 CA--C 1.551 1.016 0 N-CA-C 108.85 -0.796 . . . . 43.509999999999998 108.85 173.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -177.14 106.87 0.06 Allowed 'General case' 0 C--O 1.246 0.902 0 C-N-CA 124.08 0.952 . . . . 64.010000000000005 111.277 177.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.619 ' HB2' ' HB2' ' A' ' 163' ' ' LEU . 11.8 mt -86.67 129.52 34.84 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 115.364 -0.835 . . . . 74.230000000000004 111.025 179.481 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.416 ' HB ' ' HA ' ' A' ' 222' ' ' ASN . 66.3 mt -118.62 113.72 42.66 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.618 0 N-CA-C 105.044 -2.206 . . . . 73.25 105.044 167.381 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 64.3 mt -122.22 135.52 62.05 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.257 0 CA-C-O 121.313 0.578 . . . . 72.129999999999995 111.699 -176.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.479 ' HA ' ' O ' ' A' ' 159' ' ' ARG . 58.3 m -112.14 118.29 34.94 Favored 'General case' 0 N--CA 1.416 -2.154 0 N-CA-C 108.251 -1.018 . . . . 75.329999999999998 108.251 175.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.576 HG12 ' HA ' ' A' ' 218' ' ' VAL . 17.7 m -121.22 170.51 11.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 CA-C-O 121.436 0.636 . . . . 65.319999999999993 110.469 176.278 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.518 ' CD ' HD11 ' A' ' 219' ' ' ILE 0.336 43.0 mtpt -126.69 144.15 48.89 Favored Pre-proline 0 C--N 1.28 -2.435 0 CA-C-N 113.965 -1.471 . . . . 72.439999999999998 107.44 174.165 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -74.98 141.71 27.02 Favored 'Trans proline' 0 N--CA 1.424 -2.597 0 N-CA-C 108.035 -1.563 . . . . 71.439999999999998 108.035 167.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -53.08 -54.66 32.23 Favored 'General case' 0 CA--C 1.495 -1.135 0 CA-C-O 121.868 0.842 . . . . 61.420000000000002 108.99 178.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 37.7 t30 -91.09 81.61 5.59 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 106.375 -1.713 . . . . 71.319999999999993 106.375 172.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -74.3 151.98 39.73 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 115.192 -0.913 . . . . 64.439999999999998 113.039 -175.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? . . . . . 0 N--CA 1.416 -2.156 0 N-CA-C 105.329 -2.1 . . . . 73.25 105.329 176.012 . . . . . . . . 0 0 . 1 stop_ save_